PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pluzhnikov, A; Nolan, DK; Tan, Z; McPeek, MS; Ober, C				Pluzhnikov, Anna; Nolan, Daniel K.; Tan, Zhiqiang; McPeek, Mary Sara; Ober, Carole			Correlation of intergenerational family sizes suggests a genetic component of reproductive fitness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX TRAITS; HERITABILITY; TRANSMISSION; FERTILITY	Reproductive fitness is a complex phenotype that is a direct measure of Darwinian selection. Estimation of the genetic contribution to this phenotype in human populations is confounded by within-family correlations of sociocultural, economic, and other nongenetic factors that influence family sizes. Here, we report an intergenerational correlation in reproductive success in the Hutterites, a human population that is relatively homogeneous with respect to sociocultural factors that influence fertility. We introduce an estimator of this correlation that takes into account the presence of multiple parent-offspring pairs from the same nuclear family. Statistical significance of the estimated correlation is assessed by a permutation test that maintains the overall structure of the pedigree. Further, temporal trends in fertility within this population are accounted for. Applying these methods to the S- Leut Hutterites yields a correlation in effective family size of 0.29 between couples and their sons and 0.18 between couples and their daughters, with empirical P < 1 x and, respectively. Similar results were obtained for completed families (0.31 between couples and their 10(-6) and P = .0041 sons and 0.23 between couples and their daughters; empirical and, respectively). We interpret 56 P < 1 x 10(-6) P = .00059 these results as indicating a significant genetic component to reproductive fitness in the Hutterites.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 507C, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu	Tan, Zhiqiang/E-8470-2010; tan, zhiqiang/A-4109-2008	Nolan, Daniel/0000-0003-3584-6148; Ober, Carole/0000-0003-4626-9809	NHGRI NIH HHS [R01 HG001645, HG1645, R29 HG001645] Funding Source: Medline; NICHD NIH HHS [HD21244, R01 HD021244] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001645, R29HG001645] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Austerlitz F, 1998, P NATL ACAD SCI USA, V95, P15140, DOI 10.1073/pnas.95.25.15140; Blum MGB, 2006, PLOS GENET, V2, P1138, DOI 10.1371/journal.pgen.0020122; Helgason A, 2003, AM J HUM GENET, V72, P1370, DOI 10.1086/375453; Hostetler J, 1974, HUTTERITE SOC; IMAIZUMI Y, 1970, ANN HUM GENET, V33, P251, DOI 10.1111/j.1469-1809.1970.tb01650.x; Layman LC, 2002, J MED GENET, V39, P153, DOI 10.1136/jmg.39.3.153; Madrigal L, 2003, AM J HUM BIOL, V15, P16, DOI 10.1002/ajhb.10109; MANGE AP, 1964, HUM BIOL, V36, P104; MARGULIS SW, 1996, EFFECTS INBREEDING P; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; McElreavey K, 2006, INT J ANDROL, V29, P298, DOI 10.1111/j.1365-2605.2005.00637.x; NEEL JV, 1970, SCIENCE, V170, P815, DOI 10.1126/science.170.3960.815; Newman DL, 2004, EUR J HUM GENET, V12, P584, DOI 10.1038/sj.ejhg.5201191; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Ober C, 1999, LANCET, V354, P365, DOI 10.1016/S0140-6736(98)12055-X; Ober C, 1998, HUM REPROD, V13, P33, DOI 10.1093/humrep/13.1.33; Ober C, 1999, AM J HUM GENET, V64, P225, DOI 10.1086/302198; Ober C, 1998, CLIN EXP ALLERGY, V28, P101; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Pearson Karl L.A., 1899, PHILOS T R SOC LON A, V192, P257, DOI [10.1098/rsta.1899.0006, DOI 10.1098/RSTA.1899.0006]; SHEPS MC, 1965, POP STUD-J DEMOG, V19, P65, DOI 10.2307/2173165; St John JC, 2005, INT J ANDROL, V28, P65, DOI 10.1111/j.1365-2605.2005.00515.x; STEINBERG ARTHUR G., 1967, P267; Torgerson DG, 2005, J MOL EVOL, V61, P650, DOI 10.1007/s00239-005-0007-5; Weisberg S., 1985, APPL LINEAR REGRESSI; Zollner S, 2004, AM J HUM GENET, V74, P62, DOI 10.1086/381131	26	27	27	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					165	169		10.1086/518446	http://dx.doi.org/10.1086/518446			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564973	Green Published, Bronze			2022-12-18	WOS:000247039700015
J	Sanna-Cherchi, S; Caridi, G; Weng, PL; Dagnino, M; Seri, M; Konka, A; Somenzi, D; Carrea, A; Izzi, C; Casu, D; Allegri, L; Schmidt-Ott, KM; Barasch, J; Scolari, F; Ravazzolo, R; Ghiggeri, GM; Gharavi, AG				Sanna-Cherchi, Simone; Caridi, Gianluca; Weng, Patricia L.; Dagnino, Monica; Seri, Marco; Konka, Anita; Somenzi, Danio; Carrea, Alba; Izzi, Claudia; Casu, Domenica; Allegri, Landino; Schmidt-Ott, Kai M.; Barasch, Jonathan; Scolari, Francesco; Ravazzolo, Roberto; Ghiggeri, Gian Marco; Gharavi, Ali G.			Localization of a gene for nonsyndromic renal hypodysplasia to chromosome 1p32-33	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KIDNEY DEVELOPMENT; VESICOURETERAL REFLUX; GLOMERULAR NUMBER; LINKAGE ANALYSIS; UROPLAKIN-IIIA; NULL MUTATION; BIRTH-WEIGHT; HYPERTENSION; AGENESIS; MOUSE	Nonsyndromic defects in the urinary tract are the most common cause of end-stage renal failure in children and account for a significant proportion of adult nephropathy. The genetic basis of these disorders is not fully understood. We studied seven multiplex kindreds ascertained via an index case with a nonsyndromic solitary kidney or renal hypodysplasia. Systematic ultrasonographic screening revealed that many family members harbor malformations, such as solitary kidneys, hypodysplasia, or ureteric abnormalities ( in a total of 29 affected individuals). A genomewide scan identified significant linkage to a 6.9-Mb segment on chromosome 1p32-33 under an autosomal dominant model with reduced penetrance (peak LOD score 3.5 at D1S2652 in the largest kindred). Altogether, three of the seven families showed positive LOD scores at this interval, demonstrating heterogeneity of the trait ( peak HLOD 3.9, with 45% of families linked). The chromosome 1p32-33 interval contains 52 transcription units, and at least 23 of these are expressed at stage E12.5 in the murine ureteric bud and/or metanephric mesenchyme. These data show that autosomal dominant nonsyndromic renal hypodysplasia and associated urinary tract malformations are genetically heterogeneous and identify a locus for this common cause of human kidney failure.	Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10032 USA; Mt Sinai Sch Med, Div Nephrol, Dept Pediat, New York, NY USA; Univ Parma, Dept Clin Med Nephrol & Hlth Sci, I-43100 Parma, Italy; G Gaslini Inst Children, Lab Pathophysiol Uremia, Genoa, Italy; G Gaslini Inst Children, Mol Genet Lab, Genoa, Italy; Univ Brescia, Div & Chair Nephrol, Spedali Civili, Brescia, Italy; Hosp Alghero, Div Nephrol & Dialysis, Alghero, Italy	Columbia University; Icahn School of Medicine at Mount Sinai; University of Parma; University of Genoa; IRCCS Istituto Giannina Gaslini; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Brescia	Gharavi, AG (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, 630 W 168th Sty,P&S 10-432, New York, NY 10032 USA.	ag2239@columbia.edu	Schmidt-Ott, Kai/F-4588-2011; scolari, francesco/AAC-5957-2022; Ghiggeri, Gian Marco/N-4712-2015; Izzi, Claudia/AAB-7004-2022; Caridi, Gianluca/F-7052-2010; Izzi, Claudia/GZG-8769-2022; Seri, Marco/A-4339-2014	Schmidt-Ott, Kai/0000-0002-7700-7142; Ghiggeri, Gian Marco/0000-0003-3659-9062; Caridi, Gianluca/0000-0001-6700-3001; Seri, Marco/0000-0003-2425-2176; Izzi, Claudia/0000-0001-6253-3185; Scolari, Francesco/0000-0003-0233-9705	Telethon [E.1124] Funding Source: Medline	Telethon(Fondazione Telethon)		Angius A, 2002, HUM GENET, V111, P9, DOI 10.1007/s00439-002-0753-z; Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; CARTER CO, 1979, J MED GENET, V16, P176, DOI 10.1136/jmg.16.3.176; Caruana G, 2006, GENE EXPR PATTERNS, V6, P807, DOI 10.1016/j.modgep.2006.02.001; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DINKEL E, 1985, PEDIATR RADIOL, V15, P38, DOI 10.1007/BF02387851; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; Feather SA, 2000, AM J HUM GENET, V66, P1420, DOI 10.1086/302864; Gianfrancesco F, 2003, AM J HUM GENET, V72, P1479, DOI 10.1086/375628; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HAN BK, 1985, AM J ROENTGENOL, V145, P611, DOI 10.2214/ajr.145.3.611; HELIN I, 1986, PEDIATRICS, V78, P879; Hiraoka M, 2002, KIDNEY INT, V61, P1840, DOI 10.1046/j.1523-1755.2002.00322.x; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Jenkins D, 2005, J AM SOC NEPHROL, V16, P2141, DOI 10.1681/ASN.2004090776; Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Kume T, 2000, MOL CELL BIOL, V20, P1419, DOI 10.1128/MCB.20.4.1419-1425.2000; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; MCPHERSON E, 1987, AM J MED GENET, V26, P863, DOI 10.1002/ajmg.1320260413; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Parikh CR, 2002, AM J KIDNEY DIS, V39, P689, DOI 10.1053/ajkd.2002.31982; Pasch A, 2004, NEPHROL DIAL TRANSPL, V19, P3172, DOI 10.1093/ndt/gfh514; ROODHOOFT M, 1984, NEW ENGL J MED, V310, P1341, DOI 10.1056/NEJM198405243102101; Sanna-Cherchi S, 2005, J AM SOC NEPHROL, V16, P1781, DOI 10.1681/ASN.2004121034; Schmidt-Ott KM, 2006, NEPHRON PHYSIOL, V104, P56, DOI 10.1159/000093287; Schmidt-Ott KM, 2005, J AM SOC NEPHROL, V16, P1993, DOI 10.1681/ASN.2004121127; Schonfelder EM, 2006, AM J KIDNEY DIS, V47, P1004, DOI 10.1053/j.ajkd.2006.02.177; Sobel E, 1996, AM J HUM GENET, V58, P1323; STROUP NE, 1990, TERATOLOGY, V42, P383, DOI 10.1002/tera.1420420407; Torres M, 1995, DEVELOPMENT, V121, P4057; Tsujikawa M, 1999, NAT GENET, V21, P420, DOI 10.1038/7759; Ulinski T, 2006, J AM SOC NEPHROL, V17, P497, DOI 10.1681/ASN.2005101040; United States Renal Data System, 2005, 2005 ANN DAT REP ATL; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Vize P.D., 2003, KIDNEY NORMAL DEV CO; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Woolf AS, 2004, J AM SOC NEPHROL, V15, P998, DOI 10.1097/01.ASN.0000113778.06598.6F; Yu J, 2004, CURR OPIN GENET DEV, V14, P550, DOI 10.1016/j.gde.2004.07.009	50	27	31	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					539	549		10.1086/512248	http://dx.doi.org/10.1086/512248			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273976	Green Published, Bronze			2022-12-18	WOS:000244403300016
J	Naveed, M; Nath, SK; Gaines, M; Al-Ali, MT; Al-Khaja, N; Hutchings, D; Golla, J; Deutsch, S; Bottani, A; Antonarakis, SE; Ratnamala, U; Radhakrishna, U				Naveed, Mohammed; Nath, Swapan K.; Gaines, Mathew; Al-Ali, Mahmoud T.; Al-Khaja, Najib; Hutchings, David; Golla, Jeffrey; Deutsch, Samuel; Bottani, Armand; Antonarakis, Stylianos E.; Ratnamala, Uppala; Radhakrishna, Uppala			Genomewide linkage scan for split-hand/foot malformation with long-bone deficiency in a large Arab family identifies two novel susceptibility loci on chromosomes 1q42.2-q43 and 6q14.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TIBIAL HEMIMELIA; FOOT MALFORMATION; TANDEM DUPLICATION; LOWER-LIMBS; HAND; APLASIA; DOMINANT; DISEQUILIBRIUM; AGENESIS; ABSENCE	Split-hand/ foot malformation with long-bone deficiency (SHFLD) is a rare, severe limb deformity characterized by tibia aplasia with or without split-hand/split-foot deformity. Identification of genetic susceptibility loci for SHFLD has been unsuccessful because of its rare incidence, variable phenotypic expression and associated anomalies, and uncertain inheritance pattern. SHFLD is usually inherited as an autosomal dominant trait with reduced penetrance, although recessive inheritance has also been postulated. We conducted a genomewide linkage analysis, using a 10K SNP array in a large consanguineous family (UR078) from the United Arab Emirates (UAE) who had disease transmission consistent with an autosomal dominant inheritance pattern. The study identified two novel SHFLD susceptibility loci at 1q42.2q43 (nonparametric linkage [NPL] 9.8, P = .000065 and 6q14.1 (NPL 7.12, P = .000897). These results were also supported by multipoint parametric linkage analysis. Maximum multipoint LOD scores of 3.20 and 3.78 were detected for genomic locations 1q42.2- 43 and 6q14.1, respectively, with the use of an autosomal dominant mode of inheritance with reduced penetrance. Haplotype analysis with informative crossovers enabled mapping of the SHFLD loci to a region of similar to 18.38 cM (8.4 Mb) between single-nucleotide polymorphisms rs1124110 and rs535043 on 1q42.2-q43 and to a region of similar to 1.96 cM (4.1 Mb) between rs623155 and rs1547251 on 6q14.1. The study identified two novel loci for the SHFLD phenotype in this UAE family.	Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; CAGS, Dubai, U Arab Emirates; Oklahoma Med Res Fdn, Arthrit & Immunol Res Program, Oklahoma City, OK 73104 USA; Green Cross Blood Bank, Ahmadabad, Gujarat, India; Genet Res Ctr, Ahmadabad, Gujarat, India; Geneva Univ Hosp, Div Med Genet, Geneva, Switzerland	University of Geneva; Oklahoma Medical Research Foundation; University of Geneva	Radhakrishna, U (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	radhakrishna.uppala@medecine.unige.ch	Antonarakis, Stylianos E/N-8866-2014; Naveed, Mohammed/S-3462-2019	Antonarakis, Stylianos E/0000-0001-8907-5823; Deutsch, Samuel/0000-0001-9456-7101; Naveed, Mohammed/0000-0002-0351-0693				Abdulrazzaq YM, 1997, CLIN GENET, V51, P167; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; AHMAD M, 1987, HUM GENET, V75, P169, DOI 10.1007/BF00591081; Al Kaissi A, 2002, CLIN DYSMORPHOL, V11, P175, DOI 10.1097/00019605-200207000-00004; BOHRING A, 2005, EUR J HUM GENET, V13, pP1369; CANUN S, 1984, CLIN GENET, V25, P182; CLARK BJ, 1994, J PEDIATR OPHTHALMOL, V31, P41; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; de Mollerat XJ, 2003, HUM MOL GENET, V12, P1959, DOI 10.1093/hmg/ddg212; DERKALOUSTIAN VM, 1973, ACTA PAEDIATR SCAND, V62, P77; Evans JA, 2002, CLIN DYSMORPHOL, V11, P163, DOI 10.1097/00019605-200207000-00002; Fernandez-Palazzi F, 1998, J PEDIATR ORTHOP B, V7, P298, DOI 10.1097/01202412-199810000-00008; FLATZ S, 1979, CLIN GENET, V15, P541; HOYME HE, 1987, J PEDIATR-US, V111, P538, DOI 10.1016/S0022-3476(87)80114-2; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; Ianakiev P, 2000, AM J HUM GENET, V67, P59, DOI 10.1086/302972; JONES D, 1978, J BONE JOINT SURG BR, V60, P31, DOI 10.1302/0301-620X.60B1.627576; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; KOHN G, 1989, AM J MED GENET, V33, P172, DOI 10.1002/ajmg.1320330206; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Majewski F, 1996, AM J MED GENET, V63, P185; MAJEWSKI F, 1985, HUM GENET, V70, P136, DOI 10.1007/BF00273072; Managoli SS, 2005, INDIAN PEDIATR, V42, P190; MARINONI JC, 1994, HUM MOL GENET, V3, P1355, DOI 10.1093/hmg/3.8.1355; Matsuyama J, 2003, J HUM GENET, V48, P173, DOI 10.1007/s10038-003-0003-9; MCKAY M, 1984, AM J MED GENET, V17, P603, DOI 10.1002/ajmg.1320170308; Naveed M, 2006, AM J MED GENET A, V140A, P1440, DOI 10.1002/ajmg.a.31239; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; PARE A, 1575, OEUVRES MA PARE, pCH7; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; PRATT AD, 1971, AM J DIS CHILD, V122, P452, DOI 10.1001/archpedi.1971.02110050122021; RICHIERICOSTA A, 1987, AM J MED GENET, V27, P867, DOI 10.1002/ajmg.1320270414; RICHIERICOSTA A, 1987, AM J MED GENET, V28, P325, DOI 10.1002/ajmg.1320280209; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; SCHECHTMAN M, 1994, PHILOS PSYCHOL, V7, P3, DOI 10.1080/09515089408573107; SENER RN, 1990, PEDIATR RADIOL, V21, P57, DOI 10.1007/BF02010817; SENER RN, 1989, PEDIATR RADIOL, V19, P258, DOI 10.1007/BF02386848; Shenoy Rathika, 2004, Indian J Pediatr, V71, P948; STEFFENSEN DM, 1977, HUM GENET, V36, P25, DOI 10.1007/BF00390432; Steinkampf MP, 2003, FERTIL STERIL, V80, P643, DOI 10.1016/S0015-0282(03)00758-1; van Bever Y, 2005, AM J MED GENET A, V135A, P91, DOI 10.1002/ajmg.a.30695; Witters I, 2001, AM J MED GENET, V104, P209, DOI 10.1002/ajmg.10056.abs; ZLOTOGORA J, 1995, AM J HUM GENET, V56, P341; ZLOTOGORA J, 1994, AM J MED GENET, V53, P29, DOI 10.1002/ajmg.1320530107; ZLOTOGORA J, 1989, J MED GENET, V26, P138, DOI 10.1136/jmg.26.2.138	45	27	27	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					105	111		10.1086/510724	http://dx.doi.org/10.1086/510724			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160898	Green Published, Bronze			2022-12-18	WOS:000243102500010
J	Morris, AP				Morris, Andrew P.			A flexible Bayesian framework for modeling haplotype association with disease, allowing for dominance effects of the underlying causative variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; CLADISTIC-ANALYSIS; GENOTYPE DATA; PHENOTYPIC ASSOCIATIONS; UNRELATED INDIVIDUALS; POPULATION; GENE; RECONSTRUCTION; FREQUENCIES; SAMPLES	Multilocus analysis of single-nucleotide-polymorphism (SNP) haplotypes may provide evidence of association with disease, even when the individual loci themselves do not. Haplotype-based methods are expected to outperform single-SNP analyses because (i) common genetic variation can be structured into haplotypes within blocks of strong linkage disequilibrium and (ii) the functional properties of a protein are determined by the linear sequence of amino acids corresponding to DNA variation on a haplotype. Here, I propose a flexible Bayesian framework for modeling haplotype association with disease in population-based studies of candidate genes or small candidate regions. I employ a Bayesian partition model to describe the correlation between marker-SNP haplotypes and causal variants at the underlying functional polymorphism(s). Under this model, haplotypes are clustered according to their similarity, in terms of marker-SNP allele matches, which is used as a proxy for recent shared ancestry. Haplotypes within a cluster are then assigned the same probability of carrying a causal variant at the functional polymorphism(s). In this way, I can account for the dominance effect of causal variants, here corresponding to any deviation from a multiplicative contribution to disease risk. The results of a detailed simulation study demonstrate that there is minimal cost associated with modeling these dominance effects, with substantial gains in power over haplotype-based methods that do not incorporate clustering and that assume a multiplicative model of disease risks.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Morris, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	amorris@well.ox.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Farrall M, 2005, HUM MOL GENET, V14, pR157, DOI 10.1093/hmg/ddi273; Gammerman D., 1997, MARKOV CHAIN MONTE C; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Griffiths R., 1997, PROGR POPULATION GEN, P257; Hartigan J.A., 1975, CLUSTERING ALGORITHM; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Hosking L. K., 2002, Pharmacogenomics Journal, V2, P165, DOI 10.1038/sj.tpj.6500096; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; *INT HAP CONS, 2002, NATURE, V437, P1299; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lin DY, 2005, GENET EPIDEMIOL, V29, P299, DOI 10.1002/gepi.20098; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Molitor J, 2003, AM J HUM GENET, V73, P1368, DOI 10.1086/380415; Molitor J, 2003, GENET EPIDEMIOL, V25, P95, DOI 10.1002/gepi.10251; Morris AP, 2005, GENET EPIDEMIOL, V29, P91, DOI 10.1002/gepi.20080; Morris AP, 2003, P NATL ACAD SCI USA, V100, P13442, DOI 10.1073/pnas.2235031100; Nordborg M., 2001, HDB STAT GENETICS, P179; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachse C, 1997, AM J HUM GENET, V60, P284; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; TEMPLETON AR, 1987, GENETICS, V117, P343; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, 1993, GENETICS, V134, P659; TEMPLETON AR, 1988, GENETICS, V120, P1145; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Waldron ERB, 2006, GENET EPIDEMIOL, V30, P170, DOI 10.1002/gepi.20134; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	42	27	27	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					679	694		10.1086/508264	http://dx.doi.org/10.1086/508264			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960804	Green Published, Bronze			2022-12-18	WOS:000240855900009
J	Palmer, CGS; Hsieh, HJ; Reed, EF; Lonnqvist, J; Peltonen, L; Woodward, JA; Sinsheimer, JS				Palmer, Christina G. S.; Hsieh, Hsin-Ju; Reed, Elaine F.; Lonnqvist, Jouko; Peltonen, Leena; Woodward, J. Arthur; Sinsheimer, Janet S.			HLA-B maternal-fetal genotype matching increases risk of schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SCAN; OBSTETRIC COMPLICATIONS; NEURODEVELOPMENTAL HYPOTHESIS; HIPPOCAMPAL VOLUME; BIRTH-WEIGHT; GENETIC RISK; MFG TEST; INCOMPATIBILITY; PREGNANCY; ASSOCIATION	Schizophrenia and human leukocyte antigen (HLA) matching between couples or between mothers and offspring have independently been associated with prenatal/obstetric complications, including preeclampsia and low birth weight. Here, we report the results of a family-based candidate-gene study that brings together these two disparate lines of research by assessing maternal-fetal genotype matching at HLA-A, -B, and -DRB1 as a risk factor of schizophrenia. We used a conditional-likelihood modeling approach with a sample of 274 families that had at least one offspring with schizophrenia or a related spectrum disorder. A statistically significant HLA-B maternal-fetal genotype-matching effect on schizophrenia was demonstrated for female offspring (P = .01; parameter estimate 1.7 [95% confidence interval 1.22-2.49]). Because the matching effect could be associated with pregnancy complications rather than with schizophrenia per se, these findings are consistent with the neurodevelopmental hypothesis of schizophrenia and with accumulating evidence that the prenatal period is involved in the origins of this disease. Our approach demonstrates how genetic markers can be used to characterize the biology of prenatal risk factors of schizophrenia.	Univ Calif Los Angeles, Semel Inst Neurosci & Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90095 USA; Univ Helsinki, Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Univ Helsinki, Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA USA; MIT, Broad Inst, Boston, MA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of California System; University of California Merced; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Palmer, CGS (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Behav, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza,Room 47-422, Los Angeles, CA 90095 USA.	cpalmer@mednet.ucla.edu			NIGMS NIH HHS [R01 GM053275, GM53275] Funding Source: Medline; NIMH NIH HHS [R21 MH066001, MH066001] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066001] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AM PSYCH ASS, 1994, DIAGN STAT MAN; Beydoun H, 2005, TISSUE ANTIGENS, V65, P123, DOI 10.1111/j.1399-0039.2005.00367.x; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOLIS PF, 1987, BIOL RES PREG PERIN, V8, P42; Brunori ID, 2000, HUM REPROD, V15, P1807, DOI 10.1093/humrep/15.8.1807; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; COWAN LD, 1994, J CHILD NEUROL, V9, P173, DOI 10.1177/088307389400900214; Dalman C, 1999, ARCH GEN PSYCHIAT, V56, P234, DOI 10.1001/archpsyc.56.3.234; Ekelund J, 2001, HUM MOL GENET, V10, P1611, DOI 10.1093/hmg/10.15.1611; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; ERGUSON TS, 1996, COURSE LARGE SAMPLE; FUJISAWA S, 1985, Acta Obstetrica et Gynaecologica Japonica (Japanese Edition), V37, P124; GUYTON AC, 1981, TXB MED PHYSL, P86; HISEH HJ, 2005, THESIS U CALIFORNIA; Hollister JM, 1996, ARCH GEN PSYCHIAT, V53, P19; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Hsieh HJ, 2006, GENET EPIDEMIOL, V30, P333, DOI 10.1002/gepi.20148; Insel BJ, 2005, SCHIZOPHR RES, V80, P331, DOI 10.1016/j.schres.2005.06.005; Kraft P, 2004, EUR J HUM GENET, V12, P192, DOI 10.1038/sj.ejhg.5201129; Lange K, 2001, AM J HUM GENET, V69, P504; Larizza D, 2002, J PEDIATR ENDOCR MET, V15, P1183; Lau M, 2005, HUM IMMUNOL, V66, pS29; Marenco S, 2000, DEV PSYCHOPATHOL, V12, P501, DOI 10.1017/S0954579400003138; McGrath JJ, 2003, ANN MED, V35, P86, DOI 10.1080/07853890310010005; McNeil TF, 2000, BRAIN RES REV, V31, P166, DOI 10.1016/S0165-0173(99)00034-X; Moises HW, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-8; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Muramoto J, 2004, HUM IMMUNOL, V65, pS80, DOI 10.1016/j.humimm.2004.07.151; OBER C, 1987, AM J REPROD IMMUNOL, V15, P141; Ober C, 1998, AM J HUM GENET, V62, P1, DOI 10.1086/301692; Ober C, 1998, HUM REPROD, V13, P33, DOI 10.1093/humrep/13.1.33; OBER CL, 1983, AM J HUM GENET, V35, P994; Palmer CGS, 2002, AM J HUM GENET, V71, P1312, DOI 10.1086/344659; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Preti A, 2005, EUR PSYCHIAT, V20, P354, DOI 10.1016/j.eurpsy.2005.03.008; REZNIKOFFETIEVANT MF, 1991, AM J REPROD IMMUNOL, V25, P25, DOI 10.1111/j.1600-0897.1991.tb01059.x; SCHNEIDER K, 1994, GYNECOL OBSTET INVES, V37, P87, DOI 10.1159/000292531; Schreuder GMT, 2001, EUR J IMMUNOGENET, V28, P565, DOI 10.1046/j.0960-7420.2001.00284.x; Sinsheimer JS, 2003, GENET EPIDEMIOL, V24, P1, DOI 10.1002/gepi.10211; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Stefanis N, 1999, BIOL PSYCHIAT, V46, P697, DOI 10.1016/S0006-3223(99)00089-X; STUBBS EG, 1985, J AM ACAD CHILD PSY, V24, P182, DOI 10.1016/S0002-7138(09)60445-3; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Umbach DH, 2000, AM J HUM GENET, V66, P251, DOI 10.1086/302707; UNANDER AM, 1983, AM J REPROD IMMUNOL, V4, P171, DOI 10.1111/j.1600-0897.1983.tb00273.x; van Erp TGM, 2002, AM J PSYCHIAT, V159, P1514, DOI 10.1176/appi.ajp.159.9.1514; Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006; VERP MS, 1993, AM J REPROD IMMUNOL, V29, P195, DOI 10.1111/j.1600-0897.1993.tb00586.x; Walshe M, 2005, EUR PSYCHIAT, V20, P28, DOI 10.1016/j.eurpsy.2004.07.007	49	27	27	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					710	715		10.1086/507829	http://dx.doi.org/10.1086/507829			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960807	Green Published, Bronze			2022-12-18	WOS:000240855900012
J	Epstein, CJ				Epstein, Charles J.			Medical genetics in the genomic medicine of the 21st century	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							HEALTH-CARE; FUTURE; IMPACT		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Epstein, CJ (corresponding author), Univ Calif San Francisco, Miss Bay,RH 584B,1550 4th St, San Francisco, CA 94143 USA.	charles.epstein@ucsf.edu						[Anonymous], 2004, AM HERITAGE STEDMANS; *DEP HLTH, 2001, SPEC SERV NAT DEF; Epstein CJ, 2005, GENET MED, V7, P375, DOI 10.1097/01.GIM.0000170771.50414.79; Epstein CJ, 2004, GENET MED, V6, P165, DOI 10.1097/01.GIM.0000132683.24854.44; GELEHRTER TD, 1990, PRINCIPLES MED GENET, pR5; Ginsburg GS, 2005, J AM COLL CARDIOL, V46, P1615, DOI 10.1016/j.jacc.2005.06.075; Guttmacher AE, 2001, AM J MED GENET, V106, P216, DOI 10.1002/ajmg.10008; *HARV MIT DIV HLT, 2004, 512513 HST; JORDE LB, 1999, MED GENETICS, P1; Khoury MJ, 2003, GENET MED, V5, P261, DOI 10.1097/01.GIM.0000076977.90682.A5; Korf BR, 2005, GENET MED, V7, P293, DOI 10.1097/01.GIM.0000164551.44846.F6; MOTULSKY AG, 1978, AM J HUM GENET, V30, P123; Qureshi N, 2005, AM FAM PHYSICIAN, V72, P386; *ROY SOC, 2005, PERS MED HOP REAL; Snyderman R, 2003, ACAD MED, V78, P1079, DOI 10.1097/00001888-200311000-00002; VOGEL F, 1997, HUMAN GENETICS PROBL, P19; Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693; *WIK, 2006, MED GEN; Willard HF, 2005, PHILOS T R SOC B, V360, P1543, DOI 10.1098/rstb.2005.1683; WILLARD HF, 2004, MESSAGE DIRECTORD	20	27	31	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					434	438		10.1086/507610	http://dx.doi.org/10.1086/507610			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909381	Bronze, Green Published			2022-12-18	WOS:000239830700005
J	Cordell, HJ				Cordell, HJ			Bias toward the null hypothesis in model-free linkage analysis is highly dependent on the test statistic used	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; QUANTITATIVE-TRAIT; HASEMAN-ELSTON; STRATEGIES; COMPONENTS	Recently, it has been suggested that traditional nonparametric multipoint-linkage procedures can show a "bias" toward the null hypothesis of no effect when there is incomplete information about allele sharing at genotyped marker loci (or at positions in between marker loci). Here, I investigate the extent of this bias for a variety of test statistics commonly used in qualitative- ("affecteds only") and quantitative-trait linkage analysis. Through simulation and analytical derivation, I show that many of the test statistics available in standard linkage analysis packages (such as Genehunter, Merlin, and Allegro) are, in fact, not affected by this bias problem. A few test statistics most notably the nonparametric linkage statistic and, to a lesser extent, the Aspex-MLS and Haseman-Elston statistics - are affected by the bias. Variance-components procedures, although unbiased, can show inflation or deflation of the test statistic attributable to the inclusion of pairs with incomplete identity-by-descent information. Results obtained - for instance, in genome scans - using these methods might therefore be worth revisiting to see if greater power can be obtained by use of an alternative statistic or by eliminating or downweighting uninformative relative pairs.	Univ Cambridge, Dept Med Genet, Juvenile Diabet Res Fdn Wellcome Trust Diabet & I, Cambridge Inst Med Res, Cambridge CB2 2XY, England	University of Cambridge	Cordell, HJ (corresponding author), Univ Cambridge, Dept Med Genet, Juvenile Diabet Res Fdn Wellcome Trust Diabet & I, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	heather.cordell@cimr.cam.ac.uk		Cordell, Heather/0000-0002-1879-5572				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Forrest WF, 2001, HUM HERED, V52, P47, DOI 10.1159/000053353; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Mukhopadhyay N, 2003, HUM HERED, V55, P191, DOI 10.1159/000073203; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; *SAGE, 2002, STAT AN GEN EP; Schork NJ, 2004, AM J HUM GENET, V74, P306, DOI 10.1086/381714; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Sham PC, 2001, AM J HUM GENET, V68, P1527, DOI 10.1086/320593; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Xu X, 2000, AM J HUM GENET, V67, P1025, DOI 10.1086/303081	23	27	27	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1294	1302		10.1086/421476	http://dx.doi.org/10.1086/421476			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15124101	Green Published, Bronze			2022-12-18	WOS:000221651900024
J	Yi, ZH; Garrison, N; Cohen-Barak, O; Karafet, TM; King, RA; Erickson, RP; Hammer, MF; Brilliant, MH				Yi, ZH; Garrison, N; Cohen-Barak, O; Karafet, TM; King, RA; Erickson, RP; Hammer, MF; Brilliant, MH			A 122.5-kilobase deletion of the P gene underlies the high prevalence of oculocutaneous albinism type 2 in the Navajo population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PINK-EYED DILUTION; STRAND BREAK REPAIR; ANGELMAN-SYNDROMES; LINE-1 ELEMENTS; ASHKENAZI JEWS; PRADER-WILLI; DNA; RECOMBINATION; MUTATIONS; BREAKPOINTS	Oculocutaneous albinism (OCA) is a genetically heterogeneous disorder. There are four known types of OCA: OCA1-OCA4. The clinical manifestations of all types of OCA include skin and hair hypopigmentation and visual impairment. Although there are a few documented observations of high frequency of albinism among Native Americans, including the Hopi, Zuni, Kuna, Jemez, Laguna, San Juan, and Navajo, no causative molecular defect has been previously reported. In the present study, we show that albinism in one Native American population, the Navajo, is caused by a LINE-mediated 122.5-kilobase deletion of the P gene, thus demonstrating that albinism in this population is OCA2. This deletion appears to be Navajo specific, because this allele was not detected in 34 other individuals with albinism who listed other Native American origins, nor has it been reported in any other ethnic group. The molecular characterization of this deletion allele allowed us to design a three-primer polymerase chain reaction system to estimate the carrier frequency in the Navajo population by screening 134 unrelated normally pigmented Navajos. The carrier frequency was found to be similar to4.5%. The estimated prevalence of OCA2 in Navajos is between similar to1 per 1,500 and 1 per 2,000. We further estimate that this mutation originated 400-1,000 years ago from a single founder.	Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ 85724 USA; Univ Arizona, Grad Interdisciplinary Program Genet, Tucson, AZ 85724 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85724 USA; Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	University of Arizona; University of Arizona; University of Arizona; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Brilliant, MH (corresponding author), Univ Arizona, Coll Med, Dept Pediat, Box 245073,1501 N Campbell Ave, Tucson, AZ 85724 USA.		Garrison, Nanibaa' A./AAT-4477-2020	Garrison, Nanibaa' A./0000-0002-6228-3216	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008718] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR4596] Funding Source: Medline; NIGMS NIH HHS [T34 GM008718, T34 GM08718] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACREY BP, 1982, 22 DEP CURR MAT DEV; Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; Boissy RE, 1996, AM J HUM GENET, V58, P1145; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Burwinkel B, 1998, J MOL BIOL, V277, P513, DOI 10.1006/jmbi.1998.1641; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Drechsler M, 1996, HUM GENET, V98, P297, DOI 10.1007/s004390050210; DURHAMPIERRE D, 1994, NAT GENET, V7, P176, DOI 10.1038/ng0694-176; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Erickson RP, 1999, GENET MED, V1, P151; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; Goldstein DB, 1999, AM J HUM GENET, V64, P1071, DOI 10.1086/302313; HEDRICK PW, IN PRESS AM J PHYS A; HENTHORN PS, 1990, GENOMICS, V6, P226, DOI 10.1016/0888-7543(90)90561-8; Huie ML, 2002, AM J HUM GENET, V70, P1054, DOI 10.1086/339691; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; King RA, 1998, PIGMENTARY SYSTEM PH, P553; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; LEHMAN CW, 1994, NUCLEIC ACIDS RES, V22, P434, DOI 10.1093/nar/22.3.434; Li CC., 1955, POPULATION GENETICS; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Pastink A, 2001, MUTAT RES-FUND MOL M, V480, P37, DOI 10.1016/S0027-5107(01)00167-1; Pfeiffer P, 1998, TOXICOL LETT, V96-7, P119, DOI 10.1016/S0378-4274(98)00058-7; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Puri N, 2000, J INVEST DERMATOL, V115, P607, DOI 10.1046/j.1523-1747.2000.00108.x; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; REICH DE, 1999, MICROSATELLITES EVOL, P129; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; Ringpfeil F, 2001, AM J HUM GENET, V68, P642, DOI 10.1086/318807; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Segal Y, 1999, AM J HUM GENET, V64, P62, DOI 10.1086/302213; SPUHLER J. N., 1953, HUMAN BIOL, V25, P295; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; Underhill R., 1956, NAVAJOS; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WILLIAMS J, 1992, TRAILS TEARS AM INDI, P101; WITKOP CJ, 1989, METABOLIC BASIS INHE, V2, P2905; WOOLF CM, 1965, AM J HUM GENET, V17, P23; WOOLF CM, 1969, SCIENCE, V164, P30, DOI 10.1126/science.164.3875.30; [No title captured]	47	27	30	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					62	72		10.1086/345380	http://dx.doi.org/10.1086/345380			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12469324	Green Published, Bronze			2022-12-18	WOS:000180186800006
J	Menasche, G; Fischer, A; Basile, GD				Menasche, G; Fischer, A; Basile, GD			Griscelli syndrome types 1 and 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DISEASE; MUTATIONS; 15Q21		Hop Necker Enfants Malad, INSERM, U429, Unite Rech Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France; Hop Necker Enfants Malad, Unite Immunohematol & Rhumatol Pediat, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Basile, GD (corresponding author), Hop Necker Enfants Malad, INSERM, U429, Unite Rech Dev Normal & Pathol Syst Immunitaire, 169 Rue Sevres, F-75015 Paris, France.	sbasile@necker.fr	menasche, gael/D-8280-2017; de Saint Basile, Genevieve/G-9731-2017	de Saint Basile, Genevieve/0000-0002-1913-5269; Menasche, Gael/0000-0001-6671-3642				Anikster Y, 2002, AM J HUM GENET, V71, P407, DOI 10.1086/341606; BASILE GD, 2001, CURR OPIN IMMUNOL, V13, P549; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Ivanovich J, 2001, AM J MED GENET, V98, P313, DOI 10.1002/1096-8628(20010201)98:4<313::AID-AJMG1098>3.0.CO;2-P; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Pastural E, 2000, GENOMICS, V63, P299, DOI 10.1006/geno.1999.6081; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Provance DW, 2002, TRAFFIC, V3, P124, DOI 10.1034/j.1600-0854.2002.030205.x; Sanal O, 2000, J NEUROL, V247, P570, DOI 10.1007/s004150070162; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4	11	27	29	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1237	1238		10.1086/344140	http://dx.doi.org/10.1086/344140			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12452176	Bronze, Green Published			2022-12-18	WOS:000178884300025
J	Hefferon, TW; Broackes-Carter, FC; Harris, A; Cutting, GR				Hefferon, TW; Broackes-Carter, FC; Harris, A; Cutting, GR			Atypical 5 ' splice sites cause CFTR exon 9 to be vulnerable to skipping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MESSENGER-RNA TRANSCRIPTS; NUCLEAR FACTOR TDP-43; CYSTIC-FIBROSIS; VAS-DEFERENS; FUNCTIONAL IMPLICATIONS; CONGENITAL ABSENCE; CODING SEQUENCES; GENE; MUTATIONS	The molecular basis of the skipping of constitutive exons in many messenger RNAs is not fully understood. A well-studied example is exon 9 of the human cystic fibrosis transmembrane conductance regulator gene (CFTR), in which an abbreviated polypyrimidine tract between the branch point A and the 3 splice site is associated with increased exon skipping and disease. However, many exons, both in CFTR and in other genes and have short polypyrimidine tracts in their 3 splice sites, yet they are not skipped. Inspection of the 5 splice sites immediately up- and downstream of exon 9 revealed deviations from consensus sequence, so we hypothesized that this exon may be inherently vulnerable to skipping. To test this idea, we constructed a CFTR minigene and replicated exon 9 skipping associated with the length of the polypyrimidine tract upstream of exon 9. We then mutated the flanking 5 splice sites and determined the effect on exon skipping. Conversion of the upstream 5 splice site to consensus by replacing a pyrimidine at position +3 with a purine resulted in increased exon skipping. In contrast, conversion of the downstream 5 splice site to consensus by insertion of an adenine at position +4 resulted in a substantial reduction in exon 9 skipping, regardless of whether the upstream 5 splice site was consensus or not. These results suggested that the native downstream 5 splice site plays an important role in CFTR exon 9 skipping, a hypothesis that was supported by data from sheep and mouse genomes. Although CFTR exon 9 in sheep is preceded by a long polypyrimidine tract (Y-14), it skips exon 9 in vivo and has a nonconsensus downstream 5 splice site identical to that in humans. On the other hand, CFTR exon 9 in mice is preceded by a short polypyrimidine tract (Y-5) but is not skipped in vivo. Its downstream 5 splice site differs from that in humans by a 2-nt insertion, which, when introduced into the human CFTR minigene, abolished exon 9 skipping. Taken together, these observations place renewed emphasis on deviations at 5 splice sites in nucleotides other than the invariant GT, particularly when such changes are found in conjunction with other altered splicing sequences, such as a shortened polypyrimidine tract. Thus, careful inspection of entire 5 splice sites may identify constitutive exons that are vulnerable to skipping.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet & Mol Bi, Baltimore, MD USA; Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England	Johns Hopkins University; Johns Hopkins University; University of Oxford	Cutting, GR (corresponding author), 600 N Wolfe St,CMSC 1004, Baltimore, MD 21287 USA.							BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Chen CD, 1999, RNA, V5, P290, DOI 10.1017/S1355838299980743; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; Clark F, 2002, HUM MOL GENET, V11, P451, DOI 10.1093/hmg/11.4.451; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; DELANEY SJ, 1993, NAT GENET, V4, P426, DOI 10.1038/ng0893-426; DIRKSEN WP, 1995, J BIOL CHEM, V270, P5346, DOI 10.1074/jbc.270.10.5346; Genesio R., 1993, Journal of Circuits, Systems and Computers, V3, P151, DOI 10.1142/S0218126693000125; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; HOFFMAN BE, 1992, GENE DEV, V6, P2554, DOI 10.1101/gad.6.12b.2554; JARVI K, 1995, LANCET, V345, P1578, DOI 10.1016/S0140-6736(95)91131-6; Ketterling RP, 1999, HUM MUTAT, V13, P221, DOI 10.1002/(SICI)1098-1004(1999)13:3<221::AID-HUMU6>3.3.CO;2-L; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; Mak V, 1997, HUM MOL GENET, V6, P2099, DOI 10.1093/hmg/6.12.2099; Niksic M, 1999, HUM MOL GENET, V8, P2339, DOI 10.1093/hmg/8.13.2339; Nissim-Rafinia M, 2000, HUM MOL GENET, V9, P1771, DOI 10.1093/hmg/9.12.1771; Noone PG, 2000, AM J RESP CRIT CARE, V162, P1919, DOI 10.1164/ajrccm.162.5.2003160; Ohno K, 1999, AM J HUM GENET, V65, P635, DOI 10.1086/302551; Osborne LR, 1994, PEDIATR PULM S, V10, P214; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Rogan PK, 1998, HUM MUTAT, V12, P153, DOI 10.1002/(SICI)1098-1004(1998)12:3<153::AID-HUMU3>3.3.CO;2-O; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STRONG TV, 1993, HUM MOL GENET, V2, P225, DOI 10.1093/hmg/2.3.225; TEBBUTT SJ, 1995, P NATL ACAD SCI USA, V92, P2293, DOI 10.1073/pnas.92.6.2293; Teng H, 1997, HUM MOL GENET, V6, P85, DOI 10.1093/hmg/6.1.85; Tzetis M, 2001, HUM GENET, V109, P592, DOI 10.1007/s00439-001-0631-0; von Kodolitsch Y, 1999, CIRCULATION, V100, P693, DOI 10.1161/01.CIR.100.7.693; ZANDBERG H, 1995, NUCLEIC ACIDS RES, V23, P248; ZIELENSKI J, 1995, AM J HUM GENET, V57, P958	35	27	28	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					294	303		10.1086/341664	http://dx.doi.org/10.1086/341664			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12068373	Bronze, Green Published			2022-12-18	WOS:000176977700008
J	Kock, N; Culjkovic, B; Maniak, S; Schilling, K; Muller, B; Zuhlke, C; Ozelius, L; Klein, C; Pramstaller, PP; Kramer, PL				Kock, N; Culjkovic, B; Maniak, S; Schilling, K; Muller, B; Zuhlke, C; Ozelius, L; Klein, C; Pramstaller, PP; Kramer, PL			Mode of inheritance and susceptibility locus for restless legs syndrome, on chromosome 12q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ANTICIPATION		Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; Univ Lubeck, Dept Neurol, Lubeck, Germany; Univ Lubeck, Dept Human Genet, Lubeck, Germany; Univ Belgrade, Fac Biol, Belgrade, Yugoslavia; Gen Reg Hosp Bolzano, Dept Neurol, Bolzano, Italy; Albert Einstein Coll Med, Dept Human Genet, New York, NY USA	Oregon Health & Science University; University of Lubeck; University of Lubeck; University of Belgrade; Krankenhaus Bozen; Yeshiva University	Kramer, PL (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, CR131,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	kramer@ohsu.edu	Pramstaller, Peter P/C-2357-2008	Klein, Christine/0000-0003-2102-3431; Schuele, Birgitt/0000-0002-9952-5776; Turecki, Gustavo/0000-0003-4075-2736				Desautels A, 2001, AM J HUM GENET, V69, P1266, DOI 10.1086/324649; Lazzarini A, 1999, MOVEMENT DISORD, V14, P111, DOI 10.1002/1531-8257(199901)14:1<111::AID-MDS1018>3.3.CO;2-0; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ondo WG, 2000, NEUROLOGY, V55, P1404, DOI 10.1212/WNL.55.9.1404; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Trenkwalder C, 1996, MOVEMENT DISORD, V11, P389, DOI 10.1002/mds.870110407; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Winkelmann J, 2001, SLEEP, V24, pA102	8	27	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					A205	208		10.1086/341097	http://dx.doi.org/10.1086/341097			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12068378	Green Published, Bronze			2022-12-18	WOS:000176307700025
J	Zeniou, M; Pannetier, S; Fryns, JP; Hanauer, A				Zeniou, M; Pannetier, S; Fryns, JP; Hanauer, A			Unusual splice-site mutations in the RSK2 gene and suggestion of genetic heterogeneity in Coffin-Lowry syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION SYNDROME; MISSENSE MUTATION; LOCALIZATION; XP22.1-P22.2; REFINEMENT; MYOPATHY; RPS6KA3; LOCUS; FORM	Coffin-Lowry syndrome (CLS) is a syndromic form of X-linked mental retardation that is characterized, in male patients, by psychomotor and growth retardation and various skeletal anomalies. Typical facial changes and specific clinical and radiological hand aspects exhibited by patients are essential clues for the diagnosis. CLS is caused by mutations in a gene that is located in Xp22.2 and that encodes RSK2, a growth-factor-regulated protein kinase. RSK2 mutations are extremely heterogeneous and lead to premature termination of translation and/or loss of phosphotransferase activity. Surprisingly, among a series of 250 patients screened by single-strand conformation polymorphism (SSCP) analysis, in whom a clinical diagnosis of CLS was made, no mutations were detected in 66% (165) of the patients. To determine what proportion of these latter patients have a RSK2 mutation that has not been detected and what proportion have different disorders that are phenotypically similar to CLS, we have, in the present article, investigated, by western blot analysis and in vitro kinase assay, cell lines from 26 patients in whom no mutation was previously identified by SSCP analysis. This approach allowed us to identify seven novel RSK2 mutations: two changes in the coding sequence of RSK2, one intragenic deletion, and four unusual intronic nucleotide substitutions that do not affect the consensus GT or AG splice sites. We have also determined the nucleotide sequence of the promoter region of the RSK2 gene, and we have screened it for mutations. No disease-causing nucleotide change was identified, suggesting that mutations affecting the promoter region are unlikely to account for a large number of patients with CLS. Finally, our results provide evidence that some patients have a disease that is phenotypically very similar to CLS, which is not caused by RSK2 defects. This suggests that there are defects in either additional genes or combinations of genes that may result in a CLS-like phenotype.	Univ Louis Pasteur Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Leuven, Ctr Human Genet, Clin Genet Unit, Louvain, Belgium	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; KU Leuven	Hanauer, A (corresponding author), Univ Louis Pasteur Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, Boite Postale 10142, F-67404 Illkirch Graffenstaden, France.							BIANCALANA V, 1992, AM J HUM GENET, V50, P981; BIANCALANA V, 1994, GENOMICS, V22, P617, DOI 10.1006/geno.1994.1435; BJORBAEK C, 1995, DIABETES, V44, P90, DOI 10.2337/diabetes.44.1.90; COFFIN GS, 1966, AM J DIS CHILD, V112, P205, DOI 10.1001/archpedi.1966.02090120073006; Delaunoy JP, 2001, HUM MUTAT, V17, P103, DOI 10.1002/1098-1004(200102)17:2<103::AID-HUMU2>3.0.CO;2-N; GILGENKRANTZ S, 1988, CLIN GENET, V34, P230; HANAUER A, 1988, AM J MED GENET, V30, P523, DOI 10.1002/ajmg.1320300154; HUNTER AGW, 1982, CLIN GENET, V21, P321; Jacquot S, 1998, AM J HUM GENET, V63, P1631, DOI 10.1086/302153; Jacquot S, 2002, EUR J HUM GENET, V10, P2, DOI 10.1038/sj.ejhg.5200738; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; Laporte J, 2000, HUM MUTAT, V15, P393, DOI 10.1002/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R; LOWRY B, 1971, AM J DIS CHILD, V121, P496, DOI 10.1001/archpedi.1971.02100170078009; Manouvrier-Hanu S, 1999, J MED GENET, V36, P775, DOI 10.1136/jmg.36.10.775; McCandless SE, 2000, AM J MED GENET, V95, P93, DOI 10.1002/1096-8628(20001113)95:2<93::AID-AJMG1>3.0.CO;2-B; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Merienne K, 1998, J MED GENET, V35, P890, DOI 10.1136/jmg.35.11.890; Ohno K, 1999, AM J HUM GENET, V65, P635, DOI 10.1086/302551; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Park KY, 2000, J MED GENET, V37, P851, DOI 10.1136/jmg.37.11.851; PLOMP AS, 1995, GENET COUNSEL, V6, P259; TEMTAMY SA, 1975, J PEDIATR-US, V86, P724, DOI 10.1016/S0022-3476(75)80357-X; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; WILSON WG, 1981, AM J MED GENET, V8, P215, DOI 10.1002/ajmg.1320080212; YOUNG ID, 1988, J MED GENET, V25, P344, DOI 10.1136/jmg.25.5.344	25	27	28	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1421	1433		10.1086/340607	http://dx.doi.org/10.1086/340607			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992250	Green Published, Bronze			2022-12-18	WOS:000175445700004
J	Vanita; Singh, JR; Sarhadi, VK; Singh, D; Reis, A; Rueschendorf, F; Becker-Follmann, J; Jung, M; Sperling, K				Vanita; Singh, JR; Sarhadi, VK; Singh, D; Reis, A; Rueschendorf, F; Becker-Follmann, J; Jung, M; Sperling, K			A novel form of "central pouchlike" cataract, with sutural opacities, maps to chromosome 15q21-22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATION	Congenital cataract is a clinically and genetically highly heterogeneous eye disorder, with autosomal dominant inheritance being most common. We investigated a large seven-generation family with 74 individuals affected by autosomal dominant congenital cataract (ADCC). The phenotype in this family can be described as "central pouchlike" cataract with sutural opacities, and it differs from the other mapped cataracts. We performed linkage analysis with microsatellite markers in this family and excluded the known candidate genes. A genomewide search revealed linkage to markers on chromosome 15, with a maximum two-point LOD score of 5.98 at theta = 0 with marker D15S117. Multipoint analysis also gave a maximum LOD score of 5.98 at D15S117. Multipoint and haplotype analysis narrowed the cataract locus to a 10-cM region between markers D15S209 and D15S1036, closely linked to marker D15S117 in q21-q22 region of chromosome 15. This is the first report of a gene for a clinically new type of ADCC at 15q21-22 locus.	Guru Nank Dev Univ, Ctr Genet Disorders, Amritsar 143005, Punjab, India; Dr Daljit Singh Eye Hosp, Amritsar, Punjab, India; Charite Humboldt Univ, Inst Human Genet, Berlin, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany	Guru Nanak Dev University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Singh, JR (corresponding author), Guru Nank Dev Univ, Ctr Genet Disorders, Amritsar 143005, Punjab, India.	jairup@vsnl.com	Reis, André/D-2309-2009	Reis, André/0000-0002-6301-6363				Conley YP, 2000, AM J HUM GENET, V66, P1426, DOI 10.1086/302871; Eckstein M, 1996, BRIT J OPHTHALMOL, V80, P628, DOI 10.1136/bjo.80.7.628; Francis PJ, 1999, TRENDS GENET, V15, P191, DOI 10.1016/S0168-9525(99)01738-2; FRANCOIS J, 1982, OPHTHALMOLOGICA, V184, P61, DOI 10.1159/000309186; Gill D, 2000, INVEST OPHTH VIS SCI, V41, P159; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; Liu JJ, 1998, INVEST OPHTH VIS SCI, V39, P2584; Luo YD, 1998, BIOCHEMISTRY-US, V37, P16506, DOI 10.1021/bi9816599; PADMA T, 1995, AM J HUM GENET, V57, P840; Robinson ML, 1998, DEV BIOL, V198, P13, DOI 10.1016/S0012-1606(98)80026-2; SCOTT MH, 1994, OPHTHALMOLOGY, V101, P866; TINI M, 1995, J BIOL CHEM, V270, P20156, DOI 10.1074/jbc.270.34.20156; Vanita, 1999, CLIN GENET, V56, P389; VANITA, 1998, THESIS GURU NANAK DE	15	27	32	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					509	514						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11133359				2022-12-18	WOS:000166524800022
J	Das, S; Lese, CM; Song, M; Jensen, JL; Wells, LA; Barnoski, BL; Roseberry, JA; Camacho, JM; Ledbetter, DH; Schnur, RE				Das, S; Lese, CM; Song, M; Jensen, JL; Wells, LA; Barnoski, BL; Roseberry, JA; Camacho, JM; Ledbetter, DH; Schnur, RE			Partial paternal uniparental disomy of chromosome 6 in an infant with neonatal diabetes, macroglossia, and craniofacial abnormalities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; SOMATIC MOSAICISM; MELLITUS; TRANSIENT; GENE; ISODISOMY; PATIENT; IDDM8; MAP	Neonatal diabetes, which can be transient or permanent, is defined as hyperglycemia that presents within the first month of life and requires insulin therapy. Transient neonatal diabetes mellitus has been associated with abnormalities of the paternally inherited copy of chromosome 6, including duplications of a portion of the long arm of chromosome 6 and uniparental disomy, implicating overexpression of an imprinted gene in this disorder. To date, all patients with transient neonatal diabetes mellitus and uniparental disomy have had complete paternal isodisomy. We describe a patient with neonatal diabetes, macroglossia, and craniofacial abnormalities, with partial paternal uniparental disomy of chromosome 6 involving the distal portion of 6q, from 6q24-qter. This observation demonstrates that mitotic recombination of chromosome 6 can also give rise to uniparental disomy and neonatal diabetes, a situation similar to that observed in Beckwith-Wiedemann syndrome, another imprinted disorder. This finding has clinical implications, since somatic mosaicism for uniparental disomy of chromosome 6 should also be considered in patients with transient neonatal diabetes mellitus.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Robert Wood Johnson Med Sch, Cooper Hlth Syst, Div Genet, Camden, NJ USA	University of Chicago; Rutgers State University New Brunswick; Rutgers State University Medical Center	Das, S (corresponding author), Univ Chicago, Dept Human Genet, L040, Chicago, IL 60637 USA.	sdas@genetics.uchicago.edu						ABRAMOWICZ MJ, 1994, J CLIN INVEST, V94, P418, DOI 10.1172/JCI117339; Arthur EI, 1997, EUR J HUM GENET, V5, P417, DOI 10.1159/000484801; Battin M, 1996, J Perinatol, V16, P288; BISCHOFF FZ, 1995, HUM MOL GENET, V4, P395, DOI 10.1093/hmg/4.3.395; Catchpoole D, 1997, J MED GENET, V34, P353, DOI 10.1136/jmg.34.5.353; Cave H, 2000, DIABETES, V49, P108, DOI 10.2337/diabetes.49.1.108; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; Christian SL, 1999, J PEDIATR-US, V134, P42, DOI 10.1016/S0022-3476(99)70370-7; Davies JL, 1996, HUM MOL GENET, V5, P1071, DOI 10.1093/hmg/5.7.1071; Delepine M, 1997, AM J HUM GENET, V60, P174; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FOSEL S, 1995, EUR J PEDIATR, V154, P944; FRANCHINO CJ, 1987, J MED GENET, V24, P300, DOI 10.1136/jmg.24.5.300; Gardner RJ, 1998, CLIN GENET, V54, P522; Gardner RJ, 2000, HUM MOL GENET, V9, P589, DOI 10.1093/hmg/9.4.589; Gardner RJ, 1999, J MED GENET, V36, P192; GERRARD JW, 1962, J PEDIATR-US, V61, P89, DOI 10.1016/S0022-3476(62)80234-0; Henry I., 1993, European Journal of Human Genetics, V1, P19; Hermann R, 2000, PEDIATRICS, V105, P49, DOI 10.1542/peds.105.1.49; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; Li M, 1998, AM J MED GENET, V79, P253; Lopez-Macipe A, 1998, J MATER SYNTH PROCES, V6, P21, DOI 10.1023/A:1022603024806; LUO DF, 1995, AM J HUM GENET, V57, P911; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Marquis E, 2000, EUR J HUM GENET, V8, P137, DOI 10.1038/sj.ejhg.5200401; NICHOLLS RD, 1991, AM J MED GENET, V41, P273, DOI 10.1002/ajmg.1320410233; PIVNICK EK, 1990, J MED GENET, V27, P523, DOI 10.1136/jmg.27.8.523; SALERNO M, 1994, J PEDIATR ENDOCRINOL, V7, P47; Shield JPH, 1997, ARCH DIS CHILD-FETAL, V76, pF39, DOI 10.1136/fn.76.1.F39; SHIELD JPH, 1995, ARCH DIS CHILD, V72, P56, DOI 10.1136/adc.72.1.56; SPENCE JE, 1988, AM J HUM GENET, V42, P217; Spiro RP, 1999, PEDIATR RES, V46, P510, DOI 10.1203/00006450-199911000-00004; Temple IK, 1999, AM J HUM GENET, V65, pA107; TEMPLE IK, 1995, NAT GENET, V9, P110, DOI 10.1038/ng0295-110; Temple IK, 1996, HUM MOL GENET, V5, P1117, DOI 10.1093/hmg/5.8.1117; vandenBergLoonen EM, 1996, HUM IMMUNOL, V45, P46, DOI 10.1016/0198-8859(95)00148-4; VONMUHLENDAHL E, 1995, NEW ENGL J MED, V333, P704, DOI 10.1056/NEJM199509143331105; Whiteford ML, 1997, J MED GENET, V34, P167, DOI 10.1136/jmg.34.2.167	41	27	28	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1586	1591		10.1086/316897	http://dx.doi.org/10.1086/316897			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11038325	Bronze, Green Published			2022-12-18	WOS:000165607600025
J	McGinnis, R				McGinnis, R			General equations for P-t, P-s, and the power of the TDT and the affected-sib-pair test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION/DISEQUILIBRIUM TEST TDT; COMPLEX HUMAN-DISEASES; LINKAGE DISEQUILIBRIUM; ASSOCIATION; LOCI	Several equations are highlighted here, whose algebraic symmetries and generality make them very useful for understanding and comparing the properties of the transmission disequilibrium test (TBT) and affected sib-pair test. Methods using the equations are also presented that yield precise estimates of sample sizes needed for genome scans or for testing a single candidate gene, and these power methods are shown to compare favorably with alternative approaches recently described by Knapp (1999) and by Tu and Whittemore (1999). Simple relationships are also noted that summarize the relative sample sizes required for equivalent power to detect association by the TDT or case-control designs. As single-nucleotide polymorphism (SNP) maps revolutionize the search for disease-causing genes, the equations should prove useful for planning and evaluating studies of linkage and association across a broad range of possible disease models and relationships between markers and linked disease loci.	SmithKline Beecham Pharmaceut, Biotechnol & Genet, Harlow CM19 5AW, Essex, England	GlaxoSmithKline	McGinnis, R (corresponding author), SmithKline Beecham Pharmaceut, Biotechnol & Genet, New Frontiers Sci Pk N,H30-2-038, Harlow CM19 5AW, Essex, England.			McGinnis, Ralph/0000-0003-4540-9857				Camp NJ, 1999, AM J HUM GENET, V64, P1485, DOI 10.1086/302387; Camp NJ, 1997, AM J HUM GENET, V61, P1424, DOI 10.1086/301648; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; DARVASI A, 1998, AM J HUM GENET S, V63, pS229; KNAPP M, 1994, HUM HERED, V44, P37, DOI 10.1159/000154187; Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334; McGinnis RE, 1998, ANN HUM GENET, V62, P159, DOI 10.1046/j.1469-1809.1998.6220159.x; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schaid DJ, 1998, AM J HUM GENET, V63, P935, DOI 10.1086/302077; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Tu IP, 1999, AM J HUM GENET, V64, P641, DOI 10.1086/302253; Whittaker JC, 1999, AM J HUM GENET, V65, P578, DOI 10.1086/302485	16	27	29	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1340	1347						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11013135				2022-12-18	WOS:000165091600032
J	Bosse, K; Betz, RC; Lee, YA; Wienker, TF; Reis, A; Kleen, H; Propping, P; Cichon, S; Nothen, MM				Bosse, K; Betz, RC; Lee, YA; Wienker, TF; Reis, A; Kleen, H; Propping, P; Cichon, S; Nothen, MM			Localization of a gene for syndactyly type 1 to chromosome 2q34-q36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEDGEHOG; LINKAGE; HUMANS	Syndactyly type 1 (SD1) is an autosomal dominant limb malformation characterized in its classical form by complete or partial webbing between the third and fourth fingers and/or the second and third toes. After exclusion of a candidate region previously identified for syndactyly type 2 (synpolydactyly), we performed a genomewide linkage analysis in a large German pedigree. We found evidence for linkage of SD1 to polymorphic markers on chromosome 2q34-q36, with a maximum LOD score of 12.40 for marker D2S301. Key recombination events in affected individuals defined a 9.4-cM region between markers D2S2319 and D2S344. The identification of the responsible gene will give further insights into the molecular basis of limb development.	Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53111 Bonn, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Humboldt Univ, Dept Pediat Pneumol & Immunol, Berlin, Germany; Humboldt Univ, Inst Human Genet, Berlin, Germany; Kreiskrankenhaus Aurich, Aurich, Germany	University of Bonn; University of Bonn; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Humboldt University of Berlin	Nothen, MM (corresponding author), Univ Bonn, Inst Human Genet, Wilhelmstr 31, D-53111 Bonn, Germany.		Nöthen, Markus/B-2027-2009; Betz, Regina C/E-8591-2011; Cichon, Sven/H-8803-2013; Reis, André/D-2309-2009; Cichon, Sven/B-9618-2014	Nöthen, Markus/0000-0002-8770-2464; Betz, Regina C/0000-0001-5024-3623; Cichon, Sven/0000-0002-9475-086X; Reis, André/0000-0002-6301-6363; Cichon, Sven/0000-0002-9475-086X				Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CASTILLA EE, 1980, AM J MED GENET, V5, P357, DOI 10.1002/ajmg.1320050406; CHANG DT, 1994, DEVELOPMENT, V120, P3339; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FELLER AM, 1981, Z KINDERCHIR, V33, P166; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lenz W, 1981, LEHRBUCH RONTGENDIAG, P935; Lueken KG, 1938, Z MENSCHL VERERB KON, V22, P152; Manouvrier-Hanu S, 1999, TRENDS GENET, V15, P409, DOI 10.1016/S0168-9525(99)01823-5; MONTAGU MFA, 1953, HUM GENET, V5, P70; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; PARR BA, 1993, DEVELOPMENT, V119, P247; Rankin J, 1999, CYTOGENET CELL GENET, V84, P50, DOI 10.1159/000015212; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; TENTAMY SA, 1978, GENETICS HAND MALFOR, P301; TENTAMY SA, 1990, BIRTH DEFECTS ENCY, P1617; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Yang XP, 2000, AM J HUM GENET, V66, P892, DOI 10.1086/302806	19	27	32	1	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					492	497		10.1086/303028	http://dx.doi.org/10.1086/303028			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10877983	Green Published, Bronze			2022-12-18	WOS:000089357800024
J	MacLean, CJ; Martin, RB; Sham, PC; Wang, H; Straub, RE; Kendler, KS				MacLean, CJ; Martin, RB; Sham, PC; Wang, H; Straub, RE; Kendler, KS			The trimmed-haplotype test for linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARKER LOCI; GENE; MUTATION; HISTORY	Single-marker linkage-disequilibrium (LD) methods cannot fully describe disequilibrium in an entire chromosomal region surrounding a disease allele. With the advent of myriad tightly linked microsatellite markers, we have an opportunity to extend LD analysis from single markers to multiple-marker haplotypes. Haplotype analysis has increased statistical power to disclose the presence of a disease locus in situations where it correctly reflects the historical process involved. For maximum efficiency evidence of LD ought to come not just from a single haplotype, which may well be rare, but in addition from many similar haplotypes that could have descended from the same ancestral founder but have been trimmed in succeeding generations. We present such an analysis, called the "trimmed-haplotype method." We focus on chromosomal regions that are small enough that disequilibrium in significant portions of them may have been preserved in some pedigrees and yet that contain enough markers to minimize coincidental occurrence of the haplotype in the absence of a disease allele: perhaps regions 1-2 cM in length. In general, we could have no idea that haplotype an ancestral founder carried generations ago, nor do we usually have a precise chromosomal location for the disease-susceptibility locus. Therefore, we must search through all possible haplotypes surrounding multiple locations. Since such repeated testing obliterates the sampling distribution of the test, me employ bootstrap methods to calculate significance levels. Trimmed-haplotype analysis is performed on family data in which genotypes have been assembled into haplotypes. It can be applied either to conventional parent-affected-offspring triads or to multiplex pedigrees. We present a method for summarizing the LD evidence, in any pedigree, that can be employed in trimmed-haplotype analysis as well as in other methods.	Virginia Commonwealth Univ, Med Coll Virginia, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; Inst Psychiat, Dept Psychol Med, London SE5 8AF, England	Virginia Commonwealth University; University of London; King's College London	MacLean, CJ (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Virginia Inst Psychiat & Behav Genet, POB 980126, Richmond, VA 23298 USA.	cmaclean@bara.psi.vcu.edu	Kendler, Kenneth/AAF-2876-2019		NIMH NIH HHS [MH-41953, MH-45390, MH-52537, R01 MH041953] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052537, R01MH041953, R01MH045390] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1998, Psychiatr Genet, V8, P59; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Efron B., 1993, INTRO BOOTSTRAP; Efron B, 1982, JACKKNIFE BOOTSTRAP; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Goddard KAB, 1996, AM J HUM GENET, V58, P1286; HOGLUND P, 1995, AM J HUM GENET, V57, P95; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kendler KS, 1999, AM J MED GENET, V88, P29, DOI 10.1002/(SICI)1096-8628(19990205)88:1<29::AID-AJMG5>3.0.CO;2-7; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lazzeroni LC, 1998, AM J HUM GENET, V62, P159, DOI 10.1086/301678; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Ott J., 1991, ANAL HUMAN GENETIC L; RAMSAY M, 1993, HUM MOL GENET, V2, P1007, DOI 10.1093/hmg/2.7.1007; RELETHFORD JH, 1995, AM J PHYS ANTHROPOL, V96, P25, DOI 10.1002/ajpa.1330960104; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; VOGEL V, 1997, HUMAN GENETICS PROBL; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475; Zouali H, 1997, HUM MOL GENET, V6, P1401, DOI 10.1093/hmg/6.9.1401	29	27	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1062	1075		10.1086/302796	http://dx.doi.org/10.1086/302796			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712218	Green Published, Bronze			2022-12-18	WOS:000088373200026
J	Rothstein, MA				Rothstein, MA			Genetic testing in adoption	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHILDREN; DISEASE; HEALTH											*AM AC PED COMM EA, 1991, PEDIATRICS, V88, P642; Andrews CM, 1998, COMP HAEMATOL INT, V8, P125, DOI 10.1007/BF02642503; Blair D Marianne, 1992, North Carol Law Rev, V70, P681; Blair MB, 1996, FAM LAW QUART, V30, P427; BUCHANAN A, 1998, J HLTH CARE LAW POLI, V1, P391; Clayton E. W., 1998, CHILD LEG RIGHTS J, V18, P39; Clayton Ellen Wright, 1992, Houst Law Rev, V29, P85; Cohen CB, 1998, KENNEDY INST ETHIC J, V8, P111, DOI 10.1353/ken.1998.0014; Freundlich MD, 1998, CHILD WELFARE, V77, P663; Greely HT, 1999, J AM COLL SURGEONS, V188, P86; Harrell JS, 1998, PEDIATRICS, V102, P371, DOI 10.1542/peds.102.2.371; Hoffmann DE, 1995, J LAW MED ETHICS, V23, P331, DOI 10.1111/j.1748-720X.1995.tb01375.x; Holland J, 1997, FAM LAW QUART, V31, P321; HOWE RW, 1983, FAM LAW Q, V2, P173; KAWASHIMA Y, 1981, J FAM L, V20, P677; KLEINMAN RE, 1992, PEDIATRICS, V90, P469; Klish WJ, 1998, PEDIATRICS, V101, P141; LESHNE L, 1999, TRIAL, V35, P14; Lombardo P, 1996, U CHIC LAW SCH ROUND, V3, P589; LORANDOS DA, 1996, LOYOLA U CHICAGO LAW, V272, P277; MORRIS M, 1988, LANCET, V2, P1069, DOI 10.1016/S0140-6736(88)90078-5; MURRAY TH, 1996, WORTH CHILD; Pelias M., 1996, U CHICAGO LAW SCH RO, V3, P525; PELIAS MZ, 1999, CHILD LEG RIGHTS J, V19, P41; PELIAS MZ, 1999, CANC GENETICS CLIN; REILLY P, 1991, AM J HUM GENET, V48, P1009; Rothstein, 1997, GENETIC SECRETS PROT, P255; Rothstein Mark A, 1994, J Law Health, V9, P109; Rothstein Mark A., 1997, GENETIC SECRETS PROT, P451; WERTZ DC, 1994, JAMA-J AM MED ASSOC, V272, P875, DOI 10.1001/jama.272.11.875; WILFOND BS, 1995, AM J HUM GENET, V57, P1233	31	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					761	767						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	337QM	10712194				2022-12-18	WOS:000088373200002
J	Colombo, R				Colombo, R			Age estimate of the N370S mutation causing Gaucher disease in Ashkenazi Jews and European populations: A reappraisal of haplotype data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PYRUVATE-KINASE PKLR; FACTOR-XI DEFICIENCY; LINKAGE DISEQUILIBRIUM; GLUCOCEREBROSIDASE GBA; FAMILIAL DYSAUTONOMIA; FRENCH-CANADIANS; ORIGIN; GENES; LOCALIZATION; CHROMOSOME	The N370S mutation at the GBA locus on human chromosome 1q21, which causes Gaucher disease (GD), has a high frequency in the Ashkenazim and is the second-most- widespread GD mutation in the European non-Jewish population. A common ancient origin for the N370S mutation in the Ashkenazi Jewish and Spanish populations has been proposed on the basis of both a similar haplotype for associated markers and an age estimate that suggests that this mutation appeared several thousand years ago. However, a reappraisal of haplotype data, using the Risch formula properly along with a Luria-Delbruck setting of the genetic clock, allows identification of the likely origin of the N370S mutation in Ashkenazi Jews between the 11th and 13th centuries. This result is consistent with the estimated ages of other mutations that are frequent among Ashkenazim, with the exception of type II (Glu117Stop) factor XI deficiency, which is deemed to be >3000 years old, predating the separation of the Ashkenazi and Iraqi Jews. The present finding supports the hypothesis of a more recent origin for the N370S mutation and is consistent with both a founder chromosome transfer from Ashkenazim who assimilated in some European populations and a non-Jewish origin of the European N370S-bearing chromosomes.	Univ Cattolica Sacro Cuore, Dept Psychol, Human Biol & Genet Res Unit, I-20123 Milan, Italy	Catholic University of the Sacred Heart	Colombo, R (corresponding author), Univ Cattolica Sacro Cuore, Dept Psychol, Human Biol & Genet Res Unit, Largo A Gemelli 1, I-20123 Milan, Italy.	rcolombo@aixmiced.mi.unicatt.it						Amaral O, 1996, HUM MUTAT, V8, P280, DOI 10.1002/(SICI)1098-1004(1996)8:3<280::AID-HUMU15>3.3.CO;2-6; BARNAVI E, 1992, HIST ATLAS JEWISH PE; BEIRNART H, 1992, ATLAS MEDIEVAL JEWIS; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; BEUTLER E, 1992, BLOOD, V79, P1662; Blumenfeld A, 1999, AM J HUM GENET, V64, P1110, DOI 10.1086/302339; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; Cormand B, 1998, HUM MUTAT, V11, P295, DOI 10.1002/(SICI)1098-1004(1998)11:4<295::AID-HUMU7>3.0.CO;2-6; Cormand B, 1997, HUM GENET, V100, P75, DOI 10.1007/s004390050468; Diaz A, 1999, AM J HUM GENET, V64, P1233, DOI 10.1086/302341; ELLIS NA, 1994, AM J HUM GENET, V55, P453; Gaucher P., 1882, THESIS FM PARIS; GLENN D, 1994, HUM GENET, V93, P635; Goldstein DB, 1999, AM J HUM GENET, V64, P1071, DOI 10.1086/302313; GOODMAN RM, 1978, GENETIC DISORDERS JE; Gravel R. A., 1995, METABOLIC MOL BASIS, P2839; Guo SW, 1997, HUM HERED, V47, P315, DOI 10.1159/000154431; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Labuda M, 1996, AM J HUM GENET, V59, P633; LENZNER C, 1994, HUM MOL GENET, V3, P523, DOI 10.1093/hmg/3.3.523-a; Luria SE, 1943, GENETICS, V28, P491; Moisio AL, 1996, AM J HUM GENET, V59, P1243; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Peretz H, 1997, BLOOD, V90, P2654, DOI 10.1182/blood.V90.7.2654.2654_2654_2659; REICH DE, 1999, MICROSATELLITES EVOL, P129; RISCH N, 1995, NAT GENET, V11, P14, DOI 10.1038/ng0995-14; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Rockah R, 1998, AM J MED GENET, V78, P233	29	27	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					692	697		10.1086/302757	http://dx.doi.org/10.1086/302757			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677327	Green Published, Bronze			2022-12-18	WOS:000088373100034
J	Sun, Y; Keshava, C; Sharp, DS; Weston, A; McCanlies, EC				Sun, Y; Keshava, C; Sharp, DS; Weston, A; McCanlies, EC			DNA sequence variants of p53: Cancer and aging	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HUMAN LUNG-CANCER; GERM-LINE POLYMORPHISM; CERVICAL-CANCER; BREAST-CANCER; CODON-72 POLYMORPHISM; NASOPHARYNGEAL CARCINOMA; ALLELIC FREQUENCY; INCREASED RISK; ETHNIC-GROUPS; HAPLOTYPES		NIOSH, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Weston, A (corresponding author), NIOSH, Ctr Dis Control & Prevent, 1095 Willowdale Rd, Morgantown, WV 26505 USA.	AGW8@CDC.GOV		Keshava, Channa/0000-0002-3841-3586				BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; BIRGANDER R, 1995, CARCINOGENESIS, V16, P2233, DOI 10.1093/carcin/16.9.2233; Birgander R, 1996, HUM HERED, V46, P49; Birgander R, 1996, HUM HERED, V46, P290, DOI 10.1159/000154365; Bonafe M, 1999, AM J HUM GENET, V64, P292, DOI 10.1086/302196; Golovleva I, 1997, CARCINOGENESIS, V18, P645, DOI 10.1093/carcin/18.4.645; Hayes VM, 1998, LANCET, V352, P1756, DOI 10.1016/S0140-6736(05)79829-9; Helland A, 1998, NATURE, V396, P530, DOI 10.1038/25034; JIN XM, 1995, CARCINOGENESIS, V16, P2205, DOI 10.1093/carcin/16.9.2205; Josefsson AM, 1998, NATURE, V396, P531, DOI 10.1038/25037; KAWAJIRI K, 1993, CARCINOGENESIS, V14, P1085, DOI 10.1093/carcin/14.6.1085; Lanham S, 1998, LANCET, V352, P1631, DOI 10.1016/S0140-6736(05)61083-5; LOPEZ AD, 1990, ANN NY ACAD SCI, V609, P58, DOI 10.1111/j.1749-6632.1990.tb32057.x; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; Minaguchi T, 1998, CANCER RES, V58, P4585; Murata M, 1996, CARCINOGENESIS, V17, P261, DOI 10.1093/carcin/17.2.261; OLSCHWANG S, 1991, HUM GENET, V86, P369; Rosenthal AN, 1998, LANCET, V352, P871, DOI 10.1016/S0140-6736(98)07357-7; SJALANDER A, 1995, CARCINOGENESIS, V16, P1461, DOI 10.1093/carcin/16.7.1461; Sjalander A, 1996, HUM HERED, V46, P41, DOI 10.1159/000154324; SJALANDER A, 1995, HUM HERED, V45, P144, DOI 10.1159/000154275; Sjalander A, 1996, CARCINOGENESIS, V17, P1313, DOI 10.1093/carcin/17.6.1313; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Tagawa M, 1998, CANCER LETT, V128, P93, DOI 10.1016/S0304-3835(98)00056-1; ToFigueras J, 1996, CANCER EPIDEM BIOMAR, V5, P337; Wang-Gohrke S, 1998, ANTICANCER RES, V18, P2095; WESTON A, 1992, CANCER EPIDEM BIOMAR, V1, P481; WESTON A, 1994, CARCINOGENESIS, V15, P583, DOI 10.1093/carcin/15.4.583; Weston A, 1997, ENVIRON HEALTH PERSP, V105, P919, DOI 10.2307/3433304; Weston A, 1997, CANCER EPIDEM BIOMAR, V6, P105; Weston A, 1998, CANCER GENET CYTOGEN, V102, P153; *WHO, 1987, WORLD HLTH STAT ANN, P247; WU WJ, 1995, JPN J CANCER RES, V86, P730, DOI 10.1111/j.1349-7006.1995.tb02461.x; Yung WCW, 1997, CANCER GENET CYTOGEN, V93, P181, DOI 10.1016/S0165-4608(96)00219-1; ZHANG W, 1992, GENE, V117, P271, DOI 10.1016/0378-1119(92)90738-B	35	27	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1779	1782		10.1086/302650	http://dx.doi.org/10.1086/302650			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577934	Bronze, Green Published			2022-12-18	WOS:000084282500035
J	Rocha, H; Flores, C; Campos, Y; Arenas, J; Vilarinho, L; Santorelli, FM; Torroni, A				Rocha, H; Flores, C; Campos, Y; Arenas, J; Vilarinho, L; Santorelli, FM; Torroni, A			About the "pathological" role of the mtDNA T3308C mutation ...	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MITOCHONDRIAL GENOME; POPULATIONS		Univ Urbino, Ist Chim Biol, I-61029 Urbino, Italy; Univ La Laguna, Tenerife, Spain; Hosp Univ 12 Octubre, Ctr Invest, Madrid, Spain; Childrens Hosp Bambino Gesu, Rome, Italy; Univ La Sapienza, Dipartimento Genet & Biol Mol, Rome, Italy; Inst Genet Med Jacinto de Magalhaes, Unidade Biol Clin, Porto, Portugal	University of Urbino; Universidad de la Laguna; Hospital Universitario 12 de Octubre; IRCCS Bambino Gesu; Sapienza University Rome	Torroni, A (corresponding author), Univ Urbino, Ist Chim Biol, I-61029 Urbino, Italy.		Torroni, Antonio/E-1557-2011; Flores, Carlos/R-1159-2019; Santorelli, Filippo M/ABE-5124-2020; Yolanda, Campos Y/A-8711-2017	Torroni, Antonio/0000-0002-4163-4478; Santorelli, Filippo M/0000-0002-1359-9062; Arenas, Joaquin/0000-0002-2877-5049; Flores, Carlos/0000-0001-5352-069X; Rocha, Hugo/0000-0001-5447-615X; Vilarinho, Laura/0000-0001-6186-779X; CAMPOS, YOLANDA/0000-0003-4785-9659	Telethon [E.0890] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ArnaizVillena A, 1997, IMMUNOGENETICS, V47, P37, DOI 10.1007/s002510050324; Campos Y, 1997, BIOCHEM BIOPH RES CO, V238, P323, DOI 10.1006/bbrc.1997.7166; CHEN YS, 1995, AM J HUM GENET, V57, P133; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; Vilarinho L, 1999, J INHERIT METAB DIS, V22, P90, DOI 10.1023/A:1005471904710; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503	10	27	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1457	1459		10.1086/302641	http://dx.doi.org/10.1086/302641			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521313	Green Published, Bronze			2022-12-18	WOS:000083531000029
J	Knapp, M				Knapp, M			Using exact P values to compare the power between the reconstruction-combined transmission/disequilibrium test and the Sib transmission/disequilibrium test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LINKAGE		Univ Bonn, Inst Med Stat, D-53105 Bonn, Germany	University of Bonn	Knapp, M (corresponding author), Univ Bonn, Inst Med Stat, Sigmund Freud Str 25, D-53105 Bonn, Germany.							CURTIS D, 1995, AM J HUM GENET, V56, P811; Elston RC, 1998, AM J HUM GENET, V63, P931, DOI 10.1086/302073; Hodge SE, 1995, GENET EPIDEMIOL, V12, P545, DOI 10.1002/gepi.1370120604; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Laird NM, 1998, AM J HUM GENET, V63, P1915, DOI 10.1086/302151; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; *SAS I, 1990, SAS LANG REF VERS 6; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714	8	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1208	1210		10.1086/302591	http://dx.doi.org/10.1086/302591			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486344	Bronze, Green Published			2022-12-18	WOS:000082910000036
J	Henke, J; Henke, L				Henke, J; Henke, L			Mutation rate in human microsatellites	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DNA-MINISATELLITE MUTATIONS		Inst Blutgrp Forsch, D-50501 Cologne, Germany		Henke, J (corresponding author), Inst Blutgrp Forsch, Hohenzollernring 57,Postfach 1904 20, D-50501 Cologne, Germany.							Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; HENKE J, 1993, INT J LEGAL MED, V105, P217, DOI 10.1007/BF01642797; HENKE J, 1995, INT J LEGAL MED, V107, P204, DOI 10.1007/BF01428407; OLAISEN B, 1993, EXS, V67, P63	4	27	31	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1473	1473		10.1086/302373	http://dx.doi.org/10.1086/302373			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205281	Green Published, Bronze			2022-12-18	WOS:000080093000028
J	Rantamaki, T; Kaitila, I; Syvanen, AC; Lukka, M; Peltonen, L				Rantamaki, T; Kaitila, I; Syvanen, AC; Lukka, M; Peltonen, L			Recurrence of Marfan syndrome as a result of parental germ-line mosaicism for an FBN1 mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LETHAL OSTEOGENESIS IMPERFECTA; I COLLAGEN; FIBRILLIN; GENE; PCR; DNA; FEATURES; MARKERS	Mutations in the FBN1 gene cause Marfan syndrome (MFS), a dominantly inherited connective tissue disease. Almost all the identified FBN1 mutations have been family specific, and the rate of new mutations is high. We report here a de novo FBN1 mutation that was identified in two sisters with MFS born to clinically unaffected parents. The paternity and maternity were unequivocally confirmed by genotyping. Although one of the parents had to be an obligatory carrier for the mutation, we could not detect the mutation in the leukocyte DNA of either parent. To identify which parent was a mosaic for the mutation we analyzed several tissues from both parents, with a quantitative and sensitive solid-phase mini-sequencing method. The mutation was not, however, detectable in any of the analyzed tissues. Although the mutation could not be identified in a sperm sample from the father or in samples of multiple tissue from the mother, we concluded that the mother was the likely mosaic parent and that the mutation must have occurred during the early development of her germ-line cells. Mosaicism confined to germ-line cells has rarely been reported, and this report of mosaicism for the FBN1 mutation in MFS represents an important case, in light of the evaluation of the recurrence risk in genetic counseling of families with MFS.	Univ Helsinki, Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Peltonen, L (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Gonda Neurosci & Genet Res Ctr, Room 6506,695 Charles E Young Dr S,Box 708822, Los Angeles, CA 90095 USA.	lpeltonen@mednet.ucla.edu						BUDOWLE B, 1991, AM J HUM GENET, V48, P137; BURGIO RG, 1988, AM J MED GENET, V30, P905, DOI 10.1002/ajmg.1320300405; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHN DH, 1990, AM J HUM GENET, V46, P591; Collod-Beroud G, 1998, NUCLEIC ACIDS RES, V26, P229, DOI 10.1093/nar/26.1.229; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; Edwards Matthew J., 1992, Human Mutation, V1, P47, DOI 10.1002/humu.1380010108; GODFREY M, 1990, AM J HUM GENET, V46, P661; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; HEWETT DR, 1994, J MED GENET, V31, P338, DOI 10.1136/jmg.31.4.338; KAINULAINEN K, 1992, P NATL ACAD SCI USA, V89, P5917, DOI 10.1073/pnas.89.13.5917; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; MAGENIS RE, 1991, GENOMICS, V11, P346, DOI 10.1016/0888-7543(91)90142-2; MILEWICZ DM, 1995, J CLIN INVEST, V95, P2373, DOI 10.1172/JCI117930; MILEWICZ DM, 1993, AM J HUM GENET, V53, P62; Montgomery RA, 1998, AM J HUM GENET, V63, P1703, DOI 10.1086/302144; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PEREIRA L, 1994, NEW ENGL J MED, V331, P148, DOI 10.1056/NEJM199407213310302; Putnam EA, 1996, AM J MED GENET, V62, P233, DOI 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U; Putnam EA, 1997, AM J HUM GENET, V60, P818; Pyeritz Reed E., 1993, P437; Rantamaki T, 1997, TRENDS CARDIOVAS MED, V7, P282, DOI 10.1016/S1050-1738(97)00087-X; Rantamaki T., 1994, European Journal of Human Genetics, V2, P66; Rostedt I, 1996, FORENSIC SCI INT, V82, P217, DOI 10.1016/S0379-0738(96)02002-6; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SHIBATA DK, 1988, J EXP MED, V167, P225, DOI 10.1084/jem.167.1.225; SHPRINTZEN RJ, 1982, J CRAN GENET DEV BIO, V2, P65; Sood S, 1996, NAT GENET, V12, P209, DOI 10.1038/ng0296-209; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; SYVANEN AC, 1992, INT J CANCER, V50, P713, DOI 10.1002/ijc.2910500508; SYVANEN AC, 1989, FEBS LETT, V258, P71, DOI 10.1016/0014-5793(89)81618-7; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang M, 1996, AM J HUM GENET, V59, P1027; Yates JRW, 1997, HUM MOL GENET, V6, P2265, DOI 10.1093/hmg/6.13.2265; Zlotogora J, 1998, HUM GENET, V102, P381, DOI 10.1007/s004390050708	36	27	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					993	1001		10.1086/302309	http://dx.doi.org/10.1086/302309			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090884	Green Published, Bronze			2022-12-18	WOS:000079632900010
J	Xiao, XZ; Benjamin, IJ				Xiao, XZ; Benjamin, IJ			Stress-response proteins in cardiovascular disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ISCHEMIC-INJURY; TRANSGENIC MICE; TRANSCRIPTION; DESMIN; FILAMENTS; RAT		Univ Texas, SW Med Ctr, Dept Internal Med,Mol Cardiol Res Labs, Integrat Biol Grad Program,Div Cell & Mol Biol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Benjamin, IJ (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med,Mol Cardiol Res Labs, Integrat Biol Grad Program,Div Cell & Mol Biol, Dallas, TX 75235 USA.				NHLBI NIH HHS [HL60667, P50-HL55988] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060667, P50HL055988] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Dobson Christopher M., 1998, EMBO (European Molecular Biology Organization) Journal, V17, P5251, DOI 10.1093/emboj/17.18.5251; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goebel HH, 1997, CURR OPIN NEUROL, V10, P426, DOI 10.1097/00019052-199710000-00012; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JURIVICH DA, 1994, P NATL ACAD SCI USA, V91, P2280, DOI 10.1073/pnas.91.6.2280; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Martin JL, 1997, CIRCULATION, V96, P4343; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Neufer PD, 1996, AM J PHYSIOL-CELL PH, V271, pC1828; OSBORN M, 1983, ACTA NEUROPATHOL, V62, P149, DOI 10.1007/BF00684933; PLUMIER JCL, 1995, J CLIN INVEST, V95, P1854, DOI 10.1172/JCI117865; Plumier JCL, 1997, CELL STRESS CHAPERON, V2, P162, DOI 10.1379/1466-1268(1997)002<0162:TMETHI>2.3.CO;2; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; Richardson A, 1998, TRENDS BIOCHEM SCI, V23, P138, DOI 10.1016/S0968-0004(98)01193-1; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Suzuki K, 1997, J CLIN INVEST, V99, P1645, DOI 10.1172/JCI119327; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cb.11.110195.002301	31	27	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					685	690		10.1086/302305	http://dx.doi.org/10.1086/302305			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053001	Green Published, Bronze			2022-12-18	WOS:000079204700003
J	Kurose, K; Araki, T; Matsunaka, T; Takada, Y; Emi, M				Kurose, K; Araki, T; Matsunaka, T; Takada, Y; Emi, M			Variant manifestation of Cowden disease in Japan: Hamartomatous polyposis of the digestive tract with mutation of the PTEN gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TUMOR-SUPPRESSOR LOCUS; GERMLINE MUTATIONS; BREAST; CANCER		Nippon Med Sch, Inst Gerontol, Dept Mol Biol, Kawasaki, Kanagawa, Japan; Nippon Med Sch, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan; Saijo Cent Hosp, Dept Internal Med, Saijo, Ehime, Japan	Nippon Medical School; Nippon Medical School	Emi, M (corresponding author), Nippon Med Sch, Inst Gerontol, Dept Mol Biol, Kawasaki, Kanagawa, Japan.		, Otto/P-4127-2018	, Otto/0000-0003-2101-4105				Eng C, 1998, AM J HUM GENET, V62, P1020, DOI 10.1086/301847; Eng C, 1998, INT J ONCOL, V12, P701; HANSSEN AMN, 1995, J MED GENET, V32, P117, DOI 10.1136/jmg.32.2.117; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Jacoby RF, 1997, GASTROENTEROLOGY, V112, P1398, DOI 10.1016/S0016-5085(97)70156-2; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kurose K, 1998, JPN J CANCER RES, V89, P842, DOI 10.1111/j.1349-7006.1998.tb00638.x; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Longy M, 1996, ANN GENET-PARIS, V39, P35; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Olschwang S, 1998, NAT GENET, V18, P12, DOI 10.1038/ng0198-12; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356	17	27	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					308	310		10.1086/302207	http://dx.doi.org/10.1086/302207			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915974	Green Published, Bronze			2022-12-18	WOS:000078477400040
J	El-Maarri, O; Olek, A; Balaban, B; Montag, M; van der Ven, H; Urman, B; Olek, K; Caglayan, SH; Walter, J; Oldenburg, J				El-Maarri, O; Olek, A; Balaban, B; Montag, M; van der Ven, H; Urman, B; Olek, K; Caglayan, SH; Walter, J; Oldenburg, J			Methylation levels at selected CpG sites in the factor VIII and FGFR3 genes, in mature female and male germ cells: Implications for male-driven evolution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-3; HEMOPHILIA-A; SEX-RATIO; MUTATION FREQUENCIES; DNA METHYLATION; HOT-SPOTS; B-DOMAIN; SEQUENCES; ACHONDROPLASIA; EXPRESSION	Transitional mutations at CpG dinucleotides account for approximately a third of all point mutations. These mutations probably arise through spontaneous deamination of 5-methylcytosine. Studies of CpG mutation rates in disease-linked genes, such as factor Vm and FGFR3, have indicated that they more frequently originate in male than in female germ cells. It has been speculated that these sex-biased mutation rates might be a consequence of sex-specific methylation differences between the female and the male germ lines. Using the bisulfite based genomic-sequencing method, we investigated the methylation status of the human factor Vm and FGFR3 genes in mature male and female germ cells. With the exception of a single CpG, both genes were found to be equally and highly methylated in oocytes and spermatocytes. Whereas these observations strongly support the notion that DNA methylation is the major determining factor for recurrent CpG germ-line mutations in patients with hemophilia and achondroplasia, the higher mutation rate in the male germ line is apparently not a simple reflection of sex-specific methylation differences.	Univ Wurzburg, Inst Human Genet, Biozentrum, D-97074 Wurzburg, Germany; Inst Mol Biol Diagnost, Bonn, Germany; Univ Bonn, Inst Endokrinol & Reprod Med, D-5300 Bonn, Germany; Max Planck Inst Mol Genet, Berlin, Germany; Amer Hosp, Assisted Reprod Technol Unit, Istanbul, Turkey; Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey	University of Wurzburg; University of Bonn; Max Planck Society; Amerikan Hospital; Bogazici University	Oldenburg, J (corresponding author), Univ Wurzburg, Inst Human Genet, Biozentrum, Hubland, D-97074 Wurzburg, Germany.	J.oldenburg@biozentrum.uni-wuerzburg.de	Caglayan, Hande S/A-2368-2016; Oldenburg, Johannes/ABB-7817-2020	Caglayan, Hande S/0000-0001-6402-3306; Oldenburg, Johannes/0000-0002-1585-4100; El-Maarri, Osman/0000-0002-6859-5819				Becker J, 1996, AM J HUM GENET, V58, P657; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Crow JF, 1997, NAT GENET, V17, P129, DOI 10.1038/ng1097-129; Denissenko MF, 1997, P NATL ACAD SCI USA, V94, P3893, DOI 10.1073/pnas.94.8.3893; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; Fijnvandraat K, 1997, THROMB HAEMOSTASIS, V77, P298; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; GRUENBAUM Y, 1981, FEBS LETT, V124, P67, DOI 10.1016/0014-5793(81)80055-5; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KAUFMAN RJ, 1992, ANNU REV MED, V43, P325, DOI 10.1146/annurev.med.43.1.325; KETTERLING RP, 1993, AM J HUM GENET, V52, P152; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; Montag M, 1998, FERTIL STERIL, V69, P539, DOI 10.1016/S0015-0282(97)00538-4; OLDENBURG J, 1993, AM J HUM GENET, V53, P1229; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; ORIOLI IM, 1995, AM J MED GENET, V59, P209, DOI 10.1002/ajmg.1320590218; PATTINSON JK, 1990, BLOOD, V76, P2242; PITTMAN DD, 1994, BLOOD, V84, P4214, DOI 10.1182/blood.V84.12.4214.bloodjournal84124214; ROSENDAAL FR, 1990, HUM GENET, V86, P139, DOI 10.1007/BF00197695; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Sapienza C, 1996, NAT GENET, V13, P9, DOI 10.1038/ng0596-9; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; Sommer SS, 1996, HUM MOL GENET, V5, P1505, DOI 10.1093/hmg/5.Supplement_1.1505; TOOLE JJ, 1986, P NATL ACAD SCI USA, V83, P5939, DOI 10.1073/pnas.83.16.5939; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; Vogel F., 1997, HUMAN GENETICS PROBL; Wacey AI, 1996, NUCLEIC ACIDS RES, V24, P100, DOI 10.1093/nar/24.1.100; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	40	27	30	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1001	1008		10.1086/302065	http://dx.doi.org/10.1086/302065			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758623	Green Published, Bronze			2022-12-18	WOS:000076577800012
J	van Schothorst, EM; Jansen, JC; Grooters, E; Prins, DEM; Wiersinga, LJ; van der Mey, AGL; van Ommen, GJB; Devilee, P; Cornelisse, CJ				van Schothorst, EM; Jansen, JC; Grooters, E; Prins, DEM; Wiersinga, LJ; van der Mey, AGL; van Ommen, GJB; Devilee, P; Cornelisse, CJ			Founder effect at PGL1 in hereditary head and neck paraganglioma families from The Netherlands	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAROTID-BODY TUMORS; GLOMUS TUMORS; MEIOTIC RECOMBINATION; IMPRINTED GENE; LINKAGE; REGION; DNA	PGL1, a gene responsible for hereditary paragangliomas of the head and neck, recently was mapped to a 2-cM interval on chromosome 11q22-q23, by linkage and haplotype-sharing analysis of a large multibranch Dutch family. We determined the disease-linked haplotype, as defined by 13 markers encompassing a large interval on 11q21-q23, in 10 additional families ascertained from the same geographical locale. Alleles were identical for six contiguous markers, spanning a genetic distance of 6 cM and containing PGL1, Despite this strong indication of a common ancestor, no kinships between the families could be demonstrated through genealogical surveys going back to 1800 A.D. We conclude that a single ancestral mutation is responsible for most, if not all, hereditary paragangliomas, in this region of The Netherlands, and that strong founder effects map exist at the PGL1 locus.	Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Otorhinolaryngol, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Pathol, NL-2333 AL Leiden, Netherlands; Leiden Univ, Dept Biol, Leiden, Netherlands; Leiden Univ, Dept Hist, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Devilee, P (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.	devilee@ruly46.Medfac.Leidenuniv.nl	DEVILEE, PETER/ABR-2140-2022	van Schothorst, Evert/0000-0002-3036-5903				Baysal BE, 1997, AM J HUM GENET, V60, P121; Baysal BE, 1997, GENOMICS, V44, P214, DOI 10.1006/geno.1997.4880; BOGDASARIAN RS, 1979, OTOLARYNG HEAD NECK, V87, P648, DOI 10.1177/019459987908700520; BUYLE S, 1993, HUM GENET, V92, P269, DOI 10.1007/BF00244471; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Freimer NB, 1996, NAT GENET, V12, P436, DOI 10.1038/ng0496-436; GRUFFERMAN S, 1980, CANCER, V46, P2116, DOI 10.1002/1097-0142(19801101)46:9<2116::AID-CNCR2820460934>3.0.CO;2-S; GRUIS NA, 1995, MELANOMA RES, V5, P169, DOI 10.1097/00008390-199506000-00005; HART W, 1992, CLIN ENDOCRINOL, V36, P295, DOI 10.1111/j.1365-2265.1992.tb01446.x; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; Heutink Peter, 1994, European Journal of Human Genetics, V2, P148; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; LACK EE, 1977, CANCER, V39, P397, DOI 10.1002/1097-0142(197702)39:2<397::AID-CNCR2820390205>3.0.CO;2-C; LITTLE J, 1995, J RURAL STUD, V11, P101, DOI 10.1016/0743-0167(95)90009-8; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; MCCAFFREY TV, 1994, ARCH OTOLARYNGOL, V120, P1211; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Milunsky J, 1997, AM J MED GENET, V72, P66, DOI 10.1002/(SICI)1096-8628(19971003)72:1<66::AID-AJMG14>3.0.CO;2-S; Oosterwijk JC, 1996, J MED GENET, V33, P379, DOI 10.1136/jmg.33.5.379; PALDI A, 1995, CURR BIOL, V5, P1030, DOI 10.1016/S0960-9822(95)00207-7; PARRY DM, 1982, J NATL CANCER I, V68, P573; Peelen T, 1997, AM J HUM GENET, V60, P1041; Peltonen L, 1997, GENOME RES, V7, P765, DOI 10.1101/gr.7.8.765; ROBINSON WP, 1995, HUM MOL GENET, V4, P801, DOI 10.1093/hmg/4.5.801; SATO T, 1974, CANCER-AM CANCER SOC, V34, P1787, DOI 10.1002/1097-0142(197411)34:5<1787::AID-CNCR2820340529>3.0.CO;2-7; TASCHNER PEM, 1995, AM J MED GENET, V57, P333, DOI 10.1002/ajmg.1320570246; VANBAARS F, 1982, HUM GENET, V60, P305, DOI 10.1007/BF00569208; VANDERMEY AGL, 1989, LANCET, V2, P1291; VANGILS APG, 1992, BRIT J CANCER, V65, P903, DOI 10.1038/bjc.1992.189; vanSchothorst EM, 1996, EUR J HUM GENET, V4, P267; Woodward ER, 1997, HUM MOL GENET, V6, P1051, DOI 10.1093/hmg/6.7.1051	31	27	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					468	473		10.1086/301951	http://dx.doi.org/10.1086/301951			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683583	Green Published, Bronze			2022-12-18	WOS:000075360800022
J	Lerer, I; Wang, TL; Peretz, T; Sagi, M; Kaduri, L; Orr-Urtreger, A; Stadler, J; Gutman, H; Abeliovich, D				Lerer, I; Wang, TL; Peretz, T; Sagi, M; Kaduri, L; Orr-Urtreger, A; Stadler, J; Gutman, H; Abeliovich, D			The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Hebrew Univ Jerusalem, Hadassah Hosp, Sch Med, Dept Human Genet, Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Hosp, Sch Med, Sharett Inst Oncol, Jerusalem, Israel; Tel Aviv Suraski Med Ctr, Genet Inst, Tel Aviv, Israel; Tel Aviv Suraski Med Ctr, Breast Hlth Ctr, Tel Aviv, Israel; Rabin Med Ctr, Dept Surg B, Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Abeliovich, D (corresponding author), Hadassah Univ Hosp, Dept Human Genet, POB 12000, IL-91120 Jerusalem, Israel.							Abeliovich D, 1997, AM J HUM GENET, V60, P505; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; LERER I, 1994, AM J MED GENET, V52, P79, DOI 10.1002/ajmg.1320520116; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Thorlacius S, 1997, AM J HUM GENET, V60, P1079; ZLOTOGORA J, 1995, AM J HUM GENET, V56, P1173	8	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					272	274		10.1086/301924	http://dx.doi.org/10.1086/301924			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634522	Green Published, Bronze			2022-12-18	WOS:000074761000039
J	Petersen, GM; Parmigiani, G; Thomas, D				Petersen, GM; Parmigiani, G; Thomas, D			Missense mutations in disease genes: A Bayesian approach to evaluate causality	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME	The problem of interpreting missense mutations of disease-causing genes is an Increasingly important one. Because these point mutations result in alteration of only a single amino acid of the protein product, it is often unclear whether this change alone is sufficient to cause disease. We propose a Bayesian approach that utilizes genetic information on affected relatives in families ascertained through known missense-mutation carriers. This method is useful in evaluating known disease genes for common disease phenotypes, such as breast cancer or colorectal cancer. The posterior probability that a missense mutation is disease causing is conditioned on the relationship of the relatives to the proband, the population frequency of the mutation, and the phenocopy rate of the disease. The approach is demonstrated in two cancer data sets: BRCA1 R841W and APC I1307K. In both examples, this method helps establish that these mutations are likely to be disease causing, with Bayes factors in favor of causality of 5.09 and 66.97, respectively, and posterior probabilities of .836 and .985. We also develop a simple approximation for rare alleles and consider the case of unknown penetrance and allele frequency.	Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Duke Univ, Inst Stat & Decis Sci, Durham, England; Univ So Calif, Dept Prevent Med, Div Biostat, Los Angeles, CA 90089 USA	Johns Hopkins University; University of Southern California	Petersen, GM (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St, Baltimore, MD 21205 USA.				NATIONAL CANCER INSTITUTE [P50CA062924, R01CA063721, R01CA052862] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 63721, P50 CA 62924, CA 52862] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aragaki CC, 1997, CANCER EPIDEM BIOMAR, V6, P307; Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Barker DF, 1996, GENET EPIDEMIOL, V13, P595; Berger J.O., 1987, STAT SCI, V2, P317, DOI [10.2307/2245772, DOI 10.1214/SS/1177013238]; Cooper D. N., 1993, HUMAN GENE MUTATION; COTTON R, 1997, MUTATION DETECTION; ELANDTJOHNSON RC, 1971, PROBABILITY MODELS S; Ellsworth DL, 1997, EPIDEMIOL REV, V19, P3, DOI 10.1093/oxfordjournals.epirev.a017943; Fearon ER, 1997, SCIENCE, V278, P1043, DOI 10.1126/science.278.5340.1043; FORD D, 1995, BRIT J CANCER, V72, P805, DOI 10.1038/bjc.1995.417; Geller G, 1997, JAMA-J AM MED ASSOC, V277, P1467, DOI 10.1001/jama.277.18.1467; GREENLAND S, 1993, STAT MED, V12, P717, DOI 10.1002/sim.4780120802; GUYER MS, 1995, P NATL ACAD SCI USA, V92, P10841, DOI 10.1073/pnas.92.24.10841; Holtzman NA, 1997, SCIENCE, V278, P602, DOI 10.1126/science.278.5338.602; Hubbard R, 1996, NEW ENGL J MED, V334, P1192, DOI 10.1056/NEJM199605023341812; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; LI CC, 1954, BIOMETRICS, V10, P347, DOI 10.2307/3001590; Savill J, 1997, BRIT MED J, V314, P126, DOI 10.1136/bmj.314.7074.126; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SWIFT M, 1990, AM J HUM GENET, V47, P266	21	27	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1516	1524		10.1086/301871	http://dx.doi.org/10.1086/301871			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585599	Green Published, Bronze			2022-12-18	WOS:000074174700030
J	Stevenson, RE; Arena, JF; Ouzts, E; Gibson, A; Shokeir, MHK; Vnencak-Jones, C; Lubs, HA; May, M; Schwartz, CE				Stevenson, RE; Arena, JF; Ouzts, E; Gibson, A; Shokeir, MHK; Vnencak-Jones, C; Lubs, HA; May, M; Schwartz, CE			Renpenning syndrome maps to Xp11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; ALLAN-HERNDON SYNDROME; LINKAGE ANALYSIS; MARTIN-BELL; GENE; IDENTIFICATION; MARKERS	Mutations in genes on the X chromosome are believed to be responsible for the excess of males among individuals with mental retardation. Such genes are numerous, certainly >100, and cause both syndromal and non-syndromal types of mental retardation. Clinical and molecular studies have been conducted on the Mennonite family with X-linked mental retardation (XLMR) reported, in 1962, by Renpenning et al. The clinical phenotype includes severe mental retardation, microcephaly, up-slanting palpebral fissures, small testes, and stature shorter than that of nonaffected males. Major malformations, neuromuscular abnormalities, and behavioral disturbances were not seen. Longevity is not impaired. Carrier females do not show heterozygote manifestations. The syndrome maps to Xp11.2-p11.4, with a maximum LOD score of 3.21 (recombination fraction 0) for markers between DXS1039 and DXS1068. Renpenning syndrome (also known as "MRXS8"; gene RENS1, MIM 309500) shares phenotypic manifestations with several other XLMR syndromes, notably the Sutherland-Haan syndrome. In none of these entities has the responsible gene been isolated; hence, the possibility that two or more of them may be allelic cannot be excluded at present.	Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; Univ Miami, Sch Med, Miami, FL USA; Univ Saskatchewan Hosp, Saskatoon, SK S7N 0W8, Canada; Vanderbilt Univ, Nashville, TN USA	Greenwood Genetic Center; University of Miami; University of Saskatchewan; Vanderbilt University	Stevenson, RE (corresponding author), Greenwood Genet Ctr, JC Self Res Inst Human Genet, 1 Gregor Mendel Circle, Greenwood, SC 29646 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NICHD NIH HHS [HD26202] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allan W, 1944, AM J MENT DEF, V48, P325; ARCHIDIACONO N, 1987, Journal de Genetique Humaine, V35, P381; Arena JF, 1996, AM J MED GENET, V64, P50, DOI 10.1002/(SICI)1096-8628(19960712)64:1<50::AID-AJMG7>3.3.CO;2-4; Billuart P, 1996, HUM MOL GENET, V5, P977, DOI 10.1093/hmg/5.7.977; CLAES S, IN PRESS AM J MED GE; desPortes V, 1997, AM J HUM GENET, V60, P903; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUNN HG, 1962, AM J MENT DEFIC, V67, P827; FOX P, 1980, AM J MED GENET, V7, P491, DOI 10.1002/ajmg.1320070409; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; Gedeon AK, 1996, AM J MED GENET, V64, P158, DOI 10.1002/(SICI)1096-8628(19960712)64:1<158::AID-AJMG26>3.3.CO;2-V; GERRARD JW, 1974, LANCET, V1, P1346, DOI 10.1016/S0140-6736(74)90714-4; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; Hamel BCJ, 1996, AM J MED GENET, V64, P131, DOI 10.1002/(SICI)1096-8628(19960712)64:1<131::AID-AJMG22>3.0.CO;2-N; HAMEL BCJ, IN PRESS AM J MED GE; HOWARDPEEBLES PN, 1979, AM J HUM GENET, V31, P214; JENNINGS M, 1980, AM J MED GENET, V7, P417, DOI 10.1002/ajmg.1320070404; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LOSOWSKY MS, 1961, J MENT DEFIC RES, V5, P60, DOI 10.1111/jir.1961.5.1.60; LUBS H, 1998, IN PRESS AM J MED GE; Lubs HA, 1996, AM J MED GENET, V64, P147, DOI 10.1002/(SICI)1096-8628(19960712)64:1<147::AID-AJMG25>3.0.CO;2-M; LUBS HA, 1969, AM J HUM GENET, V21, P231; MANSFIELD DC, 1994, GENOMICS, V24, P225, DOI 10.1006/geno.1994.1610; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; MCLAUGHLIN JF, 1980, DEV MED CHILD NEUROL, V22, P84; MILES JH, 1991, AM J MED GENET, V38, P215, DOI 10.1002/ajmg.1320380209; NELSON DL, 1995, CYTOGENET CELL GENET, V71, P307; Porteous M. E. M., 1992, American Journal of Human Genetics, V51, pA106; PRIETO F, 1987, CLIN GENET, V32, P326; PROOPS R, 1981, J MED GENET, V18, P366, DOI 10.1136/jmg.18.5.366; RAEYMAEKERS P, 1996, AM J MED GENET, V64, P16; RENPENNING H, 1962, CAN MED ASSOC J, V87, P954; RICHARDS BW, 1970, LANCET, V2, P520; RICHARDS BW, 1981, J MENT DEFIC RES, V25, P253; ROBLEDO R, 1994, AM J MED GENET, V64, P134; SCHWARTZ CE, 1990, AM J HUM GENET, V47, P454; SNYDER RD, 1969, CLIN PEDIATR, V8, P669, DOI 10.1177/000992286900801114; STEELE MW, 1974, LANCET, V1, P752; STEVENSON RE, 1990, AM J HUM GENET, V47, P446; SUKPANICHNANT S, 1993, DIAGN MOL PATHOL, V2, P168, DOI 10.1097/00019606-199309000-00005; SUTHERLAND GR, 1988, AM J MED GENET, V30, P493, DOI 10.1002/ajmg.1320300152; TURNER G, 1971, DEV MED CHILD NEUROL, V13, P71; TURNER G, 1972, J MED GENET, V9, P324, DOI 10.1136/jmg.9.3.324; TURNER G, 1970, LANCET, V2, P365; VANDERMAAREL S, 1996, AM J MED GENET, V64, P19; WILSON M, 1991, AM J MED GENET, V40, P406, DOI 10.1002/ajmg.1320400405	47	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1092	1101		10.1086/301835	http://dx.doi.org/10.1086/301835			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545405	Green Published, hybrid			2022-12-18	WOS:000073487000013
J	Sainz, J; Minassian, BA; Serratosa, JM; Gee, MN; Sakamoto, LM; Iranmanesh, R; Bohlega, S; Baumann, RJ; Ryan, S; Sparkes, RS; DelgadoEscueta, AV				Sainz, J; Minassian, BA; Serratosa, JM; Gee, MN; Sakamoto, LM; Iranmanesh, R; Bohlega, S; Baumann, RJ; Ryan, S; Sparkes, RS; DelgadoEscueta, AV			Lafora progressive myoclonus epilepsy: Narrowing the chromosome 6q24 locus by recombinations and homozygosities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							POLYMERASE CHAIN-REACTION; HUMAN GENOME; LINKAGE; METHYLTRANSFERASE; POLYMORPHISMS; GENE; MAP; DNA		UNIV CALIF LOS ANGELES,SCH MED,EPILEPSY CTR,NEUROL & RES SERV 127B,W LOS ANGLES DVA MED CTR,LOS ANGELES,CA 90073; UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,CALIF COMPREHENS EPILEPSY PROGRAM,LOS ANGELES,CA 90024; FDN JIMENEZ DIAZ,EPILEPSY UNIT,E-28040 MADRID,SPAIN; KING FAISAL SPECIALIST HOSP & RES CTR,RIYADH 11211,SAUDI ARABIA; UNIV KENTUCKY,LEXINGTON,KY 40506	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; King Faisal Specialist Hospital & Research Center; University of Kentucky				Serratosa, Jose/0000-0003-2239-8948; Delgado-Escueta, Antonio V./0000-0002-1581-6999	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS021908, R01NS042376] Funding Source: NIH RePORTER; NINDS NIH HHS [5PO1-NS21908, R01 NS042376] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHUMAKOV IM, 1995, NATURE, V377, P175; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EIBERG H, 1984, CLIN GENET, V26, P23; Federico A, 1980, Acta Neurol (Napoli), V2, P466; GAMBETTI P, 1971, ARCH NEUROL-CHICAGO, V25, P483, DOI 10.1001/archneur.1971.00490060017002; GREER CE, 1991, AM J CLIN PATHOL, V95, P117, DOI 10.1093/ajcp/95.2.117; JACKSON DP, 1990, J CLIN PATHOL, V43, P499, DOI 10.1136/jcp.43.6.499; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lafora G.R., 1911, B GOV HOSP INSANE, V3, P83; Lafora GR, 1911, VIRCHOWS ARCH A, V205, P295, DOI 10.1007/BF01989438; LAFORA GR, 1955, P 2 INT C NEUR 1, P9; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MACLAREN DC, 1992, GENOMICS, V14, P852, DOI 10.1016/S0888-7543(05)80104-1; MURRAY JC, 1987, AM J HUM GENET, V40, P338; OTA IM, 1988, BIOCHEM BIOPH RES CO, V151, P1136, DOI 10.1016/S0006-291X(88)80484-4; OTT J, 1974, AM J HUM GENET, V26, P588; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Sambrook J, 1989, MOL CLONING LAB MANU; SCHWARZ GA, 1965, ARCH NEUROL-CHICAGO, V12, P172, DOI 10.1001/archneur.1965.00460260062008; SCHWARZ GA, 1965, ARCH NEUROBIOL MADRI, V28, P800; SCHWARZ GA, 1977, SCI APPROACHES CLIN, P148; SERRATOSA JM, 1995, HUM MOL GENET, V4, P1657; TSAI W, 1994, BIOCHEM BIOPH RES CO, V203, P491, DOI 10.1006/bbrc.1994.2209; WEBER JL, 1989, AM J HUM GENET, V44, P388; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002	25	27	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1205	1209		10.1086/301596	http://dx.doi.org/10.1086/301596			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345091	Green Published, Bronze			2022-12-18	WOS:A1997YH01700031
J	Wertz, DC; Reilly, PR				Wertz, DC; Reilly, PR			Laboratory policies and practices for the genetic testing of children: A survey of the helix network	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE	In order to discover whether laboratories have policies regarding the testing of unaffected children, we surveyed all laboratories registered with Helix, a national network of DNA diagnostic laboratories. Of 186 laboratories asked to respond anonymously to a four-page questionnaire, 156 (84%) replied. A screening question removed 51 laboratories that provided no clinical services. Of the remaining 105, 92% said that their requisition forms asked the person's age. Substantial minorities had policies for the testing of miners for late-onset disorders (46%), for carrier status for recessive disorders (33%), or for disorders for which the test offers no medical benefit within 3 years (33%). Most laboratories are responsive to parental requests. For 12 of 13 late-onset disorders, the majority of laboratories that offered testing had had requests to test children. The majority had tested healthy children, < 12 years of age, for eight disorders. Approximately 22% had tested children, < 12 years of age, for Huntington disease. Majorities had received requests to test healthy children for carrier status for 10 of 15 recessive or X-linked disorders and had tested children, < 12 years of age, for 6 of these disorders, including cystic fibrosis, hemophilia A, fragile X syndrome, and Duchenne muscular dystrophy. Approximately 45% of the laboratories occasionally had provided tests directly to consumers. In view of the possibility that the harms of presymptomatic diagnoses of children sometimes may outweigh the benefits, our results suggest a need for consistent laboratory policies designed for the best interests of the child and the family.			Wertz, DC (corresponding author), EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,200 TRAPELO RD,WALTHAM,MA 02254, USA.				NHGRI NIH HHS [R01-HG00550-02] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		*AM MED ASS, 1995, TEST CHILDR GEN STAT, V6; *AM SOC HUM GEN BO, 1995, AM J HUM GENET, V57, P1233; BLOCH M, 1990, AM J HUM GENET, V46, P1; Clarke A, 1996, TROUBLED HELIX SOCIA, P164; *CLIN GEN SOC, 1994, J MED GENET, V31, P785; Clow C L, 1977, Prog Clin Biol Res, V18, P381; CLOW CL, 1977, PEDIATRICS, V59, P86; *GEN INT GROUP, 1996, BRIT MED ASS GEN INT; HARPER PS, 1990, LANCET, V335, P1205, DOI 10.1016/0140-6736(90)92713-R; HELIX, 1995, USER INFORMATION CHI; Institute of Medicine Committee on assessing genetic risks, 1994, ASSESSING GENETIC RI; *NIH, IN PRESS NIH DOE WOR; PETERSEN GM, 1993, HUM GENET, V91, P307; WENT L, 1990, J MED GENET, V27, P34, DOI 10.1136/jmg.27.1.34; WERTZ DC, 1994, JAMA-J AM MED ASSOC, V272, P875, DOI 10.1001/jama.272.11.875; WERTZ DC, 1995, GENETICISTS ETHICAL; WERTZ DC, 1996, BRIT MED ASS GEN INT; ZEESMAN S, 1984, AM J MED GENET, V18, P769, DOI 10.1002/ajmg.1320180424; 1994, INT DIG HLT LEG, V46, P51	19	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1163	1168		10.1086/301593	http://dx.doi.org/10.1086/301593			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345088	Green Published, Bronze			2022-12-18	WOS:A1997YH01700023
J	Jordan, T; Ebenezer, N; Manners, R; McGill, J; Bhattacharya, S				Jordan, T; Ebenezer, N; Manners, R; McGill, J; Bhattacharya, S			Familial glaucoma iridogoniodysplasia maps to a 6p25 region implicated in primary congenital glaucoma and iridogoniodysgenesis anomaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT IRIDOGONIODYSGENESIS; OPEN-ANGLE GLAUCOMA; RIEGER SYNDROME; VARIABLE EXPRESSIVITY; FACTOR GENE; 2ND LOCUS; LINKAGE; ANIRIDIA; LOCALIZATION; CLONING	Familial glaucoma iridogoniodysplasia (FGI) is a form. of open-angle glaucoma in which developmental anomalies of the iris and irido-corneal angle are associated with a juvenile-onset glaucoma transmitted as an autosomal dominant trait. A single large family with this disorder was examined for genetic linkage to microsatellite markers. A peak LOD score of 11.63 at a recombination fraction of 0 was obtained with marker D6S967 mapping to chromosome 6p25. Haplotype analysis places the disease gene in a 6.4-cM interval between the markers D6S1713 and D6S1600. Two novel clinical appearances extend the phenotypic range and provide evidence of variable expressivity. The chromosome Gp25 region is now implicated in FGI, primary congenital glaucoma, and iridogoniodysgenesis anomaly. This may indicate the presence of a common causative gene or, alternatively, a cluster of genes involved in eye development/function.	SOUTHAMPTON GEN HOSP,SOUTHAMPTON EYE UNIT,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND	University of Southampton	Jordan, T (corresponding author), INST OPHTHALMOL,DEPT MOL GENET,BATH ST,LONDON EC1V 9EL,ENGLAND.		Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344; Manners, Ruth/0000-0001-7966-5432	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; Berg F., 1932, ACTA OPHTHALMOL, V10, P568, DOI [10.1111/j.1755-3768.1932.tb07210.x, DOI 10.1111/J.1755-3768.1932.TB07210.X]; CHISHOLM IA, 1983, BRIT J OPHTHALMOL, V67, P529, DOI 10.1136/bjo.67.8.529; CHITAYAT D, 1987, American Journal of Medical Genetics, V26, P145, DOI 10.1002/ajmg.1320260122; Courtney RH, 1931, J AMER MED ASSOC, V97, P1602; Eyre HJ, 1996, GENOMICS, V37, P406, DOI 10.1006/geno.1996.0580; FALLS HF, 1949, AM J OPHTHALMOL, V32, P41, DOI 10.1016/S0002-9394(14)78356-4; FRANCOIS J, 1950, B SOC BELGE OPHTAL, V96, P665; GILLESPIE F D, 1963, Va Med Mon (1918), V90, P556; HAMBRESIN L, 1946, B MEM SOC FR OPHTALM, V59, P219; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; HEON E, 1995, HUM MOL GENET, V4, P1435, DOI 10.1093/hmg/4.8.1435; HITTNER HM, 1980, AM J OPHTHALMOL, V89, P531, DOI 10.1016/0002-9394(80)90062-8; HITTNER HM, 1982, AM J OPHTHALMOL, V93, P57, DOI 10.1016/0002-9394(82)90700-0; JERNDAL T, 1983, AM J HUM GENET, V35, P645; JERNDAL T, 1972, AM J OPHTHALMOL, V74, P28, DOI 10.1016/0002-9394(72)91121-X; JORGENSON RJ, 1978, AM J MED GENET, V2, P307, DOI 10.1002/ajmg.1320020310; KLUYSKENS J, 1950, B SOC BELGE OPHTAL, V94, P4; Larsson C, 1995, GENOMICS, V30, P464, DOI 10.1006/geno.1995.1266; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MARTIN JP, 1974, BRIT J OPHTHALMOL, V58, P536, DOI 10.1136/bjo.58.5.536; MCCULLOCH C, 1950, T SOC OPHTHAL SOC, V13, P79; Mears AJ, 1996, AM J HUM GENET, V59, P1321; MORTON NE, 1955, AM J HUM GENET, V7, P277; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; NELSON LB, 1984, SURV OPHTHALMOL, V28, P621, DOI 10.1016/0039-6257(84)90184-X; NIELSEN F, 1984, J MED GENET, V21, P218, DOI 10.1136/jmg.21.3.218; NISHIMURA DY, 1995, INVEST OPHTH VIS SCI, V36, P2574; PALMER CG, 1991, AM J MED GENET, V39, P155, DOI 10.1002/ajmg.1320390208; Phillips JC, 1996, AM J HUM GENET, V59, P613; Raymond V, 1997, AM J HUM GENET, V60, P272; RIEGER H, 1935, GRAEFE ARCH OPHTHALM, V133, P602; SAFARAZI M, 1995, GENOMICS, V30, P171; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Stokes WH, 1940, ARCH OPHTHALMOL-CHIC, V24, P885, DOI 10.1001/archopht.1940.00870050035002; TOMA NMG, 1995, HUM MOL GENET, V4, P2393; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; WIEGEL D, 1989, CELL, V57, P645; WIEGEL D, 1990, CELL, V63, P455; Wirtz MK, 1997, AM J HUM GENET, V60, P296; ZORAB A, 1932, T OPHTHAL SOC UK, V52, P446	44	27	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					882	888		10.1086/514874	http://dx.doi.org/10.1086/514874			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382099	Green Published, Bronze			2022-12-18	WOS:A1997YA59100015
J	Starfield, M; Hennies, HC; Jung, M; Jenkins, T; Wienker, T; Hull, P; Spurdle, A; Kuster, W; Ramsay, M; Reis, A				Starfield, M; Hennies, HC; Jung, M; Jenkins, T; Wienker, T; Hull, P; Spurdle, A; Kuster, W; Ramsay, M; Reis, A			Localization of the gene causing keratolytic winter erythema to chromosome 8p22-p23, and evidence for a founder effect in South African Afrikaans-speakers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMOLYTIC PALMOPLANTAR KERATODERMA; 2ND INTERNATIONAL WORKSHOP; PACHYONYCHIA-CONGENITA; LINKAGE ANALYSIS; HUMAN GENOME; MUTATIONS; CLUSTER; DESMOCOLLIN; ASSIGNMENT; KERATIN-16	Kerarolytic winter erythema (KWE), also known as ''Oudtshoorn skin disease,'' or ''erythrokeratolysis hiemalis,'' is an autosomal dominant skin disorder of unknown etiology characterized by a cyclical erythema, hyperkeratosis, and recurrent and intermittent peeling of the palms and soles, particularly during winter. Initially KWE,was believed to be unique to South Africa, but recently a large pedigree of German origin has been identified. The disorder occurs with a prevalence of 1/7,000 in the South African Africaans-speaking Caucasoid population, and this high frequency has been attributed to founder effect. After a number of candidate regions were excluded from linkage to KWE in both the German family and several South African families, a genomewide analysis was embarked on. Linkage to the microsatellite marker D8S550 on chromosome 8p22-p23 was initially observed, with a maximum LOD score (Z(max)) of 9.2 at a maximum recombination fraction (theta(max)) of .0 in the German family. Linkage was also demonstrated in five of the larger South African families, with Z(max) = 7.4 at theta(max) = .02. When haplotypes were constructed, 11 of 14 South African KWE families had the complete ''ancestral'' haplotype, and 3 demonstrated conservation of parts of this haplotype, supporting the hypothesis of founder effect, The chromosome segregating with the disease in the German family demonstrated a different haplotype, suggesting that these chromosomes do not have a common origin. Recombination events place the KWE gene in a 6-cM interval between D8S550 and D8S552. HE it is assumed that there was a single South African founder, a proposed ancestral recombinant suggests that the gene is most likely in a 1-cM interval between D8S550 and D8S265.	HUMBOLDT UNIV BERLIN,VIRCHOW KLINIKUM,INST HUMAN GENET,D-13353 BERLIN,GERMANY; UNIV WITWATERSRAND,JOHANNESBURG,SOUTH AFRICA; S AFRICAN INST MED RES,SCH PATHOL,DEPT HUMAN GENET,JOHANNESBURG,SOUTH AFRICA; MAX DELBRUCK CTR MOL MED,BERLIN,GERMANY; UNIV MARBURG,DEPT DERMATOL,MARBURG,GERMANY	Humboldt University of Berlin; University of Witwatersrand; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Philipps University Marburg			Spurdle, Amanda B/A-4978-2011; Reis, André/D-2309-2009; Hennies, Hans C/G-9424-2014	Spurdle, Amanda B/0000-0003-1337-7897; Reis, André/0000-0002-6301-6363; Hennies, Hans C/0000-0001-7210-2389; Ramsay, Michele/0000-0002-4156-4801; Hull, Peter/0000-0002-3896-9373				ABERLE H, 1995, P NATL ACAD SCI USA, V92, P6384, DOI 10.1073/pnas.92.14.6384; ARNEMANN J, 1991, GENOMICS, V10, P640, DOI 10.1016/0888-7543(91)90446-L; BERTHJONES J, 1989, CLIN EXP DERMATOL, V14, P313, DOI 10.1111/j.1365-2230.1989.tb01991.x; BOWDEN PE, 1995, NAT GENET, V10, P363, DOI 10.1038/ng0795-363; BUXTON RS, 1994, GENOMICS, V21, P510, DOI 10.1006/geno.1994.1309; DEAN G, 1971, PORPHYRIAS; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Epstein EH, 1996, CURR OPIN GENET DEV, V6, P295, DOI 10.1016/S0959-437X(96)80005-0; FINDLAY GH, 1977, S AFR MED J, V52, P871; FINDLAY GH, 1978, BRIT J DERMATOL, V98, P491, DOI 10.1111/j.1365-2133.1978.tb01934.x; HENNIES HC, 1995, HUM MOL GENET, V4, P1015, DOI 10.1093/hmg/4.6.1015; HEYL T, 1970, BRIT J DERMATOL, V38, P338; Hull PR, 1986, THESIS U WITWATERSRA; IKEDA S, 1994, HUM MOL GENET, V3, P1147, DOI 10.1093/hmg/3.7.1147; JENKINS T, 1980, S AFR MED J, V57, P943; KIMONIS V, 1994, J INVEST DERMATOL, V103, P764, DOI 10.1111/1523-1747.ep12412771; KING IA, 1993, GENOMICS, V18, P185, DOI 10.1006/geno.1993.1453; KRAHL D, 1994, HAUTARZT, V45, P776, DOI 10.1007/s001050050170; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Maestrini E, 1996, NAT GENET, V13, P70, DOI 10.1038/ng0596-70; Mckusick V.A., 1994, MENDELIAN INHERITANC; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; Milisavljevic V, 1996, GENOMICS, V34, P134, DOI 10.1006/geno.1996.0252; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; REIS A, 1994, NAT GENET, V6, P174, DOI 10.1038/ng0294-174; ROMANO V, 1991, CYTOGENET CELL GENET, V58, P2009; SHAMSHER MK, 1995, HUM MOL GENET, V4, P1875, DOI 10.1093/hmg/4.10.1875; SPURR NK, 1995, CYTOGENET CELL GENET, V68, P148; THOMAS JR, 1984, INT J DERMATOL, V23, P652, DOI 10.1111/j.1365-4362.1984.tb01225.x; VANKESSEL AG, 1994, CYTOGENET CELL GENET, V65, P142; VOLZ A, 1993, GENOMICS, V18, P92, DOI 10.1006/geno.1993.1430; WANG YM, 1994, GENOMICS, V20, P492, DOI 10.1006/geno.1994.1207; YOON SJ, 1994, GENOMICS, V24, P502, DOI 10.1006/geno.1994.1659	34	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					370	378		10.1086/514848	http://dx.doi.org/10.1086/514848			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311742	Green Published, Bronze			2022-12-18	WOS:A1997XX70100015
J	Mirzayans, F; Mears, AJ; Guo, SW; Pearce, WG; Walter, MA				Mirzayans, F; Mears, AJ; Guo, SW; Pearce, WG; Walter, MA			Identification of the human chromosomal region containing the iridogoniodysgenesis anomaly locus by genomic-mismatch scanning	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-LINKAGE; RESOLUTION; DESCENT	Genome-mismatch scanning (GMS) is a new method of linkage analysis that rapidly isolates regions of identity between two genomes. DNA molecules from regions of identity by descent from two relatives are isolated based on their ability to form extended mismatch-free heteroduplexes. We have applied this rapid technology to identify the chromosomal region shared by two fifth-degree cousins with autosomal dominant iridogonio dysgenesis anomaly (IGDA), a rare ocular neurocristopathy. Markers on the short arm of human chromosome Gp were recovered, consistent with the results of conventional linkage analysis conducted in parallel, indicating linkage of IGDA to 6p25. Control markers tested on a second human chromosome were not recovered. A GMS error rate of similar to 11% was observed, well within an acceptable range for a rapid, first screening approach, especially since GMS results would be confirmed by family analysis with selected markers from the putative region of identity by descent. These results demonstrate not only the value of this technique in the rapid mapping of human genetic traits, but the first application of GMS to a multicellular organism.	UNIV ALBERTA,OCULAR GENET LAB,DEPT OPHTHALMOL,EDMONTON,AB T6G 2S2,CANADA; UNIV MINNESOTA,DIV EPIDEMIOL,MINNEAPOLIS,MN 55455	University of Alberta; University of Minnesota System; University of Minnesota Twin Cities					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056515, R29GM052205] Funding Source: NIH RePORTER; NIGMS NIH HHS [R29 GM52205, R01 GM56515] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berg F., 1932, ACTA OPHTHALMOL, V10, P568, DOI [10.1111/j.1755-3768.1932.tb07210.x, DOI 10.1111/J.1755-3768.1932.TB07210.X]; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; CASNA NJ, 1986, NUCLEIC ACIDS RES, V14, P7285, DOI 10.1093/nar/14.18.7285; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; GUO SW, 1995, AM J HUM GENET, V56, P1468; JERNDAL T, 1972, AM J OPHTHALMOL, V74, P28, DOI 10.1016/0002-9394(72)91121-X; LANGE K, 1985, AM J HUM GENET, V37, P853; Mann I., 1964, DEV HUMAN EYE; Mears AJ, 1996, AM J HUM GENET, V59, P1321; MIRZAYANS F, 1995, AM J HUM GENET, V57, P539; MORTON NE, 1956, AM J HUM GENET, V8, P80; NELSON SF, 1993, NAT GENET, V4, P11, DOI 10.1038/ng0593-11; NELSON SF, 1995, ELECTROPHORESIS, V16, P279, DOI 10.1002/elps.1150160144; PEARCE WG, 1983, CAN J OPHTHALMOL, V18, P7; WEATHERI.JR, 1969, BRIT J OPHTHALMOL, V53, P433, DOI 10.1136/bjo.53.7.433	15	27	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					111	119		10.1086/513894	http://dx.doi.org/10.1086/513894			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245991	Green Published, Bronze			2022-12-18	WOS:A1997XM72800018
J	Gessler, DDG; Xu, SZ				Gessler, DDG; Xu, SZ			Using the expectation or the distribution of the identity by descent for mapping quantitative trait loci under the random model	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIMPLE REGRESSION METHOD; MENDELIAN FACTORS; FLANKING MARKERS; LINKAGE	We examine the ability of four implementations of the random model to map quantitative trait loci (QTLs). The implementations use either the expectation or the distribution of the identity-by-descent value at a putative QTL and either a 2 x 1 vector of sib-pair traits or their scalar difference. When the traits of both sibs are used, there as little difference between the expectation and distribution methods, while the expectation method suffers in both precision and power when the difference between traits is used. This is consistent with the prediction that the difference between the expectation and distribution methods is inversely proportional to the amount off information available for mapping. We iind, though, that the amount of information must be very low for this difference to be noticeable. This is exemplified when both marker loci are fixed. In this case, while the expectation method is powerless to detect the QTL, the distribution method can still detect the presence (but nor the position) of the QTL 59% of the time (when using trait values) or 14% of the time (when using trait differences). We also note a confounding between estimates of the QTL, polygenic, and error variance. The degree of confounding is small when the vector ok trait values is used but can be substantial when the expectation method and trait differences are used. We discuss this in light of the general ability of the random model to partition these components.			Gessler, DDG (corresponding author), UNIV CALIF RIVERSIDE,DEPT BOT & PLANT SCI,RIVERSIDE,CA 93531, USA.							AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; CAREY G, 1986, AM J HUM GENET, V39, P775; Cornell J.A., 1990, WILEY SERIES PROBABI, V2nd; ELSTON RC, 1973, SOC BIOL, V20, P276, DOI 10.1080/19485565.1973.9988054; ELSTON RC, 1988, P 2 INT C QUANT GEN, P281; FULKER DW, 1994, AM J HUM GENET, V54, P1092; FULKER DW, 1973, SOC BIOL, V20, P266, DOI 10.1080/19485565.1973.9988053; GOLDBERGER AS, 1973, STRUCTURAL EQUATION, P11; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; Haldane JBS, 1919, J GENET, V8, P299; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; JANSEN RC, 1992, THEOR APPL GENET, V85, P252, DOI 10.1007/BF00222867; JINKS JL, 1970, PSYCHOL BULL, V73, P311, DOI 10.1037/h0029135; KNOTT SA, 1992, GENETICS, V132, P1211; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1989, GENETICS, V121, P185; LOEHLIN JC, 1978, BEHAV GENET, V8, P415, DOI 10.1007/BF01067938; MARTIN NG, 1977, HEREDITY, V38, P79, DOI 10.1038/hdy.1977.9; MARTINEZ O, 1992, THEOR APPL GENET, V85, P480, DOI 10.1007/BF00222330; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Sax K, 1923, GENETICS, V8, P552; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; Searle S. R, 1992, VARIANCE COMPONENT; Searle SR, 1971, LINEAR MODELS; XU SH, 1995, GENETICS, V141, P1189; XU SH, 1995, GENETICS, V141, P1657	30	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1382	1390						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940284				2022-12-18	WOS:A1996VV31500025
J	Touitou, I; Rey, JM; Dross, C; Dupont, M; Brun, O; Ciano, M; Demaille, J; Smaoui, N; Nedelec, B; Hamidi, L; Cattan, D; Mery, JP; Prier, A; Cabane, J; Choukroun, G; Godeau, P; Delpech, M; Grateau, G; Faure, S; Prudhomme, JF; Clepet, C; Weissenbach, J; Akopian, K; Kouyoumdjian, JC; Amselem, S; Dervichian, M; Goossens, M				Touitou, I; Rey, JM; Dross, C; Dupont, M; Brun, O; Ciano, M; Demaille, J; Smaoui, N; Nedelec, B; Hamidi, L; Cattan, D; Mery, JP; Prier, A; Cabane, J; Choukroun, G; Godeau, P; Delpech, M; Grateau, G; Faure, S; Prudhomme, JF; Clepet, C; Weissenbach, J; Akopian, K; Kouyoumdjian, JC; Amselem, S; Dervichian, M; Goossens, M			Localization of the familial Mediterranean fever gene (FMF) to a 250-kb interval in non-Ashkenazi Jewish founder haplotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; JEWS; HOMOZYGOSITY; AMYLOIDOSIS; COLCHICINE; GENOME; LOCUS; MAP	Chromosome 16p13.3 harbors a gene (MEF) associated with familial Mediterranean fever (FMF), a recessive disease very common in populations of Mediterranean ancestry. In the course of positional cloning of MEF, we genotyped 26 non-Ashkenazi Jewish FMF pedigrees (310 meioses) with 15 microsatellite markers, most of which were recently developed by Genethon. Identification of recombination events in the haplotypes allowed narrowing of the MEF interval to a region between D16S3124 (telomeric) and D16S475 (centromeric). Two markers, D16S3070 and D16S3275, a microsatellite marker isolated from a YAC that also contains D16S3070, showed no recombination with the disease. Linkage disequilibrium and haplotype analysis highlighted the existence of a founder haplotype in our population. The core ancestral alleles were present in 71% of MEF-bearing chromosomes at loci D16S3070 and D16S3275. Furthermore, identification of historical crossing-over events in these pedigrees indicated that MEF is located between these two loci, which are both contained in a 250-kb genomic fragment.	UNIV PARIS,ICGM,EA 1501,F-75252 PARIS,FRANCE; GENETHON,CNRS URA 1922,EVRY,FRANCE; HOP HENRI MONDOR,INSERM U91,F-94010 CRETEIL,FRANCE	UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Touitou, I (corresponding author), HOP A VILLENEUVE,BIOCHIM GENET LAB,F-34295 MONTPELLIER 5,FRANCE.		Gabriel, Choukroun/AAL-4969-2021					AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P644; AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P451; ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ELLIS NA, 1994, AM J HUM GENET, V55, P453; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HELLER H, 1958, ARCH INTERN MED, V102, P50, DOI 10.1001/archinte.1958.00260190052007; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; Levy EN, 1996, AM J HUM GENET, V58, P523; LIVNEH A, 1994, ARTHRITIS RHEUM-US, V37, P1804, DOI 10.1002/art.1780371215; MCALPINE PJ, 1991, CYTOGENET CELL GENET, V58, P5, DOI 10.1159/000133160; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; RODIUS F, 1994, AM J HUM GENET, V54, P1050; Sambrook J, 1989, MOL CLONING LAB MANU; SHOHAT M, 1992, AM J HUM GENET, V51, P1349; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; SOOD R, 1995, GENOME MAPPING SEQUE, P259; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weir BS, 1990, GENETIC DATA ANAL; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZEMER D, 1986, NEW ENGL J MED, V314, P1001, DOI 10.1056/NEJM198604173141601	24	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					603	612						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751861				2022-12-18	WOS:A1996VN62500014
J	Nance, MA				Nance, MA			Huntington disease - Another chapter rewritten	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							AGE-OF-ONSET; TRINUCLEOTIDE REPEAT EXPANSION; CAG REPEAT; MOLECULAR ANALYSIS; (CAG)(N) REPEAT; PHENOTYPIC VARIATION; SCOTTISH POPULATION; GENE; LENGTH; MUTATION	To those of us who began life when humans had 48 chromosomes and who began working in genetics when the (by then 46) chromosomes had no bands and chromosome 4 could not reliably be distinguished from chromosome 5, the mere ability to diagnose and correlate the clinical phenotypes of genetic disorders with their molecular genotypes is a source of continuing astonishment and pleasure. Indeed, molecular genetic analysis of neurogenetic disorders such as Huntington disease (HD) has provided a steady stream of challenges and surprises to all who believe the genetic principles that they were taught about these disorders. The paper by Rubinsztein et al. in this issue of the Journal highlights yet another surprise, which was adumbrated even in the initial paper announcing the discovery of the HD gene: incomplete penetrance of HD gene mutations.	HENNEPIN CTY MED CTR,DEPT NEUROL,MINNEAPOLIS,MN	Hennepin County Medical Center	Nance, MA (corresponding author), VET ADM MED CTR,DEPT NEUROL,1 VET DR,MINNEAPOLIS,MN 55417, USA.							ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ANDREW SE, 1994, AM J HUM GENET, V54, P852; ASHIZAWA T, 1994, NEUROLOGY, V44, P1137, DOI 10.1212/WNL.44.6.1137; BARRON LH, 1993, J MED GENET, V30, P1003, DOI 10.1136/jmg.30.12.1003; BARRON LH, 1994, HUM MOL GENET, V3, P173, DOI 10.1093/hmg/3.1.173; BEILBY J, 1994, MED J AUSTRALIA, V161, P356, DOI 10.5694/j.1326-5377.1994.tb127486.x; BRITTON JW, 1995, NEUROLOGY, V45, P443, DOI 10.1212/WNL.45.3.443; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CRAUFURD D, 1993, J MED GENET, V30, P1008, DOI 10.1136/jmg.30.12.1008; DAVIS MB, 1994, LANCET, V344, P714, DOI 10.1016/S0140-6736(94)92208-X; DEROOIJ KE, 1993, J MED GENET, V30, P996, DOI 10.1136/jmg.30.12.996; DEROOIJ KE, 1993, LANCET, V342, P1491, DOI 10.1016/0140-6736(93)92974-X; DURR A, 1995, J NEUROL SCI, V129, P51, DOI 10.1016/0022-510X(94)00250-R; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Goldberg Y. P., 1995, American Journal of Human Genetics, V57, pA28; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; GOLDBERG YP, 1993, J MED GENET, V30, P987, DOI 10.1136/jmg.30.12.987; Harper PS, 1991, HUNTINGTONS DIS; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; ILLARIOSHKIN SN, 1994, ANN NEUROL, V36, P630, DOI 10.1002/ana.410360412; KIEBURTZ K, 1994, J MED GENET, V31, P872, DOI 10.1136/jmg.31.11.872; KREMER B, 1995, AM J HUM GENET, V57, P343; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; KREMER B, 1993, J MED GENET, V30, P991, DOI 10.1136/jmg.30.12.991; Leeflang E. P., 1995, American Journal of Human Genetics, V57, pA29; Legius Eric, 1994, European Journal of Human Genetics, V2, P44; LUCOTTE G, 1995, HUM GENET, V95, P231; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1993, J MED GENET, V30, P982, DOI 10.1136/jmg.30.12.982; MACMILLAN JC, 1993, LANCET, V342, P954, DOI 10.1016/0140-6736(93)92002-B; MACMILLAN JC, 1993, J MED GENET, V30, P1012, DOI 10.1136/jmg.30.12.1012; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MCGLENNAN RC, 1995, AM J HUM GENET S, V57, pA246; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; Nance Martha A., 1996, Neurology, V46, pA251; NORREMOLLE A, 1993, HUM MOL GENET, V2, P1475, DOI 10.1093/hmg/2.9.1475; NOVELLETTO A, 1994, HUM MOL GENET, V3, P93, DOI 10.1093/hmg/3.1.93; RUBINSZTEIN DC, 1994, J MED GENET, V31, P690, DOI 10.1136/jmg.31.9.690; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; RUBINSZTEIN DC, 1993, HUM MOL GENET, V2, P1713, DOI 10.1093/hmg/2.10.1713; Sanchez A., 1995, American Journal of Human Genetics, V57, pA227; SIMPSON SA, 1993, J MED GENET, V30, P1014, DOI 10.1136/jmg.30.12.1014; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Soong Bing-Wen, 1995, Proceedings of the National Science Council Republic of China Part B Life Sciences, V19, P137; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; STCLAIR D, 1994, J MED GENET, V31, P658, DOI 10.1136/jmg.31.8.658; STEVENS D, 1969, J NEUROL NEUROSUR PS, V32, P140, DOI 10.1136/jnnp.32.2.140; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; TZAGOURNISSAKIS M, 1995, HUM MOL GENET, V4, P2239, DOI 10.1093/hmg/4.12.2239; VOGEL F, 1986, HUMAN GENETICS; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; ZUHLKE C, 1993, HUM MOL GENET, V2, P1467; ZUHLKE C, 1993, HUM MOL GENET, V2, P2063, DOI 10.1093/hmg/2.12.2063; 1993, CELL, V72, P971	59	27	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					1	6						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659511				2022-12-18	WOS:A1996VL45500001
J	Rouger, H; LeGuern, E; Gouider, R; Tardieu, S; Birouk, N; Gugenheim, M; Bouche, P; Agid, Y; Brice, A				Rouger, H; LeGuern, E; Gouider, R; Tardieu, S; Birouk, N; Gugenheim, M; Bouche, P; Agid, Y; Brice, A			High frequency of mutations in codon 98 of the peripheral myelin protein Po gene in 20 French CMT1 patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TOOTH DISEASE TYPE-1A; NEUROPATHY TYPE-1B; DUPLICATION; DNA		HOP LA PITIE SALPETRIERE,INSERM U289,F-75651 PARIS 13,FRANCE; HOP LA PITIE SALPETRIERE,FEDERAT NEUROL,F-75651 PARIS 13,FRANCE; HOP LA PITIE SALPETRIERE,SERV EXPLORAT FONCTIONNELLES NEUROL,F-75651 PARIS 13,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite			Brice, Alexis/A-2170-2009; Gouider, Riadh/AAX-2634-2020; brice, alexis/AAE-8275-2019	Gouider, Riadh/0000-0001-9615-3797; brice, alexis/0000-0002-0941-3990				BRICE A, 1992, J MED GENET, V29, P807, DOI 10.1136/jmg.29.11.807; Dyck P.J, 1993, PNP, P1094; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HAYASAKA K, 1993, BIOCHEM BIOPH RES CO, V194, P1317, DOI 10.1006/bbrc.1993.1968; HAYASAKA K, 1993, HUM MOL GENET, V2, P1369, DOI 10.1093/hmg/2.9.1369; HIMORO M, 1993, BIOCHEM MOL BIOL INT, V31, P169; KULKENS T, 1993, NAT GENET, V5, P35, DOI 10.1038/ng0993-35; LATOUR P, 1995, HUM MUTAT, V6, P50, DOI 10.1002/humu.1380060110; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; NELIS E, 1994, HUM GENET, V94, P653, DOI 10.1007/BF00206959; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PHAMDINH D, 1993, HUM MOL GENET, V2, P2051, DOI 10.1093/hmg/2.12.2051; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; SKRE H, 1974, CLIN GENET, V6, P98; SU Y, 1993, P NATL ACAD SCI USA, V90, P10856, DOI 10.1073/pnas.90.22.10856; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288	18	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					638	641						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644725				2022-12-18	WOS:A1996TV56400025
J	Henseler, M; Klein, A; Reber, M; Vanier, MT; Landrieu, P; Sandhoff, K				Henseler, M; Klein, A; Reber, M; Vanier, MT; Landrieu, P; Sandhoff, K			Analysis of a splice-site mutation in the sap-precursor gene of a patient with metachromatic leukodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPHINGOLIPID ACTIVATOR PROTEIN-2; CULTURED SKIN FIBROBLASTS; GAUCHER DISEASE; MESSENGER-RNA; CEREBROSIDE SULFATE; VARIANT FORM; DEFICIENCY; DEGRADATION; EXPRESSION; INSERTION	Sphingolipid activator proteins (SAPs) are small, nonenzymatic glycoproteins required for the lysosomal degradation of various sphingolipids with a short oligosaccharide chain by their exohydrolases. Four of the five known activator proteins (sap-A-sap-D), also called ''saposins,'' are derived from a common precursor by proteolytic processing. sap-B stimulates hydrolysis of sulfatides by arylsulfatase A in vivo. Its recessively inherited deficiency results in a metabolic disorder similar to classical metachromatic leukodystrophy, which is caused by a defect of arylsulfatase A, Here we report on a patient with sap-B deficiency. Reverse-transcription-PCR studies on the patient's mRNA revealed the occurrence of two distinct mutant species: one with an in-frame deletion of the first 21 bases of exon 6, the other with a complete in-frame deletion of this exon. The patient was homozygous for the underlying mutation, which was found to be a G-->T transversion within the acceptor splice site between intron e and exon 6, abolishing normal RNA splicing. Allele-specific oligonucleotide hybridization revealed that the parents and both grandfathers of the patient were carriers of this mutation. In order to analyze the fate of the mutant precursor proteins, both abnormal cDNAs were stably expressed in baby hamster kidney cells. Pulse-chase experiments showed that the deletion of 21 bp had no effect on the transport and the maturation of the encoded precursor. All sap forms except sap-B were detectable by immunochemical methods. The cDNA bearing a complete deletion of exon 6 encoded a shortened precursor of only 60 kD, and no mature SAPs were detectable. The carbohydrate chains of this polypeptide were of the high-mannose and hybrid type, indicating no transport of the mutant precursor beyond early Golgi apparatus. An endoplasmic-reticulum localization of this polypeptide was supported by indirect immunofluorescence analysis.	UNIV BONN,INST ORGAN CHEM & BIOCHEM,D-53121 BONN,GERMANY; LYON SUD SCH MED,DEPT BIOCHEM,CNRS 189,INSERM,OULLINS,FRANCE; UNIV PARIS 11,BICETRE HOSP,DEPT NEUROPEDIAT,PARIS,FRANCE	University of Bonn; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay								ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; Ausubel F., 1992, MOL REPROD DEV, DOI DOI 10.1002/MRD.1080010210; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; CHRISTOMANOU H, 1986, BIOL CHEM H-S, V367, P879, DOI 10.1515/bchm3.1986.367.2.879; FUJIBAYASHI S, 1986, BIOCHIM BIOPHYS ACTA, V875, P554; FUJIBAYASHI S, 1986, J BIOL CHEM, V261, P5339; FURST W, 1988, BIOL CHEM H-S, V369, P317, DOI 10.1515/bchm3.1988.369.1.317; FURST W, 1992, BIOCHIM BIOPHYS ACTA, V1126, P1, DOI 10.1016/0005-2760(92)90210-M; HARZER K, 1989, EUR J PEDIATR, V149, P31, DOI 10.1007/BF02024331; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HOLTSCHMIDT H, 1991, FEBS LETT, V280, P267, DOI 10.1016/0014-5793(91)80308-P; HOLTSCHMIDT H, 1991, J BIOL CHEM, V266, P7566; KLEIN A, 1994, BIOCHEM BIOPH RES CO, V200, P1440, DOI 10.1006/bbrc.1994.1612; KRETZ KA, 1990, P NATL ACAD SCI USA, V87, P2541, DOI 10.1073/pnas.87.7.2541; KUDOH T, 1982, J CLIN INVEST, V70, P89, DOI 10.1172/JCI110607; MORIMOTO S, 1989, P NATL ACAD SCI USA, V86, P3389, DOI 10.1073/pnas.86.9.3389; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; RAFI MA, 1990, BIOCHEM BIOPH RES CO, V166, P1017, DOI 10.1016/0006-291X(90)90912-7; RAFI MA, 1993, SOMAT CELL MOLEC GEN, V19, P1, DOI 10.1007/BF01233949; Sambrook J., 1989, MOL CLONING LAB MANU; SANDHOFF K, 1995, METABOLIC MOL BASES, P2427; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLOTE W, 1991, EUR J PEDIATR, V150, P584, DOI 10.1007/BF02072213; SCHNABEL D, 1992, J BIOL CHEM, V267, P3312; SCHNABEL D, 1991, FEBS LETT, V284, P57, DOI 10.1016/0014-5793(91)80760-Z; STAFFORD FJ, 1991, J CELL BIOL, V115, P1225, DOI 10.1083/jcb.115.5.1225; TAYAMA M, 1993, BIOCHEM J, V290, P401, DOI 10.1042/bj2900401; VARA JA, 1986, NUCLEIC ACIDS RES, V14, P4617, DOI 10.1093/nar/14.11.4617; WIRTH M, 1988, GENE, V73, P419, DOI 10.1016/0378-1119(88)90506-9; ZHANG XL, 1991, HUM GENET, V87, P211, DOI 10.1007/BF00204185; ZHANG XL, 1990, P NATL ACAD SCI USA, V87, P1426, DOI 10.1073/pnas.87.4.1426	31	27	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					65	74						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554069				2022-12-18	WOS:A1996TL69700010
J	Srivastava, AK; Montonen, O; SaarialhoKere, U; Chen, E; Baybayan, P; Pispa, J; Limon, J; Schlessinger, D; Kere, J				Srivastava, AK; Montonen, O; SaarialhoKere, U; Chen, E; Baybayan, P; Pispa, J; Limon, J; Schlessinger, D; Kere, J			Fine mapping of the EDA gene: A translocation breakpoint is associated with a CpG island that is transcribed	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; YEAST ARTIFICIAL CHROMOSOMES; LINKAGE ANALYSIS; LOCALIZATION; CONSTRUCTION; FRAGMENT; INSERTS; FEMALE	In order to identify the gene for human X-linked anhidrotic ectodermal dysplasia (EDA), a translocation breakpoint in a female with t(X;1)(q13.1;p36.3) and EDA (patient AK) was finely mapped. The EDA region contains five groups of rare-cutter restriction sites that define CpG islands. The two more centromeric of these islands are associated with transcripts of 3.5 kb and 1.8 kb. The third CpG island maps within <1 kb of the translocation breakpoint in patient AK, as indicated by a genomic rearrangement, and similar to 100 kb centromeric from another previously mapped translocation breakpoint (patient AnLy). Northern analysis with a probe from this CpG island detected an similar to G-kb mRNA in several fetal tissues tested. An extended YAC contig of 1,200 kb with an average of fivefold coverage was constructed. The two most telomeric CpG islands map 350 kb telomeric of the two translocations. Taken together, the results suggest that the CpG island just proximal of the AK translocation breakpoint lies at the 5' end of a candidate gene for EDA.	HELSINKI UNIV, DEPT MED GENET, SF-00014 HELSINKI, FINLAND; WASHINGTON UNIV, SCH MED, DEPT MOLEC MICROBIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, CTR MED GENET, ST LOUIS, MO 63110 USA; HELSINKI UNIV, DEPT DENT, SF-00014 HELSINKI, FINLAND; HELSINKI UNIV, CENT HOSP, DEPT DERMATOL, HELSINKI, FINLAND; PERKIN ELMER CORP, DIV APPL BIOSYST, FOSTER CITY, CA USA; MED ACAD GDANSK, DEPT BIOL & GENET, GDANSK, POLAND	University of Helsinki; Washington University (WUSTL); Washington University (WUSTL); University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Thermo Fisher Scientific; Applied Biosystems; Fahrenheit Universities; Medical University Gdansk			Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271				ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; Blanchard M M, 1993, PCR Methods Appl, V2, P234; BLECHER SR, 1986, J INVEST DERMATOL, V87, P720, DOI 10.1111/1523-1747.ep12456718; Chromczynski P, 1987, ANAL BIOCHEM, V162, P156; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CLARKE A, 1987, HUM GENET, V75, P378, DOI 10.1007/BF00284112; HANAUER A, 1988, HUM GENET, V80, P177, DOI 10.1007/BF00702863; KERE J, 1992, GENOMICS, V14, P241, DOI 10.1016/S0888-7543(05)80212-5; KERE J, 1993, GENOMICS, V16, P305, DOI 10.1006/geno.1993.1189; KOLVRAA S, 1986, HUM GENET, V74, P284; LEE JT, 1992, GENOMICS, V12, P526, DOI 10.1016/0888-7543(92)90444-W; LIMON J, 1991, HUM GENET, V87, P338; MACDERMOT KD, 1990, HUM GENET, V84, P577; MACDERMOT KD, 1986, HUM GENET, V74, P172, DOI 10.1007/BF00282084; MAZZARELLA R, 1994, HUM MOL GENET, V3, P1095, DOI 10.1093/hmg/3.7.1095; Mckusick V.A., 1994, MENDELIAN INHERITANC; NAGARAJA R, 1994, NUCLEIC ACIDS RES, V22, P3406, DOI 10.1093/nar/22.16.3406; SAARIALHOKERE UK, 1993, J BIOL CHEM, V268, P17354; Sambrook J., 1989, MOL CLONING LAB MANU; SHOWS TB, 1975, P NATL ACAD SCI USA, V72, P2125, DOI 10.1073/pnas.72.6.2125; SLOAN DD, 1994, GENET ANAL TECH APPL, V10, P128; Srivastava Anand K., 1994, P239; THOMAS NST, 1993, HUM MOL GENET, V10, P1679; WADA M, 1990, AM J HUM GENET, V46, P95; ZONANA J, 1988, AM J HUM GENET, V43, P75; ZONANA J, 1993, AM J HUM GENET, V52, P78	26	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					126	132						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554048				2022-12-18	WOS:A1996TL69700016
J	ASHLEY, AE; SHERMAN, SL				ASHLEY, AE; SHERMAN, SL			POPULATION-DYNAMICS OF A MEIOTIC MITOTIC EXPANSION MODEL FOR THE FRAGILE-X SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FMR-I LOCUS; MONOZYGOTIC TWINS; FETAL TISSUES; FULL MUTATION; CGG REPEAT; METHYLATION; GENE; INSTABILITY; REPLICATION; PREMUTATION	A model to explain the mutational process and population dynamics of the fragile X syndrome is presented. The mutational mechanism was assumed to be a multi-pathway, multistep process. Expansion of CGG repeats was based on an underlying biological process and was assumed to occur at two time points: meiosis and early embryonic development (mitosis). Meiotic expansion was assumed to occur equally in oogenesis and spermatogenesis, while mitotic expansion was restricted to somatic, or constitutional, alleles of maternal origin. Testable hypotheses were predicted by this meiotic/mitotic model. First, parental origin of mutation is predicted to be associated with the risk of a woman to have a full-mutation child. Second, ''contractions'' seen in premutation male transmissions are predicted not to be true contractions in repeat size, but a consequence of the lack of mitotic expansion in paternally derived alleles. Third, a portion of full-mutation males should have full-mutation alleles in their sperm, due to the lack of complete selection against the full-mutation female. Fourth, a specific premutation-allele frequency distribution is predicted and differs from that based on models assuming only meiotic expansion. Last, it is predicted that similar to 65 generations are required to achieve equilibrium, but this depends greatly on the expansion probabilities.	EMORY UNIV,SCH MED,DEPT MED & MOLEC GENET,ATLANTA,GA 30022	Emory University				Ashley-Koch, Allison/0000-0001-5409-9155	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027801] Funding Source: NIH RePORTER; NICHD NIH HHS [HD27801] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alberts B., 2017, MOL BIOL CELL; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DEPAMPHILIS ML, 1980, ANNU REV BIOCHEM, V49, P627, DOI 10.1146/annurev.bi.49.070180.003211; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FISCH GS, 1995, AM J HUM GENET, V56, P1147; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; KELLY R, 1989, GENOMICS, V5, P844, DOI 10.1016/0888-7543(89)90126-2; KOLEHMAINEN K, 1994, AM J MED GENET, V51, P428, DOI 10.1002/ajmg.1320510425; KRUYER H, 1994, AM J HUM GENET, V54, P437; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; MALMGREN H, 1992, AM J MED GENET, V43, P268, DOI 10.1002/ajmg.1320430142; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; MORRIS A, 1995, ANN HUM GENET, V53, P283; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; Oudet C., 1993, European Journal of Human Genetics, V1, P181; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; Sherman S., 1991, FRAGILE X SYNDROME D, P69; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SHERMAN SL, IN PRESS AM J MED GE; SNOW K, 1993, AM J HUM GENET, V53, P1217; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SVED JA, 1990, AM J HUM GENET, V46, P443; TUCKERMAN E, 1985, J MED GENET, V22, P85, DOI 10.1136/jmg.22.2.85; TURNER G, 1986, NEW ENGL J MED, V315, P607, DOI 10.1056/NEJM198609043151002; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VOGEL F, 1984, ANN HUM GENET, V48, P327, DOI 10.1111/j.1469-1809.1984.tb00846.x; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WINTER RM, 1987, HUM GENET, V75, P269, DOI 10.1007/BF00281072; WOHRLE D, 1992, HUM GENET, V89, P114, DOI 10.1007/BF00207057; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; YU S, 1992, AM J HUM GENET, V50, P968; ZHONG N, 1995, AM J HUM GENET, V57, P351	42	27	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1414	1425						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533772				2022-12-18	WOS:A1995TE65500020
J	SCHLEUTKER, J; LEPPANEN, P; MANSSON, JE; ERIKSON, A; WEISSENBACH, J; PELTONEN, L; AULA, P				SCHLEUTKER, J; LEPPANEN, P; MANSSON, JE; ERIKSON, A; WEISSENBACH, J; PELTONEN, L; AULA, P			LYSOSOMAL FREE SIALIC-ACID STORAGE DISORDERS WITH DIFFERENT PHENOTYPIC PRESENTATIONS - INFANTILE-FORM SIALIC-ACID STORAGE DISEASE AND SALLA DISEASE - REPRESENT ALLELIC DISORDERS ON 6Q14-15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; FINLAND; FINNISH; MONOSACCHARIDES; POPULATIONS; VARIANT	Similarities in biochemical findings have suggested that Salla disease (SD) and the infantile form of sialic acid storage disease (ISSD) could represent allelic disorders, despite their drastically different clinical phenotypes. SD and ISSD are both characterized by lysosomal storage of free N-acetyl neuraminic acid. However, in SD the increase detected in urine is 8-24-fold, whereas in ISSD the corresponding amount is 20-50-fold and patients are also more severely affected. Here we report linkage studies in 50 Finnish SD families and 26 non-Finnish families with no genealogical connections to Finns affected either with the Finnish type of SD, the ''intermediate'' form of the disease, or ISSD. All forms of the disease show linkage to the same locus on 6q14-q15. Haplotype analyses of Finnish SD chromosomes revealed one common haplotype, which was also seen in most of the non-Finnish patients with Finnish type of SD. This ancestral haplotype deviated from those observed in ISSD patients, who had a different common haplotype.	GOTHENBURG UNIV, INST CLIN NEUROSCI, DEPT PSYCHIAT & NEUROCHEM, MOLNDAL, SWEDEN; BODEN HOSP, DEPT PEDIAT, BODEN, SWEDEN; NATL PUBL HLTH INST, DEPT HUMAN MOLEC GENET, HELSINKI, FINLAND; GENETHON, EVRY, FRANCE	University of Gothenburg; Finland National Institute for Health & Welfare	SCHLEUTKER, J (corresponding author), UNIV TURKU, INST BIOMED, DEPT MED GENET, KIINAMYLLYNKATU 10, SF-20520 TURKU, FINLAND.			Schleutker, Johanna/0000-0002-1863-0305				AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; AULA P, 1986, J MENT DEFIC RES, V30, P365; AULA P, 1979, ARCH NEUROL-CHICAGO, V36, P88, DOI 10.1001/archneur.1979.00500380058006; CAMERON PD, 1990, ARCH DIS CHILD, V65, P314, DOI 10.1136/adc.65.3.314; CLEMENTS PR, 1988, J INHERIT METAB DIS, V11, P30, DOI 10.1007/BF01800055; DEKREMER RD, 1990, MEDICINA-BUENOS AIRE, V50, P107; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; FOIS A, 1987, EUR J PEDIATR, V146, P195, DOI 10.1007/BF02343235; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAATAJA L, 1994, AM J HUM GENET, V54, P1042; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; JARVELA I, 1991, GENOMICS, V10, P333, DOI 10.1016/0888-7543(91)90316-7; KESTILA M, 1994, AM J HUM GENET, V54, P757; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; MANCINI GMS, 1992, EUR J PEDIATR, V151, P590, DOI 10.1007/BF01957729; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; MANCINI GMS, 1991, DEV NEUROSCI-BASEL, V13, P327, DOI 10.1159/000112181; MANCINI GMS, 1991, J CLIN INVEST, V87, P1329, DOI 10.1172/JCI115136; MITCHISON HM, 1995, AM J HUM GENET, V56, P654; NYLANDER PO, 1991, HUM HERED, V41, P157, DOI 10.1159/000153995; Ott J., 1991, ANAL HUMAN GENETIC L; RENLUND M, 1986, SCIENCE, V232, P759, DOI 10.1126/science.3961501; RENLUND M, 1983, NEUROLOGY, V33, P57, DOI 10.1212/WNL.33.1.57; RENLUND M, 1987, AM J MED GENET, V28, P377, DOI 10.1002/ajmg.1320280216; SCHLEUTKER J, 1995, GENOMICS, V27, P286, DOI 10.1006/geno.1995.1044; SULISALO T, 1994, AM J HUM GENET, V55, P937; SYVANEN AC, 1992, GENOMICS, V12, P590, DOI 10.1016/0888-7543(92)90452-X; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; TONDEUR M, 1982, EUR J PEDIATR, V139, P142, DOI 10.1007/BF00441499; VAMOS E, 1986, PRENATAL DIAG, V6, P437, DOI 10.1002/pd.1970060607; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOLBURGBUCHHOLZ K, 1985, NEUROPEDIATRICS, V16, P67, DOI 10.1055/s-2008-1052546; WOLF U, 1995, HUM GENET, V95, P127	35	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					893	901						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573051				2022-12-18	WOS:A1995RV79300021
J	GELERNTER, J				GELERNTER, J			GENETICS OF BIPOLAR AFFECTIVE-DISORDER - TIME FOR ANOTHER REINVENTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							X-CHROMOSOME; DNA MARKERS; LINKAGE; ANTICIPATION; DISEASES		YALE UNIV,SCH MED,DEPT PSYCHIAT,NEW HAVEN,CT	Yale University	GELERNTER, J (corresponding author), VET AFFAIRS MED CTR,PSYCHIAT 116A2,950 CAMPBELL AVE,W HAVEN,CT 06516, USA.			Gelernter, Joel/0000-0002-4067-1859	NIMH NIH HHS [MH00931] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; COOK EH, 1995, AM J HUM GENET, V56, P993; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GELERNTER J, 1989, VALIDITY PSYCHIATRIC, P143; GERSHON ES, 1987, ARCH GEN PSYCHIAT, V44, P314; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; GIUFFRA LA, 1994, PSYCHOL MED, V24, P375, DOI 10.1017/S0033291700027355; Goodwin F.K., 1990, MANIC DEPRESSIVE ILL; HALL JG, 1990, AM J HUM GENET, V46, P857; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; HARPER PS, 1992, AM J HUM GENET, V51, P10; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; Morel BA, 1857, TRAITE DEGENERESCENC; Mott FW, 1911, LANCET, V1, P1251; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; NYLANDER PO, 1994, J MED GENET, V31, P686, DOI 10.1136/jmg.31.9.686; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; REICH T, 1969, AM J PSYCHIAT, V125, P1358, DOI 10.1176/ajp.125.10.1358; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; Rosanoff AJ, 1935, AM J PSYCHIAT, V91, P725, DOI 10.1176/ajp.91.4.725; ROSE S, 1995, NATURE, V373, P380, DOI 10.1038/373380a0; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; 1993, CELL, V72, P971	31	27	27	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1262	1266						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RA794	7762549				2022-12-18	WOS:A1995RA79400002
J	STRASS, E; FRIEDMAN, JM				STRASS, E; FRIEDMAN, JM			REPORT FROM THE ASHG INFORMATION AND EDUCATION COMMITTEE - MEDICAL-SCHOOL CORE CURRICULUM IN GENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											STRASS, E (corresponding author), UNIV BRITISH COLUMBIA,BRITISH COLUMBIA CHILDRENS HOSP,DEPT MED GENET,4500 OAK ST,VANCOUVER,BC V6H 3N1,CANADA.								0	27	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					535	537						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423					2022-12-18	WOS:A1995QF42300023
J	TREACY, E; CHILDS, B; SCRIVER, CR				TREACY, E; CHILDS, B; SCRIVER, CR			RESPONSE TO TREATMENT IN HEREDITARY METABOLIC DISEASE - 1993 SURVEY AND 10-YEAR COMPARISON	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MARROW TRANSPLANTATION; LIVER-TRANSPLANTATION; MENDELIAN DISEASE; GENETIC-DISEASES; HUMAN HEALTH; DEFICIENCY; DISORDERS; THERAPY	Knowledge about cause, pathogenesis, and manifestations of hereditary metabolic diseases puts them among the best known of ah human diseases. On the other hand, outcomes of treatment are cause for uncertainty and concern. In 1985, Hayes et al. analyzed efficacy of treatment up to 1983 in 65 of these diseases selected randomly from the McKusick catalogs. Disease scores were calculated for seven parameters: longevity; reproductive capability; somatic and cognitive development; and handicaps affecting schooling, work, and cosmetic appearance. Scores of the untreated and treated phenotypes were then compared. We have now measured progress over the past decade by calculating scores on the same 65 diseases from data in several hundred new reports published since 1983. Ah seven parameters in the 1993 survey reflect improved efficacy of treatment in the 10-year interval. However, the percent of diseases for which all manifestations of the disease were removed by treatment has not changed (12% in 1983; 12% in 1993). The group in which manifestations were untouched by treatment has become smaller (48% in 1983; 31% in 1993), and the group partially ameliorated by treatment had increased reciprocally (40% in 1983; 57% in 1993). Progress in the treatment of hereditary metabolic disease is thus better than it was, but it is still only a partial success. The advances are attributable to greater success with organ and tissue transplantation, better pharmacotherapy, and better support systems. Restoration of normal homeostasis, the key to successful treatment, remains an elusive challenge and is a logical, major focus for research in human genetics.	MONTREAL CHILDRENS HOSP,RES INST,MONTREAL,PQ H3H 1P3,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; JOHNS HOPKINS UNIV HOSP,DEPT PEDIAT,BALTIMORE,MD 21205	McGill University; McGill University; Johns Hopkins University; Johns Hopkins Medicine				Treacy, Eileen/0000-0002-6226-1615				ALONSO EM, 1992, EUR J PEDIATR, V151, pS23, DOI 10.1007/BF02125799; ARROW KJ, 1985, COLLECTED PAPERS KJ, P208; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BATSHAW ML, 1982, NEW ENGL J MED, V306, P1387, DOI 10.1056/NEJM198206103062303; BATSHAW ML, 1994, ANN NEUROL, V35, P133, DOI 10.1002/ana.410350204; BERNARD O, 1990, INBORN METABOLIC DIS, P651; BLAESE RM, 1993, PEDIATR RES S, V33, P49; BRADY RO, 1993, ARCH NEUROL-CHICAGO, V50, P1212, DOI 10.1001/archneur.1993.00540110088009; BURDELSKI M, 1991, J INHERIT METAB DIS, V14, P604, DOI 10.1007/BF01797930; CHANTLER C, 1992, EUR J PEDIATR, V151, pS81, DOI 10.1007/BF02125809; COSTA T, 1985, AM J MED GENET, V21, P231, DOI 10.1002/ajmg.1320210205; COUTELLE C, 1993, ARCH DIS CHILD, V68, P437, DOI 10.1136/adc.68.4.437; COWAN MJ, 1991, CLIN BIOCHEM, V24, P375, DOI 10.1016/0009-9120(91)80012-R; FRIEDMANN T, 1989, SCIENCE WASHINGTON D, V244, P275; HAYES A, 1985, AM J MED GENET, V21, P243, DOI 10.1002/ajmg.1320210206; HOBBS JR, 1992, EUR J PEDIATR, V151, pS44, DOI 10.1007/BF02125802; Ledley Fred D., 1992, Current Opinion in Pediatrics, V4, P972, DOI 10.1097/00008480-199212000-00011; MAESTRI NE, 1991, J PEDIATR-US, V119, P923, DOI 10.1016/S0022-3476(05)83044-6; McKusick V.A., 1978, MENDELIAN INHERITANC; McKusick V.A., 1992, MENDELIAN INHERITANC; MILLER AD, 1992, NATURE, V357, P455, DOI 10.1038/357455a0; MITCHELL GA, 1994, METABOLIC MOL BASIS; MOWAT AP, 1992, EUR J PEDIATR, V151, pS32, DOI 10.1007/BF02125800; Msall M, 1988, Acta Paediatr Jpn, V30, P435; PARKMAN R, 1986, SCIENCE, V232, P1373, DOI 10.1126/science.3520819; RABIER D, 1991, J INHERIT METAB DIS, V14, P277, DOI 10.1007/BF01811681; ROSENBERG LE, 1990, PEDIATR RES, V27, P510; SCHWEITZER S, 1993, EUR J PEDIATR, V152, P36, DOI 10.1007/BF02072514; Scriver C R, 1988, Acta Paediatr Jpn, V30, P472; SCRIVER CR, 1969, MED CLIN N AM, V53, P941, DOI 10.1016/S0025-7125(16)32742-0; SCRIVER GR, 1994, METABOLIC MOL BASIS; SELBY R, 1991, NEW ENGL J MED, V324, P39, DOI 10.1056/NEJM199101033240107; SOKAL EM, 1992, EUR J PEDIATR, V151, P200, DOI 10.1007/BF01954384; TUCHMAN M, 1989, NEW ENGL J MED, V320, P1498; WAGGONER DD, 1993, NIH933438 PUBL; ZITELLI BJ, 1988, PEDIATRICS, V82, P173	36	27	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					359	367						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847368				2022-12-18	WOS:A1995QF42300001
J	LANNFELT, L; AXELMAN, K; LILIUS, L; BASUN, H				LANNFELT, L; AXELMAN, K; LILIUS, L; BASUN, H			GENETIC-COUNSELING IN A SWEDISH ALZHEIMER FAMILY WITH AMYLOID PRECURSOR PROTEIN MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							APOLIPOPROTEIN-E; TYPE-4 ALLELE; DISEASE; FREQUENCY		KAROLINSKA INST,DEPT CLIN NEUROSCI,HUDDINGE,SWEDEN	Karolinska Institutet	LANNFELT, L (corresponding author), KAROLINSKA INST,ALZHEIMERS DIS RES CTR,HUDDINGE,SWEDEN.							AXELMAN K, IN PRESS ARCH NEUROL; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; COLLINGE J, 1991, AM J HUM GENET, V49, P1351; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRAUFURD D, 1989, LANCET, V336, P7; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HARDY J, 1993, LANCET, V343, P737; JOHNSTON J, 1993, HUM MOL GENET, V2, P1045, DOI 10.1093/hmg/2.7.1045; LANNFELT L, 1993, NEUROSCI LETT, V153, P85, DOI 10.1016/0304-3940(93)90083-W; LANNFELT L, 1994, NEUROSCI LETT, V168, P254, DOI 10.1016/0304-3940(94)90463-4; LANNFELT L, 1994, NEUROSCI LETT, V169, P175, DOI 10.1016/0304-3940(94)90384-0; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SJOGREN T, 1952, ACTA PSYCHIATR NEU S, V82; STGEORGEHYSLOP PH, 1991, NATURE, V347, P194; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977	18	27	27	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					332	335						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825596				2022-12-18	WOS:A1995QC10100043
J	WAGSTAFF, J; HEMANN, M				WAGSTAFF, J; HEMANN, M			A FAMILIAL BALANCED 3-9-TRANSLOCATION WITH CRYPTIC 8Q INSERTION LEADING TO DELETION AND DUPLICATION OF 9P23 LOCI IN SIBLINGS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; MOLECULAR CHARACTERIZATION; CHROMOSOME REARRANGEMENTS; PRENATAL-DIAGNOSIS; PRADER-WILLI; BROWN LOCUS; IDENTIFICATION; ASSOCIATION; ASSIGNMENT; DOMINANT	A child with phenotypic features of the 9p(-) syndrome, including metopic craniosynostosis, small ears, abdominal wall defect, and mental retardation, as well as hypopigmentation, was found to have a cytogenetically balanced 3;9 translocation, with breakpoints at 3p11 and 9p23, inherited from his phenotypically normal father. Molecular analysis showed heterozygous deletion of the TYRP (tyrosinase-related protein) locus, as well as loci D9S157, D9S274, D9S268, and D9S267, in the child but in neither parent. FISH analysis of the proband's father indicated that loci deleted in his son, including TYRP, were present on neither the der(3) nor the der(9) translocation products but had been inserted into the long arm of chromosome 8. Therefore, the apparent deletion of these loci in the proband was the result of meiotic segregation of the father's 3;9 translocation chromosomes together with his normal chromosome 8 (not bearing the insertion from 9p23). Neither the deletion of these 9p23 loci from the translocation chromosomes nor their insertion into 8q was detectable by standard chromosome banding techniques. The proband's sister exhibited speech delay, mild facial dysmorphism, and renal malformation, and her karyotype was 46,XX. Molecular analysis showed that she had inherited normal chromosomes 3 and 9, as well as the chromosome 8 with the insertion of 9p23 material, from her father. This analysis illustrates a new mechanism to explain cases in which an apparently balanced translocation has been transmitted from a normal parent to a child with a phenotypic abnormality: submicroscopic deletion of material from the translocation breakpoint and insertion into a third chromosome in the balanced parent, with meiotic segregation leading to loss of the inserted material in the child.	HARVARD UNIV,SCH MED,BOSTON,MA	Harvard University; Harvard Medical School	WAGSTAFF, J (corresponding author), CHILDRENS HOSP,DIV GENET,ENDERS 5,300 LONGWOOD AVE,BOSTON,MA 02115, USA.							ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BALDINI A, 1992, GENOMICS, V14, P181, DOI 10.1016/S0888-7543(05)80303-9; BODRUG SE, 1990, J MED GENET, V27, P426, DOI 10.1136/jmg.27.7.426; BOISSY RE, 1993, AM J HUM GENET, V53, P160; BREG WR, 1972, AM J DIS CHILD, V123, P561, DOI 10.1001/archpedi.1972.02110120085007; CENTERWALL WR, 1975, PEDIATRICS, V56, P748; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRYDMAN M, 1984, AM J MED GENET, V18, P55, DOI 10.1002/ajmg.1320180109; FRYNS JP, 1986, HUM GENET, V72, P1, DOI 10.1007/BF00278808; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; GIACALONE JP, 1992, AM J HUM GENET, V50, P725; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HENNEKAM RCM, 1990, CLIN GENET, V38, P374; HOOK EB, 1987, ANN HUM GENET, V51, P27; HURET JL, 1988, J MED GENET, V25, P741, DOI 10.1136/jmg.25.11.741; JACKSON IJ, 1990, GENETICS, V126, P451; JACOBS PA, 1974, NATURE, V249, P164, DOI 10.1038/249164a0; KWIATKOWSKI DJ, 1993, CYTOGENET CELL GENET, V64, P94; LALANDE M, 1984, CANCER GENET CYTOGEN, V13, P283, DOI 10.1016/0165-4608(84)90073-6; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MURTY VVVS, 1992, GENOMICS, V13, P227, DOI 10.1016/0888-7543(92)90228-K; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; PHILIP N, 1988, Journal de Genetique Humaine, V36, P37; PUISSANT H, 1988, HUM GENET, V79, P280, DOI 10.1007/BF00366252; ROLAND B, 1993, CLIN GENET, V43, P117, DOI 10.1111/j.1399-0004.1993.tb04434.x; Schinzel A, 1984, CATALOGUE UNBALANCED; Schinzel Albert, 1993, V384, P19; SMEETS DFCM, 1992, NEW ENGL J MED, V326, P807, DOI 10.1056/NEJM199203193261206; TEMPLE IK, 1991, J MED GENET, V28, P511, DOI 10.1136/jmg.28.8.511; THERMAL E, 1993, HUMAN CHROMOSOMES ST; TOMMERUP N, 1993, J MED GENET, V30, P958, DOI 10.1136/jmg.30.11.958; WAGSTAFF J, 1993, AM J HUM GENET, V53, P105; WANG HS, 1993, AM J MED GENET, V46, P559, DOI 10.1002/ajmg.1320460520; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WEKSBERG R, 1993, HUM MOL GENET, V2, P549, DOI 10.1093/hmg/2.5.549	36	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					302	309						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825591				2022-12-18	WOS:A1995QC10100039
J	GREENBERG, DA; BERGER, B				GREENBERG, DA; BERGER, B			USING LOD-SCORE DIFFERENCES TO DETERMINE MODE OF INHERITANCE - A SIMPLE, ROBUST METHOD EVEN IN THE PRESENCE OF HETEROGENEITY AND REDUCED PENETRANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOD SCORES; LINKAGE ANALYSIS; INFERRING MODE; DISEASE; LOCUS	Determining the mode of inheritance is often difficult under the best of circumstances, but when segregation analysis is used, the problems of ambiguous ascertainment procedures, reduced penetrance, heterogeneity, and misdiagnosis make mode-of-inheritance determinations even more unreliable. The mode of inheritance can also be determined using a linkage-based method (maximized maximum lod score or mod score) and association-based methods, which can overcome many of these problems. In this work, we determined how much information is necessary to reliably determine the mode of inheritance from linkage data when heterogeneity and reduced penetrance are present in the data set. We generated data sets under both dominant and recessive inheritance with reduced penetrance and with varying fractions of linked and unlinked families. We then analyzed those data sets, assuming reduced penetrance, both dominant and recessive inheritance, and no heterogeneity. We investigated the reliability of two methods for determining the mode of inheritance from the linkage data. The first method examined the difference (Delta) between the maximum lod scores calculated under the two mode-of-inheritance assumptions. We found that if Delta was >1.5, then the higher of the two maximum lod scores reflected the correct mode of inheritance with high reliability and that a Delta of 2.5 appeared to practically guarantee a correct mode-of-inheritance inference. Furthermore, this reliability appeared to be virtually independent of alpha, the fraction of linked families in the data set, although the reliability decreased slightly as alpha fell below .50. The second method we tested was based on choosing the higher of the two maximum lod scores calculated under the different mode-of-inheritance assumptions. This method became unreliable as alpha decreased. These results suggest that the mode of inheritance can be inferred from linkage data with high reliability, even in the presence of heterogeneity and reduced penetrance.			GREENBERG, DA (corresponding author), MT SINAI MED CTR,DEPT PSYCHIAT,BOX 1229,NEW YORK,NY 10029, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31775] Funding Source: Medline; NIMH NIH HHS [MH45212] Funding Source: Medline; NINDS NIH HHS [NS27941] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CIERGETDARPOUX F, 1986, BIOMETRICS, V42, P393; DURNER M, 1992, AM J HUM GENET, V51, P859; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; ELSTON RC, 1989, AM J MED GENET, V34, P487, DOI 10.1002/ajmg.1320340407; GREENBERG DA, 1993, AM J HUM GENET, V52, P135; GREENBERG DA, 1982, AM J HUM GENET, V34, P263; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; HODGE SE, IN PRESS GENET EPIDE; OTT J, 1974, AM J HUM GENET, V26, P588; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81	12	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					834	840						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942860				2022-12-18	WOS:A1994PJ02700025
J	JARVIK, GP; PATTON, MA; HOMFRAY, T; EVANS, JP				JARVIK, GP; PATTON, MA; HOMFRAY, T; EVANS, JP			NON-MENDELIAN TRANSMISSION IN A HUMAN DEVELOPMENTAL DISORDER - SPLIT HAND SPLIT FOOT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEGREGATION DISTORTION; MYOTONIC-DYSTROPHY; DROSOPHILA-MELANOGASTER; COMPONENTS; REGION	The study of Mendelian disorders that do not meet some Mendelian expectations has led to an increased understanding of such previously obscure genetic phenomena as anticipation. Split hand/split foot (SHSF), a human developmental malformation, demonstrates such distinctive genetic features as reduced penetrance and variable expressivity. In this study, new pedigrees with defined ascertainment confirm the existence of non-Mendelian transmission characterized by the overtransmission of SHSF from affected fathers to sons.	UNIV WASHINGTON, DEPT MED, DIV MED GENET, SEATTLE, WA 98195 USA; ST GEORGE HOSP, SCH MED, SW THAMES REG GENET SERV, LONDON, ENGLAND; UNIV N CAROLINA, DEPT MED, DIV MED GENET, CHAPEL HILL, NC USA	University of Washington; University of Washington Seattle; St Georges University London; University of North Carolina; University of North Carolina Chapel Hill			Jarvik, Gail P/N-6476-2014	Jarvik, Gail P/0000-0002-6710-8708				ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BRITTNACHER JG, 1984, GENETICS, V107, P423; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CROW JF, 1991, BIOESSAYS, V13, P305, DOI 10.1002/bies.950130609; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GANETZKY B, 1977, GENETICS, V86, P321; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARTL DL, 1975, GENETICS, V80, P539; HARTL DL, 1967, P NATL ACAD SCI USA, V58, P2240, DOI 10.1073/pnas.58.6.2240; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McMullen G, 1913, BIOMETRIKA, V9, P381; NICOLETT.B, 1967, ATTI ACCAD NAZ LIN, V43, P383; PALMER SE, 1994, AM J HUM GENET, V55, P21; Pearson K, 1908, BIOMETRIKA, V6, P69, DOI 10.2307/2331557; SANDLER L, 1959, GENETICS, V44, P233; SILVER LM, 1993, TRENDS GENET, V9, P250, DOI 10.1016/0168-9525(93)90090-5; STEVENSON AC, 1960, ANN HUM GENET, V24, P89; TEMTAMY SA, 1978, GENETICS HAND MALFOR, P53; THOMPSON MW, 1991, THOMPSON THOMPSON GE, P83	20	27	27	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					710	713						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942849				2022-12-18	WOS:A1994PJ02700014
J	LAZZERONI, LC; ARNHEIM, N; SCHMITT, K; LANGE, K				LAZZERONI, LC; ARNHEIM, N; SCHMITT, K; LANGE, K			MULTIPOINT MAPPING CALCULATIONS FOR SPERM-TYPING DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; SINGLE-SPERM; PEDIGREE ANALYSIS; EM ALGORITHM	This paper explains how multipoint likelihoods can be computed for sperm-typing data. Experimental errors such as multiple sperm per tube, inadequate amplification, and contamination by exogenous DNA are explicitly taken into account. By limiting the number of sperm theoretically possible per tube to a predetermined maximum and by assuming no chiasma interference, maximum-likelihood estimation can be carried out rapidly using the theory of hidden Markov chains.	UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOMATH,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH PUBL HLTH,DEPT BIOSTAT,LOS ANGELES,CA 90024; UNIV SO CALIF,DEPT BIOL SCI,PROGRAM MOLEC BIOL,LOS ANGELES,CA 90089	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Southern California			Lazzeroni, Laura/F-2903-2010	Lazzeroni, Laura/0000-0002-1846-6920; Arnheim, Norman/0000-0003-1247-1347				Baum LE, 1972, INEQUALITIES, V3, P1; BOEHNKE M, 1989, AM J HUM GENET, V45, P21; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DEVIJVER PA, 1985, PATTERN RECOGN LETT, V3, P369, DOI 10.1016/0167-8655(85)90023-6; FURLONG RA, 1993, AM J HUM GENET, V52, P1191; GORADIA TM, 1991, GENOMICS, V10, P748, DOI 10.1016/0888-7543(91)90459-R; GORADIA TM, 1990, ANN HUM GENET, V54, P49, DOI 10.1111/j.1469-1809.1990.tb00360.x; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LANGE K, 1994, SEARCH FORTRAN PROGR; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; SCHMITT K, 1994, AM J HUM GENET, V55, P423; WEEKS DE, 1989, IMA J MATH APPL MED, V6, P209; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	14	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					431	436						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	8079987				2022-12-18	WOS:A1994PF50900003
J	CANN, RL				CANN, RL			MTDNA AND NATIVE-AMERICANS - A SOUTHERN PERSPECTIVE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							AMERINDIAN MITOCHONDRIAL DNAS; HUMAN-POPULATIONS; AFFINITIES; DIVERSITY; LINEAGES				CANN, RL (corresponding author), UNIV HAWAII MANOA, JOHN A BURNS SCH MED, DEPT MOLEC BIOL & GENET, BIOMED SCI BLDG, 1960 E W RD, HONOLULU, HI 96822 USA.							AIGNER JS, 1984, EVOLUTION E ASIAN EN, P915; BAILLIER G, 1994, AM J HUM GENET, V55; Beaton JM., 1991, 1 AM SEARCH RES, P209; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; DILLEHAY TD, 1991, 1ST AM SEARCH RES; FLEMMING HC, 1993, MOTHER TONGUE, V20, P4; GINTHER C, 1993, EXS, V67, P211; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1993, MOL BIOL EVOL, V10, P23; KIRCH PV, 1988, T BURKE MEMORIAL WAS, V5, P157; LIVSHITS G, 1990, ANN HUM BIOL, V17, P501, DOI 10.1080/03014469000001272; LUM JK, 1994, HUM BIOL, V66, P567; Meltzer David J., 1993, EVOL ANTHROPOL, V1, P157; MORTON NE, 1993, ANNU REV GENET, V27, P523, DOI 10.1146/annurev.ge.27.120193.002515; NEI M, 1993, MOL BIOL EVOL, V10, P927; Renfrew C, 1991, CAMB ARCHAEOL J, V1, P3, DOI DOI 10.1017/S0959774300000238; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; Szathmary Emoke J. E., 1993, EVOL ANTHROPOL, V1, P202; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WRIGHT HE, 1991, 1 AM SEARCH RES, P113	33	27	27	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					7	11						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	7517627				2022-12-18	WOS:A1994NW46100002
J	STGEORGEHYSLOP, P; ROGAEVA, E; HUTERER, J; TSUDA, T; SANTOS, J; HAINES, JL; SCHLUMPF, K; ROGAEV, EI; LIANG, Y; MCLACHLAN, DRC; KENNEDY, J; WEISSENBACH, J; BILLINGSLEY, GD; COX, DW; LANG, AE; WHERRETT, JR				STGEORGEHYSLOP, P; ROGAEVA, E; HUTERER, J; TSUDA, T; SANTOS, J; HAINES, JL; SCHLUMPF, K; ROGAEV, EI; LIANG, Y; MCLACHLAN, DRC; KENNEDY, J; WEISSENBACH, J; BILLINGSLEY, GD; COX, DW; LANG, AE; WHERRETT, JR			MACHADO-JOSEPH-DISEASE IN PEDIGREES OF AZOREAN DESCENT IS LINKED TO CHROMOSOME-14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATAXIA SCA2; LINKAGE MAP; LOCUS; REPEAT; GENE	A locus for Machado-Joseph disease (MJD) has recently been mapped to a 30-cM region of chromosome 14q in five pedigrees of Japanese descent. MJD is a clinically pleomorphic neurodegenerative disease that was originally described in subjects of Azorean descent. In light of the nonallelic heterogeneity in other inherited spinocerebellar ataxias, we were interested to determine if the MJD phenotype in Japanese and Azorean pedigrees arose from mutations at the same locus. We provide evidence that MJD in five pedigrees of Azorean descent is also linked to chromosome 14q in an 18-cM region between the markers D14S67 and AACT (multipoint lod score +7.00 near D14S81). We also report molecular evidence for homozygosity at the MJD locus in an MJD-affected subject with severe, early-onset symptoms. These observations confirm the initial report of linkage of MJD to chromosome 14; suggest that MJD in Japanese and Azorean subjects may represent allelic or identical mutations at the same locus; and provide one possible explanation (MJD gene dosage) for the observed phenotypic heterogeneity in this disease.	UNIV TORONTO,DEPT MED,DIV NEUROL,TORONTO,ON,CANADA; UNIV TORONTO,INST MED SCI,TORONTO M5S 1A1,ON,CANADA; UNIV TORONTO,CLARKE INST PSYCHIAT,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PSYCHIAT,TORONTO,ON,CANADA; HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ON,CANADA; MASSACHUSETTS GEN HOSP E,MOLEC NEUROGENET UNIT,BOSTON,MA; HARVARD UNIV,SCH MED,BOSTON,MA; GENETHON,EVRY,FRANCE	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Harvard Medical School	STGEORGEHYSLOP, P (corresponding author), UNIV TORONTO,CTR RES NEURODEGENERAT DIS,TANZ NEUROSCI BLDG,6 QUEENS PK CRESENT W,TORONTO M5S 1A8,ON,CANADA.		Haines, Jonathan/C-3374-2012; Lang, Anthony/ABF-8114-2021	Haines, Jonathan/0000-0002-4351-4728; Lang, Anthony/0000-0003-1229-3667; St George-Hyslop, Peter/0000-0003-0796-7209				BARBEAU A, 1984, CAN J NEUROL SCI, V11, P510, DOI 10.1017/S0317167100034983; BEROUD C, IN PRESS CYTOGENET C; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V18, P24, DOI 10.1016/0010-4809(85)90004-7; BYTH BC, 1993, HUM MOL GENET, V2, P1085, DOI 10.1093/hmg/2.7.1085-a; CARSON WJ, 1992, GENOMICS, V13, P852, DOI 10.1016/0888-7543(92)90168-R; COOPER JA, 1983, ANN NEUROL, V14, P585, DOI 10.1002/ana.410140515; CUNHA L, 1988, CAN J NEUROL SCI, V15, P397, DOI 10.1017/S0317167100028122; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; JAIN S, 1990, NEUROLOGY, V40, P128, DOI 10.1212/WNL.40.1.128; LANG AE, IN PRESS ANN NEUROL; NAKANO KK, 1972, NEUROLOGY, V22, P49, DOI 10.1212/WNL.22.1.49; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; ROSENBERG RN, 1992, MOVEMENT DISORD, V7, P193, DOI 10.1002/mds.870070302; SAKAI T, 1983, NEUROLOGY, V33, P74, DOI 10.1212/WNL.33.1.74; SAKAKI Y, 1989, MOL BIOL MED, V6, P161; Sequeiros Jorge, 1993, V61, P139; SILVEIRA I, 1993, GENOMICS, V17, P556, DOI 10.1006/geno.1993.1371; SPINELLA GM, 1992, NEUROLOGY, V42, P2048, DOI 10.1212/WNL.42.10.2048; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	22	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					120	125						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023841				2022-12-18	WOS:A1994NW46100017
J	ANDRESEN, BS; JENSEN, TG; BROSS, P; KNUDSEN, I; WINTER, V; KOLVRAA, S; BOLUND, L; DING, JH; CHEN, YT; VANHOVE, JLK; CURTIS, D; YOKOTA, I; TANAKA, K; KIM, JJP; GREGERSEN, N				ANDRESEN, BS; JENSEN, TG; BROSS, P; KNUDSEN, I; WINTER, V; KOLVRAA, S; BOLUND, L; DING, JH; CHEN, YT; VANHOVE, JLK; CURTIS, D; YOKOTA, I; TANAKA, K; KIM, JJP; GREGERSEN, N			DISEASE-CAUSING MUTATIONS IN EXON-II OF THE MEDIUM-CHAIN ACYL-COA DEHYDROGENASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME-A DEHYDROGENASE; PIG-LIVER-MITOCHONDRIA; FATTY-ACID OXIDATION; MCAD DEFICIENCY; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; CULTURED FIBROBLASTS; NONSENSE MUTATIONS; PREVALENT MUTATION; ESCHERICHIA-COLI	Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most commonly recognized defect of the mitochondrial beta-oxidation in humans. It is a potentially fatal, autosomal recessive inherited defect. Most patients with MCAD deficiency are homozygous for a single disease-causing mutation (G985), causing a change from lysine to glutamate at position 304 (K304E) in the mature MCAD. Only seven non-G985 mutations, all of which are rare, have been reported. Because the G985 mutation and three of the non-G985 mutations are located in exon 11, it has been suggested that this exon may be a mutational hot spot. Here we describe the results from sequence analysis of exon 11 and part of the flanking introns from 36 compound heterozygous patients with MCAD deficiency. We have identified four previously unknown disease-causing mutations (M301T, S311R, R324X, and E359X) and two silent mutations in exon 11. Our results show that exon 11 is not especially mutation prone. We demonstrate that two of the identified disease-causing mutations can be detected by restriction enzyme digestion of the PCR product from the assay for the G985 mutation, a discovery that makes this assay even more useful than before. On the basis of expression of wild-type and mutant MCAD protein in COS-7 cells, we show that the identified mutations abolish MCAD enzyme activity and that they therefore must be disease causing. The M301T, S311R, and K304E mutations are located in helix H, which makes up part of the dimer-dimer interface of the MCAD tetramer. On the basis of the three-dimensional structure of MCAD and the results from the COS-7 expression experiments, we speculate that the primary effect of the M301T and S311R mutations is on correct folding/tetramer assembly, as it has previously been observed for the K304E mutation.	AARHUS UNIV,INST HUMAN GENET,DK-8000 AARHUS,DENMARK; DUKE UNIV,MED CTR,DURHAM,NC; CTR HUMAN GENET,SHEFFIELD,S YORKSHIRE,ENGLAND; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; MED COLL WISCONSIN,MILWAUKEE,WI	Aarhus University; Duke University; Yale University; Medical College of Wisconsin	ANDRESEN, BS (corresponding author), AARHUS UNIV HOSP,SKEJBY SYGEHUS,CTR MED MOLEC BIOL,DK-8200 AARHUS N,DENMARK.		Andresen, Brage/D-2515-2012; Bross, Peter/B-7219-2013	Andresen, Brage/0000-0001-7488-3035; Bross, Peter/0000-0001-9526-8525				AINSWORTH PJ, 1992, AM J HUM GENET, V51, P802; ANDRESEN BS, 1993, AM J HUM GENET, V53, P730; ANDRESEN BS, 1993, HUM MOL GENET, V2, P488, DOI 10.1093/hmg/2.4.488; ANDRESEN BS, IN PRESS J INHERIT M; ANDRESEN BS, 1992, AM J HUM GENET S, V51, pA642; Beinert H., 1963, ENZYMES, P447; BRODY LC, 1992, J BIOL CHEM, V267, P3302; BROSS P, 1993, BIOCHIM BIOPHYS ACTA, V1182, P264, DOI 10.1016/0925-4439(93)90068-C; BROSS P, 1990, J BIOL CHEM, V265, P7116; CHALMERS RA, 1980, PEDIATR RES, V14, P1097, DOI 10.1203/00006450-198010000-00002; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COATES PM, 1992, PEDIATR RES, V31, P34, DOI 10.1203/00006450-199201000-00006; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DING JH, 1992, AM J HUM GENET, V50, P229; FRERMAN FE, 1985, BIOCHEM MED METAB B, V33, P38, DOI 10.1016/0006-2944(85)90124-3; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREGERSEN N, 1991, HUM GENET, V86, P545; GREGERSEN N, 1991, CLIN CHIM ACTA, V203, P23, DOI 10.1016/0009-8981(91)90153-4; GREGERSEN N, IN PRESS J INHERIT M; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; HALL CL, 1975, J BIOL CHEM, V250, P3476; HERMANS MMP, 1993, BIOCHEM J, V289, P687, DOI 10.1042/bj2890687; IKEDA Y, 1986, PEDIATR RES, V20, P843, DOI 10.1203/00006450-198609000-00007; INDO Y, 1991, GENOMICS, V11, P609, DOI 10.1016/0888-7543(91)90068-P; IZAI K, 1992, J BIOL CHEM, V267, P1027; JENSEN TG, 1992, BIOCHIM BIOPHYS ACTA, V1180, P65, DOI 10.1016/0925-4439(92)90028-L; KELLY DP, 1987, P NATL ACAD SCI USA, V84, P4068, DOI 10.1073/pnas.84.12.4068; KELLY DP, 1992, J INHERIT METAB DIS, V15, P171, DOI 10.1007/BF01799626; KELLY DP, 1987, P NATL ACAD SCI USA, V86, P6677; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; KIM JJP, 1988, P NATL ACAD SCI USA, V85, P6677, DOI 10.1073/pnas.85.18.6677; KOLVRAA S, 1982, CLIN CHIM ACTA, V126, P53, DOI 10.1016/0009-8981(82)90361-8; KOLVRAA S, 1991, HUM GENET, V87, P425; KUIPERS OP, 1991, NUCLEIC ACIDS RES, V19, P4558, DOI 10.1093/nar/19.16.4558; MANNING NJ, 1990, J INHERIT METAB DIS, V13, P58, DOI 10.1007/BF01799333; MATSUBARA Y, 1990, LANCET, V335, P1589, DOI 10.1016/0140-6736(90)91413-5; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; MATSUBARA Y, 1987, J BIOL CHEM, V262, P10104; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; NAITO E, 1989, J CLIN INVEST, V83, P1605, DOI 10.1172/JCI114058; POWELL PJ, 1988, BIOCHEMISTRY-US, V27, P8022, DOI 10.1021/bi00421a008; RHEAD WJ, 1983, SCIENCE, V221, P73, DOI 10.1126/science.6857268; RINALDO P, 1988, NEW ENGL J MED, V319, P1308, DOI 10.1056/NEJM198811173192003; Roe C, 1989, METABOLIC BASIS INHE, P889; SAUDUBRAY JM, 1982, PEDIATR RES, V16, P877, DOI 10.1203/00006450-198210000-00015; SEAKINS JWT, 1988, J INHERIT METAB DIS, V11, P221, DOI 10.1007/BF01804241; STANLEY CA, 1983, PEDIATR RES, V17, P877, DOI 10.1203/00006450-198311000-00008; TARONI F, 1992, P NATL ACAD SCI USA, V89, P8429, DOI 10.1073/pnas.89.18.8429; VANHOVE JLK, 1993, AM J HUM GENET, V52, P958; VIANEYLIAUD C, 1987, J INHERIT METAB DIS, V10, P159, DOI 10.1007/BF01812855; YAMAGUCHI S, 1993, PEDIATR RES, V34, P111, DOI 10.1203/00006450-199307000-00025; YOKOTA I, 1992, J BIOL CHEM, V267, P26004; YOKOTA I, 1991, AM J HUM GENET, V49, P1280; YOKOTA I, 1990, J CLIN INVEST, V86, P1000, DOI 10.1172/JCI114761; ZHANG ZF, 1993, AM J HUM GENET, V52, P1111; ZHANG ZF, 1992, BIOCHEMISTRY-US, V31, P81, DOI 10.1021/bi00116a013	56	27	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					975	988						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	8198141				2022-12-18	WOS:A1994NP05300006
J	WINOKUR, ST; SCHUTTE, B; WEIFFENBACH, B; WASHINGTON, SS; MCELLIGOTT, D; CHAKRAVARTI, A; WASMUTH, JH; ALTHERR, MR				WINOKUR, ST; SCHUTTE, B; WEIFFENBACH, B; WASHINGTON, SS; MCELLIGOTT, D; CHAKRAVARTI, A; WASMUTH, JH; ALTHERR, MR			A RADIATION HYBRID MAP OF 15-LOCI ON THE DISTAL LONG ARM OF CHROMOSOME-4, THE REGION CONTAINING THE GENE RESPONSIBLE FOR FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTON DISEASE GENE; DNA-SEQUENCE; LINKAGE; MARKERS; LOCI; 4Q35; TRANSLOCATION; 4Q35-QTER	A physical map of 4q35 was constructed through radiation hybrid analysis of 134 clones generated from the cell line HHW416, a chromosome 4-only human-hamster somatic cell hybrid. This subtelomeric region contains the as-yet-unidentified gene responsible for facioscapulohumeral muscular dystrophy. The most likely order of 15 loci within 4q35 was determined. The loci ordered on this radiation hybrid map include both genes and polymorphic loci, as well as monomorphic loci which cannot be placed on a genetic linkage map. The physical distance spanning these loci was estimated to be approximately 4.5 Mb, by using a kilobase/centiray conversion factor derived from 4p16.3 marker analysis through the same set of radiation hybrids. The comparison of this physical map to establish genetic maps suggests that this region is smaller than initially estimated and that recombination rates are increased near the telomere.	LOS ALAMOS NATL LAB,GENOM & STRUCT BIOL GRP,TA43 HRL1 LS2,MAIL STOP M880,LOS ALAMOS,NM 87545; UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717; UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242; COLL ABORAT RES,WALTHAM,MA; UNIV PITTSBURGH,DEPT HUMAN GENET & PSYCHIAT,PITTSBURGH,PA 15260; SALK INST BIOL STUDIES,MOLEC BIOL LAB,LA JOLLA,CA 92037	United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Irvine; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Salk Institute					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028088] Funding Source: NIH RePORTER; NICHD NIH HHS [HD28088] Funding Source: Medline; NIGMS NIH HHS [GM07311-18] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTHERR MR, 1992, GENOMICS, V13, P1040, DOI 10.1016/0888-7543(92)90017-M; ALTHERR MR, 1991, NUCLEIC ACIDS RES, V19, P1168, DOI 10.1093/nar/19.5.1168; ALTHERR MR, 1989, GENOMICS, V5, P581, DOI 10.1016/0888-7543(89)90026-8; ALTHERR MR, UNPUB SOMATIC CELL H; ASAKAI R, 1987, BIOCHEMISTRY-US, V26, P7721; BODRUG SE, 1990, J MED GENET, V27, P426, DOI 10.1136/jmg.27.7.426; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; CARLOCK LR, 1986, SOMAT CELL MOLEC GEN, V12, P163, DOI 10.1007/BF01560663; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; FALK CT, 1991, GENOMICS, V9, P120, DOI 10.1016/0888-7543(91)90228-7; GILBERT JR, 1992, AM J HUM GENET, V51, P424; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; LI K, 1989, J BIOL CHEM, V264, P13998; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; MARIAT D, 1991, NUCLEIC ACIDS RES, V19, P4572, DOI 10.1093/nar/19.16.4572; MATHEWS KD, 1992, AM J HUM GENET, V51, P428; MILLS KA, 1992, AM J HUM GENET, V51, P432; MILNER ECB, 1989, NUCLEIC ACIDS RES, V17, P4002, DOI 10.1093/nar/17.10.4002; MYERS RM, 1992, HUM GENOME MAPPING C, V1, P5; NAKAMURA Y, 1989, GENOMICS, V4, P76, DOI 10.1016/0888-7543(89)90317-0; OVERHAUSER J, 1989, AM J HUM GENET, V45, P296; Padberg G W, 1991, Neuromuscul Disord, V1, P231, DOI 10.1016/0960-8966(91)90094-9; REBBE NF, 1987, GENE, V53, P235, DOI 10.1016/0378-1119(87)90012-6; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; UPADHYAYA M, 1992, AM J HUM GENET, V51, P404; WARRINGTON JA, 1991, GENOMICS, V11, P701, DOI 10.1016/0888-7543(91)90078-S; WASHINGTON SS, UNPUB SOMATIC CELL H, V1; WEIFFENBACH B, 1992, AM J HUM GENET, V51, P416; WEIFFENBACH B, 1993, NAT GENET, V4, P165, DOI 10.1038/ng0693-165; WIJMENGA C, 1992, AM J HUM GENET, V51, P411; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I; WIJMENGA C, IN PRESS HUM GENET; [No title captured]	36	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					874	880						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213815				2022-12-18	WOS:A1993LY62700011
J	THANH, LT; MAN, NT; LOVE, DR; HELLIWELL, TR; DAVIES, KE; MORRIS, GE				THANH, LT; MAN, NT; LOVE, DR; HELLIWELL, TR; DAVIES, KE; MORRIS, GE			MONOCLONAL-ANTIBODIES AGAINST THE MUSCLE-SPECIFIC N-TERMINUS OF DYSTROPHIN - CHARACTERIZATION OF DYSTROPHIN IN A MUSCULAR-DYSTROPHY PATIENT WITH A FRAMESHIFT DELETION OF EXONS-3-7	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKELETAL-MUSCLE; MOLECULAR-BASIS; GENE-PRODUCT; DUCHENNE; PROTEIN; BRAIN; EXPRESSION; PROMOTERS; REGIONS; CELLS	The first three exons of the human muscle dystrophin gene were expressed as a beta-galactosidase fusion protein. This protein was then used to prepare two monoclonal antibodies (mAbs) which react with native dystrophin on frozen muscle sections and with denatured dystrophin on western blots but which do not cross-react with the dystrophin-related protein, utrophin. Both mAbs recognized dystrophin in muscular dystrophy (MD) patients with deletions of exon 3, and further mapping with 11 overlapping synthetic peptides showed that they both recognize an epitope encoded by the muscle-specific exon 1. Neither mAb recognizes the brain dystrophin isoform, confirming the prediction from mRNA data that this has a different N-terminus. One Becker MD patient with a frameshift deletion of exons 3-7 is shown to produce dystrophin which reacts with the N-terminal mAbs, as well as with mAbs which bind on the C-terminal side of the deletion. The data suggest that transcription begins at the normal muscle dystrophin promoter and that the normal reading frame is restored after the deletion. A number of mechanisms have been proposed for restoration of the reading frame after deletion of exons 3-7, but those which predict dystrophin with an abnormal N-terminus do not appear to be major mechanisms in this patient.	NORTH EAST WALES INST, DIV RES, DEESIDE CH5 4BR, CLWYD, WALES; JOHN RADCLIFFE HOSP, INST MOLEC MED, MOLEC GENET GRP, OXFORD OX3 9DU, ENGLAND; UNIV LIVERPOOL, DEPT PATHOL, LIVERPOOL L69 3BX, ENGLAND	University of Oxford; University of Liverpool				Helliwell, Timothy/0000-0003-2112-4128; Love, Donald/0000-0003-4669-8769				ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; BARNEA E, 1990, NEURON, V5, P881, DOI 10.1016/0896-6273(90)90348-J; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BEGGS AH, 1992, AM J MED GENET, V44, P378, DOI 10.1002/ajmg.1320440322; BIES RD, 1992, NUCLEIC ACIDS RES, V20, P1725, DOI 10.1093/nar/20.7.1725; Blake Derek J., 1992, Human Molecular Genetics, V1, P103, DOI 10.1093/hmg/1.2.103; BULMAN DE, 1991, GENOMICS, V10, P457, DOI 10.1016/0888-7543(91)90332-9; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; CHELLY J, 1990, NATURE, V344, P64, DOI 10.1038/344064a0; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; GANGOPADHYAY SB, 1992, AM J HUM GENET, V51, P562; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; HELLIWELL TR, 1992, AM J HUM GENET, V50, P508; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LOVE DR, 1991, P NATL ACAD SCI USA, V88, P3243, DOI 10.1073/pnas.88.8.3243; MAN NT, 1990, FEBS LETT, V262, P237, DOI 10.1016/0014-5793(90)80199-S; MAN NT, 1991, J CELL BIOL, V115, P1695; MAN NT, 1990, FEBS LETT, V272, P109, DOI 10.1016/0014-5793(90)80460-Z; MAN NT, 1992, BIOCHEM J, V288, P663; NICHOLSON LVB, 1992, J MED GENET, V29, P892, DOI 10.1136/jmg.29.12.892; NUDEL U, 1989, NATURE, V337, P76, DOI 10.1038/337076a0; READ AP, 1988, HUM GENET, V80, P152, DOI 10.1007/BF00702859; RECAN D, 1992, J CLIN INVEST, V89, P712, DOI 10.1172/JCI115640; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D	27	27	27	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					131	139						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317478				2022-12-18	WOS:A1993LJ38500017
J	MCEWEN, JE; REILLY, PR				MCEWEN, JE; REILLY, PR			STATE LEGISLATIVE EFFORTS TO REGULATE USE AND POTENTIAL MISUSE OF GENETIC INFORMATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								The purpose of this study was to review existing and proposed legislation specifically intended to regulate the collection, use, and potential misuse of genetic data. The study encompasses laws relating to confidentiality, informed consent, discrimination, and related issues. It excludes from consideration legislation relating to medical records generally that may bear indirectly on genetic information. It also excludes both legislation relating to the regulation of DNA data collection for law enforcement purposes and state laws relating to the confidentiality of data collected by newborn-screening programs. While relatively few laws that explicitly regulate the treatment of genetic information have been enacted to date, a considerable amount of activity is currently underway in the nation's legislatures. Although most of the bills under consideration are not comprehensive in scope, they reflect a growing societal awareness that the uncontrolled dissemination and use of genetic data entails significant risks.	BOSTON COLL,SCH LAW,NEWTON,MA	Boston College	MCEWEN, JE (corresponding author), EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,DIV SOCIAL SCI ETHICS & LAW,200 TRAPELO RD,WALTHAM,MA 02254, USA.				PHS HHS [MCJ-259151-02-0] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BILLINGS PR, 1992, AM J HUM GENET, V50, P476; GOSTIN L, 1991, AM J LAW MED, V17, P109; REILLY P, 1992, AM J HUM GENET, V50, P640	3	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					637	647						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	JJ828	1496992				2022-12-18	WOS:A1992JJ82800020
J	BIANCALANA, V; BRIARD, ML; DAVID, A; GILGENKRANTZ, S; KAPLAN, J; MATHIEU, M; PIUSSAN, C; PONCIN, J; SCHINZEL, A; OUDET, C; HANAUER, A				BIANCALANA, V; BRIARD, ML; DAVID, A; GILGENKRANTZ, S; KAPLAN, J; MATHIEU, M; PIUSSAN, C; PONCIN, J; SCHINZEL, A; OUDET, C; HANAUER, A			CONFIRMATION AND REFINEMENT OF THE GENETIC LOCALIZATION OF THE COFFIN-LOWRY SYNDROME LOCUS IN XP22.1-P22.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; X-CHROMOSOME; SEQUENCES; FAMILIES	The Coffin-Lowry syndrome (CLS) is an X-linked inherited disease of unknown pathogenesis characterized by severe mental retardation, typical facial and digital anomalies, and progressive skeletal deformations. Our previous linkage analysis, based on four pedigrees with the disease, suggested a localization for the CLS locus in Xp22.1-p22.2, with the most likely position between the marker loci DXS41 and DXS43. We have now extended the study to 16 families by using seven RFLP marker loci spanning the Xp22.1-p22.2 region. Linkage has been established with five markers from this part of the X chromosome: DXS274 (lod score [Z](theta) = 3.53 at theta = .08), DXS43 (Z(theta) = 3.16 at theta = .08), DXS197 (Z(theta) = 3.03 at theta = .05), DXS41 (Z(theta) = 2.89 at theta = .08), and DXS207 (Z(theta) = 2.73 at theta = .13). A multipoint linkage analysis further placed, with a maximum multipoint Z of 7.30, the mutation-causing CLS within a 7-cM interval defined by the cluster of tightly linked markers (DXS207-DXS43-DXS197) on the distal side and by DXS274 on the proximal side. Thus, these further linkage data confirm and refine the map location for the gene responsible for CLS in Xp22.1-p22.2. As no linkage heterogeneity was detected, this validates the use of the Xp22.1-p22.2 markers for carrier detection and prenatal diagnosis in CLS families.	FAC MED STRASBOURG,INSERM,UNITE BIOL MOLEC & GENIE GENET 184,CNRS,F-67085 STRASBOURG,FRANCE; GRP HOSP NECKER ENFANTS MALAD,DEPT PEDIAT,GENET MED CLIN,PARIS,FRANCE; CHR NANTES,MED INFANTILE CLIN,F-44035 NANTES,FRANCE; UNIV NANTES,F-44035 NANTES,FRANCE; CTR REG TRANSFUS SANGUINE & HEMATOL,VANDOEUVRE NANCY,FRANCE; CHR AIMENS,AMIENS,FRANCE; CHU AMIENS,F-80000 AMIENS,FRANCE; HOP NORD AMIENS,AMIENS,FRANCE; CHU LIEGE,CHIM MED LAB,LIEGE,BELGIUM; UNIV ZURICH,CH-8006 ZURICH,SWITZERLAND	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Nantes Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; University of Liege; University of Zurich			Biancalana, Valerie/O-2351-2016					ALITALO T, 1991, HUM GENET, V86, P599, DOI 10.1007/BF00201548; BECK M, 1983, PEDIATR RES, V17, P926, DOI 10.1203/00006450-198311000-00018; COFFIN GS, 1966, AM J DIS CHILD, V112, P205, DOI 10.1001/archpedi.1966.02090120073006; COLLACOTT RA, 1987, J MENT DEFIC RES, V31, P199; GILGENKRANTZ S, 1988, CLIN GENET, V34, P230; HANAUER A, 1988, AM J MED GENET, V30, P523, DOI 10.1002/ajmg.1320300154; HASPESLAGH M, 1984, EUR J PEDIATR, V143, P82, DOI 10.1007/BF00445790; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LOWRY B, 1971, AM J DIS CHILD, V121, P496, DOI 10.1001/archpedi.1971.02100170078009; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; McKusick VA, 1990, MENDELIAN INHERITANC; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; PARTINGTON MW, 1988, AM J MED GENET, V30, P509, DOI 10.1002/ajmg.1320300153; TEMPTAMY SA, 1975, J PEDIATR, V86, P724; THAKKER RV, 1990, GENOMICS, V8, P189, DOI 10.1016/0888-7543(90)90271-U; VINE JSH, 1986, AM J HUM GENET, V39, pA85; YOUNG ID, 1988, J MED GENET, V25, P344, DOI 10.1136/jmg.25.5.344	17	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					981	987						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1349200				2022-12-18	WOS:A1992HR47300011
J	HART, PS; HYMES, J; WOLF, B				HART, PS; HYMES, J; WOLF, B			BIOCHEMICAL AND IMMUNOLOGICAL CHARACTERIZATION OF SERUM BIOTINIDASE IN PROFOUND BIOTINIDASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PURIFICATION; INDIVIDUALS	The biochemical and immunological characterization of biotinidase was performed in sera from 100 normal individuals, 68 children with profound biotinidase deficiency (less than 10% of mean normal activity) who were identified symptomatically and by newborn screening, and 63 of their parents. On isoelectric focusing, serum enzyme from normal individuals exhibits extensive microheterogeneity, consisting of at least four major and five minor isoforms at pH 4.15-4.35. Patients with profound biotinidase deficiency can be classified into at least nine distinct biochemical phenotypes, on the basis of (a) the presence or absence of cross-reacting material (CRM) to biotinidase, (b) the number of isoforms, and (c) the distribution frequency of the isoforms. None of the patients with CRM had an abnormal K(m) of the substrate for the enzyme. All of the parents had normal isoform patterns. The mean activities, CRM concentrations, and specific activities were not significantly different between parents of CRM-positive children and parents of CRM-negative children. There is no relationship between either the age at onset or the severity of symptoms and the isoform patterns or CRM status of the symptomatic children. The isoform patterns of children identified by newborn screening are not different from those of symptomatic children.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,POB 33,MCV STN,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PEDIAT,RICHMOND,VA 23298	Virginia Commonwealth University; Virginia Commonwealth University					NICHD NIH HHS [HD 23223] Funding Source: Medline; NIDDK NIH HHS [DK 33022] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033022] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHAUHAN J, 1986, J BIOL CHEM, V261, P4268; CRAFT DV, 1985, BIOCHEMISTRY-US, V24, P2471, DOI 10.1021/bi00331a012; HART PS, 1991, CLIN CHIM ACTA, V197, P257, DOI 10.1016/0009-8981(91)90146-4; KOIVUSALO M, 1963, ACTA PHYSIOL SCAND, V58, P13, DOI 10.1111/j.1748-1716.1963.tb02623.x; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; OZIUMI J, 1989, BIOCHIMIE, V71, P1163; PETTIT DAD, 1989, ANAL BIOCHEM, V179, P371, DOI 10.1016/0003-2697(89)90147-4; RAMAEKERS VT, 1990, 5TH P INT C INB ERR; WEISSBECKER K, 1987, THESIS MED COLLEGE V; WOLF B, 1983, CLIN CHIM ACTA, V131, P273, DOI 10.1016/0009-8981(83)90096-7; WOLF B, 1987, CLIN CHIM ACTA, V164, P27, DOI 10.1016/0009-8981(87)90104-5; WOLF B, 1990, PEDIATRICS, V85, P512; WOLF B, 1985, J INHERITED METAB S, V1, P53	13	27	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					126	136						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1729884				2022-12-18	WOS:A1992HA04000013
J	LUDWIG, M; GRIMM, T; BRACKMANN, HH; OLEK, K				LUDWIG, M; GRIMM, T; BRACKMANN, HH; OLEK, K			PARENTAL ORIGIN OF FACTOR-IX GENE-MUTATIONS, AND THEIR DISTRIBUTION IN THE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEVERE HEMOPHILIA-B; DUCHENNE MUSCULAR-DYSTROPHY; HAEMOPHILIA-B; DNA; RATES; AMPLIFICATION; DELETIONS; DIAGNOSIS; FAMILIES; CARRIERS	Genomic amplification followed by direct sequencing enabled us to establish the causative mutation in 67 unrelated hemophilia B patients of predominantly German origin. With the detection of the mutation, extensive pedigree analysis has become feasible. We therefore anticipated that determination of the origin of mutation could be achieved in a comparatively great number of families. Although these investigations often were restricted by the availability of blood samples from the maternal grandparents or great-grandparents, we were able to prove a de novo mutation in 9 of 20 families with sporadic hemophilia B and in 3 of 20 families with a history of the disease. This could be achieved with the aid of RFLP analysis and, in one case, where the mutation is still unknown, with the aid of biochemical and immunological factor IX assays. Since the maternal grandfather was deceased in two of these families, the germ line of origin could not be determined precisely. In the remaining families, the female and male germ lines turned out to be the origin of mutation in six and four cases, respectively, and an effect of paternal age on the mutations observed could not be excluded. Furthermore, our data indicate that the hemophilia B gene pool is mainly renewed by variable mutations.	INST CLIN BIOCHEM,BONN,GERMANY; INST HUMAN GENET,WURZBURG,GERMANY	University of Wurzburg	LUDWIG, M (corresponding author), INST EXPTL HAMATOL & BLUTTRANSFUSIONSWESEN,SIGMUND FREUD STR 25,W-5300 BONN 1,GERMANY.							ANSON DS, 1984, EMBO J, V3, P1053, DOI 10.1002/j.1460-2075.1984.tb01926.x; BARRAI I, 1985, AM J HUM GENET, V37, P680; BOTTEMA CDK, 1989, LANCET, V2, P526; BOTTEMA CDK, 1990, BRIT J HAEMATOL, V75, P212, DOI 10.1111/j.1365-2141.1990.tb02651.x; BOTTEMA CDK, 1989, NUCLEIC ACIDS RES, V17, P10139, DOI 10.1093/nar/17.23.10139; BOTTEMA CDK, 1990, AM J HUM GENET, V47, P835; DAVIE AM, 1979, J MED GENET, V15, P339; FERRARI N, 1986, REV BRAS GENET, V9, P87; FURIE B, 1990, SEMIN HEMATOL, V27, P270; GIANNELLI F, 1991, NUCLEIC ACIDS RES, V19, P2193, DOI 10.1093/nar/19.suppl.2193; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HANAUER A, 1990, THROMB RES, V52, P219; IKKALA EERO, 1960, SCAND JOUR CLIN AND LAB INVEST, V12, P1; ISTVAN L, 1990, HUM HERED, V40, P29, DOI 10.1159/000153898; KOEBERL DD, 1990, HUM GENET, V84, P387; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; LUDWIG M, 1989, AM J HUM GENET, V45, P115; LUDWIG M, 1991, KLIN WOCHENSCHR, V69, P196, DOI 10.1007/BF01646940; MCGRAW RA, 1985, P NATL ACAD SCI USA, V82, P2847, DOI 10.1073/pnas.82.9.2847; MONTANDON AJ, 1990, HUM GENET, V85, P200; PANG CP, 1990, NUCLEIC ACIDS RES, V18, P6731, DOI 10.1093/nar/18.22.6731; ROSENDAAL FR, 1990, THROMB HAEMOSTASIS, V61, P145; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SALIER JP, 1990, J BIOL CHEM, V265, P7062; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TANIMOTO M, 1988, J LAB CLIN MED, V112, P307; TAYLOR SAM, 1991, P NATL ACAD SCI USA, V88, P39, DOI 10.1073/pnas.88.1.39; THOMPSON AR, 1990, LANCET, V335, P418, DOI 10.1016/0140-6736(90)90259-8; Tuddenham E G, 1989, Baillieres Clin Haematol, V2, P849, DOI 10.1016/S0950-3536(89)80049-6; VIDAUD D, 1989, American Journal of Human Genetics, V45, pA226; VIDAUD M, 1986, BLOOD, V6, P961; VOGEL F, 1986, HUMAN GENETICS; WANG NS, 1990, THROMB HAEMOSTASIS, V63, P24; WINSHIP PR, 1986, LANCET, V2, P218; WINTER RM, 1983, HUM GENET, V64, P156, DOI 10.1007/BF00327115; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; YASUDA N, 1980, J MED GENET, V17, P106, DOI 10.1136/jmg.17.2.106; YASUDA N, 1982, AM J MED GENET, V13, P91, DOI 10.1002/ajmg.1320130114; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	39	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					164	173						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1346077				2022-12-18	WOS:A1992HA04000017
J	JACOBSON, DR; REVEILLE, JD; BUXBAUM, JN				JACOBSON, DR; REVEILLE, JD; BUXBAUM, JN			FREQUENCY AND GENETIC BACKGROUND OF THE POSITION 122(VAL-]ILE) VARIANT TRANSTHYRETIN GENE IN THE BLACK-POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL AMYLOIDOTIC POLYNEUROPATHY; SENILE SYSTEMIC AMYLOIDOSIS; HUMAN-SERUM PREALBUMIN; CARDIAC AMYLOIDOSIS; PRE-ALBUMIN; HEREDITARY AMYLOIDOSIS; ENDOMYOCARDIAL BIOPSY; CLINICAL-SIGNIFICANCE; NERVOUS-SYSTEM; CARDIOMYOPATHY	Transthyretin (TTR) (122 Val-->Ile), caused by a point mutation which destroys a MaeIII restriction site, is associated with cardiac amyloidosis in black individuals. To estimate the frequency of the MaeIII(-) gene in the black population without overt cardiac disease, DNA from 177 black individuals without amyloidosis was amplified by the PCR around TTR codon 122 and was digested with MaeIII. The MaeIII(-) gene frequency was 4/354 (1.1%; 95% confidence interval 0.32% 2.7%), suggesting that the variant is relatively common in blacks. HLA genotype testing did not suggest that the TTR (122 Val-->Ile) heterozygotes were of a closely related genetic background.	NEW YORK DEPT VET AFFAIRS MED CTR,RES SERV,NEW YORK,NY; NYU,SCH MED,DEPT MED,NEW YORK,NY 10003; UNIV TEXAS,SCH MED,HOUSTON,TX 77025	New York University; University of Texas System	JACOBSON, DR (corresponding author), VET ADM MED CTR,RES SERV 151C,423 E 23D ST,NEW YORK,NY 10010, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR039325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034900] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-39325] Funding Source: Medline; NIDDK NIH HHS [DK-34900] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALMEIDA MD, 1991, AMYLOID AND AMYLOIDOSIS 1990, P599; ANZAI N, 1989, CHEST, V96, P80, DOI 10.1378/chest.96.1.80; Baur M.P., 1980, HISTOCOMPATIBILITY T, P955; BENSON MD, 1987, ARTHRITIS RHEUM, V30, P195, DOI 10.1002/art.1780300210; BENSON MD, 1977, ANN INTERN MED, V86, P419, DOI 10.7326/0003-4819-86-4-419; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BUXBAUM J, 1986, J CLIN INVEST, V78, P798, DOI 10.1172/JCI112643; CHRISTMANSON L, 1991, AMYLOID AND AMYLOIDOSIS 1990, P635; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; DWULET FE, 1983, BIOCHEM BIOPH RES CO, V114, P657, DOI 10.1016/0006-291X(83)90831-8; DWULET FE, 1986, J CLIN INVEST, V78, P880, DOI 10.1172/JCI112675; ERIKSSON P, 1987, ACTA MED SCAND, V221, P39; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; FREDERIKSEN T, 1962, AM J MED, V33, P329; GLENNER GG, 1989, J NEUROL SCI, V94, P1, DOI 10.1016/0022-510X(89)90214-1; GOREVIC PD, 1989, J CLIN INVEST, V83, P836, DOI 10.1172/JCI113966; HODKINSON HM, 1977, Q J MED, V46, P381; JACOBSON DR, 1990, AM J HUM GENET, V47, P127; JACOBSON DR, IN PRESS ADV HUM GEN; KINOSHITA O, 1989, BRIT HEART J, V61, P198; KYLE RA, 1985, AM J MED, V79, P708, DOI 10.1016/0002-9343(85)90521-2; LIE JT, 1988, MAYO CLIN PROC, V63, P552, DOI 10.1016/S0025-6196(12)64885-X; NAKAZATO M, 1987, ARCH NEUROL-CHICAGO, V44, P1275, DOI 10.1001/archneur.1987.00520240053011; NIKLASSON U, 1989, ACTA NEUROL SCAND, V79, P182, DOI 10.1111/j.1600-0404.1989.tb03736.x; NIPPOLDT TB, 1982, MAYO CLIN PROC, V57, P407; NORDLIE M, 1988, SCAND J IMMUNOL, V27, P119, DOI 10.1111/j.1365-3083.1988.tb02329.x; OLSON LJ, 1987, NEW ENGL J MED, V317, P738, DOI 10.1056/NEJM198709173171205; PITKANEN P, 1984, AM J PATHOL, V117, P391; REVEILLE JD, 1991, J RHEUMATOL, V18, P14; REVEILLE JD, 1989, ARTHRITIS RHEUM, V32, P1243, DOI 10.1002/anr.1780321009; SARAIVA MJM, 1984, J CLIN INVEST, V74, P104, DOI 10.1172/JCI111390; SARAIVA MJM, 1990, SCAND J IMMUNOL, V32, P341, DOI 10.1111/j.1365-3083.1990.tb02928.x; SARAIVA MJM, 1986, NEUROLOGY, V36, P14134; SARAIVA MJM, 1990, ARQ MED, V3, P189; SASAKI H, 1985, GENE, V37, P191; SIMONS MJ, 1987, HISTOCOMPATIBILITY T, V1, P959; SLETTEN K, 1980, SCAND J IMMUNOL, V12, P503, DOI 10.1111/j.1365-3083.1980.tb00098.x; SMITH TJ, 1984, MAYO CLIN PROC, V59, P547, DOI 10.1016/S0025-6196(12)61493-1; SNYDER E L, 1989, American Journal of Human Genetics, V45, pA220; TAWARA S, 1983, BIOCHEM BIOPH RES CO, V116, P880, DOI 10.1016/S0006-291X(83)80224-1; TSUZUKI T, 1985, J BIOL CHEM, V260, P2224; VANJAARSVELD PP, 1973, J BIOL CHEM, V248, P4698; WALLACE MR, 1986, J CLIN INVEST, V78, P6, DOI 10.1172/JCI112573; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; WESTERMARK P, 1979, SCAND J IMMUNOL, V10, P303, DOI 10.1111/j.1365-3083.1979.tb01355.x; WRIGHT JR, 1969, MEDICINE, V48, P39, DOI 10.1097/00005792-196901000-00002	46	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					192	198						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063870				2022-12-18	WOS:A1991FW51100022
J	PRITCHARD, C; COX, DR; MYERS, RM				PRITCHARD, C; COX, DR; MYERS, RM			THE END IN SIGHT FOR HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							CYSTIC-FIBROSIS GENE; DNA SEGMENT; LOCUS; TELOMERE; MARKERS; D4S10; G8; IDENTIFICATION; CHROMOSOME-4P; LOCALIZATION		UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	PRITCHARD, C (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,513 PARNASSUS AVE,SAN FRANCISCO,CA 94143, USA.			Pritchard, Catrin/0000-0003-1859-4487				ADAM S, 1991, AM J HUM GENET, V48, P595; ALLITTO BA, 1991, GENOMICS, V9, P104, DOI 10.1016/0888-7543(91)90226-5; BATES GP, 1990, AM J HUM GENET, V46, P762; BATES GP, 1991, AM J HUM GENET, V49, P7; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; BUCAN M, 1990, GENOMICS, V6, P1; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1236; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; DOGGETT NA, 1989, P NATL ACAD SCI USA, V86, P10011, DOI 10.1073/pnas.86.24.10011; ERICKSON RP, 1985, AM J HUM GENET, V37, P827; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; GILLIAM TC, 1987, SCIENCE, V238, P950, DOI 10.1126/science.2890209; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LAIRD CD, 1990, TRENDS GENET, V6, P242, DOI 10.1016/0168-9525(90)90206-L; LANDEGENT JE, 1986, HUM GENET, V73, P354, DOI 10.1007/BF00279100; MACDONALD M E, 1987, Genomics, V1, P29, DOI 10.1016/0888-7543(87)90101-7; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MYERS RH, 1982, AM J HUM GENET, V34, P481; MYERS RH, 1989, AM J HUM GENET, V45, P615; POHL TM, 1988, NUCLEIC ACIDS RES, V16, P9185, DOI 10.1093/nar/16.19.9185; PRITCHARD C, 1990, P NATL ACAD SCI USA, V87, P7309, DOI 10.1073/pnas.87.18.7309; PRITCHARD CA, 1989, GENOMICS, V4, P408, DOI 10.1016/0888-7543(89)90348-0; REIK W, 1988, J MED GENET, V25, P805, DOI 10.1136/jmg.25.12.805; RICHARDS JE, 1988, P NATL ACAD SCI USA, V85, P6437, DOI 10.1073/pnas.85.17.6437; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROBBINS C, 1989, AM J HUM GENET, V44, P422; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SKRAASTAD MI, 1989, AM J HUM GENET, V44, P560; SMITH B, 1988, AM J HUM GENET, V42, P335; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P83, DOI 10.1007/BF01233207; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; YOUNGMAN S, 1986, HUM GENET, V73, P333, DOI 10.1007/BF00279096	38	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					1	6						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	1829579				2022-12-18	WOS:A1991FW51100001
J	ADAM, S; THEILMANN, J; BUETOW, K; HEDRICK, A; COLLINS, C; WEBER, B; HUGGINS, M; HAYDEN, M				ADAM, S; THEILMANN, J; BUETOW, K; HEDRICK, A; COLLINS, C; WEBER, B; HUGGINS, M; HAYDEN, M			LINKAGE DISEQUILIBRIUM AND MODIFICATION OF RISK FOR HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED DNA MARKERS; GENE; D4S95; LOCALIZATION; CHROMOSOME-4; FRAGMENTS; TELOMERE; ONSET; LOCUS	The major limitation in performing predictive testing for Huntington disease (HD) is the unavailability of DNA from crucial family members. In our program approximately 20% (36/183) of persons have been excluded from predictive testing because of this reason. The major aim of this study was to examine whether data derived from linkage disequilibrium could modify risk analysis for persons at risk for HD. As a first step, we assessed whether the previously reported linkage disequilibrium between alleles recognized by probe pBS674E-D at locus remained significant in a much larger data set. A total of 1,150 chromosomes from 622 individuals-200 affected and 422 unaffected-from 118 families were assessed. Significant haplotype association was detected with AccI and MboI RFLPs at the locus D4S95, with all the families (P = .00003), as well as for a subset from the United Kingdom (P = .0037). Data derived from linkage disequilibrium studies using D4S95 modifies the risk for HD, especially in persons of U.K. descent. Utilization of this approach for risk modification of HD awaits both validation of these data and additional information concerning ethnic-specific alleles at the D4S95 locus.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA; FOX CHASE CANC INST,PHILADELPHIA,PA 19111	University of British Columbia; Fox Chase Cancer Center			Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Adam, Shelin/0000-0002-4401-6157; Weber, Bernhard H.F./0000-0002-8808-7723	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040864] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40864] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS P, 1988, AM J HUM GENET, V43, P695; BEAUDET AL, 1989, AM J HUM GENET, V44, P319; BRANDT J, 1989, JAMA-J AM MED ASSOC, V261, P3108, DOI 10.1001/jama.261.21.3108; BROCK DJH, 1989, LANCET, V2, P463; COX DR, 1974, THEORETICAL STATISTI, P364; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; HAYDEN MR, 1987, AM J HUM GENET, V40, P421; HAYDEN MR, 1988, AM J HUM GENET, V43, P689; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; HEDRICK PW, 1986, GENETICS, V112, P135; MACDONALD ME, 1989, J CLIN INVEST, V84, P1013, DOI 10.1172/JCI114222; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P535, DOI 10.1056/NEJM198803033180903; ROBBINS C, 1989, AM J HUM GENET, V44, P422; SMITH B, 1988, AM J HUM GENET, V42, P335; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; Sokal R. R., 1969, BIOMETRY, P494; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; THEILMANN JL, 1989, AM J HUM GENET, V45, P477; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WHALEY WL, 1988, NUCLEIC ACIDS RES, V16, P11769, DOI 10.1093/nar/16.24.11769	23	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					595	603						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1671809				2022-12-18	WOS:A1991FK47000019
J	SHER, C; RAMESAR, R; MARTELL, R; LEARMONTH, I; TSIPOURAS, P; BEIGHTON, P				SHER, C; RAMESAR, R; MARTELL, R; LEARMONTH, I; TSIPOURAS, P; BEIGHTON, P			MILD SPONDYLOEPIPHYSEAL DYSPLASIA (NAMAQUALAND TYPE) - GENETIC-LINKAGE TO THE TYPE-II COLLAGEN GENE (COL2AL)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACHONDROGENESIS-HYPOCHONDROGENESIS; CHONDRODYSPLASIA; IDENTIFICATION; POLYMORPHISM; DEFECTS	Namaqualand spondyloepiphyseal dysplasia (NSED) is a mild autosomal dominant form of spondyloepiphyseal dysplasia in which changes are maximal in the femoral capital epiphyses and the vertebral bodies. The condition is present in a large multigeneration South African family, and it is clinically important by virture of severe progressive degenerative osteoarthropathy of the hip joint, which frequently necessitates prosthetic joint replacement in adulthood. Linkage studies using molecular markers have shown that the loci for the NSED and type II collagen genes are linked (LOD score 7.98 at a recombination fraction of .00).	UNIV CAPE TOWN,SCH MED,DEPT HUMAN GENET,MRC,INHERITED SKELETAL DISORDERS UNIT,CAPE TOWN 7925,SOUTH AFRICA; UNIV CAPE TOWN,SCH MED,PROVINCIAL LAB TISSUE IMMUNOL,CAPE TOWN 7925,SOUTH AFRICA; PRINCESS ALICE ORTHOPAED HOSP,DEPT ORTHOPAED SURG,CAPE TOWN,SOUTH AFRICA; UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06032; UNIV CONNECTICUT,CTR HLTH,MOLEC GENET LAB,FARMINGTON,CT 06032	University of Cape Town; University of Cape Town; University of Connecticut; University of Connecticut			Ramesar, Raj S/I-6941-2015	Ramesar, Raj S/0000-0001-5688-1634	ADAMHA HHS [AD-22610] Funding Source: Medline	ADAMHA HHS		ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; ANDERSON IJ, 1990, AM J MED GENET, V37, P272, DOI 10.1002/ajmg.1320370223; ANDERSON IJ, 1990, AM J HUM GENET, V46, P896; BEIGHTON P, 1984, AM J MED GENET, V19, P161, DOI 10.1002/ajmg.1320190116; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; EYRE DR, 1986, AM J HUM GENET, V39, P52; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; GODFREY M, 1988, AM J HUM GENET, V43, P894; GODFREY M, 1988, AM J HUM GENET, V43, P904; HORTON WA, 1985, COLLAGEN REL RES, V5, P349; KNOWLTON RG, 1990, NEW ENGL J MED, V322, P526, DOI 10.1056/NEJM199002223220807; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEARMONTH ID, 1987, CLIN ORTHOPAEDICS, V218, P142; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; MURRAY LW, 1989, AM J HUM GENET, V45, P5; OTT J, 1974, AM J HUM GENET, V26, P588; PALOTIE A, 1989, LANCET, V1, P924; SANGIORGI FO, 1985, NUCLEIC ACIDS RES, V13, P2207, DOI 10.1093/nar/13.7.2207; SPRANGER J, 1985, ENDOCRINE GENETICS G, P315; STROM CM, 1988, NUCLEIC ACIDS RES, V16, P9077, DOI 10.1093/nar/16.18.9077; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889	22	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					518	524						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1671807				2022-12-18	WOS:A1991FK47000012
J	FERGUSONSMITH, MA				FERGUSONSMITH, MA			INVITED EDITORIAL - PUTTING THE GENETICS BACK INTO CYTOGENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INDIRECT HYBRIDOCYTOCHEMICAL DETECTION; BANDED HUMAN-CHROMOSOMES; NUCLEIC-ACID SEQUENCES; INSITU HYBRIDIZATION; DNA-SEQUENCES; 2-ACETYLAMINOFLUORENE-MODIFIED PROBES; LOCALIZATION; CELLS; MICROSCOPY; SATELLITE		UNIV CAMBRIDGE,CTR MED GENET,CAMBRIDGE CB2 1QP,ENGLAND	University of Cambridge	FERGUSONSMITH, MA (corresponding author), UNIV CAMBRIDGE,DEPT PATHOL,TENNIS COURT RD,CAMBRIDGE CB2 1QP,ENGLAND.							BAUMAN JGJ, 1983, J HISTOCHEM CYTOCHEM, V31, P571, DOI 10.1177/31.5.6188779; BURNS J, 1985, J CLIN PATHOL, V38, P1085, DOI 10.1136/jcp.38.10.1085; FERGUSONSMITH MA, 1982, CYTOGENET CELL GENET, V32, P24, DOI 10.1159/000131684; GARSON JA, 1987, NUCLEIC ACIDS RES, V15, P4761, DOI 10.1093/nar/15.12.4761; GERHARD DS, 1981, P NATL ACAD SCI-BIOL, V78, P3755, DOI 10.1073/pnas.78.6.3755; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HEILES HBJ, 1988, BIOTECHNIQUES, V6, P978; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; JONES KW, 1971, NATURE-NEW BIOL, V233, P268, DOI 10.1038/newbio233268a0; KENWRICK S, 1989, AM J HUM GENET, V45, P873; LANDEGENT JE, 1984, EXP CELL RES, V153, P61, DOI 10.1016/0014-4827(84)90448-8; LANDEGENT JE, 1985, J HISTOCHEM CYTOCHEM, V33, P1241, DOI 10.1177/33.12.2415575; LANGER PR, 1981, P NATL ACAD SCI-BIOL, V78, P6633, DOI 10.1073/pnas.78.11.6633; LAWRENCE JB, 1988, CELL, V52, P51; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MALCOLM S, 1981, ANN HUM GENET, V45, P135, DOI 10.1111/j.1469-1809.1981.tb00315.x; MANUELIDIS L, 1988, CHROMOSOMA, V96, P397, DOI 10.1007/BF00303033; MORIMOTO H, 1987, LAB INVEST, V57, P737; PARDUE ML, 1970, CHROMOSOMA, V29, P268, DOI 10.1007/BF00325943; PINKEL D, 1984, P NATL ACAD SCI USA, V85, P3138; TRASK B, 1989, GENOMICS, V5, P710, DOI 10.1016/0888-7543(89)90112-2; TRASK BJ, 1990, AM J HUM GENET, V48	24	27	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					179	182						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990830				2022-12-18	WOS:A1991EV74400001
J	TIKOCHINSKI, Y; RITTE, U; GROSS, SR; PRAGER, EM; WILSON, AC				TIKOCHINSKI, Y; RITTE, U; GROSS, SR; PRAGER, EM; WILSON, AC			MTDNA POLYMORPHISM IN 2 COMMUNITIES OF JEWS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; ENDONUCLEASE CLEAVAGE PATTERNS; POPULATION; MUTATIONS; SEQUENCES	Twenty-one types of mtDNA were found in a survey of 39 Israeli Jews, of whom 18 were Sephardic and 21 Ashkenazic. The survey was made with six restriction enzymes that together recognize an average of 600 bp/genome. The differences among the types appear to be due to base substitution at 19 cleavage sites, one deletion, and one conformational mutation. The numbers of differences imply that these modern Jews stem from a minimum of 21 maternal lineages that were already distinct from one another 4,000-5,000 years ago. In three of the four cases where a type was found in more than one person, it occurred in both Ashkenazic and Sephardic populations. The diversity of types in the combined sample of two Jewish populations is lower than both that in a sample from various parts of Africa and that in a sample from various parts of East Asia. Nevertheless, it is as high as that in a sample from diverse parts of New Guinea, an area much larger than that in Israel to which the Jewish population traces back.	UNIV CALIF BERKELEY,DIV BIOCHEM & MOLEC BIOL,BARKER HALL,BERKELEY,CA 94720; HEBREW UNIV JERUSALEM,DEPT GENET,JERUSALEM,ISRAEL; DUKE UNIV,DEPT BIOCHEM,DIV GENET,DURHAM,NC 27706	University of California System; University of California Berkeley; Hebrew University of Jerusalem; Duke University								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BONNETAMIR B, 1978, TISSUE ANTIGENS, V11, P235, DOI 10.1111/j.1399-0039.1978.tb01255.x; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; Bright J., 2000, HIST ISRAEL; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CANN RL, 1984, GENETICS, V106, P79; CANN RL, 1982, THESIS U CALIFORNIA; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; HORAI S, 1986, HUM GENET, V72, P105; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; NEI M, 1981, GENETICS, V97, P145; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; SINGH G, 1987, NATURE, V329, P270, DOI 10.1038/329270a0; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1986, COLD SPRING HARB SYM, V51, P433, DOI 10.1101/SQB.1986.051.01.052; STONEKING M, 1986, THESIS U CALIFORNIA; SWOFFORD DL, 1989, PAUP PHYLOGENETIC AN; Szeinberg Aryeh., 1979, GENETIC DISEASES ASH, P77; TIKOCHINSKI Y, 1986, THESIS HEBREW U JERU; VIGILANT L, 1988, NUCLEIC ACIDS RES, V16, P5945, DOI 10.1093/nar/16.13.5945; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	25	27	28	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					129	136						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	ET188	1670749				2022-12-18	WOS:A1991ET18800018
J	MARTINIUK, F; BODKIN, M; TZALL, S; HIRSCHHORN, R				MARTINIUK, F; BODKIN, M; TZALL, S; HIRSCHHORN, R			IDENTIFICATION OF THE BASE-PAIR SUBSTITUTION RESPONSIBLE FOR A HUMAN ACID-ALPHA-GLUCOSIDASE ALLELE WITH LOWER AFFINITY FOR GLYCOGEN (GAA-2) AND TRANSIENT GENE-EXPRESSION IN DEFICIENT CELLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											MARTINIUK, F (corresponding author), NYU MED CTR,DEPT MED,550 1ST AVE,NEW YORK,NY 10016, USA.				PHS HHS [R0I 39669-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BARNES AK, 1988, PROTEINS, V4, P182, DOI 10.1002/prot.340040305; BERATIS NG, 1980, AM J HUM GENET, V32, P137; BERATIS NG, 1978, J CLIN INVEST, V62, P1264, DOI 10.1172/JCI109247; BERATIS NG, 1983, AM J HUM GENET, V35, P21; BROWN BI, 1981, BIOCHIM BIOPHYS ACTA, V110, P124; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COURTECU.V, 1965, ARCH FR PEDIATR, V22, P1153; de Barsy T, 1972, Eur J Biochem, V31, P156; ENGEL AG, 1973, NEUROLOGY, V23, P95, DOI 10.1212/WNL.23.1.95; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; Hers HG, 1989, METABOLIC BASIS INHE, P425; HIRSCHHORN R, 1989, MOL GENETICS DISEASE, P248; HOEFSLOOT LH, 1988, EMBO J, V7, P1697, DOI 10.1002/j.1460-2075.1988.tb02998.x; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Maniatis T., 1982, MOL CLONING; MARTINIUK F, 1985, J BIOL CHEM, V260, P4351; MARTINIUK F, 1985, HUM GENET, V69, P109, DOI 10.1007/BF00293278; MARTINIUK F, 1981, BIOCHIM BIOPHYS ACTA, V658, P248, DOI 10.1016/0005-2744(81)90295-3; MARTINIUK F, 1984, ARCH BIOCHEM BIOPHYS, V231, P454, DOI 10.1016/0003-9861(84)90408-9; MARTINIUK F, 1990, DNA CELL BIOL, V9, P85, DOI 10.1089/dna.1990.9.85; MARTINIUK F, 1986, P NATL ACAD SCI USA, V83, P9641, DOI 10.1073/pnas.83.24.9641; MARTINIUK F, 1990, AM J HUM GENET, V47; MEHLER M, 1977, NEUROLOGY, V27, P178, DOI 10.1212/WNL.27.2.178; NICKEL BE, 1982, ANN HUM GENET, V46, P97, DOI 10.1111/j.1469-1809.1982.tb00700.x; ORKIN SH, 1985, MOL CELL BIOL, V5, P762, DOI 10.1128/MCB.5.4.762; Pompe JC, 1932, NED TIJDSCHR GENEESK, V76, P304; QUON DVK, 1989, J BIOL CHEM, V264, P3380; REUSER AJJ, 1985, J BIOL CHEM, V260, P8336; REUSER AJJ, 1987, J CLIN INVEST, V79, P1689, DOI 10.1172/JCI113008; SABATINI D, 1989, METABOLIC BASIS INHE, P177; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SWALLOW DM, 1989, ANN HUM GENET, V53, P177, DOI 10.1111/j.1469-1809.1989.tb01782.x; SWALLOW DM, 1975, ANN HUM GENET, V38, P391, DOI 10.1111/j.1469-1809.1975.tb00629.x; TZALL S, UNPUB IDENTIFICATION; VANDERPLOEG AT, 1989, AM J HUM GENET, V44, P787; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4	40	27	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					440	445						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2203258				2022-12-18	WOS:A1990DX22300008
J	SWIFT, M; KUPPER, LL; CHASE, CL				SWIFT, M; KUPPER, LL; CHASE, CL			EFFECTIVE TESTING OF GENE-DISEASE ASSOCIATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,SCH MED,DEPT MED,DIV GENET,CHAPEL HILL,NC 27514; UNIV N CAROLINA,SCH PUBL HLTH,DEPT BIOSTAT,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	SWIFT, M (corresponding author), UNIV N CAROLINA,325 BIOL SCI RES CTR 7250,CHAPEL HILL,NC 27599, USA.				NCI NIH HHS [CA14235] Funding Source: Medline; NICHD NIH HHS [HD03110] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA014235] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Breslow N. E., 1987, STATISTICAL METHODS, VII; BURMER GC, 1989, CANCER RES, V49, P2141; CAMPBELL MA, 1971, ANN HUM GENET, V35, P225, DOI 10.1111/j.1469-1809.1956.tb01395.x; COOPER DN, 1988, HUM GENET, V78, P299, DOI 10.1007/BF00291724; DUBEAU L, 1986, CANCER RES, V46, P2964; EBRINGER RW, 1980, CLIN SCI, V59, P405, DOI 10.1042/cs0590405; Fleiss JL, 1981, STAT METHODS RATES P; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GERHARD DS, 1987, NATURE, V325, P73, DOI 10.1038/325073a0; GOLDIN LR, 1988, GENET EPIDEMIOL, V5, P35, DOI 10.1002/gepi.1370050104; HALL JM, 1990, GENOMICS, V6, P188, DOI 10.1016/0888-7543(90)90466-8; HUTCHISON DCS, 1988, AM J MED, V84, P3; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; LI CC, 1954, BIOMETRICS, V10, P347, DOI 10.2307/3001590; LIANG KY, 1985, BIOMETRIKA, V72, P678, DOI 10.1093/biomet/72.3.678; SCHILIRO G, 1989, NEW ENGL J MED, V321, P762; STRONG LC, 1984, J NATL CANCER I, V73, P303, DOI 10.1093/jnci/73.2.303; SWIFT M, 1990, CANCER GENET CYTOGEN, V46, P21, DOI 10.1016/0165-4608(90)90004-T; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	21	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					266	274						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378351				2022-12-18	WOS:A1990DT87100011
J	ANGLANI, F; PICCI, L; CAMPORESE, C; ZACCHELLO, F				ANGLANI, F; PICCI, L; CAMPORESE, C; ZACCHELLO, F			HETERODUPLEX FORMATION IN POLYMERASE CHAIN-REACTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											ANGLANI, F (corresponding author), UNIV PADUA,DEPT PEDIAT,I-35100 PADUA,ITALY.		Anglani, Franca/F-9045-2017	Anglani, Franca/0000-0003-1534-4458				KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; MATHEW CG, 1989, LANCET, V2, P1346; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; ROMMENS J, 1990, AM J HUM GENET, V46, P395; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; TRIGGSRAINE BL, 1990, AM J HUM GENET, V46, P183	7	27	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					169	170						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	2349948				2022-12-18	WOS:A1990DK48200029
J	KWIATKOWSKI, DJ; AKLOG, L; LEDBETTER, DH; MORTON, CC				KWIATKOWSKI, DJ; AKLOG, L; LEDBETTER, DH; MORTON, CC			IDENTIFICATION OF THE FUNCTIONAL PROFILIN GENE, ITS LOCALIZATION TO CHROMOSOME SUBBAND 17P13.3, AND DEMONSTRATION OF ITS DELETION IN SOME PATIENTS WITH MILLER-DIEKER SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02115; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Baylor College of Medicine; Baylor University	KWIATKOWSKI, DJ (corresponding author), MASSACHUSETTS GEN HOSP,HEMATOL ONCOL UNIT,BLDG 149,13TH ST,8 W,BOSTON,MA 02129, USA.				NHLBI NIH HHS [HL01582, HL19429] Funding Source: Medline; NICHD NIH HHS [HD20619] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020619] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL019429, K08HL001582, R01HL019429] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMPE C, 1988, EUR J BIOCHEM, V170, P597, DOI 10.1111/j.1432-1033.1988.tb13739.x; AMPE C, 1985, J BIOL CHEM, V260, P834; AMPE C, 1988, FEBS LETT, V228, P17, DOI 10.1016/0014-5793(88)80575-1; BLIKSTAD I, 1980, EUR J BIOCHEM, V105, P425, DOI 10.1111/j.1432-1033.1980.tb04517.x; BREATHNACH C, 1981, ANN REV BIOCH, V56, P467; BUCHBERG AM, 1989, GENETICS, V122, P153; Carlsson L., 1976, CONTRACTILE SYSTEMS, P39; DINUBILE MJ, 1985, J BIOL CHEM, V260, P7402; DOBYNS WB, 1984, AM J MED GENET, V18, P509, DOI 10.1002/ajmg.1320180320; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; FUJIKI M, 1988, Journal of Cell Biology, V107, p30A; HARTWIG JH, 1989, J CELL BIOL, V109, P1571, DOI 10.1083/jcb.109.4.1571; KAISER DA, 1986, J CELL BIOL, V102, P221, DOI 10.1083/jcb.102.1.221; KILLARY AM, 1984, CELL, V38, P523, DOI 10.1016/0092-8674(84)90507-5; KRAUSS C M, 1988, American Journal of Human Genetics, V43, pA238; KWIATKOWSKI DJ, 1988, J CELL BIOL, V106, P375, DOI 10.1083/jcb.106.2.375; KWIATKOWSKI DJ, 1988, J BIOL CHEM, V263, P5910; LASSING I, 1988, J CELL BIOCHEM, V37, P255, DOI 10.1002/jcb.240370302; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LEDBETTER DH, 1989, P NATL ACAD SCI USA, V86, P5136, DOI 10.1073/pnas.86.13.5136; LIN CS, 1985, P NATL ACAD SCI USA, V82, P6995, DOI 10.1073/pnas.82.20.6995; LIND SE, 1987, J CELL BIOL, V105, P833, DOI 10.1083/jcb.105.2.833; MAGDOLEN V, 1988, MOL CELL BIOL, V8, P5108, DOI 10.1128/MCB.8.12.5108; MAGNUS KA, 1986, J BIOL CHEM, V261, P3360; MARKEY F, 1981, CELL, V23, P145, DOI 10.1016/0092-8674(81)90279-8; Maxam A M, 1980, Methods Enzymol, V65, P499; MCALPINE P J, 1988, Cytogenetics and Cell Genetics, V49, P4, DOI 10.1159/000132645; MORTON CC, 1984, AM J HUM GENET, V36, P576; OECHSNER U, 1987, NUCLEIC ACIDS RES, V15, P9078, DOI 10.1093/nar/15.21.9078; REICHSTEIN E, 1979, J BIOL CHEM, V254, P6174; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SCHWARTZ CE, 1988, AM J HUM GENET, V43, P597; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANTUINEN P, 1988, AM J HUM GENET, V43, P587; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215	35	27	29	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					559	567						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	1968707				2022-12-18	WOS:A1990CT66800020
J	HERTZBERG, M; JAHROMI, K; FERGUSON, V; DAHL, HHM; MERCER, J; MICKLESON, KNP; TRENT, RJ				HERTZBERG, M; JAHROMI, K; FERGUSON, V; DAHL, HHM; MERCER, J; MICKLESON, KNP; TRENT, RJ			PHENYLALANINE-HYDROXYLASE GENE HAPLOTYPES IN POLYNESIANS - EVOLUTIONARY ORIGINS AND ABSENCE OF ALLELES ASSOCIATED WITH SEVERE PHENYLKETONURIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ROYAL CHILDRENS HOSP,MURDOCH RES INST,PARKVILLE,VIC 3052,AUSTRALIA; MIDDLEMORE HOSP,DEPT PAEDIAT,AUCKLAND 6,NEW ZEALAND	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	HERTZBERG, M (corresponding author), UNIV SYDNEY,CLIN IMMUNOL RES CTR,MOLEC BIOL LAB,SYDNEY,NSW 2006,AUSTRALIA.							Bellwood P.S., 1987, POLYNESIANS PREHISTO; CHAKRABORTY R, 1987, HUM GENET, V76, P40; DAIGER SP, 1986, LANCET, V1, P229; DILELLA AG, 1988, LANCET, V1, P497; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; GUTTLER F, 1987, J PEDIATR-US, V110, P68, DOI 10.1016/S0022-3476(87)80290-1; HERTZBERG MS, 1988, AM J HUM GENET, V43, P971; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; KOHONENCORISH MRJ, 1986, AM J HUM GENET, V39, P751; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LICHTERKONECKI U, 1988, HUM GENET, V78, P347, DOI 10.1007/BF00291733; LIDSKY AS, 1985, LANCET, V1, P549; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; OLD JM, 1983, THALASSAEMIAS METHOD, P74; SCRIVER CR, 1980, NEW ENGL J MED, V303, P1394, DOI 10.1056/NEJM198012113032404; SERJEANTSON SW, 1987, HUM IMMUNOL, V20, P145, DOI 10.1016/0198-8859(87)90028-0; SERJEANTSON SW, 1982, AM J HUM GENET, V34, P904; SPEER A, 1986, CLIN GENET, V29, P491; TRENT RJ, 1986, AM J HUM GENET, V39, P350; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WOO SLC, 1988, AM J HUM GENET, V43, P781	22	27	27	1	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					382	387						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2563633				2022-12-18	WOS:A1989T353500011
J	WORSHAM, MJ; MILLER, DA; DEVRIES, JM; MITCHELL, AR; BABU, VR; SURLI, V; WEISS, L; VANDYKE, DL				WORSHAM, MJ; MILLER, DA; DEVRIES, JM; MITCHELL, AR; BABU, VR; SURLI, V; WEISS, L; VANDYKE, DL			A DICENTRIC RECOMBINANT-9 DERIVED FROM A PARACENTRIC INVERSION - PHENOTYPE, CYTOGENETICS, AND MOLECULAR ANALYSIS OF CENTROMERES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HENRY FORD HOSP,CTR MED GENET & BIRTH DEFECTS,2799 W GRAND BLVD,DETROIT,MI 48202; WAYNE STATE UNIV,DEPT PEDIAT,DETROIT,MI 48202; WAYNE STATE UNIV,DEPT MOLEC BIOL & GENET,DETROIT,MI 48202; CORIELL INST MED RES,CAMDEN,NJ	Henry Ford Health System; Henry Ford Hospital; Wayne State University; Wayne State University; Coriell Institute for Medical Research								DANIEL A, 1979, HUM GENET, V48, P85, DOI 10.1007/BF00273279; DEWALD GW, 1979, CYTOGENET CELL GENET, V24, P15, DOI 10.1159/000131352; Fraccaro M, 1978, Prog Clin Biol Res, V26, P181; FRYNS JP, 1980, HUM GENET, V54, P413, DOI 10.1007/BF00291590; FUNDERBURK SJ, 1977, HUM GENET, V39, P243, DOI 10.1007/BF00287020; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HOO JJ, 1982, HUM GENET, V62, P113; HOOK EB, 1984, AM J HUM GENET, V36, P422; ING PS, 1983, CLIN GENET, V24, P194; KASAI R, 1985, JPN J HUM GENET, V30, P57, DOI 10.1007/BF01873578; MARASCHIO P, 1980, HUM GENET, V54, P265, DOI 10.1007/BF00278982; MASCARELLO JT, 1983, AM J MED GENET, V14, P67, DOI 10.1002/ajmg.1320140111; MITCHELL AR, 1986, CYTOGENET CELL GENET, V41, P89, DOI 10.1159/000132209; MITCHELL AR, 1985, CHROMOSOMA, V92, P369, DOI 10.1007/BF00327469; MULES EH, 1984, HUM GENET, V67, P126, DOI 10.1007/BF00272986; NAKAGOME Y, 1986, JPN J HUM GENET, V31, P21, DOI 10.1007/BF01876798; NIEBUHR E, 1972, CYTOGENETICS, V11, P165, DOI 10.1159/000130186; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; Schinzel A, 1983, CATALOGUE UNBALANCED; SCHMID M, 1983, CYTOGENET CELL GENET, V36, P554, DOI 10.1159/000131972; SPARKES RS, 1979, SCIENCE, V203, P1027, DOI 10.1126/science.424728; Swanson CP, 1981, CYTOGENETICS CHROMOS; UEHARA M, 1986, JPN J HUM GENET, V31, P27, DOI 10.1007/BF01876799; VALCARCEL E, 1983, HUM GENET, V63, P78, DOI 10.1007/BF00285405; VANDYKE DL, 1983, AM J HUM GENET, V35, P301; VIANNAMORGANTE AM, 1986, CYTOGENET CELL GENET, V42, P119, DOI 10.1159/000132263; WISNIEWSKI L, 1978, CLIN GENET, V14, P147; 1983, CLIN GENET, V31, P1; 1981, CYTOGENET CELL GENET, V31, P1; 1986, ANN GENET, V29, P169	30	27	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1989	44	1					115	123						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R5596	2909165				2022-12-18	WOS:A1989R559600018
J	MACCLUER, JW; KAMMERER, CM; BLANGERO, J; DYKE, B; MOTT, GE; VANDEBERG, JL; MCGILL, HC				MACCLUER, JW; KAMMERER, CM; BLANGERO, J; DYKE, B; MOTT, GE; VANDEBERG, JL; MCGILL, HC			PEDIGREE ANALYSIS OF HDL CHOLESTEROL CONCENTRATION IN BABOONS ON 2 DIETS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284	University of Texas System; University of Texas Health San Antonio	MACCLUER, JW (corresponding author), SW FDN BIOMED RES,DEPT GENET,POB 2847,SAN ANTONIO,TX 78284, USA.		Blangero, John/ABA-7175-2021	Kammerer, Candace M/0000-0002-2841-4761	NHLBI NIH HHS [HL06700, HL28972, HL35444] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028972, R23HL035444] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALLAIN CC, 1974, CLIN CHEM, V20, P470; BLANGERO J, 1987, American Journal of Human Genetics, V41, pA250; BOJANOVSKI D, 1978, ATHEROSCLEROSIS, V31, P481, DOI 10.1016/0021-9150(78)90144-2; BURSTEIN M, 1960, CLIN CHIM ACTA, V5, P609, DOI 10.1016/0009-8981(60)90075-9; BYARD P J, 1984, Genetic Epidemiology, V1, P43, DOI 10.1002/gepi.1370010107; DAHLEN G, 1983, INT J EPIDEMIOL, V12, P32, DOI 10.1093/ije/12.1.32; FAIN PR, 1978, ANN HUM GENET, V42, P109, DOI 10.1111/j.1469-1809.1978.tb00935.x; FLOW BL, 1982, ATHEROSCLEROSIS, V41, P403, DOI 10.1016/0021-9150(82)90204-0; FLOW BL, 1982, ATHEROSCLEROSIS, V43, P83, DOI 10.1016/0021-9150(82)90101-0; FLOW BL, 1981, J HERED, V172, P97; Fox H, 1933, ARTERIOSCLEROSIS, P153; GLUECK CJ, 1975, METABOLISM, V24, P1243, DOI 10.1016/0026-0495(75)90063-3; GREEN P, 1984, Genetic Epidemiology, V1, P123, DOI 10.1002/gepi.1370010204; GROVES CP, 1972, PATHOLOGY SIMIAN P 1, P11; HASSTEDT S J, 1985, Genetic Epidemiology, V2, P339, DOI 10.1002/gepi.1370020403; HASSTEDT SJ, 1986, AM J MED GENET, V24, P57, DOI 10.1002/ajmg.1320240108; HASSTEDT SJ, 1984, ATHEROSCLEROSIS, V51, P21, DOI 10.1016/0021-9150(84)90141-2; HASSTEDT SJ, 1979, 13 U UT DEP MED BIOP; HIXSON JE, 1987, GENETICA, V73, P85; ISELIUS L, 1985, ACTA MED SCAND, V217, P161; ISELIUS L, 1982, METABOLISM, V31, P521, DOI 10.1016/0026-0495(82)90088-9; ISELIUS L, 1979, CLIN GENET, V15, P300; KAMMERER C, 1984, American Journal of Human Genetics, V36, p171S; KAMMERER CM, 1984, AM J HUM GENET, V36, P187; KAMMERER CM, 1984, AM J MED GENET, V19, P333, DOI 10.1002/ajmg.1320190216; KARLIN S, 1981, ADV APPL PROBAB, V13, P325, DOI 10.2307/1426687; KARLIN S, 1981, AM J HUM GENET, V33, P262; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; MacCluer J W, 1984, Prog Clin Biol Res, V147, P297; MACCLUER JW, 1984, HUMAN POPULATION GEN, P125; MCGILL HC, 1988, ARTERIOSCLEROSIS, V8, P33, DOI 10.1161/01.ATV.8.1.33; MCGILL HC, 1981, ARTERIOSCLEROSIS, V1, P164, DOI 10.1161/01.ATV.1.3.164; MCGILL HC, 1981, ARTERIOSCLEROSIS, V1, P3, DOI 10.1161/01.ATV.1.1.3; MCGILL HC, 1960, CIRC RES, V8, P670, DOI 10.1161/01.RES.8.3.670; MOLL PP, 1986, AM J HUM GENET, V38, P361; MORTON NE, 1978, AM J HUM GENET, V30, P583; MOTT GE, 1978, CIRC RES, V43, P364, DOI 10.1161/01.RES.43.3.364; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; NAMBOODIRI K K, 1985, American Journal of Human Genetics, V37, pA202; NAMBOODIRI KK, 1983, ARTERIOSCLEROSIS, V3, P616, DOI 10.1161/01.ATV.3.6.616; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; POMETTA D, 1986, ATHEROSCLEROSIS, V59, P21, DOI 10.1016/0021-9150(86)90028-6; RAO DC, 1979, ANN HUM GENET, V42, P467, DOI 10.1111/j.1469-1809.1979.tb00680.x; RAO DC, 1983, AM J MED GENET, V15, P195, DOI 10.1002/ajmg.1320150203; SIERVOGEL RM, 1980, CLIN GENET, V17, P13; SOSENKO JM, 1980, AM J EPIDEMIOL, V112, P656, DOI 10.1093/oxfordjournals.aje.a113038; THIRD JLHC, 1984, METABOLISM, V33, P136, DOI 10.1016/0026-0495(84)90126-4; Vandeberg J.L., 1986, P317; VANDEBERG JL, 1987, RECENT ADV ARTERIOSC, V76, P71; WILLIAMS MC, 1987, LIPIDS, V22, P366, DOI 10.1007/BF02534008; 1974, DHEW NIH75628 PUBL	52	27	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					401	413						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	3177383				2022-12-18	WOS:A1988Q473600006
J	YOSHIDA, A; TAKIZAWA, T; PRCHAL, JT				YOSHIDA, A; TAKIZAWA, T; PRCHAL, JT			RFLP OF THE X-CHROMOSOME LINKED GLUCOSE-6-PHOSPHATE-DEHYDROGENASE LOCUS IN BLACKS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ALABAMA,SCH MED,BIRMINGHAM,AL 35233	University of Alabama System; University of Alabama Birmingham	YOSHIDA, A (corresponding author), CITY HOPE NATL MED CTR,BECKMAN RES INT,DEPT BIOCHEM GENET,DUARTE,CA 91010, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029515, R37HL029515] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-29515] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOYER SH, 1962, P NATL ACAD SCI USA, V48, P1868, DOI 10.1073/pnas.48.10.1868; KOBORI JA, 1986, SCIENCE, V234, P173, DOI 10.1126/science.3018929; LINDER D, 1965, SCIENCE, V150, P67, DOI 10.1126/science.150.3692.67; McKusick V. A., 1986, MENDELIAN INHERITANC; MCKUSICK VA, 1986, COLD SPRING HARB SYM, V51, P1123; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAKIZAWA T, 1987, Genomics, V1, P228, DOI 10.1016/0888-7543(87)90048-6; TAKIZAWA T, 1987, American Journal of Human Genetics, V41, pA241; TAKIZAWA T, 1986, P NATL ACAD SCI USA, V83, P4157, DOI 10.1073/pnas.83.12.4157; YOSHIDA A, 1986, AM J HUM GENET, V39, P203; YOSHIDA A, 1986, American Journal of Human Genetics, V39, pA228; 1967, WHO366 SCI GROUP TEC	16	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1988	42	6					872	876						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N5197	2897162				2022-12-18	WOS:A1988N519700010
J	WYATT, RJ; RIVAS, ML; JULIAN, BA; QUIGGINS, PA; WOODFORD, SY; MCMORROW, RG; BAEHLER, RW				WYATT, RJ; RIVAS, ML; JULIAN, BA; QUIGGINS, PA; WOODFORD, SY; MCMORROW, RG; BAEHLER, RW			REGIONALIZATION IN HEREDITARY IGA NEPHROPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CENT BAPTIST HOSP, DEPT MED, LEXINGTON, KY USA; UNIV TENNESSEE, CTR HLTH SCI, DEPT PEDIAT, MEMPHIS, TN 38163 USA; UNIV ALABAMA, DEPT MED, BIRMINGHAM, AL 35294 USA; UNIV TENNESSEE, DEPT ANTHROPOL, KNOXVILLE, TN 37996 USA	Central Baptist Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham; University of Tennessee System; University of Tennessee Knoxville				Wyatt, Robert/0000-0001-6077-0259				[Anonymous], 1984, APPALACHIA REGIONAL; ASAMOAH A, IN PRESS AM J MED GE; Berger J, 1984, Contrib Nephrol, V40, P4; BERGER J, 1980, NOUV PRESSE MED, V9, P219; BERTHOUX FC, 1978, NEW ENGL J MED, V298, P1034; BEUKHOF JR, 1984, CLIN NEPHROL, V22, P195; BOWMAN HS, 1965, AM J HUM GENET, V17, P1; CHAPUISCELLIER C, 1981, J IMMUNOGENET, V8, P257; CLARKSON AR, 1977, CLIN NEPHROL, V8, P459; DAMICO G, 1985, MEDICINE, V64, P49, DOI 10.1097/00005792-198501000-00004; DROZ D, 1976, CONTRIB NEPHROL, V2, P150; DUPONT B, 1977, HLA DISEASE, P233; EGIDO J, 1983, CLIN EXP IMMUNOL, V54, P532; EMANCIPATOR SN, 1985, CLIN NEPHROL, V24, P161; FAUCHET R, 1980, NEW ENGL J MED, V302, P1033; FEEHALLY J, 1984, DIS MARKERS, V2, P493; FOGAZZI GB, 1983, KIDNEY INT, V24, P825; GALLA JH, 1984, LANCET, V2, P522; HIKI Y, 1982, NEPHRON, V32, P222, DOI 10.1159/000182849; HOGG RJ, 1985, AM J KIDNEY DIS, V5, P157; JENNETTE JC, 1985, KIDNEY INT, V28, P944, DOI 10.1038/ki.1985.222; JULIAN BA, 1985, NEW ENGL J MED, V312, P202, DOI 10.1056/NEJM198501243120403; KASAHARA M, 1982, CLIN IMMUNOL IMMUNOP, V25, P189, DOI 10.1016/0090-1229(82)90181-7; KASHIWABARA H, 1982, KIDNEY INT, V22, P377, DOI 10.1038/ki.1982.185; KATZ A, 1980, TRANSPLANTATION, V29, P505, DOI 10.1097/00007890-198006000-00016; LABERGE C, 1969, AM J HUM GENET, V21, P36; MACDONALD IM, 1976, HLA DIS, P203; MCCOY RC, 1974, AM J PATHOL, V76, P123; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P306; MCKUSICK VA, 1983, MENDELIAN INHERITANC, P372; MCLEAN RH, 1984, KIDNEY INT, V26, P855, DOI 10.1038/ki.1984.228; MONTOLIU J, 1980, ARCH INTERN MED, V140, P1374, DOI 10.1001/archinte.140.10.1374; NOEL LH, 1978, CLIN IMMUNOL IMMUNOP, V10, P19, DOI 10.1016/0090-1229(78)90004-1; NOMOTO Y, 1979, AM J CLIN PATHOL, V71, P158; NOMOTO Y, 1984, AM J NEPHROL, V4, P184, DOI 10.1159/000166803; NORIO R, 1966, ANN PAEDIATR FEN S27, V12; OKADA M, 1979, GLOMERULONEPHRITIS, P201; RICHMAN AV, 1979, ANN INTERN MED, V90, P201, DOI 10.7326/0003-4819-90-2-201; SABATIER JC, 1979, CLIN NEPHROL, V11, P35; Sakai H, 1984, Contrib Nephrol, V40, P124; SAKAI H, 1979, AM J CLIN PATHOL, V72, P452; SCALF HP, 1979, KENTUCKYS LAST FRONT; Shirai T, 1978, Contrib Nephrol, V9, P88; SIMON P, 1984, PRESSE MED, V13, P257; SIMON P, 1983, KIDNEY INT, V24, P137; SINNIAH R, 1981, HISTOPATHOLOGY, V5, P469, DOI 10.1111/j.1365-2559.1981.tb01811.x; TOLKOFFRUBIN NE, 1978, TRANSPLANTATION, V26, P430, DOI 10.1097/00007890-197812000-00014; WALDO FB, 1986, KIDNEY INT, V29, P1229, DOI 10.1038/ki.1986.132; WALSHE JJ, 1984, AM J MED, V77, P765, DOI 10.1016/0002-9343(84)90382-6; WEXLER N, 1985, AM J HUM GENET, V37, pA605; WYATT RJ, 1982, J CLIN IMMUNOL, V2, P110, DOI 10.1007/BF00916894; WYATT RJ, 1984, AM J KIDNEY DIS, V4, P192, DOI 10.1016/S0272-6386(84)80071-2; WYATT RJ, 1984, DIS MARKERS, V2, P419	53	27	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1987	41	1					36	50						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J0581	3605095				2022-12-18	WOS:A1987J058100004
J	HANASH, SM; BAIER, LJ; WELCH, D; KUICK, R; GALTEAU, M				HANASH, SM; BAIER, LJ; WELCH, D; KUICK, R; GALTEAU, M			GENETIC-VARIANTS DETECTED AMONG 106 LYMPHOCYTE POLYPEPTIDES OBSERVED IN TWO-DIMENSIONAL GELS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV NANCY 1,F-54013 NANCY,FRANCE	Universite de Lorraine	HANASH, SM (corresponding author), UNIV MICHIGAN,MED CTR,ANN ARBOR,MI 48109, USA.				NCI NIH HHS [R01-CA-32146, P01-CA-26803] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA032146, P01CA026803] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		COMINGS DE, 1982, CLIN CHEM, V28, P798; DUNCAN R, 1982, CLIN CHEM, V28, P749; GOLDMAN D, 1983, AM J HUM GENET, V35, P827; GOLDMAN D, 1982, CLIN CHEM, V28, P1021; HAMAGUCHI H, 1982, HUM GENET, V62, P142; HANASH SM, 1986, AM J HUM GENET, V38, P352; HARRIS H, 1980, PRINCIPLES HUMAN BIO, P323; MCCONKEY EH, 1979, P NATL ACAD SCI USA, V76, P6500, DOI 10.1073/pnas.76.12.6500; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; ROSENBLUM BB, 1984, AM J HUM GENET, V36, P601; ROSENBLUM BB, 1983, P NATL ACAD SCI-BIOL, V80, P5002, DOI 10.1073/pnas.80.16.5002; SMITH SC, 1980, GENETICS, V96, P967; WALTON KE, 1979, J BIOL CHEM, V254, P7951; WANNER LA, 1982, AM J HUM GENET, V34, P209	15	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					317	328						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	3766538				2022-12-18	WOS:A1986E364400004
J	PALUMBO, AP; ISOBE, M; HUEBNER, K; SHANE, S; ROVERA, G; DEMUTH, D; CURTIS, PJ; BALLANTINE, M; CROCE, CM; SHOWE, LC				PALUMBO, AP; ISOBE, M; HUEBNER, K; SHANE, S; ROVERA, G; DEMUTH, D; CURTIS, PJ; BALLANTINE, M; CROCE, CM; SHOWE, LC			CHROMOSOMAL LOCALIZATION OF A HUMAN BAND 3-LIKE GENE TO REGION 7Q35-]7Q36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											PALUMBO, AP (corresponding author), WISTAR INST ANAT & BIOL,36TH & SPRUCE ST,PHILADELPHIA,PA 19104, USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NATIONAL CANCER INSTITUTE [P01CA021124, P30CA010815] Funding Source: NIH RePORTER; NCI NIH HHS [CA-21124, CA-10815, CA-24273] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER RM, 1976, BIOGENESIS TURNOVER, P93; BENNETT V, 1980, J BIOL CHEM, V255, P6424; BROCK CJ, 1983, BIOCHEM J, V213, P577, DOI 10.1042/bj2130577; CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; CURTIS PJ, 1985, GENE, V36, P357, DOI 10.1016/0378-1119(85)90191-X; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DEMUTH D, UNPUB CLONING STRUCT; ERIKSON J, 1981, NATURE, V294, P173, DOI 10.1038/294173a0; GREEN L, 1984, SCIENCE, V226, P838, DOI 10.1126/science.6494913; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HUEBNER K, 1985, P NATL ACAD SCI USA, V82, P3790, DOI 10.1073/pnas.82.11.3790; JENKINS RE, 1977, BIOCHEM J, V161, P139, DOI 10.1042/bj1610139; KARDSHEH NS, 1977, J BIOL CHEM, V252, P7418; KAY MMB, 1983, P NATL ACAD SCI-BIOL, V80, P6882, DOI 10.1073/pnas.80.22.6882; KLIMAN HJ, 1980, J BIOL CHEM, V255, P6314; Knauf P.A, 1979, CURR TOP MEMBR TRANS, V12, P249, DOI 10.1016/S0070-2161(08)60259-2; KNOWLES BB, 1977, J EXP MED, V145, P314, DOI 10.1084/jem.145.2.314; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOPITO RR, 1985, NATURE, V316, P234, DOI 10.1038/316234a0; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; MANIATIS T, 1982, MOL CLONING LABORATO; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRAPAZON E, 1977, BIOCHEMISTRY-US, V16, P2966, DOI 10.1021/bi00632a025; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; VANHEYNIGEN V, 1985, NATURE, V311, P104; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WATT R, 1983, NATURE, V303, P725, DOI 10.1038/303725a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; WILLIAMS DG, 1979, BIOCHEM J, V181, P477, DOI 10.1042/bj1810477	31	27	27	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					307	316						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	3020980				2022-12-18	WOS:A1986E364400003
J	FLEJTER, WL; VANDYKE, DL; WEISS, L				FLEJTER, WL; VANDYKE, DL; WEISS, L			BENDS IN HUMAN MITOTIC METAPHASE CHROMOSOMES, INCLUDING A BEND MARKING THE X-INACTIVATION CENTER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									HENRY FORD HOSP,CTR MED GENET & BIRTH DEFECTS,DETROIT,MI 48202	Henry Ford Health System; Henry Ford Hospital								BAJER A, 1971, ADVANCES CELL MOLECU, V1, P213; CAMARGO M, 1982, AM J HUM GENET, V34, P757; COMINGS DE, 1980, HUM GENET, V53, P131, DOI 10.1007/BF00273484; LISKAY RM, 1980, P NATL ACAD SCI-BIOL, V77, P4895, DOI 10.1073/pnas.77.8.4895; MATTEI MG, 1981, HUM GENET, V56, P401, DOI 10.1007/BF00274702; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; THERMAN E, 1974, CHROMOSOMA, V44, P361; THERMAN E, 1974, AM J HUM GENET, V26, P83; VANDYKE DL, 1983, AM J MED GENET, V15, P441, DOI 10.1002/ajmg.1320150309; VANDYKE DL, 1977, AM J HUM GENET, V29, pA109; VANDYKE DL, UNPUB CENTROMERE IND; YUNIS JJ, 1978, CHROMOSOMA, V67, P293, DOI 10.1007/BF00285963; 1972, BIRTH DEFECTS ORIG A, V8	14	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	1					218	226						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SC430	6582784				2022-12-18	WOS:A1984SC43000020
J	LAU, YF; SCHONBERG, S				LAU, YF; SCHONBERG, S			A MALE-SPECIFIC DNA PROBE DETECTS HETEROCHROMATIN SEQUENCES IN A FAMILIAL YQ- CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	LAU, YF (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.		Lau, Yun-Fai C/E-4465-2014	Lau, Yun-Fai C/0000-0002-9119-7050				BOSTOCK CJ, 1978, NATURE, V272, P324, DOI 10.1038/272324a0; COOKE H, 1976, NATURE, V262, P182, DOI 10.1038/262182a0; LAU YF, 1984, LANCET, V1, P14; SCHMIDTKE J, 1980, HUM GENET, V55, P255, DOI 10.1007/BF00291774	4	27	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1394	1396						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6517059				2022-12-18	WOS:A1984TZ59000021
J	SCHNATTERLY, P; BONO, KL; ROBINOW, M; WYANDT, HE; KARDON, N; KELLY, TE				SCHNATTERLY, P; BONO, KL; ROBINOW, M; WYANDT, HE; KARDON, N; KELLY, TE			DISTAL-15Q TRISOMY - PHENOTYPIC COMPARISON OF 9 CASES IN AN EXTENDED FAMILY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									VIRGINIA BAPTIST HOSP,LYNCHBURG,VA 24503; CHILDRENS MED CTR,DAYTON,OH 45404; N SHORE UNIV HOSP,MANHASSET,NY 11030	Cincinnati Children's Hospital Medical Center; Northwell Health; North Shore University Hospital	SCHNATTERLY, P (corresponding author), UNIV VIRGINIA,CHARLOTTESVILLE,VA 22908, USA.							BANNISTER DL, 1975, J PEDIATR-US, V86, P916, DOI 10.1016/S0022-3476(75)80228-9; BREG WR, 1974, AM J HUM GENET, V28, pA17; COCO R, 1978, J GENET HUM, V26, P203; COHEN MM, 1975, ANN GENET-PARIS, V18, P99; FUJIMOTO A, 1974, J MED GENET, V11, P287, DOI 10.1136/jmg.11.3.287; GREGOIRE MJ, 1981, HUM GENET, V59, P429, DOI 10.1007/BF00295485; HOWARDPEEBLES PN, 1982, J MED GENET, V19, P224, DOI 10.1136/jmg.19.3.224; MARASCHIO P, 1981, HUM GENET, V57, P345, DOI 10.1007/BF00281681; Pedersen C, 1976, Clin Genet, V9, P378; SCHRECK RR, 1977, HUM GENET, V36, P1, DOI 10.1007/BF00390430; TURLEAU C, 1977, ANN GENET-PARIS, V20, P214; TZANCHEVA M, 1981, HUM GENET, V56, P275, DOI 10.1007/BF00274678; WYANDT HE, 1977, NEW CHROMOSOMAL SYND, P301; YIP MY, 1982, CLIN GENET, V22, P1; ZABEL B, 1977, ANN GENET-PARIS, V20, P285	15	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					444	451						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	SM324	6711563				2022-12-18	WOS:A1984SM32400018
J	GERARD, G; VITRAC, D; LEPENDU, J; MULLER, A; ORIOL, R				GERARD, G; VITRAC, D; LEPENDU, J; MULLER, A; ORIOL, R			H-DEFICIENT BLOOD-GROUPS (BOMBAY) OF REUNION-ISLAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CTR NATL TRANSFUS SANGUINE, F-91400 ORSAY, FRANCE; HOP ST PIERRE, POSTE TRANSFUS, F-97448 ST PIERRE, Reunion, FRANCE; HOP BROUSSAIS, INST IMMUNOBIOL, F-75674 PARIS 14, FRANCE	CHU Reunion; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	GERARD, G (corresponding author), HOP BELLEPIERRE, CTR TRANSFUS, F-97405 ST DENIS, Reunion, FRANCE.		Le Pendu, Jacques/F-4760-2013; Vitrac, Didier/T-2235-2018	Le Pendu, Jacques/0000-0002-4856-0387; Vitrac, Didier/0000-0002-0114-2719				BERANOVA G, 1969, VOX SANG, V16, P449, DOI 10.1111/j.1423-0410.1969.tb04771.x; BHENDE YM, 1952, LANCET, V262, P903; GERARD G, 1975, REV FR TRANSFUS IMMU, V18, P321, DOI 10.1016/S0338-4535(75)80006-7; Gerard G, 1970, Rev Fr Transfus, V13, P267, DOI 10.1016/S0035-2977(70)80037-2; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HRUBISKO M, 1970, VOX SANG, V19, P113, DOI 10.1111/j.1423-0410.1970.tb01503.x; LEPENDU J, 1982, AM J HUM GENET, V34, P402; LEVINE P, 1955, BLOOD, V10, P1100, DOI 10.1182/blood.V10.11.1100.1100; LEVINE P, 1961, VOX SANG, V6, P561, DOI 10.1111/j.1423-0410.1961.tb03204.x; Liberge G, 1970, Rev Fr Transfus, V13, P357, DOI 10.1016/S0035-2977(70)80047-5; LOPEZ M, 1972, REV FR TRANSFUS IMMU, V15, P187, DOI 10.1016/S0035-2977(72)80016-6; MACAULIFFE, 1902, CILAOS PITTORESQUE T; MOORES P, 1981, THESIS U NATAL S AFR; MULET C, 1977, FEBS LETT, V84, P74, DOI 10.1016/0014-5793(77)81060-0; ORIOL R, 1981, AM J HUM GENET, V33, P421; ORIOL R, 1981, AM J HUM GENET, V33, P551; ROUGER P, 1981, PRATIQUE AGGLUTINATI, P82; SOLOMON JM, 1965, BLOOD-J HEMATOL, V25, P470, DOI 10.1182/blood.V25.4.470.470; VOAK D, 1968, VOX SANG, V14, P18; YUNIS EJ, 1969, BLOOD-J HEMATOL, V33, P124, DOI 10.1182/blood.V33.1.124.124	20	27	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					937	947						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU211	7180848				2022-12-18	WOS:A1982PU21100011
J	KALOUSTIAN, VMD; KHOURY, MJ; HALLAL, R; IDRISS, ZH; DEEB, ME; WAKID, NW; HADDAD, FS				KALOUSTIAN, VMD; KHOURY, MJ; HALLAL, R; IDRISS, ZH; DEEB, ME; WAKID, NW; HADDAD, FS			SANDHOFF DISEASE - A PREVALENT FORM OF INFANTILE GM2 GANGLIOSIDOSIS IN LEBANON	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									AMER UNIV BEIRUT, DEPT LAB MED, BEIRUT, LEBANON; AMER UNIV BEIRUT, DEPT SURG, BEIRUT, LEBANON	American University of Beirut; American University of Beirut	KALOUSTIAN, VMD (corresponding author), AMER UNIV BEIRUT, DEPT PEDIAT, BEIRUT, LEBANON.							ANDERMANN E, 1973, T AM NEUROL ASSOC, V98, P17; BAIN AD, 1972, J MENT DEFIC RES, V16, P119; JOHNSON WG, 1977, NEUROLOGY, V27, P1012, DOI 10.1212/WNL.27.11.1012; KRIVIT W, 1972, AM J MED, V52, P763, DOI 10.1016/0002-9343(72)90082-4; LANE AB, 1978, CLIN CHIM ACTA, V87, P219, DOI 10.1016/0009-8981(78)90341-8; LOWDEN JA, 1978, AM J HUM GENET, V30, P38; MELANCON SB, 1974, UNION MED CAN, V103, P1218; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OBRIEN JS, 1978, METABOLIC BASIS INHE, P841; OKADA S, 1972, PEDIATR RES, V6, P606; SALAM M, 1964, PEDIATRICS, V34, P658; SANDHOFF K, 1968, LIFE SCI PT 1 PHYSI, V7, P283, DOI 10.1016/0024-3205(68)90024-6; SUZUKI Y, 1971, NEUROLOGY, V21, P313, DOI 10.1212/WNL.21.4.313	13	27	27	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1981	33	1					85	89						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA930	7468596				2022-12-18	WOS:A1981LA93000010
J	PANNY, SR; SCOTT, AF; SMITH, KD; PHILLIPS, JA; KAZAZIAN, HH; TALBOT, CC; BOEHM, CD				PANNY, SR; SCOTT, AF; SMITH, KD; PHILLIPS, JA; KAZAZIAN, HH; TALBOT, CC; BOEHM, CD			POPULATION HETEROGENEITY OF THE HPA-I RESTRICTION SITE ASSOCIATED WITH THE BETA-GLOBIN GENE - IMPLICATIONS FOR PRENATAL-DIAGNOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV, SCH MED, DEPT MED, DIV MED GENET, BALTIMORE, MD 21205 USA; HOWARD HUGHES MED INST, HUMAN BIOCHEM GENET LAB, BALTIMORE, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute					NHLBI NIH HHS [HL-15026] Funding Source: Medline; NIADDK NIH HHS [AM-00423] Funding Source: Medline; NIGMS NIH HHS [GM-17471] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTER BP, 1979, J PEDIATR-US, V95, P501, DOI 10.1016/S0022-3476(79)80753-2; ALTER BP, 1976, NEW ENGL J MED, V295, P1437, DOI 10.1056/NEJM197612232952601; CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL, P490; COOPER AJ, 1963, AM J HUM GENET, V15, P420; DEISSEROTH A, 1978, P NATL ACAD SCI USA, V75, P1456, DOI 10.1073/pnas.75.3.1456; FELDENZER J, 1979, J CLIN INVEST, V64, P751, DOI 10.1172/JCI109519; FLAVELL RA, 1978, CELL, V15, P25, DOI 10.1016/0092-8674(78)90080-6; GLASS B, 1953, AM J HUM GENET, V5, P1; HOBBINS JC, 1974, NEW ENGL J MED, V290, P1065, DOI 10.1056/NEJM197405092901908; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JEFFREYS AJ, 1977, CELL, V12, P429, DOI 10.1016/0092-8674(77)90119-2; KAN YW, 1978, LANCET, V2, P910; KAZAZIAN HH, 1978, J PEDIATR-US, V93, P502, DOI 10.1016/S0022-3476(78)81179-2; KIRBY KS, 1967, BIOCHEM J, V104, P254, DOI 10.1042/bj1040254; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; KURNIT DM, 1979, LANCET, V1, P104; KURNIT DM, 1979, ANNU REV GENET, V13, P235, DOI 10.1146/annurev.ge.13.120179.001315; PHILLIPS JA, 1980, P NATL ACAD SCI-BIOL, V77, P2853, DOI 10.1073/pnas.77.5.2853; PHILLIPS JA, 1979, JOHNS HOPKINS MED J, V145, P57; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; SCHACHAT FH, 1973, COLD SPRING HARB SYM, V38, P371, DOI 10.1101/SQB.1974.038.01.040; SCOTT AF, 1979, P NATL ACAD SCI USA, V76, P4563, DOI 10.1073/pnas.76.9.4563; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; WORKMAN PL, 1963, AM J HUM GENET, V15, P429; 1976, J AM MED ASS, V236, P1471	27	27	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1981	33	1					25	35						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA930	6162380				2022-12-18	WOS:A1981LA93000003
J	FLUHARTY, AL; STEVENS, RL; DELAFLOR, SD; SHAPIRO, LJ; KIHARA, H				FLUHARTY, AL; STEVENS, RL; DELAFLOR, SD; SHAPIRO, LJ; KIHARA, H			ARYLSULFATASE-A MODULATION WITH PH IN MULTIPLE SULFATASE DEFICIENCY DISORDER FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARBOR GEN HOSP,DEPT PEDIAT,DIV MED GENET,TORRANCE,CA 90509; NEUROPSYCHIAT INST PACIFIC STATE HOSP RES GRP,POMONA,CA 91766	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	FLUHARTY, AL (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024, USA.							BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; CECCARIN.C, 1971, P NATL ACAD SCI USA, V68, P229, DOI 10.1073/pnas.68.1.229; DULANEY JT, 1978, METABOLIC BASIS INHE, P770; EAGLE H, 1971, SCIENCE, V174, P500, DOI 10.1126/science.174.4008.500; ETO Y, 1974, ARCH NEUROL-CHICAGO, V30, P153, DOI 10.1001/archneur.1974.00490320041005; FLUHARTY AL, 1978, AM J HUM GENET, V30, P249; LIE SO, 1972, P NATL ACAD SCI USA, V69, P2361, DOI 10.1073/pnas.69.9.2361; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PORTER MT, 1969, P NATL ACAD SCI USA, V62, P887, DOI 10.1073/pnas.62.3.887; RUBIN H, 1971, J CELL BIOL, V51, P686, DOI 10.1083/jcb.51.3.686	10	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	5					574	580						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HS030	41450				2022-12-18	WOS:A1979HS03000007
J	METAXOTOU, C; KALPINIMAVROU, A; PANAGOU, M; TSENGHI, C				METAXOTOU, C; KALPINIMAVROU, A; PANAGOU, M; TSENGHI, C			POLYMORPHISM OF CHROMOSOME-9 IN 600 GREEK SUBJECTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note											METAXOTOU, C (corresponding author), ATHENS UNIV,AGHIA SOPHIA CHILDRENS HOSP,DEPT PEDIAT 1,ATHENS 608,GREECE.							BOBROW M, 1972, NATURE-NEW BIOL, V238, P122, DOI 10.1038/newbio238122a0; BOUE J, 1975, HUMANGENETIK, V30, P217, DOI 10.1007/BF00279187; CRAIGHOLMES AP, 1975, AM J HUM GENET, V27, P178; CRAIGHOLMES AP, 1973, AM J HUM GENET, V25, P181; DELACHAPELLE A, 1974, AM J HUM GENET, V26, P746; GHOSH PK, 1976, HUM GENET, V32, P149, DOI 10.1007/BF00291498; HANSMANN I, 1976, HUM GENET, V31, P247, DOI 10.1007/BF00270855; KUNZE J, 1975, LANCET, V1, P273; LUBS HA, 1971, NATURE, V233, P134, DOI 10.1038/233134a0; MADAN K, 1974, ANN GENET-PARIS, V17, P81; MCKENZIE WH, 1975, CYTOGENET CELL GENET, V14, P97, DOI 10.1159/000130330; MULLER H, 1975, CYTOGENET CELL GENET, V15, P239, DOI 10.1159/000130522; NIELSEN J, 1974, HUMANGENETIK, V21, P211, DOI 10.1007/BF00279014	13	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	1					85	89						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL575	623106				2022-12-18	WOS:A1978EL57500012
J	SPENCE, MA; SPARKES, RS; HECKENLIVELY, JR; PEARLMAN, JT; ZEDALIS, D; SPARKES, M; CRIST, M; TIDEMAN, S				SPENCE, MA; SPARKES, RS; HECKENLIVELY, JR; PEARLMAN, JT; ZEDALIS, D; SPARKES, M; CRIST, M; TIDEMAN, S			PROBABLE GENETIC LINKAGE BETWEEN AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA (RP) AND AMYLASE (AMY2) - EVIDENCE OF AN RP LOCUS ON CHROMOSOME 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES, DEPT PSYCHIAT, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT BIOMATH, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT MED, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT PEDIAT, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT OPHTHALMOL, LOS ANGELES, CA 90024 USA; UNIV KENTUCKY, DEPT OPHTHALMOL, LEXINGTON, KY 40506 USA; UNIV CALIF LOS ANGELES, MENTAL RETARDAT RES CTR, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Kentucky; University of California System; University of California Los Angeles								CHEN SH, 1972, ANN HUM GENET, V35, P401; CRANDALL BF, 1974, HUM HERED, V24, P247, DOI 10.1159/000152657; Giblett ER., 1969, GENETIC MARKERS HUMA; GRUTZNER P, 1972, HUMANGENETIK, V14, P155, DOI 10.1007/BF00273301; Hamerton J L, 1976, Birth Defects Orig Artic Ser, V12, P7; HOPKINSON DA, 1973, ANN HUM GENET, V37, P119, DOI 10.1111/j.1469-1809.1973.tb01820.x; HUSSELS I, 1967, J GENET HUM, V16, P106; HUSSELSMAUMENEE I, 1975, AM J HUM GENET, V27, P505; ISSITT PD, 1975, APPLIED BLOOD GROUP; KUHNL P, 1974, HUMANGENETIK, V24, P227; McKusick V. A, 1975, MENDELIAN INHERITANC; MERRITT AD, 1973, AM J HUM GENET, V25, P510; MERRITT AD, 1973, AM J HUM GENET, V25, P523; MEYERS DA, 1976, CYTOGENET CELL GENET, V16, P335, DOI 10.1159/000130625; MORTON NE, 1957, AM J HUM GENET, V9, P55; MORTON NE, 1956, AM J HUM GENET, V8, P80; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1976, AM J HUM GENET, V28, P528; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x; WARBURG M, 1968, ACTA OPHTHALMOL, V46, P494	20	27	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1977	29	4					397	404						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN459	879170				2022-12-18	WOS:A1977DN45900009
J	HAMERTON, JL				HAMERTON, JL			HUMAN POPULATION CYTOGENETICS - DILEMMAS AND PROBLEMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									UNIV MANITOBA,DEPT PEDIAT,DIV GENET,WINNIPEG,MANITOBA,CANADA	University of Manitoba								BECKWITH, 1975, SCIENCE, V187, P298; BECKWITH J, 1974, New Scientist, V64, P474; BELL AG, 1974, CAN J GENET CYTOL, V16, P239, DOI 10.1139/g74-026; BOCHKOV NP, 1974, HUMANGENETIK, V22, P139; BORGAONKAR DS, 1974, PROG MED GENET, V10, P135; BORGAONKAR DS, 1972, AM J HUM GENET, V24, pA13; CASEY MD, 1968, ANN HUM GENET, V32, P53, DOI 10.1111/j.1469-1809.1968.tb00049.x; CASEY MD, 1966, NATURE, V209, P641, DOI 10.1038/209641a0; COURTBROWN WM, 1968, J MED GENET, V5, P341; CULLITON BJ, 1974, SCIENCE, V186, P715, DOI 10.1126/science.186.4165.715; CULLITON BJ, 1975, SCIENCE, V188, P1284, DOI 10.1126/science.11643276; CULLITON BJ, 1974, SCIENCE, V186, P1189; DeBakey L, 1975, Perspect Biol Med, V18, P522; DUNN LC, 1962, AM J HUM GENET, V14, P1; GRANT WW, 1975, POPULATION CYTOGENET; HAMERTON JL, IN PRESS; HOOK EB, 1974, AM J HUM GENET, V26, P504; HOOK EB, 1975, LANCET, V1, P98; HOOK EB, 1971, SCIENCE, V172, P284, DOI 10.1126/science.172.3980.284; HOOK EB, 1973, SCIENCE, V179, P139, DOI 10.1126/science.179.4069.139; HOOK EB, 1976, GENETICS LAW; JACOBS PA, 1965, NATURE, V208, P1351, DOI 10.1038/2081351a0; JACOBS PA, 1974, ANN HUM GENET, V37, P359, DOI 10.1111/j.1469-1809.1974.tb01843.x; JACOBS PA, 1968, ANN HUM GENET, V31, P339, DOI 10.1111/j.1469-1809.1968.tb00566.x; JACOBS PA, 1975, SCIENCE, V189, P1044, DOI 10.1126/science.189.4208.1040; LUBS HA, 1970, SCIENCE, V169, P495, DOI 10.1126/science.169.3944.495; MELLMAN WJ, 1974, ETHICAL SOCIAL LEGAL; MILLER L, 1975, LANCET, V1, P221; NIELSEN JC, IN PRESS; NOEL B, 1974, CLIN GENET, V5, P387; PRICE WC, IN PRESS; PRICE WH, 1967, BRIT MED J, V1, P533, DOI 10.1136/bmj.1.5539.533; PRICE WH, 1966, LANCET, V1, P565; PRICE WH, 1967, NATURE, V213, P815, DOI 10.1038/213815a0; PYERITZ R, 1975, NEW ENGL J MED, V293, P508; RATCLIFFE SG, 1975, LANCET, V1, P1144; SERGOVICH F, 1969, NEW ENGL J MED, V280, P851, DOI 10.1056/NEJM196904172801602; VALENTINE GH, 1971, PEDIATRICS, V48, P583; WALZER S, 1975, POPULATION CYTOGENET, V8, P223; ZEUTHEN E, 1975, ACTA PSYCHIAT SCAND, V51, P3, DOI 10.1111/j.1600-0447.1975.tb00208.x; 1975, GENETIC SCREENING PR; 1974, BIRTH DEFECTS OAS, V11	42	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	2					107	122						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BJ476	1266846				2022-12-18	WOS:A1976BJ47600001
J	MOORHEAD, PS				MOORHEAD, PS			CLOSER LOOK AT CHROMOSOMAL INVERSIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									UNIV PENN,PHILADELPHIA,PA 19174	University of Pennsylvania								ALLDERDICE PW, 1975, AM J HUM GENET, V27, P699; BOUE J, 1975, HUMANGENETIK, V30, P217, DOI 10.1007/BF00279187; BOWEN P, 1974, J PEDIATR-US, V85, P95, DOI 10.1016/S0022-3476(74)80297-0; DELACHAPELLE A, 1974, AM J HUM GENET, V26, P746; DUTRILLAUX B, 1972, JOURNEES PARISIENNES, P13; HERVA R, 1976, AM J HUM GENET, V28, P208; JACOBS PA, 1975, CLIN GENET, V8, P169; MADAN K, 1974, ANN GENET-PARIS, V17, P81; MARTIN J, 1967, CAN J GENET CYTOL, V9, P255, DOI 10.1139/g67-021; MCKENZIE WH, 1975, CYTOGENET CELL GENET, V14, P97, DOI 10.1159/000130330; SCHNIZEL A, 1974, HUMANGENETIK, V25, P171; VANDERLINDEN AGJM, 1975, CYTOGENET CELL GENET, V14, P126, DOI 10.1159/000130332; VINE DT, 1976, AM J HUM GENET, V28, P203	13	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	3					294	296						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BS306	944530				2022-12-18	WOS:A1976BS30600012
J	MIGEON, BR; HUIJING, F				MIGEON, BR; HUIJING, F			GLYCOGEN-STORAGE DISEASE ASSOCIATED WITH PHOSPHORYLASE KINASE-DEFICIENCY - EVIDENCE FOR X INACTIVATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; UNIV MIAMI,SCH MED,DEPT BIOCHEM,MIAMI,FL 33136	Johns Hopkins University; University of Miami								DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; FISCHER EH, 1958, BIOCHEM PREPN, V6, P68; HUIJING F, 1969, AM J HUM GENET, V21, P275; HUIJING F, 1970, FEBS LETT, V10, P328, DOI 10.1016/0014-5793(70)80465-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYON MF, 1962, AM J HUM GENET, V14, P135; MIGEON BR, 1971, AM J HUM GENET, V23, P199; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425	8	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	3					360	368						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T0991	4524311				2022-12-18	WOS:A1974T099100005
J	RAO, DC; MORTON, NE				RAO, DC; MORTON, NE			LARGE DEVIATIONS IN DISTRIBUTION OF RARE GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,POPULATION GENET,HONOLULU,HI 96822	University of Hawaii System								ABRAMOWITZ M, 1965, HDB MATHEMATICAL FUN; CHASE GA, 1972, AM J HUM GENET, V24, P339; McKusick V, 1966, MENDELIAN INHERITANC; MORTON NE, 1967, GENETICS INTERRACIAL, V3; MYRIANTHOPOULOS NC, 1972, AM J HUM GENET, V24, P341; MYRIANTHOPOULOS NC, 1970, NATURE, V227, P609, DOI 10.1038/227609a0; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; RAO CR, 1965, LINEAR STATISTICAL I; RAO DC, 1973, GENETIC STRUCTURE PO; SHAW RF, 1969, NATURE, V224, P1214, DOI 10.1038/2241214b0; Wright S, 1931, GENETICS, V16, P0097; WRIGHT SW, 1968, AM J HUM GENET, V20, P157	12	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	6					594	597						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R7135	4773476				2022-12-18	WOS:A1973R713500002
J	MODIANO, G; MORPURGO, G; GIGLIANI, F; KHAN, PM; KANASHIRO, VK; SANTOLAMAZZA, C; SCOZZARI, R; TERRENATO, L; PAOLUCCI, AM; BERNINI, L; CARTER, ND; BAUR, EW; BENERECE.SA; DETTER, JC; NIJENHUIS, LE				MODIANO, G; MORPURGO, G; GIGLIANI, F; KHAN, PM; KANASHIRO, VK; SANTOLAMAZZA, C; SCOZZARI, R; TERRENATO, L; PAOLUCCI, AM; BERNINI, L; CARTER, ND; BAUR, EW; BENERECE.SA; DETTER, JC; NIJENHUIS, LE			SURVEY OF SEVERAL RED-CELL AND SERUM GENETIC MARKERS IN A PERUVIAN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARENDS T, 1967, P NATL ACAD SCI USA, V57, P1252, DOI 10.1073/pnas.57.5.1252; ARENDS T, 1962, ACTA CIENT VENEZ, V13, P116; ARENDS T, 1964, 9 P C INT SOC BLOOD, P463; BAUR EW, 1964, CLIN CHIM ACTA, V9, P252, DOI 10.1016/0009-8981(64)90103-2; BAUR EW, 1963, J LAB CLIN MED, V61, P166; BENERECE.SA, 1969, AM J HUM GENET, V21, P315; BERNINI L F, 1970, Biochimica et Biophysica Acta, V200, P203, DOI 10.1016/0005-2795(70)90165-0; BERNINI LF, 1969, BIOCHEM GENET, V2, P305, DOI 10.1007/BF01458491; BOTTINI E, 1971, SCIENCE, V171, P409, DOI 10.1126/science.171.3969.409; BOWMAN JE, 1966, NATURE, V210, P811, DOI 10.1038/210811a0; CARTER ND, 1968, ACTA GENET STAT MED, V18, P109; DETTER J C, 1970, Journal of Medical Genetics, V7, P356, DOI 10.1136/jmg.7.4.356; DETTER JC, 1968, ANN HUM GENET, V31, P329, DOI 10.1111/j.1469-1809.1968.tb00565.x; FERGUSON KA, 1961, NATURE, V190, P629, DOI 10.1038/190629a0; FILDES RA, 1966, NATURE, V209, P261, DOI 10.1038/209261a0; Giblett ER., 1969, GENETIC MARKERS HUMA; HARRIS H, 1970, PRINCIPLES HUMAN BIO; HAUT A, 1962, J CLIN INVEST, V41, P579, DOI 10.1172/JCI104512; HIRSCHFELD JAN, 1960, SCI TOOLS, V7, P18; HOPKINSON DA, 1963, NATURE, V199, P969, DOI 10.1038/199969a0; ISHIMOTO G, 1969, JAP J LEGAL MED, V23, P300; KAPLAN JC, 1968, NATURE, V217, P256, DOI 10.1038/217256a0; KHAN PM, 1968, BIOCHEM GENET, V2, P231, DOI 10.1007/BF01474762; KIRK RL, 1970, AM J HUM GENET, V22, P384; LEWIS WHP, 1967, NATURE, V215, P351, DOI 10.1038/215351a0; LUCARELLI P, 1971, 13 P INT C PED VIENN; MATSON GA, 1967, AM J PHYS ANTHROPOL, V27, P157, DOI 10.1002/ajpa.1330270206; MATSON GA, 1966, AM J PHYS ANTHROPOL, V24, P51, DOI 10.1002/ajpa.1330240107; MATSON GA, 1969, AM J PHYS ANTHROPOL, V30, P61, DOI 10.1002/ajpa.1330300108; MODIANO G, 1969, HUMANGENETIK, V8, P253; MODIANO G, 1967, ACTA GENET STAT MED, V17, P17; MORPURGO G, 1970, NATURE, V227, P387, DOI 10.1038/227387a0; NEEL JV, 1967, AM J HUM GENET, V19, P554; OMOTO K, 1970, JPN J HUM GENET, V14, P298; PAOLUCCI AM, 1971, AM J PHYS ANTHROPOL, V34, P427, DOI 10.1002/ajpa.1330340312; RATTAZZI MC, 1967, NATURE, V213, P79, DOI 10.1038/213079b0; RITTER H, 1966, HUMANGENETIK, V2, P21, DOI 10.1007/BF00285905; ROBINSON AR, 1957, J LAB CLIN MED, V50, P745; SALZANO FM, 1966, ACTA GENET STAT MED, V16, P242; SALZANO FM, 1968, AM J PHYS ANTHROPOL, V28, P183, DOI 10.1002/ajpa.1330280215; SCOZZARI R, 1970, HUMANGENETIK, V8, P364, DOI 10.1007/BF00280340; SHIBATA S, 1961, ACTA HAEMATOL JAPON, V24, P51; SHIH LY, 1968, AM J HUM GENET, V20, P474; SMITHIES O, 1965, VOX SANG, V10, P359; SPENCER N, 1964, NATURE, V204, P742, DOI 10.1038/204742a0; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x; TASHIAN RE, 1967, AM J HUM GENET, V19, P524; TUDHOPE GR, 1965, NATURE, V205, P404, DOI 10.1038/205404a0; VESELL ES, 1965, MEDICAL GENETICS, V4, P128; [No title captured]	50	27	27	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	2					111	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M2541	4622730				2022-12-18	WOS:A1972M254100001
J	BREWER, GJ				BREWER, GJ			ANNOTATION - HUMAN ECOLOGY, AN EXPANDING ROLE FOR HUMAN GENETICIST	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material																		HERBER L, 1965, CRISIS OUR CITIES; HOLLAND WW, 1965, LANCET, V1, P445; KUEPPERS F, 1969, SCIENCE, V165, P899, DOI 10.1126/science.165.3896.899; LIEBERMA.J, 1969, NEW ENGL J MED, V281, P279, DOI 10.1056/NEJM196908072810601; MILLS CA, 1962, THIS AIR WE BREATHE; MITTMAN C, 1969, Clinical Research, V17, P553; MOTULSKY AG, 1970, AM J HUM GENET, V22, P109	7	27	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	1					92	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	I6190	5581986				2022-12-18	WOS:A1971I619000011
J	JENKINS, T; HARPENDING, HC; GORDON, H; KERAAN, MM; JOHNSTON, S				JENKINS, T; HARPENDING, HC; GORDON, H; KERAAN, MM; JOHNSTON, S			RED-CELL-ENZYME POLYMORPHISMS IN KHOISAN PEOPLES OF SOUTHERN AFRICA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BALINSKY D, 1966, S AFR J MED SCI, V31, P124; BALINSKY D, 1967, S AFR J MED SCI, V32, P96; BARCLAY GPT, 1970, T ROY SOC TROP MED H, V64, P78, DOI 10.1016/0035-9203(70)90197-5; BARNICOT NA, 1959, NATURE, V184, P2042, DOI 10.1038/1842042a0; Bleek Dorothea, 1927, FESTSCHRIFT MEINHOF, P55; CAVALLISFORZA LL, 1969, AM J HUM GENET, V21, P252; Giblett ER., 1969, GENETIC MARKERS HUMA; GORDON, 1965, S AFR MED J, V39, P543; GORDON H, 1968, South African Medical Journal, V42, P1242; Gordon H, 1966, S Afr Med J, V40, P1031; GORDON H, 1967, NATURE, V214, P466, DOI 10.1038/214466a0; GORDON HYMIE, 1965, S AFR MED J, V39, P533; GREENBERG JH, 1955, SW J ANTHR, V6, P223; HARVEY RG, 1969, HUM BIOL, V41, P342; HOPKINSON DA, 1966, ANN HUM GENET, V30, P167, DOI 10.1111/j.1469-1809.1966.tb00016.x; JENKINS T, 1970, AM J PHYS ANTHROPOL, V32, P197, DOI 10.1002/ajpa.1330320206; JENKINS T, 1965, HUM BIOL, V37, P371; JENKINS T, 1968, AM J HUM GENET, V20, P299; JENKINS T, 1966, AM J HUM GENET, V18, P399; JENKINS T, 1967, 35 NAM DES RES STAT, P1; JENKINS TREFOR, 1966, S AFRICAN J MED SCI, V31, P42; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; MOTULSKY AG, 1965, ABNORMAL HAEMOGLOBIN, P143; PARR CW, 1966, NATURE, V210, P487, DOI 10.1038/210487a0; PIJPER A, 1932, S AFR MED J, V6, P35; PIJPER A, 1935, S AFR MED J, V9, P192; PORTER IH, 1964, LANCET, V1, P895; REYS L, 1970, AM J HUM GENET, V22, P203; Schapera I., 1930, KHOISAN PEOPLES S AF; SCHULTZE L, 1928, ZUR KENNTNIS KORPERS, P211; Seligman CG., 1957, RACES AFRICA, V3rd; SHAPIRO M, 1953, J FORENSIC MED, V1, P2; SINGER R, 1963, SOUTHWEST J ANTHROP, V19, P168, DOI 10.1086/soutjanth.19.2.3629166; Sokal R, 1963, PRINCIPLES NUMERICAL; STEINBERG AG, 1967, 3RD P INT C HUM GEN, P267; TOPINARD P, 1877, ANTHROPOLOGY; TREVOR JC, 1950, J R ANTHR I, V77, P61; WESTPHAL EOJ, 1963, AFRICA, V33, P237, DOI 10.2307/1157418; WILSON M, 1969, OXFORD HISTORY S AFR; Woodburn J., 1968, MAN HUNTER, P49, DOI DOI 10.3382/PS.0470777; Zoutendyk A, 1955, AM J PHYS ANTHROP-NE, V13, P691, DOI 10.1002/ajpa.1330130410; Zoutendyk A, 1953, AM J PHYS ANTHROP-NE, V11, P361, DOI 10.1002/ajpa.1330110311; 1967, WHO366 TECHN REP SER; 1964, RP12 REP S AFR GOV R	44	27	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	5					513	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4744	5092600				2022-12-18	WOS:A1971K474400009
J	SCOTT, EM; WEAVER, DD; WRIGHT, RC				SCOTT, EM; WEAVER, DD; WRIGHT, RC			DISCRIMINATION OF PHENOTYPES IN HUMAN SERUM CHOLINESTERASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ASHTON GC, 1966, AM J HUM GENET, V18, P438; GUTSCHE BB, 1967, NATURE, V215, P322, DOI 10.1038/215322b0; HARRIS H, 1963, ANN HUM GENET, V26, P359, DOI 10.1111/j.1469-1809.1963.tb01335.x; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; HODGKIN WE, 1965, J CLIN INVEST, V44, P486, DOI 10.1172/JCI105162; KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; KALOW W, 1959, ANN HUM GENET, V23, P239, DOI 10.1111/j.1469-1809.1959.tb01467.x	8	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	4					363	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0227	5432286				2022-12-18	WOS:A1970H022700001
J	REED, TE				REED, TE			DISTRIBUTIONS AND TESTS OF INDEPENDENCE OF 7 BLOOD GROUP SYSTEMS IN A LARGE MULTIRACIAL SAMPLE FROM CALIFORNIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLEN FH, 1963, VOX SANG, V8, P549, DOI 10.1111/j.1423-0410.1963.tb04182.x; MI MP, 1966, VOX SANG, V11, P434, DOI 10.1111/j.1423-0410.1966.tb04240.x; MOHR J, 1966, ACTA GENET STAT MED, V16, P1; Moore RE, 1955, AM J PHYS ANTHROP-NE, V13, P121, DOI 10.1002/ajpa.1330130109; MORTON NE, 1966, VOX SANG, V11, P194, DOI 10.1111/j.1423-0410.1966.tb04222.x; Mourant A., 1954, DISTRIBUTION HUMAN B; Mourant AE., 1958, ABO BLOOD GROUPS; Neel JV, 1954, HUMAN HEREDITY; POLLITZER WS, 1958, AM J PHYS ANTHROPOL, V16, P241, DOI 10.1002/ajpa.1330160208; RACE RR, 1962, BLOOD GROUPS MAN; RAO CR, 1952, ADVANCES STATISTICAL; REED TE, 1967, AM J HUM GENET, V19, P732; REED TE, 1968, AM J HUM GENET, V20, P129; WORKMAN PL, 1963, AM J HUM GENET, V15, P429	14	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	2					142	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B2183	4966854				2022-12-18	WOS:A1968B218300006
J	ALTER, M; GORLIN, R; YUNIS, J; PEAGLER, F; BRUHL, H				ALTER, M; GORLIN, R; YUNIS, J; PEAGLER, F; BRUHL, H			DERMATOGLYPHICS IN XXYY KLINEFELTERS SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		MULDAL S, 1962, ACTA ENDOCRINOL-COP, V39, P183, DOI 10.1530/acta.0.0390183; ROBINSON GC, 1964, J PEDIATR-US, V65, P226, DOI 10.1016/S0022-3476(64)80524-2; TABATA T, 1964, CAN MED ASSOC J, V90, P590; Uchida I.A., 1963, PEDIATR CLIN N AM, V10, P409; UCHIDA IA, 1964, AM J HUM GENET, V16, P284; YUNIS JJ, 1963, CHROMOSOMA, V14, P146, DOI 10.1007/BF00336756	6	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	6					507	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	86655	5927873				2022-12-18	WOS:A19668665500001
J	HANDMAKER, SD				HANDMAKER, SD			SATELLITED CHROMOSOMES OF MAN WITH REFERENCE TO MARFAN SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOOK JA, 1960, AMER J HUM GENET, V12, P104; BUCKTON KE, PERSONAL COMMUNICATI; COOPER HL, 1962, AM J HUM GENET, V14, P107; ELLIS JR, 1961, ANN HUM GENET, V25, P159, DOI 10.1111/j.1469-1809.1961.tb01514.x; FERGUSONSMITH MA, PERSONAL COMMUNICATI; FORD CE, 1960, AM J HUM GENET, V12, P104; KALLEN B., 1962, CYTOGENETICS, V1, P5, DOI 10.1159/000129709; MCKUSICK VA, 1960, LANCET, V1, P1194; MCKUSICK VA, 1960, HERITABLE DISORDERS; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; NEEL JV, 1949, AM J HUM GENET, V1, P19; TJIO JH, 1959, P NATL ACAD SCI USA, V45, P1008, DOI 10.1073/pnas.45.7.1008; TJIO JH, 1958, J EXP MED, V108, P259, DOI 10.1084/jem.108.2.259; TJIO JH, 1960, P NATL ACAD SCI USA, V46, P532, DOI 10.1073/pnas.46.4.532	14	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	1					11	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2969A	13952502				2022-12-18	WOS:A19632969A00003
J	PAYNE, R; HACKEL, E				PAYNE, R; HACKEL, E			INHERITANCE OF HUMAN LEUKOCYTE ANTIGENS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AMOS DB, 1954, BRIT J EXP PATHOL, V35, P203; Bedson SP, 1921, J PATHOL BACTERIOL, V24, P469, DOI 10.1002/path.1700240411; BRITTINGHAM T E, 1957, Vox Sang, V2, P242; BUTLER JJ, 1956, J CLIN INVEST, V35, P1150, DOI 10.1172/JCI103369; Chew WB, 1936, J IMMUNOL, V30, P301; COCHRAN WG, 1952, ANN MATH STAT, V23, P315, DOI 10.1214/aoms/1177729380; DAUSSET J, 1957, NATURE, V180, P1430, DOI 10.1038/1801430a0; DAUSSET J, 1953, LE SANG, V24, P410; Doan CA, 1926, J AMER MED ASSOC, V86, P1593, DOI 10.1001/jama.1926.02670470001001; LALEZARI P, 1959, BLOOD, V14, P748, DOI 10.1182/blood.V14.6.748.748; LOGHEM JJ, 1957, VOX SANG, V2, P257; MOESCHLIN S, 1954, ACTA HAEMATOL-BASEL, V11, P241, DOI 10.1159/000204553; PAYNE R, 1957, ARCH INTERN MED, V99, P587, DOI 10.1001/archinte.1957.00260040087010; PAYNE R, 1958, J CLIN INVEST, V37, P1756, DOI 10.1172/JCI103768; ROOD JJV, 1959, VOX SANG BASEL, V4, P427; WICHELS P, 1928, KLIN WCHNSCHR, V7, P1741	16	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1961	13	3					306	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2961A	13733678				2022-12-18	WOS:A19612961A00005
J	BARR, ML				BARR, ML			SEXUAL DIMORPHISM IN INTERPHASE NUCLEI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARR ML, 1959, SCIENCE, V130, P679, DOI 10.1126/science.130.3377.679; BARR ML, RECENT ADV CLIN PATH, V3; BOSS J M, 1955, Tex Rep Biol Med, V13, P213; BRIGGS DK, 1958, BLOOD, V13, P986, DOI 10.1182/blood.V13.10.986.986; CARPENTIER PJ, 1956, J CLIN ENDOCR METAB, V16, P155, DOI 10.1210/jcem-16-1-155; DAVIDSON WM, 1954, BRIT MED J, V2, P6, DOI 10.1136/bmj.2.4878.6; FERGUSONSMITH MA, 1959, LANCET, V1, P219; FORD CE, 1959, NATURE, V183, P1030, DOI 10.1038/1831030a0; FORD CE, 1959, LANCET, V1, P711; GRAHAM MA, 1952, ANAT REC, V112, P709, DOI 10.1002/ar.1091120402; GRUMBACH MM, 1958, RECENT PROG HORM RES, V14, P255; GRUMBACH MM, 1955, J CLIN ENDOCR METAB, V15, P1161, DOI 10.1210/jcem-15-10-1161; GUARD HR, 1959, AM J CLIN PATHOL, V32, P145; HUNGERFORD DA, 1959, AM J HUM GENET, V11, P215; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; JOST A, 1953, RECENT PROG HORM RES, V8, P379; KLINGER HP, 1958, EXP CELL RES, V14, P207, DOI 10.1016/0014-4827(58)90229-5; KLINGER HP, 1958, NATURE, V181, P1151, DOI 10.1038/1811150a0; KLINGER HP, 1957, STAIN TECHNOL, V32, P235, DOI 10.3109/10520295709111629; KOSENOW W, 1956, ACTA HAEMAT, V15, P319; KOSIN IL, 1959, SCIENCE, V130, P43, DOI 10.1126/science.130.3366.43; MARBERGER E, 1955, P SOC EXP BIOL MED, V89, P488, DOI 10.3181/00379727-89-21854; Miller RA, 1938, ANAT REC, V70, P155, DOI 10.1002/ar.1090700204; MOORE KL, 1957, BRIT J CANCER, V11, P384, DOI 10.1038/bjc.1957.45; MOORE KL, 1953, SURG GYNECOL OBSTET, V96, P641; MOORE KL, 1953, J COMP NEUROL, V98, P213, DOI 10.1002/cne.900980203; MOORE KL, 1955, LANCET, V2, P57, DOI 10.1016/S0140-6736(55)92161-9; MOORE KL, 1954, ACTA ANAT, V21, P197; NELSON WO, 1957, FERTIL STERIL, V8, P527; NEWCOMER EARL H., 1957, JOUR HEREDITY, V48, P227; OHNO S, 1959, EXP CELL RES, V18, P415, DOI 10.1016/0014-4827(59)90031-X; OHNO S, 1959, EXP CELL RES, V16, P462, DOI 10.1016/0014-4827(59)90284-8; OHNO S, 1958, EXP CELL RES, V15, P616, DOI 10.1016/0014-4827(58)90111-3; RABOCH J, 1957, J CLIN ENDOCR METAB, V17, P1429, DOI 10.1210/jcem-17-12-1429; REITALU J, 1957, Acta Genet Med Gemellol (Roma), V6, P393; RUSSEL WL, 1959, P NATN ACAD SCI US, V45, P544; SEGAL SJ, 1957, J CLIN ENDOCR METAB, V17, P676, DOI 10.1210/jcem-17-5-676; SERR DM, 1958, NATURE, V182, P124, DOI 10.1038/182124a0; SIEBENMANN R, 1958, Schweiz Med Wochenschr, V88, P607; TJIO JH, 1959, P NATL ACAD SCI USA, V45, P1008, DOI 10.1073/pnas.45.7.1008; WELSHONS W. J., 1959, PROC NATL ACAD SCI, V45, P560, DOI 10.1073/pnas.45.4.560; WIEDEMANN H R, 1958, Med Monatsschr, V12, P665; WILKINS L, 1958, OBSTET GYNECOL, V11, P355; WITSCHI E, 1959, SCIENCE, V130, P372, DOI 10.1126/science.130.3372.372	44	27	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1960	12	1					118	127						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF077	13797016				2022-12-18	WOS:A1960WF07700009
J	LIVINGSTONE, FB				LIVINGSTONE, FB			DISTRIBUTION OF THE SICKLE CELL GENE IN LIBERIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1956, ANN HUM GENET, V21, P67, DOI 10.1111/j.1469-1809.1971.tb00266.x; ALLISON AC, 1954, T ROY SOC TROP MED H, V48, P312, DOI 10.1016/0035-9203(54)90101-7; ALLISON AC, 1957, 1ST P INT C HUM GEN, P430; Greenberg Joseph H., 1955, STUDIES AFRICAN LING; HOLAS B, 1952, IFAN14 MEM; HOOTON EA, 1947, UP APE; JOHNSTON HH, 1910, NEGRO NEW WORLD; LEHMANN H, 1956, BRIT MED J, V2, P333, DOI 10.1136/bmj.2.4988.333; LEITE A S, 1955, Arch Inst Pasteur Alger, V33, P344; NEEL JV, 1956, AM J HUM GENET, V8, P138; PROST RPA, 1953, IFAN26 MEM; ROSE J. R., 1955, WEST AFRICAN MED JOUR, V4, P35; Schwab G., 1947, TRIBES LIBERIAN HINT; YOUNG MARTIN D., 1949, JOUR NATION MALARIA SOC, V8, P247; ZUELZER WW, 1956, PROGR HEMATOLOGY, P91	15	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	1					33	41						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA218	13520696				2022-12-18	WOS:A1958WA21800003
J	HERSH, AH; DEMARINIS, F; STECHER, RM				HERSH, AH; DEMARINIS, F; STECHER, RM			ON THE INHERITANCE AND DEVELOPMENT OF CLINODACTYLY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Bell J., 1951, TREASURY HUMAN INHER, VVol 1, P1; Buschke F, 1935, J HERED, V26, P391, DOI 10.1093/oxfordjournals.jhered.a103988; COCKAYNE EA, 1933, INHERITED ABNORMALIT, P394; GREULICH WW, 1950, RADIOGRAPHIC ATLAS S, P190; HEFNER R. A., 1929, JOUR HEREDITY, V20, P395; Hefner RA, 1924, J HERED, V15, P323, DOI 10.1093/oxfordjournals.jhered.a102481; Hefner RA, 1941, J HERED, V32, P37, DOI 10.1093/oxfordjournals.jhered.a104950; Hogben LT, 1946, INTRO MATH GENETICS; KOENNER DM, 1924, J HERED, V15, P323; Mall FP, 1906, AM J ANAT, V5, P433, DOI 10.1002/aja.1000050403; Moore WG, 1936, J HERED, V27, P27, DOI 10.1093/oxfordjournals.jhered.a104135; MULLER HJ, 1949, GENETICS PALEONTOLOG, pCH23; POL R, 1921, VIRCHOWS ARCH PATH A, V229, P388; SPENCER WP, 1949, GENETICS PALEONTOLOG, pCH3; Stecher RM, 1940, NEW ENGL J MED, V222, P300, DOI 10.1056/NEJM194002222220802; Stoddard SE, 1939, J HERED, V30, P511, DOI 10.1093/oxfordjournals.jhered.a104646; STREETER GL, 1949, DEV HORIZONS HUMAN E, V583, P149	17	27	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	3					257	268						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW631	13080251				2022-12-18	WOS:A1953XW63100004
J	FREIREMAIA, N				FREIREMAIA, N			FREQUENCIES OF CONSANGUINEOUS MARRIAGES IN BRAZILIAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Boyd WC, 1941, AM J PHYS ANTHROPOL, V28, P319, DOI 10.1002/ajpa.1330280306; Dahlberg G, 1929, GENETICS, V14, P421; DAHLBERG G, 1949, MATH METHODS POPULAT; DAHLBERG GUNNAR, 1938, PROC ROY SOC EDINBURGH, V58, P213; NEEL JV, 1949, AM J HUM GENET, V1, P156	5	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1952	4	3					194	203						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS398	12985559				2022-12-18	WOS:A1952XS39800004
J	LURIE, MB; ZAPPASODI, P; DANNENBERG, AM; WEISS, GH				LURIE, MB; ZAPPASODI, P; DANNENBERG, AM; WEISS, GH			ON THE MECHANISM OF GENETIC RESISTANCE TO TUBERCULOSIS AND ITS MODE OF INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BROWN JH, 1950, AM J PUBLIC HEALTH, V40, P450; GOLDBERG LJ, 1950, SCIENCE, V112, P299, DOI 10.1126/science.112.2907.299; Gowen JW, 1943, J INFECT DIS, V73, P40, DOI 10.1093/infdis/73.1.40; Irwin MR, 1929, GENETICS, V14, P337; LURIE MB, 1949, AM REV TUBERC PULM, V59, P186; LURIE MB, 1952, J IMMUNOL, V68, P369; LURIE MB, 1952, J EXP MED, V95, P119, DOI 10.1084/jem.95.2.119; LURIE MB, 1951, SCIENCE, V113, P234, DOI 10.1126/science.113.2931.234; LURIE MB, 1949, AM REV TUBERC PULM, V59, P198; LURIE MB, 1949, AM REV TUBERC PULM, V59, P168; LURIE MB, 1950, AM REV TUBERC PULM, V61, P765; LURIE MB, 1952, IN PRESS S EFFECT AC; LURIE MB, 1941, AM REV TUBERC S1, V44; SONKIN LS, 1951, AM J HYG, V53, P337, DOI 10.1093/oxfordjournals.aje.a119459; Webster LT, 1933, J EXP MED, V57, P793, DOI 10.1084/jem.57.5.793; Wright S, 1921, AM NAT, V55, P20, DOI 10.1086/279789	16	27	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1952	4	4					302	314						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS399	13016542				2022-12-18	WOS:A1952XS39900012
J	BANTON, AH				BANTON, AH			A GENETIC STUDY OF MEDITERRANEAN ANAEMIA IN CYPRUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARAVANTINOS A, 1936, KLIN WOCHENSCHR, V15, P1792; Bywaters E G, 1938, Arch Dis Child, V13, P173; Caffey J, 1937, AM J ROENTGENOL RADI, V37, P293; Caminopetros J., 1938, ANN MED, V43, P104; Caminopetros J., 1938, ANN MED, V43, P27; Cooley TB, 1941, AM J DIS CHILD, V62, P1; Cooley TB, 1927, AM J DIS CHILD, V34, P347, DOI 10.1001/archpedi.1927.04130210022002; Dameshek W, 1943, AM J MED SCI, V205, P643, DOI 10.1097/00000441-194305000-00003; FAWDRY AL, 1946, T ROY SOC TROP MED H, V40, P87, DOI 10.1016/0035-9203(46)90064-8; Fawdry AL, 1944, LANCET, V1, P171; FAWDRY AL, 1947, COMMUNICATION; GATES RR, 1946, HUMAN GENETICS, V1, P634; HOGBEN L., 1933, Nature and Nurture.; MCINTOSH R, 1942, AM J DIS CHILD, V64, P192; Moncrieff A, 1934, LANCET, V2, P648; NEEL JV, 1945, AM J MED SCI, V209, P568; PIETRONI MAG, 1946, COMMUNICATION; RUBIE J, 1948, P ROY SOC MED, V41, P42, DOI 10.1177/003591574804100107; SILVESTRONI E, 1949, AM J HUM GENET, V1, P83; SMITH CA, 1946, COMMUNICATION; Smith CH, 1943, AM J DIS CHILD, V65, P681; Strauss MB, 1941, AM J MED SCI, V201, P30, DOI 10.1097/00000441-194101000-00003; Valentine WN, 1944, ARCH INTERN MED, V74, P185, DOI 10.1001/archinte.1944.00210210032005; Wintrobe MM, 1940, J AMER MED ASSOC, V114, P1530; WINTROBE MM, 1946, CLIN HEMATOLOGY, P862	25	27	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1951	3	1					47	64						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS392	13171373				2022-12-18	WOS:A1951XS39200003
J	KALLMANN, FJ				KALLMANN, FJ			THE GENETICS OF PSYCHOSES - AN ANALYSIS OF 1,232 TWIN INDEX FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																			0	27	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1950	2	4					385	390						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS391	14837908				2022-12-18	WOS:A1950XS39100006
J	SILVESTRONI, E; BIANCO, I				SILVESTRONI, E; BIANCO, I			MICROCYTEMIA, CONSTITUTIONAL MICROCYTIC ANEMIA, AND COOLEY ANEMIA - MEDITERRANEAN ANEMIA OR THALASSEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Angelini V., 1937, MINERVA MED, V28, P331; BERTHIER J, 1948, CR SOC BIOL, V142, P417, DOI 10.1002/hlca.19480310218; BETTONI I, 1935, MINERVA MED, V26, P278; CAMINOPETROS J, 1937, MONOGR ACAD ATHENES, V6; CROSETTI L, 1935, ATTI R ACCAD FISIOCR, V3, P148; Dameshek W, 1943, AM J MED SCI, V205, P643, DOI 10.1097/00000441-194305000-00003; Dameshek W, 1940, AM J MED SCI, V200, P445, DOI 10.1097/00000441-194010000-00002; Gatto I., 1942, ARCH ITAL PEDIAT EPU, V9, P128; Greppi E, 1928, MINN MED, V8, P1; GREPPI E, 1931, MINERVA MED, V22, P189; INTROZZI P, 1935, HAEMATOLOGICA, V16, P525; LEVI GM, 1937, ANEMIE EMOLITICHE CO; MCINTOSH R, 1942, AM J DIS CHILD, V64, P192; MICHELI F, 1929, 35 REL C SOC IT MED; MICHELI F, 1935, HAEMATOLOGICA S, V16, P5; NEEL JV, 1947, GENETICS, V32, P38; NEEL JV, 1945, AM J MED SCI, V209, P568; PONTONI L, 1942, HAEMOTOLOGICA, V24, P479; RIETTI F, 1925, ATTI ACCAD SC MED NA, V2, P13; SANSONE L, 1938, ARCH SC MED, V65, P1; SILVESTRONI E., 1948, POLICLINIO SEZ PRAT, V55, P844; SILVESTRONI E, 1948, Minerva Med, V39, P330; KREJCI J, 1949, Lek List, V4, P501; SILVESTRONI E, 1947, Policlinico Prat, V54, P1147; SILVESTRONI E, 1948, Minerva Med, V39, P205; SILVESTRONI E, 1948, Minerva Med, V39, P393; SILVESTRONI E, 1947, Ric Sci, V17, P655; SILVESTRONI E, 1949, Policlinico Prat, V56, P602; SILVESTRONI E, 1947, Policlinico Prat, V54, P1359; SILVESTRONI E., 1949, RICERCA SCI E RICONSTRUZIONE, V19, P230; SILVESTRONI E., 1945, POLICLINICO SEZ MED, V52, P105; SILVESTRONI E, 1948, Haematologica, V31, P135; Silvestroni E, 1946, HAEMATOLOGICA, V29, P455; SILVESTRONI E, 1946, MINERVA MED, V37, P290; SILVESTRONI E, 1945, B ACCAD MED ROMA, V71, P7; SILVESTRONI E, 1946, RICER MORF, V22, P325; SILVESTRONI E, 1946, MINERVA MED, V37, P91; SILVESTRONI E, 1946, B ACCAD MED ROMA, V72, P49; SILVESTRONI E, 1947, MINERVA MED, V38, P587; SILVESTRONI E, 1947, RICER SC, V17, P2021; Silvestroni E, 1944, B ATTI ACCAD MED ROM, V70, P347; SILVESTRONI E, 1944, B ATTI R ACCAD MED R, V70, P44; SILVESTRONI E, 1945, B ACCAD MED ROMA, V71, P21; SILVESTRONI E, 1943, BOLL ATTI ACCAD MED, V69, P293; SILVESTRONI E, 1946, B ACCAD MED ROMA, V72, P32; SILVESTRONI E, 1945, B ACCAD MED ROMA, V71, P3; SILVESTRONI E, 1946, RICER MORF, V22, P217; SILVESTRONI E, 1946, RICER MORF, V22, P313; SILVESTRONI E, 1944, POLICLINICO M, V51, P197; SILVESTRONI E, 1946, MINERVA MED, V37, P206; SILVESTRONI E, 1949, IN PRESS POLICLINI M; SILVESTRONI E, 1944, B ACCAD MED ROMA, V70, P108; SILVESTRONI E, 1946, RICER MORF, V22, P271; SILVESTRONI E, 1945, POLICLINICO SEZ PRAT, V52, P137; SILVESTRONI E, 1943, POLICLINICO M, V50, P47; SILVESTRONI E, 1946, POLICLINICO, V53, P265; SILVESTRONI E, 1945, B ACCAD MED ROMA, V71, P22; SILVESTRONI E, 1944, PONT ACCAD SCI COMME, V8, P633; SILVESTRONI E, 1949, POLICLINICO SEZ PRAT, V56, P906; SIMMEL H, 1923, DTSCH ARCH KLIN MED, V142, P252; Smith CH, 1941, AM J DIS CHILD, V62, P231; Smith CH, 1943, AM J DIS CHILD, V65, P681; SPADOLINI I., 1948, ARCH FISIOL, V47, P232; SPECIE R, 1941, MINERVA MED, V32, P504; Strauss MB, 1941, AM J MED SCI, V201, P30, DOI 10.1097/00000441-194101000-00003; TESTOLIN M, 1933, OSPED MAGG, V21, P275; TESTOLIN M, 1936, CLIN MED ITAL, V67, P155; USSEGLIO G, 1934, MINERVA MED, V25, P861; USSEGLIO G, 1934, MINERVA MED, V25, P603; VILLAFANE I Z, 1948, Prensa Med Argent, V35, P1207; Valentine WN, 1944, ARCH INTERN MED, V74, P185, DOI 10.1001/archinte.1944.00210210032005; Wintrobe MM, 1940, J AMER MED ASSOC, V114, P1530	72	27	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1949	1	1					83	93						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU075	17948386				2022-12-18	WOS:A1949XU07500008
J	Miller, DE; Sulovari, A; Wang, TY; Loucks, H; Hoekzema, K; Munson, KM; Lewis, AP; Fuerte, EPA; Paschal, CR; Walsh, T; Thies, J; Bennett, JT; Glass, I; Dipple, KM; Patterson, K; Bonkowski, ES; Nelson, Z; Squire, A; Sikes, M; Beckman, E; Bennett, RL; Earl, D; Lee, W; Allikmets, R; Perlman, SJ; Chow, P; Hing, AV; Wenger, TL; Adam, MP; Sun, A; Lam, C; Chang, I; Zou, X; Austin, SL; Huggins, E; Safi, A; Iyengar, AK; Reddy, TE; Majoros, WH; Allen, AS; Crawford, GE; Kishnani, PS; King, MC; Cherry, T; Chong, JX; Bamshad, MJ; Nickerson, DA; Mefford, HC; Doherty, D; Eichler, EE				Miller, Danny E.; Sulovari, Arvis; Wang, Tianyun; Loucks, Hailey; Hoekzema, Kendra; Munson, Katherine M.; Lewis, Alexandra P.; Fuerte, Edith P. Almanza; Paschal, Catherine R.; Walsh, Tom; Thies, Jenny; Bennett, James T.; Glass, Ian; Dipple, Katrina M.; Patterson, Karynne; Bonkowski, Emily S.; Nelson, Zoe; Squire, Audrey; Sikes, Megan; Beckman, Erika; Bennett, Robin L.; Earl, Dawn; Lee, Winston; Allikmets, Rando; Perlman, Seth J.; Chow, Penny; Hing, Anne, V; Wenger, Tara L.; Adam, Margaret P.; Sun, Angela; Lam, Christina; Chang, Irene; Zou, Xue; Austin, Stephanie L.; Huggins, Erin; Safi, Alexias; Iyengar, Apoorva K.; Reddy, Timothy E.; Majoros, William H.; Allen, Andrew S.; Crawford, Gregory E.; Kishnani, Priya S.; King, Mary-Claire; Cherry, Tim; Chong, Jessica X.; Bamshad, Michael J.; Nickerson, Deborah A.; Mefford, Heather C.; Doherty, Dan; Eichler, Evan E.			Targeted long-read sequencing identifies missing disease-causing variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIAGNOSIS; GENOMICS; REPEAT	Despite wide spread clinical genetic testing, many individuals with suspected genetic conditions lack a precise diagnosis, limiting their opportunity to take advantage of state-of-the-art treatments. In somecases, testing reveals difficult-to-evaluate structural differences, candidate variants that do not fully explain the phenotype, single pathogenic variants in recessive disorders, or no variants in genes of interest. Thus, there is a need for better tools to identify a precise genetic diagnosis in individuals when conventional testing approaches have been exhausted. We performed targeted long-read sequencing (T-LRS) using adaptive sampling on the Oxford Nanopore platform on 40 individuals, 10 of whom lacked a complete molecular diagnosis. We computationally targeted up to 151 Mbp of sequence per individual and searched for pathogenic substitutions, structural variants, and methylation differences using a single data source. We detected all genomic aberrations-including single-nucleotide variants, copy number changes, repeat expansions, and methylation differences-identified by prior clinical testing. In 8/8 individuals with complex structural rearrangements, T-LRS enabled more precise resolution of the mutation, leading to changes in clinical management in one case. In ten individuals with suspected Mendelian conditions lacking a precise genetic diagnosis, T-LRS identified pathogenic or likely pathogenic variants in six and variants of uncertain significance in two others. T-LRS accurately identifies pathogenic structural variants, resolves complex rearrangements, and identifies Mendelian variants not detected by other technologies. T-LRS represents an efficient and cost-effective strategy to evaluate high-priority genes and regions or complex clinical testing results.	[Miller, Danny E.; Sulovari, Arvis; Wang, Tianyun; Hoekzema, Kendra; Munson, Katherine M.; Lewis, Alexandra P.; Walsh, Tom; Patterson, Karynne; King, Mary-Claire; Bamshad, Michael J.; Nickerson, Deborah A.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Sch Med, Seattle, WA 98195 USA; [Miller, Danny E.; Loucks, Hailey; Fuerte, Edith P. Almanza; Thies, Jenny; Bennett, James T.; Glass, Ian; Dipple, Katrina M.; Bonkowski, Emily S.; Nelson, Zoe; Squire, Audrey; Sikes, Megan; Beckman, Erika; Earl, Dawn; Wenger, Tara L.; Adam, Margaret P.; Sun, Angela; Lam, Christina; Chang, Irene; Chong, Jessica X.; Bamshad, Michael J.; Mefford, Heather C.; Doherty, Dan] Univ Washington, Dept Pediat, Div Genet Med, Seattle, WA 98105 USA; [Miller, Danny E.; Loucks, Hailey; Fuerte, Edith P. Almanza; Thies, Jenny; Bennett, James T.; Glass, Ian; Dipple, Katrina M.; Bonkowski, Emily S.; Nelson, Zoe; Squire, Audrey; Sikes, Megan; Beckman, Erika; Earl, Dawn; Wenger, Tara L.; Adam, Margaret P.; Sun, Angela; Lam, Christina; Chang, Irene; Chong, Jessica X.; Bamshad, Michael J.; Mefford, Heather C.; Doherty, Dan] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Paschal, Catherine R.; Bennett, James T.] Seattle Childrens Hosp, Dept Labs, Seattle, WA 98105 USA; [Paschal, Catherine R.] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA; [Walsh, Tom; Bennett, Robin L.; King, Mary-Claire] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Bennett, James T.; Cherry, Tim] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA; [Bennett, James T.; Dipple, Katrina M.; Lam, Christina; Chong, Jessica X.; Bamshad, Michael J.; Nickerson, Deborah A.; Mefford, Heather C.; Doherty, Dan; Eichler, Evan E.] Brotman Baty Inst Precis Med, Seattle, WA 98195 USA; [Dipple, Katrina M.; Sun, Angela] Seattle Childrens Res Inst, Ctr Clin & Translat Res, Seattle, WA 98101 USA; [Lee, Winston] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Lee, Winston; Allikmets, Rando] Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA; [Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Perlman, Seth J.] Univ Washington, Seattle Childrens Hosp, Dept Neurol, Seattle, WA 98105 USA; [Chow, Penny; Hing, Anne, V] Univ Washington, Dept Pediat, Div Craniofacial Med, Seattle, WA 98195 USA; [Lam, Christina] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Zou, Xue] Duke Univ, Program Computat Biol & Bioinformat, Durham, NC 27710 USA; [Austin, Stephanie L.; Huggins, Erin; Safi, Alexias; Crawford, Gregory E.; Kishnani, Priya S.] Duke Univ, Dept Pediat, Div Med Genet, Durham, NC 27708 USA; [Iyengar, Apoorva K.; Reddy, Timothy E.; Majoros, William H.; Allen, Andrew S.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA; [Iyengar, Apoorva K.] Duke Univ, Univ Program Genet & Genom, Durham, NC 27708 USA; [Doherty, Dan] Univ Washington, Dept Pediat, Div Dev Med, Seattle, WA 98105 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Fuerte, Edith P. Almanza; Mefford, Heather C.] St Jude Childrens Res Hosp, Ctr Pediat Neurol Dis Res, Memphis, TN 38105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital; Columbia University; Columbia University; Columbia University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Duke University; Duke University; Duke University; Duke University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; St Jude Children's Research Hospital	Miller, DE; Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Sch Med, Seattle, WA 98195 USA.; Miller, DE (corresponding author), Univ Washington, Dept Pediat, Div Genet Med, Seattle, WA 98105 USA.; Miller, DE (corresponding author), Seattle Childrens Hosp, Seattle, WA 98105 USA.; Eichler, EE (corresponding author), Brotman Baty Inst Precis Med, Seattle, WA 98195 USA.; Eichler, EE (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	danny.miller@seattlechildrens.org; eee@gs.washington.edu	Lee, Winston/CAA-0102-2022; Allikmets, Rando/ABD-4533-2021; Chong, Jessica/GZH-1625-2022	Miller, Danny/0000-0001-6096-8601; Lee, Winston/0000-0002-1777-8519; Allen, Andrew/0000-0002-7232-2143; Munson, Katherine/0000-0001-8413-6498	Brotman Baty Institute for Precision Medicine; US National Institutes of Health [NIH R01 MH101221]; Simons Foundation [SFARI 608045]; NIH [R01 EY29315, R01HD100730, U54HD083091]; University of Washington Center for Mendelian Genomics (UW-CMG); NHGRI; NHLBI [UM1 HG006493, U24 HG008956]	Brotman Baty Institute for Precision Medicine; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for Mendelian Genomics (UW-CMG); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to the individuals and their families who participated in this study. We thank Angela Miller for figure preparation, Tonia Brown for assistance in editing this manuscript, and Sunday Stray and Lemlen Ghile from the laboratory of Mary-Claire King for isolation of DNA from whole blood for the SAGE BK samples. This work was supported by a grant to D.E.M. and E.E.E. from the Brotman Baty Institute for Precision Medicine. This work was also supported, in part, by grants from the US National Institutes of Health (NIH R01 MH101221 to E.E.E.) and the Simons Foundation (SFARI 608045 to E.E.E.). J.T.B. is supported by NIH R01 HL130996-05 and BWF CAMS #1014700. R.A. and T.C. are supported by NIH R01 EY29315. Sequencing and analysis were supported in part by the University of Washington Center for Mendelian Genomics (UW-CMG) and funded by NHGRI and NHLBI grants UM1 HG006493 and U24 HG008956. H.L. and D.D. are supported by NIH R01HD100730 and U54HD083091. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. M.-C.K. is an American Cancer Society Research Professor. E.E.E. is an investigator of the Howard Hughes Medical Institute.	All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Audano PA, 2019, CELL, V176, P663, DOI 10.1016/j.cell.2018.12.019; Beck CR, 2019, CELL, V176, P1310, DOI 10.1016/j.cell.2019.01.045; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Beyter D., 2020, LONG READ SEQUENCING, DOI [10.1101/531210, DOI 10.1101/531210]; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Boycott KM, 2017, AM J HUM GENET, V100, P695, DOI 10.1016/j.ajhg.2017.04.003; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Dolzhenko E, 2019, BIOINFORMATICS, V35, P4754, DOI 10.1093/bioinformatics/btz431; Ebert P, 2021, SCIENCE, V372, P48, DOI 10.1126/science.abf7117; Edge P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12493-y; Eichler EE, 2019, NEW ENGL J MED, V381, P64, DOI 10.1056/NEJMra1809315; Ewans LJ, 2018, GENET MED, V20, P1564, DOI 10.1038/gim.2018.39; Fresard L, 2018, CSH MOL CASE STUD, V4, DOI 10.1101/mcs.a003392; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gel B, 2017, BIOINFORMATICS, V33, P3088, DOI 10.1093/bioinformatics/btx346; Gilpatrick T, 2020, NAT BIOTECHNOL, V38, P433, DOI 10.1038/s41587-020-0407-5; Heller D, 2019, BIOINFORMATICS, V35, P2907, DOI 10.1093/bioinformatics/btz041; Hiatt SM, 2021, HUM GENET GENOM ADV, V2, DOI 10.1016/j.xhgg.2021.100023; Hochstenbach R, 2021, EUR J HUM GENET, V29, P541, DOI 10.1038/s41431-020-00780-y; Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015; Karamitros T, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv773; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Killick R, 2014, J STAT SOFTW, V58, P1; Lacroix AJ, 2019, AM J HUM GENET, V104, P35, DOI 10.1016/j.ajhg.2018.11.005; Lee I, 2020, NAT METHODS, V17, P1191, DOI 10.1038/s41592-020-01000-7; Levin AA, 2019, NEW ENGL J MED, V380, P57, DOI 10.1056/NEJMra1705346; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Logsdon GA, 2020, NAT REV GENET, V21, P597, DOI 10.1038/s41576-020-0236-x; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]; Loose M, 2016, NAT METHODS, V13, P751, DOI [10.1038/nmeth.3930, 10.1038/NMETH.3930]; Lowther C., 2020, SYSTEMATIC EVALUATIO, DOI [10.1101/531210, DOI 10.1101/531210]; Luo RB, 2020, NAT MACH INTELL, V2, P220, DOI 10.1038/s42256-020-0167-4; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mahmoud M, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1828-7; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Miga KH, 2020, NATURE, V585, P79, DOI 10.1038/s41586-020-2547-7; Mitsuhashi S, 2020, J HUM GENET, V65, P11, DOI 10.1038/s10038-019-0671-8; Murdock DR, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI141500; Palmer EE, 2021, NEUROLOGY, V96, pE1770, DOI 10.1212/WNL.0000000000011655; Payne A, 2021, NAT BIOTECHNOL, V39, P442, DOI 10.1038/s41587-020-00746-x; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sedlazeck FJ, 2018, NAT METHODS, V15, P461, DOI 10.1038/s41592-018-0001-7; Sulovari A, 2019, P NATL ACAD SCI USA, V116, P23243, DOI 10.1073/pnas.1912175116; Trost B, 2020, NATURE, V586, P80, DOI 10.1038/s41586-020-2579-z; Walsh T, 2021, J MED GENET, V58, P850, DOI 10.1136/jmedgenet-2020-107320; Wenger AM, 2019, NAT BIOTECHNOL, V37, P1155, DOI 10.1038/s41587-019-0217-9; Zhou YF, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0105-9; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	56	26	26	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 5	2021	108	8					1436	1449		10.1016/j.ajhg.2021.06.006	http://dx.doi.org/10.1016/j.ajhg.2021.06.006		AUG 2021	14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TW6OO	34216551	Green Published, Bronze			2022-12-18	WOS:000682516900007
J	McArthur, E; Capra, JA				McArthur, Evonne; Capra, John A.			Topologically associating domain boundaries that are stable across diverse cell types are evolutionarily constrained and enriched for heritability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CHROMATIN DOMAINS; ARCHITECTURE; REVEALS; PRINCIPLES; LOCI; ORGANIZATION; ACTIVATION; EXPRESSION; LANDSCAPE	Topologically associating domains (TADs) are fundamental units of three-dimensional (3D) nuclear organization. The regions bordering TADs-TAD boundaries-contribute to the regulation of gene expression by restricting interactions of cis-regulatory sequences to their target genes. TAD and TAD-boundary disruption have been implicated in rare-disease pathogenesis; however, we have a limited framework for integrating TADs and their variation across cell types into the interpretation of common-trait-associated variants. Here, we investigate an attribute of 3D genome architecture-the stability of TAD boundaries across cell types-and demonstrate its relevance to understanding how genetic variation in TADs contributes to complex disease. By synthesizing TAD maps across 37 diverse cell types with 41 genome-wide association studies (GWASs), we investigate the differences in disease association and evolutionary pressure on variation in TADs versus TAD boundaries. We demonstrate that genetic variation in TAD boundaries contributes more to complex-trait heritability, especially for immunologic, hematologic, and metabolic traits. We also show that TAD boundaries are more evolutionarily constrained than TADs. Next, stratifying boundaries by their stability across cell types, we find substantial variation. Compared to boundaries unique to a specific cell type, boundaries stable across cell types are further enriched for complex-trait heritability, evolutionary constraint, CTCF binding, and housekeeping genes. Thus, considering TAD boundary stability across cell types provides valuable context for understanding the genome's functional landscape and enabling variant interpretation that takes 3D structure into account.	[McArthur, Evonne; Capra, John A.] Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN 37235 USA; [Capra, John A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Capra, John A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA; [Capra, John A.] Univ Calif San Francisco, Bakar Inst Computat Hlth Sci, San Francisco, CA 94158 USA	Vanderbilt University; Vanderbilt University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Capra, JA (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN 37235 USA.; Capra, JA (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.; Capra, JA (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA.; Capra, JA (corresponding author), Univ Calif San Francisco, Bakar Inst Computat Hlth Sci, San Francisco, CA 94158 USA.	tony.capra@ucsf.edu		McArthur, Evonne/0000-0003-4566-4321	National Institutes of Health (NIH) General Medical Sciences award [R35GM127087]; NIH National Human Genome Research Institute [F30HG011200, T32GM007347]	National Institutes of Health (NIH) General Medical Sciences award; NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to thank Katherine S. Pollard, Emily Hodges, Geoff Fudenberg, Sarah Fong, Mary Lauren Benton, and other members of the Capra Lab for helpful discussions and manuscript comments. They would like to thank Margaux L.A. Hujoel and Steven Gazal for their help with LDSC implementation and heritability result interpretation. This work was conducted in part with the resources of the Advanced Computing Center for Research and Education at Vanderbilt University, Nashville, TN. This work was supported by the National Institutes of Health (NIH) General Medical Sciences award R35GM127087 to J.A.C., NIH National Human Genome Research Institute award F30HG011200 to E.M., and T32GM007347. The funding bodies had no role in the design of the study; collection, analysis, or interpretation of data; or in writing the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; An L, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1893-y; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; [Anonymous], **DATA OBJECT**, DOI DOI 10.5281/ZENODO.1313201; [Anonymous], [No title captured]; [Anonymous], **DATA OBJECT**, DOI DOI 10.5281/ZENODO.3601559; Barban N, 2016, NAT GENET, V48, P1462, DOI 10.1038/ng.3698; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Boraska V, 2014, MOL PSYCHIATR, V19, P1085, DOI 10.1038/mp.2013.187; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Dali R, 2017, NUCLEIC ACIDS RES, V45, P2994, DOI 10.1093/nar/gkx145; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; de Bruijn SE, 2020, AM J HUM GENET, V107, P802, DOI 10.1016/j.ajhg.2020.09.002; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2015, FEBS LETT, V589, P2877, DOI 10.1016/j.febslet.2015.08.044; Dekker J, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-25; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duggal G, 2014, NUCLEIC ACIDS RES, V42, P87, DOI 10.1093/nar/gkt857; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Eres IE, 2021, TRENDS GENET, V37, P216, DOI 10.1016/j.tig.2020.10.009; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Fudenberg G, 2020, NAT METHODS, V17, P1111, DOI 10.1038/s41592-020-0958-x; Fudenberg G, 2019, P NATL ACAD SCI USA, V116, P2175, DOI 10.1073/pnas.1808631116; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Gazal S, 2018, NAT GENET, V50, P1600, DOI 10.1038/s41588-018-0231-8; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Ghavi-Helm Y, 2019, NAT GENET, V51, P1272, DOI 10.1038/s41588-019-0462-3; Gong YX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03017-1; Greenwald WW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08940-5; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095; Han LD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16736-1; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hormozdiari F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11957-5; Hormozdiari F, 2018, NAT GENET, V50, P1041, DOI 10.1038/s41588-018-0148-2; Hujoel MLA, 2019, AM J HUM GENET, V104, P611, DOI 10.1016/j.ajhg.2019.02.008; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Krefting J, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0556-x; Krijger PHL, 2016, NAT REV MOL CELL BIO, V17, P771, DOI 10.1038/nrm.2016.138; Lajoie BR, 2015, METHODS, V72, P65, DOI 10.1016/j.ymeth.2014.10.031; Le Dily F, 2014, GENE DEV, V28, P2151, DOI 10.1101/gad.241422.114; Leung D, 2015, NATURE, V518, P350, DOI 10.1038/nature14217; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lumley T., 2018, R PACKAGE VERSION 3; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Meaburn KJ, 2009, J CELL BIOL, V187, P801, DOI 10.1083/jcb.200909127; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reshef YA, 2018, NAT GENET, V50, P1483, DOI 10.1038/s41588-018-0196-7; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Sauerwald N, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqz008; Sauerwald N, 2018, BIOINFORMATICS, V34, P475, DOI 10.1093/bioinformatics/bty265; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Schwessinger R, 2020, NAT METHODS, V17, P1118, DOI 10.1038/s41592-020-0960-3; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Spielmann M, 2018, NAT REV GENET, V19, P453, DOI 10.1038/s41576-018-0007-0; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Torosin NS, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009229; Wang YL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1519-9; Watanabe K, 2019, NAT GENET, V51, P1339, DOI 10.1038/s41588-019-0481-0; Whalen S, 2019, GENOME RES, V29, P334, DOI 10.1101/gr.238022.118; Xiao J, 2020, SUBTLE CHANGES 3D ST, DOI 10.22.351395; Yang Y, 2019, CELL SYST, V8, P494, DOI 10.1016/j.cels.2019.05.011; Yu JT, 2019, BMC GENET, V20, DOI 10.1186/s12863-019-0744-x; Zufferey M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1596-9	88	26	26	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2021	108	2					269	283		10.1016/j.ajhg.2021.01.001	http://dx.doi.org/10.1016/j.ajhg.2021.01.001		FEB 2021	15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX1UZ	33545030	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000629135400007
J	Zhao, ZC; Bi, WJ; Zhou, W; VandeHaar, P; Fritsche, LG; Lee, S				Zhao, Zhangchen; Bi, Wenjian; Zhou, Wei; VandeHaar, Peter; Fritsche, Lars G.; Lee, Seunggeun			UK Biobank Whole-Exome Sequence Binary Phenome Analysis with Robust Region-Based Rare-Variant Test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION ANALYSIS; COMMON DISEASES; SINGLE; RISK; GENE	In biobank data analysis, most binary phenotypes have unbalanced case-control ratios, and this can cause inflation of type I error rates. Recently, a saddle point approximation (SPA) based single-variant test has been developed to provide an accurate and scalable method to test for associations of such phenotypes. For gene- or region-based multiple-variant tests, a few methods exist that can adjust for unbalanced case-control ratios; however, these methods are either less accurate when case-control ratios are extremely unbalanced or not scalable for large data analyses. To address these problems, we propose SKAT- and SKAT-O- type region-based tests; in these tests, the singlevariant score statistic is calibrated based on SPA and efficient resampling (ER). Through simulation studies, we show that the proposed method provides well-calibrated p values. In contrast, when the case-control ratio is 1:99, the unadjusted approach has greatly inflated type I error rates (90 times that of exome-wide sequencing alpha = 2.5 x 10(-6)). Additionally, the proposed method has similar computation time to the unadjusted approaches and is scalable for large sample data. In our application, the UK Biobank whole-exome sequence data analysis of 45,596 unrelated European samples and 791 PheCode phenotypes identified 10 rare-variant associations with p value < 10(-7), including the associations between JAK2 and myeloproliferative disease, HOXB13 and cancer of prostate, and F11 and congenital coagulation defects. All analysis summary results are publicly available through a web-based visual server, and this availability can help facilitate the identification of the genetic basis of complex diseases.	[Zhao, Zhangchen; Bi, Wenjian; VandeHaar, Peter; Fritsche, Lars G.; Lee, Seunggeun] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Zhao, Zhangchen; Bi, Wenjian; VandeHaar, Peter; Fritsche, Lars G.; Lee, Seunggeun] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Zhou, Wei] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Zhou, Wei] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Zhou, Wei] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Lee, S (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA.; Lee, S (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA.	leeshawn@umich.edu	Zhao, Zhangchen/GRO-5886-2022; Fritsche, Lars G/AAF-9387-2019; Bi, Wenjian/AAQ-6251-2020	Fritsche, Lars G/0000-0002-2110-1690; 	National Institutes of Health (NIH) [R01 HG008773];  [45227]; MRC [MC_PC_12028] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has been conducted using the UK Biobank Resource under application number 45227. S.L., Z.Z., and W.B. were supported by National Institutes of Health (NIH) grant R01 HG008773.	ASAKAI R, 1987, BIOCHEMISTRY-US, V26, P7221, DOI 10.1021/bi00397a004; Aubry W, 2013, AM HEALTH DRUG BENEF, V6, P15; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bi WJ, 2019, AM J HUM GENET, V105, P1182, DOI 10.1016/j.ajhg.2019.10.008; Biobank U., 2019, UK BIOB EX DAT REL F; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chen H, 2019, AM J HUM GENET, V104, P260, DOI 10.1016/j.ajhg.2018.12.012; Chen H, 2016, AM J HUM GENET, V98, P653, DOI 10.1016/j.ajhg.2016.02.012; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Dey R, 2017, AM J HUM GENET, V101, P37, DOI 10.1016/j.ajhg.2017.05.014; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Hout C.V.V, 2019, BIORXIV, DOI DOI 10.1101/572347; Lee S, 2016, BIOSTATISTICS, V17, P1, DOI 10.1093/biostatistics/kxv033; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Regier AA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06159-4; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Verhaar MC, 2002, ARTERIOSCL THROM VAS, V22, P6, DOI 10.1161/hq0102.102190; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Longfei, 2016, BMC Proc, V10, P181; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zengini E, 2018, NAT GENET, V50, P549, DOI 10.1038/s41588-018-0079-y; Zhang XD, 2019, SEX REPROD HEALTHC, V20, P46, DOI 10.1016/j.srhc.2019.02.005; Zhou W, 2019, SCALABLE GEN LINEAR, DOI [10.1101/583278, DOI 10.1101/583278]; Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y	33	26	26	5	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2020	106	1					3	12		10.1016/j.ajhg.2019.11.012	http://dx.doi.org/10.1016/j.ajhg.2019.11.012			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JZ5VM	31866045	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000505170800001
J	Iuso, A; Wiersma, M; Schuller, HJ; Pode-Shakked, B; Marek-Yagel, D; Grigat, M; Schwarzmayr, T; Berutti, R; Alhaddad, B; Kanon, B; Grzeschik, NA; Okun, JG; Perles, Z; Salem, Y; Barel, O; Vardi, A; Rubinshtein, M; Tirosh, T; Dubnov-Raz, G; Messias, AC; Terrile, C; Barshack, I; Volkov, A; Avivi, C; Eyal, E; Mastantuono, E; Kumbar, M; Abudi, S; Braunisch, M; Strom, TM; Meitinger, T; Hoffmann, GF; Prokisch, H; Haack, TB; Brundel, BJJM; Haas, D; Sibon, OCM; Anikster, Y				Iuso, Arcangela; Wiersma, Marit; Schueller, Hans-Joachim; Pode-Shakked, Ben; Marek-Yagel, Dina; Grigat, Mathias; Schwarzmayr, Thomas; Berutti, Riccardo; Alhaddad, Bader; Kanon, Bart; Grzeschik, Nicola A.; Okun, Juergen G.; Perles, Zeev; Salem, Yishay; Barel, Ortal; Vardi, Amir; Rubinshtein, Marina; Tirosh, Tal; Dubnov-Raz, Gal; Messias, Ana C.; Terrile, Caterina; Barshack, Iris; Volkov, Alex; Avivi, Camilla; Eyal, Eran; Mastantuono, Elisa; Kumbar, Muhamad; Abudi, Shachar; Braunisch, Matthias; Strom, Tim M.; Meitinger, Thomas; Hoffmann, Georg F.; Prokisch, Holger; Haack, Tobias B.; Brundel, Bianca J. J. M.; Haas, Dorothea; Sibon, Ody C. M.; Anikster, Yair			Mutations in PPCS, Encoding Phosphopantothenoylcysteine Synthetase, Cause Autosomal-Recessive Dilated Cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRAIN IRON ACCUMULATION; COENZYME-A SYNTHESIS; PROTEIN-STRUCTURE; SWISS-MODEL; PANTETHINE RESCUES; ESCHERICHIA-COLI; NEURODEGENERATION; MACROMOLECULES; SYSTEM; COA	Coenzyme A (CoA) is an essential metabolic cofactor used by around 4% of cellular enzymes. Its role is to carry and transfer acetyl and acyl groups to other molecules. Cells can synthesize CoA de novo from vitamin B5 (pantothenate) through five consecutive enzymatic steps. Phosphopantothenoylcysteine synthetase (PPCS) catalyzes the second step of the pathway during which phosphopantothenate reacts with ATP and cysteine to form phosphopantothenoylcysteine. Inborn errors of CoA biosynthesis have been implicated in neurodegeneration with brain iron accumulation (NBIA), a group of rare neurological disorders characterized by accumulation of iron in the basal ganglia and progressive neurodegeneration. Exome sequencing in five individuals from two unrelated families presenting with dilated cardiomyopathy revealed biallelic mutations in PPCS, linking CoA synthesis with a cardiac phenotype. Studies in yeast and fruit flies confirmed the pathogenicity of identified mutations. Biochemical analysis revealed a decrease in CoA levels in fibroblasts of all affected individuals. CoA biosynthesis can occur with pantethine as a source independent from PPCS, suggesting pantethine as targeted treatment for the affected individuals still alive.	[Iuso, Arcangela; Schwarzmayr, Thomas; Alhaddad, Bader; Terrile, Caterina; Mastantuono, Elisa; Braunisch, Matthias; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger; Haack, Tobias B.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Iuso, Arcangela; Schwarzmayr, Thomas; Berutti, Riccardo; Terrile, Caterina; Mastantuono, Elisa; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger; Haack, Tobias B.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Iuso, Arcangela; Meitinger, Thomas] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, D-80802 Munich, Germany; [Wiersma, Marit; Brundel, Bianca J. J. M.] Vrije Univ Amsterdam Med Ctr, Amsterdam Cardiovasc Sci, Dept Physiol, NL-1081 HZ Amsterdam, Netherlands; [Schueller, Hans-Joachim; Grigat, Mathias] Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funkt Genomforsch, D-17489 Greifswald, Germany; [Pode-Shakked, Ben; Marek-Yagel, Dina; Abudi, Shachar; Anikster, Yair] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Metab Dis Unit, IL-52621 Tel Hashomer, Israel; [Pode-Shakked, Ben] Sheba Med Ctr, Dr Pinchas Borenstein Talpiot Med Leadership Prog, IL-52621 Tel Hashomer, Israel; [Pode-Shakked, Ben; Marek-Yagel, Dina; Salem, Yishay; Barel, Ortal; Vardi, Amir; Tirosh, Tal; Dubnov-Raz, Gal; Barshack, Iris; Volkov, Alex; Avivi, Camilla; Abudi, Shachar; Anikster, Yair] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Kanon, Bart; Grzeschik, Nicola A.; Sibon, Ody C. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [Okun, Juergen G.; Hoffmann, Georg F.; Haas, Dorothea] Univ Childrens Hosp, Div Neuropediat & Metab Med, D-69120 Heidelberg, Germany; [Perles, Zeev] Hadassah Hebrew Univ, Dept Pediat Cardiol, Med Ctr, IL-91120 Jerusalem, Israel; [Salem, Yishay; Tirosh, Tal] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Pediat Cardiol Unit, IL-52621 Tel Hashomer, Israel; [Barel, Ortal; Eyal, Eran] Sheba Med Ctr, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Vardi, Amir] Edmond & Lily Safra Childrens Hosp, Edmond Safra Int Congenital Heart Ctr, Sheba Med Ctr, Dept Pediat Cardiac Intens Care, IL-52621 Tel Hashomer, Israel; [Dubnov-Raz, Gal] Edmond & Lily Safra Childrens Hosp, Exercise Nutr & Lifestyle Clin, IL-52621 Tel Hashomer, Israel; [Messias, Ana C.] Helmholtz Zentrum Munchen, Inst Struct Biol, D-85764 Neuherberg, Germany; [Messias, Ana C.] Tech Univ Munich, Ctr Integrated Prot Sci Munich Biomol NMR Spect, Dept Chem, D-85747 Garching, Germany; [Rubinshtein, Marina] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Dept Pediat Crit Care Med, IL-52621 Tel Hashomer, Israel; [Barshack, Iris; Volkov, Alex; Avivi, Camilla] Sheba Med Ctr, Dept Pathol, IL-52621 Tel Hashomer, Israel; [Kumbar, Muhamad] Clalit Hlth Serv, IL-93133 Jerusalem, Israel; [Braunisch, Matthias] Tech Univ Munich, Dept Nephrol, Klinikum Rechts Isar, D-81675 Munich, Germany; [Haack, Tobias B.] Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany; [Anikster, Yair] Sheba Med Ctr, Wohl Inst Translat Med, IL-52621 Tel Hashomer, Israel	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Centre for Cardiovascular Research; Munich Heart Alliance; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Ernst Moritz Arndt Universitat Greifswald; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Groningen; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Clalit Health Services; Technical University of Munich; Eberhard Karls University of Tubingen; Chaim Sheba Medical Center	Anikster, Y (corresponding author), Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Metab Dis Unit, IL-52621 Tel Hashomer, Israel.; Anikster, Y (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel.; Haas, D (corresponding author), Univ Childrens Hosp, Div Neuropediat & Metab Med, D-69120 Heidelberg, Germany.; Anikster, Y (corresponding author), Sheba Med Ctr, Wohl Inst Translat Med, IL-52621 Tel Hashomer, Israel.	dorothea.haas@med.uni-heidelberg.de; yair.anikster@sheba.health.gov.il	Alhaddad, Bader/AAJ-5504-2021; Dubnov-Raz, Gal/L-3297-2016; Volkov, Alex/P-5220-2018	Alhaddad, Bader/0000-0003-4542-5267; Dubnov-Raz, Gal/0000-0003-1469-8043; Volkov, Alex/0000-0002-3157-7422; Haas, Dorothea/0000-0002-4413-7012; Sibon, Ody/0000-0002-6836-6063; Messias, Ana/0000-0002-5449-9922; Prokisch, Holger/0000-0003-2379-6286	German BMBF; Horizon2020 through E-Rare project GENOMIT [01GM1603, 01GM1207]; Horizon2020 Project SOUND [633974]; German Network for Mitochondrial Disorders [mitoNET 01GM1113C]; German Center for Heart Research [Z76010017300, Z56010015300]	German BMBF(Federal Ministry of Education & Research (BMBF)); Horizon2020 through E-Rare project GENOMIT; Horizon2020 Project SOUND; German Network for Mitochondrial Disorders; German Center for Heart Research	This study was supported by the German BMBF and Horizon2020 through E-Rare project GENOMIT (01GM1603 and 01GM1207 to H.P.); Horizon2020 Project SOUND (633974 to HP); German Network for Mitochondrial Disorders (mitoNET 01GM1113C to H.P. and T.M.); and the German Center for Heart Research (Z76010017300 and Z56010015300 to T.M.). We thank Dr. Angelika Seitz (Department of Neuroradiology, University Hospital Heidelberg) for the interpretation of the cranial MRI of individual II.2, family A, and Dr. Yussef Shahin who participates in the cardiology care of family B. S.A. is an MD PhD student at the Sackler Faculty of Medicine, Tel-Aviv University, and a candidate for the Graduate Partnership Program of the National Institutes of Health (NIH). The authors wish to thank the affected persons and their families for their continued support and collaboration.	Alrob OA, 2014, BIOCHEM SOC T, V42, P1043, DOI 10.1042/BST20140094; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Annesi G, 2016, PARKINSONISM RELAT D, V28, P150, DOI 10.1016/j.parkreldis.2016.03.011; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Balibar CJ, 2011, J BACTERIOL, V193, P3304, DOI 10.1128/JB.00334-11; Berman HM, 2009, NUCLEIC ACIDS RES, V37, pD365, DOI 10.1093/nar/gkn790; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bosveld F, 2008, HUM MOL GENET, V17, P2058, DOI 10.1093/hmg/ddn105; Bosveld Floris, 2008, BMC Res Notes, V1, P75, DOI 10.1186/1756-0500-1-75; Dusi S, 2014, AM J HUM GENET, V94, P11, DOI 10.1016/j.ajhg.2013.11.008; Evers C, 2017, AM J MED GENET A, V173, P1878, DOI 10.1002/ajmg.a.38252; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hartig MB, 2006, ANN NEUROL, V59, P248, DOI 10.1002/ana.20771; Hogarth P, 2015, J MOV DISORD, V8, P1, DOI 10.14802/jmd.14034; Khatri D, 2016, SCI REP-UK, V6, DOI 10.1038/srep37660; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; Kremer LS, 2017, METHODS MOL BIOL, V1567, P391, DOI 10.1007/978-1-4939-6824-4_24; Manoj N, 2003, STRUCTURE, V11, P927, DOI 10.1016/S0969-2126(03)00146-1; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nolte IM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16140; NUSSINOV R, 1991, P NATL ACAD SCI USA, V88, P10495, DOI 10.1073/pnas.88.23.10495; Olzhausen J, 2009, CURR GENET, V55, P163, DOI 10.1007/s00294-009-0234-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rana A, 2010, P NATL ACAD SCI USA, V107, P6988, DOI 10.1073/pnas.0912105107; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sibon OCM, 2016, NAT REV MOL CELL BIO, V17, P605, DOI 10.1038/nrm.2016.110; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Solomon O, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3028-0; Srinivasan B, 2015, NAT CHEM BIOL, V11, P784, DOI [10.1038/NCHEMBIO.1906, 10.1038/nchembio.1906]; Stanitzek S, 2004, STRUCTURE, V12, P1977, DOI 10.1016/j.str.2004.08.007; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Taghli-Lamallem O, 2008, AGING CELL, V7, P237, DOI 10.1111/j.1474-9726.2008.00367.x; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Zizioli D, 2016, NEUROBIOL DIS, V85, P35, DOI 10.1016/j.nbd.2015.10.010	37	26	27	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 7	2018	102	6					1018	1030		10.1016/j.ajhg.2018.03.022	http://dx.doi.org/10.1016/j.ajhg.2018.03.022			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GJ0LP	29754768	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000434946200002
J	Kycia, I; Wolford, BN; Huyghe, JR; Fuchsberger, C; Vadlamudi, S; Kursawe, R; Welch, RP; Albanus, RD; Uyar, A; Khetan, S; Lawlor, N; Bolisetty, M; Mathur, A; Kuusisto, J; Laakso, M; Ucar, D; Mohlke, KL; Boehnke, M; Collins, FS; Parker, SCJ; Stitzel, ML				Kycia, Ina; Wolford, Brooke N.; Huyghe, Jeroen R.; Fuchsberger, Christian; Vadlamudi, Swarooparani; Kursawe, Romy; Welch, Ryan P.; Albanus, Ricardo d'Oliveira; Uyar, Asli; Khetan, Shubham; Lawlor, Nathan; Bolisetty, Mohan; Mathur, Anubhuti; Kuusisto, Johanna; Laakso, Markku; Ucar, Duygu; Mohlke, Karen L.; Boehnke, Michael; Collins, Francis S.; Parker, Stephen C. J.; Stitzel, Michael L.			A Common Type 2 Diabetes Risk Variant Potentiates Activity of an Evolutionarily Conserved Islet Stretch Enhancer and Increases C2CD4A and C2CD4B Expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELL; INSULIN-SECRETION; GENETIC ARCHITECTURE; SUSCEPTIBILITY LOCI; TRANSCRIPTION FACTORS; GENOTYPE IMPUTATION; SUPER-ENHANCERS; FALSE DISCOVERY; GLUCOSE	Genome-wide association studies (GWASs) and functional genomics approaches implicate enhancer disruption in islet dysfunction and type 2 diabetes (T2D) risk. We applied genetic fine-mapping and functional (epi) genomic approaches to a T2D-and proinsulin-associated 15q22.2 locus to identify a most likely causal variant, determine its direction of effect, and elucidate plausible target genes. Fine-mapping and conditional analyses of proinsulin levels of 8,635 non-diabetic individuals from the METSIM study support a single association signal represented by a cluster of 16 strongly associated (p < 10(-17)) variants in high linkage disequilibrium (r(2) > 0.8) with the GWAS index SNP rs7172432. These variants reside in an evolutionarily and functionally conserved islet and beta cell stretch or super enhancer; the most strongly associated variant (rs7163757, p = 3 x 10(-19)) overlaps a conserved islet open chromatin site. DNA sequence containing the rs7163757 risk allele displayed 2-fold higher enhancer activity than the non-risk allele in reporter assays (p < 0.01) and was differentially bound by b cell nuclear extract proteins. Transcription factor NFAT specifically potentiated risk-allele enhancer activity and altered patterns of nuclear protein binding to the risk allele in vitro, suggesting that it could be a factor mediating risk-allele effects. Finally, the rs7163757 proinsulin-raising and T2D risk allele (C) was associated with increased expression of C2CD4B, and possibly C2CD4A, both of which were induced by inflammatory cytokines, in human islets. Together, these data suggest that rs7163757 contributes to genetic risk of islet dysfunction and T2D by increasing NFAT-mediated islet enhancer activity and modulating C2CD4B, and possibly C2CD4A, expression in (patho) physiologic states.	[Kycia, Ina; Kursawe, Romy; Uyar, Asli; Khetan, Shubham; Lawlor, Nathan; Bolisetty, Mohan; Mathur, Anubhuti; Ucar, Duygu; Stitzel, Michael L.] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Wolford, Brooke N.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Huyghe, Jeroen R.; Fuchsberger, Christian; Welch, Ryan P.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Huyghe, Jeroen R.; Fuchsberger, Christian; Welch, Ryan P.] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Vadlamudi, Swarooparani; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Albanus, Ricardo d'Oliveira; Parker, Stephen C. J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio 70210, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Parker, Stephen C. J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Ucar, Duygu; Stitzel, Michael L.] Univ Connecticut, Hlth Ctr, Inst Syst Genom, Farmington, CT 06032 USA	Jackson Laboratory; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Michigan System; University of Michigan; University of Connecticut	Stitzel, ML (corresponding author), Jackson Lab Genom Med, Farmington, CT 06032 USA.; Stitzel, ML (corresponding author), Univ Connecticut, Hlth Ctr, Inst Syst Genom, Farmington, CT 06032 USA.	michael.stitzel@jax.org	Parker, Stephen/ABF-1063-2021; Wolford, Brooke/Y-3162-2019; Albanus, Ricardo D'Oliveira/AAQ-2431-2021; Fuchsberger, Christian/ABD-7127-2021; Wolford, Brooke/GQZ-2025-2022; Khetan, Shubham/AGX-7170-2022	Wolford, Brooke/0000-0003-3153-1552; Fuchsberger, Christian/0000-0002-5918-8947; Lawlor, Nathan/0000-0003-3263-6057; D'Oliveira Albanus, Ricardo/0000-0003-3651-0136	National Institute of Diabetes and Digestive and Kidney Diseases [DK092251, DK099240, DK072193, DK105561, DK062370]; NIH Intramural Program [ZIAHG000024]; American Diabetes Association Pathway to Stop Diabetes [1-14-INI-07, 1-18-ACE-15]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024, T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062370, R00DK099240, R01DK072193, U01DK105561, R00DK092251, R01DK062370, P30DK020572, R56DK062370] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Pathway to Stop Diabetes; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of our laboratories and colleagues at the Jackson Laboratory for Genomic Medicine, University of Michigan, and National Human Genome Research Institute and members of the FUSION Consortium for helpful comments and suggestions throughout this study, as well as the anonymous reviewers whose comments and suggestions improved the quality and clarity of this manuscript. We are especially grateful to the pancreatic organ donors and their families, without whom this study of the genetics of human islet dysfunction and type 2 diabetes would not have been possible. Finally, we extend our appreciation to Drs. van de Bunt, McCarthy, and Gloyn for providing summary islet eQTL data from their PLoS Genetics study for analysis. This study was made possible by generous financial support from the National Institute of Diabetes and Digestive and Kidney Diseases under award numbers DK092251 (to M.L.S.), DK099240 (to S.C.J.P.), DK072193 and DK105561 (to K.L.M.), and DK062370 (to M.B.), the NIH Intramural Program (ZIAHG000024 to F.S.C.), and the American Diabetes Association Pathway to Stop Diabetes (grants 1-14-INI-07 to S.C.J.P. and 1-18-ACE-15 to M.L.S.). Opinions, interpretations, conclusions, and recommendations are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or American Diabetes Association.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arous C, 2015, J BIOL CHEM, V290, P6653, DOI 10.1074/jbc.M114.611111; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal-Mizrachi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011969; Boland BB, 2017, MOL METAB, V6, P958, DOI 10.1016/j.molmet.2017.04.010; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; Cui B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022353; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Denas O, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1245-6; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Fogarty MP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004633; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Goodyer WR, 2012, DEV CELL, V23, P21, DOI 10.1016/j.devcel.2012.05.014; Grarup N, 2011, DIABETOLOGIA, V54, P789, DOI 10.1007/s00125-010-2031-2; Hajmrle C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86055; Hajmrle C, 2014, AM J PHYSIOL-ENDOC M, V307, pE664, DOI 10.1152/ajpendo.00168.2014; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Keller MP, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006466; Kluth O, 2014, DIABETES, V63, P4230, DOI 10.2337/db14-0425; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawlor N, 2017, TRENDS GENET, V33, P244, DOI 10.1016/j.tig.2017.01.010; Lawrence MC, 2002, DIABETES, V51, P691, DOI 10.2337/diabetes.51.3.691; Lawrence MC, 2015, MOL ENDOCRINOL, V29, P274, DOI 10.1210/me.2014-1066; Lawrence MC, 2011, J BIOL CHEM, V286, P1025, DOI 10.1074/jbc.M110.158675; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Mehta ZB, 2016, AM J PHYSIOL-ENDOC M, V311, pE488, DOI 10.1152/ajpendo.00074.2016; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mohlke KL, 2015, HUM MOL GENET, V24, pR85, DOI 10.1093/hmg/ddv264; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11764; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Soleimanpour SA, 2010, J BIOL CHEM, V285, P40050, DOI 10.1074/jbc.M110.154955; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stitzel ML, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0635-0; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; Varshney A, 2017, P NATL ACAD SCI USA, V114, P2301, DOI 10.1073/pnas.1621192114; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Warton K, 2004, GENE, V342, P85, DOI 10.1016/j.gene.2004.07.027; Weischenfeldt J, 2017, NAT GENET, V49, P65, DOI 10.1038/ng.3722; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wood AR, 2017, DIABETES, V66, P2296, DOI 10.2337/db16-1452; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	78	26	26	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					620	635		10.1016/j.ajhg.2018.02.020	http://dx.doi.org/10.1016/j.ajhg.2018.02.020			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29625024	Bronze, Green Published			2022-12-18	WOS:000429340800009
J	Tan, TY; Gonzaga-Jauregui, C; Bhoj, EJ; Strauss, KA; Brigatti, K; Puffenberger, E; Li, D; Xie, LQ; Das, N; Skubas, I; Deckelbaum, RA; Hughes, V; Brydges, S; Hatsell, S; Siao, CJ; Dominguez, MG; Economides, A; Overton, JD; Mayne, V; Simm, PJ; Jones, BO; Eggers, S; Le Guyader, G; Pelluard, F; Haack, TB; Sturm, M; Riess, A; Waldmueller, S; Hofbeck, M; Steindl, K; Joset, P; Rauch, A; Hakonarson, H; Baker, NL; Farlie, PG				Tiong Yang Tan; Gonzaga-Jauregui, Claudia; Bhoj, Elizabeth J.; Strauss, Kevin A.; Brigatti, Karlla; Puffenberger, Erik; Li, Dong; Xie, LiQin; Das, Nanditha; Skubas, Ioanna; Deckelbaum, Ron A.; Hughes, Virginia; Brydges, Susannah; Hatsell, Sarah; Siao, Chia-Jen; Dominguez, Melissa G.; Economides, Aris; Overton, John D.; Mayne, Valerie; Simm, Peter J.; Jones, Bryn O.; Eggers, Stefanie; Le Guyader, Gwenael; Pelluard, Fanny; Haack, Tobias B.; Sturm, Marc; Riess, Angelika; Waldmueller, Stephan; Hofbeck, Michael; Steindl, Katharina; Joset, Pascal; Rauch, Anita; Hakonarson, Hakon; Baker, Naomi L.; Farlie, Peter G.			Monoallelic BMP2 Variants Predicted to Result in Haploinsufficiency Cause Craniofacial, Skeletal, and Cardiac Features Overlapping Those of 20p12 Deletions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRACHYDACTYLY TYPE A2; PARKINSON-WHITE-SYNDROME; EPILEPTIC ENCEPHALOPATHY; PATTERN-FORMATION; MUTATION CAUSES; CLEFT-PALATE; BONE; GENE; MOUSE; MICRODELETION	Bone morphogenetic protein 2 (BMP2) in chromosomal region 20p12 belongs to a gene superfamily encoding TGF-beta-signaling proteins involved in bone and cartilage biology. Monoallelic deletions of 20p12 are variably associated with cleft palate, short stature, and developmental delay. Here, we report a cranioskeletal phenotype due to monoallelic truncating and frameshift BMP2 variants and deletions in 12 individuals from eight unrelated families that share features of short stature, a recognizable craniofacial gestalt, skeletal anomalies, and congenital heart disease. De novo occurrence and autosomal-dominant inheritance of variants, including paternal mosaicism in two affected sisters who inherited a BMP2 splice-altering variant, were observed across all reported families. Additionally, we observed similarity to the human phenotype of short stature and skeletal anomalies in a heterozygous Bmp2-knockout mouse model, suggesting that haploinsufficiency of BMP2 could be the primary phenotypic determinant in individuals with predicted truncating variants and deletions encompassing BMP2. These findings demonstrate the important role of BMP2 in human craniofacial, skeletal, and cardiac development and confirm that individuals heterozygous for BMP2 truncating sequence variants or deletions display a consistent distinct phenotype characterized by short stature and skeletal and cardiac anomalies without neurological deficits.	[Tiong Yang Tan] Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [Tiong Yang Tan; Simm, Peter J.; Jones, Bryn O.; Eggers, Stefanie; Baker, Naomi L.; Farlie, Peter G.] Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Tiong Yang Tan; Simm, Peter J.; Baker, Naomi L.; Farlie, Peter G.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia; [Gonzaga-Jauregui, Claudia; Overton, John D.] Regeneron Pharmaceut Inc, Regeneron Genet Ctr, Tarrytown, NY 10591 USA; [Bhoj, Elizabeth J.; Li, Dong; Hakonarson, Hakon] Childrens Hosp Philadelphia, Dept Pediat, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Strauss, Kevin A.; Brigatti, Karlla; Puffenberger, Erik] Clin Special Children, Philadelphia, PA 17579 USA; [Xie, LiQin; Das, Nanditha; Skubas, Ioanna; Deckelbaum, Ron A.; Hughes, Virginia; Brydges, Susannah; Hatsell, Sarah; Siao, Chia-Jen; Dominguez, Melissa G.; Economides, Aris] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Mayne, Valerie; Simm, Peter J.; Jones, Bryn O.] Royal Childrens Hosp, Melbourne, Vic 3052, Australia; [Le Guyader, Gwenael] Univ Poitiers Hosp, Dept Med Genet, F-86021 Poitiers, France; [Pelluard, Fanny] Bordeaux Univ Hosp, Dept Pathol, F-33076 Bordeaux, France; [Haack, Tobias B.; Sturm, Marc; Riess, Angelika; Waldmueller, Stephan] Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany; [Waldmueller, Stephan; Hofbeck, Michael] Univ Klin Kinder & Jugendmed, Kinderheilkunde Kardiol Intens Med Pulmol 2, D-72076 Tubingen, Germany; [Steindl, Katharina; Joset, Pascal; Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8952 Schlieren, Switzerland	Murdoch Children's Research Institute; University of Melbourne; Regeneron; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Regeneron; Royal Children's Hospital Melbourne; CHU Poitiers; Universite de Poitiers; CHU Bordeaux; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Tan, TY (corresponding author), Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia.; Tan, TY (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.; Tan, TY (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia.	tiong.tan@vcgs.org.au	Hofbeck, Michael/ABB-3259-2020; Gonzaga-Jauregui, Claudia/H-4752-2019; Tan, Tiong Yang/AAV-6563-2020; Rauch, Anita/C-5568-2014	Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; Tan, Tiong Yang/0000-0001-8455-7778; Rauch, Anita/0000-0003-2930-3163; Puffenberger, Erik/0000-0002-6388-9148; Le Guyader, Gwenael/0000-0003-2847-8121; Sturm, Marc/0000-0002-6552-8362; Hofbeck, Michael/0000-0001-7034-1132; Hatsell, Sarah/0000-0003-1103-6087	Murdoch Children's Research Institute Cell Biology Theme; Victorian State Government through Operational Infrastructure Support Program; radiz - Rare Disease Initiative Zurich; Clinical Research Priority Program for Rare Diseases at the University of Zurich	Murdoch Children's Research Institute Cell Biology Theme; Victorian State Government through Operational Infrastructure Support Program; radiz - Rare Disease Initiative Zurich; Clinical Research Priority Program for Rare Diseases at the University of Zurich	The authors thank the affected individuals and all family members for participating in this research. This research was supported by an internal grant from the Murdoch Children's Research Institute Cell Biology Theme. The Murdoch Children's Research Institute receives funding from the Victorian State Government through the Operational Infrastructure Support Program. A.R. was supported by radiz - Rare Disease Initiative Zurich, the Clinical Research Priority Program for Rare Diseases at the University of Zurich. We thank Bernard Drew, Trent Burgess, Juliane Gohlke, and Beate Kootz for technical support.	Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Bruno DL, 2009, J MED GENET, V46, P123, DOI 10.1136/jmg.2008.062604; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; Dawson K, 2006, AM J HUM GENET, V78, P708, DOI 10.1086/503204; Delot EC, 2003, DEVELOPMENT, V130, P209, DOI 10.1242/dev.00181; Demirhan O, 2005, J MED GENET, V42, P314, DOI 10.1136/jmg.2004.023564; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Girdea M, 2013, HUM MUTAT, V34, P1057, DOI 10.1002/humu.22347; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Groza T, 2015, AM J HUM GENET, V97, P111, DOI 10.1016/j.ajhg.2015.05.020; Hackenberg A, 2014, NEUROPEDIATRICS, V45, P261, DOI 10.1055/s-0034-1372302; Jee YH, 2017, ENDOCRIN METAB CLIN, V46, P259, DOI 10.1016/j.ecl.2017.01.001; Kalkwarf HJ, 2010, J CLIN ENDOCR METAB, V95, P1690, DOI 10.1210/jc.2009-2319; Kugimiya F, 2005, J BIOL CHEM, V280, P35704, DOI 10.1074/jbc.M505166200; Lalani SR, 2009, J MED GENET, V46, P168, DOI 10.1136/jmg.2008.061002; Le Gloan L, 2008, EUR J MED GENET, V51, P651, DOI 10.1016/j.ejmg.2008.07.012; Lehmann K, 2007, AM J HUM GENET, V81, P388, DOI 10.1086/519697; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Li D, 2016, AM J HUM GENET, V99, P802, DOI 10.1016/j.ajhg.2016.07.013; Li FF, 2016, MOL MED REP, V14, P1459, DOI 10.3892/mmr.2016.5428; Liu XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094201; Lloyd KCK, 2011, ANN NY ACAD SCI, V1245, P24, DOI 10.1111/j.1749-6632.2011.06311.x; LYONS KM, 1990, DEVELOPMENT, V109, P833; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Meinhardt H, 2015, DEV BIOL, V405, P137, DOI 10.1016/j.ydbio.2015.05.025; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; RAO VVNG, 1992, HUM GENET, V90, P299; Sadedin SP, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0191-x; Sahoo T, 2011, AM J MED GENET A, V155A, P1646, DOI 10.1002/ajmg.a.34063; Satoh K, 2015, J BIOL CHEM, V290, P24152, DOI 10.1074/jbc.M115.655076; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Simpson AHRW, 2006, J BONE JOINT SURG BR, V88B, P701, DOI 10.1302/0301-620X.88B6; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sonnet C, 2013, J ORTHOP RES, V31, P1597, DOI 10.1002/jor.22407; Steinberg S, 2015, NAT GENET, V47, P445, DOI 10.1038/ng.3246; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Strauss K. A., 2017, GENET MED; Su PQ, 2011, J MED GENET, V48, P312, DOI 10.1136/jmg.2010.084814; Tan TY, 2009, CLEFT PALATE-CRAN J, V46, P583, DOI 10.1597/07-241.1; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Williams ES, 2012, AM J MED GENET A, V158A, P2616, DOI 10.1002/ajmg.a.35594; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xu JX, 2016, MOL SYNDROMOL, V7, P322, DOI 10.1159/000449115; Ye M, 2010, HUM MOL GENET, V19, P287, DOI 10.1093/hmg/ddp496; Zhang HB, 1996, DEVELOPMENT, V122, P2977	51	26	27	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2017	101	6					985	994		10.1016/j.ajhg.2017.10.006	http://dx.doi.org/10.1016/j.ajhg.2017.10.006			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP5FD	29198724	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000417644500009
J	Lee, CS; Fu, H; Baratang, N; Rousseau, J; Kumra, H; Sutton, VR; Niceta, M; Ciolfi, A; Yamamoto, G; Bertola, D; Marcelis, CL; Lugtenberg, D; Bartuli, A; Kim, C; Hoover-Fong, J; Sobreira, N; Pauli, R; Bacino, C; Krakow, D; Parboosingh, J; Yap, P; Kariminejad, A; McDonald, MT; Aracena, MI; Lausch, E; Unger, S; Superti-Furga, A; Lu, JT; Cohn, DH; Tartaglia, M; Lee, BH; Reinhardt, DP; Campeau, PM				Lee, Chae Syng; Fu, He; Baratang, Nissan; Rousseau, Justine; Kumra, Heena; Sutton, V. Reid; Niceta, Marcello; Ciolfi, Andrea; Yamamoto, Guilherme; Bertola, Debora; Marcelis, Carlo L.; Lugtenberg, Dorien; Bartuli, Andrea; Kim, Choel; Hoover-Fong, Julie; Sobreira, Nara; Pauli, Richard; Bacino, Carlos; Krakow, Deborah; Parboosingh, Jillian; Yap, Patrick; Kariminejad, Ariana; McDonald, Marie T.; Aracena, Mariana I.; Lausch, Ekkehart; Unger, Sheila; Superti-Furga, Andrea; Lu, James T.; Cohn, Dan H.; Tartaglia, Marco; Lee, Brendan H.; Reinhardt, Dieter P.; Campeau, Philippe M.		Baylor-Hopkins Ctr Mendelian	Mutations in Fibronectin Cause a Subtype of Spondylometaphyseal Dysplasia with "Corner Fractures''	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLIGOMERIC MATRIX PROTEIN; GLOBULAR DOMAINS; CARTILAGE; FIBRILLIN-1; GLOMERULOPATHY; LAMININ; BINDING; SITES; BETA; FORM	Fibronectin is a master organizer of extracellular matrices (ECMs) and promotes the assembly of collagens, fibrillin-1, and other proteins. It is also known to play roles in skeletal tissues through its secretion by osteoblasts, chondrocytes, and mesenchymal cells. Spondylo-metaphyseal dysplasias (SMDs) comprise a diverse group of skeletal dysplasias and often manifest as short stature, growth-plate irregularities, and vertebral anomalies, such as scoliosis. By comparing the exomes of individuals with SMD with the radiographic appearance of "corner fractures'' at metaphyses, we identified three individuals with fibronectin (FN1) variants affecting highly conserved residues. Furthermore, using matching tools and the SkelDys emailing list, we identified other individuals with de novo FN1 variants and a similar phenotype. The severe scoliosis in most individuals and rare developmental coxa vara distinguish individuals with FN1 mutations from those with classical Sutcliffe-type SMD. To study functional consequences of these FN1 mutations on the protein level, we introduced three disease-associated missense variants (p.Cys87Phe [c.260G>T], p.Tyr240Asp [c.718T>G], and p.Cys260Gly [c.778T>G]) into a recombinant secreted N-terminal 70 kDa fragment (rF70K) and the full-length fibronectin (rFN). The wild-type rF70K and rFN were secreted into the culture medium, whereas all mutant proteins were either not secreted or secreted at significantly lower amounts. Immunofluorescence analysis demonstrated increased intracellular retention of the mutant proteins. In summary, FN1 mutations that cause defective fibronectin secretion are found in SMD, and we thus provide additional evidence for a critical function of fibronectin in cartilage and bone.	[Lee, Chae Syng; Kumra, Heena; Reinhardt, Dieter P.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Lee, Chae Syng; Kumra, Heena] McGill Univ, Fac Dent, Montreal, PQ H3A 0C7, Canada; [Fu, He; Baratang, Nissan; Rousseau, Justine; Campeau, Philippe M.] Univ Montreal, Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada; [Sutton, V. Reid; Bacino, Carlos; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Niceta, Marcello; Ciolfi, Andrea; Bartuli, Andrea; Tartaglia, Marco] Bambino Gesu Pediat Hosp, Ist Ricovero & Cura Carattere Sci, Genet & Rare Dis Res Div, I-00146 Rome, Italy; [Yamamoto, Guilherme; Bertola, Debora] Univ Sao Paulo, Fac Med, Hosp Clin, Clin Genet,Unit Inst Crianca, BR-05403000 Sao Paulo, SP, Brazil; [Marcelis, Carlo L.; Lugtenberg, Dorien] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Marcelis, Carlo L.; Lugtenberg, Dorien] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Hoover-Fong, Julie; Sobreira, Nara] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; [Pauli, Richard] Univ Wisconsin, Midwest Reg Bone Dysplasia Clin, Madison, WI 53705 USA; [Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Parboosingh, Jillian] Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Parboosingh, Jillian] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB T2N 4N1, Canada; [Yap, Patrick] Genet Hlth Serv New Zealand Northern Hub, Auckland 1023, New Zealand; [Kariminejad, Ariana] Kariminejad Najmabadi Pathol & Genet Ctr, Tehran 14665, Iran; [McDonald, Marie T.] Duke Univ, Med Ctr, Div Med Genet, Dept Pediat, Durham, NC 27710 USA; [Aracena, Mariana I.] Pontificia Univ Catolica Chile, Hosp Dr Luis Calvo Mackenna, Unidad Genet, Div Pediat,Pediatra Genetista, Santiago, Chile; [Lausch, Ekkehart] Univ Freiburg, Dept Pediat, Med Ctr, D-79106 Freiburg, Germany; [Unger, Sheila; Superti-Furga, Andrea] Lausanne Univ Hosp CHUV, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Lu, James T.] Helix, San Carlos, CA 94070 USA; [Baylor-Hopkins Ctr Mendelian] Baylor Hopkins Ctr Mendelian Genom, Houston, TX 77030 USA; [Cohn, Dan H.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	McGill University; McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Baylor College of Medicine; IRCCS Bambino Gesu; Universidade de Sao Paulo; Radboud University Nijmegen; Baylor College of Medicine; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Calgary; University of Calgary; Duke University; Pontificia Universidad Catolica de Chile; University of Freiburg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of California System; University of California Los Angeles	Reinhardt, DP (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada.; Reinhardt, DP (corresponding author), McGill Univ, Fac Dent, Montreal, PQ H3A 0C7, Canada.; Campeau, PM (corresponding author), Univ Montreal, Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada.	dieter.reinhardt@mcgill.ca; p.campeau@umontreal.ca	Yamamoto, Guilherme/C-9973-2010; Kumra, Heena/HGA-0348-2022; Campeau, Philippe/J-8614-2015; superti-furga, andrea/E-9162-2015; Reinhardt, Dieter P/A-3102-2008; Krakow, Deborah/B-5778-2009; Ciolfi, Andrea/J-4954-2018; Lugtenberg, Dorien/B-6338-2018; Marcelis, C.L.M./L-4504-2015; Tartaglia, Marco/K-2955-2018; Niceta, Marcello/V-1557-2019; Bertola, Débora/I-5120-2016	Yamamoto, Guilherme/0000-0002-0490-8257; Kumra, Heena/0000-0001-7065-6716; Campeau, Philippe/0000-0001-9713-7107; superti-furga, andrea/0000-0002-3543-7531; Reinhardt, Dieter P/0000-0001-6535-9872; Krakow, Deborah/0000-0001-9906-4968; Ciolfi, Andrea/0000-0002-6191-0978; Marcelis, C.L.M./0000-0001-7095-4641; Tartaglia, Marco/0000-0001-7736-9672; Niceta, Marcello/0000-0003-4766-7753; Bertola, Débora/0000-0002-4701-6777; Rousseau, Justine/0000-0002-3554-2673; Hoover-Fong, Julie/0000-0002-1242-5626; Unger, Sheila/0000-0002-9539-8941; Kariminejad, Ariana/0000-0002-8467-4728	Canadian Institutes for Health Research [RN315908, MOP-137091]; Fonds de Recherche du Quebec - Santeclinical research scholar award [30647]; Quebec Network for Oral and Bone Health Research (RSBO Emerging Collaborating Project); NIH [UM1 HG006542, P01 HD070394]; Heart and Stroke Foundation of Canada [G-16-00014634]; Italian Ministry of Health (Ricerca Corrente); Fondazione Bambino Gesu (Vite Coraggiose grant); Eunice Kennedy Shriver National Institute of Child Health & Human Development [HD024064]; BCM Advanced Technology Cores through the NIH [AI036211, CA125123, RR024574]; Rolanette and Berdon Lawrence Bone Disease Program of Texas; BCM Center for Skeletal Medicine and Biology; Sao Paulo Research Foundation [FAPESP 2015/21783-9, [CEPID] 2013/08028-1]; National Council for Scientific and Technological Development [CNPq 302605/2013-4, 304130/2016-8]; German Research Foundation [CRC 1140]; German Ministry for Education and Research (MaTrOC); European Union (SYBIL grant) [602300]; European Union (RARENET); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, P01HD070394] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Santeclinical research scholar award; Quebec Network for Oral and Bone Health Research (RSBO Emerging Collaborating Project); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); Fondazione Bambino Gesu (Vite Coraggiose grant); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); BCM Advanced Technology Cores through the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rolanette and Berdon Lawrence Bone Disease Program of Texas; BCM Center for Skeletal Medicine and Biology; Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); German Research Foundation(German Research Foundation (DFG)); German Ministry for Education and Research (MaTrOC); European Union (SYBIL grant); European Union (RARENET); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported in part by operating grants from the Canadian Institutes for Health Research (clinician-scientist award RN315908 to P.M.C.; MOP-137091 to D.P.R.), the Fonds de Recherche du Quebec - Santeclinical research scholar award 30647 to P.M.C., the Quebec Network for Oral and Bone Health Research (RSBO Emerging Collaborating Project 2014-2015 to P.M.C. and D.P.R.), the NIH (UM1 HG006542 to the Baylor Hopkins Center for Mendelian Genomics), the Heart and Stroke Foundation of Canada (G-16-00014634 to D.P.R.), the Italian Ministry of Health (Ricerca Corrente 2016 to M.T. and M.N.), and Fondazione Bambino Gesu (Vite Coraggiose grant to M.T.). This work was also supported by NIH P01 HD070394, by HD024064 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development granted to the Baylor College of Medicine (BCM) Intellectual and Developmental Disabilities Research Center (for processing samples obtained and managing clinical protocols), by the BCM Advanced Technology Cores through funding from the NIH (AI036211, CA125123, and RR024574), by the Rolanette and Berdon Lawrence Bone Disease Program of Texas, and by the BCM Center for Skeletal Medicine and Biology (to B.H.L). Analysis of individual 5 was supported by the Sao Paulo Research Foundation (FAPESP 2015/21783-9; Centros de Pesquisa, Inovacao, e Difusao [CEPID] 2013/08028-1) and National Council for Scientific and Technological Development (CNPq 302605/2013-4 and 304130/2016-8 to D.B). E.L. is supported by grants from the German Research Foundation (CRC 1140), the German Ministry for Education and Research (MaTrOC), and the European Union (SYBIL grant agreement no. 602300; RARENET). We thank Dr. Deane Mosher and Dr. Douglas Annis for providing the FN1 pAcGP67A plasmid. We thank Dr. Reggie Hamdy for referring individual 7 to Dr. Campeau and Dr. Amelie Damphousse for the interpretation of the radiographs.	BARON M, 1990, NATURE, V345, P642, DOI 10.1038/345642a0; Baydar DE, 2013, AM J KIDNEY DIS, V61, P514, DOI 10.1053/j.ajkd.2012.08.050; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Castelletti F, 2008, P NATL ACAD SCI USA, V105, P2538, DOI 10.1073/pnas.0707730105; Currarino G, 2000, PEDIATR RADIOL, V30, P14, DOI 10.1007/s002479900123; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Duetting T, 1998, AM J MED GENET, V78, P61, DOI 10.1002/(SICI)1096-8628(19980616)78:1<61::AID-AJMG13>3.0.CO;2-M; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; Hecht JT, 1998, MATRIX BIOL, V17, P625, DOI 10.1016/S0945-053X(98)90113-5; Hubmacher D, 2011, BIOCHEMISTRY-US, V50, P5322, DOI 10.1021/bi200183z; Keene DR, 1997, J HISTOCHEM CYTOCHEM, V45, P1069, DOI 10.1177/002215549704500805; Kirschner R, 2011, J BIOL CHEM, V286, P32810, DOI 10.1074/jbc.M111.221804; Kozlowski K., 1984, GAMUT INDEX SKELETAL; LANGER LO, 1990, RADIOLOGY, V175, P761, DOI 10.1148/radiology.175.3.2343127; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Machol K, 2017, AM J MED GENET A, V173, P733, DOI 10.1002/ajmg.a.38059; Maddox BK, 1997, J BIOL CHEM, V272, P30993, DOI 10.1074/jbc.272.49.30993; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Mosher DF, 2006, ARTERIOSCL THROM VAS, V26, P1193, DOI 10.1161/01.ATV.0000223342.15969.7a; Ohtsubo H, 2016, PEDIATR NEPHROL, V31, P1459, DOI 10.1007/s00467-016-3368-7; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Singh P, 2012, J CELL SCI, V125, P3703, DOI 10.1242/jcs.095786; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; SUTCLIFF.J, 1966, ANN RADIOL-RADIOL CL, V9, pR215; Sutton VR, 2005, AM J MED GENET A, V133A, P209, DOI 10.1002/ajmg.a.30567; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Walter K, 2007, AM J MED GENET A, V143A, P161, DOI 10.1002/ajmg.a.31516	35	26	26	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					815	823		10.1016/j.ajhg.2017.09.019	http://dx.doi.org/10.1016/j.ajhg.2017.09.019			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100092	Green Published, Bronze			2022-12-18	WOS:000414251600012
J	Milev, MP; Grout, ME; Saint-Dic, D; Cheng, YHH; Glass, IA; Hale, CJ; Hanna, DS; Dorschner, MO; Prematilake, K; Shaag, A; Elpeleg, O; Sacher, M; Doherty, D; Edvardson, S				Milev, Miroslav P.; Grout, Megan E.; Saint-Dic, Djenann; Cheng, Yong-Han Hank; Glass, Ian A.; Hale, Christopher J.; Hanna, David S.; Dorschner, Michael O.; Prematilake, Keshika; Shaag, Avraham; Elpeleg, Orly; Sacher, Michael; Doherty, Dan; Edvardson, Simon			Mutations in TRAPPC12 Manifest in Progressive Childhood Encephalopathy and Golgi Dysfunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; MUSCULAR-DYSTROPHY; INFANTILE-ONSET; PROTEIN; AUTOPHAGY; DISEASE; COMPLEX; IDENTIFICATION; RETARDATION; TRAFFICKING	Progressive childhood encephalopathy is an etiologically heterogeneous condition characterized by progressive central nervous system dysfunction in association with a broad range of morbidity and mortality. The causes of encephalopathy can be either non-genetic or genetic. Identifying the genetic causes and dissecting the underlying mechanisms are critical to understanding brain development and improving treatments. Here, we report that variants in TRAPPC12 result in progressive childhood encephalopathy. Three individuals from two unrelated families have either a homozygous deleterious variant (c.145delG [p.Glu49Argfs*14]) or compound-heterozygous variants (c.360dupC [p.Glu121Argfs*7] and c.1880C>T [p.Ala627Val]). The clinical phenotypes of the three individuals are strikingly similar: severe disability, microcephaly, hearing loss, spasticity, and characteristic brain imaging findings. Fibroblasts derived from all three individuals showed a fragmented Golgi that could be rescued by expression of wild-type TRAPPC12. Protein transport from the endoplasmic reticulum to and through the Golgi was delayed. TRAPPC12 is a member of the TRAPP protein complex, which functions in membrane trafficking. Variants in several other genes encoding members of the TRAPP complex have been associated with overlapping clinical presentations, indicating shared and distinct functions for each complex member. Detailed understanding of the TRAPP-opathies will illuminate the role of membrane protein transport in human disease.	[Milev, Miroslav P.; Saint-Dic, Djenann; Prematilake, Keshika; Sacher, Michael] Concordia Univ, Dept Biol, Montreal, PQ H4B 1R6, Canada; [Grout, Megan E.; Cheng, Yong-Han Hank; Glass, Ian A.; Doherty, Dan] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Hale, Christopher J.; Hanna, David S.; Dorschner, Michael O.] Univ Washington, Dept Pathol, Ctr Precis Diagnost, Seattle, WA 98195 USA; [Shaag, Avraham; Elpeleg, Orly; Edvardson, Simon] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel; [Edvardson, Simon] Hadassah Hebrew Univ, Med Ctr, Pediat Neurol Unit, IL-91120 Jerusalem, Israel; [Sacher, Michael] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada	Concordia University - Canada; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; McGill University	Sacher, M (corresponding author), Concordia Univ, Dept Biol, Montreal, PQ H4B 1R6, Canada.; Doherty, D (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Sacher, M (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada.	michael.sacher@concordia.ca; ddoher@uw.edu		Milev, Miroslav/0000-0002-3354-1634; Cheng, Yong-Han/0000-0001-7686-0697; Grout Vandenberg, Megan/0000-0001-7704-2100	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Trudy Mandel Louis Charitable Trust; University of Washington Pediatrics Department; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54HD083091]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Trudy Mandel Louis Charitable Trust; University of Washington Pediatrics Department; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the families for participating in this study. This work was supported by funding from the Canadian Institutes of Health Research (M.S.), the Natural Sciences and Engineering Research Council of Canada (M.S.), the Trudy Mandel Louis Charitable Trust (O.E.), the University of Washington Pediatrics Department (D.D.), and the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development U54HD083091 Genetics Core (D.D.). The M.S. laboratory is a member of the Groupe de Recherche Axe sur la Structure des Proteines. S.E. completed this work while on sabbatical.	Armstrong L, 2014, NEUROGENETICS, V15, P157, DOI 10.1007/s10048-014-0411-3; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bogershausen N, 2013, AM J HUM GENET, V93, P181, DOI 10.1016/j.ajhg.2013.05.028; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Brunet S, 2014, TRAFFIC, V15, P803, DOI 10.1111/tra.12183; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Chong JX, 2016, AM J HUM GENET, V98, P772, DOI 10.1016/j.ajhg.2016.01.016; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dimassi S, 2016, CLIN GENET, V89, P198, DOI 10.1111/cge.12636; Edvardson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036458; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Kim JJ, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00020; Koehler K, 2017, J MED GENET, V54, P176, DOI 10.1136/jmedgenet-2016-104108; Kurata H, 2016, CLIN GENET, V90, P437, DOI 10.1111/cge.12813; Lamb CA, 2016, EMBO J, V35, P281, DOI 10.15252/embj.201592695; Liang WC, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0056-4; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Machamer CE, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fhins.2015.00421, 10.3389/fnins.2015.00421]; Mandel H, 2017, AM J MED GENET A, V173, P491, DOI 10.1002/ajmg.a.38019; Meiling-Wesse K, 2005, J BIOL CHEM, V280, P33669, DOI 10.1074/jbc.M501701200; Miley MP, 2015, J CELL BIOL, V209, P221, DOI 10.1083/jcb.201501090; Mir A, 2009, AM J HUM GENET, V85, P909, DOI 10.1016/j.ajhg.2009.11.009; Nakashima M, 2016, J HUM GENET, V61, P653, DOI 10.1038/jhg.2016.27; Rabouille C, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00489; Reynders E, 2011, GLYCOBIOLOGY, V21, P853, DOI 10.1093/glycob/cwq179; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873; Scrivens PJ, 2009, TRAFFIC, V10, P724, DOI 10.1111/j.1600-0854.2009.00906.x; Sharkia R, 2016, J BIOSOC SCI, V48, P283, DOI 10.1017/S0021932015000103; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Sirdah MM, 2014, EUR J MED GENET, V57, P90, DOI 10.1016/j.ejmg.2014.01.003; Stromme Petter, 2007, BMC Pediatr, V7, P25, DOI 10.1186/1471-2431-7-25; Wen JD, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0109-8	34	26	28	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					291	299		10.1016/j.ajhg.2017.07.006	http://dx.doi.org/10.1016/j.ajhg.2017.07.006			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28777934	Green Published, Bronze			2022-12-18	WOS:000406854800013
J	Lloyd-Jones, LR; Holloway, A; McRae, A; Yang, J; Small, K; Zhao, J; Zeng, B; Bakshi, A; Metspalu, A; Dermitzakis, M; Gibson, G; Spector, T; Montgomery, G; Esko, T; Visscher, PM; Powell, JE				Lloyd-Jones, Luke R.; Holloway, Alexander; McRae, Allan; Yang, Jian; Small, Kerrin; Zhao, Jing; Zeng, Biao; Bakshi, Andrew; Metspalu, Andres; Dermitzakis, Manolis; Gibson, Greg; Spector, Tim; Montgomery, Grant; Esko, Tonu; Visscher, Peter M.; Powell, Joseph E.			The Genetic Architecture of Gene Expression in Peripheral Blood (vol 100, pg 228, 2017)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction												l.lloydjones@uq.edu.au; joseph.powell@uq.edu.au	Visscher, Peter/ABB-6151-2020	Visscher, Peter/0000-0002-2143-8760; Small, Kerrin/0000-0003-4566-0005				Lloyd-Jones LR, 2017, AM J HUM GENET, V100, P228, DOI 10.1016/j.ajhg.2016.12.008	1	26	26	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					371	371		10.1016/j.ajhg.2017.01.026	http://dx.doi.org/10.1016/j.ajhg.2017.01.026			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28157541	Green Published, Bronze			2022-12-18	WOS:000393352000018
J	Namburi, P; Ratnapriya, R; Khateb, S; Lazar, CH; Kinarty, Y; Obolensky, A; Erdinest, I; Marks-Ohana, D; Pras, E; Ben-Yosef, T; Newman, H; Gross, M; Swaroop, A; Banin, E; Sharon, D				Namburi, Prasanthi; Ratnapriya, Rinki; Khateb, Samer; Lazar, Csilla H.; Kinarty, Yael; Obolensky, Alexey; Erdinest, Inbar; Marks-Ohana, Devorah; Pras, Eran; Ben-Yosef, Tamar; Newman, Hadas; Gross, Menachem; Swaroop, Anand; Banin, Eyal; Sharon, Dror			Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINITIS-PIGMENTOSA; GENETIC-HETEROGENEITY; USHER-SYNDROME; CILIA; PREVALENCE; EVOLUTION	Inherited retinal diseases (IRDs) are a diverse group of genetically and clinically heterogeneous retinal abnormalities. The present study was designed to identify genetic defects in individuals with an uncommon combination of autosomal recessive progressive cone-rod degeneration accompanied by sensorineural hearing loss (arCRD-SNHL). Homozygosity mapping followed by whole-exome sequencing (WES) and founder mutation screening revealed two truncating rare variants (c.893-1G>A and c.534delT) in CEP78, which encodes centrosomal protein 78, in six individuals of Jewish ancestry with CRD and SNHL. RT-PCR analysis of CEP78 in blood leukocytes of affected individuals revealed that the c.893-1G>A mutation causes exon 7 skipping leading to deletion of 65bp, predicted to result in a frameshift and therefore a truncated protein (p.Asp298Valfs*17). RT-PCR analysis of 17 human tissues demonstrated ubiquitous expression of different CEP78 transcripts. RNA-seq analysis revealed three transcripts in the human retina and relatively higher expression in S-cone-like photoreceptors of Nrl-knockout retina compared to rods. Immunohistochemistry studies in the human retina showed intense labeling of cone inner segments compared to rods. CEP78 was reported previously to interact with c-napl, encoded by CEP250 that we reported earlier to cause atypical Usher syndrome. We conclude that truncating mutations in CEP78 result in a phenotype involving both the visual and auditory systems but different from typical Usher syndrome.	[Namburi, Prasanthi; Khateb, Samer; Kinarty, Yael; Obolensky, Alexey; Erdinest, Inbar; Marks-Ohana, Devorah; Banin, Eyal; Sharon, Dror] Hadassah Hebrew Univ Med Ctr, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Ratnapriya, Rinki; Lazar, Csilla H.; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Lazar, Csilla H.] Univ Babes Bolyai, Ctr Mol Biol, Interdisciplinary Res Inst Bionano Sci, Cluj Napoca 400271, Romania; [Kinarty, Yael] Hebrew Univ Hadassah Med Sch, Dept Med Neurobiol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; [Pras, Eran] Assaf Harofeh Med Ctr, Dept Ophthalmol, IL-70300 Zerifin, Israel; [Pras, Eran; Newman, Hadas] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Ben-Yosef, Tamar] Technion Israel Inst Technol, Rappaport Fac Med, IL-3525433 Haifa, Israel; [Newman, Hadas] Tel Aviv Med Ctr & Sch Med, Dept Ophthalmol, IL-64239 Tel Aviv, Israel; [Gross, Menachem] Hadassah Hebrew Univ Med Ctr, Dept Otolaryngol Head & Neck Surg, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Babes Bolyai University from Cluj; Hebrew University of Jerusalem; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem	Banin, E; Sharon, D (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Ophthalmol, IL-91120 Jerusalem, Israel.	banine@cc.huji.ac.il; dror.sharon1@gmail.com	Sharon, Dror/P-4539-2015	Sharon, Dror/0000-0002-1789-5811	United States Israel Binational Science Foundation [2011202]; Foundation Fighting Blindness USA [BR-GE-0214-0639]; Israel Science Foundation [2154/15]; Chief Scientist office of the Israeli Ministry of Health; Lirot association [300009177]; Yedidut Research Grant; Intramural Research Program of the National Eye Institute, National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000546] Funding Source: NIH RePORTER	United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); Foundation Fighting Blindness USA; Israel Science Foundation(Israel Science Foundation); Chief Scientist office of the Israeli Ministry of Health; Lirot association; Yedidut Research Grant; Intramural Research Program of the National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank all affected individuals and family members for their participation in this study. We are grateful to Lilach Binyamini and Shelly Stika for assistance in recruitment and clinical evaluation of the individuals and Alaa Abu-Diab for technical assistance. Whole-exome analysis utilized the computational resources of the NIH HPC Biowulf cluster. We thank Matthew Brooks, Jung-Woong Kim, Hyunjin Yang, and Ashley Walton for help with RNA-seq analysis. This research was supported by the United States Israel Binational Science Foundation (grant number 2011202, to D.S. and A.S.), Foundation Fighting Blindness USA (BR-GE-0214-0639 to D.S., E.B., E.P., H.N., and T.B.-Y.), Israel Science Foundation (#2154/15 to S.K.), Chief Scientist office of the Israeli Ministry of Health and the Lirot association (#300009177 to S.K.), the Yedidut Research Grant (to E.B.), and the Intramural Research Program of the National Eye Institute, National Institutes of Health (to A.S.).	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2012, SCIENCE, V335, P461, DOI 10.1126/science.1214457; Bashir R, 2010, CLIN GENET, V78, P601, DOI 10.1111/j.1399-0004.2010.01500.x; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Beryozkin A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13187; Brekman A, 2014, AM J RESP CELL MOL, V51, P688, DOI 10.1165/rcmb.2013-0363OC; BUNDEY S, 1984, J MED GENET, V21, P421, DOI 10.1136/jmg.21.6.421; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; Di Gioia SA, 2012, HUM MOL GENET, V21, P5174, DOI 10.1093/hmg/dds368; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Fogeron ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2517; Haim Marianne, 2002, Acta Ophthalmol Scand Suppl, P1; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Kalay E, 2005, J MOL MED, V83, P1025, DOI 10.1007/s00109-005-0719-4; Keats BJB, 2004, AM J MED GENET A, V130A, P13, DOI 10.1002/ajmg.a.30052; Khateb S, 2014, J MED GENET, V51, P460, DOI 10.1136/jmedgenet-2014-102287; Kim JW, 2016, DEV CELL, V37, P520, DOI 10.1016/j.devcel.2016.05.023; Kimberling WJ, 2000, ADV OTO-RHINO-LARYNG, V56, P11; Liu XZ, 1998, AM J HUM GENET, V63, P909, DOI 10.1086/302026; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Rosenberg T, 2003, DEV OPHTHALMOL, V37, P16; Rosenberg T, 1997, CLIN GENET, V51, P314; Sharon D, 2015, MOL VIS, V21, P783; Sorusch N, 2014, ADV EXP MED BIOL, V801, P527, DOI 10.1007/978-1-4614-3209-8_67; Valente EM, 2014, NAT REV NEUROL, V10, P27, DOI 10.1038/nrneurol.2013.247; Veleri S, 2015, DIS MODEL MECH, V8, P109, DOI 10.1242/dmm.017913	30	26	29	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					777	784		10.1016/j.ajhg.2016.07.010	http://dx.doi.org/10.1016/j.ajhg.2016.07.010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27588452	Green Published, Bronze			2022-12-18	WOS:000383114800024
J	Wang, JB; Gamazon, ER; Pierce, BL; Stranger, BE; Im, HK; Gibbons, RD; Cox, NJ; Nicolae, DL; Chen, LS				Wang, Jiebiao; Gamazon, Eric R.; Pierce, Brandon L.; Stranger, Barbara E.; Im, Hae Kyung; Gibbons, Robert D.; Cox, Nancy J.; Nicolae, Dan L.; Chen, Lin S.			Imputing Gene Expression in Uncollected Tissues Within and Beyond GTEx	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSING VALUE IMPUTATION; ASSOCIATION; SELECTION; SET	Gene expression and its regulation can vary substantially across tissue types. In order to generate knowledge about gene expression in human tissues, the Genotype-Tissue Expression (GTEx) program has collected transcriptome data in a wide variety of tissue types from post-mortem donors. However, many tissue types are difficult to access and are not collected in every GTEx individual. Furthermore, in non-GTEx studies, the accessibility of certain tissue types greatly limits the feasibility and scale of studies of multi-tissue expression. In this work, we developed multi-tissue imputation methods to impute gene expression in uncollected or inaccessible tissues. Via simulation studies, we showed that the proposed methods outperform existing imputation methods in multi-tissue expression imputation and that incorporating imputed expression data can improve power to detect phenotype-expression correlations. By analyzing data from nine selected tissue types in the GTEx pilot project, we demonstrated that harnessing expression quantitative trait loci (eQTLs) and tissue-tissue expression-level correlations can aid imputation of transcriptome data from uncollected GTEx tissues. More importantly, we showed that by using GTEx data as a reference, one can impute expression levels in inaccessible tissues in non-GTEx expression studies.	[Wang, Jiebiao; Pierce, Brandon L.; Gibbons, Robert D.; Chen, Lin S.] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [Gamazon, Eric R.; Cox, Nancy J.] Vanderbilt Univ, Dept Med, Div Med Genet, Nashville, TN 37232 USA; [Gamazon, Eric R.; Cox, Nancy J.] Vanderbilt Genet Inst, Nashville, TN 37232 USA; [Gamazon, Eric R.] Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Stranger, Barbara E.; Im, Hae Kyung; Nicolae, Dan L.] Univ Chicago, Med Genet Sect, Chicago, IL 60637 USA; [Stranger, Barbara E.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; Vanderbilt University; University of Amsterdam; University of Chicago; University of Chicago; University of Chicago	Chen, LS (corresponding author), Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA.	lchen@health.bsd.uchicago.edu	Wang, Jiebiao/I-1243-2019; Gamazon, Eric/I-6873-2018	Wang, Jiebiao/0000-0003-3828-4400; Gamazon, Eric/0000-0003-4204-8734; Pierce, Brandon/0000-0002-7829-952X; Nicolae, Dan/0000-0002-0918-4630; Stranger, Barbara/0000-0001-9021-7331	 [R01GM108711];  [R03CA174984];  [R01MH101820];  [U01HG007601]; NATIONAL CANCER INSTITUTE [R03CA174984] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101820] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the GTEx Consortium. J.W. is supported by R01GM108711. L.S.C. is supported by R01GM108711, R03CA174984, R01MH101820, and U01HG007601.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2017, CLASSIFICATION REGRE; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brock GN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-12; Celton M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-15; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Chhibber A., 2016, PHARMACOGENOMICS J; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Dimas AS, 2012, GENOME RES, V22, P2368, DOI 10.1101/gr.134981.111; Donner Y, 2012, NAT METHODS, V9, P1120, DOI [10.1038/NMETH.2207, 10.1038/nmeth.2207]; Elbein SC, 2012, AM J HUM GENET, V91, P466, DOI 10.1016/j.ajhg.2012.08.002; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; FRIEDMAN JH, 1977, IEEE T COMPUT, V26, P404, DOI 10.1109/TC.1977.1674849; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Keen JC, 2015, J PERS MED, V5, P22, DOI 10.3390/jpm5010022; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Li G., 2016, ARXIV13112948; Liao SG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0346-6; Liew AWC, 2011, BRIEF BIOINFORM, V12, P498, DOI 10.1093/bib/bbq080; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Pierce BL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004818; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Schadt EE, 2012, NAT GENET, V44, P603, DOI 10.1038/ng.2248; Sela RJ, 2012, MACH LEARN, V86, P169, DOI 10.1007/s10994-011-5258-3; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Stephan J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8432; Stouffer S.A., 1949, STUDIES SOCIAL PSYCH, V1; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Torres JM, 2014, AM J HUM GENET, V95, P521, DOI 10.1016/j.ajhg.2014.10.001; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; TUKEY JW, 1949, BIOMETRICS, V5, P232, DOI 10.2307/3001938; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951	40	26	26	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					697	708		10.1016/j.ajhg.2016.02.020	http://dx.doi.org/10.1016/j.ajhg.2016.02.020			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27040689	Green Published, Bronze			2022-12-18	WOS:000374203800008
J	Shamseldin, H; Alazami, AM; Manning, M; Hashem, A; Caluseiu, O; Tabarki, B; Esplin, E; Schelley, S; Innes, AM; Parboosingh, JS; Lamont, R; Majewski, J; Bernier, FP; Alkuraya, FS				Shamseldin, Hanan; Alazami, Anas M.; Manning, Melanie; Hashem, Amal; Caluseiu, Oana; Tabarki, Brahim; Esplin, Edward; Schelley, Susan; Innes, A. Micheil; Parboosingh, Jillian S.; Lamont, Ryan; Majewski, Jacek; Bernier, Francois P.; Alkuraya, Fowzan S.		Care4Rare Canada Consortium	RTTN Mutations Cause Primary Microcephaly and Primordial Dwarfism in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONSANGUINEOUS FAMILIES; CILIA; IDENTIFICATION; DISORDERS; ROTATIN; PROTEIN; BRAIN; FLUID; FLOW	Primary microcephaly is a developmental brain anomaly that results from defective proliferation of neuroprogenitors in the germinal periventricular zone. More than a dozen genes are known to be mutated in autosomal-recessive primary microcephaly in isolation or in association with a more generalized growth deficiency (microcephalic primordial dwarfism), but the genetic heterogeneity is probably more extensive. In a research protocol involving autozygome mapping and exome sequencing, we recruited a multiplex consanguineous family who is affected by severe microcephalic primordial dwarfism and tested negative on clinical exome sequencing. Two candidate autozygous intervals were identified, and the second round of exome sequencing revealed a single intronic variant therein (c.2885+8A>G[p.Ser963*] in RTTN exon 23). RT-PCR confirmed that this change creates a cryptic splice donor and thus causes retention of the intervening 7 bp of the intron and leads to premature truncation. On the basis of this finding, we reanalyzed the exome file of a second consanguineous family affected by a similar phenotype and identified another homozygous change in RTTN as the likely causal mutation. Combined linkage analysis of the two families confirmed that RTTN maps to the only significant linkage peak. Finally, through international collaboration, a Canadian multiplex family affected by microcephalic primordial dwarfism and biallelic mutation of RTTN was identified. Our results expand the phenotype of RTTN-related disorders, hitherto limited to polymicrogyria, to include microcephalic primordial dwarfism with a complex brain phenotype involving simplified gyration.	[Shamseldin, Hanan; Alazami, Anas M.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Manning, Melanie] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Manning, Melanie; Esplin, Edward; Schelley, Susan] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Hashem, Amal; Tabarki, Brahim] Prince Sultan Mil Med City, Dept Pediat, Riyadh 11159, Saudi Arabia; [Caluseiu, Oana] Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2R3, Canada; [Innes, A. Micheil; Parboosingh, Jillian S.; Lamont, Ryan; Bernier, Francois P.] Univ Calgary, Dept Med Genet, Calgary, AB T2N 1N4, Canada; [Innes, A. Micheil; Lamont, Ryan; Bernier, Francois P.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB T2N 1N4, Canada; [Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G4, Canada; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Stanford University; Stanford University; Prince Sultan Military Medical City; University of Alberta; University of Calgary; Alberta Childrens Hospital; University of Calgary; McGill University; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	innes, allan micheil/A-9955-2017; Bernier, Francois/V-7150-2018; Bernier, Francois/AAP-2174-2020; Esplin, Ed/AAL-2226-2021	Bernier, Francois/0000-0001-7063-4269; Esplin, Edward/0000-0001-9205-3756; Innes, Micheil/0000-0001-9881-5467; Alhashem, Amal/0000-0002-9668-7809	King Salman Center for Disability; Genome Canada	King Salman Center for Disability; Genome Canada(Genome Canada)	We thank the families for their enthusiastic participation and Salma Wakil, Dorota Monies, and the genotyping and sequencing core facilities at the King Faisal Specialist Hospital and Research Center for their invaluable help. This work was supported by a King Salman Center for Disability Research Grant (to F.S.A.). Part of this work was performed by the Care4Rare Canada Consortium (funded by Genome Canada), the Canadian Institutes of Health Research, the Ontario Genomics Institute, Ontario Research Fund, Genome Quebec, and Children's Hospital of Eastern Ontario Research Foundation. We acknowledge the contribution of the high-throughput sequencing platform of the McGill University and Genome Quebec Innovation Centre.	Al-Dosari MS, 2010, J MED GENET, V47, P411, DOI 10.1136/jmg.2009.076646; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Alkuraya F. S., 2012, CURR PROTOC HUM GENE; Alkuraya FS, 2015, CURR OPIN ENDOCRINOL, V22, P55, DOI 10.1097/MED.0000000000000121; Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Awad S, 2013, HUM MOL GENET, V22, P2200, DOI 10.1093/hmg/ddt072; Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Ben-Omran T, 2015, AM J MED GENET A, V167, P2478, DOI 10.1002/ajmg.a.37175; Bernier FP, 2012, AM J HUM GENET, V90, P925, DOI 10.1016/j.ajhg.2012.04.004; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Chang B., 2007, GENEREVIEWS; Chatterjee B, 2007, MAMM GENOME, V18, P310, DOI 10.1007/s00335-007-9023-7; Faden M, 2015, AM J HUM GENET, V97, P608, DOI 10.1016/j.ajhg.2015.08.007; Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4; Faisst AM, 2002, MECH DEVELOP, V113, P15, DOI 10.1016/S0925-4773(02)00003-5; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; Hu WF, 2014, NEURON, V84, P1240, DOI 10.1016/j.neuron.2014.12.017; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kia SK, 2012, AM J HUM GENET, V91, P533, DOI 10.1016/j.ajhg.2012.07.008; Klingseisen A, 2011, GENE DEV, V25, P2011, DOI 10.1101/gad.169037; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Stevens NR, 2009, J CELL BIOL, V187, P355, DOI 10.1083/jcb.200905031; Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043; Yavarna T, 2015, HUM GENET, V134, P967, DOI 10.1007/s00439-015-1575-0	29	26	27	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					862	868		10.1016/j.ajhg.2015.10.012	http://dx.doi.org/10.1016/j.ajhg.2015.10.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26608784	Bronze, Green Published			2022-12-18	WOS:000368437900008
J	Shinwari, JMA; Khan, A; Awad, S; Shinwari, Z; Alaiya, A; Alanazi, M; Tahir, A; Poizat, C; Al Tassan, N				Shinwari, Jameela M. A.; Khan, Arif; Awad, Salma; Shinwari, Zakia; Alaiya, Ayodele; Alanazi, Mohamad; Tahir, Asma; Poizat, Coralie; Al Tassan, Nada			Recessive Mutations in COL25A1 Are a Cause of Congenital Cranial Dysinnervation Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROTUBULE DYNAMICS; KIF21A MUTATIONS; CLAC BINDS; FIBROSIS; GENE; BETA; PROTEIN; PRECURSOR; PEPTIDES; SEQUENCE	Abnormal ocular motility is a common clinical feature in congenital cranial dysinnervation disorder (CCDD). To date, eight genes related to neuronal development have been associated with different CCDD phenotypes. By using linkage analysis, candidate gene screening, and exome sequencing, we identified three mutations in collagen, type XXV, alpha 1 (COL25A1) in individuals with autosomal-recessive inheritance of CCDD ophthalmic phenotypes. These mutations affected either stability or levels of the protein. We further detected altered levels of sAPP (neuronal protein involved in axon guidance and synaptogenesis) and TUBB3 (encoded by TUBB3, which is mutated in CFEOM3) as a result of null mutations in COL25A1. Our data suggest that lack of COL25A1 might interfere with molecular pathways involved in oculomotor neuron development, leading to CCDD phenotypes.	[Shinwari, Jameela M. A.; Khan, Arif; Tahir, Asma; Al Tassan, Nada] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Res Ctr, Riyadh 11211, Saudi Arabia; [Khan, Arif] King Khalid Eye Specialist Hosp, Div Pediat Ophthalmol, Riyadh 11462, Saudi Arabia; [Awad, Salma; Poizat, Coralie] King Faisal Specialist Hosp & Res Ctr, Cardiovasc Res Program, Res Ctr, Riyadh 11211, Saudi Arabia; [Shinwari, Zakia; Alaiya, Ayodele] King Faisal Specialist Hosp & Res Ctr, Stem Cell & Tissue Engn Program, Res Ctr, Riyadh 11211, Saudi Arabia; [Alanazi, Mohamad] King Saud Univ, Genome Res Chair, Riyadh 11451, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Khaled Eye Specialist Hospital; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Saud University	Al Tassan, N (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Res Ctr, POB 3354, Riyadh 11211, Saudi Arabia.	naltassan@kfshrc.edu.sa	Tassan, Nada Al/K-5605-2019	Tassan, Nada Al/0000-0001-9076-0334; Mahmoud, Salma/0000-0003-1475-9483	KFSHRC (RAC) [2080020]; KKESH [0424-P]	KFSHRC (RAC); KKESH	The authors would like to thank Dorota Moniez and the sequencing core facility members for their help in DNA sequencing and Salma Wakil and the genotyping core facility members for their help in genotyping. We would like to thank Bashayer AlMubarak for her valuable input. This work was approved and funded by KFSHRC (RAC # 2080020) and KKESH (0424-P).	Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Bosley TM, 2005, NEUROLOGY, V64, P1196, DOI 10.1212/01.WNL.0000156349.01765.2B; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Cederquist GY, 2012, HUM MOL GENET, V21, P5484, DOI 10.1093/hmg/dds393; Chung M, 2000, OPHTHALMOLOGY, V107, P500, DOI 10.1016/S0161-6420(99)00090-1; Doherty EJ, 1999, INVEST OPHTH VIS SCI, V40, P1687; Engle EC, 1997, AM J HUM GENET, V60, P1150; Engle EC, 1997, ANN NEUROL, V41, P314, DOI 10.1002/ana.410410306; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Gutowski N J, 2003, Neuromuscul Disord, V13, P573, DOI 10.1016/S0960-8966(03)00043-9; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; HOTCHKISS MG, 1980, ARCH OPHTHALMOL-CHIC, V98, P870, DOI 10.1001/archopht.1980.01020030864013; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Kakuyama H, 2005, BIOCHEMISTRY-US, V44, P15602, DOI 10.1021/bi051263e; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Khan A.O., 2014, OPHTHALMIC GENET, P1; Khan AO, 2011, MOL VIS, V17, P218; Khan AO, 2009, OPHTHALMIC GENET, V30, P206, DOI 10.3109/13816810903183613; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; MacKinnon S, 2014, OPHTHALMOLOGY, V121, P1461, DOI 10.1016/j.ophtha.2014.01.006; McMullan TFW, 2002, HUM GENET, V110, P244, DOI 10.1007/s00439-002-0679-5; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Nakano M, 2001, NAT GENET, V29, P315, DOI 10.1038/ng744; Osada Y, 2005, J BIOL CHEM, V280, P8596, DOI 10.1074/jbc.M413340200; Parmar AS, 2012, BIOPOLYMERS, V97, P795, DOI 10.1002/bip.22070; Qu C, 2013, J CELL SCI, V126, P3070, DOI 10.1242/jcs.122184; Rama N, 2012, J BIOL CHEM, V287, P30014, DOI 10.1074/jbc.M111.324780; Tanaka T, 2014, J NEUROSCI, V34, P1370, DOI 10.1523/JNEUROSCI.2440-13.2014; Tischfield MA, 2005, NAT GENET, V37, P1035, DOI 10.1038/ng1636; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261; Yamada K, 2004, INVEST OPHTH VIS SCI, V45, P2218, DOI 10.1167/iovs.03-1413; Yang Ming-ming, 2013, Mol Vis, V19, P986	36	26	29	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					147	152		10.1016/j.ajhg.2014.11.006	http://dx.doi.org/10.1016/j.ajhg.2014.11.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25500261	Green Published, Bronze			2022-12-18	WOS:000347707800011
J	Sun, XQ; Elston, R; Morris, N; Zhu, XF				Sun, Xiangqing; Elston, Robert; Morris, Nathan; Zhu, Xiaofeng			What Is the Significance of Difference in Phenotypic Variability across SNP Genotypes?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VARIANCE HETEROGENEITY; LOCI; PERFORMANCE; SELECTION; TESTS	We studied the general problem of interpreting and detecting differences in phenotypic variability among the genotypes at a locus, from both a biological and a statistical point of view. The scales on which we measure interval-scale quantitative traits are man-made and have little intrinsic biological relevance. Before claiming a biological interpretation for genotype differences in variance, we should be sure that no monotonic transformation of the data can reduce or eliminate these differences. We show theoretically that for an autosomal diallelic SNP, when the three corresponding means are distinct so that the variance can be expressed as a quadratic function of the mean, there implicitly exists a transformation that will tend to equalize the three variances; we also demonstrate how to find a transformation that will do this. We investigate the validity of Bartlett's test, Box's modification of it, and a modified Levene's test to test for differences in variances when normality does not hold. We find that, although they may detect differences in variability, these tests do not necessarily detect differences in variance. The same is true for permutation tests that use these three statistics.	[Sun, Xiangqing; Elston, Robert; Morris, Nathan; Zhu, Xiaofeng] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Case Western Reserve University	Elston, R (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	robert.elston@cwru.edu	Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X; Morris, Nathan/0000-0001-7989-5764	U.S. Public Health Service grants from the National Heart, Lung, and Blood Institute [HL086718]; U.S. Public Health Service grants from the National Human Genome Research Institute [HG003054, U01HG006382]; National Research Foundation of Korea; Korean Government [NRF-2011-220-C00004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086718] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006382, R01HG003054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES027306] Funding Source: NIH RePORTER	U.S. Public Health Service grants from the National Heart, Lung, and Blood Institute; U.S. Public Health Service grants from the National Human Genome Research Institute; National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by U.S. Public Health Service grants from the National Heart, Lung, and Blood Institute (HL086718) and the National Human Genome Research Institute (HG003054 and U01HG006382) and by a National Research Foundation of Korea grant funded by the Korean Government (NRF-2011-220-C00004).	BARTLETT MS, 1947, BIOMETRICS, V3, P39, DOI 10.2307/3001536; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; BOX GEP, 1953, BIOMETRIKA, V40, P318, DOI 10.1093/biomet/40.3-4.318; FAIN PR, 1978, ANN HUM GENET, V42, P109, DOI 10.1111/j.1469-1809.1978.tb00935.x; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; JINKS JL, 1973, HEREDITY, V30, P33, DOI 10.1038/hdy.1973.4; MERAT P, 1968, BIOMETRICS, V24, P277, DOI 10.2307/2528035; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Parra-Frutos I, 2009, COMPUTATION STAT, V24, P671, DOI 10.1007/s00180-009-0154-z; Satagopan JM, 2013, STAT MED, V32, P1164, DOI 10.1002/sim.5628; Struchalin MV, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-92; Struchalin MV, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-4; Wang XF, 2010, HUM HERED, V70, P269, DOI 10.1159/000321967; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401	14	26	26	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					390	397		10.1016/j.ajhg.2013.06.017	http://dx.doi.org/10.1016/j.ajhg.2013.06.017			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23910463	Green Published, Bronze			2022-12-18	WOS:000323186200019
J	Elbein, SC; Gamazon, ER; Das, SK; Rasouli, N; Kern, PA; Cox, NJ				Elbein, Steven C.; Gamazon, Eric R.; Das, Swapan K.; Rasouli, Neda; Kern, Philip A.; Cox, Nancy J.			Genetic Risk Factors for Type 2 Diabetes: A Trans-Regulatory Genetic Architecture?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; FASTING GLUCOSE; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; COMMON VARIANTS; BETA-CELL; EXPRESSION; MTNR1B; METAANALYSIS	To date, 68 loci have been associated with type 2 diabetes (T2D) or glucose homeostasis traits. We report here the results of experiments aimed at functionally characterizing the SNPs replicated for T2D and glucose traits. We sought to determine whether these loci were associated with transcript levels in adipose, muscle, liver, lymphocytes, and pancreatic beta-cells. We found an excess of trans, rather than cis, associations among these SNPs in comparison to what was expected in adipose and muscle. Among transcripts differentially expressed (FDR < 0.05) between muscle or adipose cells of insulin-sensitive individuals and those of insulin-resistant individuals (matched on BMI), trans-regulated transcripts, in contrast to the cis-regulated ones, were enriched. The paucity of cis associations with transcripts was confirmed in a study of liver transcriptome and was further supported by an analysis of the most detailed transcriptome map of pancreatic p-cells. Relative to location- and allele-frequency-matched random SNPs, both the 68 loci and top T2D-associated SNPs from two large-scale genome-wide studies were enriched for trans eQTLs in adipose and muscle but not in lymphocytes. Our study suggests that T2D SNPs have broad-reaching and tissue-specific effects that often extend beyond local transcripts and raises the question of whether patterns of cis or trans transcript regulation are a key feature of the architecture of complex traits.	[Gamazon, Eric R.; Cox, Nancy J.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Elbein, Steven C.; Das, Swapan K.] Wake Forest Sch Med, Sect Endocrinol & Metab, Dept Internal Med, Winston Salem, NC 27157 USA; [Rasouli, Neda] Univ Colorado, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA; [Rasouli, Neda] Eastern Colorado Vet Hlth Care Syst, Denver, CO 80220 USA; [Kern, Philip A.] Univ Kentucky, Sch Med, Div Endocrinol, Dept Internal Med, Lexington, KY 40536 USA; [Kern, Philip A.] Univ Kentucky, Sch Med, Barnstable Brown Diabet & Obes Ctr, Lexington, KY 40536 USA	University of Chicago; Wake Forest University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Kentucky; University of Kentucky	Cox, NJ (corresponding author), Univ Chicago, Dept Med, Med Genet Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ncox@bsd.uchicago.edu	Gamazon, Eric/I-6873-2018	Gamazon, Eric/0000-0003-4204-8734; Rasouli, Neda/0000-0003-1269-3580; Das, Swapan/0000-0002-2197-8855	National Institutes of Health [DK039311, DK80327, DK71349, U01 HL084715, P60 DK20595, U01 DK085501, U01 GM61393, R01 MH090937]; VA merit grant; Sturgis Foundation; Research Service of the Department of Veterans Affairs; National Center for Research Resources [1UL1RR029884]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001998, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085501, R29DK039311, R01DK071349, R01DK039311, R01DK080327, P60DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA merit grant; Sturgis Foundation; Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants DK039311 (S.C.E. and S.K.D.), DK80327 (P.A.K.), DK71349 (P.A.K.), U01 HL084715 (N.J.C.), P60 DK20595 (N.J.C.), U01 DK085501 (N.J.C.), U01 GM61393 (N.J.C.), R01 MH090937 (N.J.C.); VA merit grant (N.R.); a generous grant from the Sturgis Foundation to the University of Arkansas for Medical Sciences (UAMS); and the Research Service of the Department of Veterans Affairs. The project was supported in part by award number 1UL1RR029884 to UAMS from the National Center for Research Resources. We thank the dedicated staff of the Clinical Research Center at UAMS for support of the clinical studies and assistance with data management. We also acknowledge technical assistance from Neeraj K. Sharma and Kurt A. Langberg for the extraction, quality control, and management of DNA and RNA samples used in this study.	Below JE, 2011, DIABETOLOGIA, V54, P2047, DOI 10.1007/s00125-011-2188-3; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Maneka N, 2010, CURR OPIN LIPIDOL, V21, P44, DOI 10.1097/MOL.0b013e328334fdb6; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Parikh H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-72; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	39	26	28	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					466	477		10.1016/j.ajhg.2012.08.002	http://dx.doi.org/10.1016/j.ajhg.2012.08.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22958899	Bronze, Green Published			2022-12-18	WOS:000308683100007
J	Elding, H; Lau, W; Swallow, DM; Maniatis, N				Elding, Heather; Lau, Winston; Swallow, Dallas M.; Maniatis, Nikolas			Dissecting the Genetics of Complex Inheritance: Linkage Disequilibrium Mapping Provides Insight into Crohn Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; LD MAPS; METAANALYSIS; NOD2; MANIFESTATIONS; REPLICATION	Family studies for Crohn disease (CD) report extensive linkage on chromosome 16q and pinpoint NOD2 as a possible causative locus. However, linkage is also observed in families that do not bear the most frequent NOD2 causative mutations, but no other signals on 16q have been found so far in published genome-wide association studies. Our aim is to identify this missing genetic contribution. We apply a powerful genetic mapping approach to the Wellcome Trust Case-Control Consortium and the National Institute of Diabetes and Digestive and Kidney Diseases genome-wide association data on CD. This method takes into account the underlying structure of linkage disequilibrium (LD) by using genetic distances from LD maps and provides a location for the causal agent. We find genetic heterogeneity within the NOD2 locus and also show an independent and unsuspected involvement of the neighboring gene, CYLD. We find associations with the IRF8 region and the region containing CDH1 and CDH3, as well as substantial phenotypic and genetic heterogeneity for CD itself. The genes are known to be involved in inflammation and immune dysregulation. These findings provide insight into the genetics of CD and suggest promising directions for understanding disease heterogeneity. The application of this method thus paves the way for understanding complex inheritance in general, leading to the dissection of different pathways and ultimately, personalized treatment.	[Elding, Heather; Lau, Winston; Swallow, Dallas M.; Maniatis, Nikolas] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England	University of London; University College London	Maniatis, N (corresponding author), UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England.	n.maniatis@ucl.ac.uk		Lau, Winston/0000-0001-5501-4619; Maniatis, Nikolas/0000-0002-6567-5936	Wellcome Trust; NIDDK	Wellcome Trust(Wellcome TrustEuropean Commission); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are very grateful to the Wellcome Trust, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, USA), and the International HapMap Project for making their invaluable data available to the scientific community. The data from the Wellcome Trust Case-Control Consortium (WTCCC, UK) was funded by the Wellcome Trust. A full list of the investigators who contributed to the generation of the data is available on the WTCCC website. The NIDDK IBD Genetics Consortium Crohn Disease GWAS was conducted by Judy H. Cho (Yale University), Steven Brant (Johns Hopkins University), Richard Duerr (University of Pittsburgh), Huiying Yang (Cedars-Sinai Medical Center), John Rioux (University of Montreal), and Mark Silverberg (University of Toronto), with support from the NIDDK. This manuscript was not prepared in collaboration with the labs of any of the investigators responsible for generating the data and does not necessarily reflect the views or opinions of these investigators or the NIDDK. The datasets used were obtained from the database of Genotypes and Phenotypes (dbGaP) under accession number phs000130. We thank Newton E. Morton (University of Southampton) and Steve Jones (UCL) for their useful comments and suggestions.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andrew T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000220; Ardizzone S, 2008, DIGEST LIVER DIS, V40, pS253, DOI 10.1016/S1590-8658(08)60534-4; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014466; Goode DL, 2010, GENOME RES, V20, P301, DOI 10.1101/gr.102210.109; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hugot JP, 2007, AM J GASTROENTEROL, V102, P1259, DOI 10.1111/j.1572-0241.2007.01149.x; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Lau W, 2007, BIOINFORMATICS, V23, P517, DOI 10.1093/bioinformatics/btl615; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li LC, 2000, CANCER RES, V60, P873; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Maniatis N, 2005, HUM MOL GENET, V14, P145, DOI 10.1093/hmg/ddi019; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; Maniatis N, 2007, GENET EPIDEMIOL, V31, P179, DOI 10.1002/gepi.20199; Milicic A, 2008, CANCER RES, V68, P7760, DOI 10.1158/0008-5472.CAN-08-0020; Morton NE, 2001, P NATL ACAD SCI USA, V98, P5217, DOI 10.1073/pnas.091062198; Need AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r7; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Tapper W, 2005, P NATL ACAD SCI USA, V102, P11835, DOI 10.1073/pnas.0505262102; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; van Heel DA, 2003, HUM MOL GENET, V12, P2569, DOI 10.1093/hmg/ddg281; Villani AC, 2010, GASTROENTEROLOGY, V138, P1502, DOI 10.1053/j.gastro.2009.12.049; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	44	26	26	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					798	805		10.1016/j.ajhg.2011.11.006	http://dx.doi.org/10.1016/j.ajhg.2011.11.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22152681	Bronze, Green Published			2022-12-18	WOS:000298208700012
J	Palomares, M; Delicado, A; Mansilla, E; de Torres, ML; Vallespin, E; Fernandez, L; Martinez-Glez, V; Garcia-Minaur, S; Nevado, J; Simarro, FS; Ruiz-Perez, VL; Lynch, SA; Sharkey, FH; Thuresson, AC; Anneren, G; Belligni, EF; Martinez-Fernandez, ML; Bermejo, E; Nowakowska, B; Kutkowska-Kazmierczak, A; Bocian, E; Obersztyn, E; Martinez-Frias, ML; Hennekam, RCM; Lapunzina, P				Palomares, Maria; Delicado, Alicia; Mansilla, Elena; Luisa de Torres, Maria; Vallespin, Elena; Fernandez, Luis; Martinez-Glez, Victor; Garcia-Minaur, Sixto; Nevado, Julian; Santos Simarro, Fernando; Ruiz-Perez, Victor L.; Lynch, Sally Ann; Sharkey, Freddie H.; Thuresson, Ann-Charlotte; Anneren, Goran; Belligni, Elga F.; Luisa Martinez-Fernandez, Maria; Bermejo, Eva; Nowakowska, Beata; Kutkowska-Kazmierczak, Anna; Bocian, Ewa; Obersztyn, Ewa; Luisa Martinez-Frias, Maria; Hennekam, Raoul C. M.; Lapunzina, Pablo			Characterization of a 8q21.11 Microdeletion Syndrome Associated with Intellectual Disability and a Recognizable Phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERSTITIAL DELETION; LONG ARM; TRANSLOCATION; CHROMOSOME-8; ANOMALIES; PROTEIN; PTOSIS	We report eight unrelated individuals with intellectual disability and overlapping submicroscopic deletions of 8q21.11 (0.66-13.55 Mb in size). The deletion was familial in one and simplex in seven individuals. The phenotype was remarkably similar and consisted of a round face with full cheeks, a high forehead, ptosis, cornea opacities, an underdeveloped alae, a short philtrum, a cupid's bow of the upper lip, down-turned corners of the mouth, micrognathia, low-set and prominent ears, and mild finger and toe anomalies (camptodactyly, syndactyly, and broadening of the first rays). Intellectual disability, hypotonia, decreased balance, sensorineural hearing loss, and unusual behavior were frequently observed. A high-resolution oligonucleotide array showed different proximal and distal breakpoints in all of the individuals. Sequencing studies in three of the individuals revealed that proximal and distal breakpoints were located in unique sequences with no apparent homology. The smallest region of overlap was a 539.7 kb interval encompassing three genes: a Zinc Finger Homeobox 4 (ZFHX4), one microRNA of unknown function, and one nonfunctional pseudogen. ZFHX4 encodes a transcription factor expressed in the adult human brain, skeletal muscle, and liver. It has been suggested as a candidate gene for congenital bilateral isolated ptosis. Our results suggest that the 8q21.11 submicroscopic deletion represents a clinically recognizable entity and that a haploinsufficient gene or genes within the minimal deletion region could underlie this syndrome.	[Palomares, Maria; Vallespin, Elena; Martinez-Glez, Victor; Nevado, Julian] Hosp Univ La Paz, Inst Invest Sanitaria IdiPAZ, Inst Genet Med & Mol INGEMM, Sect Funct & Struct Genom, Madrid 28046, Spain; [Palomares, Maria; Delicado, Alicia; Mansilla, Elena; Luisa de Torres, Maria; Vallespin, Elena; Fernandez, Luis; Martinez-Glez, Victor; Garcia-Minaur, Sixto; Nevado, Julian; Santos Simarro, Fernando; Ruiz-Perez, Victor L.; Luisa Martinez-Fernandez, Maria; Bermejo, Eva; Luisa Martinez-Frias, Maria; Lapunzina, Pablo] Inst Salud Carlos III, CIBERER, Madrid 28029, Spain; [Delicado, Alicia; Mansilla, Elena; Luisa de Torres, Maria; Fernandez, Luis; Garcia-Minaur, Sixto; Santos Simarro, Fernando; Lapunzina, Pablo] Hosp Univ La Paz, IdiPAZ, INGEMM, Madrid 28046, Spain; [Ruiz-Perez, Victor L.] UAM, CSIC, Inst Invest Biomed IIB Madrid, Madrid 28046, Spain; [Lynch, Sally Ann] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin 12, Ireland; [Sharkey, Freddie H.] Western Gen Hosp, Cytogenet Lab, Microarray Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Thuresson, Ann-Charlotte; Anneren, Goran] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Belligni, Elga F.] Univ Turin, Dept Pediat, I-10124 Turin, Italy; [Luisa Martinez-Fernandez, Maria; Bermejo, Eva; Luisa Martinez-Frias, Maria] ISCIII, ECEMC, Madrid 28029, Spain; [Bermejo, Eva; Luisa Martinez-Frias, Maria] ISCIII, IIER, Madrid 28029, Spain; [Nowakowska, Beata; Kutkowska-Kazmierczak, Anna; Bocian, Ewa; Obersztyn, Ewa] Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland; [Nowakowska, Beata] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Ctr Human Genet, B-3000 Louvain, Belgium; [Hennekam, Raoul C. M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1100 DD Amsterdam, Netherlands	Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitario La Paz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University of Edinburgh; Uppsala University; University of Turin; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER); KU Leuven; University Hospital Leuven; University of Amsterdam; Academic Medical Center Amsterdam	Palomares, M (corresponding author), Hosp Univ La Paz, Inst Invest Sanitaria IdiPAZ, Inst Genet Med & Mol INGEMM, Sect Funct & Struct Genom, Madrid 28046, Spain.	mpalomares.hulp@salud.madrid.org	Ruiz-Perez, Victor L/K-6066-2014; Martinez-Glez, Victor/E-2344-2011; Vallespin, Elena/E-5277-2018; Kutkowska-Kaźmierczak, Anna/X-6011-2018; BERMEJO-SANCHEZ, EVA/E-8703-2012; Maria Luisa, Martinez-Fernandez/AAX-3569-2021; nevado, julian/ADX-5844-2022; Santos-Simarro, Fernando/L-3063-2014; Lapunzina, Pablo/L-7075-2014	Ruiz-Perez, Victor L/0000-0003-0635-3619; Martinez-Glez, Victor/0000-0002-4680-881X; Vallespin, Elena/0000-0002-8080-8629; Kutkowska-Kaźmierczak, Anna/0000-0001-5295-7363; BERMEJO-SANCHEZ, EVA/0000-0001-7282-2714; Maria Luisa, Martinez-Fernandez/0000-0001-8615-0226; nevado, julian/0000-0001-5611-2659; Palomares-Bralo, Maria/0000-0002-2727-7654; Lynch, Sally Ann/0000-0003-3540-1333; Obersztyn, Ewa/0000-0002-3044-9517; Santos-Simarro, Fernando/0000-0002-1201-9118; Thuresson, Ann-Charlotte/0000-0002-4018-5551; Lapunzina, Pablo/0000-0002-6324-4825	Fondo de Investigaciones Sanitarias of the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion of Spain [PI081187]	Fondo de Investigaciones Sanitarias of the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We would like to thank all the individuals and families for their participation in this study. This work was supported by a grant from the Fondo de Investigaciones Sanitarias (PI081187) of the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion of Spain.	Belligni EF, 2010, EUR J MED GENET, V53, P192, DOI 10.1016/j.ejmg.2010.03.009; DALLAPICCOLA B, 1977, HUM GENET, V38, P125, DOI 10.1007/BF00527393; DONAHUE ML, 1995, AM J MED GENET, V56, P97, DOI 10.1002/ajmg.1320560122; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; FRYBURG JS, 1993, AM J MED GENET, V45, P638, DOI 10.1002/ajmg.1320450524; Hemmi K, 2006, BIOL PHARM BULL, V29, P1830, DOI 10.1248/bpb.29.1830; HITTNER HM, 1981, ARCH OPHTHALMOL-CHIC, V99, P1977, DOI 10.1001/archopht.1981.03930020853008; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; McMullan TFW, 2002, HUM GENET, V110, P244, DOI 10.1007/s00439-002-0679-5; Nakashima M, 2008, J HUM GENET, V53, P34, DOI 10.1007/s10038-007-0214-6; Nogami S, 2005, J COMP NEUROL, V482, P33, DOI 10.1002/cne.20382; Nowakowska B, 2008, AM J MED GENET A, V146A, P2361, DOI 10.1002/ajmg.a.32475; Slavotinek AM, 2008, HUM GENET, V124, P1, DOI 10.1007/s00439-008-0513-9; TAYSI K, 1979, HUM GENET, V51, P49, DOI 10.1007/BF00278291	14	26	29	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					295	301		10.1016/j.ajhg.2011.06.012	http://dx.doi.org/10.1016/j.ajhg.2011.06.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21802062	Green Published, Bronze			2022-12-18	WOS:000294148800009
J	Rosa-Rosa, JM; Pita, G; Urioste, M; Llort, G; Brunet, J; Lazaro, C; Blanco, I; Cajal, TRY; Diez, O; de la Hoya, M; Caldes, T; Tejada, MI; Gonzalez-Neira, A; Beniitez, J				Manuel Rosa-Rosa, Juan; Pita, Guillermo; Urioste, Miguel; Llort, Gemma; Brunet, Joan; Lazaro, Conxi; Blanco, Ignacio; Ramon y Cajal, Teresa; Diez, Orland; de la Hoya, Miguel; Caldes, Trinidad; Tejada, Maria-Isabel; Gonzalez-Neira, Anna; Benitez, Javier			Genome-wide Linkage Scan Reveals Three Putative Breast-Cancer-Susceptibility Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL BREAST; OVARIAN-CANCER; BRCA2 GENES; TUMORS; RISK	Despite all the research efforts made during the last few decades, most of the cases of families with breast cancer remain unexplained. Mutations in BRCA1 and BRCA2, and in other breast-cancer-susceptibility genes, account for about 25% of familial breast cancer. Linkage studies have failed to identify other breast-cancer-susceptibility genes. The selection criteria of the families, differences in the population background, or clinical and genetic heterogeneity, among other factors, might determine the power to detect the linkage signal. We have performed a SNP-based linkage scan with a total of 6000 SNP markers across the genome in 41 breast-cancer Spanish families, with an average of four breast-cancer cases per family not associated with BRCA1 or BRCA2 germline mutations. In addition, we have included three BRCA-positive families to test the power in linkage detection from a low-complexity family in which a high-penetrance mutation segregates. We have identified three regions of interest, located oil 3q25, 6q24, and 21q22. The two former regions showed a suggestive linkage signal (HLOD) scores 3,01 and 2.26, respectively), and the latter region showed a significant linkage signal (HLOD score 3.55). Moreover, we found that a subset of 13 families with bilateral breast cancer presented a HLOD of 3.13 on the 3q25 region. Our results suggest that several variables must be taken into account before performing a linkage study in familial breast cancer because of the high heterogeneity within non-BRCA1/2 families. Phenotypic and geographic homogeneity could be the most important factors.	[Pita, Guillermo; Gonzalez-Neira, Anna; Benitez, Javier] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Genotyping Unit CeGen, Madrid 28029, Spain; [Llort, Gemma; Lazaro, Conxi; Blanco, Ignacio] IDIBELL, Inst Catala Oncol, Lab Recerca Translac, Barcelona 08907, Spain; [Brunet, Joan; Ramon y Cajal, Teresa] Hosp Santa Creu & Sant Pau, Serv Oncol, Barcelona 08025, Spain; [Diez, Orland] Hosp Univ Vall Hebron, Lab Oncogenet, Barcelona 08035, Spain; [de la Hoya, Miguel; Caldes, Trinidad] Hosp Univ Vall Hebron, Lab Oncogenet, Barcelona 08035, Spain; [Tejada, Maria-Isabel] Hosp Cruces, Mol Genet Lab, Barakaldo Bizkala 48903, Spain; [Benitez, Javier] Ctr Invest Enfermedades Raras CIBERER, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Hospital of Santa Creu i Sant Pau; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitario Cruces; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Beniitez, J (corresponding author), Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Genotyping Unit CeGen, Madrid 28029, Spain.	jbenitez@cnio.es	Blanco, Ignacio/AAN-5426-2021; GARCIA, CONXI LAZARO/Q-2410-2016; Gonzalez-Neira, Anna/C-5791-2015; Blanco, Ignacio/D-2565-2013; Hereditario, Cancer/E-3311-2012; de la Hoya, MIguel/Z-2911-2019; M Isabel, Tejada/E-2394-2012; TEJADA, Maria-Isabel/O-5051-2019; Brunet, Joan/C-5292-2018	Blanco, Ignacio/0000-0002-7414-7481; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Gonzalez-Neira, Anna/0000-0002-5421-2020; Blanco, Ignacio/0000-0002-7414-7481; TEJADA, Maria-Isabel/0000-0002-7334-1864; diez, orland/0000-0001-7339-0570; Brunet, Joan/0000-0003-1945-3512; de la Hoya, Miguel/0000-0002-8113-1410	Ministerio de Educacion y Ciencia [FPU AP-2005-1720]; Fondo de Investigaciones Sanitarias [FIS-04-2240, FIS 05/0864, PI-081120]; Carlos III Health Institute [RD06/0020/1060, RD06/0020/1051]; Catalan Health Institute and Autonomous Government of Catalonia [2005SGR00018]; Asociacion Espanola Contra el Cancer; Centre of Biomedical Research on Rare Disease (CIBERER)	Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Carlos III Health Institute(Instituto de Salud Carlos III); Catalan Health Institute and Autonomous Government of Catalonia(Generalitat de Catalunya); Asociacion Espanola Contra el Cancer; Centre of Biomedical Research on Rare Disease (CIBERER)	We thank Emilio Gonzalez and Charo Alonso from the CeGen Unit at the Spanish National Cancer Research Centre and Victoria Fernandez for their technical support. We also thank Ana Osorio, Roger Milne, and Lorenzo Melchor from the Human Genetics Group for their scientific support and advice. We want to thank Emily Hodges from Cold Spring Harbor Laboratory for the English grammatical review and her useful corrections. JMRR grant sponsor was Ministerio de Educacion y Ciencia, FPU AP-2005-1720. This study has been funded by projects FIS-04-2240, FIS 05/0864, and PI-081120 from the Fondo de Investigaciones Sanitarias, RD06/0020/1060 and RD06/0020/1051 from Carlos III Health Institute, 2005SGR00018 from Catalan Health Institute and Autonomous Government of Catalonia, and by the Asociacion Espanola Contra el Cancer and the Centre of Biomedical Research on Rare Disease (CIBERER). The authors declare no conflict of interest.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Bergman A, 2007, GENE CHROMOSOME CANC, V46, P302, DOI 10.1002/gcc.20405; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; EASTON DF, 1993, AM J HUM GENET, V52, P678; Gonzalez-Neira A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-299; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Honrado E, 2005, J CLIN ONCOL, V23, P7503, DOI 10.1200/JCO.2005.01.3698; Huusko P, 2004, EUR J HUM GENET, V12, P98, DOI 10.1038/sj.ejhg.5201091; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1997, AM J HUM GENET, V61, P254; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Melchor L, 2008, ONCOGENE, V27, P3165, DOI 10.1038/sj.onc.1210975; Milne RL, 2006, CANCER RES, V66, P9420, DOI 10.1158/0008-5472.CAN-06-1418; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Murray SS, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S85; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Oldenburg RA, 2006, CLIN CANCER RES, V12, P1693, DOI 10.1158/1078-0432.CCR-05-2230; Osorio A, 2000, BRIT J CANCER, V82, P1266, DOI 10.1054/bjoc.1999.1089; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Smith P, 2006, GENE CHROMOSOME CANC, V45, P646, DOI 10.1002/gcc.20330; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thompson D, 2002, P NATL ACAD SCI USA, V99, P827, DOI 10.1073/pnas.012584499	27	26	26	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					115	122		10.1016/j.ajhg.2008.12.013	http://dx.doi.org/10.1016/j.ajhg.2008.12.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19147119	Bronze, Green Published			2022-12-18	WOS:000263799700003
J	Muers, MR; Sharpe, JA; Garrick, D; Sloane-Stanley, J; Nolan, PM; Hacker, T; Wood, WG; Higgs, DR; Gibbons, RJ				Muers, Mary R.; Sharpe, Jacqueline A.; Garrick, David; Sloane-Stanley, Jacqueline; Nolan, Patrick M.; Hacker, Terry; Wood, William G.; Higgs, Douglas R.; Gibbons, Richard J.			Defining the cause of skewed X-chromosome inactivation in X-linked mental retardation by use of a mouse model	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATR-X; GENETIC-CONTROL; YOLK-SAC; PROTEIN; MICE; CELLS; HEMATOPOIESIS; METHYLATION; MUTATIONS; CHIMERAS	Extreme skewing of X-chromosome inactivation (XCI) is rare in the normal female population but is observed frequently in carriers of some X-linked mutations. Recently, it has been shown that various forms of X-linked mental retardation (XLMR) have a strong association with skewed XCI in female carriers, but the mechanisms underlying this skewing are unknown. ATR-X syndrome, caused by mutations in a ubiquitously expressed, chromatin-associated protein, provides a clear example of XLMR in which phenotypically normal female carriers virtually all have highly skewed XCI biased against the X chromosome that harbors the mutant allele. Here, we have used a mouse model to understand the processes causing skewed XCI. In female mice heterozygous for a null Atrx allele, we found that XCI is balanced early in embryogenesis but becomes skewed over the course of development, because of selection favoring cells expressing the wild-type Atrx allele. Unexpectedly, selection does not appear to be the result of general cellular-viability defects in Atrx-deficient cells, since it is restricted to specific stages of development and is not ongoing throughout the life of the animal. Instead, there is evidence that selection results from independent tissue-specific effects. This illustrates an important mechanism by which skewed XCI may occur in carriers of XLMR and provides insight into the normal role of ATRX in regulating cell fate.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; MRC, Mammalian Genet Unit, Didcot, Oxon, England	University of Oxford; MRC Harwell	Gibbons, RJ (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England.	richard.gibbons@imm.ox.ac.uk	GARRICK, David/O-5734-2019; Garrick, David/F-1728-2017; Nolan, Patrick/W-3918-2019; Gibbons, Richard/E-6937-2011	GARRICK, David/0000-0001-7422-7986; Garrick, David/0000-0001-7422-7986; Nolan, Patrick/0000-0001-5550-0334; Gibbons, Richard/0000-0002-7680-9311; Higgs, Douglas/0000-0003-3579-8705	MRC [MC_UP_1502/1, MC_U137961147, MC_U137961145, MC_U142684173] Funding Source: UKRI; Medical Research Council [MC_U142684173, MC_UP_1502/1, MC_U137961145, MC_U137961147] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALLEN RC, 1994, AM J HUM GENET, V54, P25; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Belmont JW, 1996, AM J HUM GENET, V58, P1101; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Berube NG, 2000, HUM MOL GENET, V9, P539, DOI 10.1093/hmg/9.4.539; Brown CJ, 2000, CLIN GENET, V58, P353, DOI 10.1034/j.1399-0004.2000.580504.x; CATTANACH BM, 1967, GENETICS, V57, P331; Chadwick LH, 2005, MAMM GENOME, V16, P691, DOI 10.1007/s00335-005-0059-2; Chadwick LH, 2006, GENETICS, V173, P2103, DOI 10.1534/genetics.105.054882; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Crosby JR, 1998, NAT GENET, V18, P385, DOI 10.1038/ng0498-385; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; GECZ J, 1994, HUM MOL GENET, V3, P39, DOI 10.1093/hmg/3.1.39; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; GIBBONS RJ, 2004, INBORN ERRORS DEV; HENDRIKS RW, 1992, CLIN GENET, V42, P114; Higgs DR, 2005, POSTGRADUATE HAEMATOLOGY, 5TH EDITION, P13, DOI 10.1002/9780470987056.ch2; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; McGrath KE, 2005, EXP HEMATOL, V33, P1021, DOI 10.1016/j.exphem.2005.06.012; McGrath KE, 2003, BLOOD, V101, P1669, DOI 10.1182/blood-2002-08-2531; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nagy A, 2001, INT J DEV BIOL, V45, P577; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Picketts DJ, 1998, MAMM GENOME, V9, P400, DOI 10.1007/s003359900781; Plenge RM, 2002, AM J HUM GENET, V71, P168, DOI 10.1086/341123; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380611; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Rossant J, 1998, TRENDS GENET, V14, P358, DOI 10.1016/S0168-9525(98)01552-2; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; SPIVAK JL, 1973, BLOOD, V42, P257, DOI 10.1182/blood.V42.2.257.257; STAYTON CL, 1994, HUM MOL GENET, V3, P1957, DOI 10.1093/hmg/3.11.1957; Tam PPL, 2003, DEVELOPMENT, V130, P6155, DOI 10.1242/dev.00893; WEATHERALL DJ, 1981, NEW ENGL J MED, V305, P607, DOI 10.1056/NEJM198109103051103; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	46	26	26	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1138	1149		10.1086/518369	http://dx.doi.org/10.1086/518369			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503331	Green Published, Bronze			2022-12-18	WOS:000246553800012
J	Sarquis, MS; Agrawal, S; Shen, L; Pilarski, R; Zhou, XP; Eng, C				Sarquis, Marta S.; Agrawal, Shipra; Shen, Lei; Pilarski, Robert; Zhou, Xiao-Ping; Eng, Charis			Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME PLEASE STAND; BREAST-CANCER; GENE-EXPRESSION; MESSENGER-RNAS; HUMAN-DISEASE; PHOSPHORYLATION; PHOSPHATASE; SPECTRUM; MUTATION; TISSUES	Cowden syndrome ( CS) and Bannayan-Riley-Ruvalcaba syndrome ( BRRS) are autosomal dominant hamartoma syndromes. Germline PTEN mutations have been associated with 85% of CS cases and 65% of BRRS cases and also with other disorders, which are collectively referred to as the "PTEN hamartoma tumor syndrome." The human PTEN gene has been previously found to express two naturally occurring splice variants ( SVs). Recently, we identified eight novel naturally occurring PTEN SVs that result in different downstream signaling effects: SV3a, SV3b, SV3c ( inclusion of various lengths of intron 3 3' of exon 3), SV5a, SV5b, SV5c, SV5d ( inclusion of various lengths of intron 5 3' of exon 5), and SV Delta Ex6 ( deletion of exon 6). We therefore sought to characterize the relative expression of 5', middle, and 3' full-length PTEN mRNA ( FL-PTEN) and also of these eight PTEN SVs in 85 ( 65 female and 20 male) patients with CS/BRRS ( with or without PTEN mutations) compared with 27 controls, using a SYBR green quantitative polymerase chain reaction method. Significantly reduced FL-PTEN levels were found in the probands, compared with those of controls (). Apart from P < .01 FL-PTEN, SV3a is the most consistently relatively underexpressed in patients compared with controls. The patients showed relative underexpression of SV3a and SV3b and overexpression of SV5b (,, and, respectively). P = .005 P = .02 P = .04 Indeed, there appears to be an SV expressional genotype-phenotype correlation in which the SV expressional profiles are distinct among CS, CS-like, and BRRS. The reduced FL-PTEN transcript expression, associated with differential expression of PTEN SVs, regardless of PTEN mutation status, supports the concept that modulation of PTEN inactivation may also occur at the transcription level influencing the specific phenotypes seen in these syndromes.	Cleveland Clin Fdn, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH USA; Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH USA; Ohio State Univ, Sch Publ Hlth, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Ohio State Univ, Sch Publ Hlth, Div Epidemiol & Biomet, Columbus, OH 43210 USA; Univ Fed Minas Gerais, Fac Med, Bolsista CNPq, Belo Horizonte, MG, Brazil	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; Ohio State University; Ohio State University; Universidade Federal de Minas Gerais	Eng, C (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Genom Med Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	engc@ccf.org	Soares, Maria Marta Sarquis/H-6174-2012; Pilarski, Robert/X-3256-2019; Pilarski, Robert/E-3871-2011	Soares, Maria Marta Sarquis/0000-0002-0847-7060; Eng, Charis/0000-0002-3693-5145				Agrawal S, 2006, HUM MOL GENET, V15, P777, DOI 10.1093/hmg/ddi492; Agrawal S, 2005, HUM MOL GENET, V14, P2459, DOI 10.1093/hmg/ddi246; Bartel F, 2004, MOL CANCER RES, V2, P29; Bracco L, 2003, TRENDS BIOTECHNOL, V21, P346, DOI 10.1016/S0167-7799(03)00146-X; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Hsieh HF, 1999, J CLIN PATHOL-MOL PA, V52, P25, DOI 10.1136/mp.52.1.25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; Pilarski R, 2004, J MED GENET, V41, P323, DOI 10.1136/jmg.2004.018036; Poola I, 2001, J STEROID BIOCHEM, V78, P459, DOI 10.1016/S0960-0760(01)00118-2; Sharrard RM, 2000, BBA-GENE STRUCT EXPR, V1494, P282, DOI 10.1016/S0167-4781(00)00210-4; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Wang NM, 1999, INT J MOL MED, V3, P491; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Zhang LN, 2004, MOL CELL BIOCHEM, V262, P25, DOI 10.1023/B:MCBI.0000038212.78008.7f; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109	24	26	27	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					23	30		10.1086/504392	http://dx.doi.org/10.1086/504392			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773562	Bronze, Green Published			2022-12-18	WOS:000238341200003
J	Myers, RH				Myers, RH			Considerations for genomewide association studies in Parkinson disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Boston University	Myers, RH (corresponding author), Boston Univ, Sch Med, Dept Neurol, E-304,715 Albany St, Boston, MA 02118 USA.	rmyers@bu.edu		Myers, Richard/0000-0002-8365-2674				Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Dekker MCJ, 2003, BRAIN, V126, P1722, DOI 10.1093/brain/awg172; Farrer MJ, 2006, AM J HUM GENET, V78, P1084, DOI 10.1086/504728; Goris A, 2006, AM J HUM GENET, V78, P1088, DOI 10.1086/504726; Li YH, 2006, AM J HUM GENET, V78, P1090, DOI 10.1086/504725; Maher NE, 2002, AM J MED GENET, V109, P191, DOI 10.1002/ajmg.10335; Maraganore DM, 2005, NEUROLOGY, V64, P408, DOI 10.1212/01.WNL.0000152585.76852.9C; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	9	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					1081	1082						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685659				2022-12-18	WOS:000237553800018
J	Knapp, M; Becker, T				Knapp, M; Becker, T			Impact of genotyping errors on type I error rate of the haplotype-sharing transmission/disequilibrium test (HS-TDT)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53105 Bonn, Germany	University of Bonn	Knapp, M (corresponding author), Univ Bonn, Inst Med Biometry Informat & Epidemiol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	knapp@uni-bonn.de		Becker, Tim/0000-0002-6573-1109				BECKER T, IN PRESS GENET EPIDE; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Gordon D, 1999, HUM HERED, V49, P65, DOI 10.1159/000022846; Zhang SL, 2003, AM J HUM GENET, V73, P566, DOI 10.1086/378205	4	26	27	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					589	591		10.1086/382287	http://dx.doi.org/10.1086/382287			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14973788	Bronze, Green Published			2022-12-18	WOS:000220118500029
J	Yasuda, M; Shabbeer, J; Osawa, M; Desnick, RJ				Yasuda, M; Shabbeer, J; Osawa, M; Desnick, RJ			Fabry disease: Novel alpha-galactosidase A 3 '-terminal mutations result in multiple transcripts due to aberrant 3 '-end formation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYADENYLATION SIGNAL MUTATION; MESSENGER-RNA; CHROMOSOMAL LOCALIZATION; NUCLEOTIDE-SEQUENCE; ATYPICAL VARIANT; GENE; EUKARYOTES; THALASSEMIA; TRANSLATION; MECHANISM	Mutations in the gene that encodes the lysosomal exoglycohydrolase, alpha-galactosidase A (alpha-GalA), cause Fabry disease, an X-linked recessive inborn error of glycosphingolipid catabolism. Human alpha-GalA is one of the rare mammalian genes that has its polyadenylation signal in the coding sequence and lacks a 3' untranslated region (UTR). We identified two novel frameshift mutations, 1277delAA (del2) and 1284delACTT (del4), in unrelated men with classical Fabry disease. Both mutations occurred in the 3' terminus of the coding region and obliterated the termination codon, and del2 also altered the polyadenylation signal. To characterize these mutations, 3' rapid amplification of cDNA ends ( RACE) and polymerase chain reactions (PCR) were performed, and the amplicons were subcloned and sequenced. Both mutations generated multiple transcripts with various lengths of 3' terminal sequences, some elongating similar to1 kb. Mutant transcripts were classified as follows: type I transcripts had terminal in-frame thymidines that created termination codons when polyadenylated, type II had downstream termination codons within the elongated alpha-GalA sequence, and type III, the most abundant, lacked termination codons at their 3' ends. To determine if the type III transcripts were degraded by the recently described cytosolic messenger RNA degradation pathway for messages lacking termination codons, northern blot analysis was performed. However, the finding of similar levels of nuclear and cytoplasmic alpha-GalA mRNA in normal and patient lymphoblasts suggested that mRNA degradation did not result from either mutation. Expression of representative transcript types revealed differences in intracellular localization and/or protein stability and catalytic activity, with most mutant proteins being nonfunctional. Characterization of these 3' mutations identified a novel molecular mechanism causing classical Fabry disease.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Tokyo Womens Med Univ, Dept Pediat, Tokyo, Japan	Icahn School of Medicine at Mount Sinai; Tokyo Women's Medical University	Desnick, RJ (corresponding author), Mt Sinai Sch Med, Dept Human Genet, 1425 Madison Ave,Box 14-98, New York, NY 10029 USA.	rjdesnick@mssm.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034045] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000071, 5M01 RR 00071] Funding Source: Medline; NICHD NIH HHS [5P30 HD 28822] Funding Source: Medline; NIDDK NIH HHS [R37 DK034045, R37 DK 34045] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; [Anonymous], 2014, METABOLIC MOL BASES; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bennett CL, 2001, IMMUNOGENETICS, V53, P435, DOI 10.1007/s002510100358; BISHOP DF, 1988, P NATL ACAD SCI USA, V85, P3903, DOI 10.1073/pnas.85.11.3903; BISHOP DF, 1986, P NATL ACAD SCI USA, V83, P4859, DOI 10.1073/pnas.83.13.4859; CHEN F, 1995, NUCLEIC ACIDS RES, V23, P2614, DOI 10.1093/nar/23.14.2614; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; ECKNER R, 1991, EMBO J, V10, P3513, DOI 10.1002/j.1460-2075.1991.tb04915.x; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; HARTEVELD CL, 1994, BRIT J HAEMATOL, V87, P139, DOI 10.1111/j.1365-2141.1994.tb04883.x; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Hsu AP, 2000, AM J HUM GENET, V67, P50; Huang YQ, 1996, MOL CELL BIOL, V16, P1534; Ioannou YA, 1998, BIOCHEM J, V332, P789, DOI 10.1042/bj3320789; KORNREICH R, 1989, NUCLEIC ACIDS RES, V17, P3301, DOI 10.1093/nar/17.8.3301; MARCHUK D, 1985, P NATL ACAD SCI USA, V82, P1609, DOI 10.1073/pnas.82.6.1609; MYOHANEN S, 1991, DNA CELL BIOL, V10, P467, DOI 10.1089/dna.1991.10.467; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; ORKIN SH, 1985, EMBO J, V4, P453, DOI 10.1002/j.1460-2075.1985.tb03650.x; PITTLER SJ, 1990, GENOMICS, V6, P272, DOI 10.1016/0888-7543(90)90567-E; Preiss T, 1998, NATURE, V392, P516, DOI 10.1038/33192; RUND D, 1992, P NATL ACAD SCI USA, V89, P4324, DOI 10.1073/pnas.89.10.4324; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Shabbeer J, 2002, MOL GENET METAB, V76, P23, DOI 10.1016/S1096-7192(02)00012-4; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	29	26	40	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					162	173		10.1086/376608	http://dx.doi.org/10.1086/376608			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12796853	Green Published, Bronze			2022-12-18	WOS:000183904900014
J	Stead, JDH; Jeffreys, AJ				Stead, JDH; Jeffreys, AJ			Structural analysis of insulin minisatellite alleles reveals unusually large differences in diversity between Africans and non-Africans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN LIPOPROTEIN-LIPASE; HUMAN MITOCHONDRIAL-DNA; HUMAN-EVOLUTION; DIABETES SUSCEPTIBILITY; NUCLEOTIDE DIVERSITY; HAPLOTYPE STRUCTURE; SEQUENCE VARIATION; GENE; POPULATION; REGION	The insulin minisatellite (INS VNTR) associates with susceptibility to a variety of diseases. We have developed a high-resolution system for analyzing variant repeat distributions applicable to all known minisatellite alleles, irrespective of size, which allows lineages of related alleles to be identified. This system has previously revealed extremely low structural diversity in the minisatellite among northern Europeans from the United Kingdom, with all alleles belonging to one of only three highly diverged lineages called "I," "IIIA," and "IIIB." To explore the origins of this remarkably limited lineage diversity, we have characterized an additional 780 alleles from three non-African and three African populations. In total, 22 highly diverged lineages were identified, with structural intermediates absent from extant populations, suggesting a bottleneck within the ancestry of all humans. The difference between levels of diversity in Africans and non-Africans is unusually large, with all 22 lineages identified in Africa compared with only three lineages seen not only in the United Kingdom but also in the other non-African populations. We also find evidence for overrepresentation of lineage I chromosomes in non-Africans. These data are consistent with a common out-of-Africa origin and an unusually tight bottleneck within the ancestry of all non-African populations, possibly combined with differential and positive selection for lineage I alleles in non-Africans. The important implications of these data for future disease-association studies are discussed.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Jeffreys, AJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.		Stead, John/X-8500-2018	Stead, John/0000-0002-5726-6809				Alonso S, 2001, P NATL ACAD SCI USA, V98, P864, DOI 10.1073/pnas.011244998; Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHANG F, 1995, HUM GENET, V98, P91; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; CrouauRoy B, 1996, HUM MOL GENET, V5, P1131, DOI 10.1093/hmg/5.8.1131; DEKA R, 1995, ELECTROPHORESIS, V16, P1659, DOI 10.1002/elps.11501601275; Doria A, 1996, DIABETOLOGIA, V39, P594, DOI 10.1007/s001250050483; Dunger DB, 1998, NAT GENET, V19, P98, DOI 10.1038/ng0598-98; Eaves IA, 1999, NAT GENET, V22, P324, DOI 10.1038/11890; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EXCOFFIER L, 1992, GENETICS, V131, P479; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; Feldman MW, 1997, GENETICS, V145, P207; Fullerton SM, 2000, MOL BIOL EVOL, V17, P179, DOI 10.1093/oxfordjournals.molbev.a026230; Gilad Y, 2002, P NATL ACAD SCI USA, V99, P862, DOI 10.1073/pnas.022614799; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; Jeffreys AJ, 1998, EMBO J, V17, P4147, DOI 10.1093/emboj/17.14.4147; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V57, P523; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; KRAWCZAK M, 1991, HUM GENET, V86, P425; Le Stunff C, 2001, NAT GENET, V29, P96, DOI 10.1038/ng707; LI WH, 1991, GENETICS, V129, P513; Mateu E, 2001, AM J HUM GENET, V68, P103, DOI 10.1086/316940; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Nakajima T, 2002, AM J HUM GENET, V70, P108, DOI 10.1086/338454; Nauta MJ, 1996, GENETICS, V143, P1021; Nei M., 1987, MOL EVOLUTIONARY GEN; Relethford JH, 1999, AM J PHYS ANTHROPOL, V108, P251; SCHNEIDER S, 2000, ARLEQUIN GENETICS BI; Seielstad M, 1999, GENOME RES, V9, P558; SEINO S, 1992, MOL BIOL EVOL, V9, P193; Stead JDH, 2000, HUM MOL GENET, V9, P2929, DOI 10.1093/hmg/9.20.2929; Stead JDH, 2000, HUM MOL GENET, V9, P713, DOI 10.1093/hmg/9.5.713; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Todorova A, 1997, HUM MUTAT, V9, P537; Vega A, 2001, ANN HUM GENET, V65, P351, DOI 10.1017/S0003480001008752; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Waterworth DM, 1997, LANCET, V349, P986, DOI 10.1016/S0140-6736(96)08368-7	54	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1273	1284		10.1086/344513	http://dx.doi.org/10.1086/344513			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12404181	Green Published, Bronze			2022-12-18	WOS:000179586800002
J	Herrnstadt				Herrnstadt			Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups (vol 70, pg 1152, 2002)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction																		Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933	2	26	26	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					448	449						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE					2022-12-18	WOS:000176977700028
J	Edelmann, L; Dong, JL; Desnick, RJ; Kornreich, R				Edelmann, L; Dong, JL; Desnick, RJ; Kornreich, R			Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ABNORMAL TRANSPORT; GENE; MUTATIONS; DISEASE; IDENTIFICATION	Mutations in the MCOLN1 gene cause mucolipidosis type IV (MLIV), a severely debilitating, autosomal recessive, lysosomal storage disorder. Approximately 80% of patients with MLIV are of Ashkenazi Jewish (AJ) descent, and two mutations, IVS3-2A-->G and 511del6434, account for >95% of the mutant alleles in this population. To determine the carrier frequencies of these two mutations, 2,029 anonymous, unrelated, unaffected AJ individuals from the greater New York metropolitan area were screened. A multiplex PCR method coupled with allele-specific oligonucleotide hybridization was developed, to enable large-scale screening. The frequencies of the IVS-32A-->G and 511del6434 mutations were 0.54% and 0.25%, respectively, for a combined carrier frequency of 0.79%, or 1 in 127 individuals (95% CI 0.40%-1.17%). The addition of both AJ mutations causing this neurodegenerative disorder should be considered for prenatal carrier screening in this population.	NYU, Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University	Kornreich, R (corresponding author), NYU, Mt Sinai Sch Med, Dept Human Genet, Box 1497,5th Ave & 100th St, New York, NY 10029 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034045] Funding Source: NIH RePORTER; NCRR NIH HHS [5M01 RR 00071, M01 RR000071] Funding Source: Medline; NICHD NIH HHS [5P30 HD 28822] Funding Source: Medline; NIDDK NIH HHS [R37 DK034045, R37 DK 34045] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMIR N, 1987, PEDIATRICS, V79, P953; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bargal R, 1997, J INHERIT METAB DIS, V20, P625, DOI 10.1023/A:1005362123443; Bargal R, 2001, HUM MUTAT, V17, P397, DOI 10.1002/humu.1115; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; BERMAN ER, 1974, J PEDIATR-US, V84, P519, DOI 10.1016/S0022-3476(74)80671-2; BEUTLER E, 2000, METABOLIC MOL BASES, P3635; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Diaz GA, 2000, AM J HUM GENET, V66, P1821, DOI 10.1086/302946; Dong JL, 2001, MOL GENET METAB, V73, P160, DOI 10.1006/mgme.2001.3182; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Li L, 1998, MOL GENET METAB, V64, P286, DOI 10.1006/mgme.1998.2733; Raas-Rothschild A, 1999, EUR J HUM GENET, V7, P496, DOI 10.1038/sj.ejhg.5200277; RIEDEL KG, 1985, AM J OPHTHALMOL, V99, P125, DOI 10.1016/0002-9394(85)90220-X; Shuber AP, 1995, GENOME RES, V5, P488, DOI 10.1101/gr.5.5.488; Slaugenhaupt SA, 1999, AM J HUM GENET, V65, P773, DOI 10.1086/302549; Somlo S, 2001, CURR BIOL, V11, pR356, DOI 10.1016/S0960-9822(01)00193-2; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Wang ZH, 2001, GENET TEST, V5, P87, DOI 10.1089/109065701753145529	19	26	27	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					1023	1027		10.1086/339519	http://dx.doi.org/10.1086/339519			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11845410	Bronze, Green Published			2022-12-18	WOS:000174252100020
J	Volcik, KA; Blanton, SH; Northrup, H				Volcik, KA; Blanton, SH; Northrup, H			Examinations of methylenetetrahydrofolate reductase C677T and A1298C mutations - and in utero viability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Univ Texas, Sch Med, Dept Pediat, Div Med Genet, Houston, TX 77030 USA; Univ Virginia, Dept Pediat, Charlottesville, VA USA	University of Texas System; University of Virginia	Northrup, H (corresponding author), Univ Texas, Sch Med, Dept Pediat, Div Med Genet, 6431 Fannin St, Houston, TX 77030 USA.		Blanton, Susan Halloran/ABF-1323-2021					Friedman G, 1999, J NUTR, V129, P1656, DOI 10.1093/jn/129.9.1656; Isotalo PA, 2000, AM J HUM GENET, V67, P986, DOI 10.1086/303082; Volcik KA, 2000, AM J MED GENET, V95, P21, DOI 10.1002/1096-8628(20001106)95:1<21::AID-AJMG6>3.0.CO;2-M; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714	4	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1150	1152		10.1086/324066	http://dx.doi.org/10.1086/324066			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11590551	Green Published, Bronze			2022-12-18	WOS:000171413400024
J	Kosaki, K; Shimasaki, N; Fukushima, H; Hara, M; Ogata, T; Matsuo, N				Kosaki, K; Shimasaki, N; Fukushima, H; Hara, M; Ogata, T; Matsuo, N			Female patient showing hypohidrotic ectodermal dysplasia and immunodeficiency (HED-ID)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							INCONTINENTIA PIGMENTI		Keio Univ, Sch Med, Dept Pediat, Div Med Genet,Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Pharmacia Fund Growth & Dev Res, Tokyo 1608582, Japan; Shimizu City Hosp, Shimizu, Shizuoka, Japan	Keio University; Keio University	Kosaki, K (corresponding author), Keio Univ, Sch Med, Dept Pediat, Div Med Genet,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kkosaki@sc.itc.keio.ac.jp		Ogata, Tsutomu/0000-0001-7178-9991				AKIYAMA M, 1994, J AM ACAD DERMATOL, V30, P831, DOI 10.1016/S0190-9622(94)70090-7; Aradhya S, 2001, AM J HUM GENET, V68, P765, DOI 10.1086/318806; LANDY SJ, 1993, J MED GENET, V30, P53, DOI 10.1136/jmg.30.1.53; Parrish JE, 1996, HUM MOL GENET, V5, P1777, DOI 10.1093/hmg/5.11.1777; Smahi A, 2000, NATURE, V405, P466; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	6	26	28	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					664	665		10.1086/323003	http://dx.doi.org/10.1086/323003			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11484156	Bronze, Green Published			2022-12-18	WOS:000170271400020
J	Seielstad, M				Seielstad, M			Asymmetries in the maternal and paternal genetic histories of Colombian populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							MITOCHONDRIAL-DNA; HUMAN-EVOLUTION		Harvard Sch Publ Hlth, Program Populat Genet, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Seielstad, M (corresponding author), 665 Huntington Ave,FXB-101, Boston, MA 02115 USA.	mark@ppg.harvard.edu	Seielstad, Mark/T-7841-2019	Seielstad, Mark/0000-0001-5783-1401				CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; GARVAJALCARMONA LG, 2000, AM J HUM GENET, V67, P1287; Jorde L B, 2000, Science, V288, P1931; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kivisild T, 2000, Science, V288, P1931; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; NUNNEY L, 1991, P ROY SOC B-BIOL SCI, V246, P71, DOI 10.1098/rspb.1991.0126; NUNNEY L, 2000, SOCIAL STRUCTURES EF; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Sharma A, 2000, SCIENCE, V288, P977; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wilson JF, 2000, AM J HUM GENET, V67, P926, DOI 10.1086/303083	21	26	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1062	1066						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11023812				2022-12-18	WOS:000165091600003
J	Allison, DB; Fernandez, JR; Heo, M; Beasley, TM				Allison, DB; Fernandez, JR; Heo, M; Beasley, TM			Testing the robustness of the new Haseman-Elston quantitative-trait loci-mapping procedure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE	Variance components (VC) techniques have emerged as among the more powerful methods for detection of quantitative-trait loci (QTL) in linkage analysis. Allison et al. found that, with particularly marked leptokurtosis in the phenotypic distribution and moderate-to-high residual sibling correlation, maximum likelihood (ML) VC methods may produce a severe excess of type I errors. The new Haseman-Elston (NHE) method is a least-squares-based VC method for mapping of QTL in sib pairs (Elston et al.). Using simulation, we investigate the robustness of the NHE to marked nonnormality, by means of the same distributions and worst-case conditions identified by Allison et al. for the ML approach (i.e., 100 pairs; high residual sibling correlation). Results showed that, when marked nonnormality is present, the NHE can be used without severe type I error-rate inflation, even at very small alpha levels.	Columbia Univ, St Lukes Roosevelt Hosp, Coll Phys & Surg, Obes Res Ctr,Inst Human Nutr, New York, NY 10025 USA; St Johns Univ, Dept Psychol, Queens, NY USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Saint John's University	Allison, DB (corresponding author), Columbia Univ, St Lukes Roosevelt Hosp, Coll Phys & Surg, Obes Res Ctr,Inst Human Nutr, 1090 Amsterdam Ave,14th Floor, New York, NY 10025 USA.			Allison, David/0000-0003-3566-9399; Heo, Moonseong/0000-0001-7711-1209	NIDDK NIH HHS [DK26687, DK47256, P30 DK026687, DK51716] Funding Source: Medline; NIEHS NIH HHS [R01 ES009912] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK047256, P30DK026687, R01DK051716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Allison DB, 1997, BEHAV GENET, V27, P401, DOI 10.1023/A:1025696232582; AMOS CI, 1993, GENET EPIDEMIOL, V10, P671, DOI 10.1002/gepi.1370100657; Dolan CV, 1998, BEHAV GENET, V28, P197, DOI 10.1023/A:1021423214032; ELSTON RC, IN PRESS GENET EPIDE; EVANS M, 1996, STAT DISTRIBUTIONS, P92; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; POONI HS, 1976, HEREDITY, V36, P215, DOI 10.1038/hdy.1976.26; *SAS I, 1998, SAS REL 7 0; SAWILOWSKY SS, 1992, PSYCHOL BULL, V111, P352, DOI 10.1037/0033-2909.111.2.352; Schork N J, 1996, Stat Methods Med Res, V5, P155, DOI 10.1177/096228029600500204; Wilcox RR, 1998, AM PSYCHOL, V53, P300, DOI 10.1037/0003-066X.53.3.300	12	26	26	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					249	252		10.1086/302966	http://dx.doi.org/10.1086/302966			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10820126	Green Published, Bronze			2022-12-18	WOS:000088926900029
J	Hejna, JA; Timmers, CD; Reifsteck, C; Bruun, DA; Lucas, LW; Jakobs, PM; Toth-Fejel, S; Unsworth, N; Clemens, SL; Garcia, DK; Naylor, SL; Thayer, MJ; Olson, SB; Grompe, M; Moses, RE				Hejna, JA; Timmers, CD; Reifsteck, C; Bruun, DA; Lucas, LW; Jakobs, PM; Toth-Fejel, S; Unsworth, N; Clemens, SL; Garcia, DK; Naylor, SL; Thayer, MJ; Olson, SB; Grompe, M; Moses, RE			Localization of the fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FUNCTIONAL COMPLEMENTATION; ARTIFICIAL CHROMOSOME; TUMOR-SUPPRESSOR; FRAGILE SITE; CELL-LINES; CLONING; DNA; EXPRESSION; MAPS; MICE	Fanconi anemia (FA) is a rare autosomal recessive disease manifested by bone-marrow failure and an elevated incidence of cancer. Cells taken from patients exhibit spontaneous chromosomal breaks and rearrangements. These breaks and rearrangements are greatly elevated by treatment of FA cells with the use of DNA cross-linking agents. The FA complementation group D gene (FANCD) has previously been localized to chromosome 3p22-26, by use of microcell-mediated chromosome transfer. Here we describe the use of noncomplemented microcell hybrids to identify small overlapping deletions that narrow the FANCD critical region. A 1.2-Mb bacterial-artificial-chromosome (BAC)/P1 contig was constructed, bounded by the marker D3S3631 distally and by the gene ATP2B2 proximally. The contig contains at least 36 genes, including the oxytocin receptor (OXTR), hOGG1, the von Hippel-Lindau tumor-suppressor gene (VHL), and IRAK-2. Both hOGG1 and IRAK-2 were excluded as candidates for FANCD. BACs were then used as probes for FISH analyses, to map the extent of the deletions in four of the noncomplemented microcell hybrid cell lines. A narrow region of common overlapping deletions limits the FANCD critical region to similar to 200 kb. The three candidate genes in this region are TIGR-A004X28, SGC34603, and AA609512.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Texas, Hlth Sci Ctr, Dept Cell & Struct Biol, San Antonio, TX USA	Oregon Health & Science University; Oregon Health & Science University; University of Texas System; University of Texas Health San Antonio	Moses, RE (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, 3181 SW Sam Jackson Pk Rd,Mail Code L103, Portland, OR 97201 USA.			Grompe, Markus/0000-0002-6616-4345	NCI NIH HHS [CA56626] Funding Source: Medline; NHGRI NIH HHS [HG00470] Funding Source: Medline; NHLBI NIH HHS [1PO1HL48546] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA056626] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048546] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000470] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aburatani H, 1997, CANCER RES, V57, P2151; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; BRANDT P, 1992, GENOMICS, V14, P484, DOI 10.1016/S0888-7543(05)80246-0; Carreau M, 1999, MUTAT RES-DNA REPAIR, V435, P103, DOI 10.1016/S0921-8777(99)00041-5; COHEN MM, 1982, AM J HUM GENET, V34, P794; Coquelle A, 1998, MOL CELL, V2, P259, DOI 10.1016/S1097-2765(00)80137-9; de Winter JP, 1998, NAT GENET, V20, P281, DOI 10.1038/3093; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Drumheller T, 1996, J MED GENET, V33, P842, DOI 10.1136/jmg.33.10.842; FOURNIER REK, 1981, P NATL ACAD SCI-BIOL, V78, P6349, DOI 10.1073/pnas.78.10.6349; Fullwood P, 1999, CANCER RES, V59, P4662; Gregorini A, 1996, GENE CHROMOSOME CANC, V17, P269; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Hejna JA, 1998, NUCLEIC ACIDS RES, V26, P1124, DOI 10.1093/nar/26.4.1124; Jakobs PM, 1996, SOMAT CELL MOLEC GEN, V22, P151, DOI 10.1007/BF02369905; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; Kim UJ, 1996, GENOMICS, V34, P213, DOI 10.1006/geno.1996.0268; KLOCKER H, 1985, EUR J CELL BIOL, V37, P240; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; KUZMIN I, 1994, CANCER RES, V54, P2486; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; MARTIN NJ, 1983, AM J MED GENET, V14, P767, DOI 10.1002/ajmg.1320140418; MERCER WE, 1979, EXP CELL RES, V120, P417, DOI 10.1016/0014-4827(79)90403-8; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOUSTACCHI E, 1985, HUM GENET, V70, P236; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; PHIPPS ME, 1994, HUM MOL GENET, V3, P903, DOI 10.1093/hmg/3.6.903; PORFIRIO B, 1991, HUM GENET, V86, P256; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; SAITO H, 1993, MUTAT RES, V294, P255, DOI 10.1016/0921-8777(93)90008-5; SBRANA I, 1995, CANCER GENET CYTOGEN, V82, P123, DOI 10.1016/0165-4608(95)00020-P; Schmidt HH, 1998, CANCER GENET CYTOGEN, V104, P82, DOI 10.1016/S0165-4608(97)00453-6; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; SZYMANSKI SC, 1993, HUM GENET, V92, P282; THOMPSON KA, 1994, BIOCHEM BIOPH RES CO, V198, P1143, DOI 10.1006/bbrc.1994.1162; TRASK BJ, 1991, AM J HUM GENET, V48, P1; Waisfisz Q, 1999, AM J HUM GENET, V64, P1400, DOI 10.1086/302385; WEKSBERG R, 1979, J CELL PHYSIOL, V101, P311, DOI 10.1002/jcp.1041010211; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; Whitney MA, 1996, BLOOD, V88, P49	49	26	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1540	1551		10.1086/302896	http://dx.doi.org/10.1086/302896			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762542	Bronze, Green Published			2022-12-18	WOS:000088373700008
J	Drayna, D; Kilshaw, J; Kelly, J				Drayna, D; Kilshaw, J; Kelly, J			The sex ratio in familial persistent stuttering	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Natl Inst Deafness & Other Commun Disorders, NIH, Rockville, MD 20850 USA; Hollins Commun Res Inst, Roanoke, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Drayna, D (corresponding author), Natl Inst Deafness & Other Commun Disorders, NIH, 5 Res Court, Rockville, MD 20850 USA.				PHS HHS [ZO1-00046-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ambrose NG, 1997, J SPEECH LANG HEAR R, V40, P567, DOI 10.1044/jslhr.4003.567; Bloodstein O., 1995, HDB STUTTERING; Felsenfeld S, 1997, J SPEECH LANG HEAR R, V40, P778, DOI 10.1044/jslhr.4004.778; HOWIE PM, 1981, J SPEECH HEAR RES, V24, P317, DOI 10.1044/jshr.2403.317; JANSSEN P, 1993, J FLUENCY DISORD, V21, P105; KIDD KK, 1981, P NATL ACAD SCI-BIOL, V78, P606, DOI 10.1073/pnas.78.1.606; MELLON C, 1991, AM J HUM GENET, V49, P351; WEBSTER R, 1978, CONTROVERSIES STUTTE, P231; *WHO, 1992, ICD 10 INT STAT CLAS, P387; Yairi E, 1996, J SPEECH HEAR RES, V39, P771, DOI 10.1044/jshr.3904.771	10	26	31	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1473	1475		10.1086/302625	http://dx.doi.org/10.1086/302625			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	252YZ	10521318	Green Published, Bronze			2022-12-18	WOS:000083531000034
J	Sertie, AL; Sousa, AV; Steman, S; Pavanello, RC; Passos-Bueno, MR				Sertie, AL; Sousa, AV; Steman, S; Pavanello, RC; Passos-Bueno, MR			Linkage analysis in a large Brazilian family with van der Woude syndrome suggests the existence of a susceptibility locus for cleft palate at 17p11.2-11.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; VANDERWOUDE SYNDROME; INTERSTITIAL DELETION; FETAL HEMOGLOBIN; LIP; GENE; (17)(P11.2P11.2); DNA; MAP	van der Woude syndrome (VWS), which has been mapped to 1q32-41, is characterized by pits and/or sinuses of the lower lip, cleft lip/palate (CL/P), cleft palate (CP), bifid uvula, and hypodontia (H). The expression of VWS, which has incomplete penetrance, is highly variable. Both the occurrence of CL/P and CP within the same genealogy and a recurrence risk <40% for CP among descendants with VWS have suggested that the development of clefts in this syndrome is influenced by modifying genes at other loci. To test this hypothesis, we have conducted linkage analysis in a large Brazilian kindred with VWS, considering as affected the individuals with CP, regardless of whether it is associated with other clinical signs of VWS. Our results suggest that a gene at 17p11.2-11.1, together with the VWS gene at 1p32-41, enhances the probability of CP in an individual carrying the two at-risk genes. If this hypothesis is confirmed in other VWS pedigrees, it will represent one of the first examples of a gene, mapped through linkage analysis, which modifies the expression of a major gene. It will also have important implications for genetic counseling, particularly for more accurately predicting recurrence risks of clefts among the offspring of patients with VWS.	Univ Sao Paulo, Inst Biociencias, Dept Biol, BR-05508900 Sao Paulo, Brazil; Hosp Clin Sao Paulo, Dept Cirurg Plast, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Passos-Bueno, MR (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Biol, Rua Matao 277, BR-05508900 Sao Paulo, Brazil.		Sertie, Andrea Laurato/H-8312-2014; Passos-Bueno, Maria Rita/I-6796-2016	Sertie, Andrea Laurato/0000-0002-7453-0560; Passos-Bueno, Maria Rita/0000-0002-9248-3008				ARNHEIM N, 1985, P NATL ACAD SCI USA, V82, P6970, DOI 10.1073/pnas.82.20.6970; BURDICK AB, 1985, J CRAN GENET DEV BIO, V5, P181; CERVENKA J, 1967, AM J HUM GENET, V19, P416; CLEMENTI M, 1995, HUM HERED, V45, P157, DOI 10.1159/000154277; Craig JE, 1996, NAT GENET, V12, P58, DOI 10.1038/ng0196-58; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eeles R, 1997, AM J HUM GENET, V61, pA64; FARRALL M, 1992, AM J HUM GENET, V50, P270; FRASER FC, 1970, AM J HUM GENET, V22, P336; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HECHT JT, 1991, AM J HUM GENET, V49, P674; JANKU P, 1980, AM J MED GENET, V5, P117, DOI 10.1002/ajmg.1320050203; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARAZITA ML, 1992, AM J HUM GENET, V51, P648; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MESKIN LH, 1965, CLEFT PALATE J, V2, P40; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MURRAY JC, 1995, AM J HUM GENET, V57, P227, DOI 10.2134/agronj1965.00021962005700020028x; MURRAY JC, 1990, AM J HUM GENET, V46, P486; Pezzetti F, 1998, GENOMICS, V50, P299, DOI 10.1006/geno.1998.5273; SCHINZEL A, 1986, J MED GENET, V23, P291, DOI 10.1136/jmg.23.4.291; Schutte BC, 1996, GENOMICS, V36, P507, DOI 10.1006/geno.1996.0496; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SHPRINTZEN RJ, 1980, CLEFT PALATE J, V17, P52; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; THEIN SL, 1994, AM J HUM GENET, V54, P214; Wolf U, 1997, HUM GENET, V100, P305, DOI 10.1007/s004390050509	30	26	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					433	440		10.1086/302491	http://dx.doi.org/10.1086/302491			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417286	Green Published, Bronze			2022-12-18	WOS:000081836900019
J	Mishmar, D; Mandel-Gutfreund, Y; Margalit, H; Rahat, A; Kerem, B				Mishmar, D; Mandel-Gutfreund, Y; Margalit, H; Rahat, A; Kerem, B			Common fragile sites: G-band characteristics within an R-band	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DNA; CHROMOSOMES		Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Genet & Biotechnol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Kerem, B (corresponding author), Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel.		Margalit, Hanah/H-1651-2013; Mandel-Gutfreund, Yael/AAI-4365-2021; Mishmar, Dan/AAJ-6109-2020	Mandel-Gutfreund, Yael/0000-0002-8946-8237; Mishmar, Dan/0000-0003-3488-8792				Boldog F, 1997, HUM MOL GENET, V6, P193, DOI 10.1093/hmg/6.2.193; BURKHOLDER GD, 1991, CHROMOSOMA, V101, P11, DOI 10.1007/BF00360681; GARDINER K, 1995, CURR OPIN GENET DEV, V5, P315, DOI 10.1016/0959-437X(95)80045-X; Huang HJ, 1998, ONCOGENE, V16, P2311, DOI 10.1038/sj.onc.1200202; Inoue H, 1997, P NATL ACAD SCI USA, V94, P14584, DOI 10.1073/pnas.94.26.14584; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; SARAI A, 1989, BIOCHEMISTRY-US, V28, P7842, DOI 10.1021/bi00445a046; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; SUTHERLAND GR, 1995, CURR OPIN GENET DEV, V5, P323, DOI 10.1016/0959-437X(95)80046-8	10	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					908	910		10.1086/302299	http://dx.doi.org/10.1086/302299			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053029	Bronze, Green Published			2022-12-18	WOS:000079204700032
J	Anagnostopoulos, T; Green, PM; Rowley, G; Lewis, CM; Giannelli, F				Anagnostopoulos, T; Green, PM; Rowley, G; Lewis, CM; Giannelli, F			DNA variation in a 5-Mb region of the X chromosome and estimates of sex-specific/type-specific mutation rates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHEMICAL MISMATCH CLEAVAGE; HUMAN Y-CHROMOSOME; HUMAN-EVOLUTION; SEQUENCE VARIATION; POINT MUTATIONS; RECOMBINATION; INFERENCE; ANCESTRY; SAMPLES; GENOME	We describe a new approach for the study of human genome variation, based on our solid-phase fluorescence chemical mismatch-cleavage method. Multiplex screening rates greater than or equal to 80 kb/36-lane gels are achieved, and accuracy of mismatch location is within +/-2 bp. The density of differences between DNA from any two humans is sufficiently low and the estimate of their position is accurate enough, to avoid sequencing of most polymorphic sites when defining their allelic state. Furthermore, highly variable sequences, such as microsatellites, are distinguished easily, so that separate consideration can be given to loci that do and do not fit the definition of infinite mutation sites. We examined a 5-Mb region of Xq22 to define the haplotypes of 23 men (9 Europeans, 9 Ashkenazim, and 5 Pygmies) by reference to DNA from one Italian man. Fifty-eight 1.5-kb segments revealed 102 segregating sites. Seven of these-are shared by all three groups, two by Pygmies and Europeans, two by Pygmies and Ashkenazim, and 19 by Ashkenazim and Europeans. Europeans are the least polymorphic, and Pygmies are the most polymorphic. Conserved allelic associations were recognizable within 40-kb DNA segments, and so was recombination in the longer intervals separating such segments; The men showed only three segregating sites in a 16.5-kb unique region of the Y chromosome. Divergence between X- and Y-chromosome sequences of humans and chimpanzees indicated higher male mutation rates for different types of mutations. These rates for the X chromosomes were very similar to those estimated for the X-linked factor IX gene in the U.K. population.	Univ London Kings Coll, Guys Hosp, Div Med & Mol Genet, London SE1 9RT, England; St Thomas Hosp, Sch Med & Dent, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Giannelli, F (corresponding author), Univ London Kings Coll, Guys Hosp, Div Med & Mol Genet, 8th Floor,Guys Hosp Tower, London SE1 9RT, England.		Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010	Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476				AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; BANDELT HJ, 1995, GENETICS, V141, P743; Bentley DR, 1996, SCIENCE, V274, P533, DOI 10.1126/science.274.5287.533; BRAUER G, 1989, HUMAN REVOLUTION, P123; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; CORDELL HJ, 1995, TRENDS GENET, V11, P499, DOI 10.1016/S0168-9525(00)89160-X; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; FORREST SM, 1991, AM J HUM GENET, V49, P175; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 1997, AM J HUM GENET, V60, P772; Hey J, 1997, GENETICS, V145, P833; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miyata T., 1990, POPULATION BIOL GENE, P341; MONTANDON AJ, 1989, NUCLEIC ACIDS RES, V17, P3347, DOI 10.1093/nar/17.9.3347; OLSON MV, 1995, SCIENCE, V270, P394, DOI 10.1126/science.270.5235.394; Rowen L, 1997, SCIENCE, V278, P605, DOI 10.1126/science.278.5338.605; Rowley G, 1995, GENOMICS, V30, P574, DOI 10.1006/geno.1995.1279; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; Stoneking M, 1996, CURR OPIN GENET DEV, V6, P731, DOI 10.1016/S0959-437X(96)80028-1; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Verpy E, 1996, AM J HUM GENET, V59, P308; VERPY E, 1994, P NATL ACAD SCI USA, V91, P1873, DOI 10.1073/pnas.91.5.1873; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zerjal T, 1997, AM J HUM GENET, V60, P1174	39	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					508	517		10.1086/302250	http://dx.doi.org/10.1086/302250			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973287	Green Published, Bronze			2022-12-18	WOS:000078740600019
J	Gong, YQ; Chitayat, D; Kerr, B; Chen, TP; Babul-Hirji, R; Pal, A; Reiss, M; Warman, ML				Gong, YQ; Chitayat, D; Kerr, B; Chen, TP; Babul-Hirji, R; Pal, A; Reiss, M; Warman, ML			Brachydactyly type B: Clinical description, genetic mapping to chromosome 9q, and evidence for a shaved ancestral mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; NAIL DYSPLASIA; HUMAN GENOME; DWARFISM; MAPS	Autosomal dominant brachydactyly type B (BDB) is characterized by nail aplasia with rudimentary or absent distal and middle phalanges. We describe two unrelated families with BDB. One family is English; the other family is Canadian but of English ancestry. We assigned the BDB locus in the Canadian family to an 18-cM interval on 9q, using linkage analysis (LOD score 3.5 at recombination fraction [theta] 0, for marker D9S938). Markers across this interval also cosegregated with the BDB phenotype in the English family (LOD score 2.1 at theta = 0, for marker D9S277). Within this defined interval is a smaller (7.5-cM) region that contains 10 contiguous markers whose disease-associated haplotype is shared by the two families. This latter result suggests a common founder among families of English descent that are affected with BDB.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Shandong Med Univ, Dept Genet, Jinan, Peoples R China; Univ Toronto, Prenatal Diag Program, Toronto, ON, Canada; Royal Manchester Childrens Hosp, Reg Genet Serv, Manchester, Lancs, England; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Shandong University; University of Toronto; Royal Manchester Children's Hospital; Yale University; Yale University	Warman, ML (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, BRB-719,2109 Adelbert Rd, Cleveland, OH 44106 USA.	MLW14@po.cwru.edu	Reiss, Michael/A-8314-2009		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043827] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR43827] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bagg HJ, 1929, AM J ANAT, V43, P167, DOI 10.1002/aja.1000430203; BASS HN, 1968, PEDIATRICS, V42, P318; BATTLE HI, 1973, ANN HUM GENET, V36, P415, DOI 10.1111/j.1469-1809.1973.tb00605.x; Bean AM, 1929, AM J ANAT, V43, P221, DOI 10.1002/aja.1000430204; Bell J., 1951, TREASURY HUMAN INHER, VVol 1, P1; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Chen TP, 1998, CANCER RES, V58, P4805; Clarke DS, 1915, BRIT MED J, V1915, P255, DOI 10.1136/bmj.2.2850.255; COOKS RG, 1985, CLIN GENET, V27, P85; Cragg E, 1916, J GENET, V6, P81, DOI 10.1007/BF02981868; Cuevas-Sosa A, 1971, J Bone Joint Surg Br, V53, P101; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; FITCH N, 1979, J MED GENET, V16, P36, DOI 10.1136/jmg.16.1.36; Greene HSN, 1939, J EXP MED, V69, P301, DOI 10.1084/jem.71.3.305; Houlston R S, 1994, Clin Dysmorphol, V3, P224; Inman OR, 1941, ANAT REC, V79, P483, DOI 10.1002/ar.1090790408; IVY R H, 1957, Plast Reconstr Surg (1946), V20, P400, DOI 10.1097/00006534-195711000-00008; KELLIE DR, 1808, EDINBURGH MED SURG J, V4, P252; KUMAR D, 1986, CLIN GENET, V30, P219; Larsen WJ, 1993, HUMAN EMBRYOLOGY; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MacARTHUR J. W., 1932, HUMAN BIOL, V4, P179; MACKINDER D, 1857, BRIT MED J, P845; MALLOCH JD, 1957, ANN HUM GENET, V22, P36, DOI 10.1111/j.1469-1809.1957.tb01297.x; O'Rahilly R., 1996, HUMAN EMBRYOLOGY TER; Oldridge M, 1999, AM J HUM GENET, V64, P578, DOI 10.1086/302255; Pasche B, 1998, CANCER RES, V58, P2727; PITT P, 1985, J MED GENET, V22, P202, DOI 10.1136/jmg.22.3.202; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Polymeropoulos MH, 1996, GENOMICS, V38, P45, DOI 10.1006/geno.1996.0590; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Schuster H, 1996, NAT GENET, V13, P98, DOI 10.1038/ng0596-98; SCOTTEMUAKPOR AB, 1976, HUM HERED, V26, P198, DOI 10.1159/000152803; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; THOMPSON EM, 1988, J MED GENET, V25, P313, DOI 10.1136/jmg.25.5.313; TONOKI H, 1990, AM J MED GENET, V36, P89, DOI 10.1002/ajmg.1320360117; Vellucci VF, 1997, GENOMICS, V46, P278, DOI 10.1006/geno.1997.5023; WEINSTEIN LS, 1990, P NATL ACAD SCI USA, V87, P8287, DOI 10.1073/pnas.87.21.8287; WELLS NH, 1947, ARCH DIS CHILD, V22, P251, DOI 10.1136/adc.22.112.251; WILSON LC, 1995, AM J HUM GENET, V56, P400	41	26	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					570	577		10.1086/302249	http://dx.doi.org/10.1086/302249			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973295	Bronze, Green Published			2022-12-18	WOS:000078740600027
J	Bennett, RL; Karayiorgou, M; Sobin, CA; Norwood, TH; Kay, MA				Bennett, RL; Karayiorgou, M; Sobin, CA; Norwood, TH; Kay, MA			Identification of an interstitial deletion in an adult female with schizophrenia, mental retardation, and dysmorphic features: Further support for a putative schizophrenia-susceptibility locus at 5q21-23.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DIAGNOSIS; RELATIVES; ILLNESS; FAMILY		Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan	Keio University; Keio University	Kay, MA (corresponding author), Univ Washington, Sch Med, Dept Med, Div Med Genet, 1705 NE Pacific St,Room K236C,Hlth Sci Bldg, Seattle, WA 98195 USA.	mkay@u.washington.edu	Sobin, Christina/AAF-1927-2020	Sobin, Christina/0000-0002-2117-2034				American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; BASSETT AS, 1992, BRIT J PSYCHIAT, V161, P323, DOI 10.1192/bjp.161.3.323; BASSETT AS, 1988, LANCET, V1, P799; DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; GOTTESMAN SJ, 1982, SCHIZOPHRENIA EPIGEN; GOTTESMAN SJ, 1991, SCHIZOPHRENIA GENESI; Karayiorgou M, 1997, MOL PSYCHIATR, V2, P211, DOI 10.1038/sj.mp.4000271; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P527; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; Levinson DF, 1996, AM J MED GENET, V67, P580; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MURRAY RM, 1986, PSYCHIAT CLIN N AM, V9, P3; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258	19	26	27	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1450	1454		10.1086/301634	http://dx.doi.org/10.1086/301634			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	YT019	9399892	Green Published, Bronze			2022-12-18	WOS:000071555900031
J	Howell, N				Howell, N			mtDNA recombination: What do in vitro data mean?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MITOCHONDRIAL-DNA DELETION; ESCHERICHIA-COLI; CELL; ORGANIZATION; REPLICATION; SEGREGATION; CHROMOSOME; MOLECULES; HYBRID		UNIV TEXAS, MED BRANCH, DEPT HUMAN BIOL CHEM & GENET, GALVESTON, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Howell, N (corresponding author), UNIV TEXAS, MED BRANCH, DEPT RADIAT ONCOL, DIV 0656, 301 UNIV BLVD, GALVESTON, TX 77555 USA.							ADOUTTE A, 1979, GENETICS, V93, P797; Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460; BLOK RB, 1995, HUM GENET, V95, P75; Clayton D A, 1975, Int Rev Exp Pathol, V14, P1; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43; HORAK I, 1974, P NATL ACAD SCI USA, V71, P1828, DOI 10.1073/pnas.71.5.1828; Howell N, 1996, AM J HUM GENET, V59, P501; HOWELL N, 1984, SOMAT CELL MOLEC GEN, V10, P259, DOI 10.1007/BF01535248; Howell N, 1996, AM J HUM GENET, V59, P749; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; LOBNEROLESEN A, 1992, J BACTERIOL, V174, P7883; LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4; LOUARN J, 1994, J BACTERIOL, V176, P7524, DOI 10.1128/JB.176.24.7524-7531.1994; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; NASS MMK, 1969, J MOL BIOL, V42, P521, DOI 10.1016/0022-2836(69)90240-X; Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612; POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101; SMITH JM, 1977, NATURE, V268, P693, DOI 10.1038/268693a0; SMITH LC, 1993, J REPROD FERTIL, P31; Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028; Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536; Topcu Z, 1995, BBA-GENE STRUCT EXPR, V1264, P377, DOI 10.1016/0167-4781(95)00180-8; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699; ZUCKERMAN SH, 1984, SOMAT CELL MOLEC GEN, V10, P85, DOI 10.1007/BF01534475	32	26	26	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					19	22		10.1086/513910	http://dx.doi.org/10.1086/513910			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245980	Green Published, Bronze			2022-12-18	WOS:A1997XM72800007
J	Teng, J; Siegmund, D				Teng, J; Siegmund, D			Combining information within and between pedigrees for mapping complex traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-RESOLUTION MAPS; LINKAGE ANALYSIS; MEMBER METHOD; SIB-PAIR; IDENTITY; DESCENT; STRATEGIES; MODELS; POWER; GENE	This paper is concerned with efficient strategies for gene mapping using pedigrees containing small numbers of affecteds and identity-by-descent data from closely spaced markers throughout the genome. Particular attention is paid to additive traits involving phenocopies and/or locus heterogeneity. For a sample of pedigrees containing a particular configuration of affecteds, e.g., pairs of siblings together with a first cousin, we use a likelihood analysis to find 1-df statistics that are very efficient over a broad range of penetrances and allele frequencies. We identify configurations of affecteds that are particularly powerful for detecting linkage, and we show how pedigrees containing different numbers and configurations of affecteds can be efficiently combined in an overall test statistic.	STANFORD UNIV,DEPT STAT,STANFORD,CA 94305	Stanford University					NHGRI NIH HHS [HG00848] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000848, R55HG000848] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; DUPUIS J, 1995, GENETICS, V140, P843; DUPUIS J, 1994, THESIS STANFORD U; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; FEINGOLD E, 1993, J APPL PROBAB, V30, P766, DOI 10.2307/3214511; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; MORTON NE, 1955, AM J HUM GENET, V7, P277; NELSON SF, 1993, NAT GENET, V4, P11, DOI 10.1038/ng0593-11; Ott J., 1991, ANAL HUMAN GENETIC L; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Rogus JJ, 1996, AM J HUM GENET, V59, P1376; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; SRIBNEY WM, 1992, AM J HUM GENET, V51, P773; THOMAS A, 1994, IMA J MATH APPL MED, V11, P1; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201	22	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					979	992						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106545				2022-12-18	WOS:A1997WT61400028
J	Greger, V; Knoll, JHM; Wagstaff, J; Woolf, E; Lieske, P; Glatt, H; Benn, PA; Rosengren, SS; Lalande, M				Greger, V; Knoll, JHM; Wagstaff, J; Woolf, E; Lieske, P; Glatt, H; Benn, PA; Rosengren, SS; Lalande, M			Angelman syndrome associated with an inversion of chromosome 15q11.2q24.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROMES; DINUCLEOTIDE REPEAT POLYMORPHISM; FAMILIAL ANGELMAN; SUBMICROSCOPIC DELETION; MOLECULAR DIAGNOSIS; MATERNAL ORIGIN; DNA METHYLATION; PARENTAL ORIGIN; CRITICAL REGION; ALU-PCR	Angelman syndrome (AS) most frequently results from large (greater than or equal to 5 Mb) de novo deletions of chromosome 15q11-q13. The deletions are exclusively of maternal origin, and a few cases of paternal uniparental disomy of chromosome 15 have been reported. The latter finding indicates that AS is caused by the absence of a maternal contribution to the imprinted 15q11-q13 region. Failure to inherit a paternal 15q11-q13 contribution results in the clinically distinct disorder of Prader-Willi syndrome. Cases of AS resulting from translocations or pericentric inversions have been observed to be associated with deletions, and there have been no confirmed reports of balanced rearrangements in AS. We report the fist such case involving a paracentric inversion with a breakpoint located similar to 25 kb proximal to the reference marker D15S10. This inversion has been inherited from a phenotypically normal mother. No deletion is evident by molecular analysis in this case, by use of cloned fragments mapped to within similar to 1 kb of the inversion breakpoint. Several hypotheses are discussed to explain the relationship between the inversion and the AS phenotype.	CHILDRENS HOSP, DIV GENET, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; BETH ISRAEL HOSP, HOWARD HUGHES MED INST, BOSTON, MA 02215 USA; BETH ISRAEL HOSP, DEPT PATHOL, BOSTON, MA 02215 USA; UNIV CONNECTICUT, CTR HLTH, SCH MED, DEPT PEDIAT, DIV HUMAN GENET, FARMINGTON, CT USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; University of Connecticut				Greger, Valerie/0000-0001-7716-3973; Knoll, Joan/0000-0001-6691-1710	NICHD NIH HHS [P01-HD18658] Funding Source: Medline; NINDS NIH HHS [R01-NS30628] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030628] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681; Beuten J, 1996, AM J MED GENET, V63, P414, DOI 10.1002/ajmg.1320630206; BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Burke LW, 1996, AM J HUM GENET, V58, P777; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; CLAYTONSMITH J, 1992, J MED GENET, V29, P412, DOI 10.1136/jmg.29.6.412; DITTRICH B, 1992, HUM GENET, V90, P313; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; GLATT K, 1994, GENOMICS, V19, P157, DOI 10.1006/geno.1994.1027; Glenn CC, 1996, AM J HUM GENET, V58, P335; GREGER V, 1993, HUM MOL GENET, V2, P921, DOI 10.1093/hmg/2.7.921; GREGER V, 1994, AM J MED GENET, V53, P396, DOI 10.1002/ajmg.1320530425; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HOHEISEL JD, 1989, NUCLEIC ACIDS RES, V17, P8571; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KNOLL JHM, 1993, HUM MOL GENET, V2, P183, DOI 10.1093/hmg/2.2.183; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; LINDEMAN R, 1992, NUCLEIC ACIDS RES, V19, P5449; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; MEIJERSHEIJBOER EJ, 1992, J MED GENET, V29, P853, DOI 10.1136/jmg.29.12.853; MUTIRANGURA A, 1993, HUM MOL GENET, V2, P143, DOI 10.1093/hmg/2.2.143; MUTIRANGURA A, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67; Mutirangura A., 1992, Human Molecular Genetics, V1, P139, DOI 10.1093/hmg/1.2.139-a; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; PEMBREY M, 1989, J MED GENET, V26, P73, DOI 10.1136/jmg.26.2.73; REIS A, 1994, AM J HUM GENET, V54, P741; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; SINNETT D, 1993, AM J HUM GENET, V52, P1216; SMITH JC, 1992, HUM GENET, V88, P376, DOI 10.1007/BF00215668; Tagle Danilo A., 1992, Human Molecular Genetics, V1, P121, DOI 10.1093/hmg/1.2.121; VANDENOUWELAND AMW, 1995, HUM GENET, V95, P562, DOI 10.1007/BF00223870; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224	46	26	26	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					574	580						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042916				2022-12-18	WOS:A1997WK40300013
J	Mumm, S; Whyte, MP; Thakker, RV; Buetow, KH; Schlessinger, D				Mumm, S; Whyte, MP; Thakker, RV; Buetow, KH; Schlessinger, D			mtDNA analysis shows common ancestry in two kindreds with X-linked recessive hypoparathyroidism and reveals a heteroplasmic silent mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; IDIOPATHIC HYPOPARATHYROIDISM; EVOLUTION	Two kindreds residing in eastern Missouri and exhibiting X-linked recessive idiopathic hypoparathyroidism have been described. Genealogical records extending back five generations revealed no common ancestor. To investigate the possibility of relatedness, the DNA sequence of the mitochondrial D-loop was compared among several individuals in both kindreds. The mtDNA D-loop was amplified from the total DNA of individuals by use of nested PCR reactions, and the resulting 430-bp fragment was sequenced. The mtDNA sequence was identical among affected males and their maternal lineage for individuals in both kindreds. Conversely, the mtDNA sequence of the fathers of the affected males differed from that of the maternal lineage at three to six positions. These results demonstrate that the two kindreds exhibiting X-linked recessive hypoparathyroidism are indeed related and that an identical gene defect is responsible for the disease. A further feature of the inheritance pattern was examined when a unique point mutation was identified in the mtDNA of one branch of one of the kindreds. This mutation appears to be de novo and segregates in subsequent generations without obscuring relatedness. In addition, the results of our study of mtDNA analysis indicate that this approach may be of importance in investigating common ancestry in other X-linked disorders.	WASHINGTON UNIV,SCH MED,CTR GENET MED,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DIV BONE & MINERAL DIS,ST LOUIS,MO 63110; JEWISH HOSP ST LOUIS,ST LOUIS,FRANCE; SHRINERS HOSP CRIPPLED CHILDREN,METAB RES UNIT,ST LOUIS,MO 63131; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,MRC,MOL ENDOCRINOL GRP,LONDON W12 0HS,ENGLAND; FOX CHASE CANC CTR,DIV POPULAT SCI,PHILADELPHIA,PA 19111	Washington University (WUSTL); Washington University (WUSTL); Imperial College London; Fox Chase Cancer Center	Mumm, S (corresponding author), WASHINGTON UNIV,SCH MED,DEPT MOL MICROBIOL,660 S EUCLID AVE,ST LOUIS,MO 63110, USA.			Thakker, Rajesh/0000-0002-1438-3220	NHGRI NIH HHS [HG00247] Funding Source: Medline; NIAMS NIH HHS [5 T32 AR07033-21] Funding Source: Medline; NICHD NIH HHS [HD33013] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033013] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007033] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Blanchard M M, 1993, PCR Methods Appl, V2, P234; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GINTHER C, 1992, NAT GENET, V2, P135, DOI 10.1038/ng1092-135; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; Orrrego C., 1990, PCR PROTOCOLS, P416; PEDEN VH, 1960, AM J HUM GENET, V12, P323; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; POULTON J, 1995, AM J HUM GENET, V57, P224; Srivastava A K, 1992, PCR Methods Appl, V1, P255; THAKKER RV, 1990, J CLIN INVEST, V86, P40, DOI 10.1172/JCI114712; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WHYTE MP, 1986, J PEDIATR-US, V109, P915, DOI 10.1016/S0022-3476(86)80741-7; WHYTE MP, 1981, J PEDIATR-US, V99, P608, DOI 10.1016/S0022-3476(81)80272-7; Zucchi I, 1996, GENOMICS, V34, P42, DOI 10.1006/geno.1996.0239	17	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					153	159						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981958				2022-12-18	WOS:A1997WA81800021
J	Biancalana, V; Taine, L; Bouix, JC; Finck, S; Chauvin, A; DeVerneuil, H; Knight, SJL; Stoll, C; Lacombe, D; Mandel, JL				Biancalana, V; Taine, L; Bouix, JC; Finck, S; Chauvin, A; DeVerneuil, H; Knight, SJL; Stoll, C; Lacombe, D; Mandel, JL			Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: Analysis of four FRAXE families with mild mental retardation in males	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; REPEAT EXPANSION; 2 FAMILIES; SITE; DNA; DISTAL; IDENTIFICATION; XQ27.3	The original test for the analysis of the CCG expansion at the FRAXE locus involves Southern blot analysis of HindIII digests. We show that, by using a different probe, the FRAXE mutation can be detected easily on the same EcoRI or EagI+EcoRI blots as are used for detection of FRAXA. Unexpectedly, we found that both the expansion and methylation status can be determined on a single EcoRI digest, because of the presence of a methylation-sensitive EcoRI site very close to the CCG repeat. We thus detected in a series of mentally retarded individuals previously tested for FRAXA expansion a FRAXE proband who led to the identification of a large sibship (7 of 10 children carrying a mutation). We also show that two fragile X families without FRAXA mutation that previously have been described by Oberle et al. have the FRAXE expansion. In another family also ascertained initially by cytogenetic finding of a fragile X site, we performed the combined cytogenetic and molecular prenatal diagnosis of a mutated male fetus. All nine males (>3 years old) in whom we found a methylated mutation had mild mental retardation. Our results suggest that the threshold of repeat length for abnormal methylation and fragile-site expression may be smaller at FRAXE than at FRAXA.	CHRU,FAC MED,SERV DIAGNOST GENET,STRASBOURG,FRANCE; CHRU,INST PUERICULTURE,SERV GENET MED,STRASBOURG,FRANCE; ULP,INSERM,CNRS,INST GENET BIOL MOL & CELLULAIRE,STRASBOURG,FRANCE; CHRU,MOL BIOL UNIT,BORDEAUX,FRANCE; CHRU,SERV PEDIAT & GENET MED,BORDEAUX,FRANCE; CTR HOSP,SERV PEDIAT,HAGUENAU,FRANCE; JOHN RADCLIFFE HOSP,INST MOL MED,OXFORD OX3 9DU,ENGLAND	CHU Strasbourg; CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Bordeaux; CHU Bordeaux; University of Oxford			Biancalana, Valerie/O-2351-2016	Lacombe, Didier/0000-0002-8956-2207; Knight, Samantha/0000-0002-6047-3462				ALLINGHAMHAWKIN.DJ, 1995, AM J HUM GENET, V57, P72; Chakrabarti L, 1996, HUM MOL GENET, V5, P275, DOI 10.1093/hmg/5.2.275; DENNIS NR, 1992, AM J MED GENET, V43, P232, DOI 10.1002/ajmg.1320430137; FLYNN GA, 1993, J MED GENET, V30, P97, DOI 10.1136/jmg.30.2.97; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; HAMEL BCJ, 1994, AM J HUM GENET, V55, P923; HIRST MC, 1993, HUM MOL GENET, V2, P197, DOI 10.1093/hmg/2.2.197; KNIGHT SJL, 1994, AM J HUM GENET, V55, P81; KNIGHT SJL, 1993, CELL, V74, P1; MCCLELLAND M, 1992, NUCLEIC ACIDS RES, V20, P2145, DOI 10.1093/nar/20.suppl.2145; MULLEY JC, 1995, J MED GENET, V32, P162, DOI 10.1136/jmg.32.3.162; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; OBERLE I, 1992, AM J MED GENET, V43, P224, DOI 10.1002/ajmg.1320430136; PARRISH JE, 1994, NAT GENET, V8, P229, DOI 10.1038/ng1194-229; RITCHIE RJ, 1994, HUM MOL GENET, V3, P2115, DOI 10.1093/hmg/3.12.2115; ROUSSEAU F, 1992, AM J MED GENET, V43, P197, DOI 10.1002/ajmg.1320430133; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Sutherland Grant R., 1992, Human Molecular Genetics, V1, P111, DOI 10.1093/hmg/1.2.111; TASSERONDEJONG JG, 1988, GENE, V74, P147, DOI 10.1016/0378-1119(88)90272-7	20	26	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					847	854						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808600				2022-12-18	WOS:A1996VL28300014
J	Goldman, A; Krause, A; Ramsay, M; Jenkins, T				Goldman, A; Krause, A; Ramsay, M; Jenkins, T			Founder effect and the prevalence of myotonic dystrophy in South Africans: Molecular studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNSTABLE DNA REGION; LINKAGE DISEQUILIBRIUM; CTG REPEAT; FAMILIAL HYPERCHOLESTEROLEMIA; DELETION POLYMORPHISM; GENE; EXPANSION; LOCUS; MUTATION; POPULATION	A high prevalence of myotonic dystrophy (DM) has been described in South African Caucasoid Afrikaans-speaking families in the northern Transvaal. Evidence is presented for a strong founder effect, with a single haplotype occurring on 68% of all Caucasoid DM chromosomes; among the Afrikaans speakers, the proportion was 83%. In addition to this major haplotype, five minor DM haplotypes in the Caucasoids and two minor haplotypes in DM individuals of mixed ancestry were found. All DM chromosomes, however, had a common haplotype core, namely, Alu (ins), HinfI-2 (intron 9), and TaqI-2 (D19S463). We have detected significant linkage disequilibrium between the DM mutation and particular alleles of the extragenic markers D19S112 and D19S207. Significant differences were found in allele and haplotype distributions in the Caucasoid DM and non-DM chromosomes and Negroid non-DM chromosomes. These findings together with the strong association of allele 3 at the D19S63 locus on 93% (14/15) of the South African DM chromosomes suggest that the majority of present-day DM mutations in South African Caucasoids may have originated from a common initial founder who introduced one of the European ancestral mutations.	UNIV WITWATERSRAND,JOHANNESBURG,SOUTH AFRICA	University of Witwatersrand	Goldman, A (corresponding author), S AFRICAN INST MED RES,DEPT HUMAN GENET,SCH PATHOL,POB 1038,JOHANNESBURG,SOUTH AFRICA.		Krause, Amanda/AAQ-7038-2020	Krause, Amanda/0000-0002-7157-0807; Ramsay, Michele/0000-0002-4156-4801				ASHIZAWA T, 1991, LANCET, V338, P642, DOI 10.1016/0140-6736(91)90659-D; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BHANA S, 1990, SETTING DOWN ROOTS I; BROOK JD, 1990, NUCLEIC ACIDS RES, V18, P1086, DOI 10.1093/nar/18.4.1086-a; BROOK JD, 1990, NUCLEIC ACIDS RES, V18, P1085; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROOK JD, 1992, GENOMICS, V13, P243, DOI 10.1016/0888-7543(92)90238-N; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; COBO A, 1992, HUM GENET, V89, P287; Crow S. R., 1992, Human Molecular Genetics, V1, P451, DOI 10.1093/hmg/1.6.451; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GOLDMAN A, 1994, J MED GENET, V31, P37, DOI 10.1136/jmg.31.1.37; GOLDMAN A, 1995, AM J HUM GENET, V56, P1373; GOLDMAN A, 1995, S AFR MED J, V85, P1161; Goldman A, 1996, ANN HUM GENET, V60, P57, DOI 10.1111/j.1469-1809.1996.tb01172.x; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JANSEN G, 1992, GENOMICS, V13, P509, DOI 10.1016/0888-7543(92)90118-C; JANSEN G, 1993, HUM MOL GENET, V2, P333, DOI 10.1093/hmg/2.3.333; JENKINS T, 1980, S AFR MED J, V57, P943; KOTZE MJ, 1989, J MED GENET, V26, P255, DOI 10.1136/jmg.26.4.255; KRAHE R, 1995, AM J HUM GENET, V56, P1067; LAVEDAN C, 1994, J MED GENET, V31, P33, DOI 10.1136/jmg.31.1.33; LEITERSDORF E, 1989, J CLIN INVEST, V84, P954, DOI 10.1172/JCI114258; LOTZ BP, 1985, S AFR MED J, V67, P812; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, GENOMICS, V15, P446, DOI 10.1006/geno.1993.1087; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; ROSS R, 1975, POP STUD-J DEMOG, V29, P217, DOI 10.2307/2173508; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; YAMAGATA H, 1992, LANCET, V339, P692, DOI 10.1016/0140-6736(92)90862-W	35	26	26	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					445	452						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755933				2022-12-18	WOS:A1996VM28800022
J	Komatsu, K; Matsuura, S; Tauchi, H; Endo, S; Kodama, S; Smeets, D; Weemaes, C; Oshimura, M				Komatsu, K; Matsuura, S; Tauchi, H; Endo, S; Kodama, S; Smeets, D; Weemaes, C; Oshimura, M			The gene for Nijmegen breakage syndrome (V2) is not located on chromosome 11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ATAXIA-TELANGIECTASIA CELLS; DNA-SYNTHESIS; INSTABILITY DISORDER; COMPLEMENTATION		NAGASAKI UNIV,FAC PHARMACEUT SCI,DEPT RADIAT BIOL,NAGASAKI 852,JAPAN; UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT PAEDIAT,6500 HB NIJMEGEN,NETHERLANDS; TOTTORI UNIV,SCH LIFE SCI,DEPT MOLEC & CELL GENET,TOTTORI 680,JAPAN	Nagasaki University; Radboud University Nijmegen; Radboud University Nijmegen; Tottori University	Komatsu, K (corresponding author), HIROSHIMA UNIV,RES INST RADIAT BIOL & MED,DEPT RADIAT BIOL,HIROSHIMA,JAPAN.		Weemaes, C.M.R./L-4747-2015; Matsuura, Shinya/U-4182-2017; Endo, Satoru/D-9091-2012	Matsuura, Shinya/0000-0001-5294-081X; Endo, Satoru/0000-0001-5961-681X				GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; JASPERS NGJ, 1988, AM J HUM GENET, V42, P66; JONGMANS W, 1995, AM J HUM GENET, V56, P438; KOMATSU K, 1990, MUTAT RES, V235, P59, DOI 10.1016/0921-8777(90)90058-D; KOMATSU K, 1989, INT J RADIAT BIOL, V56, P863, DOI 10.1080/09553008914552331; MCCONVILLE CM, 1994, INT J RADIAT BIOL, V66, pS45, DOI 10.1080/09553009414551851; MURNANE JP, 1982, P NATL ACAD SCI-BIOL, V79, P1960, DOI 10.1073/pnas.79.6.1960; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SHILOH Y, 1995, EUR J HUM GENET, V3, P116; STUMM M, 1995, AM J HUM GENET, V57, P960; VERHAEGH GWCT, 1993, CYTOGENET CELL GENET, V63, P176, DOI 10.1159/000133528; VERHAEGH GWCT, 1995, AM J HUM GENET, V57, P1095; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x; WEGNER RD, 1988, CLIN GENET, V33, P20; ZDZIENICKA MZ, 1994, INT J RADIAT BIOL, V66, pS189	15	26	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					885	888						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644753				2022-12-18	WOS:A1996UA38000027
J	Huang, CH; Reid, ME; Chen, Y; Coghlan, G; Okubo, Y				Huang, CH; Reid, ME; Chen, Y; Coghlan, G; Okubo, Y			Molecular definition of red cell Rh haplotypes by tightly linked SphI RFLPs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BLOOD-GROUP SYSTEM; GENE STRUCTURE; CLONING; PROTEIN; POLYPEPTIDE; ANTIGENS; DNA; AMPLIFICATION; SEQUENCES	The Rh blood group system of human red cells contains five major antigens D, C/c, and E/e (the latter four designated ''non-D'') that are specified by eight gene complexes known as Rh haplotypes. In this paper, we report on the mapping of RH locus and identification of a set of SphI RFLPs that are tightly linked with the Rh structural genes. Using exon-specific probes, we have localized the SphI cleavage sites resulting in these DNA markers and derived a comprehensive map for the RH locus. It was found that the SphI fragments encompassing exons 4-7 of the Rh genes occur in four banding patterns or frameworks that correspond to the distribution and segregation of the common Rh haplotypes. This linkage disequilibrium allowed a genotype-phenotype correlation and direct determination of Rh zygosity related to the Rh-positive or Rh-negative status (D/D, D/d, and d/d). Studies on the occurrence of SphI RFLPs in a number of rare Rh variants indicated that Rh phenotypic diversity has taken place on different haplotype backgrounds and has arisen by diverse genetic mechanisms. The molecular definition of Rh haplotypes by SphI RFLP frameworks should provide a useful procedure for genetic counseling and prenatal assessment of Rh alloimmunization.	RH LAB,WINNIPEG,MB,CANADA; OSAKA RED CROSS,CTR BLOOD,OSAKA,JAPAN	Osaka Red Cross Hospital	Huang, CH (corresponding author), NEW YORK BLOOD CTR,LINDSLEY F KIMBALL RES INST,310 E 67TH ST,NEW YORK,NY 10021, USA.							AGRE P, 1991, BLOOD, V78, P551, DOI 10.1182/blood.V78.3.551.bloodjournal783551; ANSTEE DJ, 1993, BAILLIERE CLIN HAEM, V6, P401, DOI 10.1016/S0950-3536(05)80152-0; ARCE MA, 1993, BLOOD, V82, P651; AVENT ND, 1990, BIOCHEM J, V271, P821, DOI 10.1042/bj2710821; BENNETT PR, 1993, NEW ENGL J MED, V329, P607, DOI 10.1056/NEJM199308263290903; CARRITT B, 1994, LANCET, V344, P205, DOI 10.1016/S0140-6736(94)92814-2; CARTRON JP, 1993, SEMIN HEMATOL, V30, P193; CHERIFZAHAR B, 1994, GENOMICS, V19, P68, DOI 10.1006/geno.1994.1014; CHERIFZAHAR B, 1991, HUM GENET, V86, P398, DOI 10.1007/BF00201843; CHERIFZAHAR B, 1990, P NATL ACAD SCI USA, V87, P6243, DOI 10.1073/pnas.87.16.6243; COLIN Y, 1991, BLOOD, V78, P2747; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Goossens M, 1981, Methods Enzymol, V76, P805; HUANG CH, 1988, P NATL ACAD SCI USA, V85, P9640, DOI 10.1073/pnas.85.24.9640; HUANG CH, 1991, BLOOD, V77, P381; HUANG CH, 1995, BLOOD, V86, P784, DOI 10.1182/blood.V86.2.784.bloodjournal862784; HUANG CH, 1995, BLOOD CELL BIOCH, V6, P153; HYLAND CA, 1994, BLOOD, V84, P321; Issitt P D, 1989, Transfus Med Rev, V3, P1, DOI 10.1016/S0887-7963(89)70064-X; KAJII E, 1993, HUM GENET, V91, P157; KAPPES D, 1988, ANNU REV BIOCHEM, V57, P991, DOI 10.1146/annurev.bi.57.070188.005015; LEVANKIM C, 1992, P NATL ACAD SCI USA, V89, P10925, DOI 10.1073/pnas.89.22.10925; MACGEOCH C, 1992, CYTOGENET CELL GENET, V59, P261, DOI 10.1159/000133264; Maniatis T., 1982, MOL CLONING; MARSH WL, 1974, SCIENCE, V183, P966, DOI 10.1126/science.183.4128.966; MOLLISON PL, 1993, BLOOD TRANSFUSION CL; MOURO I, 1993, NAT GENET, V5, P62, DOI 10.1038/ng0993-62; Race RR., 1975, BLOOD GROUPS MAN; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SIMSEK S, 1994, NEW ENGL J MED, V330, P795; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TIPPETT P, 1986, ANN HUM GENET, V50, P241, DOI 10.1111/j.1469-1809.1986.tb01045.x	32	26	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					133	142						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554049				2022-12-18	WOS:A1996TL69700017
J	Zlotogora, J; Gieselmann, V; Bach, G				Zlotogora, J; Gieselmann, V; Bach, G			Multiple mutations in a specific gene in a small geographic area: A common phenomenon?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MOLECULAR ANALYSIS		CHRISTIAN ALBRECHTS UNIV KIEL,INST BIOCHEM,W-2300 KIEL,GERMANY	University of Kiel	Zlotogora, J (corresponding author), HEBREW UNIV JERUSALEM,HADASSAH UNIV HOSP,HADASSAH MED SCH,DEPT HUMAN GENET,POB 12000,IL-91120 JERUSALEM,ISRAEL.							ALLAMAND V, 1995, AM J HUM GENET, V56, P1417; BACH G, 1993, AM J HUM GENET, V53, P330; FLINT J, 1993, HUM GENET, V91, P91; HEINISCH U, 1995, AM J HUM GENET, V56, P51; JABER L, 1994, ARCH PEDIAT ADOL MED, V148, P412, DOI 10.1001/archpedi.1994.02170040078013; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; RUND D, 1991, P NATL ACAD SCI USA, V88, P310, DOI 10.1073/pnas.88.1.310	8	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					241	243						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554063				2022-12-18	WOS:A1996TL69700030
J	PALMER, SE; SCHERER, SW; KUKOLICH, M; WIJSMAN, EM; TSUI, LC; STEPHENS, K; EVANS, JP				PALMER, SE; SCHERER, SW; KUKOLICH, M; WIJSMAN, EM; TSUI, LC; STEPHENS, K; EVANS, JP			EVIDENCE FOR LOCUS HETEROGENEITY IN HUMAN AUTOSOMAL-DOMINANT SPLIT HAND SPLIT FOOT MALFORMATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLEFT-LIP PALATE; INTERSTITIAL DELETION; EEC-SYNDROME; ECTODERMAL DYSPLASIA; HUMAN GENOME; TRANSLOCATION; HAND; CHROMOSOME-7; 7Q11.21; LINKAGE	Split hand/split foot (SHSF; also known as ectrodactyly) is a human developmental disorder characterized by missing central digits and other distal limb malformations. An association between SHSF and cytogenetically visible rearrangements of chromosome 7 at bands q21-q22 provides compelling evidence for the location of a causative gene at this location, and the locus has been designated SHFD1. In the present study, marker loci were localized to the SHFD1 critical region through the analysis of somatic cell hybrids derived from individuals with SHSF and cytogenetic abnormalities involving the 7q21-q22 region. Combined genetic and physical data suggest that the order of markers in the SHFD1 critical region is cenD7S492-D7S527-(D7S473-D7S491)-SHFD1-D7S554-D7S518-qter. Dinucleotide repeat polymorphisms at three of these loci were used to test for linkage of SHSF to this region in a large pedigree that demonstrates autosomal dominant SHSF. Evidence against linkage of the SHSF gene to 7q21-q22 was obtained in this pedigree. Therefore, combined molecular and genetic data provide evidence for locus heterogeneity in autosomal dominant SHSF. We propose the name SHSF2 for this second locus.	UNIV WASHINGTON, SCH MED, DEPT MED, DIV MED GENET, SEATTLE, WA 98195 USA; UNIV WASHINGTON, SCH MED, DEPT BIOSTAT, SEATTLE, WA USA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO, ON, CANADA; HOSP SICK CHILDREN, RES INST, DEPT GENET, TORONTO M5G 1X8, ON, CANADA; GENET SCREENING & COUNSELING SERV, DENTON, TX USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)			Scherer, Stephen W./B-3785-2013; Tsui, Lap-chee/A-1081-2010	Scherer, Stephen W./0000-0002-8326-1999; 	NIAMS NIH HHS [P01 AR21557] Funding Source: Medline; NIDDK NIH HHS [F32 DK08695] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008695] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHMAD M, 1987, HUM GENET, V75, P169, DOI 10.1007/BF00591081; Akita S, 1993, Clin Dysmorphol, V2, P62; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BOLES RG, 1993, AM J HUM GENET, V53, P406; BRAVERMAN N, 1993, AM J HUM GENET, V53, P410; CUTICCHIA AJ, 1993, NUCLEIC ACIDS RES, V21, P3003, DOI 10.1093/nar/21.13.3003; Del Porto G, 1983, Pathologica, V75 Suppl, P268; FREIREMAIA A, 1971, J HERED, V62, P53, DOI 10.1093/oxfordjournals.jhered.a108124; FUKUSHIMA Y, 1993, CLIN GENET, V44, P50; GENUARDI M, 1993, AM J MED GENET, V47, P823, DOI 10.1002/ajmg.1320470606; HAQUE MFU, 1993, HUM GENET, V91, P17; HASEGAWA T, 1991, CLIN GENET, V40, P202; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Maniatis T., 1982, MOL CLONING; MOREY MA, 1990, AM J MED GENET, V35, P95, DOI 10.1002/ajmg.1320350118; NARITOMI K, 1993, AM J MED GENET, V46, P492, DOI 10.1002/ajmg.1320460505; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; OTT J, 1974, AM J HUM GENET, V26, P588; PFEIFFER RA, 1982, CLIN GENET, V21, P74; PFEIFFER RA, 1984, ANN GENET-PARIS, V27, P45; RAY AK, 1970, J HERED, V61, P169, DOI 10.1093/oxfordjournals.jhered.a108073; RIVERA H, 1991, Genetic Counseling, V2, P27; ROBERTS SH, 1991, J MED GENET, V28, P479, DOI 10.1136/jmg.28.7.479; RODINI ESO, 1990, AM J MED GENET, V37, P42, DOI 10.1002/ajmg.1320370112; SCHERER SW, 1993, HUM MOL GENET, V2, P751, DOI 10.1093/hmg/2.6.751; SCHERER SW, 1994, AM J HUM GENET, V55; SHARLAND M, 1991, AM J MED GENET, V39, P413, DOI 10.1002/ajmg.1320390410; TAJARA EH, 1989, AM J MED GENET, V32, P192, DOI 10.1002/ajmg.1320320212; THOMPSON MW, 1991, THOMPSON THOMPSON GE, P83; VERMA IC, 1976, CLIN GENET, V9, P8; Viljoen D L, 1993, Clin Dysmorphol, V2, P274; WEBER JL, 1991, GENOMICS, V10, P173; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; 1993, MIM183600 J HOPK U	34	26	27	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					21	26						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	7912888				2022-12-18	WOS:A1994NW46100004
J	GOEI, VL; PARIMOO, S; CAPOSSELA, A; CHU, TW; GRUEN, JR				GOEI, VL; PARIMOO, S; CAPOSSELA, A; CHU, TW; GRUEN, JR			ISOLATION OF NOVEL NON-HLA GENE FRAGMENTS FROM THE HEMOCHROMATOSIS REGION (6P21.3) BY CDNA HYBRIDIZATION SELECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOMES; TRANSCRIBED SEQUENCES; DNA FRAGMENTS; CLONES; IDENTIFICATION; CLONING; PROBES; STRATEGY; LOCUS; FAP	It has previously been shown that cDNA hybridization selection can identify and recover novel genes from large cloned genomic DNA such as cosmids or YACs. In an effort to identify candidate genes for hemochromatosis, this technique was applied to a 320-kb YAC containing the HLA-A gene. A short fragment cDNA library derived from human duodenum was selected with the YAC DNA. Ten novel gene fragments were isolated, characterized, and localized on the physical map of the YAC.	YALE UNIV, SCH MED, DEPT PEDIAT, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, DEPT GENET, NEW HAVEN, CT 06510 USA	Yale University; Yale University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER; NICHD NIH HHS [HD07388] Funding Source: Medline; NIDDK NIH HHS [5-P30-DK34989] Funding Source: Medline; NIGMS NIH HHS [GM07439] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AVIV H, 1972, J MOL BIOL, V134, P743; BASSETT ML, 1988, ANN NY ACAD SCI, V526, P274, DOI 10.1111/j.1749-6632.1988.tb55512.x; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BIRO PA, 1983, COLD SPRING HARB SYM, V47, P1079; BRONSON SK, 1991, P NATL ACAD SCI USA, V88, P1676, DOI 10.1073/pnas.88.5.1676; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; ELVIN P, 1990, NUCLEIC ACIDS RES, V18, P3913, DOI 10.1093/nar/18.13.3913; GERAGHTY DE, 1992, P NATL ACAD SCI USA, V89, P2669, DOI 10.1073/pnas.89.7.2669; GRUEN JR, 1992, GENOMICS, V14, P232, DOI 10.1016/S0888-7543(05)80211-3; GRUNEBAUM L, 1984, J CLIN INVEST, V73, P1491, DOI 10.1172/JCI111354; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; KAHLOUN A, 1992, HUM MOL GENET, V2, P55; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Korn Bernhard, 1992, Human Molecular Genetics, V1, P235, DOI 10.1093/hmg/1.4.235; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maniatis T., 1982, MOL CLONING; MCKUSICK VA, 1992, MENDELIAN INHERITANC, P1435; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MORGAN JG, 1992, NUCLEIC ACIDS RES, V20, P5173, DOI 10.1093/nar/20.19.5173; NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; PARIMOO S, 1993, METHODS MOL GENETICS, V1, P23; PATANJALI SR, 1991, P NATL ACAD SCI USA, V88, P1943, DOI 10.1073/pnas.88.5.1943; RAGOUSSIS J, 1991, P NATL ACAD SCI USA, V88, P3753, DOI 10.1073/pnas.88.9.3753; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SARGENT CA, 1989, EMBO J, V8, P2305, DOI 10.1002/j.1460-2075.1989.tb08357.x; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SIMON M, 1988, IMMUNOGENETICS ENDOC, P345; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VANSEVENTER GA, 1988, J IMMUNOL, V141, P417; WILSON GN, 1978, P NATL ACAD SCI USA, V75, P5367, DOI 10.1073/pnas.75.11.5367; ZOGHBI HY, 1991, GENOMICS, V9, P713, DOI 10.1016/0888-7543(91)90365-L	39	26	35	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					244	251						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304341				2022-12-18	WOS:A1994MU31500009
J	MEWAR, R; KLINE, AD; HARRISON, W; ROJAS, K; GREENBERG, F; OVERHAUSER, J				MEWAR, R; KLINE, AD; HARRISON, W; ROJAS, K; GREENBERG, F; OVERHAUSER, J			CLINICAL AND MOLECULAR EVALUATION OF 4 PATIENTS WITH PARTIAL DUPLICATIONS OF THE LONG ARM OF CHROMOSOME-18	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARTIAL TRISOMY-18; PHENOTYPE; TRANSLOCATION; REGION	Four individuals with partial duplications of the long arm of chromosome 18 were analyzed at the clinical, cytogenetic, and molecular levels. Two of the individuals had duplications of the long arm from 18q21.1-qter because of inheritance of an unbalanced translocation. Both of these individuals displayed the clinical phenotype characteristic of Edwards syndrome. Two other patients had de novo interstitial duplications of 18q but did not have a clinical diagnosis of Edwards syndrome. The extent of the duplicated material in each patient was determined initially by using cytogenetic analysis and subsequently with more detailed comparisons of the duplicated regions by using molecular probes derived from a chromosome 18-specific lambda phage library. The results demonstrated that one of the de novo interstitial duplications that did not result in the Edwards syndrome phenotype had a more proximal breakpoint than that of the partial duplications of the two patients with features of Edwards syndrome. These results suggest that a single critical region for Edwards syndrome in the proximal portion of 18q is unlikely.	THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,DIV MED GENET,PHILADELPHIA,PA; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX	Jefferson University; Jefferson University; Baylor College of Medicine					NHGRI NIH HHS [HG-00167] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BINKERT F, 1990, HUM HERED, V40, P81, DOI 10.1159/000153910; BLATTNER WA, 1980, J MED GENET, V17, P373, DOI 10.1136/jmg.17.5.373; CIRULLO RE, 1983, SOMAT CELL GENET, V8, P215; DANIEL A, 1979, J MED GENET, V16, P227, DOI 10.1136/jmg.16.3.227; DEGROUCHY J, 1984, CLIN ATLAS HUMAN CHR, P292; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRIED K, 1978, J MED GENET, V15, P76, DOI 10.1136/jmg.15.1.76; FRYNS JP, 1979, HUM GENET, V46, P341, DOI 10.1007/BF00273319; FRYNS JP, 1978, HUM GENET, V44, P201, DOI 10.1007/BF00295415; Jones K. L., 1988, SMITHS RECOGNIZABLE, P16; KLINE AD, 1993, AM J HUM GENET, V52, P895; KLINE AD, 1992, GENOMICS, V13, P1, DOI 10.1016/0888-7543(92)90193-V; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; MARION RW, 1988, J PEDIATR-US, V113, P45, DOI 10.1016/S0022-3476(88)80526-2; MATSUOKA R, 1981, HUM GENET, V57, P78; MEUCKE J, 1982, HUM GENET, V60, P205; NEU RL, 1976, J MED GENET, V13, P520, DOI 10.1136/jmg.13.6.520; NIEBUHR E, 1974, HUMANGENETIK, V21, P99, DOI 10.1007/BF00278575; PARK JP, 1987, CLIN GENET, V32, P342; TAYEL SM, 1988, AM J MED GENET, V31, P853, DOI 10.1002/ajmg.1320310419; TURLEAU C, 1977, CLIN GENET, V12, P361; TURLEAU C, 1980, CLIN GENET, V18, P20; VERMA RS, 1989, HUMAN CHROMOSOMES MA, P47; WILSON GN, 1990, AM J MED GENET, V36, P506, DOI 10.1002/ajmg.1320360427	24	26	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1269	1278						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	8250043				2022-12-18	WOS:A1993MJ81800014
J	OEHLMANN, R; ZLOTOGORA, J; WENGER, DA; KNOWLTON, RG				OEHLMANN, R; ZLOTOGORA, J; WENGER, DA; KNOWLTON, RG			LOCALIZATION OF THE KRABBE DISEASE GENE (GALC) AN CHROMOSOME-14 BY MULTIPOINT LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; LOCUS; RECOMBINATION; HUMANS	The gene responsible for Krabbe disease, an autosomal recessive disorder caused by deficiency of galactocerebrosidase (GALC), was localized by multipoint linkage analysis on chromosome 14. Eight mapped dinucleotide repeat polymorphisms were tested for linkage to GALC. Two-point linkage analysis demonstrated close linkage of GALC and D14S48, with (Z) over cap = 13.63 at <(theta)over cap> = 0. Multipoint analysis yielded strong support for this finding, with maximum likelihood for GALC located within 1 cM of D14S48. This analysis also identified markers that clearly flank the GALC locus, as the map order of D14S53-GALC-D14S45 is favored by odds greater than 10(6):1. Additional support for close linkage of GALC and D14S48 comes from the apparent linkage disequilibrium between these two loci in a consanguineous Druze community in Israel. These data localize GALC to 14q24.3-q32.1.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT MED, PHILADELPHIA, PA 19107 USA; HADASSAH MED CTR, DEPT HUMAN GENET, JERUSALEM, ISRAEL	Jefferson University; Jefferson University; Hebrew University of Jerusalem; Hadassah University Medical Center					NIAMS NIH HHS [AR39740, AR38923] Funding Source: Medline; NIDDK NIH HHS [DK38795] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923, P01AR039740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK038795, R01DK038795] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DONISKELLER H, 1992, SCIENCE, V258, P148; DONISKELLER H, 1992, SCIENCE, V258, P67; HOFKER MH, 1990, GENOMICS, V6, P33, DOI 10.1016/0888-7543(90)90445-Z; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LUTY JA, 1991, NUCLEIC ACIDS RES, V19, P4308, DOI 10.1093/nar/19.15.4308; LYERLA TA, 1989, AM J HUM GENET, V44, P198; Sambrook J., 1989, MOL CLONING LAB MANU; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; SUZUKI K, 1989, METABOLIC BASIS INHE, P1699; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WENGER DA, 1993, MOL GENETIC BASIS NE, P485; WENGER DA, 1991, TECHNIQUES DIAGNOSTI, P587; ZLOTOGORA J, 1985, AM J MED GENET, V21, P765, DOI 10.1002/ajmg.1320210420; ZLOTOGORA J, 1990, AM J HUM GENET, V47, P37	15	26	29	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1250	1255						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	8250040				2022-12-18	WOS:A1993MJ81800011
J	MAN, NT; MORRIS, GE				MAN, NT; MORRIS, GE			USE OF EPITOPE LIBRARIES TO IDENTIFY EXON-SPECIFIC MONOCLONAL-ANTIBODIES FOR CHARACTERIZATION OF ALTERED DYSTROPHINS IN MUSCULAR-DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR-BASIS; EXPRESSION VECTORS; SKELETAL-MUSCLE; POINT MUTATION; MESSENGER-RNA; DUCHENNE; DELETION; PROTEIN; GENE; IDENTIFICATION	The majority of mutations in Xp21-linked muscular dystrophy (MD) can be identified by PCR or Southern blotting, as deletions or duplications of groups of exons in the dystrophin gene, but it is not always possible to predict how much altered dystrophin, if any, will be produced. Use of exon-specific monoclonal antibodies (mAbs) on muscle biopsies from MD patients can, in principle, provide information on both the amount of altered dystrophin produced and, when dystrophin is present, the nature of the genetic deletion or point mutation. For this purpose, mAbs which recognize regions of dystrophin encoded by known exons and whose binding is unaffected by the absence of adjacent exons are required. To map mAbs to specific exons, random ''libraries'' of expressed dystrophin fragments were created by cloning DNAseI digestion fragments of a 4.3-kb dystrophin cDNA into a pTEX expression vector. The libraries were then used to locate the epitopes recognized by 48 mAbs to fragments of 25-60 amino acids within the 1,434-amino-acid dystrophin fragment used to produce the antibodies. This is sufficiently detailed to allow further refinement by using synthetic peptides and, in many cases, to identify the exon in the DMD (Duchenne MD) gene which encodes the epitope. To illustrate their use in dystrophin analysis, a Duchenne patient with a frameshift deletion of exons 42 and 43 makes a truncated dystrophin encoded by exons 1-41, and we now show that this can be detected in the sarcolemma by mAbs up to and including those specific for exon 41 epitopes but not by mAbs specific for exon 43 or later epitopes.	NE WALES INST, DIV RES, DEESIDE CH5 4BR, CLWYD, WALES	Glyndwr University								ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; BEGGS AH, 1991, AM J HUM GENET, V49, P54; Blake Derek J., 1992, Human Molecular Genetics, V1, P103, DOI 10.1093/hmg/1.2.103; BRESSAN GM, 1987, NUCLEIC ACIDS RES, V15, P10056, DOI 10.1093/nar/15.23.10056; BULMAN DE, 1991, GENOMICS, V10, P457, DOI 10.1016/0888-7543(91)90332-9; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CROSS RA, 1990, FEBS LETT, V262, P87, DOI 10.1016/0014-5793(90)80160-K; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; FORREST SM, 1987, NATURE, V329, P638, DOI 10.1038/329638a0; GANGOPADHYAY SB, 1992, AM J HUM GENET, V51, P562; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; HAYMERLE H, 1986, NUCLEIC ACIDS RES, V14, P8615, DOI 10.1093/nar/14.21.8615; HELLIWELL TR, 1992, AM J HUM GENET, V50, P508; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; HOFFMAN EP, 1989, J CELL BIOL, V108, P503, DOI 10.1083/jcb.108.2.503; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; MAN NT, 1990, FEBS LETT, V262, P237, DOI 10.1016/0014-5793(90)80199-S; MAN NT, 1990, FEBS LETT, V272, P109, DOI 10.1016/0014-5793(90)80460-Z; Maniatis T., 1982, MOL CLONING; Nguyen T M, 1991, J Cell Biol, V115, P1695, DOI 10.1083/jcb.115.6.1695; NGUYEN TM, 1992, BIOCHEM J, V288, P663, DOI 10.1042/bj2880663; NUDEL U, 1989, NATURE, V337, P76, DOI 10.1038/337076a0; READ AP, 1988, HUM GENET, V80, P152, DOI 10.1007/BF00702859; ROBERTS RG, 1992, P NATL ACAD SCI USA, V89, P2331, DOI 10.1073/pnas.89.6.2331; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D; ROBERTS RG, 1991, AM J HUM GENET, V49, P298; ROMISCH K, 1989, NATURE, V340, P478, DOI 10.1038/340478a0; SEDGWICK SG, 1991, NUCLEIC ACIDS RES, V19, P5889, DOI 10.1093/nar/19.21.5889; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Stanley K K, 1988, Methods Mol Biol, V4, P351, DOI 10.1385/0-89603-127-6:351; STANLEY KK, 1984, EMBO J, V3, P1429, DOI 10.1002/j.1460-2075.1984.tb01988.x; STANLEY KK, 1987, EMBO J, V6, P1951, DOI 10.1002/j.1460-2075.1987.tb02457.x	38	26	31	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1057	1066						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	7684887				2022-12-18	WOS:A1993LG13300006
J	WEIR, BS				WEIR, BS			INDEPENDENCE OF VNTR ALLELES DEFINED AS FLOATING BINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCI	Data bases of VNTR fragments determined for Caucasians and blacks by Cellmark Diagnostics and Lifecodes Corporation are analyzed for independence of variants within and between loci. Floating bins are constructed around specific fragment lengths and are used to define discrete genotypes. Simple chi2 test statistics for independence of bins within and between loci are described and applied to large sets of randomly generated four-locus profiles. The proportions of significant test statistics were about as expected under the hypotheses of independence, suggesting the absence of both Hardy-Weinberg and linkage disequilibrium. In any particular forensic application, however, these tests need to be performed on the fragments in question.			WEIR, BS (corresponding author), N CAROLINA STATE UNIV,DEPT STAT,PROGRAM STAT GENET,RALEIGH,NC 27695, USA.				NIGMS NIH HHS [GM45344] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berry DA, 1992, APPL STAT, V41, P499, DOI 10.1111/j.1467-9876.1992/tb02418.x; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; CHAKRABORTY R, 1991, SCIENCE, V254, P1735, DOI 10.1126/science.1763323; DEVLIN B, 1990, SCIENCE, V249, P1416, DOI 10.1126/science.2205919; DEVLIN B, 1991, AM J HUM GENET, V48, P662; HERNANDEZ JL, 1989, BIOMETRICS, V45, P53, DOI 10.2307/2532034; LEWONTIN RC, 1991, SCIENCE, V254, P1745, DOI 10.1126/science.1845040; NELSON SL, 1978, J QUAL TECHNOL, V10, P42; WEIR BS, 1992, GENETICS, V130, P873; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947	10	26	26	0	14	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					992	997						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415268				2022-12-18	WOS:A1992JU84000009
J	AINSWORTH, PJ; COULTERMACKIE, MB				AINSWORTH, PJ; COULTERMACKIE, MB			A DOUBLE MUTATION IN EXON-6 OF THE BETA-HEXOSAMINIDASE ALPHA SUBUNIT IN A PATIENT WITH THE B1 VARIANT OF TAY-SACHS DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GM2 GANGLIOSIDOSIS; GM2-GANGLIOSIDOSIS-B1 VARIANT; ASHKENAZI JEWISH; GENE; SEQUENCE; CHAIN; DNA; IDENTIFICATION; B1-VARIANT; DEFECT	The B1 variant form of Tay-Sachs disease is enzymologically unique in that the causative mutation(s) appear to affect the active site in the alpha subunit of beta-hexosaminidase A without altering its ability to associate with the beta subunit. Most previously reported B1 variant mutations were found in exon 5 within codon 178. The coding sequence of the alpha subunit gene of a patient with the B1 variant form was examined with a combination of reverse transcription of mRNA to cDNA, PCR, and dideoxy sequencing. A double mutation in exon 6 has been identified: a G574 --> C transversion causing a val192 --> leu change and a G598 --> A transition resulting in a val200 --> met alteration. The amplified cDNAs were otherwise normal throughout their sequence. The 574 and 598 alterations have been confirmed by amplification directly from genomic DNA from the patient and her mother. Transient-expression studies of the two exon 6 mutations (singly or together) in COS-1 cells show that the G574 --> C change is sufficient to cause the loss of enzyme activity. The biochemical phenotype of the 574 alteration in transfection studies is consistent with that expected for a B1 variant mutation. As such, this mutation differs from previously reported B1 variant mutations, all of which occur in exon 5.	CHILDRENS PSYCHIAT RES INST,600 SANAT RD,LONDON N6H 3W7,ONTARIO,CANADA; UNIV WESTERN ONTARIO,DEPT PAEDIAT,LONDON N6A 3K7,ONTARIO,CANADA; CHILD HLTH RES INST,MOLEC MED GENET PROGRAM,LONDON,ENGLAND	Western University (University of Western Ontario)				Coulter-Mackie, Marion/0000-0002-9552-2930				AINSWORTH PJ, 1991, NUCLEIC ACIDS RES, V19, P405, DOI 10.1093/nar/19.2.405; BAYLERAN J, 1984, CLIN CHIM ACTA, V143, P73, DOI 10.1016/0009-8981(84)90215-8; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BROWN CA, 1991, J BIOL CHEM, V266, P15855; BROWN CA, 1989, J BIOL CHEM, V264, P21705; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ELLIOTT J, 1991, HUM GENET, V86, P615; FERNANDES M, 1991, AM J HUM GENET S, V49, pA2289; GORDON BA, 1988, PEDIATR NEUROL, V4, P54, DOI 10.1016/0887-8994(88)90026-4; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; KYTZIA HJ, 1985, J BIOL CHEM, V260, P7568; LI SC, 1981, BIOCHEM BIOPH RES CO, V101, P479, DOI 10.1016/0006-291X(81)91285-7; LOWDEN JA, 1979, AM J HUM GENET, V31, P281; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHURAN DJ, 1990, CLIN BIOCHEM, V23, P409, DOI 10.1016/0009-9120(90)90153-L; MAHURAN DJ, 1991, BIOCHIM BIOPHYS ACTA, V1096, P87, DOI 10.1016/0925-4439(91)90044-A; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1986, SCIENCE, V232, P1646, DOI 10.1126/science.3754980; MYEROWITZ R, 1985, P NATL ACAD SCI USA, V82, P7830, DOI 10.1073/pnas.82.23.7830; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; NEUFELD EF, 1989, J BIOL CHEM, V264, P10927; OHNO K, 1988, J NEUROCHEM, V50, P316, DOI 10.1111/j.1471-4159.1988.tb13266.x; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; PROIA RL, 1987, J BIOL CHEM, V262, P5677; Sambrook J., 1989, MOL CLONING LAB MANU; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TANAKA A, 1990, AM J HUM GENET, V46, P329; TRIGGSRAINE BL, 1991, AM J HUM GENET, V49, P1041	31	26	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					802	809						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415222				2022-12-18	WOS:A1992JQ66700014
J	MULLER, B; MELKI, J; BURLET, P; CLERGETDARPOUX, F				MULLER, B; MELKI, J; BURLET, P; CLERGETDARPOUX, F			PROXIMAL SPINAL MUSCULAR-ATROPHY (SMA) TYPE-II AND TYPE-III IN THE SAME SIBSHIP ARE NOT CAUSED BY DIFFERENT ALLELES AT THE SMA LOCUS ON 5Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; CHROMOSOME-5; FAMILIES; MODEL; RFLP; M4	Proximal spinal muscular atrophy (SMA) is a group of progressive muscular diseases recently mapped to chromosome 5q. SMA is usually classified into types I-III, and there are cases of two types of SMA in the same sibship. Becker and others later proposed that these sibships might be due to the existence of several alleles at the same locus predisposing to the different forms of the disease. In a sample of four sibships in which both SMA type II and SMA type III occur, this hypothesis was clearly rejected for the SMA locus on 5q, by using information on the segregation of linked markers (P < .001). Thus the difference between SMA type II and SMA type III is not due to different alleles at the SMA locus on 5q. This finding is suggestive of an involvement of other factors, genetic or environmental, in the determination of disease severity in SMA.	HOP NECKER ENFANTS MALAD,INSERM,UNITE 12,F-75730 PARIS 15,FRANCE; INSERM,UNITE 155,F-75005 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	MULLER, B (corresponding author), KINDERPOLIKLIN MUNCHEN 2,PADIAT GENET & PRANATLE DIAGNOST ABT,GOETHESTK 29,W-8000 MUNICH 2,GERMANY.		Clerget-Darpoux, Francoise/I-4825-2017	Clerget-Darpoux, Francoise/0000-0003-4816-6619				ABDELHAK S, 1990, NUCLEIC ACIDS RES, V18, P5580, DOI 10.1093/nar/18.18.5580-a; ALITALO T, 1987, CYTOGENET CELL GENET, V46, P570; BECKER PE, 1964, Z MENSCHL VERERB KON, V37, P193; BOUWSMA G, 1986, CLIN GENET, V30, P145; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; DIETZSCH E, 1986, NUCLEIC ACIDS RES, V14, P1923, DOI 10.1093/nar/14.4.1923; DONISKELLER H, 1986, COLD SPRING HARB SYM, V51, P317, DOI 10.1101/SQB.1986.051.01.037; DUBOWITZ V, 1964, BRAIN, V87, P707, DOI 10.1093/brain/87.4.707; Dubowitz V, 1991, Neuromuscul Disord, V1, P77, DOI 10.1016/0960-8966(91)90051-S; Fisher R. A., 1956, STATISTICAL METHODS; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; KHAN PM, 1989, CYTOGENET CELL GENET, V51, P1043; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P649; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MULLER B, 1991, ANN HUM GENET, V55, P69, DOI 10.1111/j.1469-1809.1991.tb00399.x; Munsat TL., 1991, NEUROMUSCUL DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-t, DOI 10.1016/0960-8966(91)90052-T]; SHETH P, 1991, AM J HUM GENET, V48, P764; STEPHENS K, 1987, CYTOGENET CELL GENET, V46, P699; WEIFFENBACH B, 1989, CYTOGENET CELL GENET, V46, P699; ZERRES K, 1987, CLIN GENET, V31, P276; ZERRES K, 1983, HUM GENET, V65, P74, DOI 10.1007/BF00285033	23	26	27	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					892	895						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570842				2022-12-18	WOS:A1992HR47300002
J	TONNESEN, T; PETTERSON, A; KRUSE, TA; GERDES, AM; HORN, N				TONNESEN, T; PETTERSON, A; KRUSE, TA; GERDES, AM; HORN, N			MULTIPOINT LINKAGE ANALYSIS IN MENKES DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-CHROMOSOME; DNA PROBES; LONG ARM; CHOROIDEREMIA; DELETIONS; XQ21; LOCI	Linkage analyses were performed in 11 families with X-linked Menkes disease. In each family more than one affected patient had been diagnosed. Forty informative meioses were tested using 11 polymorphic DNA markers. From two-point linkage analyses high lod scores are seen for DXS146 (pTAK-8; maximal lod score 3.16 at recombination fraction [theta] = .0), for DXS1 (p-8; maximal lod score 3.44 at theta = .0), for PGK1 (maximal lod score 2.48 at theta = .0), and for DXS3 (p19-2; maximal lod score 2.90 at theta = .0). This indicates linkage to the pericentromeric region. Multilocus linkage analyses of the same data revealed a peak for the location score between DXS146(pTAK-8) and DXYS1X(pDP34). The most likely location is between DXS159 (cpX289) and DXYS1X(pDP34). Odds for this location relative to the second-best-supported region, between DXS146(pTAK-8) and DXS159 (cpX289), are better than 74:1. Visualization of individual recombinant X chromosomes in two of the Menkes families showed the Menkes locus to be situated between DXS159(cpX289) and DXS94(pXG-12). Combination of the present results with the reported absence of Menkes symptoms in male patients with deletions in Xq21 leads to the conclusion that the Menkes locus is proximal to DXSY1X(pDP34) and located in the region Xq12 to Xq13.3.	AARHUS UNIV,INST HUMAN GENET,DK-8000 AARHUS,DENMARK; ODENSE HOSP,DEPT CLIN CHEM,ODENSE,DENMARK	Aarhus University; University of Southern Denmark; Odense University Hospital	TONNESEN, T (corresponding author), JOHN F KENNEDY INST,GL LANDEVEJ 7,DK-2600 GLOSTRUP,DENMARK.			Gerdes, Anne-Marie/0000-0002-0328-3320				BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; CREMERS FPM, 1988, AM J HUM GENET, V43, P452; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; DANKS DM, 1972, PEDIATRICS, V50, P188; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GERDES AM, 1990, CLIN GENET, V38, P452; HORN N, 1984, ANN HUM GENET, V48, P161, DOI 10.1111/j.1469-1809.1984.tb01011.x; KAPUR S, 1987, AM J MED GENET, V26, P503, DOI 10.1002/ajmg.1320260230; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MERRY DE, 1989, AM J HUM GENET, V45, P530; SCHWARTZ M, 1988, HUM GENET, V78, P156, DOI 10.1007/BF00278188; TONNESEN T, 1991, HUM GENET, V86, P408; TONNESEN T, 1989, PRENATAL DIAG, V9, P159, DOI 10.1002/pd.1970090303; TONNESEN T, 1986, 7TH P INT C HUM GEN; TUMER Z, IN PRESS HUM GENET; VERGA V, 1991, AM J HUM GENET, V48, P1133; WIEACKER P, 1983, HUM GENET, V64, P139, DOI 10.1007/BF00327110; WIENKER TF, 1983, HUM GENET, V65, P72, DOI 10.1007/BF00285032; YANG HM, 1990, CLIN GENET, V38, P94	20	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					1012	1017						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570830				2022-12-18	WOS:A1992HR47300015
J	AUSTIN, MJF; COLLINS, JM; COREY, LA; NANCE, WE; NEALE, MC; SCHIEKEN, RM; BROWN, JA				AUSTIN, MJF; COLLINS, JM; COREY, LA; NANCE, WE; NEALE, MC; SCHIEKEN, RM; BROWN, JA			APHIDICOLIN-INDUCIBLE COMMON FRAGILE-SITE EXPRESSION - RESULTS FROM A POPULATION SURVEY OF TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME; COMMITTEE; NEOPLASIA; FOLATE; MODELS; LISREL; CANCER; DNA	Common chromosomal fragile sites appear to be ubiquitous in humans and other mammals, and, although the molecular basis and function of these sites remain an enigma, it has been speculated that they may be a cytogenetic expression of gene activity. A population survey of 28 twin pairs was conducted to assess the heritability of common fragile-site expression. Our data yielded a heritability estimate of .88 for total site expression, suggesting that these sites may result from some common process that is under relatively stringent genetic control. An analysis of the expression of individual autosomal sites revealed that expression on both homologues in the same cell occurred more frequently than expected.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PEDIAT,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT BIOCHEM & MOLEC BIOPHYS,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University			Neale, Michael C/B-1418-2008; Neale, Michael/AAD-5056-2020					AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; AKAIKE H, 1970, ANN I MATH, V21, P317; AUSTIN MJF, 1991, CANCER GENET CYTOGEN, V54, P71; BERGER R, 1985, CYTOGENET CELL GENET, V40, P490, DOI 10.1159/000132181; CRAIGHOLMES AP, 1987, HUM GENET, V76, P134, DOI 10.1007/BF00284909; DJALALI M, 1987, HUM GENET, V77, P157, DOI 10.1007/BF00272384; GLOVER TW, 1986, CANCER GENET CYTOGEN, V19, P141, DOI 10.1016/0165-4608(86)90381-X; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GREEN RJ, 1988, HUM GENET, V81, P9, DOI 10.1007/BF00283720; HEATH AC, 1989, BEHAV GENET, V19, P9, DOI 10.1007/BF01065881; HECHT F, 1988, CANCER GENET CYTOGEN, V31, P17, DOI 10.1016/0165-4608(88)90005-2; HECHT F, 1988, CANCER GENET CYTOGEN, V33, P1, DOI 10.1016/0165-4608(88)90042-8; HOLMQUIST G, 1982, CELL, V31, P121, DOI 10.1016/0092-8674(82)90411-1; KUWANO A, 1988, JPN J HUM GENET, V33, P355, DOI 10.1007/BF02032866; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; MIRO R, 1987, HUM GENET, V75, P345, DOI 10.1007/BF00284105; NEALE MC, 1989, BEHAV GENET, V19, P37, DOI 10.1007/BF01065882; ROA PN, 1988, HUM GENET, V79, P329; ROA PN, 1988, HUM GENET, V78, P21; ROBINSON TJ, 1987, CHROMOSOMA, V96, P45, DOI 10.1007/BF00285882; SETLOW RB, 1983, HUMAN CARCINOGENESIS, P231; Sorbon D., 1986, LISREL ANAL LINEAR S; STEEL RGD, 1980, PRINCIPLES PROCEDURE, P528; STOEN DM, 1988, AM J HUM GENET S, V43, pA34; SUMMER, 1981, ANTICANCER RES, V1, P205; SUTHERLAND GR, 1987, CYTOGENET CELL GENET, V46, P316, DOI 10.1159/000132482; YUNIS JJ, 1987, ONCOGENE, V1, P59; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; 1985, INT SYSTEM HUMAN CYT, P66	29	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					76	83						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1729897				2022-12-18	WOS:A1992HA04000009
J	GILL, TJ				GILL, TJ			INFLUENCE OF MHC AND MHC-LINKED GENES ON REPRODUCTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							RECURRENT SPONTANEOUS-ABORTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NEURAL-TUBE DEFECTS; HLA COMPATIBILITY; PERFORMANCE; PREGNANCY; ANTIGEN; POLYMORPHISM; FERTILITY; SELECTION				GILL, TJ (corresponding author), UNIV PITTSBURGH, SCH MED, DEPT PATHOL, PITTSBURGH, PA 15261 USA.							ALPER CA, 1986, HUM IMMUNOL, V15, P366, DOI 10.1016/0198-8859(86)90013-3; BEER AE, 1974, J REPROD FERTIL, P59; BILLINGHAM RE, 1964, NEW ENGL J MED, V270, P667, DOI 10.1056/NEJM196403262701306; CAUCHI MN, 1991, AM J REPROD IMMUNOL, V25, P16, DOI 10.1111/j.1600-0897.1991.tb01057.x; CHAOUAT G, 1983, J REPROD IMMUNOL, V5, P389, DOI 10.1016/0165-0378(83)90248-6; CLARK DA, 1980, CELL IMMUNOL, V52, P106, DOI 10.1016/0008-8749(80)90404-9; CLARK DA, 1991, AM J REPROD IMMUNOL, V25, P18, DOI 10.1111/j.1600-0897.1991.tb01058.x; CLARK DA, 1991, ANN NY ACAD SCI, V626, P524; COULAM CB, 1986, AM J REPROD IMMUNOL, V12, P10; COULAM CB, 1991, AM J REPROD IMMUNOL, V25, P96, DOI 10.1111/j.1600-0897.1991.tb01073.x; COULAM CB, 1989, AM J REPROD IMMUNOL, V21, P105, DOI 10.1111/j.1600-0897.1989.tb01012.x; COULAM CB, 1987, AM J REPROD IMMUNOL, V14, P54; DEGOS L, 1974, NATURE, V249, P62, DOI 10.1038/249062a0; Gill T J 3rd, 1984, Biochim Biophys Acta, V738, P93, DOI 10.1016/0304-419X(84)90008-8; GILL TJ, 1987, AM J REPROD IM MIC, V15, P133; GILL TJ, 1983, J EXP ZOOL, V228, P325, DOI 10.1002/jez.1402280216; GILL TJ, 1983, TRANSPLANTATION, V35, P1; GILL TJ, 1990, IMMUNOLOGY FETUS, P293; GILL TJ, IN PRESS IMMUNOLOGIC; GUILBERT LJ, 1991, MOLECULAR AND CELLULAR IMMUNOBIOLOGY OF THE MATERNAL FETAL INTERFACE, P261; HEDRICK PW, 1988, GENETICS, V119, P205; HEDRICK PW, 1988, GENETICS, V119, P199; HO HN, 1990, AM J OBSTET GYNECOL, V163, P178, DOI 10.1016/S0002-9378(11)90696-6; HO HN, 1989, AM J OBSTET GYNECOL, V161, P942, DOI 10.1016/0002-9378(89)90758-8; HO HN, 1991, AM J OBSTET GYNECOL, V165, P461, DOI 10.1016/0002-9378(91)90117-A; HO HN, 1991, AM J REPROD IMMUNOL, V25, P10, DOI 10.1111/j.1600-0897.1991.tb01056.x; KNUDSON AG, 1985, CANCER RES, V45, P1437; KUNZ HW, 1980, J EXP MED, V152, P1506, DOI 10.1084/jem.152.6.1506; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; MELHEM MF, 1989, CANCER RES, V49, P6813; MELHEM MF, 1991, AM J PATHOL, V139, P45; MOWBRAY JF, 1991, AM J REPROD IMMUNOL, V26, P17, DOI 10.1111/j.1600-0897.1991.tb00695.x; MOWBRAY JF, 1985, LANCET, V1, P941; OBER C, 1987, AM J REPROD IMMUNOL, V15, P141; OBER C, 1988, AM J REPROD IM MIC, V18, P111; OBER C, 1991, AM J HUM GENET, V50; OBER CL, 1985, FERTIL STERIL, V44, P227; OBER CL, 1983, AM J HUM GENET, V35, P994; Osborn S, 1860, CELLULAR PATHOLOGY B; REZNIKOFFETIEVA.MF, 1988, EARLY PREGNANCY LOSS, P375; SCHACTER B, 1984, AM J HUM GENET, V36, P1082; SCHAID DJ, 1982, GENETICS, V100, P615; STRICKBERGERMW, 1986, GENETICS; TAKEUCHI S, 1990, AM J REPROD IMMUNOL, V24, P108; VARDIMON D, IN PRESS IMMUNOGENET; WEITKAMP LR, 1985, NEW ENGL J MED, V313, P925, DOI 10.1056/NEJM198510103131505	46	26	28	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					1	5						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1729882				2022-12-18	WOS:A1992HA04000001
J	FEIL, R; AUBOURG, P; MOSSER, J; DOUAR, AM; LEPASLIER, D; PHILIPPE, C; MANDEL, JL				FEIL, R; AUBOURG, P; MOSSER, J; DOUAR, AM; LEPASLIER, D; PHILIPPE, C; MANDEL, JL			ADRENOLEUKODYSTROPHY - A COMPLEX CHROMOSOMAL REARRANGEMENT IN THE XQ28 RED GREEN-COLOR-PIGMENT GENE REGION INDICATES 2 POSSIBLE GENE LOCALIZATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOME; BLUE CONE MONOCHROMACY; MOLECULAR-GENETICS; HUMAN GENOME; RAPID METHOD; DNA; VISION; DELETIONS; LINKAGE; CLONING	We have characterized a complex chromosomal rearrangement in band Xq28, in an adrenoleukodystrophy patient who also has blue-cone monochromacy. A 130-kb region upstream from the color-vision pigment genes was isolated as yeast artificial chromosome or cosmid clones. Another Xq28 sequence, not included in the above region, was obtained by cloning a deletion breakpoint from the patient. Using probes derived from the cloned sequences, we have shown that the rearrangement affects the color-pigment genes and includes two deletions, most likely separated by a large (> 110-kb) inversion. One deletion encompasses part of the pigment gene duster and 33 kb of upstream sequences and accounts for the patient's blue-cone monochromacy. If this rearrangement also caused ALD, the disease gene would be expected to lie within or close to one of the deletions. However, deletions were not detected in a 50-kb region upstream of the red-color-pigment gene in 81 other ALD patients. Two CpG islands were mapped, at 46 and 115 kb upstream from the pigment genes.	FAC MED STRASBOURG,INST CHIM BIOL,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE; HOP ST VINCENT DE PAUL,INSERM,U342,F-75674 PARIS 14,FRANCE; CTR ETUD POLYMORPHISME HUMAIN,PARIS,FRANCE; CTR TRANSFUS,CYTOGENET LAB,VANDOEUVRE NANCY,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	MANDEL, JL (corresponding author), FAC MED STRASBOURG,INST CHIM BIOL,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE.		Feil, Robert P/D-2087-2013	Feil, Robert P/0000-0002-5671-5860; Le Paslier, Denis/0000-0003-4335-9956; PHILIPPE, Christophe/0000-0001-7098-6520				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ARVEILER B, 1989, GENOMICS, V4, P460, DOI 10.1016/0888-7543(89)90269-3; AUBOURG P, 1990, AM J HUM GENET, V46, P459; AUBOURG PR, 1987, ANN NEUROL, V21, P349, DOI 10.1002/ana.410210406; AUBOURG PR, 1988, AM J HUM GENET, V42, P408; BELLIS M, 1987, NUCLEIC ACIDS RES, V15, P6749, DOI 10.1093/nar/15.16.6749; BROWN WT, 1991, AM J MED GENET, V38, P343, DOI 10.1002/ajmg.1320380235; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; DAVIES KE, 1990, CYTOGENET CELL GENET, V55, P254, DOI 10.1159/000133019; DELMASTRO RG, 1990, J MED GENET, V27, P670, DOI 10.1136/jmg.27.11.670; DUSART D, IN PRESS AM J MED GE; FEIL R, 1990, AM J HUM GENET, V46, P720; FEIL R, 1990, GENOMICS, V6, P367, DOI 10.1016/0888-7543(90)90578-I; HOLM C, 1986, GENE, V42, P169, DOI 10.1016/0378-1119(86)90293-3; JENNINGS MW, 1985, NUCLEIC ACIDS RES, V13, P2897, DOI 10.1093/nar/13.8.2897; KARATHANASIS SK, 1987, P NATL ACAD SCI USA, V84, P7198, DOI 10.1073/pnas.84.20.7198; KARN J, 1984, GENE, V32, P217, DOI 10.1016/0378-1119(84)90049-0; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; LEWIS RA, 1987, ARCH OPHTHALMOL-CHIC, V105, P1055, DOI 10.1001/archopht.1987.01060080057028; MACDONALD D, 1991, NATURE, V350, P115, DOI 10.1038/350115a0; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; Moser HW, 1989, METABOLIC BASIS INHE; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEZARATI M M, 1989, American Journal of Human Genetics, V45, pA154; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; POUSTKA AM, IN PRESS P NATL ACAD; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SACK GH, 1989, AM J HUM GENET, V44, P794; SCHONK D, 1989, GENOMICS, V4, P384, DOI 10.1016/0888-7543(89)90346-7; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; TRASK BJ, 1991, AM J HUM GENET, V48, P1; VANOOST BA, 1991, HUM GENET, V86, P404, DOI 10.1007/BF00201845; WANDERS RJA, 1988, BIOCHEM BIOPH RES CO, V153, P618, DOI 10.1016/S0006-291X(88)81140-9; WEICHHOLD GM, 1990, NATURE, V347, P90, DOI 10.1038/347090a0; WILLEMS PJ, 1990, ARCH NEUROL-CHICAGO, V47, P665, DOI 10.1001/archneur.1990.00530060077022; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8; YOUSSOUFIAN H, 1987, P NATL ACAD SCI USA, V84, P3772, DOI 10.1073/pnas.84.11.3772	39	26	27	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1361	1371						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746561				2022-12-18	WOS:A1991GU67200024
J	WALTER, MA; COX, DW				WALTER, MA; COX, DW			NONUNIFORM LINKAGE DISEQUILIBRIUM WITHIN A 1,500-KB REGION OF THE HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN COMPLEX	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGMENT LENGTH POLYMORPHISMS; GLOBIN GENE-CLUSTER; IG VH LOCUS; SUBCLASS LOCUS; RECOMBINATION; RESTRICTION; ORGANIZATION; FAMILY; DNA; CHROMOSOME-14	We have characterized 10 VH polymorphic loci of the VH2, VH3, VH4, and VH5 families. Eight of 10 VH polymorphisms were found to be insertion/deletion polymorphisms, probably the result of nonhomologous recombination over the course of evolution of the current human VH repertoire. The 10 VH polymorphic loci were analyzed in 10 three-generation and 10 two-generation Canadian caucasoid families. Linkage disequilibrium (allelic association) was measured between pairs of VH polymorphic loci, and 12 significant associations were found. The degree of linkage disequilibrium measured between IGH polymorphic loci was then compared with the physical distance separating the loci. The physical distance between IGH polymorphic loci does not entirely determine the degree of linkage disequilibrium between polymorphic loci. Two regions, one in the VH region (between VH3f-2 and VH5-2 and one in the CH region (between C-delta and C-gamma-3), were found to have linkage disequilibrium values approximately 1/3,000 of that observed in other portions of the IGH region. The previous identification of recombinants in the C-delta- to C-gamma-3 region indicates that these areas of low linkage disequilibrium are consistent with the presence of recombination hot spots. The observed high amount of recombination in the subtelomeric portion of chromosome 14 therefore appears to be the result of specific hot spots for recombination, rather than a general increase in recombination in this region.	HOSP SICK CHILDREN, RES INST, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV TORONTO, DEPT MED GENET, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, DEPT PAEDIAT, TORONTO M5S 1A1, ONTARIO, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto								BARKER D, 1984, AM J HUM GENET, V36, P1159; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BENGER JC, 1989, AM J HUM GENET, V45, P606; BENGER JC, 1991, GENOMICS, V9, P614, DOI 10.1016/0888-7543(91)90354-H; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; BOTTARO A, 1989, GENOMICS, V4, P505, DOI 10.1016/0888-7543(89)90273-5; BULUWELA L, 1988, EUR J IMMUNOL, V18, P1843, DOI 10.1002/eji.1830181130; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1986, AM J HUM GENET, V38, P779; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHEN PP, 1989, J CLIN INVEST, V84, P706, DOI 10.1172/JCI114218; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; GERHARD DS, 1984, P NATL ACAD SCI-BIOL, V81, P7875, DOI 10.1073/pnas.81.24.7875; GHANEM N, 1988, EUR J IMMUNOL, V18, P1059, DOI 10.1002/eji.1830180714; GUIDON N, 1986, NATURE, V321, P769, DOI 10.1038/321769a0; HENDRICK PW, 1988, HEREDITY, V60, P435; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HOFKER MH, 1990, GENOMICS, V6, P33, DOI 10.1016/0888-7543(90)90445-Z; HOFKER MH, 1989, P NATL ACAD SCI USA, V86, P5567, DOI 10.1073/pnas.86.14.5567; JOHNSON MJ, 1986, AM J HUM GENET, V38, P617; JOHNSON MJ, 1984, P NATL ACAD SCI-BIOL, V81, P7840, DOI 10.1073/pnas.81.24.7840; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1964, GENETICS, V49, P49; LINSLEY PS, 1983, P NATL ACAD SCI-BIOL, V80, P1997, DOI 10.1073/pnas.80.7.1997; LITT M, 1986, AM J HUM GENET, V39, P166; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; MATSUDA F, 1988, EMBO J, V7, P1047, DOI 10.1002/j.1460-2075.1988.tb02912.x; MATTHYSSENS G, 1980, P NATL ACAD SCI USA, V77, P6951; MEYER J, 1986, P NATL ACAD SCI USA, V83, P6950, DOI 10.1073/pnas.83.18.6950; MIGONE N, 1985, AM J HUM GENET, V37, P1146; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; NAKAMURA Y, 1989, GENOMICS, V4, P76, DOI 10.1016/0888-7543(89)90317-0; SAM M, 1988, NUCLEIC ACIDS RES, V16, P8748, DOI 10.1093/nar/16.17.8748; SANZ I, 1989, EMBO J, V8, P3741, DOI 10.1002/j.1460-2075.1989.tb08550.x; SCHANFIELD MS, 1986, HDB EXPT IMMUNOLOGY, V3; SCHROEDER HW, 1988, P NATL ACAD SCI USA, V85, P8196, DOI 10.1073/pnas.85.21.8196; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; SHEN A, 1987, P NATL ACAD SCI USA, V84, P8563, DOI 10.1073/pnas.84.23.8563; SOUROUJON MC, 1989, J IMMUNOL, V143, P706; Steel R.G.D., 1980, PRINCIPLES STAT; SVED J A, 1971, Theoretical Population Biology, V2, P125; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; VANDIJK KW, 1989, J IMMUNOL, V142, P2547; VANLOGHEM E, 1971, ANN NY ACAD SCI, V190, P136; VANLOGHEM E, 1970, VOX SANG, V18, P421; WALTER MA, 1988, AM J HUM GENET, V42, P446; WALTER MA, 1987, NUCLEIC ACIDS RES, V15, P4697, DOI 10.1093/nar/15.11.4697; WALTER MA, 1990, EMBO J, V9, P3303, DOI 10.1002/j.1460-2075.1990.tb07530.x; WALTER MA, 1991, J EXP MED, V174, P335, DOI 10.1084/jem.174.2.335	54	26	26	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					917	931						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1928097				2022-12-18	WOS:A1991GM87300002
J	DEVOR, EJ; CLONINGER, CR; HOFFMAN, PL; TABAKOFF, B				DEVOR, EJ; CLONINGER, CR; HOFFMAN, PL; TABAKOFF, B			A GENETIC-STUDY OF PLATELET ADENYLATE-CYCLASE ACTIVITY - EVIDENCE FOR A SINGLE MAJOR LOCUS EFFECT IN FLUORIDE-STIMULATED ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; ALCOHOLISM; HETEROGENEITY; MODEL	The activity of membrane-bound platelet adenylate cyclase, when stimulated in vitro by several compounds (including fluoride), is significantly reduced in alcoholics compared with control subjects. We have begun a study of the genetics of this enzyme activity. Complex segregation analysis of basal (unstimulated) platelet adenylate cyclase activity in families reveals a mode of inheritance that cannot be accounted for by a simple mixed model of transmission. By contrast, adenylate cyclase activity stimulated by fluoride ion reveals a single major locus effect with a modest multifactorial background. These results suggest that a single factor in the second-messenger pathway may (a) account for the majority of individual differences in stimulation of adenylate cyclase of fluoride and (b) help explain the reduced activities previously observed in alcoholics.	NIAAA,DIV INTRAMURAL CLIN & BIOL RES,BETHESDA,MD; UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,DENVER,CO 80262	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	DEVOR, EJ (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,4940 AUDUBON,ST LOUIS,MO 63110, USA.		Cloninger, Claude/F-5357-2012; Tabakoff, Boris/AAX-1204-2021	Cloninger, Claude/0000-0003-3096-4807; 	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH031302, P30MH031302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA003539] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA-03539] Funding Source: Medline; NIMH NIH HHS [MH-31302] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CLONINGER CR, 1989, GENETIC ASPECTS ALCO, P55; CLONINGER CR, 1989, ALCOHOL RES BENCH BE, P3; CORASH L, 1980, SCHIZOPHRENIA BULL, V6, P254, DOI 10.1093/schbul/6.2.254; DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.ge.23.120189.000315; DEVOR EJ, 1988, SEMIN LIVER DIS, V8, P1, DOI 10.1055/s-2008-1040524; DIAMOND I, 1987, P NATL ACAD SCI USA, V84, P1413, DOI 10.1073/pnas.84.5.1413; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; FREISSMUTH M, 1989, FASEB J, V3, P2125, DOI 10.1096/fasebj.3.10.2546847; GILLIGAN SB, 1987, GENET EPIDEMIOL, V4, P395, DOI 10.1002/gepi.1370040602; IYENGAR R, 1990, G PROTEINS; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1983, AM J HUM GENET; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SMIGEL MD, 1986, J BIOL CHEM, V261, P1976; TABAKOFF B, 1988, NEW ENGL J MED, V318, P134, DOI 10.1056/NEJM198801213180302; VALVERIUS P, 1989, J NEUROCHEM, V52, P492, DOI 10.1111/j.1471-4159.1989.tb09147.x	21	26	26	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					372	377						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867196				2022-12-18	WOS:A1991GA86600013
J	CLERGETDARPOUX, F; BABRON, MC; DESCHAMPS, I; HORS, J				CLERGETDARPOUX, F; BABRON, MC; DESCHAMPS, I; HORS, J			COMPLEMENTATION AND MATERNAL EFFECT IN INSULIN-DEPENDENT DIABETES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC MODELS; MASC METHOD; MELLITUS; SUSCEPTIBILITY	The marker association segregation chi-square (MASC) method was applied to a sample of 416 Caucasians affected with insulin-dependent diabetes mellitus (IDDM), for which information on the parental and sibship status was available, as well as HLA typing. We show that the model which best explains all the observations assumes a cis or trans complementation of two tightly linked genes within the HLA region, an additional maternal effect, and other familial factors. The HLA molecule corresponding to the complementation of Arg52(+) and Asp57(-) has been recently proposed as explaining susceptibility to IDDM. However, this hypothesis does not account for the overall observations made on the HLA marker in IDDM patients and their relatives. The MASC method may also be applied to evaluate the risk for relatives of an affected individual (the "index"). For example, the risk for a sib depends not only on the parental status and on the number of HLA haplotypes he shares with the index, but also on which haplotype the index himself inherited from his mother and father.	HOP ST LOUIS,INSERM,U93,UNITE RECH IMMUNOGENET TRANSPLANTAT,F-75010 PARIS,FRANCE; HOP ENFANTS MALAD,INSERM,U30,UNITE ENDOCRINOL & DIABET ENFANT,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	CLERGETDARPOUX, F (corresponding author), INSERM,U155,UNITE RECH GENET EPIDEMIOL,CHATEAU LONGCHAMP,F-75016 PARIS,FRANCE.		; Clerget-Darpoux, Francoise/I-4825-2017	Babron, Marie-Claude/0000-0002-4100-0299; Clerget-Darpoux, Francoise/0000-0003-4816-6619				BAUR MP, 1984, HISTOCOMPATIBILITY T, P677; CLERGET-DARPOUX F, 1986, Genetic Epidemiology, V3, P313, DOI 10.1002/gepi.1370030747; CLERGETDARPOUX F, 1988, ANN HUM GENET, V52, P247, DOI 10.1111/j.1469-1809.1988.tb01102.x; CLERGETDARPOUX F, 1989, GENET EPIDEMIOL, V6, P59, DOI 10.1002/gepi.1370060112; DESCHAMPS I, 1990, DIABETOLOGIA, V33, P425, DOI 10.1007/BF00404094; HODGE SE, 1980, ANN HUM GENET, V43, P349; JARRETT RJ, 1982, GENETICS DIABETES ME, P13; KHALIL I, 1990, J CLIN INVEST, V85, P1315, DOI 10.1172/JCI114569; LOUIS EJ, 1986, DIABETES, V35, P958, DOI 10.2337/diabetes.35.9.958; PRUM B, 1990, ANN HUM GENET, V54, P315, DOI 10.1111/j.1469-1809.1990.tb00387.x; RAO DC, 1989, GENET EPIDEMIOL, V6; RAO DC, 1986, GENET EPIDEMIOL S1, V3; RISCH N, 1984, AM J HUM GENET, V36, P363; RISCH N, 1987, AM J HUM GENET, V40, P1; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0	15	26	26	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					42	48						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063876				2022-12-18	WOS:A1991FW51100006
J	KAPLAN, F; CLOW, C; SCRIVER, CR				KAPLAN, F; CLOW, C; SCRIVER, CR			CYSTIC-FIBROSIS CARRIER SCREENING BY DNA ANALYSIS - A PILOT-STUDY OF ATTITUDES AMONG PARTICIPANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DISEASE; GENE				KAPLAN, F (corresponding author), MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEBELLE LAB BIOCHEM & MOLEC GENET,MONTREAL H3H 1P3,QUEBEC,CANADA.							BEAUDET AL, 1990, AM J HUM GENET, V47, P603; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CASKEY CT, 1990, AM J HUM GENET, V46, P393; CLOW CL, 1977, PEDIATRICS, V59, P86; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; SCRIVER CR, 1984, AM J HUM GENET, V36, P1024; TRIGGSRAINE BL, 1990, AM J HUM GENET, V46, P183; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; 1990, HUM GENET, V85, P436	10	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					240	242						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	FW511	2063873				2022-12-18	WOS:A1991FW51100027
J	BOTTARO, A; CARIOTA, U; DEMARCHI, M; CARBONARA, AO				BOTTARO, A; CARIOTA, U; DEMARCHI, M; CARBONARA, AO			PULSED-FIELD ELECTROPHORESIS SCREENING FOR IMMUNOGLOBULIN HEAVY-CHAIN CONSTANT-REGION (IGHC) MULTIGENE DELETIONS AND DUPLICATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE DELETIONS; GAMMA-GENES; GENOMIC ORGANIZATION; GEL-ELECTROPHORESIS; LOCUS; POLYMORPHISMS; MULTIPLE; EVOLUTION; CLUSTER; COMPLEX	Genome regions containing multiple copies of homologous genes, such as the immunoglobulin (Ig) heavy-chain constant-region (IGHC) locus, are often unstable and give rise to duplicated and deleted haplotypes. Analysis of such processes is fundamental to understanding the mechanisms of evolution of multigene families. In the IGHC region, a number of single and multiple gene deletions, derived from either unequal crossing-over or looping-out excision, have been described. To study these haplotypes at the population level, a simple and efficient method for preparing large numbers of DNA samples suitable for pulsed-field gel electrophoresis (PFGE) analysis was set up, and a sample of 110 blood donors was screened. Deletions were found to be frequent, as expected on the basis of previous serological surveys for homozygotes. Furthermore, a number of multigene duplications, never identified before, were detected. The total frequency of individuals bearing rearranged IGHC haplotypes was 10%. The genes involved in these deletions and duplications were assessed by densitometric analysis of standard Southern blots hybridized with several IGHC probes; two types of deletion and two types of duplication could thus be characterized. These data provide further evidence of the instability of the IGHC locus and demonstrate that unequal crossing-over is the most likely origin of rearranged IGHC haplotypes; they also suggest that such recombination events may be relatively frequent. Moreover, the simplicity and effectiveness of the large-scale PFGE screening approach will be of great help in the study of multigene families and of other loci involved in aberrant recombinations.	DIPARTIMENTO GENET BIOL & CHIM MED, SEZ GENET, VIA SANTENA 19, I-10126 TURIN, ITALY; CNR, CTR IMMUNOGENET & ISTOCOMPATIBIL, TURIN, ITALY; UNIV SIENA, CATTEDRA GENET MED, I-53100 SIENA, ITALY	Consiglio Nazionale delle Ricerche (CNR); University of Siena			Bottaro, Andrea/L-1831-2017; De Marchi, Mario E./G-7558-2011	Bottaro, Andrea/0000-0003-1712-6796; De Marchi, Mario E./0000-0002-6425-3205				BAAS F, 1984, HUM GENET, V67, P301, DOI 10.1007/BF00291357; BATTEY J, 1982, P NATL ACAD SCI-BIOL, V79, P5956, DOI 10.1073/pnas.79.19.5956; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BECHHANSEN NT, 1986, AM J HUM GENET, V38, P67; BENGER JC, 1989, AM J HUM GENET, V45, P606; BOTTARO A, 1989, EUR J IMMUNOL, V19, P2151, DOI 10.1002/eji.1830191127; BOTTARO A, 1989, GENOMICS, V4, P505, DOI 10.1016/0888-7543(89)90273-5; BOTTARO A, 1989, EXP CLIN IMMUNOGENET, V6, P55; BOTTARO A, 1989, IMMUNOGENETICS, V29, P44, DOI 10.1007/BF02341612; BOTTARO A, IN PRESS HUM GENET; CARBONARA AO, 1986, SERONO S, V28, P219; CHAABANI H, 1985, AM J HUM GENET, V37, P1164; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; DUNHAM I, 1989, J EXP MED, V169, P1803, DOI 10.1084/jem.169.5.1803; DUNHAM I, 1989, GENOMICS, V5, P787, DOI 10.1016/0888-7543(89)90120-1; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; HAMMARSTROM L, 1987, SCAND J IMMUNOL, V25, P189, DOI 10.1111/j.1365-3083.1987.tb01063.x; HENDRIKS RW, 1989, SCAND J IMMUNOL, V29, P535, DOI 10.1111/j.1365-3083.1989.tb01156.x; HISAJIMA H, 1983, P NATL ACAD SCI-BIOL, V80, P2995, DOI 10.1073/pnas.80.10.2995; HOFKER MH, 1989, P NATL ACAD SCI USA, V86, P5567, DOI 10.1073/pnas.86.14.5567; HOOD L, 1975, ANNU REV GENET, V9, P305, DOI 10.1146/annurev.ge.09.120175.001513; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; KEYEUX G, 1989, NUCLEIC ACIDS RES, V17, P3624, DOI 10.1093/nar/17.9.3624; KEYEUX G, 1989, GENOMICS, V5, P431, DOI 10.1016/0888-7543(89)90006-2; KIRSCH IR, 1982, SCIENCE, V216, P301, DOI 10.1126/science.6801764; LEFRANC G, 1983, EUR J IMMUNOL, V13, P240, DOI 10.1002/eji.1830130312; Lefranc M P, 1983, Mol Biol Med, V1, P207; LEFRANC MP, 1984, NUCLEIC ACIDS RES, V12, P1303, DOI 10.1093/nar/12.3.1303; LEFRANC MP, 1982, NATURE, V300, P760, DOI 10.1038/300760a0; MAEDA N, 1986, ANNU REV GENET, V20, P81; MIGONE N, 1985, AM J HUM GENET, V37, P1146; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; MIGONE N, 1984, P NATL ACAD SCI-BIOL, V81, P5811, DOI 10.1073/pnas.81.18.5811; POUSTKA A, 1987, NATURE, V325, P353, DOI 10.1038/325353a0; PUTZOLU P, 1989, IMAGE ANAL NEUROHIST, P129; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; SMITH CIE, 1989, J IMMUNOL, V142, P4514; SMITH CIE, 1989, PROGR IMMUNOLOGY, V7, P547; SMITH CL, 1987, METHOD ENZYMOL, V155, P449; TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0; VANLOGHEM E, 1980, J IMMUNOGENET, V7, P285	42	26	26	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					745	756						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	1901690				2022-12-18	WOS:A1991FK47800014
J	LABERGE, C; GRENIER, A; VALET, JP; MORISSETTE, J				LABERGE, C; GRENIER, A; VALET, JP; MORISSETTE, J			FUMARYLACETOACETASE MEASUREMENT AS A MASS-SCREENING PROCEDURE FOR HEREDITARY TYROSINEMIA TYPE-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											LABERGE, C (corresponding author), LAVAL UNIV,MED CTR,DEPT GENET MED,ROOM 9355,2705 BLVD LAURIER,ST FOY G1V 4G2,QUEBEC,CANADA.							BERGER R, 1987, PEDIATR RES, V22, P394, DOI 10.1203/00006450-198710000-00005; ENGVALL E, 1972, J IMMUNOL, V109, P129; GRENIER A, 1982, CLIN CHIM ACTA, V123, P93, DOI 10.1016/0009-8981(82)90117-6; GRENIER A, 1974, CLIN CHIM ACTA, V57, P71, DOI 10.1016/0009-8981(74)90179-X; GRENIER A, 1976, CLIN CHEM, V22, P1001; HOLME E, 1985, LANCET, V1, P527; HSIANG HH, 1972, BIOCHEMISTRY-US, V11, P2098, DOI 10.1021/bi00761a016; KVITTINGEN EA, 1985, CLIN GENET, V27, P550; KVITTINGEN EA, 1983, PEDIATR RES, V14, P541; LABERGE C, 1985, ALPHA FETOPROTEIN CO, P123; LINDBLAD B, 1986, J INHERIT METAB DIS, V9, P257, DOI 10.1007/BF01799722; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; NICOLE LM, 1986, BIOCHEM CELL BIOL, V64, P489, DOI 10.1139/o86-068; TANGUAY RM, 1984, ADV GENE TECHNOLOGY, P256	14	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					325	328						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378358				2022-12-18	WOS:A1990DT87100019
J	ELLIS, N; KIDD, J; GOODFELLOW, PJ; KIDD, K; GOODFELLOW, PN				ELLIS, N; KIDD, J; GOODFELLOW, PJ; KIDD, K; GOODFELLOW, PN			STRONG LINKAGE DISEQUILIBRIUM BETWEEN THE XY274 POLYMORPHISM AND THE PSEUDOAUTOSOMAL BOUNDARY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Yale University	ELLIS, N (corresponding author), IMPERIAL CANC RES FUND,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.							Bowcock A M, 1987, Gene Geogr, V1, P47; BROWN WRA, 1988, EMBO J, V7, P2377, DOI 10.1002/j.1460-2075.1988.tb03082.x; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; ELLIS NA, 1989, NATURE, V337, P81, DOI 10.1038/337081a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLINT J, 1989, HUM GENET, V83, P257, DOI 10.1007/BF00285167; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; RAMSAY M, 1988, AM J HUM GENET, V43, P527; WEISSENBACH J, 1987, DEVELOPMENT, V101, P67	11	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					950	955						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	2339693				2022-12-18	WOS:A1990DD89600013
J	GILBERT, F				GILBERT, F			IS POPULATION SCREENING FOR CYSTIC-FIBROSIS APPROPRIATE NOW	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											GILBERT, F (corresponding author), CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021, USA.							BEAUDET AL, 1989, AM J HUM GENET, V44, P319; CUTTING GR, 1989, AM J HUM GENET, V44, P307; ESTIVILL X, 1988, AM J HUM GENET, V43, P23; GOODFELLOW PN, 1989, NATURE, V341, P102, DOI 10.1038/341102a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; MULIVOR RA, 1987, AM J HUM GENET, V40, P131; STEWART AD, 1989, NATURE, V341, P696, DOI 10.1038/341696b0	7	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					394	395						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	1967902				2022-12-18	WOS:A1990CM93800022
J	HOEFSLOOT, LH; VANDERPLOEG, AT; KROOS, MA; HOOGEVEENWESTERVELD, M; OOSTRA, BA; REUSER, AJJ				HOEFSLOOT, LH; VANDERPLOEG, AT; KROOS, MA; HOOGEVEENWESTERVELD, M; OOSTRA, BA; REUSER, AJJ			ADULT AND INFANTILE GLYCOGENOSIS TYPE-II IN ONE FAMILY, EXPLAINED BY ALLELIC DIVERSITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ERASMUS UNIV,DEPT CELL BIOL & GENET,POB 1738,3000 DR ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam								ANGELINI C, 1972, ARCH NEUROL-CHICAGO, V26, P344, DOI 10.1001/archneur.1972.00490100074007; ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; BERATIS NG, 1983, ISOZYMES-CURR T BIOL, V11, P25; BUSCH HFM, 1979, NEUROLOGY, V29, P415, DOI 10.1212/WNL.29.3.415; CALLAHAN JW, 1981, LYSOSOMES LYSOSOMAL; DANON MJ, 1986, NEUROLOGY, V36, P818, DOI 10.1212/WNL.36.6.818; DEJONGE AJR, 1985, HUM GENET, V69, P32, DOI 10.1007/BF00295526; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; HERS HG, 1973, LYSOSOMES STORAGE DI; Hers HG, 1989, METABOLIC BASIS INHE, P425; HOEFSLOOT LH, 1988, EMBO J, V7, P1697, DOI 10.1002/j.1460-2075.1988.tb02998.x; KOSTER JF, 1978, CLIN CHIM ACTA, V87, P541; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; LOONEN MCB, 1981, CLIN GENET, V19, P55; LOONEN MCB, 1981, NEUROLOGY, V31, P1209, DOI 10.1212/WNL.31.10.1209; Maniatis T., 1982, MOL CLONING; MARTINIUK F, 1985, HUM GENET, V69, P109, DOI 10.1007/BF00293278; MARTINIUK F, 1981, BIOCHIM BIOPHYS ACTA, V658, P248, DOI 10.1016/0005-2744(81)90295-3; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MEHLER M, 1977, NEUROLOGY, V27, P178, DOI 10.1212/WNL.27.2.178; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; MYEROWITZ R, 1986, SCIENCE, V232, P1646, DOI 10.1126/science.3754980; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P5707, DOI 10.1093/nar/16.12.5707; NICKEL BE, 1982, CYTOGENET CELL GENET, V32, P303; NINOMIYA N, 1984, J NEUROL SCI, V66, P129, DOI 10.1016/0022-510X(84)90001-7; REUSER AJJ, 1978, AM J HUM GENET, V30, P132; REUSER AJJ, 1985, J BIOL CHEM, V260, P8336; REUSER AJJ, 1987, J CLIN INVEST, V79, P1689, DOI 10.1172/JCI113008; REUSER AJJ, 1984, MOL BASIS LYSOSOMAL, P287; REUSER AJJ, 1988, LIPID STORAGE DISORD, P547; SANDISON A, 1982, CLIN GENET, V22, P30; SCRIVRER CR, 1989, METABOLIC BASIS INHE; SHANSKE S, 1986, MUSCLE NERVE, V9, P196; SWALLOW DM, 1989, ANN HUM GENET, V53, P177, DOI 10.1111/j.1469-1809.1989.tb01782.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; VANDERPLOEG AT, 1989, ANN HUM GENET, V53, P185; VANDERPLOEG AT, 1989, AM J HUM GENET, V44, P787; VANDERPLOEG AT, 1988, J NEUROL, V235, P92; WESTERVELD A, 1971, NATURE-NEW BIOL, V234, P20, DOI 10.1038/newbio234020a0	45	26	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					45	52						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2403755				2022-12-18	WOS:A1990CJ04300007
J	SUMMERS, KM; TAM, KS; HALLIDAY, JW; POWELL, LW				SUMMERS, KM; TAM, KS; HALLIDAY, JW; POWELL, LW			HLA DETERMINANTS IN AN AUSTRALIAN POPULATION OF HEMOCHROMATOSIS PATIENTS AND THEIR FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV QUEENSLAND, DEPT MED, BRISBANE, QLD 4000, AUSTRALIA	University of Queensland			Summers, Kim M/M-4086-2015	Summers, Kim M/0000-0002-7084-4386				[Anonymous], 1986, CENSUS POPULATION HO; BALCERZAK SP, 1968, ANN INTERN MED, V68, P518, DOI 10.7326/0003-4819-68-3-518; BASSETT ML, 1988, ANN NY ACAD SCI, V526, P274, DOI 10.1111/j.1749-6632.1988.tb55512.x; BASSETT ML, 1986, HEPATOLOGY, V6, P24, DOI 10.1002/hep.1840060106; BAUR MP, 1980, 8TYH INT HIST WORKSH, P955; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; CASTLES I, 1988, YB AUSTR 1988; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; KUSHNER JP, 1988, NEW ENGL J MED, V319, P1156; LALOUEL JM, 1985, AM J HUM GENET, V37, P700; MILMAN N, 1988, CLIN GENET, V33, P286; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; PIPERNO A, 1986, J CLIN PATHOL, V39, P125, DOI 10.1136/jcp.39.2.125; POWELL LW, 1980, GASTROENTEROLOGY, V78, P374; POWELL LW, 1988, ANN NY ACAD SCI, V526, P23, DOI 10.1111/j.1749-6632.1988.tb55489.x; PRICE CA, 1988, AUG AUSTR POP ASS NA; RITTER B, 1984, HUM GENET, V68, P62, DOI 10.1007/BF00293874; SIMON M, 1979, NOUV PRESSE MED, V8, P421; SIMON M, 1987, AM J HUM GENET, V41, P89; SIMON M, 1988, IMMUNOGENETICS ENDOC, P345; Sokal Robert R., 1969, BIOMETRY; ZACCHI T, 1982, ITAL J GASTROENTEROL, V14, P205	22	26	30	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1989	45	1					41	48						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE779	2741950				2022-12-18	WOS:A1989AE77900006
J	CHAKRAVARTI, A; SLAUGENHAUPT, SA; ZUBENKO, GS				CHAKRAVARTI, A; SLAUGENHAUPT, SA; ZUBENKO, GS			INHERITANCE PATTERN OF PLATELET MEMBRANE FLUIDITY IN ALZHEIMER-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,WESTERN PSYCHIAT INST & CLIN,SCH MED,DEPT PSYCHIAT,ROOM E-1231,3811 OHARA ST,PITTSBURGH,PA 15213; UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT BIOSTAT,HUMAN GENET PROGRAM,PITTSBURGH,PA 15260	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005133] Funding Source: NIH RePORTER; NIA NIH HHS [AG05133] Funding Source: Medline; NIGMS NIH HHS [GM33771] Funding Source: Medline; NIMH NIH HHS [MH43261] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARANY M, 1985, LANCET, V1, P517; BLASS JP, 1984, NEUROCHEM PATHOL, V2, P103, DOI 10.1007/BF02834249; Blom G., 1958, STAT ESTIMATES TRANS; BREITNER JCS, 1984, PSYCHOL MED, V14, P63, DOI 10.1017/S0033291700003081; BREITNER JCS, 1986, J PSYCHIAT RES, V20, P45, DOI 10.1016/0022-3956(86)90022-1; CHIA LS, 1984, BIOCHIM BIOPHYS ACTA, V775, P308, DOI 10.1016/0005-2736(84)90185-8; COHEN BM, 1987, LIFE SCI, V40, P2445, DOI 10.1016/0024-3205(87)90760-0; CORASH L, 1977, BLOOD, V49, P71; HESTON LL, 1981, ARCH GEN PSYCHIAT, V38, P1085; HEYMAN A, 1983, ANN NEUROL, V14, P507, DOI 10.1002/ana.410140503; HEYN MP, 1979, FEBS LETT, V108, P359, DOI 10.1016/0014-5793(79)80564-5; HICKS N, 1987, J ALZHEIMERS DIS ASS, V1, P90; HOLLANDER E, 1986, NEUROBIOL AGING, V7, P367, DOI 10.1016/0197-4580(86)90164-8; JAHNIG F, 1979, P NATL ACAD SCI USA, V76, P6361, DOI 10.1073/pnas.76.12.6361; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LARRSON T, 1963, ACTA PSYCHIATR  S167, V39, P1; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHS RC, 1987, ARCH GEN PSYCHIAT, V44, P405; MORTON NE, 1974, AM J HUM GENET, V26, P489; PETTEGREW JW, 1987, J NEUROPATH EXP NEUR, V46, P419, DOI 10.1097/00005072-198707000-00002; POTTEL H, 1983, BIOCHIM BIOPHYS ACTA, V730, P181, DOI 10.1016/0005-2736(83)90331-0; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; VANBLITTERSWIJK WJ, 1981, BIOCHIM BIOPHYS ACTA, V644, P323, DOI 10.1016/0005-2736(81)90390-4; ZUBENKO GS, 1987, SCIENCE, V238, P539, DOI 10.1126/science.3659926; ZUBENKO GS, 1988, ARCH NEUROL-CHICAGO, V45, P1009, DOI 10.1001/archneur.1988.00520330099016; ZUBENKO GS, 1988, ARCH GEN PSYCHIAT, V45, P889; ZUBENKO GS, 1985, BIOL PSYCHIAT, V20, P384, DOI 10.1016/0006-3223(85)90041-1; ZUBENKO GS, 1988, BIOL PSYCHIAT, V24, P918, DOI 10.1016/0006-3223(88)90226-0; ZUBENKO GS, 1987, ANN NEUROL, V22, P237, DOI 10.1002/ana.410220208; ZUBENKO GS, 1986, BRAIN RES, V385, P115, DOI 10.1016/0006-8993(86)91552-0; ZUBENKO GS, 1987, AM J PSYCHIAT, V144, P860; ZUBENKO GS, 1987, J NEUROPATH EXP NEUR, V46, P407, DOI 10.1097/00005072-198707000-00001; ZUBENKO GS, 1984, LANCET, V2, P235; ZUBENKO GS, 1987, BIOL PSYCHIAT, V22, P987, DOI 10.1016/0006-3223(87)90008-4; ZUBENKO GS, 1985, PSYCHOPHARMACOL B, V21, P641; ZUBENKO GS, IN PRESS NEUROPSYCHO	37	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1989	44	6					799	805						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U8549	2729275				2022-12-18	WOS:A1989U854900004
J	SKRAASTAD, MI; BAKKER, E; DELANGE, LF; VEGTERVANDERVLIS, M; KLEINBRETELER, EG; VANOMMEN, GJB; PEARSON, PL				SKRAASTAD, MI; BAKKER, E; DELANGE, LF; VEGTERVANDERVLIS, M; KLEINBRETELER, EG; VANOMMEN, GJB; PEARSON, PL			MAPPING OF RECOMBINANTS NEAR THE HUNTINGTON DISEASE LOCUS BY USING G8 (D4S10) AND NEWLY ISOLATED MARKERS IN THE D4S10 REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STATE UNIV LEIDEN,SYLVIUS LABS,DEPT HUMAN GENET,WASSENAARSEWEG 72,2333 AL LEIDEN,NETHERLANDS	Leiden University; Leiden University - Excl LUMC			Bakker, Egbert/D-3525-2009; Skraastad, Mette I/D-2291-2014	Bakker, Egbert/0000-0002-2843-7357; Skraastad, Mette I/0000-0003-1940-9634				ANIATIS T, 1982, MOL CLONING LABORATO; BAKKER E, 1987, NUCLEIC ACIDS RES, V15, P9100, DOI 10.1093/nar/15.21.9100; BATES PF, 1983, GENE, V26, P137, DOI 10.1016/0378-1119(83)90183-X; BREUNING MH, IN PRESS MOL PROBES; CARLE GF, 1984, NUCLEIC ACIDS RES, V12, P5647, DOI 10.1093/nar/12.14.5647; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLLINS FS, 1987, CYTOGENET CELL GENET, V46, P597; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P6812, DOI 10.1073/pnas.81.21.6812; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; FARRER LA, 1984, AM J MED GENET, V21, P307; FOLSTEIN SE, 1985, SCIENCE, V229, P776, DOI 10.1126/science.2992086; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; GUSELLA J F, 1984, American Journal of Human Genetics, V36, p139S; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HAINES JL, 1987, CYTOGENET CELL GENET, V46, P625; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; Huntington G., 1872, MED SURG REP, V26, P320; LANDEGENT JE, 1986, HUM GENET, V73, P354, DOI 10.1007/BF00279100; MACDONALD M E, 1987, Genomics, V1, P29, DOI 10.1016/0888-7543(87)90101-7; POHL TM, 1988, NUCLEIC ACIDS RES, V16, P9185, DOI 10.1093/nar/16.19.9185; POUSTKA A, 1987, NATURE, V325, P353, DOI 10.1038/325353a0; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SMITH B, 1988, AM J HUM GENET, V42, P335; VANOMMEN GJ, 1983, NUCLEIC ACIDS RES, V11, P2273; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; YOUNGMAN S, 1986, HUM GENET, V73, P333, DOI 10.1007/BF00279096; YOUNGMAN S, 1987, CYTOGENET CELL GENET, V46, P724	28	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					560	566						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2564732				2022-12-18	WOS:A1989T810900016
J	LADU, BN				LADU, BN			THE HUMAN-SERUM PARAOXONASE ARYLESTERASE POLYMORPHISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material											LADU, BN (corresponding author), UNIV MICHIGAN,DEPT PHARMACOL,ROOM 6322,ANN ARBOR,MI 48109, USA.							CARROCIAMPI G, 1983, CAN J PHYSIOL PHARM, V61, P336, DOI 10.1139/y83-051; DIEPGEN TL, 1987, TOXICOL ENVIRON CHEM, V14, P101, DOI 10.1080/02772248709357196; ECKERSON HW, 1984, DRUG METAB DISPOS, V12, P57; ECKERSON HW, 1983, AM J HUM GENET, V35, P214; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; EIBERG H, 1985, CLIN GENET, V28, P265; FURLONG CE, 1988, AM J HUM GENET, V43, P230; Geldermacher-Von M.M, 1978, HUM GENET S, V1, P65; GELDMACHER V, 1983, AM J PHYS ANTHROPOL, V62, P235; GOEDDE HW, 1984, HUM GENET, V67, P343, DOI 10.1007/BF00291366; LADU BN, 1986, ETHNIC DIFFERENCES R, P87; LADU BN, 1984, BANBURY REPORT, V16, P167; LATHROP GM, 1988, AM J HUM GENET, V42, P38; MACKNESS MI, 1987, CLIN CHEM, V33, P587; MACKNESS MI, 1988, BIOCHEM J, V250, P539, DOI 10.1042/bj2500539; MACKNESS MI, 1983, BIOCHEM PHARMACOL, V32, P2291, DOI 10.1016/0006-2952(83)90175-2; MACKNESS MI, 1987, BIOCHEM J, V245, P293, DOI 10.1042/bj2450293; MCELVEEN J, 1986, CLIN CHEM, V32, P671; MUELLER RF, 1983, AM J HUM GENET, V35, P393; ORTIGOZAFERADO J, 1984, AM J HUM GENET, V36, P295; ORTIGOZAFERADO J, 1984, BANBURY REPORT, V16, P177; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; SMOLEN A, 1982, AM J HUM GENET, V34, pA63	23	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					227	229						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	2843045				2022-12-18	WOS:A1988P884100001
J	RAMESH, V; BENOIT, LA; CRAWFORD, P; HARVEY, PT; SHOWS, TB; SHIH, VE; GUSELLA, JF				RAMESH, V; BENOIT, LA; CRAWFORD, P; HARVEY, PT; SHOWS, TB; SHIH, VE; GUSELLA, JF			THE ORNITHINE AMINOTRANSFERASE (OAT) LOCUS - ANALYSIS OF RFLPS IN GYRATE ATROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MASSACHUSETTS GEN HOSP, NEUROGENET LAB, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, NEUROL SERV, AMINO ACID DISORDER LAB, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; UNIV TORONTO, TORONTO WESTERN HOSP, OPHTHALMOL RETINAL SERV, TORONTO M5T 2S8, ONTARIO, CANADA; NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, DEPT HUMAN GENET, BUFFALO, NY 14263 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Roswell Park Cancer Institute					NEI NIH HHS [EYO5633] Funding Source: Medline; NINDS NIH HHS [NS20012, NSO5096] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS005096, R01NS020012] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ASKANAS V, 1980, NEUROLOGY, V30, P368; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; JANSSEN AJM, 1981, CLIN CHIM ACTA, V113, P213, DOI 10.1016/0009-8981(81)90156-X; ODONNELL JJ, 1977, BIOCHEM BIOPH RES CO, V79, P396, DOI 10.1016/0006-291X(77)90170-X; ODONNELL JJ, 1985, CYTOGENET CELL GENET, V40, P716; POUSTKA A, 1984, P NATL ACAD SCI-BIOL, V81, P4129, DOI 10.1073/pnas.81.13.4129; RAMESH V, 1987, HUM GENET, V76, P121, DOI 10.1007/BF00284906; RAMESH V, 1986, DNA-J MOLEC CELL BIO, V5, P493, DOI 10.1089/dna.1.1986.5.493; SHIH VE, 1978, AM J HUM GENET, V30, P174; SIPILA I, 1981, J CLIN INVEST, V67, P1805, DOI 10.1172/JCI110222; VALLE D, 1977, P NATL ACAD SCI USA, V74, P5159, DOI 10.1073/pnas.74.11.5159	14	26	26	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					365	372						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	2893548				2022-12-18	WOS:A1988M313300019
J	BERNSTEIN, R; ROSENDORFF, J; RAMSAY, M; PINTO, MR; PAGE, DC				BERNSTEIN, R; ROSENDORFF, J; RAMSAY, M; PINTO, MR; PAGE, DC			A UNIQUE DICENTRIC X-Y TRANSLOCATION WITH XQ AND YP BREAKPOINTS - CYTOGENETIC AND MOLECULAR STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WITWATERSRAND,JOHANNESBURG 2001,SOUTH AFRICA; WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA	University of Witwatersrand; Massachusetts Institute of Technology (MIT); Whitehead Institute	BERNSTEIN, R (corresponding author), S AFRICAN INST MED RES,DEPT HUMAN GENET,MRC,HUMAN ECOGENET RES UNIT,POB 1038,JOHANNESBURG 2000,SOUTH AFRICA.			Ramsay, Michele/0000-0002-4156-4801	NICHD NIH HHS [HD 20059] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R23HD020059] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSSON M, 1986, SCIENCE, V233, P786, DOI 10.1126/science.3738510; BERNSTEIN R, 1980, J MED GENET, V17, P437, DOI 10.1136/jmg.17.6.437; BERNSTEIN R, 1978, J MED GENET, V15, P466, DOI 10.1136/jmg.15.6.466; Bernstein R., 1985, Y CHROMOSOME B, P171; BORGAONKAR DS, 1974, LANCET, V1, P68; BUHLER EM, 1980, HUM GENET, V55, P145, DOI 10.1007/BF00291764; CAMERON IT, 1984, HUM GENET, V67, P457, DOI 10.1007/BF00291411; DAVIS RM, 1981, J MED GENET, V18, P161, DOI 10.1136/jmg.18.3.161; DISTECHE CM, 1986, P NATL ACAD SCI USA, V83, P7841, DOI 10.1073/pnas.83.20.7841; DUTRILLAUX B, 1973, CR ACAD SCI D NAT, V276, P3179; FRYNS JP, 1983, CYTOGENETICS MAMMA B, P245; GELDWERTH D, 1985, EMBO J, V4, P1739, DOI 10.1002/j.1460-2075.1985.tb03844.x; GOODFELLOW P, 1985, J MED GENET, V22, P329, DOI 10.1136/jmg.22.5.329; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; GUELLAEN G, 1984, NATURE, V307, P172, DOI 10.1038/307172a0; JONES HW, 1979, JOHNS HOPKINS MED J, V145, P33; KELLY TE, 1984, CYTOGENET CELL GENET, V38, P122, DOI 10.1159/000132043; KOO GC, 1977, SCIENCE, V198, P940, DOI 10.1126/science.929180; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MAGENIS RE, 1984, J PEDIATR-US, V105, P916, DOI 10.1016/S0022-3476(84)80077-3; MAGENIS RE, 1982, HUM GENET, V62, P271, DOI 10.1007/BF00333535; MAGENIS RE, 1985, Y CHROMOSOME A, P537; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PAGE DC, 1986, COLD SPRING HARBOR S, V51; PAGE DC, 1984, NATURE, V311, P114; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROSS JB, 1985, ARCH DERMATOL, V121, P1524, DOI 10.1001/archderm.121.12.1524; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPEEVAK M, 1985, CLIN GENET, V27, P595; THERMAN E, 1986, HUM GENET, V72, P191, DOI 10.1007/BF00291876; THERMAN E, 1983, CYTOGENETICS MAMMA B, P159; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; WOLFE J, 1985, J MOL BIOL, V182, P477, DOI 10.1016/0022-2836(85)90234-7; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; ZUFFARDI O, 1982, AM J MED GENET, V12, P175, DOI 10.1002/ajmg.1320120207	35	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					145	156						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	3039838				2022-12-18	WOS:A1987J757500006
J	JOHNSON, JP; GATTI, RA; SEARS, TS; WHITE, RL				JOHNSON, JP; GATTI, RA; SEARS, TS; WHITE, RL			INVERTED DUPLICATION OF JH ASSOCIATED WITH CHROMOSOME-14 TRANSLOCATION AND T-CELL LEUKEMIA IN ATAXIA-TELANGIECTASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84132; UNIV CALIF LOS ANGELES,DEPT PATHOL,LOS ANGELES,CA 90024; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; UNIV UTAH,MED CTR,DEPT CELLULAR VIRAL & MOLEC BIOL,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah					NCRR NIH HHS [RR-05428] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AURIAS A, 1980, MUTAT RES, V69, P369, DOI 10.1016/0027-5107(80)90101-3; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; CAVENEE W, 1984, AM J HUM GENET, V36, P10; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; CROCE CM, 1985, SCIENCE, V227, P1044, DOI 10.1126/science.3919442; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; DEMARTINVILLE B, 1982, AM J HUM GENET, V34, P216; DENNY CT, 1986, NATURE, V320, P549, DOI 10.1038/320549a0; DESIDERIO S, 1984, NATURE, V308, P860, DOI 10.1038/308860a0; ERIKSON J, 1985, SCIENCE, V229, P784, DOI 10.1126/science.3875152; FIORILLI M, 1985, NATURE, V313, P186, DOI 10.1038/313186a0; GATTI R, UNPUB; GELMANN EP, 1983, NATURE, V306, P799, DOI 10.1038/306799a0; GERMAN J, 1972, PROG MED GENET, V8, P61; HECHT F, 1973, NEW ENGL J MED, V289, P286, DOI 10.1056/NEJM197308092890603; HECHT F, 1977, GENETICS HUMAN CANCE, P105; IMAM AMA, 1983, NUCLEIC ACIDS RES, V11, P7427; JOHNSON JP, 1986, RECENT ADV PRIMARY A; JONES C, 1985, SCIENCE, V228, P83, DOI 10.1126/science.3919444; JUNIEN C, 1983, AM J HUM GENET, V35, P584; KIRSCH IR, 1982, SCIENCE, V216, P301, DOI 10.1126/science.6801764; LEACH DRF, 1983, NATURE, V305, P448, DOI 10.1038/305448a0; LEVITT R, 1978, BLOOD, V52, P1003; LEWIS WH, 1985, NATURE, V317, P544, DOI 10.1038/317544a0; LINSLEY PS, 1983, P NATL ACAD SCI-BIOL, V80, P1997, DOI 10.1073/pnas.80.7.1997; Maniatis T., 1982, MOL CLONING LABORATO, P179; MCCAW BK, 1977, INT J CANCER, V19, P482; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; OXFORD JM, 1975, J MED GENET, V12, P251, DOI 10.1136/jmg.12.3.251; PINCUS SH, 1985, ARTHRITIS RHEUM-US, V28, P8, DOI 10.1002/art.1780280103; RABBITTS TH, 1981, NUCLEIC ACIDS RES, V9, P4509, DOI 10.1093/nar/9.18.4509; RABBITTS TH, 1983, NATURE, V306, P806, DOI 10.1038/306806a0; RAVETCH JV, 1980, P NATL ACAD SCI-BIOL, V77, P6734, DOI 10.1073/pnas.77.11.6734; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; SCOTT MJ, 1983, T1535UV826 BECKM TEC; SHOWE LC, 1985, MOL CELL BIOL, V5, P501, DOI 10.1128/MCB.5.3.501; Sparkes R.S., 1980, CANCER GENET CYTOGEN, V1, P329; TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; UESHIMA Y, 1984, BLOOD, V63, P1028; WHITE MB, 1985, SCIENCE, V228, P733, DOI 10.1126/science.3922054; WYMAN AR, 1985, P NATL ACAD SCI USA, V82, P2880, DOI 10.1073/pnas.82.9.2880; ZECH L, 1983, INT J CANCER, V32, P431, DOI 10.1002/ijc.2910320406; ZECH L, 1976, INT J CANCER, V17, P47, DOI 10.1002/ijc.2910170108	46	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1986	39	6					787	796						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F5414	3026175				2022-12-18	WOS:A1986F541400013
J	WILLIAMS, RC; STEINBERG, AG; KNOWLER, WC; PETTITT, DJ				WILLIAMS, RC; STEINBERG, AG; KNOWLER, WC; PETTITT, DJ			GM 3,5,13,14 AND STATED-ADMIXTURE - INDEPENDENT ESTIMATES OF ADMIXTURE IN AMERICAN-INDIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									BLOOD SYST INC,HISTOCOMPATIBIL LAB,SCOTTSDALE,AZ 85257; NIADDKD,PHOENIX,AZ 85014; CASE WESTERN RESERVE UNIV,DEPT BIOL,CLEVELAND,OH 44106	Vitalant; Case Western Reserve University	WILLIAMS, RC (corresponding author), ARIZONA STATE UNIV,DEPT ANTHROPOL,TEMPE,AZ 85281, USA.							BENNETT PH, 1971, LANCET, V2, P125; BERNSTEIN F, 1931, COMITATO ITALIONA ST; BLUMBERG BS, 1964, NATURE, V202, P561, DOI 10.1038/202561a0; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; GLASS B, 1953, AM J HUM GENET, V5, P1; LONG JC, 1983, AM J PHYS ANTHROPOL, V61, P411, DOI 10.1002/ajpa.1330610403; REED TE, 1969, AM J HUM GENET, V21, P71; STEINBERG A, 1961, AM J HUM GENET, V13, P205; Steinberg A.G., 1981, DISTRIBUTION HUMAN I; STEINBERG ARTHUR G., 1962, PROGR MED GENET, V2, P1; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102	11	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					409	413						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	3464199				2022-12-18	WOS:A1986E364400014
J	CARLSON, HE; BURNS, TW; DAVENPORT, SL; LUGER, AM; SPENCE, MA; SPARKES, RS; ORTH, DN				CARLSON, HE; BURNS, TW; DAVENPORT, SL; LUGER, AM; SPENCE, MA; SPARKES, RS; ORTH, DN			COWDEN DISEASE - GENE MARKER STUDIES AND MEASUREMENTS OF EPIDERMAL GROWTH-FACTOR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARRY S TRUMAN MEM VET HOSP, MED & RES SERV, COLUMBIA, MO 65201 USA; UNIV MISSOURI, MED CTR, SCH MED, DEPT MED, COLUMBIA, MO 65201 USA; UNIV MISSOURI, MED CTR, SCH MED, DEPT CHILD HLTH, COLUMBIA, MO 65201 USA; UNIV MISSOURI, MED CTR, SCH MED, DEPT PATHOL, COLUMBIA, MO 65201 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT PSYCHIAT, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, LOS ANGELES, CA 90024 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT MED, NASHVILLE, TN 37232 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vanderbilt University					NICHD NIH HHS [HD-05615] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AYLESWORTH R, 1982, ARCH DERMATOL, V118, P136, DOI 10.1001/archderm.118.2.136; BRENNER W, 1982, HAUTARZT, V33, P37; BROWNSTEIN MH, 1979, BRIT J DERMATOL, V100, P667, DOI 10.1111/j.1365-2133.1979.tb08070.x; CIVATTE J, 1977, ANN DERMATOL VENER, V104, P645; Cohen S, 1974, Recent Prog Horm Res, V30, P533; DAILEY GE, 1978, J CLIN ENDOCR METAB, V46, P929, DOI 10.1210/jcem-46-6-929; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; DULANTO FD, 1977, ACTA DERMOSIFILIOGRA, V68, P17; FRITSCH P, 1981, HAUTARZT, V32, P285; GOSPODAROWICZ D, 1983, J PATHOL, V141, P201, DOI 10.1002/path.1711410304; GRUPPER C, 1974, B SOC FR DERMATOL SY, V81, P578; HENDLER FJ, 1984, J CLIN INVEST, V74, P647, DOI 10.1172/JCI111463; HIRATA Y, 1979, J CLIN ENDOCR METAB, V48, P673, DOI 10.1210/jcem-48-4-673; HODGE SE, 1979, AM J HUM GENET, V31, pA135; LAUGIER P, 1979, ANN DERMATOL VENER, V106, P453; LLOYD KM, 1963, ANN INTERN MED, V58, P136, DOI 10.7326/0003-4819-58-1-136; MARQUARDT H, 1984, SCIENCE, V223, P1079, DOI 10.1126/science.6320373; MORTON NE, 1955, AM J HUM GENET, V7, P277; Nudenberg B, 1977, Med Cutan Ibero Lat Am, V5, P47; OKA Y, 1983, J CLIN INVEST, V72, P249, DOI 10.1172/JCI110964; OTT J, 1974, AM J HUM GENET, V26, P588; ROZENGURT E, 1983, J PATHOL, V141, P309, DOI 10.1002/path.1711410310; SALEM OS, 1983, J AM ACAD DERMATOL, V8, P686, DOI 10.1016/S0190-9622(83)70081-2; SCHEVING LA, 1980, ENDOCRINOLOGY, V106, P1498, DOI 10.1210/endo-106-5-1498; SHOWS PB, 1984, CYTOG C GEN, V37, P340; SIEGEL JM, 1974, ARCH DERMATOL, V110, P476; SIERRA JO, 1974, ACTA DERMO SIFILOG, V65, P117; SOGOL PB, 1983, WESTERN J MED, V139, P324; SPENCE MA, 1977, AM J HUM GENET, V29, P397; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; STARINK TM, 1984, J AM ACAD DERMATOL, V11, P1127, DOI 10.1016/S0190-9622(84)70270-2; THYRESSON HN, 1981, MAYO CLIN PROC, V56, P179; WESTERMARK K, 1983, ENDOCRINOLOGY, V112, P1680, DOI 10.1210/endo-112-5-1680; 1979, DHEW NIH80545 PHS PU	34	26	26	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					908	917						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3487976				2022-12-18	WOS:A1986D392200014
J	BABU, A; VERMA, RS				BABU, A; VERMA, RS			THE HETEROMORPHIC MARKER ON CHROMOSOME-18 USING RESTRICTION ENDONUCLEASE ALUI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SUNY,DOWNSTATE MED CTR,INTERFAITH MED CTR,DIV CYTOGENET,555 PROSPECT PL,BROOKLYN,NY 11238	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College								BABU KA, 1985, KARYOGRAM, V11, P23; BABU KA, UNPUB CHARACTERIZATI; BOUE A, 1984, ADV HUM GENET, V14, P1; EVANS HJ, 1985, TRENDS GENET, V1, P123, DOI 10.1016/0168-9525(85)90046-0; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Hook E B, 1978, Birth Defects Orig Artic Ser, V14, P249; Hook E B, 1979, Birth Defects Orig Artic Ser, V15, P81; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; HOOK EB, 1984, HUM GENET, V64, P211; JUBERG RC, 1983, AM J MED GENET, V16, P111, DOI 10.1002/ajmg.1320160117; MANNING CH, 1981, HUM GENET, V59, P101, DOI 10.1007/BF00293054; MCKENZIE WH, 1975, CYTOGENET CELL GENET, V14, P97, DOI 10.1159/000130330; MIRRE C, 1980, P NATL ACAD SCI-BIOL, V77, P6017, DOI 10.1073/pnas.77.10.6017; SCHREINEMACHERS DM, 1982, HUM GENET, V61, P318; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Verma R S, 1980, Int Rev Cytol, V62, P361; VERMA RS, 1986, INT REV CYTOL; VERMA RS, 1986, MOL GEN GENET	18	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1986	38	4					549	554						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C4893	3010713				2022-12-18	WOS:A1986C489300014
J	JABS, EW; MEYERS, DA; BIAS, WB				JABS, EW; MEYERS, DA; BIAS, WB			LINKAGE STUDIES OF POLYMORPHIC, REPEATED DNA-SEQUENCES IN CENTROMERIC REGIONS OF HUMAN-CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205	Johns Hopkins University	JABS, EW (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205, USA.			Jabs, Ethylin/0000-0001-8983-5466	NICHD NIH HHS [HD-19074, HD-05465] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R23HD019074] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEDBROOK J, 1980, COLD SPRING HARB SYM, V45, P755; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BIAS WB, 1981, HUM IMMUNOL, V2, P155, DOI 10.1016/0198-8859(81)90062-8; BROWN SDM, 1980, NUCLEIC ACIDS RES, V8, P781; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; COEN E, 1982, J MOL BIOL, V158, P17, DOI 10.1016/0022-2836(82)90448-X; DOVER GA, 1984, CELL, V38, P622, DOI 10.1016/0092-8674(84)90255-1; HIGGS DR, 1981, NUCLEIC ACIDS RES, V9, P4213, DOI 10.1093/nar/9.17.4213; JABS E W, 1984, American Journal of Human Genetics, V36, p141S; JABS EW, 1984, P NATL ACAD SCI-BIOL, V81, P4884, DOI 10.1073/pnas.81.15.4884; JABS EW, 1984, SOMAT CELL MOLEC GEN, V10, P93, DOI 10.1007/BF01534476; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; MARESCA A, 1983, J MOL BIOL, V164, P493, DOI 10.1016/0022-2836(83)90047-5; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1974, AM J HUM GENET, V26, P588; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; RICE NR, 1973, P NATL ACAD SCI USA, V70, P3546, DOI 10.1073/pnas.70.12.3546; ROBSON EB, 1984, CYTOGENET CELL GENET, V37, P47, DOI 10.1159/000132004; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; WOLF SF, 1980, CELL, V21, P95, DOI 10.1016/0092-8674(80)90117-8	21	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1986	38	3					297	308						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5781	3006481				2022-12-18	WOS:A1986A578100004
J	GRABOWSKI, GA; KRUSE, JR; GOLDBERG, JD; CHOCKKALINGAM, K; GORDON, RE; BLAKEMORE, KJ; MAHONEY, MJ; DESNICK, RJ				GRABOWSKI, GA; KRUSE, JR; GOLDBERG, JD; CHOCKKALINGAM, K; GORDON, RE; BLAKEMORE, KJ; MAHONEY, MJ; DESNICK, RJ			1ST-TRIMESTER PRENATAL-DIAGNOSIS OF TAY-SACHS DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CUNY MT SINAI SCH MED,CTR JEWISH GENET DIS,DIV MATERNAL FETAL MED,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT PATHOL,NEW YORK,NY 10029; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT INTERNAL MED,NEW HAVEN,CT 06510	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Yale University; Yale University	GRABOWSKI, GA (corresponding author), CUNY MT SINAI SCH MED,CTR JEWISH GENET DIS,DIV MED GENET,NEW YORK,NY 10029, USA.							ADACHI M, 1971, ARCH PATHOL, V91, P48; BISHOP DF, 1978, BIOCHIM BIOPHYS ACTA, V524, P109, DOI 10.1016/0005-2744(78)90109-2; GRABOWSKI GA, 1982, CLIN CHIM ACTA, V124, P123, DOI 10.1016/0009-8981(82)90326-6; GRABOWSKI GA, 1982, METHODS CELL BIOL, V26, P96; GREBNER EE, 1983, LANCET, V2, P286; IKONNE JU, 1975, AM J HUM GENET, V27, P639; INUI K, 1984, CLIN GENET, V25, P93; KABACK MM, 1977, PROGR CLIN BIOL RES, V18; KRESSE H, 1981, J BIOL CHEM, V256, P2926; LANDING BH, 1972, SPHINGOLIPIDS SPHING, P15; MARIN ML, 1979, LUNG, V156, P223, DOI 10.1007/BF02714016; OBRIEN JS, 1971, SCIENCE, V172, P61, DOI 10.1126/science.172.3978.61; PERCY AK, 1973, ARCH NEUROL-CHICAGO, V28, P417, DOI 10.1001/archneur.1973.00490240077016; RATTAZZI MC, 1975, ISOZYMES II PHYSIOLO, P439; SCHNECK L, 1972, PEDIATRICS, V49, P342; SHAW MW, 1984, J LEGAL MED, V5, P63, DOI 10.1080/01947648409513403; SIMONI G, 1984, HUM GENET, V66, P252, DOI 10.1007/BF00286612; WARD RHT, 1983, BRIT MED J, V286, P1542, DOI 10.1136/bmj.286.6377.1542	18	26	26	1	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1369	1378						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6240199				2022-12-18	WOS:A1984TZ59000018
J	CHANCE, PF; GARTLER, SM				CHANCE, PF; GARTLER, SM			EVIDENCE FOR A DOSAGE EFFECT AT THE X-LINKED STEROID SULFATASE LOCUS IN HUMAN-TISSUES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	CHANCE, PF (corresponding author), UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195, USA.		Chance, Phillip/AAX-5826-2020		NIGMS NIH HHS [GM-15253] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015253] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AITKEN DA, 1981, 6TH INT C HUM GEN, V96; DANCIS J, 1980, PEDIATR RES, V14, P531; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; EPSTEIN EH, 1981, J CLIN INVEST, V67, P1257, DOI 10.1172/JCI110153; KOPPE JC, 1977, EXCERPTA MED INT C S, V426, P57; KRATZER PG, 1978, NATURE, V274, P502; MOHANDAS T, 1980, P NATL ACAD SCI-BIOL, V77, P6759, DOI 10.1073/pnas.77.11.6759; MOHANDAS T, 1979, P NATL ACAD SCI USA, V76, P5779, DOI 10.1073/pnas.76.11.5779; MULLER CR, 1980, HUM GENET, V54, P197, DOI 10.1007/BF00278971; MULLER CR, 1980, HUM GENET, V54, P201, DOI 10.1007/BF00278972; Race RR., 1975, BLOOD GROUPS MAN; ROPERS HH, 1981, HUM GENET, V57, P354, DOI 10.1007/BF00281683; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SHAPIRO LJ, 1977, PEDIATR RES, V11, P894, DOI 10.1203/00006450-197708000-00008; SHAPIRO LJ, 1978, LANCET, V1, P70; SHAPIRO LJ, 1982, CLIN RES, V30, pA119; SHAPIRO LJ, 1978, LANCET, V2, P756; Sokal R.R., 1981, BIOMETRY, V2nd ed.; STANBURY JB, 1978, METABOLIC BASIS INHE, P776; TIEPOLO L, 1980, HUM GENET, V54, P205, DOI 10.1007/BF00278973	20	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	2					234	240						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ265	6573129				2022-12-18	WOS:A1983QJ26500007
J	ELAWADY, MK; ALLMAN, DR; GRIFFIN, JE; WILSON, JD				ELAWADY, MK; ALLMAN, DR; GRIFFIN, JE; WILSON, JD			EXPRESSION OF A MUTANT ANDROGEN RECEPTOR IN CLONED FIBROBLASTS DERIVED FROM A HETEROZYGOUS CARRIER FOR THE SYNDROME OF TESTICULAR FEMINIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,HLTH SCI CTR,SW MED SCH,DEPT INTERNAL MED,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	ELAWADY, MK (corresponding author), NATL RES CTR,HUMAN GENET LAB,CAIRO,EGYPT.			El Awady, Mostafa/0000-0002-1453-763X	NIADDK NIH HHS [AM03892] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM003892] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARTSCHSANDHOFF M, 1976, HUM GENET, V31, P59, DOI 10.1007/BF00270400; BROWN TR, 1982, J CLIN ENDOCR METAB, V55, P61, DOI 10.1210/jcem-55-1-61; BROWN TR, 1981, J STEROID BIOCHEM, V14, P1013, DOI 10.1016/0022-4731(81)90209-0; GERLI M, 1979, J MED GENET, V16, P480, DOI 10.1136/jmg.16.6.480; GRIFFIN JE, 1979, J CLIN INVEST, V64, P1624, DOI 10.1172/JCI109624; GRIFFIN JE, 1981, J BIOL CHEM, V256, P3662; GRIFFIN JE, 1982, J CLIN ENDOCR METAB, V55, P465, DOI 10.1210/jcem-55-3-465; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; MEYER WJ, 1975, P NATL ACAD SCI USA, V72, P1469, DOI 10.1073/pnas.72.4.1469; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; MIGEON BR, 1971, AM J HUM GENET, V23, P199; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P6339, DOI 10.1073/pnas.78.10.6339; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; PINSKY L, 1981, AM J MED GENET, V10, P91, DOI 10.1002/ajmg.1320100111; RINALDI A, 1976, AM J HUM GENET, V28, P496; Wilson J.D., 1983, METABOLIC BASIS INHE, P1001	16	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	3					376	384						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QS160	6602545				2022-12-18	WOS:A1983QS16000003
J	JUNIEN, C; HUERRE, C; RETHORE, MO				JUNIEN, C; HUERRE, C; RETHORE, MO			DIRECT GENE DOSAGE DETERMINATION IN PATIENTS WITH UN-BALANCED CHROMOSOMAL-ABERRATIONS USING CLONED DNA-SEQUENCES - APPLICATION TO THE REGIONAL ASSIGNMENT OF THE GENE FOR ALPHA-2(I) PROCOLLAGEN (COLIA2)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INST PROGENESE,F-75270 PARIS 06,FRANCE		JUNIEN, C (corresponding author), INST PATHOL & BIOL CELLULAIRES & MOLEC,INSERM,U129,24 RUE FG ST JACQUES,F-75674 PARIS 14,FRANCE.		Jeanpierre, cecile/H-3770-2017	Jeanpierre, cecile/0000-0002-3463-5907				DAVIES KE, 1981, NATURE, V293, P374, DOI 10.1038/293374a0; JUNIEN C, 1980, ANN GENET-PARIS, V23, P165; JUNIEN C, 1982, AM J HUM GENET, V34, P381; JUNIEN C, 1980, HUM GENET, V54, P191, DOI 10.1007/BF00278970; KUNKEL LM, 1976, SCIENCE, V191, P1189, DOI 10.1126/science.1257744; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; LITTLE PFR, 1980, NATURE, V285, P144, DOI 10.1038/285144a0; MYERS JC, 1981, P NATL ACAD SCI-BIOL, V78, P3516, DOI 10.1073/pnas.78.6.3516; PERSICO MG, 1981, NATURE, V294, P778, DOI 10.1038/294778a0; RETHORE MO, 1980, ANN GENET-PARIS, V23, P35; SANDERSHAIGH L, 1980, NATURE, V283, P683, DOI 10.1038/283683a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VIEGASPEQUIGNOT E, 1978, ANN GENET-PARIS, V21, P122; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	16	26	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	4					584	591						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG731	6881137				2022-12-18	WOS:A1983RG73100004
J	SLAUGHTER, CA; GOGOLIN, KJ; COSEO, MC; MEYER, LJ; LESKO, J; HARRIS, H				SLAUGHTER, CA; GOGOLIN, KJ; COSEO, MC; MEYER, LJ; LESKO, J; HARRIS, H			DISCRIMINATION OF HUMAN PLACENTAL ALKALINE-PHOSPHATASE ALLELIC VARIANTS BY MONOCLONAL-ANTIBODIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SLAUGHTER, CA (corresponding author), UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM127018, R01GM027018] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 27018] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CANCRO MP, 1978, J EXP MED, V147, P776, DOI 10.1084/jem.147.3.776; COFFINO P, 1970, SCIENCE, V167, P186, DOI 10.1126/science.167.3915.186; DONALD LJ, 1974, ANN HUM GENET, V37, P303, DOI 10.1111/j.1469-1809.1974.tb01837.x; GERHARD W, 1976, J EXP MED, V144, P985, DOI 10.1084/jem.144.4.985; GERHARD W, 1978, J EXP MED, V148, P383, DOI 10.1084/jem.148.2.383; GOGOLIN KJ, 1982, SCIENCE, V216, P59, DOI 10.1126/science.6175022; GOGOLIN KJ, 1981, P NATL ACAD SCI-BIOL, V78, P5061, DOI 10.1073/pnas.78.8.5061; Harris, 1976, HDB ENZYME ELECTROPH; KENNETT RH, 1980, MONOCLONAL ANTIBODIE; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; MULIVOR RA, 1978, ANN HUM GENET, V42, P1, DOI 10.1111/j.1469-1809.1978.tb00927.x; POTTER M, 1972, J NATL CANCER I, V49, P305; ROBSON EB, 1965, NATURE, V207, P1257, DOI 10.1038/2071257a0; ROBSON EB, 1967, ANN HUM GENET, V30, P219, DOI 10.1111/j.1469-1809.1967.tb00023.x; SELA M, 1969, SCIENCE, V166, P1365, DOI 10.1126/science.166.3911.1365; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; SLAUGHTER CA, 1981, P NATL ACAD SCI-BIOL, V78, P1124, DOI 10.1073/pnas.78.2.1124; SLAUGHTER CA, 1980, MONOCLONAL ANTIBODIE, P385; SLAUGHTER CA, 1980, MONOCLONAL ANTIBODIE, P103; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0	20	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	1					1	20						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB703	6186142				2022-12-18	WOS:A1983QB70300001
J	MCREYNOLDS, JW; CROWLEY, B; MAHONEY, MJ; ROSENBERG, LE				MCREYNOLDS, JW; CROWLEY, B; MAHONEY, MJ; ROSENBERG, LE			AUTOSOMAL RECESSIVE INHERITANCE OF HUMAN MITOCHONDRIAL CARBAMYL-PHOSPHATE SYNTHETASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET & PEDIAT,NEW HAVEN,CT 06520; RHODE ISL HOSP,DEPT PEDIAT,PROVIDENCE,RI 02902	Yale University; Lifespan Health Rhode Island; Rhode Island Hospital					NIADDK NIH HHS [AM-09527] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM009527] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADACHI TORU, 1963, J VITAMINOL, V9, P217; ARASHIMA S, 1972, TOHOKU J EXP MED, V107, P143, DOI 10.1620/tjem.107.143; BATSHAW M, 1975, NEW ENGL J MED, V292, P1085, DOI 10.1056/NEJM197505222922101; BROWN GW, 1959, J BIOL CHEM, V234, P1769; BROWN T, 1974, LANCET, V2, P716; CLARKE S, 1976, J BIOL CHEM, V251, P950; DEMARS R, 1976, P NATL ACAD SCI USA, V73, P1693, DOI 10.1073/pnas.73.5.1693; FARRIAUX JP, 1977, ACTA PAEDIATR SCAND, V66, P529, DOI 10.1111/j.1651-2227.1977.tb07940.x; GATFIELD PD, 1975, PEDIATR RES, V9, P488, DOI 10.1203/00006450-197505000-00006; GELEHRTER TD, 1974, NEW ENGL J MED, V290, P430, DOI 10.1056/NEJM197402212900804; HOMMES FA, 1969, ARCH DIS CHILD, V44, P688, DOI 10.1136/adc.44.238.688; KLINE J, 1976, PEDIATR RES, V10, P323; LAMBOTTE C, 1977, ACTA PAEDIATR BELG, V30, P151; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAIER KP, 1976, NEW ENGL J MED, V295, P508; MANTAGOS S, 1978, ARCH DIS CHILD, V53, P230, DOI 10.1136/adc.53.3.230; MCREYNOLDS JW, 1978, J PEDIATR-US, V93, P421, DOI 10.1016/S0022-3476(78)81149-4; Nuzum CT, 1976, UREA CYCLE, P325; ODIEVRE M, 1973, ARCH FR PEDIATR, V30, P5; RICCIUTI FC, 1976, AM J HUM GENET, V28, P332; SELIGSON D, 1957, J LAB CLIN MED, V49, P962; SHEFFIELD LJ, 1976, J PEDIATR-US, V88, P450, DOI 10.1016/S0022-3476(76)80263-6; SHORT EM, 1973, NEW ENGL J MED, V288, P7, DOI 10.1056/NEJM197301042880102; SINATRA F, 1975, PEDIATR RES, V9, P829, DOI 10.1203/00006450-197511000-00005; SNODGRASS PJ, 1976, NEW ENGL J MED, V294, P855, DOI 10.1056/NEJM197604152941601; WILSON RG, 1977, AUST PAEDIATR J, V13, P119	26	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	3					345	353						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LT725	7246541				2022-12-18	WOS:A1981LT72500002
J	ROLLNICK, B; DAY, D; TISSOT, R; KAYE, C				ROLLNICK, B; DAY, D; TISSOT, R; KAYE, C			A PEDIGREE - POSSIBLE EVIDENCE FOR THE METABOLIC INTERFERENCE HYPOTHESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											ROLLNICK, B (corresponding author), UNIV ILLINOIS,ABRAHAM LINCOLN SCH MED,CTR CRANIOFACIAL ABNOMALIES,CHICAGO,IL 60612, USA.							Cohen M M Jr, 1979, Birth Defects Orig Artic Ser, V15, P85; JOHNSON WG, 1980, AM J HUM GENET, V32, P374	2	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	5					823	826						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ232	7294029				2022-12-18	WOS:A1981MJ23200018
J	SCOTT, EM; WRIGHT, RC				SCOTT, EM; WRIGHT, RC			VARIABILITY OF GLUTATHIONE S-TRANSFERASE OF HUMAN-ERYTHROCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note											SCOTT, EM (corresponding author), CTR DIS CONTROL,DIV ALASKA INVEST,225 EAGLE ST,ANCHORAGE,AK 99501, USA.							HABIG WH, 1974, J BIOL CHEM, V249, P7130; MARCUS CJ, 1978, ARCH BIOCHEM BIOPHYS, V188, P287, DOI 10.1016/S0003-9861(78)80011-3	2	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	1					115	117						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JH296	6928733				2022-12-18	WOS:A1980JH29600015
J	ERICKSON, JD				ERICKSON, JD			PATERNAL AGE AND DOWN SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											ERICKSON, JD (corresponding author), CTR DIS CONTROL,BUR EPIDEMIOL,BIRTH DEFECTS BRANCH,ATLANTA,GA 30333, USA.							ERICKSON JD, 1978, ANN HUM GENET, V41, P289, DOI 10.1111/j.1469-1809.1978.tb01896.x; HANSSON A, 1978, CYTOGENET CELL GENET, V20, P194, DOI 10.1159/000130851; IPSEN J, 1970, INTRO BIOSTATISTICS; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL N, 1967, AM J MENT DEF, V71, P1025; MATSUNAGA E, 1978, HUM GENET, V40, P259, DOI 10.1007/BF00272186; MIKKELSEN M, 1976, HUM GENET, V32, P17, DOI 10.1007/BF00569972; Snedecor G.W., 1980, STAT METHODS, V7; STENE J, 1977, ANN HUM GENET, V40, P343, DOI 10.1111/j.1469-1809.1977.tb00198.x; STENE J, 1977, ANN HUM GENET, V40, P299, DOI 10.1111/j.1469-1809.1977.tb00194.x; STENE J, 1978, ANN HUM GENET, V41, P465, DOI 10.1111/j.1469-1809.1978.tb00917.x; WAGENBICHLER P, 1976, HUM GENET, V32, P13, DOI 10.1007/BF00569971	12	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	4					489	497						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HM222	158308				2022-12-18	WOS:A1979HM22200010
J	FLEISHER, LD; RASSIN, DK; DESNICK, RJ; SALWEN, HR; ROGERS, P; BEAN, M; GAULL, GE				FLEISHER, LD; RASSIN, DK; DESNICK, RJ; SALWEN, HR; ROGERS, P; BEAN, M; GAULL, GE			ARGININOSUCCINIC ACIDURIA - PRENATAL STUDIES IN A FAMILY AT RISK	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CUNY MT SINAI SCH MED,DIV MED GENET,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT PEDIAT,NEW YORK,NY 10029; UNIV MINNESOTA,DEPT MICROBIOL,MINNEAPOLIS,MN 55455	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities	FLEISHER, LD (corresponding author), NEW YORK STATE INST BAS RES MENTAL RETARDAT,DEPT HUMAN GENET & NUTR,STATEN ISL,NY 10314, USA.							CARTON D, 1969, ACTA PAEDIATR SCAND, V58, P528, DOI 10.1111/j.1651-2227.1969.tb04755.x; COLOMBO JP, 1969, 6TH P S SOC STUDY IN, P119; GOODMAN SI, 1973, CLIN GENET, V4, P236; HARTLAGE PL, 1974, J PEDIATR-US, V85, P86, DOI 10.1016/S0022-3476(74)80293-3; JACOBY LB, 1972, AM J HUM GENET, V24, P321; KINT J, 1968, LANCET, V2, P635; KRZYZEK RA, 1976, J BACTERIOL, V125, P348; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PRESCOTT LM, 1969, ANAL BIOCH, V32, P480; RASSIN DK, CLIN CHIM ACTA; SHIH VE, 1970, LANCET, V2, P45; SHIH VE, 1969, BIOCHEM GENET, V3, P81, DOI 10.1007/BF00485974; SOLITARE GB, 1969, J MENT DEFIC RES, V13, P153; TOMLINSON S, 1964, CLIN SCI, V26, P261; TOMLINSON S, 1960, NATURE, V188, P235, DOI 10.1038/188235a0	15	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	4					439	445						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	HM222	484552				2022-12-18	WOS:A1979HM22200004
J	YUTAKA, T; FLUHARTY, AL; STEVENS, RL; KIHARA, H				YUTAKA, T; FLUHARTY, AL; STEVENS, RL; KIHARA, H			IDURONATE SULFATASE ANALYSIS OF HAIR ROOTS FOR IDENTIFICATION OF HUNTER SYNDROME HETEROZYGOTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,PACIFIC STATE HOSP,SCH MED,INST NEUROPSYCHIAT,RES GRP,POMONA,CA 91766	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA								BACH G, 1973, P NATL ACAD SCI USA, V70, P2134, DOI 10.1073/pnas.70.7.2134; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; CAPOBIANCHI MR, 1976, EXPERIENTIA, V32, P459, DOI 10.1007/BF01920795; COPPA GV, 1973, ANAL LETT, V6, P225; DANES BS, 1967, J EXP MED, V126, P509, DOI 10.1084/jem.126.3.509; GARTLER SM, 1971, SCIENCE, V172, P572, DOI 10.1126/science.172.3983.572; GARTLER SM, 1969, ANN HUM GENET, V33, P171, DOI 10.1111/j.1469-1809.1969.tb01642.x; GOMORI G, 1955, METHOD ENZYMOL, V1, P138, DOI 10.1016/0076-6879(55)01020-3; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; KAMPINE JP, 1967, SCIENCE, V155, P86, DOI 10.1126/science.155.3758.86; LIEBAERS I, 1976, PEDIATR RES, V10, P733, DOI 10.1203/00006450-197610080-00007; LIEBAERS I, 1977, J PEDIATR-US, V90, P423, DOI 10.1016/S0022-3476(77)80707-5; LIM TW, 1974, CARBOHYD RES, V37, P103, DOI 10.1016/S0008-6215(00)87067-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MIGEON BR, 1977, AM J HUM GENET, V29, P448; NEUFELD EF, 1976, CURRENT TRENDS SPHIN, P253; NWOKORO N, 1977, AM J HUM GENET, V29, pA82; SILVERS DN, 1972, NEW ENGL J MED, V286, P390, DOI 10.1056/NEJM197202242860802; SJOBERG I, 1973, BIOCHEM BIOPH RES CO, V54, P1125, DOI 10.1016/0006-291X(73)90809-7; SPENCE MW, 1977, J MED GENET, V14, P91, DOI 10.1136/jmg.14.2.91	20	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	6					575	582						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GK656	106723				2022-12-18	WOS:A1978GK65600001
J	CHILDS, B				CHILDS, B			PERSISTENT ECHOES OF NATURE-NURTURE ARGUMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA	Johns Hopkins University								Barnett Henry, 1972, PEDIATRICS; BECK E, 1974, NEW ENGL J MED, V291, P1166, DOI 10.1056/NEJM197411282912206; BEESON PB, 1975, MAN MED, V1, P65; BEESON PB, 1971, TXB MEDICINE; CARDUS D, 1973, PREV MED, V2, P309, DOI 10.1016/0091-7435(73)90024-8; CHILDS B, 1973, YALE J BIOL MED, V46, P297; CHILDS B, 1974, AM J HUM GENET, V26, P120; FEINSTEIN AR, 1973, YALE J BIOL MED, V46, P212; FREIDSON E, 1970, PROFESSION MED STUDY, P164; GALDSTON I, 1954, MEANING SOCIAL MEDIC; GERALD PS, 1976, NEW ENGL J MED, V295, P337, DOI 10.1056/NEJM197608052950610; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1533, DOI 10.1172/JCI107331; HARVEY AM, 1976, PRINCIPLES PRACTICE; HAZZARD WR, 1973, J CLIN INVEST, V52, P1569, DOI 10.1172/JCI107333; KENDALL PL, 1962, RELATIONSHIP MEDICAL; KEYES JA, 1975, J MED EDUC, V50, P319; KNUDSON AG, 1976, PEDIATR RES, V10, P513, DOI 10.1203/00006450-197605000-00001; MACMAHON B, 1970, EPIDEMIOLOGY PRINCIP, P301; MCKEOWN T, 1974, INTRO SOCIAL MEDICIN; Powles J, 1973, Sci Med Man, V1, P1; RICCARDI VM, 1976, AM J PUBLIC HEALTH, V66, P268, DOI 10.2105/AJPH.66.3.268; ROGENTINE GN, 1976, NATURE, V262, P350, DOI 10.1038/262350b0; Rosen George, 1975, PREVENTIVE MEDICINE; ROSENSTOCK IM, 1975, GENETIC SCREENING ST; RUHE CHW, 1974, JAMA-J AM MED ASSOC, V229, P881; RUHE CHW, 1975, J AM MED ASSOC     S, V233, P585; SCRIVER CR, IN PRESS; SNYDER LH, 1950, GENETICS 20TH CENTUR, P369; SWIFT M, 1974, AM J HUM GENET, V26, P304; TERRIS M, 1975, AM J PUBLIC HEALTH, V65, P161, DOI 10.2105/AJPH.65.2.161; TERRIS M, 1975, AM J PUBLIC HEALTH, V65, P1037, DOI 10.2105/AJPH.65.10.1037; THOMAS L, 1976, J MED EDUC, V51, P23; VAUGHAN V, 1975, NELSON TXB PEDIATRIC; WHITE KL, 1975, PREV MED, V4, P247, DOI 10.1016/0091-7435(75)90060-2; WINTROBE MM, 1974, HARRISONS PRINCIPLES; 1975, GENETIC SCREENING PR	37	26	26	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1977	29	1					1	13						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CU441	835568				2022-12-18	WOS:A1977CU44100001
J	ELSTON, RC; LANGE, K; NAMBOODIRI, KK				ELSTON, RC; LANGE, K; NAMBOODIRI, KK			AGE TRENDS IN HUMAN CHIASMA FREQUENCIES AND RECOMBINATION FRACTIONS .2. METHOD FOR ANALYZING RECOMBINATION FRACTIONS AND APPLICATIONS TO ABO-NAIL-PATELLA LINKAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,GENET CURRICULUM & BIOL SCI RES CTR,DEPT BIOSTATISTICS,CHAPEL HILL,NC 27514; UNIV CALIF,DEPT BIOMATH,LOS ANGELES,CA 90024	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles								BODMER WF, 1961, HEREDITY, V16, P485, DOI 10.1038/hdy.1961.54; CLARKE CA, 1961, ANN HUM GENET, V25, P25, DOI 10.1111/j.1469-1809.1961.tb01493.x; ELLIOTT GB, 1963, AM J HUM GENET, V15, P182; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1975, ANN HUM GENET, V39, P67, DOI 10.1111/j.1469-1809.1975.tb00109.x; ELSTON RC, 1975, AM J HUM GENET, V27, P31; FISHER RA, 1949, HEREDITY, V3, P229, DOI 10.1038/hdy.1949.16; JAMESON RJ, 1956, ANN HUM GENET, V20, P348; KAPLAN EB, 1972, 823 U N CAR I STAT M; LANGE K, 1975, AM J HUM GENET, V27, P410; LAWLER SD, 1957, ANN HUM GENET, V21, P410, DOI 10.1111/j.1469-1809.1972.tb00294.x; LAWLER SD, 1958, ANN HUM GENET, V22, P342, DOI 10.1111/j.1469-1809.1958.tb01428.x; LEVITAN M, 1971, TXB HUMAN GENETICS; OTT J, 1974, AM J HUM GENET, V26, P588; Race R. R, 1968, BLOOD GROUPS MAN; RAO CR, 1973, LINEAR STATISTICAL I; REID DH, 1963, HEREDITY, V18, P107, DOI 10.1038/hdy.1963.9; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; RENWICK JH, 1971, ANNU REV GENET, V5, P81, DOI 10.1146/annurev.ge.05.120171.000501; RENWICK JH, 1965, ANN HUM GENET, V28, P379, DOI 10.1111/j.1469-1809.1965.tb00493.x; SHARMA JC, 1966, ANN HUM GENET, V30, P193, DOI 10.1111/j.1469-1809.1966.tb00018.x; WALLACE M. E., 1957, HEREDITY, V11, P223, DOI 10.1038/hdy.1957.20; WEITKAMP LR, 1973, HUM HERED, V23, P197, DOI 10.1159/000152574; WEITKAMP LR, 1973, 4TH P INT C HUM GEN, P445	24	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	1					69	76						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BC888	1108643				2022-12-18	WOS:A1976BC88800009
J	FRIED, K; DAVIES, AM				FRIED, K; DAVIES, AM			SOME EFFECTS ON OFFSPRING OF UNCLE-NIECE MARRIAGE IN MOROCCAN JEWISH-COMMUNITY IN JERUSALEM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HEBREW UNIV,HADASSAH MED SCH,DEPT MED ECOL,JERUSALEM,ISRAEL	Hebrew University of Jerusalem								ADAMS MS, 1967, PEDIATRICS, V40, P55; BEMISS SM, 1858, T AM MED ASS, V11, P319; CARTER CO, 1967, LANCET, V1, P436; CAVALLISFORZA LL, 1973, AM J HUM GENET, V25, P82; DAVIES AM, 1969, ISRAEL J MED SCI, V5, P1095; DRONAMRAJU K. R., 1960, JOUR HEREDITY, V51, P239; GOLDSCHMIDT E, 1960, ANN HUM GENET, V24, P191, DOI 10.1111/j.1469-1809.1960.tb01732.x; MACLEAN CJ, 1973, ANN HUM GENET, V36, P323, DOI 10.1111/j.1469-1809.1973.tb00594.x; SCHULL WJ, 1972, AM J HUM GENET, V24, P425; Schull WJ, 1965, EFFECTS INBREEDING J; STERK VV, 1971, ISRAEL J MED SCI, V7, P1248	11	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	1					65	72						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S0166	4811756				2022-12-18	WOS:A1974S016600007
J	KUCHERLAPATI, RS; NICHOLS, EA; CREAGAN, RP; CHEN, S; BORGAONKAR, DS; RUDDLE, FH				KUCHERLAPATI, RS; NICHOLS, EA; CREAGAN, RP; CHEN, S; BORGAONKAR, DS; RUDDLE, FH			ASSIGNMENT OF GENE FOR GLUTATHIONE REDUCTASE TO HUMAN CHROMOSOME 8 BY SOMATIC-CELL HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									YALE UNIV,NEW HAVEN,CT 06520; JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21218	Yale University; Johns Hopkins University			Kucherlapati, Raju/ABC-8807-2021						0	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					A51	A51						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V0911					2022-12-18	WOS:A1974V091100146
J	RAO, DC; MORTON, NE				RAO, DC; MORTON, NE			PATH ANALYSIS OF FAMILY RESEMBLANCE IN PRESENCE OF GENE-ENVIRONMENT INTERACTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV HAWAII,POPULATION GENET LAB,HONOLULU,HI 96822	University of Hawaii System								CAVALLIS.LL, 1973, AM J HUM GENET, V25, P618; HOLZINGER SJ, 1935, J AM STAT ASSOC, V30, P274; LAYZER D, 1974, SCIENCE, V183, P1259, DOI 10.1126/science.183.4131.1259; RAO DB, IN PRESS; RAO DC, 1974, AM J HUM GENET, V26, P331; Wright S, 1931, J AM STAT ASSOC, V26, P155	6	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					767	772						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	V0911	4440682				2022-12-18	WOS:A1974V091100011
J	CURTAIN, CC; FUDENBERG, HH; SIMMONS, RT; TINDALE, NB; VOS, G; VANLOGHE.E; DOHERTY, RL				CURTAIN, CC; FUDENBERG, HH; SIMMONS, RT; TINDALE, NB; VOS, G; VANLOGHE.E; DOHERTY, RL			DISTRIBUTION OF IMMUNOGLOBULIN MARKERS AT IGG1, IGG2, IGG3, IGA2, AND K-CHAIN LOCI IN AUSTRALIAN ABORIGINES - COMPARISON WITH NEW GUINEA POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADELS BR, 1963, AM J HYG, V77, P317, DOI 10.1093/oxfordjournals.aje.a120322; CURTAIN CC, 1971, AM J PHYS ANTHROPOL, V34, P257, DOI 10.1002/ajpa.1330340209; CURTAIN CC, 1966, ACHAEOL PHYS ANTHROP, V1, P74; DOHERTY R. L., 1967, Australian Paediatric Journal, V3, P213; FLORY LL, 1964, NATURE, V201, P508, DOI 10.1038/201508a0; GALBRAITH D, 1967, AUST PAEDIATR J, V3, P206; GILES E, 1965, SCIENCE, V150, P1158, DOI 10.1126/science.150.3700.1158; Jones, 1968, ARCHAEOLOGY PHYSICAL, V3, P189; KIRK R. L., 1962, AUSTRALIAN JOUR SCI, V24, P486; KIRK R L, 1971, Human Biology in Oceania, V1, P54; KIRK RL, 1963, AM J PHYS ANTHROPOL, V21, P215, DOI 10.1002/ajpa.1330210213; KIRK RL, 1969, ARCHAEOL PHYS ANTHRO, V4, P238; KUNKEL HG, 1969, NATURE, V223, P1247, DOI 10.1038/2231247a0; MULVANEY DJ, 1969, PREHISTORY AUSTRALIA; NATVIG JACOB B., 1968, SER HAEMATOL, V1, P66; NICHOLLS EM, 1965, AM J HUM GENET, V17, P293; SANGHVI LD, 1971, HUM BIOL, V43, P445; SIMMONS R T, 1971, Human Biology in Oceania, V1, P23; SIMMONS RT, 1964, OCEANIA, V35, P66, DOI 10.1002/j.1834-4461.1964.tb00829.x; SIMMONS RT, 1962, AM J PHYS ANTHROPOL, V20, P303, DOI 10.1002/ajpa.1330200314; SIMMONS RT, 1958, AM J PHYS ANTHROPOL, V16, P59, DOI 10.1002/ajpa.1330160105; SIMMONS RT, 1969, ARCHAEOL PHYS ANTHRO, V4, P252; SIMMONS RT, 1958, 7 P C INT SOC BLOOD, P287; STEINBERG AG, 1969, ANNU REV GENET, V3, P25, DOI 10.1146/annurev.ge.03.120169.000325; STEINBERG AG, 1967, ADVANCES IMMUNOGENET, P73; STEINBERG AG, 1970, ARCHAEOL PHYS ANTHRO, V5, P163; TINDALE NORMAN B., 1962, REC S AUSTRALIAN MUS, V14, P297; VANLOGHE.E, 1967, VOX SANG, V13, P369; VANLOGHEM E, 1970, ANN HUM GENET, V33, P351; VOS GH, 1963, AM J HUM GENET, V15, P44; VYAS G N, 1969, Clinical Research, V17, P469	31	26	26	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	2					145	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M2541	5016507				2022-12-18	WOS:A1972M254100004
J	MCKENZIE, WH; LUBS, HA; HOSTETTER, TL				MCKENZIE, WH; LUBS, HA; HOSTETTER, TL			FAMILY STUDY - HERITABLE VARIATION IN LENGTH OF HUMAN Y-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HETEROCHROMATIN; ABNORMALITIES; PATERNITY; PATTERNS											ARRIGHI FE, 1971, CYTOGENETICS, V10, P81, DOI 10.1159/000130130; BENDER MA, 1961, LANCET, V2, P463; BISHOP A, 1962, LANCET, V2, P18; BOBROW M, 1971, CYTOGENETICS, V10, P190, DOI 10.1159/000130138; BOOK JA, 1960, LANCET, V1, P1063; Borgaonkar D S, 1969, Ann Genet, V12, P262; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; COHEN MM, 1966, CYTOGENETICS, V5, P34, DOI 10.1159/000129883; CRAIGHOLMES AP, 1971, SCIENCE, V174, P702, DOI 10.1126/science.174.4010.702; DELACHAP.A, 1967, ANN GENET-PARIS, V10, P60; DELACHAPELLE A, 1963, HEREDITAS, V50, P351; DRETS ME, 1971, P NATL ACAD SCI USA, V68, P2073, DOI 10.1073/pnas.68.9.2073; JACOBS PA, 1966, NATURE, V210, P352, DOI 10.1038/210352a0; LUBS HA, 1970, SCIENCE, V169, P495, DOI 10.1126/science.169.3944.495; LUBS HA, 1970, HUMAN POPULATION CYT, P119; MAKINO S, 1963, CHROMOSOMA, V14, P154, DOI 10.1007/BF00336757; MULDAL S, 1961, LANCET, V2, P601; NUZZO F, 1966, LANCET, V2, P260; PATIL SR, 1971, SCIENCE, V173, P821, DOI 10.1126/science.173.3999.821; SCHNEDL W, 1971, HUMANGENETIK, V12, P188, DOI 10.1007/BF00702774; UNNERUS V, 1967, CYTOGENETICS, V6, P213, DOI 10.1159/000129943	21	26	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	6					686	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O0504	5082919				2022-12-18	WOS:A1972O050400007
J	SIMPSON, NE				SIMPSON, NE			POLYACRYLAMIDE ELECTROPHORESIS USED FOR DETECTION OF C5+ CHOLINESTERASE IN CANADIAN CAUCASIANS, INDIANS, AND ESKIMOS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ASHTON GC, 1966, AM J HUM GENET, V18, P438; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; HARRIS H, 1963, ANN HUM GENET, V26, P359, DOI 10.1111/j.1469-1809.1963.tb01335.x; SIMPSON NE, 1968, ANN NY ACAD SCI, V151, P699; SIMPSON NE, 1966, ANN NY ACAD SCI, V134, P864, DOI 10.1111/j.1749-6632.1966.tb43074.x	5	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					317	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	5028969				2022-12-18	WOS:A1972M694800010
J	SINGER, K				SINGER, K			GENETIC ASPECTS OF TUBEROUS SCLEROSIS IN A CHINESE POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BORBERG A, 1951, ACTA PSYCHIAT SC S71, P3; BRAIN R, 1962, DISEASES NERVOUS SYS; BUNDEY S, 1969, J NEUROL NEUROSUR PS, V32, P591, DOI 10.1136/jnnp.32.6.591; CHEN C. -Y., 1961, JOUR FORMOSAN MED ASSOC, V60, P177; COSNETT JE, 1969, BRIT MED J, V2, P672, DOI 10.1136/bmj.2.5658.672; Critchley M, 1932, BRAIN, V55, P311, DOI 10.1093/brain/55.3.311; DAWSON J, 1954, Q J MED, V23, P113; GUNTHER R, 1935, J GENET, V31, P413; KIKUZAWA T, 1935, OKAYAMA MED J, V47, P1496; LAGOS JC, 1967, MAYO CLIN PROC, V42, P26; NEVIN N C, 1968, Journal of Medical Genetics, V5, P273, DOI 10.1136/jmg.5.4.273; Ross AT, 1943, ARCH NEURO PSYCHIATR, V50, P233, DOI 10.1001/archneurpsyc.1943.02290210011001; SNAPPER I, 1940, CHIN MED J, V57, P401; STEVENSON AC, 1956, BRIT J PREV SOC MED, V10, P134; Zaremba J, 1968, J Ment Defic Res, V12, P63	15	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	1					33	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	I6190	5581979				2022-12-18	WOS:A1971I619000004
J	YANAI, J; KAKIMOTO, Y; TSUJIO, T; SANO, I				YANAI, J; KAKIMOTO, Y; TSUJIO, T; SANO, I			GENETIC STUDY OF BETA-AMINOISOBUTYRIC ACID EXCRETION BY JAPANESE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARMSTRONG MD, 1963, J BIOL CHEM, V238, P1447; CALCHINOVATI C, 1954, ANN EUGENIC, V18, P335; DEGROUCHY J, 1957, AM J HUM GENET, V9, P76; Fisher RA, 1939, ANN EUGENIC, V9, P1; GARTLER SM, 1957, AM J HUM GENET, V9, P200; GARTLER SM, 1956, AM J HUM GENET, V8, P120; GARTLER SM, 1959, AM J HUM GENET, V11, P257; HARRIS H, 1953, ANN EUGENIC, V18, P43; KAKIMOTO Y, 1968, BIOCHIM BIOPHYS ACTA, V156, P374, DOI 10.1016/0304-4165(68)90267-5; KAKIMOTO Y, 1969, J BIOL CHEM, V244, P335; KUPIECKI FP, 1957, J BIOL CHEM, V229, P743; STANBURY JB, 1960, METABOLIC BASIS I ED, pCH24; SUTTON HE, 1960, METABOLIC BASIS INHE, pCH24	13	26	26	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	2					115	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3696	5814159				2022-12-18	WOS:A1969D369600002
J	MORTON, NE; YASUDA, N; MIKI, C; YEE, S				MORTON, NE; YASUDA, N; MIKI, C; YEE, S			POPULATION STRUCTURE OF ABO BLOOD GROUPS IN SWITZERLAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CROW JF, 1967, 3 P INT C HUM GEN ED, P249; DOBSON AM, 1946, J PATHOL BACTERIOL, V48, P221; Fisher RA, 1940, NATURE, V145, P590, DOI 10.1038/145590a0; Hulse Frederick, 1957, ARCH SUISS ANTHROPOL, V22, P103; Malecot Gustave, 1959, PUBL I STAT U PARIS, V8, P173; MORTON M, 1968, AMER J HUM GENET, V20, P411; MORTON NE, 1967, GENETICS INTERRACIAL; Mourant A. E., 1958, ABO BLOOD GROUPS COM; ROBERTS JAF, 1948, ANN EUGENIC, V14, P109; ROSIN S, 1956, ARCH KLAUSSTIFT VERE, V31, P1; SMITH CAB, 1957, ANN HUM GENET, V21, P254, DOI 10.1111/j.1469-1809.1972.tb00287.x; TWIESSELMANN F, 1962, POPULATION, V17, P241, DOI 10.2307/1527067; WRIGHT S, 1950, J CELL COMPAR PHYSL, V35, P187, DOI 10.1002/jcp.1030350414; YASUDA N, 1968, AM J HUM GENET, V20, P1; YASUDA N, 1966, THESIS U HAWAII; YASUDA N, IN PRESS; YASUDA N, 1967, 3RD P INT C HUM GEN, P249	17	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	5					420	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	B8383	5701614				2022-12-18	WOS:A1968B838300002
J	FIALKOW, PJ; GIBLETT, ER; MOTULSKY, AG				FIALKOW, PJ; GIBLETT, ER; MOTULSKY, AG			MEASURABLE LINKAGE BETWEEN OCULAR ALBINISM AND XG	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAM A, 1966, LANCET, V1, P877; FALLS HF, 1951, AM J OPHTHALMOL, V34, P41, DOI 10.1016/0002-9394(51)90007-4; KERR CB, 1964, LANCET, V2, P1369; LEIN JN, 1956, PEDIATRICS, V18, P214; MAYNARDSMITH S, 1961, MATHEMATICAL TABLES; MORTON NE, 1955, AM J HUM GENET, V7, P277; OPITZ JM, 1965, AM J HUM GENET, V17, P325; RENWICK JH, 1964, AM J HUM GENET, V16, P410; SINISCALCO, 1966, ANN HUM GENET LOND, V29, P231; WAARDENBURG PJ, 1956, ANN HUM GENET LOND, V5, P101; WARBURG M, 1964, ACTA OPHTHALMOL, V42, P444	11	26	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	1					63	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	88552	6019304				2022-12-18	WOS:A19678855200006
J	PLATO, CC; CRUZ, M				PLATO, CC; CRUZ, M			BLOOD GROUP AND HAPTOGLOBIN FREQUENCIES OF CHAMORROS OF GUAM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BLACKWELL RQ, 1964, NATURE, V202, P814, DOI 10.1038/202814a0; CARANO P, 1964, COMPLETE HISTORY GUA; ELIZAN TS, 1966, ARCH NEUROL-CHICAGO, V14, P356, DOI 10.1001/archneur.1966.00470100012002; FRASER G R, 1964, J Med Genet, V1, P107, DOI 10.1136/jmg.1.2.107; KURLAND LT, 1954, NEUROLOGY, V4, P438, DOI 10.1212/WNL.4.6.438; KURLAND LT, 1954, NEUROLOGY, V4, P355, DOI 10.1212/WNL.4.5.355; LIE-INJO LUAN ENG, 1967, AMER J HUM GENET, V19, P130; Mourant A., 1954, DISTRIBUTION HUMAN B; Mourant AE., 1958, ABO BLOOD GROUPS; MYRIANTHOPOULOS NC, 1959, AM J PHYS ANTHROPOL, V17, P105, DOI 10.1002/ajpa.1330170205; PLANAS J, 1966, ACTA GENET STAT MED, V16, P371; PLATO CC, 1966, AM J PHYS ANTHROPOL, V24, P147, DOI 10.1002/ajpa.1330240203; PLATO CC, 1967, AM J HUM GENET, V19, P617; PLATO CC, 1964, NATURE, V202, P728, DOI 10.1038/202728a0; REED D, 1966, AM J EPIDEMIOL, V83, P54, DOI 10.1093/oxfordjournals.aje.a120570; RODRIGUEZ H, 1963, HUM BIOL, V35, P350; SIMMONS RT, 1945, MED J AUSTRALIA, V11, P325; SPOEHR A, 1954, ETHNOLOGY WARDEVASTA; Spoehr A., 1957, FIELDIANA ANTHROPOLO, V48; SUTTON HE, 1960, AM J HUM GENET, V12, P338; TASHIAN RE, 1963, SCIENCE, V140, P53, DOI 10.1126/science.140.3562.53; Thompson L.M., 1947, GUAM ITS PEOPLE; VONKOTZUBUE O, 1921, VOYAGE DISCOVERY SOU	23	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	6					722	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A2687	6075367				2022-12-18	WOS:A1967A268700004
J	NEEL, JV; RAKIC, MT; DAVIDSON, RT; VALKENBURG, HA; MIKKELSEN, WM				NEEL, JV; RAKIC, MT; DAVIDSON, RT; VALKENBURG, HA; MIKKELSEN, WM			STUDIES ON HYPERURICEMIA .2. A RECONSIDERATION OF DISTRIBUTION OF SERUM URIC ACID VALUES IN FAMILIES OF SMYTH COTTERMAN AND FREYBERG	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BROCHNERMORTENS.K, 1963, EPIDEMIOL CHRON, V1, P140; BUNIM JJ, 1962, ANN INTERN MED, V57, P472, DOI 10.7326/0003-4819-57-3-472; DECKER JL, 1962, ARTHRITIS RHEUM, V5, P144, DOI 10.1002/art.1780050203; DECKER JL, 1963, EPIDEMIOL CHRON, V1, P163; DUNN JP, 1963, JAMA-J AM MED ASSOC, V185, P431, DOI 10.1001/jama.1963.03060060029012; GUTMAN AB, 1961, T ASSOC AM PHYSICIAN, V74, P353; GUTMAN AB, 1963, T ASSOC AM PHYSICIAN, V76, P141; HAUGE M, 1955, ACTA MED SCAND, V152, P247; KELLGREN JH, 1963, EPIDEMIOL CHRON, V1, P140; KELLGREN JH, 1963, EPIDEMIOL CHRON, V1, P163; KELLGREN JH, 1963, EPIDEMIOL CHRON, V1, P156; KELLGREN JH, 1963, EPIDEMIOL CHRON, V1, P176; KELLGREN JH, 1963, EPIDEMIOLOGY CHRO ED, V1, P170; LAWRENCE JS, 1963, EPIDEMIOL CHRON, V1, P176; LENNANE GAQ, 1960, ANN RHEUM DIS, V19, P120, DOI 10.1136/ard.19.2.120; LIEBER CS, 1962, J CLIN INVEST, V41, P1863, DOI 10.1172/JCI104643; MIKKELSEN WM, IN PRESS; MIKKELSEN WM, 1962, P CENTRAL SOC CLIN R, V35, P51; NEEL JV, 1962, AM J HUM GENET, V14, P353; NEEL JV, IN PRESS; Pearson K., 1903, BIOMETRIKA, V2, P357; POPERT AJ, 1962, ANN RHEUM DIS, V21, P154, DOI 10.1136/ard.21.2.154; RAKIC MT, 1964, AM J MED, V37, P862, DOI 10.1016/0002-9343(64)90129-9; ROSE BS, 1963, EPIDEMIOL CHRON, V1, P156; SEEGMILLER JE, 1963, NEW ENGL J MED, V268, P764, DOI 10.1056/NEJM196304042681406; SEEGMILLER JE, 1963, NEW ENGL J MED, V268, P821, DOI 10.1056/NEJM196304112681507; SEEGMILLER JE, 1963, NEW ENGL J MED, V268, P712, DOI 10.1056/NEJM196303282681306; SMYTH CJ, 1948, J CLIN INVEST, V27, P749, DOI 10.1172/JCI102025; SORENSEN LB, 1962, ARCH INTERN MED, V109, P379, DOI 10.1001/archinte.1962.03620160005002; STANBURY JB, 1960, METABOLIC BASIS INHE, P679; STECHER RM, 1949, ANN INTERN MED, V31, P595, DOI 10.7326/0003-4819-31-4-595; Steuermann N, 1960, HAWAII MED J, V20, P151; STEUERMANN N, 1963, EPIDEMIOL CHRON, V1, P170; WOLFSON WQ, 1947, J CLIN INVEST, V26, P991, DOI 10.1172/JCI101894; WYNGAARDEN JB, 1960, ARTHRITIS RHEUM, V3, P414, DOI 10.1002/art.1780030507; WYNGAARDEN JB, 1960, METABOLIC BASIS INHE, P679	36	26	26	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1965	17	1					14	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	61289	14255552				2022-12-18	WOS:A19656128900003
J	SALZANO, FM; STEINBERG, AG				SALZANO, FM; STEINBERG, AG			GM AND INV GROUPS OF INDIANS FROM SANTA CATARINA BRAZIL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Salzano, Francisco M/L-7916-2015					CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; GALLANGO ML, 1963, HUM BIOL, V35, P361; GALLANGO ML, 1964, 9 P C INT SOC BLOOD, P472; NEEL JV, 1964, AM J HUM GENET, V16, P52; ROPARTZ C., 1963, TRANSFUSION [PARIS], V6, P5, DOI 10.1016/S0372-1248(63)80017-X; SALZANO FM, 1963, NATURE, V199, P514, DOI 10.1038/199514a0; SALZANO FM, 1964, ACTA GENET MED GEMEL, V13, P278, DOI 10.1017/S1120962300015596; SALZANO FM, 1964, AM J PHYS ANTHROPOL, V22, P91, DOI 10.1002/ajpa.1330220120; SALZANO FM, 1964, AM J HUM GENET, V16, P301; SALZANO FM, 1964, ACTA GENET STAT MED, V14, P212; SALZANO FM, 1965, AM J HUM GENET, V17, P280; STEINBERG A, 1961, AM J HUM GENET, V13, P205; STEINBERG ARTHUR G., 1962, PROGR MED GENET, V2, P1	13	26	26	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1965	17	3					273	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	65219	14295495				2022-12-18	WOS:A19656521900007
J	WOOLF, CM				WOOLF, CM			ALBINISM AMONG INDIANS IN ARIZONA AND NEW MEXICO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOURKE JG, 1892, RBAE, V9, P451; BROWN KS, 1958, AM J HUM GENET, V10, P175; Harris RG, 1926, AM J PHYS ANTHROPOL, V9, P17, DOI 10.1002/ajpa.1330090113; HODGE FW, 1959, HANDBOOK AMERICAN IN; HRDLICKA A, 1908, 34 BUR AM ETHN B; JONES JV, IN PRESS; KEELER CE, 1963, B CURRENT RESEARCH, V2, P18; KEELER CE, 1963, B CURRENT RESEARCH, V2, P8; KEELER CE, 1963, 11 P INT C GEN GEN T; KEELER CLYDE E., 1950, EUGENICAL NEWS, V35, P40; NEEL JV, 1949, AM J HUM GENET, V1, P156; ORAZCO M, 1880, HISTORIA ANTIGUA CON, V1, P381; PARSONS EC, 1933, MEM AMER ANTHROPOL A, V39, P1; PARSONS EC, 1932, REPT BUR AMER ETHNOL, V47, P93; PRESCOTT WH, HISTORY CONQUEST MEX; RUSSELL F, 1908, RBAE, V26, P3; SPUHLER J. N., 1953, HUMAN BIOL, V25, P295; STEVENSON MC, 1904, RBAE, V23, P3; Stout DB, 1946, AM J PHYS ANTHROP-NE, V4, P483, DOI 10.1002/ajpa.1330040408; Stout David B., 1947, SAN BLAS CUNA ACCULT; TREVORROPER PD, 1952, BRIT J OPHTHALMOL, V36, P107, DOI 10.1136/bjo.36.2.107; WITKOP CJ, 1961, 2 INT C HUM GEN ROM; WOOLF CM, 1962, AM J HUM GENET, V14, P391; WOOLF CM, 1964, GENETICS, V49, P165; [No title captured]	25	26	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	1					23	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	61289	14255554				2022-12-18	WOS:A19656128900004
J	BIESELE, JJ; SCHMID, W; LEE, CH; SMITH, PM				BIESELE, JJ; SCHMID, W; LEE, CH; SMITH, PM			TRANSLOCATION BETWEEN ACROCENTRIC CHROMOSOMES IN A 46-CHROMOSOME MONGOLOID AND HIS 45-CHROMOSOME MOTHER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CARTER CO, 1960, LANCET, V2, P678; FORSSMAN H, 1961, LANCET, V1, P1286; FRACCARO M, 1960, LANCET, V1, P724; HUNGERFORD DA, 1959, AM J HUM GENET, V11, P215; JACOBS PA, 1959, LANCET, V1, P710; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; MOORHEAD PS, 1961, AM J HUM GENET, V13, P32; PENROSE LS, 1960, LANCET, V2, P409; POLANI PE, 1960, LANCET, V1, P721; TURPIN R, 1959, CR HEBD ACAD SCI, V248, P3636	10	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	2					125	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2963A	13869086				2022-12-18	WOS:A19622963A00002
J	GATES, RR; CHAKRAVARTTI, MR; MUKHERJEE, DR				GATES, RR; CHAKRAVARTTI, MR; MUKHERJEE, DR			FINAL PEDIGREES OF Y CHROMOSOME INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DRONAMRAJU KR, 1962, AM J HUM GENET, V14, P102; Dronamraju KR, 1960, J GENET, V57, P230; GATES R R, 1957, Acta Genet Med Gemellol (Roma), V6, P103; Gates Reginald Ruggles, 1946, HUMAN GENETICS; GATES RR, 1960, SCIENCE, V132, P145, DOI 10.1126/science.132.3420.145; GATES RR, 1961, MANKIND QUARTERLY; SARKAR SS, 1961, AM J HUM GENET, V13, P214; STERN C, 1957, AM J HUM GENET, V9, P147; THURSTON E, 1909, CASTES TRIBES SOUTH; Tommasi C, 1907, ARCH PSICHIATR NEURO, V28, P60	10	26	26	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1962	14	4					363	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2965A	13946777				2022-12-18	WOS:A19622965A00002
J	PARKER, N				PARKER, N			CONGENITAL DEAFNESS DUE TO A SEX-LINKED RECESSIVE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALDRICH RA, 1954, PEDIATRICS, V13, P133; SATALOFF J, 1955, AM J HUM GENET, V7, P201; VAN EGMOND A A, 1954, J Laryngol Otol, V68, P429, DOI 10.1017/S0022215100049859; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195	4	26	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	2					196	200						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA219	13533396				2022-12-18	WOS:A1958WA21900007
J	HSIA, DYY				HSIA, DYY			LABORATORY DETECTION OF HETEROZYGOTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review																		ABERDHALDEN E, 1903, Z PHYSL CHEM, V38, P557; ADLERSBERG D, 1951, AM J MED, V11, P600, DOI 10.1016/0002-9343(51)90046-0; ADLERSBERG D, 1955, ARCH PATHOL, V60, P481; ALDRICH RA, 1954, PEDIATRICS, V13, P133; ALEXANDER B, 1952, AM J MED, V13, P255, DOI 10.1016/0002-9343(52)90281-7; ANDERSON EP, 1956, 1ST INT C HUM GEN CO; ANDERSON RC, 1954, AM J HUM GENET, V2, P264; BARON DN, 1956, LANCET, V271, P421; BEARN AG, 1953, AM J MED, V15, P442, DOI 10.1016/0002-9343(53)90134-X; BEARN AG, 1954, P SOC EXP BIOL MED, V85, P44; BEARN AG, 1956, 1ST INT C HUM GEN CO; BEET EA, 1949, ANN EUGENIC, V14, P279; BERNARD J, 1952, Sem Hop, V28, P3741; BICKEL H, 1952, ACTA PAED        S90; BIGGS R, 1953, J CLIN PATHOL, V6, P23, DOI 10.1136/jcp.6.1.23; BOAS EP, 1948, AM HEART J, V35, P611, DOI 10.1016/0002-8703(48)90646-2; BONGIOVANNI AM, 1954, J CLIN ENDOCR METAB, V14, P409, DOI 10.1210/jcem-14-4-409; BRINKHOUS KM, 1954, JAMA-J AM MED ASSOC, V154, P481, DOI 10.1001/jama.1954.02940400019005; BRUTON OC, 1951, AMA AM J DIS CHILD, V82, P153, DOI 10.1001/archpedi.1951.02040040162006; CANNON JF, 1955, ARCH INTERN MED, V96, P215, DOI 10.1001/archinte.1955.00250130089012; CARTER C, 1956, LANCET, V271, P1069; CHERNOFF AI, 1955, NEW ENGL J MED, V253, P416, DOI [10.1056/NEJM195509082531006, 10.1056/NEJM195509012530905]; CHERNOFF AI, 1955, N ENGLAND JM, P253; CHILDS B, 1956, J CLIN INVEST, V35, P213, DOI 10.1172/JCI103266; COVEY JA, 1950, ANN INTERN MED, V33, P467, DOI 10.7326/0003-4819-33-2-467; CRIGLER JF, 1952, PEDIATRICS, V10, P169; CROCKER A, COMMUNICATION; DEBRE R, 1952, Bull Mem Soc Med Hop Paris, V68, P665; DENT CE, 1951, ANN EUGENIC, V16, P60, DOI 10.1111/j.1469-1809.1951.tb02459.x; DENT CE, 1956, J BONE JOINT SURG BR, V38, P204, DOI 10.1302/0301-620X.38B1.204; DENT CE, 1956, 8 INT C PAED COP; DEVRIES A, 1951, ACTA HAEMATOL-BASEL, V5, P129, DOI 10.1159/000203820; FAJANS SS, 1954, DIABETES, V3, P296, DOI 10.2337/diab.3.4.296; FINCH S, 1950, J CLIN INVEST, V29, P1078, DOI 10.1172/JCI102339; FINCH SC, 1955, MEDICINE, V34, P381, DOI 10.1097/00005792-195512000-00001; FLIEGELMAN MT, 1948, ARCH DERMATOL SYPH, V58, P409, DOI 10.1001/archderm.1948.01520230054008; FORSSMAN H, 1945, ACTA MED SCAND  S159; Fraenkel E, 1924, VIRCHOWS ARCH A, V248, P125, DOI 10.1007/BF02001333; FRASER D, 1955, LANCET, V1, P286; FRICK PG, 1953, J LAB CLIN MED, V42, P212; FRICK PG, 1954, PEDIATRICS, V13, P44; GIBSON QH, 1947, LANCET, V253, P941; GIORDANO AS, 1943, AM J CLIN PATHOL, V13, P285; GITLIN D, COMMUNICATION; GOOD RA, 1955, J LAB CLIN MED, V46, P167; GRAHAM JB, 1953, AM J MED SCI, V225, P46; GROEN J, 1948, BLOOD, V3, P1238, DOI 10.1182/blood.V3.11.1238.1238; HARRIS H, 1955, ANN HUM GENET, V20, P57, DOI 10.1111/j.1469-1809.1955.tb01278.x; Harris Helen Morgan, COMMUNICATION; HARSLOF E, 1948, ACTA MED SCAND, V130, P140; HERNDON N, 1954, RES PUB ASS NERV MEN, V33, P239; Holt LE, 1939, B JOHNS HOPKINS HOSP, V64, P279; HOLZEL A, 1955, ARCH DIS CHILD, V30, P155, DOI 10.1136/adc.30.150.155; HSIA DYY, 1956, NATURE, V178, P1239, DOI 10.1038/1781239a0; HSIA DYY, 1956, LANCET, V271, P1337; HSIA DYY, UNPUBLISHED; ISSELBACHER KJ, 1956, SCIENCE, V123, P635, DOI 10.1126/science.123.3198.635; KAPILA CC, 1956, BMJ-BRIT MED J, V1, P893, DOI 10.1136/bmj.1.4972.893; KAUFMANN E, 1922, LEHRB SPEZIELLE, V2, P1107; KENCH JE, 1953, Q J MED, V22, P285; KINGSLEY CS, 1954, Q J MED, V23, P323; LANGDELL RD, 1953, J LAB CLIN MED, V41, P637; LASKER MARGARET, 1936, HUMAN BIOL, V8, P243; LASKER MARGARET, 1941, HUMAN BIOL, V13, P51; LAWSON HA, 1953, NEW ENGL J MED, V248, P552, DOI 10.1056/NEJM195303262481306; LIPTON EL, 1955, PEDIATRICS, V15, P67; Macfarlane RG, 1938, LANCET, V1, P309; Maclagan NF, 1940, Q J MED, V9, P151; MARGOLIUS A, 1956, J CLIN INVEST, V35, P1316, DOI 10.1172/JCI103387; MCCANCE RA, 1956, Q J MED, V25, P523; MCCANCE RA, 1955, LANCET, V1, P131; MCQUARRIE I, 1954, AMA AM J DIS CHILD, V87, P399, DOI 10.1001/archpedi.1954.02050090387001; MERSKEY C, 1951, LANCET, V260, P487; MOTULSKY AG, 1954, BLOOD, V9, P57, DOI 10.1182/blood.V9.1.57.57; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Murphy FD, 1944, AM J MED SCI, V207, P77, DOI 10.1097/00000441-194401000-00008; NEEL JV, 1947, MEDICINE, V26, P115, DOI 10.1097/00005792-194705000-00001; NEEL JV, 1947, GENETICS, V32, P38; NEEL JV, 1949, AM J HUM GENET, V1, P19; NEEL JV, 1949, SCIENCE, V110, P64, DOI 10.1126/science.110.2846.64; NEEL JV, 1953, CLIN GENET, P27; NEEL JV, 1954, HUM HERED, P79; OWEN CA, 1955, ARCH INTERN MED, V95, P194, DOI 10.1001/archinte.1955.00250080016003; OWREN PA, 1947, ACTA MED SCAND  S194; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Peters JP, 1943, J CLIN INVEST, V22, P707, DOI 10.1172/JCI101443; PFANDLER U, 1946, SCHWEIZ MED WSCHR, V76, P1128; PFANDLER U, 1956, 1ST INT C HUM GEN CO; Pincus G, 1934, AM J MED SCI, V188, P782, DOI 10.1097/00000441-193412000-00004; PRENTICE A I D, 1951, Lancet, V1, P211; QUICK AJ, 1955, ARCH INTERN MED, V95, P2, DOI 10.1001/archinte.1955.00250070018002; QUICK AJ, 1942, HEMORRHAGIC DISEASES, P260; Race RR, 1941, ANN EUGENIC, V11, P365, DOI 10.1111/j.1469-1809.1941.tb02300.x; RAMOT B, 1955, J LAB CLIN MED, V46, P80; RAYNER S, 1952, Acta Genet Stat Med, V3, P1; ROBSON EB, 1957, CLIN SCI, V16, P75; ROSENTHAL RL, 1954, AM J MED, V17, P57, DOI 10.1016/0002-9343(54)90144-8; ROSENTHAL RL, 1953, P SOC EXP BIOL MED, V82, P171; SACKS MS, 1955, J LAB CLIN MED, V46, P98; SANTAGNESE PAD, 1955, PEDIATRICS, V15, P683; SCHAEFER LE, 1953, AM HEART J, V46, P99, DOI 10.1016/0002-8703(53)90243-9; SCHONHOLZER G, 1939, ARCH KLIN MED, V184, P496; SEEGERS WH, 1955, AM J CLIN PATHOL, V25, P983; SHWACHMAN H, COMMUNICATION; SILVESTRONI E, 1949, AM J HUM GENET, V1, P83; SMITH CH, 1948, AM J DIS CHILD, V75, P505; SMITH CH, 1950, PEDIATRICS, V5, P799; SMYTH CJ, 1948, J CLIN INVEST, V27, P749, DOI 10.1172/JCI102025; SOBEL EH, 1953, PEDIATRICS, V11, P309; STANBURY JB, 1956, J CLIN ENDOCR METAB, V16, P848, DOI 10.1210/jcem-16-7-848; STANBURY JB, 1955, J CLIN ENDOCR METAB, V15, P1216, DOI 10.1210/jcem-15-10-1216; STECHER RM, 1949, SCIENCE, V109, P61, DOI 10.1126/science.109.2821.61-a; STECHER RM, 1949, ANN INTERN MED, V31, P595, DOI 10.7326/0003-4819-31-4-595; STEFANINI M, 1951, LANCET, V260, P606; STEINBERG AG, HYPOPHOSPHATASIA; STOHLMAN F, 1951, J LAB CLIN MED, V38, P842; STURGEON P, 1955, BRIT J HAEMATOL, V1, P264, DOI 10.1111/j.1365-2141.1955.tb05509.x; TURPIN R, 1953, Proc R Soc Med, V46, P1061; UDENFRIEND S, 1953, J BIOL CHEM, V203, P953; UZMAN LL, 1952, AM J MED SCI, V223, P392, DOI 10.1097/00000441-195204000-00006; UZMAN LL, 1953, AMA ARCH PATHOL, V55, P181; WALKER NF, 1954, AM J HUM GENET, V6, P354; WEST JR, 1955, PEDIATRICS, V15, P424; WHITE P, COMMUNICATION; Wyandt H, 1941, ARCH INTERN MED, V68, P1043, DOI 10.1001/archinte.1941.00200120002001; YOUNG LE, 1955, AM J MED, V18, P486, DOI 10.1016/0002-9343(55)90229-1; YOUNG LE, 1951, BLOOD, V6, P1073, DOI 10.1182/blood.V6.11.1073.1073	127	26	26	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1957	9	2					98	116						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA215	13444248				2022-12-18	WOS:A1957WA21500002
J	FALLS, HF				FALLS, HF			HEREDITARY CONGENITAL MACULAR DEGENERATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEHR C, 1920, KLIN MONATSBL AUGENH, V65, P465; BERKLEY WL, 1949, AM J OPHTHALMOL, V32, P361, DOI 10.1016/0002-9394(49)91927-3; Best F., 1905, OPHTHALMOLOGICA, V13, P199, DOI [10.1159/000290318, DOI 10.1159/000290318]; JUNG EE, 1936, UEBER SIPPE ANGEBORE, P20; KURZ O, 1947, OPHTHALMOLOGICA, V114, P262, DOI 10.1159/000300477; RISER RO, 1948, COMMUNICATION; Sorsby A, 1940, Br J Ophthalmol, V24, P469, DOI 10.1136/bjo.24.10.469; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; VOSSIUS A, 1921, VONGRAEFES ARCH OPHT, V105, P1050; WEISEL G, 1922, THESIS GIESSEN	10	26	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1949	1	1					96	104						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU075	17948388				2022-12-18	WOS:A1949XU07500010
J	Hivert, V; Sidorenko, J; Rohart, F; Goddard, ME; Yang, J; Wray, NR; Yengo, L; Visscher, PM				Hivert, Valentin; Sidorenko, Julia; Rohart, Florian; Goddard, Michael E.; Yang, Jian; Wray, Naomi R.; Yengo, Loic; Visscher, Peter M.			Estimation of non-additive genetic variance in human complex traits from a large sample of unrelated individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; LINKAGE DISEQUILIBRIUM; QUANTITATIVE TRAIT; EPISTASIS; DOMINANCE; LOCI; SELECTION; HASEMAN; COMMON	Non-additive genetic variance for complex traits is traditionally estimated from data on relatives. It is notoriously difficult to estimate without bias in non-laboratory species, including humans, because of possible confounding with environmental covariance among relatives. In principle, non-additive variance attributable to common DNA variants can be estimated from a random sample of unrelated individuals with genome-wide SNP data. Here, we jointly estimate the proportion of variance explained by additive (h(SNP)(2)), dominance (delta(2)(SNP)) and additive-by-additive (n(SNP)(2)) genetic variance in a single analysis model. We first show by simulations that our model leads to unbiased estimates and provide a new theory to predict standard errors estimated using either least-squares or maximum likelihood. We then apply the model to 70 complex traits using 254,679 unrelated individuals from the UK Biobank and 1.1Mgenotyped and imputed SNPs. We found strong evidence for additive variance (average across traits h(SNP)(-2) = 0:208). In contrast, the average estimate of delta(-2)(SNP) across traits was 0.001, implying negligible dominance variance at causal variants tagged by common SNPs. The average epistatic variance n(SNP)(-2) across the traits was 0.055, not significantly different from zero because of the large sampling variance. Our results provide new evidence that genetic variance for complex traits is predominantly additive and that sample sizes of many millions of unrelated individuals are needed to estimate epistatic variance with sufficient precision.	[Hivert, Valentin; Sidorenko, Julia; Rohart, Florian; Yang, Jian; Wray, Naomi R.; Yengo, Loic; Visscher, Peter M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Goddard, Michael E.] AgriBio, Agr Victoria Res, 5 Ring Rd, Bundoora, Vic 3083, Australia; [Goddard, Michael E.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia; [Yang, Jian] Westlake Univ, Sch Life Sci, Hangzhou 310024, Zhejiang, Peoples R China; [Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Queensland; La Trobe University; University of Melbourne; Westlake University; University of Queensland	Visscher, PM (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	peter.visscher@uq.edu.au	Wray, Naomi/C-8639-2015; Hivert, Valentin/AAG-2179-2019; Yang, Jian/A-5852-2010; Visscher, Peter/ABB-6151-2020; Yengo, Loic/D-2692-2017	Wray, Naomi/0000-0001-7421-3357; Hivert, Valentin/0000-0002-5144-6956; Yang, Jian/0000-0003-2001-2474; Visscher, Peter/0000-0002-2143-8760; Yengo, Loic/0000-0002-4272-9305	Australian National Health and Medical Research Council [1113400, 1173790]; Australian Research Council [FT180100186, FL180100072]; University of Queensland's Research Computing Centre (RCC)	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Queensland's Research Computing Centre (RCC)	We acknowledge funding from the Australian National Health and Medical Research Council (1113400, 1173790) and the Australian Research Council (FT180100186 and FL180100072). This research has been conducted using the UK Biobank Resource under Appli-cation Number 12505. We wish to acknowledge The University of Queensland's Research Computing Centre (RCC) for its support in this research. We also thank Allan McRae for technical support, Jian Zeng for fruitful discussions, and two anonymous reviewers for helpful comments.	Abraham G, 2017, BIOINFORMATICS, V33, P2776, DOI 10.1093/bioinformatics/btx299; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chen GB, 2016, EUR J HUM GENET, V24, P1810, DOI 10.1038/ejhg.2016.89; Chen GB, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00107; COCKERHAM CC, 1954, GENETICS, V39, P859; Crow JF, 2010, PHILOS T R SOC B, V365, P1241, DOI 10.1098/rstb.2009.0275; de los Campos G, 2019, G3-GENES GENOM GENET, V9, P1429, DOI 10.1534/g3.119.400101; Del Giudice M, 2021, MULTIVAR BEHAV RES, V56, P527, DOI 10.1080/00273171.2020.1743631; DEMPSTER ER, 1950, GENETICS, V35, P212; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Falconer DS, 1996, INTRO QUANTITATIVE G; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Kuhns VHL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124269; Hansen TF, 2013, EVOLUTION, V67, P3501, DOI 10.1111/evo.12214; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hernandez RD, 2019, NAT GENET, V51, P1349, DOI 10.1038/s41588-019-0487-7; Hill WG, 2015, J ANIM BREED GENET, V132, P176, DOI 10.1111/jbg.12140; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; KEIGHTLEY PD, 1989, GENETICS, V121, P869; KEMPTHORNE O, 1954, Proc R Soc Lond B Biol Sci, V143, P102; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Lynch Michael, 1998; Maki-Tanila A, 2014, GENETICS, V198, P355, DOI 10.1534/genetics.114.165282; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Pattaro C., PLOS GENET, V8; R Core Team, 2018, R LANGUAGE ENV STAT; ROBERTSON A, 1983, PROC R SOC SER B-BIO, V219, P253, DOI 10.1098/rspb.1983.0073; Schrauf MF, 2020, G3-GENES GENOM GENET, V10, P3137, DOI 10.1534/g3.120.401300; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Steinsaltz D, 2020, GENETICS, V215, P343, DOI 10.1534/genetics.120.303161; Tin A., NAT GENET, V51, P1459; Tukey JW, 1977, EXPLORATORY DATA ANA, Vxvi; Visscher PM, 2015, GENETICS, V199, P223, DOI 10.1534/genetics.114.171017; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Vitezica ZG, 2017, GENETICS, V206, P1297, DOI 10.1534/genetics.116.199406; Wainschtein P., 2019, RECOVERY TRAIT HERIT, DOI 10.1101/588020v1; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747; Weir BS, 2008, ANNU REV GENOM HUM G, V9, P129, DOI 10.1146/annurev.genom.9.081307.164347; Xu SZ, 2013, GENETICS, V195, P1209, DOI 10.1534/genetics.113.157032; Yang J, 2017, NAT GENET, V49, P1304, DOI 10.1038/ng.3941; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zhu ZH, 2015, AM J HUM GENET, V96, P377, DOI 10.1016/j.ajhg.2015.01.001; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	51	25	25	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 6	2021	108	5					786	798		10.1016/j.ajhg.2021.02.014	http://dx.doi.org/10.1016/j.ajhg.2021.02.014		MAY 2021	13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SO3ST	33811805	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000658896700002
J	Liu, CY; Tu, CF; Wang, LB; Wu, H; Houston, BJ; Mastrorosa, FK; Zhang, W; Shen, Y; Wang, JX; Tian, SX; Meng, LL; Cong, JS; Yang, SM; Jiang, YW; Tang, SY; Zeng, YY; Lv, MR; Lin, G; Li, JS; Saiyin, H; He, XJ; Jin, L; Toure, A; Ray, PF; Veltman, JA; Shi, QH; O'Bryan, MK; Cao, YX; Tan, YQ; Zhang, F				Liu, Chunyu; Tu, Chaofeng; Wang, Lingbo; Wu, Huan; Houston, Brendan J.; Mastrorosa, Francesco K.; Zhang, Wen; Shen, Ying; Wang, Jiaxiong; Tian, Shixiong; Meng, Lanlan; Cong, Jiangshan; Yang, Shenmin; Jiang, Yiwen; Tang, Shuyan; Zeng, Yuyan; Lv, Mingrong; Lin, Ge; Li, Jinsong; Saiyin, Hexige; He, Xiaojin; Jin, Li; Toure, Aminata; Ray, Pierre F.; Veltman, Joris A.; Shi, Qinghua; O'Bryan, Moira K.; Cao, Yunxia; Tan, Yue-Qiu; Zhang, Feng			Deleterious variants in X-linked CFAP47 induce asthenoteratozoospermia and primary male infertility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE MORPHOLOGICAL ABNORMALITIES; WORLD-HEALTH-ORGANIZATION; HUMAN Y-CHROMOSOME; SPERM FLAGELLA; FIBROUS SHEATH; MUTATIONS; AZOOSPERMIA; DNAH1; LEAD	Asthenoteratozoospermia characterized by multiple morphological abnormalities of the flagella (MMAF) has been identified as a sub-type of male infertility. Recent progress has identified several MMAF-associated genes with an autosomal recessive inheritance in human affected individuals, but the etiology in approximately 40% of affected individuals remains unknown. Here, we conducted whole-exome sequencing (WES) and identified hemizygous missense variants in the X-linked CFAP47 in three unrelated Chinese individuals with MMAF. These three CFAP47 variants were absent in human control population genome databases and were predicted to be deleterious by multiple bioinformatic tools. CFAP47 encodes a cilia- and flagella-associated protein that is highly expressed in testis. Immunoblotting and immunofluorescence assays revealed obviously reduced levels of CFAP47 in spermatozoa from all three men harboring deleterious missense variants of CFAP47. Furthermore, WES data from an additional cohort of severe asthenoteratozoospermic men originating from Australia permitted the identification of a hemizygous Xp21.1 deletion removing the entire CFAP47 gene. All men harboring hemizygous CFAP47 variants displayed typical MMAF phenotypes. We also generated a Cfap47-mutated mouse model, the adult males of which were sterile and presented with reduced sperm motility and abnormal flagellar morphology and movement. However, fertility could be rescued by the use of intra-cytoplasmic sperm injections (ICSIs). Altogether, our experimental observations in humans and mice demonstrate that hemizygous mutations in CFAP47 can induce X-linked MMAF and asthenoteratozoospermia, for which good ICSI prognosis is suggested. These findings will provide important guidance for genetic counseling and assisted reproduction treatments.	[Liu, Chunyu; Wang, Lingbo; Tian, Shixiong; Cong, Jiangshan; Jiang, Yiwen; Tang, Shuyan; Zeng, Yuyan; Saiyin, Hexige; Jin, Li; Zhang, Feng] Fudan Univ, Shanghai Inst Planned Parenthood Res, NHC Key Lab Reprod Regulat, State Key Lab Genet Engn,Obstet & Gynecol Hosp,Sc, Shanghai 200011, Peoples R China; [Liu, Chunyu; Wang, Lingbo; Tian, Shixiong; Cong, Jiangshan; Tang, Shuyan; Zhang, Feng] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China; [Tu, Chaofeng; Lin, Ge; Tan, Yue-Qiu] Cent South Univ, Sch Basic Med Sci, Inst Reprod & Stem Cell Engn, Changsha 410000, Peoples R China; [Tu, Chaofeng; Meng, Lanlan; Lin, Ge; Tan, Yue-Qiu] Reprod & Genet Hosp CITIC Xiangya, Changsha 410000, Peoples R China; [Tu, Chaofeng; Lin, Ge; Tan, Yue-Qiu] Clin Res Ctr Reprod & Genet Hunan Prov, Changsha 410000, Peoples R China; [Wang, Lingbo; Li, Jinsong] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,Univ Chinese Acad, Shanghai Key Lab Mol Androl,State Key Lab Cell Bi, Shanghai 200031, Peoples R China; [Wu, Huan; Lv, Mingrong; He, Xiaojin; Cao, Yunxia] Anhui Med Univ, Reprod Med Ctr, Dept Obstet & Gynecol, Affiliated Hosp 1, Hefei 230022, Peoples R China; [Wu, Huan; Lv, Mingrong; He, Xiaojin; Cao, Yunxia] Anhui Med Univ, NHC Key Lab Study Abnormal Gametes & Reprod Tract, Hefei 230032, Peoples R China; [Wu, Huan; Lv, Mingrong; He, Xiaojin; Cao, Yunxia] Anhui Med Univ, Key Lab Populat Hlth Life Cycle, Minist Educ Peoples Republ China, Hefei 230032, Peoples R China; [Houston, Brendan J.; O'Bryan, Moira K.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Houston, Brendan J.; O'Bryan, Moira K.] Univ Melbourne, Sch BioSci, Parkville, Vic 3010, Australia; [Mastrorosa, Francesco K.; Veltman, Joris A.] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Zhang, Wen] Fudan Univ, Shanghai Key Lab Med Epigenet, Sch Basic Med Sci, Dept Syst Biol Med,Inst Biomed Sci,Pudong Med Ctr, Shanghai 200032, Peoples R China; [Shen, Ying] Sichuan Univ, Key Lab Obstet Gynecol & Pediat Dis & Birth Defec, Dept Obstet Gynecol, Minist Educ,West China Univ Hosp 2, Chengdu 610041, Peoples R China; [Wang, Jiaxiong; Yang, Shenmin] Nanjing Med Univ, State Key Lab Reprod Med, Affiliated Suzhou Hosp, Suzhou 215002, Peoples R China; [Wang, Jiaxiong; Yang, Shenmin] Suzhou Municipal Hosp, Suzhou 215002, Peoples R China; [Toure, Aminata; Ray, Pierre F.] Grenoble Alpes Univ, Inst Adv Biosci, Team Genet Epigenet & Therapies Infertil, INSERM U1209,Ctr Natl Rech Sci,UMR 5309, F-38000 Grenoble, France; [Ray, Pierre F.] Ctr Hosp Univ Grenoble Alpes, UM Genet Infertilite & Diagnost Preimplantatoire, F-38000 Grenoble, France; [Shi, Qinghua] Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis,Div Life Sci, Collaborat Innovat Ctr Genet & Dev,Sch Basic Med, Affiliated Hosp USTC 1,Hefei Natl Lab Phys Sci &, Hefei 230027, Peoples R China	Fudan University; Central South University; Central South University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Anhui Medical University; Anhui Medical University; Anhui Medical University; Ministry of Education, China; Monash University; University of Melbourne; Newcastle University - UK; Fudan University; Sichuan University; Nanjing Medical University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhang, F (corresponding author), Fudan Univ, Shanghai Inst Planned Parenthood Res, NHC Key Lab Reprod Regulat, State Key Lab Genet Engn,Obstet & Gynecol Hosp,Sc, Shanghai 200011, Peoples R China.; Zhang, F (corresponding author), Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China.; Tan, YQ (corresponding author), Cent South Univ, Sch Basic Med Sci, Inst Reprod & Stem Cell Engn, Changsha 410000, Peoples R China.; Tan, YQ (corresponding author), Reprod & Genet Hosp CITIC Xiangya, Changsha 410000, Peoples R China.; Tan, YQ (corresponding author), Clin Res Ctr Reprod & Genet Hunan Prov, Changsha 410000, Peoples R China.	tanyueqiu@csu.edu.cn; zhangfeng@fudan.edu.cn	Li, Jin/GYQ-5363-2022; liu, chunyu/GWQ-9357-2022; Zhang, Feng/C-7735-2009; TOURE, Aminata/B-3236-2018; Tang, Shuyan/K-9582-2018; Wang, Jiaxiong/AAE-6781-2020; O'Bryan, Moira/F-8256-2012; Ray, Pierre/D-7315-2019	liu, chunyu/0000-0002-6732-3758; Zhang, Feng/0000-0003-4556-8276; TOURE, Aminata/0000-0001-5629-849X; Tang, Shuyan/0000-0003-2701-1976; Wang, Jiaxiong/0000-0002-2819-165X; Houston, Brendan/0000-0002-1078-756X; Saiyin, Hexige/0000-0003-2993-6817; Zhang, Wen/0000-0002-4973-1168; Mastrorosa, Francesco Kumara/0000-0003-0579-1895; Chao-Feng, Tu/0000-0001-5682-8948; Wang, Lingbo/0000-0002-0962-8457; O'Bryan, Moira/0000-0001-7298-4940; Ray, Pierre/0000-0003-1544-7449	National Natural Science Foundation of China [31625015, 31521003, 81971447, 81971441, 81871216, 81901541, 81601340]; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]; China Postdoctoral Science Foundation [2020TQ0072, 2019M662786]; State Key Laboratory of Reproductive Medicine [SKLRM-K202002]; Science and Technology Major Project of Inner Mongolia Autonomous Region of China [zdzx2018065]; key grant of prevention and treatment of birth defect from Hunan Province [2019SK1012]; National Key Research and Developmental Program of China [2018YFC1004900]; Shanghai Municipal Commission for Science and Technology [19QA1407500, 18ZR1432300]; Foundation of the Department of Science and Technology of Anhui Province [2017070802D150]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2019PT310002]; National Key Research and Development Program of China [2016YFC1000204]; Agence Nationale pour la Recherche [FLAGEL-OME ANR-19-CE17-0014]; Innovative Research Team of High-level Local Universities in Shanghai [SSMUZLCX20180500]; National Health and Medical Research Council [APP1120356]; Investigator Award in Science from TheWellcome Trust [209451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Major Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); State Key Laboratory of Reproductive Medicine; Science and Technology Major Project of Inner Mongolia Autonomous Region of China; key grant of prevention and treatment of birth defect from Hunan Province; National Key Research and Developmental Program of China; Shanghai Municipal Commission for Science and Technology; Foundation of the Department of Science and Technology of Anhui Province; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences; National Key Research and Development Program of China; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Innovative Research Team of High-level Local Universities in Shanghai; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Investigator Award in Science from TheWellcome Trust	We would like to thank the families for participating and supporting this study. We also thank the Center of Cryo-electron Microscopy at Zhejiang University for technical support. This work was supported by National Natural Science Foundation of China (31625015, 31521003, 81971447, 81971441, 81871216, 81901541, and 81601340), Shanghai Municipal Science and Technology Major Project (2017SHZDZX01), China Postdoctoral Science Foundation (2020TQ0072 and 2019M662786), State Key Laboratory of Reproductive Medicine (SKLRM-K202002), Science and Technology Major Project of Inner Mongolia Autonomous Region of China (zdzx2018065), the key grant of prevention and treatment of birth defect from Hunan Province (2019SK1012), the National Key Research and Developmental Program of China (2018YFC1004900), Shanghai Municipal Commission for Science and Technology (19QA1407500 and 18ZR1432300), Foundation of the Department of Science and Technology of Anhui Province (2017070802D150), the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019PT310002), the National Key Research and Development Program of China (2016YFC1000204), the Agence Nationale pour la Recherche (FLAGEL-OME ANR-19-CE17-0014), and Innovative Research Team of High-level Local Universities in Shanghai (SSMUZLCX20180500). The sequencing and analysis of Australian patients was supported in part by a grant from the National Health and Medical Research Council (APP1120356) and an Investigator Award in Science from TheWellcome Trust (209451). We acknowledge the ongoing support of Professor Rob McLachlan and the Monash IVF Group of infertility clinics in Australia for their role in patient recruitment and treatment.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auger J, 2016, HUM REPROD, V31, P10, DOI 10.1093/humrep/dev251; Baccetti B, 2005, HUM REPROD, V20, P2790, DOI 10.1093/humrep/dei126; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Chemes HE, 2012, ASIAN J ANDROL, V14, P14, DOI 10.1038/aja.2011.168; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Geoffroy V, 2018, BIOINFORMATICS, V34, P3572, DOI 10.1093/bioinformatics/bty304; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; He XJ, 2020, AM J HUM GENET, V107, P514, DOI 10.1016/j.ajhg.2020.07.010; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee WR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18064-9; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li WY, 2020, J MED GENET, V57, P89, DOI 10.1136/jmedgenet-2019-106344; Liu CY, 2020, AM J HUM GENET, V107, P330, DOI 10.1016/j.ajhg.2020.06.004; Liu CY, 2019, AM J HUM GENET, V105, P1168, DOI 10.1016/j.ajhg.2019.10.010; Liu WJ, 2019, AM J HUM GENET, V104, P738, DOI 10.1016/j.ajhg.2019.02.020; Lv MR, 2020, J MED GENET, V57, P445, DOI 10.1136/jmedgenet-2019-106479; Martinez G, 2020, J MED GENET, V57, P708, DOI 10.1136/jmedgenet-2019-106775; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Patat O, 2016, AM J HUM GENET, V99, P437, DOI 10.1016/j.ajhg.2016.06.012; R Development Core Team, 2011, R LANG ENV STAT COMP; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sha YW, 2017, GENE, V633, P48, DOI 10.1016/j.gene.2017.08.033; Shahrokhi SZ, 2020, ANDROLOGIA, V52, DOI 10.1111/and.13463; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sullivan R, 2016, HUM REPROD UPDATE, V22, P574, DOI 10.1093/humupd/dmw015; Tang SY, 2017, AM J HUM GENET, V100, P854, DOI 10.1016/j.ajhg.2017.04.012; Toure A, 2021, HUM GENET, V140, P21, DOI 10.1007/s00439-020-02113-x; Tournaye H, 2017, LANCET DIABETES ENDO, V5, P544, DOI 10.1016/S2213-8587(16)30040-7; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Vockel M, 2021, HUM GENET, V140, P203, DOI 10.1007/s00439-019-02101-w; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Wambergue C, 2016, HUM REPROD, V31, P1164, DOI 10.1093/humrep/dew083; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LB, 2017, CELL RES, V27, P815, DOI 10.1038/cr.2017.58; Wang WL, 2019, J MED GENET, V56, P750, DOI 10.1136/jmedgenet-2019-106031; Wang YX, 2014, FERTIL STERIL, V101, P945, DOI 10.1016/j.fertnstert.2013.12.047; Whitfield M, 2019, AM J HUM GENET, V105, P198, DOI 10.1016/j.ajhg.2019.04.015; Yatsenko AN, 2015, NEW ENGL J MED, V372, P2097, DOI 10.1056/NEJMoa1406192; Zhang XG, 2019, CLIN GENET, V96, P541, DOI 10.1111/cge.13644	44	25	28	5	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2021	108	2					309	323		10.1016/j.ajhg.2021.01.002	http://dx.doi.org/10.1016/j.ajhg.2021.01.002		FEB 2021	15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX1UZ	33472045	Bronze, Green Published			2022-12-18	WOS:000629135400010
J	Fritsche, LG; Patil, S; Beesley, LJ; VandeHaar, P; Salvatore, M; Ma, Y; Peng, RB; Taliun, D; Zhou, X; Mukherjee, B				Fritsche, Lars G.; Patil, Snehal; Beesley, Lauren J.; VandeHaar, Peter; Salvatore, Maxwell; Ma, Ying; Peng, Robert B.; Taliun, Daniel; Zhou, Xiang; Mukherjee, Bhramar			Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER; SUSCEPTIBILITY LOCI; VARIANTS; IDENTIFICATION; PREDICTION; REGRESSION; ACCURACY; PATTERNS; ALLELES	To facilitate scientific collaboration on polygenic risk scores (PRSs) research, we created an extensive PRS online repository for 35 common cancer traits integrating freely available genome-wide association studies (GWASs) summary statistics from three sources: published GWASs, the NHGRI-EBI GWAS Catalog, and UK Biobank-based GWASs. Our framework condenses these summary statistics into PRSs using various approaches such as linkage disequilibrium pruning/p value thresholding (fixed or data-adaptively optimized thresholds) and penalized, genome-wide effect size weighting. We evaluated the PRSs in two biobanks: the Michigan Genomics Initiative (MGI), a longitudinal biorepository effort at Michigan Medicine, and the population-based UK Biobank (UKB). For each PRS construct, we provide measures on predictive performance and discrimination. Besides PRS evaluation, the Cancer-PRSweb platform features construct downloads and phenome-wide PRS association study results (PRS-PheWAS) for predictive PRSs. We expect this integrated platform to accelerate PRS-related cancer research.	[Fritsche, Lars G.; Patil, Snehal; Beesley, Lauren J.; VandeHaar, Peter; Salvatore, Maxwell; Ma, Ying; Peng, Robert B.; Taliun, Daniel; Zhou, Xiang; Mukherjee, Bhramar] Univ Michigan, Dept Biostat, Sch Publ Hlth, 1415 Washington Hts,SPH Tower Room 4636, Ann Arbor, MI 48109 USA; [Fritsche, Lars G.; Patil, Snehal; VandeHaar, Peter; Ma, Ying; Taliun, Daniel; Zhou, Xiang; Mukherjee, Bhramar] Univ Michigan, Ctr Stat Genet, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Fritsche, Lars G.; Beesley, Lauren J.; Salvatore, Maxwell; Peng, Robert B.; Zhou, Xiang; Mukherjee, Bhramar] Univ Michigan, Ctr Precis Hlth Data Sci, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Peng, Robert B.] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [Mukherjee, Bhramar] Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA; [Mukherjee, Bhramar] Univ Michigan, Dept Epidemiol, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Fritsche, Lars G.; Mukherjee, Bhramar] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Northwestern University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mukherjee, B (corresponding author), Univ Michigan, Dept Biostat, Sch Publ Hlth, 1415 Washington Hts,SPH Tower Room 4636, Ann Arbor, MI 48109 USA.; Mukherjee, B (corresponding author), Univ Michigan, Ctr Stat Genet, Sch Publ Hlth, Ann Arbor, MI 48109 USA.; Mukherjee, B (corresponding author), Univ Michigan, Ctr Precis Hlth Data Sci, Sch Publ Hlth, Ann Arbor, MI 48109 USA.; Mukherjee, B (corresponding author), Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA.; Mukherjee, B (corresponding author), Univ Michigan, Dept Epidemiol, Sch Publ Hlth, Ann Arbor, MI 48109 USA.; Mukherjee, B (corresponding author), Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.	larsf@umich.edu; bhramar@umich.edu	Fritsche, Lars G/AAF-9387-2019	Fritsche, Lars G/0000-0002-2110-1690; Ma, Ying/0000-0003-3791-7018	National Institutes of Health/NIH [NCI P30CA046592, NHGRI R01 HG008773, T32 CA83654]; University of Michigan (UM-Precision Health Investigators Award) [U063790]; National Science Foundation [DMS-1712933]	National Institutes of Health/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan (UM-Precision Health Investigators Award); National Science Foundation(National Science Foundation (NSF))	The authors acknowledge the Michigan Genomics Initiative participants, Precision Health at the University of Michigan, and the University of Michigan Medical School Data Office for Clinical and Translational Research, the University of Michigan Medical School Central Biorepository, and the University of Michigan Advanced Genomics Core for providing data storage, management, processing, and distribution services, and the Center for Statistical Genetics in the Department of Biostatistics at the School of Public Health for genotype data curation, imputation, and management in support of the research reported in this publication.; This material is based in part upon work supported by the National Institutes of Health/NIH (NCI P30CA046592 [L.G.F., L.J.B., M.S., B.M.], NHGRI R01 HG008773 [B.M.], and T32 CA83654 [R.B.P.]), by the University of Michigan (UM-Precision Health Investigators Award U063790 [L.G.F., S.P., Y.M., B.M.]), and by the National Science Foundation under grant number DMS-1712933. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. Additional acknowledgments of GWAS sources are listed in Supplemental Acknowledgments.	Abraham KJ, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-6; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Beesley L., 2018, EMERGING LANDSCAPE E, DOI [10.20944/pre-prints201809.0388.v1, DOI 10.20944/PRE-PRINTS201809.0388.V1]; Beesley LJ, 2020, STAT MED, V39, P773, DOI 10.1002/sim.8445; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Carroll RJ, 2014, BIOINFORMATICS, V30, P2375, DOI 10.1093/bioinformatics/btu197; Chahal HS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12510; Chahal HS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12048; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Dai XY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003493; Das JK, 2019, GENOMICS, V111, P549, DOI 10.1016/j.ygeno.2018.03.010; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Du ZH, 2020, INT J CANCER, V146, P1819, DOI 10.1002/ijc.32525; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Flint E, 2016, LANCET DIABETES ENDO, V4, P420, DOI 10.1016/S2213-8587(16)00053-X; Fritsche LG, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008202; Fritsche LG, 2018, AM J HUM GENET, V102, P1048, DOI 10.1016/j.ajhg.2018.04.001; Garcia-Closas M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju305; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gaudet MM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003173; Ge T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09718-5; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Ho DE, 2011, J STAT SOFTW, V42; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Huyghe JR, 2019, NAT GENET, V51, P76, DOI 10.1038/s41588-018-0286-6; Janes H, 2009, BIOMETRIKA, V96, P371, DOI 10.1093/biomet/asp002; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kosmidis I., 2018, ARXIV180404085; Lambert SA., 2020, POLYGENIC SCORE CATA, DOI [10.1101/2020.05.20.20108217, DOI 10.1101/2020.05.20.20108217]; Lawrenson K, 2019, GYNECOL ONCOL, V153, P343, DOI 10.1016/j.ygyno.2019.02.023; Lee JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31859-8; Leo PJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006866; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lindstrom S, 2017, CANCER EPIDEM BIOMAR, V26, P1427, DOI 10.1158/1055-9965.EPI-17-0211; Lloyd-Jones LR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12653-0; Maas P, 2016, JAMA ONCOL, V2, P1295, DOI 10.1001/jamaoncol.2016.1025; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mak TSH, 2017, GENET EPIDEMIOL, V41, P469, DOI 10.1002/gepi.22050; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; Mavaddat N, 2019, AM J HUM GENET, V104, P21, DOI 10.1016/j.ajhg.2018.11.002; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Millard LAC, 2018, INT J EPIDEMIOL, V47, P29, DOI 10.1093/ije/dyx204; Milne RL, 2017, NAT GENET, V49, P1767, DOI 10.1038/ng.3785; National Institutes of Health (NIH), 2018, UPDATE NIH MANAGEMEN; Orsted DD, 2011, EUR UROL, V60, P691, DOI 10.1016/j.eururo.2011.06.016; Phelan CM, 2017, NAT GENET, V49, P680, DOI 10.1038/ng.3826; Prive F, 2019, GENETICS, V212, P65, DOI 10.1534/genetics.119.302019; Prive F, 2018, BIOINFORMATICS, V34, P2781, DOI 10.1093/bioinformatics/bty185; R Core Team, 2016, R LANG ENV STAT COMP; Ransohoff KJ, 2017, ONCOTARGET, V8, P17586, DOI 10.18632/oncotarget.15230; Rinella ES, 2013, HUM GENET, V132, P523, DOI 10.1007/s00439-013-1269-4; Schumacher FR, 2018, NAT GENET, V50, P928, DOI 10.1038/s41588-018-0142-8; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; Shi X, 2017, ANN APPL STAT, V11, P1349, DOI 10.1214/17-AOAS1028; Shieh Y, 2020, JNCI-J NATL CANCER I, V112, P590, DOI 10.1093/jnci/djz174; Sirugo G, 2019, CELL, V177, P26, DOI 10.1016/j.cell.2019.02.048; Song MS, 2015, BIOSTATISTICS, V16, P143, DOI 10.1093/biostatistics/kxu034; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tanikawa C, 2018, CARCINOGENESIS, V39, P652, DOI 10.1093/carcin/bgy026; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Wang CL, 2014, NAT GENET, V46, P409, DOI 10.1038/ng.2924; Wei WQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175508; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]; Wu P, 2018, DEV EVALUATING MAPPI, DOI [10.1101/462077, DOI 10.1101/462077]; Yang S, 2020, AM J HUM GENET, V106, P679, DOI 10.1016/j.ajhg.2020.03.013; Zhang YD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16483-3; Zhou W., 2019, 69 ANN M AM SOC HUM; Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	89	25	25	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2020	107	5					815	836		10.1016/j.ajhg.2020.08.025	http://dx.doi.org/10.1016/j.ajhg.2020.08.025			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	OP1QL	32991828	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000587855200004
J	Meisner, A; Kundu, P; Zhang, YD; Lan, LV; Kim, S; Ghandwani, D; Choudhury, PP; Berndt, SI; Freedman, ND; Garcia-Closas, M; Chatterjee, N				Meisner, Allison; Kundu, Prosenjit; Zhang, Yan Dora; Lan, Lauren, V; Kim, Sungwon; Ghandwani, Disha; Choudhury, Parichoy Pal; Berndt, Sonja, I; Freedman, Neal D.; Garcia-Closas, Montserrat; Chatterjee, Nilanjan			Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause Mortality	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMOKING-CESSATION INTERVENTION; UK BIOBANK; SERUM TRIGLYCERIDE; HUMAN LONGEVITY; SLEEP DURATION; CANCER RISK; ASSOCIATION; PREDICTION; REGRESSION; GENETICS	While genome-wide association studies have identified susceptibility variants for numerous traits, their combined utility for predicting broad measures of health, such as mortality, remains poorly understood. We used data from the UK Biobank to combine polygenic risk scores (PRS) for 13 diseases and 12 mortality risk factors into sex-specific composite PRS (cPRS). These cPRS were moderately associated with all-cause mortality in independent data within the UK Biobank: the estimated hazard ratios per standard deviation were 1.10 (95% confidence interval: 1.05, 1.16) and 1.15 (1.10, 1.19) for women and men, respectively. Differences in life expectancy between the top and bottom 5% of the cPRS were estimated to be 4.79 (1.76, 7.81) years and 6.75 (4.16, 9.35) years for women and men, respectively. These associations were substantially attenuated after adjusting for non-genetic mortality risk factors measured at study entry (i.e., middle age for most participants). The cPRS may be useful in counseling younger individuals at higher genetic risk of mortality on modification of non-genetic factors.	[Meisner, Allison; Kundu, Prosenjit; Zhang, Yan Dora; Lan, Lauren, V; Kim, Sungwon; Ghandwani, Disha; Chatterjee, Nilanjan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Zhang, Yan Dora] Univ Hong Kong, Dept Stat, Hong Kong 999077, Peoples R China; [Ghandwani, Disha] Indian Stat Inst, Kolkata 700108, W Bengal, India; [Choudhury, Parichoy Pal; Berndt, Sonja, I; Freedman, Neal D.; Garcia-Closas, Montserrat] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chatterjee, Nilanjan] Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Hong Kong; Indian Statistical Institute; Indian Statistical Institute Kolkata; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University	Chatterjee, N (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.; Chatterjee, N (corresponding author), Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD 21205 USA.	nilanjan@jhu.edu	Garcia-Closas, Montserrat/AAZ-6930-2021; Kundu, Prosenjit/ABB-5220-2021; Freedman, Neal David/B-9741-2015	Garcia-Closas, Montserrat/0000-0003-1033-2650; Freedman, Neal David/0000-0003-0074-1098; Zhang, Yan/0000-0002-5302-3690; Meisner, Allison/0000-0001-5177-7635; Kim, Elle Sungwon/0000-0003-1947-1964	Patient-Centered Outcomes Research Institute [ME-160234530]; National Institutes of Health [1 R01 HG010480-01]; Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health	This research has been conducted using the UK Biobank Resource under Application Number 17712. This research was supported by the Patient-Centered Outcomes Research Institute (ME-160234530), the National Institutes of Health (1 R01 HG010480-01), and the Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Beekman M, 2013, AGING CELL, V12, P184, DOI 10.1111/acel.12039; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; da Silva Andressa Alves, 2016, BMJ Open, V6, pe008119, DOI 10.1136/bmjopen-2015-008119; Dashti HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08917-4; Dziedzic T, 2004, STROKE, V35, pE151, DOI 10.1161/01.STR.0000128705.63891.67; Eastwood SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162388; Frampton MJE, 2016, ANN ONCOL, V27, P429, DOI 10.1093/annonc/mdv540; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Ganna A, 2013, HUM GENET, V132, P553, DOI 10.1007/s00439-013-1267-6; Garcia-Closas M, 2013, CANCER RES, V73, P2211, DOI 10.1158/0008-5472.CAN-12-2388; Godard B, 2003, EUR J HUM GENET, V11, pS123, DOI 10.1038/sj.ejhg.5201117; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; Hsu L, 2015, GASTROENTEROLOGY, V148, P1330, DOI 10.1053/j.gastro.2015.02.010; Hunt SE, 2018, DATABASE-OXFORD, DOI [10.1093/database/bay119, 10.1186/1471-2164-11-293]; Jain M., 2013, NEUROSCI J, V2013; Joshi PK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00934-5; Joshi RC, 2016, COMPUT COMMUN NETW S, P3, DOI 10.1007/978-1-4471-7299-4_1; Keyes KM, 2019, LANCET, V393, P1297, DOI 10.1016/S0140-6736(18)33067-8; Khera AV, 2019, CELL, V177, P587, DOI 10.1016/j.cell.2019.03.028; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Krapohl E, 2018, MOL PSYCHIATR, V23, P1368, DOI 10.1038/mp.2017.163; Lambert SA, 2019, HUM MOL GENET, V28, pR133, DOI 10.1093/hmg/ddz187; Langenberg C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001647; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Lewis CM, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0489-y; Li M, 2017, J AM SOC NEPHROL, V28, P981, DOI 10.1681/ASN.2016020131; Li W, 2008, ADV THER, V25, P329, DOI 10.1007/s12325-008-0045-7; Liu MZ, 2019, NAT GENET, V51, P237, DOI 10.1038/s41588-018-0307-5; Liu TZ, 2017, SLEEP MED REV, V32, P28, DOI 10.1016/j.smrv.2016.02.005; Maas P, 2016, JAMA ONCOL, V2, P1295, DOI 10.1001/jamaoncol.2016.1025; Marioni RE, 2016, P NATL ACAD SCI USA, V113, P13366, DOI 10.1073/pnas.1605334113; Mavaddat N, 2019, AM J HUM GENET, V104, P21, DOI 10.1016/j.ajhg.2018.11.002; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; Melzer D, 2020, NAT REV GENET, V21, P88, DOI 10.1038/s41576-019-0183-6; Mohiuddin SM, 2007, CHEST, V131, P446, DOI 10.1378/chest.06-1587; Mostafavi H, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002458; Natarajan P, 2017, CIRCULATION, V135, P2091, DOI 10.1161/CIRCULATIONAHA.116.024436; Pilling LC, 2017, AGING-US, V9, P2504, DOI 10.18632/aging.101334; Pilling LC, 2016, AGING-US, V8, P547, DOI 10.18632/aging.100930; Prive F, 2019, AM J HUM GENET, V105, P1213, DOI 10.1016/j.ajhg.2019.11.001; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rudolph A, 2018, INT J EPIDEMIOL, V47, P526, DOI 10.1093/ije/dyx242; Rutten-Jacobs LC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4168; Ryu WS, 2010, ATHEROSCLEROSIS, V212, P299, DOI 10.1016/j.atherosclerosis.2010.05.006; Sakaue S, 2020, NAT MED, V26, P542, DOI 10.1038/s41591-020-0785-8; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; SEIBERT TM, 2018, BMJ-BRIT MED J, V360, DOI DOI 10.1136/BMJ.J5757; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Timmers P.R., 2019, ELIFE, V8, P8; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; Treff NR, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00845; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Wald NJ, 2019, GENET MED, V21, P1705, DOI 10.1038/s41436-018-0418-5; Wickham H, 2016, GGPLOT2 ELEGANT GRAP; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wright KM, 2019, G3-GENES GENOM GENET, V9, P2863, DOI 10.1534/g3.119.400448; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Zeileis A, 2004, J STAT SOFTW, V11, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09; Zeng J, 2018, NAT GENET, V50, P746, DOI 10.1038/s41588-018-0101-4; Zhang Y, 2018, NAT GENET, V50, P1318, DOI 10.1038/s41588-018-0193-x; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	70	25	25	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2020	107	3					418	431		10.1016/j.ajhg.2020.07.002	http://dx.doi.org/10.1016/j.ajhg.2020.07.002			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ2TF	32758451	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000565899700004
J	Wagner, JK; Colwell, C; Claw, KG; Stone, AC; Bolnick, DA; Hawks, J; Brothers, KB; Garrison, NA				Wagner, Jennifer K.; Colwell, Chip; Claw, Katrina G.; Stone, Anne C.; Bolnick, Deborah A.; Hawks, John; Brothers, Kyle B.; Garrison, Nanibaa A.			Fostering Responsible Research on Ancient DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							POSTCOLONIAL CONTEXTS; POPULATION HISTORY; MOLECULAR-CLONING; NEW-WORLD; AMERICAN; GENOME; ANTHROPOLOGY; ANCESTRY; VIEW; PARTNERSHIP	Anticipating and addressing the social implications of scientific work is a fundamental responsibility of all scientists. However, expectations for ethically sound practices can evolve over time as the implications of science come to be better understood. Contemporary researchers who work with ancient human remains, including those who conduct ancient DNA research, face precisely this challenge as it becomes clear that practices such as community engagement are needed to address the important social implications of this work. To foster and promote ethical engagement between researchers and communities, we offer five practical recommendations for ancient DNA researchers: (1) formally consult with communities; (2) address cultural and ethical considerations; (3) engage communities and support capacity building; (4) develop plans to report results and manage data; and (5) develop plans for long-term responsibility and stewardship. Ultimately, every member of a research team has an important role in fostering ethical research on ancient DNA. Preface from the ASHG Board of Directors To realize the benefits of human genetics and genomics research, ASHG believes researchers should understand and integrate important ethical, legal, and social considerations into their professional practices. To support these efforts, ASHG will be producing and approving formal guidance documents on a variety of topics. This guidance on ancient DNA research was developed by the ASHG Responsible Ancient DNA Research Working Group, led by members of the ASHG Professional Practice and Social Implications Committee and engaging others with relevant subject matter expertise. It was approved by the ASHG Board of Directors for publication in April 2020, and the Board thanks the group for its time and engagement.	[Wagner, Jennifer K.; Brothers, Kyle B.; Garrison, Nanibaa A.] Amer Soc Human Genet, Profess Practice & Social Implicat Comm, Bethesda, MD 20814 USA; [Wagner, Jennifer K.; Colwell, Chip; Claw, Katrina G.; Stone, Anne C.; Bolnick, Deborah A.; Hawks, John; Brothers, Kyle B.; Garrison, Nanibaa A.] Amer Soc Human Genet, Responsible Ancient DNA Res Working Grp, Bethesda, MD 20814 USA; [Wagner, Jennifer K.] Geisinger, Ctr Translat Bioeth & Hlth Care Policy, Danville, PA 17822 USA; [Colwell, Chip] Denver Museum Nat & Sci, Dept Anthropol, Denver, CO 80205 USA; [Claw, Katrina G.] Univ Colorado, Div Biomed Informat & Personalized Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Stone, Anne C.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Bolnick, Deborah A.] Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA; [Bolnick, Deborah A.] Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA; [Hawks, John] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Brothers, Kyle B.] Univ Louisville, Dept Pediat, Louisville, KY 40202 USA; [Garrison, Nanibaa A.] Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA 90095 USA; [Garrison, Nanibaa A.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Precis Hlth, Los Angeles, CA 90095 USA; [Garrison, Nanibaa A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Arizona State University; Arizona State University-Tempe; University of Connecticut; University of Connecticut; University of Wisconsin System; University of Wisconsin Madison; University of Louisville; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wagner, JK (corresponding author), Amer Soc Human Genet, Profess Practice & Social Implicat Comm, Bethesda, MD 20814 USA.; Wagner, JK (corresponding author), Amer Soc Human Genet, Responsible Ancient DNA Res Working Grp, Bethesda, MD 20814 USA.; Wagner, JK (corresponding author), Geisinger, Ctr Translat Bioeth & Hlth Care Policy, Danville, PA 17822 USA.	jwagner1@geisinger.edu		Stone, Anne/0000-0001-8021-8314; Claw, Katrina/0000-0003-2239-5018	NIH NHGRI [K01 HG008818]	NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors appreciate the meaningful contributions and support for this work provided by the members of the ASHG's Responsible Ancient DNA Research Working Group, which included (in addition to the authors and listed in alphabetical order) Yvonne Bombard, Carlos Bustamante, Graciela Cabana, Dorothy Lippert, Ripan Malhi, Dennis O'Rourke, George (PJ) Perry, Charmaine D. Royal, Consuelo Wilkins, and Joon-Ho Yu. The authors also thank the ASHG Board of Directors for their encouragement in addressing this topic and Derek Scholes, Nikki Meadows, Jillian Galloway, and Lyly Luhachack for their assistance to the working group. N.A.G. was supported by NIH NHGRI K01 HG008818.	American Society of Human Genetics, 2019, ASHG STRAT PLAN; ANDERSON D C, 1978, Plains Anthropologist, V23, P183; [Anonymous], EPISTEMIC INJUSTICE; [Anonymous], 2013, THESIS; Arbour L, 2006, COMMUNITY GENET, V9, P153, DOI 10.1159/000092651; Atalay S, 2008, EVALUATING MULTIPLE NARRATIVES, P29, DOI 10.1007/978-0-387-71825-5_3; Atalay Sonya, 2012, COMMUNITY BASED ARCH; Bader AC, 2019, AM ANTHROPOL, V121, P476, DOI 10.1111/aman.13218; Bardill J, 2018, SCIENCE, V360, P384, DOI 10.1126/science.aaq1131; Bergstrom A, 2020, SCIENCE, V367, P1339, DOI 10.1126/science.aay5012; Bernardini W., 2005, HOPI ORAL TRADITION; Bolnick DA, 2016, ANNU REV ANTHROPOL, V45, P319, DOI 10.1146/annurev-anthro-102215-100036; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; Bowekaty Malcolm B, 2002, Jurimetrics, V42, P145; Boyer Bert B, 2005, Int J Circumpolar Health, V64, P281; Browning SR, 2018, CELL, V173, P53, DOI 10.1016/j.cell.2018.02.031; Burhansstipanov L, 2001, GENETICS, V158, P941; Burhansstipanov Linda, 2005, Cancer Control, V12 Suppl 2, P70; Burke H., 2008, KENNEWICK MAN PERSPE; Callaway E., 2016, N AM OLDEST MUMMY RE; Claw KG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05188-3; Claw KG, 2018, HUM BIOL, V89, P177, DOI 10.13110/humanbiology.89.3.01; Colbran LL, 2019, NAT ECOL EVOL, V3, P1598, DOI 10.1038/s41559-019-0996-x; Colwell Chip, 2017, PLUNDERED SKULLS STO; Colwell-Chanthaphonh C, 2011, MUS MANAGE CURATOR, V26, P27, DOI 10.1080/09647775.2011.540125; Colwell-Chanthaphonh C, 2010, J SOC ARCHAEOL, V10, P325, DOI 10.1177/1469605310377960; Cooper Karen, 2008, SPIRITED ENCOUNTERS; Cove John J., 1995, WHAT BONES SAY TASMA; Cui YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066948; Cunningham H, 1998, CRIT ANTHROPOL, V18, P205, DOI 10.1177/0308275X9801800205; Echo-Hawk R.C., 1994, BATTLEFIELDS BURIAL, P25; Echo-Hawk RC, 2000, AM ANTIQUITY, V65, P267, DOI 10.2307/2694059; Fehren-Schmitz L, 2014, P NATL ACAD SCI USA, V111, P9443, DOI 10.1073/pnas.1403466111; Ferguson T.J., 1984, ETHICS VALUES ARCHAE, P224; Fforde C., 2004, COLLECTING DEAD ARCH; Fine -Dare Kathleen S., 2002, GRAVE INJUSTICE AM I; Flegontov P, 2019, NATURE, V570, P236, DOI 10.1038/s41586-019-1251-y; Fox K, 2019, NATURE, V572, P581, DOI 10.1038/d41586-019-02516-5; Fregel R, 2018, P NATL ACAD SCI USA, V115, P6774, DOI 10.1073/pnas.1800851115; Furholt M, 2018, EUR J ARCHAEOL, V21, P159, DOI 10.1017/eaa.2017.43; Golding Viv, 2013, MUSEUMS COMMUNITIES; Gutaker RM, 2017, CURR OPIN PLANT BIOL, V36, P38, DOI 10.1016/j.pbi.2017.01.002; Guyot R.E., 1979, ACIRL P REPORT, P79; Haber M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-015-0866-z; HAGELBERG E, 1989, NATURE, V342, P485, DOI 10.1038/342485a0; Hajdinjak M, 2018, NATURE, V555, P652, DOI 10.1038/nature26151; Halcrow S.E., 2018, GENOME RES, V28, P423, DOI DOI 10.1101/GR.223693.117; Halcrow SE, 2018, INT J PALEOPATHOL, V22, P97, DOI 10.1016/j.ijpp.2018.06.007; Halffman CM, 2015, P NATL ACAD SCI USA, V112, P12344, DOI 10.1073/pnas.1509747112; Hammil J., 1983, REBURIAL HUMAN SKELE; Hebda RJ., 2017, KWADAY DAN TSINCHI T; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Hollowell J, 2009, INT J CULT PROP, V16, P131, DOI 10.1017/S0940739109090079; Indigenous Wellness Research Institute, 2019, ENG EQ; Indigenous Wellness Research Institute, 2019, ETH ETH TRAIN HLTH I; International Council of Museums, 2018, INT REP HUM REM IND; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Jarvik G., 2019, UPDATED COMMITTEE ST; JOHNSON E, 1973, AM ANTIQUITY, V38, P129, DOI 10.1017/S0002731600089204; Keeler H, 2012, ARIZ ST LJ, V44, P703; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kent M, 2013, SOC STUD SCI, V43, P534, DOI 10.1177/0306312712468520; Khrameeva EE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4584; King TE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6631; Laegassick M., 2000, SKELETONS CUPBOARD S; Leonardi M, 2017, SYST BIOL, V66, pE1, DOI 10.1093/sysbio/syw059; Lindo J, 2018, AM J HUM GENET, V102, P806, DOI 10.1016/j.ajhg.2018.03.008; Lindo J, 2017, P NATL ACAD SCI USA, V114, P4093, DOI 10.1073/pnas.1620410114; Lindo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13175; MacHugh DE, 2017, ANNU REV ANIM BIOSCI, V5, P329, DOI 10.1146/annurev-animal-022516-022747; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Malhi R.S., 2015, AM ANTHROPOL, V117, P736; Marciniak S, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.65; MatisooSmith E., 2018, ARCHAEOL OCEAN, V53, P2015; McKeown CT, 2013, SMALLER SCOPE CONSCI; MEIGHAN CW, 1992, AM ANTIQUITY, V57, P704; Menzies CR, 2006, TRADITIONAL ECOLOGIC; Moreno-Mayar JV, 2018, NATURE, V553, P203, DOI 10.1038/nature25173; Muller R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3236; National Congress of American Indians, 2012, GEN RES AM IND AL NA; National Park Service, 2019, NAT NAGPRA FREQ ASK; ORourke D.H., 2005, BIOL ANTHR ETHICS; PAABO S, 1985, NATURE, V314, P644, DOI 10.1038/314644a0; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Pilli E, 2008, FORENS SCI INT-GEN S, V1, P469, DOI 10.1016/j.fsigss.2007.11.001; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Posth C, 2018, CELL, V175, P1185, DOI 10.1016/j.cell.2018.10.027; Potter B, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5473; Prendergast ME, 2018, ANTIQUITY, V92, P803, DOI 10.15184/aqy.2018.70; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Pullman D, 2018, AM ANTHROPOL, V120, P11, DOI 10.1111/aman.12970; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reardon J, 2012, CURR ANTHROPOL, V53, pS233, DOI 10.1086/662629; Redman S.J., 2016, BONE ROOMS SCI RACIS; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reynolds AW, 2019, P NATL ACAD SCI USA, V116, P9312, DOI 10.1073/pnas.1819467116; Rubicz R, 2003, HUM BIOL, V75, P809, DOI 10.1353/hub.2004.0009; Santos RV, 2009, CURR ANTHROPOL, V50, P787, DOI 10.1086/644532; Santos RV, 2002, CRIT ANTHROPOL, V22, P81; Schuenemann VJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006997; Shapiro B, 2014, SCIENCE, V343, DOI 10.1126/science.1236573; Sikora M, 2019, NATURE, V570, P182, DOI 10.1038/s41586-019-1279-z; Silliman, 2008, COLLABORATING TROWEL, V2; Simonti CN, 2016, SCIENCE, V351, P737, DOI 10.1126/science.aad2149; Skoglund P, 2018, ANNU REV GENOM HUM G, V19, P381, DOI 10.1146/annurev-genom-083117-021749; Skoglund P, 2016, CURR OPIN GENET DEV, V41, P27, DOI 10.1016/j.gde.2016.06.016; Slatkin M, 2016, P NATL ACAD SCI USA, V113, P6380, DOI 10.1073/pnas.1524306113; Smith SE, 2009, HUM BIOL, V81, P407, DOI 10.3378/027.081.0402; Smylie J, 2014, J CAN HEALTH LIBRARI, V35, P16, DOI 10.5596/c14-009; Spyrou MA, 2019, NAT REV GENET, V20, P323, DOI 10.1038/s41576-019-0119-1; Spyrou MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04550-9; Sten S., 2016, FORNVAN NEN, V111; Stone A.C., 2019, ORTNERS IDENTIFICATI; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; TallBear K, 2015, WHO OWNS ANCIENT ONE; TallBear K, 2013, SOC STUD SCI, V43, P509, DOI 10.1177/0306312713483893; Thomas DH, 2019, AM ANTIQUITY, V84, P1, DOI 10.1017/aaq.2018.73; Turnbull P., 2017, SCI MUSEUMS COLLECTI; Turner C.G., 1986, Q REV ARCHAEOLOGY, V7, P1; Turner TR, 2019, AM J PHYS ANTHROPOL, V170, P3, DOI 10.1002/ajpa.23909; Vagene AJ, 2018, NAT ECOL EVOL, V2, P520, DOI 10.1038/s41559-017-0446-6; Wade L., 2018, SCI NEWS; Walker A., 2016, S P; Wallerstein N, 2018, COMMUNITY BASED PART; Watkins J, 2004, J SOC ARCHAEOL, V4, P60, DOI 10.1177/1469605304039850; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Woodahl EL, 2014, PHARMACOGENOMICS, V15, P1235, DOI [10.2217/PGS.14.91, 10.2217/pgs.14.91]; Wright JL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau5064; Wylie A., 2015, OBJECTIVITY SCI NEW, P189; Wylie A, 2008, EVALUATING MULTIPLE NARRATIVES, P201, DOI 10.1007/978-0-387-71825-5_14; Zakrzewski PA, 2002, U TORONTO MED J, V79, P252	134	25	25	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2020	107	2					183	195		10.1016/j.ajhg.2020.06.017	http://dx.doi.org/10.1016/j.ajhg.2020.06.017			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	MY5YF	32763189	Green Published, Bronze			2022-12-18	WOS:000558491800002
J	DeBoever, C; Tanigawa, Y; Aguirre, M; McInnes, G; Lavertu, A; Rivas, MA				DeBoever, Christopher; Tanigawa, Yosuke; Aguirre, Matthew; McInnes, Greg; Lavertu, Adam; Rivas, Manuel A.			Assessing Digital Phenotyping to Enhance Genetic Studies of Human Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; METAANALYSIS; LOCI; INDIVIDUALS; LIFE	Population-scale biobanks that combine genetic data and high-dimensional phenotyping for a large number of participants provide an exciting opportunity to perform genome-wide association studies (GWAS) to identify genetic variants associated with diverse quantitative traits and diseases. A major challenge for GWAS in population biobanks is ascertaining disease cases from heterogeneous data sources such as hospital records, digital questionnaire responses, or interviews. In this study, we use genetic parameters, including genetic correlation, to evaluate whether GWAS performed using cases in the UK Biobank ascertained from hospital records, questionnaire responses, and family history of disease implicate similar disease genetics across a range of effect sizes. We find that hospital record and questionnaire GWAS largely identify similar genetic effects for many complex phenotypes and that combining together both phenotyping methods improves power to detect genetic associations. We also show that family history GWAS using cases ascertained on family history of disease agrees with combined hospital record and questionnaire GWAS and that family history GWAS has better power to detect genetic associations for some phenotypes. Overall, this work demonstrates that digital phenotyping and unstructured phenotype data can be combined with structured data such as hospital records to identify cases for GWAS in biobanks and improve the ability of such studies to identify genetic associations.	[DeBoever, Christopher; Tanigawa, Yosuke; Aguirre, Matthew; McInnes, Greg; Lavertu, Adam; Rivas, Manuel A.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA	Stanford University	Rivas, MA (corresponding author), Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA.	mrivas@stanford.edu	DeBoever, Christopher/ABA-9512-2020; Tanigawa, Yosuke/AAI-7931-2020; Rivas, Manuel/ABE-8173-2020	Tanigawa, Yosuke/0000-0001-9759-157X; Rivas, Manuel/0000-0003-1457-9925; Lavertu, Adam/0000-0003-2396-1915	Stanford University; National Institutes of Health (NIH) Center for Multi-and Trans-ethnic Mapping of Mendelian and Complex Diseases grant [5U01 HG009080]; Stanford Center for Computational, Evolutionary, and Human Genomics; Stanford ChEM-H Institute; Funai Overseas Scholarship from Funai Foundation for Information Technology; Stanford University Biomedical Informatics Training Program; National Human Genome Research Institute of the NIH [R01HG010140]	Stanford University(Stanford University); National Institutes of Health (NIH) Center for Multi-and Trans-ethnic Mapping of Mendelian and Complex Diseases grant; Stanford Center for Computational, Evolutionary, and Human Genomics; Stanford ChEM-H Institute; Funai Overseas Scholarship from Funai Foundation for Information Technology; Stanford University Biomedical Informatics Training Program; National Human Genome Research Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research has been conducted using the UK Biobank resource. We thank all the participants in the UK Biobank study. M.A.R. is supported by Stanford University and a National Institutes of Health (NIH) Center for Multi-and Trans-ethnic Mapping of Mendelian and Complex Diseases grant (5U01 HG009080). C.D. is supported by a postdoctoral fellowship from the Stanford Center for Computational, Evolutionary, and Human Genomics and a seed grant from the Stanford ChEM-H Institute. Y.T. is supported by a Funai Overseas Scholarship from Funai Foundation for Information Technology and the Stanford University Biomedical Informatics Training Program. The primary and processed data used to generate the analyses presented here are available in the UK Biobank access management system (see Web Resources) for application 24983, "Generating effective therapeutic hypotheses from genomic and hospital linkage data'' (see Web Resources), and the results are displayed in the Global Biobank Engine (see Web Resources). Research reported in this publication was supported by the National Human Genome Research Institute of the NIH under Award Number R01HG010140. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Bulik-Sullivan B., 2014, LD SCORE REGRESSION; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cichonska A, 2016, BIOINFORMATICS, V32, P1981, DOI 10.1093/bioinformatics/btw052; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; DeBoever C, 2018, BAYESIAN MODEL COMP, P257162, DOI [10.1101/257162, DOI 10.1101/257162]; DeBoever C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03910-9; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Emdin CA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03911-8; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Hill A, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix009; Hinds DA, 2016, HUM MOL GENET, V25, P1867, DOI 10.1093/hmg/ddw037; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Horsky J, 2018, AMIA ANN S P, V2017, P912; Hu YN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10448; Kirby JC, 2016, J AM MED INFORM ASSN, V23, P1046, DOI 10.1093/jamia/ocv202; Li Y, 2017, CHIN INSIGHT, P23, DOI 10.1007/978-981-10-4385-7_3; Liu JZ, 2017, NAT GENET, V49, P325, DOI 10.1038/ng.3766; McConnell MV, 2017, JAMA CARDIOL, V2, P67, DOI 10.1001/jamacardio.2016.4395; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Onnela JP, 2016, NEUROPSYCHOPHARMACOL, V41, P1691, DOI 10.1038/npp.2016.7; Purcell S, 2005, AM J HUM GENET, V76, P249, DOI 10.1086/427886; Rivas MA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12342; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Smith D, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006659; Thomas NJ, 2018, LANCET DIABETES ENDO, V6, P122, DOI 10.1016/S2213-8587(17)30362-5; Turchin MC, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008431; Wiberg A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08993-6	36	25	25	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2020	106	5					611	622		10.1016/j.ajhg.2020.03.007	http://dx.doi.org/10.1016/j.ajhg.2020.03.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LK8FQ	32275883	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000531096100003
J	Aguirre, M; Rivas, MA; Priest, J				Aguirre, Matthew; Rivas, Manuel A.; Priest, James			Phenome-wide Burden of Copy-Number Variation in the UK Biobank	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DELETION SYNDROME; SEGMENTAL DUPLICATIONS; GENE; ASSOCIATION; METAANALYSIS; IDENTIFICATION; ARCHITECTURE; EXPRESSION; MUTATIONS; RESOURCE	Copy-number variations (CNVs) represent a significant proportion of the genetic differences between individuals and many CNVs associate causally with syndromic disease and clinical outcomes. Here, we characterize the landscape of copy-number variation and their phenome-wide effects in a sample of 472,228 array-genotyped individuals from the UK Biobank. In addition to population-level selection effects against genic loci conferring high mortality, we describe genetic burden from potentially pathogenic and previously uncharacterized CNV loci across more than 3,000 quantitative and dichotomous traits, with separate analyses for common and rare classes of variation. Specifically, we highlight the effects of CNVs at two well-known syndromic loci 16p11.2 and 22q11.2, previously uncharacterized variation at 9p23, and several genic associations in the context of acute coronary artery disease and high body mass index. Our data constitute a deeply contextualized portrait of population-wide burden of copy-number variation, as well as a series of dosage-mediated genic associations across the medical phenome.	[Aguirre, Matthew; Rivas, Manuel A.] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Aguirre, Matthew; Priest, James] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Priest, James] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94035 USA	Stanford University; Stanford University; Stanford University	Priest, J (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.; Priest, J (corresponding author), Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94035 USA.	jpriest@stanford.edu	Rivas, Manuel/ABE-8173-2020	Rivas, Manuel/0000-0003-1457-9925; Aguirre, Matthew/0000-0001-9069-6475	Stanford University; National Institute of Health center for Multi- and Trans-ethnic Mapping of Mendelian and Complex Diseases grant [5U01 HG009080]; National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) [R01HG010140]; Stanford University Department of Pediatrics; National Heart Lung and Blood Institute [R00 HL130523]; Chan-Zuckerberg Biohub; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL130523] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG010140, U01HG009080] Funding Source: NIH RePORTER	Stanford University(Stanford University); National Institute of Health center for Multi- and Trans-ethnic Mapping of Mendelian and Complex Diseases grant; National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Stanford University Department of Pediatrics; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Chan-Zuckerberg Biohub; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	M.A.R. is supported by Stanford University and a National Institute of Health center for Multi- and Trans-ethnic Mapping of Mendelian and Complex Diseases grant (5U01 HG009080). This work was supported by National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) under awards R01HG010140. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. J.P. is supported by the Stanford University Department of Pediatrics, National Heart Lung and Blood Institute (R00 HL130523), and Chan-Zuckerberg Biohub.	Akbaroghli S, 2018, CLIN DYSMORPHOL, V27, P97, DOI 10.1097/MCD.0000000000000224; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Bachmann-Gagescu R, 2010, GENET MED, V12, P641, DOI 10.1097/GIM.0b013e3181ef4286; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cario H, 1999, CLIN GENET, V55, P487, DOI 10.1034/j.1399-0004.1999.550616.x; Carvill GL, 2013, CURR OPIN GENET DEV, V23, P232, DOI 10.1016/j.gde.2013.03.004; Castel SE, 2018, NAT GENET, V50, P1327, DOI 10.1038/s41588-018-0192-y; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Collins RL, 2019, OPEN SOURCE STRUCTUR, DOI [10.1101/578674, DOI 10.1101/578674]; Crawford K, 2019, J MED GENET, V56, P131, DOI 10.1136/jmedgenet-2018-105477; DeBoever C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03910-9; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Fudenberg G, 2019, P NATL ACAD SCI USA, V116, P2175, DOI 10.1073/pnas.1808631116; Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095; HALL JM, 1992, AM J HUM GENET, V50, P1235; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; HORII A, 1992, CANCER RES, V52, P3231; Hout C.V.V, 2019, BIORXIV, DOI DOI 10.1101/572347; Howrigan DP, 2016, MOL PSYCHIATR, V21, P837, DOI 10.1038/mp.2015.120; Iwakoshi M, 2004, AM J MED GENET A, V126A, P278, DOI 10.1002/ajmg.a.20602; Jordan VK, 2015, APPL CLIN GENET, V8, P189, DOI 10.2147/TACG.S65698; Kendall KM, 2017, BIOL PSYCHIAT, V82, P103, DOI 10.1016/j.biopsych.2016.08.014; Kirov G, 2017, EUR NEUROPSYCHOPHARM, V27, pS491, DOI 10.1016/j.euroneuro.2016.09.584; Klaassen P, 2016, AM J MED GENET B, V171, P790, DOI 10.1002/ajmg.b.32441; Kohler S, 2019, NUCLEIC ACIDS RES, V47, pD1018, DOI 10.1093/nar/gky1105; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Mace A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00556-x; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; Maynard TM, 2003, P NATL ACAD SCI USA, V100, P14433, DOI 10.1073/pnas.2235651100; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McInnes G, 2019, BIOINFORMATICS, V35, P2495, DOI 10.1093/bioinformatics/bty999; Medina-Gomez C, 2018, AM J HUM GENET, V102, P88, DOI 10.1016/j.ajhg.2017.12.005; Mikhail FM, 2014, CURR OPIN PEDIATR, V26, P646, DOI 10.1097/MOP.0000000000000142; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Noyes NC, 2016, BIOCHEMISTRY-US, V55, P1204, DOI 10.1021/acs.biochem.5b01218; Olsen L, 2018, LANCET PSYCHIAT, V5, P573, DOI 10.1016/S2215-0366(18)30168-8; Owen D, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5292-7; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; Pott J, 2017, ATHEROSCLEROSIS, V259, P32, DOI 10.1016/j.atherosclerosis.2017.02.018; Povey S, 2001, HUM GENET, V109, P678, DOI 10.1007/s00439-001-0615-0; Priest JR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005963; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu Y., 2019, BIORXIV, DOI [10.1101/540732, DOI 10.1101/540732]; Ranganathan S, 2011, J NEUROSCI, V31, P10836, DOI 10.1523/JNEUROSCI.5065-10.2011; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Rippey C, 2013, AM J HUM GENET, V93, P697, DOI 10.1016/j.ajhg.2013.09.004; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Saito Natsuko, 2017, Biochem Biophys Rep, V9, P322, DOI 10.1016/j.bbrep.2017.01.009; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Syrbe S, 2017, BRAIN, V140, P2322, DOI 10.1093/brain/awx195; Takeshita S, 2012, GENES GENET SYST, V87, P253, DOI 10.1266/ggs.87.253; van der Harst P, 2018, CIRC RES, V122, P433, DOI [10.1161/CIRCRESAHA.117.312086, 10.1161/circresaha.117.312086]; Voll SL, 2017, GENET MED, V19, P204, DOI 10.1038/gim.2016.98; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang NK, 2019, GENET MED, V21, P1280, DOI 10.1038/s41436-018-0347-3; Warland A, 2020, MOL PSYCHIATR, V25, P854, DOI 10.1038/s41380-019-0355-y; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Zufferey F, 2012, J MED GENET, V49, P660, DOI 10.1136/jmedgenet-2012-101203	68	25	25	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2019	105	2					373	383		10.1016/j.ajhg.2019.07.001	http://dx.doi.org/10.1016/j.ajhg.2019.07.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM5GK	31353025	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000478022200011
J	Knaus, A; Kortrum, F; Kleefstra, T; Stray-Pedersen, A; Dukic, D; Murakami, Y; Gerstner, T; van Bokhoven, H; Iqbal, Z; Horn, D; Kinoshita, T; Hempe, MA; Krawitz, PM				Knaus, Alexej; Kortruem, Fanny; Kleefstra, Tjitske; Stray-Pedersen, Asbjorg; Dukic, Dejan; Murakami, Yoshiko; Gerstner, Thorsten; van Bokhoven, Hans; Iqbal, Zafar; Horn, Denise; Kinoshita, Taroh; Hempe, Maj A.; Krawitz, Peter M.			Mutations in PIGU Impair the Function of the GPI Transamidase Complex, Causing Severe Intellectual Disability, Epilepsy, and Brain Anomalies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOXOPLASMA-GONDII; BIOSYNTHESIS; PROTEIN; ANCHORS	The glycosylphosphatidylinositol (GPI) anchor links over 150 proteins to the cell surface and is present on every cell type. Many of these proteins play crucial roles in neuronal development and function. Mutations in 18 of the 29 genes implicated in the biosynthesis of the GPI anchor have been identified as the cause of GPI biosynthesis deficiencies (GPIBDs) in humans. GPIBDs are associated with intellectual disability and seizures as their cardinal features. An essential component of the GPI transamidase complex is PIGU, along with PIGK, PIGS, PIGT, and GPAA1, all of which link GPI-anchored proteins (GPI-APs) onto the GPI anchor in the endoplasmic reticulum (ER). Here, we report two homozygous missense mutations (c.209T>A [p.Ile70Lys] and c.1149C>A [p.Asn383Lys]) in five individuals from three unrelated families. All individuals presented with global developmental delay, severe-to-profound intellectual disability, muscular hypotonia, seizures, brain anomalies, scoliosis, and mild facial dysmorphism. Using multicolor flow cytometry, we determined a characteristic profile for GPI transamidase deficiency. On granulocytes this profile consisted of reduced cell-surface expression of fluorescein-labeled proaerolysin (FLAER), CD16, and CD24, but not of CD55 and CD59; additionally, B cells showed an increased expression of free GPI anchors determined by T5 antibody. Moreover, computer-assisted facial analysis of different GPIBDs revealed a characteristic facial gestalt shared among individuals with mutations in PIGU and GPAA1. Our findings improve our understanding of the role of the GPI transamidase complex in the development of nervous and skeletal systems and expand the clinical spectrum of disorders belonging to the group of inherited GPI-anchor deficiencies.	[Knaus, Alexej; Dukic, Dejan; Krawitz, Peter M.] Rheinische Friedrich Wilhelms Univ Bonn, Univ Hosp Bonn, Inst Genom Stat & Bioinformat, D-53127 Bonn, Germany; [Kortruem, Fanny; Hempe, Maj A.] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Kleefstra, Tjitske; van Bokhoven, Hans; Iqbal, Zafar] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Stray-Pedersen, Asbjorg] Oslo Univ Hosp, Div Pediat & Adolescent Med, Norwegian Natl Unit Newborn Screening, N-0424 Oslo, Norway; [Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Gerstner, Thorsten] Sorlandet Hosp, Dept Pediat, N-4838 Arendal, Norway; [Iqbal, Zafar] Oslo Univ Hosp, Dept Neurol, N-0424 Oslo, Norway; [Horn, Denise] Charite Univ Med Berlin, Inst Med & Human Genet, D-13353 Berlin, Germany	University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Radboud University Nijmegen; University of Oslo; Osaka University; Osaka University; University of Oslo; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Knaus, A (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Univ Hosp Bonn, Inst Genom Stat & Bioinformat, D-53127 Bonn, Germany.	knausa@uni-bonn.de	Bokhoven, J.H.L.M. van van/H-8015-2014; Kinoshita, Taroh/C-7353-2009	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Stray-Pedersen, Asbjorg/0000-0002-9168-0878; Iqbal, Zafar/0000-0002-6387-8019	Berlin-Brandenburg Center for Regenerative Therapies (BCRT) (Bundesministerium fur Bildung und Forschung) [0313911]	Berlin-Brandenburg Center for Regenerative Therapies (BCRT) (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) (Bundesministerium fur Bildung und Forschung, project number 0313911). We would like to thank Samuel C. C. Chiang and professor Yenan T. Bryceson at Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden for performing the initial flow-cytometry analysis with staining of GPI-linked cell-surface markers in whole blood for the proband P-5 in family 3.	Azzouz N, 2006, INT J BIOCHEM CELL B, V38, P1914, DOI 10.1016/j.biocel.2006.05.006; Bayat A, 2019, GENET MED, V21, P2216, DOI 10.1038/s41436-019-0512-3; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Eisenhaber B, 2018, CELL CYCLE, V17, P874, DOI 10.1080/15384101.2018.1456294; Ferry Q, 2014, ELIFE, V3, DOI 10.7554/eLife.02020; Gurovich Y, 2019, NAT MED, V25, P60, DOI 10.1038/s41591-018-0279-0; Hirata T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02799-0; Hong YJ, 2003, MOL BIOL CELL, V14, P1780, DOI 10.1091/mbc.E02-12-0794; Jaeken J, 2017, J INHERIT METAB DIS, V40, P569, DOI 10.1007/s10545-017-0050-6; Kawamoto Michi, 2018, BMJ Case Rep, V2018, DOI 10.1136/bcr-2018-225910; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Kinoshita T, 2014, P JPN ACAD B-PHYS, V90, P130, DOI 10.2183/pjab.90.130; Knaus A, 2018, GENOME MED, V10, DOI 10.1186/s13073-017-0510-5; Kvarnung M, 2013, J MED GENET, V50, P521, DOI 10.1136/jmedgenet-2013-101654; Lam C, 2015, MOL GENET METAB, V115, P128, DOI 10.1016/j.ymgme.2015.04.007; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li MX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003143; Nakashima M, 2014, NEUROGENETICS, V15, P193, DOI 10.1007/s10048-014-0408-y; Ng BG, 2015, J INHERIT METAB DIS, V38, P171, DOI 10.1007/s10545-014-9752-1; Pagnamenta AT, 2017, EUR J HUM GENET, V25, P669, DOI 10.1038/ejhg.2017.32; Pantel JT, 2018, J INHERIT METAB DIS, V41, P533, DOI 10.1007/s10545-018-0174-3; Reijnders MRF, 2018, J MED GENET, V55, P104, DOI 10.1136/jmedgenet-2017-104946; Schroff F., 2015, P IEEE C COMP VIS PA, P815; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sobreira N.L.M., 2017, CURR PROTOC HUM GENE, V95, P1; Striepen B, 1992, BIOCH SOC T, V20; Nguyen TTM, 2018, AM J HUM GENET, V103, P602, DOI 10.1016/j.ajhg.2018.08.014; Nguyen TTM, 2017, AM J HUM GENET, V101, P856, DOI 10.1016/j.ajhg.2017.09.020; TOMAVO S, 1994, PARASITOLOGY, V108, P139, DOI 10.1017/S0031182000068220; Wang YC, 2019, J BIOL CHEM, V294, P5038, DOI 10.1074/jbc.RA119.007472; Yang L, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00153	32	25	25	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2019	105	2					395	402		10.1016/j.ajhg.2019.06.009	http://dx.doi.org/10.1016/j.ajhg.2019.06.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM5GK	31353022	Green Published, Bronze			2022-12-18	WOS:000478022200013
J	Machini, K; Ceyhan-Birsoy, O; Azzariti, DR; Sharma, H; Rossetti, P; Mahanta, L; Hutchinson, L; McLaughlin, H; Green, RC; Lebo, M; Rehm, HL				Machini, Kalotina; Ceyhan-Birsoy, Ozge; Azzariti, Danielle R.; Sharma, Himanshu; Rossetti, Peter; Mahanta, Lisa; Hutchinson, Laura; McLaughlin, Heather; Green, Robert C.; Lebo, Matthew; Rehm, Heidi L.		MedSeq Project	Analyzing and Reanalyzing the Genome: Findings from the MedSeq Project	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION VARIANTS; CLINICAL EXOME; INCIDENTAL FINDINGS; MEDICAL GENETICS; AMERICAN-COLLEGE; ASSOCIATION; RECOMMENDATIONS; GUIDELINES; MUTATIONS; STANDARDS	Although genome sequencing is increasingly available in clinical and research settings, many questions remain about the interpretation of sequencing data. In the MedSeq Project, we explored how much effort is required to evaluate and report on more than 4,500 genes reportedly associated with monogenic conditions, as well as pharmacogenomic (PGx) markers, blood antigen serotyping, and polygenic risk scores in 100 individuals (50 with cardiomyopathy and 50 healthy) randomized to the sequencing arm. We defined the quality thresholds for determining the need for Sanger confirmation. Finally, we examined the effort needed and new findings revealed by reanalyzing each genome (6-23 months after initial analysis; mean 13 months). Monogenic disease risk and carrier status were reported in 21% and 94% of participants, respectively. Only two participants had no monogenic disease risk or carrier status identified. For the PGx results (18 genotypes in six genes for five drugs), the identified diplotypes prompted recommendation for non-standard dosing of at least one of the analyzed drugs in 95% of participants. For blood antigen studies, we found that 31% of participants had a rare blood antigen genotype. In the cardiomyopathy cohort, an explanation for disease was identified in 48% of individuals. Over the course of the study, 14 variants were reclassified and, upon reanalysis, 18 new variants met criteria for reporting. These findings highlight the quantity of medically relevant findings from a broad analysis of genomic sequencing data as well as the need for periodic reinterpretation and reanalysis of data for both diagnostic indications and secondary findings.	[Machini, Kalotina; Ceyhan-Birsoy, Ozge; Azzariti, Danielle R.; Sharma, Himanshu; Rossetti, Peter; Mahanta, Lisa; Hutchinson, Laura; McLaughlin, Heather; Lebo, Matthew; Rehm, Heidi L.] Partners Healthcare Personalized Med, Mol Med Lab, Cambridge, MA 02139 USA; [Machini, Kalotina; Lebo, Matthew; Rehm, Heidi L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Machini, Kalotina; Green, Robert C.; Lebo, Matthew; Rehm, Heidi L.] Harvard Med Sch, Boston, MA 02115 USA; [Azzariti, Danielle R.; Green, Robert C.; Lebo, Matthew; Rehm, Heidi L.] Broad Inst MIT & Harvard, Med & Populat Genet, Cambridge, MA 02142 USA; [Green, Robert C.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Rehm, Heidi L.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Ceyhan-Birsoy, Ozge] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [McLaughlin, Heather] Invitae, San Francisco, CA 94103 USA	Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center	Rehm, HL (corresponding author), Partners Healthcare Personalized Med, Mol Med Lab, Cambridge, MA 02139 USA.; Rehm, HL (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Rehm, HL (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Rehm, HL (corresponding author), Broad Inst MIT & Harvard, Med & Populat Genet, Cambridge, MA 02142 USA.; Rehm, HL (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.	hrehm@mgh.harvard.edu		Lebo, Matthew/0000-0002-9733-5207	National Institutes of Health [U01HG006500, U41HG006834]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006834, U01HG006500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research reported in this publication was supported by the National Institutes of Health under award numbers U01HG006500 and U41HG006834. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abou Tayoun AN, 2018, HUM MUTAT, V39, P1517, DOI 10.1002/humu.23626; Almomani R, 2016, J AM COLL CARDIOL, V67, P515, DOI 10.1016/j.jacc.2015.10.093; Aronson S, 2016, J PERS MED, V6, DOI 10.3390/jpm6010004; Aronson SJ, 2015, NATURE, V526, P336, DOI 10.1038/nature15816; Aronson SJ, 2012, GENET MED, V14, P713, DOI 10.1038/gim.2012.19; Aronson SJ, 2011, HUM MUTAT, V32, P532, DOI 10.1002/humu.21470; Baudhuin LM, 2015, J MOL DIAGN, V17, P456, DOI 10.1016/j.jmoldx.2015.03.004; Biesecker LG, 2014, NEW ENGL J MED, V371, P1170, DOI 10.1056/NEJMc1408914; Boycott KM, 2017, AM J HUM GENET, V100, P695, DOI 10.1016/j.ajhg.2017.04.003; Ceyhan-Birsoy O, 2017, GENET MED, V19, P809, DOI 10.1038/gim.2016.193; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Cirino AL, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001768; Costain G, 2018, EUR J HUM GENET, V26, P740, DOI 10.1038/s41431-018-0114-6; Dai ZY, 2017, EUR J MED GENET, V60, P312, DOI 10.1016/j.ejmg.2017.03.012; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Harrison SM, 2017, GENET MED, V19, P1096, DOI 10.1038/gim.2017.14; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Klinkenberg-Ramirez S, 2016, APPL CLIN INFORM, V7, P461, DOI 10.4338/ACI-2015-11-RA-0162; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Kong SW, 2015, GENET MED, V17, P536, DOI 10.1038/gim.2014.143; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lane WJ, 2018, LANCET HAEMATOL, V5, pE241, DOI 10.1016/S2352-3026(18)30053-X; Lane WJ, 2016, TRANSFUSION, V56, P743, DOI 10.1111/trf.13416; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Linderman MD, 2016, J PERS MED, V6, DOI 10.3390/jpm6020014; Lindor NM, 2017, MAYO CLIN PROC, V92, P159, DOI 10.1016/j.mayocp.2016.10.019; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; McLaughlin HM, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0134-1; Pinard A, 2016, HUM MUTAT, V37, P1299, DOI 10.1002/humu.23112; Rehm HL, 2017, NAT REV GENET, V18, P259, DOI 10.1038/nrg.2016.162; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roy S, 2018, J MOL DIAGN, V20, P4, DOI 10.1016/j.jmoldx.2017.11.003; Safarova MS, 2017, EUR J HUM GENET, V25, P410, DOI 10.1038/ejhg.2016.193; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Strande NT, 2017, AM J HUM GENET, V100, P895, DOI 10.1016/j.ajhg.2017.04.015; Tsai EA, 2016, J PERS MED, V6, DOI 10.3390/jpm6010012; Van Driest SL, 2016, JAMA-J AM MED ASSOC, V315, P47, DOI 10.1001/jama.2015.17701; Vassy JL, 2017, ANN INTERN MED, V167, P159, DOI 10.7326/M17-0188; Vassy JL, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-85; Wenger AM, 2017, GENET MED, V19, P209, DOI 10.1038/gim.2016.88; Yang S, 2017, GENET MED, V19, P1118, DOI 10.1038/gim.2017.60; Zimmerman RS, 2010, GENET MED, V12, P268, DOI 10.1097/GIM.0b013e3181d6f7c0	45	25	25	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 3	2019	105	1					177	188		10.1016/j.ajhg.2019.05.017	http://dx.doi.org/10.1016/j.ajhg.2019.05.017			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG3RM	31256874	Green Published, Bronze			2022-12-18	WOS:000473723000014
J	Laval, G; Peyregne, S; Zidane, N; Harmant, C; Renaud, F; Patin, E; Prugnolle, F; Quintana-Murci, L				Laval, Guillaume; Peyregne, Stephane; Zidane, Nora; Harmant, Christine; Renaud, Francois; Patin, Etienne; Prugnolle, Franck; Quintana-Murci, Lluis			Recent Adaptive Acquisition by African Rainforest Hunter-Gatherers of the Late Pleistocene Sickle-Cell Mutation Suggests Past Differences in Malaria Exposure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-GLOBIN GENE; BALANCING SELECTION; POSITIVE SELECTION; MOLECULAR ANALYSIS; DEFORESTATION; EVOLUTION; ORIGIN; MAP; PROTECTION; GENOME	The hemoglobin beta(S) sickle mutation is a textbook case in which natural selection maintains a deleterious mutation at high frequency in the human population. Homozygous individuals for this mutation develop sickle-cell disease, whereas heterozygotes benefit from higher protection against severe malaria. Because the overdominant beta(S) allele should be purged almost immediately from the population in the absence of malaria, the study of the evolutionary history of this iconic mutation can provide important information about the history of human exposure to malaria. Here, we sought to increase our understanding of the origins and time depth of the beta(S) mutation in populations with different lifestyles and ecologies, and we analyzed the diversity of HBB in 479 individuals from 13 populations of African farmers and rainforest hunter-gatherers. Using an approximate Bayesian computation method, we estimated the age of the beta(S) allele while explicitly accounting for population subdivision, past demography, and balancing selection. When the effects of balancing selection are taken into account, our analyses indicate a single emergence of beta(S) in the ancestors of present-day agriculturalist populations similar to 22,000 years ago. Furthermore, we show that rainforest hunter-gatherers have more recently acquired the beta(S) mutation from the ancestors of agriculturalists through adaptive gene flow during the last similar to 6,000 years. Together, our results provide evidence for a more ancient exposure to malarial pressures among the ancestors of agriculturalists than previously appreciated, and they suggest that rainforest hunter-gatherers have been increasingly exposed to malaria during the last millennia.	[Laval, Guillaume; Peyregne, Stephane; Zidane, Nora; Harmant, Christine; Patin, Etienne; Quintana-Murci, Lluis] CNRS, UMR 2000, Human Evolutionary Genet Unit, Inst Pasteur, F-75015 Paris, France; [Laval, Guillaume; Peyregne, Stephane; Zidane, Nora; Harmant, Christine; Patin, Etienne; Quintana-Murci, Lluis] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, F-75015 Paris, France; [Peyregne, Stephane] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Renaud, Francois; Prugnolle, Franck] CNRS, Inst Rech Dev, Lab MIVEGEC, UMR 5290, F-34394 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Laval, G; Quintana-Murci, L (corresponding author), CNRS, UMR 2000, Human Evolutionary Genet Unit, Inst Pasteur, F-75015 Paris, France.; Laval, G; Quintana-Murci, L (corresponding author), Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, F-75015 Paris, France.	glaval@pasteur.fr; quintana@pasteur.fr	peyregne, stephane/AAA-5537-2021; Quintana-Murci, Lluis/AAB-7468-2022	Peyregne, Stephane/0000-0002-9823-9102; Prugnolle, Franck/0000-0001-8519-1253	Institut Pasteur, the Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR) [ANR-14-CE14-0008-02, ANR-14-CE14-0007-02, ANR-14-E02-0003-01]; French government's Investissement d'Avenir program through the Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' [ANR-10-LABX-62-IBEID]	Institut Pasteur, the Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); French government's Investissement d'Avenir program through the Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases''	We thank Paul Verdu, Luis B. Barreiro, and George H. Perry for providing western and eastern hunter-gatherer DNA samples. This work was supported by the Institut Pasteur, the Centre National de la Recherche Scientifique (CNRS), and the Agence Nationale de la Recherche (ANR) grants "EIHSEER'' ANR-14-CE14-0008-02, "BPATHGEN'' ANR-14-CE14-0007-02, and "GRHUM'' ANR-14-E02-0003-01. The laboratory of L.Q.-M. has received funding from the French government's Investissement d'Avenir program through the Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' (grant no. ANR-10-LABX-62-IBEID).	Ackerman H, 2005, ANN HUM GENET, V69, P559, DOI 10.1111/j.1529-8817.2005.00180.x; Afrane YA, 2012, ANN NY ACAD SCI, V1249, P204, DOI 10.1111/j.1749-6632.2011.06432.x; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; ALLISON AC, 1956, ANN HUM GENET, V21, P67, DOI 10.1111/j.1469-1809.1971.tb00266.x; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Beaumont MA, 2002, GENETICS, V162, P2025; Brandt DYC, 2018, G3-GENES GENOM GENET, V8, P2805, DOI 10.1534/g3.118.200367; Cavalli-Sforza L. L., 1986, AFRICAN PYGMIES; CHEBLOUNE Y, 1988, P NATL ACAD SCI USA, V85, P4431, DOI 10.1073/pnas.85.12.4431; Crawford JE, 2010, MOL BIOL EVOL, V27, P1739, DOI 10.1093/molbev/msq070; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; FLINT J, 1993, HUM GENET, V91, P91; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grollemund R, 2015, P NATL ACAD SCI USA, V112, P13296, DOI 10.1073/pnas.1503793112; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Guerra CA, 2006, ANN TROP MED PARASIT, V100, P189, DOI 10.1179/136485906X91512; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Haller BC, 2017, MOL BIOL EVOL, V34, P230, DOI 10.1093/molbev/msw211; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Kabaria CW, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1694-2; KURNIT DM, 1979, LANCET, V1, P104; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lapierre M, 2017, GENETICS, V206, P439, DOI 10.1534/genetics.116.192708; Leffler EM, 2013, SCIENCE, V339, P1578, DOI 10.1126/science.1234070; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu XY, 2013, AM J HUM GENET, V92, P866, DOI 10.1016/j.ajhg.2013.04.021; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; Lopez M, 2018, NAT ECOL EVOL, V2, P721, DOI 10.1038/s41559-018-0496-4; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; MEARS JG, 1981, J CLIN INVEST, V68, P606, DOI 10.1172/JCI110294; Otto TD, 2018, NAT MICROBIOL, V3, P687, DOI 10.1038/s41564-018-0162-2; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Patin E, 2017, SCIENCE, V356, P543, DOI 10.1126/science.aal1988; Patin E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4163; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Phillipson D. W., 2005, AFRICAN ARCHAEOLOGY; Rasmussen MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004342; Roberts P, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.93; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; Shriner D, 2018, AM J HUM GENET, V102, P547, DOI 10.1016/j.ajhg.2018.02.003; SOLOMON E, 1979, LANCET, V1, P923; STINE OC, 1992, J MOL EVOL, V34, P336; Tewari S, 2015, HAEMATOLOGICA, V100, P1108, DOI 10.3324/haematol.2014.120030; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WALSH JF, 1993, PARASITOLOGY, V106, pS55, DOI 10.1017/S0031182000086121; WIESENFELD SL, 1967, SCIENCE, V157, P1134, DOI 10.1126/science.157.3793.1134	51	25	25	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2019	104	3					553	561		10.1016/j.ajhg.2019.02.007	http://dx.doi.org/10.1016/j.ajhg.2019.02.007			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HN9SY	30827499	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000460541200019
J	Santos-Cortez, RLP; Chiong, CM; Frank, DN; Ryan, AF; Giese, APJ; Roberts, TB; Daly, KA; Steritz, MJ; Szeremeta, W; Pedro, M; Pine, H; Yarza, TKL; Scholes, MA; Llanes, EGDV; Yousaf, S; Friedman, N; Tantoco, MLC; Wine, TM; Labra, PJ; Benoit, J; Ruiz, AG; de la Cruz, RAR; Greenlee, C; Yousaf, A; Cardwell, J; Nonato, RMA; Ray, D; Ong, KMC; So, E; Robertson, CE; Dinwiddie, J; Lagrana-Villagracia, SM; Gubbels, SP; Shaikh, RS; Cass, SP; Einarsdottir, E; Lee, NR; Schwartz, DA; Gloria-Cruz, TLI; Bamshad, MJ; Yang, IV; Kere, J; Abes, GT; Prager, JD; Riazuddin, S; Chan, AL; Yoon, PJ; Nickerson, DA; Cutiongco-de la Paz, EM; Streubel, SO; Reyes-Quintos, MRT; Jenkins, HA; Mattila, P; Chan, KH; Mohlke, KL; Leal, SM; Hafren, L; Chonmaitree, T; Sale, MM; Ahmed, ZM				Santos-Cortez, Regie Lyn P.; Chiong, Charlotte M.; Frank, Daniel N.; Ryan, Allen F.; Giese, Arnaud P. J.; Roberts, Tori Bootpetch; Daly, Kathleen A.; Steritz, Matthew J.; Szeremeta, Wasyl; Pedro, Melquiadesa; Pine, Harold; Yarza, Talitha Karisse L.; Scholes, Melissa A.; Llanes, Erasmo Gonzalo D. V.; Yousaf, Saira; Friedman, Norman; Tantoco, Ma Leah C.; Wine, Todd M.; John Labra, Patrick; Benoit, Jeanne; Ruiz, Amanda G.; de la Cruz, Rhodieleen Anne R.; Greenlee, Christopher; Yousaf, Ayesha; Cardwell, Jonathan; Nonato, Rachelle Marie A.; Ray, Dylan; Ong, Kimberly Mae C.; So, Edward; Robertson, Charles E.; Dinwiddie, Jordyn; Lagrana-Villagracia, Sheryl Mae; Gubbels, Samuel P.; Shaikh, Rehan S.; Cass, Stephen P.; Einarsdottir, Elisabet; Lee, Nanette R.; Schwartz, David A.; Gloria-Cruz, Teresa Luisa I.; Bamshad, Michael J.; Yang, Ivana V.; Kere, Juha; Abes, Generoso T.; Prager, Jeremy D.; Riazuddin, Saima; Chan, Abner L.; Yoon, Patricia J.; Nickerson, Deborah A.; Cutiongco-de la Paz, Eva Maria; Streubel, Sven-Olrik; Reyes-Quintos, Maria Rina T.; Jenkins, Herman A.; Mattila, Petri; Chan, Kenny H.; Mohlke, Karen L.; Leal, Suzanne M.; Hafren, Lena; Chonmaitree, Tasnee; Sale, Michele M.; Ahmed, Zubair M.		UWCMG	FUT2 Variants Confer Susceptibility to Familial Otitis Media	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							READ ALIGNMENT; GENE; EXPRESSION; RARE; REVEALS; BIOLOGY; LEWIS	Non-secretor status due tohomozygosity for the commonFUT2 variant c. 461G> A(p. Trp154*) is associated witheither risk for autoimmune diseases or protection against viral diarrhea and HIV. We determined the role of FUT2 in otitis media susceptibility by obtaining DNA samples from 609 multi-ethnic families and simplex case subjectswith otitis media. Exome and Sanger sequencing, linkage analysis, and Fisher exact and transmission disequilibrium tests (TDT) were performed. The common FUT2 c. 604C> T (p. Arg202*) variant co-segregates with otitismedia in a Filipino pedigree (LOD = 4.0). Additionally, a rare variant, c. 412C> T (p. Arg138Cys), is associated with recurrent/ chronic otitismedia in European-American children (p = 1.2310(-5)) and US trios (TDT p = 0.01). The c. 461G> A (p. Trp154*) variant was also overtransmitted in US trios (TDT p = 0.01) and was associated with shifts inmiddle ear microbiota composition (PERMANOVA p < 10(-7)) and increased biodiversity. When all missense and nonsense variants identified in multi-ethnic US trios withCADD> 20 were combined, FUT2 variantswere over-transmitted in trios (TDTp = 0.001). Fut2 is transiently upregulated inmouse middle ear after inoculation withnon-typeable Haemophilus influenzae. Four FUT2 variants-namely p. Ala104Val, p. Arg138Cys, p. Trp154*, and p. Arg202*-reduced A antigen in mutant-transfected COS-7 cells, while the nonsense variants also reduced FUT2 protein levels. Common and rare FUT2 variants confer susceptibility to otitis media, likely by modifying the middle ear microbiome through regulation of A antigen levels in epithelial cells. Our familiesdemonstratemarked intra-familial genetic heterogeneity, suggesting thatmultiple combinations of common and rare variants plus environmental factors influence the individual otitis media phenotype as a complex trait.	[Santos-Cortez, Regie Lyn P.; Roberts, Tori Bootpetch; Steritz, Matthew J.; Scholes, Melissa A.; Friedman, Norman; Wine, Todd M.; Ruiz, Amanda G.; Greenlee, Christopher; Ray, Dylan; Dinwiddie, Jordyn; Gubbels, Samuel P.; Cass, Stephen P.; Prager, Jeremy D.; Yoon, Patricia J.; Streubel, Sven-Olrik; Jenkins, Herman A.; Chan, Kenny H.] Univ Colorado, Sch Med CUSOM, Dept Otolaryngol, Aurora, CO 80045 USA; [Santos-Cortez, Regie Lyn P.] Childrens Hosp Colorado CHCO, Ctr Childrens Surg, Aurora, CO 80045 USA; [Santos-Cortez, Regie Lyn P.; Chiong, Charlotte M.; Pedro, Melquiadesa; Yarza, Talitha Karisse L.; Llanes, Erasmo Gonzalo D. V.; Tantoco, Ma Leah C.; Lagrana-Villagracia, Sheryl Mae; Gloria-Cruz, Teresa Luisa I.; Abes, Generoso T.; Chan, Abner L.; Reyes-Quintos, Maria Rina T.] Univ Philippines UP Manila, NIH, Philippine Natl Ear Inst, Manila 1000, Philippines; [Chiong, Charlotte M.; Yarza, Talitha Karisse L.; Reyes-Quintos, Maria Rina T.] UP Manila, Natl Hearing Screening Reference Ctr, NIH, Manila 1000, Philippines; [Chiong, Charlotte M.; Llanes, Erasmo Gonzalo D. V.; Tantoco, Ma Leah C.; John Labra, Patrick; de la Cruz, Rhodieleen Anne R.; Nonato, Rachelle Marie A.; Ong, Kimberly Mae C.; Gloria-Cruz, Teresa Luisa I.; Abes, Generoso T.; Chan, Abner L.; Reyes-Quintos, Maria Rina T.] UP Manila, Coll Med, Philippine Gen Hosp, Dept Otorhinolaryngol, Manila 1000, Philippines; [Frank, Daniel N.; Benoit, Jeanne; Robertson, Charles E.] CUSOM, Dept Med, Div Infect Dis, Aurora, CO 80045 USA; [Ryan, Allen F.] Univ Calif San Diego, Sch Med, Dept Surg, Div Otolaryngol, La Jolla, CA 92093 USA; [Giese, Arnaud P. J.; Yousaf, Saira; So, Edward; Riazuddin, Saima; Ahmed, Zubair M.] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Daly, Kathleen A.] Univ Minnesota, Dept Otolaryngol Head & Neck Surg, Minneapolis, MN 55455 USA; [Szeremeta, Wasyl; Pine, Harold] Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA; [Scholes, Melissa A.; Friedman, Norman; Wine, Todd M.; Ruiz, Amanda G.; Greenlee, Christopher; Dinwiddie, Jordyn; Prager, Jeremy D.; Yoon, Patricia J.; Streubel, Sven-Olrik; Chan, Kenny H.] CHCO, Dept Pediat Otolaryngol, Aurora, CO 80045 USA; [Yousaf, Ayesha; Shaikh, Rehan S.] Bahauddin Zakariya Univ, Inst Mol Biol & Biotechnol, Multan, Punjab, Pakistan; [Cardwell, Jonathan; Schwartz, David A.; Yang, Ivana V.] CUSOM, Dept Med, Aurora, CO 80045 USA; [Einarsdottir, Elisabet; Kere, Juha] Univ Helsinki, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; [Einarsdottir, Elisabet; Kere, Juha] Univ Helsinki, Mol Neurol Res Program, FIN-00014 Helsinki, Finland; [Einarsdottir, Elisabet; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Lee, Nanette R.] Univ San Carlos, USC Off Populat Studies Fdn, Cebu 6000, Philippines; [Lee, Nanette R.] Univ San Carlos, Dept Anthropol Sociol & Hist, Cebu 6000, Philippines; [Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kere, Juha] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Cutiongco-de la Paz, Eva Maria; Reyes-Quintos, Maria Rina T.] UP Manila, NIH, Manila 1000, Philippines; [Cutiongco-de la Paz, Eva Maria] UP, Philippine Genome Ctr, Quezon City 1101, Philippines; [Mattila, Petri; Hafren, Lena] Univ Helsinki, Dept Otorhinolaryngol Head & Neck Surg, Helsinki 00029, Finland; [Mattila, Petri; Hafren, Lena] Helsinki Univ Hosp, Helsinki 00029, Finland; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Chonmaitree, Tasnee] UTMB, Div Infect Dis, Dept Pediat, Galveston, TX 77555 USA; [Sale, Michele M.] Univ Virginia, Sch Med, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Sale, Michele M.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Sale, Michele M.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of the Philippines System; University of the Philippines Manila; University of California System; University of California San Diego; University System of Maryland; University of Maryland Baltimore; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Medical Branch Galveston; Bahauddin Zakariya University; University of Helsinki; University of Helsinki; Karolinska Institutet; University of San Carlos; University of San Carlos; University of Washington; University of Washington Seattle; University of London; King's College London; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; University of Virginia; University of Virginia; University of Virginia	Santos-Cortez, RLP (corresponding author), Univ Colorado, Sch Med CUSOM, Dept Otolaryngol, Aurora, CO 80045 USA.; Santos-Cortez, RLP (corresponding author), Childrens Hosp Colorado CHCO, Ctr Childrens Surg, Aurora, CO 80045 USA.; Santos-Cortez, RLP (corresponding author), Univ Philippines UP Manila, NIH, Philippine Natl Ear Inst, Manila 1000, Philippines.	regie.santos-cortez@ucdenver.edu	Giese, Arnaud P.J./P-1683-2019; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Wine, Todd/0000-0002-8996-0854; Hafren, Lena/0000-0002-4968-4357; ROBERTSON, CHARLES/0000-0002-4136-4121; Giese, Arnaud/0000-0001-7228-9542; G Ruiz, Amanda/0000-0002-4231-6391; Chua Ong, Kimberly Mae/0000-0002-1151-3368; Blue, Elizabeth/0000-0002-0633-0305; Einarsdottir, Elisabet/0000-0003-3101-2285	NIH [DK078150, TW005596, HL085144, TW008288]; US NIH via National Human Genome Research Institute; US NIH via National Heart, Lung and Blood Institute [HG006493]; Philippine Council for Health Research and Development - Department of Science and Technology via the Balik Scientist Program; NIH - National Institute on Deafness and Communication Disorders [R01 DC015004];  [RR020649];  [ES010126];  [DK056350]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097163, R33HL120770] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015004] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH via National Human Genome Research Institute; US NIH via National Heart, Lung and Blood Institute; Philippine Council for Health Research and Development - Department of Science and Technology via the Balik Scientist Program; NIH - National Institute on Deafness and Communication Disorders; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank all study participants. We also thank E. Valdivia for data collection efforts at UTMB, E. Leinonen for collection and handling of Finnish samples, the Office of Population Studies Foundation research and data collection teams, and C. Brands for general support. The Cebu Longitudinal Health and Nutrition Survey (CLHNS) was supported by NIH grants DK078150, TW005596, HL085144, and TW008288 and pilot funds from RR020649, ES010126, and DK056350. Exome sequencing was performed at the UWCMG which is funded by the US NIH via grants from the National Human Genome Research Institute and the National Heart, Lung and Blood Institute HG006493 (to D.A.N., M.J.B., and S.M.L.). This work was funded by the Philippine Council for Health Research and Development - Department of Science and Technology via the Balik Scientist Program and the NIH - National Institute on Deafness and Communication Disorders R01 DC015004 (both to R.L.P.S.-C.).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adair LS, 2011, INT J EPIDEMIOL, V40, P619, DOI 10.1093/ije/dyq085; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Chang JG, 2002, J HUM GENET, V47, P60, DOI 10.1007/s100380200001; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Gampa A, 2017, PHYSIOL GENOMICS, V49, P473, DOI 10.1152/physiolgenomics.00043.2017; Goto Y, 2016, NAT IMMUNOL, V17, P1244, DOI 10.1038/ni.3587; Hafren L, 2012, INT J PEDIATR OTORHI, V76, P41, DOI 10.1016/j.ijporl.2011.09.026; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Heneghan MA, 1998, FEMS IMMUNOL MED MIC, V20, P257, DOI 10.1111/j.1574-695X.1998.tb01135.x; Hobbs JK, 2018, FEBS LETT, V592, P3865, DOI 10.1002/1873-3468.13045; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; LINDSTEDT R, 1991, INFECT IMMUN, V59, P1086, DOI 10.1128/IAI.59.3.1086-1092.1991; Maniu A, 2014, ROM J MORPHOL EMBRYO, V55, P7; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ott CE, 2013, BONE, V55, P292, DOI 10.1016/j.bone.2013.04.007; Pata M, 2008, J BIOL CHEM, V283, P30522, DOI 10.1074/jbc.M805242200; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rehman AU, 2015, EUR J HUM GENET, V23, P1207, DOI 10.1038/ejhg.2014.266; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sale MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022297; Santos-Cortez RLP, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0189-7; Santos-Cortez RLP, 2015, NAT GENET, V47, P917, DOI 10.1038/ng.3347; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Soejima Mikiko, 2005, Legal Medicine, V7, P266, DOI 10.1016/j.legalmed.2004.12.003; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Tian C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00257-5; Uchida H, 2006, RES MICROBIOL, V157, P659, DOI 10.1016/j.resmic.2006.03.001; Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443	43	25	25	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 1	2018	103	5					679	690		10.1016/j.ajhg.2018.09.010	http://dx.doi.org/10.1016/j.ajhg.2018.09.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY9EO	30401457	Green Published, Bronze			2022-12-18	WOS:000448942100005
J	Delle Vedove, A; Storbeck, M; Heller, R; Holker, I; Hebbar, M; Shukla, A; Magnusson, O; Cirak, S; Girisha, KM; O'Driscoll, M; Loeys, B; Wirth, B				Delle Vedove, Andrea; Storbeck, Markus; Heller, Raoul; Hoelker, Irmgard; Hebbar, Malavika; Shukla, Anju; Magnusson, Olafur; Cirak, Sebahattin; Girisha, Katta M.; O'Driscoll, Mary; Loeys, Bart; Wirth, Brunhilde			Biallelic Loss of Proprioception-Related PIEZO2 Causes Muscular Atrophy with Perinatal Respiratory Distress, Arthrogryposis, and Scoliosis (vol 99, pg 1206, 2016)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction												brunhilde.wirth@uk-koeln.de	Cirak, Sebahattin/AAX-9593-2020; Loeys, Bart/B-3236-2017; KM, Girisha/AAK-6867-2020; Cirak, Sebahattin/AAZ-6829-2020	Loeys, Bart/0000-0003-3703-9518; KM, Girisha/0000-0002-0139-8239; 				Delle Vedove A, 2016, AM J HUM GENET, V99, P1206, DOI 10.1016/j.ajhg.2016.09.019	1	25	25	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1406	1408		10.1016/j.ajhg.2016.11.009	http://dx.doi.org/10.1016/j.ajhg.2016.11.009			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27912047	Green Published, Bronze			2022-12-18	WOS:000389148600018
J	Haber, M; Mezzavilla, M; Bergstrom, A; Prado-Martinez, J; Hallast, P; Saif-Ali, R; Al-Habori, M; Dedoussis, G; Zeggini, E; Blue-Smith, J; Wells, RS; Xue, Y; Zalloua, PA; Tyler-Smith, C				Haber, Marc; Mezzavilla, Massimo; Bergstroem, Anders; Prado-Martinez, Javier; Hallast, Pille; Saif-Ali, Riyadh; Al-Habori, Molham; Dedoussis, George; Zeggini, Eleftheria; Blue-Smith, Jason; Wells, R. Spencer; Xue, Yali; Zalloua, Pierre A.; Tyler-Smith, Chris			Chad Genetic Diversity Reveals an African History Marked by Multiple Holocene Eurasian Migrations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME SEQUENCES; POPULATION; ADMIXTURE; CHROMOSOME; ANCESTRY; INDIVIDUALS; ASSOCIATION; HAPLOGROUP; LANGUAGES; FORMAT	Understanding human genetic diversity in Africa is important for interpreting the evolution of all humans, yet vast regions in Africa, such as Chad, remain genetically poorly investigated. Here, we use genotype data from 480 samples from Chad, the Near East, and southern Europe, as well as whole-genome sequencing from 19 of them, to show that many populations today derive their genomes from ancient African-Eurasian admixtures. We found evidence of early Eurasian backflow to Africa in people speaking the unclassified isolate Laal language in southern Chad and estimate from linkage-disequilibrium decay that this occurred 4,750-7,200 years ago. It brought to Africa a Y chromosome lineage (R1b-V88) whose closest relatives are widespread in present-day Eurasia; we estimate from sequence data that the Chad R1b-V88 Y chromosomes coalesced 5,700-7,300 years ago. This migration could thus have originated among Near Eastern farmers during the African Humid Period. We also found that the previously documented Eurasian backflow into Africa, which occurred similar to 3,000 years ago and was thought to be mostly limited to East Africa, had a more westward impact affecting populations in northern Chad, such as the Toubou, who have 20%-30% Eurasian ancestry today. We observed a decline in heterozygosity in admixed Africans and found that the Eurasian admixture can bias inferences on their coalescent history and confound genetic signals from adaptation and archaic introgression.	[Haber, Marc; Mezzavilla, Massimo; Bergstroem, Anders; Prado-Martinez, Javier; Hallast, Pille; Zeggini, Eleftheria; Xue, Yali; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Mezzavilla, Massimo] Univ Trieste, IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy; [Hallast, Pille] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Saif-Ali, Riyadh; Al-Habori, Molham] Sanaa Univ, Fac Med & Hlth Sci, Dept Biochem & Mol Biol, Sanaa 19065, Yemen; [Dedoussis, George] Harokopio Univ Athens, Dept Nutr & Dietet, Athens 17671, Greece; [Blue-Smith, Jason] Natl Geog Soc, Washington, DC 20036 USA; [Wells, R. Spencer] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Zalloua, Pierre A.] Lebanese Amer Univ, Beirut 11022801, Lebanon; [Zalloua, Pierre A.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Blue-Smith, Jason] Karius Inc, 1505A Adams Dr, Menlo Pk, CA 94025 USA	Wellcome Trust Sanger Institute; IRCCS Burlo Garofolo; University of Trieste; University of Tartu; Harokopio University Athens; National Geographic Society; University of Texas System; University of Texas Austin; Lebanese American University; Harvard University; Harvard T.H. Chan School of Public Health	Haber, M; Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.	mh25@sanger.ac.uk; cts@sanger.ac.uk	Haber, Marc/Y-5090-2019; Dedoussis, George/AAN-7252-2021; Mezzavilla, Massimo/J-2948-2018; Prado-Martinez, Javier/AAA-6341-2020; Mezzavilla, Massimo/AAL-8225-2020	Haber, Marc/0000-0003-1000-1448; Dedoussis, George/0000-0002-7798-6221; Mezzavilla, Massimo/0000-0002-9000-4595; Prado-Martinez, Javier/0000-0001-5402-2721; Mezzavilla, Massimo/0000-0002-9000-4595; Bergstrom, Anders/0000-0002-4096-9268; Saif-Ali, Riyadh/0000-0002-0246-3856; Hallast, Pille/0000-0002-0588-3987	Wellcome Trust [098051]; Estonian Research Council [PUT1036]	Wellcome Trust(Wellcome TrustEuropean Commission); Estonian Research Council(Estonian Research Council)	We thank all sample donors for making this work possible and the Wellcome Trust Sanger Institute pipelines for generating genotype and sequence data. We also thank Andrea Massaia for comments on analyzing Y chromosome haplogroups from array data and David Soria-Hernanz for comments on the ethnic groups and languages in Chad. M.H., M.M., A.B., J.P.-M., E.Z., Y.X., and C.T.-S. were supported by the Wellcome Trust (098051). P.H. was supported by Estonian Research Council grant PUT1036. J.B.-S. is a full-time employee of Karius, Inc., and R.S.W. is founder and CEO of Insitome.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ayub Q, 2015, AM J HUM GENET, V96, P775, DOI 10.1016/j.ajhg.2015.03.012; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Batini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8152; Bergstrom A, 2016, CURR BIOL, V26, P809, DOI 10.1016/j.cub.2016.01.028; Brisbin A, 2012, HUM BIOL, V84, P343, DOI 10.3378/027.084.0401; Central Intelligence Agency, 2014, WORLD FACTB 2014; Cerezo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018682; Cerny V, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-63; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; deMenocal PB, 2012, NATURE ED KNOWLEDGE, V3, P12; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Forster P, 1996, AM J HUM GENET, V59, P935; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haber M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-015-0866-z; Haber M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003316; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Larrasoana JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076514; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Lohr D., 2009, MIGRATIONS SPATIAL M, P665; Pagani L, 2015, AM J HUM GENET, V96, P986, DOI 10.1016/j.ajhg.2015.04.019; Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodriguez-Flores JL, 2016, GENOME RES, V26, P151, DOI 10.1101/gr.191478.115; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Triska P, 2015, GENOME BIOL EVOL, V7, P3484, DOI 10.1093/gbe/evv236; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	43	25	25	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1316	1324		10.1016/j.ajhg.2016.10.012	http://dx.doi.org/10.1016/j.ajhg.2016.10.012			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27889059	Green Published, hybrid			2022-12-18	WOS:000389148600007
J	Jerber, J; Zaki, MS; Al-Aama, JY; Rosti, RO; Ben-Omran, T; Dikoglu, E; Silhavy, JL; Caglar, C; Musaev, D; Albrecht, B; Campbell, KP; Willer, T; Almuriekhi, M; Caglayan, AO; Vajsar, J; Bilguvar, K; Ogur, G; Abou Jamra, R; Gunel, M; Gleeson, JG				Jerber, Julie; Zaki, Maha S.; Al-Aama, Jumana Y.; Rosti, Rasim Ozgur; Ben-Omran, Tawfeg; Dikoglu, Esra; Silhavy, Jennifer L.; Caglar, Caner; Musaev, Damir; Albrecht, Beate; Campbell, Kevin P.; Willer, Tobias; Almuriekhi, Mariam; Caglayan, Ahmet Okay; Vajsar, Jiri; Bilguvar, Kaya; Ogur, Gonul; Abou Jamra, Rami; Gunel, Murat; Gleeson, Joseph G.			Biallelic Mutations in TMTC3, Encoding a Transmembrane and TPR-Containing Protein, Lead to Cobblestone Lissencephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WALKER-WARBURG-SYNDROME; CONGENITAL MUSCULAR-DYSTROPHIES; CORTICAL DEVELOPMENT; DYSTROGLYCAN; CLASSIFICATION; IDENTIFICATION; MALFORMATIONS; GENE; DISEASE; SMOOTH	Cobblestone lissencephaly (COB) is a severe brain malformation in which overmigration of neurons and glial cells into the arachnoid space results in the formation of cortical dysplasia. COB occurs in a wide range of genetic disorders known as dystroglycanopathies, which are congenital muscular dystrophies associated with brain and eye anomalies and range from Walker-Warburg syndrome to Fukuyama congenital muscular dystrophy. Each of these conditions has been associated with alpha-dystroglycan defects or with mutations in genes encoding basement membrane components, which are known to interact with alpha-dystroglycan. Our screening of a cohort of 25 families with recessive forms of COB identified six families affected by biallelic mutations in TMTC3 (encoding transmembrane and tetratricopeptide repeat containing 3), a gene without obvious functional connections to alpha-dystroglycan. Most affected individuals showed brainstem and cerebellum hypoplasia, as well as ventriculomegaly. However, the minority of the affected individuals had eye defects or elevated muscle creatine phosphokinase, separating the TMTC3 COB phenotype from typical congenital muscular dystrophies. Our data suggest that loss of TMTC3 causes COB with minimal eye or muscle involvement.	[Jerber, Julie; Rosti, Rasim Ozgur; Dikoglu, Esra; Silhavy, Jennifer L.; Caglar, Caner; Musaev, Damir; Gleeson, Joseph G.] Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10065 USA; [Jerber, Julie; Rosti, Rasim Ozgur; Dikoglu, Esra; Silhavy, Jennifer L.; Musaev, Damir; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, La Jolla, CA 92093 USA; [Zaki, Maha S.] Natl Res Ctr, Human Genet & Genome Res Div, Clin Genet Dept, Cairo 12311, Egypt; [Al-Aama, Jumana Y.] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21453, Saudi Arabia; [Al-Aama, Jumana Y.] King Abdulaziz Univ, Dept Genet Med, Fac Med, Jeddah 21453, Saudi Arabia; [Ben-Omran, Tawfeg; Almuriekhi, Mariam] Hamad Med Corp, Clin & Metab Genet Sect, Dept Pediat, POB 3050, Doha, Qatar; [Ben-Omran, Tawfeg; Almuriekhi, Mariam] Weill Cornell Med Coll, POB 24144, Doha, Qatar; [Albrecht, Beate] Univ Duisburg Essen, Inst Humangenet, Univ Klinikum Essen, D-45122 Essen, Germany; [Campbell, Kevin P.; Willer, Tobias] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Campbell, Kevin P.; Willer, Tobias] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Campbell, Kevin P.; Willer, Tobias] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Caglayan, Ahmet Okay] Istanbul Bilim Univ, Dept Med Genet, Sch Med, TR-34394 Istanbul, Turkey; [Vajsar, Jiri] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg, Yale Program Neurogenet, New Haven, CT 06510 USA; [Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Dept Neurobiol, Yale Program Neurogenet, New Haven, CT 06510 USA; [Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Dept Genet, Yale Program Neurogenet, New Haven, CT 06510 USA; [Ogur, Gonul] Ondokuz Mayis Univ, Sch Med, Dept Genet, TR-55000 Samsun, Turkey; [Abou Jamra, Rami] Univ Leipzig Hosp & Clin, Inst Human Genet, Philipp Rosenthal Str 55, D-04103 Leipzig, Germany; [Abou Jamra, Rami] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany	Rockefeller University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Abdulaziz University; King Abdulaziz University; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Duisburg Essen; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Demiroglu Bilim University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Yale University; Yale University; Yale University; Ondokuz Mayis University; Leipzig University; University of Erlangen Nuremberg	Gleeson, JG (corresponding author), Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10065 USA.; Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, La Jolla, CA 92093 USA.	jogleeson@mail.rockefeller.edu	Abou Jamra, Rami/AAC-8192-2019; Caglayan, Ahmet O/D-1066-2012; Wang, Guilin/G-8794-2018; Caglar, Caner/ABE-5815-2021; Zaki, Maha S/B-9361-2013; Al-aama, Jumana/AAA-8653-2021	Abou Jamra, Rami/0000-0002-1542-1399; Caglayan, Ahmet O/0000-0002-2332-322X; Zaki, Maha/0000-0001-7840-0002; Campbell, Kevin/0000-0003-2066-5889; caglar, caner/0000-0002-5857-757X	Francois Wallace Mohanan fellowship; NIH [R01GM077243, R01NS041537, R01NS048453, R01NS052455, P01HD070494]; Deutsche Forschungsgemeinschaft [AB393/2-1, AB393/2-2]; Simons Foundation Autism Research Initiative; Qatar National Research Fund [6-1463]; Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [1U54NS053672]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, UM1HG008900, U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, U54NS053672, R01NS052455, R01NS041537] Funding Source: NIH RePORTER	Francois Wallace Mohanan fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Simons Foundation Autism Research Initiative; Qatar National Research Fund(Qatar National Research Fund (QNRF)); Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the children and their families for their contributions to this study. This work was supported by the Francois Wallace Mohanan fellowship (J.J.); NIH grant R01GM077243 (J.A.-A.); Deutsche Forschungsgemeinschaft grants AB393/2-1 and AB393/2-2 (R.A.J.); NIH grants R01NS041537, R01NS048453, R01NS052455, and P01HD070494, the Simons Foundation Autism Research Initiative, and Qatar National Research Fund grant 6-1463 (T.B.-O., M.A., and J.G.G.); and Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant 1U54NS053672 (K.P.C.). K.P.C. and J.G.G. are Howard Hughes Medical Institute Investigators. We thank the Broad Institute (U54HG003067 to E. Lander and UM1HG008900 to D. MacArthur), the Yale Center for Mendelian Disorders (U54HG006504 to R. Lifton and M.G.), and the Gregory M. Kiez and Mehmet Kutman Foundation (M.G.). We acknowledge M. Gerstein, S. Mane, A.B. Ekici, and S. Uebe; the Yale Biomedical High Performance Computing Center for data analysis and storage; the Yale Program on Neurogenetics; and the Yale Center for Human Genetics and Genomics.	Bahi-Buisson N, 2010, BRAIN, V133, P3194, DOI 10.1093/brain/awq259; Barak T, 2011, NAT GENET, V43, P590, DOI 10.1038/ng.836; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P1389; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Brouard S, 2007, P NATL ACAD SCI USA, V104, P15448, DOI 10.1073/pnas.0705834104; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; de Bernabe DBV, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013870; Devisme L, 2012, BRAIN, V135, P469, DOI 10.1093/brain/awr357; DOBYNS WB, 1995, NEUROPEDIATRICS, V26, P132, DOI 10.1055/s-2007-979744; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Ishigaki Keiko, 2016, Brain Nerve, V68, P119, DOI 10.11477/mf.1416200361; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Kirschner J, 2004, ARCH NEUROL-CHICAGO, V61, P189, DOI 10.1001/archneur.61.2.189; Labelle-Dumais C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002062; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Parakh S, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00030; Racape M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019321; Radmanesh F, 2013, AM J HUM GENET, V92, P468, DOI 10.1016/j.ajhg.2013.02.005; Riemersma M, 2015, NEUROLOGY, V84, P2177, DOI 10.1212/WNL.0000000000001615; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Sunryd JC, 2014, J BIOL CHEM, V289, P16085, DOI 10.1074/jbc.M114.554071; Tsukahara F, 1996, J BIOCHEM-TOKYO, V120, P820; vanderKnaap MS, 1997, ANN NEUROL, V42, P50, DOI 10.1002/ana.410420110; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Yun EJ, 2012, ANAT REC, V295, P167, DOI 10.1002/ar.21475; Zeytuni N., 2012, PROTEIN INTERACTIONS, P103	34	25	27	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1181	1189		10.1016/j.ajhg.2016.09.007	http://dx.doi.org/10.1016/j.ajhg.2016.09.007			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27773428	Green Published, Bronze			2022-12-18	WOS:000387529600015
J	Kurolap, A; Armbruster, A; Hershkovitz, T; Hauf, K; Mory, A; Paperna, T; Hannappel, E; Tal, G; Nijem, Y; Sella, E; Mahajnah, M; Ilivitzki, A; Hershkovitz, D; Ekhilevitch, N; Mandel, H; Eulenburg, V; Baris, HN				Kurolap, Alina; Armbruster, Anja; Hershkovitz, Tova; Hauf, Katharina; Mory, Adi; Paperna, Tamar; Hannappel, Ewald; Tal, Galit; Nijem, Yusif; Sella, Ella; Mahajnah, Muhammad; Ilivitzki, Anat; Hershkovitz, Dov; Ekhilevitch, Nina; Mandel, Hanna; Eulenburg, Volker; Baris, Hagit N.			Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONKETOTIC HYPERGLYCINEMIA; CHROMAFFIN CELLS; IN-VIVO; MUTATIONS; GLYT1; HYPEREKPLEXIA; ASSOCIATION; INHIBITION; GENETICS; RELEASE	Glycine is a major neurotransmitter that activates inhibitory glycine receptors and is a co-agonist for excitatory glutamatergic N-methyl-D-aspartate (NMDA) receptors. Two transporters, GLYT1 and GLYT2, regulate extracellular glycine concentrations within the CNS. Dysregulation of the extracellular glycine has been associated with hyperekplexia and nonketotic hyperglycinemia. Here, we report four individuals from two families who presented at birth with facial dysmorphism, encephalopathy, arthrogryposis, hypotonia progressing to hypertonicity with startle-like clonus, and respiratory failure. Only one individual survived the respiratory failure and was weaned off ventilation but has significant global developmental delay. Mildly elevated cerebrospinal fluid (CSF) glycine and normal serum glycine were observed in two individuals. In both families, we identified truncating mutations in SLC6A9, encoding GLYT1. We demonstrate that pharmacologic or genetic abolishment of GlyT1 activity in mice leads to mildly elevated glycine in the CSF but not in blood. Additionally, previously reported slc6a9-null mice and zebrafish mutants also display phenotypes consistent with the affected individuals we examined. Our data suggest that truncating SLC6A9 mutations lead to a distinct human neurological syndrome hallmarked by mildly elevated CSF glycine and normal serum glycine.	[Kurolap, Alina; Hershkovitz, Tova; Mory, Adi; Paperna, Tamar; Ekhilevitch, Nina; Baris, Hagit N.] Rambam Hlth Care Campus, Genet Inst, IL-310601 Haifa, Israel; [Kurolap, Alina; Mahajnah, Muhammad; Ilivitzki, Anat; Hershkovitz, Dov; Ekhilevitch, Nina; Mandel, Hanna; Baris, Hagit N.] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, IL-3525433 Haifa, Israel; [Armbruster, Anja; Hauf, Katharina; Hannappel, Ewald; Eulenburg, Volker] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Tal, Galit; Mandel, Hanna] Rambam Hlth Care Campus, Metab Unit, IL-3109601 Haifa, Israel; [Nijem, Yusif; Sella, Ella] EMMS Nazareth Hosp, Pediat & Neonatal Unit, IL-1607907 Nazareth, Israel; [Mahajnah, Muhammad] Hillel Yaffe Med Ctr, Child Neurol & Dev Ctr, IL-3810101 Hadera, Israel; [Ilivitzki, Anat] Rambam Hlth Care Campus, Dept Radiol, Pediat Radiol Unit, IL-3109601 Haifa, Israel; [Hershkovitz, Dov] Rambam Hlth Care Campus, Dept Pathol, IL-3109601 Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Erlangen Nuremberg; Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus	Baris, HN (corresponding author), Rambam Hlth Care Campus, Genet Inst, IL-310601 Haifa, Israel.; Baris, HN (corresponding author), Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, IL-3525433 Haifa, Israel.; Eulenburg, V (corresponding author), Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany.	volker.eulenburg@fau.de; hb_feldman@rambam.health.gov.il	Eulenburg, Volker/B-7263-2013	Eulenburg, Volker/0000-0002-4878-5746; Hershkovitz, Dov/0000-0002-7954-4486; Kurolap, Alina/0000-0002-7005-3621	Rambam-Ofakim Research Program; DFG [EU110/3-1]; Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg [TP E15]	Rambam-Ofakim Research Program; DFG(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg	We would like to thank the families for their participation and full cooperation with this study. We would also like to thank the expert consultation and technical help of the Cytogenetics and Molecular Genetics Laboratories and the clinical staff at the Genetics Institute, as well as the Pathology Department at Ram barn Health Care Campus, Haifa, Israel, and Noa Weisbrot for her graphical assistance. This research was supported by the Rambam-Ofakim Research Program (to T.H.), and by the DFG (EU110/3-1 to V.E.) and the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg (TP E15 to V.E.).	Baker PR, 2014, BRAIN, V137, P366, DOI 10.1093/brain/awt328; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Bongers EMHF, 2005, CLIN GENET, V68, P302, DOI 10.1111/j.1399-0004.2005.00508.x; Chang YT, 2012, BIOMEDICINE-TAIWAN, V2, P80, DOI 10.1016/j.biomed.2012.04.002; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Cui WW, 2005, J NEUROSCI, V25, P6610, DOI 10.1523/JNEUROSCI.5009-04.2005; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Eulenburg V, 2005, TRENDS BIOCHEM SCI, V30, P325, DOI 10.1016/j.tibs.2005.04.004; Eulenburg V, 2006, BIOCHEM BIOPH RES CO, V348, P400, DOI 10.1016/j.bbrc.2006.07.080; Eulenburg V, 2010, GLIA, V58, P1066, DOI 10.1002/glia.20987; Eyal S, 2015, DEVELOPMENT, V142, P1831, DOI 10.1242/dev.121970; Flusser H, 2005, NEUROLOGY, V64, P1426, DOI 10.1212/01.WNL.0000158475.12907.D6; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; GRASER TA, 1985, ANAL BIOCHEM, V151, P142, DOI 10.1016/0003-2697(85)90064-8; Hall JG, 2014, EUR J MED GENET, V57, P464, DOI 10.1016/j.ejmg.2014.03.008; HANNAPPEL E, 1988, ARCH BIOCHEM BIOPHYS, V260, P546, DOI 10.1016/0003-9861(88)90480-8; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Harvey RJ, 2013, NAT REV DRUG DISCOV, V12, P866, DOI 10.1038/nrd3893; Harvey RJ, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.001.2008; Howard A, 2010, J PHYSIOL-LONDON, V588, P995, DOI 10.1113/jphysiol.2009.186262; Huber K, 2009, AUTON NEUROSCI-BASIC, V151, P10, DOI 10.1016/j.autneu.2009.07.020; Javitt DC, 2005, NEUROPSYCHOPHARMACOL, V30, P649, DOI 10.1038/sj.npp.1300589; Jiang J, 2015, J NEUROSCI, V35, P1991, DOI 10.1523/JNEUROSCI.1627-14.2015; Korman SH, 2006, ANN NEUROL, V59, P411, DOI 10.1002/ana.20759; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Obrenovitch TP, 1997, BRAIN RES, V746, P190, DOI 10.1016/S0006-8993(96)01197-3; Olivares L, 1997, J BIOL CHEM, V272, P1211, DOI 10.1074/jbc.272.2.1211; Pramod AB, 2013, MOL ASPECTS MED, V34, P197, DOI 10.1016/j.mam.2012.07.002; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Safory H, 2015, EMBO REP, V16, P590, DOI 10.15252/embr.201439561; Schlosser L, 2015, NEUROSCI LETT, V600, P213, DOI 10.1016/j.neulet.2015.06.026; Shen HY, 2015, NEUROPHARMACOLOGY, V99, P554, DOI 10.1016/j.neuropharm.2015.08.031; Swanson MA, 2015, ANN NEUROL, V78, P606, DOI 10.1002/ana.24485; Tsai G, 2004, P NATL ACAD SCI USA, V101, P8485, DOI 10.1073/pnas.0402662101; Ueno T, 2009, J ATHEROSCLER THROMB, V16, P201, DOI 10.5551/jat.E125; YADID G, 1992, EUR J PHARMACOL, V221, P389, DOI 10.1016/0014-2999(92)90729-N; YADID G, 1993, NEUROSCIENCE, V55, P1147, DOI 10.1016/0306-4522(93)90328-D; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu J. Y., 2013, EPILEPSY RES TREAT, V2013	40	25	27	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1172	1180		10.1016/j.ajhg.2016.09.004	http://dx.doi.org/10.1016/j.ajhg.2016.09.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27773429	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000387529600014
J	Guimier, A; Gordon, CT; Godard, F; Ravenscroft, G; Oufadem, M; Vasnier, C; Rambaud, C; Nitschke, P; Bole-Feysot, C; Masson, C; Dauger, S; Longman, C; Laing, NG; Kugener, B; Bonnet, D; Bouvagnet, P; Di Filippo, S; Probst, V; Redon, R; Charron, P; Rotig, A; Lyonnet, S; Dautant, A; de Pontual, L; di Rago, JP; Delahodde, A; Amiel, J				Guimier, Anne; Gordon, Christopher T.; Godard, Francois; Ravenscroft, Gianina; Oufadem, Myriam; Vasnier, Christelle; Rambaud, Caroline; Nitschke, Patrick; Bole-Feysot, Christine; Masson, Cecile; Dauger, Stephane; Longman, Cheryl; Laing, Nigel G.; Kugener, Beatrice; Bonnet, Damien; Bouvagnet, Patrice; Di Filippo, Sylvie; Probst, Vincent; Redon, Richard; Charron, Philippe; Rotig, Agnes; Lyonnet, Stanislas; Dautant, Alain; de Pontual, Loic; di Rago, Jean-Paul; Delahodde, Agnes; Amiel, Jeanne			Biallelic PPA2 Mutations Cause Sudden Unexpected Cardiac Arrest in Infancy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; INORGANIC PYROPHOSPHATASE; MITOCHONDRIAL-FUNCTION; YEAST-CELLS; METABOLISM; GENE; ATP; BIOGENESIS; PROTEINS; SYSTEM	Sudden unexpected death in infancy occurs in apparently healthy infants and remains largely unexplained despite thorough investigation. The vast majority of cases are sporadic. Here we report seven individuals from three families affected by sudden and unexpected cardiac arrest between 4 and 20 months of age. Whole-exome sequencing revealed compound heterozygous missense mutations in PPA2 in affected infants of each family. PPA2 encodes the mitochondrial pyrophosphatase, which hydrolyzes inorganic pyrophosphate into two phosphates. This is an essential activity for many biosynthetic reactions and for energy metabolism of the cell. We show that deletion of the orthologous gene in yeast (ppa24) compromises cell viability due to the loss of mitochondria. Expression of wild-type human PPA2, but not PPA2 containing the mutations identified in affected individuals, preserves mitochondrial function in ppa24 yeast. Using a regulatable (doxycycline-repressible) gene expression system, we found that the pathogenic PPA2 mutations rapidly inactivate the mitochondrial energy transducing system and prevent the maintenance of a sufficient electrical potential across the inner membrane, which explains the subsequent disappearance of mitochondria from the mutant yeast cells. Altogether these data demonstrate that PPA2 is an essential gene in yeast and that biallelic mutations in PPA2 cause a mitochondrial disease leading to sudden cardiac arrest in infants.	[Guimier, Anne; Gordon, Christopher T.; Oufadem, Myriam; Nitschke, Patrick; Bole-Feysot, Christine; Masson, Cecile; Rotig, Agnes; Lyonnet, Stanislas; de Pontual, Loic; Amiel, Jeanne] Univ Paris 05, INSERM, U1163, Sorbonne Paris Cite,Inst Imagine, 24 Blvd Montparnasse, F-75015 Paris, France; [Godard, Francois; Dautant, Alain; di Rago, Jean-Paul] Univ Bordeaux, CNRS, Inst Cellular Biochem & Genet, IBGC,UMR 5095, F-33000 Bordeaux, France; [Ravenscroft, Gianina; Laing, Nigel G.] Univ Western Australia, Ctr Med Res, Nedlands, WA 6009, Australia; [Ravenscroft, Gianina; Laing, Nigel G.] Harry Perkins Inst Med Res, Nedlands, WA 6009, Australia; [Vasnier, Christelle; Delahodde, Agnes] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell,I2BC,CEA, F-91198 Gif Sur Yvette, France; [Rambaud, Caroline] Raymond Poincare Univ Hosp, APHP, Forens & Pathol Dept, F-92380 Garches, France; [Dauger, Stephane] Robert Debre Univ Hosp, AP HP, Pediat Intens Care Unit, F-75019 Paris, France; [Dauger, Stephane] Univ Paris 07, Sorbonne Paris Cite, F-75019 Paris, France; [Longman, Cheryl] Southern Gen Hosp, West Scotland Reg Genet Serv, Glasgow, Lanark, Scotland; [Longman, Cheryl] Western Gen Hosp, Dept Clin Genet, South East Scotland Reg Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Kugener, Beatrice] Hos Civils Lyon, Hop Femme Mere Enfant, SIDS Reference Ctr, F-69677 Bron, France; [Bonnet, Damien] Hop Necker Enfants Malad, AP HP, Unite Medicochirurg Cardiol Congenitale & Pediat, Ctr Reference Malformat Cardiaques Congenitales C, F-75015 Paris, France; [Bouvagnet, Patrice] Hosp Civils Lyon, Lab Cardiogenet, F-69667 Bron, France; [Bouvagnet, Patrice] Univ Lyon 1, INSERM, U1217, CNRS,UMR5310, Lyon, France; [Di Filippo, Sylvie] Hosp Civils Lyon, Serv Cardiol Pediat, 59 Bd Pinel, F-69667 Bron, France; [Probst, Vincent; Redon, Richard] Univ Nantes, INSERM, UMR 1087, Inst Thorax,CNRS,UMR 6291, F-44007 Nantes, France; [Probst, Vincent; Redon, Richard] Ctr Hosp Univ CHU Nantes, Inst Thorax, Serv Cardiol, F-44093 Nantes, France; [Charron, Philippe] Hop Ambroise Pare, Ctr Reference Malad Cardiaques Hereditaires, F-75651 Paris 13, France; [Charron, Philippe] Univ Versailles St Quentin, Hop Pitie Salpetriere, F-75651 Paris 13, France; [Charron, Philippe] AP HP, F-75651 Paris 13, France; [Lyonnet, Stanislas] Hop Necker Enfants Malad, AP HP, Serv Genet, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Western Australia; Harry Perkins Institute of Medical Research; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Edinburgh; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Amiel, J (corresponding author), Univ Paris 05, INSERM, U1163, Sorbonne Paris Cite,Inst Imagine, 24 Blvd Montparnasse, F-75015 Paris, France.; Delahodde, A (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell,I2BC,CEA, F-91198 Gif Sur Yvette, France.	agnes.delahodde@i2bc.paris-saclay.fr; jeanne.amiel@inserm.fr	Rötig, Agnès/G-9592-2017; Di+Filippo, Sylvie/AAH-8191-2021; Redon, Richard/F-3303-2014; probst, vincent/D-4996-2015; Ravenscroft, Gina/H-5695-2014; Dauger, Stéphane/AAX-9669-2021; amiel, jeanne/AGX-1124-2022; Lyonnet, Stanislas/H-5483-2017; Di Filippo, Sylvie/AAM-2016-2020; Gordon, Chris/F-1267-2017; amiel, jeanne/H-3501-2017; Carmen, Team3/Y-7384-2019	Rötig, Agnès/0000-0003-0589-0703; Redon, Richard/0000-0001-7751-2280; probst, vincent/0000-0002-5492-8619; Ravenscroft, Gina/0000-0003-3634-211X; Lyonnet, Stanislas/0000-0001-5426-9417; Gordon, Chris/0000-0002-9300-8399; amiel, jeanne/0000-0001-5973-4728; Carmen, Team3/0000-0002-3614-0924; DE PONTUAL, LOIC/0000-0002-3123-0453; Laing, Nigel/0000-0001-5111-3732; Lab, Carmen/0000-0002-5935-3236; Guimier, Anne/0000-0002-4759-0621; Charron, Philippe/0000-0002-1782-1118	GIS-Institut des Maladies Rares; Agence Nationale de la Recherche [ANR-10-IAHU-01]; ECF from the NHMRC [APP1035955]; WA Department of Health; AFM [18724]; NHMRC [APP1002147, APP1080587]; EU Collaborative grant [APP1055295]	GIS-Institut des Maladies Rares; Agence Nationale de la Recherche(French National Research Agency (ANR)); ECF from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); WA Department of Health; AFM(Association Francaise contre les Myopathies); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); EU Collaborative grant	We acknowledge the active participation of the parents in the research, the GIS-Institut des Maladies Rares for financial support, Hayley Goullee for technical assistance, and Professor Hans Goebel for reviewing the pathology in the family F3 proband. This work was supported by grants from the Agence Nationale de la Recherche (ANR-10-IAHU-01). G.R. is supported by an ECF (APP1035955) from the NHMRC and Merit Awards from the WA Department of Health and AFM (18724). N.G.L. is supported by NHMRC Fellowship grant APP1002147, Project Grant APP1080587, and EU Collaborative grant APP1055295.	BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Curbo S, 2006, GENOMICS, V87, P410, DOI 10.1016/j.ygeno.2005.09.017; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Fleming PJ, 2015, ARCH DIS CHILD, V100, P984, DOI 10.1136/archdischild-2014-306424; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; GBELSKA Y, 1983, EUR J BIOCHEM, V130, P281, DOI 10.1111/j.1432-1033.1983.tb07148.x; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; GRIFFITHS EJ, 1993, BIOCHEM J, V290, P489, DOI 10.1042/bj2900489; Guerin B, 1979, Methods Enzymol, V55, P149; Hertz C.L., 2016, EUR J HUM GENET; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klaver EC, 2011, INT J CARDIOL, V152, P162, DOI 10.1016/j.ijcard.2010.12.051; Komberg A., 1962, HORIZONS IN BIOCHEMI, P251; Lamont PJ, 2004, NEUROPEDIATRICS, V35, P302, DOI 10.1055/s-2004-821243; Lasserre JP, 2015, DIS MODEL MECH, V8, P509, DOI 10.1242/dmm.020438; Lefebvre-Legendre L, 2003, MOL MICROBIOL, V47, P1329, DOI 10.1046/j.1365-2958.2003.03371.x; LUNDIN M, 1991, J BIOL CHEM, V266, P12168; MANSUROVA SE, 1989, BIOCHIM BIOPHYS ACTA, V977, P237, DOI 10.1016/S0005-2728(89)80078-7; Mehawej C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004311; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Opdal SH, 2011, FORENSIC SCI MED PAT, V7, P26, DOI 10.1007/s12024-010-9182-9; Ravenscroft G, 2015, AM J HUM GENET, V96, P955, DOI 10.1016/j.ajhg.2015.04.014; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sivula T, 1999, FEBS LETT, V454, P75, DOI 10.1016/S0014-5793(99)00779-6; van Rijt WJ, 2016, NEONATOLOGY, V109, P297, DOI 10.1159/000443874; Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L	29	25	27	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					666	673		10.1016/j.ajhg.2016.06.021	http://dx.doi.org/10.1016/j.ajhg.2016.06.021			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27523598	Green Published, Bronze			2022-12-18	WOS:000383114800011
J	Decker, B; Karyadi, DM; Davis, BW; Karlins, E; Tillmans, LS; Stanford, JL; Thibodeau, SN; Ostrander, EA				Decker, Brennan; Karyadi, Danielle M.; Davis, Brian W.; Karlins, Eric; Tillmans, Lori S.; Stanford, Janet L.; Thibodeau, Stephen N.; Ostrander, Elaine A.			Biallelic BRCA2 Mutations Shape the Somatic Mutational Landscape of Aggressive Prostate Tumors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER; GENE; FRAMEWORK; REPAIR; PTEN; END; PROGRESSION; PHENOTYPE; DISCOVERY; PATHWAYS	To identify clinically important molecular subtypes of prostate cancer (PCa), we characterized the somatic landscape of aggressive tumors via deep, whole-genome sequencing. In our discovery set of ten tumor/normal subject pairs with Gleason scores of 8-10 at diagnosis, coordinated analysis of germline and somatic variants, including single-nucleotide variants, indels, and structural variants, revealed biallelic BRCA2 disruptions in a subset of samples. Compared to the other samples, the PCa BRCA2-deficient tumors exhibited a complex and highly specific mutation signature, featuring a 2.88-fold increased somatic mutation rate, depletion of context-specific C>T substitutions, and an enrichment for deletions, especially those longer than 10 bp. We next performed a BRCA2 deficiency-targeted reanalysis of 150 metastatic PCa tumors, and each of the 18 BRCA2-mutated samples recapitulated the BRCA2 deficiency-associated mutation signature, underscoring the potent influence of these lesions on somatic mutagenesis and tumor evolution. Among all 21 individuals with BRCA2-deficient tumors, only about half carried deleterious germline alleles. Importantly, the somatic mutation signature in tumors with one germline and one somatic risk allele was indistinguishable from those with purely somatic mutations. Our observations clearly demonstrate that BRCA2-disrupted tumors represent a unique and clinically relevant molecular subtype of aggressive PCa, highlighting both the promise and utility of this mutation signature as a prognostic and treatment-selection biomarker. Further, any test designed to leverage BRCA2 status as a biomarker for PCa must consider both germline and somatic mutations and all types of deleterious mutations.	[Decker, Brennan; Karyadi, Danielle M.; Davis, Brian W.; Karlins, Eric; Ostrander, Elaine A.] NHGRI, NIH, Canc Genet Branch, Bethesda, MD 20892 USA; [Decker, Brennan] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Tillmans, Lori S.; Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Stanford, Janet L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Cambridge; Mayo Clinic; Fred Hutchinson Cancer Center	Ostrander, EA (corresponding author), NHGRI, NIH, Canc Genet Branch, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov		Decker, Brennan/0000-0003-4516-7421; Karlins, Eric/0000-0002-7541-393X; Ostrander, Elaine/0000-0001-6075-9738; Karyadi, Danielle/0000-0003-4164-5625	National Human Genome Research Institute; Prostate Cancer SPORE Grant [CA17205]; NIH-Cambridge Scholars Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Prostate Cancer SPORE Grant; NIH-Cambridge Scholars Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by Intramural Research Program of the National Human Genome Research Institute (E.A.O., B.D., D.M.K., B.W.D., E.K.), Prostate Cancer SPORE Grant # CA17205 (S.N.T., L.S.T.), and the NIH-Cambridge Scholars Program (B.D.). We thank the Mayo Clinic Pathology Core for sample processing. This work utilized the NIH Biowulf high-performance computing cluster. Finally, we thank the many men who provided samples for this study.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Agalliu I, 2007, BRIT J CANCER, V97, P826, DOI 10.1038/sj.bjc.6603929; Alexandrov LB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9683; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bancroft EK, 2014, EUR UROL, V66, P489, DOI 10.1016/j.eururo.2014.01.003; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Castro E, 2015, EUR UROL, V68, P186, DOI 10.1016/j.eururo.2014.10.022; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Gayther SA, 2000, CANCER RES, V60, P4513; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hubner A, 2012, P NATL ACAD SCI USA, V109, P12046, DOI 10.1073/pnas.1209660109; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kote-Jarai Z, 2011, BRIT J CANCER, V105, P1230, DOI 10.1038/bjc.2011.383; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Martins FC, 2012, CANCER DISCOV, V2, P503, DOI 10.1158/2159-8290.CD-11-0325; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Mayrhofer M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r24; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mitra A, 2008, BRIT J CANCER, V98, P502, DOI 10.1038/sj.bjc.6604132; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Narod SA, 2008, BRIT J CANCER, V99, P371, DOI 10.1038/sj.bjc.6604453; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; R Core Team, 2019, R LANG ENV STAT COMP; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sinclair CS, 2000, CANCER RES, V60, P1371; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456; Yu VPCC, 2000, GENE DEV, V14, P1400; Zheng L, 2000, ONCOGENE, V19, P6159, DOI 10.1038/sj.onc.1203968	50	25	26	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					818	829		10.1016/j.ajhg.2016.03.003	http://dx.doi.org/10.1016/j.ajhg.2016.03.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27087322	Green Published, Bronze			2022-12-18	WOS:000375869300002
J	Levinsohn, JL; Sugarman, JL; McNiff, JM; Antaya, RJ; Choate, KA				Levinsohn, Jonathan L.; Sugarman, Jeffrey L.; McNiff, Jennifer M.; Antaya, Richard J.; Choate, Keith A.		Yale Ctr Mendelian Genomics	Somatic Mutations in NEK9 Cause Nevus Comedonicus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CENTROSOME SEPARATION; EPIDERMAL MOSAICISM; ACNE-VULGARIS; KINASE; EXPRESSION; INVERSA; NERCC1; FGFR2; EG5	Acne vulgaris (AV) affects most adolescents, and of those affected, moderate to severe disease occurs in 20%. Comedones, follicular plugs consisting of desquamated keratinocytes and sebum, are central to its pathogenesis. Despite high heritability in first-degree relatives, AV genetic determinants remain incompletely understood. We therefore employed whole-exome sequencing (WES) in nevus comedonicus (NC), a rare disorder that features comedones and inflammatory acne cysts in localized, linear configurations. WES identified somatic NEK9 mutations, each affecting highly conserved residues within its kinase or RCC1 domains, in affected tissue of three out of three NC-affected subjects. All mutations are gain of function, resulting in increased phosphorylation at Thr210, a hallmark of NEK9 kinase activation. We found that comedo formation in NC is marked by loss of follicular differentiation markers, expansion of keratin-15-positive cells from localization within the bulge to the entire sub-bulge follicle and cyst, and ectopic expression of keratin 10, a marker of interfollicular differentiation not present in normal follicles. These findings suggest that NEK9 mutations in NC disrupt normal follicular differentiation and identify NEK9 as a potential regulator of follicular homeostasis.	[Levinsohn, Jonathan L.; Choate, Keith A.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Levinsohn, Jonathan L.; McNiff, Jennifer M.; Antaya, Richard J.; Choate, Keith A.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Sugarman, Jeffrey L.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Sugarman, Jeffrey L.] Univ Calif San Francisco, Dept Family Med, San Francisco, CA 94143 USA; [McNiff, Jennifer M.; Choate, Keith A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Antaya, Richard J.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA	Yale University; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; Yale University	Choate, KA (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.; Choate, KA (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.; Choate, KA (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	keith.choate@yale.edu	Wang, Guilin/G-8794-2018		Doris Duke Charitable Foundation; Yale Center for Mendelian Genomics [NIH U54 HG006504]; Medical Scientist Training Program at Yale University [NIH NIGMS GM007205]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Yale Center for Mendelian Genomics; Medical Scientist Training Program at Yale University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Valerie Horsley, Richard Lifton, Young Lim, Haris Mirza, Lynn Boyden, and Peggy Myung for review of the manuscript. We would also like to thank Jing Zhou and Rong Hua Hu for technical assistance. Research was supported by the Doris Duke Charitable Foundation Clinical Scientist Development Award to K.A.C. and a Yale Center for Mendelian Genomics grant (NIH U54 HG006504). J.L.L. is supported by the Medical Scientist Training Program (NIH NIGMS GM007205) at Yale University and is a recipient of a clinical research mentorship award from the Doris Duke Charitable Foundation. J.L.S. is an investigator for Galderma, Ranbaxy, and Activis, a consultant for Galderma, and a Medical Safety Monitor for Seegpharm and Valeant.	Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; BECK MH, 1980, ARCH DERMATOL, V116, P1048, DOI 10.1001/archderm.116.9.1048; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Bose A, 2013, INT J MOL SCI, V14, P19385, DOI 10.3390/ijms141019385; Casey J.P., 2016, HUM MOL GENET; Castillo A, 2007, CANCER RES, V67, P10138, DOI 10.1158/0008-5472.CAN-07-0326; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cunliffe WJ, 2004, CLIN DERMATOL, V22, P367, DOI 10.1016/j.clindermatol.2004.03.011; Frank V, 2013, HUM MOL GENET, V22, P2177, DOI 10.1093/hmg/ddt070; Grose R, 2007, EMBO J, V26, P1268, DOI 10.1038/sj.emboj.7601583; Happle R, 2010, J AM ACAD DERMATOL, V63, P1, DOI 10.1016/j.jaad.2010.01.017; He L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3870; Hu B, 2010, GENE DEV, V24, P1519, DOI 10.1101/gad.1886910; Jansen T, 1998, INT J DERMATOL, V37, P96, DOI 10.1046/j.1365-4362.1998.00414.x; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Kurioka D, 2014, SCI REP-UK, V4, DOI 10.1038/srep06111; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim YH, 2014, HUM MOL GENET, V23, P397, DOI 10.1093/hmg/ddt429; MOSS C, 1993, J MED GENET, V30, P752, DOI 10.1136/jmg.30.9.752; Munro CS, 1998, LANCET, V352, P704, DOI 10.1016/S0140-6736(05)60820-3; Navarini AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5020; Niemann C, 2002, DEVELOPMENT, V129, P95; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Pink AE, 2013, J INVEST DERMATOL, V133, P601, DOI 10.1038/jid.2012.372; Roig J, 2005, MOL BIOL CELL, V16, P4827, DOI 10.1091/mbc.E05-04-0315; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Sdelci S, 2011, CELL CYCLE, V10, P3816, DOI 10.4161/cc.10.22.18226; Shaheen R, 2015, GENET MED; Smith SC, 2014, NUCLEIC ACIDS RES, V42, P11517, DOI 10.1093/nar/gku840; SOLOMON LM, 1970, ARCH DERMATOL, V102, P381, DOI 10.1001/archderm.102.4.381; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tchernev G, 2013, DERMATOLOGY THER, V3, P33, DOI 10.1007/s13555-013-0027-9; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Toyoda Masahiko, 2001, Medical Electron Microscopy, V34, P29, DOI 10.1007/s007950100002; Wang BX, 2010, SCIENCE, V330, P1065, DOI 10.1126/science.1196284; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8; Zhang MF, 2014, HUM GENET, V133, P259, DOI 10.1007/s00439-013-1374-4; Zouboulis CC, 2015, BRIT J DERMATOL, V172, P27, DOI 10.1111/bjd.13639	42	25	26	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					1030	1037		10.1016/j.ajhg.2016.03.019	http://dx.doi.org/10.1016/j.ajhg.2016.03.019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27153399	Bronze, Green Published			2022-12-18	WOS:000375869300020
J	Greene, D; Richardson, S; Turro, E				Greene, Daniel; Richardson, Sylvia; Turro, Ernest		NIHR BioResource	Phenotype Similarity Regression for Identifying the Genetic Determinants of Rare Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HERMANSKY-PUDLAK-SYNDROME; HUMAN HOMOLOG; MUTATION; DISORDERS; MOUSE; ONTOLOGIES; DISCOVERY; GENOTYPE; FAMILIES; ACCURATE	Rare genetic disorders, which can now be studied systematically with affordable genome sequencing, are often caused by high-penetrance rare variants. Such disorders are often heterogeneous and characterized by abnormalities spanning multiple organ systems ascertained with variable clinical precision. Existing methods for identifying genes with variants responsible for rare diseases summarize phenotypes with unstructured binary or quantitative variables. The Human Phenotype Ontology (HPO) allows composite phenotypes to be represented systematically but association methods accounting for the ontological relationship between HPO terms do not exist. We present a Bayesian method to model the association between an HPO-coded patient phenotype and genotype. Our method estimates the probability of an association together with an HPO-coded phenotype characteristic of the disease. We thus formalize a clinical approach to phenotyping that is lacking in standard regression techniques for rare disease research. We demonstrate the power of our method by uncovering a number of true associations in a large collection of genome-sequenced and HPO-coded-cases with rare diseases.	[Greene, Daniel; Turro, Ernest] Univ Cambridge, NHS Blood & Transplant, Dept Haematol, Cambridge Biomed Campus, Cambridge CB2 0PT, England; [Greene, Daniel; Richardson, Sylvia; Turro, Ernest] MRC, Biostat Unit, Cambridge Biomed Campus, Cambridge CB2 0SR, England	University of Cambridge; MRC Biostatistics Unit	Turro, E (corresponding author), Univ Cambridge, NHS Blood & Transplant, Dept Haematol, Cambridge Biomed Campus, Cambridge CB2 0PT, England.; Turro, E (corresponding author), MRC, Biostat Unit, Cambridge Biomed Campus, Cambridge CB2 0SR, England.	et341@cam.ac.uk	Richardson, Sylvia T/G-4691-2015	Richardson, Sylvia T/0000-0003-1998-492X; Turro, Ernest/0000-0002-1820-6563	NIHR [RG65966]; Medical Research Council [MC_UP_0801/1]; MRC [MC_UP_0801/1] Funding Source: UKRI; Medical Research Council [1381192] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by NIHR award RG65966 (D.G. and E.T.) and the Medical Research Council programme grant MC_UP_0801/1 (D.G. and S.R.). The NIHR BioResource - Rare Diseases projects were approved by Research Ethics Committees in the UK and appropriate national ethics authorities in non-UK enrollment centers (see Supplemental Note). We are grateful to Dr. William J. Astle for advice on the statistical model and for providing comments on the manuscript. We are particularly thankful to the BPD project members for granting access to detailed HPO terms of subjects.	Akawi N, 2015, NAT GENET, V47, P1363, DOI 10.1038/ng.3410; Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; Bauer S, 2012, BIOINFORMATICS, V28, P2502, DOI 10.1093/bioinformatics/bts471; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Canault M, 2014, J EXP MED, V211, P1346, DOI 10.1084/jem.20130477; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cullinane AR, 2011, AM J HUM GENET, V88, P778, DOI 10.1016/j.ajhg.2011.05.009; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Javed A, 2014, NAT METHODS, V11, P935, DOI [10.1038/NMETH.3046, 10.1038/nmeth.3046]; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Kohler Sebastian, 2013, F1000Res, V2, P30, DOI 10.12688/f1000research.2-30.v1; Kunishima S, 2013, AM J HUM GENET, V92, P431, DOI 10.1016/j.ajhg.2013.01.015; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Morgan NV, 2006, AM J HUM GENET, V78, P160, DOI 10.1086/499338; Murayama S, 2013, PEDIATR INT, V55, P102, DOI 10.1111/j.1442-200X.2012.03619.x; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Seri M, 2000, NAT GENET, V26, P103; Singleton MV, 2014, AM J HUM GENET, V94, P599, DOI 10.1016/j.ajhg.2014.03.010; Smith CL, 2009, WIRES SYST BIOL MED, V1, P390, DOI 10.1002/wsbm.44; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Stritt S, 2016, BLOOD, V127, P2903, DOI 10.1182/blood-2015-10-675629; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; Westbury SK, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0151-5; Yang H, 2015, NAT METHODS, V12, P841, DOI [10.1038/nmeth.3484, 10.1038/NMETH.3484]; Zemojtel T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009262; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087	34	25	27	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					490	499		10.1016/j.ajhg.2016.01.008	http://dx.doi.org/10.1016/j.ajhg.2016.01.008			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26924528	hybrid, Green Published			2022-12-18	WOS:000372383100012
J	Flickinger, M; Jun, G; Abecasis, GR; Boehnke, M; Kang, HM				Flickinger, Matthew; Jun, Goo; Abecasis, Goncalo R.; Boehnke, Michael; Kang, Hyun Min			Correcting for Sample Contamination in Genotype Calling of DNA Sequence Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION	DNA sample contamination is a frequent problem in DNA sequencing studies and can result in genotyping errors and reduced power for association testing. We recently described methods to identify within-species DNA sample contamination based on sequencing read data, showed that our methods can reliably detect and estimate contamination levels as low as 1%, and suggested strategies to identify and remove contaminated samples from sequencing studies. Here we propose methods to model contamination during genotype calling as an alternative to removal of contaminated samples from further analyses. We compare our contamination-adjusted calls to calls that ignore contamination and to calls based on uncontaminated data. We demonstrate that, for moderate contamination levels (5%-20%), contamination-adjusted calls eliminate 48%-77% of the genotyping errors. For lower levels of contamination, our contamination correction methods produce genotypes nearly as accurate as those based on uncontaminated data. Our contamination correction methods are useful generally, but are particularly helpful for sample contamination levels from 2% to 20%.	[Flickinger, Matthew; Jun, Goo; Abecasis, Goncalo R.; Boehnke, Michael; Kang, Hyun Min] Univ Michigan, Dept Biostat, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Flickinger, Matthew; Jun, Goo; Abecasis, Goncalo R.; Boehnke, Michael; Kang, Hyun Min] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Jun, Goo] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Houston, TX 77030 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, Sch Publ Hlth, 1415 Washington Hts, Ann Arbor, MI 48109 USA.	boehnke@umich.edu; hmkang@umich.edu	Jun, Goo/F-1941-2017; Jun, Goo/M-5235-2016	Jun, Goo/0000-0003-0891-0204; Jun, Goo/0000-0003-0891-0204	NIH [HG000376, HG007022, HG006513]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007022, R01HG000376, U01HG006513, R29HG000376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors acknowledge support from NIH grants HG000376 (M.B.), HG007022 (G.R.A.), and HG006513 (G.R.A.).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Brent R.P., 1973, ALGORITHMS MINIMIZAT; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110	8	25	25	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					284	290		10.1016/j.ajhg.2015.07.002	http://dx.doi.org/10.1016/j.ajhg.2015.07.002			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26235984	Green Published, Bronze			2022-12-18	WOS:000359328800008
J	Malik, S; Percin, FE; Bornholdt, D; Albrecht, B; Percesepe, A; Koch, MC; Landi, A; Fritz, B; Khan, R; Mumtaz, S; Akarsu, NA; Grzeschik, KH				Malik, Sajid; Percin, Ferda E.; Bornholdt, Dorothea; Albrecht, Beate; Percesepe, Antonio; Koch, Manuela C.; Landi, Antonio; Fritz, Barbara; Khan, Rizwan; Mumtaz, Sara; Akarsu, Nurten A.; Grzeschik, Karl-Heinz			Mutations Affecting the BHLHA9 DNA-Binding Domain Cause MSSD, Mesoaxial Synostotic Syndactyly with Phalangeal Reduction, Malik-Percin Type	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PITT-HOPKINS-SYNDROME; SPLIT-HAND/FOOT MALFORMATION; LOOP-HELIX PROTEINS; LONG-BONE DEFICIENCY; SAETHRE-CHOTZEN-SYNDROME; CENANI-LENZ SYNDROME; TRANSCRIPTION FACTOR; EXPRESSION; TCF4; 17P13.3	Mesoaxial synostotic syndactyly, Malik-Percin type (MSSD) (syndactyly type IX) is a rare autosomal-recessive nonsyndromic digit anomaly with only two affected families reported so far. We previously showed that the trait is genetically distinct from other syndactyly types, and through autozygosity mapping we had identified a locus on chromosome 17p13.3 for this unique limb malformation. Here, we extend the number of independent pedigrees from various geographic regions segregating MSSD to a total of six. We demonstrate that three neighboring missense mutations affecting the highly conserved DNA-binding region of the basic helix-loop-helix A9 transcription factor (BHLHA9) are associated with this phenotype. Recombinant BHLHA9 generated by transient gene expression is shown to be located in the cytoplasm and the cell nucleus. Transcription factors 3, 4, and 12, members of the E protein (class I) family of helix-loop-helix transcription factors, are highlighted in yeast two-hybrid analysis as potential dimerization partners for BHLHA9. In the presence of BHLHA9, the potential of these three proteins to activate expression of an E-box-regulated target gene is reduced considerably. BHLHA9 harboring one of the three substitutions detected in MSSD-affected individuals eliminates entirely the transcription activation by these class I bHLH proteins. We conclude that by dimerizing with other bHLH protein monomers, BHLHA9 could fine tune the expression of regulatory factors governing determination of central limb mesenchyme cells, a function made impossible by altering critical amino acids in the DNA binding domain. These findings identify BHLHA9 as an essential player in the regulatory network governing limb morphogenesis in humans.	[Malik, Sajid; Bornholdt, Dorothea; Koch, Manuela C.; Fritz, Barbara; Grzeschik, Karl-Heinz] Univ Marburg, Zentrum Humangenet, D-35033 Marburg, Germany; [Malik, Sajid; Khan, Rizwan; Mumtaz, Sara] Quaid I Azam Univ, Fac Biol Sci, Human Genet Program, Dept Anim Sci, Islamabad 45320, Pakistan; [Percin, Ferda E.] Gazi Univ, Fac Med, Dept Med Genet, TR-06500 Ankara, Turkey; [Albrecht, Beate] Univ Duisburg Essen, Inst Humangenet, Univ Klinikum Essen, D-45147 Essen, Germany; [Percesepe, Antonio] Univ Hosp Modena, Med Genet Unit, Dept Mother & Child, I-41124 Modena, Italy; [Landi, Antonio] Univ Hosp Modena, Dept Hand Surg & Microsurg, I-41100 Modena, Italy; [Akarsu, Nurten A.] Hacettepe Univ, Dept Med Genet, Gene Mapping Lab, Fac Med, TR-06100 Ankara, Turkey	Philipps University Marburg; Quaid I Azam University; Gazi University; University of Duisburg Essen; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Hacettepe University	Grzeschik, KH (corresponding author), Univ Marburg, Zentrum Humangenet, D-35033 Marburg, Germany.	grzeschi@staff.uni-marburg.de	mumtaz, sara/ABD-5323-2020; Malik, Sajid/H-7816-2019; Akarsu, Nurten/E-9758-2013; Percin, Ferda E/H-6850-2016; Malik, Sajid/I-1513-2015; Percesepe, Antonio/A-6076-2012	mumtaz, sara/0000-0003-0503-1060; Malik, Sajid/0000-0001-5563-9053; Akarsu, Nurten/0000-0001-5432-0032; Percin, Ferda E/0000-0001-9317-8155; Percesepe, Antonio/0000-0002-3268-6786	Deutsche Forschungsgemeinschaft (DFG) [Gr373-21, GRK 767]; Stiftungen P.E. Kempkes and Emil von Behring, Marburg, Germany; Cumhuriyet University Research Committee, Turkey (CUBAP) [T-180]; Higher Education Commission, Islamabad, Pakistan	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Stiftungen P.E. Kempkes and Emil von Behring, Marburg, Germany; Cumhuriyet University Research Committee, Turkey (CUBAP)(Cumhuriyet University); Higher Education Commission, Islamabad, Pakistan(Higher Education Commission of Pakistan)	The participation of the individuals and their families in this study is gratefully acknowledged. We thank Howard Cann (CEPH, Paris, France) for a control DNA sample, M. Sigvardsson (Department of Clinical and Experimental Medicine, Linkoping University, Linkoping, Sweden) for reporter vectors, Manfred Koegl, Frank Schwarz, and Sara Burmester (DKFZ Heidelberg, Germany) for plasmid production and advice on interpretation of Y2H data, Michael Putz (Marburg) for helpful discussions and advice on graphical presentations, and Ulrike Neidel (Marburg) for competent technical assistance. This research was supported by the Deutsche Forschungsgemeinschaft (DFG) (Gr373-21; GRK 767), Stiftungen P.E. Kempkes and Emil von Behring, Marburg, Germany, Cumhuriyet University Research Committee, Turkey (CUBAP) (grant number T-180), and Higher Education Commission, Islamabad, Pakistan.	Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Armour CM, 2011, EUR J HUM GENET, V19, P1144, DOI 10.1038/ejhg.2011.97; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Capra V, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-93; CENANI A, 1967, Z KINDERHEILKD, V101, P181, DOI 10.1007/BF00438491; de Pontual L, 2009, HUM MUTAT, V30, P669, DOI 10.1002/humu.20935; El Ghouzzi V, 2001, FEBS LETT, V492, P112, DOI 10.1016/S0014-5793(01)02238-4; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Khan TN, 2013, EUR J MED GENET, V56, P371, DOI 10.1016/j.ejmg.2013.04.007; Klopocki E, 2012, J MED GENET, V49, P119, DOI 10.1136/jmedgenet-2011-100409; Krawchuk D, 2010, DEV BIOL, V347, P133, DOI 10.1016/j.ydbio.2010.08.015; Leupin O, 2011, J BIOL CHEM, V286, P19489, DOI 10.1074/jbc.M110.190330; Lezirovitz K, 2008, HUM GENET, V123, P625, DOI 10.1007/s00439-008-0515-7; Li Y, 2010, AM J HUM GENET, V86, P696, DOI 10.1016/j.ajhg.2010.03.004; Maia AM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-184; Malik S, 2005, GENET COUNSEL, V16, P229; Malik S, 2005, AM J MED GENET A, V134A, P404, DOI 10.1002/ajmg.a.30656; Malik S, 2004, AM J MED GENET A, V126A, P61, DOI 10.1002/ajmg.a.20555; Malik S, 2012, EUR J HUM GENET, V20, P817, DOI 10.1038/ejhg.2012.14; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McLellan AS, 2002, MECH DEVELOP, V119, pS285, DOI 10.1016/S0925-4773(03)00130-8; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; O'Rourke MP, 2002, INT J DEV BIOL, V46, P401; Ota S, 2007, DEVELOPMENT, V134, P1583, DOI 10.1242/dev.000703; Percin EF, 1998, J MED GENET, V35, P868, DOI 10.1136/jmg.35.10.868; Petit F, 2014, CLIN GENET, V85, P464, DOI 10.1111/cge.12219; Petit F, 2013, EUR J MED GENET, V56, P88, DOI 10.1016/j.ejmg.2012.11.002; RICHIERICOSTA A, 1987, AM J MED GENET, V28, P971, DOI 10.1002/ajmg.1320280424; Schatz O, 2014, HUM MOL GENET, V23, P5394, DOI 10.1093/hmg/ddu257; Sepp M, 2012, HUM MOL GENET, V21, P2873, DOI 10.1093/hmg/dds112; Sigvardsson M, 2000, MOL CELL BIOL, V20, P3640, DOI 10.1128/MCB.20.10.3640-3654.2000; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang C, 2006, CELL RES, V16, P585, DOI 10.1038/sj.cr.7310076; Zweier C, 2008, J MED GENET, V45, P738, DOI 10.1136/jmg.2008.060129; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	37	25	29	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					649	659		10.1016/j.ajhg.2014.10.012	http://dx.doi.org/10.1016/j.ajhg.2014.10.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25466284	Green Published, Bronze			2022-12-18	WOS:000346623100002
J	Benton, MC; Lea, RA; Macartney-Coxson, D; Carless, MA; Goring, HH; Bellis, C; Hanna, M; Eccles, D; Chambers, GK; Curran, JE; Harper, JL; Blangero, J; Griffiths, LR				Benton, Miles C.; Lea, Rod A.; Macartney-Coxson, Donia; Carless, Melanie A.; Goering, Harald H.; Bellis, Claire; Hanna, Michelle; Eccles, David; Chambers, Geoffrey K.; Curran, Joanne E.; Harper, Jacquie L.; Blangero, John; Griffiths, Lyn R.			Mapping eQTLs in the Norfolk Island Genetic Isolate Identifies Candidate Genes for CVD Risk Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; METABOLIC-SYNDROME; LINKAGE ANALYSIS; C677T POLYMORPHISM; CARDIAC METABOLISM; COMMON VARIANTS; LIFE-STYLE; EXPRESSION; LOCI	Cardiovascular disease (CVD) affects millions of people worldwide and is influenced by numerous factors, including lifestyle and genetics. Expression quantitative trait loci (eQTLs) influence gene expression and are good candidates for CVD risk. Founder-effect pedigrees can provide additional power to map genes associated with disease risk. Therefore, we identified eQTLs in the genetic isolate of Norfolk Island (NI) and tested for associations between these and CVD risk factors. We measured genome-wide transcript levels of blood lymphocytes in 330 individuals and used pedigree-based heritability analysis to identify heritable transcripts. eQTLs were identified by genome-wide association testing of these transcripts. Testing for association between CVD risk factors (i.e., blood lipids, blood pressure, and body fat indices) and eQTLs revealed 1,712 heritable transcripts (p < 0.05) with heritability values ranging from 0.18 to 0.84. From these, we identified 200 cis-acting and 70 trans-acting eQTLs (p < 1.84 x 10(-7)) An eQTL-centric analysis of CVD risk traits revealed multiple associations, including 12 previously associated with CVD-related traits. Trait versus eQTL regression modeling identified four CVD risk candidates (NAAA, PAPSS1, NME1, and PRDX1), all of which have known biological roles in disease. In addition, we implicated several genes previously associated with CVD risk traits, including MTHFR and FN3KRP. We have successfully identified a panel of eQTLs in the NI pedigree and used this to implicate several genes in CVD risk. Future studies are required for further assessing the functional importance of these eQTLs and whether the findings here also relate to outbred populations.	[Benton, Miles C.; Lea, Rod A.; Hanna, Michelle; Eccles, David; Griffiths, Lyn R.] Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Southport, Qld 4222, Australia; [Macartney-Coxson, Donia] Kenepuru Sci Ctr, Inst Environm Sci & Res, Wellington 5240, New Zealand; [Carless, Melanie A.; Goering, Harald H.; Bellis, Claire; Curran, Joanne E.; Blangero, John] Texas Biomed Res Inst, San Antonio, TX 78227 USA; [Hanna, Michelle; Griffiths, Lyn R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [Chambers, Geoffrey K.] Victoria Univ Wellington, Sch Biol Sci, Wellington 6140, New Zealand; [Harper, Jacquie L.] Malaghan Inst Med Res, Wellington 6242, New Zealand	Griffith University; Menzies Health Institute Queensland; Institute of Environmental Science & Research (ESR) - New Zealand; Texas Biomedical Research Institute; Queensland University of Technology (QUT); Victoria University Wellington; Malaghan Institute; Victoria University Wellington	Griffiths, LR (corresponding author), Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Southport, Qld 4222, Australia.	lyn.griffiths@qut.edu.au	Belllis, Claire/GYA-5547-2022; Blangero, John/ABA-7175-2021	Belllis, Claire/0000-0001-5073-9610; Benton, Miles/0000-0003-3442-965X; Macartney-Coxson, Donia/0000-0002-1051-537X; Chambers, Geoffrey/0000-0003-1019-6855; Carless, Melanie/0000-0001-8350-2302; Griffiths, Lyn/0000-0002-6774-5475; Curran, Joanne/0000-0002-6898-155X; Lea, Rodney/0000-0002-1148-5862	National Health and Medical Research Council of Australia; Corbett Postgraduate Research Scholarship; Corbett Research; Griffith University Areas of Strategic Investment for Chronic Disease Fellowship; US National Institute of Mental Health [MH059490]; Research Computing Services team at Griffith University; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Corbett Postgraduate Research Scholarship; Corbett Research; Griffith University Areas of Strategic Investment for Chronic Disease Fellowship; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Research Computing Services team at Griffith University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by funding from a National Health and Medical Research Council of Australia project grant. M.C.B. was supported by a Corbett Postgraduate Research Scholarship, and R.A.L. was partially supported by a Corbett Research and a Griffith University Areas of Strategic Investment for Chronic Disease Fellowship. The SOLAR statistical genetics computer package is supported by a grant from the US National Institute of Mental Health (MH059490). We would like to acknowledge the Research Computing Services team at Griffith University, particularly Amanda Miotto for providing support for this project. Lastly, we extend our appreciation to the Norfolk Islanders who volunteered for this study.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bannink Lot, 2006, N Z Med J, V119, pU2313; Bellis C, 2008, HEREDITY, V100, P366, DOI 10.1038/sj.hdy.6801083; Bellis C, 2005, HUM HERED, V60, P211, DOI 10.1159/000090545; Bellis C, 2008, HUM GENET, V124, P543, DOI 10.1007/s00439-008-0580-y; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Bullaughey K, 2009, HUM MOL GENET, V18, P4296, DOI 10.1093/hmg/ddp382; Bushel PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034286; Cameron AJ, 2007, DIABETES RES CLIN PR, V77, P471, DOI 10.1016/j.diabres.2007.02.002; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.0.CO;2-T; Cox HC, 2012, GENE, V494, P119, DOI 10.1016/j.gene.2011.11.056; Cox HC, 2009, HUM HERED, V68, P55, DOI 10.1159/000210449; Degnan JH, 2008, GENOMICS, V92, P129, DOI 10.1016/j.ygeno.2008.05.012; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Edgecombe J., 1999, NORFOLK ISLAND S PAC; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Garagnani P, 2009, EUR J HUM GENET, V17, P1490, DOI 10.1038/ejhg.2009.69; Garnier S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003240; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; Grieve IC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004033; Hernandez DG, 2012, NEUROBIOL DIS, V47, P20, DOI 10.1016/j.nbd.2012.03.020; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hippe HJ, 2007, CIRC RES, V100, P1191, DOI 10.1161/01.RES.0000264058.28808.cc; Hoare M., 1999, NORFOLK ISLAND REVIS, V5th ed.; Hoffmann K, 2009, J HYPERTENS, V27, P983, DOI 10.1097/HJH.0b013e328328123d; Huo Y, 2013, GENE, V512, P179, DOI 10.1016/j.gene.2012.10.067; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Lindsay J, 2008, CURR DRUG METAB, V9, P99; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Lutz S, 2004, METHOD ENZYMOL, V390, P403; Macgregor S, 2010, EUR J HUM GENET, V18, P67, DOI 10.1038/ejhg.2009.111; Maher BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037903; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McEvoy BP, 2010, HEREDITY, V105, P229, DOI 10.1038/hdy.2009.175; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Mornet E, 1997, HUM GENET, V100, P512, DOI 10.1007/s004390050544; Nath Artika Praveeta, 2012, Frontiers in Genetics, V3, P243, DOI 10.3389/fgene.2012.00243; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Oterino A, 2004, CEPHALALGIA, V24, P491, DOI 10.1111/j.1468-2982.2004.00692.x; Pare G, 2009, CIRC-CARDIOVASC GENE, V2, P142, DOI 10.1161/CIRCGENETICS.108.829804; Payne LS, 2008, BIOCHEM J, V416, P281, DOI 10.1042/BJ20080389; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Powell JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035430; Powell JE, 2012, GENOME RES, V22, P456, DOI 10.1101/gr.126540.111; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Pritlove DC, 2006, PLACENTA, V27, P924, DOI 10.1016/j.placenta.2005.08.010; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian XQ, 2007, EUR J HUM GENET, V15, P1239, DOI 10.1038/sj.ejhg.5201914; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Sauzeau V, 2006, NAT MED, V12, P841, DOI 10.1038/nm1426; Sauzeau V, 2011, J BIOL CHEM, V286, P2896, DOI 10.1074/jbc.M110.187534; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Scher AI, 2006, ANN NEUROL, V59, P372, DOI 10.1002/ana.20755; SIEBERT PD, 1987, P NATL ACAD SCI USA, V84, P6735, DOI 10.1073/pnas.84.19.6735; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Szwergold BS, 2007, MED HYPOTHESES, V68, P37, DOI 10.1016/j.mehy.2006.06.030; Taylor JMW, 2010, CARDIOVASC RES, V86, P526, DOI 10.1093/cvr/cvq015; Team RC., 2022, R LANG ENV STAT COMP; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Varilo T, 2004, CURR OPIN GENET DEV, V14, P316, DOI 10.1016/j.gde.2004.04.008; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	85	25	25	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1087	1099		10.1016/j.ajhg.2013.11.004	http://dx.doi.org/10.1016/j.ajhg.2013.11.004			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24314549	Green Published, Bronze			2022-12-18	WOS:000328521300008
J	Sergouniotis, PI; Davidson, AE; Mackay, DS; Lenassi, E; Li, Z; Robson, AG; Yang, X; Kam, JH; Isaacs, TW; Holder, GE; Jeffery, G; Beck, JA; Moore, AT; Plagnol, V; Webster, AR				Sergouniotis, Panagiotis I.; Davidson, Alice E.; Mackay, Donna S.; Lenassi, Eva; Li, Zheng; Robson, Anthony G.; Yang, Xu; Kam, Jaimie Hoh; Isaacs, Timothy W.; Holder, Graham E.; Jeffery, Glen; Beck, Jonathan A.; Moore, Anthony T.; Plagnol, Vincent; Webster, Andrew R.			Biallelic Mutations in PLA2G5, Encoding Group V Phospholipase A(2), Cause Benign Fleck Retina	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECOMBINANT EXPRESSION; GROUP-X; MICE; ENZYMES; CLONING; BINDING; CELLS; ATHEROSCLEROSIS; INFLAMMATION; SPLA(2)	Flecked-retina syndromes, including fundus flavimaculatus, fundus albipunctatus, and benign fleck retina, comprise a group of disorders with widespread or limited distribution of yellow-white retinal lesions of various sizes and configurations. Three siblings who have benign fleck retina and were born to consanguineous parents are the basis of this report. A combination of homozygosity mapping and exome sequencing helped to identify a homozygous missense mutation, c.133G>T (p.Gly45Cys), in PLA2G5, a gene encoding a secreted phospholipase (group V phospholipase A(2)). A screen of a further four unrelated individuals with benign fleck retina detected biallelic variants in the same gene in three patients. In contrast, no loss of function or common (minor-allele frequency>0.05%) nonsynonymous PLA2G5 variants have been previously reported (EVS, dbSNP, 1000 Genomes Project) or were detected in an internal database of 224 exomes (from subjects with adult onset neurodegenerative disease and without a diagnosis of ophthalmic disease). All seven affected individuals had fundoscopic features compatible with those previously described in benign fleck retina and no visual or electrophysiological deficits. No medical history of major illness was reported. Levels of low-density lipoprotein were mildly elevated in two patients. Optical coherence tomography and fundus autofluorescence findings suggest that group V phospholipase A2 plays a role in the phagocytosis of photoreceptor outer-segment discs by the retinal pigment epithelium. Surprisingly, immunohistochemical staining of human retinal tissue revealed localization of the protein predominantly in the inner and outer plexiform layers.	[Sergouniotis, Panagiotis I.; Davidson, Alice E.; Mackay, Donna S.; Lenassi, Eva; Li, Zheng; Robson, Anthony G.; Kam, Jaimie Hoh; Holder, Graham E.; Jeffery, Glen; Moore, Anthony T.; Webster, Andrew R.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Sergouniotis, Panagiotis I.; Lenassi, Eva; Robson, Anthony G.; Holder, Graham E.; Moore, Anthony T.; Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England; [Yang, Xu] Beijing Genom Inst Shenzhen, Shenzhen 518083, Peoples R China; [Isaacs, Timothy W.] Lions Eye Inst, Nedlands, WA 6009, Australia; [Beck, Jonathan A.] UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Beijing Genomics Institute (BGI); Lions Eye Institute; University of Western Australia; University of London; University College London; University of London; University College London	Webster, AR (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EL, England.	andrew.webster@ucl.ac.uk	Plagnol, Vincent/A-5667-2011	Robson, Anthony/0000-0002-8391-6123; Sergouniotis, Panos/0000-0003-0986-4123; Plagnol, Vincent/0000-0002-5597-9215; Li, Zheng/0000-0002-7060-2213; Mackay, Donna/0000-0002-2499-1203	British Retinitis Pigmentosa Society; Fight for Sight; Moorfields Eye Hospital Special Trustees; National Institute for Health Research UK (Moorfields Eye Hospital and Institute of Ophthalmology, London, UK); Foundation Fighting Blindness (USA); Medical Research Council UK; Wellcome Trust; University College London Hospitals Biomedical Research Centre; MRC [MC_U123160651] Funding Source: UKRI; Medical Research Council [MC_U123160651] Funding Source: researchfish	British Retinitis Pigmentosa Society; Fight for Sight; Moorfields Eye Hospital Special Trustees; National Institute for Health Research UK (Moorfields Eye Hospital and Institute of Ophthalmology, London, UK)(National Institute for Health Research (NIHR)); Foundation Fighting Blindness (USA); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University College London Hospitals Biomedical Research Centre(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge the cooperation and help provided by the family members in this study. We thank Thomas Daskalakis for his key contribution in developing the python program and Jill Urquhart and Sarah Daly at the National Institute for Health Research Manchester Biomedical Research Centre for their technical assistance with Affymetrix SNP Array 6.0 genotyping. We are grateful to colleagues who referred individuals from Moorfields Eye Hospital to us, as well as to those who contributed to the assembly of the Benign Fleck Retina panel; we are particularly grateful to Naushin Waseem, Bev Scott, Genevieve Wright, Sophie Devery, Michel Michaelides, and Mandeep Sagoo. We thank Kaoru Fujinami, Professor Alan Bird, Professor Philippa Talmud, and Professor Yozo Miyake for their insightful comments. We acknowledge the following sources of funding: British Retinitis Pigmentosa Society, Fight for Sight, Moorfields Eye Hospital Special Trustees, National Institute for Health Research UK (Moorfields Eye Hospital and Institute of Ophthalmology, London, UK), the Foundation Fighting Blindness (USA), the Medical Research Council UK, the Wellcome Trust, and the University College London Hospitals Biomedical Research Centre.	Affymetrix, 2006, BRLMM IMPR GEN CALL; AISH S F S, 1980, British Journal of Ophthalmology, V64, P652; [Anonymous], DBSNP; [Anonymous], BLOSSUM62; [Anonymous], POLYMORPHISM PHENOTY; Audo I, 2007, ARCH OPHTHALMOL-CHIC, V125, P714, DOI 10.1001/archopht.125.5.714; Balestrieri B, 2006, BBA-MOL CELL BIOL L, V1761, P1280, DOI 10.1016/j.bbalip.2006.07.008; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; Boyanovsky B, 2009, ARTERIOSCL THROM VAS, V29, P532, DOI 10.1161/ATVBAHA.108.183038; CHEN J, 1994, J BIOL CHEM, V269, P2365; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Galindo-Ferreiro Alicia, 2010, Ophthalmic Surg Lasers Imaging, V41 Online, pe1, DOI 10.3928/15428877-20101025-05; Gass JDM., 1997, DIAGNOSIS TREATMENT, V4th edition; Giannattasio G, 2010, J IMMUNOL, V185, P4430, DOI 10.4049/jimmunol.1001384; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Isaacs TW, 1996, BRIT J OPHTHALMOL, V80, P267, DOI 10.1136/bjo.80.3.267; Jang Y., 2011, PLOS ONE, V6; Kim KP, 2001, J BIOL CHEM, V276, P11126, DOI 10.1074/jbc.M004604200; Kolko M, 2004, J NEUROSCI RES, V77, P517, DOI 10.1002/jnr.20187; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Munoz NM, 2009, AM J PHYSIOL-LUNG C, V296, pL879, DOI 10.1152/ajplung.90580.2008; Munoz NM, 2003, J BIOL CHEM, V278, P38813, DOI 10.1074/jbc.M302476200; Murakami M, 2005, J BIOL CHEM, V280, P24987, DOI 10.1074/jbc.M502088200; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Rohrschneider K, 2008, PROG RETIN EYE RES, V27, P536, DOI 10.1016/j.preteyeres.2008.07.003; Rosengren B, 2006, BBA-MOL CELL BIOL L, V1761, P1301, DOI 10.1016/j.bbalip.2006.06.008; Rosenson RS, 2009, LANCET, V373, P649, DOI 10.1016/S0140-6736(09)60403-7; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Schmitz-Valckenberg S, 2008, RETINA-J RET VIT DIS, V28, P385, DOI 10.1097/IAE.0b013e318164a907; Seeds MC, 2000, AM J RESP CELL MOL, V23, P37, DOI 10.1165/ajrcmb.23.1.4034; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Song K, 2012, PHARMACOGENOMICS J, V12, P425, DOI 10.1038/tpj.2011.20; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Valentin E, 2000, BIOCHEM BIOPH RES CO, V279, P223, DOI 10.1006/bbrc.2000.3908; WING GL, 1978, INVEST OPHTH VIS SCI, V17, P601; Winget JM, 2006, BBA-MOL CELL BIOL L, V1761, P1260, DOI 10.1016/j.bbalip.2006.08.002; Wootton PTE, 2007, HUM MOL GENET, V16, P1437, DOI 10.1093/hmg/ddm094; INTERACTIVE GENOMICS; CLUSTALW; UNIGENE; EYESAGE	52	25	27	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					782	791		10.1016/j.ajhg.2011.11.004	http://dx.doi.org/10.1016/j.ajhg.2011.11.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22137173	Green Published, Bronze			2022-12-18	WOS:000298208700010
J	Funari, VA; Krakow, D; Nevarez, L; Chen, ZG; Funari, TL; Vatanavicharn, N; Wilcox, WR; Rimoin, DL; Nelson, SF; Cohn, DH				Funari, Vincent A.; Krakow, Deborah; Nevarez, Lisette; Chen, Zugen; Funari, Tara L.; Vatanavicharn, Nithiwat; Wilcox, William R.; Rimoin, David L.; Nelson, Stanley F.; Cohn, Daniel H.			BMPER Mutation in Diaphanospondylodysostosis Identified by Ancestral Autozygosity Mapping and Targeted High-Throughput Sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ABNORMAL VERTEBRAL OSSIFICATION; TWISTED GASTRULATION; CAPTURE; CROSSVEINLESS-2; HOMOZYGOSITY; DROSOPHILA; PROTEINS; FEATURES; EMBRYO; EYE	Diaphanospondylodysostosis (DSD) is a rare, recessively inherited, perinatal lethal skeletal disorder The low frequency and perinatal lethality of DSD makes assembling a large set of families for traditional linkage-based genetic approaches challenging By searching for evidence of unknown ancestral consanguinity, we identified two autozygous intervals, comprising 34 Mbps, unique to a single case of DSD Empirically testing for ancestral consanguinity was effective in localizing the causative variant, thereby reducing the genomic space within which the mutation resides High-throughput sequence analysis of exons captured from these intervals demonstrated that the affected individual was homozygous for a null mutation in BMPER, which encodes the bone morphogenetic protein-binding endothelial cell precursor-derived regulator. Mutations in BMPER were subsequently found in three additional DSD cases, confirming that defects in BMPER produce DSD Phenotypic similarities between DSD and Bmper null mice indicate that BMPER-mediated signaling plays an essential role in vertebral segmentation early in human development	[Funari, Vincent A.; Krakow, Deborah; Nevarez, Lisette; Funari, Tara L.; Wilcox, William R.; Rimoin, David L.; Cohn, Daniel H.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Funari, Vincent A.; Wilcox, William R.; Rimoin, David L.; Nelson, Stanley F.; Cohn, Daniel H.] Univ Calif Los Angeles, Dept Pediat, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Krakow, Deborah] Univ Calif Los Angeles, Dept Orthopaed Surg, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Krakow, Deborah; Chen, Zugen; Rimoin, David L.; Nelson, Stanley F.; Cohn, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Krakow, Deborah] Univ Calif Los Angeles, Dept Obstet & Gynecol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Vatanavicharn, Nithiwat] Mahidol Univ, Div Med Genet, Dept Pediat, Siriraj Hosp, Bangkok 10700, Thailand; [Rimoin, David L.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Mahidol University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Funari, VA (corresponding author), Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA.		Nelson, Stanley F/D-4771-2009; Krakow, Deborah/B-5778-2009	Nelson, Stanley F/0000-0002-2082-3114; Krakow, Deborah/0000-0001-9906-4968	National Institutes of Health [DE019567, HD22657, M01-RR00425]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the families for their active participation in this work We thank Stephen Moore and Keith Brown for providing resources that contributed greatly to the project Microarray data were generated and analyses were performed within the UCLA DNA Microarray Facility This work was supported in part by grants from the National Institutes of Health (DE019567, HD22657, and M01-RR00425)	Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Conley CA, 2000, DEVELOPMENT, V127, P3947; Dunwoodie SL, 2009, CURR OPIN GENET DEV, V19, P329, DOI 10.1016/j.gde.2009.06.005; Gonzales M, 2005, AM J MED GENET A, V136A, P373, DOI 10.1002/ajmg.a.30537; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; Ikeya M, 2010, DEV BIOL, V337, P405, DOI 10.1016/j.ydbio.2009.11.013; Jena N, 1997, EXP CELL RES, V230, P28, DOI 10.1006/excr.1996.3411; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lee H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-646; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Mizutani CM, 2005, DEV CELL, V8, P915, DOI 10.1016/j.devcel.2005.04.009; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nisbet DL, 1999, PRENATAL DIAG, V19, P642, DOI 10.1002/(SICI)1097-0223(199907)19:7<642::AID-PD610>3.0.CO;2-1; Prefumo F, 2003, AM J MED GENET A, V120A, P386, DOI 10.1002/ajmg.a.20097; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Shtir CJ, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-71; Sparrow DB, 2008, HUM MOL GENET, V17, P3761, DOI 10.1093/hmg/ddn272; Tompson SW, 2009, AM J HUM GENET, V84, P72, DOI 10.1016/j.ajhg.2008.12.001; Turnpenny PD, 2007, DEV DYNAM, V236, P1456, DOI 10.1002/dvdy.21182; Vatanavicharn N, 2007, AM J MED GENET A, V143A, P2292, DOI 10.1002/ajmg.a.31934; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875; Zakin L, 2008, DEV BIOL, V323, P6, DOI 10.1016/j.ydbio.2008.08.019; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200	33	25	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					532	537		10.1016/j.ajhg.2010.08.015	http://dx.doi.org/10.1016/j.ajhg.2010.08.015			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20869035	Green Published, Bronze			2022-12-18	WOS:000283037600009
J	Payseur, BA; Place, M; Weber, JL				Payseur, Bret A.; Place, Michael; Weber, James L.			Linkage disequilibrium between STRPs and SNPs across the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN Y-CHROMOSOME; RECENT POSITIVE SELECTION; MICROSATELLITE MARKERS; GAMETIC DISEQUILIBRIUM; HUMAN-POPULATIONS; MUTATION-RATES; HAPLOTYPE DIVERSITY; DISEASE GENES; LOCI; RECOMBINATION	Patterns of linkage disequilibrium (LD) reveal the action of evolutionary processes and provide crucial information for association mapping of disease genes. Although recent studies have described the landscape of LD among single nucleotide polymorphisms (SNPs) from across the human genome, associations involving other classes of molecular variation remain poorly understood. In addition to recombination and population history, mutation rate and process are expected to shape LD. To test this idea, we measured associations between short-tandem-repeat polymorphisms (STRPs), which can mutate rapidly and recurrently, and SNPs in 721 regions across the human genome. We directly compared STRP-SNP LD with SNP-SNP LD from the same genomic regions in the human HapMap populations. The intensity of STRP-SNP LD, measured by the average of D', was reduced, consistent with the action of recurrent mutation. Nevertheless, a higher fraction of STRP-SNP pairs than SNP-SNP pairs showed significant LD, on both short (up to 50 kb) and long (cM) scales. These results reveal the substantial effects of mutational processes on LD at STRPs and provide important measures of the potential of STRPs for association mapping of disease genes.	[Payseur, Bret A.; Place, Michael] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Weber, James L.] Prevent Genet, Marshfield, WI 54449 USA	University of Wisconsin System; University of Wisconsin Madison	Payseur, BA (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	payseur@wisc.edu			NHGRI NIH HHS [R01 HG004498, R01 HG004498-01A1] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004498] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amos W, 1996, NAT GENET, V12, P13, DOI 10.1038/ng0196-13; BAHRAM S, 2007, NAT REV GENET, P8; Bataillon T, 2006, EUR J HUM GENET, V14, P1044, DOI 10.1038/sj.ejhg.5201669; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Chapman NH, 1997, AM J HUM GENET, V61, pA271; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Clark AG, 2003, AM J HUM GENET, V73, P285, DOI 10.1086/377138; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Cooper G, 1999, P NATL ACAD SCI USA, V96, P11916, DOI 10.1073/pnas.96.21.11916; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; de Knijff P, 2000, AM J HUM GENET, V67, P1055; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dupuy BM, 2004, HUM MUTAT, V23, P117, DOI 10.1002/humu.10294; Eberle MA, 2006, PLOS GENET, V2, P1319, DOI 10.1371/journal.pgen.0020142; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghebranious N, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-6; HEDRICK PW, 1987, GENETICS, V117, P331; Hey J, 2004, MOL ECOL, V13, P909, DOI 10.1046/j.1365-294X.2003.02031.x; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Holtkemper U, 2001, HUM MOL GENET, V10, P629, DOI 10.1093/hmg/10.6.629; Huang QY, 2002, AM J HUM GENET, V70, P625, DOI 10.1086/338997; Huttley GA, 1999, GENETICS, V152, P1711; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; JORGENSON E, 2007, NAT REV GENET, P8; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LEWONTIN RC, 1964, GENETICS, V49, P49; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mountain JL, 2002, GENOME RES, V12, P1766, DOI 10.1101/gr.238602; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nachman MW, 2000, GENETICS, V156, P297; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Ohashi J, 2003, J HUM GENET, V48, P487, DOI 10.1007/s10038-003-0058-7; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Payseur BA, 2006, TRENDS GENET, V22, P424, DOI 10.1016/j.tig.2006.06.009; Pe'er I, 2006, AM J HUM GENET, V78, P588, DOI 10.1086/502803; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Ptak SE, 2004, GENETICS, V167, P387, DOI 10.1534/genetics.167.1.387; Ramakrishnan U, 2004, MOL BIOL EVOL, V21, P1960, DOI 10.1093/molbev/msh212; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; RISCH N, 1996, SCIENCE, V273, P1517; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaid DJ, 2004, GENETICS, V166, P505, DOI 10.1534/genetics.166.1.505; Schulze TG, 2002, HUM MOL GENET, V11, P1363, DOI 10.1093/hmg/11.12.1363; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tamiya G, 2005, HUM MOL GENET, V14, P2305, DOI 10.1093/hmg/ddi234; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Varilo T, 2003, HUM MOL GENET, V12, P51, DOI 10.1093/hmg/ddg005; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weber JL, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-16; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEBER JL, 2001, PAST PRESENT FUTURE, V42, P77; Weir B., 1996, GENETIC DATA ANAL; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; Xiong MM, 1999, AM J HUM GENET, V64, P629, DOI 10.1086/302231; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Yatsu K, 2006, J HYPERTENS, V24, P55; Zapata C, 1997, ANN HUM GENET, V61, P71, DOI 10.1017/S0003480096005969; Zapata C, 2000, EVOLUTION, V54, P1809, DOI 10.1111/j.0014-3820.2000.tb00711.x; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	86	25	27	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1039	1050		10.1016/j.ajhg.2008.02.018	http://dx.doi.org/10.1016/j.ajhg.2008.02.018			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18423524	Green Published, Bronze			2022-12-18	WOS:000255923600004
J	Stephan, DA				Stephan, Dietrich A.			Unraveling autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPECTRUM DISORDERS; MUTATIONS; CONTACTIN-ASSOCIATED-PROTEIN-LIKE-2; CNTNAP2; SHANK3; GENE		Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA	Translational Genomics Research Institute	Stephan, DA (corresponding author), Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA.	dstephan@tgen.org						Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Blasi F, 2006, AM J MED GENET B, V141B, P220, DOI 10.1002/ajmg.b.30287; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Hu-Lince D, 2005, AM J PHARMACOGENOMIC, V5, P233, DOI 10.2165/00129785-200505040-00004; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773	9	25	25	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					7	9		10.1016/j.ajhg.2007.12.003	http://dx.doi.org/10.1016/j.ajhg.2007.12.003			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179879	Green Published, Bronze			2022-12-18	WOS:000253223800001
J	Benito-Sanz, S; Del Blanco, DG; Huber, C; Thomas, NS; Aza-Carmona, M; Bunyan, D; Maloney, V; Argente, J; Cormier-Daire, V; Campos-Barros, A; Heath, KE				Benito-Sanz, Sara; Gorbenko Del Blanco, Darya; Huber, Celine; Thomas, N. Simon; Aza-Carmona, Miriam; Bunyan, David; Maloney, Vivienne; Argente, Jesus; Cormier-Daire, Valerie; Campos-Barros, Angel; Heath, Karen E.			Characterization of SHOX deletions in Leri-Weill dyschondrosteosis (LWD) reveals genetic heterogeneity and no recombination hotspots	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TURNER-SYNDROME; DISTAL XP; REGION		Univ Autonoma Madrid, Serv Endocrinol, Dept Endocrinol, Hosp Infantil Univ Nino Jesus, Madrid 28009, Spain; Hop Necker Enfants Malad, Dept Genet, Paris, France; Hop Necker Enfants Malad, INSERM, U393, Paris, France; Salisbury Dist Hosp, Western Reg Genet Lab, Salisbury, Wilts, England; Salisbury Dist Hosp, Natl Genet Reference Lab, Salisbury, Wilts, England	Autonomous University of Madrid; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Salisbury District Hospital; Salisbury District Hospital	Heath, KE (corresponding author), Univ Autonoma Madrid, Serv Endocrinol, Dept Endocrinol, Hosp Infantil Univ Nino Jesus, Ave Menendez Pelayo 65, Madrid 28009, Spain.	karen.heath@uam.es	Barros, Angel Campos/E-6427-2018; Argente, Jesús/K-1167-2014; del Blanco, Darya Gorbenko/N-6069-2018; Benito-Sanz, Sara/ABB-4188-2021; Argente, Jesús/M-5226-2019; Heath, K. E./ABG-4658-2020; Heath, Karen Elise/K-7760-2014; cormier-daire, valerie/H-6520-2017	Barros, Angel Campos/0000-0003-4649-2971; Argente, Jesús/0000-0001-5826-0276; del Blanco, Darya Gorbenko/0000-0002-9674-2388; Argente, Jesús/0000-0001-5826-0276; Heath, K. E./0000-0002-5816-7044; Heath, Karen Elise/0000-0002-5816-7044; huber, celine/0000-0002-8601-9655; BENITO-SANZ, SARA/0000-0002-6101-9413; cormier-daire, valerie/0000-0002-2839-9856; Aza-Carmona, Miriam/0000-0003-4448-9541				Benito-Sanz S, 2005, AM J HUM GENET, V77, P533, DOI 10.1086/449313; James RS, 1998, HUM GENET, V102, P507, DOI 10.1007/s004390050733; Kosho T, 1999, J CLIN ENDOCR METAB, V84, P4613, DOI 10.1210/jc.84.12.4613; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; Ogata T, 2001, J CLIN ENDOCR METAB, V86, P5498, DOI 10.1210/jc.86.11.5498; Ross JL, 2000, AM J HUM GENET, V67, P672, DOI 10.1086/303039; Ross JL, 2006, AM J HUM GENET, V78, P523, DOI 10.1086/500958; Schneider KU, 2005, AM J HUM GENET, V77, P89, DOI 10.1086/431655; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Thomas NS, 2004, AM J MED GENET A, V128A, P179, DOI 10.1002/ajmg.a.30095; WAPENAAR MC, 1992, GENOMICS, V13, P167, DOI 10.1016/0888-7543(92)90217-G	14	25	26	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					409	414		10.1086/506390	http://dx.doi.org/10.1086/506390			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826534	Green Published, Bronze			2022-12-18	WOS:000239040400025
J	Bartlett, CW; Goedken, R; Vieland, VJ				Bartlett, CW; Goedken, R; Vieland, VJ			Effects of updating linkage evidence across subsets of data: Reanalysis of the autism genetic resource exchange data set	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POSTERIOR PROBABILITY; LOCUS HETEROGENEITY; GENOMEWIDE SCREEN; GENOMIC SCREEN; SUSCEPTIBILITY; CHROMOSOME-2; DISORDER; DISEQUILIBRIUM; SCHIZOPHRENIA; INHERITANCE	Results of autism linkage studies have been difficult to interpret across research groups, prompting the use of ever-increasing sample sizes to increase power. However, increasing sample size by pooling disparate collections for a single analysis may, in fact, not increase power in the face of genetic heterogeneity. Here, we applied the posterior probability of linkage (PPL), a method designed specifically to analyze multiple heterogeneous data sets, to the Autism Genetic Resource Exchange collection of families by analyzing six clinically defined subsets of the data and updating the PPL sequentially over the subsets. Our results indicate a substantial probability of linkage to chromosome 1, which had been previously overlooked; our findings also provide a further characterization of the possible parent-of-origin effects at the 17q11 locus that were previously described in this sample. This analysis illustrates that the way in which heterogeneity is addressed in linkage analysis can dramatically affect the overall conclusions of a linkage study.	Univ Iowa, Coll Publ Hlth, Ctr Stat Genet Res, Iowa City, IA 52242 USA; Univ Iowa, Coll Publ Hlth, Program Publ Hlth Genet, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Bartlett, CW (corresponding author), Univ Iowa, Coll Publ Hlth, Ctr Stat Genet Res, 2188 Westlawn, Iowa City, IA 52242 USA.	christopher-bartlett@uiowa.edu	Bartlett, Christopher/AAD-8813-2022; Bartlett, Christopher/B-4958-2009	Bartlett, Christopher/0000-0001-7837-6348; Bartlett, Christopher/0000-0001-7837-6348	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052841] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007638, T32 HL07638] Funding Source: Medline; NIMH NIH HHS [R01 MH052841] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Bailey A, 1998, HUM MOL GENET, V7, P571; Bartlett CW, 2004, HUM HERED, V57, P10, DOI 10.1159/000077385; Bartlett CW, 2002, AM J HUM GENET, V71, P45, DOI 10.1086/341095; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Brzustowicz LM, 2004, AM J HUM GENET, V74, P1057, DOI 10.1086/420774; Buxbaum, 2001, AM J HUM GENET, V69, P470; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; CANTORCHIU RM, 2004, AM SOC HUM GEN ANN M; Collaborative Linkage Study of Autism, 2001, Am J Med Genet, V105, P609; Feenstra B, 2004, HUM HERED, V57, P100, DOI 10.1159/000077547; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Greenberg DA, 2000, AM J HUM GENET, V66, P508, DOI 10.1086/302763; Huang J, 2001, HUM HERED, V51, P217, DOI 10.1159/000053345; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Logue MW, 2004, HUM HERED, V57, P90, DOI 10.1159/000077546; Logue MW, 2003, AM J MED GENET B, V121B, P95, DOI 10.1002/ajmg.b.20072; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Ludington EA, 2000, AM J HUM GENET, V67, P319; LUDINGTON EA, 2000, SEX SPECIFIC RECOMBI, P35; Nurmi EL, 2003, J AM ACAD CHILD PSY, V42, P856, DOI 10.1097/01.CHI.0000046868.56865.0F; Nylander L, 2001, ACTA PSYCHIAT SCAND, V103, P428, DOI 10.1034/j.1600-0447.2001.00175.x; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1976, AM J HUM GENET, V28, P528; Palferman S, 2001, AM J HUM GENET, V69, P570; *PAR AUT RES INT S, 1999, HUM MOL GENET, V8, P805; RISCH N, 1990, AM J HUM GENET, V46, P229; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Shao YJ, 2003, AM J HUM GENET, V72, P539, DOI 10.1086/367846; Shao YJ, 2002, AM J HUM GENET, V70, P1058, DOI 10.1086/339765; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; SMALLEY SL, 1993, AM J HUM GENET, V52, P210; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Stahlberg O, 2004, J NEURAL TRANSM, V111, P891, DOI 10.1007/s00702-004-0115-1; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Vieland VJ, 2003, AM J HUM GENET, V73, P196; Vieland VJ, 2002, HUM HERED, V53, P23, DOI 10.1159/000048601; Vieland VJ, 1998, AM J HUM GENET, V63, P947, DOI 10.1086/302076; Vieland VJ, 2001, HUM HERED, V51, P199, DOI 10.1159/000053343; Wang K, 1999, GENET EPIDEMIOL, V17, pS749; Wassink TH, 2004, MENT RETARD DEV D R, V10, P272, DOI 10.1002/mrdd.20041; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778	47	25	25	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					688	695		10.1086/429345	http://dx.doi.org/10.1086/429345			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	904RS	15729670	Bronze, Green Published			2022-12-18	WOS:000227516000015
J	Modin, H; Olsson, W; Hillert, J; Masterman, T				Modin, H; Olsson, W; Hillert, J; Masterman, T			Modes of action of HLA-DR susceptibility specificities in multiple sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DISEASE		Huddinge Univ Hosp, Div Neurol, Neurotec Dept, Karolinska Inst, SE-14186 Stockholm, Sweden	Karolinska Institutet	Masterman, T (corresponding author), Huddinge Univ Hosp, Div Neurol, Neurotec Dept, Karolinska Inst, SE-14186 Stockholm, Sweden.	Thomas.Masterman@neurotec.ki.se						Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; *GRAPH PAD SOFTW, 1993, INSTAT REL; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Oksenberg JR, 1996, BRAIN PATHOL, V6, P289, DOI 10.1111/j.1750-3639.1996.tb00856.x; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Zanelli E, 2000, RHEUMATOLOGY, V39, P1060, DOI 10.1093/rheumatology/39.10.1060	7	25	27	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1321	1322		10.1086/420977	http://dx.doi.org/10.1086/420977			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15195659	Green Published, Bronze			2022-12-18	WOS:000221651900028
J	Page, DC				Page, DC			2003 Curt Stern Award address - On low expectations exceeded; or, the genomic salvation of the Y chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							GENE; REGION		MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	page@wi.mit.edu						FORD CE, 1959, LANCET, V1, P711; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Ohno S., 1967, SEX CHROMOSOMES SEX; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; STERN C, 1957, AM J HUM GENET, V9, P147	14	25	29	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					399	402		10.1086/382659	http://dx.doi.org/10.1086/382659			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	15053010	Bronze, Green Published			2022-12-18	WOS:000220118500007
J	Mathews, LM; Chi, SY; Greenberg, N; Ovchinnikov, I; Swergold, GD				Mathews, LM; Chi, SY; Greenberg, N; Ovchinnikov, I; Swergold, GD			Large differences between LINE-1 amplification rates in the human and chimpanzee lineages	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONHOMOLOGOUS RECOMBINATION; L1 RETROTRANSPOSITION; DNA-SEQUENCES; GENOMIC DNA; ELEMENTS; GENE; EVOLUTION; HOMINOIDS; DELETION; TRANSDUCTION	The genomic evolution and causes of phenotypic variation among humans and great apes remain largely unknown, although the phylogenetic relationships among them have been extensively explored. Previous studies that focus on differences at the amino acid and nucleotide sequence levels have revealed a high degree of similarity between humans and chimpanzees, suggesting that other types of genomic change may have contributed to the relatively large phenotypic differences between them. For example, the activity of long interspersed element 1 (LINE-1) retrotransposons may impose significant changes on genomic structure and function and, consequently, on phenotype. Here we investigate the relative rates of LINE-1 amplification in the lineages leading to humans, bonobos (Pan paniscus), and chimpanzees (P. troglodytes). Our data indicate that LINE-1 insertions have accumulated at significantly greater rates in bonobos and chimpanzees than in humans, provide insights into the timing of major LINE-1 amplification events during great ape evolution, and identify a Pan-specific LINE-1 subfamily.	Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA	Columbia University	Swergold, GD (corresponding author), Columbia Univ, Dept Med, Div Mol Med, 630 W 168th St, New York, NY 10032 USA.	gs314@columbia.edu			NCI NIH HHS [R21CA87356-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA087356] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arkhipova I, 2000, P NATL ACAD SCI USA, V97, P14473, DOI 10.1073/pnas.97.26.14473; Arnason U, 1996, J MOL EVOL, V43, P650, DOI 10.1007/BF02202113; Bestor TH, 1999, GENETICA, V107, P289, DOI 10.1023/A:1003990818251; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; Burwinkel B, 1998, J MOL BIOL, V277, P513, DOI 10.1006/jmbi.1998.1641; CACCONE A, 1989, EVOLUTION, V43, P925, DOI 10.1111/j.1558-5646.1989.tb02540.x; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; DeBerardinis RJ, 1998, J MOL EVOL, V47, P292, DOI 10.1007/PL00006387; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Drechsler M, 1996, HUM GENET, V98, P297, DOI 10.1007/s004390050210; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kimmel M, 1998, GENETICS, V148, P1921; Kumatori A, 1998, GENOMICS, V53, P123, DOI 10.1006/geno.1998.5510; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ovchinnikov I, 2002, P NATL ACAD SCI USA, V99, P10522, DOI 10.1073/pnas.152346799; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Satta Y, 2000, MOL PHYLOGENET EVOL, V14, P259, DOI 10.1006/mpev.2000.0704; Segal Y, 1999, AM J HUM GENET, V64, P62, DOI 10.1086/302213; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Suminaga R, 2000, J HUM GENET, V45, P331, DOI 10.1007/s100380070003; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Takahata N, 1997, P NATL ACAD SCI USA, V94, P4811, DOI 10.1073/pnas.94.9.4811; Yang ZY, 1998, J BIOL CHEM, V273, P891, DOI 10.1074/jbc.273.2.891; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang XQ, 1998, HUM GENET, V103, P90, DOI 10.1007/s004390050789	43	25	25	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					739	748		10.1086/368275	http://dx.doi.org/10.1086/368275			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12574987	Green Published, Bronze			2022-12-18	WOS:000181152600025
J	Street, VA; Goldy, JD; Golden, AS; Tempel, BL; Bird, TD; Chance, PF				Street, VA; Goldy, JD; Golden, AS; Tempel, BL; Bird, TD; Chance, PF			Mapping of Charcot-Marie-Tooth disease type 1C to chromosome 16p identifies a novel locus for demyelinating neuropathies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY MOTOR; GENE; DUPLICATION; MUTATIONS; PMP-22; PROTEIN-2; LINKAGE; FAMILY	Charcot-Marie-Tooth (CMT) neuropathy represents a genetically heterogeneous group of diseases affecting the peripheral nervous system. We report genetic mapping of the disease to chromosome 16p13.1-p12.3, in two families with autosomal dominant CMT type 1C (CMT1C). Affected individuals in these families manifest characteristic CMT symptoms, including high-arched feet, distal muscle weakness and atrophy, depressed deep-tendon reflexes, sensory impairment, slow nerve conduction velocities, and nerve demyelination. A maximal combined LOD score of 14.25 was obtained with marker D16S500. The combined haplotype analysis in these two families localizes the CMT1C gene within a 9-cM interval flanked by markers D16S519 and D16S764. The disease-linked haplotypes in these two pedigrees are not conserved, suggesting that the gene mutation underlying the disease in each family arose independently. The epithelial membrane protein 2 gene (EMP2), which maps to chromosome 16p13.2, was evaluated as a candidate gene for CMT1C.	Univ Washington, Dept Pediat, Div Genet & Dev, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, VM Bloedel Hearing Res Ctr, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA; Univ Washington, Undergrad Neurobiol Res Program, Seattle, WA 98195 USA; VA Puget Sound Hlth Care Syst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Chance, PF (corresponding author), Univ Washington, Dept Pediat, Div Genet & Dev, Box 356320, Seattle, WA 98195 USA.	pchance@u.washington.edu	Chance, Phillip/AAX-5826-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002739] Funding Source: NIH RePORTER; NIA NIH HHS [AG00057, T32 AG000057] Funding Source: Medline; NICHD NIH HHS [P30 HD002274, HD02274] Funding Source: Medline; NIDCD NIH HHS [DC02739, R01 DC002739] Funding Source: Medline; NINDS NIH HHS [NS38181, R01 NS038181] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Brancolini C, 1999, MOL BIOL CELL, V10, P2441, DOI 10.1091/mbc.10.7.2441; CHANCE PF, 1990, AM J HUM GENET, V47, P915; CHANCE PF, 1992, NEUROLOGY, V42, P2037, DOI 10.1212/WNL.42.10.2037; De Jonghe P, 2001, ANN NEUROL, V49, P245, DOI 10.1002/1531-8249(20010201)49:2<245::AID-ANA45>3.0.CO;2-A; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; KENNEDY WR, 1977, ARCH NEUROL-CHICAGO, V34, P337, DOI 10.1001/archneur.1977.00500180031007; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Liehr T, 1999, GENOMICS, V58, P106, DOI 10.1006/geno.1999.5803; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, MOL MED, V4, P3, DOI 10.1007/BF03401724; LYON G, 1969, ACTA NEUROPATHOL, V13, P131, DOI 10.1007/BF00687025; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; NELIS E, 1994, HUM MOL GENET, V3, P515; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; SKRE H, 1974, CLIN GENET, V6, P98; Taylor V, 1996, GENE, V175, P115, DOI 10.1016/0378-1119(96)00134-5; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Warner LE, 1996, HUM MUTAT, V8, P362, DOI 10.1002/(SICI)1098-1004(1996)8:4<362::AID-HUMU10>3.0.CO;2-0; WISE CA, 1993, AM J HUM GENET, V53, P853; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	36	25	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					244	250		10.1086/337943	http://dx.doi.org/10.1086/337943			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11713717	Green Published, Bronze			2022-12-18	WOS:000172571900022
J	Weber, BL; Punzalan, C; Eisen, A; Lynch, HT; Narod, SA; Garber, JE; Isaacs, C; Daly, MB; Neuhausen, SL; Rebbeck, TR				Weber, BL; Punzalan, C; Eisen, A; Lynch, HT; Narod, SA; Garber, JE; Isaacs, C; Daly, MB; Neuhausen, SL; Rebbeck, TR			Ovarian cancer risk reduction after bilateral prophylactic oophorectomy (BPO) in BRCA1 and BRCA2 mutation carriers.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Penn, Philadelphia, PA 19104 USA; Creighton Univ, Omaha, NE 68178 USA; Womens Coll Hosp, Toronto, ON M5S 1B2, Canada; Dana Farber Canc Inst, Boston, MA 02115 USA; Georgetown Univ, Washington, DC USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Utah, Salt Lake City, UT USA	University of Pennsylvania; Creighton University; University of Toronto; University Toronto Affiliates; Womens College Hospital; Harvard University; Dana-Farber Cancer Institute; Georgetown University; Fox Chase Cancer Center; Utah System of Higher Education; University of Utah			Narod, Steven A/AAA-6112-2022						0	25	26	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		251	59	59						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	355TA					2022-12-18	WOS:000089400700252
J	Ott, J; Hoh, J				Ott, J; Hoh, J			Statistical approaches to gene mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							NONPARAMETRIC LINKAGE ANALYSIS; HAPLOTYPE RELATIVE RISK; REGIONAL INFERENCE; COMPLEX DISEASE; DISEQUILIBRIUM; ASSOCIATION; POWER; TESTS; INHERITANCE; PATTERNS		Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA	Rockefeller University	Ott, J (corresponding author), Rockefeller Univ, Lab Stat Genet, 1230 York Ave,Box 192, New York, NY 10021 USA.				NHGRI NIH HHS [R01 HG000008, HG00008] Funding Source: Medline; NIMH NIH HHS [MH44292, R37 MH044292, R01 MH044292] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH044292, R01MH044292] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Cordell HJ, 2000, AM J HUM GENET, V66, P1273, DOI 10.1086/302847; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Getz G, 2000, PHYSICA A, V279, P457, DOI 10.1016/S0378-4371(99)00524-5; Goldin LR, 1997, GENET EPIDEMIOL, V14, P785, DOI 10.1002/(SICI)1098-2272(1997)14:6<785::AID-GEPI37>3.0.CO;2-K; Goldin LR, 1999, GENET EPIDEMIOL, V17, P157, DOI 10.1002/(SICI)1098-2272(1999)17:3<157::AID-GEPI1>3.0.CO;2-P; Gordon D, 2000, GENOMICS, V66, P87, DOI 10.1006/geno.2000.6190; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HASTIE T, 2000, GENE SHAVING NEW CLA; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Heath SC, 1998, HUM HERED, V48, P1, DOI 10.1159/000022775; HOH J, IN PRESS ANN HUM GEN; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Lucek P, 1998, HUM HERED, V48, P275, DOI 10.1159/000022816; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J, 2000, P NATL ACAD SCI USA, V97, P2, DOI 10.1073/pnas.97.1.2; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Ott J, 1999, ANAL HUMAN GENETIC L; Plasilova M, 1998, HUM HERED, V48, P30; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Spielman RS, 1996, AM J HUM GENET, V59, P983; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129	43	25	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					289	294		10.1086/303031	http://dx.doi.org/10.1086/303031			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10884361	Bronze, Green Published			2022-12-18	WOS:000089357800005
J	Betard, C; Rasquin-Weber, A; Brewer, C; Drouin, E; Clark, S; Verner, A; Darmond-Zwaig, C; Fortin, J; Mercier, J; Chagnon, P; Fujiwara, TM; Morgan, K; Richter, A; Hudson, TJ; Mitchell, GA				Betard, C; Rasquin-Weber, A; Brewer, C; Drouin, E; Clark, S; Verner, A; Darmond-Zwaig, C; Fortin, J; Mercier, J; Chagnon, P; Fujiwara, TM; Morgan, K; Richter, A; Hudson, TJ; Mitchell, GA			Localization of a recessive gene for North American Indian childhood cirrhosis to chromosome region 16q22 - and identification of a shared haplotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; MULTILOCUS LINKAGE ANALYSIS; CANADIAN OJI-CREE; HUMAN GENOME; DISEASE; COMPUTATIONS; TRANSPORTER; MUTATIONS; CHILDREN	North American Indian childhood cirrhosis (NAIC, or CIRH1A) is an isolated nonsyndromic form of familial cholestasis reported in Ojibway-Cree children and young adults in northwestern Quebec. The pattern of transmission is consistent with an autosomal recessive mode of inheritance. To map the NAIC locus, we performed a genomewide scan on three DNA pools of samples from 13 patients, 16 unaffected siblings, and 22 parents from five families. Analysis of 333 highly polymorphic markers revealed 3 markers with apparent excess allele sharing among affected individuals. Additional mapping identified a chromosome 16q segment shared by all affected individuals. When the program FASTLINK/LINKAGE was used and a completely penetrant autosomal recessive mode of inheritance was assumed, a maximum LOD score of 4.44 was observed for a recombination fraction of 0, with marker D16S3067. A five-marker haplotype (D16S3067, D16S752, D16S2624, D16S3025, and D16S3106) spanning 4.9 cM was shared by all patients. These results provide significant evidence of linkage for a candidate gene on chromosome 16q22.	Univ Montreal, Hop St Justine, Dept Pediat, Serv Genet Med, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Hop St Justine, Dept Pediat, Gastroenterol Serv, Montreal, PQ H3T 1C5, Canada; Montreal Gen Hosp, Res Inst, Montreal Genome Ctr, Montreal, PQ, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University; McGill University; McGill University	Hudson, TJ (corresponding author), Univ Montreal, Hop St Justine, Dept Pediat, Serv Genet Med, Room 7615,3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.							Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; Birt A R, 1975, Int J Dermatol, V14, P105, DOI 10.1111/j.1365-4362.1975.tb01425.x; BLACK DN, 1988, ANN NEUROL, V24, P490, DOI 10.1002/ana.410240403; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Camacho JA, 1999, NAT GENET, V22, P151, DOI 10.1038/9658; CLAYTON RJ, 1969, AM J DIS CHILD, V117, P112, DOI 10.1001/archpedi.1969.02100030114014; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; GRAY OP, 1966, ARCH DIS CHILD, V41, P320, DOI 10.1136/adc.41.217.320; GREENBERG CR, 1995, HUM MOL GENET, V4, P493, DOI 10.1093/hmg/4.3.493; HAWORTH JC, 1991, J PEDIATR-US, V118, P52, DOI 10.1016/S0022-3476(05)81843-8; Hegele RA, 1998, CLIN GENET, V54, P394; Hegele RA, 1999, J HUM GENET, V44, P10, DOI 10.1007/s100380050097; IVES EJ, 1980, AM J MED GENET, V7, P351, DOI 10.1002/ajmg.1320070317; Kocak N, 1997, J PEDIATR GASTR NUTR, V24, P44, DOI 10.1097/00005176-199701000-00011; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LOWDEN JA, 1978, AM J HUM GENET, V30, P38; McMillan AlanD., 1995, NATIVE PEOPLES CULTU; Naveh Y, 1997, J PEDIATR GASTR NUTR, V24, P548, DOI 10.1097/00005176-199705000-00011; NIELSEN IM, 1986, ACTA PAEDIATR SCAND, V75, P1010, DOI 10.1111/j.1651-2227.1986.tb10332.x; Richter A, 1999, AM J HUM GENET, V64, P768, DOI 10.1086/302274; ROBINSON BH, 1984, AM J HUM GENET, V36, P283; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Sheffield VC, 1998, TRENDS GENET, V14, P391, DOI 10.1016/S0168-9525(98)01556-X; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Toussaint W, 1966, Dtsch Z Verdau Stoffwechselkr, V26, P23; WEBER AM, 1981, GASTROENTEROLOGY, V81, P653; WELLER T, 1996, AM J HUM GENET, V59, P872; WILLIAMS CN, 1972, J PEDIATR-US, V81, P493, DOI 10.1016/S0022-3476(72)80175-6	36	25	26	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					222	228		10.1086/302993	http://dx.doi.org/10.1086/302993			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10820129	Bronze, Green Published			2022-12-18	WOS:000088926900025
J	Reyniers, E; Van Bogaert, P; Peeters, N; Vits, L; Pauly, F; Fransen, E; Van Regemorter, N; Kooy, RF				Reyniers, E; Van Bogaert, P; Peeters, N; Vits, L; Pauly, F; Fransen, E; Van Regemorter, N; Kooy, RF			A new neurological syndrome with mental retardation, choreoathetosis, and abnormal behavior maps to chromosome Xp11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERIODIC PARALYSIS; DEFICIENT MICE; CHANNEL GENE; X-CHROMOSOME; SYNAPSIN-I; SYNAPTOPHYSIN; MUTATIONS	Choreoathetosis is a major clinical feature in only a small number of hereditary neurological disorders. We define a new X-linked syndrome with a unique clinical picture characterized by mild mental retardation, choreoathetosis, and abnormal behavior. We mapped the disease in a four-generation pedigree to chromosome Xp11 by linkage analysis and defined a candidate region containing a number of genes possibly involved in neuronal signaling, including a potassium channel gene and a neuronal G protein-coupled receptor.	Univ Instelling Antwerp, Dept Med Genet, B-2610 Wilrijk, Belgium; ULB, Hop Erasme, Brussels, Belgium; Ctr Hosp Luxembourg, Luxembourg, Luxembourg	University of Antwerp; Universite Libre de Bruxelles; Luxembourg Hospital Center	Kooy, RF (corresponding author), Univ Instelling Antwerp, Dept Med Genet, Univ Pl 1, B-2610 Wilrijk, Belgium.		Kooy, Frank/F-5276-2014; Fransen, Erik/C-4102-2015	Kooy, Frank/0000-0003-2024-0485; Fransen, Erik/0000-0001-7785-4790				Bienvenu T, 1998, HUM MOL GENET, V7, P1311, DOI 10.1093/hmg/7.8.1311; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BLUM K, 1997, HDB PSYCHIAT GENETIC; Bokoch GM, 1996, FASEB J, V10, P1290, DOI 10.1096/fasebj.10.11.8836042; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Engle SJ, 1996, HUM MOL GENET, V5, P1607, DOI 10.1093/hmg/5.10.1607; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Fisher SE, 1997, GENOMICS, V45, P340, DOI 10.1006/geno.1997.4941; JURKATROTT K, 1994, HUM MOL GENET, V3, P1415, DOI 10.1093/hmg/3.8.1415; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lubs H, 1999, AM J MED GENET, V83, P237, DOI 10.1002/(SICI)1096-8628(19990402)83:4<237::AID-AJMG2>3.3.CO;2-#; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; Martinez F, 1998, J MED GENET, V35, P284, DOI 10.1136/jmg.35.4.284; NYHAN WL, 1967, PEDIATR RES, V1, P5, DOI 10.1203/00006450-196701000-00001; OZCELIK T, 1990, AM J HUM GENET, V47, P551; PETTIGREW AL, 1991, AM J MED GENET, V38, P200, DOI 10.1002/ajmg.1320380206; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; ROSSITER BJF, 1991, MOL GENETIC APPROACH; SCHIMKE RN, 1984, AM J MED GENET, V17, P323, DOI 10.1002/ajmg.1320170125; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; SUTHERLAND GR, 1988, AM J MED GENET, V30, P493, DOI 10.1002/ajmg.1320300152; YANGFENG TL, 1986, P NATL ACAD SCI USA, V83, P8679, DOI 10.1073/pnas.83.22.8679	27	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1406	1412		10.1086/302638	http://dx.doi.org/10.1086/302638			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	252YZ	10521307	Green Published, Bronze			2022-12-18	WOS:000083531000023
J	Cooper, G; Amos, W; Bellamy, R; Siddiqui, MR; Frodsham, A; Hill, AVS; Rubinsztein, DC				Cooper, G; Amos, W; Bellamy, R; Siddiqui, MR; Frodsham, A; Hill, AVS; Rubinsztein, DC			An Empirical exploration of the (delta mu)(2) genetic distance for 213 human microsatellite markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RANGE CONSTRAINTS; POPULATION; MUTATION; EVOLUTION; BIAS; DIFFERENTIATION; DIRECTIONALITY; RECONSTRUCTION; POLYMORPHISMS; VARIABILITY	Microsatellites are now used ubiquitously as genetic markers. One important application is to the assessment of population subdivision and phylogenetic relatedness. Such applications require a method of estimation of genetic distance. Here we examine the most widely used measure of microsatellite genetic distance, Goldstein et al.'s delta-mu squared ([delta mu](2)), with respect to a large data set of 213 markers typed across samples from four diverse human populations. We find that (delta mu)(2) yields plausible interpopulation distances. For the first time, we report significant interpopulation differences in mean microsatellite length, although the effect of these differences on (delta mu)(2) is negligible. However, we also show that the method is extremely sensitive to one or two loci that contribute extreme values, even when a sample size of >200 loci is used. Some of these extreme loci can be removed on the grounds that some alleles carry large indels, but for others there is no clear justification for exclusion a priori. Our data suggest a rather recent African/non-African split, with an upper limit of some 70,000-80,000 years ago.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics	Amos, W (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.		HILL, Adrian V>S>/C-1306-2008; Rubinsztein, David C/C-3472-2011	Siddiqui, Ruby/0000-0002-9638-594X; Talbot, Angela/0000-0002-0386-8070	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLSOPP CEM, 1992, AM J HUM GENET, V50, P411; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Cavalli-Sforza LL, 1992, HIST GEOGRAPHY HUMAN; Coltman DW, 1998, P ROY SOC B-BIOL SCI, V265, P803, DOI 10.1098/rspb.1998.0363; Cooper G, 1998, HUM MOL GENET, V7, P1425, DOI 10.1093/hmg/7.9.1425; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Crawford AM, 1998, J MOL EVOL, V46, P256, DOI 10.1007/PL00006301; ELLEGREN H, 1995, NAT GENET, V11, P360, DOI 10.1038/ng1295-360; Feldman MW, 1997, GENETICS, V145, P207; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Goodman SJ, 1998, MOL BIOL EVOL, V15, P104, DOI 10.1093/oxfordjournals.molbev.a025907; Kimmel M, 1996, GENETICS, V143, P549; Nei M, 1996, MOL BIOL EVOL, V13, P170, DOI 10.1093/oxfordjournals.molbev.a025553; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pollock DD, 1998, THEOR POPUL BIOL, V53, P256, DOI 10.1006/tpbi.1998.1363; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; RUBINSZTEIN DC, 1995, NAT GENET, V10, P337, DOI 10.1038/ng0795-337; Rubinsztein DC, 1995, GENOMICS, V30, P610, DOI 10.1006/geno.1995.1285; SLATKIN M, 1995, GENETICS, V139, P457; Sokal R. R., 1995, BIOMETRY PRINCIPLES; Takezaki N, 1996, GENETICS, V144, P389; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEISS KM, 1973, AM ANTIQUITY, V38, P1; ZHIVOTOVSKY LA, 1995, P NATL ACAD SCI USA, V92, P11549, DOI 10.1073/pnas.92.25.11549	27	25	26	1	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1125	1133		10.1086/302574	http://dx.doi.org/10.1086/302574			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486332	Bronze, Green Published			2022-12-18	WOS:000082910000022
J	Schwartzman, JS; Zatz, M; Vasques, LD; Gomes, RR; Koiffmann, CP; Fridman, C; Otto, PG				Schwartzman, JS; Zatz, M; Vasques, LD; Gomes, RR; Koiffmann, CP; Fridman, C; Otto, PG			Rett syndrome in a boy with a 47,XXY karyotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							X-CHROMOSOME-INACTIVATION; ANGELMAN SYNDROME; GENE; MUTATIONS; MALES; PHENOTYPE; TRANSLOCATION; METHYLATION; INHERITANCE; PATTERNS		Univ Sao Paulo, Inst Biociencias, Dept Biol, Ctr Estud Genoma Humano, BR-05508900 Sao Paulo, Brazil; Univ Mackenzie, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Presbiteriana Mackenzie	Zatz, M (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Biol, Ctr Estud Genoma Humano, BR-05508900 Sao Paulo, Brazil.		KOIFFMANN, CELIA/F-9828-2012; Fridman, Cintia/E-2657-2013; Fridman, Cintia/G-1837-2012; Zatz, Mayana/M-5338-2015; Vasques, Luciana/C-7273-2012	Fridman, Cintia/0000-0003-2430-4888; Zatz, Mayana/0000-0003-3970-8025; Vasques, Luciana/0000-0003-2229-6773				ALEMBIK Y, 1995, GENET COUNSEL, V6, P207; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ARCHIDIACONO N, 1991, HUM GENET, V86, P604; Camus P, 1996, HUM GENET, V97, P247, DOI 10.1007/BF02265275; CHRISTEN HJ, 1995, NEUROPEDIATRICS, V26, P81, DOI 10.1055/s-2007-979729; COLEMAN M, 1990, BRAIN DEV-JPN, V12, P31, DOI 10.1016/S0387-7604(12)80171-9; CorreaCerro LS, 1997, J MED GENET, V34, P161, DOI 10.1136/jmg.34.2.161; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; EASTHAUGH P, 1996, WORLD C RETT SYNDR G; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EEGOLOFSSON O, 1990, BRAIN DEV-JPN, V12, P529, DOI 10.1016/S0387-7604(12)80221-X; ELLISON KA, 1993, AM J MED GENET, V47, P1124, DOI 10.1002/ajmg.1320470736; Glenn CC, 1996, AM J HUM GENET, V58, P335; HAGBERG B, 1995, ACTA PAEDIATR, V84, P971, DOI 10.1111/j.1651-2227.1995.tb13809.x; HERDER GA, 1996, WORLD C RETT SYNDR G; JOURNEL H, 1990, AM J MED GENET, V35, P142, DOI 10.1002/ajmg.1320350130; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KORMANNBORTOLOTTO MH, 1992, CLIN GENET, V42, P296; Krepischi ACV, 1998, HUM GENET, V102, P319; LORDASANCHEZ I, 1992, HUM GENET, V89, P524; MARTINHO PS, 1990, HUM GENET, V86, P131; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; MIGEON BR, 1995, AM J HUM GENET, V56, P647; Naumova AK, 1996, AM J HUM GENET, V58, P1111; PEGORARO E, 1994, AM J HUM GENET, V54, P989; PHILIP N, 1988, J MED GENET, V25, P857, DOI 10.1136/jmg.25.12.857; PHILIPPART M, 1990, BRAIN DEV-JPN, V12, P33, DOI 10.1016/S0387-7604(12)80172-0; RICCARDI VM, 1986, AM J MED GENET, V24, P389; Schanen C, 1998, AM J HUM GENET, V63, P267, DOI 10.1086/301932; SCHMIDT M, 1992, AM J MED GENET, V42, P161, DOI 10.1002/ajmg.1320420205; SEABRIGH.M, 1971, LANCET, V2, P971; Sirianni N, 1998, AM J HUM GENET, V63, P1552, DOI 10.1086/302105; Sumita DR, 1998, AM J MED GENET, V80, P356, DOI 10.1002/(SICI)1096-8628(19981204)80:4<356::AID-AJMG10>3.3.CO;2-F; Thomas GH, 1996, AM J HUM GENET, V58, P1364; TOPCU M, 1991, BRAIN DEV-JPN, V13, P62, DOI 10.1016/S0387-7604(12)80303-2; TREVATHAN E, 1988, J CHILD NEUROL S, V3, P6; Vorsanova SG, 1996, NEUROREPORT, V8, P187, DOI 10.1097/00001756-199612200-00038; WAHLSTROM J, 1996, WORLD C RETT SYDNR G; Webb T, 1996, CLIN GENET, V49, P189; WEBB T, 1993, CLIN GENET, V44, P236; Wolff DJ, 1998, AM J MED GENET, V77, P401, DOI 10.1002/(SICI)1096-8628(19980605)77:5<401::AID-AJMG9>3.0.CO;2-P; Xiang FQ, 1998, J MED GENET, V35, P297, DOI 10.1136/jmg.35.4.297; ZOGHBI HY, 1990, BRAIN DEV-JPN, V12, P131, DOI 10.1016/S0387-7604(12)80194-X	43	25	25	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1781	1785		10.1086/302424	http://dx.doi.org/10.1086/302424			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330367	Bronze, Green Published			2022-12-18	WOS:000080696200032
J	Plenge, RM; Tranebjaerg, L; Jensen, PKA; Schwartz, C; Willard, HF				Plenge, RM; Tranebjaerg, L; Jensen, PKA; Schwartz, C; Willard, HF			Evidence that mutations in the X-linked DDP gene cause incompletely penetrant and variable skewed X inactivation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE DEAFNESS SYNDROME; CHROMOSOME-INACTIVATION; LINKAGE ANALYSIS; MENTAL DEFICIENCY; LARGE FAMILY; EXPRESSION; SELECTION; PHENOTYPE; BLINDNESS; PATTERNS	X chromosome inactivation results in the random transcriptional silencing of one of the two X chromosomes early in female development. After random inactivation, certain deleterious X-linked mutations can create a selective disadvantage for cells in which the mutation is on the active X chromosome, leading to X inactivation patterns with the mutation on the inactive X chromosome in nearly 100% of the individual's cells. In contrast to the homogeneous patterns of complete skewed inactivation noted for many X-linked disorders, here we describe a family segregating a mutation in the dystonia-deafness peptide (DDP) gene, in which female carriers show incompletely penetrant and variable X inactivation patterns in peripheral blood leukocytes, ranging between 50:50 and >95:5. To address the genetic basis for the unusual pattern of skewing in this family, we first mapped the locus responsible for the variable skewing to the proximal long arm (Xq12-q22) of the X chromosome (Z = 5.7, P =.002, LOD score 3.57), a region that includes both the DDP and the XIST genes. Examination of multiple cell types from women carrying a DDP mutation and of peripheral blood leukocytes from women from two unrelated families who carry different mutations in the DDP gene suggests that the skewed X inactivation is the result of selection against cells containing the mutant DDP gene on the active X chromosome, although skewing is apparently not as severe as that seen for many other deleterious X-linked mutations. Thus, DDP is an example of an X-linked gene for which mutations cause partial cell selection and thus incompletely skewed X inactivation in peripheral blood leukocytes.	Case Western Reserve Univ, Sch Med, Dept Genet, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Tromso Hosp, Dept Med Genet, N-9012 Tromso, Norway; Univ Aarhus, Dept Clin Genet, Aarhus, Denmark; Greenwood Genet Ctr, JC Self Res Inst, Greenwood, SC 29646 USA	Case Western Reserve University; University Hospitals of Cleveland; UiT The Arctic University of Tromso; University Hospital of North Norway; Aarhus University; Greenwood Genetic Center	Willard, HF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Ctr Human Genet, 2109 Adelbert Rd, Cleveland, OH 44106 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045441] Funding Source: NIH RePORTER; NICHD NIH HHS [HD26202] Funding Source: Medline; NIGMS NIH HHS [GM45441] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abkowitz JL, 1998, P NATL ACAD SCI USA, V95, P3862, DOI 10.1073/pnas.95.7.3862; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; BELMONT JW, 1995, TRENDS GENET, V11, P112, DOI 10.1016/S0168-9525(00)89012-5; Belmont JW, 1996, AM J HUM GENET, V58, P1101; Blair HJ, 1998, HUM MOL GENET, V7, P549, DOI 10.1093/hmg/7.3.549; Brown CJ, 1997, AM J HUM GENET, V60, P1333, DOI 10.1086/515488; Busque L, 1996, BLOOD, V88, P59; Carrel L, 1998, NAT GENET, V19, P211, DOI 10.1038/878; CATTANACH BM, 1967, GENETICS, V57, P331; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Devriendt K, 1997, AM J HUM GENET, V60, P581; deVries BBA, 1996, AM J HUM GENET, V58, P1025; FEY MF, 1994, BLOOD, V83, P931; Filosa S, 1996, AM J HUM GENET, V59, P887; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; JENSEN PKA, 1981, AM J MED GENET, V9, P55; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; JOHNSTON PG, 1981, GENET RES, V37, P151, DOI 10.1017/S0016672300020127; KRIETSCH WKG, 1986, DIFFERENTIATION, V31, P50, DOI 10.1111/j.1432-0436.1986.tb00382.x; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; LUZZATTO L, 1979, SCIENCE, V205, P1418, DOI 10.1126/science.472761; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1998, CELL, V92, P657, DOI 10.1016/S0092-8674(00)81133-2; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; Naumova AK, 1996, AM J HUM GENET, V58, P1111; Orstavik KH, 1996, AM J MED GENET, V64, P31, DOI 10.1002/(SICI)1096-8628(19960712)64:1<31::AID-AJMG4>3.0.CO;2-U; Orstavik KH, 1998, AM J HUM GENET, V63, P1457, DOI 10.1086/302095; Parolini O, 1998, NEW ENGL J MED, V338, P291, DOI 10.1056/NEJM199801293380504; Parrish JE, 1996, HUM MOL GENET, V5, P1777, DOI 10.1093/hmg/5.11.1777; Pegoraro E, 1997, AM J HUM GENET, V61, P160, DOI 10.1086/513901; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380611; REISS AL, 1995, NAT GENET, V11, P331, DOI 10.1038/ng1195-331; TRANEBJAERG L, 1995, J MED GENET, V32, P257, DOI 10.1136/jmg.32.4.257; Willard H, 1995, METABOLIC MOL BASES, P719	41	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					759	767		10.1086/302286	http://dx.doi.org/10.1086/302286			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053010	Bronze, Green Published			2022-12-18	WOS:000079204700013
J	Huang, CH; Cheng, GJ; Reid, ME; Chen, Y				Huang, CH; Cheng, GJ; Reid, ME; Chen, Y			Rh-mod syndrome: A family study of the translation-initiator mutation in the Rh50 glycoprotein gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR-CLONING; DEFICIENCY SYNDROME; PROTEIN; EXPRESSION; MEMBRANE; POLYPEPTIDE; ANTIGENS; ANTIBODY	Rh-mod syndrome is a rare genetic disorder thought to result from mutations at a "modifier" but not at the suppressor underlying the regulator type of Rh-null disease. We studied this disorder in a Jewish family with a consanguineous background and analyzed RH and RHAG, the two loci that control Rh-antigen expression and Rh-complex assembly. Despite the presence of a d (D-negative) haplotype, no other gross alteration was found at RH, and cDNA sequencing showed a normal structure for D, Ce, and ce Rh transcripts in family members. However, analysis of RHAG transcript, which encodes Rh50 glycoprotein, identified a single G-->T transversion in the initiation codon, causing a missense amino acid change (ATG[Met]-->ATT[Ile]). This point mutation also occurred in the genomic region spanning exon 1 of RHAG, and its genotypic status in the mother and two children was confirmed by analysis of single-strand conformation polymorphism. Although blood typing showed a very weak expression of Rh antigens, immunoblotting barely detected the Rh proteins in the Rh-mod membrane. In vitro transcription-coupled translation assays showed that the initiator mutants of Rh-mod-but not those of the wild type-could be translated from ATG codons downstream, Our findings point to incomplete penetrance of the Rh-mod mutation, in the form of "leaky" translation, leading to some posttranslational defects affecting the structure, interaction, and processing of Rh50 glycoprotein.	New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Biochem & Mol Genet, New York, NY 10021 USA; New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Immunochem, New York, NY 10021 USA	New York Blood Center; New York Blood Center	Huang, CH (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Biochem & Mol Genet, New York, NY 10021 USA.	chuang@nybc.org		Cheng, Guangjie/0000-0002-9368-379X	NHLBI NIH HHS [HL54459] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054459] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGRE P, 1991, BLOOD, V78, P551, DOI 10.1182/blood.V78.3.551.bloodjournal783551; Agre P, 1991, Baillieres Clin Haematol, V4, P793, DOI 10.1016/S0950-3536(06)80031-4; ANSTEE DJ, 1993, BAILLIERE CLIN HAEM, V6, P401, DOI 10.1016/S0950-3536(05)80152-0; Apoil PA, 1997, BRIT J HAEMATOL, V98, P365, DOI 10.1046/j.1365-2141.1997.2183041.x; ARCE MA, 1993, BLOOD, V82, P651; AVENT ND, 1990, BIOCHEM J, V271, P821, DOI 10.1042/bj2710821; Basseres DS, 1998, BLOOD, V91, P368, DOI 10.1182/blood.V91.1.368.368_368_369; BAYSAL E, 1995, HEMOGLOBIN, V19, P213, DOI 10.3109/03630269509036943; Carritt B, 1997, HUM MOL GENET, V6, P843, DOI 10.1093/hmg/6.6.843; CARTRON JP, 1995, BLOOD CEL B, V6, P189; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cherif-Zahar B, 1998, BLOOD, V92, P639, DOI 10.1182/blood.V92.2.639.414k28_639_646; CHERIFZAHAR B, 1990, P NATL ACAD SCI USA, V87, P6243, DOI 10.1073/pnas.87.16.6243; CherifZahar B, 1996, NAT GENET, V12, P168, DOI 10.1038/ng0296-168; CHOWN B, 1972, AM J HUM GENET, V24, P623; DEEN PMT, 1995, J CLIN INVEST, V95, P2291, DOI 10.1172/JCI117920; EYERS SAC, 1994, J BIOL CHEM, V269, P6417; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Goossens M, 1981, Methods Enzymol, V76, P805; Hermand P, 1996, BLOOD, V87, P2962, DOI 10.1182/blood.V87.7.2962.bloodjournal8772962; Huang C H, 1997, Curr Opin Hematol, V4, P94; Huang CH, 1998, BLOOD, V92, P1776, DOI 10.1182/blood.V92.5.1776.417k25_1776_1784; Huang CH, 1996, AM J HUM GENET, V58, P133; Huang CH, 1998, J BIOL CHEM, V273, P2207, DOI 10.1074/jbc.273.4.2207; Huang CH, 1998, BLOOD, V92, P664, DOI 10.1182/blood.V92.2.664.414k27_664_671; Huang CH, 1996, BLOOD, V88, P2326, DOI 10.1182/blood.V88.6.2326.bloodjournal8862326; Hyland CA, 1998, BLOOD, V91, P1458, DOI 10.1182/blood.V91.4.1458; Iwamoto S, 1998, BIOCHEM BIOPH RES CO, V243, P233, DOI 10.1006/bbrc.1997.8023; Kawano M, 1998, ANN HUM GENET, V62, P107, DOI 10.1046/j.1469-1809.1998.6220107.x; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEVANKIM C, 1992, P NATL ACAD SCI USA, V89, P10925, DOI 10.1073/pnas.89.22.10925; Lida Y, 1996, NUCLEIC ACIDS RES, V24, P3313, DOI 10.1093/nar/24.17.3313; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; MALLINSON G, 1990, TRANSFUSION, V30, P222, DOI 10.1046/j.1537-2995.1990.30390194341.x; McGuire D, 1976, Vox Sang, V30, P430; NASH R, 1987, AM J HEMATOL, V24, P267, DOI 10.1002/ajh.2830240306; Race RR., 1975, BLOOD GROUPS MAN; RIDGWELL K, 1992, BIOCHEM J, V287, P223, DOI 10.1042/bj2870223; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; Tippett P, 1990, Transfus Med Rev, V4, P56, DOI 10.1016/S0887-7963(90)70248-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VENEZIA ND, 1992, J CLIN INVEST, V90, P1713, DOI 10.1172/JCI116044; VOS GH, 1961, LANCET, V1, P14	43	25	26	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					108	117		10.1086/302215	http://dx.doi.org/10.1086/302215			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915949	Green Published, Bronze			2022-12-18	WOS:000078477400015
J	Suzuki, K; Bustos, T; Spritz, RA				Suzuki, K; Bustos, T; Spritz, RA			Linkage disequilibrium mapping of the gene for Margarita Island ectodermal dysplasia (ED4) to 11q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLEFT-LIP; MENTAL-RETARDATION; DNA; PALATE; LOCUS; POPULATION; MAPS	Margarita Island ectodermal dysplasia (ED4) is an autosomal recessive disorder characterized by unusual facies, dental anomalies, hypotrichosis, palmoplantar hyperkeratosis and onychodysplasia, syndactyly, and cleft lip/cleft palate. We have used an affected-only DNA-pooling strategy to carry out linkage disequilibrium mapping of the ED4 gene to 11q23. Haplotype analysis of four complex Margarita Island ED4 families localized the ED4 gene to an similar to 1-2-Mb interval spanned by just two YACs.	Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; Cent Univ Venezuela, Ctr Nacl Genet Humana & Expt, Caracas, Venezuela	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Central Venezuela	Spritz, RA (corresponding author), Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, 4200 E 9th Ave,Campus Box B161, Denver, CO 80262 USA.							BUSTOS T, 1991, AM J MED GENET, V41, P398, DOI 10.1002/ajmg.1320410403; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; FREIREMAIA N, 1987, REV BRAS GENET, V10, P403; FREIREMAIA N, 1984, ECTODERMAL DYSPLASIS, P189; GORLIN RJ, 1970, Z KINDERHEILKD, V108, P1, DOI 10.1007/BF00440560; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; OGUR G, 1988, J MED GENET, V25, P37, DOI 10.1136/jmg.25.1.37; RODINI ESO, 1990, AM J MED GENET, V36, P473, DOI 10.1002/ajmg.1320360420; Scott DA, 1996, AM J HUM GENET, V59, P385; Sheffield VC, 1996, NAT GENET, V12, P424, DOI 10.1038/ng0496-424; SMITH CAB, 1953, J R STAT SOC B, V15, P153; WILDENBERG SC, 1995, AM J HUM GENET, V57, P755; ZLOTOGORA J, 1988, J MED GENET, V25, P503, DOI 10.1136/jmg.25.7.503; ZLOTOGORA J, 1994, J MED GENET, V31, P957, DOI 10.1136/jmg.31.12.957; ZLOTOGORA J, 1987, J MED GENET, V24, P291, DOI 10.1136/jmg.24.5.291	16	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1102	1107		10.1086/302072	http://dx.doi.org/10.1086/302072			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758630	Green Published, Bronze			2022-12-18	WOS:000076577800024
J	Moynihan, LM; Bundey, SE; Heath, D; Jones, EL; McHale, DP; Mueller, RF; Markham, AF; Lench, NJ				Moynihan, LM; Bundey, SE; Heath, D; Jones, EL; McHale, DP; Mueller, RF; Markham, AF; Lench, NJ			Autozygosity mapping, to chromosome 11q25, of a rare autosomal recessive syndrome causing histiocytosis, joint contractures, and sensorineural deafness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; LINKAGE; MAP	We describe a highly consanguineous family, originating from Pakistan, displaying histiocytosis, joint contractures, and sensorineural deafness. The form of histiocytosis exhibited by this family does not fit readily into any of the recognized classes of this disease. It appears to represent a novel form of familial histiocytosis demonstrating autosomal recessive inheritance. Using autozygosity mapping, we have identified a homozygous region of similar to 1 cM at chromosome 11q25, in affected individuals. A maximum two-point LOD score of 3.42 (recombination fraction theta = .00) was obtained with marker D11S968. This is the first genetic locus to be described that is involved in the molecular pathogenesis of histiocytosis.	St James Univ Hosp, Mol Med Unit, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, Mol Med Unit, Leeds, W Yorkshire, England; Birmingham Womens Hosp, Dept Clin Genet, Birmingham, W Midlands, England; Univ Birmingham, Dept Pathol, Birmingham, W Midlands, England; Queen Elizabeth Hosp, Dept Med, Birmingham B15 2TH, W Midlands, England	Saint James's University Hospital; University of Leeds; University of Leeds; Birmingham Women's Hospital; University of Birmingham; University of Birmingham	Lench, NJ (corresponding author), St James Univ Hosp, Mol Med Unit, Dept Clin Genet, Clin Sci Bldg, Leeds LS9 7TF, W Yorkshire, England.	desnl@stjames.leeds.ac.uk	Lench, Nicholas/AAB-1791-2021	Lench, Nicholas/0000-0002-6108-0759	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CLINE MJ, 1994, BLOOD, V84, P2840; CODLING BW, 1972, BRIT J OPHTHALMOL, V56, P517, DOI 10.1136/bjo.56.7.517; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EGELER RM, 1995, J PEDIATR-US, V127, P1, DOI 10.1016/S0022-3476(95)70248-2; FAVARA BE, 1987, LANCET, V1, P208; Jacobsen P, 1973, HUM HERED, V23, P368; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OTT J, 1974, AM J HUM GENET, V26, P773; Pivnick EK, 1996, J MED GENET, V33, P772, DOI 10.1136/jmg.33.9.772; PRITCHARD J, 1994, BRIT J CANCER, V70, pS1; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; ROSAI J, 1969, ARCH PATHOL, V87, P63; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; WATKINS WS, 1994, AM J HUM GENET, V55, P348	15	25	25	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1123	1128		10.1086/301824	http://dx.doi.org/10.1086/301824			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545394	Bronze, Green Published			2022-12-18	WOS:000073487000018
J	Gregersen, PK				Gregersen, PK			Instant recognition: The genetics of pitch perception	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							ABSOLUTE-PITCH; POSSESSORS		NYU, N Shore Univ Hosp, Sch Med, Div Biol & Human Genet, Manhasset, NY 11030 USA	New York University; Northwell Health; North Shore University Hospital	Gregersen, PK (corresponding author), NYU, N Shore Univ Hosp, Sch Med, Div Biol & Human Genet, 350 Community Dr, Manhasset, NY 11030 USA.							Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Gregersen Peter K., 1996, American Journal of Human Genetics, V59, pA179; Gregersen PK, 1997, AM J HUM GENET, V61, pA399; MIYAZAKI K, 1988, PERCEPT PSYCHOPHYS, V44, P501, DOI 10.3758/BF03207484; PROFITA J, 1988, AM J MED GENET, V29, P763, DOI 10.1002/ajmg.1320290405; Rasch R., 1982, PSYCHOL MUSIC, P1; Risset J, 1982, PSYCHOL MUSIC, P26; SACKS O, 1995, SCIENCE, V268, P621, DOI 10.1126/science.7732360; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Smalley SL, 1997, AM J HUM GENET, V60, P1276, DOI 10.1086/515485; TAKEUCHI AH, 1991, MUSIC PERCEPT, V9, P27; Ward W.D., 1982, PSYCHOL MUSIC, V2nd ed., P431; YOON CK, 1997, J NIH RES, V9, P25; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1989, MEM COGNITION, V17, P582, DOI 10.3758/BF03197081	16	25	25	0	7	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					221	223		10.1086/301734	http://dx.doi.org/10.1086/301734			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	ZA927	9463341	Bronze, Green Published			2022-12-18	WOS:000072416000003
J	Akarsu, AN; Ozbas, F; Kostakoglu, N				Akarsu, AN; Ozbas, F; Kostakoglu, N			Mapping of the second locus of postaxial polydactyly type A (PAP-A2) to chromosome 13q21-q32.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									TUBITAK, DNA Cell Bank & Gene Res Lab, Ankara, Turkey; Hacettepe Univ, Dept Plast & Reconstruct Surg, Ankara, Turkey	Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Hacettepe University			Akarsu, Nurten/E-9758-2013; GERCEKER, FILIZ OZBAS/N-1010-2018	Akarsu, Nurten/0000-0001-5432-0032; GERCEKER, FILIZ OZBAS/0000-0003-1243-5880					0	25	27	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4		S		1542	A265	A265						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YQ995					2022-12-18	WOS:000071446001543
J	Bandelt, HJ; Forster, P				Bandelt, HJ; Forster, P			The myth of bumpy Hunter-Gatherer mismatch distributions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HUMAN MITOCHONDRIAL-DNA; MTDNA-SEQUENCE DIVERSITY; CONTROL-REGION SEQUENCE; HUMAN-POPULATIONS; EVOLUTION; GENOME; ORIGIN		UNIV HAMBURG,HEINRICH PETTE INST EXPT VIROL & IMMUNOL,D-20146 HAMBURG,GERMANY	Heinrich Pette Institute; University of Hamburg	Bandelt, HJ (corresponding author), UNIV HAMBURG,MATH SEMINAR,BUNDESSTR 55,D-20146 HAMBURG,GERMANY.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BANDELT HJ, 1995, GENETICS, V141, P743; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Forster P, 1996, AM J HUM GENET, V59, P935; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HORAI S, 1990, AM J HUM GENET, V46, P828; MACAULAY VA, 1995, MACPAIRWISE 5 0 COMP; MARJORAM P, 1994, GENETICS, V136, P673; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers AR, 1996, MOL BIOL EVOL, V13, P895, DOI 10.1093/molbev/13.7.895; SHERRY ST, 1994, HUM BIOL, V66, P761; Smith B, 1994, EMERGENCE AGR; Soodyall H, 1996, AM J HUM GENET, V58, P595; SOODYALL H, 1993, THESIS U WITWATERSRA; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VIGILANT L, 1990, THESIS U CALIFORNIAA; WAKELEY J, 1993, J MOL EVOL, V37, P613; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1996, AM J HUM GENET, V59, P437	25	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					980	983		10.1086/514878	http://dx.doi.org/10.1086/514878			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382112	Green Published, Bronze			2022-12-18	WOS:A1997YA59100028
J	Durham, LK; Feingold, E				Durham, LK; Feingold, E			Genome scanning for segments shared identical by descent among distant relatives in isolated populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; COMPLEX TRAITS; GENE	In this paper, we address some of the statistical issues concerning false-positive rates that arise when the whole genome, or a portion thereof, is scanned in distantly related individuals, to search for a disease locus. We derive a method for correcting false-positive probabilities for the large number of comparisons that are performed when scanning a large portion of the genome. We consider both the idealized situation of a dense set of fully informative markers and the more realistic data-collection strategy of an initial scan at low resolution to identify promising areas, which then are typed with markers at high resolution. We also examine the accuracy of false-positive rates approximated using a conservative estimate of the separation distance between affected individuals in the current generation and the common ancestral couple. Calculation of false-positive rates when inbreeding is present in the pedigree also is considered.	EMORY UNIV,ROLLINS SCH PUBL HLTH,DEPT BIOSTAT,ATLANTA,GA 30322	Emory University; Rollins School Public Health				Feingold, Eleanor/0000-0003-2898-6484	NHGRI NIH HHS [R01-HG00848-01A1] Funding Source: Medline; NIAID NIH HHS [T32-AI07442] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007442] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aldous D., 1989, PROBABILITY APPROXIM, DOI [10.1007/978-1-4757-6283-9, DOI 10.1007/978-1-4757-6283-9]; Bickeboller H, 1996, THEOR POPUL BIOL, V50, P66, DOI 10.1006/tpbi.1996.0023; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; FEINGOLD E, 1993, J APPL PROBAB, V30, P766, DOI 10.2307/3214511; GUO SW, 1995, AM J HUM GENET, V56, P1468; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; THOMAS A, 1994, IMA J MATH APPL MED, V11, P1; WEEKS DE, 1988, AM J HUM GENET, V42, P315	17	25	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					830	842		10.1086/514891	http://dx.doi.org/10.1086/514891			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382093	Green Published, Bronze			2022-12-18	WOS:A1997YA59100009
J	Goldberg, JD				Goldberg, JD			Fetal cells in maternal circulation: Progress in analysis of a rare event	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							PERIPHERAL-BLOOD; PRENATAL-DIAGNOSIS; NUCLEATED ERYTHROCYTES; PREGNANT-WOMEN; DNA; THALASSEMIA				Goldberg, JD (corresponding author), UNIV CALIF SAN FRANCISCO,REPROD GENET UNIT,DEPT OBSTET GYNECOL & REPROD SCI,ROOM U-262,SAN FRANCISCO,CA 94143, USA.							Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/pnas.87.9.3279; Bianchi DW, 1997, AM J HUM GENET, V61, P822, DOI 10.1086/514885; BIANCHI DW, 1997, FLORIDA TIMES U 0729; CACHEUX V, 1992, FETAL DIAGN THER, V7, P190, DOI 10.1159/000263699; CAMASCHELLA C, 1990, BLOOD, V75, P2102; Cheung MC, 1996, NAT GENET, V14, P264, DOI 10.1038/ng1196-264; CLAYTON EM, 1964, OBSTET GYNECOL, V23, P915; DELACRUZ F, 1995, AM J OBSTET GYNECOL, V173, P1354, DOI 10.1016/0002-9378(95)91393-9; Durrant LG, 1996, EARLY HUM DEV, V47, pS79, DOI 10.1016/S0378-3782(96)01827-0; GANSHIRTAHLERT D, 1993, AM J REPROD IMMUNOL, V30, P194; Goldberg JD, 1997, AM J OBSTET GYNECOL, V176, P1349, DOI 10.1016/S0002-9378(97)70356-9; HAMADA H, 1993, HUM GENET, V91, P427; HAWES CS, 1994, ANN NY ACAD SCI, V731, P181, DOI 10.1111/j.1749-6632.1994.tb55767.x; HERZENBERG LA, 1979, P NATL ACAD SCI USA, V76, P1453, DOI 10.1073/pnas.76.3.1453; LO YMD, 1993, LANCET, V341, P1147, DOI 10.1016/0140-6736(93)93161-S; LO YMD, 1994, LANCET, V344, P264; LO YMD, 1989, LANCET, V2, P1363; MUELLER UW, 1990, LANCET, V336, P197, DOI 10.1016/0140-6736(90)91731-O; SIMPSON JL, 1993, JAMA-J AM MED ASSOC, V270, P2357, DOI 10.1001/jama.270.19.2357; SLUNGATALLBERG A, 1995, HUM GENET, V96, P53, DOI 10.1007/BF00214186; TAKABAYASHI H, 1995, PRENATAL DIAG, V15, P74, DOI 10.1002/pd.1970150116; THOMAS DB, 1962, BRIT J HAEMATOL, V8, P290, DOI 10.1111/j.1365-2141.1962.tb06523.x; THOMAS MR, 1994, LANCET, V343, P413, DOI 10.1016/S0140-6736(94)91248-3; Valerio D, 1996, PRENATAL DIAG, V16, P1073, DOI 10.1002/(SICI)1097-0223(199612)16:12<1073::AID-PD38>3.0.CO;2-D; WALKNOWSKA J, 1969, LANCET, V1, P1119; ZHENG YL, 1993, J MED GENET, V30, P1051, DOI 10.1136/jmg.30.12.1051	27	25	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					806	809		10.1086/514889	http://dx.doi.org/10.1086/514889			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382089	Bronze, Green Published			2022-12-18	WOS:A1997YA59100005
J	Hasson, T				Hasson, T			Unconventional myosins, the basis for deafness in mouse and man	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							GENE; VIIA; SHAKER-1; MOTOR; 1B; REGION; CELLS				Hasson, T (corresponding author), YALE UNIV, DEPT BIOL, 266 WHITNEY AVE, ROOM 342 KBT, NEW HAVEN, CT 06520 USA.			HASSON, TAMA/0000-0002-5405-662X				Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; BROWN KA, 1992, GENOMICS, V13, P189, DOI 10.1016/0888-7543(92)90219-I; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; Crozet F, 1997, GENOMICS, V40, P332, DOI 10.1006/geno.1996.4526; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Gillespie PG, 1996, COLD SPRING HARB SYM, V61, P309; Hasson T, 1996, J BIOL CHEM, V271, P16431, DOI 10.1074/jbc.271.28.16431; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; Liu XR, 1997, CELL MOTIL CYTOSKEL, V37, P240, DOI 10.1002/(SICI)1097-0169(1997)37:3<240::AID-CM6>3.0.CO;2-A; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Tamagawa Y, 1996, HUM MOL GENET, V5, P849, DOI 10.1093/hmg/5.6.849; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; VanCamp G, 1997, AM J HUM GENET, V60, P758; Vikstrom KL, 1996, CURR OPIN CELL BIOL, V8, P97, DOI 10.1016/S0955-0674(96)80053-6; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074	27	25	27	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					801	805		10.1086/514890	http://dx.doi.org/10.1086/514890			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382088	Green Published, Bronze			2022-12-18	WOS:A1997YA59100004
J	Shaffer, LG; McCaskill, C; Egli, CA; Baker, JC; Johnston, KM				Shaffer, LG; McCaskill, C; Egli, CA; Baker, JC; Johnston, KM			Is there an abnormal phenotype associated with maternal isodisomy for chromosome 2 in the presence of two isochromosomes?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							UNIPARENTAL DISOMY; TRISOMY-2; MOSAICISM		PERMANENTE MED GRP INC,DEPT PEDIAT,SAN FRANCISCO,CA; PERMANENTE MED GRP INC,DEPT PEDIAT,OAKLAND,CA	Permanente Medical Groups; Permanente Medical Groups	Shaffer, LG (corresponding author), BAYLOR COLL MED,DEPT MOL & HUMAN GENET,1 BAYLOR PLAZA,ROOM 15E,HOUSTON,TX 77030, USA.							Bernard L. E., 1995, American Journal of Human Genetics, V57, pA51; Bernasconi F, 1996, AM J HUM GENET, V59, P1114; HARRISON K, 1995, AM J MED GENET, V58, P147, DOI 10.1002/ajmg.1320580211; Nesbitt T. H., 1996, American Journal of Human Genetics, V59, pA40; Webb AL, 1996, PRENATAL DIAG, V16, P958, DOI 10.1002/(SICI)1097-0223(199610)16:10<958::AID-PD971>3.0.CO;2-U	5	25	25	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					461	462						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311755				2022-12-18	WOS:A1997XX70100028
J	Gu, C; Rao, DC				Gu, C; Rao, DC			A linkage strategy for detection of human quantitative-trait loci .1. Generalized relative risk ratios and power of sib pairs with extreme trait values	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS	We generalize the concept of the relative risk ratio (lambda) to the case of quantitative traits, to take into account the various trait outcomes of a relative pair. Formulas are derived to express the expected proportion of genes shared identical by descent by a sib pair, in terms of the generalized lambda's for sib pairs (lambda(s)), parent-offspring pairs (lambda(o)), and monozygotic twins (lambda(M)) and in terms of the recombination fraction, with the assumption of no residual correlations. If residual correlations are nonzero among relative pairs, we assume that they are the same among sib pairs, parent-offspring pairs, and monozygotic twins, and we employ a slightly different definition for the generalized lambda so that the same set of formulas still hold. The power (or, the sample size necessary) to detect quantitative-trait loci (QTLs) by use of extreme sib pairs (ESPs) is shown to be a function of the three generalized lambda's. Since lambda(M) can be derived by use of values of lambda(s) and lambda(o), estimates of the latter two lambda's will suffice for the analysis of power and the necessary sample sizes of ESPs, for a QTL linkage study.	WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)	Gu, C (corresponding author), WASHINGTON UNIV,SCH MED,DIV BIOSTAT,BOX 8067,660 S EUCLID AVE,ST LOUIS,MO 63110, USA.		Gu, C. Charles/A-7934-2010	Gu, C. Charles/0000-0002-8527-8145	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH031302, P50MH031302] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28719] Funding Source: Medline; NIMH NIH HHS [MH31302] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CAREY G, 1991, AM J HUM GENET, V49, P786; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; FULKER DW, 1991, READ WRIT, V3, P299, DOI 10.1007/BF00354964; Gu C, 1996, GENET EPIDEMIOL, V13, P513, DOI 10.1002/(SICI)1098-2272(1996)13:6<513::AID-GEPI1>3.0.CO;2-1; Gu C, 1997, AM J HUM GENET, V61, P211, DOI 10.1086/513909; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x	10	25	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					200	210		10.1086/513908	http://dx.doi.org/10.1086/513908			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9246001	Bronze, Green Published			2022-12-18	WOS:A1997XM72800028
J	Feingold, E; Siegmund, DO				Feingold, E; Siegmund, DO			Strategies for mapping heterogeneous recessive traits by allele-sharing methods	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE SUSCEPTIBILITY LOCI; GENETICALLY COMPLEX TRAITS; HIGH-RESOLUTION MAPS; SIB-PAIR TESTS; LINKAGE ANALYSIS; NUCLEAR FAMILIES; DISSECTION; IDENTITY; DESCENT; MODELS	We investigate strategies for detecting linkage of recessive and partially recessive traits, using sibling pairs and inbred individuals. We assume that a genomewide search is being conducted and that locus heterogeneity of the trait is likely. For sibling pairs, we evaluate the efficiency of different statistics under the assumption that one does not know the true degree of recessiveness of the trait. We recommend a sibling-pair statistic that is a linear compromise between two previously suggested statistics. We also compare the power of sibling pairs to that of more distant relatives, such as cousins. For inbred individuals, we evaluate the power of offspring of different types of matings and compare them to sibling pairs. Over a broad range of trait etiologies, sibling pairs are more powerful than inbred individuals, but for traits caused by very rare alleles, particularly in the case of heterogeneity, inbred individuals can be much more powerful. The models we develop can also be used to examine specific situations other than those we look at. We present this analysis in the idealized context of a dense set of highly polymorphic markers. In general, incorporation of real-world complexities makes inbred individuals, particularly offspring of distant relatives, look slightly less useful than our results imply.	STANFORD UNIV, DEPT STAT, STANFORD, CA 94305 USA	Stanford University	Feingold, E (corresponding author), EMORY UNIV, DEPT BIOSTAT, 1518 CLIFTON RD, ROOM 314, ATLANTA, GA 30322 USA.			Feingold, Eleanor/0000-0003-2898-6484	NHGRI NIH HHS [R01 HG00848-01A1] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000848] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Bodmer W. F., 1976, GENETICS EVOLUTION M; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DUPUIS J, 1995, GENETICS, V140, P843; ELSTON RC, 1992, 16TH P INT BIOM C HA, P39; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P225, DOI 10.1002/gepi.1370100403; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; FEINGOLD E, 1993, J APPL PROBAB, V30, P766, DOI 10.2307/3214511; Gschwend M, 1996, AM J HUM GENET, V59, P377; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; KEMPTHORNE O, 1957, INTRO GENETIC STATIS; Khoury M, 1993, FUNDAMENTALS GENETIC; KNAPP M, 1994, HUM HERED, V44, P37, DOI 10.1159/000154187; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Knapp M, 1996, AM J HUM GENET, V59, P485; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; NELSON SF, 1993, NAT GENET, V4, P11, DOI 10.1038/ng0593-11; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Rogus JJ, 1996, AM J HUM GENET, V59, P1376; SCHAID DJ, 1990, GENET EPIDEMIOL, V7, P359, DOI 10.1002/gepi.1370070506; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; Teng J, 1997, AM J HUM GENET, V60, P979; TSAI MS, 1994, AM J HUM GENET, V54, P643	33	25	25	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					965	978						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106544				2022-12-18	WOS:A1997WT61400027
J	Matassi, G; CherifZahar, B; Mouro, I; Cartron, JP				Matassi, G; CherifZahar, B; Mouro, I; Cartron, JP			Characterization of the recombination hot spot involved in the genomic rearrangement leading to the hybrid D-CE-D gene in the D-VI phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MONOCLONAL ANTI-D; MISMATCH REPAIR; RH; DNA; INDIVIDUALS; SEQUENCES; TRACTS; CANCER	In the Caucasian population, the RH locus of RhD-positive individuals is composed of two homologous genes, RHD and RHCE, arranged in tandem but of a single gene, RHCE, in RhD-negative individuals. Many variants recently characterized carry rearranged RH genes, most often by an unidirectional segmental DNA-exchange (gene-conversion) event. In D-VI variants of type II, RND is a D-CE-D hybrid gene in which the DNA fragment carrying exons 4-6 has been replaced by the corresponding sequences from the RHCE gene. To identify precisely and characterize the two transition sites, we have studied, by both PCR and sequence analysis, a genomic region between the 3' end of intron 3 and exon 7 in normal RHCE and RHD genes as well as in D-VI DNA. We show that the D-CE breakpoint is located in intron 3, within a 250-bp fragment comprising an Alu S sequence, and that the CE-D breakpoint lies within a 39-bp fragment in intron 6. This Alu S sequence (and the 100-bp region immediately downstream) most likely defines a recombination hot spot, since there lies also the 5' breakpoint of different rearrangement events leading to D-CE and CE-D transitions in hybrid D-VI,DFR and Dc-,R(N) gene complexes, respectively.	INST NATL TRANSFUS SANGUINE,INSERM U76,F-75015 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)			Isabelle, Mouro-Chanteloup/M-9750-2018; Matassi, Giorgio/G-6301-2014	Isabelle, Mouro-Chanteloup/0000-0002-6368-9904; Matassi, Giorgio/0000-0003-4923-226X; Cherif-Zahar, Baya/0000-0002-4965-7252				AGRE P, 1991, BLOOD, V78, P551, DOI 10.1182/blood.V78.3.551.bloodjournal783551; ANSTEE DJ, 1993, BAILLIERE CLIN HAEM, V6, P401, DOI 10.1016/S0950-3536(05)80152-0; ARCE MA, 1993, BLOOD, V82, P651; Batzer MA, 1996, J MOL EVOL, V42, P3, DOI 10.1007/BF00163204; Beckers EAM, 1996, BRIT J HAEMATOL, V93, P720, DOI 10.1046/j.1365-2141.1996.d01-1710.x; Beckers EAM, 1996, BRIT J HAEMATOL, V92, P751, DOI 10.1046/j.1365-2141.1996.382918.x; BOEHM T, 1989, EMBO J, V8, P2621, DOI 10.1002/j.1460-2075.1989.tb08402.x; CARTRON JP, 1994, BLOOD REV, V8, P199, DOI 10.1016/0268-960X(94)90108-2; CHERIFZAHAR B, 1994, GENOMICS, V19, P68, DOI 10.1006/geno.1994.1014; CHERIFZAHAR B, 1994, BLOOD, V84, P4354, DOI 10.1182/blood.V84.12.4354.bloodjournal84124354; CherifZahar B, 1996, BLOOD, V88, P1518, DOI 10.1182/blood.V88.4.1518.bloodjournal8841518; COLIN Y, 1991, BLOOD, V78, P2747; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; FISHEL R, 1994, SCIENCE, V266, P1403, DOI 10.1126/science.7973733; JOHNSTON BH, 1992, METHOD ENZYMOL, V211, P127; JONES J, 1995, TRANSFUSION MED, V5, P171, DOI 10.1111/j.1365-3148.1995.tb00225.x; JONES J, 1995, VOX SANG, V69, P236, DOI 10.1111/j.1423-0410.1995.tb02601.x; JURKA J, 1990, NUCLEIC ACIDS RES, V18, P137, DOI 10.1093/nar/18.1.137; JURKA J, IN PRESS COMP CHEM; Labuda D, 1995, IMPACT SHORT INTERSP, P1; LOMAS C, 1994, TRANSFUSION, V34, P612, DOI 10.1046/j.1537-2995.1994.34794330017.x; MODRICH P, 1994, SCIENCE, V266, P1959, DOI 10.1126/science.7801122; Mollison PL, 1993, BLOOD TRANSFUSION CL, P543; MOURO I, 1994, BLOOD, V83, P1129, DOI 10.1182/blood.V83.4.1129.bloodjournal8341129; Mouro I, 1996, BRIT J HAEMATOL, V93, P472, DOI 10.1046/j.1365-2141.1996.4851028.x; Race RR., 1975, BLOOD GROUPS MAN; ROUILLAC C, 1995, BRIT J HAEMATOL, V89, P424, DOI 10.1111/j.1365-2141.1995.tb03323.x; Rouillac C, 1996, BLOOD, V87, P4853, DOI 10.1182/blood.V87.11.4853.bloodjournal87114853; ROUILLAC C, 1995, BLOOD, V85, P2937, DOI 10.1182/blood.V85.10.2937.bloodjournal85102937; ROUILLAC C, 1995, AM J HEMATOL, V49, P87, DOI 10.1002/ajh.2830490115; Sambrook J., 1989, MOL CLONING; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; STOPPALYONNET D, 1991, AM J HUM GENET, V49, P1055; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tippett P, 1996, VOX SANG, V70, P123, DOI 10.1111/j.1423-0410.1996.tb01309.x; TIPPETT P, 1977, ARZTL LAB, V23, P476; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238	38	25	27	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					808	817						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106526				2022-12-18	WOS:A1997WT61400009
J	Ottman, R; Hauser, WA; BarkerCummings, C; Lee, JH; Risch, N				Ottman, R; Hauser, WA; BarkerCummings, C; Lee, JH; Risch, N			Segregation analysis of cryptogenic epilepsy and an empirical test of the validity of the results	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL NEONATAL CONVULSIONS; SEMISTRUCTURED INTERVIEW; SEIZURE CLASSIFICATION; LOCALIZATION; GENE; PREVALENCE; DISORDERS; ROCHESTER; MINNESOTA; RISK	We used POINTER to perform segregation analysis of cryptogenic epilepsy in 1,557 three-generation families (probands and their parents, siblings, and offspring) ascertained from voluntary organizations. Analysis of the full data set indicated that the data were most consistent with an autosomal dominant (AD) model with 61% penetrance of the susceptibility gene. However, subsequent analyses revealed that the patterns of familial aggregation differed markedly between siblings and offspring of the probands. Risks in siblings were consistent with an autosomal recessive (AR) model and inconsistent with an AD model whereas risks in offspring were inconsistent with an AR model and more consistent with an AD model. As a further test of the validity of the AD model, we used sequential ascertainment to extend the family history information in the subset of families judged likely to carry the putative susceptibility gene because they contained at least three affected individuals. Prevalence of idiopathic/cryptogenic epilepsy was only 3.7% in newly identified relatives expected to have a 50% probability of carrying the susceptibility gene under an AD model. Approximately 30% (i.e., 50% x 61%) were expected to be affected under the AD model resulting from the segregation analysis. These results suggest that the familial distribution of cryptogenic epilepsy is inconsistent with any conventional genetic model. The differences between siblings and offspring in the patterns of familial risk are intriguing and should be investigated further.	COLUMBIA UNIV, SCH PUBL HLTH, DIV EPIDEMIOL, NEW YORK, NY 10032 USA; NEW YORK STATE PSYCHIAT INST & HOSP, EPIDEMIOL BRAIN DISORDERS RES DEPT, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA; STANFORD UNIV, SCH MED, DEPT GENET, STANFORD, CA 94305 USA	Columbia University; New York State Psychiatry Institute; Columbia University; Stanford University	Ottman, R (corresponding author), COLUMBIA UNIV, GH SERGIEVSKY CTR, 630 W 168TH ST, NEW YORK, NY 10032 USA.		Hauser, W Allen/AAB-5277-2020; Lee, Joseph H/D-2441-2012; Ottman, Ruth/O-2371-2013	Lee, Joseph H/0000-0002-2000-4821; Ottman, Ruth/0000-0001-7074-242X	NINDS NIH HHS [R01-NS20656] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020656] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANNEGERS JF, 1982, NEUROLOGY, V32, P174, DOI 10.1212/WNL.32.2.174; [Anonymous], 1981, Epilepsia, V22, P489; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; DAVIE AM, 1979, ANN HUM GENET, V42, P507, DOI 10.1111/j.1469-1809.1979.tb00683.x; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LEHESJOKI AE, 1991, P NATL ACAD SCI USA, V88, P3696, DOI 10.1073/pnas.88.9.3696; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; LEWIS TB, 1993, AM J HUM GENET, V53, P670; MORTON NE, 1969, COMPUTER APPLICATION, P129; Ottman R, 1996, EPILEPSIA, V37, P353, DOI 10.1111/j.1528-1157.1996.tb00571.x; OTTMAN R, 1987, J CHRON DIS, V40, P165, DOI 10.1016/0021-9681(87)90068-3; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; OTTMAN R, 1995, AM J EPIDEMIOL, V141, P235, DOI 10.1093/oxfordjournals.aje.a117425; OTTMAN R, 1992, J CLIN EPIDEMIOL, V45, P721, DOI 10.1016/0895-4356(92)90049-S; Ottman R, 1996, ANN NEUROL, V39, P442, DOI 10.1002/ana.410390406; OTTMAN R, 1995, NEUROLOGY, V45, pA215; OTTMAN R, 1990, EPILEPSIA, V31, P110, DOI 10.1111/j.1528-1157.1990.tb05368.x; OTTMAN R, 1993, NEUROLOGY, V43, P2526, DOI 10.1212/WNL.43.12.2526; OTTMAN R, 1985, AM J EPIDEMIOL, V122, P923, DOI 10.1093/oxfordjournals.aje.a114197; OTTMAN R, 1993, EPILEPSIA, V34, P469, DOI 10.1111/j.1528-1157.1993.tb02587.x; OTTMAN R, 1988, AM J HUM GENET, V43, P257; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; SCHUPF N, 1994, EPILEPSIA, V35, P750, DOI 10.1111/j.1528-1157.1994.tb02506.x; Schupf N, 1996, EPILEPSIA, V37, P833, DOI 10.1111/j.1528-1157.1996.tb00035.x; TAHVANAINEN E, 1994, P NATL ACAD SCI USA, V91, P7267, DOI 10.1073/pnas.91.15.7267	28	25	26	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					667	675						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042928				2022-12-18	WOS:A1997WK40300025
J	tHart, LM; Stolk, RP; Heine, RJ; Grobbee, DE; vanderDoes, FEE; Maassen, JA				tHart, LM; Stolk, RP; Heine, RJ; Grobbee, DE; vanderDoes, FEE; Maassen, JA			Association of the insulin-receptor variant Met-985 with hyperglycemia and non-insulin-dependent diabetes mellitus in the Netherlands: A population-based study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLUCAGON RECEPTOR; GLUCOKINASE GENE; RESISTANCE; MUTATIONS; HYPERINSULINEMIA; POLYMORPHISMS; SUBSTITUTION; DETERMINANTS; PEDIGREE; NIDDM	One of the characteristics of non-insulin-dependent diabetes mellitus (NIDDM) is the presence of insulin resistance. Most NIDDM patients have a normal sequence of the insulin receptor, indicating that, if insulin-receptor mutations contribute to the development of NIDDM, they will be present only in a minor fraction of the NlDDM population. The goal of the present study was to examine whether insulin-receptor mutations contribute to the development of NIDDM. We examined 161 individuals with NIDDM and 538 healthy controls from the population-based Rotterdam study for the presence of mutations in the insulin-receptor gene by SSCP. A heterozygous mutation changing valine-985 into methionine was detected in 5.6% of diabetic subjects and in 1.3% of individuals with normal oral glucose tolerance test. Adjusted for age, gender, and body-mass index, this revealed a relative risk for diabetes of 4.49 (95% confidence interval 1.59-12.25) for Met-985 carriers. When the total study group was analyzed, the prevalence of the mutation increased with increasing serum glucose levels (test for trend P < .005). We conclude that the Met-985 insulin-receptor variant associates with hyperglycemia and represents a risk factor for NIDDM.	LEIDEN UNIV,SYLVIUS LAB,DEPT BIOCHEM MED,NL-2333 AL LEIDEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,SCH MED,DEPT EPIDEMIOL & BIOSTAT,NL-3000 DR ROTTERDAM,NETHERLANDS; FREE UNIV AMSTERDAM,INST RES EXTRAMURAL MED,AMSTERDAM,NETHERLANDS	Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; Vrije Universiteit Amsterdam			Stolk, Ronald P/B-2341-2013; Grobbee, Diederick/C-7651-2014; 't Hart, Leen/ABG-3185-2021	Stolk, Ronald P/0000-0002-0518-1205; Grobbee, Diederick/0000-0003-4472-4468; 't Hart, Leen/0000-0003-4401-2938				[Anonymous], 1985, TECHN REP SER WHO; BECKNIELSEN H, 1994, J CLIN INVEST, V94, P1714, DOI 10.1172/JCI117518; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; ELBEIN SC, 1993, DIABETES, V42, P429, DOI 10.2337/diabetes.42.3.429; ERIKSSON J, 1989, NEW ENGL J MED, V321, P337, DOI 10.1056/NEJM198908103210601; FESKENS EJM, 1994, AM J EPIDEMIOL, V140, P350, DOI 10.1093/oxfordjournals.aje.a117257; FLIER JS, 1993, J CLIN ENDOCR METAB, V76, P1533, DOI 10.1210/jc.76.6.1533; GARVEY WT, 1993, BAILLIERE CLIN ENDOC, V7, P785; HAGER J, 1995, NAT GENET, V9, P299, DOI 10.1038/ng0395-299; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; HE WM, 1995, J BIOL CHEM, V270, P23258, DOI 10.1074/jbc.270.40.23258; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; IMAMURA T, 1994, J BIOL CHEM, V269, P31019; KROOK A, 1994, DIABETES, V43, P357, DOI 10.2337/diabetes.43.3.357; Maassen JA, 1996, DIABETOLOGIA, V39, P375; MOLLER DE, 1989, DIABETES, V88, P1496; Nijpels G, 1996, DIABETOLOGIA, V39, P113; ORAHILLY S, 1991, DIABETES, V40, P777, DOI 10.2337/diabetes.40.6.777; ORAHILLY S, 1992, DIABETOLOGIA, V35, P486, DOI 10.1007/BF02342449; RENFREWHAFT C, 1994, J BIOL CHEM, V269, P26286; SEINO S, 1990, DIABETES, V39, P123, DOI 10.2337/diabetes.39.1.123; STRACK V, 1996, EXP CLIN ENDOCRIN S2, V104, P100; TAYLOR SI, 1992, ENDOCR REV, V13, P566, DOI 10.1210/er.13.3.566; THART LM, 1995, DIABETES CARE, V18, P1400; VAAG A, 1992, J CLIN INVEST, V89, P782, DOI 10.1172/JCI115656; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; VANDERVORM ER, 1992, J BIOL CHEM, V267, P66; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; YKIJARVINEN H, 1994, LANCET, V343, P91, DOI 10.1016/S0140-6736(94)90821-4	30	25	27	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1119	1125						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900242				2022-12-18	WOS:A1996VN90000021
J	Weber, BHF; Brohm, M; Stec, I; Backe, J; Caffier, H				Weber, BHF; Brohm, M; Stec, I; Backe, J; Caffier, H			Somatic truncating mutation in BRCA2 in a sporadic breast tumor	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CANCER SUSCEPTIBILITY GENE; HETEROZYGOSITY		UNIV WURZBURG,FRAUENKLIN,D-8700 WURZBURG,GERMANY	University of Wurzburg	Weber, BHF (corresponding author), UNIV WURZBURG,INST HUMANGENET,BIOZENTRUM,HUBLAND,D-97074 WURZBURG,GERMANY.			Weber, Bernhard H.F./0000-0002-8808-7723				CLETONJANSEN AM, 1995, BRIT J CANCER, V72, P1241, DOI 10.1038/bjc.1995.493; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; KERANGUEVEN F, 1995, GENE CHROMOSOME CANC, V13, P291, DOI 10.1002/gcc.2870130410; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Miki Y, 1996, NAT GENET, V13, P245, DOI 10.1038/ng0696-245; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teng DHF, 1996, NAT GENET, V13, P241, DOI 10.1038/ng0696-241; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	10	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					962	964						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808615				2022-12-18	WOS:A1996VL28300029
J	Hodes, ME; Dlouhy, SR				Hodes, ME; Dlouhy, SR			The proteolipid protein gene: Double, double, ... and trouble	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							PELIZAEUS-MERZBACHER-DISEASE; DUPLICATION; DOSAGE; FAMILY; DEMYELINATION; PHENOTYPE; DELETION; CMT1A; MOUSE; PLP				Hodes, ME (corresponding author), INDIANA UNIV,SCH MED,DEPT MED & MOL GENET,975 W WALNUT ST,INDIANAPOLIS,IN 46202, USA.							BACH ML, 1995, YEAST, V11, P169, DOI 10.1002/yea.320110208; Cambi F, 1996, NEUROLOGY, V46, P1112, DOI 10.1212/WNL.46.4.1112; CARANGO P, 1995, ANN NEUROL, V38, P610, DOI 10.1002/ana.410380409; CHANCE PF, 1992, NEUROLOGY, V42, P2295, DOI 10.1212/WNL.42.12.2295; CREMERS FPM, 1987, HUM GENET, V77, P23, DOI 10.1007/BF00284707; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; ENG CM, 1994, HUM MUTAT, V3, P103, DOI 10.1002/humu.1380030204; GRIFFITHS IR, 1995, BRAIN PATHOL, V5, P275, DOI 10.1111/j.1750-3639.1995.tb00604.x; HARDING B, 1995, NEUROPATH APPL NEURO, V21, P111, DOI 10.1111/j.1365-2990.1995.tb01036.x; HODES ME, 1993, DEV NEUROSCI-BASEL, V15, P383, DOI 10.1159/000111361; HODES ME, IN PRESS AM J MED GE; Inoue K, 1996, AM J HUM GENET, V59, P32; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; KLEINDORFER DO, 1995, AM J MED GENET, V55, P405, DOI 10.1002/ajmg.1320550404; MANSFIELD ES, 1993, MOL CELL PROBE, V7, P311, DOI 10.1006/mcpr.1993.1045; MASTRONARDI FG, 1993, J NEUROSCI RES, V36, P315, DOI 10.1002/jnr.490360309; Merzbacher L., 1910, Z F R GESAMTE NEUROL, V3, P1, DOI [10.1007/BF02893591, DOI 10.1007/BF02893591]; NANCE MA, IN PRESS AM J MED GE; NEZU A, 1995, BRAIN DEV-JPN, V17, P175, DOI 10.1016/0387-7604(95)00028-A; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; SCHERER SS, 1995, NAT GENET, V11, P226, DOI 10.1038/ng1195-226; Seitelberger F., 1970, HDB CLINICAL NEUROLO, V10, P150; SUTER U, 1995, ANNU REV NEUROSCI, V18, P45, DOI 10.1146/annurev.ne.18.030195.000401; TOSCANO A, 1995, NEUROMUSCULAR DISORD, V5, P475, DOI 10.1016/0960-8966(95)00008-B; TROFATTER JA, 1991, NUCLEIC ACIDS RES, V19, P6057, DOI 10.1093/nar/19.21.6057-a; ZEMAN W, 1964, J NEUROPATH EXP NEUR, V23, P334, DOI 10.1097/00005072-196404000-00008	27	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					12	15						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659515				2022-12-18	WOS:A1996VL45500003
J	Turner, G				Turner, G			Finding genes on the X chromosome by which Homo may have become sapiens	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							LINKED MENTAL-RETARDATION		UNIV NEWCASTLE,WARATAH,NSW,AUSTRALIA	University of Newcastle	Turner, G (corresponding author), HUNTER GENET,POB 84,WARATAH,NSW 2298,AUSTRALIA.							GEDEON AK, IN PRESS AM J MED GE; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; KERR B, 1991, J MED GENET, V28, P378, DOI 10.1136/jmg.28.6.378; LEHRKE R, 1972, AM J MENT DEF, V76, P611; LEHRKE R G, 1974, Birth Defects Original Article Series, V10, P1; Lindsay S, 1996, AM J HUM GENET, V58, P1120; OHNO S, 1976, EVOLUTION GENE DUPLI; TURNER G, 1974, J MED GENET, V11, P109, DOI 10.1136/jmg.11.2.109	8	25	28	1	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1109	1110						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651286				2022-12-18	WOS:A1996UM27100002
J	Tomatsu, S; Fukuda, S; Yamagishi, A; Cooper, A; Wraith, JE; Hori, T; Kato, Z; Yamada, N; Isogai, K; Kondo, N; Suzuki, Y; Shimozawa, N; Orii, T				Tomatsu, S; Fukuda, S; Yamagishi, A; Cooper, A; Wraith, JE; Hori, T; Kato, Z; Yamada, N; Isogai, K; Kondo, N; Suzuki, Y; Shimozawa, N; Orii, T			Mucopolysaccharidosis IVA: Four new exonic mutations in patients with N-acetylgalactosamine-6-sulfate sulfatase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MORQUIO-DISEASE; STEROID-SULFATASE; POINT MUTATIONS; COMMON MUTATION; CDNA CLONING; EXPRESSION; GENE; DNA; ARYLSULFATASE; PURIFICATION	We report four new mutations in Japanese patients with mucopolysaccharidosis IVA (MPSIVA) who were heterozygous for a common double gene deletion. A nonsense mutation of CAG to TAG at codon 148 in exon 4 was identified, resulting in a change of Q to a stop codon and three missense mutations. V (GTC) to A (GCC) at codon 138 in exon 4, P (CCC) to S (TCC) at codon 151 in exon 5, and P (CCC) to L (CTC) at codon 151 in exon 5. Introduction of these mutations into the normal GALNS cDNA and transient expression in cultured fibroblasts resulted in a significant decrease in the enzyme activity. V138A and Q148X mutations result in changes of restriction site, which were analyzed by restriction-enzyme assay. P151S and P151L mutations that did not alter the restriction site were detected by direct sequencing or allele specific oligohybridization. Detection of the double gene deletion was initially done using Southern blots and was confirmed by PCR. Haplotypes were determined using seven polymorphisms to the GALNS locus in families with the double gene deletion. Haplotype analysis showed that the common double gene deletion occurred on a single haplotype, except for some variation in a VNTR-like polymorphism. This finding is consistent with a common founder for all individuals with this mutation.	GIFU UNIV,SCH MED,DEPT PEDIAT,GIFU 500,JAPAN; UNIV MANCHESTER,SCH MED,ROYAL MANCHESTER CHILDRENS HOSP,MANCHESTER,LANCS,ENGLAND	Gifu University; Royal Manchester Children's Hospital; University of Manchester			Kato, Zenichiro/E-8900-2010	Shimozawa, Nobuyuki/0000-0003-3040-5458				BAKER E, 1993, AM J HUM GENET, V52, P96; BECK M, 1986, CLIN GENET, V29, P325; BIELICKI J, 1991, BIOCHEM J, V279, P515, DOI 10.1042/bj2790515; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DIFERRANTE N, 1978, SCIENCE, V199, P79, DOI 10.1126/science.199.4324.79; FUJIMOTO A, 1983, AM J MED GENET, V18, P369; FUKUDA S, 1992, J CLIN INVEST, V90, P1049, DOI 10.1172/JCI115919; GLOSSL J, 1978, CLIN CHIM ACTA, V88, P111, DOI 10.1016/0009-8981(78)90157-2; GLOSSL J, 1981, PEDIATR RES, V15, P976; HECHIT JT, 1984, AM J MED GENET, V15, P265; HORI T, 1995, GENOMICS, V26, P535, DOI 10.1016/0888-7543(95)80172-I; HORWITZ AL, 1978, BIOCHEM BIOPH RES CO, V80, P819, DOI 10.1016/0006-291X(78)91318-9; IWATA H, 1995, HUM GENET, V95, P257; MAROTEAUX P, 1967, LANCET, V2, P510; MASUE M, 1991, J BIOCHEM-TOKYO, V110, P965, DOI 10.1093/oxfordjournals.jbchem.a123697; MASUNO M, 1993, GENOMICS, V16, P777, DOI 10.1006/geno.1993.1266; Matalon R, 1974, BIOCHEM BIOPH RES CO, V61, P709; MATSUMURA M, 1988, NATURE, V334, P406, DOI 10.1038/334406a0; Morquio L., 1929, B SOC PEDIAT PARIS, V27, P145; NAKASHIMA Y, 1994, GENOMICS, V20, P99, DOI 10.1006/geno.1994.1132; Orii T, 1981, CONNECT TISSUE RES, V13, P169; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PETERS C, 1990, J BIOL CHEM, V265, P3374; POLTEN A, 1991, NEW ENGL J MED, V324, P18, DOI 10.1056/NEJM199101033240104; ROBERTSON DA, 1988, BIOCHEM BIOPH RES CO, V157, P218, DOI 10.1016/S0006-291X(88)80035-4; SASAKI H, 1988, EUR J BIOCHEM, V177, P9, DOI 10.1111/j.1432-1033.1988.tb14338.x; SCOTT HS, 1992, HUM GENET, V88, P701, DOI 10.1007/BF02265303; SHORTLE D, 1990, BIOCHEMISTRY-US, V29, P8033, DOI 10.1021/bi00487a007; SINGH J, 1976, J CLIN INVEST, V57, P1036, DOI 10.1172/JCI108345; STEIN C, 1989, J BIOL CHEM, V264, P13865; STEIN C, 1989, J BIOL CHEM, V265, P3374; SUKEGAWA K, 1982, J INHERIT METAB DIS, V5, P231, DOI 10.1007/BF02179150; SVENSSON E, 1991, HUM GENET, V87, P11, DOI 10.1007/BF01213084; TARONI F, 1993, NAT GENET, V4, P314, DOI 10.1038/ng0793-314; TOMATSU S, 1994, HUM MOL GENET, V3, P1208, DOI 10.1093/hmg/3.7.1208-a; TOMATSU S, 1995, AM J HUM GENET, V57, P556; TOMATSU S, 1991, BIOCHEM BIOPH RES CO, V181, P677, DOI 10.1016/0006-291X(91)91244-7; TOMATSU S, 1994, HUM MOL GENET, V3, P1427, DOI 10.1093/hmg/3.8.1427; TOMATSU S, 1995, HUM MOL GENET, V4, P741, DOI 10.1093/hmg/4.4.741; TOMATSU S, 1995, HUM GENET, V95, P376; TOMATSU S, 1995, HUM MUTAT, V6, P195, DOI 10.1002/humu.1380060218; Tomatsu S., 1992, American Journal of Human Genetics, V51, pA178; TOMATSU S, 1995, HUM GENET, V95, P234; TOMATSU S, 1994, J INHERIT METAB DIS, V5, P169; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; ZHANG ZF, 1993, AM J HUM GENET, V52, P1111	47	25	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					950	962						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651279				2022-12-18	WOS:A1996UH19200007
J	Levy, EN; Shen, Y; Kupelian, A; Kruglyak, L; Aksentijevich, I; Pras, E; Balow, JE; Linzer, B; Chen, XG; Shelton, DA; Gumucio, D; Pras, M; Shohat, M; Rotter, JI; FischelGhodsian, N; Richards, RI; Kastner, DL				Levy, EN; Shen, Y; Kupelian, A; Kruglyak, L; Aksentijevich, I; Pras, E; Balow, JE; Linzer, B; Chen, XG; Shelton, DA; Gumucio, D; Pras, M; Shohat, M; Rotter, JI; FischelGhodsian, N; Richards, RI; Kastner, DL			Linkage disequilibrium mapping places the gene causing familial mediterranean fever close to D16S246	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISMS; MOROCCAN JEWS; HOMOZYGOSITY; CHROMOSOME-16; ARMENIANS; MAP	This report presents refined genetic mapping data for the gene causing familial Mediterranean fever (FMF), a recessively inherited disorder of inflammation. We sampled 65 Jewish, Armenian, and Arab families and typed them for eight markers from chromosome 16p. Using a new algorithm that permits multipoint calculations for a dense map of markers in consanguineous families, we obtained a maximal LOD score of 49.2 at a location 1.6 cM centromeric to D16S246. A specific haplotype at D16S283-D16S94-D16S246 was found in 76% of Moroccan and 32% of non-Moroccan Jewish carrier chromosomes, but this haplotype was not overrepresented in Armenian or Arab FMF carriers. Moreover, the 2.5-kb allele at D16S246 was significantly associated with FMF in Moroccan and non-Moroccan Jews but not in Armenians or Arabs. Since the Moroccan Jewish community represents a relatively recently established and genetically isolated founder population, we analyzed the Moroccan linkage-disequilibrium data by using Luria-Delbruck formulas and simulations based on a Poisson branching process. These methods place the FMF susceptibility gene within 0.305 cM of D16S246 (2-LOD-unit range 0.02-0.64 cM).	NIAMSD,ARTHRIT & RHEUMATISM BRANCH,BETHESDA,MD 20892; ADELAIDE WOMENS & CHILDRENS HOSP,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA,AUSTRALIA; CEDARS SINAI MED CTR,DEPT PEDIAT,LOS ANGELES,CA 90048; CEDARS SINAI MED CTR,DEPT MED GENET,LOS ANGELES,CA 90048; WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; UNIV MICHIGAN,DEPT ANAT & CELL BIOL,ANN ARBOR,MI 48109; CHAIM SHEBA MED CTR,HELLER INST MED RES,IL-52621 TEL HASHOMER,ISRAEL; BEILINSON MED CTR,DEPT MED GENET,IL-49100 PETAH TIQWA,ISRAEL	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Womens & Childrens Hospital Australia; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Michigan System; University of Michigan; Chaim Sheba Medical Center; Rabin Medical Center			Richards, Robert/ABE-6423-2020; Aksentijevich, Ivona/AAF-1335-2019	Richards, Robert Ian/0000-0002-5978-6453	NHGRI NIH HHS [HG00017] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P644; AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P451; BARAKAT MH, 1986, Q J MED, V60, P837; FARRALL M, 1993, NAT GENET, V5, P107, DOI 10.1038/ng1093-107; FISCHELGHODSIAN N, 1993, AM J MED GENET, V46, P689, DOI 10.1002/ajmg.1320460619; Goodman R. M., 1979, GENETIC DISORDERS JE; HAATAJA L, 1994, AM J HUM GENET, V54, P1042; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1975, THEOR POPUL BIOL, V8, P117, DOI 10.1016/0040-5809(75)90028-3; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KAPLAN NL, 1995, AM J HUM GENET, V57, P1486; KESTILA M, 1994, AM J HUM GENET, V54, P757; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KOZMAN HM, 1995, GENOMICS, V25, P44, DOI 10.1016/0888-7543(95)80108-X; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; Luria SE, 1943, GENETICS, V28, P491; MITCHISON HM, 1995, AM J HUM GENET, V56, P654; NAVON R, 1991, AM J HUM GENET, V48, P412; OZDEMIR A I, 1969, American Journal of Gastroenterology, V51, P311; PIGG M, 1994, NAT GENET, V8, P361, DOI 10.1038/ng1294-361; PRAS E, 1994, HUM GENET, V94, P576; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; Roth C., 1972, ENCY JUDAICA; SCHWABE AD, 1974, MEDICINE, V53, P453, DOI 10.1097/00005792-197411000-00005; SHEN Y, 1993, HUM MOL GENET, V2, P1745, DOI 10.1093/hmg/2.10.1745; SHEN Y, 1993, HUM MOL GENET, V2, P1506, DOI 10.1093/hmg/2.9.1506; SHOHAT M, 1992, AM J HUM GENET, V51, P1349; SMITH CAB, 1953, J R STAT SOC B, V15, P153; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; SULISALO T, 1994, AM J HUM GENET, V55, P937; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WEIR BS, 1978, GENETICS, V88, P633; Weir BS, 1990, GENETIC DATA ANAL; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	41	25	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					523	534						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644712				2022-12-18	WOS:A1996TV56400011
J	SHAW, MA; DAVIES, CR; LLANOSCUENTAS, EA; COLLINS, A				SHAW, MA; DAVIES, CR; LLANOSCUENTAS, EA; COLLINS, A			HUMAN GENETIC SUSCEPTIBILITY AND INFECTION WITH LEISHMANIA-PERUVIANA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; CUTANEOUS LEISHMANIASIS; MEXICANA INFECTION; MAJOR INFECTION; MICE; LEPROSY; FAMILIES; LINKAGE; HLA; IMMUNOGENETICS	Racial differences, familial clustering, and murine studies are suggestive of host genetic control of Leishmania infections. Complex segregation analysis has been carried out by use of the programs POINTER and COMDS and data from a total population survey, comprising 636 nuclear families, from an L. peruviana endemic area. The data support genetic components controlling susceptibility to clinical leishmaniasis, influencing severity of disease and resistance to disease among healthy individuals. A multifactorial model is favored over a sporadic model. Two-locus models provided the best fit to the data, the optimal model being a recessive gene (frequency .57) plus a modifier locus. Individuals infected at an early age and with recurrent lesions are genetically more susceptible than those infected with a single episode of disease at a later age. Among people with no lesions, those with a positive skin-test response are genetically less susceptible than those with a negative response. The possibility of the involvement of more than one gene together with environmental effects has implications for the design of future linkage studies.	UNIV LONDON LONDON SCH HYG & TROP MED,DEPT MED PARASITOL,LONDON WC1E 7HT,ENGLAND; UNIV PERUANA CAYETANO HEREDIA,INST MED TROP ALEXANDER VONHUMBOLDT,LIMA,PERU; PRINCESS ANNE HOSP,CTR HUMAN GENET,SOUTHAMPTON,HANTS,ENGLAND	University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia	SHAW, MA (corresponding author), UNIV CAMBRIDGE,ADDENBROOKES HOSP,SCH CLIN,DEPT MED,LEVEL 5,HILLS RD,CAMBRIDGE CB2 2QQ,ENGLAND.		Collins, Andrew/A-6595-2010; Collins, Andrew/S-2196-2019	Collins, Andrew/0000-0001-7108-0771; Collins, Andrew/0000-0001-7108-0771; Llanos-Cuentas, Alejandro/0000-0002-7567-5534	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABEL L, 1988, AM J HUM GENET, V42, P256; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BARBIER D, 1987, TISSUE ANTIGENS, V30, P63, DOI 10.1111/j.1399-0039.1987.tb01598.x; DAVIES CR, 1995, EPIDEMIOL INFECT, V114, P297, DOI 10.1017/S0950268800057964; DUJARDIN JC, 1993, ANN TROP MED PARASIT, V87, P335, DOI 10.1080/00034983.1993.11812777; FINE PEM, 1981, INT J LEPROSY, V49, P437; HAILE RWC, 1985, HUM HERED, V35, P43, DOI 10.1159/000153514; HOWARD JG, 1980, PARASITE IMMUNOL, V2, P303, DOI 10.1111/j.1365-3024.1980.tb00061.x; HYER RN, 1991, AM J HUM GENET, V48, P243; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LARA ML, 1991, HUM IMMUNOL, V30, P129, DOI 10.1016/0198-8859(91)90081-J; LAWRENCE S, 1994, ANN HUM GENET, V58, P359, DOI 10.1111/j.1469-1809.1994.tb00732.x; MACLEAN CJ, 1984, COMPUT BIOMED RES, V17, P471, DOI 10.1016/0010-4809(84)90013-2; MARSDEN PA, 1994, GENOMICS, V19, P183, DOI 10.1006/geno.1994.1039; MOCK B, 1993, EUR J IMMUNOGENET, V20, P335, DOI 10.1111/j.1744-313X.1993.tb00153.x; MONTOYA F, 1987, BIOMEDICA, V26; MORTON NE, 1991, ANN HUM GENET, V55, P301, DOI 10.1111/j.1469-1809.1991.tb00857.x; MORTON NE, 1974, AM J HUM GENET, V26, P489; NASCIMENTO MDSB, 1993, T ROY SOC TROP MED H, V87, P91, DOI 10.1016/0035-9203(93)90439-W; PETZLERLER ML, 1991, HUM IMMUNOL, V32, P254, DOI 10.1016/0198-8859(91)90088-Q; ROBERTS M, 1993, EUR J IMMUNOGENET, V20, P349, DOI 10.1111/j.1744-313X.1993.tb00154.x; ROBERTS M, 1990, J IMMUNOGENET, V17, P89; ROBERTS M, 1989, INFECT IMMUN, V57, P875, DOI 10.1128/IAI.57.3.875-881.1989; SHAW MA, 1993, ANN HUM GENET, V57, P251, DOI 10.1111/j.1469-1809.1993.tb00899.x; SHEN FM, 1991, AM J HUM GENET, V49, P88; SHIELDS DC, 1994, AM J HUM GENET, V55, P540; VILLASECA P, 1993, AM J TROP MED HYG, V49, P260, DOI 10.4269/ajtmh.1993.49.260; WAGENER DK, 1988, GENET EPIDEMIOL, V5, P95, DOI 10.1002/gepi.1370050205; WALTON BC, 1979, ANN TROP MED PARASIT, V73, P23, DOI 10.1080/00034983.1979.11687222; XU WM, 1994, GENOMICS, V21, P419, DOI 10.1006/geno.1994.1286; ZHANG XO, 1994, INFECT IMMUN, V62, P33, DOI 10.1128/IAI.62.1.33-40.1994	31	25	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1159	1168						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485168				2022-12-18	WOS:A1995TA44900024
J	GOLDMAN, A; RAMSAY, M; JENKINS, T				GOLDMAN, A; RAMSAY, M; JENKINS, T			NEW FOUNDER HAPLOTYPES AT THE MYOTONIC-DYSTROPHY LOCUS IN SOUTHERN AFRICA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; CTG REPEAT; UNSTABLE DNA; TRIPLET REPEAT; KINASE GENE; EXPANSION; REGION; POPULATIONS; MUTATION; EVOLUTION	The association between normal alleles at the CTG repeat and two nearby polymorphisms in the myotonin protein kinase gene, the Alu insertion/deletion polymorphism and the myotonic dystrophy kinase (DMK)(G/T) intron 9/HinfI: polymorphism, has been analyzed in South African Negroids, a population in which myotonic dystrophy (DM) has not been described. South African Negroids have a CTG allelic distribution that is significantly different from that in Caucasoids and Japanese: the CTG repeat lengths of greater than or equal to 19 are very rare. The striking linkage disequilibrium between specific alleles at the Alu polymorphism (Alu(ins) and Alu(del)), the HinfI polymorphism (HinfI-1 and HinfI-2), and the CTG repeat polymorphism seen in Caucasoid (Europeans and Canadians) populations was also found in the South African Negroid population. Numerous haplotypes, not previously described in Europeans, were, however, found. It thus seems likely that only a small number of these ''African'' chromosomes were present in the progenitors of all non-African peoples. These data provide support for the ''out of Africa'' model for the origin of modern humans and suggest that the rare ancestral DM mutation event may have occurred after the migration from Africa, hence the absence of DM in sub-Saharan Negroid peoples.	UNIV WITWATERSRAND,JOHANNESBURG,SOUTH AFRICA	University of Witwatersrand	GOLDMAN, A (corresponding author), S AFRICAN INST MED RES,SCH PATHOL,DEPT HUMAN GENET,POB 1038,JOHANNESBURG,SOUTH AFRICA.			Ramsay, Michele/0000-0002-4156-4801				ASHIZAWA T, 1991, LANCET, V338, P642, DOI 10.1016/0140-6736(91)90659-D; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; DAVIES J, 1992, J MED GENET, V29, P766, DOI 10.1136/jmg.29.11.766; ECKHART M, 1993, AM J HUM GENET, V53, P796; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GOLDMAN A, 1994, J MED GENET, V31, P37, DOI 10.1136/jmg.31.1.37; GRUN R, 1990, NATURE, V344, P537, DOI 10.1038/344537a0; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; LOTZ BP, 1985, S AFR MED J, V67, P812; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, GENOMICS, V15, P446, DOI 10.1006/geno.1993.1087; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; MANLY BFJ, 1985, STATISTICS NATURAL S; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; NEI M, 1974, GENETICS, V76, P379; NEI M, 1993, MOL BIOL EVOL, V10, P927; NEI M, 1971, MOL EVOLUTIONARY GEN; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; Nurse GT., 1985, PEOPLES SO AFRICA TH; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; RUBINSZTEIN DC, 1994, HUM MOL GENET, V3, P2031; SHAW AM, 1993, AM J HUM GENET, V53, P731; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; YAMAGATA H, 1992, LANCET, V339, P692, DOI 10.1016/0140-6736(92)90862-W	31	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1373	1378						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762560				2022-12-18	WOS:A1995RA79400016
J	MICHAUD, J; THOMPSON, GN; BRODY, LC; STEEL, G; OBIE, C; FONTAINE, G; SCHAPPERT, K; KEITH, CG; VALLE, D; MITCHELL, GA				MICHAUD, J; THOMPSON, GN; BRODY, LC; STEEL, G; OBIE, C; FONTAINE, G; SCHAPPERT, K; KEITH, CG; VALLE, D; MITCHELL, GA			PYRIDOXINE-RESPONSIVE GYRATE ATROPHY OF THE CHOROID AND RETINA - CLINICAL AND BIOCHEMICAL CORRELATES OF THE MUTATION A226V	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ORNITHINE-DELTA-AMINOTRANSFERASE; OMEGA-AMINO ACID; MOLECULAR CHARACTERIZATION; PYRUVATE AMINOTRANSFERASE; SYNTHASE DEFICIENCY; ESCHERICHIA-COLI; CDNA CLONE; SEQUENCE; GENE; EXPRESSION	We discovered the missense mutation, A226V, in the ornithine-delta-aminotransferase (OAT) genes of two unrelated patients with gyrate atrophy of the choroid and retina (GA). One patient, who was a compound for A226V and for the premature termination allele R398ter, showed a significant (P < .01) decrease in mean plasma ornithine levels, following pyridoxine supplementation with a constant protein intake: 826 +/- 128 mu M (n = 5; no pyridoxine supplementation) versus 504 +/- 112 mu M (n = 6; 500 mg pyridoxine/d) and 546 +/- 19 mu M (n = 6; 1,000 mg pyridoxine/d). In extracts of fibroblasts from a second GA patient homozygous for A226V and from Chinese hamster ovary cells expressing an OAT-cDNA-containing A226V, we found that OAT activity increased from undetectable levels to similar to 10% of normal when the concentration of pyridoxal phosphate was increased from 50 to 600 mu M. A226V is the fourth disease-causing pyridoxine-responsive human mutation to be reported.	HOP ST JUSTINE, SERV GENET MED, MONTREAL, PQ H3T 1C5, CANADA; ROYAL CHILDRENS HOSP, CANADIAN GENET DIS NETWORK, MELBOURNE, VIC, AUSTRALIA; ROYAL CHILDRENS HOSP, MURDOCH INST, MELBOURNE, VIC, AUSTRALIA; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT BIOL MOLEC, BALTIMORE, MD USA; JOHNS HOPKINS UNIV, SCH MED, HOWARD HUGHES MED INST, BALTIMORE, MD USA; HOSP SICK CHILDREN, DEPT MED GENET, TORONTO, ON M5G 1X8, CANADA	Universite de Montreal; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)					NEI NIH HHS [EY02948] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002948] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AKAKI Y, 1992, J BIOL CHEM, V267, P12950; BERSON EL, 1978, OPHTHALMOLOGY, V85, P1018; BRODY LC, 1992, J BIOL CHEM, V267, P3302; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COTTER PD, 1992, P NATL ACAD SCI USA, V89, P4028, DOI 10.1073/pnas.89.9.4028; COX TC, 1994, NEW ENGL J MED, V330, P675, DOI 10.1056/NEJM199403103301004; DEGOLS G, 1987, EUR J BIOCHEM, V165, P289, DOI 10.1111/j.1432-1033.1987.tb11440.x; DELAUNEY AJ, 1993, J BIOL CHEM, V268, P18673; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HAYASAKA S, 1981, BRIT J OPHTHALMOL, V65, P478, DOI 10.1136/bjo.65.7.478; HU FL, 1993, HUM MOL GENET, V2, P1857, DOI 10.1093/hmg/2.11.1857; INANA G, 1988, INVEST OPHTH VIS SCI, V29, P1001; INANA G, 1986, P NATL ACAD SCI USA, V83, P1203, DOI 10.1073/pnas.83.5.1203; INANA G, 1989, J BIOL CHEM, V264, P17432; KENNAWAY NG, 1980, AM J HUM GENET, V32, P529; KENNAWAY NG, 1989, AM J HUM GENET, V44, P344; KOZICH V, 1993, HUM MOL GENET, V2, P815, DOI 10.1093/hmg/2.6.815; KRAUS JP, 1993, HUM MOL GENET, V2, P1633, DOI 10.1093/hmg/2.10.1633; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LABUDA D, 1989, NUCLEIC ACIDS RES, V17, P2477, DOI 10.1093/nar/17.7.2477; MARKOVICHOUSLEY Z, 1987, EUR J BIOCHEM, V162, P345, DOI 10.1111/j.1432-1033.1987.tb10607.x; MARTIN LS, 1991, NUCLEIC ACIDS RES, V19, P1962, DOI 10.1093/nar/19.8.1962; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; MCCLATCHEY AI, 1990, AM J HUM GENET, V47, P790; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; MITCHELL GA, 1988, J CLIN INVEST, V81, P630, DOI 10.1172/JCI113365; MITCHELL GA, 1988, J BIOL CHEM, V263, P14288; MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; MORINO Y, 1990, ANN NY ACAD SCI, V585, P32, DOI 10.1111/j.1749-6632.1990.tb28039.x; MUECKLER MM, 1985, J BIOL CHEM, V260, P2993; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; OTSUKA AJ, 1988, J BIOL CHEM, V263, P19577; PARK JK, 1992, GENOMICS, V14, P553, DOI 10.1016/S0888-7543(05)80271-X; RAMESH V, 1986, DNA-J MOLEC CELL BIO, V5, P493, DOI 10.1089/dna.1.1986.5.493; RAMESH V, 1988, P NATL ACAD SCI USA, V85, P3777, DOI 10.1073/pnas.85.11.3777; RAMESH V, 1990, Investigative Ophthalmology and Visual Science, V31, P310; RICHARDSON IB, 1989, MOL GEN GENET, V217, P118, DOI 10.1007/BF00330950; SCHAUMBURG HH, 1988, CLIN PHYSL APPLICATI, P403; SCHMID SR, 1993, MOL BIOCHEM PARASIT, V61, P311, DOI 10.1016/0166-6851(93)90076-A; SIMMACO M, 1986, FEBS LETT, V199, P39, DOI 10.1016/0014-5793(86)81219-4; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; VALLE D, 1989, METABOLIC BASIS INHE, P599; WATANABE N, 1989, J BIOCHEM, V105, P1, DOI 10.1093/oxfordjournals.jbchem.a122600; WATANABE N, 1990, INT UNION BIOCH S, V199, P121; YONAHA K, 1992, J BIOL CHEM, V267, P12506	46	25	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					616	622						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887415				2022-12-18	WOS:A1995QK91800009
J	SASAKI, H; WAKISAKA, A; TAKADA, A; YOSHIKI, T; IHARA, T; SUZUKI, Y; HAMADA, T; IWABUCHI, K; ONARI, K; TADA, J; SUZUKI, T; TASHIRO, K				SASAKI, H; WAKISAKA, A; TAKADA, A; YOSHIKI, T; IHARA, T; SUZUKI, Y; HAMADA, T; IWABUCHI, K; ONARI, K; TADA, J; SUZUKI, T; TASHIRO, K			MAPPING OF THE GENE FOR MACHADO-JOSEPH DISEASE WITHIN A 3.6-CM INTERVAL FLANKED BY D143291/D14S280 AND D14S81, ON THE BASIS OF STUDIES OF LINKAGE AND LINKAGE DISEQUILIBRIUM IN 24 JAPANESE FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT CEREBELLAR-ATAXIA; MYOCLONUS EPILEPSY; CAG REPEAT; DEGENERATION; RECOMBINATION; DISORDER; KINDREDS; ATROPHY; LOCUS; MAPS	The gene locus of Machado-Joseph disease (MJD) has recently been mapped within a 29-cM subregion of 14q chromosome. We did a linkage study of 24 multigenerational MJD Japanese pedigrees, in an attempt to narrow the candidate region of this gene. Pairwise and multipoint linkage analysis, together with haplotype segregation analysis, led to the conclusion that the MJD gene is located at the 6.8-cM interval between D14S256 and D14S81 (Z(max) = 24.78, multipoint linkage analysis). D14S291 and D14S280, located at the center of this interval, showed no obligate recombination with the MJD gene (Z(max) = 5.93 for D14S291 and 9.99 for D14S280). A weak, but significant, linkage disequilibrium of MSD gene was noted with D14S81 (P < .05) but not with D14S291 or D14S280. These results suggest that a 3.6-cM interval flanked by D14S291/D14S280 and D14S81 is the most likely location of the MJD gene and that it is closest to D14S81.	HOKKAIDO UNIV,SCH MED,DEPT PATHOL,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN; HOKKAIDO UNIV,SCH MED,DEPT NEUROL,SAPPORO,HOKKAIDO 060,JAPAN; HOKUYUKAI NEUROL HOSP,SAPPORO,HOKKAIDO,JAPAN; YAMAGATA UNIV,DEPT INTERNAL MED,YAMAGATA,JAPAN; TOKYO INST PSYCHIAT,DEPT NEUROPATHOL,TOKYO,JAPAN; UNIV OCCUPAT & ENVIRONM HLTH,DEPT NEUROL,KITAKYUSHU,FUKUOKA,JAPAN; KYUSHU UNIV,DEPT CLIN GENET,BEPPU,OITA,JAPAN	Hokkaido University; Hokkaido University; Yamagata University; Tokyo Institute of Psychiatry; University of Occupational & Environmental Health - Japan; Kyushu University								BUESTOW KH, 1994, NAT GENET, V6, P391; CANCEL G, 1994, NAT GENET, V6, P8, DOI 10.1038/ng0194-8; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; IIZUKA R, 1984, J NEUROL NEUROSUR PS, V47, P1288, DOI 10.1136/jnnp.47.12.1288; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIMA L, 1980, NEUROLOGY, V30, P319, DOI 10.1212/WNL.30.3.319; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; NAKANO KK, 1972, NEUROLOGY, V22, P49, DOI 10.1212/WNL.22.1.49; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1985, ANAL HUMAN GENETIC L; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; PULST SM, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8c; RANUM LPW, 1991, AM J HUM GENET, V49, P31; ROMANUL FCA, 1977, NEW ENGL J MED, V296, P1505, DOI 10.1056/NEJM197706302962606; ROSENBERG RN, 1976, NEUROLOGY, V26, P703, DOI 10.1212/WNL.26.8.703; SAKAI T, 1983, NEUROLOGY, V33, P74, DOI 10.1212/WNL.33.1.74; SASAKI H, 1992, CLIN NEUROL TOKYO, V32, P13; STEVANIN G, 1994, AM J HUM GENET, V54, P11; TAKAHATA N, 1978, NEUROLOGY, V28, P913, DOI 10.1212/WNL.28.9.913; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; WOODS BT, 1972, J NEUROL SCI, V17, P149, DOI 10.1016/0022-510X(72)90137-2; YUASA T, 1986, ANN NEUROL, V19, P152, DOI 10.1002/ana.410190207; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	33	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					231	242						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825583				2022-12-18	WOS:A1995QC10100030
J	HEWETT, D; LYNCH, J; CHILD, A; FIRTH, H; SYKES, B				HEWETT, D; LYNCH, J; CHILD, A; FIRTH, H; SYKES, B			DIFFERENTIAL ALLELIC EXPRESSION OF A FIBRILLIN GENE (FBNI) IN PATIENTS WITH MARFAN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OSTEOGENESIS IMPERFECTA; CALCIUM-BINDING; CHROMOSOME-15; MUTATION; SEQUENCE; COLLAGEN; LINKAGE; DNA	Marfan syndrome is a connective-tissue disorder affecting cardiovascular, skeletal, and ocular systems. The major Marfan locus has been identified as the FBN1 gene on chromosome 15; this codes for the extracellular-matrix protein fibrillin, a 350-kD constituent of the 8-10-nm elastin-associated microfibrils. We identified five MFS patients who were heterozygous for an RsaI restriction-site dimorphism in the 3' UTR of the FBN1 gene. This expressed variation was used to distinguish the mRNA output from each of the two FBN1 alleles in fibroblast cultures from these five patients. Three of the patients were shown to produce <5% of the normal level of FBN1 transcripts from one of their alleles. This null-allele phenotype was not observed in 10 nonmarfanoid fibroblast cell lines.	UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; CHURCHILL HOSP,DEPT MED GENET,OXFORD OX3 7LJ,ENGLAND; ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON SW17 0RE,ENGLAND	University of Oxford; University of Oxford; St Georges University London								BYERS PH, 1993, HUM MUTAT, V2, P80, DOI 10.1002/humu.1380020203; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1991, GENOMICS, V9, P355, DOI 10.1016/0888-7543(91)90264-F; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; HEWETT DR, 1994, J MED GENET, V31, P338, DOI 10.1136/jmg.31.4.338; HEWETT DR, 1993, HUM MOL GENET, V2, P475, DOI 10.1093/hmg/2.4.475; KAINULAINEN K, 1990, NEW ENGL J MED, V323, P935, DOI 10.1056/NEJM199010043231402; KAZAZIAN HH, 1989, PCR TECHNOLOGY, P165; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; MAGENIS RE, 1991, GENOMICS, V11, P346, DOI 10.1016/0888-7543(91)90142-2; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; MCINNES RR, 1993, CURR OPIN GENET DEV, V3, P475, DOI 10.1016/0959-437X(93)90123-7; MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589; ORKIN SH, 1984, ANNU REV GENET, V18, P131; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Pyeritz Reed E., 1993, P437; RAGHUNATH M, 1993, AM J HUM GENET, V47, P143; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; STACEY A, 1988, NATURE, V332, P131, DOI 10.1038/332131a0; SYKES B, 1993, NAT GENET, V3, P99, DOI 10.1038/ng0293-99; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; Weatherall David J., 1991, NEW GENETICS CLIN PR; WILLING MC, 1992, AM J HUM GENET, V51, P508	26	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					447	452						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	7915876				2022-12-18	WOS:A1994PF50900005
J	LEDOUX, P; SCRIVER, C; HECHTMAN, P				LEDOUX, P; SCRIVER, C; HECHTMAN, P			4 NOVEL PEPD ALLELES CAUSING PROLIDASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; ESCHERICHIA-COLI; METACHROMATIC LEUKODYSTROPHY; BETA-HEXOSAMINIDASE; MOLECULAR-BASIS; GENE; FIBROBLASTS; IMINODIPEPTIDURIA; SUBSTITUTION; EXPRESSION	Mutations at the PEPD locus cause prolidase deficiency (McKusick 170100), a rare autosomal recessive disorder characterized by iminodipeptiduria, skin ulcers, mental retardation, and recurrent infections. Four PEPD mutations from five severely affected individuals were characterized by analysis of reverse-transcribed, PCR-amplified (RT-PCR) cDNA. We used SSCP analysis on four overlapping cDNA fragments covering the entire coding region of the PEPD gene and detected abnormal SSCP bands for the fragment spanning all or part of exons 13-15 in three of the probands. Direct sequencing of the mutant cDNAs showed a G --> A, 1342 substitution (G448R) in two patients and a 3-bp deletion (Delta E452 or Delta E453) in another. In the other two probands the amplified products were of reduced size. Direct sequencing of these mutant cDNAs revealed a deletion of exon 5 in one patient and of exon 7 in the other. Intronic sequences flanking exons 5 and 7 were identified using inverse PCR followed by direct sequencing. Conventional PCR and direct sequencing then established the intron-exon borders of the mutant genomic DNA revealing two splice acceptor mutations: a G --> C substitution at position -1 of intron 4 and an A --> G substitution at position -2 of intron 6. Our results indicate that the severe form of prolidase deficiency is caused by multiple PEPD alleles. In this report we attempt to begin the process of describing these alleles and cataloging their phenotypic expression.	MCGILL UNIV,DEPT BIOL,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 2T5,PQ,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA	McGill University; McGill University; McGill University								BISSONNETTE R, 1993, J AM ACAD DERMATOL, V29, P818, DOI 10.1016/0190-9622(93)70245-O; BORIGHT AP, 1989, AM J HUM GENET, V44, P731; BUTLER MJ, 1993, GENE, V123, P115, DOI 10.1016/0378-1119(93)90549-I; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; ENDO F, 1989, J BIOL CHEM, V264, P4476; FRANCIS GS, 1993, ANN NEUROL, V34, P212, DOI 10.1002/ana.410340218; GIESELMANN V, 1991, HUM GENET, V86, P251; GRAY RGF, 1983, J INHERIT METAB DIS, V6, P143; ISEMURA M, 1979, CLIN CHIM ACTA, V93, P401, DOI 10.1016/0009-8981(79)90291-2; JACKSON SH, 1975, CAN MED ASSOC J, V113, P759; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMIEUX B, 1984, J INHERIT METAB DIS, V7, P145; MANIATIS T, 1992, MOL CLONING; NAKAHIGASHI K, 1990, NUCLEIC ACIDS RES, V18, P6439, DOI 10.1093/nar/18.21.6439; NAUGHTEN ER, 1984, PEDIATR RES, V18, P259, DOI 10.1203/00006450-198403000-00008; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; OCHMAN H, 1988, GENETICS, V120, P621; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; Phang JM, 1989, METABOLIC BASIS INHE, P577; PROIA RL, 1984, J BIOL CHEM, V259, P3350; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SILVER J, 1989, J CELL BIOCH E S, V13, P306; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; TANOUE A, 1990, J BIOL CHEM, V265, P11306; TANOUE A, 1990, J CLIN INVEST, V86, P351, DOI 10.1172/JCI114708; TRIGGSRAINE BL, 1992, AM J HUM GENET, V51, P793; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; UMEMURA S, 1978, PHYSIOL CHEM PHYS M, V10, P279; YOSHIMOTO T, 1989, J BIOCHEM, V105, P412, DOI 10.1093/oxfordjournals.jbchem.a122678	31	25	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					1014	1021						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	8198124				2022-12-18	WOS:A1994NP05300009
J	OWERBACH, D; GABBAY, KH				OWERBACH, D; GABBAY, KH			LINKAGE OF THE VNTR INSULIN-GENE AND TYPE-I DIABETES-MELLITUS - INCREASED GENE SHARING IN AFFECTED SIBLING PAIRS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN INSULIN GENE; HLA-D; SUSCEPTIBILITY; REGION; INDIVIDUALS; ASSOCIATION; DISEASE; LOCUS; IDDM	Ninety-six multiplex type I diabetic families were typed at the 5' flanking region of the insulin gene by using a PCR assay that better resolves the VNTR into multiple alleles. Affected sibling pairs shared 2, 1, and 0 VNTR alleles-identical by descent-at a frequency of .47, .45, and .08, respectively, a ratio that deviated from the expected 1:2:1 ratio (P<.001). These results confirm linkage of the chromosome 11p15.5 region with type I diabetes mellitus susceptibility.	BAYLOR COLL MED,DIABET RES CTR,MOLEC DIABET & METAB SECT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine	OWERBACH, D (corresponding author), BAYLOR COLL MED,DEPT PEDIAT,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.		Owerbach, David/A-3144-2008		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039044] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-39044] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; EASTON DF, 1989, GENET EPIDEMIOL, V6, P83, DOI 10.1002/gepi.1370060116; FIELD LL, 1988, AM J HUM GENET, V43, P793; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; LAW A, 1992, HUM GENET, V88, P562, DOI 10.1007/BF00219345; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; OWERBACH D, 1989, DIABETES, V38, P942, DOI 10.2337/diabetes.38.7.942; OWERBACH D, 1983, NATURE, V303, P815, DOI 10.1038/303815a0; OWERBACH D, 1988, DIABETOLOGIA, V31, P751, DOI 10.1007/BF00274778; OWERBACH D, 1983, GENETICS, V32, P475; OWERBACH D, 1993, DIABETES, V72, P1708; PLATZ P, 1981, DIABETOLOGIA, V21, P108; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P3753, DOI 10.1093/nar/19.13.3753; RISCH N, 1987, AM J HUM GENET, V40, P1; ROTTER JI, 1984, CLIN GENET, V26, P529; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; WALKER A, 1980, DIABETES, V29, P1036, DOI 10.2337/diabetes.29.12.1036; WOLF E, 1983, DIABETOLOGIA, V24, P224	20	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					909	912						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	7909987				2022-12-18	WOS:A1994NH39400021
J	BOWCOCK, AM; TOMFOHRDE, J; WEISSENBACH, J; BONNETAMIR, B; STGEORGEHYSLOP, P; GIAGHEDDU, M; CAVALLISFORZA, LL; FARRER, LA				BOWCOCK, AM; TOMFOHRDE, J; WEISSENBACH, J; BONNETAMIR, B; STGEORGEHYSLOP, P; GIAGHEDDU, M; CAVALLISFORZA, LL; FARRER, LA			REFINING THE POSITION OF WILSON DISEASE BY LINKAGE DISEQUILIBRIUM WITH POLYMORPHIC MICROSATELLITES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ESTERASE-D; GENETIC-ANALYSIS; LOCUS; IDENTIFICATION; CHROMOSOME-13; MARKERS; REGION	Wilson disease (WND) is an autosomal recessive disorder that is due to an inability of the liver to eliminate copper. Copper buildup in the liver, brain, kidney, and other tissues can result in liver cirrhosis, neurologic and psychiatric defects, and other problems. We have localized the disease-containing region to between D13S31 and D13S59, with >70 multiply affected families, and have constructed a YAC contig of >4.5 Mb that spans these loci and orders nine highly polymorphic microsatellites. Here we present an analysis of disequilibrium with markers in this interval and provide evidence for strong allelic associations between AFM084xc5 alleles and WND alleles in European, Middle Eastern, and East Asian populations. Significant but weaker allelic associations were also observed between WND alleles and alleles at D13S137 and D13S169. The strength of the association between AFM084xc5 and WND in all non-Sardinian populations combined (linkage-disequilibrium coefficient [PHI]= .61) suggests that the number of mutations accounting for WND is less than expected on the basis of the variety of clinical symptoms that are observed.	UNIV TEXAS, SW MED CTR, DEPT PEDIAT, DALLAS, TX 75230 USA; GENETHON, PARIS, FRANCE; TEL AVIV UNIV, SCH MED, DEPT HUMAN GENET, IL-69978 TEL AVIV, ISRAEL; UNIV TORONTO, DEPT NEUROL, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, DEPT MED, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV CAGLIARI, IST CLIN NEUROL & MED, I-09100 CAGLIARI, ITALY; STANFORD UNIV, MED CTR, SCH MED, DEPT GENET, STANFORD, CA 94305 USA; BOSTON UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02118 USA; BOSTON UNIV, SCH MED, DEPT EPIDEMIOL & BIOSTAT, BOSTON, MA 02118 USA; HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tel Aviv University; University of Toronto; University of Toronto; University of Cagliari; Stanford University; Boston University; Boston University; Harvard University; Harvard Medical School			Farrer, Lindsay/AAS-1035-2020	Bowcock, Anne/0000-0001-8691-9090; Farrer, Lindsay/0000-0001-5533-4225	NIDDK NIH HHS [DK45052] Funding Source: Medline; NIGMS NIH HHS [GM28428] Funding Source: Medline; NINDS NIH HHS [NS26454] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS026454] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BONNETAMIR B, 1990, ANN HUM GENET, V54, P155, DOI 10.1111/j.1469-1809.1990.tb00372.x; BONNETAMIR B, 1986, GENET EPIDEMIOL, V3, P201, DOI 10.1002/gepi.1370030307; BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BOWCOCK AM, 1988, AM J HUM GENET, V43, P664; CHUANG LM, 1991, HUM GENET, V87, P465; COX DW, 1972, AM J HUM GENET, V24, P646; Danks DM, 1989, METABOLIC BASIS INHE, P1411; FARRALL M, 1987, LANCET, V2, P156; FARRER LA, 1991, NEUROLOGY, V41, P992, DOI 10.1212/WNL.41.7.992; FIGUS A, 1989, J MED GENET, V26, P78, DOI 10.1136/jmg.26.2.78; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; GIAGHEDDU A, 1985, ACTA NEUROL SCAND, V72, P43; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HILL GM, 1986, AM J MED SCI, V292, P344, DOI 10.1097/00000441-198612000-00002; KENDALL MG, 1979, ADV THEORY STATISTIC, V2; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MIGONE N, 1985, AM J HUM GENET, V37, P1146; PETRUKHIN KE, 1993, GENOMICS, V15, P76, DOI 10.1006/geno.1993.1012; SCHEFFER H, 1992, HUM GENET, V89, P607; SCHEINBERG H, 1984, MAJOR PROBLEMS INTER, V23; SCHEINBERG IH, 1987, NEW ENGL J MED, V317, P209, DOI 10.1056/NEJM198707233170405; STANBURY JB, 1978, METABOLIC BASIS INHE, P1098; STEWART EA, 1993, AM J HUM GENET, V53, P864; VOGEL F, 1986, HUMAN GENETICS; WEIR BS, 1990, GENTEIC DATA ANAL; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITE A, 1993, IN PRESS P NATL ACAD; Wilson SAK, 1911, BRAIN, V34, P295; YUZBASIYANGURKAN V, 1988, AM J HUM GENET, V42, P825; 1990, SAS USERS GUIDE STAT	32	25	25	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					79	87						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279473				2022-12-18	WOS:A1994MQ70000011
J	WILLIAMS, R; VESA, J; JARVELA, I; MCKAY, T; MITCHISON, H; HELLSTEN, E; THOMPSON, A; CALLEN, D; SUTHERLAND, G; LUNABATTADANO, D; STALLINGS, R; PELTONEN, L; GARDINER, M				WILLIAMS, R; VESA, J; JARVELA, I; MCKAY, T; MITCHISON, H; HELLSTEN, E; THOMPSON, A; CALLEN, D; SUTHERLAND, G; LUNABATTADANO, D; STALLINGS, R; PELTONEN, L; GARDINER, M			GENETIC-HETEROGENEITY IN NEURONAL CEROID-LIPOFUSCINOSIS (NCL) - EVIDENCE THAT THE LATE-INFANTILE SUBTYPE (JANSKY-BIELSCHOWSKY DISEASE CLN2) IS NOT AN ALLELIC FORM OF THE JUVENILE OR INFANTILE SUBTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BATTEN DISEASE; HUMAN CHROMOSOME-16; LINKAGE; VARIANT; LOCUS; MAPS	The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative disorders characterized by the accumulation of autofluorescent lipopigment in neurons and other cell types. Inheritance is autosomal recessive. Three main childhood subtypes are recognized: infantile (Haltia-Santavuori disease; MIM 256743), late infantile (Jansky-Bielschowsky disease; MIM 204500), and juvenile (Spielmeyer-Sjogren-Vogt, or Batten, disease; MIM 204200). The gene loci for the juvenile (CLN3) and infantile (CLN1) types have been mapped to human chromosomes 16p and lp, respectively, by linkage analysis. Linkage analysis of 25 families segregating for late-infantile NCL has excluded these regions as the site of this disease locus (CLN2). The three childhood subtypes of NCL therefore arise from mutations at distinct loci.	UNIV LONDON UNIV COLL,SCH MED,RAYNE INST,DEPT PAEDIAT,UNIV ST,LONDON WC1E 6JJ,ENGLAND; NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,SF-00280 HELSINKI 28,FINLAND; WOMEN & CHILDRENS HOSP,DEPT CYTOGENET & MOLEC GENET,CTR MED GENET,ADELAIDE,AUSTRALIA; HOSP NACL NINOS DR CARLOS SAENZ HERRERA,CAJA COSTARRICENSE SEGURO SOCIAL,SAN JOSE,COSTA RICA; LOS ALAMOS NATL LAB,CTR HUMAN GENOME STUDIES,LOS ALAMOS,NM 87544	University of London; King's College London; University College London; UCL Medical School; Finland National Institute for Health & Welfare; United States Department of Energy (DOE); Los Alamos National Laboratory			Sutherland, Grant Robert/D-2606-2012; Jarvela, Irma E/L-5836-2013; Mitchison, Hannah M./C-1891-2008; Stallings, Raymond/A-7213-2008; Callen, David F/G-1975-2012	Jarvela, Irma E/0000-0002-1770-6187; Callen, David/0000-0002-6189-9991; Mitchison, Hannah/0000-0002-3163-6293; McKay, Tristan/0000-0002-9128-9115				CALLEN DF, 1991, AM J HUM GENET, V49, P1372; EIBERG H, 1989, CLIN GENET, V36, P217; GARDINER M, 1990, GENOMICS, V8, P387, DOI 10.1016/0888-7543(90)90297-8; HALL NA, 1991, BIOCHEM J, V275, P269, DOI 10.1042/bj2750269; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; JARVELA I, 1991, GENOMICS, V9, P170, DOI 10.1016/0888-7543(91)90235-7; JARVELA I, 1991, GENOMICS, V10, P333, DOI 10.1016/0888-7543(91)90316-7; KONRADI C, 1991, NUCLEIC ACIDS RES, V19, P5449, DOI 10.1093/nar/19.19.5449; LAKE BD, 1978, J NEUROL SCI, V36, P265, DOI 10.1016/0022-510X(78)90087-4; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MAKELA TP, 1992, HUM MOL GENET, V1, P217, DOI 10.1093/hmg/1.3.217-a; MITCHISON HM, 1993, GENOMICS, V16, P455, DOI 10.1006/geno.1993.1210; SANTAVUORI P, 1988, BRAIN DEV-JPN, V10, P80, DOI 10.1016/S0387-7604(88)80075-5; SANTAVUORI P, 1974, DEV MED CHILD NEUROL, V16, P644; SANTAVUORI P, 1982, NEUROPEDIATRICS, V13, P135, DOI 10.1055/s-2008-1059612; THOMPSON AD, 1992, GENOMICS, V13, P402, DOI 10.1016/0888-7543(92)90260-Y; Vesa J., 1993, European Journal of Human Genetics, V1, P125	17	25	25	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					931	935						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213822				2022-12-18	WOS:A1993LY62700018
J	PUCK, JM; CONLEY, ME; BAILEY, LC				PUCK, JM; CONLEY, ME; BAILEY, LC			REFINEMENT OF LINKAGE OF HUMAN SEVERE COMBINED IMMUNODEFICIENCY (SCIDX1) TO POLYMORPHIC MARKERS IN XQ13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-CHROMOSOME INACTIVATION; TRANSLOCATION; LOCALIZATION; REGION; FEMALE	The most commmon form of human severe combined immunodeficiency (SCID) is inherited as an X-linked recessive genetic defect, MIM 300400. The disease locus, SCIDX1, has previously been placed in Xq13.1-q21.1 by demonstration of linkage to polymorphic markers between DXS159 and DXS3 and by exclusion from interstitial deletions of Xq21.1-q21.3. We report an extension of previous linkage studies, with new markers and a total of 25 SCIDX1 families including female carriers identified by nonrandom X chromosome inactivation in their T lymphocytes. SCIDX1 was nonrecombinant with DXS441, with a lod score of 17.96. Linkage relationships of new markers in the SCIDX1 families were consistent with the linkage map generated in the families of the Centre d'Etude du Polymorphisme Humain (CEPH) and with available physical map data. The most likely locus order was DXS1-(DXS159,DXS153)-DXS106-DXS132-DXS453-(SCIDX1,PGK1, DXS325,DXS347,DXS441)-DXS447-DXS72-DXYS1X-DXS3. The SCIDX1 region now spans approximately 10 Mb of DNA in Xq13; this narrowed genetic localization will assist efforts to identify gene candidates and will improve genetic management for families with SCID.	UNIV PENN, SCH MED, PHILADELPHIA, PA 19104 USA; ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN 38101 USA; UNIV TENNESSEE CTR HLTH SCI, SCH MED, MEMPHIS, TN 38163 USA	University of Pennsylvania; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	PUCK, JM (corresponding author), CHILDRENS HOSP PHILADELPHIA, DIV INFECT DIS & IMMUNOL, 1 CHILDRENS CTR, PHILADELPHIA, PA 19104 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023679] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI025129, R01AI025129, R37AI025129] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00233] Funding Source: Medline; NIAID NIH HHS [AI25129] Funding Source: Medline; NICHD NIH HHS [HD23679] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CONLEY ME, 1988, P NATL ACAD SCI USA, V85, P3090, DOI 10.1073/pnas.85.9.3090; CONLEY ME, 1991, CLIN IMMUNOL IMMUNOP, V61, pS94, DOI 10.1016/S0090-1229(05)80043-1; CONLEY ME, 1990, J CLIN INVEST, V85, P1548, DOI 10.1172/JCI114603; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DESAINTBASILE G, 1987, P NATL ACAD SCI USA, V84, P7576; FIREMAN P, 1966, PEDIATRICS, V37, P485; FISCHER A, 1990, LANCET, V336, P850, DOI 10.1016/0140-6736(90)92348-L; GATTI RA, 1968, LANCET, V2, P1366; HIMELSTEIN BP, 1993, J PEDIATR-US, V122, P289, DOI 10.1016/S0022-3476(06)80135-6; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MAHTANI MM, 1991, GENOMICS, V10, P849, DOI 10.1016/0888-7543(91)90172-B; PUCK JM, 1992, AM J HUM GENET, V50, P742; PUCK JM, 1993, PEDIATR RES, V33, pS29; PUCK JM, 1987, J CLIN INVEST, V79, P1395, DOI 10.1172/JCI112967; PUCK JM, 1990, NEW ENGL J MED, V322, P1063, DOI 10.1056/NEJM199004123221508; PUCK JM, 1989, AM J HUM GENET, V44, P724; RAM KT, 1992, NUCLEIC ACIDS RES, V20, P1428, DOI 10.1093/nar/20.6.1428; STIEHM R, 1993, PEDIATR RES S, V33, pS2; TUMER Z, 1992, HUM MOL GENET, V1, P483, DOI 10.1093/hmg/1.7.483; VERGA V, 1991, AM J HUM GENET, V48, P1133; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4037, DOI 10.1093/nar/18.13.4037; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727; ZONANA J, 1988, J MED GENET, V25, P383, DOI 10.1136/jmg.25.6.383; 1992, IMMUNODEFIC REV, V3, P195	25	25	26	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					176	184						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317482				2022-12-18	WOS:A1993LJ38500021
J	FARRALL, M; BUETOW, KH; MURRAY, JC				FARRALL, M; BUETOW, KH; MURRAY, JC			RESOLVING AN APPARENT PARADOX CONCERNING THE ROLE OF TGFA IN CL/P	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GROWTH-FACTOR-ALPHA; CLEFT-LIP; GENETIC-VARIATION; PALATE; LINKAGE; ASSOCIATION		FOX CHASE CANC CTR,PHILADELPHIA,PA 19111; UNIV IOWA HOSP & CLIN,DEPT PEDIAT,IOWA CITY,IA 52242	Fox Chase Cancer Center; University of Iowa	FARRALL, M (corresponding author), ROYAL POSTGRAD MED SCH,MRC,MOLEC MED GRP,LONDON W12 0HS,ENGLAND.							ARDINGER HH, 1989, AM J HUM GENET, V45, P348; CARTER CO, 1982, J MED GENET, V19, P246, DOI 10.1136/jmg.19.4.246; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; CHOTAI J, 1984, ANN HUM GENET, V48, P359, DOI 10.1111/j.1469-1809.1984.tb00849.x; CLERGETDARPOUX F, 1992, ANN HUM GENET, V56, P145, DOI 10.1111/j.1469-1809.1992.tb01140.x; Fogh-Andersen, 1942, INHERITANCE HARELIP; HECHT JT, 1991, AM J HUM GENET, V49, P674; HECHT JT, 1991, AM J HUM GENET, V49, P682; HOLDER SE, 1991, CYTOGENET CELL GENET, V58, P1869; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; MORTON NE, 1955, AM J HUM GENET, V7, P277; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1987, AM J HUM GENET, V40, P1; SHIANG R, 1991, CYTOGENET CELL GENET, V58, P1872; STOLL C, 1992, AM J HUM GENET, V50, P870	16	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					434	436						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8094269				2022-12-18	WOS:A1993KN27500024
J	STANKOVICS, J; LEDLEY, FD				STANKOVICS, J; LEDLEY, FD			CLONING OF FUNCTIONAL ALPHA-PROPIONYL COA CARBOXYLASE AND CORRECTION OF ENZYME DEFICIENCY IN PCCA FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE-CHAIN-REACTION; GENETIC COMPLEMENTATION; METHYLMALONIC ACIDEMIA; CDNA CLONING; MUT; CELLS	Propionyl CoA carboxylase (PPC) is a heteromeric enzyme composed of alpha subunits (PCCA) and beta (PCCB) subunits. We describe cDNA clones expressing human PCCA and complementation of the genetic defect in pccA fibroblasts by DNA-mediated gene transfer. Two cDNA clones were constructed. The first corresponds to the previously reported, putatively full-length, open reading frame. The second encodes a chimera composed of the mitochondrial leader sequence of human methylmalonyl CoA mutase and the mature PCCA protein. Both clones reconstitute propionate flux to normal levels in fibroblasts from patients genetically deficient in PCCA (pccA). The maximal level of propionate flux approached, but never exceeded, the levels seen in control plates of normal cells. In contrast, the maximal level of PPC holoenzyme activity reached only 10%-20% that of normal controls, which corresponded roughly to the fraction of cells actually transformed with the recombinant gene. These data suggest that the level of PCCA expression in fibroblasts does not normally limit PCC holoenzyme activity or propionate flux. The fact that a small fraction of cells reconstitutes propionate flux to normal levels suggests that metabolic cooperation between cells is capable of increasing the metabolic capacity of recombinant enzyme in a subpopulation of cells. These factors may have important implications for the rational design of somatic gene therapy for PCCA deficiency.	BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT PEDIAT,HOUSTON,TX 77030	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Howard Hughes Medical Institute					NICHD NIH HHS [HD-24186, HD-24064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD024186, R01HD024186] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDREWS E, UNPUB ACTIVITY RECOM; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; BROWNER MF, 1989, J BIOL CHEM, V21, P12685; GRAVEL RA, 1977, AM J HUM GENET, V29, P378; HSIA YE, 1971, J CLIN INVEST, V50, P127, DOI 10.1172/JCI106466; INNIS MA, 1990, PCR PROTOCOLS; JANSEN R, 1989, GENOMICS, V4, P198, DOI 10.1016/0888-7543(89)90300-5; JANSEN R, 1990, AM J HUM GENET, V47, P808; KRAUS JP, 1986, P NATL ACAD SCI USA, V83, P2047, DOI 10.1073/pnas.83.7.2047; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; Lam Hon Wah A M, 1983, Am J Hum Genet, V35, P889; LAMHONWAH AM, 1986, P NATL ACAD SCI USA, V83, P4864, DOI 10.1073/pnas.83.13.4864; LAMHONWAH AM, 1987, AM J HUM GENET, V41, P1124; LEDLEY FD, 1990, AM J HUM GENET, V46, P539; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; OHURA T, 1989, AM J HUM GENET, V45, P33; ROSENBERG LE, 1989, METABOLIC BASIS INHE, V1, P821; SAWADA T, IN PRESS SOMAT CEL M; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; WILKEMEYER M, IN PRESS SOMAT CELL; WILKEMEYER MF, 1991, J CLIN INVEST, V87, P915, DOI 10.1172/JCI115098; WOLF B, 1980, AM J HUM GENET, V32, P16; WOLF B, 1978, AM J HUM GENET, V30, P455; WOLF B, 1979, J PEDIATR-US, V95, P563, DOI 10.1016/S0022-3476(79)80768-4	24	25	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					144	151						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434582				2022-12-18	WOS:A1993KK90800017
J	ZONANA, J; GAULT, J; DAVIES, KJP; JONES, M; BROWNE, D; LITT, M; BROCKDORFF, N; RASTAN, S; CLARKE, A; THOMAS, NST				ZONANA, J; GAULT, J; DAVIES, KJP; JONES, M; BROWNE, D; LITT, M; BROCKDORFF, N; RASTAN, S; CLARKE, A; THOMAS, NST			DETECTION OF A MOLECULAR DELETION AT THE DXS732 LOCUS IN A PATIENT WITH X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA (EDA), WITH THE IDENTIFICATION OF A UNIQUE JUNCTIONAL FRAGMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; CHROMOSOME; FEMALE; MOUSE; CONSTRUCTION; LIBRARIES; TABBY	X-linked hypohidrotic ectodermal dysplasia (EDA) has been localized to the Xq12-q13.1 region. A panel of genomic DNA samples from 80 unrelated males with EDA has been screened for deletions at seven genetic loci within the Xq12-13 region. A single individual was identified with a deletion at the DXS732 locus by hybridization with the mouse genomic probe pcos169E/4. This highly conserved DNA probe is from locus DXCrc169, which is tightly linked to the Ta locus, the putative mouse homologue of EDA. The proband had the classical phenotype of EDA, with no other phenotypic abnormalities, and a normal cytogenetic analysis. A human genomic DNA clone, homologous to pcos169E/4, was isolated from a human X-chromosome cosmid library. On hybridization with the cosmid, the proband was found to be only partially deleted at the DXS732 locus, with a unique junctional fragment identified in the proband and in three of his maternal relatives. This is the first determination of carrier status for EDA in females, by direct mutation analysis. Failure to detect deletion of the other loci tested in the proband suggests that the DXS732 locus is the closest known locus to the EDA gene. Since the DXS732 locus contains a highly conserved sequence, it must be considered to be a candidate locus for the EDA gene itself.	OREGON HLTH SCI UNIV,DEPT PEDIAT,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201; UNIV WALES COLL MED,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES; MRC,CLIN RES CTR,COMPARAT BIOL SECT,HARROW HA1 3UJ,MIDDX,ENGLAND	Oregon Health & Science University; Oregon Health & Science University; Cardiff University; Medical Research Council Clinical Trials Unit	ZONANA, J (corresponding author), OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,L-103,3181 SW SAM JACKSON PK RD,PORTLAND,OR 97201, USA.			Brockdorff, Neil/0000-0003-4838-2653	NHGRI NIH HHS [HG00022] Funding Source: Medline; NIAMS NIH HHS [R01 AR40741] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040741] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BLECHER SR, 1986, J INVEST DERMATOL, V87, P720, DOI 10.1111/1523-1747.ep12456718; BORGANOKAR D, 1989, CHROMOSOMAL VARIATIO, P556; BROCKDORFF N, 1991, MAMM GENOME, V1, P152, DOI 10.1007/BF00351061; BROCKDORFF N, 1990, GENOMICS, V7, P573, DOI 10.1016/0888-7543(90)90201-5; BROCKDORFF N, 1991, GENOMICS, V10, P17, DOI 10.1016/0888-7543(91)90478-W; CATTANACH BM, 1991, CYTOGENET CELL GENET, V56, P137, DOI 10.1159/000133070; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; CRAWFORD PJM, 1991, J MED GENET, V28, P181, DOI 10.1136/jmg.28.3.181; LIMON J, 1991, HUM GENET, V87, P338; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; THOMAS NS, 1991, AM J HUM GENET, V49, P205; TURLEAU C, 1989, CLIN GENET, V35, P462; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4037, DOI 10.1093/nar/18.13.4037; ZONANA J, 1988, J MED GENET, V25, P383, DOI 10.1136/jmg.25.6.383; ZONANA J, 1989, J PEDIATR-US, V114, P392, DOI 10.1016/S0022-3476(89)80556-6; ZONANA J, 1992, AM J HUM GENET, V51, P1036; ZONANA J, 1988, AM J HUM GENET, V43, P75	18	25	27	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					78	84						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434608				2022-12-18	WOS:A1993KK90800009
J	COVONE, AE; CAROLI, F; ROMEO, G				COVONE, AE; CAROLI, F; ROMEO, G			SCREENING DUCHENNE AND BECKER MUSCULAR-DYSTROPHY PATIENTS FOR DELETIONS IN 30 EXONS OF THE DYSTROPHIN GENE BY 3-MULTIPLEX PCR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											COVONE, AE (corresponding author), IST GIANNINA GASLINI,GENET MOLEC LAB,I-16148 GENOA,ITALY.		Covone, Angela/AAA-7859-2020; Caroli, Francesco/ABF-6080-2020	Covone, Angela/0000-0002-7669-5270; Caroli, Francesco/0000-0003-1828-6900				BEGGS AH, 1990, HUM GENET, V86, P45; BEGGS AH, 1991, AM J HUM GENET, V49, P54; CHAMBERLAIN JS, 1989, PCR PROTOCOLS GUIDE, P272; COVONE AE, 1991, HUM GENET, V87, P353; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; KUNKEL LM, 1991, ETIOLOGY HUMAN DIS D, P51; MENG G, 1991, MUSCULAR DYSTROPHY R, P23	7	25	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					675	676						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496997				2022-12-18	WOS:A1992JJ82800026
J	BACH, I; BRUNNER, HG; BEIGHTON, P; RUVALCABA, RHA; REARDON, W; PEMBREY, ME; VANDERVELDEVISSER, SD; BRUNS, GAP; CREMERS, CWRJ; CREMERS, FPM; ROPERS, HH				BACH, I; BRUNNER, HG; BEIGHTON, P; RUVALCABA, RHA; REARDON, W; PEMBREY, ME; VANDERVELDEVISSER, SD; BRUNS, GAP; CREMERS, CWRJ; CREMERS, FPM; ROPERS, HH			MICRODELETIONS IN PATIENTS WITH GUSHER-ASSOCIATED, X-LINKED MIXED DEAFNESS (DFN3)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERILYMPHATIC GUSHER; STAPES FIXATION; CHOROIDEREMIA; DELETION; GENE; CHROMOSOME; SURGERY; REGION; XQ21	Employing various probes from the proximal part of the Xq21 region, which is known to harbor the DFN3 gene, we have investigated 13 unrelated male probands with X-linked deafness, to detect possible deletions. For two of these patients, microdeletions could be detected by using probe pHU16 (DXS26). One of these deletions also encompasses locus DXS169, indicating that it extends farther toward the centromere. The presence of normal hybridization patterns in the DNA of 25 unrelated control males suggests that these deletions are the primary cause of progressive mixed deafness in these patients. If so, their molecular characterization may pave the way for the identification and isolation of the corresponding gene.	UNIV HOSP NIJMEGEN,DEPT OTOLARYNGOL,6500 HB NIJMEGEN,NETHERLANDS; UNIV CAPE TOWN,DEPT HUMAN GENET,CAPE TOWN,SOUTH AFRICA; UNIV WASHINGTON,RAINIER SCH,DSHS,SEATTLE,WA 98195; UNIV LONDON KINGS COLL,INST CHILD HLTH,LONDON WC2R 2LS,ENGLAND; CHILDRENS HOSP MED CTR,DIV GENET,BOSTON,MA 02115	Radboud University Nijmegen; University of Cape Town; University of Washington; University of Washington Seattle; University of London; King's College London; University College London; Harvard University; Boston Children's Hospital	BACH, I (corresponding author), UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.		Cremers, C.W.R.J./L-4254-2015; Brunner, Han/C-9928-2013; Cremers, Frans/A-5625-2014	Cremers, Frans/0000-0002-4954-5592				BACH I, IN PRESS HUM GENET; BRUNNER HG, 1988, HUM GENET, V80, P337, DOI 10.1007/BF00273647; BRUNNER HG, 1991, P NY ACAD SCI, V630, P176; CREMERS CWRJ, 1985, ARCH OTOLARYNGOL, V111, P249; CREMERS CWRJ, 1985, AM J OTOL, V6, P243; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; CREMERS FPM, 1990, AM J HUM GENET, V47, P622; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; FEIL R, 1991, AM J HUM GENET, V49, P1361; GLASSCOC.ME, 1973, ARCH OTOLARYNGOL, V98, P82; JENSEN J, 1977, ARCH OTO-RHINO-LARYN, V214, P271, DOI 10.1007/BF00458322; McKusick VA, 1990, MENDELIAN INHERITANC; MERRY DE, 1989, AM J HUM GENET, V45, P530; MICHEL O, 1991, HNO, V39, P486; MYHRE SA, 1982, CLIN GENET, V22, P299; NANCE W E, 1971, Birth Defects Original Article Series, V7, P64; NUSSBAUM RL, 1987, P NATL ACAD SCI USA, V84, P6521, DOI 10.1073/pnas.84.18.6521; OLSON NR, 1968, LARYNGOSCOPE, V78, P352, DOI 10.1288/00005537-196803000-00006; PAGE DC, 1990, NATURE, V346, P279, DOI 10.1038/346279a0; PHELPS PD, 1991, NEURORADIOLOGY, V33, P326, DOI 10.1007/BF00587816; REARDON W, 1991, GENOMICS, V11, P885, DOI 10.1016/0888-7543(91)90011-3; REARDON W, IN PRESS AM J MED GE; REARDON W, IN PRESS BR J AUDIOL; ROPERS HH, 1987, HUM GENET, P133; ROSENBERG T, 1987, OPTHALMIC PEDIAT GEN, V3, P139; Sambrook J., 1989, MOL CLONING LAB MANU; SANKILA EM, 1990, HUM GENET, V85, P117, DOI 10.1007/BF00276335; TABOR A, 1983, HUM GENET, V64, P196, DOI 10.1007/BF00327127; THORPE P, 1974, S AFR MED J, V48, P587; VANDENHURK JAJM, 1992, AM J HUM GENET, V50, P1195; WALLIS C, 1988, GENOMICS, V3, P299, DOI 10.1016/0888-7543(88)90119-X; WELLS S, 1991, J MED GENET, V28, P163, DOI 10.1136/jmg.28.3.163	33	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					38	44						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609803				2022-12-18	WOS:A1992JA46700005
J	JORDAN, E				JORDAN, E			THE HUMAN-GENOME-PROJECT - WHERE DID IT COME FROM, WHERE IS IT GOING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material											JORDAN, E (corresponding author), NIH,NATL CTR HUMAN GENOME RES,BLDG 38A,ROOM 605,BETHESDA,MD 20892, USA.							[Anonymous], 1988, MAPPING SEQUENCING H; [Anonymous], 1988, MAPPING OUR GENES GE; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; WATSON JD, 1990, SCIENCE, V248, P44, DOI 10.1126/science.2181665; 1990, UNDERSTANDING OUR GE	5	25	27	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					1	6						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609788				2022-12-18	WOS:A1992JA46700001
J	GOLDGAR, DE; ONIKI, RS				GOLDGAR, DE; ONIKI, RS			COMPARISON OF A MULTIPOINT IDENTITY-BY-DESCENT METHOD WITH PARAMETRIC MULTIPOINT LINKAGE ANALYSIS FOR MAPPING QUANTITATIVE TRAITS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENDELIAN FACTORS; PEDIGREES; MARKER; LOCUS	We previously developed a method of partitioning genetic variance of a quantitative trait to loci in specific chromosomal regions. In this paper, we compare this method - multipoint IBD (identical by descent) method (MIM) - with parametric multipoint linkage analysis (MLINK). A simulation study was performed comparing the methods for the major-locus, mixed, and two-locus models. The criterion for comparisons between MIM and MLINK was the average lod score from multiple replicates of simulated data sets. The effect of gene frequency, dominance, model misspecification, marker spacing, and informativeness are also considered in a smaller set of simulations. Within the context of the models examined, the MIM approach was found to be comparable in power with parametric multipoint linkage analysis when (a) parental data are unknown, (b) the effect of the major locus is small and there is additional genetic variation, or (c) the parameters of the major-locus model are misspecified. The performance of the MIM method relative to MLINK was markedly lower when the allele frequency at the trait locus was .2 versus .5, particularly for the case when parental data were assumed to be known. Dominance at the trait major locus, as well as marker spacing and heterozygosity, did not appear to have a large effect on the ELOD comparisons.	UNIV UTAH,DEPT MED INFORMAT,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah					NATIONAL CANCER INSTITUTE [R01CA036362, R23CA036362, P01CA048711] Funding Source: NIH RePORTER; NCI NIH HHS [CA 48711, CA 36362] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMOS CI, 1989, GENET EPIDEMIOL, V6, P349, DOI 10.1002/gepi.1370060205; AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; BOEHNKE M, 1990, AM J HUM GENET, V47, P218; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; DEMENAIS F, 1988, ANN HUM GENET, V52, P237, DOI 10.1111/j.1469-1809.1988.tb01101.x; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; GOLDSTEIN DJ, 1990, AM J HUM GENET, V47, pA136; Haldane JBS, 1919, J GENET, V8, P299; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; LANDER ES, 1989, GENETICS, V121, P185; LANGE K, 1986, AM J HUM GENET, V39, P148; LANGE K, 1976, AM J HUM GENET, V28, P167; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1974, AM J HUM GENET, V26, P588; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PENROSE LS, 1935, ANN EUGEN, V6, P133; RISCH N, 1989, MULTIPOINT MAPPING L, V6, P183; SKOLNICK MH, 1989, MULTIPOINT MAPPING L, V6, P177; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WILSON AF, 1991, AM J HUM GENET, V48, P862	23	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					598	606						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1539596				2022-12-18	WOS:A1992HH97400020
J	HIRSCHHORN, R; CHAKRAVARTI, V; PUCK, J; DOUGLAS, SD				HIRSCHHORN, R; CHAKRAVARTI, V; PUCK, J; DOUGLAS, SD			HOMOZYGOSITY FOR A NEWLY IDENTIFIED MISSENSE MUTATION IN A PATIENT WITH VERY SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE-DEAMINASE DEFICIENCY (ADA-SCID)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POINT MUTATION; 1ST EXON; GENE; CDNA; DELETION; ENZYME; DNA; EXPRESSION; SEQUENCES; PROMOTER	We have identified a previously unrecognized missense mutation in a patient with severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID). The mutation is a G646-to-A transition at a CG dinucleotide and predicts a glycine-to-arginine substitution at codon 216. Computer analysis of secondary structure predicts a major alteration with loss of a beta-pleated sheet in a highly conserved region of the protein. The basepair substitution also generates a new site for the restriction enzyme BstXI in exon 7 of the genomic DNA. Digestion of genomic DNA from the patient and from his parents revealed that he was homozygous for the mutation and that his mother and father were carriers. This mutation in homozygous form appears to be associated with very severe disease, since the patient had perinatal onset of clinical manifestations of SCID, the highest concentration of the toxic metabolite deoxyATP in nine patients studied, and a relatively poor immunologic response during the initial 2 years of therapy with polyethylene glycol-adenosine deaminase. Analysis of DNA from 21 additional patients with ADA-SCID and from 19 unrelated normals revealed that, while none of the normal individuals showed the abnormal restriction fragment, two of the 21 patients studied were heterozygous for the G646-to-A mutation.	UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; CHILDRENS HOSP,DIV INFECT DIS & IMMUNOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	HIRSCHHORN, R (corresponding author), NYU MED CTR,DEPT MED,DIV MED GENET,550 1ST AVE,NEW YORK,NY 10016, USA.			Douglas, Steven/0000-0002-3748-3603	NIAID NIH HHS [AI R3710353] Funding Source: Medline; NIMH NIH HHS [MH 47422] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH047422] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKESON AL, 1987, P NATL ACAD SCI USA, V84, P5947, DOI 10.1073/pnas.84.16.5947; AKESON AL, 1988, J BIOL CHEM, V263, P16291; BERKVENS TM, 1990, GENOMICS, V7, P486, DOI 10.1016/0888-7543(90)90190-6; BERKVENS TM, 1987, NUCLEIC ACIDS RES, V15, P9365, DOI 10.1093/nar/15.22.9365; BONTHRON DT, 1985, J CLIN INVEST, V76, P894, DOI 10.1172/JCI112050; CEDERBAUM SD, 1976, J PEDIATR-US, V89, P737, DOI 10.1016/S0022-3476(76)80793-7; CHANG Z, 1991, BIOCHEMISTRY-US, V30, P2273, DOI 10.1021/bi00222a033; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COOPER DN, 1990, HUM GENET, V85, P55; DADDONA PE, 1984, J BIOL CHEM, V259, P2101; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GARTY BZ, 1989, J ALLERGY CLIN IMMUN, V84, P515, DOI 10.1016/0091-6749(89)90365-5; GIBLETT ER, 1972, LANCET, V2, P1067; HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005; HIRSCHHORN R, 1990, P NATL ACAD SCI USA, V87, P6171, DOI 10.1073/pnas.87.16.6171; HIRSCHHORN R, 1980, NEW ENGL J MED, V303, P377, DOI 10.1056/NEJM198008143030706; HIRSCHHORN R, 1986, CLIN IMMUNOL IMMUNOP, V40, P157, DOI 10.1016/0090-1229(86)90081-4; HIRSCHHORN R, 1990, Immunodeficiency Reviews, V2, P175; HIRSCHHORN R, 1979, J CLIN INVEST, V64, P1130, DOI 10.1172/JCI109552; HIRSCHHORN R, 1989, J CLIN INVEST, V83, P497, DOI 10.1172/JCI113909; HIRSCHHORN R, 1980, J CLIN INVEST, V65, P768, DOI 10.1172/JCI109725; KREDICH NM, 1989, METABOLIC BASIS INHE, P1045; Maniatis T., 1982, MOL CLONING; MARKERT ML, 1988, J CLIN INVEST, V81, P1323, DOI 10.1172/JCI113458; MARKERT ML, 1989, AM J HUM GENET, V45, P354; MARKERT ML, 1987, J IMMUNOL, V138, P3203; MIERENDORF RC, 1987, METHOD ENZYMOL, V152, P556; ORKIN SH, 1983, J BIOL CHEM, V258, P2753; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHRADER WP, 1976, P NATL ACAD SCI USA, V75, P446; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TZALL S, 1989, AM J HUM GENET, V44, P864; VALERIO D, 1985, EMBO J, V4, P437, DOI 10.1002/j.1460-2075.1985.tb03648.x; VALERIO D, 1986, EMBO J, V5, P113, DOI 10.1002/j.1460-2075.1986.tb04184.x; VALERIO D, 1984, GENE, V31, P147, DOI 10.1016/0378-1119(84)90205-1; VALERIO D, 1983, GENE, V25, P231, DOI 10.1016/0378-1119(83)90227-5; WIGINTON DA, 1984, NUCLEIC ACIDS RES, V12, P2439, DOI 10.1093/nar/12.5.2439; WIGINTON DA, 1986, BIOCHEMISTRY-US, V25, P8234, DOI 10.1021/bi00373a017; WIGINTON DA, 1983, P NATL ACAD SCI-BIOL, V80, P7481, DOI 10.1073/pnas.80.24.7481; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539	41	25	25	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					878	885						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1680289				2022-12-18	WOS:A1991GG66500020
J	AVIGAD, S; KLEIMAN, S; WEINSTEIN, M; COHEN, BE; SCHWARTZ, G; WOO, SLC; SHILOH, Y				AVIGAD, S; KLEIMAN, S; WEINSTEIN, M; COHEN, BE; SCHWARTZ, G; WOO, SLC; SHILOH, Y			COMPOUND HETEROZYGOSITY IN NONPHENYLKETONURIA HYPERPHENYLALANEMIA - THE CONTRIBUTION OF MUTATIONS FOR CLASSICAL PHENYLKETONURIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHENYLALANINE-HYDROXYLASE LOCUS; RECURRENT MUTATION; GENE; AMPLIFICATION; HAPLOTYPES; POPULATION	Hyperphenylalaninemia (HPA) results from defective hydroxylation of phenylalanine in the liver, in most cases because of defective phenylalanine hydroxylase. HPA is highly variable, ranging from moderate elevation of plasma phenylalanine with no clinical consequences to a severe disease, classical phenylketonuria (PKU). Non-PKU HPA was found in excess of PKU in Israel, while the opposite is true in Europe. To study the genetic basis of non-PKU HPA, we performed haplotype analysis at the phenylalanine hydroxylase locus in 27 families with non-PKU HPA. All individuals with this condition were compound heterozygotes. In six of these families, in which both PKU and non-PKU HPA were segregating, haplotype analysis showed that non-PKU HPA resulted from compound heterozygosity for a PKU mutation and a second mutation, with milder effect, which is probably expressed only when it interacts with the severe mutation. The involvement of PKU mutations in non-PKU HPA was further demonstrated in Jewish Yemenite families with non-PKU HPA, in which the individuals with this condition were carriers of the single PKU allele which exists in this community. In addition, two previously known PKU point mutations (R261Q and R408W) were found in individuals with non-PKU HPA. These mutations are associated, in our population, with the same haplotypes as those with which it is associated in Europe. Based on the above-mentioned genetic model for non-PKU HPA, successful prenatal diagnosis of this condition was performed in one family. Another practical implication of these results is the use of molecular analysis in distinguishing between PKU and non-PKU HPA in the early postnatal period, when these two conditions are not readily differentiated on the basis of plasma phenylalanine levels.	TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,IL-69978 TEL AVIV,ISRAEL; CHAIM SHEBA MED CTR,INST CHILD DEV,IL-52621 TEL HASHOMER,ISRAEL; BAYLOR COLL MED,DEPT CELL BIOL & GENET,HOUSTON,TX 77030	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Baylor College of Medicine								ANDERSON JA, 1966, J PEDIATR-US, V68, P351, DOI 10.1016/S0022-3476(66)80237-8; AVIGAD S, 1990, NATURE, V344, P168, DOI 10.1038/344168a0; BARTHOLOME K, 1984, HUM GENET, V65, P405, DOI 10.1007/BF00291569; BARTHOLOME K, 1975, PEDIATR RES, V9, P899, DOI 10.1203/00006450-197509120-00006; BERMAN JL, 1969, AM J DIS CHILD, V117, P54, DOI 10.1001/archpedi.1969.02100030056006; BLASKOVICS ME, 1974, ARCH DIS CHILD, V49, P835, DOI 10.1136/adc.49.11.835; CAILLAUD C, UNPUB 3 BP FRAME DEL; CHAKRABORTY R, 1987, HUM GENET, V76, P40; Cohen B E, 1978, Monogr Hum Genet, V9, P95; COUTTS NA, 1971, ARCH DIS CHILD, V46, P50; FIRON N, 1990, AM J HUM GENET, V46, P527; GUTHRIE R, 1963, PEDIATRICS, V32, P338; GUTTLER F, 1980, ACTA PAEDIATR SCAN S, V280; GUTTLER F, 1990, 5TH INT C INB ERR ME; HSIA DYY, 1968, AM J DIS CHILD, V116, P143, DOI 10.1001/archpedi.1968.02100020145005; JOHN SWM, 1990, AM J HUM GENET, V46, P970; KANG ES, 1970, PEDIATRICS, V45, P83; KAUFMAN S, 1975, PEDIATR RES, V9, P632, DOI 10.1203/00006450-197508000-00004; LEDLEY FD, 1986, NEW ENGL J MED, V314, P1276, DOI 10.1056/NEJM198605153142002; LEEMING RJ, 1984, ARCH DIS CHILD, V59, P58, DOI 10.1136/adc.59.1.58; LICHTERKONECKI U, 1988, HUM GENET, V78, P347, DOI 10.1007/BF00291733; LICHTERKONECKI U, 1990, 5TH INT C INB ERR ME; NAVON R, 1990, AM J HUM GENET, V46, P817; NIEDERWIESER A, 1982, EUR J PEDIATR, V138, P111; OKANO Y, 1990, AM J HUM GENET, V46, P919; OKANO Y, 1990, 5TH INT C INB ERR ME; REY F, 1988, AM J HUM GENET, V43, P914; SAKAI K, 1985, CANCER GENET CYTOGEN, V17, P95, DOI 10.1016/0165-4608(85)90020-2; SULLIVAN SE, 1989, AM J HUM GENET, V44, P652; TREFZ FK, 1981, J INHERIT METAB DIS, V4, P101, DOI 10.1007/BF02263611; WANG T, 1990, SOMAT CELL MOLEC GEN, V16, P85, DOI 10.1007/BF01650483; WONG PWK, 1964, CLIN CHEM, V10, P1098; WOO SLC, 1989, BIOCHEMISTRY-US, V28, P1, DOI 10.1021/bi00427a001; WOO SLC, 1988, AM J HUM GENET, V43, P781; WOOLF LI, 1967, NATURE, V213, P882, DOI 10.1038/213882a0; WOOLF LI, 1968, LANCET, V1, P114; [No title captured]	37	25	25	1	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					393	399						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867197				2022-12-18	WOS:A1991GA86600016
J	BENLIAN, P; BOILEAU, C; LOUX, N; PASTIER, D; MASLIAH, J; COULON, M; NIGOU, M; RAGAB, A; GUIMARD, J; RUIDAVETS, JB; BONAITIPELLIE, C; FRUCHART, JC; DOUSTEBLAZY, P; BEREZIAT, G; JUNIEN, C				BENLIAN, P; BOILEAU, C; LOUX, N; PASTIER, D; MASLIAH, J; COULON, M; NIGOU, M; RAGAB, A; GUIMARD, J; RUIDAVETS, JB; BONAITIPELLIE, C; FRUCHART, JC; DOUSTEBLAZY, P; BEREZIAT, G; JUNIEN, C			EXTENDED HAPLOTYPES AND LINKAGE DISEQUILIBRIUM BETWEEN II-MARKERS AT THE APOAI-C3-A4 GENE-CLUSTER ON CHROMOSOME-II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-C-III; DEOXYRIBONUCLEIC-ACID POLYMORPHISM; DNA POLYMORPHISM; AIV GENE; A-I; CIII; DISEASE; HYPERTRIGLYCERIDEMIA; ASSOCIATION; INSULIN	One hundred fifty-four unrelated French Caucasian subjects were typed for 11 RFLPs at or near the APOA1-C3-A4 gene cluster on the long arm of chromosome 11. All subjects belonged to families having lived in the Toulouse area (in the southwest of France) for over three generations. Allele frequencies for each RFLP were in agreement with previous studies in Caucasian populations for the APOA1/SstI marker. Pairwise linkage disequilibrium was determined. Among the 55 pairs studied, 30 are newly reported. Only three significant nonrandom associations were found: APOA1/MspI-3'APOC3/SstI, APOA1/MspI-3'APOA4/XbaI, and APOA4/DraI-APOA4/XbaI. Extended 11-marker haplotypes were constructed. Haplotype frequencies were estimated by the maximum-likelihood procedure and compared to expected frequencies calculated under the assumption of equilibrium. Among the 37 estimated haplotypes, seven containing at least four nonrandomly associated alleles showed markedly increased frequencies. These results, obtained in a geographically homogeneous population, confirm the existence of disequilibrium in the apolipoprotein cluster, but to a lower extent than previously reported in Caucasian populations, which were geographically more heterogeneous.	INSERM,U73,CHATEAU LONGCHAMP,BOIS BOULOGNE,F-75016 PARIS,FRANCE; CHU ST ANTOINE,CNRS,URA 1283,F-75571 PARIS 12,FRANCE; INSERM,U155,F-75005 PARIS,FRANCE; HOP AMBROISE PARE,BIOCHIM & GENET MOLEC LAB,F-92100 BOULOGNE,FRANCE; INSERM,U101,TOULOUSE,FRANCE; INSERM,U326,TOULOUSE,FRANCE; INST PASTEUR,INSERM,U279,LILLE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille			boileau, catherine/M-4482-2017	boileau, catherine/0000-0002-0371-7539				ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; ANTONARAKIS SE, 1988, HUM GENET, V80, P265, DOI 10.1007/BF01790095; BRESLOW JL, 1988, PHYSIOL REV, V68, P85, DOI 10.1152/physrev.1988.68.1.85; CAMBIEN F, 1989, MED SCI, V6, P379; COHEN T, 1986, NUCLEIC ACIDS RES, V14, P1924, DOI 10.1093/nar/14.4.1924; COLE SA, 1989, AM J HUM GENET, V44, P835; COLEMAN RT, 1986, MOL BIOL MED, V3, P213; COLEMAN RT, 1988, NUCLEIC ACIDS RES, V16, P1222, DOI 10.1093/nar/16.3.1222; COOPER DN, 1988, HUM GENET, V78, P299, DOI 10.1007/BF00291724; COX NJ, 1988, AM J HUM GENET, V43, P495; FERNS GAA, 1985, LANCET, V2, P300; FRITSCH EF, 1980, CELL, V19, P959, DOI 10.1016/0092-8674(80)90087-2; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P8699, DOI 10.1093/nar/14.21.8699; HAYDEN MR, 1987, AM J HUM GENET, V40, P421; HENDERSON HE, 1987, HUM GENET, V75, P62; HENRY I, 1984, AM J HUM GENET, V36, P760; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; KARATHANASIS SK, 1986, P NATL ACAD SCI USA, V83, P8457, DOI 10.1073/pnas.83.22.8457; KARATHANASIS SK, 1985, P NATL ACAD SCI USA, V82, P6374, DOI 10.1073/pnas.82.19.6374; KESSLING AM, 1988, HUM GENET, V78, P237, DOI 10.1007/BF00291668; KESSLING AM, 1985, CLIN GENET, V28, P296; LUSIS AJ, 1988, J LIPID RES, V29, P397; MANIATIS T, 1980, ANNU REV GENET, V14, P145, DOI 10.1146/annurev.ge.14.120180.001045; MASLIAH J, UNPUB DNA POLYMORPHI; MCLEAN CJ, 1985, GENET EPIDEMIOL, V2, P263; MORRIS SW, 1985, LANCET, V1, P1127; ORDOVAS JM, 1986, NEW ENGL J MED, V314, P671, DOI 10.1056/NEJM198603133141102; PAUL H, 1987, HUM GENET, V75, P264, DOI 10.1007/BF00281071; REES A, 1986, HUM GENET, V72, P168; REES A, 1985, J CLIN INVEST, V76, P1090, DOI 10.1172/JCI112062; REES A, 1983, LANCET, V1, P444; SMIT M, 1988, HUM GENET, V78, P90, DOI 10.1007/BF00291243; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; TREMBATH RC, 1987, BRIT MED J, V294, P1577, DOI 10.1136/bmj.294.6587.1577	34	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					903	910						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1673288				2022-12-18	WOS:A1991FK89700009
J	KONDO, R; WAKAMATSU, N; YOSHINO, H; FUKUHARA, N; MIYATAKE, T; TSUJI, S				KONDO, R; WAKAMATSU, N; YOSHINO, H; FUKUHARA, N; MIYATAKE, T; TSUJI, S			IDENTIFICATION OF A MUTATION IN THE ARYLSULFATASE-A GENE OF A PATIENT WITH ADULT-TYPE METACHROMATIC LEUKODYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLASMID DNA; FIBROBLASTS; CLONING	To analyze the genetic abnormality in a Japanese patient with adult-type metachromatic leukodystrophy (MLD), we first elucidated the genomic organization of the human arylsulfatase A (ASA) gene and then compared the nucleotide sequences of exons and splice junctions of the mutant ASA gene to those of a normal control. We have identified a new mutation, a G-to-A transition in exon 2, which results in amino acid substitution of Asp for 99GLY. In a transient expression study, COS cells transfected with the mutant cDNA carrying 99GLY-->Asp did not show an increase of ASA activity, which confirms that the mutation is a cause of adult-type MLD.	NATL SAIGATA HOSP,DEPT NEUROL,OGATA,JAPAN		KONDO, R (corresponding author), NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,1 ASAHIMACHI DORI,NIIGATA 951,JAPAN.			Nobuaki, Wakamatsu/0000-0003-1956-8977				BACH G, 1983, BIOCHEM BIOPH RES CO, V112, P198, DOI 10.1016/0006-291X(83)91816-8; BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; CHANG PL, 1983, P NATL ACAD SCI-BIOL, V80, P7323, DOI 10.1073/pnas.80.23.7323; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; DUBOIS G, 1975, NEW ENGL J MED, V293, P302; Fluharty A L, 1978, Methods Enzymol, V50, P537; GIESELMANN V, 1989, P NATL ACAD SCI USA, V86, P9436, DOI 10.1073/pnas.86.23.9436; GIESELMANN V, 1990, 5TH INT C INB ERR ME; INUZUKA T, 1989, EUR NEUROL, V29, P328, DOI 10.1159/000116440; KOLODNY EH, 1983, METABOLIC BASIS INHE, P881; KREYSING J, 1990, EUR J BIOCHEM, V191, P627, DOI 10.1111/j.1432-1033.1990.tb19167.x; Maniatis T, 1989, DECONTAMINATION DILU; PORTER MT, 1972, BIOCHIM BIOPHYS ACTA, V258, P769, DOI 10.1016/0005-2744(72)90178-7; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STEIN C, 1989, J BIOL CHEM, V264, P1252; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	18	25	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					971	978						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1673291				2022-12-18	WOS:A1991FK89700016
J	HOFMAN, KJ; STEEL, G; KAZAZIAN, HH; VALLE, D				HOFMAN, KJ; STEEL, G; KAZAZIAN, HH; VALLE, D			PHENYLKETONURIA IN UNITED-STATES BLACKS - MOLECULAR ANALYSIS OF THE PHENYLALANINE-HYDROXYLASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC DNA HAPLOTYPES; PAH LOCUS; FUNCTIONAL DOMAINS; MUTATION; PKU; FAMILIES; LINKAGE; ALLELES	We investigated the frequency, origin, and molecular basis of phenylketonuria (PKU) in U.S. blacks. On the basis of 10 years of Maryland newborn-screening data, we found the frequency to be 1/50,000, or one-third that in whites. We performed haplotype analysis of the phenylalanine hydroxylase (PAH) gene of 36 U.S. blacks, 16 from individuals with classical PKU and 20 from controls. In blacks, 20% of wild-type PAH alleles have a common Caucasian haplotype (i.e., haplotype 1), whereas 80% had a variety of haplotypes, all rare in Caucasians and Asians. One of these, haplotype 15, accounted for a large fraction (30%). Among black mutant PAH alleles, 20% have a haplotype (i.e., either haplotype 1 or haplotype 4) common in Caucasians; 40% have a haplotype rare in Caucasians and Asians, and 40% have one of two previously undescribed haplotypes. Both can be derived from known haplotypes by a single event. One of these haplotypes is characterized by a new MspI restriction site, located in intron 8, which was present in five of 16 black mutant alleles but was not present in 60 U.S. black control, 20 U.S. Caucasian control, or 20 Caucasian mutant PAH alleles. Sequence analysis of DNA from a single individual, homozygous for the new MspI associated haplotype, shows homozygosity for a C-->T transition at nucleotide 896 in exon 7 of the PAH cDNA, resulting in the conversion of leucine 255 to serine (L255S).	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,GENET LAB,BALTIMORE,MD 21205	Howard Hughes Medical Institute; Johns Hopkins University	HOFMAN, KJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,CTR MED GENET,BLALOCK 1008,600 N WOLFE ST,BALTIMORE,MD 21205, USA.			HOFMAN, KAREN/0000-0001-9512-7220	NIGMS NIH HHS [5T32GM0747-11] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; BEAUDET AL, 1989, METABOLIC BASIS INHE, P119; DAIGER SP, 1989, AM J HUM GENET, V45, P319; DAIGER SP, 1989, AM J HUM GENET, V45, P310; DEVOTO M, 1989, American Journal of Human Genetics, V45, pA183; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; DILELLA AG, 1987, NATURE, V327, P332; DWORNICZAK B, 1989, HUM GENET, V84, P95, DOI 10.1007/BF00210683; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRENETT HE, 1987, P NATL ACAD SCI USA, V84, P5530, DOI 10.1073/pnas.84.16.5530; HERTZBERG M, 1989, AM J HUM GENET, V44, P382; HOFMAN KJ, 1989, MOL BIOL MED, V6, P245; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEDLEY FD, 1985, BIOCHEMISTRY-US, V24, P3389, DOI 10.1021/bi00335a001; LIDSKY AS, 1984, AM J HUM GENET, V36, P527; LYONNET S, 1989, AM J HUM GENET, V44, P511; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; OKANO Y, 1990, AM J HUM GENET, V46, P18; OKANO Y, 1989, American Journal of Human Genetics, V45, pA211; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; REITNAUER PJ, 1982, DIABETES, V31, P532, DOI 10.2337/diabetes.31.6.532; THALHAMMER O, 1975, HUMANGENETIK, V30, P273, DOI 10.1007/BF00275139; WANG T, 1989, AM J HUM GENET, V45, P675; WANG T, 1990, AM J HUM GENET, V47, pA241; WILLIAMS LT, 1977, J CLIN INVEST, V60, P815, DOI 10.1172/JCI108835; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; WOO SLC, 1988, AM J HUM GENET, V43, P781; WOO SLC, 1974, BIOCHEM J, V139, P741, DOI 10.1042/bj1390741; [No title captured]	31	25	26	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					791	798						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	FK478	2014802				2022-12-18	WOS:A1991FK47800019
J	DIANZANI, I; FORREST, SM; CAMASCHELLA, C; SAGLIO, G; PONZONE, A; COTTON, RGH				DIANZANI, I; FORREST, SM; CAMASCHELLA, C; SAGLIO, G; PONZONE, A; COTTON, RGH			SCREENING FOR MUTATIONS IN THE PHENYLALANINE-HYDROXYLASE GENE FROM ITALIAN PATIENTS WITH PHENYLKETONURIA BY USING THE CHEMICAL CLEAVAGE METHOD - A NEW SPLICE MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; MOLECULAR-GENETICS; HAPLOTYPE ANALYSIS; DEFICIENCY; SUBSTITUTION; REACTIVITY; POPULATION; CYTOSINE; THYMINE	To investigate the molecular basis of phenylketonuria in Italy we applied the chemical cleavage method (CCM) on amplified DNA encompassing exons 7 and 8 of the phenylalanine hydroxylase gene. These exons are in a region likely to be involved in enzyme function. Using this approach, we could simultaneously screen for novel mutations and for seven reported mutations which map in this area. Three mutations were identified. The first was shown to be a not previously described mutation: a G --> A substitution at the 5' donor junction splice site of intron 7. The second change was a reported G --> A mutation at codon 261. The third change corresponded to a polymorphism at codon 245. Our results indicate that CCM analysis of amplified genomic DNA fragments can be successfully used to search for mutations in large genes whose transcripts are not readily available.	CNR,CTR IMMUNOGENET & ISTOCOMPATIBIL,TURIN,ITALY; ROYAL CHILDRENS HOSP,MURDOCH INST,PARKVILLE,VIC 3052,AUSTRALIA	Consiglio Nazionale delle Ricerche (CNR); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	DIANZANI, I (corresponding author), IST CLIN PEDIAT,PIAZZA POLONIA 94,I-10126 TURIN,ITALY.		Camaschella, Clara/A-3289-2015	Saglio, Giuseppe/0000-0002-1046-3514				ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; AVIGAD S, 1990, NATURE, V344, P168, DOI 10.1038/344168a0; COTTON RGH, 1989, NUCLEIC ACIDS RES, V17, P4223, DOI 10.1093/nar/17.11.4223; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; DIANZANI I, 1989, J INHERIT METAB DIS, V12, P162, DOI 10.1007/BF01800721; DIANZANI I, 1991, AM J HUM GENET, V48, P423; DIANZANI I, IN PRESS HUM GENET; DILELLA AG, 1988, LANCET, V1, P497; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; FORREST S M, 1989, American Journal of Human Genetics, V45, pA186; GRENETT HE, 1987, P NATL ACAD SCI USA, V84, P5530, DOI 10.1073/pnas.84.16.5530; GUTTLER F, 1980, ACTA PAEDIATR SC   S, V280, P1; HOWELLS DW, 1990, AM J HUM GENET, V47, P279; IWAKI M, 1986, J BIOL CHEM, V261, P2051; JOHN SWM, 1989, AM J HUM GENET, V45, P905; LICHTERKONECKI U, 1989, HUM GENET, V81, P373, DOI 10.1007/BF00283695; LICHTERKONECKI U, 1988, BIOCHEMISTRY-US, V27, P2881, DOI 10.1021/bi00408a032; LYONNET S, 1989, AM J HUM GENET, V44, P511; MARVIT J, 1987, NUCLEIC ACIDS RES, V15, P5613, DOI 10.1093/nar/15.14.5613; OKANO Y, 1990, AM J HUM GENET, V46, P18; OKANO Y, 1989, American Journal of Human Genetics, V45, pA211; STUHRMANN M, 1989, CLIN GENET, V36, P117; SVENSSON E, 1989, 27TH SSIEM ANN S MUN; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; TREISMAN R, 1982, CELL, V29, P903, DOI 10.1016/0092-8674(82)90452-4; WANG T, 1989, American Journal of Human Genetics, V45, pA228; WANG T, 1989, AM J HUM GENET, V45, P675	28	25	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					631	635						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1671810				2022-12-18	WOS:A1991FK47000025
J	DIXON, MJ; HAAN, E; BAKER, E; DAVID, D; MCKENZIE, N; WILLIAMSON, R; MULLEY, J; FARRALL, M; CALLEN, D				DIXON, MJ; HAAN, E; BAKER, E; DAVID, D; MCKENZIE, N; WILLIAMSON, R; MULLEY, J; FARRALL, M; CALLEN, D			ASSOCIATION OF TREACHER-COLLINS SYNDROME AND TRANSLOCATION 6P21.31/16P13.11 - EXCLUSION OF THE LOCUS FROM THESE CANDIDATE REGIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; LINKAGE; GENE; HLA; COMMITTEE	Treacher Collins syndrome (TCS) is an autosomal dominant defect of craniofacial development which has not been chromosomally localized. We have identified a mother and two children who have TCS and also a balanced translocation t(6;16)(p21.31:p13.11), which suggested the possibility that the TCS locus might be located at one of the translocation breakpoints. These were defined by in-situ hybridization as 6p21.31 (by using loci in the HLA complex defined by the probes p45.1DPbeta003/HLA-DPB2 and pRS5.10/HLA class I chain) and 16p13.11 (by using probes pACHF1.3.2/D16S8 and VK45/D16S131). Pairwise and multipoint linkage analysis using localized chromosome 6 probes and chromosome 16 probes in 12 unrelated TCS families with multiple affected siblings excluded the TCS locus from proximity to both translocation breakpoints. These data were confirmed when a third affected child, who did not exhibit the translocation, was born to the mother.	ADELAIDE CHILDRENS HOSP INC,DEPT MED GENET,ADELAIDE,SA 5006,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,CYTOGENET UNIT,ADELAIDE,SA 5006,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,AUSTRALIAN CRANIOFACIAL UNIT,ADELAIDE,SA 5006,AUSTRALIA; ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON,ENGLAND; NORTHWICK PK HOSP & CLIN RES CTR,CLIN RES CTR,HARROW HA1 3UJ,MIDDX,ENGLAND	Imperial College London; Imperial College London	DIXON, MJ (corresponding author), UNIV MANCHESTER,DEPT CELL & STRUCT BIOL,3RD FLOOR STOPFORD BLDG,MANCHESTER M13 9PT,LANCS,ENGLAND.		Callen, David F/G-1975-2012	Callen, David/0000-0002-6189-9991	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AUFFRAY C, 1982, P NATL ACAD SCI-BIOL, V79, P6337, DOI 10.1073/pnas.79.20.6337; BALESTRAZZI P, 1983, HUM GENET, V64, P305, DOI 10.1007/BF00279420; BOCIAN M, 1987, AM J MED GENET, V26, P437, DOI 10.1002/ajmg.1320260223; BRUETON L, 1988, AM J MED GENET, V31, P799, DOI 10.1002/ajmg.1320310412; CALLEN D F, 1988, Genomics, V2, P144, DOI 10.1016/0888-7543(88)90096-1; CALLEN DF, 1989, GENOMICS, V4, P348, DOI 10.1016/0888-7543(89)90341-8; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRAZEN LE, 1967, AM J DIS CHILD, V113, P406; GEDEON AK, 1989, NUCLEIC ACIDS RES, V17, P4905, DOI 10.1093/nar/17.12.4905; HYLAND VJ, 1989, HUM GENET, V83, P61, DOI 10.1007/BF00274150; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; MURRAY JC, 1990, AM J HUM GENET, V46, P486; PHELPS PD, 1981, CLIN OTOLARYNGOL, V6, P15, DOI 10.1111/j.1365-2273.1981.tb01782.x; ROVIN S, 1964, J PEDIATR-US, V65, P215, DOI 10.1016/S0022-3476(64)80522-9; Sambrook J., 1989, MOL CLONING LAB MANU; SPENCE MA, 1989, CYTOGENET CELL GENET, V51, P149, DOI 10.1159/000132790; SRIVASTAVA R, 1987, P NATL ACAD SCI USA, V84, P4224, DOI 10.1073/pnas.84.12.4224; TOMMERUP N, 1983, AM J MED GENET, V16, P313, DOI 10.1002/ajmg.1320160304; WHEATER RF, 1987, J MED GENET, V24, P113, DOI 10.1136/jmg.24.2.113; ZOGHBI HY, 1988, AM J HUM GENET, V42, P877	23	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					274	280						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1671319				2022-12-18	WOS:A1991EV74400012
J	LESTER, DH; INGLEHEARN, CF; BASHIR, R; ACKFORD, H; ESAKOWITZ, L; JAY, M; BIRD, AC; WRIGHT, AF; PAPIHA, SS; BHATTACHARYA, SS				LESTER, DH; INGLEHEARN, CF; BASHIR, R; ACKFORD, H; ESAKOWITZ, L; JAY, M; BIRD, AC; WRIGHT, AF; PAPIHA, SS; BHATTACHARYA, SS			LINKAGE TO D3S47 (C17) IN ONE LARGE AUTOSOMAL DOMINANT RETINITIS-PIGMENTOSA FAMILY AND EXCLUSION IN ANOTHER - CONFIRMATION OF GENETIC-HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV NEWCASTLE UPON TYNE,DEPT HUMAN GENET,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; ROYAL ALEXANDRIA HOSP,EYE CLIN,PAISLEY,SCOTLAND; MOORFIELDS EYE HOSP,INST OPHTHALMOL,DEPT CLIN OPHTHALMOL,LONDON WC1V 7AN,ENGLAND; WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	Newcastle University - UK; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Edinburgh								ARDEN GB, 1983, BRIT J OPHTHALMOL, V67, P405, DOI 10.1136/bjo.67.7.405; ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BUNDEY S, 1984, J MED GENET, V21, P421, DOI 10.1136/jmg.21.6.421; DAIGER SP, 1989, CYTOGENET CELL GENET, V50, P181, DOI 10.1159/000132758; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; FARBER MD, 1985, ARCH OPHTHALMOL-CHIC, V103, P524, DOI 10.1001/archopht.1985.01050040066019; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; INGLEHEARN CF, 1990, GENOMICS, V6, P168, DOI 10.1016/0888-7543(90)90462-4; KEMP CM, 1988, INVEST OPHTH VIS SCI, V29, P1235; KEMP CM, 1984, T OPHTHAL SOC UK, V103, P453; LYNESS AL, 1985, BRIT J OPHTHALMOL, V69, P326, DOI 10.1136/bjo.69.5.326; MASSOF RW, 1981, SURV OPHTHALMOL, V20, P303; MCWILLIAM P, 1989, GENOMICS, V5, P619, DOI 10.1016/0888-7543(89)90031-1; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NAYLOR SL, 1989, CYTOGENET CELL GENET, V51, P106, DOI 10.1159/000132783; OLSSON JE, 1990, AM J MED GENET, V35, P595, DOI 10.1002/ajmg.1320350434; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; OTT J, 1974, AM J HUM GENET, V26, P588; RICHARDSON CC, 1965, P NATL ACAD SCI USA, V54, P158, DOI 10.1073/pnas.54.1.158; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WEBER JL, 1989, AM J HUM GENET, V44, P388	23	25	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					536	541						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2393026				2022-12-18	WOS:A1990DX22300018
J	CHERNOS, JE; MARTIN, RH				CHERNOS, JE; MARTIN, RH			A CYTOGENETIC INVESTIGATION OF THE EFFECTS OF CRYOPRESERVATION ON HUMAN-SPERM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ALBERTA CHILDRENS PROV GEN HOSP,MED GENET CLIN,1820 RICHMOND RD SW,CALGARY T2T 5C7,ALBERTA,CANADA; UNIV CALGARY,FAC MED,DEPT PEDIAT,DIV MED GENET,CALGARY T2N 1N4,ALBERTA,CANADA	Alberta Childrens Hospital; University of Calgary; University of Calgary								ALFREDSSON JH, 1984, INT J FERTIL, V29, P152; BEHRMAN SJ, 1969, AM J OBSTET GYNECOL, V103, P654, DOI 10.1016/0002-9378(69)90562-6; BENET J, 1989, HUM GENET, V81, P239; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; BRANDRIFF B, 1985, HUM GENET, V70, P18, DOI 10.1007/BF00389451; BRANDRIFF B, 1984, HUM GENET, V66, P193, DOI 10.1007/BF00286600; Breslow NE, 1980, STATISTICAL METHODS, V1, P122; CHERNOS JE, 1986, CYTOGENET CELL GENET, V42, P57, DOI 10.1159/000132251; FORD JH, 1988, AM J HUM GENET, V43, P733; FRIEDMAN S, 1981, FERTIL STERIL, V35, P321; JENDERNY J, 1987, HUM GENET, V76, P385, DOI 10.1007/BF00272450; KAMIGUCHI Y, 1986, AM J HUM GENET, V38, P724; KAROW A, 1979, NEW SCI, V81, P236; LAUFER N, 1985, ARCH ANDROLOGY, V14, P217, DOI 10.3109/01485018508988302; MARTIN RH, 1987, HUM GENET, V77, P108, DOI 10.1007/BF00272374; MARTIN RH, 1983, CYTOGENET CELL GENET, V35, P252, DOI 10.1159/000131876; MATTEI JF, 1983, CLIN GENET, V23, P132; MORTIMER D, 1982, BRIT J OBSTET GYNAEC, V89, P132, DOI 10.1111/j.1471-0528.1982.tb04679.x; PELLESTOR F, 1988, THESIS GRENOBLE LA T; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; SANGER WG, 1979, INT J FERTIL, V24, P257; SELE B, 1985, ANN GENET-PARIS, V28, P81; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; WITHERINGTON R, 1977, J UROLOGY, V118, P510, DOI 10.1016/S0022-5347(17)58088-X; 1980, LABORATORY MANUAL EX; 1985, BIRTH DEFECTS, V21, P1	26	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					766	777						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AZ049	2816942				2022-12-18	WOS:A1989AZ04900013
J	KOSTYU, DD; OBER, CL; DAWSON, DV; GHANAYEM, M; ELIAS, S; MARTIN, AO				KOSTYU, DD; OBER, CL; DAWSON, DV; GHANAYEM, M; ELIAS, S; MARTIN, AO			GENETIC-ANALYSIS OF HLA IN THE UNITED-STATES SCHMIEDENLEUT HUTTERITES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									DUKE UNIV,MED CTR,DEPT COMMUNITY HLTH & FAMILY MED,DIV BIOMETRY & MED INFORMAT,DURHAM,NC 27710; UNIV CHICAGO,DEPT OBSTET & GYNECOL,CHICAGO,IL 60637; NORTHWESTERN UNIV,SCH MED,DEPT OBSTET & GYNECOL,CHICAGO,IL 60611; UNIV TENNESSEE,CTR HLTH SCI,COLL MED,DEPT OBSTET & GYNECOL,MEMPHIS,TN 38163	Duke University; University of Chicago; Northwestern University; University of Tennessee System; University of Tennessee Health Science Center	KOSTYU, DD (corresponding author), DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,DIV IMMUNOL,BOX 3010,DURHAM,NC 27710, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD021244, HD-21244] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALPER CA, 1986, HUM IMMUNOL, V15, P366, DOI 10.1016/0198-8859(86)90013-3; AMOS DB, 1980, MANUAL CLIN IMMUNOLO, P978; AMOS DB, 1975, TRANSPL P, V7, P93; BAUR MP, 1980, HISTOCOMPATIBILITY T, P994; BAUR MP, 1984, HISTOCOMPATIBILITY T, P756; BODMER JG, 1987, BRIT MED BULL, V43, P94, DOI 10.1093/oxfordjournals.bmb.a072179; BODMER W, 1977, HLA DISEASE, P280; BODMER WF, 1987, J CLIN PATHOL, V40, P948, DOI 10.1136/jcp.40.9.948; CAMPBELL RD, 1988, ANNU REV IMMUNOL, V6, P161, DOI 10.1146/annurev.iy.06.040188.001113; CEPPELLINI R., 1967, P149; DAUSSET J, 1978, TISSUE ANTIGENS, V12, P297, DOI 10.1111/j.1399-0039.1978.tb01337.x; DAUSSET J, 1973, HISTOCOMPATIBILITY T, P99; DEGOS L, 1974, IMMUNOGENETICS, V3, P195; GRANGE D, 1981, TISSUE ANTIGENS, V18, P166, DOI 10.1111/j.1399-0039.1981.tb01379.x; GYODI E, 1981, TISSUE ANTIGENS, V18, P1, DOI 10.1111/j.1399-0039.1981.tb01355.x; Hostetler J, 1974, HUTTERITE SOC; HOSTETLER JA, 1985, AM J MED GENET, V22, P453, DOI 10.1002/ajmg.1320220303; KAY PH, 1988, HUM IMMUNOL, V23, P27, DOI 10.1016/0198-8859(88)90015-8; KLITZ W, 1987, GENETICS, V116, P633; MARTIN AO, 1980, BANBURY REPORT, V4, P235; MENDELL NM, 1984, MATH MODELS MED, V4, P161; MORGAN K, 1980, AM J HUM GENET, V32, P246; OBER C, 1988, AM J REPROD IM MIC, V18, P111; OBER CL, 1985, FERTIL STERIL, V44, P227; OBER CL, 1983, AM J HUM GENET, V35, P994; SCHACTER B, 1984, AM J HUM GENET, V36, P1082; STEINBERG AG, 1967, 3RD P INT C HUM GEN, P267; WERKMEISTER JW, 1986, AM J HUM GENET, V39, P461; 1988, TISSUE ANTIGENS, V32, P177	29	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					261	269						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2757031				2022-12-18	WOS:A1989AK38000008
J	CAI, SP; ZHANG, JZ; DOHERTY, M; KAN, YW				CAI, SP; ZHANG, JZ; DOHERTY, M; KAN, YW			A NEW TATA BOX MUTATION DETECTED AT PRENATAL-DIAGNOSIS FOR BETA-THALASSEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST LAB,SAN FRANCISCO,CA 94143; NAN FANG HOSP,GUANGZHOU,PEOPLES R CHINA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Southern Medical University - China					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK016666] Funding Source: NIH RePORTER; NIDDK NIH HHS [5R37-DK16666] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P1154, DOI 10.1073/pnas.81.4.1154; CAI SP, 1989, BLOOD, V73, P372; CAI SP, 1988, BLOOD, V71, P1357; CHAN V, 1988, BLOOD, V72, P1420; CHEHAB FF, 1987, NATURE, V329, P293, DOI 10.1038/329293b0; HUANG SZ, 1986, HUM GENET, V74, P162, DOI 10.1007/BF00282081; ORKIN SH, 1983, NUCLEIC ACIDS RES, V11, P4727, DOI 10.1093/nar/11.14.4727; PONCZ M, 1983, J BIOL CHEM, V257, P5994; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, NEW ENGL J MED, V319, P537, DOI 10.1056/NEJM198809013190903; TAKIHARA Y, 1986, BLOOD, V67, P547; ZHANG JZ, 1988, HUM GENET, V78, P37, DOI 10.1007/BF00291231	12	25	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1989	45	1					112	114						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE779	2741940				2022-12-18	WOS:A1989AE77900013
J	WADELIUS, C; FAGERHOLM, P; PETTERSSON, U; ANNEREN, G				WADELIUS, C; FAGERHOLM, P; PETTERSSON, U; ANNEREN, G			LOWE OCULOCEREBRORENAL SYNDROME - DNA-BASED LINKAGE OF THE GENE TO XQ24-Q26, USING TIGHTLY LINKED FLANKING MARKERS AND THE CORRELATION TO LENS EXAMINATION IN CARRIER DIAGNOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									KAROLINSKA INST,DEPT OPHTHALMOL,S-10401 STOCKHOLM 60,SWEDEN; UNIV HOSP UPPSALA,DEPT CLIN GENET,UPPSALA,SWEDEN	Karolinska Institutet; Uppsala University; Uppsala University Hospital	WADELIUS, C (corresponding author), UNIV UPPSALA,DEPT MED GENET,BOX 589,S-75123 UPPSALA,SWEDEN.							ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; CIBIS GW, 1986, OPHTHALMOLOGY, V93, P1041; FRANCKE U, 1985, AM J HUM GENET, V37, P250; GARDNER RJM, 1976, J MED GENET, V13, P449, DOI 10.1136/jmg.13.6.449; HODGSON SV, 1986, AM J MED GENET, V23, P837, DOI 10.1002/ajmg.1320230311; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LOWE CU, 1952, AM J DIS CHILD, V83, P389; Maniatis T., 1982, MOL CLONING; MULLIGAN LM, 1985, AM J HUM GENET, V37, P463; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; OTT J, 1974, AM J HUM GENET, V26, P588; REILLY DS, 1988, AM J HUM GENET, V42, P748; SCHMECKPEPER BJ, 1985, NUCLEIC ACIDS RES, V13, P5724, DOI 10.1093/nar/13.15.5724; SILVER DN, 1987, J CLIN INVEST, V79, P282, DOI 10.1172/JCI112795; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SVORC J, 1967, AM J DIS CHILD, V114, P186, DOI 10.1001/archpedi.1967.02090230116015; THAKKER RV, 1987, J MED GENET, V24, P756, DOI 10.1136/jmg.24.12.756; YAMASHINA I, 1983, MOL CELL BIOCHEM, V52, P107; YUNIS JJ, 1983, BIRTH DEFECTS-ORIG, V19, P11	20	25	25	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1989	44	2					241	247						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R9705	2912070				2022-12-18	WOS:A1989R970500009
J	MAGENIS, RE				MAGENIS, RE			ON THE ORIGIN OF CHROMOSOME ANOMALY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									OREGON HLTH SCI UNIV,DEPT MED GENET,DIV CRIPPLED CHILDRENS,PORTLAND,OR 97201	Oregon Health & Science University								BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; CASPERSSON T, 1970, EXP CELL RES, V62, P490, DOI 10.1016/0014-4827(70)90586-0; CASPERSSON T, 1970, EXP CELL RES, V63, P240, DOI 10.1016/0014-4827(70)90363-0; de Grouchy J, 1970, Ann Genet, V13, P52; DELMAZO J, 1982, HUM GENET, V62, P316, DOI 10.1007/BF00304546; EMANUEL I, 1972, LANCET, V2, P361; FERGUSONSMITH MA, 1966, LANCET, V2, P475; FIALKOW PJ, 1971, AM J HUM GENET, V23, P67; FINEMAN RM, 1976, NATURE, V260, P320, DOI 10.1038/260320a0; FORD JH, 1973, LANCET, V1, P54; FRASER J, 1876, J MENT SCI, V22, P168; GERMAN J, 1968, NATURE, V217, P516, DOI 10.1038/217516a0; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HASSOLD T, 1987, J MED GENET, V24, P725, DOI 10.1136/jmg.24.12.725; HOOK EB, 1983, HUM GENET, V64, P24, DOI 10.1007/BF00289473; HSU LYF, 1971, AM J HUM GENET, V23, P592; JACOBS PA, 1981, ANN HUM GENET, V45, P357, DOI 10.1111/j.1469-1809.1981.tb00349.x; JONGBLOET P H, 1971, Clinical Genetics, V2, P315; JONGBLOET PH, 1982, HUM GENET, V62, P134; JONGBLOET PH, 1981, CLIN GENET, V20, P304; JUBERG RC, 1970, NEW ENGL J MED, V282, P292, DOI 10.1056/NEJM197002052820602; KAJII T, 1977, CYTOGENET CELL GENET, V18, P109, DOI 10.1159/000130756; LEJEUNE J, 1970, ANN NEW YORK ACADEMY, P381; LICZNERSKI G, 1970, HEREDITAS, V70, P153; LINDER D, 1975, NEW ENGL J MED, V292, P63, DOI 10.1056/NEJM197501092920202; MAGENIS RE, 1988, AM J MED GENET, V29, P9, DOI 10.1002/ajmg.1320290103; MAGENIS RE, 1987, HUM GENET, V75, P228, DOI 10.1007/BF00281064; MAGENIS RE, 1980, 31ST AM SOC HUM GEN; MAGENIS RE, 1981, TRISOMY, V21, P77; MANNING CH, 1981, HUM GENET, V59, P101, DOI 10.1007/BF00293054; MARASCHIO P, 1981, HUM GENET, V57, P345, DOI 10.1007/BF00281681; MATTEI JF, 1979, HUM GENET, V46, P107, DOI 10.1007/BF00278908; MATTEI JF, 1980, J MED GENET, V17, P368, DOI 10.1136/jmg.17.5.368; MATTEI MG, 1984, HUM GENET, V66, P313, DOI 10.1007/BF00287636; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; NIELSEN J, 1974, HUMANGENETIK, V21, P211, DOI 10.1007/BF00279014; OLSON SB, IN PRESS CYTOGENETIC; PAGE DC, 1984, AM J HUM GENET, V36, P565; Penrose LS, 1933, J GENET, V27, P219, DOI 10.1007/BF02984413; PENROSE LS, 1961, BRIT MED BULL, V17, P184, DOI 10.1093/oxfordjournals.bmb.a069906; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SCHMIDT R, 1981, CLIN GENET, V20, P203; STOLLER A, 1965, NATURE, V208, P903, DOI 10.1038/208903b0; TIPPETT P, 1985, HUM GENET, V70, P92, DOI 10.1007/BF00389469; UCHIDA IA, 1968, LANCET, V2, P1045; VASSILAKOS P, 1977, AM J OBSTET GYNECOL, V127, P167, DOI 10.1016/S0002-9378(16)33244-6; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519	47	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1988	42	4					529	533						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6316	2964777				2022-12-18	WOS:A1988M631600001
J	GLERUM, M; ROBINSON, BH; SPRATT, C; WILSON, J; PATRICK, D				GLERUM, M; ROBINSON, BH; SPRATT, C; WILSON, J; PATRICK, D			ABNORMAL KINETIC-BEHAVIOR OF CYTOCHROME-OXIDASE IN A CASE OF LEIGH DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,RES INST,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; GEN HOSP,ST HELIER,JERSEY,ENGLAND; UNIV TORONTO,DEPT PAEDIAT & BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV LONDON,INST CHILD HLTH,LONDON,ENGLAND	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); St Helier Hospital; University of Toronto; University of London; University College London			Patrick, Donald/Y-2460-2019	Patrick, Donald/0000-0003-0756-0492				DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209; DIMAURO S, 1980, NEUROLOGY, V30, P795, DOI 10.1212/WNL.30.8.795; ERECINSKA M, 1982, J MEMBRANE BIOL, V70, P1, DOI 10.1007/BF01871584; FISCHER JC, 1985, CLIN CHIM ACTA, V145, P89, DOI 10.1016/0009-8981(85)90022-1; GROEN AK, 1982, J BIOL CHEM, V257, P2754; HEIMANPATTERSON TD, 1982, NEUROLOGY, V32, P898, DOI 10.1212/WNL.32.8.898; JACOBUS WE, 1982, J BIOL CHEM, V257, P2397; MILLIS AJT, 1973, BIOCHIM BIOPHYS ACTA, V292, P73, DOI 10.1016/0005-2728(73)90251-X; MIYABAYASHI S, 1983, J INHERIT METAB DIS, V6, P121, DOI 10.1007/BF01800742; MONNENS L, 1975, J PEDIATR-US, V86, P983, DOI 10.1016/S0022-3476(75)80269-1; MOREADITH RW, 1984, J CLIN INVEST, V74, P685, DOI 10.1172/JCI111484; MULLERHOCKER J, 1983, VIRCHOWS ARCH A, V399, P11; ROBINSON BH, 1986, J CLIN INVEST, V77, P1422, DOI 10.1172/JCI112453; ROBINSON BH, 1980, PEDIATR RES, V14, P956, DOI 10.1203/00006450-198008000-00013; ROBINSON BH, 1985, AM J HUM GENET, V37, P938; SENGERS RCA, 1984, EUR J PEDIATR, V141, P178, DOI 10.1007/BF00443221; STANSBIE D, 1982, J INHERIT METAB DIS, V5, P27, DOI 10.1007/BF01799812; TRIJBELS F, 1983, J INHERIT METAB DIS, V6, P127, DOI 10.1007/BF01810360; VANBIERVLIET JPGM, 1977, PEDIATR RES, V11, P1088, DOI 10.1203/00006450-197711100-00005; WILLEMS JL, 1977, PEDIATRICS, V60, P850	20	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1987	41	4					584	593						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4621	2821802				2022-12-18	WOS:A1987K462100007
J	GRAVES, PN; GRABOWSKI, GA; LUDMAN, MD; PALESE, P; SMITH, FI				GRAVES, PN; GRABOWSKI, GA; LUDMAN, MD; PALESE, P; SMITH, FI			HUMAN ACID BETA-GLUCOSIDASE - NORTHERN BLOT AND S1 NUCLEASE ANALYSIS OF MESSENGER-RNA FROM HELA-CELLS AND NORMAL AND GAUCHER DISEASE FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CUNY MT SINAI SCH MED,DIV MED GENET,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT PEDIAT,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	GRAVES, PN (corresponding author), CUNY MT SINAI SCH MED,DEPT MICROBIOL,NEW YORK,NY 10029, USA.			Ludman, Mark/0000-0002-9658-6784; Palese, Peter/0000-0002-0337-5823	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI011823] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-71] Funding Source: Medline; NIADDK NIH HHS [AM-3629] Funding Source: Medline; NIAID NIH HHS [AI-11823] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMARA SG, 1984, MOL CELL BIOL, V4, P2151, DOI 10.1128/MCB.4.10.2151; AMARA SG, 1985, MOL CELL ENDOCRINOL, V42, P191, DOI 10.1016/0303-7207(85)90049-8; ARNHEIM N, 1979, GENE, V7, P83, DOI 10.1016/0378-1119(79)90025-8; BEUTLER E, 1984, P NATL ACAD SCI-BIOL, V81, P6506, DOI 10.1073/pnas.81.20.6506; BRINN L, 1962, N Y State J Med, V62, P2346; CHOUDARY PV, 1985, DNA-J MOLEC CELL BIO, V4, P74; DODEMONT HJ, 1982, EMBO J, V1, P167, DOI 10.1002/j.1460-2075.1982.tb01142.x; FABBRO D, 1987, AM J HUM GENET; FRANKLIN RM, 1966, P NATL ACAD SCI USA, V55, P1504, DOI 10.1073/pnas.55.6.1504; Frederickson DS, 1972, METABOLIC BASIS INHE, P730; GONZALEZ IL, 1986, AM J HUM GENET, V38, P419; GONZALEZ IL, 1985, P NATL ACAD SCI US, V82, P7606; GRABOWSKI GA, 1985, AM J HUM GENET, V37, P499; GRABOWSKI GA, 1985, AM J MED GENET, V21, P529, DOI 10.1002/ajmg.1320210316; GRABOWSKI GA, 1986, J BIOL CHEM, V261, P8263; HODSON P, 1979, ARCH DIS CHILD, V54, P707, DOI 10.1136/adc.54.9.707; Institute of Gaucher Disease, 2020, EP GAUCH DIS; MANIATIS T, 1982, MOL CLONING LABORATO, P201; MEDOFF AS, 1954, ANN INTERN MED, V40, P481, DOI 10.7326/0003-4819-40-3-481; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MYEROWITZ R, 1985, P NATL ACAD SCI USA, V82, P7830, DOI 10.1073/pnas.82.23.7830; PENTCHEV PG, 1983, AM J HUM GENET, V35, P621; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SCHENBORN ET, 1985, NUCLEIC ACIDS RES, V13, P6223, DOI 10.1093/nar/13.17.6223; SHEINESS D, 1973, NATURE-NEW BIOL, V241, P265, DOI 10.1038/newbio241265a0; SORGE J, 1985, P NATL ACAD SCI USA, V82, P7289, DOI 10.1073/pnas.82.21.7289; SORGE J, 1986, P NATL ACAD SCI USA, V83, P3567; TSUJI S, 1986, J BIOL CHEM, V261, P50; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611	30	25	25	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1986	39	6					763	774						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F5414	3026174				2022-12-18	WOS:A1986F541400011
J	SPENCE, JE; ROSENBLOOM, CL; OBRIEN, WE; SEILHEIMER, DK; COLE, S; FERRELL, RE; STERN, RC; BEAUDET, AL				SPENCE, JE; ROSENBLOOM, CL; OBRIEN, WE; SEILHEIMER, DK; COLE, S; FERRELL, RE; STERN, RC; BEAUDET, AL			LINKAGE OF DNA MARKERS TO CYSTIC-FIBROSIS IN 26 FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT BIOSTAT,PITTSBURGH,PA 15261; CASE WESTERN RESERVE UNIV,SCH MED,DEPT PEDIAT,CLEVELAND,OH 44106; HOWARD HUGHES MED INST,HOUSTON,TX 77030	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; Howard Hughes Medical Institute	SPENCE, JE (corresponding author), BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [F32AM007637] Funding Source: NIH RePORTER; NIADDK NIH HHS [F32 AM07637] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BARTELS I, 1986, AM J HUM GENET, V38, P280; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BIRD AG, 1981, NATURE, V289, P300, DOI 10.1038/289300a0; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BROCK DJH, 1985, PRENATAL DIAG, V5, P129, DOI 10.1002/pd.1970050206; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; EIBERG H, 1985, CLIN GENET, V28, P265; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; MANIATIS T, 1982, MOL CLONING LABORATO; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; MULLER F, 1985, PRENATAL DIAG, V5, P97, DOI 10.1002/pd.1970050203; OTT J, 1974, AM J HUM GENET, V26, P588; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0	16	25	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1986	39	6					729	734						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F5414	2879439				2022-12-18	WOS:A1986F541400007
J	ELSTON, RC				ELSTON, RC			PROBABILITY AND PATERNITY TESTING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											ELSTON, RC (corresponding author), LOUISIANA STATE UNIV,MED CTR,DEPT BIOMETRY & GENET,NEW ORLEANS,LA 70112, USA.							AICKIN M, 1984, AM J HUM GENET, V36, P904; BAUR MP, 1981, 9TH LINT C SOC FOR H, P389; BAUR MP, UNPUB NO FALLACIES F; BAYES T, 1958, BIOMETRIKA, V45, P296; CHAKRABORTY R, 1981, HUM HERED, V31, P363, DOI 10.1159/000153239; CHAKRAVARTI A, 1984, FORENSIC SCI INT, V24, P143, DOI 10.1016/0379-0738(84)90094-X; LI CC, 1985, AM J HUM GENET, V37, P809; MAJUMDER PP, 1983, HUM HERED, V33, P29, DOI 10.1159/000153343; POTTHOFF RF, 1965, AM J HUM GENET, V17, P480; READING PL, 1981, THESIS U N CAROLINA; WALKER RH, 1985, AM J HUM GENET, V37, P819	11	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1986	39	1					112	122						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	D9615	3752078				2022-12-18	WOS:A1986D961500010
J	MUENSCH, H; GAIDULIS, L; KUEPPERS, F; SO, SY; ESCANO, G; KIDD, VJ; WOO, SLC				MUENSCH, H; GAIDULIS, L; KUEPPERS, F; SO, SY; ESCANO, G; KIDD, VJ; WOO, SLC			COMPLETE ABSENCE OF SERUM ALPHA-1-ANTITRYPSIN IN CONJUNCTION WITH AN APPARENTLY NORMAL GENE STRUCTURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TEMPLE UNIV, HLTH SCI CTR, SCH MED, PULM DIS SECT, PHILADELPHIA, PA 19140 USA; UNIV HONG KONG, QUEEN MARY HOSP, DEPT MED, HONG KONG, HONG KONG; ORANGE PULM GRP, ORLANDO, FL 32803 USA; BAYLOR COLL MED, HOWARD HUGHES MED INST, DEPT CELL BIOL, HOUSTON, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Hong Kong; Baylor College of Medicine; Howard Hughes Medical Institute	MUENSCH, H (corresponding author), CITY HOPE NATL MED CTR, DIV CLIN PATHOL, DUARTE, CA 91010 USA.				NHLBI NIH HHS [HL-27509, HL-20994, HL-29516] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL027509] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTAY C, 1973, NEW ENGL J MED, V289, P754; BLUNDELL G, 1974, LANCET, V2, P404; BLUNDELL G, 1976, PROTIDES BIOL FLUIDS, V23, P367; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BURN J, 1982, ARCH DIS CHILD, V57, P311, DOI 10.1136/adc.57.4.311; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; FELDMANN G, 1975, GUT, V16, P796, DOI 10.1136/gut.16.10.796; GAIDULIS L, 1983, CLIN CHEM, V29, P1838; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; KUEPPERS F, 1978, GENETIC DETERMINANTS, V11, P23; LAURELL CB, 1974, ACTA PAEDIATR SCAND, V63, P855, DOI 10.1111/j.1651-2227.1974.tb04876.x; LIEBERMAN J, 1976, CHEST, V70, P532, DOI 10.1378/chest.70.4.532; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; LONG GL, 1986, BIOCHEMISTRY; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; MARTIN JP, 1975, PATHOL BIOL, V23, P521; MARTIN JP, 1973, LANCET, V2, P845; SHARP H, 1972, PULMONARY EMPHYSEMA, P102; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TALAMO RC, 1973, SCIENCE, V181, P70, DOI 10.1126/science.181.4094.70; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0; YOSHIDA A, 1976, P NATL ACAD SCI USA, V73, P1324, DOI 10.1073/pnas.73.4.1324	25	25	25	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					898	907						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3014871				2022-12-18	WOS:A1986D392200013
J	SCHWARTZ, S; SCHWARTZ, MF; PANNY, SR; PETERSON, CJ; WATERS, E; COHEN, MM				SCHWARTZ, S; SCHWARTZ, MF; PANNY, SR; PETERSON, CJ; WATERS, E; COHEN, MM			INHERITED X-CHROMOSOME INVERTED TANDEM DUPLICATION IN A MALE TRACED TO A GRANDPARENTAL MITOTIC ERROR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SCHWARTZ, S (corresponding author), UNIV MARYLAND, SCH MED, DEPT OBSTET GYNECOL & PEDIAT, DIV HUMAN GENET, BALTIMORE, MD 21201 USA.							BARNABEI VM, 1981, AM J HUM GENET, V33, P61; BERNSTEIN R, 1980, J MED GENET, V17, P291, DOI 10.1136/jmg.17.4.291; BEUTLER E, 1965, Semin Hematol, V2, P91; BISHOP DF, 1981, J BIOL CHEM, V256, P1307; BISHOP DF, 1978, BIOCHIM BIOPHYS ACTA, V524, P109, DOI 10.1016/0005-2744(78)90109-2; BOHLEN P, 1973, ARCH BIOCHEM BIOPHYS, V155, P213, DOI 10.1016/S0003-9861(73)80023-2; CARSON PE, 1966, AM J MED, V41, P744, DOI 10.1016/0002-9343(66)90035-0; CASPERSSON T, 1971, ANN GENET-PARIS, V14, P143; CHIYO H, 1976, HUM GENET, V34, P217, DOI 10.1007/BF00278892; CURRY CJR, 1984, NEW ENGL J MED, V311, P1010, DOI 10.1056/NEJM198410183111603; de Grouchy J., 1984, CLIN ATLAS HUMAN CHR; DELACHAPELLE A, 1975, HEREDITAS, V80, P113; FOX MF, 1984, CYTOGENET CELL GENET, V38, P45, DOI 10.1159/000132028; FRANCKE U, 1985, AM J HUM GENET, V37, P250; GOTO K, 1978, CHROMOSOMA, V66, P351, DOI 10.1007/BF00328535; GRASS FS, 1981, CLIN GENET, V20, P28; HARROD MJE, 1980, AM J MED GENET, V7, P123, DOI 10.1002/ajmg.1320070206; KEITGES EA, 1982, HUM GENET, V62, P210, DOI 10.1007/BF00333520; LATT SA, 1976, CHROMOSOMA, V57, P135, DOI 10.1007/BF00292912; MADAN K, 1981, HUM GENET, V59, P290, DOI 10.1007/BF00295460; MAGENIS RE, 1984, CYTOGENET CELL GENET, V37, P528; MILLER OJ, 1984, CYTOGENET CELL GENET, V37, P176, DOI 10.1159/000132009; NARAHARA K, 1979, JPN J HUM GENET, V24, P105, DOI 10.1007/BF01888928; NIELSEN KB, 1982, J MED GENET, V19, P222, DOI 10.1136/jmg.19.3.222; SARTO GE, 1973, AM J HUM GENET, V25, P262; SPARKES RS, 1977, CLIN GENET, V12, P114; STEINBACH P, 1980, HUM GENET, V54, P309, DOI 10.1007/BF00291574; Summitt R L, 1978, Birth Defects Orig Artic Ser, V14, P219; TABOR A, 1983, HUM GENET, V64, P196, DOI 10.1007/BF00327127; TAYLOR KM, 1977, AM J MED GENET, V1, P3, DOI 10.1002/ajmg.1320010103; VANDENBERGH N, 1983, GEN RELAT GRAVIT, V15, P441, DOI 10.1007/BF00759938; VARELLAGARCIA M, 1981, J MED GENET, V18, P228, DOI 10.1136/jmg.18.3.228; VERJERSLEV LO, 1985, CLIN GENET, V27, P276; WEGNER RD, 1982, HUM GENET, V61, P79, DOI 10.1007/BF00291343; WILLARD HF, 1977, CHROMOSOMA, V61, P61, DOI 10.1007/BF00292681; YIP MY, 1982, CLIN GENET, V22, P1; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	37	25	25	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1986	38	5					741	750						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C9730	3459356				2022-12-18	WOS:A1986C973000012
J	SELIGMAN, PA; BUTLER, CD; MASSEY, EJ; KAUR, JA; BROWN, JP; PLOWMAN, GD; MILLER, Y; JONES, C				SELIGMAN, PA; BUTLER, CD; MASSEY, EJ; KAUR, JA; BROWN, JP; PLOWMAN, GD; MILLER, Y; JONES, C			THE P97 ANTIGEN IS MAPPED TO THE Q24-QTER REGION OF CHROMOSOME-3 - THE SAME REGION AS THE TRANSFERRIN RECEPTOR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,SCH MED,ELEANOR ROOSEVELT INST CANC RES,DENVER,CO 80262; ONCOGEN,SEATTLE,WA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	SELIGMAN, PA (corresponding author), UNIV COLORADO,SCH MED,DEPT MED,DENVER,CO 80202, USA.		PLOWMAN, Greg D/E-2012-2011		NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM027039] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-27039] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aisen P, 1975, Prog Hematol, V9, P25; BROWN JP, 1982, NATURE, V296, P171, DOI 10.1038/296171a0; BROWN JP, 1981, P NATL ACAD SCI-BIOL, V78, P539, DOI 10.1073/pnas.78.1.539; BROWN JP, 1981, J IMMUNOL, V127, P539; CHEVRANTBRETON J, 1977, ARCH DERMATOL, V113, P161, DOI 10.1001/archderm.113.2.161; CHITAMBAR CR, 1983, J CLIN INVEST, V72, P1314, DOI 10.1172/JCI111087; ENNS CA, 1982, P NATL ACAD SCI-BIOL, V79, P3241, DOI 10.1073/pnas.79.10.3241; FRAZIER JL, 1982, J CLIN INVEST, V69, P853, DOI 10.1172/JCI110525; GOODFELLOW PN, 1982, SOMAT CELL GENET, V8, P197, DOI 10.1007/BF01538677; GRAHAM G, 1979, AM J HEMATOL, V6, P207, DOI 10.1002/ajh.2830060305; Hadley M., 1975, AM ZOOL, V15, P81; HAMILTON TA, 1979, P NATL ACAD SCI USA, V76, P6406, DOI 10.1073/pnas.76.12.6406; HUERRE C, 1984, ANN GENET-PARIS, V27, P5; JANDL JH, 1963, J CLIN INVEST, V42, P314, DOI 10.1172/JCI104718; JONES C, 1980, CYTOGENET CELL GENET, V28, P181, DOI 10.1159/000131529; KARIN M, 1981, J BIOL CHEM, V256, P3245; KORNFELD S, 1969, BIOCHIM BIOPHYS ACTA, V194, P25, DOI 10.1016/0005-2795(69)90175-5; LARRICK JW, 1979, J SUPRAMOL STR CELL, V11, P579, DOI 10.1002/jss.400110415; LOT TT, 1980, J CLIN INVEST, V65, P1182; MILLER YE, 1983, AM J HUM GENET, V35, P573; MORGAN EH, 1964, BRIT J HAEMATOL, V10, P442, DOI 10.1111/j.1365-2141.1964.tb00721.x; PLOWMAN GD, 1983, NATURE, V303, P70, DOI 10.1038/303070a0; RABIN M, 1984, American Journal of Human Genetics, V36, p109S; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHNEIDER C, 1984, NATURE, V311, P675, DOI 10.1038/311675b0; SELIGMAN PA, 1979, J BIOL CHEM, V254, P9943; SUTHERLAND R, 1981, P NATL ACAD SCI-BIOL, V78, P4515, DOI 10.1073/pnas.78.7.4515; TROWBRIDGE IS, 1981, P NATL ACAD SCI-BIOL, V78, P3039, DOI 10.1073/pnas.78.5.3039; VANBOCKXMEER FM, 1978, EUR J BIOCHEM, V92, P147; WADA HG, 1979, J BIOL CHEM, V254, P2629; WITT DP, 1978, BIOCHEMISTRY-US, V17, P3913, DOI 10.1021/bi00612a004; YANG FM, 1984, P NATL ACAD SCI-BIOL, V81, P2752, DOI 10.1073/pnas.81.9.2752	32	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1986	38	4					540	548						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C4893	3010712				2022-12-18	WOS:A1986C489300013
J	BARRAI, I; CANN, HM; CAVALLISFORZA, LL; BARBUJANI, G; DENICOLA, P				BARRAI, I; CANN, HM; CAVALLISFORZA, LL; BARBUJANI, G; DENICOLA, P			SEGREGATION ANALYSIS OF HEMOPHILIA-A AND HEMOPHILIA-B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV,DEPT PEDIAT,STANFORD,CA 94305; STANFORD UNIV,DEPT GENET,STANFORD,CA 94305; UNIV PAVIA,INST GERONTOL,I-27100 PAVIA,ITALY; NATL ACAD LINCEI,CTR INTERDISCIPLINARY,ROME,ITALY	Stanford University; Stanford University; University of Pavia	BARRAI, I (corresponding author), UNIV FERRARA,INST ZOOL,I-44100 FERRARA,ITALY.		Barbujani, Guido/ABE-9998-2020	Barbujani, Guido/0000-0001-7854-6669				BARRAI I, 1979, AM J HUM GENET, V31, P226; BARRAI I, 1968, AM J HUM GENET, V20, P175; DANIELI GA, 1984, HUM GENET, V67, P252, DOI 10.1007/BF00291351; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; KOSOWER D, 1962, AM J HUM GENET, V14, P159; MORTON NE, 1959, AM J HUM GENET, V11, P1; VOGEL F, 1975, ADV HUM GENET, V5, P223; VOGEL F, 1977, AM J HUM GENET, V29, P312; VOGEL VF, 1956, BLUT, V1, P91; YASUDA N, 1980, J MED GENET, V17, P106, DOI 10.1136/jmg.17.2.106; YASUDA N, 1982, AM J MED GENET, V13, P91, DOI 10.1002/ajmg.1320130114	12	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					680	699						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556658				2022-12-18	WOS:A1985APR1800006
J	ERICKSON, RP				ERICKSON, RP			CHROMOSOMAL IMPRINTING AND THE PARENT TRANSMISSION SPECIFIC VARIATION IN EXPRESSIVITY OF HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											ERICKSON, RP (corresponding author), UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,BOX 015,ANN ARBOR,MI 48109, USA.							CHANDRA HS, 1975, NATURE, V253, P165, DOI 10.1038/253165a0; CROUSE HV, 1960, GENETICS, V45, P1429; ERICKSON RP, 1976, DEV BIOL, V53, P134, DOI 10.1016/0012-1606(76)90216-5; FALCONER DS, 1982, GENET RES, V39, P237, DOI 10.1017/S0016672300020930; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; JOHNSON DR, 1975, GENET RES CAMB, V24, P207; KORENYI C, 1973, ADV NEUROL, V1, P75; KRATZER PG, 1983, CELL, V33, P37, DOI 10.1016/0092-8674(83)90332-X; LAZZARINI A, 1984, American Journal of Human Genetics, V36, p62S; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; LYON MF, 1984, DIFFERENTIATION, V26, P63, DOI 10.1111/j.1432-0436.1984.tb01375.x; MANN JR, 1984, NATURE, V310, P66, DOI 10.1038/310066a0; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MCGRATH J, 1984, NATURE, V308, P550, DOI 10.1038/308550a0; MYERS RH, 1983, LANCET, V1, P208; SANFORD J, 1984, NUCLEIC ACID RES, V12, P2833; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; ZELLWEGER H, 1973, AM J DIS CHILD, V125, P601, DOI 10.1001/archpedi.1973.04160040097021	20	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					827	829						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556671				2022-12-18	WOS:A1985APR1800021
J	NEEL, JV				NEEL, JV			A REVISED ESTIMATE OF THE AMOUNT OF GENETIC-VARIATION IN HUMAN PROTEINS - IMPLICATIONS FOR THE DISTRIBUTION OF DNA POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material											NEEL, JV (corresponding author), UNIV MICHIGAN,SCH MED,ANN ARBOR,MI 48104, USA.							ANDERSON NG, 1969, SCIENCE, V166, P317, DOI 10.1126/science.166.3903.317; AQUADRO CF, 1982, GENETICS, V102, P269; AYALA FJ, 1982, P NATL ACAD SCI-BIOL, V79, P550, DOI 10.1073/pnas.79.2.550; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BERNSTEIN SC, 1973, P NATL ACAD SCI USA, V70, P3928, DOI 10.1073/pnas.70.12.3928; BONHOMME F, 1978, ORIGINS INBRED MICE, P569; BURTIS CA, 1972, CLIN CHEM, V18, P753; COCHRANE BJ, 1979, GENETICS, V93, P461; COMINGS DE, 1982, CLIN CHEM, V28, P798; CZELUSNIAK J, 1982, NATURE, V298, P297, DOI 10.1038/298297a0; EWENS WJ, 1981, P NATL ACAD SCI-BIOL, V78, P3748, DOI 10.1073/pnas.78.6.3748; FIELEK S, 1979, CLIN CHEM, V25, P384; FUERST PA, 1980, GENETICS, V94, P185; Gadek JECR, 1983, METABOLIC BASIS INHE; GOLDMAN D, 1983, AM J HUM GENET, V35, P827; HAMAGUCHI H, 1982, HUM GENET, V62, P142; HAMAGUCHI H, 1981, HUM GENET, V59, P215; HAMAGUCHI H, 1982, HUM GENET, V60, P176, DOI 10.1007/BF00569708; HANASH SM, UNPUB GENETIC ANAL 5; HARRIS H, 1970, PRINCIPLES HUMAN BIO; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JENKINS T, 1979, ANN HUM GENET, V42, P425, DOI 10.1111/j.1469-1809.1979.tb00676.x; JOHNSON GB, 1977, GENETICS, V87, P139; JOHNSON GB, 1974, GENETICS, V78, P771; KAZAZIAN HH, 1983, AM J HUM GENET, V35, P1028; KAZAZIAN HH, 1983, EVOLUTION GENES PROT, P137; KLOSE J, 1983, HUM GENET, V63, P262; KLOSE J, 1975, HUMANGENETIK, V26, P231; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; LEWIS WHP, 1973, ANN HUM GENET, V36, P267, DOI 10.1111/j.1469-1809.1973.tb00589.x; MACCLUER J, CITED INDIRECTLY; MARSHALL DR, 1975, J MOL EVOL, V6, P149, DOI 10.1007/BF01732353; MCCONKEY EH, 1979, P NATL ACAD SCI USA, V76, P6500, DOI 10.1073/pnas.76.12.6500; MERRIL CR, 1979, P NATL ACAD SCI USA, V76, P4335, DOI 10.1073/pnas.76.9.4335; MOHRENWEISER HW, 1982, BIOCHIM BIOPHYS ACTA, V702, P90, DOI 10.1016/0167-4838(82)90030-9; MOHRENWEISER HW, 1984, AM J HUM GENET, V36, P655; MOHRENWEISER HW, 1981, P NATL ACAD SCI-BIOL, V78, P5046, DOI 10.1073/pnas.78.8.5046; MOHRENWEISER HW, 1982, PEDIATR RES, V16, P960, DOI 10.1203/00006450-198211000-00012; MOHRENWEISER HW, 1981, P NATL ACAD SCI-BIOL, V78, P5729, DOI 10.1073/pnas.78.9.5729; MURRAY JC, 1983, P NATL ACAD SCI-BIOL, V80, P5951, DOI 10.1073/pnas.80.19.5951; NEEL JV, 1982, PERSPECT BIOL MED, V25, P518; NEEL JV, 1984, METHODS APPLICATIONS, P259; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PERLER F, 1980, CELL, V20, P555, DOI 10.1016/0092-8674(80)90641-8; PONCZ M, 1983, J BIOL CHEM, V258; RAMSHAW JAM, 1979, GENETICS, V93, P1019; ROSENBLUM BB, 1984, AM J HUM GENET, V36, P601; ROSENBLUM BB, 1983, P NATL ACAD SCI-BIOL, V80, P5002, DOI 10.1073/pnas.80.16.5002; SAMMONS DW, 1981, ELECTROPHORESIS, V2, P135, DOI 10.1002/elps.1150020303; SAMPSELL B, 1977, BIOCHEM GENET, V15, P971, DOI 10.1007/BF00483992; SATOH C, 1983, AM J HUM GENET, V35, P656; SATOH C, 1979, ANN HUM GENET, V42, P283, DOI 10.1111/j.1469-1809.1979.tb00662.x; SATOH C, UNPUB FREQUENCY THER; SCHEELE GA, 1975, J BIOL CHEM, V250, P5375; SCOZZARI R, 1981, ANN HUM GENET, V45, P313, DOI 10.1111/j.1469-1809.1981.tb00344.x; SHAW CR, 1965, SCIENCE, V149, P936, DOI 10.1126/science.149.3687.936; SINGH RS, 1975, GENETICS, V80, P637; SINGH RS, 1976, GENETICS, V84, P609; SINGH RS, 1982, GENETICS, V102, P437; SMITH CR, 1981, GENETICS, V96, P967; TAKAHASHI N, 1982, P NATL ACAD SCI-BIOL, V79, P6636, DOI 10.1073/pnas.79.21.6636; TANIS RJ, 1977, AM J HUM GENET, V29, P419; TRIPPA G, 1976, NATURE, V260, P42, DOI 10.1038/260042a0; WALTON KE, 1979, J BIOL CHEM, V254, P7951; WANNER LA, 1982, AM J HUM GENET, V34, P209; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; WURZINGER KH, 1982, ANN HUM GENET, V46, P191, DOI 10.1111/j.1469-1809.1982.tb00711.x; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	70	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	5					1135	1148						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TS302	6093507				2022-12-18	WOS:A1984TS30200018
J	WAHEED, A; STECKEL, F; HASILIK, A; VONFIGURA, K				WAHEED, A; STECKEL, F; HASILIK, A; VONFIGURA, K			2 ALLELIC FORMS OF HUMAN ARYLSULFATASE-A WITH DIFFERENT NUMBERS OF ASPARAGINE-LINKED OLIGOSACCHARIDES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MUNSTER, INST PHYSIOL CHEM, D-4400 MUNSTER, FED REP GER	University of Munster								BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; Cantz M, 1972, METHOD ENZYMOL, V28, P884; DULANEY JT, 1978, METABOLIC BASIS INHE, P770; ETO Y, 1974, J BIOL CHEM, V249, P4955; FLUHARTY AL, 1974, BIOCHEM BIOPH RES CO, V61, P348, DOI 10.1016/0006-291X(74)90573-7; HARZER K, 1974, H-S Z PHYSIOL CHEM, V355, P744; HASILIK A, 1981, EUR J BIOCHEM, V121, P125, DOI 10.1111/j.1432-1033.1981.tb06440.x; HASILIK A, 1982, EUR J BIOCHEM, V122, P119, DOI 10.1111/j.1432-1033.1982.tb05856.x; HASILIK A, 1980, J BIOL CHEM, V255, P4937; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MCKUSICK VA, 1978, METABOLIC BASIS INHE, P1282; MEHL E, 1968, BIOCHIM BIOPHYS ACTA, V151, P619, DOI 10.1016/0005-2744(68)90008-9; ROY AB, 1975, BIOCHIM BIOPHYS ACTA, V377, P356, DOI 10.1016/0005-2744(75)90316-2; WAHEED A, 1982, H-S Z PHYSIOL CHEM, V363, P425, DOI 10.1515/bchm2.1982.363.1.425; WAHEED A, 1982, EUR J BIOCHEM, V123, P317, DOI 10.1111/j.1432-1033.1982.tb19770.x; YAMATO K, 1974, J BIOCHEM-TOKYO, V75, P1241, DOI 10.1093/oxfordjournals.jbchem.a130507	17	25	25	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1983	35	2					228	233						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ265	6132551				2022-12-18	WOS:A1983QJ26500006
J	FERRELL, RE; HITTNER, HM; KRETZER, FL; ANTOSZYK, JH				FERRELL, RE; HITTNER, HM; KRETZER, FL; ANTOSZYK, JH			ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS - PROBABLE LINKAGE TO THE MNS BLOOD-GROUP ON CHROMOSOME-4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,CULLEN EYE INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine	FERRELL, RE (corresponding author), UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULAT GENET,GRAD SCH BIOMED SCI,HOUSTON,TX 77025, USA.				NEI NIH HHS [EY-02607, EY-03430] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARKER RF, 1978, ANN HUM GENET, V42, P143, DOI 10.1111/j.1469-1809.1978.tb00644.x; BOOTSMA D, 1979, CYTOGENET CELL GENET, V25, P21, DOI 10.1159/000131396; CONSTANS J, 1977, SCIENCE, V198, P1070, DOI 10.1126/science.73222; FALK CT, 1979, CYTOGENET CELL GENET, V25, P152; FERRELL RE, 1980, AM J HUM GENET, V32, P92; HITTNER HM, 1982, AM J OPHTHALMOL, V93, P57, DOI 10.1016/0002-9394(82)90700-0; KEATS BJB, 1979, SOURCE BOOK LINKAGE; KENYON KR, 1973, AM J OPHTHALMOL, V76, P419, DOI 10.1016/0002-9394(73)90726-5; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1978, CYTOGENET CELL GENET, V22, P15, DOI 10.1159/000130916; OTT J, 1974, AM J HUM GENET, V26, P588; TOWNSEND WM, 1974, AM J OPHTHALMOL, V77, P80, DOI 10.1016/0002-9394(74)90610-2; VANDERHAGEN CB, 1979, CYTOGENET CELL GENET, V25, P214; Waring G O 3rd, 1975, Surv Ophthalmol, V20, P3, DOI 10.1016/0039-6257(75)90034-X	14	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	2					245	249						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH732	6978612				2022-12-18	WOS:A1982NH73200008
J	BISHOP, DF; GRABOWSKI, GA; DESNICK, RJ				BISHOP, DF; GRABOWSKI, GA; DESNICK, RJ			FABRY DISEASE - AN ASYMPTOMATIC HEMIZYGOTE WITH SIGNIFICANT RESIDUAL ALPHA-GALACTOSIDASE A ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									CUNY MT SINAI SCH MED,DIV MED GENET,NEW YORK,NY 10028	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai									0	25	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	6					A71	A71						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV199					2022-12-18	WOS:A1981MV19900157
J	DARLINGTON, GJ; DUTKOWSKI, R; BROWN, WT				DARLINGTON, GJ; DUTKOWSKI, R; BROWN, WT			SISTER CHROMATID EXCHANGE FREQUENCIES IN PROGERIA AND WERNER SYNDROME PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											DARLINGTON, GJ (corresponding author), CORNELL UNIV,COLL MED,DEPT MED,NEW YORK,NY 10021, USA.		Brown, William/GXN-2777-2022		NIA NIH HHS [AG-00632, AG-00541] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG000541] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARTRAM CR, 1976, ANN HUM GENET, V40, P79, DOI 10.1111/j.1469-1809.1976.tb00166.x; BROWN WT, 1980, AM J HUM GENET, V32, P614; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; EPSTEIN J, 1974, BIOCHEM BIOPH RES CO, V59, P850, DOI 10.1016/S0006-291X(74)80057-4; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; FUJIWARA Y, 1977, J CELL PHYSIOL, V92, P365, DOI 10.1002/jcp.1040920305; GERMAN J, 1974, CHROMOSOMA, V48, P361, DOI 10.1007/BF00290993; HAND R, 1975, P NATL ACAD SCI USA, V72, P758, DOI 10.1073/pnas.72.2.758; HOEHN H, 1975, CYTOGENET CELL GENET, V15, P282, DOI 10.1159/000130526; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; REGAN JD, 1974, BIOCHEM BIOPH RES CO, V59, P858, DOI 10.1016/S0006-291X(74)80058-6; SCHNEIDER EL, 1979, HUM GENET, V46, P57, DOI 10.1007/BF00278902; SCHNEIDER EL, 1978, EXP CELL RES, V115, P269, DOI 10.1016/0014-4827(78)90281-1; WOLFF S, 1977, NATURE, V265, P347, DOI 10.1038/265347a0; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	17	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	5					762	766						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ232	7294025				2022-12-18	WOS:A1981MJ23200012
J	KARLIN, S; WILLIAMS, PT; CARMELLI, D				KARLIN, S; WILLIAMS, PT; CARMELLI, D			STRUCTURED EXPLORATORY DATA-ANALYSIS (SEDA) FOR DETERMINING MODE OF INHERITANCE OF QUANTITATIVE TRAITS .1. SIMULATION STUDIES ON THE EFFECT OF BACKGROUND DISTRIBUTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,LATTER DAY ST HOSP,DEPT BIOPHYS,SALT LAKE CITY,UT 84143	Utah System of Higher Education; University of Utah	KARLIN, S (corresponding author), STANFORD UNIV,DEPT MATH,STANFORD,CA 94305, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010452] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HV-2161] Funding Source: Medline; NIGMS NIH HHS [5R01 GM-10452-17] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARMELLI D, 1979, GENETIC ANAL COMMON, P259; FAIN RR, 1968, ANN HUM GENET, V42, P109; KARLIN S, 1981, AM J HUM GENET, V33, P282; KARLIN S, 1979, THEOR POPUL BIOL, V16, P81, DOI 10.1016/0040-5809(79)90007-8; KARLIN S, AM J EPIDEMIOL; KARLIN S, P NATL ACAD SCI US; KARLIN S, 1978, J THEOR BIOL, V28, P197; MORTON NE, 1979, GENETIC ANAL COMMON, P431; OTT J, 1979, HUM GENET, V51, P79, DOI 10.1007/BF00278296; Rosner B, 1977, APPL STATIST, V26, P179; SCHROTT HG, 1979, GENETIC ANAL COMMON, P619; SPEILMAN RS, 1979, AM J HUM GENET, V31, pA63; WEINSHILBOUM RM, 1977, AM J HUM GENET, V29, P125; WEINSHILBOUM RM, 1974, NATURE, V252, P490, DOI 10.1038/252490a0; WEINSHILBOUM RM, 1978, HUM GENET S, V1, P101	15	25	26	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	2					262	281						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LH910	7211841				2022-12-18	WOS:A1981LH91000013
J	CURIECOHEN, M				CURIECOHEN, M			THE FREQUENCY OF CONSANGUINEOUS MATINGS DUE TO MULTIPLE USE OF DONORS IN ARTIFICIAL-INSEMINATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											CURIECOHEN, M (corresponding author), UNIV WISCONSIN,GENET LAB,MADISON,WI 53706, USA.							CAVALLISFORZA LL, 1966, GENETICS, V54, P37; CHAKRABO.R, 1974, AM J HUM GENET, V26, P477; CLARK PJ, 1956, AM J HUM GENET, V8, P49; CURIECOHEN M, 1979, NEW ENGL J MED, V300, P585, DOI 10.1056/NEJM197903153001103; DAVID A, 1976, FERTIL STERIL, V27, P528; ECKLAND BK, 1968, EUGEN QUART, V15, P71, DOI 10.1080/19485565.1968.9987759; FINEGOLD WJ, 1964, ARTIFICIAL INSEMINAT, P57; FREIREMAIA N, 1968, EUGEN QUART, V15, P22, DOI 10.1080/19485565.1968.9987749; GARRISON RJ, 1968, EUGEN QUART, V15, P113, DOI 10.1080/19485565.1968.9987762; GLASS DV, 1960, REPORT DEP COMMITTEE, P12; GLASS DV, 1960, JR STAT SOC        A, P174; HAJNAL J, 1960, JR STAT SOC        A, P182; JOHANSSON I, 1968, ANIMAL BREEDING AGE, P25; MCLAREN A, 1973, LAW ETHICS EMBRYO TR, P3; NAGYLAKI T, 1978, ANN HUM GENET, V42, P131, DOI 10.1111/j.1469-1809.1978.tb00938.x; Pearson K., 1903, BIOMETRIKA, V2, P357; RAMSOY NR, 1966, AM SOC REV, V31, P772; RAO DC, 1978, GENETIC EPIDEMIOLOGY, P145; Reed E. W., 1965, MENTAL RETARDATION F; Rodman H, 1965, MARRIAGE FAMILY SOC, P48; SCHACHT LE, 1961, 2ND P INT C HUM GEN, pE39; Schull W.J., 1965, EFFECTS INBREEDING J, P419; SCHULL WJ, 1972, AM J HUM GENET, V24, P425; SMITH SB, 1974, US MED, V10, P3; SPUHLER JN, 1968, EUGEN QUART, V15, P128, DOI 10.1080/19485565.1968.9987763; TANAKA K, 1977, JPN J HUM GENET, V21, P239; VANDENBERG SG, 1972, BEHAV GENET, V2, P127, DOI 10.1007/BF01065686; 1977, VITAL STATISTICS US, V1; 1977, VITAL STATISTICS US, V3; 1973, CENSUS POPULATION 19	30	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	4					589	600						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB522	7395872				2022-12-18	WOS:A1980KB52200013
J	HECHT, F; KAISERMCCAW, B				HECHT, F; KAISERMCCAW, B			IMPORTANCE OF BEING A FRAGILE SITE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									GENET CTR,TEMPE,AZ		HECHT, F (corresponding author), SOUTHWEST BIOMED RES INST,TEMPE,AZ, USA.							ANGELL RR, 1978, AM J HUM GENET, V30, P144; DEKABAN A, 1965, J NUCL MED, V6, P740; EMANUEL BS, 1978, AM J HUM GENET, V30, P153; GIRAUD F, 1976, HUM GENET, V34, P125, DOI 10.1007/BF00278880; HARVEY J, 1977, J MED GENET, V14, P46, DOI 10.1136/jmg.14.1.46; LUBS HA, 1969, AM J HUM GENET, V21, P231; MAGENIS RE, 1970, SCIENCE, V170, P85, DOI 10.1126/science.170.3953.85; MAGENIS RE, 1978, SCIENCE, V202, P64; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P136; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125	11	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	2					223	225						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GZ386	453205				2022-12-18	WOS:A1979GZ38600012
J	CHAKRAVARTI, A; CHAKRABORTY, R				CHAKRAVARTI, A; CHAKRABORTY, R			ELEVATED FREQUENCY OF TAY-SACHS DISEASE AMONG ASHKENAZIC JEWS UNLIKELY BY GENETIC DRIFT ALONE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77025	University of Texas System; University of Texas Health Science Center Houston								ADAM A, 1974, GENETIC POLYMORPHISM, P257; ARONSON SM, 1970, HDB CLINICAL NEUROLO, V10, P556; CHASE GA, 1972, AM J HUM GENET, V24, P339; KARLIN S, 1968, AM NAT, V102, P443, DOI 10.1086/282557; KELLY TE, 1975, AM J HUM GENET, V27, P287; KNUDSON AG, 1973, AM J HUM GENET, V25, P108; Knudson AG., 1962, CEREBRAL SPHINGOLIPI, P395; MAYO O, 1970, ANN HUM GENET, V33, P307, DOI 10.1111/j.1469-1809.1970.tb01655.x; McKusick V. A, 1975, MENDELIAN INHERITANC; MYRIANTHOPOULOS NC, 1972, AM J HUM GENET, V24, P341; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; NEI M, 1969, GENETICS, V63, P669; NEI M, 1976, GENET RES, V28, P205, DOI 10.1017/S0016672300016906; RAO DC, 1973, AM J HUM GENET, V25, P594; Wright S, 1937, P NATL ACAD SCI USA, V23, P307, DOI 10.1073/pnas.23.6.307	15	25	25	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	3					256	261						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FE044	677122				2022-12-18	WOS:A1978FE04400003
J	CARNEVALE, A; BLANCOIBANEZ, B; CASTILLO, VD				CARNEVALE, A; BLANCOIBANEZ, B; CASTILLO, VD			SEGREGATION OF C-BAND POLYMORPHISMS ON CHROMOSOMES 1, 9, AND 16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP DEL NINO IMAN,DEPT GENET,MEXICO CITY,MEXICO									CORNEO G, 1973, MODERN ASPECTS CYTOG, P29; CRAIGHOLMES AP, 1971, SCIENCE, V174, P702, DOI 10.1126/science.174.4010.702; CRAIGHOLMES AP, 1973, AM J HUM GENET, V25, P181; DAR H, 1969, Journal of Medical Genetics, V6, P298, DOI 10.1136/jmg.6.3.298; FITZGERALD PH, 1973, CYTOGENET CELL GENET, V12, P404, DOI 10.1159/000130483; JONASSON J, 1972, NATURE, V236, P312, DOI 10.1038/236312a0; JONES KW, 1971, NATURE-NEW BIOL, V233, P268, DOI 10.1038/newbio233268a0; LICZNERSKI G, 1972, HEREDITAS-GENETISK A, V70, P153; PALMER CG, 1971, J MED GENET, V8, P202, DOI 10.1136/jmg.8.2.202; PEARSON PL, 1973, MODERN ASPECTS CYTOG, P201; SALAMANCA F, 1974, ANN GENET-PARIS, V17, P135; 1972, BIRTH DEFECTS OAS, V8	12	25	25	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	4					412	416						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BX345	60060				2022-12-18	WOS:A1976BX34500012
J	BOTTINI, E; ORZALESI, M; SPENNATI, GF; PIGRAM, P; PALMARINO, R; LUCARELLI, P				BOTTINI, E; ORZALESI, M; SPENNATI, GF; PIGRAM, P; PALMARINO, R; LUCARELLI, P			INTERACTION BETWEEN PLACENTAL ALKALINE-PHOSPHATASE AND ABO SYSTEM POLYMORPHISMS DURING INTRAUTERINE LIFE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AHMED Z, 1959, BIOCHIM BIOPHYS ACTA, V34, P313, DOI 10.1016/0006-3002(59)90285-9; AHMED Z, 1960, BIOCHIM BIOPHYS ACTA, V45, P581, DOI 10.1016/0006-3002(60)91497-9; ARFORS KE, 1963, ACTA GENET STAT MED, V13, P89; BAMFORD KF, 1965, LANCET, V1, P530; BARDAWIL WA, 1969, ANN NY ACAD SCI, V166, P402; BECKMAN G, 1969, HUM HERED, V19, P524, DOI 10.1159/000152262; BECKMAN G, 1970, HUM HERED, V20, P187, DOI 10.1159/000152309; BECKMAN G, 1967, ACTA GENET STAT MED, V17, P413; BECKMAN G, 1970, HUM HERED, V20, P74, DOI 10.1159/000152296; BECKMAN L, 1968, Series Haematologica, V1, P137; BECKMAN L, 1964, ACTA GENET STAT MED, V14, P286; BECKMAN L, 1967, ACTA GENET STAT MED, V17, P406; BLAKE N M, 1969, Japanese Journal of Human Genetics, V13, P243; Blake N M, 1968, Med J Aust, V2, P1042; BLAKE NM, 1969, HUM HERED, V19, P20, DOI 10.1159/000152194; BOTTINI E, 1968, EXPERIENTIA, V24, P614, DOI 10.1007/BF02153807; BOTTINI E, 1972, AM J HUM GENET, V24, P505; BOYER SH, 1961, SCIENCE, V134, P1002, DOI 10.1126/science.134.3484.1002; BOYER SH, 1963, ANN NY ACAD SCI, V103, P938, DOI 10.1111/j.1749-6632.1963.tb53746.x; EDWARDS JH, 1967, ANN HUM GENET, V30, P233, DOI 10.1111/j.1469-1809.1967.tb00024.x; FICHTNER K, 1967, HUMANGENETIK, V4, P244, DOI 10.1007/BF00292197; FISHMAN WH, 1968, NATURE, V219, P697, DOI 10.1038/219697a0; ISHIMOTO G, 1970, HUM HERED, V20, P193, DOI 10.1159/000152310; KIMBALL AW, 1954, BIOMETRICS, V10, P452, DOI 10.2307/3001617; LUCARELLI-PALMARINO P, 1970, Atti Associazione Genetica Italiana, V15, P196; NEALE FC, 1965, J CLIN PATHOL, V18, P359, DOI 10.1136/jcp.18.3.359; ROBSON EB, 1965, NATURE, V207, P1257, DOI 10.1038/2071257a0; ROBSON EB, 1967, ANN HUM GENET, V30, P219, DOI 10.1111/j.1469-1809.1967.tb00023.x; SUSSMAN HH, 1968, NATURE, V218, P359, DOI 10.1038/218359a0	29	25	25	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	5					495	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N4590	4626565				2022-12-18	WOS:A1972N459000001
J	HUSSELS, IE; MORTON, NE				HUSSELS, IE; MORTON, NE			PINGELAP AND MOKIL ATOLLS - ACHROMATOPSIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BRODY JA, 1970, LANCET, V1, P1253; CARR RE, 1971, AM J OPHTHALMOL, V72, P746, DOI 10.1016/0002-9394(71)90013-4; EDWARDS JH, 1967, 3RD P INT C HUM GEN, P483; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; MORTON NE, 1971, AM J HUM GENET, V23, P602; MORTON NE, IN PRESS	6	25	25	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					304	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	4555088				2022-12-18	WOS:A1972M694800008
J	JACOBY, LB; WILROY, RS; SHIH, VE; MILUNSKY, A; LITTLEFIELD, JW				JACOBY, LB; WILROY, RS; SHIH, VE; MILUNSKY, A; LITTLEFIELD, JW			MICROASSAY FOR ARGININOSUCCINASE IN CULTURED CELLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article														Milunsky, Aubrey/0000-0003-2114-4823				EFRON MARY L., 1966, P393; SCHIMKE RT, 1964, J BIOL CHEM, V239, P136; SHIH VE, 1970, LANCET, V2, P45; SHIH VE, 1969, BIOCHEM GENET, V3, P81, DOI 10.1007/BF00485974; TEDESCO TA, 1967, P NATL ACAD SCI USA, V57, P829, DOI 10.1073/pnas.57.3.829	5	25	25	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					321	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	5028970				2022-12-18	WOS:A1972M694800011
J	KITCHIN, FD; GAJDUSEK, DC; ALPERS, M; BEARN, AG				KITCHIN, FD; GAJDUSEK, DC; ALPERS, M; BEARN, AG			GENETIC STUDIES IN RELATION TO KURU .3. DISTRIBUTION OF INHERITED SERUM GROUP-SPECIFIC PROTEIN (GC) PHENOTYPES IN NEW GUINEANS - AN ASSOCIATION OF KURU AND GC AB PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		[Anonymous], 1964, ECOLOGICAL GENETICS; BEARN AG, 1964, J EXP MED, V120, P83, DOI 10.1084/jem.120.1.83; BENNETT JH, 1961, BMJ-BRIT MED J, V2, P428, DOI 10.1136/bmj.2.5249.428; BOWMAN BH, 1965, P NATL ACAD SCI USA, V53, P722, DOI 10.1073/pnas.53.4.722; CLEVE H, 1963, AM J HUM GENET, V15, P368; CLEVE H, 1967, ACTA GENET STAT MED, V17, P511; CLEVE HARTWIG, 1962, PROGR MED GENET, V2, P64; CURTAIN CC, 1965, AM J TROP MED HYG, V14, P678, DOI 10.4269/ajtmh.1965.14.678; CURTAIN CC, 1965, AM J PHYS ANTHROPOL, V23, P363, DOI 10.1002/ajpa.1330230410; CURTAIN CC, 1965, AM J TROP MED HYG, V14, P671, DOI 10.4269/ajtmh.1965.14.671; CURTAIN CC, 1961, AM J TROP MED HYG, V10, P92, DOI 10.4269/ajtmh.1961.10.92; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; GAJDUSEK DC, 1957, NEW ENGL J MED, V257, P974, DOI 10.1056/NEJM195711142572005; GAJDUSEK DC, 1972, AM J HUM GENET, V24, pS1; GAJDUSKE DC, 1964, COLD SPRING HARB SYM, V29, P121, DOI 10.1101/SQB.1964.029.01.017; Gorham J.R., 1965, SLOW LATENT TEMP VIR, V2, P279; HIRSCHFELD J, 1959, ACTA PATHOL MIC SC, V46, P224; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; Huxley J., 1954, EVOLUTION PROCESS; KENRICK KG, 1967, ACTA GENET STAT MED, V17, P222; KIRK R. L., 1965, PROGR MED GENET, V4, P202; KIRK RL, 1963, AM J PHYS ANTHROPOL, V21, P215, DOI 10.1002/ajpa.1330210213; KIRK RL, 1964, ACTA GENET STAT MED, V14, P41; KIRK RL, 1963, ACTA GENET STAT MED, V13, P140; KITCHIN FD, 1966, AM J HUM GENET, V18, P201; KITCHIN FD, 1965, P SOC EXP BIOL MED, V119, P1153; Mayr E., 1963, ANIMAL SPECIES EVOLU; NERSTROM B, 1964, ACTA PATHOL MIC SC, V60, P540, DOI 10.1111/apm.1964.60.4.540; RAYMOND S, 1964, ANN NY ACAD SCI, V121, P350, DOI 10.1111/j.1749-6632.1964.tb14208.x; REINSKOU T, 1965, ACTA GENET STAT MED, V15, P33; REINSKOU T, 1963, ACTA PATHOL MIC SC, V59, P526; SCHEIDEGGER JJ, 1955, INT ARCH ALLER A IMM, V7, P103, DOI 10.1159/000228215; SIMMONS RT, 1961, AM J TROP MED HYG, V10, P665, DOI 10.4269/ajtmh.1961.10.665; SIMMONS RT, 1972, AM J HUM GENET, V24, pS39; STEINBERG AG, 1972, AM J HUM GENET, V24, pS95; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	36	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	6					S72	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O0505					2022-12-18	WOS:A1972O050500003
J	MORTON, NE; LITTLE, GF; LEW, R; HUSSELS, IE				MORTON, NE; LITTLE, GF; LEW, R; HUSSELS, IE			PINGELAP AND MOKIL ATOLLS - HISTORICAL GENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AGASSIZ A, 1903, MEMOIRS MUSEUM COMPA, V28; BASCOM WR, 1946, PACIFIC ECONOMY TRAN, V8; BEIGUELMAN B, 1968, ACTA GENET MED GEMEL, V17, P584, DOI 10.1017/S1120962300012452; BENTZEN C, 1949, 1159 COORD INV MIC 2; CARR RE, 1971, AM J OPHTHALMOL, V72, P746, DOI 10.1016/0002-9394(71)90013-4; CROW JF, 1955, EVOLUTION, V9, P202, DOI 10.2307/2405589; HAMMET LU, 1954, NAUTICAL MAG; HARRIS DA, IN PRESS; HERMANN R, 1910, KOLONIALRECHT KOLONI, V11, P550; HERMANN R, 1910, KOLONIALRECHT KOLONI, V11, P626; HUSSELS IE, 1972, AM J HUM GENET, V24, P304; MORTON NE, 1971, AM J HUM GENET, V23, P339; MORTON NE, 1971, AM J HUM GENET, V23, P602; MORTON NE, 1971, AM J HUM GENET, V23, P350; MORTON NE, IN PRESS; SLOAN NR, IN PRESS; STEINBERG AG, IN PRESS; WECKLER JE, 1949, 2569 COORD INV MIC 1; YAMAMOTO M, IN PRESS; 1969, PONAPE ALMANAC	20	25	26	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					277	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	4537352				2022-12-18	WOS:A1972M694800005
J	FREIREMAIA, N; AZEVEDO, JBC				FREIREMAIA, N; AZEVEDO, JBC			INBREEDING LOAD IN BRAZILIAN WHITES AND NEGROES AS ESTIMATED WITH SIB AND COUSIN CONTROLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AZEVEDO JBC, 1963, CIENCIA CULT, V15, P192; AZEVEDO JBC, 1965, CIENCIA CULT, V17, P156; FREIREMA.N, 1964, COLD SPRING HARB SYM, V29, P31, DOI 10.1101/SQB.1964.029.01.008; FREIREMAIA N, 1964, GENETICS, V50, P527; FREIREMAIA N, 1967, AM J HUM GENET, V19, P686; FREIREMAIA N, 1970, HUM HERED, V20, P248, DOI 10.1159/000152317; FREIREMAIA N, 1963, HUM HERED, V13, P185; FREIREMAIA N, 1963, HUM HERED BASEL, V13, P199; FREIREMAIA N, 1960, SOC BIOL, V7, P193; KRIEGER H, 1971, AM J HUM GENET, V23, P8; KRIEGER H, 1966, THESIS U HAWAII; MARCALLO FA, 1964, ANN HUM GENET, V27, P203, DOI 10.1111/j.1469-1809.1963.tb00787.x; MARCALLO FA, 1962, B SOC BRASIL GENET, V4, P158; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MORTON NEWTON E., 1961, PROGR MED GENET, V1, P261; QUELCESALGADO A, 1968, CIENCIA CULT, V21, P252; Schull WJ, 1965, EFFECTS INBREEDING J	17	25	25	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	1					1	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	I6190	5581978				2022-12-18	WOS:A1971I619000001
J	NISWANDER, JD; BROWN, KS; IBA, BY; LEYSHON, WC; WORKMAN, PL				NISWANDER, JD; BROWN, KS; IBA, BY; LEYSHON, WC; WORKMAN, PL			POPULATION STUDIES ON SOUTHWESTERN INDIAN TRIBES .1. HISTORY, CULTURE, AND GENETICS OF PAPAGO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOLTON HE, 1948, KINOS HISTORICAL MEM; BOLTON HE, 1930, ANZAS CALIFORNIA EXP, V2; Bolton Herbert Eugene, 1936, RIM CHRISTENDOM; Breazeale EL, 1941, J IMMUNOL, V40, P161; BROWN KS, 1958, AM J HUM GENET, V10, P175; Castetter Edward F., 1942, PIMA PAPAGO INDIAN A; CORDOVA MS, 1967, AM J PHYS ANTHROPOL, V26, P55, DOI 10.1002/ajpa.1330260108; Di Peso Charles, 1956, UPPER PIMA SAN CAYET; DIPESO CC, 1958, REEVE RUIN SOUTHEAST; DIPESO CC, 1953, SOBAIPURI INDIANS UP; Ezell PH, 1955, AM ANTIQUITY, V20, P367, DOI 10.2307/277070; EZELL PH, 1954, KIVA, V19, P1; FONTANA BL, 1960, THESIS U ARIZONA; GERSHOWITZ H, 1967, AM J HUM GENET, V19, P502; GLADWIN HS, 1957, HISTORY ANCIENT SOUT; Hackenberg R., 1964, PAPAGO INDIANS; HACKENBERG RA, 1966, MILBANK FUND Q, V44, P470, DOI 10.2307/3348999; HACKENBERG RA, 1967, AM ANTHROPOL, V69, P478, DOI 10.1525/aa.1967.69.5.02a00040; HANNA BL, 1962, AM J PHYS ANTHROPOL, V20, P499, DOI 10.1002/ajpa.1330200410; HANNA BL, 1953, AM J HUM GENET, V5, P377; Haury EmilW., 1950, STRATIGRAPHY ARCHAEO; HAURY EW, 1967, NATL GEOGR, V131, P670; HIRSCHFELD JAN, 1961, SCI TOOLS, V8, P17; Hoover JW, 1935, AM ANTHROPOL, V37, P257, DOI 10.1525/aa.1935.37.2.02a00060; JONES DJ, 1962, THESIS U ARIZONA; JONES RD, 1969, THESIS U ARIZONA; LISKER R, 1967, AM J PHYS ANTHROPOL, V27, P27, DOI 10.1002/ajpa.1330270105; Matson GA, 1947, AM J PHYS ANTHROP-NE, V5, P357, DOI 10.1002/ajpa.1330050307; MATSON GA, 1968, AM J PHYS ANTHROPOL, V29, P311, DOI 10.1002/ajpa.1330290308; MILLER M, 1968, 165 PAN AM HEALTH OR; NEEL JV, 1964, AM J HUM GENET, V16, P52; PETRAKIS NL, 1967, SCIENCE, V158, P1192, DOI 10.1126/science.158.3805.1192; Race R. R, 1968, BLOOD GROUPS MAN; RODRIGUEZ H, 1963, HUM BIOL, V35, P350; RUND N, 1968, DEMOGRAPHIC SOCIOCUL; RUSSELL F, 1908, 26 BUR AM ETHN ANN R; Sauer Carl O., 1935, ABORIGINAL POPULATIO; SPICER RB, 1949, DESERT PEOPLE, P3; UNDERHILL RM, 1939, SOCIAL ORGANIZATION, V30; Withers AM, 1944, AM ANTIQUITY, V10, P33, DOI 10.2307/275181; WORKMAN PL, 1970, AM J HUM GENET, V22, P24; WORKMAN PL, 1968, HUM BIOL, V40, P260; WORKMAN PL, 1969, HUM BIOL, V41, P97; ZIMMERLY DW, 1968, B AM ANTHROPOL ASS, V1, P153	44	25	25	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	1					7	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F4294	4904195				2022-12-18	WOS:A1970F429400002
J	MUKERJEE, D; BURDETTE, WJ				MUKERJEE, D; BURDETTE, WJ			A FAMILIAL MINUTE ISOCHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BLAKESLEE AF, 1930, SMITHSONIAN REPORT, P431; Bridges CB, 1916, GENETICS, V1, P107; Darlington CD, 1940, J GENET, V39, P351, DOI 10.1007/BF02982848; DENT T, 1963, LANCET, V2, P484; EDWARDS JH, 1960, LANCET, V1, P787; ELLIS JR, 1962, ANN HUM GENET, V26, P77, DOI 10.1111/j.1469-1809.1962.tb01312.x; FROLAND A, 1963, Cytogenetics, V2, P99, DOI 10.1159/000129771; HALL B, 1963, LANCET, V1, P558; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; LEJEUNE JEROME, 1964, PROGR MED GENET, V3, P144; MAKINO S, 1952, STAIN TECHNOL, V27, P1; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; PATAU K, 1960, LANCET, V1, P790; PENROSE LS, 1961, BRIT MED BULL, V17, P184, DOI 10.1093/oxfordjournals.bmb.a069906; 1964, ANN HUM GENET LOND, V27, P295	15	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	1					62	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	72413	4221443				2022-12-18	WOS:A19667241300007
J	STAMATOYANNOPOULOS, G; PANAYOTOPOULOS, A; MOTULSKY, AG				STAMATOYANNOPOULOS, G; PANAYOTOPOULOS, A; MOTULSKY, AG			DISTRIBUTION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN GREECE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1961, ANN NY ACAD SCI, V91, P710, DOI 10.1111/j.1749-6632.1961.tb31102.x; ALLISON AC, 1963, ANN HUM GENET, V26, P237, DOI 10.1111/j.1469-1809.1963.tb01980.x; BARNICOT NA, 1963, ANN HUM GENET, V26, P229, DOI 10.1111/j.1469-1809.1963.tb01979.x; BLUMBERG BS, 1961, GENETIC POLYMORPHISM, P159; CHOREMIS C, 1962, LANCET, V1, P17; CHOREMIS C, 1963, LANCET, V1, P907; DOXIADIS SA, 1964, LANCET, V2, P1210; FESSAS P, 1962, BRIT MED J, P1359, DOI 10.1136/bmj.2.5316.1359; FLATZ G, 1963, ARCH DIS CHILD, V38, P566, DOI 10.1136/adc.38.202.566; FRASER G. R., 1966, J MED GENET, V3, P35, DOI 10.1136/jmg.3.1.35; FRASER GR, 1964, ANN HUM GENET, V27, P395; JONXIS JHP, 1964, ABNORMAL HEMOGLOBINS, P143; LIVADAS C, 1940, MALARIA GREECE; MALAMOS B, 1962, BRIT J HAEMATOL, V8, P5, DOI 10.1111/j.1365-2141.1962.tb06489.x; MOTULSKY AG, 1964, ABNORMAL HEMOGLOBINS, P143; MOTULSKY AG, 1961, GENETIC POLYMORPHISM, P159; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; SANSONE G, 1958, FAVISMO; STAMATOYANNOPOU.G, 1964, BRIT MED J, V1, P875, DOI 10.1136/bmj.1.5387.875; STAMATOYANNOPOU.G, 1964, LANCET, V2, P932; STAMATOYANNOPOULOS G, 1966, AM J HUM GENET, V18, P253; ZANNOSMARIOLEA L, 1961, BLOOD, V18, P34, DOI 10.1182/blood.V18.1.34.34	22	25	25	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	3					296	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	77584	5944422				2022-12-18	WOS:A19667758400007
J	COX, DW				COX, DW			INVESTIGATION OF POSSIBLE GENETIC DAMAGE IN OFFSPRING OF WOMEN RECEIVING MULTIPLE DIAGNOSTIC PELVIC X RAYS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDREN L, 1961, ACTA ENDOCRINOL-COP, V37, P423, DOI 10.1530/acta.0.0370423; ANDREN L, 1961, ACTA ENDOCRINOL-COP, V37, P427, DOI 10.1530/acta.0.0370427; ARAKAWA ET, 1960, NEW ENGL J MED, V263, P488, DOI 10.1056/NEJM196009082631005; BIRCH AM, 1960, NEW ENGL J MED, V262, P1004, DOI 10.1056/NEJM196005192622002; Ciocco A., 1938, HUM BIOL, V10, P36; CROW JF, 1955, AMER J ROENTGENOL RA, V73, P467; KAPLAN I I, 1960, J Natl Med Assoc, V52, P13; KARN MN, 1951, ANN EUGENIC, V16, P147, DOI 10.1111/j.1469-1809.1951.tb02469.x; KITABATAKE TAKASHI, 1960, NAGOYAJOUR MED SCI, V23, P227; LEJEUNE J, 1957, CR HEBD ACAD SCI, V244, P1833; LINCOLN TA, 1958, JAMA-J AM MED ASSOC, V166, P233, DOI 10.1001/jama.1958.02990030031007; MACHT SH, 1955, AMER J ROENTGENOL RA, V73, P442; MULLER C, 1962, ZENTRALBL GYNAKOL, V84, P558; MUSIL J, 1962, EXCERPTA MED HUM GEN, V1, P70; NEEL JV, 1956, 461 NAT AC SCIENC RE; NEEL JV, 1963, CHANGING PERSPECTIVE; NEWCOMBE HB, 1962, RADIAT RES, V16, P531, DOI 10.2307/3571086; NORWOOD WD, 1959, AMER J ROENTGENOL RA, V82, P1081; NOVITSKI E, 1958, AM J HUM GENET, V10, P268; NOVITSKI E, 1953, SCIENCE, V117, P531, DOI 10.1126/science.117.3046.531; ROBSON EB, 1955, ANN HUM GENET, V19, P262, DOI 10.1111/j.1469-1809.1955.tb01352.x; RUSSELL WL, 1959, P NATL ACAD SCI USA, V45, P18, DOI 10.1073/pnas.45.1.18; SCHOLTE PJL, 1964, AM J HUM GENET, V16, P26; SCHULL WJ, 1958, SCIENCE, V128, P343, DOI 10.1126/science.128.3320.343; SCHULL WJ, 1963, NUCLEONICS, V21, P54; TANAKA K, 1958, JPN J HUM GENET, V3, P135; TURPIN R, 1956, Acta Genet Stat Med, V6, P204; 1962, 17 UN NAT SCIEN  S16; 1962, EFFECTS NUCLEAR WEAP, P46	29	25	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	2					214	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2972A	14174802				2022-12-18	WOS:A19642972A00002
J	CLARK, JI; PUITE, RH; MANN, JD; MARCZYNSKI, R				CLARK, JI; PUITE, RH; MANN, JD; MARCZYNSKI, R			EVIDENCE FOR ABSENCE OF DETECTABLE LINKAGE BETWEEN GENES FOR DUCHENNE MUSCULAR DYSTROPHY AND XG BLOOD GROUP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CLARK J, 1962, LANCET, V1, P1026; FORD CE, 1956, NATURE, V178, P1020, DOI 10.1038/1781020a0; MANN JD, 1962, LANCET, V1, P8; MAYNARDSMITH S, 1961, MATHEMATICAL TABLES; MORTON NE, 1955, AM J HUM GENET, V7, P277; SANGER R, 1962, VOX SANG, V7, P571, DOI 10.1111/j.1423-0410.1962.tb04286.x; SMITH CAB, 1959, AM J HUM GENET, V11, P289	7	25	25	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1963	15	3					292	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2967A	14021522				2022-12-18	WOS:A19632967A00002
J	CROW, JF				CROW, JF			GENETIC LOAD - 3 VIEWS .2. CONCEPT OF GENETIC LOAD - A REPLY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Crow J. F., 1952, Heterosis., P282; CROW JAMES F., 1958, HUMAN BIOL, V30, P1; CROW JF, 1960, AM NAT, V94, P413, DOI 10.1086/282145; CROW JF, 1948, GENETICS, V33, P477; CROW JF, 1961, AM J HUM GENET, V13, P137; GREENBERG R, 1960, GENETICS, V45, P1153; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; HIRAIZUMI Y, 1960, GENETICS, V45, P1071; KIMURA M, 1956, P NATL ACAD SCI USA, V42, P336, DOI 10.1073/pnas.42.6.336; KIMURA M, 1955, EVOLUTION, V9, P419, DOI 10.2307/2405476; KIMURA M, 1961, JAPAN J GENET      S, V36, P179; LI CC, 1963, AM J MED, V34, P702, DOI 10.1016/0002-9343(63)90109-8; LI CC, 1963, P NATL ACAD SCI USA, V49, P439, DOI 10.1073/pnas.49.4.439; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MULLER HJ, 1950, AM J HUM GENET, V2, P111	16	25	26	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	3					310	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2967A	14024029				2022-12-18	WOS:A19632967A00003
J	COHEN, BH				COHEN, BH			ABO-RH INTERACTION IN AN RH-INCOMPATIBLY MATED POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOORMAN KE, 1945, J PATHOL BACTERIOL, V57, P157, DOI 10.1002/path.1700570202; BOORMAN KE, 1950, ANN EUGENIC, V15, P120; BRAMBELL FWR, 1951, ANTIBODIES EMBRYOS; BRENDEMOEN O J, 1952, Acta Pathol Microbiol Scand, V31, P579; BRESLER J, 1959 M AM SOC HUM GE; BROMAN, 1944, ACTA PAEDIAT S2, V32; BRYCE LM, 1950, ANN EUGENIC, V15, P271; COCHRAN WG, 1952, ANN MATH STAT, V23, P315, DOI 10.1214/aoms/1177729380; COHEN B. H., 1956, HUMAN BIOL, V28, P20; COHEN BH, 1959, AM J HUM GENET, V11, P414; COHEN BH, 1959, AM J HUM GENET, V11, P274; DIENST A, 1905, ZENTRALBLATT GYNEKOL, V29, P353; DOBSON AM, 1946, J PATHOL BACTERIOL, V58, P221, DOI 10.1002/path.1700580209; DUNGERN EV, 1911, Z IMMUNITATSFORSCH, V8, P526; FISHER RA, 1953, STATISTICAL TABLES B; GLASS B, 1953, AM J HUM GENET, V5, P1; GLASS B, 1950, AM J HUM GENET, V2, P269; GLASS B, 1949, AM J OBSTET GYNECOL, V57, P323; GRUBB R., 1955, ANN HUMAN GENETICS, V19, P183, DOI 10.1111/j.1469-1809.1955.tb01343.x; GUNSON HH, 1957, AM J CLIN PATHOL, V27, P35; Haldane JBS, 1941, ANN EUGENIC, V11, P333, DOI 10.1111/j.1469-1809.1941.tb02297.x; HEISTO HELGE, 1955, ACTA PATHOL ET MICROBIOL SCAND, V36, P257; HIRSZFELD H, 1928, Z IMMUNITATSFORSCH, V54, P81; HIRSZFELD L, 1925, KLIN WOCHENSCHR, V4, P1152; Hirszfeld Ludwik, 1928, KONSTITUTIONSSEROLOG; Johnstone JM, 1954, BRIT J PREV SOC MED, V8, P117; Johnstone JM, 1954, BRIT J PREV SOC MED, V8, P124; Kirk RL, 1955, BRIT J PREV SOC MED, V9, P104; Kirk RL, 1953, BRIT J PREV SOC MED, V7, P1; LEVINE P, 1953, ADV PEDIATR, V6, P97; LEVINE P, 1958, AM ANTHROPOL, V60, P14; LEVINE P, 1948, BLOOD, V3, P404; Levine P, 1943, J HERED, V34, P71, DOI 10.1093/oxfordjournals.jhered.a105249; Li CC., 1955, POPULATION GENETICS; LOGHEM JJ, 1948, REV HEMATOL, V3, P276; LUCIA SP, 1950, BLOOD, V5, P767, DOI 10.1182/blood.V5.8.767.767; LUCIA SP, 1950, J LAB CLIN MED, V35, P24; LUCIA SP, 1950, J LAB CLIN MED, V35, P28; Malone RH, 1949, BR J SOC MED, V3, P228; MATSUNAGA E, 1959, J MED EDUC, V34, P405; MATSUNAGA E, 1955, AM J HUM GENET, V7, P66; MATSUNAGA E, 1957, ANN HUM GENET, V22, P111, DOI 10.1111/j.1469-1809.1957.tb01926.x; MATSUNAGA E, 1956, BLUT Z GESAMTE BLUTF, V11, P188; Nevanlinna HR, 1956, VOX SANG, V1, P26; NEVANLINNA HR, 1953, ANNULES MED EXP B S2, V31; OVERSTREET EW, 1947, AM J OBSTET GYNECOL, V54, P235; OWEN RD, 1954, P NATL ACAD SCI USA, V40, P420, DOI 10.1073/pnas.40.6.420; Race R R, 1943, Br Med J, V2, P289; RACE RR, 1952, MED RES COUNCIL MEMO, V27; REED TE, 1956, AM J HUM GENET, V8, P257; REED TE, 1957, ANN HUM GENET, V22, P165, DOI 10.1111/j.1469-1809.1957.tb01932.x; REEPMAKER J, 1956, ABO ANTAGONISME MORB; SANGHVI LD, 1951, NATURE, V168, P1077, DOI 10.1038/1681077a0; SNEDECOR GW, 1950, STATISTICAL METHODS; SPEISER P, 1953, KLIN WOCHENSCHR, V31, P995, DOI 10.1007/BF01533818; STERN K, 1956, AM J CLIN PATHOL, V26, P833, DOI 10.1093/ajcp/26.8.833; Struthers D, 1951, BR J SOC MED, V5, P223; Waterhouse JAH, 1947, BR J SOC MED, V1, P1; WIENER AS, 1945, P SOC EXP BIOL MED, V58, P133; WIENER AS, 1953, BLOOD, V8, P1024, DOI 10.1182/blood.V8.11.1024.1024; Wiener AS, 1942, SCIENCE, V96, P407, DOI 10.1126/science.96.2496.407; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	62	25	25	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1960	12	2					180	209						30	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF078	13810924				2022-12-18	WOS:A1960WF07800005
J	KNOX, WE				KNOX, WE			GARROD,ARCHIBALD INBORN ERRORS OF METABOLISM .3. ALBINISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ASCOLEO, 1871, ARCH ANTHR, V1, P367; BECKER SW, 1952, AMA ARCH DERM SYPH, V65, P511, DOI 10.1001/archderm.1952.01530240003001; Bloch B, 1925, BIOCHEM Z, V162, P181; BLOCH B, 1927, HANDB HAUT GESCHL, V1, P434; BUSTI-ROSNER LYDIA, 1956, JOUR GENET HUMAINE, V5, P197; CHURCH WS, 1909, P R SOC M, V2; DAVENPORT CB, 1916, J HERED, V7, P221; Davenport GC, 1910, AM NAT, V44, P641, DOI 10.1086/279181; Davenport GC, 1910, AM NAT, V44, P705, DOI 10.1086/279186; Edwards EA, 1939, AM J ANAT, V65, P1, DOI 10.1002/aja.1000650102; Edwards EA, 1941, ENDOCRINOLOGY, V28, P119, DOI 10.1210/endo-28-1-119; FALLS HF, 1951, AM J OPHTHALMOL, V34, P41, DOI 10.1016/0002-9394(51)90007-4; FALLS HF, 1953, T AM ACAD OPHTHALMOL, P324; FITZPATRICK TB, 1954, AMA ARCH DERM SYPH, V69, P133, DOI 10.1001/archderm.1954.01540140001001; FITZPATRICK TB, 1950, SCIENCE, V112, P223, DOI 10.1126/science.112.2904.223; FOSTER M, 1956, GENETICS, V41, P396; FOSTER M, 1957, J BIOL CHEM, V225, P247; Fox D.L., 1953, ANIMAL BIOCHROMES ST; FRANCESCHETTI A, 1930, KZ HDB OPHTH, V1, P704; FRANCOIS J, 1952, Bull Soc Belge Ophtalmol, V102, P724; Garrod AE, 1908, LANCET, V2, P73; Gates Reginald Ruggles, 1946, HUMAN GENETICS; GOLDZIEHER JW, 1951, AMA ARCH DERM SYPH, V64, P533, DOI 10.1001/archderm.1951.01570110003001; GORDON M, 1953, PIGMENT CELL GROWTH; GORDON M, 1948, BIOL MELANOMAS, P216; Greenstein JP, 1940, J NATL CANCER I, V1, P377; HANHART E, 1953, Acta Genet Med Gemellol (Roma), V2, P380; Harris RG, 1926, AM J PHYS ANTHROPOL, V9, P17, DOI 10.1002/ajpa.1330090113; Hogben L, 1931, J GENET, V25, P97, DOI 10.1007/BF02983936; Hogeboom GH, 1942, J BIOL CHEM, V145, P273; LERNER AB, 1949, J BIOL CHEM, V178, P185; LERNER AB, 1953, ADV ENZYMOL REL S BI, V14, P73; LERNER AB, 1950, PHYSIOL REV, V30, P91, DOI 10.1152/physrev.1950.30.1.91; LERNER AB, 1953, PIGMENT CELL GROWTH, P319; LORINCZ AL, 1954, PHYSL BIOCH SKIN, P515; MAGNUS V, 1922, JAMA-J AM MED ASSOC, V79, P780; Mason H. S., 1953, PIGMENT CELL GROWTH, P277; MASON HS, 1947, P SOC EXP BIOL MED, V66, P421; McCrackin RH, 1937, AM J DIS CHILD, V54, P786, DOI 10.1001/archpedi.1937.01980040090007; Meirowsky E, 1940, BRIT J DERMATOL SYPH, V52, P205, DOI 10.1111/j.1365-2133.1940.tb09916.x; NETTLESHIP E, 1906, T OPHTHAL SOC UK, V26, P244; OHRT V, 1957, Acta Genet Stat Med, V7, P298; PEARSON K, 1911, MONOGRAPH ALBINI 6 1; PEARSON K, 1912, MONOGRAPH ALBINI 8 2; PEARSON K, 1913, MONOGRAPH ALBINI 9 4; PFANDLER U., 1950, BULL SCHWEIZ AKAD MED WISS, V6, P134; Raper HS, 1928, PHYSIOL REV, V8, P245, DOI 10.1152/physrev.1928.8.2.245; Rawles M. E., 1953, PIGMENT CELL GROWTH, P1; RAWLES ME, 1948, PHYSIOL REV, V28, P383, DOI 10.1152/physrev.1948.28.4.383; RILEY VT, 1949, SCIENCE, V109, P361, DOI 10.1126/science.109.2832.361-a; ROTHMAN S, 1946, P SOC EXP BIOL MED, V62, P208; RUSSELL WL, 1948, BIOL MELANOMAS, P447; SANDERS J, 1938, GENETICA, V20, P97; SHAPIRO MP, 1953, BRIT J CANCER, V7, P45, DOI 10.1038/bjc.1953.5; TAYLOR AC, 1949, J EXP ZOOL, V110, P77, DOI 10.1002/jez.1401100106; TREVORROPER FD, 1952, BRIT J OPHTH, V36, P107; WAARDENBURG PJ, 1947, NED TIJDSCHR GENEES, V91, P1863; WAARDENBURG PJ, 1932, BIBLIOGR GENET, V7, P19; Wakefield EG, 1936, ANN INTERN MED, V9, P1149, DOI 10.7326/0003-4819-9-8-1149; WOODS M, 1950, ZOOLOGICA, V35, P30; WRIGHT S., 1942, Biol. Sympos., V6, P337; YOUNG TE, 1957, ARCH PATHOL, V64, P186	62	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	3					249	267						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA220	13571217				2022-12-18	WOS:A1958WA22000001
J	SATALOFF, J; PASTORE, PN; BLOOM, E				SATALOFF, J; PASTORE, PN; BLOOM, E			SEX-LINKED HEREDITARY DEAFNESS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		FOWLER EP, COMMUNICATION; HOPKINS LA, COMMUNICATION; HOPKINS LA, 1949, 1 EDW BROTH INC MON	3	25	25	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	2					201	203						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA211	14388008				2022-12-18	WOS:A1955WA21100010
J	HERNDON, CN; BENDER, JR				HERNDON, CN; BENDER, JR			GAUCHERS DISEASE - CASES IN 5 RELATED NEGRO SIBSHIPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Anderson JP, 1933, J AMER MED ASSOC, V101, P979, DOI 10.1001/jama.1933.02740380015005; BESSIE EM, 1937, MED REC NY, V145, P403; Bloem TF, 1936, Q J MED, V5, P517; COLLIER WA, 1895, T PATHOL SOC LOND, V46, P148; Cotterman CW, 1941, SCI MON, V53, P227; DELANGE C, 1939, ACTA PAEDIATR, V27, P34; Haldane JBS, 1936, ANN EUGENIC, V7, P28, DOI 10.1111/j.1469-1809.1936.tb02127.x; HOFFMAN SJ, 1929, AM J DIS CHILD, V38, P775; Kohne G, 1939, BEITR PATHOL ANAT AL, V102, P512; Pachman DJ, 1938, AM J DIS CHILD, V56, P248; Reiss O, 1932, AM J DIS CHILD, V43, P365, DOI 10.1001/archpedi.1932.01950020097011; SIEGMUND, 1921, VERHANDL DTSCH PATH, V18, P59; SNYDER LH, 1941, MED GENETICS, P98; SPACKMAN WC, 1925, IND M GAZ, V40, P69; Thannhauser SJ, 1939, J BIOL CHEM, V129, P709; THANNHAUSER SJ, 1940, LIPIDOSES DISEASES C, P265; WORINGER P, 1934, MED INF PARIS, V41, P190; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	18	25	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1950	2	1					49	60						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS388	15425505				2022-12-18	WOS:A1950XS38800004
J	Prive, F; Aschard, H; Carmi, S; Folkersen, L; Hoggart, C; O'Reilly, PF; Vilhjalmsson, BJ				Prive, Florian; Aschard, Hugues; Carmi, Shai; Folkersen, Lasse; Hoggart, Clive; O'Reilly, Paul F.; Vilhjalmsson, Bjarni J.			Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RISK SCORES; POPULATION-STRUCTURE; WIDE ASSOCIATION; PREDICTION; INFERENCE; TRAITS; SNP	The low portability of polygenic scores (PGSs) across global populations is a major concern that must be addressed before PGSs can be used for everyone in the clinic. Indeed, prediction accuracy has been shown to decay as a function of the genetic distance between the training and test cohorts. However, such cohorts differ not only in their genetic distance but also in their geographical distance and their data collection and assaying, conflating multiple factors. In this study, we examine the extent to which PGSs are transferable between ancestries by deriving polygenic scores for 245 curated traits from the UK Biobank data and applying them in nine ancestry groups from the same cohort. By restricting both training and testing to the UK Biobank data, we reduce the risk of environmental and genotyping confounding from using different cohorts. We define the nine ancestry groups at a sub-continental level, based on a simple, robust, and effective method that we introduce here. We then apply two different predictive methods to derive polygenic scores for all 245 phenotypes and show a systematic and dramatic reduction in portability of PGSs trained using Northwestern European individuals and applied to nine ancestry groups. These analyses demonstrate that prediction already drops off within European ancestries and reduces globally in proportion to genetic distance. Altogether, our study provides unique and robust insights into the PGS portability problem.	[Prive, Florian; Vilhjalmsson, Bjarni J.] Aarhus Univ, Natl Ctr Register Based Res, DK-8210 Aarhus, Denmark; [Aschard, Hugues] Inst Pasteur, Dept Computat Biol, F-75015 Paris, France; [Aschard, Hugues] Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Carmi, Shai] Hebrew Univ Jerusalem, Braun Sch Publ Hlth & Community Med, IL-9112102 Jerusalem, Israel; [Folkersen, Lasse] Danish Natl Genome Ctr, DK-2300 Copenhagen, Denmark; [Hoggart, Clive; O'Reilly, Paul F.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Vilhjalmsson, Bjarni J.] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus, Denmark	Aarhus University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Harvard University; Harvard T.H. Chan School of Public Health; Hebrew University of Jerusalem; Icahn School of Medicine at Mount Sinai; Aarhus University	Prive, F (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, DK-8210 Aarhus, Denmark.	florian.prive.21@gmail.com	Vilhjálmsson, Bjarni/ABC-1369-2020	Vilhjálmsson, Bjarni/0000-0003-2277-9249	Danish National Research Foundation; Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH [R248-2017-2003]; Lundbeck Foundation Fellowship [R335-2019-2339]	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH; Lundbeck Foundation Fellowship	F.P. and B.J.V. are supported by the Danish National Research Foundation (Niels Bohr Professorship to Prof. John McGrath) and also acknowledge the Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH (R248-2017-2003). B.J.V. is also supported by a Lundbeck Foundation Fellowship (R335-2019-2339).	Abraham G, 2017, BIOINFORMATICS, V33, P2776, DOI 10.1093/bioinformatics/btx299; Abraham G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004137; Albinana C, 2021, AM J HUM GENET, V108, P1001, DOI 10.1016/j.ajhg.2021.04.014; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Behar DM, 2013, HUM BIOL, V85, P859, DOI 10.3378/027.085.0604; Bengtsson H.., 2021, ARXIV200800553; Berg JJ, 2019, ELIFE, V8, DOI 10.7554/eLife.39725; Bitarello BD, 2020, G3-GENES GENOM GENET, V10, P4027, DOI 10.1534/g3.120.401658; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Byun J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4166-8; Cabreros I, 2019, GENETICS, V212, P1009, DOI 10.1534/genetics.119.302159; Carroll RJ, 2014, BIOINFORMATICS, V30, P2375, DOI 10.1093/bioinformatics/btu197; Cavazos TB, 2021, HUM GENET GENOM ADV, V2, DOI 10.1016/j.xhgg.2020.100017; Censin JC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002362; Chen CY, 2013, BIOINFORMATICS, V29, P1399, DOI 10.1093/bioinformatics/btt144; Cheng JY, 2017, BIOINFORMATICS, V33, P2148, DOI 10.1093/bioinformatics/btx098; Choi SW, 2020, NAT PROTOC, V15, P2759, DOI 10.1038/s41596-020-0353-1; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Duncan L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11112-0; Frichot E, 2014, GENETICS, V196, P973, DOI 10.1534/genetics.113.160572; Fritsche LG, 2020, AM J HUM GENET, V107, P815, DOI 10.1016/j.ajhg.2020.08.025; Taliun SAG, 2020, NAT GENET, V52, P550, DOI 10.1038/s41588-020-0622-5; Haller T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170325; Haworth S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08219-1; Jin YM, 2019, G3-GENES GENOM GENET, V9, P2447, DOI 10.1534/g3.118.200925; Kunert-Graf J., 2020, ALLELE FREQUENCY MIS, DOI [10.1101/2020.08.03.235150, DOI 10.1101/2020.08.03.235150]; Lambert SA, 2021, NAT GENET, V53, P420, DOI 10.1038/s41588-021-00783-5; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Marquez-Luna C, 2017, GENET EPIDEMIOL, V41, P811, DOI 10.1002/gepi.22083; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Naseri A, 2021, BMC BIOL, V19, DOI 10.1186/s12915-021-00964-y; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prive F, 2020, BIOINFORMATICS, V36, P5424, DOI 10.1093/bioinformatics/btaa1029; Prive F, 2020, BIOINFORMATICS, V36, P4449, DOI 10.1093/bioinformatics/btaa520; Prive F, 2019, GENETICS, V212, P65, DOI 10.1534/genetics.119.302019; Prive F, 2018, BIOINFORMATICS, V34, P2781, DOI 10.1093/bioinformatics/bty185; Qian JY, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009141; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Ruan Y, 2021, IMPROVING POLYGENIC, DOI [10.1101/2020.12.27.20248738, DOI 10.1101/2020.12.27]; Schumacher FR, 2018, NAT GENET, V50, P928, DOI 10.1038/s41588-018-0142-8; Scutari M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006288; Shi JX, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006493; Sinnott-Armstrong N, 2021, NAT GENET, V53, P185, DOI 10.1038/s41588-020-00757-z; Sohail M, 2019, ELIFE, V8, DOI 10.7554/eLife.39702; Soholm Hansen C, 2020, IPSYCH2015 CASE COHO, DOI [10.1101/2020.11.30.20237768, DOI 10.1101/2020.11.30.20237768]; Wang Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17719-y; Wojcik GL, 2019, NATURE, V570, P514, DOI 10.1038/s41586-019-1310-4; Wu P, 2019, JMIR MED INF, V7, P360, DOI 10.2196/14325; Zhang DW, 2020, BIOINFORMATICS, V36, P3439, DOI 10.1093/bioinformatics/btaa152; Zhang QQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24485-y; Zhong H, 2008, BIOSTATISTICS, V9, P621, DOI 10.1093/biostatistics/kxn001; Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	59	24	24	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 6	2022	109	1					12	23		10.1016/j.ajhg.2021.11.008	http://dx.doi.org/10.1016/j.ajhg.2021.11.008			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP2YV	34995502	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000748493200002
J	Dershem, R; Gorvin, CM; Metpally, RPR; Krishnamurthy, S; Smelser, DT; Hannan, FM; Carey, DJ; Thakker, RV; Breitwieser, GE				Dershem, Ridge; Gorvin, Caroline M.; Metpally, Raghu P. R.; Krishnamurthy, Sarathbabu; Smelser, Diane T.; Hannan, Fadil M.; Carey, David J.; Thakker, Rajesh, V; Breitwieser, Gerda E.		Regeneron Genetics Ctr	Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CALCIUM-SENSING RECEPTOR; NEUROPSYCHOLOGICAL PERFORMANCE; PRIMARY HYPERPARATHYROIDISM; CASR MUTATIONS; SERUM-CALCIUM; VARIANTS; IDENTIFICATION; DIAGNOSIS; AP2S1; RISK	The calcium-sensing receptor (CaSR) regulates serum calcium concentrations. CASR loss- or gain-of-function mutations cause familial hypocalciuric hypercalcemia type 1 (FHH1) or autosomal-dominant hypocalcemia type 1 (ADH1), respectively, but the population prevalence of FHH1 or ADH1 is unknown. Rare CASR variants were identified in whole-exome sequences from 51,289 de-identified individuals in the DiscovEHR cohort derived from a single US healthcare system. We integrated bioinformatics pathogenicity triage, mean serum Ca concentrations, and mode of inheritance to identify potential FHH1 or ADH1 variants, and we used a Sequence Kernel Association Test (SKAT) to identify rare variant-associated diseases. We identified predicted heterozygous loss-of-function CASR variants (6 different nonsense/frameshift variants and 12 different missense variants) in 38 unrelated individuals, 21 of whom were hypercalcemic. Missense CASR variants were identified in two unrelated hypocalcemic individuals. Functional studies showed that all hypercalcemiaassociated missense variants impaired heterologous expression, plasma membrane targeting, and/or signaling, whereas hypocalcemiaassociated missense variants increased expression, plasma membrane targeting, and/or signaling. Thus, 38 individuals with a genetic diagnosis of FHH1 and two individuals with a genetic diagnosis of ADH1 were identified in the 51,289 cohort, giving a prevalence in this population of 74.1 per 100,000 for FHH1 and 3.9 per 100,000 for ADH1. SKAT combining all nonsense, frameshift, and missense loss-of-function variants revealed associations with cardiovascular, neurological, and other diseases. In conclusion, FHH1 is a common cause of hypercalcemia, with prevalence similar to that of primary hyperparathyroidism, and is associated with altered disease risks, whereas ADH1 is a major cause of non-surgical hypoparathyroidism.	[Dershem, Ridge; Metpally, Raghu P. R.; Krishnamurthy, Sarathbabu; Smelser, Diane T.; Carey, David J.; Thakker, Rajesh, V; Breitwieser, Gerda E.] Weis Ctr Res, Mol & Funct Genom, Danville, PA 17822 USA; [Gorvin, Caroline M.; Hannan, Fadil M.] Univ Oxford, Acad Endocrine Unit, Radcliffe Dept Med, Oxford OX3 9DU, England; [Hannan, Fadil M.] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford OX3 9DU, England; [Regeneron Genetics Ctr] Regeneron Genet Ctr, Tarrytown, NY 10591 USA; [Dershem, Ridge; Breitwieser, Gerda E.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA; [Gorvin, Caroline M.] Univ Birmingham, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England; [Gorvin, Caroline M.] Univ Birmingham, Ctr Membrane Prot & Receptors, Birmingham B15 2TT, W Midlands, England; [Krishnamurthy, Sarathbabu] Columbia Univ, Irving Med Ctr, Ctr Precis Med & Genom CPMG, New York, NY 10032 USA	University of Oxford; University of Oxford; Regeneron; State University System of Florida; Florida Atlantic University; University of Birmingham; University of Birmingham; Columbia University; NewYork-Presbyterian Hospital	Breitwieser, GE (corresponding author), Weis Ctr Res, Mol & Funct Genom, Danville, PA 17822 USA.; Breitwieser, GE (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA.	gbreitwieser@health.fau.edu	Gorvin, Caroline/T-2406-2019	Gorvin, Caroline/0000-0002-1361-9174; Hannan, Fadil/0000-0002-2975-5170; Breitwieser, Gerda/0000-0001-9081-0362	Geisinger; Wellcome Trust Investigator Award; National Institute for Health Research Senior InvestigatorAward; National Institute for Health Research Oxford Biomedical Research Centre Programme	Geisinger; Wellcome Trust Investigator Award(Wellcome Trust); National Institute for Health Research Senior InvestigatorAward; National Institute for Health Research Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR))	We thank Geisinger and Regeneron Genetics Center for access to the DiscovEHR whole-exome sequencing cohort, and the MyCode participants who generously allow research use of their DNA and clinical records. This work was supported by Geisinger (D.T.S., R.P.R.M., D.J.C., and G.E.B.), by a Wellcome Trust Investigator Award, by a National Institute for Health Research Senior InvestigatorAward, by and a National Institute for Health Research Oxford Biomedical Research Centre Programme to R.V.T.	Bilezikian JP, 2011, J BONE MINER RES, V26, P2317, DOI 10.1002/jbmr.483; Brown EM, 2013, BEST PRACT RES CL EN, V27, P333, DOI 10.1016/j.beem.2013.02.006; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Conigrave AD, 2013, BEST PRACT RES CL EN, V27, P315, DOI 10.1016/j.beem.2013.05.010; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Eastell R, 2014, J CLIN ENDOCR METAB, V99, P3570, DOI 10.1210/jc.2014-1414; Gorvin CM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan3714; Gorvin CM, 2018, CELL REP, V22, P1054, DOI 10.1016/j.celrep.2017.12.089; Gorvin CM, 2018, J BONE MINER RES, V33, P32, DOI 10.1002/jbmr.3241; Gromadzinski L, 2014, J CARDIOL, V63, P198, DOI 10.1016/j.jjcc.2013.08.003; Grutzner TM, 2018, PSYCHONEUROENDOCRINO, V91, P198, DOI 10.1016/j.psyneuen.2018.03.012; Guarnieri V, 2010, J CLIN ENDOCR METAB, V95, P1819, DOI 10.1210/jc.2008-2430; Hannan FM, 2016, J MOL ENDOCRINOL, V57, pR127, DOI 10.1530/JME-16-0124; Hannan FM, 2013, BEST PRACT RES CL EN, V27, P359, DOI 10.1016/j.beem.2013.04.007; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; Hendy GN, 2014, J CLIN ENDOCR METAB, V99, pE1311, DOI 10.1210/jc.2014-1120; Hinnie J, 2001, CALCIFIED TISSUE INT, V68, P216, DOI 10.1007/s002230001201; Hovden S, 2017, EUR J ENDOCRINOL, V176, P177, DOI 10.1530/EJE-16-0842; Jakobsen NFB, 2016, EUR J ENDOCRINOL, V175, P299, DOI 10.1530/EJE-16-0369; Lerstad G, 2017, EUR J ENDOCRINOL, V176, P625, DOI 10.1530/EJE-16-1037; Lo Giudice M, 2019, MOLECULES, V24, DOI 10.3390/molecules24142546; MARX SJ, 1977, AM J MED, V62, P698, DOI 10.1016/0002-9343(77)90873-7; Marx SJ, 2015, J CLIN ENDOCR METAB, V100, pL29, DOI 10.1210/jc.2014-4221; Moore EC, 2018, ENDOCR PRACT, V24, P988, DOI 10.4158/EP-2018-0350; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Nissen PH, 2019, CLIN ENDOCRINOL, V91, P683, DOI 10.1111/cen.14078; Nissen PH, 2012, CLIN CHIM ACTA, V413, P605, DOI 10.1016/j.cca.2011.12.004; Pearce SHS, 1996, J CLIN INVEST, V98, P1860, DOI 10.1172/JCI118987; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schreckenberg R, 2018, VASCUL PHARM, VS1537-1891, P30323; Sharma A, 2017, PSYCHIAT RES, V252, P80, DOI 10.1016/j.psychres.2017.01.101; Staples J, 2018, AM J HUM GENET, V102, P874, DOI 10.1016/j.ajhg.2018.03.012; Stepanchick A, 2010, CELL PHYSIOL BIOCHEM, V26, P363, DOI 10.1159/000320560; Szalat A, 2017, ENDOCRINE, V55, P741, DOI 10.1007/s12020-017-1241-5; Verma A, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2135-0; Vigouroux C, 2000, CLIN ENDOCRINOL, V53, P393, DOI 10.1046/j.1365-2265.2000.01042.x; Yeh MW, 2013, J CLIN ENDOCR METAB, V98, P1122, DOI 10.1210/jc.2012-4022; Zhang XD, 2019, SEX REPROD HEALTHC, V20, P46, DOI 10.1016/j.srhc.2019.02.005	38	24	25	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2020	106	6					734	747		10.1016/j.ajhg.2020.04.006	http://dx.doi.org/10.1016/j.ajhg.2020.04.006			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LW4IW	32386559	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000539109000003
J	Alston, CL; Veling, MT; Heidler, J; Taylor, LS; Alaimo, JT; Sung, AY; He, LP; Hopton, S; Broomfield, A; Pavaine, J; Diaz, J; Leon, E; Wolf, P; McFarland, R; Prokisch, H; Wortmann, SB; Bonnen, PE; Wittig, I; Pagliarini, DJ; Taylor, RW				Alston, Charlotte L.; Veling, Mike T.; Heidler, Juliana; Taylor, Lucie S.; Alaimo, Joseph T.; Sung, Andrew Y.; He, Langping; Hopton, Sila; Broomfield, Alexander; Pavaine, Julija; Diaz, Jullianne; Leon, Eyby; Wolf, Philipp; McFarland, Robert; Prokisch, Holger; Wortmann, Saskia B.; Bonnen, Penelope E.; Wittig, Ilka; Pagliarini, David J.; Taylor, Robert W.			Pathogenic Bi-allelic Mutations in NDUFAF8 Cause Leigh Syndrome with an Isolated Complex I Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL COMPLEX; DISEASE; BIOGENESIS; METABOLISM; DISORDER; TMEM126B; GENOMICS; HEALTH; CELLS	Leigh syndrome is one of the most common neurological phenotypes observed in pediatric mitochondrial disease presentations. It is characterized by symmetrical lesions found on neuroimaging in the basal ganglia, thalamus, and brainstem and by a loss of motor skills and delayed developmental milestones. Genetic diagnosis of Leigh syndrome is complicated on account of the vast genetic heterogeneity with >75 candidate disease-associated genes having been reported to date. Candidate genes are still emerging, being identified when "omics" tools (genomics, proteomics, and transcriptomics) are applied to manipulated cell lines and cohorts of clinically characterized individuals who lack a genetic diagnosis. NDUFAF8 is one such protein; it has been found to interact with the well-characterized complex I (CI) assembly factor NDUFAF5 in a large-scale protein-protein interaction screen. Diagnostic next-generation sequencing has identified three unrelated pediatric subjects, each with a clinical diagnosis of Leigh syndrome, who harbor bi-allelic pathogenic variants in NDUFAF8. These variants include a recurrent splicing variant that was initially overlooked due to its deep-intronic location. Subject fibroblasts were found to express a complex I deficiency, and lentiviral transduction with wild-type NDUFAF8-cDNA ameliorated both the assembly defect and the biochemical deficiency. Complexome profiling of subject fibroblasts demonstrated a complex I assembly defect, and the stalled assembly intermediates corroborate the role of NDUFAF8 in early complex I assembly. This report serves to expand the genetic heterogeneity associated with Leigh syndrome and to validate the clinical utility of orphan protein characterization. We also highlight the importance of evaluating intronic sequence when a single, definitively pathogenic variant is identified during diagnostic testing.	[Alston, Charlotte L.; Taylor, Lucie S.; He, Langping; Hopton, Sila; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Alston, Charlotte L.; He, Langping; Hopton, Sila; McFarland, Robert; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, NHS Highly Specialised Serv Rare Mitochondrial Di, Queen Victoria Rd, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Veling, Mike T.; Sung, Andrew Y.; Pagliarini, David J.] Morgridge Inst Res, Madison, WI 53715 USA; [Veling, Mike T.; Sung, Andrew Y.; Pagliarini, David J.] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA; [Veling, Mike T.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Heidler, Juliana; Wittig, Ilka] Goethe Univ, Funct Prote, D-60590 Frankfurt, Germany; [Alaimo, Joseph T.; Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Broomfield, Alexander] St Marys Hosp, Manchester Ctr Genom Med, Oxford Rd, Manchester M13 9WL, Lancs, England; [Pavaine, Julija] Manchester Univ Hosp NHS Fdn Trust, Royal Manchester Childrens Hosp, Acad Unit Paediat Radiol, Oxford Rd, Manchester M13 9WL, Lancs, England; [Pavaine, Julija] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Div Informat Imaging & Data Sci, Oxford Rd, Manchester M13 9PT, Lancs, England; [Diaz, Jullianne; Leon, Eyby] Childrens Natl Hosp, Rare Dis Inst, Washington, DC 20010 USA; [Wolf, Philipp] DRK Kinderklin Siegen, Wellersbergstr 60, D-57072 Siegen, Germany; [Prokisch, Holger; Wortmann, Saskia B.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Prokisch, Holger; Wortmann, Saskia B.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Wortmann, Saskia B.] PMU, Salzburger Landeskliniken SALK, Dept Pediat, A-5020 Salzburg, Austria; [Wittig, Ilka] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, D-60590 Frankfurt, Germany	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Goethe University Frankfurt; Baylor College of Medicine; University of Manchester; Royal Manchester Children's Hospital; Wythenshawe Hospital NHS Foundation Trust; University of Manchester; Children's National Health System; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Paracelsus Private Medical University; German Centre for Cardiovascular Research	Taylor, RW (corresponding author), Newcastle Univ, Wellcome Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Taylor, RW (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, NHS Highly Specialised Serv Rare Mitochondrial Di, Queen Victoria Rd, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.; Pagliarini, DJ (corresponding author), Morgridge Inst Res, Madison, WI 53715 USA.; Pagliarini, DJ (corresponding author), Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA.	dpagliarini@morgridge.org; robert.taylor@ncl.ac.uk	Alston, Charlotte/ABG-9602-2020; Alaimo, Joseph/AHC-1981-2022	Alston, Charlotte/0000-0003-2095-5464; Pagliarini, David J./0000-0002-0001-0087; Sung, Andrew/0000-0002-1601-2538; Leon, Eyby/0000-0002-1852-2849	Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease; Newcastle University Centre for Aging and Vitality (Biotechnology and Biological Sciences Research Council); Newcastle University Centre for Aging and Vitality (Medical Research Council) [G016354/1]; National Institute of Health Research (NIHR) Biomedical Research Centre in Age and Age Related Diseases award; NHS Highly Specialised Service for Rare Mitochondrial Disorders; Lily Foundation; National Institutes of Health (NIH) [R35GM131795]; National Institute for Health Research (NIHR) [PDF-2018-11-ST2-021]; National Science Foundation (NSF) [DGE-1256259]; Deutsche Forschungsgemeinschaft from the Bundesministerium fur Bildung und Forschung (BMBF) mitoNET-German Network for Mitochondrial Disorders [SFB 815/Z1, 01GM1906D]; BMBF through E-Rare project GENOMIT [01GM1603]; Horizon2020 through E-Rare project GENOMIT [01GM1603]; German Network for Mitochondrial Disorders [mitoNET 01GM1906B]; NIH National Institute of Neurological Disorders and Stroke [R01NS083726]	Wellcome Centre for Mitochondrial Research; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newcastle University Centre for Aging and Vitality (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle University Centre for Aging and Vitality (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research (NIHR) Biomedical Research Centre in Age and Age Related Diseases award(National Institute for Health Research (NIHR)); NHS Highly Specialised Service for Rare Mitochondrial Disorders; Lily Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Science Foundation (NSF)(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft from the Bundesministerium fur Bildung und Forschung (BMBF) mitoNET-German Network for Mitochondrial Disorders; BMBF through E-Rare project GENOMIT(Federal Ministry of Education & Research (BMBF)); Horizon2020 through E-Rare project GENOMIT; German Network for Mitochondrial Disorders; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank the families who participated in this study. Work in our laboratories is supported by the Wellcome Centre for Mitochondrial Research (203105/Z/16/Z), the Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease, Newcastle University Centre for Aging and Vitality (supported by the Biotechnology and Biological Sciences Research Council and Medical Research Council [G016354/1]), the National Institute of Health Research (NIHR) Biomedical Research Centre in Age and Age Related Diseases award to the Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation, the Medical Research Council (MRC) and Engineering and Physical Sciences Research Council (ESPRC) Newcastle Molecular Pathology Node, the NHS Highly Specialised Service for Rare Mitochondrial Disorders, the Lily Foundation, and the National Institutes of Health (NIH) (R35GM131795 to D.J.P.). C.L.A. is supported by the National Institute for Health Research (NIHR) Post-Doctoral Fellowship (PDF-2018-11-ST2-021). M.T.V. is supported by the National Science Foundation (NSF) Graduate Research Fellowship (DGE-1256259). I.W. is supported by the Deutsche Forschungsgemeinschaft: SFB 815/Z1 from the Bundesministerium fur Bildung und Forschung (BMBF) mitoNET-German Network for Mitochondrial Disorders (01GM1906D). H.P. is supported by the BMBF and Horizon2020 through E-Rare project GENOMIT (01GM1603) and the German Network for Mitochondrial Disorders (mitoNET 01GM1906B). P.E.B. is supported by the NIH National Institute of Neurological Disorders and Stroke (R01NS083726). We thank Jana Meisterknecht for excellent technical assistance in BN-PAGE and sample preparation for complexome profiling. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care.	Ahmed ST, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14623-2; Alston CL, 2018, AM J HUM GENET, V103, P592, DOI 10.1016/j.ajhg.2018.08.013; Alston CL, 2016, J MED GENET, V53, P634, DOI 10.1136/jmedgenet-2015-103576; Bosley TM, 2008, INVEST OPHTH VIS SCI, V49, P5250, DOI 10.1167/iovs.08-2193; Cavallaro G, 2010, MOL BIOSYST, V6, P2459, DOI 10.1039/c0mb00058b; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Formosa LE, 2018, SEMIN CELL DEV BIOL, V76, P154, DOI 10.1016/j.semcdb.2017.08.011; Fuhrmann DC, 2018, CELL MOL LIFE SCI, V75, P3051, DOI 10.1007/s00018-018-2779-y; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; Hayer A, 2016, NAT CELL BIOL, V18, P1311, DOI 10.1038/ncb3438; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Josephs KS, 2019, CLIN MED, V19, P269, DOI 10.7861/clinmedicine.19-4-269; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551; Lax NZ, 2015, J NEUROPATH EXP NEUR, V74, P688, DOI 10.1097/NEN.0000000000000209; Li TR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00347; Miliara X, 2015, EMBO REP, V16, P824, DOI 10.15252/embr.201540229; Modjtahedi N, 2016, TRENDS BIOCHEM SCI, V41, P245, DOI 10.1016/j.tibs.2015.12.004; Naito E, 1997, J INHERIT METAB DIS, V20, P539, DOI 10.1023/A:1005305614374; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; Olahova M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Peters H, 2014, BRAIN, V137, P2903, DOI 10.1093/brain/awu216; Poole OV, 2019, MITOCHONDRION, V47, P294, DOI 10.1016/j.mito.2019.02.004; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Simon MT, 2019, MOL GENET METAB, V126, P53, DOI 10.1016/j.ymgme.2018.11.001; Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Wust S, 2018, CELL METAB, V27, P1026, DOI 10.1016/j.cmet.2018.02.022; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	40	24	24	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2020	106	1					92	101		10.1016/j.ajhg.2019.12.001	http://dx.doi.org/10.1016/j.ajhg.2019.12.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JZ5VM	31866046	Green Published, hybrid			2022-12-18	WOS:000505170800007
J	Murakami, Y; Nguyen, TTM; Baratang, N; Raju, PK; Knaus, A; Ellard, S; Jones, G; Lace, B; Rousseau, J; Ajeawung, NF; Kamei, A; Minase, G; Akasaka, M; Araya, N; Koshimizu, E; van den Ende, J; Erger, F; Altmuller, J; Krumina, Z; Strautmanis, J; Inashkina, I; Stavusis, J; El-Gharbawy, A; Sebastian, J; Puri, RD; Kulshrestha, S; Verma, IC; Maier, EM; Haack, TB; Israni, A; Baptista, J; Gunning, A; Rosenfeld, JA; Liu, PF; Joosten, M; Rocha, ME; Hashem, MO; Aldhalaan, HM; Alkuraya, FS; Miyatake, S; Matsumoto, N; Krawitz, PM; Rossignol, E; Kinoshita, T; Campeau, PM				Murakami, Yoshiko; Thi Tuyet Mai Nguyen; Baratang, Nissan; Raju, Praveen K.; Knaus, Alexej; Ellard, Sian; Jones, Gabriela; Lace, Baiba; Rousseau, Justine; Ajeawung, Norbert Fonya; Kamei, Atsushi; Minase, Gaku; Akasaka, Manami; Araya, Nami; Koshimizu, Eriko; van den Ende, Jenneke; Erger, Florian; Altmueller, Janine; Krumina, Zita; Strautmanis, Jurgis; Inashkina, Inna; Stavusis, Janis; El-Gharbawy, Areeg; Sebastian, Jessica; Puri, Ratna Dua; Kulshrestha, Samarth; Verma, Ishwar C.; Maier, Esther M.; Haack, Tobias B.; Israni, Anil; Baptista, Julia; Gunning, Adam; Rosenfeld, Jill A.; Liu, Pengfei; Joosten, Marieke; Rocha, Maria Eugenia; Hashem, Mais O.; Aldhalaan, Hesham M.; Alkuraya, Fowzan S.; Miyatake, Satoko; Matsumoto, Naomichi; Krawitz, Peter M.; Rossignol, Elsa; Kinoshita, Taroh; Campeau, Philippe M.			Mutations in PIGB Cause an Inherited GPI Biosynthesis Defect with an Axonal Neuropathy and Metabolic Abnormality in Severe Cases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOOR SYNDROME; MENTAL-RETARDATION; PROTEIN; DEFICIENCY; CD59	Proteins anchored to the cell surface via glycosylphosphatidylinositol (GPI) play various key roles in the human body, particularly in development and neurogenesis. As such, many developmental disorders are caused by mutations in genes involved in the GPI biosynthesis and remodeling pathway. We describe ten unrelated families with bi-allelic mutations in PIGB, a gene that encodes phosphatidy-linositol glycan class B, which transfers the third mannose to the GPI. Ten different PIGB variants were found in these individuals. Flow cytometric analysis of blood cells and fibroblasts from the affected individuals showed decreased cell surface presence of GPI-anchored proteins. Most of the affected individuals have global developmental and/or intellectual delay, all had seizures, two had polymicrogyria, and four had a peripheral neuropathy. Eight children passed away before four years old. Two of them had a clinical diagnosis of DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures), a condition that includes sensorineural deafness, shortened terminal phalanges with small finger and toenails, intellectual disability, and seizures; this condition overlaps with the severe phenotypes associated with inherited GPI deficiency. Most individuals tested showed elevated alkaline phosphatase, which is a characteristic of the inherited GPI deficiency but not DOORS syndrome. It is notable that two severely affected individuals showed 2-oxoglutaric aciduria, which can be seen in DOORS syndrome, suggesting that severe cases of inherited GPI deficiency and DOORS syndrome might share some molecular pathway disruptions.	[Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Yabumoto Dept Intractable Dis Res, Suita, Osaka 5650871, Japan; [Thi Tuyet Mai Nguyen; Baratang, Nissan; Raju, Praveen K.; Rousseau, Justine; Ajeawung, Norbert Fonya; Rossignol, Elsa; Campeau, Philippe M.] Ctr Hosp Univ St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Knaus, Alexej; Krawitz, Peter M.] Univ Hosp Bonn, Inst Genom Stat & Bioinformat, D-53127 Bonn, Germany; [Ellard, Sian; Baptista, Julia; Gunning, Adam] Royal Devon & Exeter NHS Fdn Trust, Exeter EX2 5DW, Devon, England; [Jones, Gabriela] Nottingham Univ Hosp NHS Trust, Clin Genet Dept, Nottingham NGS 1PB, England; [Lace, Baiba] Ctr Hosp Univ Quebec, 2705 Blvd Laurier, Ville De Quebec, PQ G1V 4G2, Canada; [Kamei, Atsushi; Akasaka, Manami; Araya, Nami] Iwate Med Univ, Sch Med, Dept Pediat, Morioka, Iwate 0208505, Japan; [Minase, Gaku; Koshimizu, Eriko; Miyatake, Satoko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [van den Ende, Jenneke] Ctr Med Genet Antwerpen, B-2650 Edegem, Belgium; [Erger, Florian] Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Erger, Florian] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Altmueller, Janine] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Krumina, Zita] Riga Stradins Univ, Dept Biol & Microbiol, LV-1029 Riga, Latvia; [Strautmanis, Jurgis] Childrens Clin Univ Hosp, LV-1004 Riga, Latvia; [Inashkina, Inna; Stavusis, Janis] Latvian Biomed Res & Study Ctr, Ratsupites Str 1 K-1, LV-1067 Riga, Latvia; [El-Gharbawy, Areeg; Sebastian, Jessica] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Med Genet, Pittsburgh, PA 15224 USA; [Puri, Ratna Dua; Kulshrestha, Samarth; Verma, Ishwar C.] Sir Ganga Ram Hosp, Inst Med Genet & Genom, New Delhi 110060, India; [Maier, Esther M.] Dr von Hauner Childrens Hosp, Dept Inborn Errors Metab, D-80337 Munich, Germany; [Haack, Tobias B.] Univ Tubingen, Inst Med Genet & Appl Genom, D-72074 Tubingen, Germany; [Haack, Tobias B.] Tech Univ Tubingen, Inst Human Genet, D-72074 Tubingen, Germany; [Israni, Anil] Leicester Royal Infirm, Dept Paediat Neurol, Leicester LE1 5WW, Leics, England; [Rosenfeld, Jill A.; Liu, Pengfei] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Joosten, Marieke] Erasmus MC, Dept Clin Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Rocha, Maria Eugenia] CENTOGENE AG, Rare Dis Co, D-18055 Rostock, Germany; [Hashem, Mais O.; Aldhalaan, Hesham M.; Alkuraya, Fowzan S.; Rossignol, Elsa] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Rossignol, Elsa] Ctr Hosp Univ St Justine, Dept Neurosci, Montreal, PQ H3T 1C5, Canada; [Rossignol, Elsa; Campeau, Philippe M.] Univ Montreal, Montreal, PQ H3T 1C5, Canada; [Campeau, Philippe M.] Ctr Hosp Univ St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada	Osaka University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Bonn; University of Exeter; Nottingham University Hospital NHS Trust; Laval University; Iwate Medical University; Yokohama City University; University of Cologne; University of Cologne; University of Cologne; Riga Stradins University; Latvian Biomedical Research & Study Centre; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Leicester; Baylor College of Medicine; Erasmus University Rotterdam; Erasmus MC; CENTOGENE AG; King Faisal Specialist Hospital & Research Center; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Kinoshita, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, Yabumoto Dept Intractable Dis Res, Suita, Osaka 5650871, Japan.; Campeau, PM (corresponding author), Ctr Hosp Univ St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada.; Campeau, PM (corresponding author), Univ Montreal, Montreal, PQ H3T 1C5, Canada.; Campeau, PM (corresponding author), Ctr Hosp Univ St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada.	tkinoshi@biken.osaka-u.ac.jp; p.campeau@umontreal.ca	Erger, Florian/I-4298-2019; Campeau, Philippe/J-8614-2015; Puri, Ratna Dua/AAY-5849-2021; Lace, Baiba/AAY-9362-2020; Kinoshita, Taroh/C-7353-2009; Inashkina, Inna/AAH-9955-2021; Baptista, Julia/AGR-5239-2022	Erger, Florian/0000-0002-2768-1702; Campeau, Philippe/0000-0001-9713-7107; Lace, Baiba/0000-0001-5371-6756; Baptista, Julia/0000-0003-0915-5028; Rousseau, Justine/0000-0002-3554-2673; Inashkina, Inna/0000-0002-7560-797X; Rossignol, Elsa/0000-0002-9304-9385; Kulshrestha, Samarth/0000-0001-6749-3661; Altmuller, Janine/0000-0003-4372-1521	grant for Research on Measures for Intractable Diseases from the Japan Agency for Medical Research and Development (AMED); grant for Comprehensive Research on Disability Health and Welfare from the Japan Agency for Medical Research and Development (AMED); Strategic Research Program for Brain Science (SRPBS) from the Japan Agency for Medical Research and Development (AMED) [JP19dm0107090]; Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED) [JP19ek0109280, JP19ek0109301, JP18kk0205001, JP19ek0109348]; Japan Society for the Promotion of Science (JSPS) [JP17K15639, 17K10080]; Ministry of Health, Labor and Welfare; Takeda Science Foundation; Canadian Institutes of Health Research (CIHR) [RN 324373]; Savoy Foundation; German Bundesministerium fur Bildung und Forschung (BMBF) through the Juniorverbund in der Systemmedizin "mitOmics'' [FKZ 01ZX1405C]	grant for Research on Measures for Intractable Diseases from the Japan Agency for Medical Research and Development (AMED); grant for Comprehensive Research on Disability Health and Welfare from the Japan Agency for Medical Research and Development (AMED); Strategic Research Program for Brain Science (SRPBS) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Savoy Foundation; German Bundesministerium fur Bildung und Forschung (BMBF) through the Juniorverbund in der Systemmedizin "mitOmics''(Federal Ministry of Education & Research (BMBF))	This work is supported in part by a grant for Research on Measures for Intractable Diseases, a grant for Comprehensive Research on Disability Health and Welfare, the Strategic Research Program for Brain Science (SRPBS) (JP19dm0107090) (N.M.), and the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED) (JP19ek0109280, JP19ek0109301, JP18kk0205001, and JP19ek0109348 for N.M.); Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) under grant numbers JP17K15639 (N.M.) and 17K10080 (S.M.); grants from the Ministry of Health, Labor and Welfare (for N.M. and Y.M.); and the Takeda Science Foundation (N.M.). P.M.C. and E.R. are supported by the Canadian Institutes of Health Research (CIHR) (grant number RN 324373) and T.T.M.N. is supported by the Savoy Foundation. T.B.H. was supported by the German Bundesministerium fur Bildung und Forschung (BMBF) through the Juniorverbund in der Systemmedizin "mitOmics'' (FKZ 01ZX1405C). S.E. is a Wellcome Senior Investigator. We thank Hessa Alsaif, Mohammed Alamoudi, Saori Umeshita, and Kana Miyanagi for technical assistance.	Alessandri JL, 2018, EUR J HUM GENET, V26, P340, DOI 10.1038/s41431-017-0087-x; Ashida H, 2005, MOL BIOL CELL, V16, P1439, DOI 10.1091/mbc.E04-09-0802; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bellai-Dussault K, 2019, CLIN GENET, V95, P112, DOI 10.1111/cge.13425; Cai BS, 2011, TRAFFIC, V12, P102, DOI 10.1111/j.1600-0854.2010.01135.x; Campeau PM, 2014, LANCET NEUROL, V13, P44, DOI 10.1016/S1474-4422(13)70265-5; Chelban V, 2019, ANN NEUROL, V86, P225, DOI 10.1002/ana.25524; Falace A, 2014, P NATL ACAD SCI USA, V111, P2337, DOI 10.1073/pnas.1316294111; Felix TM, 2002, CLIN DYSMORPHOL, V11, P133; Fleming L, 2016, AM J MED GENET A, V170, P77, DOI 10.1002/ajmg.a.37369; James AW, 2007, AM J MED GENET A, V143A, P2821, DOI 10.1002/ajmg.a.32054; Kato M, 2014, NEUROLOGY, V82, P1587, DOI 10.1212/WNL.0000000000000389; Kinoshita T, 2016, J LIPID RES, V57, P6, DOI 10.1194/jlr.R063313; Knaus A, 2018, GENOME MED, V10, DOI 10.1186/s13073-017-0510-5; Maddirevula S, 2019, GENET MED, V21, P736, DOI 10.1038/s41436-018-0138-x; Maddirevula S, 2018, GENET MED, V20, P1609, DOI 10.1038/gim.2018.50; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; PATTON M A, 1987, American Journal of Medical Genetics, V26, P207, DOI 10.1002/ajmg.1320260131; Rajab A, 2000, CLIN DYSMORPHOL, V9, P247, DOI 10.1097/00019605-200009040-00003; Sheehan Patricia, 2019, Small GTPases, V10, P54, DOI 10.1080/21541248.2016.1270392; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Takahashi M, 1996, EMBO J, V15, P4254, DOI 10.1002/j.1460-2075.1996.tb00800.x; Tarailo-Graovac M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0243-8; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; van Bever Y, 2007, AM J MED GENET A, V143A, P763, DOI 10.1002/ajmg.a.31641	26	24	24	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2019	105	2					384	394		10.1016/j.ajhg.2019.05.019	http://dx.doi.org/10.1016/j.ajhg.2019.05.019			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM5GK	31256876	Green Published, Bronze			2022-12-18	WOS:000478022200012
J	Paine, I; Posey, JE; Grochowski, CM; Jhangiani, SN; Rosenheck, S; Kleyner, R; Marmorale, T; Yoon, M; Wang, K; Robison, R; Cappuccio, G; Pinelli, M; Magli, A; Akdemir, ZC; Hui, J; Yeung, WL; Wong, BKY; Ortega, L; Bekheirnia, MR; Bierhals, T; Hempel, M; Johannsen, J; Santer, R; Aktas, D; Alikasifoglu, M; Bozdogan, S; Aydin, H; Karaca, E; Bayram, Y; Ityel, H; Dorschner, M; White, JJ; Wilichowski, E; Wortmann, SB; Casella, EB; Kitajima, JP; Kok, F; Monteiro, F; Muzny, DM; Bamshad, M; Gibbs, RA; Sutton, VR; Van Esch, H; Brunetti-Pierri, N; Hildebrandt, F; Brautbar, A; Van den Veyver, IB; Glass, I; Lessel, D; Lyon, GJ; Lupski, JR				Paine, Ingrid; Posey, Jennifer E.; Grochowski, Christopher M.; Jhangiani, Shalini N.; Rosenheck, Sarah; Kleyner, Robert; Marmorale, Taylor; Yoon, Margaret; Wang, Kai; Robison, Reid; Cappuccio, Gerarda; Pinelli, Michele; Magli, Adriano; Akdemir, Zeynep Coban; Hui, Joannie; Yeung, Wai Lan; Wong, Bibiana K. Y.; Ortega, Lucia; Bekheirnia, Mir Reza; Bierhals, Tatjana; Hempel, Maja; Johannsen, Jessika; Santer, Rene; Aktas, Dilek; Alikasifoglu, Mehmet; Bozdogan, Sevcan; Aydin, Hatip; Karaca, Ender; Bayram, Yavuz; Ityel, Hadas; Dorschner, Michael; White, Janson J.; Wilichowski, Ekkehard; Wortmann, Saskia B.; Casella, Erasmo B.; Kitajima, Joao Paulo; Kok, Fernando; Monteiro, Fabiola; Muzny, Donna M.; Bamshad, Michael; Gibbs, Richard A.; Sutton, V. Reid; Van Esch, Hilde; Brunetti-Pierri, Nicola; Hildebrandt, Friedhelm; Brautbar, Ariel; Van den Veyver, Ignatia B.; Glass, Ian; Lessel, Davor; Lyon, Gholson J.; Lupski, James R.		Univ Washington Ctr Mendelian Geno; Baylor-Hopkins Ctr Mendelian Genom; Telethon Undiagnosed Dis Program	Paralog Studies Augment Gene Discovery: DDX and DHX Genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; DE-NOVO; COMMON-CAUSE; MUTATIONS; IDENTIFICATION; PROTEIN; VARIANTS; MUTANTS; NMD	Members of a paralogous gene family in which variation in one gene is known to cause disease are eight times more likely to also be associated with human disease. Recent studies have elucidated DHX30 and DDX3X as genes for which pathogenic variant alleles are involved in neurodevelopmental disorders. We hypothesized that variants in paralogous genes encoding members of the DExD/H-box RNA helicase superfamily might also underlie developmental delay and/or intellectual disability (DD and/or ID) disease phenotypes. Here we describe 15 unrelated individuals who have DD and/or ID, central nervous system (CNS) dysfunction, vertebral anomalies, and dysmorphic features and were found to have probably damaging variants in DExD/H-box RNA helicase genes. In addition, these individuals exhibit a variety of other tissue and organ system involvement including ocular, outer ear, hearing, cardiac, and kidney tissues. Five individuals with homozygous (one), compound-heterozygous (two), or de novo (two) missense variants in DHX37 were identified by exome sequencing. We identified ten total individuals with missense variants in three other DDX/DHX paralogs: DHX16 (four individuals), DDX54 (three individuals), and DHX34 (three individuals). Most identified variants are rare, predicted to be damaging, and occur at conserved amino acid residues. Taken together, these 15 individuals implicate the DExD/H-box helicases in both dominantly and recessively inherited neurodevelopmental phenotypes and highlight the potential for more than one disease mechanism underlying these disorders.	[Paine, Ingrid; Posey, Jennifer E.; Grochowski, Christopher M.; Akdemir, Zeynep Coban; Bekheirnia, Mir Reza; Muzny, Donna M.; Gibbs, Richard A.; Sutton, V. Reid; Van den Veyver, Ignatia B.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jhangiani, Shalini N.; Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Rosenheck, Sarah; Kleyner, Robert; Marmorale, Taylor; Yoon, Margaret; Lyon, Gholson J.] Cold Spring Harbor Lab, Stanley Inst Cognit Genom, POB 100, Cold Spring Harbor, NY 11724 USA; [Wang, Kai] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Robison, Reid; Lyon, Gholson J.] Utah Fdn Biomed Res, Salt Lake City, UT 84107 USA; [Cappuccio, Gerarda; Pinelli, Michele; Brunetti-Pierri, Nicola] Univ Naples Federico II, Dept Translat Med, I-80131 Naples, Italy; [Cappuccio, Gerarda; Pinelli, Michele; Brunetti-Pierri, Nicola] Telethon Inst Genet & Med, I-80078 Pozzuoli, Italy; [Magli, Adriano] Univ Salerno, Dept Pediat Ophthalmol, I-84081 Baronissi, SA, Italy; [Hui, Joannie] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Pediat, Hong Kong, Peoples R China; [Yeung, Wai Lan] Alice Ho Miu Ling Nethersole Hosp, Dept Pediat & Adolescent Med, Hong Kong, Peoples R China; [Wong, Bibiana K. Y.; Van den Veyver, Ignatia B.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Wong, Bibiana K. Y.; Van den Veyver, Ignatia B.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Ortega, Lucia; Brautbar, Ariel] Cook Childrens Hosp, Med Genet Dept, Ft Worth, TX 76104 USA; [Bekheirnia, Mir Reza] Baylor Coll Med, Dept Pediat, Sect Pediat Renal, Houston, TX 77030 USA; [Bekheirnia, Mir Reza] Texas Childrens Hosp, Dept Genet, Houston, TX 76104 USA; [Bierhals, Tatjana; Hempel, Maja; Lessel, Davor] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Johannsen, Jessika; Santer, Rene] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, D-20246 Hamburg, Germany; [Aktas, Dilek; Alikasifoglu, Mehmet] DAMAGEN Genet Diagnost Ctr, TR-06690 Ankara, Turkey; [Bozdogan, Sevcan] Cukurova Univ, Dept Med Genet, Fac Med, TR-01330 Adana, Turkey; [Aydin, Hatip] Namik Kemal Univ, Dept Med Genet, Med Fac, TR-59100 Tekirdag, Turkey; [Karaca, Ender] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Bayram, Yavuz] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Ityel, Hadas; Hildebrandt, Friedhelm] Harvard Med Sch, Dept Pediat, Div Nephrol, Boston, MA 02115 USA; [Dorschner, Michael] Univ Washington, Ctr Precis Diagnost, Seattle, WA 98195 USA; [White, Janson J.; Bamshad, Michael] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Wilichowski, Ekkehard] Georg August Univ Gottingen, Dept Pediat & Pediat Neurol, D-37075 Gottingen, Germany; [Wortmann, Saskia B.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Wortmann, Saskia B.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Wortmann, Saskia B.] Paracelsus Med Univ, Univ Childrens Hosp, A-5020 Salsburg, Austria; [Casella, Erasmo B.] Univ Sao Paulo, Hosp Clin, Childrens Inst, BR-05405000 Sao Paulo, Brazil; [Kitajima, Joao Paulo; Kok, Fernando; Monteiro, Fabiola] Mendelics Genom Anal, BR-04013000 Sao Paulo, Brazil; [Kok, Fernando] Univ Sao Paulo, Dept Neurol, Sch Med, BR-01246903 Sao Paulo, Brazil; [Bamshad, Michael] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bamshad, Michael; Glass, Ian] Univ Washington, Div Genet Med, Seattle, WA 98195 USA; [Van Esch, Hilde] Univ Hosp Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Lyon, Gholson J.] Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Cold Spring Harbor Laboratory; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Salerno; Chinese University of Hong Kong; Prince of Wales Hospital; Alice Ho Miu Ling Nethersole Hospital; Baylor College of Medicine; Baylor College of Medicine; Cook Children's Medical Center; Baylor College of Medicine; Baylor College of Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cukurova University; Namik Kemal University; University of Alabama System; University of Alabama Birmingham; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Gottingen; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Paracelsus Private Medical University; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; KU Leuven; University Hospital Leuven; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.	jlupski@bcm.edu	Lessel, Davor/ABD-6088-2021; Pinelli, Michele/A-1584-2010; aydin, hatip/AAE-5540-2021; Van den Veyver, Ignatia B/AAF-4510-2021; Magli, Adriano/AAU-7380-2020; Grochowski, Christopher/AAZ-2462-2020; Van+Esch, Hilde/AAU-5688-2020; Hui, Joannie/A-8415-2012; Cappuccio, Gerarda/W-3576-2018; Brunetti-Pierri, Nicola/K-8465-2016	Pinelli, Michele/0000-0002-5927-1185; Van den Veyver, Ignatia B/0000-0002-0651-5924; Magli, Adriano/0000-0002-6490-2068; Grochowski, Christopher/0000-0002-3884-7720; Hui, Joannie/0000-0002-7408-9859; Cappuccio, Gerarda/0000-0003-3934-2342; Blue, Elizabeth/0000-0002-0633-0305; Posey, Jennifer/0000-0003-4814-6765; Brunetti-Pierri, Nicola/0000-0002-6895-8819; Lessel, Davor/0000-0003-4496-244X; Van Esch, Hilde/0000-0002-9604-5726	National Human Genome Research Institute (NHGRI) [UM1 HG006542, UM1 HG006493]; National Heart, Lung, and Blood Institute (NHLBI); University of Washington Center for Mendelian Genomics [R01 NS058529, R35 NS105078]; National Institute of Neurological Disorders and Stroke (NINDS); NHGRI [K08 HG008986]; Telethon Undiagnosed Diseases Program [GSP15001]; Telethon Foundation; Aicardi Syndrome Foundation [2T32NS043124-16]; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK088767]; Werner Otto Stiftung [K12 DK083014]; German Research Foundation (DFG) [LE 4223/1]; Common Fund of the Office of the Director of the National Institutes of Health; National Cancer Institute, NHGRI; NHLBI; National Institute on Drug Abuse; National Institute of Mental Health; NINDS; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K08HG008986, UM1HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS105078] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Washington Center for Mendelian Genomics; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Telethon Undiagnosed Diseases Program; Telethon Foundation(Fondazione Telethon); Aicardi Syndrome Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Werner Otto Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG)); Common Fund of the Office of the Director of the National Institutes of Health; National Cancer Institute, NHGRI; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants UM1 HG006542 (J.R.L) and UM1 HG006493 (M.B.) from the National Human Genome Research Institute (NHGRI) and the National Heart, Lung, and Blood Institute (NHLBI) to the Baylor Hopkins Center for Mendelian Genomics and the University of Washington Center for Mendelian Genomics, R01 NS058529 and R35 NS105078(J.R.L.) from the National Institute of Neurological Disorders and Stroke (NINDS), U54-HG003273 (R.A.G.) from NHGRI, and Telethon Undiagnosed Diseases Program (TUDP) GSP15001 (N.B.-P.) from the Telethon Foundation, and also by the Aicardi Syndrome Foundation. I.P. was supported by 2T32NS043124-16 through the National Institutes of Health. J.E.P. was supported by NHGRI K08 HG008986. F.H. was supported by the National Institutes of Health (DK088767). M.R.B. was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) K12 DK083014. D.L was supported by the Werner Otto Stiftung and the German Research Foundation (DFG; LE 4223/1). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by the National Cancer Institute, NHGRI, NHLBI, the National Institute on Drug Abuse, the National Institute of Mental Health, and NINDS. The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 10/29/18. The authors would like to thank Hans-Jurgen Kreienkamp for the help in identifying helicase core motifs and the Genome Aggregation Database (gnomAD) and the groups that provided exome and genome variant data to this resource. A full list of contributing groups can be found at https://gnomad.broadinstitute.org/about.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ajmal M, 2014, J MED GENET, V51, P444, DOI 10.1136/jmedgenet-2014-102316; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Barshir R, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007327; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Blair DR, 2013, CELL, V155, P70, DOI 10.1016/j.cell.2013.08.030; Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004; Bostwick BL, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0463-8; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chen J, 2014, INT J MOL SCI, V15, P4635, DOI 10.3390/ijms15034635; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Coban-Akdemir Z, 2018, AM J HUM GENET, V103, P171, DOI 10.1016/j.ajhg.2018.06.009; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dikow N, 2017, AM J MED GENET A, V173, P1369, DOI 10.1002/ajmg.a.38164; Eldomery MK, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0412-6; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Gambin T, 2017, NUCLEIC ACIDS RES, V45, P1633, DOI 10.1093/nar/gkw1237; Gencheva M, 2010, J BIOL CHEM, V285, P35624, DOI 10.1074/jbc.M110.122309; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; Gonzaga-Jauregui C, 2015, EUR J HUM GENET, V23, P342, DOI 10.1038/ejhg.2014.107; Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007; Harel T, 2016, AM J HUM GENET, V98, P562, DOI 10.1016/j.ajhg.2016.01.011; Hempel M, 2015, AM J HUM GENET, V97, P493, DOI 10.1016/j.ajhg.2015.08.003; Hirata H, 2013, J NEUROSCI, V33, P14638, DOI 10.1523/JNEUROSCI.1157-13.2013; Hug N, 2014, CELL REP, V8, P1845, DOI 10.1016/j.celrep.2014.08.020; Karaca E, 2018, GENET MED, V20, P1528, DOI 10.1038/gim.2018.33; Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Labonne JDJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0642-z; Latif Z, 2018, INVEST OPHTH VIS SCI, V59, P4552, DOI 10.1167/iovs.18-23849; Lessel D, 2017, AM J HUM GENET, V101, P716, DOI 10.1016/j.ajhg.2017.09.014; Longman D, 2013, NUCLEIC ACIDS RES, V41, P8319, DOI 10.1093/nar/gkt585; Maksimova N, 2010, J MED GENET, V47, P538, DOI 10.1136/jmg.2009.074815; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; Melero R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10585; Milek M, 2017, GENOME RES, V27, P1344, DOI 10.1101/gr.218438.116; Miyatake S, 2015, J HUM GENET, V60, P175, DOI 10.1038/jhg.2014.124; MULLER H. J., 1932, Proceedings. 6th Int. Congr. Genet., V1, P213; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Posey JE, 2019, GENET MED, V21, P798, DOI 10.1038/s41436-018-0408-7; Posey JE, 2017, NEW ENGL J MED, V376, P21, DOI 10.1056/NEJMoa1516767; Rainger J, 2014, AM J HUM GENET, V94, P915, DOI 10.1016/j.ajhg.2014.05.005; Rajendran RR, 2003, J BIOL CHEM, V278, P4628, DOI 10.1074/jbc.M210066200; Regan JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118270; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; Sutton VR, 2005, AM J MED GENET A, V138A, P254, DOI 10.1002/ajmg.a.30963; Swayne A, 2018, EUR J NEUROL, V25, P1290, DOI 10.1111/ene.13721; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang X, 2018, ANN CLIN TRANSL NEUR, V5, P1277, DOI 10.1002/acn3.622; White J, 2016, GENOME MED, V8, DOI 10.1186/s13073-015-0253-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Zhan R, 2013, J NEUROSCI RES, V91, P335, DOI 10.1002/jnr.23162	60	24	26	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2019	105	2					302	316		10.1016/j.ajhg.2019.06.001	http://dx.doi.org/10.1016/j.ajhg.2019.06.001			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM5GK	31256877	Bronze, Green Published			2022-12-18	WOS:000478022200006
J	Bauer, CK; Schneeberger, PE; Kortum, F; Altmuller, J; Santos-Simarro, F; Baker, L; Keller-Ramey, J; White, SM; Campeau, PM; Gripp, KW; Kutsche, K				Bauer, Christiane K.; Schneeberger, Pauline E.; Kortuem, Fanny; Altmueller, Janine; Santos-Simarro, Fernando; Baker, Laura; Keller-Ramey, Jennifer; White, Susan M.; Campeau, Philippe M.; Gripp, Karen W.; Kutsche, Kerstin			Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-KINASE CK2; POTASSIUM CHANNEL; GARDOS CHANNEL; TEMPLE-BARAITSER; PRIMARY CILIUM; EXPRESSION; CA2+; OVEREXPRESSION; MECHANISM; DOPAMINE	Zimmermann-Laband syndrome (ZLS) is characterized by coarse facial features with gingival enlargement, intellectual disability (ID), hypertrichosis, and hypoplasia or aplasia of nails and terminal phalanges. De novo missense mutations in KCNH1 and KCNK4, encoding K+ channels, have been identified in subjects with ZLS and ZLS-like phenotype, respectively. We report de novo missense variants in KCNN3 in three individuals with typical clinical features of ZLS. KCNN3 (SK3/KCa2.3) constitutes one of three members of the small-conductance Ca2+-activated (SK) channels that are part of a multiprotein complex consisting of the pore-forming channel subunits, the constitutively bound Ca2+ sensor calmodulin, protein kinase CK2, and protein phosphatase 2A. CK2 modulates Ca2+ sensitivity of the channels by phosphorylating SK-bound calmodulin. Patch-clamp whole-cell recordings of KCNN3 channel-expressing CHO cells demonstrated that disease-associated mutations result in gain of function of the mutant channels, characterized by increased Ca2+ sensitivity leading to faster and more complete activation of KCNN3 mutant channels. Pretreatment of cells with the CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole revealed basal inhibition of wild-type and mutant KCNN3 channels by CK2. Analogous experiments with the KCNN3 p.Va1450Leu mutant previously identified in a family with portal hypertension indicated basal constitutive channel activity and thus a different gain-of-function mechanism compared to the ZLS-associated mutant channels. With the report on de novo KCNK4 mutations in subjects with facial dysmorphism, hypertrichosis, epilepsy, ID, and gingival overgrowth, we propose to combine the phenotypes caused by mutations in KCNH1, KCNK4, and KCNN3 in a group of neurological potassium channelopathies caused by an increase in K+ conductance.	[Bauer, Christiane K.] Univ Med Ctr Hamburg Eppendorf, Dept Cellular & Integrat Physiol, D-20246 Hamburg, Germany; [Schneeberger, Pauline E.; Kortuem, Fanny; Kutsche, Kerstin] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Altmueller, Janine] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Altmueller, Janine] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Santos-Simarro, Fernando] Hosp Univ La Paz, Inst Genet Med & Mol INGEMM, Secc Genet Clin, IdiPAZ,CIBERER,ISCIII, Madrid 28046, Spain; [Baker, Laura; Gripp, Karen W.] Alfred I duPont Hosp Children, Div Med Genet, Wilmington, DE 19803 USA; [Keller-Ramey, Jennifer] GeneDx, Gaithersburg, MD 20877 USA; [White, Susan M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [White, Susan M.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Campeau, Philippe M.] Univ Montreal, St Justine Hosp, Dept Pediat, Montreal, PQ H3T 1C5, Canada	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Cologne; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; Instituto de Salud Carlos III; Nemours Alfred I. duPont Hospital for Children; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Bauer, CK (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Cellular & Integrat Physiol, D-20246 Hamburg, Germany.; Kutsche, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany.	cbauer@uke.de; kkutsche@uke.de	Campeau, Philippe/J-8614-2015; Santos-Simarro, Fernando/L-3063-2014	Campeau, Philippe/0000-0001-9713-7107; Santos-Simarro, Fernando/0000-0002-1201-9118; Schneeberger, Pauline E/0000-0001-8282-7367; Bauer, Christiane K./0000-0002-2078-3503; Altmuller, Janine/0000-0003-4372-1521	Deutsche Forschungsgemeinschaft [KO 4576/1-2]; Federal Ministry of Education and Research [01DQ17003]; Canadian Institutes of Health Research; Fonds de Recherche du Quebec en Sante	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec)	We thank all subjects and family members for their participation in this study, Christine Brinker, Annett Hasse, and Inka Jantke for skillful technical assistance, and Hans-Jurgen Kreienkamp for technical advice and helpful discussion. This work was supported by grants from the Deutsche Forschungsgemeinschaft (KO 4576/1-2 to F.K. and K.K.), the Federal Ministry of Education and Research (01DQ17003 to K.K.), and the Canadian Institutes of Health Research to P.M.C. and the Fonds de Recherche du Quebec en Sante to P.M.C.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Altmuller J, 2016, BIOL CHEM, V397, P791, DOI 10.1515/hsz-2015-0300; Andolfo I, 2015, AM J HEMATOL, V90, P921, DOI 10.1002/ajh.24117; Balut CM, 2012, CHEMMEDCHEM, V7, P1741, DOI 10.1002/cmdc.201200226; BARR M, 1974, J PEDIATR-US, V84, P254, DOI 10.1016/S0022-3476(74)80615-3; Bauer CK, 2018, AM J HUM GENET, V103, P621, DOI 10.1016/j.ajhg.2018.09.001; Bauer CK, 2018, J PHYSIOL-LONDON, V596, P769, DOI 10.1113/JP275477; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Blank T, 2003, NAT NEUROSCI, V6, P911, DOI 10.1038/nn1101; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Bramswig NC, 2015, HUM GENET, V134, P1089, DOI 10.1007/s00439-015-1590-1; Brohawn SG, 2015, ANN NY ACAD SCI, V1352, P20, DOI 10.1111/nyas.12874; Castori M, 2013, EUR J MED GENET, V56, P570, DOI 10.1016/j.ejmg.2013.08.004; Cazares-Ordonez V, 2017, BIOCHEM CELL BIOL, V95, P531, DOI 10.1139/bcb-2017-0062; Chacon-Camacho OF, 2011, AM J MED GENET A, V155A, P1716, DOI 10.1002/ajmg.a.34030; DANIELSSON BRG, 1992, TERATOLOGY, V45, P247, DOI 10.1002/tera.1420450304; DANIELSSON BRG, 1990, TERATOLOGY, V41, P185, DOI 10.1002/tera.1420410210; de Villavicencio-Diaz TN, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010027; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Faber ES, 2009, CELL BIOCHEM BIOPHYS, V55, P127, DOI 10.1007/s12013-009-9062-7; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Freise C, 2015, LIVER INT, V35, P1244, DOI 10.1111/liv.12681; Fukai R, 2016, J HUM GENET, V61, P381, DOI 10.1038/jhg.2016.1; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Girisha KM, 2016, EUR J HUM GENET, V24, P1206, DOI 10.1038/ejhg.2015.261; Glogowska E, 2015, BLOOD, V126, P1281, DOI 10.1182/blood-2015-07-657957; Grube S, 2011, EMBO MOL MED, V3, P309, DOI 10.1002/emmm.201100135; HANSON JW, 1986, TERATOLOGY, V33, P349, DOI 10.1002/tera.1420330314; Harms FL, 2018, AM J HUM GENET, V103, P579, DOI 10.1016/j.ajhg.2018.09.005; Harms FL, 2017, AM J HUM GENET, V100, P117, DOI 10.1016/j.ajhg.2016.11.012; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; Jacobsen JPR, 2009, NEUROSCIENCE, V163, P73, DOI 10.1016/j.neuroscience.2009.05.062; Jacobsen JPR, 2008, GENES BRAIN BEHAV, V7, P836, DOI 10.1111/j.1601-183X.2008.00416.x; Kohler R, 2000, CIRC RES, V87, P496; Koot BGP, 2016, J HEPATOL, V64, P974, DOI 10.1016/j.jhep.2015.11.027; Kortum F, 2015, NAT GENET, V47, P661, DOI 10.1038/ng.3282; LABAND PETER F., 1964, ORAL SURG ORAL MED AND ORAL PATHOL, V17, P339, DOI 10.1016/0030-4220(64)90506-7; Lee CH, 2018, SCIENCE, V360, P508, DOI 10.1126/science.aas9466; LEIST KH, 1974, TERATOLOGY, V10, P55, DOI 10.1002/tera.1420100109; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Martin S, 2017, MOL NEUROBIOL, V54, P1078, DOI 10.1007/s12035-015-9680-6; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Megarbane A, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0304-4; Milkau M, 2010, FASEB J, V24, P3572, DOI 10.1096/fj.10-158956; Nam YW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28783-2; Ogawa M, 2019, CURR OPIN STRUC BIOL, V56, P72, DOI 10.1016/j.sbi.2018.12.002; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Pusapati GV, 2014, DEV CELL, V28, P483, DOI 10.1016/j.devcel.2014.01.021; Rapetti-Mauss R, 2016, HAEMATOLOGICA, V101, pE431, DOI 10.3324/haematol.2016.149104; Rapetti-Mauss R, 2015, BLOOD, V126, P1273, DOI 10.1182/blood-2015-04-642496; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Rogers MS, 2001, J BIOL CHEM, V276, P12182, DOI 10.1074/jbc.M010056200; Ruiz-Perez VL, 2009, AM J MED GENET C, V151C, P341, DOI 10.1002/ajmg.c.30226; Sanchez A, 2016, EMBO REP, V17, P708, DOI 10.15252/embr.201541082; Sarpal D, 2004, SYNAPSE, V53, P104, DOI 10.1002/syn.20042; Schouten JNL, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0288-8; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Simons C, 2015, NAT GENET, V47, P73, DOI 10.1038/ng.3153; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Stittrich AB, 2014, AM J HUM GENET, V95, P275, DOI 10.1016/j.ajhg.2014.07.011; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Swartz EN, 1999, AM J MED GENET, V82, P49, DOI 10.1002/(SICI)1096-8628(19990101)82:1<49::AID-AJMG10>3.0.CO;2-M; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Turowec JP, 2010, METHOD ENZYMOL, V484, P471, DOI [10.1016/S0076-6879(10)84023-6, 10.1016/B978-0-12-381298-8.00023-X]; Urrego D, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600190; Urrego D, 2016, CELL CYCLE, V15, P799, DOI 10.1080/15384101.2016.1138187; Wang HM, 2003, J CELL BIOCHEM, V88, P812, DOI 10.1002/jcb.10438; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Y, 1996, J BIOL CHEM, V271, P18107, DOI 10.1074/jbc.271.30.18107; Weston AH, 2010, BRIT J PHARMACOL, V160, P836, DOI 10.1111/j.1476-5381.2010.00657.x; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yap FC, 2016, AM J PHYSIOL-HEART C, V310, pH1151, DOI 10.1152/ajpheart.00787.2015; Zhang M, 2014, NAT CHEM BIOL, V10, P753, DOI [10.1038/NCHEMBIO.1592, 10.1038/nchembio.1592]; Zimmermann, 1928, VJSCHR ZAHNHEILK, V44, P419	80	24	24	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2019	104	6					1139	1157		10.1016/j.ajhg.2019.04.012	http://dx.doi.org/10.1016/j.ajhg.2019.04.012			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB4KJ	31155282	Green Published, Bronze			2022-12-18	WOS:000470240000010
J	Fragoulakis, V; Roncato, R; Fratte, CD; Ecca, F; Bartsakoulia, M; Innocenti, F; Toffoli, G; Cecchin, E; Patrinos, GP; Mitropoulou, C				Fragoulakis, Vasileios; Roncato, Rossana; Fratte, Chiara Dalle; Ecca, Fabrizio; Bartsakoulia, Marina; Innocenti, Federico; Toffoli, Giuseppe; Cecchin, Erika; Patrinos, George P.; Mitropoulou, Christina			Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLINICAL VALIDITY; IRINOTECAN; DISEASE; TIME	Fluoropyrimidines (FLs) have been widely used for more than 60 years against a range of solid tumors and still remains the cornerstone for the treatment of colorectal, gastric, and breast cancer. Here, we performed an economic analysis to estimate the cost of DPYD-guided toxicity management and the clinical benefit expressed as quality adjusted life years (QALYs) in a large group of 571 individuals of Italian origin suffering from cancer and treated with a fluoropyrimidines-based chemotherapy. Individuals suffering from cancer with a histologically confirmed diagnosis of cancer, who received a fluoropyrimidines-based treatment, were retrospectively genotyped in the DPYD gene. Effectiveness was measured as survival of individuals from chemotherapy, while study data on safety and efficacy as well as on resource utilization associated with each adverse drug reaction were used to measure costs to treat these adverse drug reactions. A generalized linear regression model was used to estimate cost differences for both study groups. DPYD extensive metabolizers (528 individuals) had greater effectiveness and lesser cost, representing a cost-saving option over DPYD intermediate and poor metabolizers (43 individuals) with mean QALYs of 4.18 (95%CI: 3.16-5.55) versus 3.02 (95%CI: 1.94-4.25), respectively. Our economic analysis showed that there are some indications for differences in survival between the two groups (p > 0.05), while the cost of DPYD extensive metabolizers was significantly lower (p < 0.01) compared with those belonging to the group of intermediate/poor metabolizers. These findings suggest that DPYD-guided fluoropyrimidines treatment represent a cost-saving choice for individuals suffering from cancer in the Italian healthcare setting.	[Fragoulakis, Vasileios; Mitropoulou, Christina] Golden Helix Fdn, London WC2N 5AP, England; [Roncato, Rossana; Fratte, Chiara Dalle; Ecca, Fabrizio; Toffoli, Giuseppe; Cecchin, Erika] Ctr Riferimento Oncol Aviano CRO IRCCS, Expt & Clin Pharmacol Unit, I-33081 Aviano, Italy; [Bartsakoulia, Marina; Patrinos, George P.] Univ Patras, Sch Hlth Sci, Dept Pharm, Patras 26504, Greece; [Innocenti, Federico] Univ N Carolina, Ctr Pharmacogen & Individualized Therapy, Chapel Hill, NC 27599 USA; [Patrinos, George P.] United Arab Emirates Univ, Zayed Ctr Hlth Sci, Al Ain 15551, U Arab Emirates; [Patrinos, George P.] United Arab Emirates Univ, Dept Pathol, Coll Med & Hlth Sci, Al Ain 15551, U Arab Emirates	University of Patras; University of North Carolina; University of North Carolina Chapel Hill; United Arab Emirates University; United Arab Emirates University	Mitropoulou, C (corresponding author), Golden Helix Fdn, London WC2N 5AP, England.; Patrinos, GP (corresponding author), Univ Patras, Sch Hlth Sci, Dept Pharm, Patras 26504, Greece.; Patrinos, GP (corresponding author), United Arab Emirates Univ, Zayed Ctr Hlth Sci, Al Ain 15551, U Arab Emirates.; Patrinos, GP (corresponding author), United Arab Emirates Univ, Dept Pathol, Coll Med & Hlth Sci, Al Ain 15551, U Arab Emirates.	gpatrinos@upatras.gr; c.mitropoulou@goldenhelix.org	Toffoli, Giuseppe/F-6642-2018; Cecchin, Erika/K-2448-2018; Roncato, Rossana/AAB-6786-2019; Innocenti, Federico/G-3206-2018; Mitropoulou, Christina/C-2851-2009; Fratte, Chiara Dalle/AAX-6246-2020	Toffoli, Giuseppe/0000-0002-5323-4762; Cecchin, Erika/0000-0001-7517-7490; Roncato, Rossana/0000-0002-4219-6182; Fratte, Chiara Dalle/0000-0003-4205-2741; Ecca, Fabrizio/0000-0002-4525-1626	European Commission (U-PGx) [H2020-668353]	European Commission (U-PGx)	This work was partly funded by a European Commission grant (H2020-668353; U-PGx) to C.M. and encouraged and coordinated by the Genomic Medicine Alliance Health Economics Working Group. Nothing contained in this paper is intended to guarantee the appropriateness of any medical treatment or to be used for therapeutic purposes or as a substitute for a health professional's advice.	Ayvaci MUS, 2013, MED DECIS MAKING, V33, P521, DOI 10.1177/0272989X12470755; Bang H, 2000, BIOMETRIKA, V87, P329, DOI 10.1093/biomet/87.2.329; Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Byford S, 1998, BRIT MED J, V316, P1529, DOI 10.1136/bmj.316.7143.1529; Calhoun EA, 2001, ONCOLOGIST, V6, P441, DOI 10.1634/theoncologist.6-5-441; Campbell MK, 1999, QJM-INT J MED, V92, P177, DOI 10.1093/qjmed/92.3.177; Cecchin E, 2013, PHARMACOGENOMICS J, V13, P403, DOI 10.1038/tpj.2012.31; Cortejoso L, 2016, PHARMACOGENOMICS, V17, P979, DOI 10.2217/pgs-2016-0006; Deenen MJ, 2016, J CLIN ONCOL, V34, P227, DOI 10.1200/JCO.2015.63.1325; Djalalov S, 2014, MED DECIS MAKING, V34, P809, DOI 10.1177/0272989X14536779; Henricks LM, 2019, EUR J CANCER, V107, P60, DOI 10.1016/j.ejca.2018.11.010; Henricks LM, 2018, LANCET ONCOL, V19, P1459, DOI 10.1016/S1470-2045(18)30686-7; Huang YJ, 2009, MED CARE, V47, pS115, DOI 10.1097/MLR.0b013e31819bc08a; Hughes DA, 2018, PHARMACOGENOMICS, V19, P243, DOI 10.2217/pgs-2017-0300; Johnson MR, 2001, ADV ENZYME REGUL, V41, P151, DOI 10.1016/S0065-2571(00)00011-X; Kurz CF, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0445-y; Lee AM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju298; Lin DY, 2003, STAT MED, V22, P1181, DOI 10.1002/sim.1377; Lloyd A, 2006, BRIT J CANCER, V95, P683, DOI 10.1038/sj.bjc.6603326; Lousdal ML, 2017, MED DECIS MAKING, V37, P391, DOI 10.1177/0272989X16655341; Malinowski KP, 2016, EXPERT REV PHARM OUT, V16, P441, DOI 10.1080/14737167.2016.1190644; Murphy C, 2018, DOSE-RESPONSE, V16, DOI 10.1177/1559325818803042; Offer SM, 2016, J CLIN ONCOL, V34, P205, DOI 10.1200/JCO.2015.64.2546; Paracha N, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0994-8; Roncato R, 2017, CLIN PHARMACOL THER, V102, P123, DOI 10.1002/cpt.615; Stahmeyer JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169401; Stein J D, 2002, J Clin Hypertens (Greenwich), V4, P181, DOI 10.1111/j.1524-6175.2002.00970.x; Swen JJ, 2018, CLIN PHARMACOL THER, V103, P795, DOI 10.1002/cpt.1049; Toffoli G., CLIN PHARM THER, V105, P994; Toffoli G, 2006, J CLIN ONCOL, V24, P3061, DOI 10.1200/JCO.2005.05.5400; Toffoli G, 2015, INT J CANCER, V137, P2971, DOI 10.1002/ijc.29654; Tonk ECM, 2017, PHARMACOGENOMICS J, V17, P386, DOI 10.1038/tpj.2016.34; Wijeysundera HC, 2012, CLINICOECONOMIC OUTC, V4, P145, DOI 10.2147/CEOR.S31552; Wong W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196007	34	24	24	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2019	104	6					1158	1168		10.1016/j.ajhg.2019.04.017	http://dx.doi.org/10.1016/j.ajhg.2019.04.017			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB4KJ	31155283	Bronze, Green Published			2022-12-18	WOS:000470240000011
J	Gonorazky, HD; Naumenko, S; Ramani, AK; Nelakuditi, V; Mashouri, P; Wang, PQ; Kao, D; Ohri, K; Viththiyapaskaran, S; Tarnopolsky, MA; Mathews, KD; Moore, SA; Osorio, AN; Villanova, D; Kemaladewi, DU; Cohn, RD; Brudno, M; Dowling, JJ				Gonorazky, Hernan D.; Naumenko, Sergey; Ramani, Arun K.; Nelakuditi, Viswateja; Mashouri, Pouria; Wang, Peiqui; Kao, Dennis; Ohri, Krish; Viththiyapaskaran, Senthuri; Tarnopolsky, Mark A.; Mathews, Katherine D.; Moore, Steven A.; Osorio, Andres N.; Villanova, David; Kemaladewi, Dwi U.; Cohn, Ronald D.; Brudno, Michael; Dowling, James J.			Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease (vol 104, pg 466, 2019)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction												brudno@cs.toronto.edu; james.dowling@sickkids.ca	Cohn, Ronald/AAC-5835-2021	mathews, katherine/0000-0003-4160-0435				Gonorazky HD, 2019, AM J HUM GENET, V104, P466, DOI 10.1016/j.ajhg.2019.01.012	1	24	25	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2019	104	5					1007	1007		10.1016/j.ajhg.2019.04.004	http://dx.doi.org/10.1016/j.ajhg.2019.04.004			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW3QV	31051109	Green Published, Bronze			2022-12-18	WOS:000466608700020
J	Zawerton, A; Yao, BJ; Yeager, JP; Pippucci, T; Haseeb, A; Smith, JD; Wischmann, L; Kuhl, SJ; Dean, JCS; Pilz, DT; Holder, SE; McNeill, A; Graziano, C; Lefebvre, V				Zawerton, Ash; Yao, Baojin; Yeager, J. Paige; Pippucci, Tommaso; Haseeb, Abdul; Smith, Joshua D.; Wischmann, Lisa; Kuehl, Susanne J.; Dean, John C. S.; Pilz, Daniela T.; Holder, Susan E.; McNeill, Alisdair; Graziano, Claudio; Lefebvre, Veronique		Deciphering Dev Disorders Study; Univ Washington	De Novo SOX4 Variants Cause a Neurodevelopmental Disease Associated with Mild Dysmorphism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOXC TRANSCRIPTION FACTORS; DNA-BINDING ACTIVITY; CAMPOMELIC DYSPLASIA; NEURONAL DIFFERENTIATION; GONADAL-DYSGENESIS; MISSENSE MUTATIONS; SRY; DISORDERS; MOUSE; IDENTIFICATION	SOX4, together with SOX11 and SOX12, forms group C of SRY-related (SOX) transcription factors. They play key roles, often in redundancy, in multiple developmental pathways, including neurogenesis and skeletogenesis. De novo SOX11 heterozygous mutations have been shown to cause intellectual disability, growth deficiency, and dysmorphic features compatible with mild Coffin-Siris syndrome. Using trio-based exome sequencing, we here identify de novo SOX4 heterozygous missense variants in four children who share developmental delay, intellectual disability, and mild facial and digital morphological abnormalities. SOX4 is highly expressed in areas of active neurogenesis in human fetuses, and sox4 knockdown in Xenopus embryos diminishes brain and whole-body size. The SOX4 variants cluster in the highly conserved, SOX family-specific HMG domain, but each alters a different residue. In silico tools predict that each variant affects a distinct structural feature of this DNA-binding domain, and functional assays demonstrate that these SOX4 proteins carrying these variants are unable to bind DNA in vitro and transactivate SOX reporter genes in cultured cells. These variants are not found in the gnomAD database of individuals with presumably normal development, but 12 other SOX4 HMG-domain missense variants are recorded and all demonstrate partial to full activity in the reporter assay. Taken together, these findings point to specific SOX4 HMG-domain missense variants as the cause of a characteristic human neurodevelopmental disorder associated with mild facial and digital dysmorphism.	[Zawerton, Ash] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44195 USA; [Yao, Baojin] Changchun Univ Chinese Med, Jilin Ginseng Acad, Changchun 130117, Jilin, Peoples R China; [Yeager, J. Paige; Haseeb, Abdul; Lefebvre, Veronique] Childrens Hosp Philadelphia, Dept Surg, Div Orthopaed Surg, Philadelphia, PA 19104 USA; [Pippucci, Tommaso; Graziano, Claudio] St Orsola Marcello Malpighi Hosp, Med Genet Unit, I-40138 Bologna, Italy; [Smith, Joshua D.; Univ Washington] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wischmann, Lisa; Kuehl, Susanne J.] Ulm Univ, Inst Biochem & Mol Biol, D-89018 Ulm, Germany; [Dean, John C. S.] Aberdeen Royal Infirm, Dept Med Genet, Aberdeen AB25 2ZA, Scotland; [Pilz, Daniela T.] Queen Elizabeth Univ Hosp, West Scotland Genet Serv, Glasgow G51 4TF, Lanark, Scotland; [Pilz, Daniela T.] Cardiff Univ, Sch Med, Div Canc & Genet, Cardiff CF14 4XN, S Glam, Wales; [Holder, Susan E.] London North West Healthcare NHS Trust, Northwick Pk Hosp, Harrow HA1 3UJ, Middx, England; [Deciphering Dev Disorders Study] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [McNeill, Alisdair] Univ Sheffield, Sheffield Childrens Hosp, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England	Cleveland Clinic Foundation; Changchun University of Chinese Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Washington; University of Washington Seattle; Ulm University; University of Aberdeen; Queen Elizabeth University Hospital (QEUH); Cardiff University; Imperial College London; Wellcome Trust Sanger Institute; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Sheffield	Lefebvre, V (corresponding author), Childrens Hosp Philadelphia, Dept Surg, Div Orthopaed Surg, Philadelphia, PA 19104 USA.; Graziano, C (corresponding author), St Orsola Marcello Malpighi Hosp, Med Genet Unit, I-40138 Bologna, Italy.	claudio.graziano@unibo.it; lefebvrev1@email.chop.edu	Haseeb, Abdul/I-5278-2017	Haseeb, Abdul/0000-0002-2623-1275; Blue, Elizabeth/0000-0002-0633-0305; Yao, Baojin/0000-0002-7542-1585; Graziano, Claudio/0000-0003-3875-6869; Dean, John/0000-0003-3841-0841; mcneill, alisdair/0000-0001-5702-3631	National Institutes of Health NHGRI [UM1 HG006493, U24 HG008956]; National Institutes of Health NHLBI [UM1 HG006493, U24 HG008956]; Wellcome [HICF-1009-003]; Department of Health [HICF-1009-003]; Wellcome Sanger Institute [WT098051]; National Institute for Health Research, through the Comprehensive Clinical Research Network; Cleveland Clinic Lerner Research Institute (Chair's Innovative Research Award); National Institutes of HealthNIAMS [AR68308]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U24HG008956, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068308] Funding Source: NIH RePORTER	National Institutes of Health NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome; Department of Health; Wellcome Sanger Institute; National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); Cleveland Clinic Lerner Research Institute (Chair's Innovative Research Award); National Institutes of HealthNIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the children and their families who contributed to this study. We also thank Okan Elci for help with statistical analyses. Sequencing was provided by the University ofWashington Center for Mendelian Genomics (UW-CMG) and was funded by National Institutes of Health NHGRI and NHLBI (UM1 HG006493 and U24 HG008956 grants to the UW-CMG and to the CMG coordinating center). The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between Wellcome and the Department of Health, and the Wellcome Sanger Institute (grant number WT098051). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. This study makes use of DECIPHER, which is funded by the Wellcome. Part of this study was conducted in the former Lefebvre laboratory at and funded by the Cleveland Clinic Lerner Research Institute (Chair's Innovative Research Award to V. L.). Funding was also received from the National Institutes of HealthNIAMS (AR68308 grant to V.L.). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bhattaram P, 2014, J CELL BIOL, V207, P657, DOI 10.1083/jcb.201405098; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Chaoui A, 2011, HUM MUTAT, V32, P1436, DOI 10.1002/humu.21583; Chen C, 2015, J NEUROSCI, V35, P10629, DOI 10.1523/JNEUROSCI.1663-15.2015; Chen J, 2016, CLIN TRANSL ONCOL, V18, P65, DOI 10.1007/s12094-015-1337-4; Cizelsky W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069372; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Hempel A, 2016, J MED GENET, V53, P152, DOI 10.1136/jmedgenet-2015-103393; Hoffmeister M, 2017, DEV BIOL, V429, P200, DOI 10.1016/j.ydbio.2017.06.026; Hoser M, 2008, MOL CELL BIOL, V28, P4675, DOI 10.1128/MCB.00338-08; Hou LL, 2017, SEMIN CELL DEV BIOL, V63, P2, DOI 10.1016/j.semcdb.2016.08.005; Jauch R, 2012, BIOCHEM J, V443, P39, DOI 10.1042/BJ20111768; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Karaer K, 2014, TURK PEDIATR ARSIVI, V49, P154, DOI 10.5152/tpa.2014.1187; Kato K, 2015, J BONE MINER RES, V30, P1560, DOI 10.1002/jbmr.2504; Katoh-Fukui Y, 2015, MOL GENET GENOM MED, V3, P550, DOI 10.1002/mgg3.165; Kozhemyakina E, 2015, DEVELOPMENT, V142, P817, DOI 10.1242/dev.105536; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lamb AN, 2012, HUM MUTAT, V33, P728, DOI 10.1002/humu.22037; Lefebvre V, 2016, CURR OSTEOPOROS REP, V14, P32, DOI 10.1007/s11914-016-0296-1; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; MOODY SA, 1990, ANAT EMBRYOL, V182, P347, DOI 10.1007/BF02433495; Morin M, 2008, AM J MED GENET A, V146A, P1032, DOI 10.1002/ajmg.a.32181; Mu LF, 2012, J NEUROSCI, V32, P3067, DOI 10.1523/JNEUROSCI.4679-11.2012; Nikolova G, 2006, NAT CLIN PRACT ENDOC, V2, P231, DOI 10.1038/ncpendmet0143; Okamoto N, 2018, CONGENIT ANOM, V58, P105, DOI 10.1111/cga.12242; Ortega JA, 2018, NEUROSCIENTIST, V24, P156, DOI 10.1177/1073858417691009; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Pingault V, 2013, AM J HUM GENET, V92, P707, DOI 10.1016/j.ajhg.2013.03.024; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Preiss S, 2001, J BIOL CHEM, V276, P27864, DOI 10.1074/jbc.M101278200; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Scherer G, 1998, CYTOGENET CELL GENET, V80, P188, DOI 10.1159/000014978; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Tsurusaki Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5011; Turner TN, 2017, NUCLEIC ACIDS RES, V45, pD804, DOI 10.1093/nar/gkw865; Turner TN, 2015, HUM MOL GENET, V24, P5995, DOI 10.1093/hmg/ddv309; Urban N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00396; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wang X, 2018, GENE, V651, P143, DOI 10.1016/j.gene.2018.01.076; Ware J.S., 2015, CURR PROTOC HUM GENE, V87, P1; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; ZENG YT, 1993, J MED GENET, V30, P655, DOI 10.1136/jmg.30.8.655	57	24	25	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2019	104	2					246	259		10.1016/j.ajhg.2018.12.014	http://dx.doi.org/10.1016/j.ajhg.2018.12.014			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL2SW	30661772	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000458557800006
J	Schoch, K; Meng, LY; Szelinger, S; Bearden, DR; Stray-Pedersen, A; Busk, OL; Stong, N; Liston, E; Cohn, RD; Scaglia, F; Rosenfeld, JA; Tarpinian, J; Skraban, CM; Deardorff, MA; Friedman, JN; Akdemir, ZC; Walley, N; Mikati, MA; Kranz, PG; Jasien, J; McConkie-Rosell, A; McDonald, M; Wechsler, SB; Freemark, M; Kansagra, S; Freedman, S; Bali, D; Millan, F; Bale, S; Nelson, SF; Lee, H; Dorrani, N; Goldstein, DB; Xiao, R; Yang, YP; Posey, JE; Martinez-Agosto, JA; Lupski, JR; Wangler, MF; Shashi, V				Schoch, Kelly; Meng, Linyan; Szelinger, Szabolcs; Bearden, David R.; Stray-Pedersen, Asbjorg; Busk, Oyvind L.; Stong, Nicholas; Liston, Eriskay; Cohn, Ronald D.; Scaglia, Fernando; Rosenfeld, Jill A.; Tarpinian, Jennifer; Skraban, Cara M.; Deardorff, Matthew A.; Friedman, Jeremy N.; Akdemir, Zeynep Coban; Walley, Nicole; Mikati, Mohamad A.; Kranz, Peter G.; Jasien, Joan; McConkie-Rosell, Allyn; McDonald, Marie; Wechsler, Stephanie Burns; Freemark, Michael; Kansagra, Sujay; Freedman, Sharon; Bali, Deeksha; Millan, Francisca; Bale, Sherri; Nelson, Stanley F.; Lee, Hane; Dorrani, Naghmeh; Goldstein, David B.; Xiao, Rui; Yang, Yaping; Posey, Jennifer E.; Martinez-Agosto, Julian A.; Lupski, James R.; Wangler, Michael F.; Shashi, Vandana		UCLA Clinical Genomics Ctr; Undiag Dis Network	A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BTB/POZ PROTEIN; POINT MUTATIONS; BINDING PROTEIN; EXPRESSION; DISORDERS; INTERACTS	Whole-exome sequencing (WES) has increasingly enabled new pathogenic gene variant identification for undiagnosed neurodevelopmental disorders and provided insights into both gene function and disease biology. Here, we describe seven children with a neurodevelopmental disorder characterized by microcephaly, profound developmental delays and/or intellectual disability, cataracts, severe epilepsy including infantile spasms, irritability, failure to thrive, and stereotypic hand movements. Brain imaging in these individuals reveals delay in myelination and cerebral atrophy. We observe an identical recurrent de novo heterozygous c.892C>T (p.Arg298Trp) variant in the nucleus accumbens associated 1 (NACC1)gene in seven affected individuals. One of the seven individuals is mosaic for this variant. NACC1 encodes a transcriptional repressor implicated in gene expression and has not previously been associated with germline disorders. The probability of finding the same missense NACC1 variant by chance in 7 out of 17,228 individuals who underwent WES for diagnoses of neurodevelopmental phenotypes is extremely small and achieves genome-wide significance (p = 1.25 x 10(-14)). Selective constraint against missense variants in NACC1 makes this excess of an identical missense variant in all seven individuals more remarkable. Our findings are consistent with a germline recurrent mutational hotspot associated with an allele-specific neurodevelopmental phenotype in NACC1.	[Schoch, Kelly; Walley, Nicole; McConkie-Rosell, Allyn; McDonald, Marie; Wechsler, Stephanie Burns; Shashi, Vandana] Duke Hlth, Div Med Genet, Dept Pediat, Durham, NC 27710 USA; [Meng, Linyan; Scaglia, Fernando; Rosenfeld, Jill A.; Xiao, Rui; Yang, Yaping; Posey, Jennifer E.; Lupski, James R.; Wangler, Michael F.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Meng, Linyan; Xiao, Rui; Yang, Yaping] Baylor Genet, Houston, TX 77021 USA; [Szelinger, Szabolcs; Nelson, Stanley F.; Lee, Hane] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Bearden, David R.] Univ Rochester, Sch Med, Div Child Neurol, Dept Neurol, Rochester, NY 14627 USA; [Stray-Pedersen, Asbjorg; Posey, Jennifer E.; Lupski, James R.; Wangler, Michael F.] Baylor Coll Med, Baylor Hopkins Ctr Mendelian Genom, Dept Mol & Human Genet, Houston, TX 77030 USA; [Stray-Pedersen, Asbjorg; Akdemir, Zeynep Coban] Oslo Univ Hosp, Norwegian Natl Unit Newborn Screening, N-0424 Oslo, Norway; [Busk, Oyvind L.] Telemark Hosp, Med Genet Sect, Dept Lab Med, N-3710 Skien, Norway; [Stong, Nicholas; Goldstein, David B.] Columbia Univ, Inst Genom Med, New York, NY 10032 USA; [Liston, Eriskay; Cohn, Ronald D.] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Cohn, Ronald D.; Friedman, Jeremy N.] Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Tarpinian, Jennifer; Skraban, Cara M.; Deardorff, Matthew A.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Skraban, Cara M.; Deardorff, Matthew A.] Childrens Hosp Philadelphia, Roberts Individualized Med Genet Ctr, Philadelphia, PA 19104 USA; [Skraban, Cara M.; Deardorff, Matthew A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mikati, Mohamad A.; Jasien, Joan; Kansagra, Sujay] Duke Hlth, Div Pediat Neurol, Dept Pediat, Durham, NC 27710 USA; [Kranz, Peter G.] Duke Hlth, Dept Radiol, Div Neuroradiol, Durham, NC 27710 USA; [Wechsler, Stephanie Burns] Duke Hlth, Dept Pediat, Div Cardiol, Durham, NC 27710 USA; [Freemark, Michael] Duke Hlth, Dept Pediat, Div Pediat Endocrinol & Diabet, Durham, NC 27710 USA; [Freedman, Sharon] Duke Hlth, Duke Eye Ctr, Durham, NC 27710 USA; [Bali, Deeksha] Duke Hlth, Dept Pathol, Durham, NC 27710 USA; [Millan, Francisca; Bale, Sherri] GeneDx, Gaithersburg, MD 20877 USA; [Lee, Hane; Dorrani, Naghmeh; Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Clin Genom Ctr, Los Angeles, CA 90095 USA; [Nelson, Stanley F.; Dorrani, Naghmeh; Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Scaglia, Fernando; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Wangler, Michael F.] Texas Childrens Hosp, Jan & Dan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Rochester; Baylor College of Medicine; University of Oslo; Telemark Hospital Trust; Columbia University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Duke University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Shashi, V (corresponding author), Duke Hlth, Div Med Genet, Dept Pediat, Durham, NC 27710 USA.; Wangler, MF (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Wangler, MF (corresponding author), Baylor Coll Med, Baylor Hopkins Ctr Mendelian Genom, Dept Mol & Human Genet, Houston, TX 77030 USA.; Wangler, MF (corresponding author), Texas Childrens Hosp, Jan & Dan Neurol Res Inst, Houston, TX 77030 USA.	michael.wangler@bcm.edu; vandana.shashi@duke.edu	Posey, Jennifer E./J-3048-2019; Nelson, Stanley F/D-4771-2009; Stong, Nicholas/ABB-7516-2021; Cohn, Ronald/AAC-5835-2021; Yamamoto, Shinya/ABB-2837-2021; Martinez-Agosto, Julian A/I-9435-2019; Kranz, Peter G/B-2471-2016; Wangler, Michael/H-6368-2019; Goldstein, David/AAY-8125-2020	Posey, Jennifer E./0000-0003-4814-6765; Nelson, Stanley F/0000-0002-2082-3114; Yamamoto, Shinya/0000-0003-2172-8036; Martinez-Agosto, Julian A/0000-0001-6776-6949; Kranz, Peter G/0000-0001-5410-7135; Wangler, Michael/0000-0001-5245-5910; Brown, Donna/0000-0002-8805-7225; Sweetser, David/0000-0002-1621-3284; Hackbarth, Mary/0000-0003-1325-3165; Mikati, Mohamad/0000-0003-0363-8715; Holm, Ingrid/0000-0003-4712-8821; Stong, Nicholas/0000-0002-0678-637X; Stray-Pedersen, Asbjorg/0000-0002-9168-0878; Haendel, Melissa/0000-0001-9114-8737; Allard, Patrick/0000-0001-7765-1547	Duke Undiagnosed Diseases Network [1U01HG007672-03]; Simons Foundation Functional Screen [368479]; National Heart Lung and Blood Institute [UM1 HG006542]; Common Fund [U54NS093793]; March of Dimes [6-FY12-324]; UCLA Children's Discovery Institute, UCLA CART (NIH/NICHD) [P50-HD-055784]; NIH/NCATS UCLA CTSI [UL1TR000124]; Ting Tsung and Wei Fong Chao Foundation; National Human Genome Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542, U01HG007672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS093793] Funding Source: NIH RePORTER	Duke Undiagnosed Diseases Network; Simons Foundation Functional Screen; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Common Fund; March of Dimes(March of Dimes); UCLA Children's Discovery Institute, UCLA CART (NIH/NICHD); NIH/NCATS UCLA CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Ting Tsung and Wei Fong Chao Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the individuals and their families who contributed to this study and allowed us to publish their information and pictures. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular testing offered at the Baylor Genetics Laboratories. D.B.G. has received consultancy fees and has equity ownership in Pairnomix, LLC. S.B. is the founder and F.M. is an employee of GeneDx. J.R.L. has stock ownership in 23 and Me, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, Inc., and is a co inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting.This work was supported by Duke Undiagnosed Diseases Network (1U01HG007672-03 to V.S. and D.B.G.), Simons Foundation Functional Screen (368479 to M.F.W.), the National Human Genome Research Institute and National Heart Lung and Blood Institute (UM1 HG006542 to J.R.L.), Common Fund (U54NS093793 to M.F.W. and others), March of Dimes (grant# 6-FY12-324 to J.A.M.-A.), UCLA Children's Discovery Institute, UCLA CART (NIH/NICHD grant# P50-HD-055784 to J.A.M.-A.), NIH/NCATS UCLA CTSI (grant# UL1TR000124 to J.A.M.-A.), and Ting Tsung and Wei Fong Chao Foundation (to J.E.P.).	Acuna-Hidalgo R, 2015, AM J HUM GENET, V97, P67, DOI 10.1016/j.ajhg.2015.05.008; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Blanchard MG, 2015, J MED GENET, V52, P330, DOI 10.1136/jmedgenet-2014-102813; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Cooper David N, 2010, Hum Genomics, V4, P406; de Ligt J, 2013, CURR OPIN GENET DEV, V23, P257, DOI 10.1016/j.gde.2013.01.007; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Freed D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006245; Gauthier J, 2012, GENOME MED, V4, DOI 10.1186/gm372; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Hernandez-Porras I, 2016, J PATHOL, V239, P206, DOI 10.1002/path.4719; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Ishibashi M, 2009, CLIN CANCER RES, V15, P804, DOI 10.1158/1078-0432.CCR-08-2134; Ishikawa M, 2010, INT J ONCOL, V36, P1097, DOI 10.3892/ijo_00000591; Jorge R, 2015, AM J MED GENET A, V167, P2839, DOI 10.1002/ajmg.a.37280; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Korutla L, 2005, J NEUROCHEM, V94, P786, DOI 10.1111/j.1471-4159.2005.03206.x; Korutla L, 2014, NEUROSCIENCE, V257, P86, DOI 10.1016/j.neuroscience.2013.11.001; Korutla L, 2009, NEUROCHEM INT, V54, P245, DOI 10.1016/j.neuint.2008.12.008; Krkljus S, 1998, Hum Mutat, V11, P411, DOI 10.1002/(SICI)1098-1004(1998)11:5<411::AID-HUMU11>3.3.CO;2-U; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Nakayama K, 2006, P NATL ACAD SCI USA, V103, P18739, DOI 10.1073/pnas.0604083103; Nakayama K, 2010, GYNECOL ONCOL, V119, P469, DOI 10.1016/j.ygyno.2010.08.031; Nimmakayalu M, 2013, AM J MED GENET A, V161A, P1105, DOI 10.1002/ajmg.a.35790; Ohba C, 2015, EPILEPSIA, V56, pE121, DOI 10.1111/epi.13072; Petrovski S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005492; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Scofield MD, 2012, NEUROSCIENCE, V227, P44, DOI 10.1016/j.neuroscience.2012.09.043; Shashi V, 2016, AM J HUM GENET, V99, P991, DOI 10.1016/j.ajhg.2016.08.017; Shih IM, 2011, MODERN PATHOL, V24, P638, DOI 10.1038/modpathol.2010.230; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stevenson DA, 2016, AM J MED GENET A, V170, P1959, DOI 10.1002/ajmg.a.37723; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; White J, 2016, GENOME MED, V8, DOI 10.1186/s13073-015-0253-0; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yap KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069099; Yap KL, 2012, CANCER RES, V72, P4085, DOI 10.1158/0008-5472.CAN-12-0302; Yeasmin S, 2012, HUM PATHOL, V43, P506, DOI 10.1016/j.humpath.2011.05.021	46	24	25	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					343	351		10.1016/j.ajhg.2016.12.013	http://dx.doi.org/10.1016/j.ajhg.2016.12.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28132692	Green Published, Bronze			2022-12-18	WOS:000393352000014
J	Johnston, IG; Jones, NS				Johnston, Iain G.; Jones, Nick S.			Evolution of Cell-to-Cell Variability in Stochastic, Controlled, Heteroplasmic mtDNA Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RANDOM GENETIC DRIFT; MITOCHONDRIAL-DNA; RAPID SEGREGATION; GERM-CELLS; REPLICATION; EXPRESSION; GENOMES; MODEL; REDUCTION; NETWORKS	Populations of physiologically vital mitochondrial DNA (mtDNA) molecules evolve in cells under control from the nucleus. The evolution of populations of mixed mtDNA types is complicated and poorly understood, and variability of these controlled admixtures plays a central role in the inheritance and onset of genetic disease. Here, we develop a mathematical theory describing the evolution of, and variability in, these stochastic populations for any type of cellular control, showing that cell-to-cell variability in mtDNA and mutant load inevitably increases with time, according to rates that we derive and which are notably independent of the mechanistic details of feedback signaling. We show with a set of experimental case studies that this theory explains disparate quantitative results from classical and modem experimental and computational research on heteroplasmy variance in different species. We demonstrate that our general model provides a host of specific insights, including a modification of the often-used but hard-to-interpret Wright formula to correspond directly to biological observables, the ability to quantify selective and mutational pressure in mtDNA populations, and characterization of the pronounced variability inevitably arising from the action of possible mtDNA quality-control mechanisms. Our general theoretical framework, supported by existing experimental results, thus helps us to understand and predict the evolution of stochastic mtDNA populations in cell biology.	[Johnston, Iain G.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Jones, Nick S.] Imperial Coll London, Dept Math, London SW7 2BB, England	University of Birmingham; Imperial College London	Johnston, IG (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	i.johnston.1@bham.ac.uk		Johnston, Iain/0000-0001-8559-3519	EPSRC [EP/N014529/1] Funding Source: UKRI; MRC [MR/J013617/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/N014529/1] Funding Source: researchfish; Medical Research Council [MR/J013617/1] Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2012, INTRO STOCHASTIC CON; Assaf M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021116; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Borkar VS, 2005, PROBAB SURV, V2, P213, DOI 10.1214/154957805100000131; Burgstaller JP, 2015, MOL HUM REPROD, V21, P11, DOI 10.1093/molehr/gau090; Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Diot A, 2015, PHARMACOL RES, V100, P24, DOI 10.1016/j.phrs.2015.07.014; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Figge MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002576; Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Jajoo R, 2016, SCIENCE, V351, P169, DOI 10.1126/science.aaa8714; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Johnston IG, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2015.0050; Johnston IG, 2015, ELIFE, V4, DOI 10.7554/eLife.07464; Johnston IG, 2014, BIOPHYS J, V107, P2612, DOI 10.1016/j.bpj.2014.08.040; Johnston IG, 2014, STAT APPL GENET MOL, V13, P379, DOI 10.1515/sagmb-2013-0061; Johnston IG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002416; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KIMURA M, 1955, P NATL ACAD SCI USA, V41, P144, DOI 10.1073/pnas.41.3.144; Kopsidas G, 2000, ANN NY ACAD SCI, V908, P226; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lygeros J, 2008, P NATL ACAD SCI USA, V105, P12295, DOI 10.1073/pnas.0805549105; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Poovathingal SK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000572; Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; SOLIGNAC M, 1987, GENETICS, V117, P687; St John J, 2014, BBA-GEN SUBJECTS, V1840, P1345, DOI 10.1016/j.bbagen.2013.10.036; van Kampen N.G., 1992, STOCHASTIC PROCESSES; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007; Wonnapinij P, 2010, AM J HUM GENET, V86, P540, DOI 10.1016/j.ajhg.2010.02.023; Wright S., 1942, Bull Amer Math Soc, V48, P223, DOI 10.1090/S0002-9904-1942-07641-5	44	24	24	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1150	1162		10.1016/j.ajhg.2016.09.016	http://dx.doi.org/10.1016/j.ajhg.2016.09.016			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27843124	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000387529600012
J	Nieuwboer, HA; Pool, R; Dolan, CV; Boomsma, DI; Nivard, MG				Nieuwboer, Harold A.; Pool, Rene; Dolan, Conor V.; Boomsma, Dorret I.; Nivard, Michel G.			GWIS: Genome-Wide Inferred Statistics for Functions of Multiple Phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCI	Here we present a method of genome-wide inferred study (GWIS) that provides an approximation of genome-wide association study (GWAS) summary statistics for a variable that is a function of phenotypes for which GWAS summary statistics, phenotypic means, and covariances are available. A GWIS can be performed regardless of sample overlap between the GWAS of the phenotypes on which the function depends. Because a GWIS provides association estimates and their standard errors for each SNP, a GWIS can form the basis for polygenic risk scoring, LD score regression, Mendelian randomization studies, biological annotation, and other analyses. GWISs can also be used to boost power of a GWAS meta-analysis where cohorts have not measured all constituent phenotypes in the function. We demonstrate the accuracy of a BMI GWIS by performing power simulations and type I error simulations under varying circumstances, and we apply a GWIS by reconstructing a body mass index (BMI) GWAS based on a weight GWAS and a height GWAS. Furthermore, we apply a GWIS to further our understanding of the underlying genetic structure of bipolar disorder and schizophrenia and their relation to educational attainment. Our analyses suggest that the previously reported genetic correlation between schizophrenia and educational attainment is probably induced by the observed genetic correlation between schizophrenia and bipolar disorder and the previously reported genetic correlation between bipolar disorder and educational attainment.	[Nieuwboer, Harold A.; Pool, Rene; Dolan, Conor V.; Boomsma, Dorret I.; Nivard, Michel G.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Nivard, MG (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands.	m.g.nivard@vu.nl	Boomsma, Dorret I/AAX-4470-2020; Pool, René/AFO-8147-2022	Pool, René/0000-0001-5579-0933; Nivard, Michel/0000-0003-2015-1888; Nieuwboer, Harold/0000-0003-3627-3636	Royal Netherlands Academy of Science Professor Award [PAH/6635]; BBMRI-NL, a research infrastructure - Netherlands Organization for Scientific Research (NWO) [184.021.007]	Royal Netherlands Academy of Science Professor Award; BBMRI-NL, a research infrastructure - Netherlands Organization for Scientific Research (NWO)	M.G.N. is supported by Royal Netherlands Academy of Science Professor Award (PAH/6635) to D.I.B. and is funded by the BBMRI-NL, a research infrastructure financed by the Netherlands Organization for Scientific Research (NWO project 184.021.007). H.A.N. is a University Research Fellow (URF) of the VU University Amsterdam.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bulik-Sullivan B., GIANT CONSORTIUM DAT; Finn J.D., 1974, GEN MODEL MULTIVARIA; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Greene W, 2018, ECONOMETRIC ANAL, V8th; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; Vink JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047371; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071	16	24	25	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					917	927		10.1016/j.ajhg.2016.07.020	http://dx.doi.org/10.1016/j.ajhg.2016.07.020			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27616482	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000385333700012
J	Angius, A; Uva, P; Buers, I; Oppo, M; Puddu, A; Onano, S; Persico, I; Loi, A; Marcia, L; Hohne, W; Cuccuru, G; Fotia, G; Deiana, M; Marongiu, M; Atalay, HT; Inan, S; El Assy, O; Smit, LME; Okur, I; Boduroglu, K; Utine, GE; Kilic, E; Zampino, G; Crisponi, G; Crisponi, L; Rutsch, F				Angius, Andrea; Uva, Paolo; Buers, Insa; Oppo, Manuela; Puddu, Alessandro; Onano, Stefano; Persico, Ivana; Loi, Angela; Marcia, Loredana; Hoehne, Wolfgang; Cuccuru, Gianmauro; Fotia, Giorgio; Deiana, Manila; Marongiu, Mara; Atalay, Hatice Tuba; Inan, Sibel; El Assy, Osama; Smit, Leo M. E.; Okur, Ilyas; Boduroglu, Koray; Utine, Gulen Eda; Kilic, Esra; Zampino, Giuseppe; Crisponi, Giangiorgio; Crisponi, Laura; Rutsch, Frank			Bi-allelic Mutations in KLHL7 Cause a Crisponi/CISS1-like Phenotype Associated with Early-Onset Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BTB-KELCH PROTEIN; FRAMEWORK; CRLF1; DIFFERENTIATION; CRISPONI; FACTOR-1	Crisponi syndrome (CS)/cold-induced sweating syndrome type 1 (CISS1) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood. CS/CISS1 can be caused by mutations in cytokine receptor-like factor 1 (CRLF1). However, the physiopathological role of CRLF1 is still poorly understood. A subset of CS/CISS1 cases remain yet genetically unexplained after CRLF1 sequencing. In five of them, exome sequencing and targeted Sanger sequencing identified four homozygous disease-causing mutations in kelch-like family member 7 (KLHL7), affecting the Kelch domains of the protein. KLHL7 encodes a BTB-Kelch-related protein involved in the ubiquitination of target proteins for proteasome-mediated degradation. Mono-allelic substitutions in other domains of KLHL7 have been reported in three families affected by a late-onset form of autosomal-dominant retinitis pigmentosa. Retinitis pigmentosa was also present in two surviving children reported here carrying bi-allelic KLHL7 mutations. KLHL7 mutations are thus associated with a more severe phenotype in recessive than in dominant cases. Although these data further support the pathogenic role of KLHL7 mutations in a CS/CISS1-like phenotype, they do not explain all their clinical manifestations and highlight the high phenotypic heterogeneity associated with mutations in KLHL7.	[Angius, Andrea; Oppo, Manuela; Puddu, Alessandro; Onano, Stefano; Persico, Ivana; Loi, Angela; Marcia, Loredana; Deiana, Manila; Marongiu, Mara; Crisponi, Laura] CNR, Ist Ric Genet & Biomed, I-09042 Cagliari, Italy; [Uva, Paolo; Cuccuru, Gianmauro; Fotia, Giorgio] Ctr Adv Studies Res & Dev Sardinia CRS4, Sci & Technol Pk Polaris, I-09010 Pula, Italy; [Buers, Insa; Rutsch, Frank] Munster Univ Childrens Hosp, Dept Gen Pediat, D-48149 Munster, Germany; [Oppo, Manuela; Onano, Stefano; Marcia, Loredana] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Hoehne, Wolfgang] Univ Cologne, CCG, D-50931 Cologne, Germany; [Atalay, Hatice Tuba] Gazi Univ, Dept Ophthalmol, Sch Med, TR-06560 Ankara, Turkey; [Inan, Sibel] Afyon Kocatepe Univ, Opthalmol Dept, TR-03200 Afyon, Turkey; [El Assy, Osama] Dibba Hosp, Pediat Dept SCBU, Dibba Al Fujaira 11414, U Arab Emirates; [Smit, Leo M. E.] Haga Ziekenhuis Den Haag, Dept Neurol, Leyweg 275, NL-2545 CH The Hague, Netherlands; [Okur, Ilyas] Gazi Univ, Dept Pediat Nutr & Metab, Sch Med, TR-06500 Ankara, Turkey; [Boduroglu, Koray; Utine, Gulen Eda] Hacettepe Univ, Div Pediat Genet, Dept Pediat, Fac Med, TR-06100 Ankara, Turkey; [Kilic, Esra] Pediat Hematol Oncol Res Training Hosp, Pediat Genet, TR-06110 Ankara, Turkey; [Zampino, Giuseppe] Univ Cattolica S Cuore, Ist Pediat, Policlin A Gemelli, I-00168 Rome, Italy; [Crisponi, Giangiorgio] Clin St Anna, I-09127 Cagliari, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Munster; University of Sassari; University of Cologne; Gazi University; Afyon Kocatepe University; Haga Hospital; Gazi University; Hacettepe University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Crisponi, L (corresponding author), CNR, Ist Ric Genet & Biomed, I-09042 Cagliari, Italy.	laura.crisponi@irgb.cnr.it	Okur, Ilyas/AAM-2081-2021; Persico, Ivana/AAX-7255-2020; Angius, Andrea/P-9549-2015; BODUROGLU, KORAY O/I-9094-2013; Kılıç, Esra/AFR-3024-2022; Atalay, Hatice Tuba/AAB-1605-2020; Inan, sibel/AAB-7691-2021; Crisponi, Laura/AAC-2642-2019; Uva, Paolo/A-2877-2011; Zampino, Giuseppe/AAC-2152-2019; Marongiu, Mara/H-9437-2019	Okur, Ilyas/0000-0002-8772-0689; Persico, Ivana/0000-0001-9946-1509; Angius, Andrea/0000-0003-2596-6461; Kılıç, Esra/0000-0003-0522-1809; Atalay, Hatice Tuba/0000-0002-1847-615X; Crisponi, Laura/0000-0001-9128-8537; Uva, Paolo/0000-0002-9524-8492; Marongiu, Mara/0000-0002-7321-2384; Onano, Stefano/0000-0002-8478-5137; cuccuru, gianmauro/0000-0002-5335-545X; Boduroglu, Koray/0000-0001-6260-1942	TELETHON exploratory grant [GEP13093]; Associazione Sindrome di Crisponi e Malattie Rare, Italy; Innovative Medical Research, Munster, Germany	TELETHON exploratory grant(Fondazione Telethon); Associazione Sindrome di Crisponi e Malattie Rare, Italy; Innovative Medical Research, Munster, Germany	We are grateful to all family members for their participation to the study and to their treating physicians. In particular we thank the following physicians who supplied DNA material and clinical information from individuals with CS/CISS1-like phenotype: Margot Van Allen, Jaime Campos Castello, Francesco Muntoni, Goran Anneren, Fernando Santos, Mohnish Suri, Davide Firinu, Peter Toth-Heyn, Rosario Casalone, Giuseppina Timpani, Maria Teresa Sinelli, Charu Deshpande, Robert Robinson, Adnan Manzur, Arnaud Isapof, Nelida Montano, J. Van Harssel, Livia Garavelli, Paolo Villani, Cigdem Seher Kasapkara, and Irina Snoeck. We thank Prof. Francesco Cucca, director of IRGB-CNR, for his continuous encouragement and support to the study. We are thankful to the CRS4 HPC group for IT support. We thank Prof. Tomoki Chiba, University of Tsukuba, Japan, for kindly providing the HA-CUL3 plasmid used in this study. In particular, we would like to acknowledge the Associazione Sindrome di Crisponi e Malattie Rare for its constant support, encouragement, and active participation both with us and the involved families. This work was supported by TELETHON exploratory grant GEP13093 to L.C., by a grant from the Associazione Sindrome di Crisponi e Malattie Rare, Italy, to L.C., and by a grant from Innovative Medical Research, Munster, Germany, to I.B. and F.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bredholt G, 2006, SCAND J IMMUNOL, V64, P325, DOI 10.1111/j.1365-3083.2006.01821.x; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Crisponi L, 2007, AM J HUM GENET, V80, P971, DOI 10.1086/516843; Cuccuru G, 2014, BIOINFORMATICS, V30, P1928, DOI 10.1093/bioinformatics/btu135; Dagoneau N, 2007, AM J HUM GENET, V80, P966, DOI 10.1086/513608; Di Rocco M, 2003, AM J MED GENET A, V118A, P362, DOI 10.1002/ajmg.a.10242; Elliott J, 2006, DEV BIOL, V300, P583, DOI 10.1016/j.ydbio.2006.09.002; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; Forger NG, 2003, J NEUROSCI, V23, P8854; Friedman JS, 2009, AM J HUM GENET, V84, P792, DOI 10.1016/j.ajhg.2009.05.007; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hugosson T, 2010, ARCH OPHTHALMOL-CHIC, V128, P772, DOI 10.1001/archophthalmol.2010.98; Injarie AM, 2012, CORNEA, V31, P269, DOI 10.1097/ICO.0b013e3182182089; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Magi A, 2014, BIOINFORMATICS, V30, P2852, DOI 10.1093/bioinformatics/btu401; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ozawa S, 2009, RETINA-J RET VIT DIS, V29, P793, DOI 10.1097/IAE.0b013e3181a3b7d9; Palejwala Neal V, 2015, Retin Cases Brief Rep, V9, P245, DOI 10.1097/ICB.0000000000000150; Piras R, 2014, HUM MUTAT, V35, P424, DOI 10.1002/humu.22522; Rhee KD, 2004, J NEUROSCI, V24, P9779, DOI 10.1523/JNEUROSCI.1785-04.2004; Van der Auwera GA, 2002, CURRENT PROTOCOLS BI; Wen YQ, 2011, EXP EYE RES, V92, P202, DOI 10.1016/j.exer.2010.12.014; Zhang SSM, 2004, INVEST OPHTH VIS SCI, V45, P2407, DOI 10.1167/iovs.04-0003	27	24	24	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					236	245		10.1016/j.ajhg.2016.05.026	http://dx.doi.org/10.1016/j.ajhg.2016.05.026			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27392078	Bronze, Green Published			2022-12-18	WOS:000381616600021
J	Cho, SY; Bae, JS; Kim, NKD; Forzano, F; Girisha, KM; Baldo, C; Faravelli, F; Cho, TJ; Kim, D; Lee, KY; Ikegawa, S; Shim, JS; Ko, AR; Miyake, N; Nishimura, G; Superti-Furga, A; Spranger, J; Kim, OH; Park, WY; Jin, DK				Cho, Sung Yoon; Bae, Jun-Seok; Kim, Nayoung K. D.; Forzano, Francesca; Girisha, Katta Mohan; Baldo, Chiara; Faravelli, Francesca; Cho, Tae-Joon; Kim, Dongsup; Lee, Kyoung Yeul; Ikegawa, Shiro; Shim, Jong Sup; Ko, Ah-Ra; Miyake, Noriko; Nishimura, Gen; Superti-Furga, Andrea; Spranger, Juergen; Kim, Ok-Hwa; Park, Woong-Yang; Jin, Dong-Kyu			BGN Mutations in X-Linked Spondyloepimetaphyseal Dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; PROTEOGLYCANS BIGLYCAN; DISEASES; MICE; OSTEOPOROSIS; EXPRESSION; PATHWAYS; DECORIN; MODELS	Spondyloepimetaphyseal dysplasias (SEMDs) comprise a heterogeneous group of autosomal-dominant and autosomal-recessive disorders. An apparent X-linked recessive (XLR) form of SEMD in a single Italian family was previously reported. We have been able to restudy this family together with a second family from Korea by segregating a severe SEMD in an X-linked pattern. Exome sequencing showed missense mutations in BGN c.439A>G (p.Lys147Glu) in the Korean family and c.776G>T (p.Gly259Val) in the Italian family; the c.439A>G (p.Lys147Glu) mutation was also identified in a further simplex SEMD case from India. Biglycan is an extracellular matrix proteoglycan that can bind transforming growth factor beta (TGF-beta) and thus regulate its free concentration. In 3-dimensional simulation, both altered residues localized to the concave arc of leucine-rich repeat domains of biglycan that interact with TGF-beta. The observation of recurrent BGN mutations in XLR SEMD individuals from different ethnic backgrounds allows us to define "XLR SEMD, BGN type'' as a nosologic entity.	[Cho, Sung Yoon; Jin, Dong-Kyu] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul 06351, South Korea; [Bae, Jun-Seok; Kim, Nayoung K. D.; Park, Woong-Yang] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Samsung Genome Inst, Seoul 06351, South Korea; [Bae, Jun-Seok; Park, Woong-Yang] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Samsung Med Ctr, Dept Hlth Sci & Technol,Sch Med, Seoul 06351, South Korea; [Forzano, Francesca; Faravelli, Francesca] Galliera Hosp, Div Med Genet, Via Volta 6, I-16128 Genoa, Italy; [Girisha, Katta Mohan] Manipal Univ, Kasturba Med Coll, Dept Med Genet, Manipal 576104, Karnataka, India; [Baldo, Chiara] Galliera Hosp, Lab Human Genet, I-16128 Genoa, Italy; [Cho, Tae-Joon] Seoul Natl Univ, Childrens Hosp, Div Pediat Orthopaed, Seoul 03080, South Korea; [Kim, Dongsup; Lee, Kyoung Yeul] Korea Adv Inst Sci & Technol, Dept Syst Biol, Daejon 34141, South Korea; [Ikegawa, Shiro] RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Shim, Jong Sup] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Orthoped Surg, Seoul 06351, South Korea; [Ko, Ah-Ra] Samsung Biomed Res Ctr, Clin Res Ctr, Seoul 06351, South Korea; [Miyake, Noriko] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Fuchu, Tokyo 1838561, Japan; [Superti-Furga, Andrea] Univ Lausanne, CHUV, Dept Pediat, CH-1011 Lausanne, Switzerland; [Spranger, Juergen] Fuchsberg 14, D-76547 Sinzheim, Germany; [Kim, Ok-Hwa] Woorisoa Childrens Hosp, Dept Radiol, Seoul 08291, South Korea; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 16419, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Ente Ospedaliero Ospedali Galliera; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Ente Ospedaliero Ospedali Galliera; Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST); RIKEN; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Yokohama City University; Tokyo Metropolitan Children's Medical Center; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Sungkyunkwan University (SKKU)	Jin, DK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul 06351, South Korea.; Park, WY (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Samsung Genome Inst, Seoul 06351, South Korea.; Park, WY (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Samsung Med Ctr, Dept Hlth Sci & Technol,Sch Med, Seoul 06351, South Korea.; Park, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 16419, South Korea.	woongyang.park@samsung.com; jindk@skku.edu	Baldo, Chiara/AAB-1435-2020; Kim, Dongsup/C-1612-2011; superti-furga, andrea/E-9162-2015; KM, Girisha/AAK-6867-2020; Ikegawa, Shiro/N-6895-2015	Baldo, Chiara/0000-0001-7508-3953; superti-furga, andrea/0000-0002-3543-7531; KM, Girisha/0000-0002-0139-8239; Ikegawa, Shiro/0000-0003-0316-2147; Park, Woong-Yang/0000-0003-4234-0380; Cho, Tae-Joon/0000-0001-8514-377X	Samsung Medical Center [GFO1130061]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [Hl12C0014]; Network Telethon of Genetic Biobanks [GTB12001A]	Samsung Medical Center(Samsung); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Network Telethon of Genetic Biobanks	This study was supported by a grant from Samsung Medical Center (#GFO1130061 to D.-K.J.) and the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Hl12C0014 to W.-Y.P.). The Galliera Genetic Bank member of "Network Telethon of Genetic Biobanks" (project no. GTB12001A) and of EuroBioBank Network provided us with specimens. The authors express gratitude to the family members in the study, especially the Italian family who allowed their group photo to be included.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Bross P, 1999, HUM MUTAT, V14, P186, DOI 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J; CAMERA G, 1994, J MED GENET, V31, P371, DOI 10.1136/jmg.31.5.371; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hocking AM, 1998, MATRIX BIOL, V17, P1; Iacob S, 2010, CONNECT TISSUE RES, V51, P347, DOI 10.3109/03008200903427695; Wang XY, 2010, BIOL PHARM BULL, V33, P1891, DOI 10.1248/bpb.33.1891; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Young MF, 2002, GLYCOCONJUGATE J, V19, P257, DOI 10.1023/A:1025336114352	14	24	25	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1243	1248		10.1016/j.ajhg.2016.04.004	http://dx.doi.org/10.1016/j.ajhg.2016.04.004			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27236923	Green Published, Bronze			2022-12-18	WOS:000377286000018
J	Yang, LX; Lee, MS; Lu, HY; Oh, DY; Kim, YJ; Park, D; Park, G; Ren, XJ; Bristow, CA; Haseley, PS; Lee, S; Pantazi, A; Kucherlapati, R; Park, WY; Scott, KL; Choi, YL; Park, PJ				Yang, Lixing; Lee, Mi-Sook; Lu, Hengyu; Oh, Doo-Yi; Kim, Yeon Jeong; Park, Donghyun; Park, Gahee; Ren, Xiaojia; Bristow, Christopher A.; Haseley, Psalm S.; Lee, Soohyun; Pantazi, Angeliki; Kucherlapati, Raju; Park, Woong-Yang; Scott, Kenneth L.; Choi, Yoon-La; Park, Peter J.			Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TERT PROMOTER MUTATIONS; CHROMOSOMAL-ABERRATIONS; GENE FUSIONS; RET; IDENTIFICATION; LANDSCAPE; MECHANISMS; PATTERNS; RECEPTOR; REVEALS	Although exome sequencing data are generated primarily to detect single-nucleotide variants and indels, they can also be used to identify a subset of genomic rearrangements whose breakpoints are located in or near exons. Using >4,600 tumor and normal pairs across 15 cancer types, we identified over 9,000 high confidence somatic rearrangements, including a large number of gene fusions. We find that the 50 fusion partners of functional fusions are often housekeeping genes, whereas the 30 fusion partners are enriched in tyrosine kinases. We establish the oncogenic potential of ROR1-DNAJC6 and CEP85L-ROS1 fusions by showing that they can promote cell proliferation in vitro and tumor formation in vivo. Furthermore, we found that similar to 4% of the samples have massively rearranged chromosomes, many of which are associated with upregulation of oncogenes such as ERBB2 and TERT. Although the sensitivity of detecting structural alterations from exomes is considerably lower than that from whole genomes, this approach will be fruitful for the multitude of exomes that have been and will be generated, both in cancer and in other diseases.	[Yang, Lixing; Haseley, Psalm S.; Lee, Soohyun; Park, Peter J.] Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA; [Lee, Mi-Sook; Oh, Doo-Yi; Park, Woong-Yang; Choi, Yoon-La] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul 06351, South Korea; [Lu, Hengyu; Scott, Kenneth L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kim, Yeon Jeong; Park, Donghyun; Park, Gahee; Park, Woong-Yang] Samsung Med Ctr, Samsung Genome Inst, Seoul 06351, South Korea; [Kim, Yeon Jeong; Park, Donghyun] Samsung Elect Co, Samsung Adv Inst Technol, Samsung Biomed Res Inst, Seoul 06351, South Korea; [Ren, Xiaojia; Haseley, Psalm S.; Kucherlapati, Raju] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Bristow, Christopher A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Bristow, Christopher A.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Pantazi, Angeliki; Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Choi, Yoon-La] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul 06351, South Korea; [Park, Peter J.] Harvard Univ, Sch Med, Ludwig Ctr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Sungkyunkwan University (SKKU); Samsung Medical Center; Baylor College of Medicine; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Samsung Electronics; Harvard University; Brigham & Women's Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Sungkyunkwan University (SKKU); Samsung Medical Center; Harvard University; Harvard Medical School	Park, PJ (corresponding author), Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA.; Choi, YL (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul 06351, South Korea.; Choi, YL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul 06351, South Korea.; Park, PJ (corresponding author), Harvard Univ, Sch Med, Ludwig Ctr, Boston, MA 02115 USA.	ylachoi@skku.edu; peter_park@harvard.edu	Kucherlapati, Raju/ABC-8807-2021; Lu, Hengyu/AAV-9745-2021; Park, Donghyun/I-5849-2019	Lu, Hengyu/0000-0003-1093-9364; Park, Donghyun/0000-0002-7946-6924; Park, Gahee/0000-0002-9599-687X; Kim, Yeon Jeong/0000-0003-3297-9463; Lee, Soohyun/0000-0002-3594-6213; Park, Woong-Yang/0000-0003-4234-0380; Park, Peter/0000-0001-9378-960X	Harvard Ludwig Center; NIH [U24CA144025, U01CA168394]; National Research Foundation - Korean Ministry of Science, Information and Communications Technology & Future Planning [NRF-2013M3C8A1078501, NRF-2013R1A2A2A01068922, 2015R1C1A1A02037066]; Cancer Prevention and Research Institute of Texas [RP140102, RP120046]; NATIONAL CANCER INSTITUTE [U24CA144025, U01CA168394] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY024230] Funding Source: NIH RePORTER	Harvard Ludwig Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation - Korean Ministry of Science, Information and Communications Technology & Future Planning; Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The results published here are in whole or in part based upon data generated by The Cancer Genome Atlas (TCGA) project established by the National Cancer Institute and the National Human Genome Research Institute. Information about the TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov. This work was supported by the Harvard Ludwig Center (P.J.P.), NIH grant U24CA144025 (R.K. and P.J.P.), National Research Foundation grants NRF-2013M3C8A1078501, NRF-2013R1A2A2A01068922 (Y.L.C.) and 2015R1C1A1A02037066 (M.L.) funded by the Korean Ministry of Science, Information and Communications Technology & Future Planning, Cancer Prevention and Research Institute of Texas grants RP140102 (H.L.) and RP120046 (K.L.S), and NIH grant U01CA168394 (K.L.S). This work made use of the Bionimbus Protected Data Cloud.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; Chmielecki J, 2013, NAT GENET, V45, P131, DOI 10.1038/ng.2522; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Davies KD, 2013, CLIN CANCER RES, V19, P4040, DOI 10.1158/1078-0432.CCR-12-2851; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giacomini CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003464; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Grubbs EG, 2015, J CLIN ENDOCR METAB, V100, P788, DOI 10.1210/jc.2014-4153; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kim J., 2014, J ELECT MAT, V2014, P1, DOI DOI 10.1167/14.7.1.[; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Maher CA, 2012, CELL, V148, P29, DOI 10.1016/j.cell.2012.01.006; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Rozen S, 2000, Methods Mol Biol, V132, P365; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2013, NAT REV CANCER, V13, P772, DOI 10.1038/nrc3612; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; SOULE HD, 1990, CANCER RES, V50, P6075; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/NMETH.1628, 10.1038/nmeth.1628]; Wang K, 2010, NUCL ACIDS RES, V38; Wang L, 2012, GENE CHROMOSOME CANC, V51, P127, DOI 10.1002/gcc.20937; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; Weber A, 2003, CLIN CANCER RES, V9, P5683; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	57	24	24	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					843	856		10.1016/j.ajhg.2016.03.017	http://dx.doi.org/10.1016/j.ajhg.2016.03.017			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27153396	Green Published, Bronze			2022-12-18	WOS:000375869300004
J	Hua, X; Hyland, PL; Huang, J; Song, L; Zhu, B; Caporaso, NE; Landi, MT; Chatterjee, N; Shi, JX				Hua, Xing; Hyland, Paula L.; Huang, Jing; Song, Lei; Zhu, Bin; Caporaso, Neil E.; Landi, Maria Teresa; Chatterjee, Nilanjan; Shi, Jianxin			MEGSA: A Powerful and Flexible Framework for Analyzing Mutual Exclusivity of Tumor Mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATED DRIVER PATHWAYS; HUMAN P53 GENE; CANCER; EXPRESSION; DISCOVERY; HETEROGENEITY; REQUIREMENT; ARID1A; CELLS; SMRT	The central challenges in tumor sequencing studies is to identify driver genes and pathways, investigate their functional relationships, and nominate drug targets. The efficiency of these analyses, particularly for infrequently mutated genes, is compromised when subjects carry different combinations of driver mutations. Mutual exclusivity analysis helps address these challenges. To identify mutually exclusive gene sets (MEGS), we developed a powerful and flexible analytic framework based on a likelihood ratio test and a model selection procedure. Extensive simulations demonstrated that our method outperformed existing methods for both statistical power and the capability of identifying the exact MEGS, particularly for highly imbalanced MEGS. Our method can be used for de novo discovery, for pathway-guided searches, or for expanding established small MEGS. We applied out Method to the whole-exome sequencing data for 13 cancer types from The Cancer Genome Atlas (TCGA). We identified multiple previously unreported non-pairwise MEGS in multiple cancer types. For acute myeloid leukemia, we identified a MEGS with five genes (FLT3, IDH2, NRAS, KIT, and TP53) and a MEGS (NPM1, TP53, and RUNX1) whose mutation status was strongly associated with survival (p = 6.7 x 10(-4)). For breast cancer, we identified a significant MEGS consisting of TP53 and four infrequently mutated genes (ARID1A, AKT1, MED23, and TBL1XR1), providing support for their role as cancer drivers.	[Hua, Xing; Hyland, Paula L.; Song, Lei; Zhu, Bin; Caporaso, Neil E.; Landi, Maria Teresa; Chatterjee, Nilanjan; Shi, Jianxin] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Huang, Jing] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shi, JX (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	jianxin.shi@nih.gov	Song, Lei/F-6946-2018; ZHU, BIN/GLQ-8199-2022		National Cancer Institute Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIACP010181] Funding Source: NIH RePORTER	National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study utilized the computational resources of the NIH HPC Biowulf cluster. The authors are supported by the National Cancer Institute Intramural Research Program.	Adikesavan AK, 2014, MOL CELL BIOL, V34, P1246, DOI 10.1128/MCB.01216-13; Babur O., 2015, SYSTEMATIC IDENTIFIC, DOI [http://dx.doi.org/10.1101/009878, DOI 10.1101/009878]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chimge NO, 2013, ONCOGENE, V32, P2121, DOI 10.1038/onc.2012.328; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cohen AL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0345-4; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jiang Peng, 2013, J Carcinog, V12, P21, DOI 10.4103/1477-3163.122760; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0700-7; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Miller CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-34; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Oesper L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r80; Ozaki T, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/271347; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Peterson EJ, 2003, CANCER RES, V63, P6579; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Saldana-Meyer R, 2014, GENE DEV, V28, P723, DOI 10.1101/gad.236869.113; Samartzis EP, 2014, ONCOTARGET, V5, P5295, DOI 10.18632/oncotarget.2092; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Smolkova Katarina, 2012, Int J Cell Biol, V2012, P273947, DOI 10.1155/2012/273947; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Soto-Reyes E, 2010, ONCOGENE, V29, P2217, DOI 10.1038/onc.2009.509; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Szczurek E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003503; van Lith SAM, 2014, BBA-REV CANCER, V1846, P66, DOI 10.1016/j.bbcan.2014.04.004; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yang X, 2012, P NATL ACAD SCI USA, V109, pE2813, DOI 10.1073/pnas.1204311109; Zhao JF, 2012, BIOINFORMATICS, V28, P2940, DOI 10.1093/bioinformatics/bts564	47	24	24	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					442	455		10.1016/j.ajhg.2015.12.021	http://dx.doi.org/10.1016/j.ajhg.2015.12.021			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26899600	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000372383100009
J	Kasher, PR; Schertz, KE; Thomas, M; Jackson, A; Annunziata, S; Ballesta-Martinez, MJ; Campeau, PM; Clayton, PE; Eaton, JL; Granata, T; Guillen-Navarro, E; Hernando, C; Laverriere, CE; Lieden, A; Villa-Marcos, O; McEntagart, M; Nordgren, A; Pantaleoni, C; Pebrel-Richard, C; Sarret, C; Sciacca, FL; Wright, R; Kerr, B; Glasgow, E; Banka, S				Kasher, Paul R.; Schertz, Katherine E.; Thomas, Megan; Jackson, Adam; Annunziata, Silvia; Ballesta-Martinez, Maria J.; Campeau, Philippe M.; Clayton, Peter E.; Eaton, Jennifer L.; Granata, Tiziana; Guillen-Navarro, Encarna; Hernando, Cristina; Laverriere, Caroline E.; Lieden, Agne; Villa-Marcos, Olaya; McEntagart, Meriel; Nordgren, Ann; Pantaleoni, Chiara; Pebrel-Richard, Celine; Sarret, Catherine; Sciacca, Francesca L.; Wright, Ronnie; Kerr, Bronwyn; Glasgow, Eric; Banka, Siddharth			Small 6q16.1 Deletions Encompassing POU3F2 Cause Susceptibility to Obesity and Variable Developmental Delay with Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ISOTOCIN CELL-DEVELOPMENT; NEUROTROPHIC FACTOR; FACTOR BRN-2; SIM1 GENE; ZEBRAFISH; HYPOTHALAMUS; BRAIN; BHLH; SINGLE-MINDED-1; ORTHOPEDIA	Genetic studies of intellectual disability and identification of monogenic causes of obesity in humans have made immense contribution toward the understanding of the brain and control of body mass. The leptin > melanocortin > SIM1 pathway is dysregulated in multiple monogenic human obesity syndromes but its downstream targets are still unknown. In ten individuals from six families, with overlapping 6q16.1 deletions, we describe a disorder of variable developmental delay, intellectual disability, and susceptibility to obesity and hyperphagia. The 6q16.1 deletions segregated with the phenotype in multiplex families and were shown to be de novo in four families, and there was dramatic phenotypic overlap among affected individuals who were independently ascertained without bias from clinical features. Analysis of the deletions revealed a similar to 350 kb critical region on chromosome 6q16.1 that encompasses a gene for proneuronal transcription factor POU3F2, which is important for hypothalamic development and function. Using morpholino and mutant zebrafish models, we show that POU3F2 lies downstreamof SIM1 and controls oxytocin expression in the hypothalamic neuroendocrine preoptic area. We show that this finding is consistent with the expression patterns of POU3F2 and related genes in the human brain. Our work helps to further delineate the neuro-endocrine control of energy balance/body mass and demonstrates that this molecular pathway is conserved across multiple species.	[Kasher, Paul R.; Kerr, Bronwyn; Banka, Siddharth] Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Schertz, Katherine E.; Laverriere, Caroline E.; Glasgow, Eric] Georgetown Univ, Dept Oncol, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Thomas, Megan; Jackson, Adam] Blackpool Teaching Hosp, Child Hlth Directorate, Blackpool FY3 8NR, England; [Thomas, Megan] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YW, England; [Annunziata, Silvia; Granata, Tiziana; Pantaleoni, Chiara; Sciacca, Francesca L.] Fdn IRCCS Ist Neurol C Besta, I-20133 Milan, Italy; [Ballesta-Martinez, Maria J.; Guillen-Navarro, Encarna] UCAM, Secc Genet Med, Hosp Clin Univ Virgen de la Arrixaca, IMIB Arrixaca,Catedra Genet, Murcia 30120, Spain; [Campeau, Philippe M.] Univ Montreal, Dept Paediat, Montreal, PQ H3T 1J4, Canada; [Clayton, Peter E.] Univ Manchester, Ctr Paediat & Child Hlth, Inst Human Dev, Manchester M13 9WL, Lancs, England; [Eaton, Jennifer L.] Summa Hlth Syst, Akron, OH 44304 USA; [Hernando, Cristina; Villa-Marcos, Olaya] Quantitat Genom Med Labs qGenom, Barcelona 08950, Spain; [Lieden, Agne; McEntagart, Meriel] St Georges Univ Hosp NHS Fdn Trust, Med Genet, London SW17 0QT, England; [Nordgren, Ann] Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Pebrel-Richard, Celine] CHU Estaing, Cytogenet Med, F-63003 Clermont Ferrand, France; [Sarret, Catherine] CHU Clermont Ferrand, Hop Estaing, Genet Med, F-63000 Clermont Ferrand, France; [Wright, Ronnie; Kerr, Bronwyn; Banka, Siddharth] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England	University of Manchester; Georgetown University; Lancaster University; IRCCS Istituto Neurologico Besta; Hospital Clinico Universitario Virgen de la Arrixaca; Universidad Catolica de Murcia; Universite de Montreal; University of Manchester; Summa Health System; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; CHU Clermont Ferrand; CHU Clermont Ferrand; University of Manchester	Banka, S (corresponding author), Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England.; Banka, S (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England.	siddharth.banka@manchester.ac.uk	Thomas, Megan/GWQ-4391-2022; Nordgren, Ann C/N-4057-2013; pantaleoni, chiara/K-4492-2016; Hernando, Cristina/AAA-6837-2019; Hernando, Cristina/GNM-8667-2022; Campeau, Philippe/J-8614-2015; Granata, Tiziana/J-9012-2016; Sciacca, Francesca/AAL-8917-2021; Annunziata, Silvia/AAB-2452-2019; Nordgren, Ann/AAQ-9142-2021; Guillén Navarro, Encarna/AFU-6717-2022	Nordgren, Ann C/0000-0003-3285-4281; pantaleoni, chiara/0000-0003-4417-1672; Hernando, Cristina/0000-0002-5811-134X; Campeau, Philippe/0000-0001-9713-7107; Granata, Tiziana/0000-0002-0170-6836; Sciacca, Francesca/0000-0002-7411-4567; Annunziata, Silvia/0000-0002-0213-9810; Nordgren, Ann/0000-0003-3285-4281; Guillén Navarro, Encarna/0000-0002-2915-7381; Clayton, Peter/0000-0003-1225-4537; Jackson, Adam/0000-0002-3674-3960; Ballesta Martinez, Maria Juliana/0000-0001-8479-1388; Banka, Siddharth/0000-0002-8527-2210; Kasher, Paul/0000-0002-9213-502X; Glasgow, Eric/0000-0001-7729-3954	Manchester Biomedical Research Centre; Frimurare Barnhuset i Stockholm; Swedish Brain Foundation (Hjarnfonden); Karolinska Institutet research funds; NIH/NCI [CA51008]; Canadian Institutes of Health Research [RN315908, RN324373]; Fonds de recherche du Quebec en Sante [FRQS 30647]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Frimurare Barnhuset i Stockholm; Swedish Brain Foundation (Hjarnfonden); Karolinska Institutet research funds; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the support of Manchester Biomedical Research Centre, Frimurare Barnhuset i Stockholm, The Swedish Brain Foundation (Hjarnfonden), and the Karolinska Institutet research funds. Zebrafish work was supported in part by NIH/NCI grant CA51008. P.M.C. is funded in part by the Canadian Institutes of Health Research (RN315908 and RN324373) and the Fonds de recherche du Quebec en Sante (FRQS 30647). We thank Kit Albaugh for technical assistance with the zebrafish experiments. We thank Karen Marks for assistance with microarray analysis. We thank Yanick J. Crow for providing consumables and equipment for some genetic and zebrafish experiments that are not presented here. We thank Caroline Wright and Rosemary Kelsell from the Sanger Institute for their help in providing the data from the DDD study. We thank the families for taking part in the study and agreeing to publication.	Antonarakis SE, 2006, NAT REV GENET, V7, P277, DOI 10.1038/nrg1826; Banka S, 2015, ANN RHEUM DIS, V74, P1249, DOI 10.1136/annrheumdis-2013-204309; Bonnefond A, 2013, J CLIN INVEST, V123, P3037, DOI 10.1172/JCI68035; Carter CS, 2014, ANNU REV PSYCHOL, V65, P17, DOI 10.1146/annurev-psych-010213-115110; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Dominguez MH, 2013, CEREB CORTEX, V23, P2632, DOI 10.1093/cercor/bhs252; Duplan SM, 2009, EUR J NEUROSCI, V30, P2239, DOI 10.1111/j.1460-9568.2009.07028.x; Eaton JL, 2008, DEV DYNAM, V237, P995, DOI 10.1002/dvdy.21503; Eaton JL, 2007, DEV GENES EVOL, V217, P149, DOI 10.1007/s00427-006-0123-2; Eaton JL, 2006, DEV DYNAM, V235, P2071, DOI 10.1002/dvdy.20848; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; Hawrylycz M, 2014, SPRINGER HANDBOOK OF BIO-/NEUROINFORMATICS, P1111; Holder JL, 2000, HUM MOL GENET, V9, P101; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Louis A, 2015, NUCLEIC ACIDS RES, V43, pD682, DOI 10.1093/nar/gku1112; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Maricic T, 2013, MOL BIOL EVOL, V30, P844, DOI 10.1093/molbev/mss271; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Michaud JL, 2000, MECH DEVELOP, V90, P253, DOI 10.1016/S0925-4773(99)00328-7; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Mou ZY, 2015, CELL REP, V13, P1073, DOI 10.1016/j.celrep.2015.09.065; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Ramachandrappa S, 2013, J CLIN INVEST, V123, P3042, DOI 10.1172/JCI68016; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Rosenfeld JA, 2012, NEUROGENETICS, V13, P31, DOI 10.1007/s10048-011-0306-5; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Unger JL, 2003, GENE EXPR PATTERNS, V3, P105, DOI 10.1016/S1567-133X(02)00064-9; Westerfield M, 1995, ZEBRAFISH BOOK; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Zheng JJ, 2014, NAT NEUROSCI, V17, P391, DOI 10.1038/nn.3634	44	24	24	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					363	372		10.1016/j.ajhg.2015.12.014	http://dx.doi.org/10.1016/j.ajhg.2015.12.014			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26833329	Bronze, Green Published			2022-12-18	WOS:000370502300013
J	Christofidou, P; Nelson, CP; Nikpay, M; Qu, L; Li, M; Loley, C; Debiec, R; Braund, PS; Denniff, M; Charchar, FJ; Arjo, AR; Tregouet, DA; Goodall, AH; Cambien, F; Ouwehand, WH; Roberts, R; Schunkert, H; Hengstenberg, C; Reilly, MP; Erdmann, J; McPherson, R; Konig, IR; Thompson, JR; Samani, NJ; Tomaszewski, M				Christofidou, Paraskevi; Nelson, Christopher P.; Nikpay, Majid; Qu, Liming; Li, Mingyao; Loley, Christina; Debiec, Radoslaw; Braund, Peter S.; Denniff, Matthew; Charchar, Fadi J.; Arjo, Ares Rocanin; Tregouet, David-Alexandre; Goodall, Alison H.; Cambien, Francois; Ouwehand, Willem H.; Roberts, Robert; Schunkert, Heribert; Hengstenberg, Christian; Reilly, Muredach P.; Erdmann, Jeanette; McPherson, Ruth; Koenig, Inke R.; Thompson, John R.; Samani, Nilesh J.; Tomaszewski, Maciej			Runs of Homozygosity: Association with Coronary Artery Disease and Gene Expression in Monocytes and Macrophages	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DETECTABLE CLONAL MOSAICISM; GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; HUMAN-POPULATIONS; MYOCARDIAL-INFARCTION; RISK-FACTORS; NO EVIDENCE; CANCER; LOCUS; SCHIZOPHRENIA	Runs of homozygosity (ROHs) are recognized signature of recessive inheritance. Contributions of ROHs to the genetic architecture of coronary artery disease and regulation of gene expression in cells relevant to atherosclerosis are not known. Our combined analysis of 24,320 individuals from 11 populations of white European ethnicity showed an association between coronary artery disease and both the count and the size of ROHs. Individuals with coronary artery disease had approximately 0.63 (95% CI: 0.4-0.8) excess of ROHs when compared to coronary-artery-disease-free control subjects (p = 1.49 x 10(-9)). The average total length of ROHs was approximately 1,046.92 (95% CI: 634.4-1,459.5) kb greater in individuals with coronary artery disease than control subjects (p = 6.61 x 10(-7)). None of the identified individual ROHs was associated with coronary artery disease after correction for multiple testing. However, in aggregate burden analysis, ROHs favoring increased risk of coronary artery disease were much more common than those showing the opposite direction of association with coronary artery disease (p = 2.69 x 10(-33)). Individual ROHs showed significant associations with monocyte and macrophage expression of genes in their close proximity-subjects with several individual ROHs showed significant differences in the expression of 44 mRNAs in monocytes and 17 mRNAs in macrophages when compared to subjects without those ROHs. This study provides evidence for an excess of homozygosity in coronary artery disease in outbred populations and suggest the potential biological relevance of ROHs in cells of importance to the pathogenesis of atherosclerosis.	[Christofidou, Paraskevi; Nelson, Christopher P.; Debiec, Radoslaw; Braund, Peter S.; Denniff, Matthew; Goodall, Alison H.; Samani, Nilesh J.; Tomaszewski, Maciej] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Nelson, Christopher P.; Goodall, Alison H.; Samani, Nilesh J.; Tomaszewski, Maciej] NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Nikpay, Majid; Roberts, Robert; McPherson, Ruth] Univ Ottawa, Inst Heart, Ruddy Cardiovasc Genet Ctr, Ottawa, ON K1Y 4W7, Canada; [Nikpay, Majid; Roberts, Robert; McPherson, Ruth] Univ Ottawa, Inst Heart, Atherogen Lab, Ottawa, ON KLY 3V5, Canada; [Qu, Liming; Li, Mingyao] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA USA; [Loley, Christina; Koenig, Inke R.] Med Univ Lubeck, Inst Med Biometry & Stat, D-23562 Lubeck, Germany; [Charchar, Fadi J.] Federat Univ Australia, Sch Appl & Biomed Sci, Fac Sci & Technol, Ballarat, Vic 3350, Australia; [Arjo, Ares Rocanin; Tregouet, David-Alexandre; Cambien, Francois] ICAN Inst Cardiometab & Nutr, F-75013 Paris, France; [Arjo, Ares Rocanin; Tregouet, David-Alexandre; Cambien, Francois] INSERM, UMR S 1166, Team Genom & Pathophysiol Cardiovascular Dis, F-75013 Paris, France; [Arjo, Ares Rocanin; Tregouet, David-Alexandre; Cambien, Francois] Univ Paris 06, Sorbonne Univ, UMR S 1166, F-75013 Paris, France; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 OPT, England; [Ouwehand, Willem H.] NHS Blood & Transplant, Cambridge CB2 OPT, England; [Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Schunkert, Heribert; Hengstenberg, Christian] Tech Univ Munich, Deutsches Herzzentrum Munchen, D-80636 Munich, Germany; [Schunkert, Heribert; Hengstenberg, Christian] DZHK, D-80636 Munich, Germany; [Reilly, Muredach P.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19148 USA; [Erdmann, Jeanette] Med Univ Lubeck, Inst Integrat & Expt Gen, D-23562 Lubeck, Germany; [Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester LE3 9QP, Leics, England	University of Leicester; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; University of Pennsylvania; University of Lubeck; Federation University Australia; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Cambridge; Wellcome Trust Sanger Institute; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; University of Pennsylvania; University of Lubeck; University of Leicester	Tomaszewski, M (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England.	mt142@le.ac.uk	Trégouët, David-Alexandre/P-9210-2019; Erdmann, Jeanette/A-4417-2009; Hengstenberg, Christian/U-5485-2019; König, Inke R/A-4544-2009; Charchar, Fadi/I-6656-2017; Tregouet, David-Alexandre/E-3961-2016; Erdmann, Jeanette/P-7513-2014; Cambien, Francois/AAP-9751-2020	Trégouët, David-Alexandre/0000-0001-9084-7800; König, Inke R/0000-0003-0504-6465; Charchar, Fadi/0000-0002-6164-9941; Erdmann, Jeanette/0000-0002-4486-6231; Tomaszewski, Maciej/0000-0001-8215-6567; Goodall, Alison/0000-0002-7883-9645; Nelson, Christopher/0000-0001-8025-2897; Reilly, Muredach/0000-0002-3035-9386; Debiec, Radoslaw/0000-0003-2292-467X; Ouwehand, Willem/0000-0002-7744-1790	Alumni Association of University of Leicester PhD studentship; International Mentoring Travel Award by American Heart Association; British Heart Foundation; UK NIHR senior investigator; European Union [LSHM-CT-2006-037593]; Wellcome Trust [084183/Z/07/Z]; NIHR [RP-PG-0310-1002]; British Heart Foundation [PG/12/9/29376] Funding Source: researchfish; National Institute for Health Research [ACF-2012-11-001, RP-PG-0310-1002, NF-SI-0611-10170] Funding Source: researchfish	Alumni Association of University of Leicester PhD studentship; International Mentoring Travel Award by American Heart Association; British Heart Foundation(British Heart Foundation); UK NIHR senior investigator; European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Alumni Association of University of Leicester PhD studentship and International Mentoring Travel Award by American Heart Association (to P.C.). M.T. is supported by the British Heart Foundation. N.J.S. holds a personal chair supported by the British Heart Foundation and is a UK NIHR senior investigator. C.P.N. is funded by the British Heart Foundation. The Cardiogenics project was supported by the European Union 6th Framework Program (LSHM-CT-2006-037593). The UKBS collection of Common Controls has been funded by the Wellcome Trust grant 084183/Z/07/Z and by NIHR programme grant to NHSBT (RP-PG-0310-1002). The collection was established as part of the WTCCC. We would like to thank the participants and members of the CARDIoGRAM and the Cardiogenics consortia. Members of the Cardiogenics Consortium are listed in the Supplemental Data.	Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Abecasis GR, 2005, HUM HERED, V59, P118, DOI 10.1159/000085226; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Browning SR, 2012, GENETICS, V190, P1521, DOI 10.1534/genetics.111.136937; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Curtis D, 2008, ANN HUM GENET, V72, P261, DOI 10.1111/j.1469-1809.2007.00411.x; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Di Gaetano C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091237; Enciso-Mora V, 2010, EUR J HUM GENET, V18, P909, DOI 10.1038/ejhg.2010.53; Erdmann J, 2011, EUR HEART J, V32, P158, DOI 10.1093/eurheartj/ehq405; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Ghani M, 2013, JAMA NEUROL, V70, P1261, DOI 10.1001/jamaneurol.2013.3545; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Heron EA, 2014, SCHIZOPHR RES, V154, P79, DOI 10.1016/j.schres.2014.01.038; Hosking FJ, 2010, BLOOD, V115, P4472, DOI 10.1182/blood-2009-09-244483; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Ismail J, 2004, HEART, V90, P259, DOI 10.1136/hrt.2003.013631; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Ku CS, 2011, HUM GENET, V129, P1, DOI 10.1007/s00439-010-0920-6; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li LH, 2006, HUM MUTAT, V27, P1115, DOI 10.1002/humu.20399; Lin PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072056; Machiela MJ, 2013, SEMIN HEMATOL, V50, P348, DOI 10.1053/j.seminhematol.2013.09.001; MacLeod IM, 2009, GENET RES, V91, P413, DOI 10.1017/S0016672309990358; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; McQuillan R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002655; McWhirter RE, 2014, GYNECOL ONCOL, V133, P421, DOI 10.1016/j.ygyno.2014.03.566; Mittelstadt M, 2008, NUCLEIC ACIDS RES, V36, P998, DOI 10.1093/nar/gkm1129; Nalls MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000415; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; Power RA, 2014, AM J MED GENET B, V165, P157, DOI 10.1002/ajmg.b.32217; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puzyrev V P, 1992, Arctic Med Res, V51, P136; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Rudan I, 2003, J MED GENET, V40, P925, DOI 10.1136/jmg.40.12.925; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; SHAMI SA, 1991, LANCET, V338, P954, DOI 10.1016/0140-6736(91)91828-I; Spain SL, 2009, CANCER RES, V69, P7422, DOI 10.1158/0008-5472.CAN-09-0659; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Szpiech ZA, 2013, AM J HUM GENET, V93, P90, DOI 10.1016/j.ajhg.2013.05.003; Vine AE, 2009, PSYCHIAT GENET, V19, P165, DOI 10.1097/YPG.0b013e32832a4faa; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wang C, 2013, J BIOMED RES, V27, P208, DOI 10.7555/JBR.27.20130017; Xie XD, 2007, MOL CELL BIOCHEM, V301, P115, DOI 10.1007/s11010-006-9402-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	56	24	24	2	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					228	237		10.1016/j.ajhg.2015.06.001	http://dx.doi.org/10.1016/j.ajhg.2015.06.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26166477	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000359328800003
J	Tang, ZZ; Lin, DY				Tang, Zheng-Zheng; Lin, Dan-Yu			Meta-analysis for Discovering Rare-Variant Associations: Statistical Methods and Software Programs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DISEASE ASSOCIATIONS; GENERAL FRAMEWORK; COMMON DISEASES; SEQUENCING DATA; STRATEGIES; TRAITS; DESIGN; MODELS; HEART	There is heightened interest in using next-generation sequencing technologies to identify rare variants that influence complex human diseases and traits. Meta-analysis is essential to this endeavor because large sample sizes are required for detecting associations with rare variants. In this article, we provide a comprehensive overview of statistical methods for meta-analysis of sequencing studies for discovering rare-variant associations. Specifically, we discuss the calculation of relevant summary statistics from participating studies, the construction of gene-level association tests, the choice of transformation for quantitative traits, the use of fixed-effects versus random-effects models, and the removal of shadow association signals through conditional analysis. We also show that meta-analysis based on properly calculated summary statistics is as powerful as joint analysis of individual-participant data. In addition, we demonstrate the performance of different meta-analysis methods by using both simulated and empirical data. We then compare four major software packages for meta-analysis of rare-variant associations-MASS, RAREMETAL, MetaSKAT, and seqMeta-in terms of the underlying statistical methodology, analysis pipeline, and software interface. Finally, we present PreMeta, a software interface that integrates the four meta-analysis packages and allows a consortium to combine otherwise incompatible summary statistics.	[Tang, Zheng-Zheng] Vanderbilt Univ, Dept Biostat, Sch Med, Nashville, TN 37203 USA; [Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA	Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill	Lin, DY (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA.	lin@bios.unc.edu			NIH [R01CA082659, R37GM047845, P01CA142538]; NATIONAL CANCER INSTITUTE [R01CA082659, P01CA142538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047845, R37GM047845] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH awards R01CA082659, R37GM047845, and P01CA142538.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Chen H, 2014, GENET EPIDEMIOL, V38, P191, DOI 10.1002/gepi.21791; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Feng S, 2014, BIOINFORMATICS, V30, P2828, DOI 10.1093/bioinformatics/btu367; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Hu YJ, 2015, P NATL ACAD SCI USA, V112, P1019, DOI 10.1073/pnas.1406143112; Hu YJ, 2013, AM J HUM GENET, V93, P236, DOI 10.1016/j.ajhg.2013.06.011; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2010, BIOMETRIKA, V97, P321, DOI 10.1093/biomet/asq006; Lin DY, 2013, P NATL ACAD SCI USA, V110, P12247, DOI 10.1073/pnas.1221713110; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Lin HH, 2014, CIRC-CARDIOVASC GENE, V7, P335, DOI 10.1161/CIRCGENETICS.113.000350; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Lumley T. B. J., 2012, METAANALYSIS RARE VA; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Tang ZZ, 2014, GENET EPIDEMIOL, V38, P389, DOI 10.1002/gepi.21798; Tang ZZ, 2013, BIOINFORMATICS, V29, P1803, DOI 10.1093/bioinformatics/btt280; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tzeng JY, 2007, AM J HUM GENET, V81, P927, DOI 10.1086/521558; Wang GT, 2014, AM J HUM GENET, V94, P770, DOI 10.1016/j.ajhg.2014.04.004; Wojczynski MK, 2010, J LIPID RES, V51, P3316, DOI 10.1194/jlr.P001834; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57; Zhang LN, 2013, CLIN BIOCHEM, V46, P727, DOI 10.1016/j.clinbiochem.2013.01.013	38	24	24	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					35	53		10.1016/j.ajhg.2015.05.001	http://dx.doi.org/10.1016/j.ajhg.2015.05.001			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26094574	Bronze, Green Published			2022-12-18	WOS:000358189500004
J	Lin, ZM; Zhao, JH; Nitoiu, D; Scott, CA; Plagnol, V; Smith, FJD; Wilson, NJ; Cole, C; Schwartz, ME; McLean, WHI; Wang, HJ; Feng, C; Duo, LN; Zhou, EY; Ren, YL; Dai, LL; Chen, YL; Zhang, JG; Xu, X; O'Toole, EA; Kelsell, DP; Yang, Y				Lin, Zhimiao; Zhao, Jiahui; Nitoiu, Daniela; Scott, Claire A.; Plagnol, Vincent; Smith, Frances J. D.; Wilson, Neil J.; Cole, Christian; Schwartz, Mary E.; McLean, W. H. Irwin; Wang, Huijun; Feng, Cheng; Duo, Lina; Zhou, Eray Yihui; Ren, Yali; Dai, Lanlan; Chen, Yulan; Zhang, Jianguo; Xu, Xun; O'Toole, Edel A.; Kelsell, David P.; Yang, Yong			Loss-of-Function Mutations in CAST Cause Peeling Skin, Leukonychia, Acral Punctate Keratoses, Cheilitis, and Knuckle Pads	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CALPAIN-MEDIATED PROTEOLYSIS; SERINE-PROTEASE INHIBITOR; ENCODING CYSTATIN-A; PALMOPLANTAR KERATOSIS; MISSENSE MUTATION; ADHESION DYNAMICS; FOCAL ADHESION; APOPTOSIS; MICE; DERMATITIS	Calpastatin is an endogenous specific inhibitor of calpain, a calcium-dependent cysteine protease. Here we show that loss-of-function mutations in calpastatin (CAST) are the genetic causes of an autosomal-recessive condition characterized by generalized peeling skin, leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, which we propose to be given the acronym PLACK syndrome. In affected individuals with PLACK syndrome from three families of different ethnicities, we identified homozygous mutations (c.607dup, c.424A>T, and c.1750delG) in CAST, all of which were predicted to encode truncated proteins (p.Ile203Asnfs*8, p.Lys142*, and p.Val584Trpfs*37). Immunohistochemistry shows that staining of calpastatin is reduced in skin from affected individuals. Transmission electron microscopy revealed widening of intercellular spaces with chromatin condensation and margination in the upper stratum spinosum in lesional skin, suggesting impaired intercellular adhesion as well as keratinocyte apoptosis. A significant increase of apoptotic keratinocytes was also observed in TUNEL assays. In vitro studies utilizing siRNA-mediated CAST knockdown revealed a role for calpastatin in keratinocyte adhesion. In summary, we describe PLACK syndrome, as a clinical entity of defective epidermal adhesion, caused by loss-of-function mutations in CAST.	[Lin, Zhimiao; Zhao, Jiahui; Wang, Huijun; Feng, Cheng; Duo, Lina; Zhou, Eray Yihui; Yang, Yong] Peking Univ, Hosp 1, Dept Dermatol, Beijing 100034, Peoples R China; [Lin, Zhimiao; Zhao, Jiahui; Wang, Huijun; Feng, Cheng; Duo, Lina; Zhou, Eray Yihui; Yang, Yong] Beijing Key Lab Mol Diag Dermatoses, Beijing 100034, Peoples R China; [Nitoiu, Daniela; Scott, Claire A.; O'Toole, Edel A.; Kelsell, David P.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London E1 2AT, England; [Plagnol, Vincent] UCL, Dept Genet, London WC1E 6BT, England; [Smith, Frances J. D.; Wilson, Neil J.; Cole, Christian; McLean, W. H. Irwin] Univ Dundee, Ctr Dermatol & Genet Med, Coll Life Sci & Med, Dundee DD1 5EH, Scotland; [Smith, Frances J. D.; Wilson, Neil J.; Cole, Christian; McLean, W. H. Irwin] Univ Dundee, Ctr Dermatol & Genet Med, Coll Dent, Dundee DD1 5EH, Scotland; [Smith, Frances J. D.; Wilson, Neil J.; Cole, Christian; McLean, W. H. Irwin] Univ Dundee, Ctr Dermatol & Genet Med, Coll Nursing, Dundee DD1 5EH, Scotland; [Cole, Christian] Univ Dundee, Coll Life Sci, Div Computat Biol, Dundee DD1 5EH, Scotland; [Schwartz, Mary E.] PC Project, Salt Lake City, UT 84109 USA; [Wang, Huijun; Duo, Lina; Yang, Yong] Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Ren, Yali] Peking Univ, Hosp 1, Lab Electron Microscopy, Beijing 100034, Peoples R China; [Dai, Lanlan; Chen, Yulan; Zhang, Jianguo; Xu, Xun] BGI Shenzhen, Shenzhen 518083, Peoples R China	Peking University; University of London; Queen Mary University London; University of London; University College London; University of Dundee; University of Dundee; University of Dundee; University of Dundee; Peking University; Beijing Genomics Institute (BGI)	Kelsell, DP (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London E1 2AT, England.	d.p.kelsell@qmul.ac.uk; dryongyang@bjmu.edu.cn	Kelsell, David P/F-8767-2011; Xu, Xun/AAI-6763-2020; wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022	Xu, Xun/0000-0002-5338-5173; O'Toole, Edel/0000-0002-4084-4836; Zhang, Jianguo/0000-0003-0723-1701; Cole, Christian/0000-0002-2560-2484; Plagnol, Vincent/0000-0002-5597-9215; Kelsell, David/0000-0002-9910-7144	China National Funds for Distinguished Young Scientists [81425020]; National Natural Science Foundation of China [81271744, 81201220]; Beijing Higher Education Young Elite Teacher Project [YETP0069]; Shenzhen Key Laboratory of Cognitive Genomics [CXB201108250094A]; Pachyonychia Congenita Project; Wellcome Trust Strategic Award [098439/Z/12/Z]; Barts; London Charity	China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Higher Education Young Elite Teacher Project; Shenzhen Key Laboratory of Cognitive Genomics; Pachyonychia Congenita Project; Wellcome Trust Strategic Award(Wellcome Trust); Barts; London Charity	We are grateful to the patients and their family members for participation in this study. We gratefully acknowledge Dr. Deirdre Buckley (Bath, UK) who referred individual 2 to us. This work was supported in part by China National Funds for Distinguished Young Scientists (81425020 to Y.Y.), National Natural Science Foundation of China (81271744 to Y.Y. and 81201220 to Z.L.), Beijing Higher Education Young Elite Teacher Project (YETP0069 for Z.L.), and Shenzhen Key Laboratory of Cognitive Genomics (CXB201108250094A). F.J.D.S. and N.J.W. are supported by grants from the Pachyonychia Congenita Project. The Centre for Dermatology and Genetic Medicine at the University of Dundee is supported by a Wellcome Trust Strategic Award (098439/Z/12/Z to W.H.I.M.). This study is also funded, in part, by Barts and the London Charity (D.P.K.).	Barnoy S, 2005, BIOCHEM BIOPH RES CO, V332, P697, DOI 10.1016/j.bbrc.2005.05.010; Blaydon DC, 2011, AM J HUM GENET, V89, P564, DOI 10.1016/j.ajhg.2011.09.001; Cabral RM, 2012, GENOMICS, V99, P202, DOI 10.1016/j.ygeno.2012.01.005; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Cassidy AJ, 2005, AM J HUM GENET, V77, P909, DOI 10.1086/497707; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Chang YY, 2012, BRIT J DERMATOL, V167, P1076, DOI 10.1111/j.1365-2133.2012.11175.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; de Veer SJ, 2014, TRENDS MOL MED, V20, P166, DOI 10.1016/j.molmed.2013.11.005; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; HABER RM, 1986, ARCH DERMATOL, V122, P919, DOI 10.1001/archderm.122.8.919; HACHAMZADEH S, 1985, ARCH DERMATOL, V121, P545, DOI 10.1001/archderm.121.4.545; Inoue A, 2004, J DERMATOL SCI, V36, P60, DOI 10.1016/j.jdermsci.2004.02.011; Kharfi M, 2009, J INVEST DERMATOL, V129, P2512, DOI 10.1038/jid.2009.118; Krunic AL, 2013, PEDIATR DERMATOL, V30, pE87, DOI 10.1111/pde.12092; Kubo A, 2013, AM J HUM GENET, V93, P945, DOI 10.1016/j.ajhg.2013.09.015; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Nakajima R, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-7; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Oji V, 2010, AM J HUM GENET, V87, P274, DOI 10.1016/j.ajhg.2010.07.005; PARRISH EP, 1987, J PATHOL, V153, P265, DOI 10.1002/path.1711530311; Pavlovic S, 2012, PEDIATR DERMATOL, V29, P258, DOI 10.1111/j.1525-1470.2011.01563.x; Pigors M, 2012, J INVEST DERMATOL, V132, P2422, DOI 10.1038/jid.2012.166; PURKIS PE, 1990, J CELL SCI, V97, P39; Samuelov L, 2014, J ALLERGY CLIN IMMUN, V134, P808, DOI 10.1016/j.jaci.2014.07.061; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Wang HJ, 2015, HUM MOL GENET, V24, P243, DOI 10.1093/hmg/ddu442; Yin JH, 2014, J INVEST DERMATOL, V134, P2269, DOI 10.1038/jid.2014.80	35	24	27	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					440	447		10.1016/j.ajhg.2014.12.026	http://dx.doi.org/10.1016/j.ajhg.2014.12.026			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25683118	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000350747800016
J	Breyer, JP; Dorset, DC; Clark, TA; Bradley, KM; Wahlfors, TA; McReynolds, KM; Maynard, WH; Chang, SS; Cookson, MS; Smith, JA; Schleutker, J; Dupont, WD; Smith, JR				Breyer, Joan P.; Dorset, Daniel C.; Clark, Travis A.; Bradley, Kevin M.; Wahlfors, Tiina A.; McReynolds, Kate M.; Maynard, William H.; Chang, Sam S.; Cookson, Michael S.; Smith, Joseph A.; Schleutker, Johanna; Dupont, William D.; Smith, Jeffrey R.			An Expressed Retrogene of the Master Embryonic Stem Cell Gene POU5F1 Is Associated with Prostate Cancer Susceptibility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LONG-RANGE INTERACTION; COLORECTAL-CANCER; SELF-RENEWAL; DIFFERENTIAL EXPRESSION; TUMOR-DEVELOPMENT; MYC EXPRESSION; 8Q24 PROSTATE; SNP RS6983267; MULTIPLE LOCI	Genetic association studies of prostate and other cancers have identified a major risk locus at chromosome 8q24. Several independent risk variants at this locus alter transcriptional regulatory elements, but an affected gene and mechanism for cancer predisposition have remained elusive. The retrogene POU5F1B within the locus has a preserved open reading frame encoding a homolog of the master embryonic stem cell transcription factor Oct4. We find that 8q24 risk alleles are expression quantitative trait loci correlated with reduced expression of POU5F1B in prostate tissue and that predicted deleterious POU5F1B missense variants are also associated with risk of transformation. POU5F1 is known to be self-regulated by the encoded Oct4 transcription factor. We further observe that POU5F1 expression is directly correlated with POU5F1B expression. Our results suggest that a pathway critical to self-renewal of embryonic stem cells may also have a role in the origin of cancer.	[Breyer, Joan P.; Dorset, Daniel C.; Clark, Travis A.; Bradley, Kevin M.; McReynolds, Kate M.; Maynard, William H.; Smith, Jeffrey R.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA; [Bradley, Kevin M.] Fdn Appl Mol Evolut, Gainesville, FL 32604 USA; [Wahlfors, Tiina A.] Univ Tampere, Inst Biomed Technol BioMediTech, Tampere 33520, Finland; [Wahlfors, Tiina A.] Fimlab Labs, Tampere 33520, Finland; [Chang, Sam S.; Cookson, Michael S.; Smith, Joseph A.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Urol Surg, Nashville, TN 37232 USA; [Schleutker, Johanna] Univ Turku, Inst Biomed, Dept Med Biochem & Genet, Turku 20014, Finland; [Dupont, William D.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Biostat, Nashville, TN 37232 USA; [Smith, Jeffrey R.] Vet Affairs Tennessee Valley Healthcare Syst, Med Res Serv, Nashville, TN 37212 USA	Vanderbilt University; Tampere University; Vanderbilt University; University of Turku; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Smith, JR (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA.	jeffrey.smith@vanderbilt.edu	; Wahlfors, Tiina/U-7635-2018	Smith, Jeffrey/0000-0001-8424-910X; Schleutker, Johanna/0000-0002-1863-0305; Wahlfors, Tiina/0000-0002-3910-796X	MERIT grant from the US Department of Veterans Affairs; V Foundation; NCI; NHGRI; NIH [U01 CA89600]; Sigrid Juselius Foundation; Academy of Finland [116437, 251074]; NATIONAL CANCER INSTITUTE [U01CA089600] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002502] Funding Source: NIH RePORTER	MERIT grant from the US Department of Veterans Affairs(US Department of Veterans Affairs); V Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	We extend particular thanks to the study participants and to Peter Clark, Rodney Davis, S. Duke Herrell, Richard Hock, Douglas Milam, and Jason Pereira. This work was supported by a MERIT grant from the US Department of Veterans Affairs and by an award from the V Foundation to J.R.S. The results published here are in part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI. The Finnish study population was supported by NIH U01 CA89600, the Sigrid Juselius Foundation, and Academy of Finland grants 116437 and 251074 to J.S.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Alaiyan B, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-196; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Badeaux MA, 2013, CELL CYCLE, V12, P2395, DOI 10.4161/cc.25402; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cao J, 2013, LEUKEMIA RES, V37, P1170, DOI 10.1016/j.leukres.2013.04.021; Cauffman G, 2006, STEM CELLS, V24, P2685, DOI 10.1634/stemcells.2005-0611; Cheng I, 2012, CANCER EPIDEM BIOMAR, V21, P2048, DOI 10.1158/1055-9965.EPI-12-0598; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Fairbanks DJ, 2012, G3-GENES GENOM GENET, V2, P1447, DOI 10.1534/g3.112.004366; Fairbanks DJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-12; Fromont G, 2013, HUM PATHOL, V44, P1617, DOI 10.1016/j.humpath.2013.01.012; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hu TS, 2008, CANCER RES, V68, P6533, DOI 10.1158/0008-5472.CAN-07-6642; Ibrahim EE, 2012, STEM CELLS, V30, P2076, DOI 10.1002/stem.1182; Ishiguro T, 2012, BIOCHEM BIOPH RES CO, V418, P199, DOI 10.1016/j.bbrc.2011.10.123; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kastler S, 2010, PROSTATE, V70, P666, DOI 10.1002/pros.21100; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liu F, 2011, CANCER SCI, V102, P1916, DOI 10.1111/j.1349-7006.2011.02036.x; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Nissan A, 2012, INT J CANCER, V130, P1598, DOI 10.1002/ijc.26170; Palla A.R., 2013, ONCOGENE, DOI DOI 10.1038/0NC.2013.196; Panagopoulos I, 2008, ONCOL REP, V20, P1029, DOI 10.3892/or_00000105; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Peng B, 2010, HUM GENET, V127, P699, DOI 10.1007/s00439-010-0824-5; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Prokunina-Olsson L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-96; Schleutker J, 2003, PROSTATE, V57, P280, DOI 10.1002/pros.10302; Schleutker J, 2000, CLIN CANCER RES, V6, P4810; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Sotomayor P, 2009, PROSTATE, V69, P401, DOI 10.1002/pros.20895; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Uchino K, 2012, EXP CELL RES, V318, P1799, DOI 10.1016/j.yexcr.2012.04.011; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu JF, 2009, CANCER EPIDEM BIOMAR, V18, P2145, DOI 10.1158/1055-9965.EPI-09-0091; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461; Zhang JY, 2010, ONCOL LETT, V1, P457, DOI 10.3892/ol_00000081; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x	74	24	27	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					395	404		10.1016/j.ajhg.2014.01.019	http://dx.doi.org/10.1016/j.ajhg.2014.01.019			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24581739	Green Published, Bronze			2022-12-18	WOS:000332611400013
J	Cutting, GR				Cutting, Garry R.			Annotating DNA Variants Is the Next Major Goal for Human Genetics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS; CLINICAL-SIGNIFICANCE; CFTR POTENTIATOR; DATABASES; PHENOTYPE; MUTATION; GENOTYPE; TOOL; MICROATTRIBUTION; INFORMATION	Clinical genetic testing has undergone a dramatic transformation in the past two decades. Diagnostic laboratories that previously tested for well-established disease-causing DNA variants in a handful of genes have evolved into sequencing factories identifying thousands of variants of known and unknown medical consequence. Sorting out what does and does not cause disease in our genomes is the next great challenge in making genetics a central feature of healthcare. I propose that closing the gap in our ability to interpret variation responsible for Mendelian disorders provides a grand and unprecedented opportunity for geneticists. Human geneticists are well placed to coordinate a systematic evaluation of variants in collaboration with basic scientists and clinicians. Sharing of knowledge, data, methods, and tools will aid both researchers and healthcare workers in achieving their common goal of defining the pathogenic potential of variants. Generation of variant annotations will inform genetic testing and will deepen our understanding of gene and protein function, thereby aiding the search for molecular targeted therapies.	[Cutting, Garry R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Cutting, Garry R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Cutting, GR (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	gcutting@jhmi.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044003] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001079] Funding Source: Medline; NIDDK NIH HHS [R01 DK044003] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; [Anonymous], NAT BIOTECHNOL, V31, P661; Antonarakis SE, 2006, NAT REV GENET, V7, P277, DOI 10.1038/nrg1826; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Carey JC, 2012, HUM MUTAT, V33, P781, DOI 10.1002/humu.22053; Celli J, 2012, HUM MUTAT, V33, P291, DOI 10.1002/humu.21626; Condit CM, 2002, HUM MUTAT, V19, P69, DOI 10.1002/humu.10023; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cotton RGH, 2008, SCIENCE, V322, P861, DOI 10.1126/science.1167363; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Eichers ER, 2004, ANN MED, V36, P262, DOI 10.1080/07853890410026214; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Giardine B, 2011, NAT GENET, V43, P295, DOI 10.1038/ng.785; Grody WW, 2007, GENET MED, V9, P739, DOI 10.1097/GIM.0b013e318159a331; Grody Wayne W., 2001, Genetics in Medicine, V3, P149, DOI 10.1097/00125817-200103000-00010; Hamosh A, 2013, HUM MUTAT, V34, P566, DOI 10.1002/humu.22283; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; KING RC, 2002, DICT GENETICS; Landrum MJ, 2013, NUCL ACIDS RES; Lubin IM, 2008, J MOL DIAGN, V10, P459, DOI 10.2353/jmoldx.2008.080050; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mitropoulou C, 2010, HUM MUTAT, V31, P1109, DOI 10.1002/humu.21332; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Palomaki GE, 2004, GENET MED, V6, P405, DOI 10.1097/01.GIM.0000139505.06194.39; Patrinos GP, 2012, HUM MUTAT, V33, P1513, DOI 10.1002/humu.22147; Patrinos GP, 2012, HUM MUTAT, V33, P1503, DOI 10.1002/humu.22144; Patrinos GP, 2005, TRENDS GENET, V21, P333, DOI 10.1016/j.tig.2005.04.004; Plazzer JP, 2013, FAM CANCER, V12, P175, DOI 10.1007/s10689-013-9616-0; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Riggs ER, 2012, HUM MUTAT, V33, P787, DOI 10.1002/humu.22052; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Robinson PN, 2012, HUM MUTAT, V33, P777, DOI 10.1002/humu.22080; Scriver CR, 2000, HUM MUTAT, V15, P99, DOI 10.1002/(SICI)1098-1004(200001)15:1<99::AID-HUMU18>3.0.CO;2-P; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Spurdle AB, 2012, HUM MUTAT, V33, P2, DOI 10.1002/humu.21628; Stenson P. D., 2013, HUM GENET; Strom CM, 2011, GENET MED, V13, P166, DOI 10.1097/GIM.0b013e3181fa24c4; Thorisson GA, 2009, NAT REV GENET, V10, P9, DOI 10.1038/nrg2483; Torjesen I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6690; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vihinen M, 2012, HUM MUTAT, V33, P298, DOI 10.1002/humu.21646; Wagener JS, 2012, CURR OPIN PEDIATR, V24, P329, DOI 10.1097/MOP.0b013e328353489a; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C; Weatherall DJ, 2001, METABOLIC MOL BASES, P4571; Webb AJ, 2011, HUM MUTAT, V32, P543, DOI 10.1002/humu.21469; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005	57	24	24	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					5	10		10.1016/j.ajhg.2013.12.008	http://dx.doi.org/10.1016/j.ajhg.2013.12.008			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24387988	Bronze, Green Published			2022-12-18	WOS:000329888400001
J	Genovese, G; Handsaker, RE; Li, H; Kenny, EE; McCarroll, SA				Genovese, Giulio; Handsaker, Robert E.; Li, Heng; Kenny, Eimear E.; McCarroll, Steven A.			Mapping the Human Reference Genome's Missing Sequence by Three-Way Admixture in Latino Genomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY NUMBER; DNA PRIMASE; DISCOVERY; POLYMORPHISM; CHROMOSOMES; ASSEMBLIES; DIVERSITY; EVOLUTION; GENES; MAPS	A principal obstacle to completing maps and analyses of the human genome involves the genome's "inaccessible" regions: sequences (often euchromatic and containing genes) that are isolated from the rest of the euchromatic genome by heterochromatin and other repeat-rich sequence. We describe a way to localize these sequences by using ancestry linkage disequilibrium in populations that derive ancestry from at least three continents, as is the case for Latinos. We used this approach to map the genomic locations of almost 20 mega-bases of sequence unlocalized or missing from the current human genome reference (NCBI Genome GRCh37)-a substantial fraction of the human genome's remaining unmapped sequence. We show that the genomic locations of most sequences that originated from fosmids and larger clones can be admixture mapped in this way, by using publicly available whole-genome sequence data. Genome assembly efforts and future builds of the human genome reference will be strongly informed by this localization of genes and other euchromatic sequences that are embedded within highly repetitive pericentromeric regions.	[Genovese, Giulio; McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Genovese, Giulio; Handsaker, Robert E.; Li, Heng; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Genovese, Giulio; Handsaker, Robert E.; Li, Heng; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kenny, Eimear E.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Ctr Stat Genet, New York, NY 10029 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Stanford University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Genovese, G (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.	giulio.genovese@gmail.com; mccarroll@genetics.med.harvard.edu	Li, Heng/D-9344-2011; Handsaker, Bob/AAX-9095-2021	Li, Heng/0000-0003-4874-2874; Handsaker, Bob/0000-0002-3128-3547; Kenny, Eimear/0000-0001-9198-759X; McCarroll, Steven/0000-0002-6954-8184; Genovese, Giulio/0000-0003-3066-5575	NHGRI [R01 HG006855-01]; Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006855] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a grant from NHGRI (R01 HG006855-01 to S.A.M.) and by the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkt1030, 10.1093/nar/gkr1202, 10.1093/nar/gkq1079, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkn723, 10.1093/nar/gkx1094]; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; CHOO KH, 1988, NUCLEIC ACIDS RES, V16, P1273, DOI 10.1093/nar/16.4.1273; CHOO KH, 1989, GENOMICS, V5, P332, DOI 10.1016/0888-7543(89)90066-9; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Chung J, 2012, EPIGENETICS-US, V7, P429, DOI 10.4161/epi.19777; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Churchhouse C, 2013, GENET EPIDEMIOL, V37, P1, DOI 10.1002/gepi.21692; Cole CG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r78; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dimalanta ET, 2004, ANAL CHEM, V76, P5293, DOI 10.1021/ac0496401; Finelli P, 1996, GENOMICS, V38, P325, DOI 10.1006/geno.1996.0635; Genovese G, 2013, NAT GENET, V45, P406, DOI 10.1038/ng.2565; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hayden KE, 2012, CHROMOSOME RES, V20, P621, DOI 10.1007/s10577-012-9295-y; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; Nagarajan N, 2008, BIOINFORMATICS, V24, P1229, DOI 10.1093/bioinformatics/btn102; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; SHIRATORI A, 1995, GENOMICS, V28, P350, DOI 10.1006/geno.1995.1155; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; Valouev A, 2006, P NATL ACAD SCI USA, V103, P15770, DOI 10.1073/pnas.0604040103; Via M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016513; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	44	24	26	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					411	421		10.1016/j.ajhg.2013.07.002	http://dx.doi.org/10.1016/j.ajhg.2013.07.002			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23932108	Green Published, Bronze			2022-12-18	WOS:000330268900001
J	Moffatt, P; Ben Amor, M; Glorieux, FH; Roschger, P; Klaushofer, K; Schwartzentruber, JA; Paterson, AD; Hu, PZ; Marshall, C; Fahiminiya, S; Majewski, J; Beaulieu, CL; Boycott, KM; Rauch, F				Moffatt, Pierre; Ben Amor, Mouna; Glorieux, Francis H.; Roschger, Paul; Klaushofer, Klaus; Schwartzentruber, Jeremy A.; Paterson, Andrew D.; Hu, Pingzhao; Marshall, Christian; Fahiminiya, Somayyeh; Majewski, Jacek; Beaulieu, Chandree L.; Boycott, Kym. M.; Rauch, Frank		FORGE Canada Consortium	Metaphyseal Dysplasia with Maxillary Hypoplasia and Brachydactyly Is Caused by a Duplication in RUNX2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLEIDOCRANIAL DYSPLASIA; NORMATIVE DATA; CBFA1; MUTATIONS; GENE; DIFFERENTIATION; OSTEOBLASTS; CHILDREN	Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly (MDMHB) is an autosomal-dominant bone dysplasia characterized by metaphyseal flaring of long bones, enlargement of the medial halves of the clavicles, maxillary hypoplasia, variable brachydactyly, and dystrophic teeth. We performed genome-wide SNP genotyping in five affected and four unaffected members of an extended family With MDMHB. Analysis for copy-number variations revealed that a 105 kb duplication within RUNX2 segregated with the MDMHB phenotype in a region with maximum linkage. Real-time PCR for copy-number variation in genomic DNA in eight samples, as well as sequence analysis of fibroblast cDNA from one subject with MDMHB confirmed that affected family members were heterozygous for the presence of an intragenic duplication encompassing exons 3 to 5 of RUNX2. These three exons code for the Q/A. domain and the functionally essential DNA-binding runt domain of RUNX2. Transfection studies with murine Runx2 cDNA showed that cellular levels of mutated RUNX2 were markedly higher than those of wild-type RUNX2, suggesting that the RUNX2 duplication found in individuals with MDMHB leads to a gain of function. Until now, only loss-of-function mutations have been detected in RUNX2; the present report associates an apparent gain-of-function alteration of RUNX2 function with a distinct rare disease.	[Moffatt, Pierre; Ben Amor, Mouna; Glorieux, Francis H.; Rauch, Frank] Shriners Hosp Children, Genet Unit, Montreal, PQ H3G 1A6, Canada; [Moffatt, Pierre; Glorieux, Francis H.; Fahiminiya, Somayyeh; Majewski, Jacek; Rauch, Frank] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Roschger, Paul; Klaushofer, Klaus] Hanusch Hosp WGKK, Ludwig Boltzmann Inst Osteol, A-1140 Vienna, Austria; [Roschger, Paul; Klaushofer, Klaus] Hanusch Hosp, AUVA Trauma Ctr Meidling, Dept Med 1, A-1140 Vienna, Austria; [Schwartzentruber, Jeremy A.] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Schwartzentruber, Jeremy A.] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Paterson, Andrew D.; Hu, Pingzhao; Marshall, Christian] Univ Toronto, Hosp Sick Children, Res Inst, Program Genet & Genome Biol,Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Paterson, Andrew D.; Hu, Pingzhao; Marshall, Christian] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1L7, Canada; [Beaulieu, Chandree L.; Boycott, Kym. M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada	McGill University; McGill University; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; WGKK - Hanusch Hospital; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Ottawa; Children's Hospital of Eastern Ontario	Rauch, F (corresponding author), Shriners Hosp Children, Genet Unit, Montreal, PQ H3G 1A6, Canada.	frauch@shriners.mcgill.ca	Scherer, Stephen W./B-3785-2013; Paterson, Andrew/AAQ-7511-2020; Rauch, Frank/D-1554-2009; Paterson, Andrew D/A-4088-2011; Fratzl, Peter/H-9095-2012	Scherer, Stephen W./0000-0002-8326-1999; Paterson, Andrew/0000-0002-9169-118X; Paterson, Andrew D/0000-0002-9169-118X; Fratzl, Peter/0000-0003-4437-7830; Rauch, Frank/0000-0002-6261-0360; Moffatt, Pierre/0000-0002-5793-1944; Hu, Pingzhao/0000-0002-9546-2245; Schwartzentruber, Jeremy/0000-0002-6183-2092	Shriners of North America; Government of Canada through Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia; McLaughlin Centre; Fonds de recherche du Quebec - Sante	Shriners of North America; Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; McLaughlin Centre; Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Shriners of North America and received funding by the Government of Canada through Genome Canada, the Canadian Institutes of Health Research, and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec, Genome British Columbia, and the McLaughlin Centre. F.R. received support from the Chercheur-Boursier Clinicien program of the Fonds de recherche du Quebec - Sante.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Fratzl-Zelman N, 2009, BONE, V44, P1043, DOI 10.1016/j.bone.2009.02.021; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Glorieux FH, 2000, BONE, V26, P103, DOI 10.1016/S8756-3282(99)00257-4; HALAL F, 1982, AM J MED GENET, V13, P71, DOI 10.1002/ajmg.1320130112; Hansen L, 2011, CLIN GENET, V79, P254, DOI 10.1111/j.1399-0004.2010.01458.x; He N, 2011, J CELL BIOCHEM, V112, P653, DOI 10.1002/jcb.22968; Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Li ST, 2011, BIOCHEM BIOPH RES CO, V410, P698, DOI 10.1016/j.bbrc.2011.06.065; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; Mefford HC, 2010, AM J MED GENET A, V152A, P2203, DOI 10.1002/ajmg.a.33557; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Ott CE, 2010, HUM MUTAT, V31, pE1587, DOI 10.1002/humu.21298; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Wilkie AOM, 2007, AM J MED GENET A, V143A, P1941, DOI 10.1002/ajmg.a.31905; Yoshida T, 2002, AM J HUM GENET, V71, P724, DOI 10.1086/342717	22	24	27	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					252	258		10.1016/j.ajhg.2012.12.001	http://dx.doi.org/10.1016/j.ajhg.2012.12.001			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23290074	Bronze, Green Published			2022-12-18	WOS:000315179600009
J	Garcia-Diaz, B; Barros, MH; Sanna-Cherchi, S; Emmanuele, V; Akmand, HO; Ferreiro-Barros, CC; Horvath, R; Tadesse, S; El Gharaby, N; DiMaurod, S; De Vivo, DC; Shokr, A; Hirano, M; Quinzii, CM				Garcia-Diaz, Beatriz; Barros, Mario H.; Sanna-Cherchi, Simone; Emmanuele, Valentina; Akmand, Hasan O.; Ferreiro-Barros, Claudia C.; Horvath, Rita; Tadesse, Saba; El Gharaby, Nader; DiMaurod, Salvatore; De Vivo, Darryl C.; Shokr, Aly; Hirano, Michio; Quinzii, Catarina M.			Infantile Encephaloneuromyopathy and Defective Mitochondrial Translation Are Due to a Homozygous RMND1 Mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIDEROBLASTIC ANEMIA-MLASA; ELONGATION-FACTOR EFTS; C-OXIDASE DEFICIENCY; RNA-SYNTHETASE GENE; PROTEIN-SYNTHESIS; LEIGH-SYNDROME; BRAIN-STEM; LEUKOENCEPHALOPATHY; CELL; ASSOCIATION	Defects of mitochondrial protein synthesis are clinically and genetically heterogeneous. We previously described a male infant who was born to consanguineous parents and who presented with severe congenital encephalopathy, peripheral neuropathy, myopathy, and lactic acidosis associated with deficiencies of multiple mitochondrial respiratory-chain enzymes and defective mitochondrial translation. In this work, we have characterized four additional affected family members, performed homozygosity mapping, and identified a homozygous splicing mutation in the splice donor site of exon 2 (c.504+1G>A) of RMND1 (required for meiotic nuclear division-1) in the affected individuals. Fibroblasts from affected individuals expressed two aberrant transcripts and had decreased wild-type mRNA and deficiencies of mitochondrial respiratory-chain enzymes. The RMND1 mutation caused haploinsufficiency that was rescued by overexpression of the wild-type transcript in mutant fibroblasts; this overexpression increased the levels and activities of mitochondrial respiratory-chain proteins. Knockdown of RMND1 via shRNA recapitulated the biochemical defect of the mutant fibroblasts, further supporting a loss-of-function pathomechanism in this disease. RMND1 belongs to the sif2 family, an evolutionary conserved group of proteins that share the DUF155 domain, have unknown function, and have never been associated with human disease. We documented that the protein localizes to mitochondria in mammalian and yeast cells. Further studies are necessary for understanding the function of this protein in mitochondrial protein translation.	[Garcia-Diaz, Beatriz; Emmanuele, Valentina; Akmand, Hasan O.; Tadesse, Saba; DiMaurod, Salvatore; De Vivo, Darryl C.; Hirano, Michio; Quinzii, Catarina M.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA; [Barros, Mario H.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, BR-05508900 Sao Paulo, Brazil; [Sanna-Cherchi, Simone] Columbia Univ, Div Nephrol, Med Ctr, Dept Med, New York, NY 10032 USA; [Sanna-Cherchi, Simone] St Lukes Roosevelt Hosp, Dept Med, New York, NY 10025 USA; [Ferreiro-Barros, Claudia C.] Hosp Israelita Albert Einstein, Inst Cerebro, BR-05652000 Sao Paulo, Brazil; [Horvath, Rita] Newcastle Univ, Inst Med Genet, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [El Gharaby, Nader; Shokr, Aly] Bugshan Gen Hosp, Dept Obstet & Gynecol, Jeddah, Saudi Arabia	Columbia University; Universidade de Sao Paulo; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Hospital Israelita Albert Einstein; Newcastle University - UK	Hirano, M (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.	mh29@columbia.edu	Barros, Mario/Q-6358-2019; Barros, Mario H/B-8118-2012; Horvath, Rita/AAY-7042-2020; Ferreiro-Barros, Claudia/D-5873-2012; Diaz, Beatriz Garcia/AAB-7002-2019	Barros, Mario/0000-0003-2977-9815; Diaz, Beatriz Garcia/0000-0003-2655-571X; Horvath, Rita/0000-0002-9841-170X	Marriott Mitochondrial Disorder Clinical Research Fund; National Institute of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD065871]; NIH from the NICHD [R01 HD057543, R01 HD056103]; Office of Dietary Supplements; National Institute of Neurological Disorders and Stroke [U54NS078059]; Muscular Dystrophy Association; Fundacao Amparo a Pesquisa Sao Paulo; American Heart Association [0930151N]; American Society of Nephrology; NICHD; MRC [G1000848] Funding Source: UKRI; Medical Research Council [G1000848] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056103, R01HD057543, K23HD065871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS078059] Funding Source: NIH RePORTER	Marriott Mitochondrial Disorder Clinical Research Fund; National Institute of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH from the NICHD; Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Muscular Dystrophy Association(Muscular Dystrophy Association); Fundacao Amparo a Pesquisa Sao Paulo; American Heart Association(American Heart Association); American Society of Nephrology; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to all of the affected individuals and relatives and Ali Gharavi for their collaborations. The work was partially supported by the Marriott Mitochondrial Disorder Clinical Research Fund. C.M.Q. is supported by National Institute of Health (NIH) grant K23 HD065871 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD). M.H. is supported by NIH grants R01 HD057543 and R01 HD056103 from the NICHD and the Office of Dietary Supplements, as well as U54NS078059 from the National Institute of Neurological Disorders and Stroke and the NICHD, and a grant from the Muscular Dystrophy Association. M.H.B. and C.C.F.B. are supported by Fundacao Amparo a Pesquisa Sao Paulo. S.S.C. is supported by the American Heart Association Scientist Development Grant 0930151N and by the American Society of Nephrology Carl W. Gottschalk Research Scholar Grant.	Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252; Ferreiro-Barros CC, 2008, J NEUROL SCI, V275, P128, DOI 10.1016/j.jns.2008.08.028; Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Isohanni P, 2010, J MED GENET, V47, P66, DOI 10.1136/jmg.2009.068221; Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; Rotig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; Smits P, 2011, EUR J HUM GENET, V19, P275, DOI 10.1038/ejhg.2010.208; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559; Vedrenne V, 2012, J HEPATOL, V56, P294, DOI 10.1016/j.jhep.2011.06.014; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Yoo YA, 2005, MOL CELL BIOL, V25, P6603, DOI 10.1128/MCB.25.15.6603-6616.2005; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004; Zhou XJ, 2011, PLANT PHYSIOL, V157, P1793, DOI 10.1104/pp.111.185827	35	24	26	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					729	736		10.1016/j.ajhg.2012.08.019	http://dx.doi.org/10.1016/j.ajhg.2012.08.019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23022099	Green Published, Bronze			2022-12-18	WOS:000309568500015
J	Camacho-Vanegas, O; Camacho, SC; Till, J; Miranda-Lorenzo, I; Terzo, E; Ramirez, MC; Schramm, V; Cordovano, G; Watts, G; Mehta, S; Kimonis, V; Hoch, B; Philibert, KD; Raabe, CA; Bishop, DF; Glucksman, MJ; Martignetti, JA				Camacho-Vanegas, Olga; Camacho, Sandra Catalina; Till, Jacob; Miranda-Lorenzo, Irene; Terzo, Esteban; Ramirez, Maria Celeste; Schramm, Vern; Cordovano, Grace; Watts, Giles; Mehta, Sarju; Kimonis, Virginia; Hoch, Benjamin; Philibert, Keith D.; Raabe, Carsten A.; Bishop, David F.; Glucksman, Marc J.; Martignetti, John A.			Primate Genome Gain and Loss: A Bone Dysplasia, Muscular Dystrophy, and Bone Cancer Syndrome Resulting from Mutated Retroviral-Derived MTAP Transcripts	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MALIGNANT FIBROUS HISTIOCYTOMA; DIAPHYSEAL MEDULLARY STENOSIS; METHYLTHIOADENOSINE PHOSPHORYLASE; HOMOZYGOUS DELETIONS; MESSENGER-RNA; CELL-LINES; POLYAMINES; INTERFERON; ENZYME; COMMON	Diaphyseal medullary stenosis with malignant fibrous histiocytoma (DMS-MFH) is an autosomal-dominant syndrome characterized by bone dysplasia, myopathy, and bone cancer. We previously mapped the DMS-MFH tumor-suppressing-gene locus to chromosomal region 9p21-22 but failed to identify mutations in known genes in this region. We now demonstrate that DMS-MFH results from mutations in the most proximal of three previously uncharacterized terminal exons of the gene encoding methylthioadenosine phosphorylase, MTAP. Intriguingly, two of these MTAP exons arose from early and independent retroviral-integration events in primate genomes at least 40 million years ago, and since then, their genomic integration has gained a functional role. MTAP is a ubiquitously expressed homotrimeric-subunit enzyme critical to polyamine metabolism and adenine and methionine salvage pathways and was believed to be encoded as a single transcript from the eight previously described exons. Six distinct retroviral-sequence-containing MTAP isoforms, each of which can physically interact with archetype MTAP, have been identified. The disease-causing mutations occur within one of these retroviral-derived exons and result in exon skipping and dysregulated alternative splicing of all MTAP isoforms. Our results identify a gene involved in the development of bone sarcoma, provide evidence of the primate-specific evolution of certain parts of an existing gene, and demonstrate that mutations in parts of this gene can result in human disease despite its relatively recent origin.	[Camacho-Vanegas, Olga; Camacho, Sandra Catalina; Till, Jacob; Miranda-Lorenzo, Irene; Terzo, Esteban; Ramirez, Maria Celeste; Bishop, David F.; Martignetti, John A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Schramm, Vern; Cordovano, Grace] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Watts, Giles; Mehta, Sarju; Kimonis, Virginia] Univ Calif Irvine, Irvine, CA 92868 USA; [Philibert, Keith D.; Glucksman, Marc J.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Midw Proteome Ctr, Chicago, IL 60064 USA; [Philibert, Keith D.; Glucksman, Marc J.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, Chicago, IL 60064 USA; [Hoch, Benjamin] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [Raabe, Carsten A.] Univ Munster, Inst Expt Pathol, D-48149 Munster, Germany; [Martignetti, John A.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Martignetti, John A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Irvine; Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science; Icahn School of Medicine at Mount Sinai; University of Munster; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Martignetti, JA (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	john.martignetti@mssm.edu	Bishop, David F./X-4102-2019	Till, Jacob/0000-0002-2824-1282				Appleby TC, 1999, STRUCTURE, V7, P629, DOI 10.1016/S0969-2126(99)80084-7; ARNOLD WH, 1973, ANN INTERN MED, V78, P902, DOI 10.7326/0003-4819-78-6-902; Baertsch R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-466; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Christopher SA, 2002, CANCER RES, V62, P6639; DELLARAGIONE F, 1986, J BIOL CHEM, V261, P2324; DELLARAGIONE F, 1990, J BIOL CHEM, V265, P6241; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; DIAZ MO, 1990, NEW ENGL J MED, V322, P77, DOI 10.1056/NEJM199001113220202; Dowling O, 2003, AM J HUM GENET, V73, P957, DOI 10.1086/378781; Fearon ER, 1997, SCIENCE, V278, P1043, DOI 10.1126/science.278.5340.1043; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; Garcia-Castellano JM, 2002, CLIN CANCER RES, V8, P782; GHANDURMNAYMNEH L, 1982, CANCER-AM CANCER SOC, V49, P698, DOI 10.1002/1097-0142(19820215)49:4<698::AID-CNCR2820490418>3.0.CO;2-7; HARDCASTLE P, 1986, J BONE JOINT SURG AM, V68A, P1079, DOI 10.2106/00004623-198668070-00017; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Harris SP, 2000, AM J PHYSIOL-HEART C, V279, pH1383, DOI 10.1152/ajpheart.2000.279.3.H1383; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; HENRY E W, 1958, Can Med Assoc J, V78, P331; Huang HY, 2009, CLIN CANCER RES, V15, P6963, DOI 10.1158/1078-0432.CCR-09-1511; Jeon DG, 2011, CLIN ORTHOP RELAT R, V469, P584, DOI 10.1007/s11999-010-1428-z; KAMATANI N, 1981, P NATL ACAD SCI-BIOL, V78, P1219, DOI 10.1073/pnas.78.2.1219; KAMATANI N, 1982, BLOOD, V60, P1387; Karikari CA, 2005, MOL CANCER THER, V4, P1860, DOI 10.1158/1535-7163.MCT-05-0103; Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Krull M, 2005, MOL BIOL EVOL, V22, P1702, DOI 10.1093/molbev/msi164; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LUKEIS R, 1990, GENE CHROMOSOME CANC, V2, P116, DOI 10.1002/gcc.2870020207; Martignetti JA, 1999, AM J HUM GENET, V64, P801, DOI 10.1086/302297; Martignetti JA, 2000, GENE CHROMOSOME CANC, V27, P191, DOI 10.1002/(SICI)1098-2264(200002)27:2<191::AID-GCC11>3.0.CO;2-L; Mayer J, 2005, CYTOGENET GENOME RES, V110, P448, DOI 10.1159/000084977; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mitelman F., 1994, CATALOG CHROMOSOME A; MIYAKOSHI J, 1990, CANCER RES, V50, P278; Miyazaki S, 2007, INT J ONCOL, V31, P1069; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Nobori T, 1996, P NATL ACAD SCI USA, V93, P6203, DOI 10.1073/pnas.93.12.6203; Norton KI, 1996, PEDIATR RADIOL, V26, P675, DOI 10.1007/BF01356833; OLOPADE OI, 1992, CANCER RES, V52, P2523; Picci P, 1997, ANN ONCOL, V8, P1107, DOI 10.1023/A:1008283516969; SAVARESE TM, 1981, BIOCHEM PHARMACOL, V30, P189, DOI 10.1016/0006-2952(81)90077-0; Schmid M, 1998, ONCOGENE, V17, P2669, DOI 10.1038/sj.onc.1202205; Schramm VL, 2007, J BIOL CHEM, V282, P28297, DOI 10.1074/jbc.R700018200; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stevens AP, 2009, J CELL BIOCHEM, V106, P210, DOI 10.1002/jcb.21984; Subhi AL, 2004, CLIN CANCER RES, V10, P7290, DOI 10.1158/1078-0432.CCR-04-0972; TAKIGAWA M, 1990, BIOCHEM BIOPH RES CO, V171, P1264, DOI 10.1016/0006-291X(90)90822-5; Tantini B, 2006, J MOL CELL CARDIOL, V40, P775, DOI 10.1016/j.yjmcc.2006.03.002; TRACKMAN PC, 1981, BIOCHEM BIOPH RES CO, V103, P1238, DOI 10.1016/0006-291X(81)90255-2; TRACKMAN PC, 1983, J BIOL CHEM, V258, P6717; vanderKooi AJ, 1996, ANN NEUROL, V39, P638; Volff J. -N., 2007, V3, P175, DOI 10.1159/000107611; Watts GDJ, 2005, HUM GENET, V118, P508, DOI 10.1007/s00439-005-0075-z; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X	65	24	26	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					614	627		10.1016/j.ajhg.2012.02.024	http://dx.doi.org/10.1016/j.ajhg.2012.02.024			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22464254	Green Published, Bronze			2022-12-18	WOS:000302833400004
J	Boyden, ED; Campos-Xavier, AB; Kalamajski, S; Cameron, TL; Suarez, P; Tanackovich, G; Andria, G; Ballhausen, D; Briggs, MD; Hartley, C; Cohn, DH; Davidson, HR; Hal, C; Ikegawa, S; Jouk, PS; Konig, R; Megarbane, A; Nishimura, G; Lachman, RS; Mortier, G; Rimoin, DL; Rogers, RC; Rossi, M; Sawada, H; Scott, R; Unger, S; Valadares, ER; Bateman, JF; Warman, ML; Superti-Furga, A; Bonafe, L				Boyden, Eric D.; Campos-Xavier, A. Belinda; Kalamajski, Sebastian; Cameron, Trevor L.; Suarez, Philippe; Tanackovich, Goranka; Andria, Generoso; Ballhausen, Diana; Briggs, Michael D.; Hartley, Claire; Cohn, Daniel H.; Davidson, H. Rosemarie; Hal, Christine; Ikegawa, Shiro; Jouk, Pierre-Simon; Koenig, Rainer; Megarbane, Andre; Nishimura, Gen; Lachman, Ralph S.; Mortier, Geert; Rimoin, David L.; Rogers, R. Curtis; Rossi, Massimiliano; Sawada, Hirotake; Scott, Richard; Unger, Sheila; Valadares, Eugenia Ribeiro; Bateman, John F.; Warman, Matthew L.; Superti-Furga, Andrea; Bonafe, Luisa			Recurrent Dominant Mutations Affecting Two Adjacent Residues in the Motor Domain of the Monomeric Kinesin KIF22 Result in Skeletal Dysplasia and Joint Laxity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISLOCATIONS HALL TYPE; SPONDYLOEPIMETAPHYSEAL DYSPLASIA; MULTIPLE DISLOCATIONS; LEPTODACTYLIC FORM; DIAGNOSTIC FEATURE; CHROMOKINESIN KID; DISTINCT FORM; CLASSIFICATION; INHERITANCE; DISORDERS	Spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type (lepto-SEMDJL, aka SEMDJL, Hall type), is an autosomal dominant skeletal disorder that, in spite of being relatively common among skeletal dysplasias, has eluded molecular elucidation so far. We used whole-exome sequencing of five unrelated individuals with lepto-SEMDJL to identify mutations in KIF22 as the cause of this skeletal condition. Missense mutations affecting one of two adjacent amino acids in the motor domain of KIF22 were present in 20 familial cases from eight families and in 12 other sporadic cases. The skeletal and connective tissue phenotype produced by these specific mutations point to functions of KIF22 beyond those previously ascribed functions involving chromosome segregation. Although we have found Kif22 to be strongly upregulated at the growth plate, the precise pathogenetic mechanisms remain to be elucidated.	[Campos-Xavier, A. Belinda; Suarez, Philippe; Ballhausen, Diana; Superti-Furga, Andrea; Bonafe, Luisa] CHU Vaudois, Div Mol Pediat, CH-1011 Lausanne, Switzerland; [Boyden, Eric D.; Kalamajski, Sebastian; Warman, Matthew L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp Boston, Boston, MA 02115 USA; [Cameron, Trevor L.; Bateman, John F.] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Tanackovich, Goranka] Univ Lausanne, Dept Med Genet, CH-1011 Lausanne, Switzerland; [Andria, Generoso; Rossi, Massimiliano] Univ Naples Federico II, Dept Pediat, I-80131 Naples, Italy; [Briggs, Michael D.; Hartley, Claire] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Cohn, Daniel H.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90048 USA; [Cohn, Daniel H.] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90048 USA; [Davidson, H. Rosemarie] Yorkhill Hosp, Ferguson Smith Ctr Clin Genet, Glasgow G3 8SJ, Lanark, Scotland; [Hal, Christine] Great Ormond St Hosp Sick Children, Inst Child Hlth, Dept Radiol, London WC1N 3JH, England; [Ikegawa, Shiro] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Jouk, Pierre-Simon] CHU Grenoble, Dept Genet & Procreat, F-38043 Grenoble, France; [Koenig, Rainer] Johann Wolfgang Goethe Univ Hosp, Inst Human Genet, D-60590 Frankfurt, Germany; [Megarbane, Andre] Univ St Joseph, INSERM, Unite Genet Med & Lab Associe, Beirut, Lebanon; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Radiol & Med Imaging, Fuchu, Tokyo 1838561, Japan; [Lachman, Ralph S.; Rimoin, David L.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Mortier, Geert] Univ Antwerp, Univ Antwerp Hosp, Dept Med Genet, B-2650 Edegem, Belgium; [Rimoin, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Rimoin, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat & Med, Los Angeles, CA 90095 USA; [Rogers, R. Curtis] Greenwood Genet Ctr, Greenville, SC 29605 USA; [Sawada, Hirotake] Miyazaki Univ, Dept Pediat, Miyazaki Med Coll, Miyazaki 8891692, Japan; [Scott, Richard] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Unger, Sheila] CHU Vaudois, Dept Med Genet, CH-1011 Lausanne, Switzerland; [Valadares, Eugenia Ribeiro] Univ Fed Minas Gerais, Fac Med, Lab & Clin Inborn Errors Metab, BR-30130100 Belo Horizonte, MG, Brazil; [Bateman, John F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Murdoch Children's Research Institute; University of Lausanne; University of Naples Federico II; University of Manchester; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; RIKEN; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Goethe University Frankfurt; Goethe University Frankfurt Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Saint Joseph University Beirut; Tokyo Metropolitan Children's Medical Center; Cedars Sinai Medical Center; University of Antwerp; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Greenwood Genetic Center; University of Miyazaki; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universidade Federal de Minas Gerais; University of Melbourne	Bonafe, L (corresponding author), CHU Vaudois, Div Mol Pediat, CH-1011 Lausanne, Switzerland.	luisa.bonafe@chuv.ch	Ikegawa, Shiro/N-6895-2015; Rossi, Massimiliano/AAO-5615-2020; Jouk, Pierre-Simon/M-7367-2014; superti-furga, andrea/E-9162-2015; Mortier, Geert/D-2542-2012; unger, sheila/E-9177-2015; Melis, Daniela/AAD-3623-2019; Valadares, Eugenia Ribeiro/D-7110-2013; andria, generoso/V-7172-2019; Megarbane, Andre/ABD-5574-2021; Jouk, Pierre-Simon/AAB-5262-2022	Ikegawa, Shiro/0000-0003-0316-2147; Rossi, Massimiliano/0000-0002-5797-8152; superti-furga, andrea/0000-0002-3543-7531; Mortier, Geert/0000-0001-9871-4578; Melis, Daniela/0000-0002-9458-3926; Jouk, Pierre-Simon/0000-0001-8301-320X; Campos-Xavier, Belinda/0000-0002-6271-0724; Kalamajski, Sebastian/0000-0002-6600-9302; Unger, Sheila/0000-0002-9539-8941; Ballhausen, Diana/0000-0003-2940-3439; Bateman, John/0000-0001-8542-0730	Howard Hughes Medical Institute; Swiss National Research Foundation [310030_132940]; National Institutes of Health [HD22657]; National Health and Medical Research Council of Australia [607398]; Victorian Government; Leenaards Foundation (Lausanne, Switzerland); Faculty of Biology and Medicine of the Lausanne University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Leenaards Foundation (Lausanne, Switzerland); Faculty of Biology and Medicine of the Lausanne University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Howard Hughes Medical Institute, by the Swiss National Research Foundation, grant 310030_132940 to L.B., by the National Institutes of Health grant HD22657 to D.H.C., and by the National Health and Medical Research Council of Australia, Project grant 607398 to J.F.B. and the Victorian Government's Operational Infrastructure Support Program. A.S.F. is supported by the Leenaards Foundation (Lausanne, Switzerland) and by the Faculty of Biology and Medicine of the Lausanne University (Fonds de Recherche en Pediatrie). We thank the staff of the Harvard Medical School Biopolymers Facility for assistance in exome sequencing. We are grateful to S. Miyagawa, Department of Pediatrics, Kure Medical Center, Japan, for collaboration in sample collection.	Ali Mahmood, 2004, Ophthalmic Genet, V25, P247, DOI 10.1080/13816810490498198; [Anonymous], INTEGRATIVE GENOMICS; Bowen ME, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002050; Cameron TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024600; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Gueye Y, 2011, GLIA, V59, P750, DOI 10.1002/glia.21146; Hall CM, 2002, J MED GENET, V39, P666, DOI 10.1136/jmg.39.9.666; Hall CM, 1998, J MED GENET, V35, P566, DOI 10.1136/jmg.35.7.566; Holder-Espinasse M, 2004, CLIN DYSMORPHOL, V13, P133, DOI 10.1097/01.mcd.0000130236.02981.c5; Kim OH, 2009, SKELETAL RADIOL, V38, P803, DOI 10.1007/s00256-009-0671-4; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Levesque AA, 2003, MOL BIOL CELL, V14, P3541, DOI 10.1091/mbc.E03-02-0082; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maddika S, 2009, J BIOL CHEM, V284, P12998, DOI 10.1074/jbc.M900333200; Megarbane A, 2003, AM J MED GENET A, V122A, P252, DOI 10.1002/ajmg.a.20262; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; NHLBI, NAT HEART LUNG BLOOD; Nishimura G, 2003, AM J MED GENET A, V117A, P147, DOI 10.1002/ajmg.a.10927; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Park SM, 2007, AM J MED GENET A, V143A, P2024, DOI 10.1002/ajmg.a.31857; Putoux A, 2011, NAT GENET, V43, P601, DOI 10.1038/ng.826; Riviere JB, 2011, AM J HUM GENET, V89, P219, DOI 10.1016/j.ajhg.2011.06.013; Rossi M, 2005, CLIN DYSMORPHOL, V14, P13, DOI 10.1097/00019605-200501000-00003; Schnaeker EM, 2004, CANCER RES, V64, P8924, DOI 10.1158/0008-5472.CAN-04-0324; Shiroguchi K, 2003, J BIOL CHEM, V278, P22460, DOI 10.1074/jbc.M212274200; Superti-Furga A, 2001, AM J MED GENET, V106, P282, DOI 10.1002/ajmg.10233; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang PF, 2011, INT J MOL MED, V28, P973, DOI 10.3892/ijmm.2011.759; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wiesner C, 2010, BLOOD, V116, P1559, DOI 10.1182/blood-2009-12-257089; Yajima J, 2003, EMBO J, V22, P1067, DOI 10.1093/emboj/cdg102; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; ZHU G, 2009, THESIS U HONG KONG H	36	24	26	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					767	772		10.1016/j.ajhg.2011.10.016	http://dx.doi.org/10.1016/j.ajhg.2011.10.016			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22152678	Bronze, Green Published			2022-12-18	WOS:000298208700008
J	Appenzeller, S; Schirmacher, A; Halfter, H; Baumer, S; Pendziwiat, M; Timmerman, V; De Jonghe, P; Fekete, K; Stogbauer, F; Ludemann, P; Hund, M; Quabius, ES; Ringelstein, EB; Kuhlenbaumer, G				Appenzeller, Silke; Schirmacher, Anja; Halfter, Hartmut; Baeumer, Sebastian; Pendziwiat, Manuela; Timmerman, Vincent; De Jonghe, Peter; Fekete, Klara; Stoegbauer, Florian; Luedemann, Peter; Hund, Margret; Quabius, Elgar Susanne; Ringelstein, E. Bernd; Kuhlenbaeumer, Gregor			Autosomal-Dominant Striatal Degeneration Is Caused by a Mutation in the Phosphodiesterase 8B Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARKINSONS-DISEASE; DOPAMINE-RECEPTORS; ORGANIZATION; LOCALIZATION; PDE8B	Autosomal-dominant striatal degeneration (ADSD) is an autosomal-dominant movement disorder affecting the striatal part of the basal ganglia. ADSD is characterized by bradykinesia, dysarthria, and Muscle rigidity. These symptoms resemble idiopathic Parkinson disease, but tremor is not present. Using genetic linkage analysis, we have mapped the causative genetic defect to a 3.25 megabase candidate region on chromosome 5q13.3-q14.1. A maximum LOD score of 4.1 (Theta = 0) was obtained at marker DSS1962. Here we show that ADSD is caused by a complex frameshift mutation (c.94G>C+c.95delT) in the phosphodiesterase 8B (PDE8B) gene, which results in a loss of enzymatic phosphodiesterase activity. We found that PDF8B is highly expressed in the brain, especially in the putamen, which is affected by ADSD. PDE8B degrades cyclic AMP, a second messenger implied in dopamine signaling. Dopamine is one of the main neurotransmitters involved in movement control and is deficient in Parkinson disease. We believe that the functional analysis of PDE8B will help to further elucidate the pathomechanism of ADSD as well as contribute to a better understanding of movement disorders.	[Appenzeller, Silke; Kuhlenbaeumer, Gregor] Univ Kiel, Inst Expt Med, Dept Mol Neurobiol, D-24105 Kiel, Germany; [Schirmacher, Anja; Halfter, Hartmut; Baeumer, Sebastian; Pendziwiat, Manuela; Ringelstein, E. Bernd] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Timmerman, Vincent; De Jonghe, Peter] VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; [Timmerman, Vincent; De Jonghe, Peter] Univ Antwerp, B-2610 Antwerp, Belgium; [Fekete, Klara] Univ Debrecen, Dept Neurol, H-4012 Debrecen, Hungary; [Stoegbauer, Florian] Klinikum Osnabruck, Dept Neurol, D-49076 Osnabruck, Germany; [Luedemann, Peter] St Franziskus Hosp Ahlen, D-59227 Ahlen, Germany; [Hund, Margret] Zurcher Hohenklin, CH-8639 Faltigberg, Switzerland; [Quabius, Elgar Susanne] Univ Kiel, Dept Immunol, D-24105 Kiel, Germany	University of Kiel; University of Munster; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Debrecen; University of Kiel	Kuhlenbaumer, G (corresponding author), Univ Kiel, Inst Expt Med, Dept Mol Neurobiol, D-24105 Kiel, Germany.	g.kuhlenbaeumer@neurologie.uni-kiel.de	Kuhlenbäumer, Gregor/A-5110-2009; Timmerman, Vincent/O-7283-2019; Baeumer, Sebastian/GYU-0544-2022	Timmerman, Vincent/0000-0002-2162-0933; Appenzeller, Silke/0000-0002-5472-8692				Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Dekker MCJ, 2003, BRAIN, V126, P1722, DOI 10.1093/brain/awg172; Gamanuma M, 2003, CELL SIGNAL, V15, P565, DOI 10.1016/S0898-6568(02)00146-8; Hayashi M, 2002, BIOCHEM BIOPH RES CO, V297, P1253, DOI 10.1016/S0006-291X(02)02371-9; Hayashi M, 1998, BIOCHEM BIOPH RES CO, V250, P751, DOI 10.1006/bbrc.1998.9379; Horvath A, 2008, EUR J HUM GENET, V16, P1245, DOI 10.1038/ejhg.2008.85; Kruger R, 2002, TRENDS MOL MED, V8, P236, DOI 10.1016/S1471-4914(02)02333-X; Kuhlenbaumer G, 2004, NEUROLOGY, V62, P2203, DOI 10.1212/01.WNL.0000130485.89814.10; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189	10	24	25	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2010	86	1					83	87		10.1016/j.ajhg.2009.12.003	http://dx.doi.org/10.1016/j.ajhg.2009.12.003			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	554XZ	20085714	Bronze, Green Published			2022-12-18	WOS:000274471200009
J	Newcombe, PJ; Verzilli, C; Casas, JP; Hingorani, AD; Smeeth, L; Whittaker, JC				Newcombe, Paul J.; Verzilli, Claudio; Casas, Juan P.; Hingorani, Aroon D.; Smeeth, Liam; Whittaker, John C.			Multilocus Bayesian Meta-Analysis of Gene-Disease Associations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ISCHEMIC-STROKE; PHOSPHODIESTERASE 4D; COMPLEX DISEASES; PDE4D GENE; POLYMORPHISMS; RISK; SETS	Meta-analysis is a vital tool in genetic epidemiology. However, meta-analyses to identify gene-disease associations are compromised when contributing studies have typed partially overlapping sets of markers. Currently, only marginal analyses are possible, and these are restricted to the subset of studies typing that marker. This does not allow full use of available data and leads to the confounding of marker effects by closely associated markers. We present a Bayesian approach that exploits prior information on underlying haplotypes to allow multi-marker analysis incorporating data from all relevant studies of a gene or region, irrespective of the markers typed. We present results from application of our approach to data on a possible association between PDE4D and ischemic stroke.	[Newcombe, Paul J.; Verzilli, Claudio; Casas, Juan P.; Smeeth, Liam; Whittaker, John C.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, London WC1E 6JJ, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Whittaker, JC (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England.	john.whittaker@lshtm.ac.uk	Smeeth, Liam/X-5862-2018; Whittaker, John/B-8609-2012	Smeeth, Liam/0000-0002-9168-6022; Whittaker, John/0000-0002-3529-2379; Hingorani, Aroon/0000-0001-8365-0081	Wellcome Trust Senior Research Fellowship in Clinical Science [G0600580]; MRC [G0600580] Funding Source: UKRI; Medical Research Council [G0600580] Funding Source: researchfish	Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council research grant G0600580. L.S. was supported by a Wellcome Trust Senior Research Fellowship in Clinical Science. A.D.H. holds a British Heart Foundation Senior Research Fellowship (FS05/125).	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bevan S, 2008, STROKE, V39, P1966, DOI 10.1161/STROKEAHA.107.509992; Bishop YM., 2007, DISCRETE MULTIVARIAT; Brophy VH, 2006, STROKE, V37, P1385, DOI 10.1161/01.STR.0000221788.10723.66; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; GILKS W, 1996, PRACTICE; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Kuhlenbaumer G, 2006, J NEUROL NEUROSUR PS, V77, P521, DOI 10.1136/jnnp.2005.073577; Lunn DJ, 2006, GENET EPIDEMIOL, V30, P231, DOI 10.1002/gepi.20140; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Meschia JF, 2005, ANN NEUROL, V58, P351, DOI 10.1002/ana.20585; Seaman SR, 2004, BIOMETRIKA, V91, P15, DOI 10.1093/biomet/91.1.15; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES; Staton JM, 2006, J NEUROL NEUROSUR PS, V77, P1067, DOI 10.1136/jnnp.2006.092106; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Verzilli C, 2008, AM J HUM GENET, V82, P859, DOI 10.1016/j.ajhg.2008.01.016; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Woo D, 2006, STROKE, V37, P371, DOI 10.1161/01.STR.0000198843.72824.0a; Zee RYL, 2006, STROKE, V37, P2012, DOI 10.1161/01.STR.0000230608.56048.38; Zeggini E, 2005, NAT GENET, V37, P1320, DOI 10.1038/ng1670	26	24	25	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					567	580		10.1016/j.ajhg.2009.04.001	http://dx.doi.org/10.1016/j.ajhg.2009.04.001			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19409523	Green Published, Bronze			2022-12-18	WOS:000266338800002
J	Tan, JT; Kremer, F; Freddi, S; Bell, KM; Lamande, SR; Bateman, JE				Tan, Jacqueline T.; Kremer, Friederike; Freddi, Susanna; Bell, Katrina M.; Lamande, Shireen R.; Bateman, John E.			Competency for nonsense-mediated reduction in collagen X mRNA is specified by the 3 ' UTR and corresponds to the position of mutations in schmid metaphyseal chondrodysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; IN-VITRO; GROWTH-PLATE; DECAY; SURVEILLANCE; TERMINATION; NC1; COL10A1; INTRON; DOMAIN	Nonsense-mediated decay (NMD) is a eukaryotic cellular RNA surveillance and quality-control mechanism that degrades mRNA containing premature stop codons (nonsense mutations) that otherwise may exert a deleterious effect by the production of dysfunctional truncated proteins. Collagen X (COL10A1) nonsense mutations in Schmid-type metaphyseal chondrodysplasia are localized in a region toward the 3' end of the last exon (exon 3) and result in mRNA decay, in contrast to most other genes in which terminal-exon nonsense mutations are resistant to NMD. We introduce nonsense mutations into the mouse Col10al gene and express these in a hypertrophic-chondrocyte cell line to explore the mechanism of last-exon mRNA decay of Col10al and demonstrate that mRNA decay is spatially restricted to mutations occurring in a 3' region of the exon 3 coding sequence; this region corresponds to where human mutations have been described. This localization of mRNA-decay competency suggested that a downstream region, such as the 3' UTR, may play a role in specifying decay of mutant Col10al mRNA containing nonsense mutations. We found that deleting any of the three conserved sequence regions within the 3' UTR (region 1, 23 bp; region 11, 170 bp; and region 111, 76 bp) prevented mutant mRNA decay, but a smaller 13 bp deletion within region III was permissive for decay. These data suggest that the 3' UTR participates in collagen X last-exon mRNA decay and that overall 3' UTR configuration, rather than specific linear-sequence motifs, maybe important in specifying decay of Col10al mRNA containing nonsense mutations.	[Tan, Jacqueline T.; Kremer, Friederike; Freddi, Susanna; Bell, Katrina M.; Lamande, Shireen R.; Bateman, John E.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Lamande, Shireen R.; Bateman, John E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Bateman, JE (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	john.bateman@mcri.edu.au		Lamande, Shireen/0000-0003-2938-2711; Bateman, John/0000-0001-8542-0730				Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Bateman JF, 2005, HUM MUTAT, V25, P525, DOI 10.1002/humu.20183; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Behm-Ansmant I, 2006, GENE DEV, V20, P391, DOI 10.1101/gad.1407606; Byers PH, 2002, J CLIN INVEST, V109, P3, DOI 10.1172/JCI14841; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chan D, 1998, MATRIX BIOL, V17, P169, DOI 10.1016/S0945-053X(98)90056-7; CHAN D, 1995, J BIOL CHEM, V270, P4558, DOI 10.1074/jbc.270.9.4558; Chan D, 1996, J BIOL CHEM, V271, P13566, DOI 10.1074/jbc.271.23.13566; Chan D, 1999, J BIOL CHEM, V274, P13091, DOI 10.1074/jbc.274.19.13091; Chan D, 1998, J CLIN INVEST, V101, P1490, DOI 10.1172/JCI1976; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chou YT, 2006, J BIOL CHEM, V281, P18451, DOI 10.1074/jbc.M601720200; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gregory CA, 2000, J MED GENET, V37, P627, DOI 10.1136/jmg.37.8.627; HAGAN KW, 1995, MOL CELL BIOL, V15, P809; Harries LW, 2005, HUM GENET, V118, P214, DOI 10.1007/s00439-005-0023-y; Ho MSP, 2007, HUM MOL GENET, V16, P1201, DOI 10.1093/hmg/ddm067; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; KONG RYC, 1993, EUR J BIOCHEM, V213, P99, DOI 10.1111/j.1432-1033.1993.tb17739.x; Lamande SR, 1998, HUM MOL GENET, V7, P981, DOI 10.1093/hmg/7.6.981; LEFEBVRE V, 1995, J CELL BIOL, V128, P239, DOI 10.1083/jcb.128.1.239; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Maquat LE, 2002, CURR BIOL, V12, pR196, DOI 10.1016/S0960-9822(02)00747-9; Maquat LE, 2002, GENE DEV, V16, P1743, DOI 10.1101/gad.1014502; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Peat RA, 2007, NEUROMUSCULAR DISORD, V17, P547, DOI 10.1016/j.nmd.2007.03.017; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Ruiz-Echevarria MJ, 1998, EMBO J, V17, P575, DOI 10.1093/emboj/17.2.575; Schell T, 2002, GENOME BIOL, V3; Singh G, 2003, TRENDS BIOCHEM SCI, V28, P464, DOI 10.1016/S0968-0004(03)00176-2; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Wilkinson MF, 2003, MOL CELL, V12, P1059, DOI 10.1016/S1097-2765(03)00448-9; Wilson R, 2005, J BIOL CHEM, V280, P15544, DOI 10.1074/jbc.M410758200; Wilson R, 2002, J BIOL CHEM, V277, P12516, DOI 10.1074/jbc.M112044200; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang MC, 1999, MOL CELL BIOL, V19, P7314	42	24	25	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					786	793		10.1016/j.ajhg.2008.01.006	http://dx.doi.org/10.1016/j.ajhg.2008.01.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18304492	Bronze, Green Published			2022-12-18	WOS:000254067800024
J	Jarmuz, M; Glotzbach, CD; Bailey, KA; Bandyopadhyay, R; Shaffer, LG				Jarmuz, Malgorzata; Glotzbach, Caron D.; Bailey, Kristen A.; Bandyopadhyay, Ruma; Shaffer, Lisa G.			The evolution of satellite III DNA subfamilies among primates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN ACROCENTRIC CHROMOSOMES; 14P+ VARIANT; RDNA; SEQUENCES; PATTERNS; HETEROCHROMATIN; TRANSLOCATIONS; AMPLIFICATION; LOCATION	We demonstrate that satellite III (SatIII) DNA subfamilies cloned from human acrocentric chromosomes arose in the Hominoidea superfamily. Two groups, distinguished by sequence composition, evolved nonconcurrently, with group 2 evolving 16-23 million years ago (MYA) and the more recent group 1 sequences emerging similar to 4.5 MYA. We also show the relative order of emergence of each group 2 subfamily in the various primate species. Our results show that each SatIII subfamily is an independent evolutionary unit, that the rate of evolution is not uniform between species, and that the evolution within a species is not uniform between chromosomes.	Washington State Univ, Hlth Res & Educ Ctr, Spokane, WA 99210 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Washington State University; Baylor College of Medicine	Shaffer, LG (corresponding author), Washington State Univ, Hlth Res & Educ Ctr, Box 1495, Spokane, WA 99210 USA.	lshaffer@wsu.edu		Jarmuz-Szymczak, Malgorzata/0000-0003-0437-5806				Bandyopadhyay R, 2001, CHROMOSOME RES, V9, P223, DOI 10.1023/A:1016648404388; CHOO KH, 1990, NUCLEIC ACIDS RES, V18, P5641, DOI 10.1093/nar/18.19.5641; CHOO KH, 1989, GENOMICS, V5, P332, DOI 10.1016/0888-7543(89)90066-9; CHOO KHA, 1992, AM J HUM GENET, V50, P706; COOKE HJ, 1979, NUCLEIC ACIDS RES, V6, P3177, DOI 10.1093/nar/6.10.3177; COOKE HJ, 1982, CHROMOSOMA, V87, P491, DOI 10.1007/BF00333470; DALE S, 1989, HUM GENET, V82, P154, DOI 10.1007/BF00284049; EARLE E, 1989, HUM GENET, V82, P187, DOI 10.1007/BF00284055; FOWLER JCS, 1989, MOL BIOL EVOL, V6, P553; Gonzalez IL, 2001, GENOMICS, V73, P255, DOI 10.1006/geno.2001.6540; GOSDEN JR, 1981, HUM GENET, V58, P276, DOI 10.1007/BF00294922; GOSDEN JR, 1981, AM J HUM GENET, V33, P243; Hall SE, 2003, GENOME RES, V13, P195, DOI 10.1101/gr.593403; HAN JY, 1994, AM J HUM GENET, V55, P960; HENDERSON AS, 1979, CYTOGENET CELL GENET, V23, P213, DOI 10.1159/000131328; HENDERSON AS, 1977, CYTOGENET CELL GENET, V19, P281, DOI 10.1159/000130821; HENDERSON AS, 1976, CHROMOSOMA, V59, P147, DOI 10.1007/BF00328483; Hirai H, 1999, CHROMOSOME RES, V7, P531, DOI 10.1023/A:1009237412155; John B, 1979, Int Rev Cytol, V58, P1, DOI 10.1016/S0074-7696(08)61473-4; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; KOEHLER U, 1995, GENOMICS, V30, P287, DOI 10.1006/geno.1995.9875; Metz A, 2004, J CELL SCI, V117, P4551, DOI 10.1242/jcs.01329; MITCHELL AR, 1981, NUCLEIC ACIDS RES, V9, P3235, DOI 10.1093/nar/9.14.3235; MOYZIS RK, 1987, CHROMOSOMA, V95, P375, DOI 10.1007/BF00333988; Mravinac B, 2004, GENE, V332, P169, DOI 10.1016/j.gene.2004.02.055; NAKAHORI Y, 1986, NUCLEIC ACIDS RES, V14, P7569, DOI 10.1093/nar/14.19.7569; QUIRK S, 1985, CYTOGENET CELL GENET, V39, P134, DOI 10.1159/000132121; SCHWARZACHERROBINSON T, 1988, CYTOGENET CELL GENET, V47, P192, DOI 10.1159/000132547; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; Ugarkovic D, 2005, EMBO REP, V6, P1035, DOI 10.1038/sj.embor.7400558; Ugarkovic D, 2002, EMBO J, V21, P5955, DOI 10.1093/emboj/cdf612; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	32	24	24	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					495	501		10.1086/512132	http://dx.doi.org/10.1086/512132			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273970	Green Published, Bronze			2022-12-18	WOS:000244403300010
J	Radhakrishna, U; Ratnamala, U; Gaines, M; Beiraghi, S; Hutchings, D; Golla, J; Husain, SA; Gambhir, PS; Sheth, JJ; Sheth, FJ; Chetan, GK; Naveed, M; Solanki, JV; Patel, UC; Master, DC; Memon, R; Antonarakis, GS; Antonarakis, SE; Nath, SK				Radhakrishna, Uppala; Ratnamala, Uppala; Gaines, Mathew; Beiraghi, Soraya; Hutchings, David; Golla, Jeffrey; Husain, Syed A.; Gambhir, Prakash S.; Sheth, Jayesh J.; Sheth, Frenny J.; Chetan, Ghati K.; Naveed, Mohammed; Solanki, Jitendra V.; Patel, Uday C.; Master, Dilipkumar C.; Memon, Rafiq; Antonarakis, Gregory S.; Antonarakis, Stylianos E.; Nath, Swapan K.			Genomewide scan for nonsyndromic cleft lip and palate in multigenerational Indian families reveals significant evidence of linkage at 13q33.1-34	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; MICROSATELLITE MARKERS; CHROMOSOMAL REGIONS; MULTIPLEX FAMILIES; ANKYLOGLOSSIA CPX; OROFACIAL CLEFT; PARTIAL TRISOMY; DISTAL SEGMENT; LONG ARM; GENE	Nonsyndromic cleft lip with or without cleft palate (CL-P) is a common congenital anomaly with incidence ranging from 1 in 300 to 1 in 2,500 live births. We analyzed two Indian pedigrees (UR017 and UR019) with isolated, nonsyndromic CL-P, in which the anomaly segregates as an autosomal dominant trait. The phenotype was variable, ranging from unilateral to bilateral CL-P. A genomewide linkage scan that used similar to 10,000 SNPs was performed. Nonparametric linkage (NPL) analysis identified 11 genomic regions (NPL > 3.5; P < .005) that could potentially harbor CL-P susceptibility variations. Among those, the most significant evidence was for chromosome 13q33.1-34 at marker rs1830756 . This was also supported by parametric linkage; MOD score (LOD scores maximized over genetic NPL p 5.57 P p.00024 model parameters) analysis favored an autosomal dominant model. The maximum LOD score was 4.45, and heterogeneity LOD was 4.45 (alpha = 100%). Haplotype analysis with informative crossovers enabled the mapping of the CL-P locus to a region of similar to 20.17 cM (7.42 Mb) between SNPs rs951095 and rs726455. Thus, we have identified a novel genomic region on 13q33.1-34 that harbors a high-risk variant for CL-P in these Indian families.	Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; Fdn Res Genet & Endocrinol, Ahmadabad, Gujarat, India; Oklahoma Med Res Fdn, Arthritis & Immunol Res Program, Oklahoma City, OK 73104 USA; Univ Minnesota, Div Pediat Dent, Minneapolis, MN USA; Jamia Millia Islamia, Dept Biosci, New Delhi, India; Bryramjee Jeejeebhoy Med Coll, Dept Pediat, Pune, Maharashtra, India; Natl Inst Mental Hlth & Neurosci, Dept Human Genet, Bangalore, Karnataka, India; Canadian Specialist Hosp, Dubai, U Arab Emirates; Gujarat Agr Univ, Dept Anim Genet, Anand, Gujarat, India; Gujarat Agr Univ, Dept Breeding, Anand, Gujarat, India; Sir Sayajirao Gaekwad Hosp, Vadodara, India; Coll Med, Div Human Mol Genet, Dept Anat, Vadodara, India	University of Geneva; Oklahoma Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; Jamia Millia Islamia; National Institute of Mental Health & Neurosciences - India; Anand Agricultural University; Anand Agricultural University; Maharaja Sayajirao University Baroda; Baroda Medical College	Radhakrishna, U (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, 1 Rue Miche Servet, CH-1211 Geneva, Switzerland.	uppala@medecine.unige.ch	Antonarakis, Gregory/ABA-1855-2020; Sheth, Jayesh J./L-9966-2013; Naveed, Mohammed/S-3462-2019; Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Gregory/0000-0001-6741-6922; Antonarakis, Stylianos E/0000-0001-8907-5823; Naveed, Mohammed/0000-0002-0351-0693				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ADEYOKUNNU A A, 1983, African Journal of Medicine and Medical Sciences, V12, P81; Ankola Anil V, 2005, J Indian Soc Pedod Prev Dent, V23, P80; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BEIRAGHI S, 1994, CLIN GENET, V46, P255; Berge SJ, 2001, ULTRASOUND OBST GYN, V18, P422, DOI 10.1046/j.0960-7692.2001.00575.x; Blanton SH, 2005, AM J MED GENET A, V137A, P259, DOI 10.1002/ajmg.a.30887; Blanton SH, 2004, AM J MED GENET A, V125A, P28, DOI 10.1002/ajmg.a.20423; Blanton SH, 2004, AM J MED GENET A, V125A, P23, DOI 10.1002/ajmg.a.20426; Brewer CM, 1999, AM J HUM GENET, V65, P387, DOI 10.1086/302498; Carreno H, 1999, REV MED CHILE, V127, P1189; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; DIXON MJ, 1993, AM J HUM GENET, V52, P907; EIBERG H, 1987, CLIN GENET, V32, P129; ESCOBAR JI, 1974, AM J DIS CHILD, V128, P221, DOI 10.1001/archpedi.1974.02110270095020; ESCOBAR JI, 1974, AM J DIS CHILD, V128, P217, DOI 10.1001/archpedi.1974.02110270091019; Field LL, 2004, AM J MED GENET A, V130A, P265, DOI 10.1002/ajmg.a.30252; FORBES SA, 1995, HUM GENET, V95, P342; GORSKI SM, 1992, AM J HUM GENET, V50, P1129; HABEDANK M, 1979, HUM GENET, V52, P91; Houdayer C, 2001, AM J MED GENET, V104, P86, DOI 10.1002/1096-8628(20011115)104:1<86::AID-AJMG10053>3.0.CO;2-E; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; JOTTERAND M, 1976, HUM GENET, V33, P213, DOI 10.1007/BF00286845; KAYE CI, 1977, CLEFT PALATE J, V14, P244; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Marazita ML, 2002, AM J HUM GENET, V71, P349, DOI 10.1086/341944; Marazita ML, 2002, CLEFT PALATE-CRAN J, V39, P149, DOI 10.1597/1545-1569(2002)039<0149:NCLWOW>2.0.CO;2; Martin GR, 1998, TRENDS PHARMACOL SCI, V19, P2, DOI 10.1016/S0165-6147(97)01143-7; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; MOORE GE, 1991, J CRAN GENET DEV BIO, V11, P372; Moreno LM, 2004, AM J MED GENET A, V125A, P135, DOI 10.1002/ajmg.a.20425; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; NAJAFZADEH TM, 1983, AM J MED GENET, V16, P15, DOI 10.1002/ajmg.1320160104; Noce TR, 2001, AM J MED GENET, V98, P145; NOEL B, 1976, CLIN GENET, V9, P593; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; PAAVOLA P, 1995, NAT GENET, V11, P213, DOI 10.1038/ng1095-213; Perrotin F, 2001, EUR J OBSTET GYN R B, V99, P19, DOI 10.1016/S0301-2115(01)00347-5; Pezzetti F, 1998, GENOMICS, V50, P299, DOI 10.1006/geno.1998.5273; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; RAO VVNG, 1995, AM J MED GENET, V58, P50, DOI 10.1002/ajmg.1320580111; RICCARDI VM, 1979, CLIN GENET, V15, P332; RIVAS F, 1984, HUM GENET, V67, P86, DOI 10.1007/BF00270563; Scapoli L, 2005, AM J HUM GENET, V76, P180, DOI 10.1086/427344; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; SCHINZEL A, 1976, HUM GENET, V32, P1, DOI 10.1007/BF00569970; SCHINZEL A, 1974, HUMANGENETIK, V22, P287, DOI 10.1007/BF00295488; Schultz RE, 2004, AM J MED GENET A, V125A, P17, DOI 10.1002/ajmg.a.20424; Slaney SF, 1996, AM J HUM GENET, V58, P923; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; STANIER P, 1993, GENOMICS, V17, P549, DOI 10.1006/geno.1993.1370; Stanier P, 2004, HUM MOL GENET, V13, pR73, DOI 10.1093/hmg/ddh052; STEIN J, 1995, AM J HUM GENET, V57, P257; Strauch K, 2003, HUM HERED, V56, P200, DOI 10.1159/000076394; Suzuki Y, 2004, GENET MED, V6, P117, DOI 10.1097/01.GIM.0000127275.52925.05; Tapper JK, 2002, FETAL DIAGN THER, V17, P347, DOI 10.1159/000065383; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; WIKTOR A, 1994, AM J MED GENET, V52, P315, DOI 10.1002/ajmg.1320520312; Wyszynski DF, 1997, HUM GENET, V99, P22; Wyszynski DF, 2003, AM J MED GENET A, V123A, P140, DOI 10.1002/ajmg.a.20283; YANAGISAWA S, 1978, HUM GENET, V45, P345, DOI 10.1007/BF00278733; Yoshiura K, 1998, GENOMICS, V54, P231, DOI 10.1006/geno.1998.5577; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	67	24	25	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					580	585		10.1086/507487	http://dx.doi.org/10.1086/507487			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909398	Bronze, Green Published			2022-12-18	WOS:000239830700022
J	Zhang, Y; Niu, TH; Liu, JS				Zhang, Yu; Niu, Tianhua; Liu, Jun S.			A coalescence-guided hierarchical Bayesian method for haplotype inference	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; HUMAN GENOME; MAXIMUM-LIKELIHOOD; GENOTYPE DATA; POPULATION; RECONSTRUCTION; RECOMBINATION; RESOLUTION; ALGORITHM; PHYLOGENY	Haplotype inference from phase-ambiguous multilocus genotype data is an important task for both disease-gene mapping and studies of human evolution. We report a novel haplotype-inference method based on a coalescence-guided hierarchical Bayes model. In this model, a hierarchical structure is imposed on the prior haplotype frequency distributions to capture the similarities among modern-day haplotypes attributable to their common ancestry. As a consequence, the model both allows distinct haplotypes to have different a priori probabilities according to the inferred hierarchical ancestral structure and results in a proper joint posterior distribution for all the parameters of interest. A Markov chain Monte Carlo scheme is designed to draw from this posterior distribution. By using coalescence-based simulation and empirically generated data sets (Whitehead Institute's inflammatory bowel disease data sets and HapMap data sets), we demonstrate the merits of the new method in comparison with HAPLOTYPER and PHASE, with or without the presence of recombination hotspots and missing genotypes.	Harvard Univ, Ctr Sci, Dept Stat, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Div Prevent Med, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Liu, JS (corresponding author), Harvard Univ, Ctr Sci, Dept Stat, Sci Ctr 7th Floor,1 Oxford St, Cambridge, MA 02138 USA.	jliu@stat.harvard.edu			NHGRI NIH HHS [R01HG002518, R01 HG002518] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002518] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bafna V, 2003, J COMPUT BIOL, V10, P323, DOI 10.1089/10665270360688048; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Chiano MN, 1998, ANN HUM GENET, V62, P55, DOI 10.1046/j.1469-1809.1998.6210055.x; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eskin Eleazar, 2003, J Bioinform Comput Biol, V1, P1, DOI 10.1142/S0219720003000174; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Greenspan G, 2004, J COMPUT BIOL, V11, P495, DOI 10.1089/1066527041410300; GRIFFITHS RC, 1980, THEOR POPUL BIOL, V17, P37, DOI 10.1016/0040-5809(80)90013-1; Gusfield D., 2002, P 6 ANN INT C COMP B, P166; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Hudson RR, 1991, OXF SURV EVOL BIOL, V7, P1; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; JUNDSON R, 2001, PHARMACOGENOMICS, V2, P7; Kimmel G, 2005, P NATL ACAD SCI USA, V102, P158, DOI 10.1073/pnas.0404730102; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kingman J.F.C., 1982, EXCHANGEABILITY PROB, P97; Li N, 2003, GENETICS, V165, P2213; Liu JS., 2001, MONTE CARLO STRATEGI, DOI DOI 10.1007/978-0-387-76371-2; LONG JC, 1995, AM J HUM GENET, V56, P799; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Niu TH, 2004, GENET EPIDEMIOL, V27, P334, DOI 10.1002/gepi.20024; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1983, GENETICS, V105, P437; Templeton AR, 1997, CURR OPIN GENET DEV, V7, P841, DOI 10.1016/S0959-437X(97)80049-4; XING EP, 2004, P 21 INT C MACH LEAR, P879	44	24	25	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					313	322		10.1086/506276	http://dx.doi.org/10.1086/506276			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826521	Green Published, Bronze			2022-12-18	WOS:000239040400012
J	Chappell, S; Daly, L; Morgan, K; Baranes, TG; Roca, J; Rabinovich, R; Millar, A; Donnelly, SC; Keatings, V; MacNee, W; Stolk, J; Hiemstra, PS; Miniati, M; Monti, S; O'Connor, CM; Kalsheker, N				Chappell, Sally; Daly, Leslie; Morgan, Kevin; Baranes, Tamar Guetta; Roca, Josep; Rabinovich, Roberto; Millar, Ann; Donnelly, Seamas C.; Keatings, Vera; MacNee, William; Stolk, Jan; Hiemstra, Pieter S.; Miniati, Massimo; Monti, Simonetta; O'Connor, Clare M.; Kalsheker, Noor			The SERPINE2 gene and chronic obstructive pulmonary disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Univ Nottingham, Queens Med Ctr, Div Clin Chem, Inst Genet, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Queens Med Ctr, Inst Genet, Div Clin Chem Mol Med Sci, Nottingham NG7 2UH, England; Univ Coll Dublin, Conway Inst, Dept Publ Hlth Med & Epidemiol, Dublin 2, Ireland; Univ Coll Dublin, Conway Inst, Dept Med & Therapeut, Dublin 2, Ireland; Hosp Clin Barcelona, Serv Pneumol, Barcelona, Spain; Univ Bristol, Bristol, Avon, England; Southmead Gen Hosp, Dept Clin Sci N Bristol, Lung Res Grp, Bristol, Avon, England; Letterkenny Gen Hosp, Letterkenny, Ireland; Univ Edinburgh, ELEGI Colt Labs, Edinburgh, Midlothian, Scotland; Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; CNR, Inst Clin Physiol, I-56100 Pisa, Italy	University of Nottingham; University of Nottingham; University College Dublin; University College Dublin; University of Barcelona; Hospital Clinic de Barcelona; University of Bristol; Southmead Hospital; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Kalsheker, N (corresponding author), Univ Nottingham, Queens Med Ctr, Div Clin Chem, Inst Genet, Nottingham NG7 2UH, England.	noor.kalsheker@nottingham.ac.uk	Roca, Josep/J-2583-2015; Hiemstra, Pieter S/K-8587-2018; MONTI, SIMONETTA/A-9766-2016	Roca, Josep/0000-0003-4768-8722; Hiemstra, Pieter S/0000-0002-0238-5982; Morgan, Kevin/0000-0002-8217-2396; MONTI, SIMONETTA/0000-0001-7825-6987; Chappell, Sally/0000-0002-0841-6655; Donnelly, Seamas/0000-0001-7145-1843; MacNee, William/0000-0002-3692-1448; O'Connor, Clare/0000-0003-0390-5991; Miniati, Massimo/0000-0002-6977-8916				Chappell S, 2006, HUM MUTAT, V27, P103, DOI 10.1002/humu.20275; DeMeo DL, 2006, AM J HUM GENET, V78, P253, DOI 10.1086/499828	2	24	26	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					184	186		10.1086/505268	http://dx.doi.org/10.1086/505268			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773582	Bronze, Green Published			2022-12-18	WOS:000238341200023
J	Diao, G; Lin, DY				Diao, G; Lin, DY			A powerful and robust method for mapping quantitative trait loci in general pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VARIANCE-COMPONENTS APPROACH; ASSESSING GENETIC-LINKAGE; HASEMAN-ELSTON; SIB-PAIR; REGRESSION; ASSOCIATION; PLATELET; SCAN; QTL	The variance- components model is the method of choice for mapping quantitative trait loci in general human pedigrees. This model assumes normally distributed trait values and includes a major gene effect, random polygenic and environmental effects, and covariate effects. Violation of the normality assumption has detrimental effects on the type I error and power. One possible way of achieving normality is to transform trait values. The true transformation is unknown in practice, and different transformations may yield conflicting results. In addition, the commonly used transformations are ineffective in dealing with outlying trait values. We propose a novel extension of the variance- components model that allows the true transformation function to be completely unspecified. We present efficient likelihood- based procedures to estimate variance components and to test for genetic linkage. Simulation studies demonstrated that the new method is as powerful as the existing variance- components methods when the normality assumption holds; when the normality assumption fails, the new method still provides accurate control of type I error and is substantially more powerful than the existing methods. We performed a genomewide scan of monoamine oxidase B for the Collaborative Study on the Genetics of Alcoholism. In that study, the results that are based on the existing variance- components method changed dramatically when three outlying trait values were excluded from the analysis, whereas our method yielded essentially the same answers with or without those three outliers. The computer program that implements the new method is freely available.	Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lin, DY (corresponding author), Univ N Carolina, Dept Biostat, McGavran Greenberg Hall,CB 7420, Chapel Hill, NC 27599 USA.	lin@bios.unc.edu	Diao, Guoqing/B-9513-2011; Peng, Bo/A-6920-2009	Diao, Guoqing/0000-0001-7304-9591; Peng, Bo/0000-0001-8225-2284	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM031575, GM31575] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Allison DB, 2000, AM J HUM GENET, V67, P249, DOI 10.1086/302966; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; Amos CI, 1997, GENET EPIDEMIOL, V14, P743, DOI 10.1002/(SICI)1098-2272(1997)14:6<743::AID-GEPI30>3.0.CO;2-O; Barnholtz JS, 1999, GENET EPIDEMIOL, V17, pS49; Begleiter H, 1995, ALCOHOL HEALTH RES W, V19, P228; Blangero J, 2000, GENET EPIDEMIOL, V19, pS8, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI2>3.0.CO;2-Y; Breslow NE., 1972, J R STAT SOC B, V34, P216, DOI DOI 10.1111/J.2517-6161.1972.TB00900.X; Chiou JM, 2005, GENET EPIDEMIOL, V28, P58, DOI 10.1002/gepi.20036; COX DR, 1972, J R STAT SOC B, V34, P187; de Andrade M, 2000, GENET EPIDEMIOL, V19, P333, DOI 10.1002/1098-2272(200012)19:4<333::AID-GEPI5>3.3.CO;2-R; de Andrade M, 2002, GENET EPIDEMIOL, V22, P221, DOI 10.1002/gepi.01118; Drigalenko E, 1998, AM J HUM GENET, V63, P1242; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Epstein MP, 2003, AM J HUM GENET, V72, P611, DOI 10.1086/367924; Feingold E, 2001, THEOR POPUL BIOL, V60, P167, DOI 10.1006/tpbi.2001.1545; Feingold E, 2002, AM J HUM GENET, V71, P217, DOI 10.1086/341964; Forrest WF, 2001, HUM HERED, V52, P47, DOI 10.1159/000053353; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Geller F, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S91; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Higgins M, 1996, AM J EPIDEMIOL, V143, P1219, DOI 10.1093/oxfordjournals.aje.a008709; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lin DY, 2004, GENET EPIDEMIOL, V26, P255, DOI 10.1002/gepi.10317; MAJOR LF, 1978, BRIT J PSYCHIAT, V132, P548, DOI 10.1192/bjp.132.6.548; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; PRENTICE RL, 1991, BIOMETRICS, V47, P825, DOI 10.2307/2532642; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; Putter H, 2002, GENET EPIDEMIOL, V22, P345, DOI 10.1002/gepi.01104; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Sham PC, 2001, AM J HUM GENET, V68, P1527, DOI 10.1086/320593; Strug L, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S14; SULLIVAN JL, 1979, BIOL PSYCHIAT, V14, P385; Tang H K, 2001, Biostatistics, V2, P147, DOI 10.1093/biostatistics/2.2.147; Visscher PM, 2001, ANN HUM GENET, V65, P583, DOI [10.1046/j.1469-1809.2001.6560583.x, 10.1017/S0003480001008909]; Wang K, 2002, AM J HUM GENET, V70, P412, DOI 10.1086/338659; Wellner, 1993, EFFICIENT ADAPTIVE E; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; Wright FA, 1997, AM J HUM GENET, V60, P740; Xu X, 2000, AM J HUM GENET, V67, P1025, DOI 10.1086/303081	46	24	24	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					97	111		10.1086/431683	http://dx.doi.org/10.1086/431683			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15918154	Green Published, Bronze			2022-12-18	WOS:000229794500009
J	Vieland, VJ; Huang, J				Vieland, VJ; Huang, J			Two-locus heterogeneity cannot be distinguished from two-locus epistasis on the basis of affected-sib-pair data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; STRATEGIES; LOCI	The observation of multiple linkage signals in the course of conducting genome screens for complex disorders raises the question of whether distinct genes represent independent causes of disease ( heterogeneity) or whether they interact to produce the phenotype of interest ( epistasis); and there has been a corresponding interest in statistical methods for detecting and/or exploiting the distinction between these two possibilities. At the same time, researchers are increasingly relying on affected-sib-pair ( ASP) data. Here, we demonstrate an apparently unrecognized fact about two-locus (2L) models and ASP data, namely, 2L heterogeneity and 2L epistasis cannot, in general, be distinguished from one another on the basis of ASP marker data, as a matter of mathematical principle and therefore regardless of sample size. By the same token, correlations across ASPs in single-locus LOD scores or other measures also cannot be used to distinguish 2L heterogeneity from 2L epistasis. This raises questions about the measurement of gene-gene interactions in terms of patterns of correlation in marker data. Portions of our results carry over to larger pedigree structures as well, as long as only affected individuals are included in analyses; the extent to which our overall findings apply to general pedigrees ( including unaffected individuals) remains to be investigated.	Univ Iowa, Coll Publ Hlth, Dept Biostat, Div Stat Genet, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Vieland, VJ (corresponding author), Univ Iowa, Coll Publ Hlth & Med, Ctr Stat Genet Res, 2190 Westlawn Bldg, Iowa City, IA 52242 USA.	veronica-vieland@uiowa.edu		HUANG, Jian/0000-0002-5218-9269	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH001541, R01MH052841] Funding Source: NIH RePORTER; NIMH NIH HHS [R01-MH52841, K01-MH01541] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; DURNER M, 1992, AM J HUM GENET, V51, P859; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HODGE SE, 1981, AM J HUM GENET, V33, P396; Holmans P, 2002, HUM HERED, V53, P92, DOI 10.1159/000057987; LI CC, 1954, BIOMETRICS, V10, P347, DOI 10.2307/3001590; MACLEAN CJ, 1993, AM J HUM GENET, V53, P353; RISCH N, 1990, AM J HUM GENET, V46, P222	8	24	24	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					223	232		10.1086/376563	http://dx.doi.org/10.1086/376563			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12830401	Green Published, Bronze			2022-12-18	WOS:000184223900001
J	Siegmund, D				Siegmund, D			Upward bias in estimation of genetic effects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; MODELS; LOCUS	Because of the large number of tests for linkage that are performed in genome scans, the naive estimator of the size of a genetic effect in cases of borderline significance can be inflated and lead to unrealistic expectations for successful replication. As a remedy, this report proposes lower confidence limits that account for the multiple comparisons of the genome scan.	Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University	Siegmund, D (corresponding author), Stanford Univ, Dept Stat, Stanford, CA 94305 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000848] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG000848, R01 HG00848] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Allison DB, 2002, AM J HUM GENET, V70, P575, DOI 10.1086/339273; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; Lehmann E RJ, 2005, TESTING STAT HYPOTHE, V3; RISCH N, 1990, AM J HUM GENET, V46, P222; Siegmund DO, 1985, SEQUENTIAL ANAL TEST; Tang H K, 2001, Biostatistics, V2, P147, DOI 10.1093/biostatistics/2.2.147; TENG J, 1998, BIOMETRICS, V54, P379	10	24	24	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1183	1188		10.1086/343819	http://dx.doi.org/10.1086/343819			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12386837	Green Published, Bronze			2022-12-18	WOS:000178884300016
J	Lira, MG; Benetazzo, MG; Marzari, MG; Bombieri, C; Belpinati, F; Castellani, C; Cavallini, GC; Mastella, G; Pignatti, PF				Lira, MG; Benetazzo, MG; Marzari, MG; Bombieri, C; Belpinati, F; Castellani, C; Cavallini, GC; Mastella, G; Pignatti, PF			High frequency of cystic fibrosis transmembrane regulator mutation L997F in patients with recurrent idiopathic pancreatitis and in newborns with hypertrypsinemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CFTR GENE; DISEASE		Univ Verona, Dept Mother & Child Biol & Genet, Sect Biol & Genet, I-37134 Verona, Italy; Univ Verona, Dept Surg & Gastroenterol Sci, I-37100 Verona, Italy; Osped Civile Maggiore, Cyst Fibrosis Ctr, I-37126 Verona, Italy	University of Verona; University of Verona	Lira, MG (corresponding author), Univ Verona, Dept Mother & Child Biol & Genet, Sect Biol & Genet, Str Grazie 8, I-37134 Verona, Italy.		Castellani, Carlo/AAB-3847-2019					Bombieri C, 2000, HUM GENET, V106, P172, DOI 10.1007/s004390051025; Bombieri C, 1998, HUM GENET, V103, P718, DOI 10.1007/s004390050897; Castellani C, 1999, AM J HUM GENET, V64, P303, DOI 10.1086/302212; CROSSLEY JR, 1979, LANCET, V1, P472; DEANGELIS C, 1992, PANCREAS, V7, P193, DOI 10.1097/00006676-199203000-00010; Estivill X, 1996, NAT GENET, V12, P348, DOI 10.1038/ng0496-348; FANEN P, 1992, GENOMICS, V13, P770, DOI 10.1016/0888-7543(92)90152-I; Girodon E, 1997, EUR J HUM GENET, V5, P149, DOI 10.1159/000484750; Lebenthal Emanuel, 1993, P1041; Oppenheimer E H, 1975, Perspect Pediatr Pathol, V2, P241; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Tucker Stephen J., 1992, Human Molecular Genetics, V1, P77, DOI 10.1093/hmg/1.2.77	13	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					2013	2014						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10801389				2022-12-18	WOS:000088373800034
J	Miura, K; Obama, M; Yun, K; Masuzaki, H; Ikeda, Y; Yoshimura, S; Akashi, T; Niikawa, N; Ishimaru, T; Jinno, Y				Miura, K; Obama, M; Yun, K; Masuzaki, H; Ikeda, Y; Yoshimura, S; Akashi, T; Niikawa, N; Ishimaru, T; Jinno, Y			Methylation imprinting of H19 and SNRPN genes in human benign ovarian teratomas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLATION; PARTHENOGENETIC DEVELOPMENT; CPG ISLAND; ORIGIN; MOUSE; EXPRESSION; DIAGNOSIS; ANGELMAN; GENETICS; BIOLOGY	In humans, studies of female germ cells are very limited by ethics. The current study investigated the usefulness of benign ovarian teratomas as a substitute for ova in analyses of imprinted genes. Twenty-five human benign ovarian teratomas were typed with 45 microsatellite DNA markers and classified according to their genotypic features. Two oppositely imprinted genes, H19 and SNRPN, were then chosen for analysis of their methylation states in these tumors. These analyses revealed that benign ovarian teratomas consist of a mixture of genetically and epigenetically heterogeneous cell populations. In contrast to previous reports, we could document only one case rising from germ cells by meiosis-II nondisjunction. H19 and SNRPN were methylated in individual teratomas to various degrees, ranging from normal somatic cell to expected ovum levels. The allele with residual methylation of H19 was consistent with that methylated in the patient's blood DNA, thus being of paternal origin. Degrees of H19 hypomethylation and SNRPN hypermethylation increased as the cellular origin of the tumors advanced in oogenesis and were closely correlated in individual teratomas. These results could be best explained by the assumption that the primary imprinting is a progressively organized process and suggest that the establishment of primary imprints on different genes might be mechanistically linked, even when those genes are oppositely imprinted.	Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan; Nagasaki Univ, Sch Med, Dept Obstet & Gynecol, Nagasaki 852, Japan; Univ Otago, Sch Med, Dept Pathol, Dunedin, New Zealand	Nagasaki University; Nagasaki University; University of Otago	Jinno, Y (corresponding author), Univ Ryukyus, Sch Med, Dept Mol Biol, Nishihara, Okinawa 9030215, Japan.							BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; DAHL N, 1990, CANCER GENET CYTOGEN, V46, P115, DOI 10.1016/0165-4608(90)90017-5; DEKA R, 1990, AM J HUM GENET, V47, P644; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eppig JJ, 1996, CANCER RES, V56, P5047; Jinno Y, 1996, HUM MOL GENET, V5, P1155, DOI 10.1093/hmg/5.8.1155; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Kubota T, 1996, J MED GENET, V33, P1011, DOI 10.1136/jmg.33.12.1011; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; LINDER D, 1975, NEW ENGL J MED, V292, P63, DOI 10.1056/NEJM197501092920202; MANSFIELD DC, 1994, GENOMICS, V24, P225, DOI 10.1006/geno.1994.1610; Mitsuya K, 1998, GENES CELLS, V3, P245, DOI 10.1046/j.1365-2443.1998.00183.x; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Obata Y, 1998, DEVELOPMENT, V125, P1553; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; Saitoh S, 1997, AM J MED GENET, V68, P195, DOI 10.1002/(SICI)1096-8628(19970120)68:2<195::AID-AJMG15>3.3.CO;2-T; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SURTI U, 1990, AM J HUM GENET, V47, P635; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	24	24	25	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1359	1367		10.1086/302615	http://dx.doi.org/10.1086/302615			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521301	Green Published, Bronze			2022-12-18	WOS:000083531000017
J	Whittaker, JC; Lewis, CM				Whittaker, JC; Lewis, CM			Power comparisons of the transmission/disequilibrium test and sib-transmission/disequilibrium-test statistics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ASSOCIATION; LOCI		Univ Reading, Dept Appl Stat, Reading RG6 2AH, Berks, England; Univ London Kings Coll, Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London, England	University of Reading; University of London; King's College London	Lewis, CM (corresponding author), Guys Hosp, Div Med & Mol Genet, 8th Floor,Guys Tower, London SE1 9RT, England.		Whittaker, John C/B-8609-2012; Lewis, Cathryn M/A-5225-2010; Lewis, Cathryn/M-8766-2019	Whittaker, John C/0000-0002-3529-2379; Lewis, Cathryn M/0000-0002-8249-8476; Lewis, Cathryn/0000-0002-8249-8476				Bickeboller H, 1995, GENET EPIDEMIOL, V12, P577, DOI 10.1002/gepi.1370120609; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; Risch N., 1996, SCIENCE, V273, P516; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Whittaker JC, 1998, GENET EPIDEMIOL, V15, P193, DOI 10.1002/(SICI)1098-2272(1998)15:2<193::AID-GEPI7>3.0.CO;2-7	6	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					578	580		10.1086/302485	http://dx.doi.org/10.1086/302485			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417304	Green Published, Bronze			2022-12-18	WOS:000081836900037
J	Oldridge, M; Temple, IK; Santos, HG; Gibbons, RJ; Mustafa, Z; Chapman, KE; Loughlin, J; Wilkie, AOM				Oldridge, M; Temple, IK; Santos, HG; Gibbons, RJ; Mustafa, Z; Chapman, KE; Loughlin, J; Wilkie, AOM			Brachydactyly type B: Linkage to chromosome 9q22 and evidence for genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; CHARACTERISTIC FACIES; MOLECULAR-CLONING; MAP; CRANIOSYNOSTOSIS; MUTATIONS; DELETION; GROWTH	Brachydactyly type B (BDB), an autosomal dominant disorder, is the most severe of the brachydactylies and is characterized by hypoplasia or absence of the terminal portions of the index to little fingers, usually with absence of the nails. The thumbs may be of normal length but are often flattened and occasionally are bifid. The feet are similarly but less severely affected. We have per formed a genomewide linkage analysis of three families with BDB, two English and one Portugese. The two English families show linkage to the same region on chromosome 9 (combined multipoint maximum LOD score 8.69 with marker D9S257). The 16-cM disease interval is defined by recombinations with markers D9S1680 and D9S1786. These two families share an identical disease haplotype over 18 markers, inclusive of D9S278-D9S280. This provides strong evidence that the English families have the same ancestral mutation, which reduces the disease interval to <12.7 cM between markers D9S257 and D9S1851 in chromosome band 9q22. In the Portuguese family, we excluded linkage to this region, a result indicating that BDB is genetically heterogeneous. Reflecting this, there were atypical clinical features in this family, with shortening of the thumbs and absence or hypoplasia of the nails of the thumb and hallux. These results enable a refined classification of BDB and identify a novel locus for digit morphogenesis in 9q22.	John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England; Churchill Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; Wellcome Trust Ctr Human Genet, Osteoarthrit Genet Grp, Oxford, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; Hosp Santa Maria, Serv Pediat, Unidade Genet, Lisbon, Portugal	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Universidade de Lisboa; Hospital Santa Maria	Wilkie, AOM (corresponding author), John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England.		Wilkie, Andrew/AAC-3820-2020; temple, isabel K/K-2391-2015; Gibbons, Richard/E-6937-2011	Wilkie, Andrew/0000-0002-2972-5481; Loughlin, John/0000-0003-2018-3361; Gibbons, Richard/0000-0002-7680-9311	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BASS HN, 1968, PEDIATRICS, V42, P318; BATTLE HI, 1973, ANN HUM GENET, V36, P415, DOI 10.1111/j.1469-1809.1973.tb00605.x; Bell J., 1951, TREASURY HUMAN INHER, VVol 1, P1; Blair IP, 1998, GENOMICS, V51, P277, DOI 10.1006/geno.1998.5373; CARTER TC, 1959, J GENET, V54, P311; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cragg E, 1916, J GENET, V6, P81, DOI 10.1007/BF02981868; Cuevas-Sosa A, 1971, J Bone Joint Surg Br, V53, P101; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEGENHARDT KH, 1954, Z MENSCHLICHE VERERB, V32, P227; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FARRELL SA, 1991, CLIN GENET, V40, P207; FITCH N, 1979, J MED GENET, V16, P36, DOI 10.1136/jmg.16.1.36; Glass I A, 1994, Clin Dysmorphol, V3, P215; Gong YQ, 1999, AM J HUM GENET, V64, P570, DOI 10.1086/302249; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Houlston R S, 1994, Clin Dysmorphol, V3, P224; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JOHNSON KR, 1995, GENOMICS, V29, P457, DOI 10.1006/geno.1995.9981; KELLIE, 1808, EDINB MED SURG J, V4, P252; KROES HY, 1994, J MED GENET, V31, P156, DOI 10.1136/jmg.31.2.156; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LINDGREN V, 1994, AM J MED GENET, V49, P67, DOI 10.1002/ajmg.1320490112; MacARTHUR J. W., 1932, HUMAN BIOL, V4, P179; MACKINDER D, 1857, BMJ-BRIT MED J, V1, P845; MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; Mock BA, 1998, MAMM GENOME, V8, pS68, DOI 10.1007/s003359900649; Moloney DM, 1997, LANCET, V349, P1059, DOI 10.1016/S0140-6736(96)09082-4; NISWANDER L, 1993, NATURE, V361, P68, DOI 10.1038/361068a0; Pasche B, 1998, CANCER RES, V58, P2727; PFEIFFER RA, 1993, ANN GENET-PARIS, V36, P167; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Polymeropoulos MH, 1996, GENOMICS, V38, P45, DOI 10.1006/geno.1996.0590; Povey S, 1997, ANN HUM GENET, V61, P183, DOI 10.1017/S0003480097006106; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Santos H G, 1981, Acta Med Port, V3, P147; SANTOS HG, 1995, CLIN DYSMORPHOL, V4, P274, DOI 10.1097/00019605-199507000-00015; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Schuster H, 1996, NAT GENET, V13, P98, DOI 10.1038/ng0596-98; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Stephenson DA, 1998, MAMM GENOME, V8, pS258, DOI 10.1007/s003359900658; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; THOMPSON EM, 1988, J MED GENET, V25, P313, DOI 10.1136/jmg.25.5.313; UJITA M, 1995, GENE, V158, P237, DOI 10.1016/0378-1119(95)00070-M; WELLS NH, 1947, ARCH DIS CHILD, V22, P251, DOI 10.1136/adc.22.112.251; WILSON LC, 1995, AM J HUM GENET, V56, P400; WINTER RM, 1990, CLIN GENET, V37, P494; Xie JW, 1997, GENE CHROMOSOME CANC, V18, P305; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	54	24	27	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					578	585		10.1086/302255	http://dx.doi.org/10.1086/302255			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973296	Bronze, Green Published			2022-12-18	WOS:000078740600028
J	Zapata, C; Alvarez, G; Carollo, C				Zapata, C; Alvarez, G; Carollo, C			Approximate variance of the standardized measure of gametic disequilibrium D'	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GENETIC-ANALYSIS; RECURRENT BRCA1; ASHKENAZI JEWS; POPULATIONS; MUTATIONS; FAMILIES		UNIV SANTIAGO,DEPT ESTADIST & IO,SANTIAGO COMPOSTE,SPAIN	Universidade de Santiago de Compostela	Zapata, C (corresponding author), UNIV SANTIAGO,FAC BIOL,AREA GENET,DEPT BIOL FUNDAMENTAL,SANTIAGO COMPOSTE,SPAIN.							BARNAVI E, 1992, HIST ATLAS JEWISH PE; Beinart Haim, 1992, ATLAS MEDIEVAL JEWIS; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; BOUCHARD G, 1990, HIST GENOME; DAVIES N, 1984, GODS PLAYGROUND HIST; DEBRAEKELEER M, 1991, HUM HERED, V41, P141, DOI 10.1159/000153992; DIAMOND JM, 1987, NATURE, V329, P105, DOI 10.1038/329105a0; GAUVREAU D, 1990, HIST GENOME, P145; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Jennings HS, 1917, GENETICS, V2, P97; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Labuda M, 1996, AM J HUM GENET, V59, P633; Luria SE, 1943, GENETICS, V28, P491; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; RISCH N, 1995, NAT GENET, V11, P14, DOI 10.1038/ng0995-14; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; ROBBINS RB, 1917, GENETICS, V3, P375; ROBERTS DF, 1968, NATURE, V220, P1084, DOI 10.1038/2201084a0; Thompson EA, 1997, AM J HUM GENET, V60, P197; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; ZOOSSMANNDISKIN A, 1995, NAT GENET, V11, P13, DOI 10.1038/ng0995-13; ZUCKERKANDL EMILE, 1965, P97	24	24	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					771	774						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326344				2022-12-18	WOS:A1997XY52300036
J	Stevanin, G; Lebre, AS; Mathieux, C; Cancel, G; Abbas, N; Didierjean, O; Durr, A; Trottier, Y; Agid, Y; Brice, A				Stevanin, G; Lebre, AS; Mathieux, C; Cancel, G; Abbas, N; Didierjean, O; Durr, A; Trottier, Y; Agid, Y; Brice, A			Linkage disequilibrium between the spinocerebellar ataxia 3 Machado-Joseph disease mutation and two intragenic polymorphisms, one of which, X359Y, affects the stop codon	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CAG REPEAT; HUNTINGTONS-DISEASE; BRAZILIAN FAMILIES; EXPANSION; GENE; LOCUS; MAPS		HOP LA PITIE SALPETRIERE,INSERM U289,F-75651 PARIS 13,FRANCE; HOP LA PITIE SALPETRIERE,FEDERAT NEUROL,F-75651 PARIS 13,FRANCE; INST GENET & BIOL MOL & CELLULAIRE,ILLKIRCH GRAFFENS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)			Lebre, Anne-Sophie/AAO-1413-2020; Trottier, Yvon/H-8852-2016; brice, alexis/AAE-8275-2019; Stevanin, Giovanni/E-5038-2016; Brice, Alexis/A-2170-2009	brice, alexis/0000-0002-0941-3990; Stevanin, Giovanni/0000-0001-9368-8657; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Trottier, Yvon/0000-0001-7230-4810				CANCEL G, 1995, AM J HUM GENET, V57, P809; Durr A, 1996, CURR OPIN NEUROL, V9, P290; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Endo K, 1996, AM J MED GENET, V67, P437, DOI 10.1002/(SICI)1096-8628(19960920)67:5<437::AID-AJMG1>3.0.CO;2-H; Gaspar C, 1996, HUM GENET, V98, P620, DOI 10.1007/s004390050270; GOLDBERGSTERN H, 1994, NEUROLOGY, V44, P1298, DOI 10.1212/WNL.44.7.1298; GOTO J, 1996, EUR J NEUROSCI S, V9; HARDING AE, 1993, ADV NEUROL, V61, P1; Igarashi S, 1996, HUM MOL GENET, V5, P923, DOI 10.1093/hmg/5.7.923; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; Iughetti P, 1996, J MED GENET, V33, P439, DOI 10.1136/jmg.33.5.439; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; SEQUEIROS J, 1993, ADV NEUROL, V61, P139; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; STEVANIN G, 1994, AM J HUM GENET, V54, P11; Stevanin G, 1994, Neurobiol Dis, V1, P79, DOI 10.1006/nbdi.1994.0010; STEVANIN G, 1995, AM J HUM GENET, V57, P1247; STEVANIN G, 1995, J MED GENET, V32, P827, DOI 10.1136/jmg.32.10.827; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0	22	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1548	1552						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199580				2022-12-18	WOS:A1997XE29400037
J	SerovaSinilnikova, OM; Boutrand, L; StoppaLyonnet, D; BressacdePaillerets, B; Dubois, V; Lasset, C; Janin, N; Bignon, YJ; Longy, M; Maugard, C; Lidereau, R; Leroux, D; Frebourg, T; Mazoyer, S; Lenoir, GM				SerovaSinilnikova, OM; Boutrand, L; StoppaLyonnet, D; BressacdePaillerets, B; Dubois, V; Lasset, C; Janin, N; Bignon, YJ; Longy, M; Maugard, C; Lidereau, R; Leroux, D; Frebourg, T; Mazoyer, S; Lenoir, GM			BRCA2 mutations in hereditary breast and ovarian cancer in France	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PROTEIN TRUNCATION TEST; RAPID DETECTION; SUSCEPTIBILITY GENE		CTR INT RECH CANC,F-69372 LYON 08,FRANCE; CNRS,GENET LAB,UMR5641,LYON,FRANCE; HOP EDOUARD HERRIOT,LYON,FRANCE; CTR LEON BERARD,F-69373 LYON,FRANCE; INST CURIE,PARIS,FRANCE; INST GUSTAVE ROUSSY,VILLEJUIF,FRANCE; CTR JEAN PERRIN,CLERMONT FERRAN,FRANCE; CTR RENE GAUDUCHEAU,F-44035 NANTES,FRANCE; INST BERGONIE,BORDEAUX,FRANCE; CTR RENE HUGUENIN,ST CLOUD,FRANCE; CHU GRENOBLE,F-38043 GRENOBLE,FRANCE; CHR ROUEN,HOP CHARLES NICOLLE,ROUEN,FRANCE	World Health Organization; International Agency for Research on Cancer (IARC); Centre National de la Recherche Scientifique (CNRS); CHU Lyon; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Gustave Roussy; UNICANCER; Centre Jean Perrin; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Institut Bergonie; Rene Huguenin Hospital; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU de Rouen			Frebourg, Thierry/AAK-8390-2020; Paillerets, Brigitte Bressac-de/D-8954-2018; Mazoyer, Sylvie/N-7559-2017; , bignon/Y-3243-2019; Leroux, Dominique/G-7309-2014	Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Mazoyer, Sylvie/0000-0002-2135-0160; DUBOIS, VALERIE/0000-0002-1169-7697				Berman DB, 1996, CANCER RES, V56, P3409; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; Friedman LS, 1997, AM J HUM GENET, V60, P313; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; Johannesdottir G, 1996, CANCER RES, V56, P3663; KEEN J, 1991, TRENDS GENET, V7, P5; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Serova OM, 1997, AM J HUM GENET, V60, P486; Takahashi H, 1996, CANCER RES, V56, P2738; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; TONIN P, 1996, NAT MED, V2, P1174; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	22	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1236	1239						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150172				2022-12-18	WOS:A1997WX76000025
J	Haire, RN; Ohta, Y; Strong, SJ; Litman, RT; Liu, YY; Prchal, JT; Cooper, MD; Litman, GW				Haire, RN; Ohta, Y; Strong, SJ; Litman, RT; Liu, YY; Prchal, JT; Cooper, MD; Litman, GW			Unusual patterns of exon skipping in Bruton tyrosine kinase are associated with mutations involving the intron 17 3' splice site	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-LINKED AGAMMAGLOBULINEMIA; IMMUNODEFICIENT XID MICE; GENE; IDENTIFICATION; EXPRESSION; CHROMOSOME; FAMILY; CELLS; BTK; CLONING	Seven individuals with the diagnosis of X-linked agammaglobulinemia were analyzed for mutations in Bruton tyrosine kinase (Btk) gene at both the cDNA transcript and genomic DNA levels. In addition, maternal carrier status was determined in six of the seven families by examining X chromosome-inactivation patterns for B cells in comparison with other types of blood cells. Three categories of mutations were identified: (1) three patients have missense mutations in either the pleckstrin or SH2 domains of Btk; (2) three patients exhibit mutations at or near intron/exon splice sites, two of which represent inherited mutations within the kinase domain; and (3) one patient has inherited a 2.5-kb deletion with the loss of a DNA segment encoding three exons of the kinase domain. Variation in the lengths of Btk transcripts was evident in two patients with splice-site mutations and in the patient with the DNA deletion. Sequences of the different cDNA transcripts from the patients with 3' splice-site mutations reveal complex patterns of exon skipping involving from one to four exons of the kinase domain. These findings implicate 3' splice sites of the penultimate exon in the recognition or processing of upstream exons.	UNIV S FLORIDA,ALL CHILDRENS HOSP,ST PETERSBURG,FL 33701; UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294; UNIV ALABAMA,HOWARD HUGHES MED INST,BIRMINGHAM,AL 35294	State University System of Florida; University of South Florida; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham					NHLBI NIH HHS [R)1 HL50077, R01 HL51650] Funding Source: Medline; NIAID NIH HHS [R37 AI23338] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050077, R01HL051650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023338] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRUTON OC, 1952, PEDIATRICS, V9, P722; Bykowsky MJ, 1996, AM J HUM GENET, V58, P477; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CONLEY ME, 1986, NEW ENGL J MED, V315, P564, DOI 10.1056/NEJM198608283150907; CONLEY ME, 1994, HUM MOL GENET, V3, P1751, DOI 10.1093/hmg/3.10.1751; COOPER DN, 1993, HUMAN GENET MUTATION; COOPER MD, 1993, PROGR IMMUNOLOGY, V8, P535; DEWEERS M, 1994, HUM MOL GENET, V3, P161, DOI 10.1093/hmg/3.1.161; DEWEERS M, 1993, EUR J IMMUNOL, V23, P3109, DOI 10.1002/eji.1830231210; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DURIEZ B, 1994, FEBS LETT, V346, P165, DOI 10.1016/0014-5793(94)00457-9; FEARON ER, 1987, NEW ENGL J MED, V316, P427, DOI 10.1056/NEJM198702193160802; Gardella R, 1996, AM J HUM GENET, V59, P292; GIBSON S, 1993, BLOOD, V82, P1561; HAGEMANN TL, 1995, HUM MUTAT, V5, P296, DOI 10.1002/humu.1380050405; HAIRE RN, 1994, HUM MOL GENET, V3, P897, DOI 10.1093/hmg/3.6.897; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Hashimoto S, 1996, BLOOD, V88, P561, DOI 10.1182/blood.V88.2.561.bloodjournal882561; JIN H, 1995, HUM MOL GENET, V4, P693, DOI 10.1093/hmg/4.4.693; Kobayashi S, 1996, HUM GENET, V97, P424, DOI 10.1007/s004390050066; Kornfeld SJ, 1996, MOL MED, V2, P619, DOI 10.1007/BF03401645; Luhovy M, 1995, Biol Blood Marrow Transplant, V1, P81; Maquat LE, 1996, AM J HUM GENET, V59, P279; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; NAYLOR JA, 1991, LANCET, V337, P635, DOI 10.1016/0140-6736(91)92450-G; OHTA Y, 1991, P NATL ACAD SCI USA, V91, P9061; PRCHAL JT, 1978, NATURE, V274, P590, DOI 10.1038/274590a0; PRCHAL JT, 1993, BLOOD, V81, P269; PRCHAL TT, 1996, J EXP MED, V183, P561; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; ROSEN FS, 1995, NEW ENGL J MED, V333, P431, DOI 10.1056/NEJM199508173330707; SATO K, 1994, LEUKEMIA, V8, P1663; SMITH CIE, 1994, J IMMUNOL, V152, P557; TAMAGNONE L, 1994, ONCOGENE, V9, P3683; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VIHINEN M, 1995, IMMUNOL TODAY, V16, P460, DOI 10.1016/0167-5699(95)80027-1; Vihinen M, 1996, NUCLEIC ACIDS RES, V24, P160, DOI 10.1093/nar/24.1.160; VORECHOVSKY I, 1993, LANCET, V341, P1153, DOI 10.1016/0140-6736(93)93172-W; ZHU BQ, 1994, J EXP MED, V180, P461	42	24	24	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					798	807						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106525				2022-12-18	WOS:A1997WT61400008
J	Brulhart, MC; Dussoix, P; Ruiz, J; Passa, P; Froguel, P; James, RW				Brulhart, MC; Dussoix, P; Ruiz, J; Passa, P; Froguel, P; James, RW			The (Ala-Val) mutation of methylenetetrahydrofolate reductase as a genetic risk factor for vascular disease in non-insulin-dependent diabetic patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV HOSP GENEVA,DIV ENDOCRINOL & DIABETOL,CLIN DIABET UNIT,CH-1211 GENEVA 14,SWITZERLAND; UNIV LAUSANNE HOSP,DIV ENDOCRINOL,LAUSANNE,SWITZERLAND; HOP ST LOUIS,SERV DIABETOL,PARIS,FRANCE; INST PASTEUR,CNRS EP10,F-59019 LILLE,FRANCE	University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille			FROGUEL, Philippe/O-6799-2017	FROGUEL, Philippe/0000-0003-2972-0784				BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; KANG SS, 1991, AM J HUM GENET, V48, P536; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; RUIZ J, 1995, LANCET, V346, P869, DOI 10.1016/S0140-6736(95)92709-3	7	24	27	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					228	229						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981966				2022-12-18	WOS:A1997WA81800029
J	Huang, CH; Chen, Y; Reid, M; Ghosh, S				Huang, CH; Chen, Y; Reid, M; Ghosh, S			Genetic recombination at the human RH locus: A family study of the red-cell Evans phenotype reveals a transfer of exons 2-6 from the RHD to the RHCE gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR-CLONING; PROTEIN; CDNA; IDENTIFICATION; HYBRIDIZATION; EXPRESSION; ANTIGENS; DELETION	The human RH locus appears to consist of two structural genes, D and CE, which map on the short arm p34-36 of chromosome 1 and specify a most complex system of blood-group genetic polymorphisms. Here we describe a family study of the Evans (also known as ''D ..'') phenotype, a codominant trait associated with both qualitative and quantitative changes in D-antigen expression. A cataract-causing mutation was also inherited in this family and was apparently cotransmitted with Evans, suggesting a chromosomal linkage of these two otherwise unrelated traits. Southern blot analysis and allele-specific PCR showed the linkage of Evans with a SphI RFLP marker and the presence of a hybrid gene in the RHlocus. To delineate the pattern of gene expression, the composition and structure of Rh-polypeptide transcripts were characterized by reverse transcriptase-PCR and nucleotide sequencing. This resulted in the identification of a novel Rh transcript expressed only in the Evans-positive erythroid cells. Sequence analysis showed that the transcript maintained a normal open reading frame but occurred as a CE-D-CE composite in which exons 2-6 of the CE gene were replaced by the homologous counterpart of the D gene. This hybrid gene was predicted to encode a CE-D-CE fusion protein whose surface expression correlates with the Evans phenotype. The mode and consequence of such a recombination event suggest the occurrence, in the RH locus, of a segmental DNA transfer via the mechanism of gene conversion.	NINEWELLS HOSP,E SCOTLAND BLOOD TRANSFUS SERV,DUNDEE DD1 9SY,SCOTLAND	University of Dundee	Huang, CH (corresponding author), NEW YORK BLOOD CTR,LINDSLEY F KIMBALL RES INST,310 E 67TH ST,NEW YORK,NY 10021, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054459] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54459] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGRE P, 1991, BLOOD, V78, P551, DOI 10.1182/blood.V78.3.551.bloodjournal783551; ANSTEE DJ, 1993, BAILLIERE CLIN HAEM, V6, P401, DOI 10.1016/S0950-3536(05)80152-0; ARCE MA, 1993, BLOOD, V82, P651; AVENT ND, 1990, BIOCHEM J, V271, P821, DOI 10.1042/bj2710821; BLUNT T, 1994, ANN HUM GENET, V58, P19, DOI 10.1111/j.1469-1809.1994.tb00722.x; CARTRON JP, 1995, BLOOD CEL B, V6, P189; CHERIFZAHAR B, 1991, HUM GENET, V86, P398, DOI 10.1007/BF00201843; CHERIFZAHAR B, 1990, P NATL ACAD SCI USA, V87, P6234; CONTRERAS M, 1978, VOX SANG, V34, P208, DOI 10.1111/j.1423-0410.1978.tb02469.x; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Goossens M, 1981, Methods Enzymol, V76, P805; Huang CH, 1996, AM J HUM GENET, V58, P133; HUANG CH, 1991, BLOOD, V77, P381; HUANG CH, 1991, J BIOL CHEM, V266, P7248; HUANG CH, 1995, BLOOD, V86, P784, DOI 10.1182/blood.V86.2.784.bloodjournal862784; HUANG CH, 1995, BLOOD CELL BIOCH, V6, P153; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEVANKIM C, 1992, P NATL ACAD SCI USA, V89, P10925, DOI 10.1073/pnas.89.22.10925; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; MACGEOCH C, 1992, CYTOGENET CELL GENET, V59, P261, DOI 10.1159/000133264; MATHEW S, 1994, CYTOGENET CELL GENET, V67, P68, DOI 10.1159/000133801; McKusick V.A., 1992, MENDELIAN INHERITANC; MOLLISON PL, 1993, BLOOD TRANSFUSION CL; MOURO I, 1993, NAT GENET, V5, P62, DOI 10.1038/ng0993-62; MOURO I, 1994, BLOOD, V83, P1129, DOI 10.1182/blood.V83.4.1129.bloodjournal8341129; Race RR., 1975, BLOOD GROUPS MAN; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; ROUILLAC C, 1995, BLOOD, V85, P2937, DOI 10.1182/blood.V85.10.2937.bloodjournal85102937; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Smythe JS, 1996, BLOOD, V87, P2968, DOI 10.1182/blood.V87.7.2968.bloodjournal8772968; STAMBOLIAN D, 1995, NAT GENET, V10, P307, DOI 10.1038/ng0795-307	31	24	29	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					825	833						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808597				2022-12-18	WOS:A1996VL28300011
J	Hewitt, R; Krause, A; Goldman, A; Campbell, G; Jenkins, T				Hewitt, R; Krause, A; Goldman, A; Campbell, G; Jenkins, T			beta-globin haplotype analysis suggests that a major source of Malagasy ancestry is derived from Bantu-speaking Negroids	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SICKLE-CELL MUTATION; GENETIC EPIDEMIOLOGY; ORIGIN; DNA; AFRICA	The origins of the inhabitants of Madagascar have not been fully resolved. Anthropological studies and preliminary genetic data point to two main sources of ancestry of the Malagasy, namely, Indonesian and African, with additional contributions from India and Arabia. The sickle-cell (beta(S)) mutation is found in populations of African and Indian origin. The frequency of the beta(S)-globin gene, derived from 1,425 Malagasy individuals, varies from 0 in some highland populations to .25 in some coastal populations. The beta(s) mutation is thought to have arisen at least five times, on the basis of the presence of five distinct beta(S)-associated haplotypes, each found in a separate geographic area. Twenty-five of the 35 Malagasy beta(S) haplotypes were of the typical ''Bantu'' type, 1 ''Senegal'' haplotype was found, and 2 rare or atypical haplotypes were observed; the remaining 7 haplotypes were consistent with the Bantu haplotype. The Bantu beta(S) mutation is thought to have been introduced into Madagascar by Bantu-speaking immigrants (colonists or slaves) from central or east Africa. The Senegal beta(s) mutation may have been introduced to the island via Portuguese naval explorers. This study provides the first definitive biological evidence that a major component of Malagasy ancestry is derived from African populations, in particular, Bantu-speaking Negroids. beta(A) haplotypes are also consistent with the claim for a significant African contribution to Malagasy ancestry but are also suggestive of Asian/Oceanic and Caucasoid admixture within the Malagasy population.	S AFRICAN INST MED RES,SCH PATHOL,DEPT HUMAN GENET,JOHANNESBURG 2000,SOUTH AFRICA; UNIV WITWATERSRAND,DEPT ECON HIST,JOHANNESBURG,SOUTH AFRICA	University of Witwatersrand			Krause, Amanda/AAQ-7038-2020	Krause, Amanda/0000-0002-7157-0807				BURNS AL, 1981, BLOOD, V57, P140; CAMPBELL G, 1992, J AFR HIST, V32, P427; CAMPBELL G, IN PRESS EC HIST MAD; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLINT J, 1993, BAILLIERE CLIN HAEM, V6, P215, DOI 10.1016/S0950-3536(05)80071-X; FLINT J, 1993, HUM GENET, V91, P91; FOURQUET R., 1974, Arch. Inst. Pasteur Madagascar, V43, P185; GILMAN JG, 1985, BLOOD, V66, P783; KULOZIK AE, 1986, AM J HUM GENET, V39, P239; LAPOUMEROULIE C, 1992, HUM GENET, V89, P333; Leroi-Gourhan A., 1953, ETHNOLOGIE UNION FRA, V2; MONTEIRO C, 1989, HUM GENET, V82, P255, DOI 10.1007/BF00291165; NAGEL RL, 1990, SEMIN HEMATOL, V27, P342; NAGEL RL, 1992, BAILLIERE CLIN HAEM, V5, P331, DOI 10.1016/S0950-3536(11)80023-5; Old J M, 1991, Baillieres Clin Haematol, V4, P391, DOI 10.1016/S0950-3536(05)80165-9; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; RAMSAY M, 1987, AM J HUM GENET, V41, P1132; RAMSAY M, 1985, S AFR J SCI, V81, P98; SINGER R, 1957, AM J PHYS ANTHROPOL, V15, P91, DOI 10.1002/ajpa.1330150113; SOODYALL H, IN PRESS MOL BIOL HU; TUAN D, 1979, NUCLEIC ACIDS RES, V6, P2519, DOI 10.1093/nar/6.7.2519	21	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1303	1308						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651308				2022-12-18	WOS:A1996UM27100024
J	UNDLIEN, DE; AKSELSEN, HE; JONER, G; DAHLJORGENSEN, K; AAGENAES, O; SOVIK, O; THORSBY, E; RONNINGEN, KS				UNDLIEN, DE; AKSELSEN, HE; JONER, G; DAHLJORGENSEN, K; AAGENAES, O; SOVIK, O; THORSBY, E; RONNINGEN, KS			NO DIFFERENCE IN THE PARENTAL ORIGIN OF SUSCEPTIBILITY HLA CLASS-II HAPLOTYPES AMONG NORWEGIAN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ALLELES; TRANSMISSION; DISORDERS; RISK; IDDM		AKER UNIV HOSP, AKER DIABET RES CTR, OSLO, NORWAY; UNIV BERGEN, DEPT PAEDIAT, BERGEN, NORWAY	University of Oslo; University of Bergen	UNDLIEN, DE (corresponding author), NATL HOSP NORWAY, INST TRANSPLANTAT IMMUNOL, N-0027 OSLO, NORWAY.							BAIN SC, 1994, DIABETES, V43, P1462, DOI 10.2337/diabetes.43.12.1462; CAILLATZUCMAN S, 1992, J CLIN INVEST, V90, P2242, DOI 10.1172/JCI116110; DAHLQUIST G, 1989, DIABETOLOGIA, V32, P2; DESCHAMPS I, 1990, DIABETOLOGIA, V33, P425, DOI 10.1007/BF00404094; FIELD LL, 1988, AM J HUM GENET, V43, P793; FIELD LL, 1994, NATO ADV SCI INST SE, V270, P69; MARGARITTEJEANNIN P, 1995, AM J HUM GENET, V56, P1080; MCCARTHY BJ, 1991, GENET EPIDEMIOL, V8, P177, DOI 10.1002/gepi.1370080304; RONNINGEN KS, 1990, HUM IMMUNOL, V29, P275, DOI 10.1016/0198-8859(90)90041-M; RONNINGEN KS, 1991, TISSUE ANTIGENS, V37, P105, DOI 10.1111/j.1399-0039.1991.tb01854.x; RONNINGEN KS, 1989, HUM IMMUNOL, V26, P215; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; TAIT BD, 1995, HUM IMMUNOL, V42, P116, DOI 10.1016/0198-8859(94)00075-2; THIVOLET C, 1988, DIABETOLOGIA, V31, P741, DOI 10.1007/BF00274776; THORSBY E, 1993, DIABETOLOGIA, V36, P371, DOI 10.1007/BF00402270; TUOMILEHTO J, 1992, DIABETOLOGIA, V35, P70, DOI 10.1007/BF00400854; VADHEIM CM, 1986, NEW ENGL J MED, V315, P1314, DOI 10.1056/NEJM198611203152103; WARRAM JH, 1984, NEW ENGL J MED, V311, P149, DOI 10.1056/NEJM198407193110304	19	24	24	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1511	1514						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533785				2022-12-18	WOS:A1995TE65500033
J	DESVIAT, LR; PEREZ, B; DELUCCA, M; CORNEJO, V; SCHMIDT, B; UGARTE, M				DESVIAT, LR; PEREZ, B; DELUCCA, M; CORNEJO, V; SCHMIDT, B; UGARTE, M			EVIDENCE IN LATIN-AMERICA OF RECURRENCE OF V388M, A PHENYLKETONURIA MUTATION WITH HIGH IN-VITRO RESIDUAL ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN PHENYLALANINE-HYDROXYLASE; MESSENGER-RNA; GENE; EUROPE; LOCUS	Phenylketonuria mutation V388M is frequent in the Iberian Peninsula. In vitro, the V388M mutant enzyme has similar immunoreactive protein and phenylalanine hydroxylase mRNA and has 43% residual activity, which correlates well with the mild phenotype exhibited by the homozygous patients. In Spain it has been detected in 5.7% of the mutant alleles and is always associated with haplotype 1.7. This mutation is also present in high frequency in some Latin American countries (Brazil, 9%; Chile, 13%). It is interesting that in Chile most of the alleles bearing this mutation carry haplotype 4.3, although in Brazil it is found only on the background of haplotype 1.7. The origin of V388M in Spain on haplotype 1.7 and in Chile on haplotype 4.3 is clearly different. Recurrence is the most plausible explanation, because the mutation involves a CpG dinucleotide, and a recombination event transferring the mutation from haplotype 1 to 4 is unlikely.	UNIV AUTONOMA MADRID,CSIC,CTR BIOL MOLEC SEVERO OCHOA,E-28049 MADRID,SPAIN; INTA,SANTIAGO,CHILE; APAE,SAO PAULO,BRAZIL	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Chile			; DESVIAT, LOURDES R/L-3055-2013	De Lucca, Marisel/0000-0002-1557-2955; DESVIAT, LOURDES R/0000-0003-0492-3323				ARZIMANOGLOU I, 1995, AM J HUM GENET, V56, P544; Cavalli-Sforza Menozzi P, 1994, HIST GEOGRAPHY HUMAN; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DWORNICZAK B, 1991, GENOMICS, V11, P242, DOI 10.1016/0888-7543(91)90129-3; EISENSMITH RC, 1992, AM J HUM GENET, V51, P1445; EISENSMITH RC, 1995, AM J HUM GENET, V56, P278; EISENSMITH RC, 1992, AM J HUM GENET, V51, P1355; GOLTSOV AA, 1992, AM J HUM GENET, V51, P627; GOLTSOV AA, 1993, HUM MOL GENET, V2, P577, DOI 10.1093/hmg/2.5.577; KONECKI DS, 1991, HUM GENET, V87, P377; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEANDRO P, IN PRESS HUM MUTAT; LICHTERKONECKI U, 1994, HUM GENET, V94, P306; LYONNET S, 1989, AM J HUM GENET, V44, P511; MORRAL N, 1994, AM J HUM GENET, V55, P890; OKANO Y, 1990, AM J HUM GENET, V46, P919; OKANO Y, 1991, EUR J PEDIATR, V150, P347, DOI 10.1007/BF01955938; PEREZ B, 1995, HUM MUTAT, V5, P188, DOI 10.1002/humu.1380050217; PEREZ B, 1993, HUM MOL GENET, V2, P1289, DOI 10.1093/hmg/2.8.1289; Perez B., 1994, American Journal of Human Genetics, V55, pA161; PEREZ B, 1994, ACTA PAEDIATR, V407, P34; RIOS J, 1994, HUM GENET, V94, P291; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; TAKAHASHI K, 1992, LANCET, V340, P1473, DOI 10.1016/0140-6736(92)92665-3; TSAI TF, 1990, HUM GENET, V84, P409; WANG T, 1991, P NATL ACAD SCI USA, V88, P2146, DOI 10.1073/pnas.88.6.2146; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; ZSCHOCKE J, 1994, ACTA PAEDIATRICA S, V407, P41	29	24	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					337	342						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668259				2022-12-18	WOS:A1995RL77100016
J	HEUTINK, P; VANDEWETERING, BJM; PAKSTIS, AJ; KURLAN, R; SANDOR, P; OOSTRA, BA; SANDKUIJL, LA				HEUTINK, P; VANDEWETERING, BJM; PAKSTIS, AJ; KURLAN, R; SANDOR, P; OOSTRA, BA; SANDKUIJL, LA			LINKAGE STUDIES ON GILLES-DE-LA-TOURETTE SYNDROME - WHAT IS THE STRATEGY OF CHOICE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-LINKAGE; LOD SCORES; SCHIZOPHRENIA; PEDIGREE; CHROMOSOME-5; TRANSMISSION; SEGREGATION; SIMULATION; DISORDERS; ILLNESS	For a Linkage study it is important to ascertain family material that is sufficiently informative. The statistical power of a linkage sample can be determined via computer simulation. For complex traits uncertain parameters such as incomplete penetrance, frequency of phenocopies, gene frequency and variable expression have to be taken into account. One can either include only the most severe phenotype in the analysis or apply multiple linkage tests for a gradually broadened disease phenotype. Gilles de la Tourette syndrome (GTS) is a chronic neurological disorder characterized by multiple, intermittent motor and vocal ties. Segregation analyses suggest that GTS and milder phenotypes are caused by a single dominant gene. We report here the results of an extensive simulation study on a large set of families. We compared the effectiveness of linkage tests with only the GTS phenotype versus multiple tests that included various milder phenotypes and different gene frequencies. The scenario of multiple tests yielded superior power. Our results show that computer simulation can indicate the strategy of choice in linkage studies of multiple, complex phenotypes.	ERASMUS UNIV ROTTERDAM,DEPT PSYCHIAT,3000 DR ROTTERDAM,NETHERLANDS; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT; UNIV ROCHESTER,SCH MED & DENT,ROCHESTER,NY; TORONTO HOSP,DEPT PSYCHIAT,TORONTO,ON,CANADA; UNIV TORONTO,TORONTO,ON,CANADA	Erasmus University Rotterdam; Yale University; University of Rochester; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	HEUTINK, P (corresponding author), ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.		Sandor, Paul/I-7211-2016	Sandor, Paul/0000-0003-2397-0758; Heutink, Peter/0000-0001-5218-1737	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024278] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24278] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], HDB TOURETTES SYNDRO; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BARON M, 1990, NATURE, V346, P618, DOI 10.1038/346618a0; BOEHNKE M, 1986, AM J HUM GENET, V39, P513; BYERLEY WF, 1989, NATURE, V340, P340, DOI 10.1038/340340a0; DEVOR EJ, 1990, HUM HERED, V40, P105, DOI 10.1159/000153914; DEVOR EJ, 1992, ADV NEUROL, V58, P181; Egeland Janice A., 1990, Psychiatric Genetics, V1, P5; GREENBERG DA, 1984, AM J HUM GENET, V36, P167; HEUTINK P, 1992, ADV NEUROL, V58, P167; HEUTINK P, 1990, J MED GENET, V27, P433, DOI 10.1136/jmg.27.7.433; HEUTINK P, 1993, HDB TOURETTES SYNDRO, P317; HODGE SE, 1992, AM J HUM GENET, V50, P1053; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; KURLAN R, 1986, NEUROLOGY, V36, P772, DOI 10.1212/WNL.36.6.772; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MAZIADE M, 1992, AM J PSYCHIAT, V149, P1674; PAKSTIS AJ, 1991, AM J HUM GENET, V48, P281; PAULS DL, 1986, ARCH GEN PSYCHIAT, V43, P1180; PAULS DL, 1981, ARCH GEN PSYCHIAT, V38, P1091; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PAULS DL, 1990, J AM ACAD CHILD PSY, V29, P195, DOI 10.1097/00004583-199003000-00007; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RISCH N, 1991, AM J HUM GENET, V48, P1058; ROBERTSON MM, 1989, BRIT J PSYCHIAT, V154, P147, DOI 10.1192/bjp.154.2.147; Shapiro Arthur K., 1988, GILLES TOURETTE SYND, VSecond; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; TERWILLIGER JD, 1992, CYTOGENET CELL GENET, V59, P142, DOI 10.1159/000133228; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WILKIE PJ, 1992, ADV NEUROL, V58, P173; 1994, DIAGNOSTIC STATISTIC	33	24	26	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					465	473						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668273				2022-12-18	WOS:A1995RL77100030
J	TORRONI, A; PETROZZI, M; SANTOLAMAZZA, P; SELLITTO, D; CRUCIANI, F; SCOZZARI, R				TORRONI, A; PETROZZI, M; SANTOLAMAZZA, P; SELLITTO, D; CRUCIANI, F; SCOZZARI, R			ABOUT THE ASIAN-SPECIFIC 9-BP DELETION OF MTDNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HUMAN MITOCHONDRIAL-DNA; LENGTH MUTATIONS; AFFINITIES; MIGRATIONS; LINEAGES		UNIV ROMA LA SAPIENZA,CTR GENET EVOLUZ,ROME,ITALY	Sapienza University Rome	TORRONI, A (corresponding author), UNIV ROMA LA SAPIENZA,DIPARTIMENTO GENET & BIOL MOLEC,ROME,ITALY.		Torroni, Antonio/E-1557-2011; Cruciani, Fulvio/G-6105-2012	Torroni, Antonio/0000-0002-4163-4478; Cruciani, Fulvio/0000-0002-6900-024X	Telethon [E.0069] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; CANN RL, 1983, GENETICS, V104, P699; CHEN YS, 1995, AM J HUM GENET, V57; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1993, MOL BIOL EVOL, V10, P23; PASSARINO G, 1993, AM J HUM GENET, V53, P609; SCHURR TG, 1990, AM J HUM GENET, V46, P613; STONEKING M, 1990, GENETICS, V124, P717; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	19	24	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					507	508						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668278				2022-12-18	WOS:A1995RL77100035
J	LOUGHLIN, J; IRVEN, C; ATHANASOU, N; CARR, A; SYKES, B				LOUGHLIN, J; IRVEN, C; ATHANASOU, N; CARR, A; SYKES, B			DIFFERENTIAL ALLELIC EXPRESSION OF THE TYPE-II COLLAGEN GENE (COL2A1) IN OSTEOARTHRITIC CARTILAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STICKLER SYNDROME ARTHROOPHTHALMOPATHY; PROCOLLAGEN GENE; OSTEOGENESIS IMPERFECTA; MILD CHONDRODYSPLASIA; IDENTIFICATION; POLYMORPHISM; MUTATION; ASSOCIATION; FAMILY; DOMAIN	Osteoarthritis (OA) is a common debilitating disease resulting from the degeneration of articular cartilage. The major protein of cartilage is type II collagen, which is encoded by the COL2A1 gene. Mutations at this locus have been discovered in several individuals with inherited disorders of cartilage. We have identified 27 primary OA patients who are heterozygous for sequence dimorphisms located in the coding region of COL2A1. These dimorphisms were used to distinguish the mRNA output from each of the two COL2A1 alleles in articular cartilage obtained from each patient. Three patients demonstrated differential allelic expression and produced <12% of the normal level of mRNA from one of their COL2A1 alleles. The same allele shows reduced expression in ah three patients, and this allele is more frequent in a well-defined OA population than in a control group, suggesting the possible existence of a rare COL2A1 allele that predisposes to OA.	NUFFIELD ORTHOPAED CTR,OXFORD OX3 7LD,ENGLAND	Nuffield Orthopaedic Centre	LOUGHLIN, J (corresponding author), UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,COLLAGEN GENET GRP,OXFORD OX3 9DU,ENGLAND.			Loughlin, John/0000-0003-2018-3361				AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; AHMAD NN, 1993, AM J HUM GENET, V52, P39; AIGNER T, 1992, VIRCHOWS ARCH B, V62, P337, DOI 10.1007/BF02899701; ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; BALDWIN CT, 1989, BIOCHEM J, V262, P521, DOI 10.1042/bj2620521; BEIGHTON P, 1992, AM J MED GENET, V42, P431, DOI 10.1002/ajmg.1320420406; BROWN DM, 1992, ARCH OPHTHALMOL-CHIC, V110, P1589, DOI 10.1001/archopht.1992.01080230089027; CHEAH KSE, 1985, P NATL ACAD SCI USA, V82, P2555, DOI 10.1073/pnas.82.9.2555; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; HEWETT D, 1994, AM J HUM GENET, V55, P447; HORTON WE, 1992, DNA CELL BIOL, V11, P193, DOI 10.1089/dna.1992.11.193; HULL R, 1989, LANCET, V1, P1337; HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; KNOWLTON RG, 1990, NEW ENGL J MED, V322, P526, DOI 10.1056/NEJM199002223220807; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; LOUGHLIN J, 1994, BRIT J RHEUMATOL, V33, P1103; PALOTIE A, 1989, LANCET, V1, P924; PRIESTLEY L, 1991, BRIT J RHEUMATOL, V30, P272; RIRVANIEMI P, 1994, HUM MUTAT, V3, P261; RITVANIEMI P, 1993, GENOMICS, V17, P218, DOI 10.1006/geno.1993.1306; RYAN MC, 1990, GENOMICS, V8, P41, DOI 10.1016/0888-7543(90)90224-I; STACEY A, 1988, NATURE, V332, P131, DOI 10.1038/332131a0; Tiller G. E., 1992, American Journal of Human Genetics, V51, pA37; VIKKULA M, 1993, ARTHRITIS RHEUM, V36, P401, DOI 10.1002/art.1780360317; VIKKULA M, 1993, ANN RHEUM DIS, V52, P762, DOI 10.1136/ard.52.10.762; VISSING H, 1990, NUCLEIC ACIDS RES, V18, P3431, DOI 10.1093/nar/18.11.3431; Williams Charlene J., 1992, Human Mutation, V1, P403, DOI 10.1002/humu.1380010510; WILLING MC, 1994, AM J HUM GENET, V55, P638; WILLING MC, 1992, AM J HUM GENET, V51, P508	31	24	26	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1186	1193						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726176				2022-12-18	WOS:A1995QU58600023
J	TRIGGSRAINE, B; RICHARD, M; WASEL, N; PRENCE, EM; NATOWICZ, MR				TRIGGSRAINE, B; RICHARD, M; WASEL, N; PRENCE, EM; NATOWICZ, MR			MUTATIONAL ANALYSES OF TAY-SACHS-DISEASE - STUDIES ON TAY-SACHS CARRIERS OF FRENCH-CANADIAN BACKGROUND LIVING IN NEW-ENGLAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-HEXOSAMINIDASE-A; ALPHA-CHAIN; PSEUDODEFICIENCY ALLELE; ASHKENAZI JEWISH; HEXA-GENE; DNA; IDENTIFICATION; FREQUENCY; JEWS; DIAGNOSIS	Tay-Sachs disease (TSD) results from mutations in HEXA that cause Hex A deficiency. Heterozygote-screening programs have been applied in groups with an increased TSD incidence, such as Ashkenazi Jews and French Canadians in Quebec. These programs are complicated by benign mutations that cause apparent Hex A deficiency but not TSD. Benign mutations account for only similar to 2% of Jewish and similar to 36% of non-Jewish enzyme-defined carriers. A carrier frequency of 1/53 (n = 1,434) was found in an ongoing prospective analysis of persons of French Canadian background living in New England by using an enzyme-based assay. DNA from enzyme-defined carriers from this population was analyzed to determine the molecular basis of Hex A deficiency. Samples (36) were tested for common mutations, and samples that were negative for these were screened for uncommon or novel mutations by using SSCP analysis. Exons showing mobility shifts were sequenced, and most mutations were confirmed by restriction enzyme digestion. Known disease-causing mutations were found in nine samples (four had a 7.6-kb deletion found in 80% of French Canadian TSD alleles), and known benign mutations were found in four samples. Seven novel changes were identified, including G748A in four samples. The molecular basis of Hex A deficiency in this carrier population differs from that of French Canadian TSD patients. Screening centers should be aware of the presence of benign mutations among U.S. French Canadians or Franco-Americans. Although the clinical significance of the novel mutations is unknown, the frequency of the G748A mutation, and the fact that it has not been detected in a TSD patient, suggests that it too may be benign.	EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC, DIV MED GENET, WALTHAM, MA 02254 USA; HARVARD UNIV, SCH MED, BOSTON, MA USA	Harvard University; Harvard Medical School	TRIGGSRAINE, B (corresponding author), UNIV MANITOBA, FAC MED, DEPT BIOCHEM & MOLEC BIOL, 770 BANNATYNE AVE, WINNIPEG, MB R3E 0W3, CANADA.		Triggs-Raine, Barbara/AAF-6209-2021	Triggs-Raine, Barbara/0000-0003-4719-6779				Akerman B. R., 1992, Human Mutation, V1, P303, DOI 10.1002/humu.1380010407; AKLI S, 1993, HUM MOL GENET, V2, P61, DOI 10.1093/hmg/2.1.61; AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; Andermann E, 1977, Prog Clin Biol Res, V18, P161; Brault G. J., 1986, FRENCH CANADIAN HERI; CAO Z, 1993, AM J HUM GENET, V53, P1198; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; DEBRAEKELEER M, 1992, HUM GENET, V89, P83, DOI 10.1007/BF00207048; Fernandes Maria, 1992, Human Molecular Genetics, V1, P759, DOI 10.1093/hmg/1.9.759; FERNANDES MJG, 1992, GENET EPIDEMIOL, V9, P169, DOI 10.1002/gepi.1370090303; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; Gravel R. A., 1995, METABOLIC MOL BASIS, P2839; GREBNER EE, 1991, AM J HUM GENET, V48, P604; GRINSHPUN J, IN PRESS HUM MUTAT; HAYASHI K, 1993, HUM MUTAT, V2, P338, DOI 10.1002/humu.1380020503; HECHTMAN P, 1990, AM J HUM GENET, V47, P815; HECHTMAN P, 1992, HUM GENET, V90, P402, DOI 10.1007/BF00220467; HOAR DI, 1984, PRENATAL DIAG, V4, P241, DOI 10.1002/pd.1970040402; KABACK M, 1993, JAMA-J AM MED ASSOC, V270, P2307, DOI 10.1001/jama.270.19.2307; KABACK MM, 1977, PROGR CLIN BIOL RES, P267; KANZLER EM, 1982, THESIS ILLINOIS STAT; KAPLAN F, 1991, J INHERIT METAB DIS, V14, P707, DOI 10.1007/BF01799939; LANDELS EC, 1991, J MED GENET, V28, P177, DOI 10.1136/jmg.28.3.177; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; MULES EH, 1992, AM J HUM GENET, V50, P834; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1986, SCIENCE, V232, P1646, DOI 10.1126/science.3754980; PALOMAKI GE, IN PRESS AM J MED GE; PAW BH, 1990, AM J HUM GENET, V47, P698; PETERSEN GM, 1983, AM J HUM GENET, V35, P1258; PRENCE EM, 1993, CLIN CHEM, V39, P1811; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TOMCZAK J, 1993, AM J HUM GENET, V53, P537; TRIGGSRAINE BL, 1991, AM J HUM GENET, V49, P1041; TRIGGSRAINE BL, 1992, AM J HUM GENET, V51, P793; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; VICERO RV, 1968, THESIS U WISCONSIN M	39	24	26	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					870	879						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717398				2022-12-18	WOS:A1995QP66300008
J	OLSON, JM				OLSON, JM			MULTIPOINT LINKAGE ANALYSIS USING SIB PAIRS - AN INTERVAL MAPPING APPROACH FOR DICHOTOMOUS OUTCOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; PEDIGREE-MEMBER METHOD; QUANTITATIVE TRAIT; DISEASE; STRATEGIES; MODELS; GENES; LOCUS	I propose an interval mapping approach suitable for a dichotomous outcome, with emphasis on samples of affected sib pairs. The method computes a lod score for each of a set of locations in the interval between two nanking markers and takes as its estimate of trait-locus location the maximum lod score in the interval, provided it exceeds the prespecified critical value. Use of the method depends on prior knowledge of the genetic model for the disease only through available estimates of recurrence risk to relatives of affected individuals. The method gives an unbiased estimate of location, provided the recurrence risks are correctly specified and provided the marker identity-by-descent probabilities are jointly, rather than individually, estimated. I also discuss use of the method for traits determined by two loci and give an approximation that has good power for a wide range of two-locus models.			OLSON, JM (corresponding author), ROSWELL PK CANC INST,DEPT BIOMATH,ELM & CARLTON ST,BUFFALO,NY 14263, USA.				NCI NIH HHS [CA09168] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; DEVRIES RRP, 1976, LANCET, V2, P1328; FULKER DW, 1994, AM J HUM GENET, V54, P1092; GREEN JR, 1977, TISSUE ANTIGENS, V9, P31; Haldane JBS, 1919, J GENET, V8, P299; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KNAPP M, 1994, AM J HUM GENET, V55, P1030; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANDER ES, 1989, GENETICS, V121, P125; LANGE K, 1986, AM J HUM GENET, V39, P148; LATHROP GM, 1985, AM J HUM GENET, V37, P482; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; OLSON JM, 1994, 132 U WASH DEP BIOST; OLSON JM, IN PRESS GENET EPIDE; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SUAREZ BK, 1979, CLIN GENET, V15, P126; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; SUAREZ BK, 1976, ANN HUM GENET, V40, P231, DOI 10.1111/j.1469-1809.1976.tb00186.x; TODOROV AA, 1992, THESIS LOUISIANA STA; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859	25	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					788	798						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887435				2022-12-18	WOS:A1995QK91800030
J	SCHNUR, RE; WICK, PA; BAILEY, C; REBBECK, T; WELEBER, RG; WAGSTAFF, J; GRIX, AW; PAGON, RA; HOCKEY, A; EDWARDS, MJ				SCHNUR, RE; WICK, PA; BAILEY, C; REBBECK, T; WELEBER, RG; WAGSTAFF, J; GRIX, AW; PAGON, RA; HOCKEY, A; EDWARDS, MJ			PHENOTYPIC VARIABILITY IN X-LINKED OCULAR ALBINISM - RELATIONSHIP TO LINKAGE GENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DELETION; GENE; LOCALIZATION; XP22.3; OA1	One hundred nineteen individuals from 11 families with X-linked ocular albinism (OA1) were studied with respect to both their clinical phenotypes and their linkage geno-types. In a four-generation Australian family, two affected males and an obligatory carrier lacked cutaneous melanin macroglobules (MMGs); ocular features were identical to those of Nettleship-Falls OA1. Four other families had more unusual phenotypic features in addition to OA1. All OA1 families were genotyped at DXS16, DXS85, DXS143, STS, and DXS452 and for a CA-repeat polymorphism at the Kallmann syndrome locus (KAL). Separate two-point linkage analyses were performed for the following: group A, six families with biopsy-proved MMGs in at least one affected male; group B, four families whose biopsy status was not known; and group C, OA-9 only (16 samples), the family without MMGs. At the set of loci closest to OA1, there is no clear evidence in our data set for locus heterogeneity between groups A and C or among the four other families with complex phenotypes. Combined multipoint analysis (LINKMAP) in the 11 families and analysis of individual recombination events confirms that the major locus for OA1 resides within the DXS85-DXS143 interval. We suggest that more detailed clinical evaluations of OA1 individuals and families should be performed for future correlation with specific mutations in candidate OA1 genes.	UNIV PENN,SCH MED,PHILADELPHIA,PA 19104; FOX CHASE CANC CTR,PHILADELPHIA,PA 19111; OREGON HLTH SCI UNIV,PORTLAND,OR 97201; BOSTON CHILDRENS HOSP,BOSTON,MA; UNIV CALIF DAVIS,DAVIS,CA 95616; CHILDRENS HOSP & MED CTR,SEATTLE,WA 98105; PRINCESS MARGARET HOSP CHILDREN,PERTH,WA,AUSTRALIA; NEWCASTLE WESTERN SUBURBS HOSP,WARATAH,AUSTRALIA	University of Pennsylvania; Fox Chase Cancer Center; Oregon Health & Science University; Harvard University; Boston Children's Hospital; University of California System; University of California Davis; Seattle Children's Hospital; University of Western Australia	SCHNUR, RE (corresponding author), CHILDRENS HOSP,5082 WOOD BLDG,34TH ST & CIVIC CTR BLVD,PHILADELPHIA,PA 19104, USA.		Edwards, Matthew/A-7560-2011; Edwards, Matthew/L-8698-2019	Edwards, Matthew/0000-0001-8437-8120; Edwards, Matthew/0000-0001-8437-8120	NCI NIH HHS [K07-CA-60798] Funding Source: Medline; NEI NIH HHS [1 K11 EY00298-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA060798] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K11EY000298] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BERGEN AAB, 1990, OPHTHALMIC PAED GEN, V11, P165, DOI 10.3109/13816819009020975; BERGEN AAB, 1993, GENOMICS, V16, P272, DOI 10.1006/geno.1993.1176; BERGEN AAB, 1991, HUM GENET, V88, P162, DOI 10.1007/BF00206065; BOULOUX PMG, 1991, NUCLEIC ACIDS RES, V19, P5453, DOI 10.1093/nar/19.19.5453; CHARLES SJ, 1992, EYE, V6, P75, DOI 10.1038/eye.1992.15; CHARLES SJ, 1992, J MED GENET, V29, P552, DOI 10.1136/jmg.29.8.552; CHARLES SJ, 1993, GENOMICS, V16, P259, DOI 10.1006/geno.1993.1171; CREEL D, 1978, SCIENCE, V201, P931, DOI 10.1126/science.684419; FALLS HT, 1951, AM J OPHTHALMOL, V43, P41; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LYON MF, 1962, AM J HUM GENET, V14, P135; MANDEL JL, 1993, GENOME PRIORITY REPO, V1, P588; MEINDL A, 1993, J MED GENET, V30, P838, DOI 10.1136/jmg.30.10.838; MORTON NE, 1956, AM J HUM GENET, V8, P80; NAKAGAWA H, 1984, J INVEST DERMATOL, V83, P134, DOI 10.1111/1523-1747.ep12263325; NETTLESHIP E, 1909, T OPHTHALMOLOGICAL S, V29, P57; ODONNELL FE, 1976, ARCH OPHTHALMOL-CHIC, V94, P1883, DOI 10.1001/archopht.1976.03910040593001; ODONNELL FE, 1978, ARCH OPHTHALMOL-CHIC, V96, P1189, DOI 10.1001/archopht.1978.03910060023005; Pillers D. M., 1992, American Journal of Human Genetics, V51, pA44; REICHEL M, 1992, PEDIATR DERMATOL, V9, P103, DOI 10.1111/j.1525-1470.1992.tb01223.x; RUSSELLEGGITT I, 1990, BRIT J OPHTHALMOL, V74, P136, DOI 10.1136/bjo.74.3.136; SCHAEFER L, 1993, NAT GENET, V4, P272, DOI 10.1038/ng0793-272; SCHNUR RE, 1990, GENOMICS, V8, P255, DOI 10.1016/0888-7543(90)90280-8; SCHNUR RE, 1993, GENOMICS, V15, P500, DOI 10.1006/geno.1993.1100; SCHNUR RE, 1989, AM J HUM GENET, V45, P706; SCHNUR RE, 1991, GENOMICS, V9, P605, DOI 10.1016/0888-7543(91)90353-G; VANDORP DB, 1987, CLIN GENET, V31, P228; WAPENAAR MC, 1993, HUM MOL GENET, V2, P947, DOI 10.1093/hmg/2.7.947; ZHANG Y, 1993, J MED GENET, V30, P923, DOI 10.1136/jmg.30.11.923	29	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					484	496						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	7915878				2022-12-18	WOS:A1994PF50900010
J	MCEWEN, JE; REILLY, PR				MCEWEN, JE; REILLY, PR			A REVIEW OF STATE LEGISLATION ON DNA FORENSIC DATA BANKING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIVACY	Recent advances in DNA identification technology are making their way into the criminal law. States across the country are enacting legislation to create repositories for the storage both of DNA samples collected from convicted offenders and of the DNA profiles derived from them. These data banks will be used to assist in the resolution of future crimes. This study surveys existing state statutes, pending legislation, and administrative regulations that govern these DNA forensic data banks. We critically analyzed these laws with respect to their treatment of the collection, storage, analysis, retrieval, and use of DNA and DNA data. We found much variation among data-banking laws and conclude that, while DNA forensic data banking carries tremendous potential for law enforcement, many states, in their rush to create data banks, have paid little attention to issues of quality control, quality assurance, and privacy. In addition, the sweep of some laws is unnecessarily broad. Legislative modifications are needed in many states to better safeguard civil liberties and individual privacy.	BOSTON COLL,SCH LAW,NEWTON,MA	Boston College	MCEWEN, JE (corresponding author), EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,DIV SOCIAL SCI ETH & LAW,200 TRAPELO RD,WALTHAM,MA 02254, USA.				PHS HHS [MCH MCJ-259151-02-0] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSON C, 1992, NATURE, V359, P349, DOI 10.1038/359349a0; ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346; [Anonymous], 1992, DNA TECHNOLOGY FOREN; BALLANTYN J, 1989, BANBURY REP, V32; DEGORGEY A, 1990, AM J LAW MED, V16, P381; Jonakait RN, 1991, HARVARD J LAW TECHNO, V4, P109; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; ROBERTS L, 1991, SCIENCE, V254, P1721, DOI 10.1126/science.1763321; 1989, RECIDIVISM PRISIONER; 1987, RECIDIVISM YOUNG PAR; 1992, SOURCEBOOK CRIMINAL; 1990, AM J HUM GENET, V46, P631; 1989, JTECHNICAL WORKING G; 1990, OTABA US C OFF TECHN; 1991, LEGISLATIVE GUIDELIN	15	24	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					941	958						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	NP053	8198138				2022-12-18	WOS:A1994NP05300003
J	MCEWEN, JE; MCCARTY, K; REILLY, PR				MCEWEN, JE; MCCARTY, K; REILLY, PR			A SURVEY OF MEDICAL DIRECTORS OF LIFE-INSURANCE COMPANIES CONCERNING USE OF GENETIC INFORMATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Rapid advances in our ability to test persons presymptomatically for genetic diseases have generated increasing concern that genetic information will be abused by insurance companies. Reasoning that the insurance companies may have the strongest interest in using genetic data and that the medical directors of those companies with responsibility for rating applicants would be a good source of information on the use of such data, we conducted a large survey of medical directors of North American life insurance companies. We receive responses from 27 medical directors. Our results suggest that (1) few insurers perform genetic tests on applicants, but most are interested in accessing genetic test information about applicants that already exists; (2) the degree of insurers' interest in using genetic test results may depend on the face amount of the policy applied for an on the specificity and sensitivity of the test; (3) many companies employ underwriting guidelines with respect to certain genetic conditions but may not always have specific actuarial data in house to support their rating decisions; (4) a considerable degree of subjectivity is involved in most insurers' rating decisions; and (5) some of the medical directors who responded to our survey are not fully informed about certain basic principles of medical genetics.	BOSTON COLL,SCH LAW,NEWTON,MA	Boston College	MCEWEN, JE (corresponding author), SHRIVER CTR MENTAL RETARDAT INC,DIV SOCIAL SCI ETHICS & LAW,200 TRAPELO RD,WALTHAM,MA 02254, USA.				PHS HHS [MCJ-259151-02-0] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BILLINGS PR, 1992, AM J HUM GENET, V50, P476; CLIFFORD KA, 1987, HARVARD LAW REV, V100, P1806, DOI 10.2307/1341233; Hiam P, 1987, Law Med Health Care, V15, P212; HOOK EB, 1992, AM J HUM GENET, V51, P899; LEW EA, 1991, MED RISKS TRENDS MOR, V2; LEW EA, 1991, MED RISKS TRENDS MOR, V1; LOWDEN JA, 1992, AM J HUM GENET, V51, P901; MCEWEN JE, 1992, AM J HUM GENET, V51, P785; MCEWEN JE, 1992, AM J HUM GENET, V51, P637	9	24	25	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					33	45						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	LJ385	8317496				2022-12-18	WOS:A1993LJ38500006
J	WARD, PJ				WARD, PJ			SOME DEVELOPMENTS ON THE AFFECTED-PEDIGREE-MEMBER METHOD OF LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; CORONARY-ARTERY DISEASE; AFFECTED RELATIVE PAIRS; APOLIPOPROTEIN-B-GENE; DNA POLYMORPHISMS; IDENTITY; SUSCEPTIBILITY; STRATEGIES; POWER; LOCUS	Some improvements are presented for the affected-pedigree-member method of linkage analysis, which is a generalization of the sib-pair method. The test statistic is extended to include contrasts between affected and unaffected pedigree members, so that it now utilizes marker information from all typed pedigree members rather than just the typed affected members. Computer simulation using a sample pedigree of 14 individuals shows that this modification can substantially increase statistical power where there is a direct association between marker variation and disease and where disease risk is elevated in carriers of the disease allele. Data on Huntington disease in 16 British families, which were analyzed previously using only the affected individuals, are reanalyzed with the unaffected individuals included. Strong rejection of the null hypothesis of no association between Huntington disease and the HindIII polymorphism is confirmed, but the particular families in which the association is significant differs from that obtained through an analysis based only on affected individuals and reflects more closely the results obtained from a lod-score analysis. The test statistic is also modified here to incorporate contrasts between individuals of zero kinship, if needed. This enables contrasts between individuals from different pedigrees, as well as contrasts involving individuals sampled from the general population, to be incorporated into the test of association. For population data, the methodology reduces to a type of contingency-table analysis, in which the rows of the table correspond to different marker-locus genotypes and in which the two columns categorize subjects into an ''affected'' group versus an ''unaffected,'' or control, group. This aspect of the methodology is illustrated using two population data sets, the first relating APO-E genotype to the frequency of individuals undergoing maintenance hemodialysis and the second relating APO-B genotype to the frequency of coronary artery disease. The present methodology confirms the lack of association between marker and disease in the former data set and confirms the presence of association in the latter. Finally, the methodology is formulated here in terms of ordinary, multiperson kinship coefficients rather than in terms of the generalized kinship coefficients originally proposed. This greatly reduces the number of coefficients to be calculated, thereby enhancing the computational efficiency of the computer program.			WARD, PJ (corresponding author), INST GUSTAVE ROUSSY,UNITE RECH EPIDEMIOL CANC,INSERM,U351,39 RUE CAMILLE DESMOULINS,F-94805 VILLEJUIF,FRANCE.		Ward, Patrick John/L-5120-2019					BISHOP DT, 1990, AM J HUM GENET, V46, P254; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; FEUSSNER G, 1992, HUM GENET, V88, P307; FISHMAN PM, 1978, AM J HUM GENET, V30, P308; GENEST JJ, 1990, ATHEROSCLEROSIS, V82, P7, DOI 10.1016/0021-9150(90)90138-9; GOLDSTEIN AM, 1989, MULTIPOINT MAPPING L, V6, P135; GREEN JR, 1977, TISSUE ANTIGENS, V9, P31; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HEGELE RA, 1986, NEW ENGL J MED, V315, P1509, DOI 10.1056/NEJM198612113152403; KARIGL G, 1981, ANN HUM GENET, V45, P299, DOI 10.1111/j.1469-1809.1981.tb00341.x; LANGE K, 1986, AM J HUM GENET, V39, P148; LANGE K, 1986, ANN HUM GENET, V50, P283, DOI 10.1111/j.1469-1809.1986.tb01049.x; MACCLUER JW, 1991, AM J HUM GENET, V49, P1139; MYANT NB, 1989, ATHEROSCLEROSIS, V77, P193, DOI 10.1016/0021-9150(89)90081-6; NEEL JV, 1990, GENETIC ANAL COMPLEX; Ott J., 1991, ANAL HUMAN GENETIC L; PENROSE LS, 1935, ANN EUGEN, V6, P133; RENGES HH, 1991, ATHEROSCLEROSIS, V91, P267, DOI 10.1016/0021-9150(91)90174-2; Renyi A., 1970, PROBABILITY THEORY; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; SING CF, 1990, ANNU REV GENET, V24, P171; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; Thomson G, 1977, HLA DISEASE, P84; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WOLF CR, 1990, CANCER SURV, V9, P437; YOUNGMAN S, 1986, HUM GENET, V73, P333, DOI 10.1007/BF00279096	29	24	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1200	1215						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8099256				2022-12-18	WOS:A1993LG13300022
J	SMALLEY, SL				SMALLEY, SL			SEX-SPECIFIC RECOMBINATION FREQUENCIES - A CONSEQUENCE OF IMPRINTING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											SMALLEY, SL (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT PSYCHIAT, LOS ANGELES, CA USA.							CHAKRABORTY R, 1989, GENETICS, V122, P713; FARRER LA, 1992, AM J HUM GENET, V50, P528; HALL JG, 1990, AM J HUM GENET, V46, P857; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MONK M, 1988, GENE DEV, V2, P921, DOI 10.1101/gad.2.8.921; MONK M, 1987, NATURE, V328, P203, DOI 10.1038/328203a0; Ott J., 1991, ANAL HUMAN GENETIC L; SURANI MAH, 1986, EXPT APPROACHES MAMM, P401	8	24	24	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					210	212						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434589				2022-12-18	WOS:A1993KK90800029
J	BRANDT, B; GREGER, V; YANDELL, D; PASSARGE, E; HORSTHEMKE, B				BRANDT, B; GREGER, V; YANDELL, D; PASSARGE, E; HORSTHEMKE, B			A SIMPLE AND NONRADIOACTIVE METHOD FOR DETECTING THE RB1.20 DNA POLYMORPHISM IN THE RETINOBLASTOMA GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									MASSACHUSETTS EYE & EAR INFIRM,DEPT OPHTHALMOL,BOSTON,MA 02114	Harvard University; Massachusetts Eye & Ear Infirmary	BRANDT, B (corresponding author), UNIV ESSEN GESAMTHSCH KLINIKUM,INST HUMAN GENET,W-4300 ESSEN 1,GERMANY.			Greger, Valerie/0000-0001-7716-3973				LOHMANN D, 1992, HUM GENET, V89, P49, DOI 10.1007/BF00207041; YANDELL DW, 1989, AM J HUM GENET, V45, P547	2	24	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1450	1451						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463022				2022-12-18	WOS:A1992KC99500030
J	DRUCKER, L; PROIA, RL; NAVON, R				DRUCKER, L; PROIA, RL; NAVON, R			IDENTIFICATION AND RAPID DETECTION OF 3 TAY-SACHS MUTATIONS IN THE MOROCCAN JEWISH POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-HEXOSAMINIDASE; ASHKENAZI JEWS; ALPHA-SUBUNIT; DISEASE; GENE; INSERTION; CARRIERS; DEFECT; CHAIN; DNA	Infantile Tay-Sachs disease (TSD) is caused by mutations in the HEXA gene that result in the complete absence of beta-hexosaminidase A activity. It is well known that an elevated frequency of TSD mutations exists among Ashkenazi Jews. More recently it has become apparent that elevated carrier frequencies for TSD also occur in several other ethnic groups, including Moroccan Jews, a subgroup of Sephardic Jews. Elsewhere we reported an in-frame deletion of one of the two adjacent phenylalanine codons at position 304 or 305 (DELTA-F304/305) in one HEXA allele of a Moroccan Jewish TSD patient and in three obligate carriers from six unrelated Moroccan Jewish families. We have now identified two additional mutations within exon 5 of the HEXA gene that account for the remaining TSD alleles in the patient and carriers. One of the mutations is a novel C-to-G transversion, resulting in a replacement of Tyr180 by a stop codon. The other mutation is a G-to-A transition resulting in an Arg170-to-Gln substitution. This mutation is at a CpG site in a Japanese infant with Tay-Sachs disease and was described elsewhere. Analysis of nine obligate carriers from seven unrelated families showed that four harbor the DELTA-F304/305 mutation, two the Arg170-->Gln mutation, and one the Tyr180-->Stop mutation. We also have developed rapid, nonradioactive assays for the detection of each mutation, which should be helpful for carrier screening.	SAPIR MED CTR,MOLEC GENET UNIT,IL-44281 KEFAR SAVA,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,TEL AVIV,ISRAEL; NIDDKD,GENET & BIOCHEM BRANCH,BETHESDA,MD	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270				AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; Andermann E, 1977, Prog Clin Biol Res, V18, P161; ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; BESERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; Gilbert Martin, 1969, JEWISH HIST ATLAS; GRAVEL RA, 1991, CAN J NEUROL SCI, V18, P419, DOI 10.1017/S0317167100032583; GREBNER EE, 1991, AM J HUM GENET, V48, P604; KELLY ET, 1975, AM J HUM GENET, V27, P287; LAU MMH, 1989, J BIOL CHEM, V264, P21376; Maniatis T., 1982, MOL CLONING; MCDOWELL GA, 1991, AM J HUM GENET S, V49, pA9; MULES EH, 1992, AM J HUM GENET, V50, P834; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P1955; NAKANO T, 1990, ANN NEUROL, V27, P465, DOI 10.1002/ana.410270503; NAVON R, 1991, AM J HUM GENET, V48, P412; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; NISHIMOTO J, 1991, J BIOL CHEM, V266, P14306; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; PAW BH, 1990, AM J HUM GENET, V47, P698; PAW BH, 1991, AM J HUM GENET, V48, P1139; ROMMENS J, 1990, AM J HUM GENET, V46, P395; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SHORE S, 1990, ANAL BIOCHEM, V186, P179, DOI 10.1016/0003-2697(90)90593-X; TRIGGSRAINE BL, 1991, AM J HUM GENET, V49, P1041; TRIGGSRAINE BL, 1990, AM J HUM GENET, V46, P183; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VECHT J, 1983, ISRAEL J MED SCI, V19, P67	33	24	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					371	377						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1322637				2022-12-18	WOS:A1992JF77600017
J	CHEN, J; SAHOTA, A; LAXDAL, T; SCRINE, M; BOWMAN, S; CUI, C; STAMBROOK, PJ; TISCHFIELD, JA				CHEN, J; SAHOTA, A; LAXDAL, T; SCRINE, M; BOWMAN, S; CUI, C; STAMBROOK, PJ; TISCHFIELD, JA			IDENTIFICATION OF A SINGLE MISSENSE MUTATION IN THE ADENINE PHOSPHORIBOSYLTRANSFERASE (APRT) GENE FROM 5 ICELANDIC PATIENTS AND A BRITISH PATIENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							2,8-DIHYDROXYADENINE UROLITHIASIS; DEFICIENCY; JAPANESE; FAMILIES; COMMON; ENZYME; SEQUENCE; CLONING	We have completely sequenced the adenine phosphoribosyltransferase (APRT) gene from each of six patients-five (I-V) from Iceland and one (VI) from Britain. Cases I and II shared a common ancestor six and seven generations ago, and cases I and V shared a common ancestor seven generations ago, but cases III and IV were unrelated to the above or to each other, over seven generations. Genomic DNA was amplified by PCR, subcloned into M13mp18, and sequenced. Genomic and PCR-amplified DNAs were also analyzed by restriction-enzyme digestion and Southern blotting. The same missense mutation was identified in all six patients. This mutation leads to the replacement of asp (GAC) by val (GTC), at amino acid position 65. The gene sequences from all patients were otherwise identical to our wild-type sequence. The homozygous nature of the mutation was confirmed by sequencing the PCR product directly. All six patients were homozygous for the 1.25-kb TaqI RFLP. The Icelandic patients were also homozygous for the 8-kb SphI RFLP, but the British patient was heterozygous at this site. These studies suggest that a founder effect is likely to be responsible for APRT deficiency in the Icelandic population. The finding of the same mutation in a patient from Britain suggests that this mutation may have originated in mainland Europe.	INDIANA UNIV,SCH MED,DEPT MED & MOLEC GENET,1B 130,975 W WALNUT ST,INDIANAPOLIS,IN 46202; ST JOSEPHS HOSP,DEPT PEDIAT,REYKJAVIK,ICELAND; ROYAL FREE HOSP,DEPT PEDIAT,LONDON,ENGLAND; UNIV CINCINNATI,COLL MED,DEPT ANAT & CELL BIOL,CINCINNATI,OH 45221	Indiana University System; Indiana University-Purdue University Indianapolis; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University System of Ohio; University of Cincinnati	SAHOTA, A (corresponding author), INDIANA UNIV,SCH MED,DEPT MED & MOLEC GENET,1B 130,975 W WALNUT ST,INDIANAPOLIS,IN 46202, USA.		Chen, Ju/E-5579-2011	Tischfield, Jay/0000-0003-3217-8287	NATIONAL CANCER INSTITUTE [R01CA036897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038185] Funding Source: NIH RePORTER; NCI NIH HHS [CA36897] Funding Source: Medline; NIDDK NIH HHS [DK38185] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHEN J, 1991, MUTAT RES, V249, P169, DOI 10.1016/0027-5107(91)90143-C; FUJIMORI S, 1985, HUM GENET, V71, P171; GATHOF BS, IN PRESS KLIN WOCHEN; GREENWOOD MC, 1982, EUR J PEDIATR, V138, P346, DOI 10.1007/BF00442515; HIDAKA Y, 1988, J CLIN INVEST, V81, P945, DOI 10.1172/JCI113408; HIDAKA Y, 1987, J CLIN INVEST, V80, P1409, DOI 10.1172/JCI113219; JOHNSON DH, 1987, GENE, V59, P77, DOI 10.1016/0378-1119(87)90268-X; KAMATANI N, 1990, HUM GENET, V85, P500; KAMATANI N, 1987, HUM GENET, V75, P163, DOI 10.1007/BF00591080; KAMATANI N, 1990, HUM GENET, V85, P600; LAXDAL T, 1988, ACTA MED SCAND, V224, P621; MIMORI A, 1991, AM J HUM GENET, V48, P103; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; SAHOTA A, 1990, NUCLEIC ACIDS RES, V18, P5915, DOI 10.1093/nar/18.19.5915; SAHOTA A, 1991, AM J HUM GENET, V48, P983; SIMMONDS HA, 1989, METABOLIC BASIS INHE, P1029; STAMBROOK PJ, 1984, SOMAT CELL MOLEC GEN, V10, P359, DOI 10.1007/BF01535631	17	24	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1306	1311						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746557				2022-12-18	WOS:A1991GU67200017
J	PETERSEN, MB; ADELSBERGER, PA; SCHINZEL, AA; BINKERT, F; HINKEL, GK; ANTONARAKIS, SE				PETERSEN, MB; ADELSBERGER, PA; SCHINZEL, AA; BINKERT, F; HINKEL, GK; ANTONARAKIS, SE			DOWN-SYNDROME DUE TO DENOVO ROBERTSONIAN TRANSLOCATION T(14Q-21Q) - DNA POLYMORPHISM ANALYSIS SUGGESTS THAT THE ORIGIN OF THE EXTRA 21Q IS MATERNAL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN ACROCENTRIC CHROMOSOMES; ALPHOID REPETITIVE DNA; GT DINUCLEOTIDE REPEAT; RIBOSOMAL GENES; FIBRILLAR CENTER; RECOMBINATION; ASSOCIATION; SEQUENCES; NUCLEOLUS; NONDISJUNCTION	Down syndrome is rarely due to a de novo Robertsonian translocation t(14q;21q). DNA polymorphisms in eight families with Down syndrome due to de novo t(14q;21q) demonstrated maternal origin of the extra chromosome 21q in all cases. In seven nonmosaic cases the DNA markers showed crossing-over between two maternal chromosomes 21, and in one mosaic case no crossing-over was observed (this case was probably due to an early postzygotic nondisjunction). In the majority of cases (five of six informative families) the proximal marker D21S120 was reduced to homozygosity in the offspring with trisomy 21. The data can be best explained by chromatid translocation in meiosis I and by normal crossover and segregation in meiosis I and meiosis II.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PEDIAT,BALTIMORE,MD 21205; UNIV ZURICH,INST MED GENET,CH-8006 ZURICH,SWITZERLAND; MED ACAD CARL GUSTAV CARUS,INST CLIN GENET,O-8019 DRESDEN,GERMANY	Johns Hopkins University; University of Zurich; Technische Universitat Dresden			Slagboom, P. Eline/R-4790-2016; Petersen, Michael Bjørn B/D-1483-2017; Antonarakis, Stylianos/N-8866-2014	Slagboom, P. Eline/0000-0002-2875-4723; Petersen, Michael Bjørn B/0000-0003-0316-8207; Antonarakis, Stylianos/0000-0001-8907-5823	NIGMS NIH HHS [GM41015] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM041015] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONARAKIS SE, 1990, AM J HUM GENET, V47, P968; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; BURMELSTER M, 1990, NUCLEIC ACIDS RES, V18, P4969, DOI 10.1093/nar/18.16.4969; CHEUNG SW, 1990, CYTOGENET CELL GENET, V54, P97, DOI 10.1159/000132970; CHOO KH, 1988, NUCLEIC ACIDS RES, V16, P1273, DOI 10.1093/nar/16.4.1273; CHOO KH, 1989, GENOMICS, V5, P332, DOI 10.1016/0888-7543(89)90066-9; DEVILEE P, 1986, CYTOGENET CELL GENET, V41, P193, DOI 10.1159/000132229; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GRASSO M, 1989, HUM GENET, V84, P63, DOI 10.1007/BF00210673; HANSSON A, 1978, CYTOGENET CELL GENET, V20, P194, DOI 10.1159/000130851; HECHT F, 1971, AM J HUM GENET, V23, P361; JABS EW, 1991, GENOMICS, V9, P141, DOI 10.1016/0888-7543(91)90231-3; JORGENSEN A L, 1988, Genomics, V3, P100, DOI 10.1016/0888-7543(88)90139-5; JORGENSEN AL, 1987, P NATL ACAD SCI USA, V84, P1075, DOI 10.1073/pnas.84.4.1075; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEWIS JG, 1990, GENOMICS, V8, P400, DOI 10.1016/0888-7543(90)90300-J; LITT M, 1989, AM J HUM GENET, V44, P397; MAGENIS RE, 1981, TRISOMY, V21, P77; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MIKKELSEN M, 1976, ANN HUM GENET, V40, P177, DOI 10.1111/j.1469-1809.1976.tb00177.x; MIKKELSEN M, 1989, MOL CYTOGENETIC STUD, P183; MIRRE C, 1980, P NATL ACAD SCI-BIOL, V77, P6017, DOI 10.1073/pnas.77.10.6017; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P381, DOI 10.1093/nar/16.1.381; OHNO S, 1961, LANCET, V2, P123; PETERSEN MB, 1990, GENOMICS, V7, P136, DOI 10.1016/0888-7543(90)90531-X; PETERSEN MB, 1991, AM J HUM GENET, V48, P65; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; PETERSEN MB, IN PRESS HUM GENET; PULLIAM LH, 1986, AM J HUM GENET, V39, P361; ROBINSON JA, 1973, LANCET, V1, P131; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHMICKEL RD, 1985, ANN NY ACAD SCI, V450, P121, DOI 10.1111/j.1749-6632.1985.tb21488.x; SHAFFER LG, 1991, HUM GENET, V86, P375; STAHL A, 1983, P NATL ACAD SCI-BIOL, V80, P5946, DOI 10.1073/pnas.80.19.5946; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WARREN AC, 1989, GENOMICS, V4, P579, DOI 10.1016/0888-7543(89)90282-6; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL	42	24	36	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					529	536						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1831959				2022-12-18	WOS:A1991GE36700005
J	BEAUDET, AL; PERCIACCANTE, RG; CUTTING, GR				BEAUDET, AL; PERCIACCANTE, RG; CUTTING, GR			HOMOZYGOUS NONSENSE MUTATION CAUSING CYSTIC-FIBROSIS WITH UNIPARENTAL DISOMY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DISEASE; GENE		HOUSE GOOD SAMARITAN,WATERTOWN,NY; JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205	Johns Hopkins University	BEAUDET, AL (corresponding author), BAYLOR UNIV,HOWARD HUGHES MED INST,HOUSTON,TX 77030, USA.							CUTTING GR, 1990, NEW ENGL J MED, V323, P1685, DOI 10.1056/NEJM199012133232407; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; SPENCE JE, 1988, AM J HUM GENET, V42, P217	4	24	24	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1213	1213						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035541				2022-12-18	WOS:A1991FP09200035
J	DISILVESTRE, D; KOCH, R; GROFFEN, J				DISILVESTRE, D; KOCH, R; GROFFEN, J			DIFFERENT CLINICAL MANIFESTATIONS OF HYPERPHENYLALANINEMIA IN 3 SIBLINGS WITH IDENTICAL PHENYLALANINE-HYDROXYLASE GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HYPERVARIABLE RFLP; ABR GENE; PHENYLKETONURIA; DIAGNOSIS		CHILDRENS HOSP LOS ANGELES,DIV MED GENET,LOS ANGELES,CA 90054	Children's Hospital Los Angeles	DISILVESTRE, D (corresponding author), CHILDRENS HOSP LOS ANGELES,DEPT PATHOL,LOS ANGELES,CA 90054, USA.		Heisterkamp, Nora/C-1698-2012	Heisterkamp, Nora/0000-0003-2769-2273	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD043807] Funding Source: NIH RePORTER; NICHD NIH HHS [N0I-HDO-4-3807] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BLASKOVICS ME, 1986, J INHERIT METAB DIS, V9, P178, DOI 10.1007/BF01799702; DHONDT JL, 1987, EUR J PEDIATR, V146, pA38, DOI 10.1007/BF00442055; DISILVESTRE D, 1990, AM J HUM GENET, V47, P706; DISILVESTRE D, 1990, NUCLEIC ACIDS RES, V18, P5925, DOI 10.1093/nar/18.19.5925; DISILVESTRE D, 1990, NUCLEIC ACIDS RES, V18, P5924, DOI 10.1093/nar/18.19.5924; JOHN SWM, 1990, AM J HUM GENET, V46, P970; KANG ES, 1970, PEDIATRICS, V45, P83; LIDSKY AS, 1985, LANCET, V1, P549; WOO SLC, 1989, BIOCHEMISTRY-US, V28, P1, DOI 10.1021/bi00427a001	9	24	26	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					1014	1016						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	2018035				2022-12-18	WOS:A1991FK89700026
J	FINKELSTEIN, JE; DOEGE, K; YAMADA, Y; PYERITZ, RE; GRAHAM, JM; MOESCHLER, JB; PAULI, RM; HECHT, JT; FRANCOMANO, CA				FINKELSTEIN, JE; DOEGE, K; YAMADA, Y; PYERITZ, RE; GRAHAM, JM; MOESCHLER, JB; PAULI, RM; HECHT, JT; FRANCOMANO, CA			ANALYSIS OF THE CHONDROITIN SULFATE PROTEOGLYCAN CORE PROTEIN (CSPGCP) GENE IN ACHONDROPLASIA AND PSEUDOACHONDROPLASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRENATAL-DIAGNOSIS; COMPRESSION; APNEA; DNA	Achondroplasia and pseudoachondroplasia are autosomal dominant skeletal dysplasias resulting in short-limbed dwarfism. Histologic and ultrastructural studies of the cartilage in pseudoachondroplasia and in homozygous achondroplasia have suggested a structural abnormality in chondroitin sulfate proteoglycan (CSPG), a major structural protein in the extra-cellular matrix. The gene encoding CSPG core protein (CSPGCP) is thus a logical "candidate gene" for analysis in these conditions. cDNA probes encoding CSPGCP were used to identify restriction fragment length polymorphisms (RFLPs) in DNA from a panel of control individuals. No gross alterations at the CSPGCP locus were noted in DNA from 37 individuals with achondroplasia and 5 individuals with pseudoachondroplasia. In addition, allelic frequencies of the RFLPs were not significantly different among controls and patients with either condition. In one three-generation family with achondroplasia, close linkage of the CSPGCP locus and the skeletal dysplasia was excluded using a Bgl II polymorphism. Similarly, in a three-generation family with pseudoachondroplasia, the CSPGCP gene was not tightly linked to the disease phenotype. These results indicate that mutations at the chondroitin sulfate proteoglycan core protein locus do not cause achondroplasia or pseudoachondroplasia in these families.	JOHNS HOPKINS UNIV,DEPT PEDIAT,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,DEPT MED,BALTIMORE,MD 21218; NIDR,BETHESDA,MD 20892; UNIV CALIF LOS ANGELES,SCH MED,CEDARS SINAI MED CTR,AHMANSON PEDIAT CTR,LOS ANGELES,CA 90024; DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT MATERNAL & CHILD HLTH,HANOVER,NH 03756; UNIV WISCONSIN,DEPT MATERNAL & CHILD HLTH,MADISON,WI 53706; UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53706; UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53706; UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX 77025	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Dartmouth College; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System			Graham, John M./J-1429-2019; Pyeritz, Reed/A-1364-2010		NIADDK NIH HHS [AM01361] Funding Source: Medline; NIGMS NIH HHS [GM 07471, GM41015-02] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [K11AM001361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM041015] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATERMAN K, 1983, PATHOL RES PRACT, V178, P27, DOI 10.1016/S0344-0338(83)80082-X; COHEN ME, 1967, J PEDIATR-US, V71, P367, DOI 10.1016/S0022-3476(67)80296-8; DOEGE K, 1990, EXTRACELLULAR MATRIX, P137; FRANCOMANO CA, 1988, AM J MED GENET, V29, P955, DOI 10.1002/ajmg.1320290433; FREMION AS, 1984, J PEDIATR-US, V104, P398, DOI 10.1016/S0022-3476(84)81103-8; HALL J G, 1969, Birth Defects Original Article Series, V5, P24; HALL JG, 1987, AM J MED GENET, V28, P143, DOI 10.1002/ajmg.1320280121; HALL JG, 1979, AM J MED GENET, V3, P371, DOI 10.1002/ajmg.1320030408; Hay E. D., 1981, CELL BIOL EXTRACELLU; HECHT JT, 1987, AM J HUM GENET, V41, P454; HORTON WA, 1982, AM J DIS CHILD, V136, P316, DOI 10.1001/archpedi.1982.03970400034010; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MALONEY F P, 1969, Birth Defects Original Article Series, V5, P242; NILSSON K, 1976, IN VITRO METHODS CEL, P713; ORIOLI IM, 1986, J MED GENET, V23, P328, DOI 10.1136/jmg.23.4.328; PAULI RM, 1984, J PEDIATR-US, V104, P342, DOI 10.1016/S0022-3476(84)81092-6; PEDRINIMILLE A, 1982, J BONE JOINT SURG AM, V64, P39, DOI 10.2106/00004623-198264010-00007; REID CS, 1987, J PEDIATR-US, V110, P522, DOI 10.1016/S0022-3476(87)80542-5; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STANESCU V, 1984, J BONE JOINT SURG AM, V66A, P817, DOI 10.2106/00004623-198466060-00002; STANESCU V, 1982, EUR J PEDIATR, V138, P221, DOI 10.1007/BF00441206; WARD PA, 1989, AM J HUM GENET, V44, P270; WYNNEDAVIES R, 1986, J MED GENET, V23, P425, DOI 10.1136/jmg.23.5.425; YASSOUFIAN H, 1987, P NATL ACAD SCI USA, V84, P3772	24	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					97	102						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1670752				2022-12-18	WOS:A1991ET18800013
J	APOLD, J; EIKEN, HG; ODLAND, E; FREDRIKSEN, A; BAKKEN, A; LORENS, JB; BOMAN, H				APOLD, J; EIKEN, HG; ODLAND, E; FREDRIKSEN, A; BAKKEN, A; LORENS, JB; BOMAN, H			A TERMINATION MUTATION PREVALENT IN NORWEGIAN HAPLOTYPE-7 PHENYLKETONURIA GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BERGEN,DEPT MED GENET,N-5014 BERGEN,NORWAY; UNIV BERGEN,CTR BIOTECHNOL,N-5014 BERGEN,NORWAY; UNIV OSLO,DEPT PEDIAT RES,OSLO 3,NORWAY	University of Bergen; University of Bergen; University of Oslo			Lorens, James/B-9737-2017	Lorens, James/0000-0002-6782-3349; Eiken, Hans Geir/0000-0002-5368-3648				ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; AVIGAD S, 1990, NATURE, V344, P168, DOI 10.1038/344168a0; CHAKRABORTY R, 1987, HUM GENET, V76, P40; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; DWORNICZAK B, 1989, HUM GENET, V84, P95, DOI 10.1007/BF00210683; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; JOHN SWM, 1989, AM J HUM GENET, V45, P905; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LICHTERKONECKI U, 1988, BIOCHEMISTRY-US, V27, P2881, DOI 10.1021/bi00408a032; LYONNET S, 1989, AM J HUM GENET, V44, P511; OKANO Y, 1990, AM J HUM GENET, V46, P18; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAUGSTAD LF, 1975, CLIN GENET, V7, P52; SULLIVAN SE, 1989, AM J HUM GENET, V44, P652; SVENSSON E, IN PRESS HUM GENET; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; WANG T, 1989, AM J HUM GENET, V45, P675; WOO SLC, 1988, AM J HUM GENET, V43, P781	20	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					1002	1007						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	1978553				2022-12-18	WOS:A1990EK40000018
J	KAJIHARA, S; MUKAI, T; ARAI, Y; OWADA, M; KITAGAWA, T; HORI, K				KAJIHARA, S; MUKAI, T; ARAI, Y; OWADA, M; KITAGAWA, T; HORI, K			HEREDITARY FRUCTOSE INTOLERANCE CAUSED BY A NONSENSE MUTATION OF THE ALDOLASE-B GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NATL CARDIOVASC CTR,RES INST,DEPT BIOSCI,5-7-1 FUJISHIRODAI,SUITA,OSAKA 565,JAPAN; SAGA MED SCH,DEPT BIOCHEM,SAGA 84001,JAPAN; NIHON UNIV,DEPT PEDIAT,TOKYO 101,JAPAN	National Cerebral & Cardiovascular Center - Japan; Saga University; Nihon University								BURGESS DG, 1985, J BIOL CHEM, V260, P4604; CHAMBERS RA, 1956, LANCET, V2, P340; CROSS NCP, 1988, CELL, V53, P881, DOI 10.1016/S0092-8674(88)90349-2; CROSS NCP, 1990, LANCET, V1, P306; Gitzelmann R, 1983, METABOLIC BASIS INHE, P118; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; Horecker B. L, 1972, ENZYMES, P213, DOI DOI 10.1016/S1874-6047(08)60450-3; JOH K, 1986, J MOL BIOL, V190, P401, DOI 10.1016/0022-2836(86)90011-2; KISHI H, 1987, P NATL ACAD SCI USA, V84, P8623, DOI 10.1073/pnas.84.23.8623; KUKITA A, 1988, EUR J BIOCHEM, V171, P471, DOI 10.1111/j.1432-1033.1988.tb13813.x; MAIRE P, 1987, J MOL BIOL, V197, P425, DOI 10.1016/0022-2836(87)90556-0; MEDA H, 1985, PATHOL JPN, V74, P150; MIWA S, 1981, AM J HEMATOL, V11, P425, DOI 10.1002/ajh.2830110412; MUKAI T, 1987, J BIOCHEM-TOKYO, V102, P1043, DOI 10.1093/oxfordjournals.jbchem.a122142; MULLER N, 1986, J ORG CHEM, V51, P263, DOI 10.1021/jo00352a032; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; NAKAMURA R, 1978, J JPN PEDIATR SOC, V82, P132; Rajkumar T.V, 1966, METHOD ENZYMOL, V9, P491; ROTTMANN WH, 1987, BIOCHIMIE, V69, P137, DOI 10.1016/0300-9084(87)90246-X; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAKAKIBARA M, 1989, BIOCHIM BIOPHYS ACTA, V1007, P334, DOI 10.1016/0167-4781(89)90156-5; SAKAKIBARA M, 1985, NUCLEIC ACIDS RES, V13, P5055, DOI 10.1093/nar/13.14.5055; SAKAKIBARA M, 1985, BIOCHEM BIOPH RES CO, V131, P413, DOI 10.1016/0006-291X(85)91818-2; SANCAR A, 1979, J BACTERIOL, V137, P692, DOI 10.1128/JB.137.1.692-693.1979; SHIOKAWA O, 1981, DIABETES J, V9, P77; SYGUSCH J, 1987, P NATL ACAD SCI USA, V84, P7846, DOI 10.1073/pnas.84.22.7846; TOLAN DR, 1986, MOL BIOL MED, V3, P245; TSUTSUMI K, 1984, J BIOL CHEM, V259, P4572	29	24	24	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					562	567						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2203259				2022-12-18	WOS:A1990DX22300021
J	HUANG, LS; JANNE, PA; DEGRAAF, J; COOPER, M; DECKLEBAUM, RJ; KAYDEN, H; BRESLOW, JL				HUANG, LS; JANNE, PA; DEGRAAF, J; COOPER, M; DECKLEBAUM, RJ; KAYDEN, H; BRESLOW, JL			EXCLUSION OF LINKAGE BETWEEN THE HUMAN APOLIPOPROTEIN-B GENE AND ABETALIPOPROTEINEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLUMBIA UNIV COLL PHYS & SURG,DEPT PEDIAT,NEW YORK,NY 10032; NYU,SCH MED,NEW YORK,NY 10003; KAPLAN HOSP,DEPT PEDIAT,IL-76100 REHOVOT,ISRAEL	Columbia University; New York University; Hebrew University of Jerusalem; Kaplan Medical Center	HUANG, LS (corresponding author), ROCKEFELLER UNIV,BIOCHEM GENET & METAB LAB,1230 YORK AVE,NEW YORK,NY 10021, USA.		Breslow, Jan L/B-7544-2008		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030842, R37HL036461, R01HL032435] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32435, HL36461, HL30842] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; DULLAART RPF, 1986, J CLIN INVEST, V78, P1397, DOI 10.1172/JCI112727; GLICKMAN RM, 1979, GASTROENTEROLOGY, V76, P288; HEGELE RA, 1986, NEW ENGL J MED, V315, P1509, DOI 10.1056/NEJM198612113152403; HERBERT PN, 1983, METABOLIC BASIS INHE, P589; HUANG LS, 1986, P NATL ACAD SCI USA, V83, P644, DOI 10.1073/pnas.83.3.644; HUANG LS, 1987, J BIOL CHEM, V262, P8952; HUANG LS, 1989, J BIOL CHEM, V264, P11394; HUANG LS, 1990, J LIPID RES, V31, P71; HUANG LS, 1988, J LIPID RES, V29, P63; KAYDEN HJ, 1972, ANNU REV MED, V23, P285, DOI 10.1146/annurev.me.23.020172.001441; LACKNER KJ, 1986, J CLIN INVEST, V78, P1707, DOI 10.1172/JCI112766; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEPPERT M, 1988, J CLIN INVEST, V82, P847, DOI 10.1172/JCI113688; Maniatis T., 1982, MOL CLONING; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1974, AM J HUM GENET, V26, P588; PULLINGER CR, 1988, NUCLEIC ACIDS RES, V16, P8361; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCANU AM, 1974, J CLIN INVEST, V53, P440, DOI 10.1172/JCI107578; SCHWARTZ JF, 1963, ARCH NEUROL-CHICAGO, V8, P438, DOI 10.1001/archneur.1963.00460040108010; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; TALMUD PJ, 1988, J CLIN INVEST, V82, P1803, DOI 10.1172/JCI113795; WANG X, 1988, ARTERIOSCLEROSIS, V8, P429, DOI 10.1161/01.ATV.8.4.429; YOUNG SG, 1986, P NATL ACAD SCI USA, V83, P1101, DOI 10.1073/pnas.83.4.1101; YOUNG SG, 1988, SCIENCE, V241, P591, DOI 10.1126/science.3399894; 1974, DHEW75 LIP RES CLIN	27	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1141	1148						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2339706				2022-12-18	WOS:A1990DF20200014
J	CHANG, PL; MUELLER, OT; LAFRENIE, RM; VAREY, PA; ROSA, NE; DAVIDSON, RG; HENRY, WM; SHOWS, TB				CHANG, PL; MUELLER, OT; LAFRENIE, RM; VAREY, PA; ROSA, NE; DAVIDSON, RG; HENRY, WM; SHOWS, TB			THE HUMAN ARYLSULFATASE-C ISOENZYMES - 2 DISTINCT GENES THAT ESCAPE FROM X INACTIVATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCMASTER UNIV,DEPT BIOMED SCI,HAMILTON L8N 3Z5,ONTARIO,CANADA; NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT HUMAN GENET,BUFFALO,NY 14263	McMaster University; Roswell Park Cancer Institute	CHANG, PL (corresponding author), MCMASTER UNIV,DEPT PEDIAT,1200 MAIN ST W,HAMILTON L8N 3Z5,ONTARIO,CANADA.			Lafrenie, Robert/0000-0001-9981-997X				ALHADEFF JA, 1975, DEV BIOL, V47, P319, DOI 10.1016/0012-1606(75)90286-9; BALLABIO A, 1987, P NATL ACAD SCI USA, V84, P4519, DOI 10.1073/pnas.84.13.4519; BOYER SH, 1962, P NATL ACAD SCI USA, V48, P1868, DOI 10.1073/pnas.48.10.1868; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG PL, 1986, J BIOL CHEM, V261, P4443; CHANG PL, 1982, HUM GENET, V61, P231, DOI 10.1007/BF00296448; CHANG PL, 1985, ANAL BIOCHEM, V144, P362, DOI 10.1016/0003-2697(85)90129-0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CONARY JT, 1987, BIOCHEM BIOPH RES CO, V144, P1010, DOI 10.1016/S0006-291X(87)80064-5; CRAWFURD MD, 1982, J INHERIT METAB DIS, V5, P153, DOI 10.1007/BF01800171; DEFERRA F, 1985, CELL, V43, P721, DOI 10.1016/0092-8674(85)90245-4; DOLLY JO, 1972, BIOCHEM J, V128, P337, DOI 10.1042/bj1280337; ETO Y, 1974, ARCH NEUROL-CHICAGO, V30, P153, DOI 10.1001/archneur.1974.00490320041005; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHMAN WH, 1974, AM J MED, V56, P617, DOI 10.1016/0002-9343(74)90631-7; FLUHARTY AL, 1975, BIOCHEM BIOPH RES CO, V64, P955, DOI 10.1016/0006-291X(75)90140-0; GOODFELLOW P, 1984, AM J HUM GENET, V36, P777; HAGENBUCHLE O, 1981, NATURE, V289, P6443; IWAMORI M, 1976, ARCH BIOCHEM BIOPHYS, V174, P199, DOI 10.1016/0003-9861(76)90339-8; Maniatis T., 1982, MOL CLONING; MARKERT CL, 1963, SCIENCE, V140, P1329, DOI 10.1126/science.140.3573.1329; MEHL E, 1968, BIOCHIM BIOPHYS ACTA, V151, P619, DOI 10.1016/0005-2744(68)90008-9; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MOHANDAS T, 1979, P NATL ACAD SCI USA, V76, P5779, DOI 10.1073/pnas.76.11.5779; MULLER CR, 1980, HUM GENET, V54, P201, DOI 10.1007/BF00278972; MUNROE DG, 1987, AM J HUM GENET, V40, P102; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PONTE P, 1984, NUCLEIC ACIDS RES, V12, P1687, DOI 10.1093/nar/12.3.1687; Race RR., 1975, BLOOD GROUPS MAN; ROSE FA, 1982, J INHERIT METAB DIS, V5, P145, DOI 10.1007/BF01800170; ROY AB, 1976, AUST J EXP BIOL MED, V54, P111, DOI 10.1038/icb.1976.13; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SHAPIRO LJ, 1983, METABOLIC BASIS INHE, P1027; SHOWS TB, 1975, P NATL ACAD SCI USA, V72, P2125, DOI 10.1073/pnas.72.6.2125; SHOWS TB, 1978, CYTOGENET CELL GENET, V21, P99, DOI 10.1159/000130882; SHOWS TB, 1979, SOMAT CELL GENET, V5, P147, DOI 10.1007/BF01539157; SHOWS TB, 1982, ADV HUM GENET, V12, P341; SHOWS TB, 1979, GENETIC MECHANISMS S, P253; SIMARD JPS, 1985, BIOCHEM BIOPH RES CO, V128, P1388, DOI 10.1016/0006-291X(85)91094-0; SMITH M, 1973, ANN HUM GENET, V36, P401, DOI 10.1111/j.1469-1809.1973.tb00604.x; TURNER BM, 1975, ISOZYMES, V1; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8; 1979, BIORAD B, V1069	44	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					729	737						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	1690506				2022-12-18	WOS:A1990CW54900010
J	AUBOURG, P; FEIL, R; GUIDOUX, S; KAPLAN, JC; MOSER, H; KAHN, A; MANDEL, JL				AUBOURG, P; FEIL, R; GUIDOUX, S; KAPLAN, JC; MOSER, H; KAHN, A; MANDEL, JL			THE RED-GREEN VISUAL PIGMENT GENE REGION IN ADRENOLEUKODYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHU COCHIN,UNITE GENET & PATHOL MOLEC,INSERM,U129,F-75674 PARIS 14,FRANCE; CHU COCHIN,BIOCHIM GENET LAB,F-75674 PARIS 14,FRANCE; FAC MED STRASBOURG,INST CHIM BIOL,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,F-67000 STRASBOURG,FRANCE; JOHNS HOPKINS UNIV,KENNEDY INST,BALTIMORE,MD 21218	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Johns Hopkins University	AUBOURG, P (corresponding author), CHU COCHIN,RECH CROISSANCE LAB,INSERM,U188,74 AVE DENFERT ROCHEREAU,F-75014 PARIS,FRANCE.		Feil, Robert P/D-2087-2013	Feil, Robert P/0000-0002-5671-5860				AUBOURG P, 1985, J LIPID RES, V26, P263; AUBOURG PR, 1987, ANN NEUROL, V21, P349, DOI 10.1002/ana.410210406; AUBOURG PR, 1988, AM J HUM GENET, V42, P408; CHEN W W, 1988, American Journal of Human Genetics, V43, pA140; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P227; DRUMMONDBORG M, 1989, P NATL ACAD SCI USA, V86, P983, DOI 10.1073/pnas.86.3.983; FEIL R, IN PRESS GENOMICS; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; KALMUS H, 1965, DIAGNOSIS GENETICS D; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LAZO O, 1988, P NATL ACAD SCI USA, V85, P7647, DOI 10.1073/pnas.85.20.7647; LEWIS RA, 1987, ARCH OPHTHALMOL-CHIC, V105, P1055, DOI 10.1001/archopht.1987.01060080057028; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; MOSER HW, 1984, ANN NEUROL, V16, P628, DOI 10.1002/ana.410160603; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SACK GH, 1989, AM J HUM GENET, V44, P794; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; VANOMMEN GJB, 1986, CELL, V47, P499, DOI 10.1016/0092-8674(86)90614-8; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WANDERS RJA, 1988, J INHERIT METAB DIS, V11, P173, DOI 10.1007/BF01804228	26	24	24	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					459	469						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2309698				2022-12-18	WOS:A1990CT66800008
J	SVED, JA; LAIRD, CD				SVED, JA; LAIRD, CD			POPULATION GENETIC CONSEQUENCES OF THE FRAGILE-X SYNDROME, BASED ON THE X-INACTIVATION IMPRINTING MODEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON, DEPT ZOOL, NJ-15, SEATTLE, WA 98195 USA; UNIV SYDNEY, SCH BIOL SCI, SYDNEY, NSW 2006, AUSTRALIA; UNIV WASHINGTON, DEPT GENET, SEATTLE, WA 98195 USA; UNIV WASHINGTON, CTR CHILD DEV & MENTAL RETARDAT, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Sydney; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle								Brown W T, 1987, Ups J Med Sci Suppl, V44, P137; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; HOLMGREN G, 1988, J MED GENET, V30, P673; LAIRD CD, 1987, GENETICS, V117, P587; LAIRD CD, 1990, IN PRESS AM J HUM GE, V46; LAIRD CD, IN PRESS AM J MED GE; MCKUSICK VA, 1988, MENDELIAN INHERITANC; NAGYLAKI T, 1977, ANN HUM GENET, V41, P241, DOI 10.1111/j.1469-1809.1977.tb01920.x; PEMBREY ME, 1985, AM J MED GENET, V21, P709, DOI 10.1002/ajmg.1320210413; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SVED JA, 1988, BRAIN DYSFUNCT, V1, P245; VOGEL F, 1984, ANN HUM GENET, V48, P327, DOI 10.1111/j.1469-1809.1984.tb00846.x; WINTER RM, 1987, HUM GENET, V75, P269, DOI 10.1007/BF00281072	14	24	24	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					443	451						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2309697				2022-12-18	WOS:A1990CT66800006
J	MATSUO, Y; YOKOYAMA, S				MATSUO, Y; YOKOYAMA, S			CLONING AND SEQUENCING OF A PROCESSED PSEUDOGENE DERIVED FROM A HUMAN CLASS-III ALCOHOL-DEHYDROGENASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ILLINOIS, DEPT ECOL ETHOL & EVOLUT, SHELFORD VIVARIUM, 606 E HEALEY ST, CHAMPAIGN, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign								[Anonymous], 1984, AM NAT; BEISSWENGER TB, 1985, P NATL ACAD SCI USA, V82, P8369, DOI 10.1073/pnas.82.24.8369; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BOSRON WF, 1979, BIOCHEMISTRY-US, V18, P1101, DOI 10.1021/bi00573a026; BOSRON WF, 1983, BIOCHEMISTRY-US, V22, P1852, DOI 10.1021/bi00277a017; BUHLER R, 1984, EUR J BIOCHEM, V145, P447, DOI 10.1111/j.1432-1033.1984.tb08575.x; DAFELDECKER WP, 1986, BIOCHEM BIOPH RES CO, V134, P1056, DOI 10.1016/0006-291X(86)90358-X; DUESTER G, 1986, J BIOL CHEM, V261, P2027; HATTORI M, 1985, NUCLEIC ACIDS RES, V13, P7813, DOI 10.1093/nar/13.21.7813; HEMPEL J, 1984, EUR J BIOCHEM, V145, P437, DOI 10.1111/j.1432-1033.1984.tb08573.x; HOOG JO, 1987, BIOCHEMISTRY-US, V26, P1926, DOI 10.1021/bi00381a021; IKUTA T, 1986, P NATL ACAD SCI USA, V83, P634, DOI 10.1073/pnas.83.3.634; JULIA P, 1988, EUR J BIOCHEM, V172, P73, DOI 10.1111/j.1432-1033.1988.tb13857.x; KAISER R, 1988, BIOCHEMISTRY-US, V27, P1132, DOI 10.1021/bi00404a009; KEUNG WM, 1988, BIOCHEM BIOPH RES CO, V156, P38, DOI 10.1016/S0006-291X(88)80802-7; LEMISCHKA I, 1982, NATURE, V300, P330, DOI 10.1038/300330a0; MATSUO Y, 1989, FEBS LETT, V243, P57, DOI 10.1016/0014-5793(89)81217-7; MATSUO Y, 1989, EUR J BIOCHEM, V183, P317, DOI 10.1111/j.1432-1033.1989.tb14931.x; MODIANO G, 1981, P NATL ACAD SCI-BIOL, V78, P1110, DOI 10.1073/pnas.78.2.1110; MOOS M, 1982, NUCLEIC ACIDS RES, V10, P7843, DOI 10.1093/nar/10.23.7843; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NISHIOKA Y, 1980, P NATL ACAD SCI-BIOL, V77, P2806, DOI 10.1073/pnas.77.5.2806; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVTCHENKO ES, 1988, AM J HUM GENET, V43, P630; SCARPULLA RC, 1984, MOL CELL BIOL, V4, P2279, DOI 10.1128/MCB.4.11.2279; SCARPULLA RC, 1982, P NATL ACAD SCI USA, V83, P4167; SMITH M, 1986, ADV HUM GENET, V15, P249; SMITH M, 1972, ANN HUM GENET, V35, P243, DOI 10.1111/j.1469-1809.1957.tb01398.x; SMITH M, 1971, ANN HUM GENET, V34, P251, DOI 10.1111/j.1469-1809.1971.tb00238.x; VANIN EF, 1980, NATURE, V286, P222, DOI 10.1038/286222a0; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; WAGNER FW, 1984, BIOCHEMISTRY-US, V23, P2193, DOI 10.1021/bi00305a014; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WILDE CD, 1982, SCIENCE, V217, P549, DOI 10.1126/science.6178164; WILDE CD, 1982, NATURE, V297, P83, DOI 10.1038/297083a0; YIN SJ, 1984, BIOCHEMISTRY-US, V23, P5847, DOI 10.1021/bi00319a026; YOKOYAMA S, 1987, JPN J GENET, V62, P241, DOI 10.1266/jjg.62.241; YOKOYAMA S, 1987, MOL BIOL EVOL, V4, P504; YOKOYAMA S, IN PRESS MOL BIOL EV	41	24	24	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					85	91						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294756				2022-12-18	WOS:A1990CJ04300010
J	TSINTSOF, AS; HERTZBERG, MS; PRIOR, JF; MICKLESON, KNP; TRENT, RJ				TSINTSOF, AS; HERTZBERG, MS; PRIOR, JF; MICKLESON, KNP; TRENT, RJ			ALPHA-GLOBIN GENE MARKERS IDENTIFY GENETIC-DIFFERENCES BETWEEN AUSTRALIAN ABORIGINES AND MELANESIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV SYDNEY,CLIN IMMUNOL RES CTR,MOLEC BIOL LAB,SYDNEY,NSW 2006,AUSTRALIA; MIDDLEMORE HOSP,DEPT NEONATAL PAEDIAT,AUCKLAND 6,NEW ZEALAND; SIR CHARLES GAIRDNER HOSP,NEDLANDS,WA 6009,AUSTRALIA	University of Sydney; University of Western Australia								EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; FUCHAROEN S, 1987, HEMOGLOBIN, V11, P65, DOI 10.3109/03630268709036587; GOOSSENS M, 1980, P NATL ACAD SCI-BIOL, V77, P518, DOI 10.1073/pnas.77.1.518; HARDISON RC, 1986, NUCLEIC ACIDS RES, V14, P1903, DOI 10.1093/nar/14.4.1903; HERTZBERG MS, 1988, AM J HUM GENET, V43, P971; HIGGS DR, 1980, NATURE, V284, P632, DOI 10.1038/284632a0; HIGGS DR, 1984, NUCLEIC ACIDS RES, V12, P6965, DOI 10.1093/nar/12.18.6965; HIGGS DR, 1981, NUCLEIC ACIDS RES, V9, P4213, DOI 10.1093/nar/9.17.4213; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5156; HILL AVS, 1987, AM J HUM GENET, V40, P453; HILL AVS, 1985, AM J HUM GENET, V37, P571; HILL AVS, 1985, CELL, V42, P809, DOI 10.1016/0092-8674(85)90277-6; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; JARMAN AP, 1988, EMBO J, V5, P249; Kirk RL, 1979, 1ST AM ORIGINS AFFIN, P211; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LEUNG S, 1987, NATURE, V329, P551, DOI 10.1038/329551a0; LIEINJO LE, 1981, NUCLEIC ACIDS RES, V9, P3707, DOI 10.1093/nar/9.15.3707; MARKS J, 1986, NATURE, V321, P785, DOI 10.1038/321785a0; Old JM., 1983, METHODS HEMATOLOGY T, V6, P74; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; RAMSAY M, 1988, AM J HUM GENET, V43, P527; SERJEANTSON SW, 1985, OUT ASIA PEOPLING AM, P133; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STONEKING M, IN PRESS COLONIZATIO; TRENT RJ, 1988, AM J HUM GENET, V42, P601; TRENT RJ, 1981, BRIT J HAEMATOL, V49, P149, DOI 10.1111/j.1365-2141.1981.tb07207.x; WINICHAGOON P, 1982, NUCLEIC ACIDS RES, V10, P5853, DOI 10.1093/nar/10.19.5853; YENCHITSOMANUS P, 1986, HUM GENET, V74, P432, DOI 10.1007/BF00280500; YENCHITSOMANUS PT, 1986, AUST J EXP BIOL MED, V64, P297, DOI 10.1038/icb.1986.31	31	24	24	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					138	143						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294746				2022-12-18	WOS:A1990CJ04300018
J	MARKERT, ML; NORBYSLYCORD, C; WARD, FE				MARKERT, ML; NORBYSLYCORD, C; WARD, FE			A HIGH PROPORTION OF ADA POINT MUTATIONS ASSOCIATED WITH A SPECIFIC ALANINE-TO-VALINE SUBSTITUTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,DIV IMMUNOL,DURHAM,NC 27710	Duke University	MARKERT, ML (corresponding author), DUKE UNIV,MED CTR,DEPT PEDIAT,DIV ALLERGY & IMMUNOL,BOX 3068,DURHAM,NC 27710, USA.				NCRR NIH HHS [M01-RR-30] Funding Source: Medline; NIAID NIH HHS [AI-23791] Funding Source: Medline; NIGMS NIH HHS [GM-10356] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI023791, R01AI023791, R23AI023791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010356] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADRIAN GS, 1984, MOL CELL BIOL, V4, P1712, DOI 10.1128/MCB.4.9.1712; AKESON AL, 1987, P NATL ACAD SCI USA, V84, P5947, DOI 10.1073/pnas.84.16.5947; AKESON AL, 1988, J BIOL CHEM, V263, P16291; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P9573; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BERKVENS TM, 1987, NUCLEIC ACIDS RES, V15, P9365, DOI 10.1093/nar/15.22.9365; BONTHRON DT, 1985, J CLIN INVEST, V76, P894, DOI 10.1172/JCI112050; BORTIN MM, 1977, JAMA-J AM MED ASSOC, V238, P591, DOI 10.1001/jama.238.7.591; BUCKLEY RH, 1986, J IMMUNOL, V136, P2398; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIBLETT ER, 1972, LANCET, V2, P1067; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; KATSUKI T, 1975, INT J CANCER, V15, P203, DOI 10.1002/ijc.2910150205; Kredich NM, 1983, METABOLIC BASIS INHE, P1157; Maniatis T., 1982, MOL CLONING; MARKERT ML, 1988, J CLIN INVEST, V81, P1323, DOI 10.1172/JCI113458; MARKERT ML, 1987, J IMMUNOL, V138, P3203; MARKERT ML, 1987, J CLIN IMMUNOL, V7, P389, DOI 10.1007/BF00917017; ORKIN SH, 1983, J BIOL CHEM, V258, P2753; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VALERIO D, 1986, EMBO J, V5, P113, DOI 10.1002/j.1460-2075.1986.tb04184.x; VALERIO D, 1983, GENE, V25, P231, DOI 10.1016/0378-1119(83)90227-5; WIGINTON DA, 1982, J BIOL CHEM, V257, P3211; WIGINTON DA, 1986, BIOCHEMISTRY-US, V25, P8234, DOI 10.1021/bi00373a017; WIGINTON DA, 1983, P NATL ACAD SCI-BIOL, V80, P7481, DOI 10.1073/pnas.80.24.7481; WOLF J, 1976, J RETICULOENDOTH SOC, V20, pA48	37	24	24	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					354	361						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	2773932				2022-12-18	WOS:A1989AN87900003
J	BOWDEN, DW; MULLERKAHLE, H; GRAVIUS, TC; HELMS, C; WATTMORGAN, D; GREEN, P; DONISKELLER, H				BOWDEN, DW; MULLERKAHLE, H; GRAVIUS, TC; HELMS, C; WATTMORGAN, D; GREEN, P; DONISKELLER, H			IDENTIFICATION AND CHARACTERIZATION OF 23 RFLP LOCI BY SCREENING RANDOM COSMID GENOMIC CLONES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BOWDEN, DW (corresponding author), COLLABORAT RES INC,DEPT HUMAN GENET,1365 MAIN ST,WALTHAM,MA 02154, USA.							BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BATES PF, 1983, GENE, V26, P137, DOI 10.1016/0378-1119(83)90183-X; BOWDEN DW, 1988, GENE, V71, P391, DOI 10.1016/0378-1119(88)90056-X; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; RALEIGH EA, 1988, NUCLEIC ACIDS RES, V16, P1563, DOI 10.1093/nar/16.4.1563; RALEIGH EA, 1986, P NATL ACAD SCI USA, V83, P9070, DOI 10.1073/pnas.83.23.9070; SCHUMM JW, 1988, AM J HUM GENET, V42, P143; Sokal Robert R., 1969, BIOMETRY	14	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					671	678						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2565079				2022-12-18	WOS:A1989U333800007
J	KENNAWAY, NG; STANKOVA, L; WIRTZ, MK; WELEBER, RG				KENNAWAY, NG; STANKOVA, L; WIRTZ, MK; WELEBER, RG			GYRATE ATROPHY OF THE CHOROID AND RETINA - CHARACTERIZATION OF MUTANT ORNITHINE AMINOTRANSFERASE AND MECHANISM OF RESPONSE TO VITAMIN-B6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									OREGON HLTH SCI UNIV,DEPT OPHTHALMOL,PORTLAND,OR 97201	Oregon Health & Science University	KENNAWAY, NG (corresponding author), OREGON HLTH SCI UNIV,DEPT MED GENET,L473,3181 SW SAM JACKSON PK RD,PORTLAND,OR 97201, USA.							GEYSEN J, 1984, ELECTROPHORESIS, V5, P129, DOI 10.1002/elps.1150050212; HAYASAKA S, 1981, BRIT J OPHTHALMOL, V65, P478, DOI 10.1136/bjo.65.7.478; HOTTA Y, 1988, Investigative Ophthalmology and Visual Science, V29, P383; INANA G, 1988, INVEST OPHTH VIS SCI, V29, P1001; KAISERKUPFER MI, 1980, AM J OPHTHALMOL, V89, P219, DOI 10.1016/0002-9394(80)90114-2; KENNAWAY NG, 1980, AM J HUM GENET, V32, P529; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LITWACK G, 1973, BIOCHEM BIOPH RES CO, V52, P181, DOI 10.1016/0006-291X(73)90971-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; O'DONNELL J, 1982, Investigative Ophthalmology and Visual Science, V22, P227; OHURA T, 1984, CLIN CHIM ACTA, V136, P29, DOI 10.1016/0009-8981(84)90244-4; OHURA T, 1982, J BIOCHEM-TOKYO, V92, P1785, DOI 10.1093/oxfordjournals.jbchem.a134108; RHEAD WJ, 1980, P NATL ACAD SCI-BIOL, V77, P580, DOI 10.1073/pnas.77.1.580; SHIH VE, 1978, AM J HUM GENET, V30, P174; SIMELL O, 1973, LANCET, V1, P1031; SIPILA I, 1981, J CLIN INVEST, V67, P1805, DOI 10.1172/JCI110222; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRYFIATES GP, 1971, LIFE SCI 2-BIOCH GEN, V10, P1147, DOI 10.1016/0024-3205(71)90318-3; Valle D, 1983, METABOLIC BASIS INHE, V5th, P382; WELEBER RG, 1982, BIRTH DEFECTS-ORIG, V18, P219; WELEBER RG, 1981, OPHTHALMOLOGY, V88, P316; WELEBER RG, 1988, RETINITIS PIGMENTOSA, P198; WIRTZ MK, 1985, J INHERIT METAB DIS, V8, P71, DOI 10.1007/BF01801668; WONG PTH, 1981, J NEUROCHEM, V36, P501, DOI 10.1111/j.1471-4159.1981.tb01620.x	24	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					344	352						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2916580				2022-12-18	WOS:A1989T353500006
J	BAMFORTH, SJ; BAIRD, PA				BAMFORTH, SJ; BAIRD, PA			SPINA-BIFIDA AND HYDROCEPHALUS - A POPULATION STUDY OVER A 35-YEAR PERIOD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA, DEPT MED GENET, 226-6174 UNIV BLVD, VANCOUVER V6T 1W5, BC, CANADA; BRITISH COLUMBIA HLTH SURVEILLANCE REGISTRY, VANCOUVER, BC, CANADA	University of British Columbia								BAIRD PA, 1987, CAN MED ASSOC J, V136, P109; BAIRD PA, 1983, AM J MED GENET, V16, P49, DOI 10.1002/ajmg.1320160109; BAIRD PA, 1982, LANCET, V2, P615; CAMERON AH, 1957, J PATHOL BACTERIOL, V73, P213, DOI 10.1002/path.1700730125; CZEIZEL A, 1985, AM J MED GENET, V21, P105, DOI 10.1002/ajmg.1320210115; CZEIZEL A, 1981, AM J MED GENET, V10, P25, DOI 10.1002/ajmg.1320100105; EDWARDS JH, 1961, ANN HUM GENET, V25, P89, DOI 10.1111/j.1469-1809.1961.tb01502.x; EDWARDS JH, 1961, ANN HUM GENET, V25, P83, DOI 10.1111/j.1469-1809.1961.tb01501.x; FRASER C, 1987, TERATOLOGY, V36, P363, DOI 10.1002/tera.1420360313; FRASER FC, 1982, LANCET, V2, P144; JAMES N, 1985, MAINWARINGHUGHS AWAR, V2; LAURENCE KM, 1960, P ROY SOC MED, V53, P1055; LAURENCE KM, 1980, BRIT MED J, V4, P1542; LEE ET, 1980, STATISTICAL METHODS; LORBER J, 1973, BRIT MED J, V4, P201, DOI 10.1136/bmj.4.5886.201; LORBER J, 1961, ARCH DIS CHILD, V36, P381, DOI 10.1136/adc.36.188.381; LOWRY R B, 1969, Journal of Medical Genetics, V6, P67; MCKEOWN T, 1951, LANCET, V260, P192; MILUNKSY A, 1980, PRENAT DIAGN, P23; RECORD RG, 1961, BRIT J PREV SOC MED, V15, P93; SADOVNICK AD, 1985, TERATOLOGY, V32, P355, DOI 10.1002/tera.1420320305; SANDAHL B, 1977, ACTA PAEDIATR SCAND, V66, P65, DOI 10.1111/j.1651-2227.1977.tb07809.x; SHARRARD WJ, 1963, ARCH DIS CHILD, V38, P18, DOI 10.1136/adc.38.197.18; SMITHELLS RW, 1980, LANCET, V1, P339; TOLAROVA M, 1987, SCAND J PLAST RECONS, V21, P19, DOI 10.3109/02844318709083574; TRIMBLE BK, 1978, TERATOLOGY, V17, P43, DOI 10.1002/tera.1420170111; VERMA IC, 1978, LANCET, V1, P879; 1977, LANCET, V1, P1323	28	24	25	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1989	44	2					225	232						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R9705	2643314				2022-12-18	WOS:A1989R970500007
J	NEEL, JV; SATOH, C; SMOUSE, P; ASAKAWA, J; TAKAHASHI, N; GORIKI, K; FUJITA, M; KAGEOKA, T; HAZAMA, R				NEEL, JV; SATOH, C; SMOUSE, P; ASAKAWA, J; TAKAHASHI, N; GORIKI, K; FUJITA, M; KAGEOKA, T; HAZAMA, R			PROTEIN VARIANTS IN HIROSHIMA AND NAGASAKI - TALES OF 2 CITIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									RADIAT EFFECTS RES FDN,HIROSHIMA 730,JAPAN	Radiation Effects Research Foundation - Japan	NEEL, JV (corresponding author), UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,4708 MED SCI 2,BOX 015,ANN ARBOR,MI 48109, USA.							Aikens C.M., 1982, PREHISTORY JAPAN; [Anonymous], 1973, HISTOCOMPATIBILITY T; ASAKAWA J, 1984, HUM GENET, V68, P185, DOI 10.1007/BF00279312; CHAKRABORTY R, 1980, GENETICS, V94, P1039; CHAKRABORTY R, 1983, NATURE, V304, P755, DOI 10.1038/304755a0; CHAKRABORTY R, 1988, AM J HUM GENET, V43, P709; CHAKRABORTY R, 1978, AM J HUM GENET, V30, P550; EGAMI N, 1981, NIHONJIN TOWA NANINK; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; FERRELL RE, 1977, ANN HUM GENET, V40, P407, DOI 10.1111/j.1469-1809.1977.tb02028.x; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.1093/biomet/38.1-2.141; FUJITA M, 1985, JPN J HUM GENET, V30, P43, DOI 10.1007/BF01873576; FUJITA M, 1985, JPN J HUM GENET, V30, P191, DOI 10.1007/BF01876469; HANASH SM, 1988, P NATL ACAD SCI USA, V85, P165, DOI 10.1073/pnas.85.1.165; HARRIS H, 1974, ANN HUM GENET, V37, P237, DOI 10.1111/j.1469-1809.1974.tb01832.x; HILL AVS, 1985, AM J HUM GENET, V37, P571; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1987, HUM GENET, P177; ISHIDA T, 1986, NATURE, V322, P504, DOI 10.1038/322504a0; KAGEOKA T, 1985, HUM GENET, V70, P101, DOI 10.1007/BF00273066; KIRK RL, 1975, ISOZYMES, V4, P169; KIRK RL, 1982, HUMAN GENETICS A, P195; KOEHN RK, 1978, EVOL BIOL, V11, P39; KOMATSU I, 1963, JAPANESE PEOPLE ORIG; LESLIE PH, 1955, BIOMETRIKA, V42, P522, DOI 10.2307/2333400; MOHRENWEISER HW, 1987, ANN HUM GENET, V51, P303, DOI 10.1111/j.1469-1809.1987.tb01065.x; Mourant AE, 1976, DISTRIBUTION HUMAN B; NEEL IV, 1978, AM J HUM GENET, V41, P429; NEEL JV, 1988, MUTAT RES, V204, P365, DOI 10.1016/0165-1218(88)90035-3; NEEL JV, 1986, P NATL ACAD SCI USA, V83, P389, DOI 10.1073/pnas.83.2.389; NEEL JV, 1988, AM J HUM GENET, V42, P663; NEEL JV, 1980, P NATL ACAD SCI-BIOL, V77, P4221, DOI 10.1073/pnas.77.7.4221; NEEL JV, 1978, AM J HUM GENET, V30, P465; NEEL JV, 1956, NAS NRC PUBL, V461; NEEL JV, 1980, POPULATION STRUCTURE, P173; NISHIOKA K, 1984, VIRAL HEPATITIS LIVE, P423; OGATA T, 1981, ANTHROPOLOGY, V5, P264; OHTA T, 1976, THEOR POPUL BIOL, V10, P254, DOI 10.1016/0040-5809(76)90019-8; OMOTO K, 1975, ANTHR GENETIC STUDIE, P269; ROTHMAN ED, 1978, P NATL ACAD SCI USA, V75, P5094, DOI 10.1073/pnas.75.10.5094; SATOH C, 1984, JPN J HUM GENET, V29, P287, DOI 10.1007/BF01871246; SATOH C, 1986, JPN J HUM GENET, V31, P1, DOI 10.1007/BF01876796; SATOH C, 1984, JPN J HUM GENET, V29, P89, DOI 10.1007/BF01873529; SATOH C, 1977, ANN HUM GENET, V41, P169, DOI 10.1111/j.1469-1809.1977.tb01912.x; SATOH C, 1979, ANN HUM GENET, V42, P283, DOI 10.1111/j.1469-1809.1979.tb00662.x; SKIBINSKI DOF, 1982, NATURE, V298, P490, DOI 10.1038/298490a0; SMITH RJ, 1962, VIKING FUND PUBLICAT, V34; SMOUSE PE, 1982, BIOMETRICS, V38, P757, DOI 10.2307/2530055; SUZUKI H, 1981, RASSENGESCHICHTE MEN, V1, P7; TAKAHASHI N, 1982, P NATL ACAD SCI-BIOL, V79, P6636, DOI 10.1073/pnas.79.21.6636; TANIS RJ, 1977, AM J HUM GENET, V29, P419; TANIS RJ, 1978, ANN HUM GENET, V41, P419, DOI 10.1111/j.1469-1809.1978.tb00912.x; THOMPSON EA, 1978, P NATL ACAD SCI USA, V75, P1442, DOI 10.1073/pnas.75.3.1442; THOMPSON EA, 1976, AM J HUM GENET, V28, P442; TILLS D, 1983, DISTRIBUTION HUMAN S, V1; UEDA N, 1977, ANN HUM GENET, V41, P43, DOI 10.1111/j.1469-1809.1977.tb01960.x; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WURZINGER KH, 1982, ANN HUM GENET, V46, P191, DOI 10.1111/j.1469-1809.1982.tb00711.x; 1958, JAPAN ITS LAND PEOPL; [No title captured]	61	24	24	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1988	43	6					870	893						24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R3449	3195587				2022-12-18	WOS:A1988R344900009
J	DARBY, JK; WILLEMS, PJ; NAKASHIMA, P; JOHNSEN, J; FERRELL, RE; WIJSMAN, EM; GERHARD, DS; DRACOPOLI, NC; HOUSMAN, D; HENKE, J; FOWLER, ML; SHOWS, TB; OBRIEN, JS; CAVALLISFORZA, LL				DARBY, JK; WILLEMS, PJ; NAKASHIMA, P; JOHNSEN, J; FERRELL, RE; WIJSMAN, EM; GERHARD, DS; DRACOPOLI, NC; HOUSMAN, D; HENKE, J; FOWLER, ML; SHOWS, TB; OBRIEN, JS; CAVALLISFORZA, LL			RESTRICTION ANALYSIS OF THE STRUCTURAL ALPHA-L-FUCOSIDASE GENE AND ITS LINKAGE TO FUCOSIDOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305; UNIV CALIF SAN DIEGO,SCH MED,DEPT NEUROSCI,LA JOLLA,CA 92093; UNIV INSTELLING ANTWERP,DEPT MED GENET,B-2610 WILRIJK,BELGIUM; UNIV PITTSBURGH,DEPT BIOSTAT,PITTSBURGH,PA 15260; MIT,CTR CANC RES,CAMBRIDGE,MA 02139; LAB FORENS BLUTGRUPPENKUNDE,DUSSELDORF,FED REP GER; NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT HUMAN GENET,BUFFALO,NY 14263	Stanford University; University of California System; University of California San Diego; University of Antwerp; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massachusetts Institute of Technology (MIT); Roswell Park Cancer Institute	DARBY, JK (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305, USA.			Dracopoli, Nicholas/0000-0003-3962-4059	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 18983] Funding Source: Medline; NIGMS NIH HHS [GM 28428] Funding Source: Medline; NINDS NIH HHS [NS 08682] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CARRITT B, 1987, HUM GENET, V75, P248, DOI 10.1007/BF00281068; CARRITT B, 1982, ANN HUM GENET, V46, P329, DOI 10.1111/j.1469-1809.1982.tb01583.x; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CORNEY G, 1977, ANN HUM GENET, V40, P403; DARBY JK, 1986, NUCLEIC ACIDS RES, V14, P95; DEWET JR, 1984, DNA-J MOLEC CELL BIO, V3, P437, DOI 10.1089/dna.1.1984.3.437; DURAND P, 1969, J PEDIATR, V75, P665, DOI 10.1016/S0022-3476(69)80464-6; DURAND P, 1966, LANCET, V2, P1313; EIBERG H, 1984, CLIN GENET, V26, P23; FEDER J, 1985, AM J HUM GENET, V37, P635; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOWLER ML, 1986, CYTOGENET CELL GENET, V43, P103, DOI 10.1159/000132304; FUKUSHIMA H, 1985, P NATL ACAD SCI USA, V82, P1262, DOI 10.1073/pnas.82.4.1262; HENKE J, 1982, FORENSIC SCI INT, V19, P107, DOI 10.1016/0379-0738(82)90037-8; KOUSSEFF BG, 1976, PEDIATRICS, V57, P205; MATSUDA I, 1975, CLIN CHIM ACTA, V63, P55, DOI 10.1016/0009-8981(75)90378-2; MURRAY JC, 1987, AM J HUM GENET, V40, P338; OBRIEN JS, 1987, ENZYME, V38, P45, DOI 10.1159/000469189; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1976, AM J HUM GENET, V28, P528; POENARU L, 1976, CLIN GENET, V10, P260; SHOWS TB, 1975, P NATL ACAD SCI USA, V72, P2125, DOI 10.1073/pnas.72.6.2125; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TURNER BM, 1975, AM J HUM GENET, V27, P651; TURNER BM, 1978, SOMAT CELL GENET, V4, P45, DOI 10.1007/BF01546492; TURNER BM, 1975, NATURE, V27, P391; VANELSEN AF, 1983, HUM GENET, V64, P253; VANHOOF F, 1968, LANCET, V1, P1198; Wald A., 1947, SEQUENTIAL ANAL; WARNER TG, 1983, ANNU REV GENET, V17, P395, DOI 10.1146/annurev.ge.17.120183.002143; WIEDERSCHAIN GY, 1971, CLIN CHIM ACTA, V35, P99, DOI 10.1016/0009-8981(71)90299-3; WILLEMS PJ, 1988, AM J HUM GENET, V43, P756; WILLEMS PJ, 1981, HUM GENET, V59, P115, DOI 10.1007/BF00293058; WILLEMS PJ, 1988, CLIN GENET, V34, P7	35	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					749	755						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2903667				2022-12-18	WOS:A1988Q933600023
J	GOLDGAR, DE; FAIN, PR				GOLDGAR, DE; FAIN, PR			MODELS OF MULTILOCUS RECOMBINATION - NONRANDOMNESS IN CHIASMA NUMBER AND CROSSOVER POSITIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,DEPT MED INFORMAT,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah			Fain, Pamela/ABI-7961-2020		NCI NIH HHS [CA-36362, CA-28854] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA028854, R01CA036362, R23CA036362] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailey NTJ., 1961, INTRO MATH THEORY GE; CALLAN HG, 1977, PHILOS T ROY SOC B, V277, P227, DOI 10.1098/rstb.1977.0013; Darlington C.D., 1932, RECENT ADV CYTOLOGY; FAIN P R, 1985, Genetic Epidemiology, V2, P215, DOI 10.1002/gepi.1370020218; FISHER RA, 1947, HEREDITY, V1, P355, DOI 10.1038/hdy.1947.23; GOLDGAR DE, 1982, AM J HUM GENET, V34, pA181; GOLDGAR DE, 1986, GENET EPIDEMIOL S, V1, P141; GOLDGAR DE, 1981, THESIS U COLORADO BO; HALDANE JSB, 1919, J GENET, V8, P229; HULTEN M, 1974, HEREDITAS, V76, P55; JOHN B, 1976, CHROMOSOMA, V54, P295, DOI 10.1007/BF00292812; JONES GH, 1984, CONTROLLING EVENTS M, P293; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LALOUEL JM, 1979, 14 U UT DEP BIOPH CO; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; Mather K, 1936, J GENET, V33, P207, DOI 10.1007/BF02982533; Mather K, 1938, BIOL REV CAMB PHILOS, V13, P252, DOI 10.1111/j.1469-185X.1938.tb00516.x; OWEN ARG, 1950, ADV GENET, V3, P117, DOI 10.1016/S0065-2660(08)60084-X; PASCOE L, 1987, AM J HUM GENET, V40, P174; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; RISCH N, 1979, ANN HUM GENET, V43, P61, DOI 10.1111/j.1469-1809.1979.tb01549.x; RISCH N, 1983, BIOMETRICS, V39, P949, DOI 10.2307/2531330; RISCH N, 1979, ANN HUM GENET, V43, P177, DOI 10.1111/j.1469-1809.1979.tb02010.x; SHAW DD, 1976, CHROMOSOMA, V59, P103, DOI 10.1007/BF00328480; STURT E, 1976, ANN HUM GENET, V40, P147, DOI 10.1111/j.1469-1809.1976.tb00175.x; WEINSTEIN A, 1935, GENETICS, V21, P155; [No title captured]	28	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1988	43	1					38	45						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N9863	3163889				2022-12-18	WOS:A1988N986300006
J	YOUSSOUFIAN, H; WONG, C; ARONIS, S; PLATOKOUKIS, H; KAZAZIAN, HH; ANTONARAKIS, SE				YOUSSOUFIAN, H; WONG, C; ARONIS, S; PLATOKOUKIS, H; KAZAZIAN, HH; ANTONARAKIS, SE			MODERATELY SEVERE HEMOPHILIA-A RESULTING FROM GLU-]GLY SUBSTITUTION IN EXON-7 OF THE FACTOR-VIII GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,GENET UNIT,BALTIMORE,MD 21205; UNIV ATHENS,SCH MED,DEPT PEDIAT 1,COAGULAT LAB,ATHENS,GREECE	Johns Hopkins University; Athens Medical School; National & Kapodistrian University of Athens			Antonarakis, Stylianos/N-8866-2014	Antonarakis, Stylianos/0000-0001-8907-5823	NIGMS NIH HHS [GM 07814] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONARAKIS SE, 1987, MOL BIOL MED, V4, P81; ANTONARAKIS SE, 1985, NEW ENGL J MED, V313, P842, DOI 10.1056/NEJM198510033131402; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; GITSCHIER J, 1986, SCIENCE, V232, P1415, DOI 10.1126/science.3012775; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HALDANE JSB, 1946, ANN EUGENIC, V13, P262; LAZARCHICK J, 1978, J CLIN INVEST, V62, P1048, DOI 10.1172/JCI109209; LEVINSON B B, 1987, American Journal of Human Genetics, V41, pA225; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; WALLACE RB, 1981, NUCLEIC ACIDS RES, V9, P879, DOI 10.1093/nar/9.4.879; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718; YOUSSOUFIAN H, 1987, P NATL ACAD SCI USA, V84, P3772, DOI 10.1073/pnas.84.11.3772	18	24	25	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1988	42	6					867	871						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N5197	2835904				2022-12-18	WOS:A1988N519700009
J	HARLAP, S; SHAHAR, S; BARAS, M				HARLAP, S; SHAHAR, S; BARAS, M			OVERRIPE OVA AND TWINNING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HARLAP, S (corresponding author), HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT MED ECOL,POB 1172,IL-91010 JERUSALEM,ISRAEL.				NICHD NIH HHS [N01-HD-4-2853] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Austin C R, 1970, J Reprod Fertil Suppl, V12, P39; BARRETT JC, 1969, POP STUD-J DEMOG, V23, P455, DOI 10.1080/00324728.1969.10405297; BLANDAU RJ, 1975, AGING GAMETES THEIR; Bulmer M. G., 1970, BIOL TWINNING MAN; BUTCHER R L, 1976, International Journal of Gynecology and Obstetrics, V14, P105; Edwards RG, 1980, CONCEPTION HUMAN FEM; GUERRERO R, 1975, STUD FAMILY PLANN, V6, P367, DOI 10.2307/1964917; GUERREROV R, 1975, NEW ENGL J MED, V293, P573; HALEVY HS, 1973, STUD JEWISH DEMOGR; HARLAP S, 1979, NEW ENGL J MED, V300, P1445, DOI 10.1056/NEJM197906283002601; HYTTON FE, 1971, PHYSL HUMAN PREGNANC; LANMAN JT, 1968, NEW ENGL J MED, V278, P1047, DOI 10.1056/NEJM196805092781906; MEDVEDEZ ZA, 1981, MECH AGE DEV, V19, P331; MODAN B, 1968, AM J EPIDEMIOL, V88, P189, DOI 10.1093/oxfordjournals.aje.a120877; SHAHAR S, 1985, UNPUB TWIN ZYGOSITIE; SPIRA N, 1982, HUMAN FERTILITY FACT, P437; TRELOAR AE, 1967, INT J FERTIL, V12, P77; Vollman RF., 1977, MENSTRUAL CYCLE; Weinberg W, 1901, ARCH GESAMTE PHYSIOL, V88, P346, DOI 10.1007/BF01657695; WITSCHI E, 1952, CANCER RES, V12, P763; Witschi E., 1970, EXCERPTA MED INT C S, V204, P157	21	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1985	37	6					1206	1215						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AXE36	4083282				2022-12-18	WOS:A1985AXE3600015
J	BLAKEMORE, KJ; WATSON, MS; SAMUELSON, J; BREG, WR; MAHONEY, MJ				BLAKEMORE, KJ; WATSON, MS; SAMUELSON, J; BREG, WR; MAHONEY, MJ			A METHOD OF PROCESSING 1ST-TRIMESTER CHORIONIC VILLOUS BIOPSIES FOR CYTOGENETIC ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note											BLAKEMORE, KJ (corresponding author), YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510, USA.				NICHD NIH HHS [HD-11624] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		KALOUSEK DK, 1983, SCIENCE, V221, P665, DOI 10.1126/science.6867735; NIAZI M, 1981, BRIT J OBSTET GYNAEC, V88, P1081, DOI 10.1111/j.1471-0528.1981.tb01756.x; RODECK CH, 1983, BRIT MED BULL, V39, P338, DOI 10.1093/oxfordjournals.bmb.a071845; SIMONI G, 1983, HUM GENET, V63, P349, DOI 10.1007/BF00274761; SIMONI G, 1984, HUM GENET, V66, P252, DOI 10.1007/BF00286612; STROMBERG K, 1978, IN VITRO CELL DEV B, V14, P631; SUN NC, 1974, CARYOLOGIA, V27, P315, DOI 10.1080/00087114.1974.10796584; THIEDE HA, 1960, AM J OBSTET GYNECOL, V79, P636, DOI 10.1016/0002-9378(60)90621-9; WATANABE M, 1978, HUM GENET, V44, P191, DOI 10.1007/BF00295413	9	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1386	1393						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6517058				2022-12-18	WOS:A1984TZ59000020
J	FLATZ, G				FLATZ, G			GENE-DOSAGE EFFECT ON INTESTINAL LACTASE ACTIVITY DEMONSTRATED INVIVO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											FLATZ, G (corresponding author), MED HSCH HANNOVER, DEPT HUMAN GENET, HANNOVER, GERMANY.							ASP NG, 1972, ANAL BIOCHEM, V47, P527, DOI 10.1016/0003-2697(72)90147-9; DAHLQVIST A, 1968, ANAL BIOCHEM, V22, P99, DOI 10.1016/0003-2697(68)90263-7; DAHLQVIST A, 1974, SUGARS NUTRITION; FLATZ G, 1982, HUM GENET, V62, P152; HO MW, 1982, AM J HUM GENET, V34, P650; HOWELL JN, 1981, HUM GENET, V57, P276, DOI 10.1007/BF00278943; HOWELL JN, 1981, THESIS U HANNOVER; KERRY K. R., 1965, Australian Paediatric Journal, V1, P223; Li CC., 1955, POPULATION GENETICS; LISKER R, 1975, AM J HUM GENET, V27, P662; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NEWCOMER AD, 1967, GASTROENTEROLOGY, V53, P881; RANSOMEKUTI O, 1975, GASTROENTEROLOGY, V68, P431; ROSENSWEIG NS, 1967, LANCET, V2, P188; SAHI T, 1974, SCAND J GASTROENTERO, V9, P7; SCHMITZ J, 1973, BIOCHIM BIOPHYS ACTA, V323, P98, DOI 10.1016/0005-2736(73)90434-3; SIMOONS FJ, 1978, AM J DIG DIS, V23, P963, DOI 10.1007/BF01263095	17	24	24	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					306	310						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6424439				2022-12-18	WOS:A1984SM32400005
J	CARMEL, R				CARMEL, R			GASTRIC-JUICE IN CONGENITAL PERNICIOUS-ANEMIA CONTAINS NO IMMUNOREACTIVE INTRINSIC-FACTOR MOLECULE - STUDY OF 3 KINDREDS WITH VARIABLE AGES AT PRESENTATION, INCLUDING A PATIENT 1ST DIAGNOSED IN ADULTHOOD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											CARMEL, R (corresponding author), UNIV SO CALIF,SCH MED,DEPT MED,LOS ANGELES,CA 90033, USA.				NIADDK NIH HHS [AM-23027] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CARMEL R, 1972, BIOCHIM BIOPHYS ACTA, V263, P747, DOI 10.1016/0005-2795(72)90058-X; CARMEL R, 1971, BLOOD-J HEMATOL, V37, P360, DOI 10.1182/blood.V37.3.360.360; CARMEL R, 1969, BLOOD-J HEMATOL, V33, P1; CARMEL R, 1977, BLOOD, V49, P987; CARMEL R, 1981, CONT HEMATOLOGY ONCO, V2, P79; CHANARIN I, 1969, MEGALOBLASTIC ANAEMI, P732; CHANARIN I, 1979, MEGALOBLASTIC ANAEMI, P430; CHANARIN I, 1979, MEGALOBLASTIC ANAEMI, P250; DONIACH D, 1965, ANN NY ACAD SCI, V124, P605, DOI 10.1111/j.1749-6632.1965.tb18990.x; FAKATSELLI NM, 1978, AM J MED SCI, V276, P144, DOI 10.1097/00000441-197809000-00001; GOTTLIEB C, 1965, BLOOD-J HEMATOL, V25, P875, DOI 10.1182/blood.V25.6.875.875; HALL CA, 1977, AM J HUM GENET, V29, P619; HERBERT V, 1964, MEDICINE, V43, P679, DOI 10.1097/00005792-196411000-00011; JACOB E, 1977, SCAND J HAEMATOL, V19, P201; JEFFRIES GRAHAM H., 1963, JOUR CLIN INVEST, V42, P442, DOI 10.1172/JCI104732; KATZ M, 1974, J CLIN INVEST, V53, P1274, DOI 10.1172/JCI107674; LAZAR GS, 1981, J LAB CLIN MED, V97, P123; LEIKIN SL, 1960, PEDIATRICS, V25, P91; LEVINE JS, 1981, GASTROENTEROLOGY, V80, P1210; MCINTYRE OR, 1965, NEW ENGL J MED, V272, P981, DOI 10.1056/NEJM196505132721901; MCNICHOLL B, 1968, PEDIATRICS, V42, P149; MILLER DR, 1966, NEW ENGL J MED, V275, P978, DOI 10.1056/NEJM196611032751802; PEARSON HA, 1964, J PEDIATR-US, V65, P334, DOI 10.1016/S0022-3476(64)80396-6; REISNER EH, 1951, PEDIATRICS, V8, P88; ROTHENBERG SP, 1966, J LAB CLIN MED, V67, P879; SAMLOFF IM, 1968, J IMMUNOL, V101, P578; SIEGEL SE, 1980, CLIN RES, V28, pA106; SULLIVAN LW, 1963, J CLIN INVEST, V42, P1443, DOI 10.1172/JCI104829; WATERS AH, 1963, BRIT J HAEMATOL, V9, P1, DOI 10.1111/j.1365-2141.1963.tb05435.x; WHEBY MS, 1968, BLOOD, V31, P817, DOI 10.1182/blood.V31.6.817.817	30	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	1					67	77						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB703	6823973				2022-12-18	WOS:A1983QB70300007
J	COPELAND, BR; TODD, SA; FURLONG, CE				COPELAND, BR; TODD, SA; FURLONG, CE			HIGH-RESOLUTION TWO-DIMENSIONAL GEL-ELECTROPHORESIS OF HUMAN-ERYTHROCYTE MEMBRANE-PROTEINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	COPELAND, BR (corresponding author), UNIV WASHINGTON,DEPT GENET,DIV MED GENET,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015253] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-15253, GM-0745, GM-00452] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMES GFL, 1976, BIOCHEMISTRY-US, V15, P616, DOI 10.1021/bi00648a026; ANDERSON NG, 1978, ANAL BIOCHEM, V85, P331, DOI 10.1016/0003-2697(78)90229-4; ANDERSON NL, 1978, ANAL BIOCHEM, V85, P341, DOI 10.1016/0003-2697(78)90230-0; ANSTEE DJ, 1979, BIOCHEM J, V183, P193, DOI 10.1042/bj1830193; EDWARDS JJ, 1979, BLOOD, V53, P1121; EDWARDS Y, 1980, NATURE, V284, P511, DOI 10.1038/284511a0; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; GIOMETTI CS, 1980, ANAL BIOCHEM, V102, P47, DOI 10.1016/0003-2697(80)90315-2; HARELL D, 1979, ARCH BIOCHEM BIOPHYS, V193, P158, DOI 10.1016/0003-9861(79)90019-5; JONES PP, 1977, J EXP MED, V146, P1261, DOI 10.1084/jem.146.5.1261; KOCHETOV GA, 1970, BIOCHEM BIOPH RES CO, V40, P873, DOI 10.1016/0006-291X(70)90984-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU SC, 1977, BIOCHEMISTRY-US, V16, P4066, DOI 10.1021/bi00637a020; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; ROSENBLUM BB, 1979, AM J HUM GENET, V31, pA60; ROSES AD, 1976, NEW ENGL J MED, V294, P193, DOI 10.1056/NEJM197601222940404; ROSES AD, 1975, NATURE, V254, P350, DOI 10.1038/254350a0; ROSES AD, 1976, J NEUROL SCI, V30, P167, DOI 10.1016/0022-510X(76)90264-1; RUBIN RW, 1978, BIOCHIM BIOPHYS ACTA, V509, P100, DOI 10.1016/0005-2736(78)90011-1; SIEGEL DL, 1980, BIOCHIM BIOPHYS ACTA, V598, P517, DOI 10.1016/0005-2736(80)90032-2; Stark GR., 1967, METHOD ENZYMOL, V25, P590; Steck T L, 1974, Methods Enzymol, V31, P172; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; TANNER MJA, 1971, BIOCHEM J, V125, P1109, DOI 10.1042/bj1251109; THOMPSON S, 1980, BIOCHIM BIOPHYS ACTA, V600, P756, DOI 10.1016/0005-2736(80)90478-2	27	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	1					15	31						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ585	7081216				2022-12-18	WOS:A1982MZ58500002
J	CHOY, FYM; DAVIDSON, RG				CHOY, FYM; DAVIDSON, RG			GAUCHER DISEASE .3. SUBSTRATE-SPECIFICITY OF GLUCOCEREBROSIDASE AND THE USE OF NON-LABELED NATURAL SUBSTRATES FOR THE INVESTIGATION OF PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											CHOY, FYM (corresponding author), MCMASTER UNIV,MED CTR,DEPT PEDIAT,HAMILTON L8N 325,ONTARIO,CANADA.							ARONEFF S, 1956, TECHNIQUES RADIOCHEM; BARTHELMAI W, 1962, KLIN WOCHENSCHR, V40, P585, DOI 10.1007/BF01478633; BARTON NW, 1975, J BIOL CHEM, V250, P3966; BENYOSEPH Y, 1978, J CLIN PATHOL, V31, P1091, DOI 10.1136/jcp.31.11.1091; BEUTLER E, 1971, AM J HUM GENET, V23, P62; BEUTLER E, 1970, J LAB CLIN MED, V76, P745; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; BRADY RO, 1978, METABOLIC BASIS INHE, P731; BROADHEAD DN, 1977, CLIN CHIM ACTA, V74, P155; CHIAO YB, 1978, P NATL ACAD SCI USA, V75, P2448, DOI 10.1073/pnas.75.5.2448; CHOY FYM, 1980, PEDIATR RES, V14, P54, DOI 10.1203/00006450-198014010-00013; CHOY FYM, 1978, PEDIATR RES, V12, P1115, DOI 10.1203/00006450-197812000-00003; Halliday N, 1940, J BIOL CHEM, V132, P171; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; HO MW, 1973, BIOCHEM J, V136, P721, DOI 10.1042/bj1360721; HO MW, 1972, AM J HUM GENET, V24, P37; HYUN JC, 1975, ARCH BIOCHEM BIOPHYS, V166, P382, DOI 10.1016/0003-9861(75)90401-4; KLIBANSKY C, 1974, BIOMEDICINE, V20, P24; KOERNER TAW, 1979, J BIOL CHEM, V254, P2326; KUSKE TT, 1972, J LAB CLIN MED, V80, P523; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MUELLER OT, 1977, J BIOL CHEM, V252, P825; MUELLER OT, 1979, J BIOL CHEM, V254, P3521; OCKERMAN PA, 1968, BIOCHIM BIOPHYS ACTA, V165, P59, DOI 10.1016/0304-4165(68)90187-6; OWADA M, 1977, PEDIATR RES, V11, P641, DOI 10.1203/00006450-197705000-00004; PATRICK AD, 1965, BIOCHEM J, V97, pC17, DOI 10.1042/bj0970017C; PENTCHEV PG, 1978, P NATL ACAD SCI USA, V75, P3970, DOI 10.1073/pnas.75.8.3970; PENTCHEV PG, 1973, J BIOL CHEM, V248, P5256; PETERS SP, 1975, CLIN CHIM ACTA, V60, P391, DOI 10.1016/0009-8981(75)90083-2; PETERS SP, 1976, ARCH BIOCHEM BIOPHYS, V175, P569, DOI 10.1016/0003-9861(76)90547-6; PETERS SP, 1976, THESIS U PITTSBURGH; PETERS SP, 1977, PRACTICAL ENZYMOLOGY, P71; ROSENBERG A, 1956, J BIOL CHEM, V233, P1323; SCRUTTON MC, 1968, ANNU REV BIOCHEM, V37, P249, DOI 10.1146/annurev.bi.37.070168.001341; SUOMI WD, 1965, J LIPID RES, V6, P211; TURNER BM, 1977, BIOCHIM BIOPHYS ACTA, V480, P422; WENGER DA, 1978, CLIN GENET, V13, P145	37	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	5					670	680						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KJ795	6775530				2022-12-18	WOS:A1980KJ79500005
J	MACFARLANE, JD; HOLLISTER, DW; WEAVER, DD; BRANDT, KD; LUZZATTI, L; BIEGEL, AA				MACFARLANE, JD; HOLLISTER, DW; WEAVER, DD; BRANDT, KD; LUZZATTI, L; BIEGEL, AA			A NEW EHLERS-DANLOS SYNDROME WITH SKELETAL DYSPLASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									INDIANA UNIV,INDIANAPOLIS,IN 46204; UNIV CALIF LOS ANGELES,TORRANCE,CA 90509; STANFORD UNIV,STANFORD,CA 94305	Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Los Angeles; Stanford University									0	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	6					A118	A118						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT964					2022-12-18	WOS:A1980KT96400293
J	MORTON, NE; MACLEAN, CJ; KAGAN, A; GULBRANDSEN, CL; RHOADS, GG; YEE, S; LEW, R				MORTON, NE; MACLEAN, CJ; KAGAN, A; GULBRANDSEN, CL; RHOADS, GG; YEE, S; LEW, R			COMMINGLING IN DISTRIBUTIONS OF LIPIDS AND RELATED VARIABLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									POPULAT GENET LAB,HONOLULU,HI 96822; UNIV HAWAII,SCH PUBL HLTH,HONOLULU,HI 96822	University of Hawaii System								BEATON AE, 1969, SOCIO ECON PLAN SCI, V2, P355, DOI 10.1016/0038-0121(69)90030-5; BELSKY JL, 1971, EPIDEMIOLOGIC STUDIE, P12; CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL, P139; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GULBRANDSEN CL, IN PRESS; HARBURG E, 1970, J CHRON DIS, V23, P69, DOI 10.1016/0021-9681(70)90066-4; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1966, AM J HUM GENET, V18, P153; MORTON NE, IN PRESS; NEEL JV, 1962, AM J HUM GENET, V14, P353; SING CF, 1975, AM J HUM GENET, V27, P333; STANBURY JB, 1972, METABOLIC BASIS INHE; STEINBERG AG, 1952, AM J HUM GENET, V4, P113; TILLOTSON JL, 1973, AM J CLIN NUTR, V26, P177, DOI 10.1093/ajcn/26.2.177	16	24	24	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	1					52	59						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CU441	835575				2022-12-18	WOS:A1977CU44100006
J	LANGE, K; SPENCE, MA; FRANK, MB				LANGE, K; SPENCE, MA; FRANK, MB			APPLICATION OF LOD METHOD TO DETECTION OF LINKAGE BETWEEN A QUANTITATIVE TRAIT AND A QUALITATIVE MARKER - SIMULATION EXPERIMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF,DEPT BIOMATH,LOS ANGELES,CA 90024; UNIV CALIF,DEPT PSYCHIAT,LOS ANGELES,CA 90024; UNIV CALIF,COLL LETTERS & SCI,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles								BLACKWELDER WC, 1974, BEHAV GENET, V4, P97, DOI 10.1007/BF01066708; BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; COOK PJL, 1972, ANN HUM GENET, V35, P239, DOI 10.1111/j.1469-1809.1957.tb01397.x; COOK PJL, 1965, ANN HUM GENET, V28, P393; ELANDTJOHNSON RC, 1971, PROBABILITY MODELS S, P117; ELSTON RC, 1975, ANN HUM GENET, V39, P67, DOI 10.1111/j.1469-1809.1975.tb00109.x; ELSTON RC, 1974, AM J HUM GENET, V26, P13; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; GOLD RJM, 1974, ANN HUM GENET, V37, P315, DOI 10.1111/j.1469-1809.1974.tb01838.x; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HILL AP, 1975, ANN HUM GENET, V38, P439, DOI 10.1111/j.1469-1809.1975.tb00633.x; MERRITT AD, 1973, AM J HUM GENET, V25, P510; MERRITT AD, 1973, AM J HUM GENET, V25, P523; MEYERS DA, 1975, 2D P INT WORKSH HUM; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1974, AM J HUM GENET, V26, P588; Race R. R, 1968, BLOOD GROUPS MAN; RAO CR, 1973, LINEAR STATISTICAL I; RENWICK JH, 1971, ANNU REV GENET, V5, P81, DOI 10.1146/annurev.ge.05.120171.000501; RENWICK JH, 1965, ANN HUM GENET, V28, P379, DOI 10.1111/j.1469-1809.1965.tb00493.x; WEITKAMP LR, 1973, HUM HERED, V23, P197, DOI 10.1159/000152574; WEITKAMP LR, 1973, 4TH P INT C HUM GEN, P445	22	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	2					167	173						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	BJ476	1266848				2022-12-18	WOS:A1976BJ47600007
J	SHINOHARA, K; MIWA, S; NAKASHIMA, K; ODA, E; KAGEOKA, T; TSUJINO, G				SHINOHARA, K; MIWA, S; NAKASHIMA, K; ODA, E; KAGEOKA, T; TSUJINO, G			NEW PYRUVATE-KINASE VARIANT (PK OSAKA) DEMONSTRATED BY PARTIAL-PURIFICATION AND CONDENSATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YAMAGUCHI UNIV,SCH MED,DEPT INTERN MED,UBE,YAMAGUCHI 755,JAPAN; CHILDRENS MED CTR,OSAKA CITY,OSAKA 537,JAPAN	Yamaguchi University								BIGLEY RH, 1968, ENZYMOL BIOL CLIN, V9, P10, DOI 10.1159/000458230; BLUME KG, 1973, CLIN CHIM ACTA, V43, P443, DOI 10.1016/0009-8981(73)90487-7; BOIVIN P, 1974, ENZYME, V18, P37, DOI 10.1159/000459412; BRANDT NJ, 1971, SCAND J HAEMATOL, V8, P126; FELLENBERG RV, 1963, ENZYMOL BIOL CLIN, V3, P240; IMAMURA K, 1973, J BIOCHEM, V74, P1165, DOI 10.1093/oxfordjournals.jbchem.a130344; IMAMURA K, 1972, J BIOCHEM-TOKYO, V71, P1043, DOI 10.1093/oxfordjournals.jbchem.a129852; KOLER RD, 1964, COLD SPRING HARB SYM, V29, P213, DOI 10.1101/SQB.1964.029.01.025; LOHR GW, 1968, LANCET, V1, P753; MIWA S, 1975, BRIT J HAEMATOL, V29, P157, DOI 10.1111/j.1365-2141.1975.tb01809.x; MIWA S, 1974, ACTA HAEMATOLOGICA J, V37, P1; NAKASHIMA K, 1974, BLOOD, V43, P537, DOI 10.1182/blood.V43.4.537.537; OSKI FA, 1969, BRIT J HAEMATOL, V17, P289, DOI 10.1111/j.1365-2141.1969.tb01375.x; PAGLIA DE, 1968, J CLIN INVEST, V47, P1929, DOI 10.1172/JCI105883; STAAL G E J, 1970, Biochimica et Biophysica Acta, V220, P613, DOI 10.1016/0005-2744(70)90293-7; STAAL GEJ, 1971, BIOCHIM BIOPHYS ACTA, V227, P86, DOI 10.1016/0005-2744(71)90170-7; STAAL GEJ, 1972, BIOCHIM BIOPHYS ACTA, V258, P685, DOI 10.1016/0005-2744(72)90262-8; TANAKA KR, 1971, SEMIN HEMATOL, V8, P367; TANAKA T, 1967, J BIOCHEM-TOKYO, V62, P71, DOI 10.1093/oxfordjournals.jbchem.a128639; VALENTINE W, 1961, T ASSOC AM PHYSICIAN, V74, P100; WIESMANN U, 1966, NATURE, V209, P612, DOI 10.1038/209612a0	21	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	5					474	481						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH661	984043				2022-12-18	WOS:A1976CH66100005
J	PAGLIA, DE; PAREDES, R; VALENTINE, WN; DORANTES, S; KONRAD, PN				PAGLIA, DE; PAREDES, R; VALENTINE, WN; DORANTES, S; KONRAD, PN			UNIQUE PHENOTYPIC EXPRESSION OF GLUCOSEPHOSPHATE ISOMERASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WADSWORTH GEN HOSP,VET ADM CTR,LOS ANGELES,CA 90073; UNIV CALIF,SCH MED,DIV SURG PATHOL,LOS ANGELES,CA 90024; UNIV CALIF,SCH MED,DEPT MED,LOS ANGELES,CA 90024; CITY HOPE MED CTR,DEPT PEDIAT,DUARTE,CA 91010; HOSP NINO,INST MEXICANA ASISTENCIA NINEZ,MEXICO CITY 22,MEXICO; HOSP INFANTIL MEXICO,DEPT HEMATOL,MEXICO CITY 7,MEXICO	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; City of Hope								ARNOLD H, 1973, BLOOD, V41, P691, DOI 10.1182/blood.V41.5.691.691; ARNOLD H, 1970, 13 P INT C HEM MUN, P122; BAUGHAN MA, 1968, BLOOD, V32, P236, DOI 10.1182/blood.V32.2.236.236; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BEUTLER E, 1969, J CLIN INVEST, V48, P461, DOI 10.1172/JCI106003; BLUME KG, 1972, J LAB CLIN MED, V79, P942; CARTIER P, 1969, ENZYMOL BIOL CLIN, V10, P439; CHAPMAN RG, 1962, J CLIN INVEST, V41, P1249, DOI 10.1172/JCI104587; DAVIDSON WD, 1969, J LAB CLIN MED, V73, P173; DETTER JC, 1968, ANN HUM GENET, V31, P329, DOI 10.1111/j.1469-1809.1968.tb00565.x; ENGELHARDT R, 1973, ERYTHROCYTES THROMBO, P180; FITCH LI, 1968, BIOCHEM J, V110, P56; KRIMSKY I, 1963, METHOD ENZYMAT AN, P238; LOHR GW, 1973, BLUT, V26, P393, DOI 10.1007/BF01632749; MINAKAMI S, 1965, J BIOCHEM, V58, P543, DOI 10.1093/oxfordjournals.jbchem.a128240; MIWA S, 1973, ACTA HAEMATOL JAPON, V36, P70; MIWA S, 1973, ACTA HAEMATOL JPN, V36, P65; NAKASHIM.K, 1973, AM J HUM GENET, V25, P294; OSKI F, 1971, CLIN RES, V19, P427; PAGLIA DE, 1969, NEW ENGL J MED, V280, P66, DOI 10.1056/NEJM196901092800203; PAGLIA DE, IN PRESS; PAYNE DM, 1972, ARCH BIOCHEM BIOPHYS, V151, P122, DOI 10.1016/0003-9861(72)90480-8; SCHROTER W, 1971, BRIT J HAEMATOL, V20, P249, DOI 10.1111/j.1365-2141.1971.tb07036.x; TARIVERD.G, 1970, HUMANGENETIK, V10, P218, DOI 10.1007/BF00295783; VALENTINE WN, 1973, BLOOD, V41, P857, DOI 10.1182/blood.V41.6.857.857; VALENTINE WN, 1969, NEW ENGL J MED, V280, P528, DOI 10.1056/NEJM196903062801003	26	24	24	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	1					62	70						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V5202	1155451				2022-12-18	WOS:A1975V520200005
J	SING, CF; CHAMBERLAIN, MA; BLOCK, WD; FEILER, S				SING, CF; CHAMBERLAIN, MA; BLOCK, WD; FEILER, S			ANALYSIS OF GENETIC AND ENVIRONMENTAL SOURCES OF VARIATION IN SERUM-CHOLESTEROL IN TECUMSEH, MICHIGAN .1. ANALYSIS OF FREQUENCY DISTRIBUTION FOR EVIDENCE OF A GENETIC POLYMORPHISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,MED SCH,DEPT HUMAN GENET,ANN ARBOR,MI 48104; UNIV MICHIGAN,MED SCH,DEPT EPIDEMIOL,ANN ARBOR,MI 48104; UNIV MICHIGAN,MED SCH,DEPT BIOL CHEM,ANN ARBOR,MI 48104	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan				Sing, Charles/0000-0001-5872-7956	PHS HHS [H-6378] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABELL LL, 1952, J BIOL CHEM, V195, P357; BLOCK WD, 1966, TECHNICON S, P345; DAWBER TR, 1967, AM J PUBLIC HEALTH, V47, P4; EPSTEIN FH, 1965, ANN INTERN MED, V62, P1170, DOI 10.7326/0003-4819-62-6-1170; EPSTEIN FH, 1965, GENETICS EPIDEMIOLOG; FRANCIS T, 1965, MILBANK FUND Q, V43, P333, DOI 10.2307/3348903; Goldstein J L, 1972, Trans Assoc Am Physicians, V85, P120; GOLDSTEIN JL, 1973, P NATL ACAD SCI USA, V70, P2804, DOI 10.1073/pnas.70.10.2804; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GOLDSTEIN JL, 1974, AM J HUM GENET, V26, P199; HARDING JP, 1949, J MAR BIOL ASSOC UK, V28, P141, DOI 10.1017/S0025315400055259; JENSEN J, 1972, AM J MED, V52, P499, DOI 10.1016/0002-9343(72)90041-1; JOHNSON BC, 1965, J CHRON DIS, V18, P147, DOI 10.1016/0021-9681(65)90098-6; MOORE FE, 1967, SERUM CHOLESTEROL 11; NAPIER JA, 1962, AM J PUBLIC HEALTH N, V52, P208, DOI 10.2105/AJPH.52.2.208; NAPIER JA, 1971, CASEBOOK COMMUNITY S, P25; RAO CR, 1952, ADV STATISTICAL METH; SCHAEFER LE, 1958, CIRCULATION, V17, P537, DOI 10.1161/01.CIR.17.4.537; SMITH C, 1971, Clinical Genetics, V2, P303; TRUETT J, 1967, J CHRON DIS, V20, P511, DOI 10.1016/0021-9681(67)90082-3; WRIGHT S, 1968, GENETIC BIOMETRIC F, V1	21	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	3					333	347						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AD236	803015				2022-12-18	WOS:A1975AD23600009
J	STEINBERG, AG; JENKINS, T; NURSE, GT; HARPENDING, HC				STEINBERG, AG; JENKINS, T; NURSE, GT; HARPENDING, HC			GAMMAGLOBULIN GROUPS OF KHOISAN PEOPLES OF SOUTHERN AFRICA - EVIDENCE FOR POLYMORPHISM FOR A GM1,5,13,14,21 HAPLOTYPE AMONG SAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CASE WESTERN RESERVE UNIV,DEPT BIOL,CLEVELAND,OH 44106; S AFRICAN INST MED RES,JOHANNESBURG,SOUTH AFRICA; HARVARD UNIV,DEPT ANTHROPOL,CAMBRIDGE,MA 02138	Case Western Reserve University; Harvard University								JENKINS T, 1970, AM J PHYS ANTHROPOL, V32, P197, DOI 10.1002/ajpa.1330320206; JENKINS T, 1966, AM J HUM GENET, V18, P399; JENKINS T, 1967, 35 NAM DES RES STAT; JENKINS T, 1973, THESIS U LONDON; KURCZYNSKI TW, 1967, AM J HUM GENET, V19, P178; MILSTEIN CP, 1974, NATURE, V248, P160, DOI 10.1038/248160a0; STEINBERG A. G., 1964, HUM BIOL, V36, P77; STEINBERG AG, 1965, AM J HUM GENET, V17, P133; STEINBERG AG, 1969, ANNU REV GENET, V3, P25, DOI 10.1146/annurev.ge.03.120169.000325; STEINBERG AG, 1973, AM J PHYS ANTHROPOL, V39, P403, DOI 10.1002/ajpa.1330390308; STEINBERG AG, 1974, IMMUNOGENETICS, V2, P1; STEINBERG ARTHUR G., 1962, PROGR MED GENET, V2, P1; TREVOR JC, 1955, ENCY HEBRAICA, P500; WILSON M, 1969, OXFORD HISTORY S AFR, V1	14	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	4					528	542						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	AM544	808124				2022-12-18	WOS:A1975AM54400011
J	TEDESCO, TA; MILLER, KL; RAWNSLEY, BE; MENNUTI, MT; SPIELMAN, RS; MELLMAN, WJ				TEDESCO, TA; MILLER, KL; RAWNSLEY, BE; MENNUTI, MT; SPIELMAN, RS; MELLMAN, WJ			HUMAN ERYTHROCYTE GALACTOKINASE AND GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE - POPULATION SURVEY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV S FLORIDA,DEPT PEDIAT,TAMPA,FL 33620; UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19174; UNIV PENN HOSP,DEPT OBSTET & GYNECOL,PHILADELPHIA,PA 19104	State University System of Florida; University of South Florida; University of Pennsylvania; University of Pennsylvania								BEUTLER E, 1966, J LAB CLIN MED, V68, P646; BEUTLER E, 1973, ISRAEL J MED SCI, V9, P1323; BRANDT NJ, 1969, GALACTOSEMIA, P140; ELLIS G, 1972, ARCH DIS CHILD, V47, P34, DOI 10.1136/adc.47.251.34; HANSEN RG, 1964, P SOC EXP BIOL MED, V64, P115; HSIA DYY, 1969, GALACTOSEMIA, P154; Kalckar HM, 1973, BIOLOGY BRAIN DYSFUN, P31; KALOUD H, 1972, Z KINDERHEILKD, V113, P205, DOI 10.1007/BF00464624; KELLY S, 1970, PUBLIC HEALTH REP, V85, P575, DOI 10.2307/4593909; MATHAI CK, 1967, ENZYMOLOGIA, V33, P224; MAYES JS, 1968, BIOCHEM GENET, V2, P219, DOI 10.1007/BF01474761; MCGUINNESS R, 1967, CLIN CHIM ACTA, V16, P221, DOI 10.1016/0009-8981(67)90184-2; MELLMAN WJ, 1968, ANN HUM GENET, V32, P1, DOI 10.1111/j.1469-1809.1968.tb00043.x; MELLMAN WJ, 1970, PEDIATRICS, V45, P672; NG WG, 1965, J LAB CLIN MED, V66, P115; NG WG, 1973, ANN HUM GENET, V37, P1, DOI 10.1111/j.1469-1809.1973.tb01808.x; NG WG, 1969, BIOCHEM BIOPH RES CO, V37, P354, DOI 10.1016/0006-291X(69)90742-6; PICKERING WR, 1972, J PEDIATR-US, V81, P50, DOI 10.1016/S0022-3476(72)80373-1; SCHEIBENREITER S, 1972, WIEN KLIN WOCHENSCHR, V84, P93; SCHWARZ V, 1961, ANN HUM GENET, V25, P179; SHIH VE, 1971, NEW ENGL J MED, V284, P753, DOI 10.1056/NEJM197104082841404; SPIELMAN RS, IN PRESS; TEDESCO TA, 1969, J CLIN INVEST, V48, P2390, DOI 10.1172/JCI106205; TEDESCO TA, 1972, SCIENCE, V178, P176, DOI 10.1126/science.178.4057.176; TEDESCO TA, 1973, PEDIATR RES, V7, P394; TEDESCO TA, TO BE PUBLISHED	26	24	24	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	6					737	747						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX924	173184				2022-12-18	WOS:A1975AX92400004
J	BEUTLER, E; WEST, C				BEUTLER, E; WEST, C			RED-CELL GLUTATHIONE PEROXIDASE POLYMORPHISM IN AFRO-AMERICANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									CITY HOPE NATL MED CTR,DIV MED,DUARTE,CA 91010	City of Hope								BEUTLER E, 1969, PHARMACOL REV, V21, P73; Beutler E., 1971, RED CELL METABOLISM; FLOHE L, 1971, H-S Z PHYSIOL CHEM, V352, P151, DOI 10.1515/bchm2.1971.352.1.151; GUNZLER WA, 1973, H-S Z PHYSIOL CHEM, V354, P833; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585	5	24	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	2					255	258						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S7582	4823031				2022-12-18	WOS:A1974S758200015
J	GOLD, RJM; SCRIVER, CR				GOLD, RJM; SCRIVER, CR			PROPERTIES OF HAIR KERATIN IN AN AUTOSOMAL DOMINANT FORM OF ECTODERMAL DYSPLASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BLACKBURN S, 1951, BIOCHEM J, V49, P554, DOI 10.1042/bj0490554; BRADFIEL.RB, 1970, NATURE, V225, P283, DOI 10.1038/225283a0; BRIGHAM MP, 1960, J CLIN INVEST, V39, P1633, DOI 10.1172/JCI104186; Clouston HR, 1939, CAN MED ASSOC J, V40, P1; Clouston HR, 1929, CAN MED ASSOC J, V21, P18; CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3; CREWTHER WG, 1966, BIOPOLYMERS, V4, P905, DOI 10.1002/bip.1966.360040807; FRITZ JS, 1955, ANAL CHEM, V27, P1461; GILLESPIE JM, 1965, COMP BIOCHEM PHYSIOL, V15, P175, DOI 10.1016/0010-406X(65)90345-2; GILLESPIE JM, 1962, AUST J BIOL SCI, V15, P409, DOI 10.1071/BI9620409; Goddard DR, 1935, J BIOL CHEM, V112, P361; Goddard DR, 1934, J BIOL CHEM, V106, P605; GOLD RJM, 1970, CLIN RES, V18, P394; HILL ROBERT L., 1965, ADVANCE PROTEIN CHEM, V20, P37, DOI 10.1016/S0065-3233(08)60388-5; JOUBERT FJ, 1967, S FIBROUS PROTEINS A, P343; LEACH SJ, 1960, AUST J CHEM, V13, P547, DOI 10.1071/CH9600547; MACDONALD AMG, 1965, ADVANCES ANALYTICAL, V4, P75; MCKUSICK VA, 1966, HERITABLE DISORDERS; POLITT RJ, 1971, BIOCHEM J, V122, P433; PROTA G, 1968, CORSI SEMINARI CHEM, V11, P136; REID EE, 1960, INORGANIC CHEMISTRY, V2; REIS PJ, 1964, AUST J BIOL SCI, V17, P532, DOI 10.1071/BI9640532; ROGERS GE, 1959, ANN NY ACAD SCI, V83, P378; SCHRAM E, 1954, BIOCHEM J, V57, P33, DOI 10.1042/bj0570033; SCRIVER CR, 1965, J PEDIATR-US, V67, P946, DOI 10.1016/S0022-3476(65)81861-3; SCRIVER CR, 1968, CLIN BIOCHEM, V1, P179; SMITH D W, 1969, Birth Defects Original Article Series, V5, P255; SPIES JR, 1949, ANAL CHEM, V21, P1249, DOI 10.1021/ac60034a033; WILLIAMS M, 1971, CANAD MED ASS J, V96, P36	29	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	5					549	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N4590	5054225				2022-12-18	WOS:A1972N459000006
J	SLY, WS; HADDAD, J; MCALISTE.W; AVIOLI, L; LUBOWITZ, H; LANG, R				SLY, WS; HADDAD, J; MCALISTE.W; AVIOLI, L; LUBOWITZ, H; LANG, R			RECESSIVE OSTEOPETROSIS - NEW CLINICAL PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract																		GUIBAUD, 1972, ARCH FRANC PED, V29, P269	1	24	24	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	6					A34	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O0504					2022-12-18	WOS:A1972O050400087
J	DANES, BS; FLENSBORG, EW				DANES, BS; FLENSBORG, EW			CYSTIC FIBROSIS - CELL CULTURE STUDIES ON A DANISH POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Bearn A G, 1969, Trans Assoc Am Physicians, V82, P248; CROW JF, 1965, 1163 US PUBL HEALTH, P23; DANES BS, 1969, J EXP MED, V129, P775, DOI 10.1084/jem.129.4.775; DANES BS, 1968, LANCET, V1, P1061; DANES BS, 1969, BIOCHEM BIOPH RES CO, V36, P919, DOI 10.1016/0006-291X(69)90291-5; DANES BS, 1966, J EXP MED, V123, P1, DOI 10.1084/jem.123.1.1; DANES BS, 1970, J EXP MED, V132, P765, DOI 10.1084/jem.132.4.765; DANES BS, 1969, 5 P INT CYST FIBR C, P67; DANKS DM, 1965, ANN HUM GENET, V28, P323, DOI 10.1111/j.1469-1809.1965.tb00489.x; DISANTAGNESE PA, 1967, NEW ENGL J MED, V277, P1287, DOI 10.1056/NEJM196712142772404; MATALON R, 1968, BIOCHEM BIOPH RES CO, V33, P954, DOI 10.1016/0006-291X(68)90405-1; SCOTT JE, 1965, HISTOCHEMISTRY, V5, P221, DOI 10.1007/BF00306130; STEINBERG AG, 1960, AM J HUM GENET, V12, P416	13	24	24	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	3					297	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J3602	4103774				2022-12-18	WOS:A1971J360200006
J	SING, CF; SHREFFLER, DC; NEEL, JV; NAPIER, JA				SING, CF; SHREFFLER, DC; NEEL, JV; NAPIER, JA			STUDIES ON GENETIC SELECTION IN A COMPLETELY ASCERTAINED CAUCASIAN POPULATION .2. FAMILY ANALYSES OF 11 BLOOD GROUP SYSTEMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article														Sing, Charles/0000-0001-5872-7956				BAILEY NTJ, 1961, INTRODUCTION MATHEMA; CHUNG CS, 1960, JPN J HUM GENET, V5, P124; CHUNG CS, 1961, JPN J HUM GENET, V6, P1; DEMPSTER ER, 1955, COLD SPRING HARB SYM, V20, P25, DOI 10.1101/SQB.1955.020.01.005; EHRMAN L, 1969, AM NAT, V103, P675, DOI 10.1086/282636; ELANDTJOHNSON RC, 1970, AM J HUM GENET, V22, P129; ELANDTJOHNSON RC, IN PRESS; Ewens W.J., 1969, POPULATION GENETICS; Fisher RA, 1934, ANN EUGENIC, V6, P13, DOI 10.1111/j.1469-1809.1934.tb02105.x; Ford E. B., 1940, NEW SYSTEMATICS, P493; GERSHOWITZ H, 1965, ACTA GENET STAT MED, V15, P261; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HIRAIZUMI Y, 1964, AM J HUM GENET, V16, P375; KIMURA M, 1969, P NATL ACAD SCI USA, V63, P1181, DOI 10.1073/pnas.63.4.1181; KIMURA M, 1964, GENETICS, V49, P725; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; KOJIMA KI, 1967, P NATL ACAD SCI USA, V57, P645, DOI 10.1073/pnas.57.3.645; LEVINS RICHARD, 1968; LEWONTIN RC, 1967, AM J HUM GENET, V19, P681; LEWONTIN RC, 1959, EVOLUTION, V13, P561, DOI 10.2307/2406136; LEWONTIN RC, 1966, GENETICS, V54, P595; MATSUNAGA E, 1957, ANN HUM GENET, V22, P111, DOI 10.1111/j.1469-1809.1957.tb01926.x; MI MP, 1967, AM J HUM GENET, V19, P313; MORTON NE, 1959, AM J HUM GENET, V11, P237; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1966, AM J HUM GENET, V18, P153; MORTON NE, IN PRESS; MORTON NE, 1962, METHODOLOGY HUMAN GE, P17; NEEL JV, 1968, PERSPECT BIOL MED, V11, P565; OBRIEN SJ, 1969, AM NAT, V103, P97, DOI 10.1086/282587; PERITZ E, 1967, ANN HUM GENET, V30, P259, DOI 10.1111/j.1469-1809.1967.tb00026.x; REED TE, 1964, AM J HUM GENET, V16, P161; REED TE, 1968, AM J HUM GENET, V20, P129; REED TE, 1968, AM J HUM GENET, V20, P579; REED TE, 1967, 1965 P WORLD POP C B, V2, P498; SCHACHT LE, 1961, 2 P INT C HUM GEN RO, P894; SCHACHT LE, 1963, 2ND P INT C HUM GEN, P894; SHREFFLER DC, 1971, AM J HUM GENET, V23, P150; STONE WS, 1969, JAP J GENET, V2, P153; SVED JA, 1967, GENETICS, V55, P469; WALLACE B, 1958, EVOLUTION, V12, P113, DOI 10.2307/2405911; Wallace B., 1968, TOPICS POPULATION GE; Wallace B., 1970, GENETIC LOAD ITS BIO; WARD RH, 1970, AM NAT, V104, P355, DOI 10.1086/282669; WIENER A S, 1953, Acta Genet Med Gemellol (Roma), V2, P391; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	46	24	24	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	2					164	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J1653	4997204				2022-12-18	WOS:A1971J165300006
J	SANDS, VE				SANDS, VE			SHORT ARM ENLARGEMENT IN ACROCENTRIC CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BROWN WMC, 1965, LANCET, V2, P561; BROWN WMC, 1966, CHROMOSOME STUDIES A; CARR DH, 1963, CAN MED ASSOC J, V88, P456; CHANDRA H. S., 1963, CYTOGENETICS [BASEL], V2, P34, DOI 10.1159/000129763; COOPER HL, 1962, AM J HUM GENET, V14, P107; CRAWFURD MD, 1965, ANN HUM GENET, V29, P199, DOI 10.1111/j.1469-1809.1965.tb00514.x; DE LA CHAPELLE A., 1963, CYTOGENETICS [BASEL], V2, P129, DOI 10.1159/000129774; DEKABAN A. S., 1963, CYTOGENETICS [BASEL], V2, P61, DOI 10.1159/000129768; EDGREN J, 1966, J MENT DEFIC RES, V10, P47; ELLIS JR, 1961, ANN HUM GENET, V25, P159, DOI 10.1111/j.1469-1809.1961.tb01514.x; GRAY JE, 1962, LANCET, V1, P21; HAMERTON JL, 1965, CYTOGENETICS, V4, P171, DOI 10.1159/000129853; HAMERTON JL, 1962, CHROMOSOMES MEDICINE, P140; HAMERTON JL, 1962, CHROMOSOMES MEDICINE; HANDMAKER SD, 1963, AM J HUM GENET, V15, P11; HARNDEN DG, 1960, BRIT J EXP PATHOL, V41, P31; JACOBS PA, 1964, ANN HUM GENET, V27, P353; JACOBSON JS, 1964, ANN HUM GENET, V28, P21; KALLEN B., 1962, CYTOGENETICS, V1, P5, DOI 10.1159/000129709; MILLER OJ, 1962, T NEW YORK ACAD SCI, V24, P372, DOI 10.1111/j.2164-0947.1962.tb01413.x; MOORES EC, 1966, ANN HUM GENET, V30, P77, DOI 10.1111/j.1469-1809.1966.tb00008.x; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MOORHEAD PS, 1961, AM J HUM GENET, V13, P32; OHNO S, 1961, LANCET, V2, P123; PATAU K, 1961, AM J HUM GENET, V13, P287; SAKSELA E., 1962, CYTOGENETICS [BASEL], V1, P225, DOI 10.1159/000129733; SASAKI MS, 1963, AM J HUM GENET, V15, P24; SCHMID W., 1962, CYTOGENETICS, V1, P199, DOI 10.1159/000129729; SMITH MAF, 1962, CYTOGENETICS, V1, P325; SMITH MAF, 1963, ANN HUM GENET, V27, P143; STARKMAN MN, 1967, AM J HUM GENET, V19, P162; THERKELSEN AJ, 1964, CYTOGENETICS, V3, P441, DOI 10.1159/000129832; TJIO JH, 1960, P NATL ACAD SCI USA, V46, P532, DOI 10.1073/pnas.46.4.532; UCHIDA IA, 1968, AM J HUM GENET, V20, P107; WOLF U., 1964, CYTOGENETICS, V3, P112, DOI 10.1159/000129802	35	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	3					293	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D4606	4240107				2022-12-18	WOS:A1969D460600008
J	REED, TE				REED, TE			RESEARCH ON BLOOD GROUPS AND SELECTION FROM CHILD HEALTH AND DEVELOPMENT STUDIES OAKLAND CALIFORNIA .3. COUPLE MATING TYPE AND REPRODUCTIVE PERFORMANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		HEIKEN A, 1966, HEREDITAS-GENETISK A, V55, P192; LEWONTIN RC, 1966, GENETICS, V54, P595; MORTON NE, 1966, AM J HUM GENET, V18, P153; Mourant A., 1954, DISTRIBUTION HUMAN B; PERITZ E, 1967, ANN HUM GENET, V30, P259, DOI 10.1111/j.1469-1809.1967.tb00026.x; REED TE, 1967, AM J HUM GENET, V19, P732; REED TE, 1964, AM J HUM GENET, V16, P161; REED TE, 1968, AM J HUM GENET, V20, P119; REED TE, 1967, 1965 P WORLD POP C B, V2, P498; SVED JA, 1967, GENETICS, V55, P469; 1965, 1000 US PUBL HEALT 3; 1965, 1000 US PUBL HEALTH	12	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	2					129	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B2183	4966853				2022-12-18	WOS:A1968B218300005
J	CLEVE, H; GORDON, S; BOWMAN, BH; BEARN, AG				CLEVE, H; GORDON, S; BOWMAN, BH; BEARN, AG			COMPARISON OF TRYPTIC PEPTIDES AND AMINO ACID COMPOSITION OF BETA POLYPEPTIDE CHAINS OF 3 COMMON HAPTOGLOBIN PHENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOWMAN BH, 1967, BIOCHEM BIOPH RES CO, V26, P466, DOI 10.1016/0006-291X(67)90570-0; CHEFTEL RI, 1966, CR ACAD SCI D NAT, V262, P1982; CLEVE H, 1965, HUMANGENETIK, V1, P537, DOI 10.1007/BF00338342; CONNELL GE, 1962, NATURE, V193, P505, DOI 10.1038/193505a0; EASLEY CAROLINE W., 1965, BIOCHIM BIOPHYS ACTA, V107, P386, DOI 10.1016/0304-4165(65)90147-9; GIBLETT ER, 1966, AM J HUM GENET, V18, P448; GOHLER W, 1962, Z ARZTL FORTBILD, V56, P765; GORDON S, 1966, P SOC EXP BIOL MED, V121, P846; GORDON S, TO BE PUBLISHED; HEILMANN J, 1957, Z PHYSIOL CHEM, V309, P219; INGRAM VM, 1958, BIOCHIM BIOPHYS ACTA, V28, P539, DOI 10.1016/0006-3002(58)90516-X; JAVID J, 1967, P NATL ACAD SCI USA, V57, P920, DOI 10.1073/pnas.57.4.920; MOORE S, 1958, ANAL CHEM, V30, P297; NANCE WE, 1963, NATURE, V198, P869, DOI 10.1038/198869a0; RENWICK JH, 1966, ANN HUM GENET, V29, P389, DOI 10.1111/j.1469-1809.1966.tb00536.x; ROBSON EB, 1964, ANN HUM GENET, V28, P77, DOI 10.1111/j.1469-1809.1964.tb00462.x; SHIM BS, 1964, AM J HUM GENET, V16, P477; SHIM BS, 1965, NATURE, V207, P1264, DOI 10.1038/2071264a0; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; SMITHIES O, 1962, AM J HUM GENET, V14, P14; SMITHIES O, 1964, COLD SPRING HARB SYM, V29, P309, DOI 10.1101/SQB.1964.029.01.033; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; SMITHIES O, 1959, BIOCHEMISTRY HUMAN G, P178; SPACKMAN DH, 1958, ANAL CHEM, V30, P411; UMANSKY I, 1964, COLD SPRING HARBOR S, V29, P321; WOLSTENHOLME GEW, 1959, BIOCHEMISTRY HUMA ED, P178	26	24	24	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	6					713	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A2687	6075366				2022-12-18	WOS:A1967A268700003
J	DRONAMRAJU, KR; HALDANE, JBS				DRONAMRAJU, KR; HALDANE, JBS			INHERITANCE OF HAIRY PINNAE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter																		DRONAMRAJU K, 1961, NATURE, V190, P653, DOI 10.1038/190653a0; DRONAMRAJU K, UNPUBLISHED; Dronamraju KR, 1960, J GENET, V57, P230; GATES RR, 1960, SCIENCE, V132, P145, DOI 10.1126/science.132.3420.145; GATES RR, 1960, SCIENCE, V6, P103; SARKAR SS, 1961, AM J HUM GENET, V13, P214; STERN C, 1957, AM J HUM GENET, V9, P147; TOMMASI C, 1907, GIORN PSYCH CLIN TEC, V35, P1; Tommasi C, 1907, ARCH PSICHIATR NEURO, V28, P60	9	24	24	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	1					102	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2966A	13887907				2022-12-18	WOS:A19622966A00001
J	NEMOTO, H; NEEL, JV; DREW, AL; YANASE, T; MATSUMOTO, YS				NEMOTO, H; NEEL, JV; DREW, AL; YANASE, T; MATSUMOTO, YS			HOSOJIMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		HOSHIMOTO T, 1941, NIPPON HIFU HINYOKI, V49, P316; ICHIKAWA T, 1933, NIPPON HIFU HINYOKI, V34, P360; IKUTA T, 1940, NIPPON HIFU HINYOKI, V48, P82; ITO M, 1950, Tohoku J Exp Med, V53, P69; KANO E, 1956, HIFUBYO BAIDOKU GAKU, V66, P392; KATO T, 1957, HIFUKA KIYO, V52, P50; Komaya G, 1924, ARCH DERMATOL SYPH-G, V147, P389, DOI 10.1007/BF01843639; LINDENOV H, 1945, OPERA DOMO BIOL HERE, V8; MATSUMOTO S, 1924, HIFUKA KIYO, V2, P191; MUNAKATA T, 1955, FUKUSHIMA MED J, V5, P131; SCHULL WJ, 1958, AM J HUM GENET, V10, P294; SHINOZAKI N, 1955, JINKO MONDAI KENKYUS, V102, P1; SPUHLER J. N., 1953, HUMAN BIOL, V25, P295; SUGIMOTO T, 1950, IGAKU TO SEIBUTSUGAK, V16, P49; TOYAMA I, 1929, NIPPON HIFU HINYO KI, V29, P95	15	24	24	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1960	12	1					67	75						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF077	14405916				2022-12-18	WOS:A1960WF07700004
J	BUCKWALTER, JA; KNOWLER, LA				BUCKWALTER, JA; KNOWLER, LA			BLOOD DONOR CONTROLS FOR BLOOD GROUP DISEASE RESEARCHES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; AIRD I, 1954, Br Med J, V2, P315; BILLINGTON B. P., 1956, AUSTRALASIAN ANN MED, V5, P141; BILLINGTON BP, 1956, LANCET, V2, P859; BROWN DAP, 1956, BRIT MED J, V2, P135; BUCKWALTER JA, 1957, SURG GYNECOL OBSTET, V104, P176; BUCKWALTER JA, 1956, JAMA-J AM MED ASSOC, V162, P1210, DOI 10.1001/jama.1956.02970300010005; BUCKWALTER JA, 1956, JAMA-J AM MED ASSOC, V162, P1215, DOI 10.1001/jama.1956.02970300015006; BUCKWALTER JA, 1957, ACTA GENETICA, V6, P561; BUCKWALTER JA, 1956, SURG FORUM AM COLLEG, V7, P610; CLARKE CA, 1955, BRIT MED J, V2, P643, DOI 10.1136/bmj.2.4940.643; CLARKE CA, 1956, BRIT MED J, V2, P725, DOI 10.1136/bmj.2.4995.725; CREGER WP, 1956, ARCH INTERN MED, V98, P136, DOI 10.1001/archinte.1956.00250260008002; HOLLANDER, 1953, CITED INDIRECTLY; JENNINGS D, 1956, LANCET, V2, P11; KOSTER KH, 1955, LANCET, V2, P52; MAYR E, 1956, SCIENCE, V124, P932, DOI 10.1126/science.124.3228.932; MCCONNELL R B, 1956, Br Med J, V1, P772; 1956, BRIT M J, V2, P723	19	24	24	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	2					164	174						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA219	13533394				2022-12-18	WOS:A1958WA21900005
J	GARTLER, SM; FIRSCHEIN, IL; KRAUS, BS				GARTLER, SM; FIRSCHEIN, IL; KRAUS, BS			INVESTIGATION INTO THE GENETICS AND RACIAL VARIATION OF BAIB EXCRETION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CALCHINOVATI C, 1954, ANN EUGENIC, V18, P335; FISHER RA, 1939, ANN EUGEN, V9, P150; GARTLER SM, 1956, AM J HUM GENET, V8, P120; GARTLER SM, 1956, 1ST INT C HUM GEN CO; HARRIS H, 1953, ANN EUGENIC, V18, P43; PENROSE LS, 1951, ANN EUGENIC, V16, P134, DOI 10.1111/j.1469-1809.1951.tb02467.x; Sutton HE, 1955, AM J PHYS ANTHROP-NE, V13, P53, DOI 10.1002/ajpa.1330130106	7	24	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1957	9	3					200	207						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA216	13469796				2022-12-18	WOS:A1957WA21600007
J	SALDANHA, PH				SALDANHA, PH			GENE FLOW FROM WHITE INTO NEGRO POPULATIONS IN BRAZIL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARMATTOE R. E. G., 1953, WEST AFRICAN MED JOUR, V2, P89; BARNICOT NA, 1950, ANN EUGENIC, V15, P248; Boyd WC., 1950, GENETICS RACES MAN; BROOKS PJ, 1952, ANN EUGENIC, V17, P75; CHALMERS JNM, 1953, ANN EUGENIC, V17, P168; DAVID JHS, 1949, PUBLICACOES CULTURAI, V3, P53; FARIA R., 1951, ARQ BIOL [SAO PAULO], V35, P68; GLASS B, 1955, AM J HUM GENET, V7, P368; GLASS B, 1953, AM J HUM GENET, V5, P1; GLASS B, 1950, AM J HUM GENET, V2, P269; Haldane JBS, 1941, ANN EUGENIC, V11, P333, DOI 10.1111/j.1469-1809.1941.tb02297.x; HARRIS H, 1950, ANN EUGENIC, V15, P24, DOI 10.1111/j.1469-1809.1949.tb02419.x; LAMBOTTE-LEGRAND J, 1950, Ann Soc Belg Med Trop (1920), V30, P547; LOPES MBL, 1952, SEARA MED, V6, P483; MELLONE O, 1952, Rev Paul Med, V40, P287; MORTARA G, 1947, APLICACOES CENSO DEM; Mourant A., 1954, DISTRIBUTION HUMAN B; NINA RR, 1932, AFRICANOS BRASIL; NOVAIS M, 1953, Hospital (Rio J), V43, P471; PEDREIRA CM, 1954, FATORES RH HR ASPECT; Race R.R., 1950, BLOOD GROUPS MAN; RAMOS A, 1951, NEGRO BRASILEIRO; Ramos A., 1951, INTRO ANTROPOLOGIA B; ROBERTS DF, 1955, AM J HUM GENET, V7, P361; SALDANHA P., 1954, REV BRASIL BIOL, V14, P285; SHAPIRO M, 1951, S Afr Med J, V25, P406; SHAPIRO M, 1953, J FORENSIC MED, V1, P2; Silva EM, 1948, AM J PHYS ANTHROPOL, V6, P423; TAUNNAY E, 1941, 3 C HIST NAC RIO JAN, V3; Wiener AS, 1942, SCIENCE, V96, P407, DOI 10.1126/science.96.2496.407; 1950, CENSO DEMOGRAFICO; 1872, DIRETORIA GERAL ESTA; 1890, MINISTERIO IND VIACA	33	24	25	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1957	9	4					299	309						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA217	13497998				2022-12-18	WOS:A1957WA21700004
J	MACMAHON, B				MACMAHON, B			DATA ON THE ETIOLOGY OF ACUTE INTUSSUSCEPTION IN CHILDHOOD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Bolling RW, 1923, ANN SURG, V78, P349, DOI 10.1097/00000658-192309000-00006; CLOSE HG, 1931, GUYS HOSP REP, V81, P436; Fitzwilliams DCL, 1908, LANCET, V1, P628; GROSS RE, 1948, NEW ENGL J MED, V239, P645, DOI 10.1056/NEJM194810282391801; Hipsley P L, 1935, Br Med J, V2, P717; Hogben L, 1931, J GENET, V25, P97, DOI 10.1007/BF02983936; HOGG BM, 1946, ANN SURG, V124, P262, DOI 10.1097/00000658-194608000-00012; KOCH A, 1912, EDINBURGH MED J, V9, P227; MCKEOWN T, 1951, ANN EUGENIC, V16, P260, DOI 10.1111/j.1469-1809.1951.tb02479.x; Perrin WS, 1921, BRIT J SURG, V9, P46, DOI 10.1002/bjs.1800093308; RAVITCH MM, 1950, J PEDIATR-US, V37, P153, DOI 10.1016/S0022-3476(50)80019-7; Record RG, 1949, BR J SOC MED, V3, P183; Smith A, 1955, BRIT J PREV SOC MED, V9, P51; SPENCE J, 1950, BRIT MED J, V2, P920, DOI 10.1136/bmj.2.4685.920; WAKELEY CPG, 1938, BRIT J CHILD DIS, V35, P241; WANSBROUGH RM, 1952, CAN MED ASSOC J, V67, P307	16	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	4					430	438						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA213	13275464				2022-12-18	WOS:A1955WA21300007
J	GOWEN, JW				GOWEN, JW			HUMORAL AND CELLULAR ELEMENTS IN NATURAL AND ACQUIRED RESISTANCE TO TYPHOID	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Brownlee J, 1912, P R SOC EDINB, V31, P262, DOI [10.1017/S0370164600025116, DOI 10.1017/S0370164600025116]; Brownlee J, 1906, P R SOC EDINB, V26, P484, DOI 10.1017/S037016460002472X; FROST WH, 1941, EPIDEMIOLOGY, P493; GOWEN JW, 1945, J INFECT DIS, V77, P85, DOI 10.1093/infdis/77.2.85; Gowen JW, 1933, AM J HYG, V18, P688, DOI 10.1093/oxfordjournals.aje.a117973; Gowen JW, 1933, AM J HYG, V18, P674, DOI 10.1093/oxfordjournals.aje.a117972; Gowen JW, 1933, J HYG-CAMBRIDGE, V33, P370, DOI 10.1017/S0022172400018672; GOWEN JW, 1948, ANNU REV MICROBIOL, V2, P215, DOI 10.1146/annurev.mi.02.100148.001243; Gowen JW, 1943, J INFECT DIS, V73, P40, DOI 10.1093/infdis/73.1.40; GOWEN JW, 1951, GENETICS DISEASES RE, V19, P401; GOWEN JW, IN PRESS CHEM BASIS; HALDANE JBS, 1948, PROC R SOC SER B-BIO, V135, P147, DOI 10.1098/rspb.1948.0002; Hetzer HO, 1937, GENETICS, V22, P264; Lincoln RE, 1942, GENETICS, V27, P0441; MURPHY HC, 1948, BREEDING OATS IMPROV; Oakberg Eugene F., 1946, JOUR INFECT DIS, V78, P79, DOI 10.1093/infdis/78.2.79; PLOUGH HH, 1950, J BACTERIOL, V60, P145, DOI 10.1128/JB.60.2.145-157.1950; RICH FA, 1923, VERMONT AGR EXPT STA, V230, P1; ROSS R, 1915, P R SOC LONDON A 2, V93, P212; ROSS R, 1915, P R SOC LOND       A, V92, P204; Schutze H, 1936, J HYG-CAMBRIDGE, V36, P37, DOI 10.1017/S0022172400043400; Soper HE, 1929, J R STAT SOC, V92, P34, DOI 10.2307/2341437; TYZZER EE, 1917, J MED RES, V37, P207; Webster LT, 1933, J EXP MED, V57, P819, DOI 10.1084/jem.57.5.819; WILSON EB, 1945, AM SCI, V33, P246; Zelle MR, 1942, J INFECT DIS, V71, P131, DOI 10.1093/infdis/71.2.131	26	24	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1952	4	4					285	302						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS399	13016541				2022-12-18	WOS:A1952XS39900011
J	Neveling, K; Mantere, T; Vermeulen, S; Oorsprong, M; van Beek, R; Kater-Baats, E; Pauper, M; van der Zande, G; Smeets, D; Weghuis, DO; Stevens-Kroef, MJPL; Hoischen, A				Neveling, Kornelia; Mantere, Tuomo; Vermeulen, Susan; Oorsprong, Michiel; van Beek, Ronald; Kater-Baats, Ellen; Pauper, Marc; van der Zande, Guillaume; Smeets, Dominique; Weghuis, Daniel Olde; Stevens-Kroef, Marian J. P. L.; Hoischen, Alexander			Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRUCTURAL VARIATION DETECTION; TRANSCRIPTOME; GUIDELINES; LEUKEMIA; PROTEIN; PLASMA; GENE; MSI2; DNA	Somatic structural variants (SVs) are important drivers of cancer development and progression. In a diagnostic set-up, especially for hematological malignancies, the comprehensive analysis of all SVs in a given sample still requires a combination of cytogenetic techniques, including karyotyping, FISH, and CNV microarrays. We hypothesize that the combination of these classical approaches could be replaced by optical genome mapping (OGM). Samples from 52 individuals with a clinical diagnosis of a hematological malignancy, divided into simple (<5 aberrations, n = 36) and complex (R5 aberrations, n =16) cases, were processed for OGM, reaching on average: 283-fold genome coverage. OGM called a total of 918 high-confidence SVs per sample, of which, on average, 13 were rare and >100 kb. In addition, on average, 73 CNVs were called per sample, of which six were >5 Mb. For the 36 simple cases, all clinically reported aberrations were detected, including deletions, insertions, inversions, aneuploidies, and translocations. For the 16 complex cases, results were largely concordant between standard-of-care and OGM, but OGM often revealed higher complexity than previously recognized. Detailed technical comparison with standard-of-care tests showed high analytical validity of OGM, resulting in a sensitivity of 100% and a positive predictive value of >80%. Importantly, OGM resulted in a more complete assessment than any previous single test and most likely reported the most accurate underlying genomic architecture (e.g., for complex translocations, chromoanagenesis, and marker chromosomes). In conclusion, the excellent concordance of OGM with diagnostic standard assays demonstrates its potential to replace classical cytogenetic tests as well as to rapidly map novel leukemia drivers.	[Neveling, Kornelia; Mantere, Tuomo; Vermeulen, Susan; Oorsprong, Michiel; van Beek, Ronald; Kater-Baats, Ellen; Pauper, Marc; van der Zande, Guillaume; Smeets, Dominique; Weghuis, Daniel Olde; Stevens-Kroef, Marian J. P. L.; Hoischen, Alexander] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Neveling, Kornelia] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Nijmegen, Netherlands; [Mantere, Tuomo; Hoischen, Alexander] Radboud Univ Nijmegen, Radboud Inst Med Life Sci, Med Ctr, Nijmegen, Netherlands; [Mantere, Tuomo] Univ Oulu, Canc & Translat Med Res Unit, Lab Canc Genet & Tumor Biol, Oulu, Finland; [Mantere, Tuomo] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Hoischen, Alexander] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6532 GA Nijmegen, Netherlands; [Hoischen, Alexander] Radboud Univ Nijmegen, Radboud Ctr Infect Dis, Med Ctr, NL-6532 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Oulu; University of Oulu; Radboud University Nijmegen; Radboud University Nijmegen	Hoischen, A (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6500 HB Nijmegen, Netherlands.; Hoischen, A (corresponding author), Radboud Univ Nijmegen, Radboud Inst Med Life Sci, Med Ctr, Nijmegen, Netherlands.; Hoischen, A (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6532 GA Nijmegen, Netherlands.; Hoischen, A (corresponding author), Radboud Univ Nijmegen, Radboud Ctr Infect Dis, Med Ctr, NL-6532 GA Nijmegen, Netherlands.	alexander.hoischen@radboudumc.nl	Hoischen, Alexander/AGF-7293-2022; Stevens-Kroef, M.J.P.L./L-4675-2015; Pauper, Marc/AGZ-0438-2022; van Beek, Ronald/AAC-8456-2019; Mantere, Tuomo/U-4413-2018	Hoischen, Alexander/0000-0002-8072-4476; Pauper, Marc/0000-0001-6274-9891; van Beek, Ronald/0000-0002-8387-7750; Mantere, Tuomo/0000-0003-3284-4403	Department of Human Genetics; European Union [779257]; Dutch X-omics Initiative by NWO [184.034.019]; Sigrid Juselius Foundation	Department of Human Genetics; European Union(European Commission); Dutch X-omics Initiative by NWO; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	We are thankful to the Department of Human Genetics (especially Helger Yntema, Lisenka Vissers, Marjolijn Ligtenberg, Marcel Nelen, and Han Brunner) for providing support and critical feedback. We are grateful to the Radboud UMC Genome Technology Center for infrastructural and computational support. We would like to acknowledge support from scientists and staff at Bionano Genomics, including Alex Hastie, Andy Pang, Lucia Muraro, Kees-Jan Francoijs, Sven Bocklandt, Yannick Delpu, Mark Oldakowski, Ernest Lam, Thomas Anantharaman, Scott Way, Henry Sadowski, Amy Files, and Carly Proskow. Financial support (to A.H.) was given by the European Union's Horizon 2020 research and innovation program Solve-RD (grant agreement 779257) and the Dutch X-omics Initiative, which is partly funded by NWO (184.034.019). T.M. was supported by the Sigrid Juselius Foundation.	Barbouti A, 2003, CANCER RES, V63, P1202; Barseghyan H, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0479-0; Bickhart DM, 2017, NAT GENET, V49, P643, DOI 10.1038/ng.3802; Bionano Genomics, 2019, 30321 BION GEN; Bionano Genomics, 2019, 30210 BION GEN; Bionano Genomics, 2021, BIOAN SOLV THEOR OP; Bocklandt S, 2019, ADV EXP MED BIOL, V1129, P97, DOI 10.1007/978-981-13-6037-4_7; Brockschmidt A, 2012, BRAIN, V135, P1027, DOI 10.1093/brain/aws045; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Chan S, 2018, METHODS MOL BIOL, V1833, P193, DOI 10.1007/978-1-4939-8666-8_16; De Coster W, 2019, GENOME RES, V29, P1178, DOI 10.1101/gr.244939.118; Duncavage EJ, 2021, NEW ENGL J MED, V384, P924, DOI 10.1056/NEJMoa2024534; Ebert P, 2021, SCIENCE, V372, P48, DOI 10.1126/science.abf7117; Engels H, 2003, EUR J HUM GENET, V11, P643, DOI 10.1038/sj.ejhg.5201028; Gao QS, 2018, CELL REP, V23, P227, DOI 10.1016/j.celrep.2018.03.050; Goldrich DY, 2021, J PERS MED, V11, DOI 10.3390/jpm11020142; Hastie A.R., 2017, RAPID AUTOMATED LARG; Jaratlerdsiri W, 2017, ONCOTARGET, V8, P23588, DOI 10.18632/oncotarget.15802; Jiao YP, 2017, NATURE, V546, P524, DOI 10.1038/nature22971; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Levy-Sakin M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08992-7; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 2016, ANN NY ACAD SCI, V1376, P14, DOI 10.1111/nyas.13163; Luebeck J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18099-z; Mak ACY, 2016, GENETICS, V202, P351, DOI 10.1534/genetics.115.183483; Mantere T., 2020, NEXT GENERATION CYTO, DOI [10.1101/2020. 07.15.20524, DOI 10.1101/2020.07.15.20524]; Mardis ER, 2014, SEMIN HEMATOL, V51, P250, DOI 10.1053/j.seminhematol.2014.08.003; Martin-Subero J, 2007, LEUKEMIA, V21, P1532, DOI 10.1038/sj.leu.2404695; Merker JD, 2018, GENET MED, V20, P159, DOI 10.1038/gim.2017.86; Mikhail FM, 2016, GENET MED, V18, P635, DOI 10.1038/gim.2016.50; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Pellestor F, 2022, SEMIN CELL DEV BIOL, V123, P90, DOI 10.1016/j.semcdb.2021.01.004; Qian MX, 2017, GENOME RES, V27, P185, DOI 10.1101/gr.209163.116; Rack KA, 2019, LEUKEMIA, V33, P1851, DOI 10.1038/s41375-019-0378-z; Sarsani VK, 2019, G3-GENES GENOM GENET, V9, P1795, DOI 10.1534/g3.119.400071; Schoumans J, 2016, GENE CHROMOSOME CANC, V55, P480, DOI 10.1002/gcc.22350; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Sedlazeck FJ, 2018, NAT METHODS, V15, P461, DOI 10.1038/s41592-018-0001-7; Seo JS, 2016, NATURE, V538, P243, DOI 10.1038/nature20098; Shi LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12065; Stancu MC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01343-4; Vissers LELM, 2017, GENET MED, V19, P1055, DOI 10.1038/gim.2017.1; Xu XJ, 2018, CANCER GENET-NY, V228, P218, DOI 10.1016/j.cancergen.2018.07.005; Zhao HZ, 2016, NEOPLASMA, V63, P150, DOI 10.4149/neo_2016_018; Zook J.M., 2019, NAT BIOTECHNOL, V38, P1347	47	23	23	3	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 5	2021	108	8					1423	1435		10.1016/j.ajhg.2021.06.001	http://dx.doi.org/10.1016/j.ajhg.2021.06.001		AUG 2021	13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TW6OO	34237281	Bronze, Green Published			2022-12-18	WOS:000682516900006
J	Stern, AJ; Speidel, L; Zaitlen, NA; Nielsen, R				Stern, Aaron J.; Speidel, Leo; Zaitlen, Noah A.; Nielsen, Rasmus			Disentangling selection on genetically correlated polygenic traits via whole-genome genealogies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX TRAITS; ADAPTATION; HEMOGLOBIN; DISEASES; HEIGHT; HAIR	We present a full-likelihood method to infer polygenic adaptation from DNA sequence variation and GWAS summary statistics to quantify recent transient directional selection acting on a complex trait. Through simulations of polygenic trait architecture evolution and GWASs, we show the method substantially improves power over current methods. We examine the robustness of the method under stratification, uncertainty and bias in marginal effects, uncertainty in the causal SNPs, allelic heterogeneity, negative selection, and low GWAS sample size. The method can quantify selection acting on correlated traits, controlling for pleiotropy even among traits with strong genetic correlation (vertical bar r(g)vertical bar = 80%) while retaining high power to attribute selection to the causal trait. When the causal trait is excluded from analysis, selection is attributed to its closest proxy. We discuss limitations of the method, cautioning against strongly causal interpretations of the results, and the possibility of undetectable gene-by-environment (GxE) interactions. We apply the method to 56 human polygenic traits, revealing signals of directional selection on pigmentation, life history, glycated hemoglobin (HbA1c), and other traits. We also conduct joint testing of 137 pairs of genetically correlated traits, revealing widespread correlated response acting on these traits (2.6-fold enrichment, p = 1.5 x 10(-7)). Signs of selection on some traits previously reported as adaptive (e.g., educational attainment and hair color) are largely attributable to correlated response (p = 2.9 x 10(-6) and 1.7 x 10(-4), respectively). Lastly, our joint test shows antagonistic selection has increased type 2 diabetes risk and decrease HbA1c (p = 1.5 x 10(-5)).	[Stern, Aaron J.] Univ Calif Berkeley, Grad Grp Computat Biol, Berkeley, CA 94703 USA; [Speidel, Leo] Univ Oxford, Dept Stat, Oxford, England; [Zaitlen, Noah A.] UC Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94703 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94703 USA	University of California System; University of California Berkeley; University of Oxford; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Stern, AJ (corresponding author), Univ Calif Berkeley, Grad Grp Computat Biol, Berkeley, CA 94703 USA.	ajstern@berkeley.edu			NIH [R01GM138634, R56MD013312, R01HG006399, R01CA227237, R01CA227466, R01ES029929, R01MH122688, U01HG009080]; Chan Zuckerberg Initiative; DoD [W81XWH-16-2-0018]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chan Zuckerberg Initiative; DoD(United States Department of Defense)	We thank our anonymous reviewers, Doc Edge, Sasha Gusev, and Arbel Harpak for insightful comments and suggestions that have strengthened the manuscript and Jeremy Berg, Jennifer Blanc, Yun Deng, Arun Durvasula, Daniel Geschwind, Iain Mathieson, Priya Moorjani, Maxim Rabinovich, Monty Slatkin, and Lawrence Uricchio for helpful discussions. R.N. was supported by an NIH grant (R01GM138634). N.A.Z. was funded by NIH grants (R56MD013312, R01HG006399, R01CA227237, R01CA227466, R01ES029929, R01MH122688, and U01HG009080), the Chan Zuckerberg Initiative, and a DoD grant (W81XWH-16-2-0018).	Berg JJ, 2019, ELIFE, V8, DOI 10.7554/eLife.39725; Berg JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004412; Berg JJ, 2017, BIORXIV, DOI [10.1101/167551, DOI 10.1101/167551]; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; Bower JK, 2012, DIABETES CARE, V35, P1031, DOI 10.2337/dc11-2248; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cheesman R, 2020, PSYCHOL SCI, V31, P582, DOI 10.1177/0956797620904450; Chevin LM, 2008, GENETICS, V180, P301, DOI 10.1534/genetics.108.089706; Churchhouse C., 2017, RAPID GWAS OF 1000 O; Dahl A, 2020, AM J HUM GENET, V106, P71, DOI 10.1016/j.ajhg.2019.11.015; Edge MD, 2019, GENETICS, V211, P235, DOI 10.1534/genetics.118.301687; Field Y, 2016, SCIENCE, V354, P760, DOI 10.1126/science.aag0776; Frost P, 2006, EVOL HUM BEHAV, V27, P85, DOI 10.1016/j.evolhumbehav.2005.07.002; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Haller BC, 2019, MOL BIOL EVOL, V36, P632, DOI 10.1093/molbev/msy228; Hayward L.K., 2019, POLYGENIC ADAPTATION, DOI 10.1101/792952; Hujoel MLA, 2020, NAT GENET, V52, P541, DOI 10.1038/s41588-020-0613-6; JENSEN AR, 1969, HARVARD EDUC REV, V39, P1; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; LEWONTIN RC, 1970, SCI PUBLIC AFF, V26, P2; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Lyons TJ, 2012, TRANSL RES, V159, P303, DOI 10.1016/j.trsl.2012.01.009; Mostafavi H, 2020, ELIFE, V9, DOI 10.7554/eLife.48376; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Connor LJ, 2019, AM J HUM GENET, V105, P456, DOI 10.1016/j.ajhg.2019.07.003; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Racimo F, 2018, GENETICS, V208, P1565, DOI 10.1534/genetics.117.300489; Rasmussen MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004342; Robinson MR, 2015, NAT GENET, V47, P1357, DOI 10.1038/ng.3401; Sanjak JS, 2018, P NATL ACAD SCI USA, V115, P151, DOI 10.1073/pnas.1707227114; Schoech AP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08424-6; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Simons YB, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2002985; Sinnott-Armstrong N, 2019, GENETICS 38 BLOOD UR, V2019, DOI [10.1101/660506, DOI 10.1101/660506]; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Sohail M, 2019, ELIFE, V8, DOI 10.7554/eLife.39702; Speidel Leo, 2019, Nat Genet, V51, P1321, DOI 10.1038/s41588-019-0484-x; Stern AJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008384; STERN AJ, 2019, HDB STAT GENOMICS, P397; Thornton KR, 2019, GENETICS, V213, P1513, DOI 10.1534/genetics.119.302662; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Uricchio LH, 2019, EVOL LETT, V3, P69, DOI 10.1002/evl3.97; Walsh B., 2018, EVOLUTION AND SELECT; Watanabe K, 2019, NAT GENET, V51, P1339, DOI 10.1038/s41588-019-0481-0; Wilde S, 2014, P NATL ACAD SCI USA, V111, P4832, DOI 10.1073/pnas.1316513111; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Yang ZH, 2018, MOL BIOL EVOL, V35, P2272, DOI 10.1093/molbev/msy136; Young AI, 2018, NAT GENET, V50, P1304, DOI 10.1038/s41588-018-0178-9; Zeng J, 2018, NAT GENET, V50, P746, DOI 10.1038/s41588-018-0101-4	54	23	22	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2021	108	2					219	239		10.1016/j.ajhg.2020.12.005	http://dx.doi.org/10.1016/j.ajhg.2020.12.005		FEB 2021	21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX1UZ	33440170	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000629135400004
J	Amendola, LM; Muenzen, K; Biesecker, LG; Bowling, KM; Cooper, GM; Dorschner, MO; Driscoll, C; Foreman, AKM; Golden-Grant, K; Greally, JM; Hindorff, L; Kanavy, D; Jobanputra, V; Johnston, JJ; Kenny, EE; McNulty, S; Murali, P; Ou, J; Powell, BC; Rehm, HL; Rolf, B; Roman, TS; Van Ziffle, J; Guha, S; Abhyankar, A; Crosslin, D; Venner, E; Yuan, B; Zouk, H; Jarvik, GP				Amendola, Laura M.; Muenzen, Kathleen; Biesecker, Leslie G.; Bowling, Kevin M.; Cooper, Greg M.; Dorschner, Michael O.; Driscoll, Catherine; Foreman, Ann Katherine M.; Golden-Grant, Katie; Greally, John M.; Hindorff, Lucia; Kanavy, Dona; Jobanputra, Vaidehi; Johnston, Jennifer J.; Kenny, Eimear E.; McNulty, Shannon; Murali, Priyanka; Ou, Jeffrey; Powell, Bradford C.; Rehm, Heidi L.; Rolf, Bradley; Roman, Tamara S.; Van Ziffle, Jessica; Guha, Saurav; Abhyankar, Avinash; Crosslin, David; Venner, Eric; Yuan, Bo; Zouk, Hana; Jarvik, Gail P.		CSER Sequencing Diagnost Yield Wor	Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLINICAL LABORATORIES; INCIDENTAL FINDINGS; MEDICAL GENETICS; AMERICAN-COLLEGE; RECOMMENDATIONS; SPECIFICATION; EXOME	Harmonization of variant pathogenicity classification across laboratories is important for advancing clinical genomics. The two CLIA-accredited Electronic Medical Record and Genomics Network sequencing centers and the six CLIA-accredited laboratories and one research laboratory performing genome or exome sequencing in the Clinical Sequencing Evidence-Generating Research Consortium collaborated to explore current sources of discordance in classification. Eight laboratories each submitted 20 classified variants in the ACMG secondary finding v.2.0 genes. After removing duplicates, each of the 158 variants was annotated and independently classified by two additional laboratories using the ACMG-AMP guidelines. Overall concordance across three laboratories was assessed and discordant variants were reviewed via teleconference and email. The submitted variant set included 28 P/LP variants, 96 VUS, and 34 LB/B variants, mostly in cancer (40%) and cardiac (27%) risk genes. Eighty-six (54%) variants reached complete five-category (i.e., P, LP, VUS, LB, B) concordance, and 17 (11%) had a discordance that could affect clinical recommendations (P/LP versus VUS/LB/B). 21% and 63% of variants submitted as P and LP, respectively, were discordant with VUS. Of the 54 originally discordant variants that underwent further review, 32 reached agreement, for a post-review concordance rate of 84% (118/140 variants). This project provides an updated estimate of variant concordance, identifies considerations for LP classified variants, and highlights ongoing sources of discordance. Continued and increased sharing of variant classifications and evidence across laboratories, and the ongoing work of ClinGen to provide general as well as gene- and disease-specific guidance, will lead to continued increases in concordance.	[Amendola, Laura M.; Dorschner, Michael O.; Golden-Grant, Katie; Murali, Priyanka; Ou, Jeffrey; Rolf, Bradley; Jarvik, Gail P.] Univ Washington, Dept Med, Div Med Genet, Med Ctr, Seattle, WA 98195 USA; [Muenzen, Kathleen; Crosslin, David] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Biesecker, Leslie G.; Driscoll, Catherine; Johnston, Jennifer J.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Bowling, Kevin M.; Cooper, Greg M.] Hudson Alpha Inst Biotechnol, Huntsville, AL 35806 USA; [Foreman, Ann Katherine M.; Kanavy, Dona; McNulty, Shannon; Powell, Bradford C.; Roman, Tamara S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Greally, John M.] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Hindorff, Lucia] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Jobanputra, Vaidehi; Guha, Saurav; Abhyankar, Avinash] New York Genome Ctr, New York, NY 10013 USA; [Jobanputra, Vaidehi] Columbia Univ, Med Ctr, New York, NY 10032 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Inst Genom Hlth, New York, NY 10029 USA; [Rehm, Heidi L.] Massachusetts Gen Hosp, Boston, MA 02142 USA; [Rehm, Heidi L.] Broad Inst MIT & Harvard, Boston, MA 02142 USA; [Van Ziffle, Jessica] Univ Calif San Francisco, Inst Human Genet, Dept Pathol, San Francisco, CA 94143 USA; [Venner, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; [Yuan, Bo] Baylor Coll Med, Dept Mol & Human Genet, Baylor Genet, Houston, TX 77030 USA; [Zouk, Hana] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02139 USA; [Zouk, Hana] Partners HealthCare Personalized Med, Lab Mol Med, Boston, MA 02139 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of North Carolina; University of North Carolina Chapel Hill; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Columbia University; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Francisco; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Partners Healthcare System	Amendola, LM (corresponding author), Univ Washington, Dept Med, Div Med Genet, Med Ctr, Seattle, WA 98195 USA.	lauraa7@uw.edu	guha, saurav/C-8246-2011	guha, saurav/0000-0002-0620-5408; Ferar, Kathleen/0000-0002-0840-614X; McNulty, Shannon/0000-0002-0566-4629	National Human Genome Research Institute (NHGRI); National Institute on Minority Health and Health Disparities (NIMHD); National Cancer Institute (NCI);  [U01HG007292];  [U01HG007301];  [U01HG009599];  [U01HG009610];  [U01HG006487];  [U01HG006485];  [U24HG007307];  [U01HG008676];  [U41HG006834];  [Z1AHG200359];  [Z1AHG200387]	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; ; ; ; ; ; ; 	The CSER consortium is funded by the National Human Genome Research Institute (NHGRI) with co-funding from the National Institute on Minority Health and Health Disparities (NIMHD) and the National Cancer Institute (NCI). This work was funded by the following grants: U01HG007292, U01HG007301, U01HG009599, U01HG009610, U01HG006487, U01HG006485, U24HG007307, U01HG008676, U41HG006834, Z1AHG200359, and Z1AHG200387. Sequencing for the ClinSeq A2 cohort was performed at the NIH Intramural Sequencing Center.	Abou Tayoun AN, 2018, HUM MUTAT, V39, P1517, DOI 10.1002/humu.23626; Ackerman Sara L, 2018, AJOB Empir Bioeth, V9, P48, DOI 10.1080/23294515.2017.1405095; Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Biesecker LG, 2018, GENET MED, V20, P1687, DOI 10.1038/gim.2018.42; Bland A, 2018, GENET MED, V20, P369, DOI 10.1038/gim.2017.212; Brnich SE, 2019, GENOME MED, V12, DOI 10.1186/s13073-019-0690-2; Elmore JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI 10.1001/jama.2015.1405; Furqan A, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001700; Garber KB, 2016, AM J HUM GENET, V99, P1140, DOI 10.1016/j.ajhg.2016.09.015; Gelb BD, 2018, GENET MED, V20, P1334, DOI 10.1038/gim.2018.3; Ghosh R, 2018, HUM MUTAT, V39, P1525, DOI 10.1002/humu.23642; Gordon AS, 2020, GENET MED, V22, P1470, DOI 10.1038/s41436-020-0810-9; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harrison SM, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0688-9; Harrison SM, 2018, HUM MUTAT, V39, P1641, DOI 10.1002/humu.23643; Harrison SM, 2017, GENET MED, V19, P1096, DOI 10.1038/gim.2017.14; Herzog R, 2017, SPINE J, V17, P554, DOI 10.1016/j.spinee.2016.11.009; Jarvik GP, 2016, AM J HUM GENET, V98, P1077, DOI 10.1016/j.ajhg.2016.04.003; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Kelly MA, 2018, GENET MED, V20, P351, DOI 10.1038/gim.2017.218; Lee K, 2018, HUM MUTAT, V39, P1553, DOI 10.1002/humu.23650; Lincoln SE, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.16.00020; Luo X, 2019, BLOOD ADV, V3, P2962, DOI 10.1182/bloodadvances.2019000644; Mester JL, 2018, HUM MUTAT, V39, P1581, DOI 10.1002/humu.23636; Murray J, 2019, NEW ENGL J MED, V381, P1884, DOI 10.1056/NEJMc1912496; Niehaus A, 2019, GENET MED, V21, P1699, DOI 10.1038/s41436-018-0432-7; Nykamp K, 2017, GENET MED, V19, P1105, DOI 10.1038/gim.2017.37; Olfson E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135193; Oza AM, 2018, HUM MUTAT, V39, P1593, DOI 10.1002/humu.23630; Rehm HL, 2017, GENET MED, V19, P1092, DOI 10.1038/gim.2017.90; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rivera-Munoz EA, 2018, HUM MUTAT, V39, P1614, DOI 10.1002/humu.23645; Schwartz MLB, 2018, AM J HUM GENET, V103, P328, DOI 10.1016/j.ajhg.2018.07.009; SoRelle JA, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3812; Tavtigian SV, 2018, GENET MED, V20, P1054, DOI 10.1038/gim.2017.210; Wain KE, 2020, GENET MED, V22, P785, DOI 10.1038/s41436-019-0705-9; Walsh R, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0616-z; Yang S, 2017, GENET MED, V19, P1118, DOI 10.1038/gim.2017.60; Zastrow DB, 2018, HUM MUTAT, V39, P1569, DOI 10.1002/humu.23649; Zouk H, 2019, AM J HUM GENET, V105, P588, DOI 10.1016/j.ajhg.2019.07.018	42	23	23	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2020	107	5					932	941		10.1016/j.ajhg.2020.09.011	http://dx.doi.org/10.1016/j.ajhg.2020.09.011			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	OP1QL	33108757	Bronze, Green Published			2022-12-18	WOS:000587855200011
J	Dhindsa, RS; Copeland, BR; Mustoe, AM; Goldstein, DB				Dhindsa, Ryan S.; Copeland, Brett R.; Mustoe, Anthony M.; Goldstein, David B.			Natural Selection Shapes Codon Usage in the Human Genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA STABILITY; SYNONYMOUS MUTATIONS; BREAST-CANCER; TRANSLATION EFFICIENCY; DNA-DAMAGE; EXPRESSION; OPTIMALITY; OVARIAN; EVOLUTION; GENES	Synonymous codon usage has been identified as a determinant of translational efficiency and mRNA stability in model organisms and human cell lines. However, whether natural selection shapes human codon content to optimize translation efficiency is unclear. Furthermore, aside from those that affect splicing, synonymous mutations are typically ignored as potential contributors to disease. Using genetic sequencing data from nearly 200,000 individuals, we uncover clear evidence that natural selection optimizes codon content in the human genome. In deriving intolerance metrics to quantify gene-level constraint on synonymous variation, we discover that dosage-sensitive genes, DNA-damage-response genes, and cell-cycle-regulated genes are particularly intolerant to synonymous variation. Notably, we illustrate that reductions in codon optimality in BRCA1 can attenuate its function. Our results reveal that synonymous mutations most likely play an underappreciated role in human variation.	[Dhindsa, Ryan S.; Copeland, Brett R.; Goldstein, David B.] Columbia Univ, Inst Genom Med, Irving Med Ctr, New York, NY 10032 USA; [Dhindsa, Ryan S.] Columbia Univ, Irving Med Ctr, Lntegrated Program Cellular Mol & Biomed Studies, New York, NY 10032 USA; [Mustoe, Anthony M.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Goldstein, David B.] Columbia Univ, Dept Genet & Dev, Irving Med Ctr, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Baylor College of Medicine; Columbia University; NewYork-Presbyterian Hospital	Dhindsa, RS; Goldstein, DB (corresponding author), Columbia Univ, Inst Genom Med, Irving Med Ctr, New York, NY 10032 USA.; Dhindsa, RS (corresponding author), Columbia Univ, Irving Med Ctr, Lntegrated Program Cellular Mol & Biomed Studies, New York, NY 10032 USA.; Goldstein, DB (corresponding author), Columbia Univ, Dept Genet & Dev, Irving Med Ctr, New York, NY 10032 USA.	rsd2135@cumc.columbia.edu; dg2875@cumc.columbia.edu	Dhindsa, Ryan/W-9678-2019; Goldstein, David/AAY-8125-2020	Dhindsa, Ryan/0000-0002-8965-0813; 				Bazzini AA, 2016, EMBO J, V35, P2087, DOI 10.15252/embj.201694699; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Blair JD, 2017, CELL REP, V21, P2005, DOI 10.1016/j.celrep.2017.10.095; Bornelov S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1726-z; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Burow DA, 2018, CELL REP, V24, P1704, DOI 10.1016/j.celrep.2018.07.039; Bustamante CD, 2002, MOL BIOL EVOL, V19, P110, DOI 10.1093/oxfordjournals.molbev.a003975; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Carneiro RL, 2019, NUCLEIC ACIDS RES, V47, P2216, DOI 10.1093/nar/gkz033; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Comeron JM, 2006, P NATL ACAD SCI USA, V103, P6940, DOI 10.1073/pnas.0510638103; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dershem R, 2019, J BIOL CHEM, V294, P18109, DOI 10.1074/jbc.RA119.009253; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; EYREWALKER AC, 1991, J MOL EVOL, V33, P442, DOI 10.1007/BF02103136; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Forrest ME, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228730; Frenkel-Morgenstern M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.3; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Goffena J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03221-z; Goodarzi H, 2016, CELL, V165, P1416, DOI 10.1016/j.cell.2016.05.046; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; Harpak A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006489; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Huang YF, 2019, GENOME RES, V29, P1310, DOI 10.1101/gr.245522.118; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Keightley PD, 2011, GENETICS, V188, P931, DOI 10.1534/genetics.111.128355; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; Lappalainen T, 2019, CELL, V177, P70, DOI 10.1016/j.cell.2019.02.032; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Lawrie DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003527; Machado HE, 2020, GENETICS, V214, P511, DOI 10.1534/genetics.119.302542; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Narula A, 2019, RNA, V25, P1751, DOI 10.1261/rna.073239.119; Pan T, 2018, CELL RES, V28, P395, DOI 10.1038/s41422-018-0013-y; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Petrovski S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005492; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Pouyet F, 2017, ELIFE, V6, DOI 10.7554/eLife.27344; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Radhakrishnan A, 2016, CELL, V167, P122, DOI 10.1016/j.cell.2016.08.053; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rudolph KLM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006024; Saikia M, 2016, RNA, V22, P1719, DOI 10.1261/rna.058180.116; Savisaar R, 2018, GENOME RES, V28, P1442, DOI 10.1101/gr.233999.117; Semon M, 2006, MOL BIOL EVOL, V23, P523, DOI 10.1093/molbev/msj053; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Smit AFA, 2013, REPEATMASKER OPEN 4; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Tahmasebi S, 2018, NAT REV MOL CELL BIO, V19, P791, DOI 10.1038/s41580-018-0034-x; Taliun D., 2019, GENOMICS, DOI [10.1101/563866, DOI 10.1101/563866., DOI 10.1101/563866]; Torrent M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat6409; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wang XC, 2019, ELIFE, V8, DOI 10.7554/eLife.42265; Wickham H, 2016, GGPLOT2 ELEGANT GRAP; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Zhou Y, 2009, BIOCHEM BIOPH RES CO, V385, P160, DOI 10.1016/j.bbrc.2009.05.031; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191	83	23	23	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2020	107	1					83	95		10.1016/j.ajhg.2020.05.011	http://dx.doi.org/10.1016/j.ajhg.2020.05.011			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MH4EU	32516569	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000546685300008
J	Kibinge, NK; Relton, CL; Gaunt, TR; Richardson, TG				Kibinge, Nelson K.; Relton, Caroline L.; Gaunt, Tom R.; Richardson, Tom G.			Characterizing the Causal Pathway for Genetic Variants Associated with Neurological Phenotypes Using Human Brain-Derived Proteome Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GWAS; CANALIZATION; MECHANISMS; NETWORKS; SYSTEM; ATLAS	Leveraging high-dimensional molecular datasets can help us develop mechanistic insight into associations between genetic variants and complex traits. In this study, we integrated human proteome data derived from brain tissue to evaluate whether targeted proteins putatively mediate the effects of genetic variants on seven neurological phenotypes (Alzheimer disease, amyotrophic lateral sclerosis, depression, insomnia, intelligence, neuroticism, and schizophrenia). Applying the principles of Mendelian randomization (MR) systematically across the genome highlighted 43 effects between genetically predicted proteins derived from the dorsolateral prefrontal cortex and these outcomes. Furthermore, genetic colocalization provided evidence that the same causal variant at 12 of these loci was responsible for variation in both protein and neurological phenotype. This included genes such as DCC, which encodes the netrin-1 receptor and has an important role in the development of the nervous system (p = 4.29 x 10(-11) with neuroticism), as well as SARM1, which has been previously implicated in axonal degeneration (p = 1.76 x 10(-08) with amyotrophic lateral sclerosis). We additionally conducted a phenome-wide MR study for each of these 12 genes to assess potential pleiotropic effects on 700 complex traits and diseases. Our findings suggest that genes such as SNX32, which was initially associated with increased risk of Alzheimer disease, may potentially influence other complex traits in the opposite direction. In contrast, genes such as CTSH (which was also associated with Alzheimer disease) and SARM1 may make worthwhile therapeutic targets because they did not have genetically predicted effects on any of the other phenotypes after correcting for multiple testing.	[Kibinge, Nelson K.; Relton, Caroline L.; Gaunt, Tom R.; Richardson, Tom G.] Univ Bristol, Bristol Med Sch, Med Res Council MRC Integrat Epidemiol Unit IEU, Populat Hlth Sci, Oakfield House, Bristol BS8 2BN, Avon, England	University of Bristol	Richardson, TG (corresponding author), Univ Bristol, Bristol Med Sch, Med Res Council MRC Integrat Epidemiol Unit IEU, Populat Hlth Sci, Oakfield House, Bristol BS8 2BN, Avon, England.	Tom.G.Richardson@bristol.ac.uk	Gaunt, Tom R/O-3918-2014	Gaunt, Tom R/0000-0003-0924-3247; Relton, Caroline/0000-0003-2052-4840; Kibinge, Nelson/0000-0002-1980-2017; Richardson, Tom/0000-0002-7918-2040	Integrative Epidemiology Unit from the UK Medical Research Council [MC_UU_00011/4, MC_UU_00011/5]; University of Bristol [MC_UU_00011/4, MC_UU_00011/5]; MRC [MR/S003886/1, MC_UU_00011/4, MC_UU_00011/5, MC_UU_12013/2] Funding Source: UKRI	Integrative Epidemiology Unit from the UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank the developers of the brainqtl.org resource, the participants of the ROS and MAP studies, and the GWAS consortia for making their summary statistics available for the benefit of this study. This work was supported by the Integrative Epidemiology Unit, which receives funding from the UK Medical Research Council and the University of Bristol (MC_UU_00011/4 and MC_UU_00011/5). C.L.R and T.R.G conduct research at the National Institute for Health Research (NIHR) Biomedical Research Centre at the University Hospitals Bristol National Health Service (NHS) Foundation Trust and the University of Bristol. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. T.G.R is a UK Research and Innovation (UKRI) Research Fellow (MR/S003886/1). The reference panel used in the study was created using data from the UK Biobank study (app 15825).	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Bowden J, 2019, INT J EPIDEMIOL, V48, P728, DOI 10.1093/ije/dyy258; Bowden J, 2016, INT J EPIDEMIOL, V45, P1961, DOI 10.1093/ije/dyw220; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cannon ME, 2018, AM J HUM GENET, V103, P637, DOI 10.1016/j.ajhg.2018.10.001; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cully M, 2015, NAT REV DRUG DISCOV, V14, P525, DOI 10.1038/nrd4692; Dantuma NP, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00070, 10.3389/fnmol.2014.00070]; De Jager PL, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.142; Emilsson V, 2018, SCIENCE, V361, P769, DOI 10.1126/science.aaq1327; Folkersen L, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006706; Gallagher MD, 2018, AM J HUM GENET, V102, P717, DOI 10.1016/j.ajhg.2018.04.002; Geisler S, 2019, J EXP MED, V216, P294, DOI 10.1084/jem.20181040; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gotoda T, 2015, J ATHEROSCLER THROMB, V22, P442, DOI 10.5551/jat.ED017; Hatcher C, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0437-2; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Howard DM, 2019, NAT NEUROSCI, V22, P343, DOI 10.1038/s41593-018-0326-7; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Jansen PR, 2019, NAT GENET, V51, P394, DOI 10.1038/s41588-018-0333-3; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; King EA, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008489; Li JJ, 2015, CELL SYST, V1, P361, DOI 10.1016/j.cels.2015.11.002; Luciano M, 2018, NAT GENET, V50, P6, DOI 10.1038/s41588-017-0013-8; McGowan LM, 2019, HUM MOL GENET, V28, P3293, DOI 10.1093/hmg/ddz155; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Qi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04558-1; Richardson TG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13921-9; Richardson TG, 2018, HUM MOL GENET, V27, P3293, DOI 10.1093/hmg/ddy210; Robins C, 2019, GENETIC CONTR HUMAN, DOI [10.1101/816652, DOI 10.1101/816652]; Ruderfer DM, 2018, CELL, V173, P1705, DOI 10.1016/j.cell.2018.05.046; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Schaid DJ, 2018, NAT REV GENET, V19, P491, DOI 10.1038/s41576-018-0016-z; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Skene NG, 2018, NAT GENET, V50, P825, DOI 10.1038/s41588-018-0129-5; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Thibaudeau TA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03509-0; Thul PJ, 2018, PROTEIN SCI, V27, P233, DOI 10.1002/pro.3307; Trenkmann M, 2018, NAT REV GENET, V19, P592, DOI 10.1038/s41576-018-0047-5; van Rheenen W, 2016, NAT GENET, V48, P1043, DOI 10.1038/ng.3622; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Vosberg DE, 2020, MOL PSYCHIATR, V25, P297, DOI 10.1038/s41380-019-0561-7; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wald A, 1940, ANN MATH STAT, V11, P284, DOI 10.1214/aoms/1177731868; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang B, 2013, GENOME RES, V23, P1522, DOI 10.1101/gr.156539.113; Zheng J., 2019, PHENOMEWIDE MENDELIA, DOI [10.1101/627398., DOI 10.1101/627398]	53	23	23	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2020	106	6					885	892		10.1016/j.ajhg.2020.04.007	http://dx.doi.org/10.1016/j.ajhg.2020.04.007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LW4IW	32413284	Green Published, hybrid			2022-12-18	WOS:000539109000014
J	Shang, LL; Smith, JA; Zhao, W; Kho, M; Turner, ST; Mosley, TH; Kardia, SLR; Zhou, X				Shang, Lulu; Smith, Jennifer A.; Zhao, Wei; Kho, Minjung; Turner, Stephen T.; Mosley, Thomas H.; Kardia, Sharon L. R.; Zhou, Xiang			Genetic Architecture of Gene Expression in European and African Americans: An eQTL Mapping Study in GENOA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WIDE ASSOCIATION; TRANSCRIPTOME; DATABASES; VARIANTS; DISEASE; POWER; LINK	Most existing expression quantitative trait locus (eQTL) mapping studies have been focused on individuals of European ancestry and are underrepresented in other populations including populations with African ancestry. Lack of large-scale well-powered eQTL mapping studies in populations with African ancestry can both impede the dissemination of eQTL mapping results that would otherwise benefit individuals with African ancestry and hinder the comparable analysis for understanding how gene regulation is shaped through evolution. We fill this critical knowledge gap by performing a large-scale in-depth eQTL mapping study on 1,032 African Americans (AA) and 801 European Americans (EA) in the GENOA cohort. We identified a total of 354,931 eSNPs in AA and 371,309 eSNPs in EA, with 112,316 eSNPs overlapped between the two. We found that eQTL harboring genes (eGenes) are enriched in metabolic pathways and tend to have higher SNP heritability compared to non-eGenes. We found that eGenes that are common in the two populations tend to be less conserved than eGenes that are unique to one population, which are less conserved than non-eGenes. Through conditional analysis, we found that eGenes in AA tend to harbor more independent eQTLs than eGenes in EA, suggesting potentially diverse genetic architecture underlying expression variation in the two populations. Finally, the large sample sizes in GENOA allow us to construct accurate expression prediction models in both AA and EA, facilitating powerful transcriptome-wide association studies. Overall, our results represent an important step toward revealing the genetic architecture underlying expression variation in African Americans.	[Shang, Lulu; Zhou, Xiang] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Smith, Jennifer A.; Zhao, Wei; Kho, Minjung; Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Turner, Stephen T.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Mosley, Thomas H.] Univ Mississippi, Memory Impairment & Neurodegenerat Dementia MIND, Med Ctr, Jackson, MS 39126 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Mayo Clinic; University of Mississippi; University of Mississippi Medical Center	Zhou, X (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA.; Kardia, SLR (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	skardia@umich.edu; xzhousph@umich.edu	Turner, Stephen/GXM-4654-2022	Shang, Lulu/0000-0002-2480-3065; Smith, Jennifer Ann/0000-0002-3575-5468	National Heart, Lung and Blood Institute of the National Institutes of Health [HL054457, HL100185, HL119443, HL133221]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [NS041558]; National Human Genome Research Institutes [R01HG009124]; National Science Foundation [DMS1712933]	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF))	Support for the Genetic Epidemiology Network of Arteriopathy (GENOA) data collection and analysis was provided by the National Heart, Lung and Blood Institute (HL054457, HL100185, HL119443, and HL133221) and the National Institute of Neurological Disorders and Stroke (NS041558) of the National Institutes of Health. This study was also partially supported by the National Human Genome Research Institutes grant R01HG009124 and National Science Foundation grant DMS1712933. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003514; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Aguiar VRC, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008091; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Daniels PR, 2004, AM J MED, V116, P676, DOI 10.1016/j.amjmed.2003.12.032; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dobbyn A, 2018, AM J HUM GENET, V102, P1169, DOI 10.1016/j.ajhg.2018.04.011; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Gershoni M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5438; Glassberg EC, 2019, GENETICS, V211, P757, DOI 10.1534/genetics.118.301833; Gonzalez S, 2016, BIPOLAR DISORD, V18, P520, DOI 10.1111/bdi.12438; Guan YT, 2014, GENETICS, V196, P625, DOI 10.1534/genetics.113.160697; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hao XJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007186; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jansen R, 2017, HUM MOL GENET, V26, P1444, DOI 10.1093/hmg/ddx043; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kelly Derek E, 2017, Curr Opin Syst Biol, V1, P102, DOI 10.1016/j.coisb.2016.12.018; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; LI WH, 1985, MOL BIOL EVOL, V2, P150; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Lockstone HE, 2011, BRIEF BIOINFORM, V12, P634, DOI 10.1093/bib/bbq086; Mikhaylova AV, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00261; Mogil LS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007586; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Peters JE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005908; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Safran M, 2003, NUCLEIC ACIDS RES, V31, P142, DOI 10.1093/nar/gkg050; Saha Ashis, 2018, F1000Res, V7, P1860, DOI 10.12688/f1000research.17145.1; Sanjak JS, 2016, G3-GENES GENOM GENET, V6, P1023, DOI 10.1534/g3.115.026013; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Torres JM, 2014, AM J HUM GENET, V95, P521, DOI 10.1016/j.ajhg.2014.10.001; Tung J, 2015, ELIFE, V4, DOI 10.7554/eLife.04729; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wheeler HE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006423; Zanetti D, 2016, J EPIDEMIOL, V26, P264, DOI 10.2188/jea.JE20150034; Zeng P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00470-2; Zhong YZ, 2019, AM J HUM GENET, V104, P1097, DOI 10.1016/j.ajhg.2019.04.009; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	70	23	23	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2020	106	4					496	512		10.1016/j.ajhg.2020.03.002	http://dx.doi.org/10.1016/j.ajhg.2020.03.002			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KZ5MJ	32220292	Green Published, Bronze			2022-12-18	WOS:000523306000007
J	Wang, XC; Goldstein, DB				Wang, Xinchen; Goldstein, David B.			Enhancer Domains Predict Gene Pathogenicity and Inform Gene Discovery in Complex Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DE-NOVO MUTATIONS; TRANSCRIPTIONAL ENHANCERS; SUSCEPTIBILITY LOCI; SHADOW ENHANCERS; EXPRESSION; ARCHITECTURE; ANNOTATION; IDENTIFICATION; INSIGHTS	Non-coding transcriptional regulatory elements are critical for controlling the spatiotemporal expression of genes. Here, we demonstrate that the sizes and number of enhancers linked to a gene reflect its disease pathogenicity. Moreover, genes with redundant enhancer domains are depleted of cis-acting genetic variants that disrupt gene expression, and they are buffered against the effects of disruptive non-coding mutations. Our results demonstrate that dosage-sensitive genes have evolved a robustness to the disruptive effects of genetic variation by expanding their regulatory domains. This solves a puzzle about why genes associated with human disease are depleted of cis-eQTLs (cis-expression quantitative trait loci), suggesting that this relationship might complicate gene identification in causal genome-wide association studies GWASs) using eQTL information, and establishes a framework for identifying non-coding regulatory variation with phenotypic consequences.	[Wang, Xinchen; Goldstein, David B.] Columbia Univ, Inst Genom Med, Hammer Hlth Sci, Med Ctr, 701 West 168th St, New York, NY 10032 USA; [Goldstein, David B.] Columbia Univ, Dept Genet & Dev, Hammer Hlth Sci, Med Ctr, 701 West 168th St, New York, NY 10032 USA	Columbia University; Columbia University	Wang, XC; Goldstein, DB (corresponding author), Columbia Univ, Inst Genom Med, Hammer Hlth Sci, Med Ctr, 701 West 168th St, New York, NY 10032 USA.; Goldstein, DB (corresponding author), Columbia Univ, Dept Genet & Dev, Hammer Hlth Sci, Med Ctr, 701 West 168th St, New York, NY 10032 USA.	xw2553@cumc.columbia.edu; dg2875@cumc.columbia.edu	Goldstein, David/AAY-8125-2020	Wang, Xinchen/0000-0002-5198-6581	NIH [U01 MH105670]; Biogen	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biogen(Biogen)	We wish to thank Abhishek Sarkar, Hae Kyung Im, and Tuuli Lappalainen for very helpful discussions and Athma Pai, Sarah A. Dugger, Michael Wainberg, Nasa Sinnott-Armstrong, and Andrew S. Allen for helpful comments on the manuscript. This work was supported by funds from the NIH under grant U01 MH105670 and by a genome-sequencing and -analysis grant from Biogen.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Cannavo E, 2016, CURR BIOL, V26, P38, DOI 10.1016/j.cub.2015.11.034; Cao Q, 2017, NAT GENET, V49, P1428, DOI 10.1038/ng.3950; Chun S, 2017, NAT GENET, V49, P600, DOI 10.1038/ng.3795; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Day FR, 2017, NAT GENET, V49, P834, DOI 10.1038/ng.3841; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Deplancke B, 2016, CELL, V166, P538, DOI 10.1016/j.cell.2016.07.012; Dickel DE, 2018, CELL, V172, P491, DOI 10.1016/j.cell.2017.12.017; Eppinga RN, 2016, NAT GENET, V48, P1557, DOI 10.1038/ng.3708; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gheorghe M, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gky1210; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Hait TA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1432-2; Han XW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04552-7; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jung I, 2019, NAT GENET, V51, P1442, DOI 10.1038/s41588-019-0494-8; Knowlest DA, 2018, ELIFE, V7, DOI [10.7554/elife.33480, 10.7554/eLife.33480]; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li X, 2017, NATURE, V550, P239, DOI 10.1038/nature24267; Li ZQ, 2017, NAT GENET, V49, P1576, DOI 10.1038/ng.3973; Liu BX, 2019, NAT GENET, V51, P768, DOI 10.1038/s41588-019-0404-0; Liu YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1308-x; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mancuso N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06302-1; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Natarajan P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05747-8; Ndungu A., MULTITISSUE TRANSCRI, DOI [10.1101/773630, DOI 10.1101/773630]; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nielsen JB, 2018, NAT GENET, V50, P1234, DOI 10.1038/s41588-018-0171-3; Nolte MJ, 2014, EVOL DEV, V16, P207, DOI 10.1111/ede.12084; Osterwalder M, 2018, NATURE, V554, P239, DOI 10.1038/nature25461; Pai AA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004857; Pennacchio LA, 2013, NAT REV GENET, V14, P288, DOI 10.1038/nrg3458; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schwartzentruber J, 2018, NAT GENET, V50, P54, DOI 10.1038/s41588-017-0005-8; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Short PJ, 2018, NATURE, V555, P611, DOI 10.1038/nature25983; Spielmann M, 2012, AM J HUM GENET, V91, P629, DOI 10.1016/j.ajhg.2012.08.014; Stacey D, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gky837; Turner TN, 2017, CELL, V171, P710, DOI 10.1016/j.cell.2017.08.047; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wainberg M, 2019, NAT GENET, V51, P592, DOI 10.1038/s41588-019-0385-z; Wang XC, 2016, ELIFE, V5, DOI 10.7554/eLife.10557; Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Wheeler HE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006423; Whitaker JW, 2015, METHODS, V72, P86, DOI 10.1016/j.ymeth.2014.10.008; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wright CF, 2018, NAT REV GENET, V19, P253, DOI 10.1038/nrg.2017.116; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Zhao W, 2017, NAT GENET, V49, P1450, DOI 10.1038/ng.3943; Zhao XL, 2007, AM J HUM GENET, V80, P361, DOI 10.1086/511387	73	23	23	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2020	106	2					215	233		10.1016/j.ajhg.2020.01.012	http://dx.doi.org/10.1016/j.ajhg.2020.01.012			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK7IW	32032514	Green Submitted, Green Published			2022-12-18	WOS:000512913300007
J	Lores, P; Dacheux, D; Kherraf, ZE; Mbango, JFN; Coutton, C; Stouvenel, L; Ialy-Radio, C; Amiri-Yekta, A; Whitfield, M; Schmitt, A; Cazin, C; Givelet, M; Ferreux, L; Ben Mustapha, SF; Halouani, L; Marrakchi, O; Daneshipour, A; El Khouri, E; Do Cruzeiro, M; Favier, M; Guillonneau, F; Chaudhry, M; Sakheli, Z; Wolf, JP; Patrat, C; Gacon, G; Savinov, SN; Hosseini, SH; Robinson, DR; Zouari, R; Ziyyat, A; Arnoult, C; Dulioust, E; Bonhivers, M; Ray, PF; Toure, A				Lores, Patrick; Dacheux, Denis; Kherraf, Zine-Eddine; Mbango, Jean-Fabrice Nsota; Coutton, Charles; Stouvenel, Laurence; Ialy-Radio, Come; Amiri-Yekta, Amir; Whitfield, Marjorie; Schmitt, Alain; Cazin, Caroline; Givelet, Maelle; Ferreux, Lucile; Ben Mustapha, Selima Fourati; Halouani, Lazhar; Marrakchi, Ouafi; Daneshipour, Abbas; El Khouri, Elma; Do Cruzeiro, Marcio; Favier, Maryline; Guillonneau, Francois; Chaudhry, Marhaba; Sakheli, Zeinab; Wolf, Jean-Philippe; Patrat, Catherine; Gacon, Gerard; Savinov, Sergey N.; Hosseini, Seyedeh Hanieh; Robinson, Derrick R.; Zouari, Raoudha; Ziyyat, Ahmed; Arnoult, Christophe; Dulioust, Emmanuel; Bonhivers, Melanie; Ray, Pierre F.; Toure, Aminata			Mutations in TTC29, Encoding an Evolutionarily Conserved Axonemal Protein, Result in Asthenozoospermia and Male Infertility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE MORPHOLOGICAL ABNORMALITIES; FIBROUS SHEATH; TETRATRICOPEPTIDE-REPEAT; PROTEOMIC ANALYSIS; PARAFLAGELLAR ROD; ADENYLATE KINASE; STRUCTURAL BASIS; SPERM FLAGELLA; CILIA; COMPLEX	In humans, structural or functional defects of the sperm flagellum induce asthenozoospermia, which accounts for the main sperm defect encountered in infertile men. Herein we focused on morphological abnormalities of the sperm flagellum (MMAF), a phenotype also termed "short tails," which constitutes one of the most severe sperm morphological defects resulting in asthenozoospermia. In previous work based on whole-exome sequencing of a cohort of 167 MMAF-affected individuals, we identified bi-allelic loss-of-function mutations in more than 30% of the tested subjects. In this study, we further analyzed this cohort and identified five individuals with homozygous truncating variants in TTC29, a gene preferentially and highly expressed in the testis, and encoding a tetratricopeptide repeat-containing protein related to the intraflagellar transport (IFT). One individual carried a frameshift variant, another one carried a homozygous stop-gain variant, and three carried the same splicing variant affecting a consensus donor site. The deleterious effect of this last variant was confirmed on the corresponding transcript and protein product. In addition, we produced and analyzed TTC29 loss-of-function models in the flagellated protist T. brucei and in M. musculus. Both models confirmed the importance of TTC29 for flagellar beating. We showed that in T. brucei the TPR structural motifs, highly conserved between the studied orthologs, are critical for TTC29 axonemal localization and flagellar beating. Overall our work demonstrates that TTC29 is a conserved axonemal protein required for flagellar structure and beating and that 11 C29 mutations are a cause of male sterility due to MMAF.	[Lores, Patrick; Mbango, Jean-Fabrice Nsota; Stouvenel, Laurence; Ialy-Radio, Come; Whitfield, Marjorie; Schmitt, Alain; Givelet, Maelle; El Khouri, Elma; Do Cruzeiro, Marcio; Favier, Maryline; Guillonneau, Francois; Chaudhry, Marhaba; Sakheli, Zeinab; Wolf, Jean-Philippe; Patrat, Catherine; Gacon, Gerard; Ziyyat, Ahmed; Dulioust, Emmanuel; Toure, Aminata] INSERM, Inst Cochin, U1016, F-75014 Paris, France; [Lores, Patrick; Mbango, Jean-Fabrice Nsota; Stouvenel, Laurence; Ialy-Radio, Come; Whitfield, Marjorie; Schmitt, Alain; Givelet, Maelle; El Khouri, Elma; Do Cruzeiro, Marcio; Favier, Maryline; Guillonneau, Francois; Chaudhry, Marhaba; Sakheli, Zeinab; Gacon, Gerard; Ziyyat, Ahmed; Toure, Aminata] CNRS, UMR8104, F-75014 Paris, France; [Lores, Patrick; Mbango, Jean-Fabrice Nsota; Stouvenel, Laurence; Ialy-Radio, Come; Whitfield, Marjorie; Schmitt, Alain; Givelet, Maelle; El Khouri, Elma; Do Cruzeiro, Marcio; Favier, Maryline; Guillonneau, Francois; Chaudhry, Marhaba; Sakheli, Zeinab; Wolf, Jean-Philippe; Patrat, Catherine; Ziyyat, Ahmed; Dulioust, Emmanuel; Toure, Aminata] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75014 Paris, France; [Dacheux, Denis; Robinson, Derrick R.; Bonhivers, Melanie] Univ Bordeaux, Microbiol Fondamentale & Pathogen, CNRS, UMR 5234, Bordeaux, France; [Dacheux, Denis] CNRS, Microbiol Fondamentale & Pathogen, Inst Polytech Bordeaux, UMR 5234, F-33000 Bordeaux, France; [Kherraf, Zine-Eddine; Coutton, Charles; Cazin, Caroline; Arnoult, Christophe; Ray, Pierre F.] Univ Grenoble Alpes, CNRS, INSERM, U1209,UMR 5309, F-38000 Grenoble, France; [Kherraf, Zine-Eddine; Ray, Pierre F.] CHU Grenoble, UM GI DPI, F-38000 Grenoble, France; [Coutton, Charles] CHU Grenoble Alpes, UM Genet Chromosom, Grenoble, France; [Amiri-Yekta, Amir; Daneshipour, Abbas] ACECR, Royan Inst Reprod Biomed, Reprod Biomed Res Ctr, Dept Genet, Tehran, Iran; [Ferreux, Lucile; Wolf, Jean-Philippe; Patrat, Catherine; Ziyyat, Ahmed; Dulioust, Emmanuel] CECOS Grp Hosp, AP HP, Univ Paris Ctr, Lab Histol Embryol Biol Reprod, F-75014 Paris, France; [Ben Mustapha, Selima Fourati; Halouani, Lazhar; Marrakchi, Ouafi; Zouari, Raoudha] Polyclin Jasmins, Ctr Promot Sci Reprod, Histol Embryol & Biol Reprod, Ctr Urbain Nord, Tunis 1003, Tunisia; [Savinov, Sergey N.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Hosseini, Seyedeh Hanieh] ACECR, Royan Inst Reprod Biomed, Reprod Biomed Res Ctr, Dept Androl, Tehran, Iran	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Academic Center for Education, Culture & Research (ACECR); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; University of Massachusetts System; University of Massachusetts Amherst; Academic Center for Education, Culture & Research (ACECR)	Toure, A (corresponding author), INSERM, Inst Cochin, U1016, F-75014 Paris, France.; Toure, A (corresponding author), CNRS, UMR8104, F-75014 Paris, France.; Toure, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75014 Paris, France.	aminata.toure@inserm.fr	TOURE, Aminata/B-3236-2018; KHERRAF, Zine-Eddine/F-1585-2019; Ray, Pierre F/D-7315-2019; ZIYYAT, Ahmed/ABB-1861-2021; Dacheux, Denis/AGF-5359-2022; El Khouri, Elma/GRN-8601-2022; Amiri-Yekta, Amir/AAF-1062-2020; WHITFIELD, Marjorie/ABH-3433-2021	TOURE, Aminata/0000-0001-5629-849X; KHERRAF, Zine-Eddine/0000-0003-0351-6689; Ray, Pierre F/0000-0003-1544-7449; ZIYYAT, Ahmed/0000-0001-9724-3831; WHITFIELD, Marjorie/0000-0001-7956-3436; FOURATI BEN MUSTAPHA, Selima/0000-0002-0107-6440; Amiri-Yekta, Amir/0000-0002-8099-7984; Lores, Patrick/0000-0002-3191-9488; CAZIN, Caroline/0000-0001-8962-3447; DACHEUX, Denis/0000-0002-9956-4839; Guillonneau, Francois/0000-0003-1484-4696	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Universite Paris Descartes; University of Bordeaux; French National Research Agency [MUCOFERTIL ANR-12-BSV1-0011-01, MASFLAGELLA ANR-14-CE15-0002-03]; LabEx ParaFrap [ANR-11-LABX-0024]; FEDER (2007-2013 Operational Programme for Competitiveness Factors and employment); Canceropole Ile de France	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; University of Bordeaux; French National Research Agency(French National Research Agency (ANR)); LabEx ParaFrap; FEDER (2007-2013 Operational Programme for Competitiveness Factors and employment); Canceropole Ile de France(Region Ile-de-France)	We thank all the individuals and their families for their cooperation, as well as all the referring physicians. We thank all the technicians from the Service de Biologie de la Reproduction at the Ho<^> pital Cochin (Paris) for routine semen sample evaluation (Jacques Bras, Nathalie Cheriau, Veronique Hernandorena, Jean-Claude Cambronne, and Caroline Villalon). We thank the core facilities of the Institut Cochin: Transgenesis-Homologous recombination-Cryosconservation, Cellular Imaging Facility for electron microscopy procedures, histology facility HistIM (Rachel Onifarasoaniaina) together with the 3P5 proteomic facility of the University Paris Descartes (Virginie Salnot, Cedric Broussard, and Evangeline Bennana). We thank Keith Gull for the L8C4 antibody (Oxford University), Klaus Ersfeld (Bayreuth University) for the anti-myc antibody (9E10), Nicolas Biteau (Bordeaux University) for the anti-PFR2 antibody, Frederic Bringaud (Bordeaux University) for the anti-enolase and anti-FTZC, Philippe Bastin (Institut Pasteur, Paris) for the BB2 antibody, and Samuel Dean (Oxford University) for the pPOT vectors. This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), the Universite Paris Descartes, the University of Bordeaux, the French National Research Agency (grant MUCOFERTIL ANR-12-BSV1-0011-01 to A.T. and M.B., grant MASFLAGELLA ANR-14-CE15-0002-03 to P.F.R., A.T., and M.B.), the LabEx ParaFrap (ANR-11-LABX-0024 to D.R.R.), the FEDER (2007-2013 Operational Programme for Competitiveness Factors and employment to F.G.), and the Canceropole Ile de France (funding to F.G.).	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Auger J, 2016, HUM REPROD, V31, P10, DOI 10.1093/humrep/dev251; Auguste Y, 2018, AM J HUM GENET, V103, P413, DOI 10.1016/j.ajhg.2018.07.013; Baker N, 2011, MOL BIOCHEM PARASIT, V176, P55, DOI 10.1016/j.molbiopara.2010.11.010; Bastin P, 1999, J CELL SCI, V112, P3769; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Beneke T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007828; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Blackburn K, 2017, J PROTEOME RES, V16, P1579, DOI 10.1021/acs.jproteome.6b00972; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; CHEMES HE, 1987, FERTIL STERIL, V48, P664; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Chung MI, 2014, ELIFE, V3, DOI 10.7554/eLife.01439; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Costantini S, 2006, BIOCHEM BIOPH RES CO, V342, P441, DOI 10.1016/j.bbrc.2006.01.159; Coutton C, 2019, AM J HUM GENET, V104, P331, DOI 10.1016/j.ajhg.2018.12.013; Coutton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02792-7; Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Darde TA, 2019, BIOINFORMATICS, V35, P3133, DOI 10.1093/bioinformatics/btz047; Darde TA, 2015, NUCLEIC ACIDS RES, V43, pW109, DOI 10.1093/nar/gkv345; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; DESOUZA W, 1980, J PARASITOL, V66, P229, DOI 10.2307/3280809; Dong FN, 2018, AM J HUM GENET, V102, P636, DOI 10.1016/j.ajhg.2018.03.007; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Escalier D, 2006, ANDROLOGIA, V38, P54, DOI 10.1111/j.1439-0272.2006.00711.x; Ferramosca A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/902953; Florimond C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004654; Hashemitabar M, 2015, J ASSIST REPROD GEN, V32, P853, DOI 10.1007/s10815-015-0465-7; Holstein A. F. C., 1981, ATLAS HUMAN SPERMATO; Ishikawa T, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028076; Kherraf ZE, 2018, AM J HUM GENET, V103, P400, DOI 10.1016/j.ajhg.2018.07.014; Li Y, 2019, CLIN GENET, V95, P590, DOI 10.1111/cge.13525; Liu CY, 2020, J MED GENET, V57, P31, DOI 10.1136/jmedgenet-2019-106011; Liu WJ, 2019, AM J HUM GENET, V104, P738, DOI 10.1016/j.ajhg.2019.02.020; Lores P, 2018, HUM MOL GENET, V27, P1196, DOI 10.1093/hmg/ddy034; Martinez G, 2018, HUM REPROD, V33, P1973, DOI 10.1093/humrep/dey264; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; Oberholzer M, 2007, FASEB J, V21, P720, DOI 10.1096/fj.06-6818com; Oberholzer M, 2009, METHOD CELL BIOL, V93, P21, DOI 10.1016/S0091-679X(08)93002-8; Ohta M, 2012, BIOSCI BIOTECH BIOCH, V76, P1540, DOI 10.1271/bbb.120293; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Perez-Riba A, 2019, CURR OPIN STRUC BIOL, V54, P43, DOI 10.1016/j.sbi.2018.12.004; Pirovano L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09999-w; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Ray PF, 2017, CLIN GENET, V91, P217, DOI 10.1111/cge.12905; Ridgley E, 2000, MOL BIOCHEM PARASIT, V109, P195, DOI 10.1016/S0166-6851(00)00246-2; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sha YW, 2017, GENE, V633, P48, DOI 10.1016/j.gene.2017.08.033; Sha YW, 2017, FERTIL STERIL, V107, P1312, DOI 10.1016/j.fertnstert.2017.04.007; Shen Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08182-x; Tadenev ALD, 2011, P NATL ACAD SCI USA, V108, P10320, DOI 10.1073/pnas.1016531108; Takayanagi H, 2015, ACTA CRYSTALLOGR F, V71, P175, DOI 10.1107/S2053230X14028143; Tang SY, 2017, AM J HUM GENET, V100, P854, DOI 10.1016/j.ajhg.2017.04.012; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; van Dam TJP, 2013, P NATL ACAD SCI USA, V110, P6943, DOI 10.1073/pnas.1221011110; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; Wang X, 2017, CLIN GENET, V91, P313, DOI 10.1111/cge.12857; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wu H, 2019, REPROD BIOMED ONLINE, V38, P769, DOI 10.1016/j.rbmo.2018.12.037; Xu YA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124378; Yamamoto R, 2008, EUKARYOT CELL, V7, P154, DOI 10.1128/EC.00341-07; Yuzawa S, 2011, P NATL ACAD SCI USA, V108, P19210, DOI 10.1073/pnas.1110951108; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006	71	23	26	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2019	105	6					1148	1167		10.1016/j.ajhg.2019.10.007	http://dx.doi.org/10.1016/j.ajhg.2019.10.007			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JT4BB	31735292	Green Published, Bronze			2022-12-18	WOS:000500935400007
J	Yan, HF; Helman, G; Murthy, SE; Ji, HR; Crawford, J; Kubisiak, T; Bent, SJ; Xiao, JX; Taft, RJ; Coombs, A; Wu, Y; Pop, A; Li, DX; de Vries, LS; Jiang, YW; Salomons, GS; van der Knaap, MS; Patapoutian, A; Simons, C; Burmeister, M; Wang, JM; Wolf, NI				Yan, Huifang; Helman, Guy; Murthy, Swetha E.; Ji, Haoran; Crawford, Joanna; Kubisiak, Thomas; Bent, Stephen J.; Xiao, Jiangxi; Taft, Ryan J.; Coombs, Adam; Wu, Ye; Pop, Ana; Li, Dongxiao; de Vries, Linda S.; Jiang, Yuwu; Salomons, Gajja S.; van der Knaap, Marjo S.; Patapoutian, Ardem; Simons, Cas; Burmeister, Margit; Wang, Jingmin; Wolf, Nicole I.			Heterozygous Variants in the Mechanosensitive Ion Channel TMEM63A Result in Transient Hypomyelination during Infancy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEUKODYSTROPHIES; MUTATIONS; LEUKOENCEPHALOPATHY; CLASSIFICATION; DISEASE	Mechanically activated (MA) ion channels convert physical forces into electrical signals. Despite the importance of this function, the involvement of mechanosensitive ion channels in human disease is poorly understood. Here we report heterozygous missense mutations in the gene encoding the MA ion channel TMEM63A that result in an infantile disorder resembling a hypomyelinating leukodystrophy. Four unrelated individuals presented with congenital nystagmus, motor delay, and deficient myelination on serial scans in infancy, prompting the diagnosis of Pelizaeus-Merzbacher (like) disease. Genomic sequencing revealed that all four individuals carry heterozygous missense variants in the pore-forming domain of TMEM63A. These variants were confirmed to have arisen de novo in three of the four individuals. While the physiological role of TMEM63A is incompletely understood, it is highly expressed in oligodendrocytes and it has recently been shown to be a MA ion channel. Using patch clamp electrophysiology, we demonstrated that each of the modeled variants result in strongly attenuated stretch-activated currents when expressed in naive cells. Unexpectedly, the clinical evolution of all four individuals has been surprisingly favorable, with substantial improvements in neurological signs and developmental progression. In the three individuals with follow-up scans after 4 years of age, the myelin deficit had almost completely resolved. Our results suggest a previously unappreciated role for mechanosensitive ion channels in myelin development.	[Yan, Huifang; Ji, Haoran; Wu, Ye; Li, Dongxiao; Jiang, Yuwu; Wang, Jingmin] Peking Univ, Hosp 1, Dept Pediat, Beijing Key Lab Mol Diag & Study Pediat Genet Dis, Beijing 100871, Peoples R China; [Yan, Huifang; Kubisiak, Thomas] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Yan, Huifang] Joint Int Res Ctr Translat & Clin Res, Beijing 100871, Peoples R China; [Helman, Guy] Murdoch Childrens Res Inst, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Helman, Guy; Crawford, Joanna; Simons, Cas] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Murthy, Swetha E.; Coombs, Adam; Patapoutian, Ardem] Howard Hughes Med Inst, Dept Neurosci, Dorris Neurosci Ctr, Scripps Res, La Jolla, CA 92037 USA; [Ji, Haoran] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou 310058, Peoples R China; [Bent, Stephen J.] CSIRO, Data61, Brisbane, Qld 4067, Australia; [Xiao, Jiangxi] Peking Univ, Dept Radiol, Hosp 1, Beijing 100871, Peoples R China; [Taft, Ryan J.] Illumina Inc, San Diego, CA 92121 USA; [Pop, Ana] Univ Amsterdam, Vrije Univ, Dept Clin Chem, Metab Unit,Med Ctr, NL-1081 HV Amsterdam, Netherlands; [Pop, Ana] Univ Amsterdam, Med Ctr, Amsterdam Gastroenterol & Metab, NL-1081 HV Amsterdam, Netherlands; [Li, Dongxiao] Zhengzhou Univ, Childrens Hosp, Henan Prov Key Lab Childrens Genet & Metab Dis, Zhengzhou 450018, Peoples R China; [de Vries, Linda S.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, NL-3584 EA Utrecht, Netherlands; [de Vries, Linda S.] UMC Utrecht Brain Ctr, NL-3584 CG Utrecht, Netherlands; [Jiang, Yuwu] Peking Univ, Key Lab Neurosci, Minist Educ Natl Hlth & Family Planning Commiss, Beijing 100871, Peoples R China; [Salomons, Gajja S.] Univ Amsterdam, Dept Genet Metab Dis, Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Salomons, Gajja S.; Wolf, Nicole I.] Univ Amsterdam, Med Ctr, Dept Child Neurol, Emma Childrens Hosp, Amsterdam, Netherlands; [van der Knaap, Marjo S.] Amsterdam Neurosci, NL-1081 HV Amsterdam, Netherlands; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Amsterdam Neurosci, Dept Funct Genom, Amsterdam, Netherlands; [Burmeister, Margit] Univ Michigan, Dept Computat Med Bioinformat, Psychiat & Human Genet, Ann Arbor, MI 48109 USA	Peking University; University of Michigan System; University of Michigan; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Queensland; Howard Hughes Medical Institute; Scripps Research Institute; Zhejiang University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Peking University; Illumina; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Zhengzhou University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Peking University; University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Michigan System; University of Michigan	Wolf, NI (corresponding author), Univ Amsterdam, Med Ctr, Dept Child Neurol, Emma Childrens Hosp, Amsterdam, Netherlands.	n.wolf@amsterdamumc.nl	/AAD-1783-2020; Simons, Cas/A-7905-2011; Wolf, Nicole I/H-3943-2014; de Vries, Linda S/AAB-6454-2021; Crawford, Joanna/F-9135-2013; jiang, yu/HGU-0029-2022; Helman, Guy/C-7935-2017; Bent, Stephen/A-7094-2011	Simons, Cas/0000-0003-3147-8042; Wolf, Nicole I/0000-0003-1721-0728; Crawford, Joanna/0000-0003-0786-6889; van der Knaap, Marjo/0000-0001-8912-0954; Coombs, Adam/0000-0001-5690-0364; Helman, Guy/0000-0002-4784-7423; Bent, Stephen/0000-0003-1563-2855; Murthy, Swetha/0000-0001-9580-3380	National Key Research and Development Program of China [2016YFC1306201, 2016YFC0901505]; China Scholarship Council; UMHS-PUHSC Joint Institute for Translational and Clinical Research [BMU2019JI009]; Australian National Health and Medical Research Council [NHMRC 1068278]; Victorian Government's Operational Infrastructure Support Program	National Key Research and Development Program of China; China Scholarship Council(China Scholarship Council); UMHS-PUHSC Joint Institute for Translational and Clinical Research; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported in part by the National Key Research and Development Program of China (No. 2016YFC1306201 and No. 2016YFC0901505). H.Y.'s visit in M.B.'s laboratory was supported by the China Scholarship Council. H.Y. also reports funding from the UMHS-PUHSC Joint Institute for Translational and Clinical Research (BMU2019JI009). The participation of G.H. and C.S. is in part financed by the Australian National Health and Medical Research Council (NHMRC 1068278). The research conducted at the Murdoch Children's Research Institute was supported by the Victorian Government's Operational Infrastructure Support Program. A. Patapoutian is an investigator of the Howard Hughes Medical Institute.	Azzolini S, 2014, BRAIN DEV-JPN, V36, P716, DOI 10.1016/j.braindev.2013.10.009; Barkovich AJ, 2005, J INHERIT METAB DIS, V28, P311, DOI 10.1007/s10545-005-5952-z; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dorboz I, 2017, BRAIN, V140, P2550, DOI [10.1093/brain/awx215, 10.1093/brain/awx314, 10.1093/brain/awx207]; Geisheker MR, 2017, NAT NEUROSCI, V20, P1043, DOI 10.1038/nn.4589; Harting I, 2019, AM J NEURORADIOL, V40, P903, DOI 10.3174/ajnr.A6051; Hobson GM, 2012, SEMIN NEUROL, V32, P62, DOI 10.1055/s-0032-1306388; Hou CC, 2014, CELL RES, V24, P632, DOI 10.1038/cr.2014.14; Jojoa-Cruz S, 2018, ELIFE, V7, DOI 10.7554/eLife.41845; Karle KN, 2013, NEUROLOGY, V81, P2039, DOI 10.1212/01.wnl.0000436945.01023.ac; Kevelam SH, 2016, NEUROPEDIATRICS, V47, P349, DOI 10.1055/s-0036-1588020; Miyake N, 2017, NEUROGENETICS, V18, P185, DOI 10.1007/s10048-017-0520-x; Murthy SE, 2018, ELIFE, V7, DOI 10.7554/eLife.41844; Pouwels PJW, 2014, ANN NEUROL, V76, P5, DOI 10.1002/ana.24194; Schiffmann R, 2004, CURR OPIN NEUROL, V17, P187, DOI 10.1097/00019052-200404000-00017; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Simons C, 2013, AM J HUM GENET, V92, P767, DOI 10.1016/j.ajhg.2013.03.018; Sobreira Nara L M, 2017, Curr Protoc Hum Genet, V95, DOI 10.1002/cphg.50; Steenweg ME, 2010, BRAIN, V133, P2971, DOI 10.1093/brain/awq257; van der Knaap MS, 2019, LANCET NEUROL, V18, P962, DOI 10.1016/S1474-4422(19)30143-7; van der Knaap MS, 2017, ACTA NEUROPATHOL, V134, P351, DOI 10.1007/s00401-017-1739-1; Van der Knaap MS., 2005, MAGNETIC RESONANCE M; Vanderver A, 2016, ANN NEUROL, V79, P1031, DOI 10.1002/ana.24650; Vanderver A, 2015, MOL GENET METAB, V114, P494, DOI 10.1016/j.ymgme.2015.01.006; Vaurs-Barriere C, 2009, ANN NEUROL, V65, P114, DOI 10.1002/ana.21579; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wolf NI, 2014, NEUROLOGY, V83, P1898, DOI 10.1212/WNL.0000000000001002; Zhao X, 2016, CELL BIOCHEM FUNCT, V34, P238, DOI 10.1002/cbf.3185	28	23	24	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2019	105	5					996	1004		10.1016/j.ajhg.2019.09.011	http://dx.doi.org/10.1016/j.ajhg.2019.09.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JL9XL	31587869	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000495878800010
J	Accogli, A; Calabretta, S; St-Onge, J; Boudrahem-Addour, N; Dionne-Laporte, A; Joset, P; Azzarello-Burri, S; Rauch, A; Krier, J; Fieg, E; Pallais, JC; McConkie-Rosell, A; McDonald, M; Freedman, SF; Riviere, JB; Lafond-Lapalme, J; Simpson, BN; Hopkin, RJ; Trimouille, A; Van-Gils, J; Begtrup, A; McWalter, K; Delphine, H; Keren, B; Genevieve, D; Argilli, E; Sherr, EH; Severino, M; Rouleau, GA; Yam, PT; Charron, F; Srour, M				Accogli, Andrea; Calabretta, Sara; St-Onge, Judith; Boudrahem-Addour, Nassima; Dionne-Laporte, Alexandre; Joset, Pascal; Azzarello-Burri, Silvia; Rauch, Anita; Krier, Joel; Fieg, Elizabeth; Pallais, Juan C.; McConkie-Rosell, Allyn; McDonald, Marie; Freedman, Sharon F.; Riviere, Jean-Baptiste; Lafond-Lapalme, Joel; Simpson, Brittany N.; Hopkin, Robert J.; Trimouille, Aurelien; Van-Gils, Julien; Begtrup, Amber; McWalter, Kirsty; Delphine, Heron; Keren, Boris; Genevieve, David; Argilli, Emanuela; Sherr, Elliott H.; Severino, Mariasavina; Rouleau, Guy A.; Yam, Patricia T.; Charron, Frederic; Srour, Myriam		Undiagnosed Dis Network	De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OBSESSIVE-COMPULSIVE DISORDER; CELL-ADHESION; CLASSICAL CADHERINS; MOTOR CONTROL; GENE; MUTATIONS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; ORGANIZATION	Cadherins constitute a family of transmembrane proteins that mediate calcium-dependent cell-cell adhesion. The extracellular domain of cadherins consists of extracellular cadherin (EC) domains, separated by calcium binding sites. The EC interacts with other cadherin molecules in cis and in trans to mechanically hold apposing cell surfaces together. CDH2 encodes N-cadherin, whose essential roles in neural development include neuronal migration and axon pathfinding. However, CDH2 has not yet been linked to a Mendelian neuro-developmental disorder. Here, we report de novo heterozygous pathogenic variants (seven missense, two frameshift) in CDH2 in nine individuals with a syndromic neurodevelopmental disorder characterized by global developmental delay and/or intellectual disability, variable axon pathfinding defects (corpus callosum agenesis or hypoplasia, mirror movements, Duane anomaly), and ocular, cardiac, and genital anomalies. All seven missense variants (c.1057G>A [p.Asp353Asn]; c.1789G>A [p.Asp597Asn]; c.1789G>T [p.Asp597Tyr]; c.1802A>C [p.Asn601Thr]; c.1839C>G [p.Cys613Trp]; c.1880A>G [p.Asp627Gly]; c.2027A>G [p.Tyr676Cys]) result in substitution of highly conserved residues, and six of seven cluster within EC domains 4 and 5. Four of the substitutions affect the calcium-binding site in the EC4-EC5 interdomain. We show that cells expressing these variants in the EC4-EC5 domains have a defect in cell-cell adhesion; this defect includes impaired binding in trans with N-cadherin-WT expressed on apposing cells. The two frameshift variants (c.2563_2564delCT [p.Leu855Valfs*4]; c.2564_2567dupTGTT [p.Leu856Phefs*5]) are predicted to lead to a truncated cytoplasmic domain. Our study demonstrates that de novo heterozygous variants in CDH2 impair the adhesive activity of N-cadherin, resulting in a multisystemic developmental disorder, that could be named ACOG syndrome (agenesis of corpus callosum, axon pathfinding, cardiac, ocular, and genital defects).	[Accogli, Andrea; Srour, Myriam] McGill Univ, Div Pediat Neurol, Dept Pediat, Montreal, PQ H4A 3J1, Canada; [Accogli, Andrea] IRCCS Osped Policlin San Martino, Med Genet Unit, I-16132 Genoa, Italy; [Accogli, Andrea] Univ Genoa, Dipartimento Neurosci Reabil Oftalmol Genet & Sci, I-16132 Genoa, Italy; [Calabretta, Sara; Yam, Patricia T.; Charron, Frederic] Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; [St-Onge, Judith; Boudrahem-Addour, Nassima; Riviere, Jean-Baptiste; Lafond-Lapalme, Joel; Srour, Myriam] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ H4A 3J1, Canada; [Dionne-Laporte, Alexandre; Rouleau, Guy A.] Montreal Neurol Inst, McGill Univ, Montreal, PQ H3A 2B4, Canada; [Joset, Pascal; Azzarello-Burri, Silvia; Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8952 Schlieren, Switzerland; [Krier, Joel; Fieg, Elizabeth; Pallais, Juan C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [McConkie-Rosell, Allyn; McDonald, Marie; Undiagnosed Dis Network] Duke Univ, Div Med Genet, Dept Pediat, Durham, NC 27707 USA; [Freedman, Sharon F.] Duke Univ, Dept Ophthalmol, Med Ctr, Durham, NC 27710 USA; [Simpson, Brittany N.; Hopkin, Robert J.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Coll Med, Cincinnati, OH 45229 USA; [Trimouille, Aurelien; Van-Gils, Julien] Ctr Hosp Univ Bordeaux, F-33076 Bordeaux, France; [Trimouille, Aurelien; Van-Gils, Julien] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H4A 3J1, Canada; [Begtrup, Amber; McWalter, Kirsty] McGill Univ, Dept Expt Med, Montreal, PQ H4A 3J1, Canada	McGill University; University of Genoa; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; McGill University; Harvard University; Brigham & Women's Hospital; Duke University; Duke University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; CHU Bordeaux; McGill University; McGill University	Srour, M (corresponding author), McGill Univ, Div Pediat Neurol, Dept Pediat, Montreal, PQ H4A 3J1, Canada.; Charron, F (corresponding author), Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada.; Srour, M (corresponding author), McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ H4A 3J1, Canada.	frederic.charron@ircm.qc.ca; myriam.srour@mcgill.ca	Rauch, Anita/C-5568-2014; Severino, Mariasavina/F-8367-2011; Charron, Frederic/D-2140-2009	Rauch, Anita/0000-0003-2930-3163; Accogli, Andrea/0000-0001-8724-6721; Wheeler, Matthew/0000-0001-8721-3022; Stong, Nicholas/0000-0002-0678-637X; Urv, Tiina/0000-0002-2040-4972; Yam, Patricia/0000-0002-3631-3151; Haendel, Melissa/0000-0001-9114-8737; Oglesbee, Devin/0000-0002-7147-5527; Brown, Donna/0000-0002-8805-7225; Lanza, Ian/0000-0002-9858-3384; Fisher, Paul/0000-0002-1196-1590; Bademci, Guney/0000-0002-4052-8833; Azamian, Mahshid/0000-0002-8543-8284; Severino, Mariasavina/0000-0003-4730-5322; Eppenberger, Patrick/0000-0002-9526-8709; Charron, Frederic/0000-0003-3483-8672; Douine, Emilie/0000-0002-6048-2887; Allard, Patrick/0000-0001-7765-1547; Hopkin, Robert/0000-0003-0770-5516; McCauley, Jacob/0000-0002-1805-1733	Fonds de Recherche du Quebec Sante (FRQS); Mel Hoppenheim Fund in Pediatric Neurology (Montreal Children's Foundation); Rotary Foundation (Rotary district 2032, Genoa, Italy) [GC1641420]; Canadian Institutes of Health Research (CIHR); Sick Kids Foundation [NI16-028]; CIHR [FDN334023]; FRQS; Canada Foundation for Innovation [CFI 33768]; National Institutes of Health Common Fund, through the Office of Strategic Coordination; National Institutes of Health Common Fund, through the Office of the NIH Director [2U01HG007690]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG008900, U01HG007690] Funding Source: NIH RePORTER	Fonds de Recherche du Quebec Sante (FRQS); Mel Hoppenheim Fund in Pediatric Neurology (Montreal Children's Foundation); Rotary Foundation (Rotary district 2032, Genoa, Italy); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Sick Kids Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); FRQS; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); National Institutes of Health Common Fund, through the Office of Strategic Coordination(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Common Fund, through the Office of the NIH Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Laurens van deWiel from the Radboud Institute for Molecular Life Sciences (Nijmegen, the Netherlands) for his assistance in calculating significance of spatial clustering of de novo variants. M. S. holds a clinician-scientist award from Fonds de Recherche du Quebec Sante (FRQS). A.A.' s training fellowship was supported by the Mel Hoppenheim Fund in Pediatric Neurology (Montreal Children's Foundation) and the Rotary Foundation (global grant GC1641420 scholarship sponsored by the Rotary district 2032, Genoa, Italy). Work performed in the M.S. laboratory was supported by funding from the Canadian Institutes of Health Research (CIHR) and Sick Kids Foundation (NI16-028). Work performed in the F.C. laboratory was supported by funding from the CIHR (FDN334023), the FRQS, and the Canada Foundation for Innovation (CFI 33768). F.C. holds the Canada Research Chair in Developmental Neurobiology. Research reported in this manuscript was in part supported by the National Institutes of Health Common Fund, through the Office of Strategic Coordination and Office of the NIH Director under award number 2U01HG007690. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Sequencing centers for subject 1 and subject 8 were the University of Washington Center for Mendelian Genomics and the Broad Institute of MIT and Harvard.	Ahmed I, 2014, HUM GENET, V133, P1419, DOI 10.1007/s00439-014-1475-8; Aiga M, 2011, J BIOL CHEM, V286, P851, DOI 10.1074/jbc.M110.176305; Akins MR, 2006, J COMP NEUROL, V499, P979, DOI 10.1002/cne.21147; ANDERSSON AM, 1994, INT J ANDROL, V17, P174, DOI 10.1111/j.1365-2605.1994.tb01239.x; Asano K, 2004, J NEURO-ONCOL, V70, P3, DOI 10.1023/B:NEON.0000040811.14908.f2; Babb-Clendenon S, 2006, J CELL SCI, V119, P5169, DOI 10.1242/jcs.03299; Bhalla K, 2008, AM J HUM GENET, V83, P703, DOI 10.1016/j.ajhg.2008.10.020; Bindal N, 2016, CURR PROTOC HUM GENE, V91, DOI DOI 10.11.1-10.11.37; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Bozdagi O, 2010, J NEUROSCI, V30, P9984, DOI 10.1523/JNEUROSCI.1223-10.2010; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Chalasani K, 2011, MOL BIOL CELL, V22, P1505, DOI 10.1091/mbc.E10-08-0675; Cincotta M, 2008, CLIN NEUROPHYSIOL, V119, P744, DOI 10.1016/j.clinph.2007.11.047; CIOLCZYKWIERZBICKA, 2018, MED ONCOL, V35, DOI DOI 10.1007/S12032-018-1104-9; Crepel A, 2014, AM J MED GENET B, V165, P391, DOI 10.1002/ajmg.b.32243; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; Depienne C, 2012, AM J HUM GENET, V90, P301, DOI 10.1016/j.ajhg.2011.12.002; El-Amraoui A, 2013, PROG MOL BIOL TRANSL, V116, P361, DOI 10.1016/B978-0-12-394311-8.00016-9; Franz M, 2018, NUCLEIC ACIDS RES, V46, pW60, DOI 10.1093/nar/gky311; Garcia-Castro MI, 2000, SCIENCE, V288, P1047, DOI 10.1126/science.288.5468.1047; Ghoumid J, 2017, GENET MED, V19, P1013, DOI 10.1038/gim.2017.11; Goodwin K, 2017, EXP CELL RES, V358, P45, DOI 10.1016/j.yexcr.2017.03.016; Guang SQ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00470; Han H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11432; Harrison OJ, 2005, J CELL SCI, V118, P711, DOI 10.1242/jcs.01665; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; Hawi Z, 2018, AM J MED GENET B, V177, P168, DOI 10.1002/ajmg.b.32592; Jiang XH, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126334; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Keller R, 2017, NEUROL SCI, V38, P1353, DOI 10.1007/s10072-017-2974-x; Kim SA, 2011, P NATL ACAD SCI USA, V108, P9857, DOI 10.1073/pnas.1019003108; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; Klingelhofer J, 2002, MOL CELL BIOL, V22, P7449, DOI 10.1128/MCB.22.21.7449-7458.2002; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; LEE CH, 1995, DEV BIOL, V171, P363, DOI 10.1006/dbio.1995.1288; Lelieveld SH, 2017, AM J HUM GENET, V101, P478, DOI 10.1016/j.ajhg.2017.08.004; Leombroni M, 2018, EUR J PAEDIATR NEURO, V22, P951, DOI 10.1016/j.ejpn.2018.08.007; Leonard M, 2011, DEV BIOL, V349, P363, DOI 10.1016/j.ydbio.2010.10.009; Logan CM, 2017, DEV BIOL, V428, P118, DOI 10.1016/j.ydbio.2017.05.022; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; Marsh APL, 2017, NAT GENET, V49, P511, DOI 10.1038/ng.3794; Mayosi BM, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001605; McGregor NW, 2016, METAB BRAIN DIS, V31, P191, DOI 10.1007/s11011-015-9693-x; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Meneret A, 2017, J CLIN INVEST, V127, P3923, DOI 10.1172/JCI95442; Miyamoto Y, 2015, CELL ADHES MIGR, V9, P183, DOI 10.1080/19336918.2015.1005466; Moya PR, 2013, EUR J HUM GENET, V21, P850, DOI 10.1038/ejhg.2012.245; Mrozik KM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4845-0; Mu LM, 2015, GENET MOL RES, V14, P9882, DOI 10.4238/2015.August.19.22; Nazaryan L, 2015, PSYCHIAT RES, V228, P974, DOI 10.1016/j.psychres.2015.05.010; NEWTON SC, 1993, DEV DYNAM, V197, P1, DOI 10.1002/aja.1001970102; Nikitczuk JS, 2014, HIPPOCAMPUS, V24, P943, DOI 10.1002/hipo.22282; Nugent AA, 2012, CURR OPIN NEUROBIOL, V22, P837, DOI 10.1016/j.conb.2012.02.006; Okumura M, 2016, GENES CELLS, V21, P53, DOI 10.1111/gtc.12321; Peng J, 2013, CURR OPIN NEUROBIOL, V23, P109, DOI 10.1016/j.conb.2012.08.007; Prasad A, 2005, BIOCHEMISTRY-US, V44, P13692, DOI 10.1021/bi0510274; Priest AV, 2017, EXP CELL RES, V358, P10, DOI 10.1016/j.yexcr.2017.03.015; Protonotarios A, 2019, HEART, V105, P1117, DOI 10.1136/heartjnl-2017-311160; Quinodoz M, 2017, AM J HUM GENET, V101, P623, DOI 10.1016/j.ajhg.2017.09.001; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Rebman JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164433; Reyes-Mugica M, 2001, LAB INVEST, V81, P201, DOI 10.1038/labinvest.3780228; Rivero O, 2013, EUR NEUROPSYCHOPHARM, V23, P492, DOI 10.1016/j.euroneuro.2012.06.009; Sakane F, 2013, DEV NEUROBIOL, V73, P518, DOI 10.1002/dneu.22077; Schwarting GA, 2011, J CELL BIOCHEM, V112, P2663, DOI 10.1002/jcb.23203; Seong E, 2015, CELL ADHES MIGR, V9, P202, DOI 10.4161/19336918.2014.994919; Shan WS, 2004, J BIOL CHEM, V279, P55914, DOI 10.1074/jbc.M407827200; Shikanai Mima, 2011, Commun Integr Biol, V4, P326, DOI 10.4161/cib.4.3.14886; Smith L, 2018, EPILEPSIA, V59, P679, DOI 10.1111/epi.14003; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Su Y, 2012, ONCOGENE, V31, P4484, DOI 10.1038/onc.2011.574; Taskiran EZ, 2017, AM J MED GENET A, V173, P3143, DOI 10.1002/ajmg.a.38495; Tiwari P, 2018, ADV EXP MED BIOL, V1112, P107, DOI 10.1007/978-981-13-3065-0_9; Turkowski KL, 2017, CONGENIT HEART DIS, V12, P226, DOI 10.1111/chd.12462; Uccella S, 2019, J NEUROL, V266, P1167, DOI 10.1007/s00415-019-09247-7; Veitia RA, 2018, CLIN GENET, V93, P419, DOI 10.1111/cge.13107; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; von Spiczak S, 2017, NEUROLOGY, V89, P385, DOI 10.1212/WNL.0000000000004152; Vunnam N, 2011, BIOCHEMISTRY-US, V50, P2973, DOI 10.1021/bi101872b; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Whitman MC, 2017, HUM MOL GENET, V26, pR37, DOI 10.1093/hmg/ddx168; Wickstrom SA, 2018, CURR OPIN CELL BIOL, V54, P89, DOI 10.1016/j.ceb.2018.05.003; Wiel L, 2019, HUM MUTAT, V40, P1030, DOI 10.1002/humu.23798; Xu CD, 2015, J NEUROSCI, V35, P14517, DOI 10.1523/JNEUROSCI.1266-15.2015; Yamagata M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00142; Yang CQ, 2019, HISTOCHEM CELL BIOL, V151, P239, DOI 10.1007/s00418-018-1733-2; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yi SG, 2014, PATHOL RES PRACT, V210, P363, DOI 10.1016/j.prp.2014.01.014; Yulis M, 2018, J PHYSIOL-LONDON, V596, P3883, DOI 10.1113/JP275328; Zhang QL, 2017, AM J HUM GENET, V100, P817, DOI 10.1016/j.ajhg.2017.03.011; Zuppinger C, 2000, Heart Fail Rev, V5, P251, DOI 10.1023/A:1009809520194	100	23	24	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2019	105	4					854	868		10.1016/j.ajhg.2019.09.005	http://dx.doi.org/10.1016/j.ajhg.2019.09.005			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC0EX	31585109	Green Published, Bronze			2022-12-18	WOS:000488953400015
J	Sarnowski, C; Leong, A; Raffield, LM; Wu, PT; de Vries, PS; DiCorpo, D; Guo, XQ; Xu, HC; Liu, YM; Zheng, XW; Hu, Y; Brody, JA; Goodarzi, MO; Hidalgo, BA; Highland, HM; Jain, D; Liu, CT; Naik, RP; O'Connell, JR; Perry, JA; Porneala, BC; Selvin, E; Wessel, J; Psaty, BM; Curran, JE; Peralta, JM; Blangero, J; Kooperberg, C; Mathias, R; Johnson, AD; Reiner, AP; Mitchell, BD; Cupples, LA; Vasan, RS; Correa, A; Morrison, AC; Boerwinkle, E; Rotter, JI; Rich, SS; Manning, AK; Dupuis, J; Meigs, JB				Sarnowski, Chloe; Leong, Aaron; Raffield, Laura M.; Wu, Peitao; de Vries, Paul S.; DiCorpo, Daniel; Guo, Xiuqing; Xu, Huichun; Liu, Yongmei; Zheng, Xiuwen; Hu, Yao; Brody, Jennifer A.; Goodarzi, Mark O.; Hidalgo, Bertha A.; Highland, Heather M.; Jain, Deepti; Liu, Ching-Ti; Naik, Rakhi P.; O'Connell, Jeffrey R.; Perry, James A.; Porneala, Bianca C.; Selvin, Elizabeth; Wessel, Jennifer; Psaty, Bruce M.; Curran, Joanne E.; Peralta, Juan M.; Blangero, John; Kooperberg, Charles; Mathias, Rasika; Johnson, Andrew D.; Reiner, Alexander P.; Mitchell, Braxton D.; Cupples, L. Adrienne; Vasan, Ramachandran S.; Correa, Adolfo; Morrison, Alanna C.; Boerwinkle, Eric; Rotter, Jerome I.; Rich, Stephen S.; Manning, Alisa K.; Dupuis, Josee; Meigs, James B.		TOPMed Diabet Working Grp; TOPMed Hematology Working Grp; TOPMed Hemostasis Working Grp; Natl Heart Lung Blood Inst TOPMed	Impact of Rare and Common Genetic Variants on Diabetes Diagnosis by Hemoglobin A1c in Multi-Ancestry Cohorts: The Trans-Omics for Precision Medicine Program	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SIGNIFICANCE; A(1C) MEASUREMENT; CELL TRAIT; S-TRAITS; ASSOCIATION	Hemoglobin A1c (HbA1c) is widely used to diagnose diabetes and assess glycemic control in individuals with diabetes. However, nonglycemic determinants, including genetic variation, may influence how accurately HbA1c reflects underlying glycemia. Analyzing the NHLBI Trans-Omics for Precision Medicine (TOPMed) sequence data in 10,338 individuals from five studies and four ancestries (6,158 Europeans, 3,123 African-Americans, 650 Hispanics, and 407 East Asians), we confirmed five regions associated with HbA1c (GCK in Europeans and African-Americans, HK1 in Europeans and Hispanics, FN3K and/or FN3KRP in Europeans, and G6PD in African-Americans and Hispanics) and we identified an African-ancestry-specific low-frequency variant (rs1039215 in HBG2 and HBE1, minor allele frequency (MAF) = 0.03). The most associated G6PD variant (rs1050828-T, p.Va198Met, MAF = 12% in African-Americans, MAF = 2% in Hispanics) lowered HbA1c (-0.88% in hemizygous males, -0.34% in heterozygous females) and explained 23% of HbA1c variance in African-Americans and 4% in Hispanics. Additionally, we identified a rare distinct G6PD coding variant (rs76723693, p.Leu353Pro, MAF = 0.5%; -0.98% in hemizygous males, -0.46% in heterozygous females) and detected significant association with HbA1c when aggregating rare missense variants in G6PD. We observed similar magnitude and direction of effects for rs1039215 (HBG2) and rs76723693 (G6PD) in the two largest TOPMed African American cohorts, and we replicated the rs76723693 association in the UK Biobank African-ancestry participants. These variants in G6PD and HBG2 were monomorphic in the European and Asian samples. African or Hispanic ancestry individuals carrying G6PD variants may be underdiagnosed for diabetes when screened with HbA1c. Thus, assessment of these variants should be considered for incorporation into precision medicine approaches for diabetes diagnosis.	[Sarnowski, Chloe; Wu, Peitao; DiCorpo, Daniel; Liu, Ching-Ti; Cupples, L. Adrienne; Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, 801 Massachusetts Ave, Boston, MA 02118 USA; [Leong, Aaron; Porneala, Bianca C.; Manning, Alisa K.; Meigs, James B.] Massachusetts Gen Hosp, Div Gen Internal Med, 100 Cambridge St 16th Floor, Boston, MA 02114 USA; [Leong, Aaron; Manning, Alisa K.; Meigs, James B.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Leong, Aaron; Manning, Alisa K.; Meigs, James B.] Broad Inst MIT & Harvard, Program Metab & Med, Cambridge, MA 02142 USA; [Leong, Aaron; Manning, Alisa K.; Meigs, James B.] Broad Inst MIT & Harvard, Program Populat Genet, Cambridge, MA 02142 USA; [Raffield, Laura M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [de Vries, Paul S.; Morrison, Alanna C.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Human Genet Ctr,Dept Epidemiol, Houston, TX 77030 USA; [Guo, Xiuqing; Rotter, Jerome I.] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, LABioMed, Torrance, CA 90502 USA; [Guo, Xiuqing; Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Xu, Huichun; Mitchell, Braxton D.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Liu, Yongmei] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC 27101 USA; [Zheng, Xiuwen; Jain, Deepti] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Hu, Yao; Kooperberg, Charles; Reiner, Alexander P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98108 USA; [Brody, Jennifer A.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Hidalgo, Bertha A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Highland, Heather M.] Univ N Carolina, Dept Epidemiol, UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Naik, Rakhi P.] Johns Hopkins Univ, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [O'Connell, Jeffrey R.; Perry, James A.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Selvin, Elizabeth; Mathias, Rasika] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Wessel, Jennifer] Indiana Univ, Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46202 USA; [Wessel, Jennifer] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Wessel, Jennifer] Indiana Univ Sch Med, Diabet Translat Res Ctr, Indianapolis, IN 46202 USA; [Psaty, Bruce M.] Kaiser PermanenteWashington Hlth Res Inst, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Curran, Joanne E.; Peralta, Juan M.; Blangero, John] Univ Texas Rio Grande Valley, Sch Med, Dept Human Genet, Brownsville, TX 78520 USA; [Curran, Joanne E.; Peralta, Juan M.; Blangero, John] Univ Texas Rio Grande Valley, Sch Med, South Texas Diabet & Obes Inst, Brownsville, TX 78520 USA; [Mathias, Rasika] Johns Hopkins Univ, Dept Med, GeneSTAR Res Program, Baltimore, MD 21205 USA; [Johnson, Andrew D.; Cupples, L. Adrienne; Vasan, Ramachandran S.; Dupuis, Josee] NHLBI, Framingham, MA 01702 USA; [Johnson, Andrew D.; Cupples, L. Adrienne; Vasan, Ramachandran S.; Dupuis, Josee] Boston Univ, Framingham Heart Study, Framingham, MA 01702 USA; [Johnson, Andrew D.] NHLBI, Populat Sci Branch, NIH, Bethesda, MD 20814 USA; [Reiner, Alexander P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Mitchell, Braxton D.] Baltimore Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Prevent Med & Epidemiol Sect, Evans Dept Med, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Evans Dept Med, Cardiol Sect, Boston, MA 02118 USA; [Correa, Adolfo] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Correa, Adolfo] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Correa, Adolfo] Univ Mississippi, Med Ctr, Dept Populat Hlth Sci, Jackson, MS 39216 USA; [Correa, Adolfo] Jackson Heart Study, Jackson, MS 39213 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University System of Maryland; University of Maryland Baltimore; Wake Forest University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; Boston University; Boston University; Boston University; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Baylor College of Medicine; University of Virginia	Sarnowski, C (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, 801 Massachusetts Ave, Boston, MA 02118 USA.; Leong, A (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, 100 Cambridge St 16th Floor, Boston, MA 02114 USA.; Leong, A (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Leong, A (corresponding author), Broad Inst MIT & Harvard, Program Metab & Med, Cambridge, MA 02142 USA.; Leong, A (corresponding author), Broad Inst MIT & Harvard, Program Populat Genet, Cambridge, MA 02142 USA.	chloesar@bu.edu; ASLEONG@partners.org	Zheng, Xiuwen/J-4047-2019; Goodarzi, Mark/AAH-7106-2021; Johnson, Andrew D/G-6520-2013; Mitchell, Braxton/CAF-0876-2022; Hu, Yao/L-1424-2019; Rotter, Jerome/AAY-6598-2021; Manning, Alisa Knodle/ABC-7711-2021; Blangero, John/ABA-7175-2021	Zheng, Xiuwen/0000-0002-1390-0708; Goodarzi, Mark/0000-0001-6364-5103; Johnson, Andrew D/0000-0001-6369-5178; Blangero, John/0000-0001-6250-5723; Curran, Joanne/0000-0002-6898-155X; Raffield, Laura/0000-0002-7892-193X; Rich, Stephen/0000-0003-3872-7793; Sarnowski, Chloe/0000-0002-6090-7099	NHLBI [T32 HL007055, T32 HL129982]; National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K01 DK107836, R03 DK118305]; American Heart Association [18CDA34110116]; NIH NIDDK [K24 DK080140, U01 DK078616, U01 DK105554]; American Diabetes Association [1-19-PDF-045]; TOPMed [U01 HL137181];  [R01HL131136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117626, R01HL131136, T32HL129982, U01HL137181, R01HL120393, T32HL007055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK105554, K01DK107836, K24DK080140, P30DK079626, U01DK078616, R03DK118305] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); TOPMed; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	L.M.R. is funded by NHLBI grant T32 HL129982. A.K.M. is supported by National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants K01 DK107836 and R03 DK118305. P.S.dV. is supported by American Heart Association grant 18CDA34110116. J.B.M. and the project are supported by NIH NIDDK grants K24 DK080140, U01 DK078616, and U01 DK105554 Opportunity Pool OP6. The Analysis Commons was funded by R01HL131136. H.M.H. was supported by NHLBI training grants T32 HL007055 and T32 HL129982 and American Diabetes Association grant 1-19-PDF-045. J.R.O. is supported by the TOPMed grant U01 HL137181.	American Diabetes Association, 2019, Diabetes Care, V42, pS13, DOI 10.2337/dc19-S002; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Bergenstal RM, 2017, ANN INTERN MED, V167, P95, DOI 10.7326/M16-2596; Brody JA, 2017, NAT GENET, V49, P1560, DOI 10.1038/ng.3968; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chami N, 2016, AM J HUM GENET, V99, P8, DOI 10.1016/j.ajhg.2016.05.007; Chen Z, 2013, HUM MOL GENET, V22, P2529, DOI 10.1093/hmg/ddt087; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gomez-Manzo S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122069; Hodonsky CJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006760; Jun G, 2018, PGMNR 3186 IDENTIFIC; Kanai M, 2016, J HUM GENET, V61, P861, DOI 10.1038/jhg.2016.72; Lacy ME, 2017, JAMA-J AM MED ASSOC, V317, P507, DOI 10.1001/jama.2016.21035; Leong Aaron, 2015, Rev Diabet Stud, V12, P351, DOI 10.1900/RDS.2015.12.351; Leong Aaron, 2007, Mcgill J Med, V10, P31; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Little RR, 2011, CLIN CHEM, V57, P205, DOI 10.1373/clinchem.2010.148841; Little Randie R, 2009, J Diabetes Sci Technol, V3, P446; Liu XM, 2016, J MED GENET, V53, P111, DOI 10.1136/jmedgenet-2015-103423; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Mongia SK, 2008, AM J CLIN PATHOL, V130, P136, DOI 10.1309/1YU0D34VJKNUCGT1; MORTENSEN HB, 1983, CLIN CHIM ACTA, V134, P317, DOI 10.1016/0009-8981(83)90370-4; MOTULSKY AG, 1966, ANN INTERN MED, V65, P1329, DOI 10.7326/0003-4819-65-6-1329; Paterson AD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002384; Regier AA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06159-4; Roberts WL, 2005, CLIN CHEM, V51, P776, DOI 10.1373/clinchem.2004.047142; Rohfing CL, 2008, AM J CLIN PATHOL, V129, P811, DOI 10.1309/YFVTUD0GHJF7D16H; Rohlfing C, 2017, JAMA-J AM MED ASSOC, V317, P2237, DOI 10.1001/jama.2017.4643; Sarnowski C, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1022-4; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235; Shriner D, 2018, AM J HUM GENET, V102, P547, DOI 10.1016/j.ajhg.2018.02.003; Sidorenko J, 2018, BIORXIV; Strickland SW, 2018, CLIN CHIM ACTA, V476, P67, DOI 10.1016/j.cca.2017.11.012; Wheeler E, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002383; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xu CJ, 2014, GENET EPIDEMIOL, V38, P281, DOI 10.1002/gepi.21797; Zheng XW, 2017, BIOINFORMATICS, V33, P2251, DOI 10.1093/bioinformatics/btx145; Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	41	23	23	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2019	105	4					706	718		10.1016/j.ajhg.2019.08.010	http://dx.doi.org/10.1016/j.ajhg.2019.08.010			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC0EX	31564435	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000488953400003
J	Kanca, O; Andrews, JC; Lee, PT; Patel, C; Braddock, SR; Slavotinek, AM; Cohen, JS; Gubbels, CS; Aldinger, KA; Williams, J; Indaram, M; Fatemi, A; Yu, TW; Agrawal, PB; Vezina, G; Simons, C; Crawford, J; Lau, CC; Chung, WK; Markello, TC; Dobyns, WB; Adams, DR; Gahl, WA; Wangler, MF; Yamamoto, S; Bellen, HJ; Malicdan, MCV				Kanca, Oguz; Andrews, Jonathan C.; Lee, Pei-Tseng; Patel, Chirag; Braddock, Stephen R.; Slavotinek, Anne M.; Cohen, Julie S.; Gubbels, Cynthia S.; Aldinger, Kimberly A.; Williams, Judy; Indaram, Maanasa; Fatemi, Ali; Yu, Timothy W.; Agrawal, Pankaj B.; Vezina, Gilbert; Simons, Cas; Crawford, Joanna; Lau, C. Christopher; Chung, Wendy K.; Markello, Thomas C.; Dobyns, William B.; Adams, David R.; Gahl, William A.; Wangler, Michael F.; Yamamoto, Shinya; Bellen, Hugo J.; Malicdan, May Christine, V		Undiagnosed Dis Network	De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNDIAGNOSED DISEASES; SEIZURE-SUSCEPTIBILITY; DROSOPHILA; INTEGRATION; EXPRESSION; GENETICS; SEQUENCE; PROGRAM	WD40 repeat-containing proteins form a large family of proteins present in all eukaryotes. Here, we identified five pediatric probands with de novo variants in WDR37, which encodes a member of the WD40 repeat protein family. Two probands shared one variant and the others have variants in nearby amino acids outside the WD40 repeats. The probands exhibited shared phenotypes of epilepsy, colobomas, facial dysmorphology reminiscent of CHARGE syndrome, developmental delay and intellectual disability, and cerebellar hypoplasia. The WDR37 protein is highly conserved in vertebrate and invertebrate model organisms and is currently not associated with a human disease. We generated a null allele of the single Drosophila ortholog to gain functional insights and replaced the coding region of the fly gene CG12333/wdr37 with GAL4. These flies are homozygous viable but display severe bang sensitivity, a phenotype associated with seizures in flies. Additionally, the mutant flies fall when climbing the walls of the vials, suggesting a defect in grip strength, and repeat the cycle of climbing and falling. Similar to wall clinging defect, mutant males often lose grip of the female abdomen during copulation. These phenotypes are rescued by using the GAL4 in the CG12333/wdr37 locus to drive the UAS-human reference WDR37 cDNA. The two variants found in three human subjects failed to rescue these phenotypes, suggesting that these alleles severely affect the function of this protein. Taken together, our data suggest that variants in WDR37 underlie a novel syndromic neurological disorder.	[Kanca, Oguz; Andrews, Jonathan C.; Lee, Pei-Tseng; Wangler, Michael F.; Yamamoto, Shinya; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Patel, Chirag] Royal Brisbane & Womens Hosp, Genet Hlth Queensland, Brisbane, Qld 4029, Australia; [Braddock, Stephen R.] SSM Hlth Cardinal Glennon Childrens Med Ctr, Div Med Genet, St Louis, MO 63104 USA; [Braddock, Stephen R.] St Louis Univ Hosp, Dept Pediat, St Louis, MO 63104 USA; [Slavotinek, Anne M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Cohen, Julie S.; Fatemi, Ali] Kennedy Krieger Inst, Div Neurogenet, Baltimore, MD 21205 USA; [Cohen, Julie S.; Fatemi, Ali] Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD 21205 USA; [Gubbels, Cynthia S.; Yu, Timothy W.] Harvard Med Sch, Broad Inst MIT & Harvard, Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02138 USA; [Aldinger, Kimberly A.; Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Williams, Judy] Bundaberg Hosp, Paediat Dept, Bundaberg, Qld 4670, Australia; [Indaram, Maanasa] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Agrawal, Pankaj B.] Harvard Med Sch, Div Newborn Med & Genet & Genom, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Vezina, Gilbert] Childrens Natl Hlth Syst, Div Diagnost Imaging & Radiol, 111 Michigan Ave NW, Washington, DC 20010 USA; [Simons, Cas; Crawford, Joanna] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Simons, Cas] Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Lau, C. Christopher; Markello, Thomas C.; Adams, David R.; Gahl, William A.; Malicdan, May Christine, V] NIH, Undiag Dis Program, Common Fund, Off Director, Bethesda, MD 20892 USA; [Undiagnosed Dis Network] NIH, Undiagnosed Dis Network, Common Fund, Off Director, Bethesda, MD 20892 USA; [Chung, Wendy K.] Columbia Univ, Dept Pediat & Med, New York, NY 10032 USA; [Markello, Thomas C.; Adams, David R.; Gahl, William A.; Malicdan, May Christine, V] NIH, Off Clin Director, Natl Human Genome Res Inst, Bethesda, MD 20892 USA; [Dobyns, William B.] Univ Washington, Dept Pediat Genet, Seattle, WA 98195 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Wangler, Michael F.; Yamamoto, Shinya; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Wangler, Michael F.; Yamamoto, Shinya; Bellen, Hugo J.] Texas Childrens Hosp, Jan & Duncan Neurol Res Inst, Houston, TX 77030 USA; [Yamamoto, Shinya; Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Royal Brisbane & Women's Hospital; Saint Louis University; University of California System; University of California San Francisco; Kennedy Krieger Institute; Kennedy Krieger Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Seattle Children's Hospital; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Children's National Health System; University of Queensland; Murdoch Children's Research Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; Columbia University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Malicdan, MCV (corresponding author), NIH, Undiag Dis Program, Common Fund, Off Director, Bethesda, MD 20892 USA.; Malicdan, MCV (corresponding author), NIH, Off Clin Director, Natl Human Genome Res Inst, Bethesda, MD 20892 USA.; Bellen, HJ (corresponding author), Texas Childrens Hosp, Jan & Duncan Neurol Res Inst, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.	hbellen@bcm.edu; maychristine.malicdan@nih.gov	Dobyns, William Brian/ABC-6525-2021; Braddock, Stephen/AAL-1667-2021; Adams, David/ABC-7557-2021; Malicdan, May Christine/AAK-7422-2021; Dobyns, William/AAI-2768-2020; Patel, Chirag/AAF-4953-2019; Yu, Timothy W./AAF-5738-2019; Crawford, Joanna/F-9135-2013; Aldinger, Kimberly/ABB-1561-2020; Simons, Cas/A-7905-2011; Slavotinek, Anne/AAK-6794-2020; Yamamoto, Shinya/ABB-2837-2021; Agrawal, Pankaj/ABG-8957-2021	Dobyns, William/0000-0002-7681-2844; Patel, Chirag/0000-0002-6374-5224; Yu, Timothy W./0000-0003-2988-7701; Crawford, Joanna/0000-0003-0786-6889; Aldinger, Kimberly/0000-0002-5406-8911; Simons, Cas/0000-0003-3147-8042; Yamamoto, Shinya/0000-0003-2172-8036; Azamian, Mahshid/0000-0002-8543-8284; Haendel, Melissa/0000-0001-9114-8737; Urv, Tiina/0000-0002-2040-4972; Fisher, Paul/0000-0002-1196-1590; Lanza, Ian/0000-0002-9858-3384; Bademci, Guney/0000-0002-4052-8833; Brown, Donna/0000-0002-8805-7225; Stong, Nicholas/0000-0002-0678-637X; McCauley, Jacob/0000-0002-1805-1733; Douine, Emilie/0000-0002-6048-2887; Allard, Patrick/0000-0001-7765-1547; Wheeler, Matthew/0000-0001-8721-3022; Oglesbee, Devin/0000-0002-7147-5527	Common Fund of the NIH, Office of the Director; NIH NHGRI Intramural Research Grant; NIH [U54NS093793, R24OD022005, R01GM067858, 1F32 NS110174-01]; Simons Foundation Autism Research Initiative [368479]; SFARI; JPB Foundation; Wellcome Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215, ZIAHG200402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS093793, R01NS050375] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD022005] Funding Source: NIH RePORTER	Common Fund of the NIH, Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NHGRI Intramural Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; SFARI; JPB Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the probands and their families for participating in this study. We thank Dr. Jessica Tenney and Dr. Balram Gangaram (UCSF) for their inputs on proband 3, and Dr. Jill Madden (The Manton Center, Boston Children's Hospital) for facilitating data collection for proband 5. This paper is supported in part by The Common Fund of the NIH, Office of the Director; NIH NHGRI Intramural Research Grant; NIH grants U54NS093793 to H.J.B., M.F.W., and S.Y.; R24OD022005 and R01GM067858 to H.J.B.; 1F32 NS110174-01 Fellowship award to J.C.A.; Simons Foundation Autism Research Initiative (Award#368479) to M.F.W. and S.Y.; and SFARI and the JPB Foundation (W.K.C). We are thankful for the technical assistance provided by Y. Huang (NIH UDP Translational Laboratory) for Sanger sequencing and Ellen Macnamara for facilitating confirmation of mutation in proband 1. We thank the Bloomington Drosophila Stock Center, Drosophila Genomics and Genetic Resources, and FlyORF for numerous stocks and the Developmental Studies Hybridoma Bank for antibodies. This study made use of data generated by the DECIPHER community; a full list of centers that contributed to the generation of the data is available at https://decipher.sanger.ac.uk and via email at decipher@sanger.ac.uk; funding for the project was provided by the Wellcome Trust. H.J.B. is an investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brownstein CA, 2015, HUM MUTAT, V36, P985, DOI 10.1002/humu.22840; Chong JX, 2016, GENET MED, V18, P788, DOI 10.1038/gim.2015.161; Chow CY, 2017, TRENDS GENET, V33, P391, DOI 10.1016/j.tig.2017.03.007; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Gahl WA, 2016, MOL GENET METAB, V117, P393, DOI 10.1016/j.ymgme.2016.01.007; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Kuebler D, 2002, BRAIN RES, V958, P36, DOI 10.1016/S0006-8993(02)03431-5; Kuebler D, 2000, J NEUROPHYSIOL, V83, P998, DOI 10.1152/jn.2000.83.2.998; Leader DP, 2018, NUCLEIC ACIDS RES, V46, pD809, DOI 10.1093/nar/gkx976; Lee PT, 2018, ELIFE, V7, DOI 10.7554/eLife.33007; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Nagarkar-Jaiswal S, 2015, ELIFE, V4, DOI 10.7554/eLife.05338; Oriel C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072041; Parker L, 2011, INT REV NEUROBIOL, V99, P1, DOI 10.1016/B978-0-12-387003-2.00001-X; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Salazar JL, 2018, ADV EXP MED BIOL, V1066, P141, DOI 10.1007/978-3-319-89512-3_8; Sanchez CE, 2012, DEV PSYCHOBIOL, V54, P77, DOI 10.1002/dev.20579; Senturk M, 2018, CURR OPIN NEUROBIOL, V50, P24, DOI 10.1016/j.conb.2017.10.017; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Song J, 2008, PROG NEUROBIOL, V84, P182, DOI 10.1016/j.pneurobio.2007.10.006; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Wang J, 2017, AM J HUM GENET, V100, P843, DOI 10.1016/j.ajhg.2017.04.010; Zou XD, 2016, SCI REP-UK, V6, DOI 10.1038/srep39262	32	23	23	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2019	105	2					413	424		10.1016/j.ajhg.2019.06.014	http://dx.doi.org/10.1016/j.ajhg.2019.06.014			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM5GK	31491411	Bronze, Green Published			2022-12-18	WOS:000478022200015
J	Sapp, JC; Johnston, JJ; Driscoll, K; Heidlebaugh, AR; Sagardia, AM; Dogbe, DN; Umstead, KL; Turbitt, E; Alevizos, I; Baron, J; Bonnemann, C; Brooks, B; Donkervoort, S; Jee, YH; Linehan, WM; McMahon, FJ; Moss, J; Mullikin, JC; Nielsen, D; Pelayo, E; Remaley, AT; Siegel, R; Su, H; Zarate, C; Manolio, TA; Biesecker, BB; Biesecker, LG				Sapp, Julie C.; Johnston, Jennifer J.; Driscoll, Kate; Heidlebaugh, Alexis R.; Sagardia, Ane Miren; Dogbe, D. Nadine; Umstead, Kendall L.; Turbitt, Erin; Alevizos, Ilias; Baron, Jeffrey; Bonnemann, Carsten; Brooks, Brian; Donkervoort, Sandra; Jee, Youn Hee; Linehan, W. Marston; McMahon, Francis J.; Moss, Joel; Mullikin, James C.; Nielsen, Deborah; Pelayo, Eileen; Remaley, Alan T.; Siegel, Richard; Su, Helen; Zarate, Carlos; Manolio, Teri A.; Biesecker, Barbara B.; Biesecker, Leslie G.		NISC Comparative Sequencing	Evaluation of Recipients of Positive and Negative Secondary Findings Evaluations in a Hybrid CLIA-Research Sequencing Pilot	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INCIDENTAL FINDINGS; GENOMIC FINDINGS; INFORMED-CONSENT; RETURN; ASSOCIATION	While consensus regarding the return of secondary genomic findings in the clinical setting has been reached, debate about such findings in the research setting remains. We developed a hybrid, research-clinical translational genomics process for research exome data coupled with a CLIA-validated secondary findings analysis. Eleven intramural investigators from ten institutes at the National Institutes of Health piloted this process. Nearly 1,200 individuals were sequenced and 14 secondary findings were identified in 18 participants. Positive secondary findings were returned by a genetic counselor following a standardized protocol, including referrals for specialty follow-up care for the secondary finding local to the participants. Interviews were undertaken with 13 participants 4 months after receipt of a positive report. These participants reported minimal psychologic distress within a process to assimilate their results. Of the 13, 9 reported accessing the recommended health care services. A sample of 107 participants who received a negative findings report were surveyed 4 months after receiving it. They demonstrated good understanding of the negative secondary findings result and most expressed reassurance (64%) from that report. However, a notable minority (up to 17%) expressed confusion regarding the distinction of primary from secondary findings. This pilot shows it is feasible to couple CLIA-compliant secondary findings to research sequencing with minimal harms. Participants managed the surprise of a secondary finding with most following recommended follow up, yet some with negative findings conflated secondary and primary findings. Additional work is needed to understand barriers to follow-up care and help participants distinguish secondary from primary findings.	[Sapp, Julie C.; Johnston, Jennifer J.; Driscoll, Kate; Biesecker, Leslie G.] NHGRI, Med Genom & Metab Genet Branch, Bethesda, MD 20892 USA; [Heidlebaugh, Alexis R.; Sagardia, Ane Miren; Dogbe, D. Nadine; Umstead, Kendall L.; Turbitt, Erin; Biesecker, Barbara B.] NHGRI, Social & Behav Res Branch, Bethesda, MD 20892 USA; [Alevizos, Ilias; Pelayo, Eileen] Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA; [Baron, Jeffrey; Jee, Youn Hee] NICHHD, Sect Growth Dev, Bethesda, MD 20892 USA; [Bonnemann, Carsten; Donkervoort, Sandra] NINDS, Neuromuscular & Neurogenet Disorders Childhood Se, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Brooks, Brian] NEI, Off Clin Director, Bethesda, MD 20892 USA; [Linehan, W. Marston; Nielsen, Deborah] NCI, Urol Oncol Branch, Bethesda, MD 20892 USA; [McMahon, Francis J.; Zarate, Carlos] NIMH, Human Genet Branch, Bethesda, MD 20892 USA; [Moss, Joel] NHLBI, Lab Translat Res, Bldg 10, Bethesda, MD 20892 USA; [Mullikin, James C.; NISC Comparative Sequencing] NHGRI, NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Remaley, Alan T.] NHLBI, Lipoprotein Metab Lab, Bldg 10, Bethesda, MD 20892 USA; [Siegel, Richard] NIAMSD, Off Clin Director, Bethesda, MD 20892 USA; [Su, Helen] NIAID, Human Immunol Dis Sect, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Manolio, Teri A.] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [Biesecker, Barbara B.] RTI Int, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Research Triangle Institute	Biesecker, LG (corresponding author), NHGRI, Med Genom & Metab Genet Branch, Bethesda, MD 20892 USA.	lesb@mail.nih.gov	Su, Helen C/H-9541-2015; Zarate, Carlos/ABD-6843-2021; Biesecker, Leslie/AAG-2526-2021; Turbitt, Erin/F-7419-2015; McMahon, Francis/A-7290-2009	Su, Helen C/0000-0002-5582-9110; Alevizos, Ilias/0000-0001-5331-1652; Vemulapalli, Meghana/0000-0003-3687-313X; Sapp, Julie/0000-0002-4003-258X; Turbitt, Erin/0000-0002-6650-9702; Biesecker, Barbara/0000-0001-9665-8963; McMahon, Francis/0000-0002-9469-305X	National Institutes of Health; Intramural Research Program of NHGRI [HG200359-09, HG200387-04, HG200317-14]; Office of the Director of the National Human Genome Research Institute; NATIONAL CANCER INSTITUTE [ZIABC011038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200387, ZIBHG000196, Z01HG200317, ZIAHG200359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIDAR041180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002844, ZIAMH002857, ZIAMH002810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of NHGRI; Office of the Director of the National Human Genome Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The CCGO sequencing was funded by the Deputy Director's Challenge Funding Program of the Intramural Research Program of the National Institutes of Health. J.C.S., J.J.J., K.D., A.R.H., K.L.U., E.T., B.B.B., and L.G.B. were funded by the Intramural Research Program of NHGRI including grants HG200359-09, HG200387-04, and HG200317-14. T.A.M. was supported by the Office of the Director of the National Human Genome Research Institute. These individuals supported CCGO by participating in one or more advisory committees: David Adams, Ivona Aksentijevich, Larry Brody, Kenneth Fischbeck, Suzanne Hart, Javed Khan, Paul Meltzer, Sergio Rosenzweig, Wendy Rubinstein, and Jeffrey Schloss. We are grateful to Ashlyn Gruber for assistance in sending out secondary findings reports and to Katie L. Lewis for returning one of the positive results.	Appelbaum PS, 2014, GENET MED, V16, P367, DOI 10.1038/gim.2013.145; Bollinger JM, 2012, GENET MED, V14, P451, DOI 10.1038/gim.2011.66; Darnell AJ, 2016, AM J HUM GENET, V98, P435, DOI 10.1016/j.ajhg.2016.01.010; Facio FM, 2011, EUR J HUM GENET, V19, P1213, DOI 10.1038/ejhg.2011.123; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9; Jarvik GP, 2014, AM J HUM GENET, V94, P818, DOI 10.1016/j.ajhg.2014.04.009; Kaphingst KA, 2012, CLIN GENET, V82, P408, DOI 10.1111/j.1399-0004.2012.01909.x; Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133; Klitzman R, 2013, JAMA-J AM MED ASSOC, V310, P369, DOI 10.1001/jama.2013.41709; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Loud JT, 2016, GENET MED, V18, P1218, DOI 10.1038/gim.2016.36; Pyeritz RE, 2011, NEW ENGL J MED, V365, P1367, DOI 10.1056/NEJMp1107564; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sanderson SC, 2016, GENET MED, V18, P501, DOI 10.1038/gim.2015.118; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; US Presidential Commission for the Study of Bioethical Issues, 2013, ANT COMM ETH MAN INC; Weinfurt KP, 2003, CANCER-AM CANCER SOC, V98, P166, DOI 10.1002/cncr.11483; Wolf SM, 2015, J LAW MED ETHICS, V43, P486, DOI 10.1111/jlme.12291; Wynn J, 2015, J GENET COUNS, V24, P833, DOI 10.1007/s10897-014-9817-1	21	23	23	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 6	2018	103	3					358	366		10.1016/j.ajhg.2018.07.018	http://dx.doi.org/10.1016/j.ajhg.2018.07.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GS6PJ	30122538	Green Published, Bronze			2022-12-18	WOS:000443819500005
J	Tokita, MJ; Chen, CA; Chitayat, D; Macnamara, E; Rosenfeld, JA; Hanchard, N; Lewis, AM; Brown, CW; Marom, R; Shao, YR; Novacic, D; Wolfe, L; Wahl, C; Tifft, CJ; Toro, C; Bernstein, JA; Hale, CL; Silver, J; Hudgins, L; Ananth, A; Hanson-Kahn, A; Shuster, S; Magoulas, PL; Patel, VN; Zhu, WM; Chen, SM; Jiang, YJ; Liu, PF; Eng, CM; Batkovskyte, D; di Ronza, A; Sardiello, M; Lee, BH; Schaaf, CP; Yang, YP; Wang, X				Tokita, Mari J.; Chen, Chun-An; Chitayat, David; Macnamara, Ellen; Rosenfeld, Jill A.; Hanchard, Neil; Lewis, Andrea M.; Brown, Chester W.; Marom, Ronit; Shao, Yunru; Novacic, Danica; Wolfe, Lynne; Wahl, Colleen; Tifft, Cynthia J.; Toro, Camilo; Bernstein, Jonathan A.; Hale, Caitlin L.; Silver, Julia; Hudgins, Louanne; Ananth, Amitha; Hanson-Kahn, Andrea; Shuster, Shirley; Magoulas, Pilar L.; Patel, Vipulkumar N.; Zhu, Wenmiao; Chen, Stella M.; Jiang, Yanjun; Liu, Pengfei; Eng, Christine M.; Batkovskyte, Dominyka; di Ronza, Alberto; Sardiello, Marco; Lee, Brendan H.; Schaaf, Christian P.; Yang, Yaping; Wang, Xia		Undiagnosed Dis Network	De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; PTPN11; BRCA2	TRAF7 is a multi-functional protein involved in diverse signaling pathways and cellular processes. The phenotypic consequence of germ-line TRAF7 variants remains unclear. Here we report missense variants in TRAF7 in seven unrelated individuals referred for clinical exome sequencing. The seven individuals share substantial phenotypic overlap, with developmental delay, congenital heart defects, limb and digital anomalies, and dysmorphic features emerging as key unifying features. The identified variants are de novo in six individuals and comprise four distinct missense changes, including a c.1964G>A (p.Arg655Gln) variant that is recurrent in four individuals. These variants affect evolutionarily conserved amino acids and are located in key functional domains. Gene-specific mutation rate analysis showed that the occurrence of the de novo variants in TRAF7 (p = 2.6 x 10(-3)) and the recurrent de novo c.1964G>A (p.Arg655Gln) variant (p = 1.9 x 10(-8)) in our exome cohort was unlikely to have occurred by chance. In vitro analyses of the observed TRAF7 mutations showed reduced ERK1/2 phosphorylation. Our findings suggest that missense mutations in TRAF7 are associated with a multisystem disorder and provide evidence of a role for TRAF7 in human development.	[Tokita, Mari J.; Chen, Chun-An; Rosenfeld, Jill A.; Hanchard, Neil; Lewis, Andrea M.; Marom, Ronit; Shao, Yunru; Magoulas, Pilar L.; Liu, Pengfei; Eng, Christine M.; Batkovskyte, Dominyka; di Ronza, Alberto; Sardiello, Marco; Lee, Brendan H.; Schaaf, Christian P.; Yang, Yaping; Wang, Xia] Baylor Coll Med, Mol & Human Genet, Houston, TX 77030 USA; [Chitayat, David; Shuster, Shirley] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1Z5, Canada; [Macnamara, Ellen; Novacic, Danica; Wolfe, Lynne; Wahl, Colleen; Tifft, Cynthia J.; Toro, Camilo] NIH, Undiagnosed Dis Program, Bldg 10, Bethesda, MD 20892 USA; [Hanchard, Neil; Lewis, Andrea M.; Marom, Ronit; Shao, Yunru; Magoulas, Pilar L.] Texas Childrens Hosp, Houston, TX 77030 USA; [Brown, Chester W.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38163 USA; [Brown, Chester W.] Le Bonheur Childrens Hosp, Memphis, TN 38103 USA; [Novacic, Danica; Wolfe, Lynne] NHGRI, Off Clin Director, Bethesda, MD 20892 USA; [Bernstein, Jonathan A.; Hudgins, Louanne; Hanson-Kahn, Andrea] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Hale, Caitlin L.; Hanson-Kahn, Andrea] Lucile Packard Childrens Hosp Stanford, Stanford, CA 94305 USA; [Silver, Julia] Univ Calif San Francisco, Prenatal Diagnost Ctr, San Francisco, CA 94158 USA; [Ananth, Amitha] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Patel, Vipulkumar N.; Zhu, Wenmiao; Chen, Stella M.; Jiang, Yanjun; Liu, Pengfei; Eng, Christine M.; Yang, Yaping; Wang, Xia] Baylor Genet, Houston, TX 77021 USA; [Schaaf, Christian P.] Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Schaaf, Christian P.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Schaaf, Christian P.] Univ Hosp Cologne, Ctr Rare Dis, D-50931 Cologne, Germany; [Chen, Chun-An; Schaaf, Christian P.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; National Institutes of Health (NIH) - USA; Baylor College of Medicine; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Stanford University; Lucile Packard Children's Hospital (LPCH); University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; University of Cologne; University of Cologne; University of Cologne; Baylor College of Medicine	Yang, YP; Wang, X (corresponding author), Baylor Coll Med, Mol & Human Genet, Houston, TX 77030 USA.; Yang, YP; Wang, X (corresponding author), Baylor Genet, Houston, TX 77021 USA.	yapingy@bcm.edu; xiaw@bcm.edu	Hanchard, Neil/AAY-9075-2021; Patel, Vipulkumar/ABD-2846-2020; Marom, Ronit/AAU-8204-2020; Schaaf, Christian P/AAJ-7318-2021; Yamamoto, Shinya/ABB-2837-2021; Liu, Pengfei/U-9743-2019; Wang, Xia/O-4036-2014	Hanchard, Neil/0000-0003-1925-2665; Patel, Vipulkumar/0000-0001-6708-6812; Schaaf, Christian P/0000-0002-2148-7490; Yamamoto, Shinya/0000-0003-2172-8036; Liu, Pengfei/0000-0002-4177-709X; Brown, Donna/0000-0002-8805-7225; Marom, Ronit/0000-0003-3524-661X; Wang, Xia/0000-0002-7750-1167; Macnamara, Ellen/0000-0002-9418-3287	Department of Molecular and Human Genetics at Baylor College of Medicine; Intramural Research Program of the NHGRI and the Common Fund, Office of the Director, NIH; Osteogenesis Imperfecta Foundation Michael Geisman Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200402] Funding Source: NIH RePORTER	Department of Molecular and Human Genetics at Baylor College of Medicine; Intramural Research Program of the NHGRI and the Common Fund, Office of the Director, NIH; Osteogenesis Imperfecta Foundation Michael Geisman Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors sincerely thank all the family members for their participation in this study. This work was supported by the departmental fund from the Department of Molecular and Human Genetics at Baylor College of Medicine. This work was supported in part by the Intramural Research Program of the NHGRI and the Common Fund, Office of the Director, NIH. R.M. is supported by the Osteogenesis Imperfecta Foundation Michael Geisman Fellowship.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004; Hanby AM, 2000, INT J CANCER, V88, P204; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Kamm N., 2015, NAT GENET, V47, P582; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Wang X, 2017, NAT GENET, V49, P613, DOI 10.1038/ng.3815; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zotti T, 2017, J CELL PHYSIOL, V232, P1233, DOI 10.1002/jcp.25676; Zotti T, 2012, J CELL PHYSIOL, V227, P1280, DOI 10.1002/jcp.24011	15	23	23	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 5	2018	103	1					154	162		10.1016/j.ajhg.2018.06.005	http://dx.doi.org/10.1016/j.ajhg.2018.06.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM5IG	29961569	Bronze, Green Published			2022-12-18	WOS:000438168800014
J	Xu, ZW; Lo, WS; Beck, DB; Schuch, LA; Olahova, M; Kopajtich, R; Chong, YE; Alston, CL; Seidl, E; Zhai, LT; Lau, CF; Timchak, D; LeDuc, CA; Borczuk, AC; Teich, AF; Juusola, J; Sofeso, C; Muller, C; Pierre, G; Hilliard, T; Turnpenny, PD; Wagner, M; Kappler, M; Brasch, F; Bouffard, JP; Nangle, LA; Yang, XL; Zhang, MJ; Taylor, RW; Prokisch, H; Griese, M; Chung, WK; Schimmel, P				Xu, Zhiwen; Lo, Wing-Sze; Beck, David B.; Schuch, Luise A.; Olahova, Monika; Kopajtich, Robert; Chong, Yeeting E.; Alston, Charlotte L.; Seidl, Elias; Zhai, Liting; Lau, Ching-Fun; Timchak, Donna; LeDuc, Charles A.; Borczuk, Alain C.; Teich, Andrew F.; Juusola, Jane; Sofeso, Christina; Mueller, Christoph; Pierre, Germaine; Hilliard, Tom; Turnpenny, Peter D.; Wagner, Matias; Kappler, Matthias; Brasch, Frank; Bouffard, John Paul; Nangle, Leslie A.; Yang, Xiang-Lei; Zhang, Mingjie; Taylor, Robert W.; Prokisch, Holger; Griese, Matthias; Chung, Wendy K.; Schimmel, Paul			Bi-allelic Mutations in Phe-tRNA Synthetase Associated with a Multi-system Pulmonary Disease Support Non-translational Function	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPOUND HETEROZYGOSITY; GROWTH-RETARDATION; IARS MUTATIONS; BINDING; PATHOGENICITY; NEUROPATHY; VARIANTS; SUNSET; CHILD; ONSET	The tRNA synthetases catalyze the first step of protein synthesis and have increasingly been studied for their nuclear and extra-cellular ex-translational activities. Human genetic conditions such as Charcot-Marie-Tooth have been attributed to dominant gain-of-function mutations in some tRNA synthetases. Unlike dominantly inherited gain-of-function mutations, recessive loss-of-function mutations can potentially elucidate ex-translational activities. We present here five individuals from four families with a multi-system disease associated with bi-allelic mutations in FARSB that encodes the beta chain of the alpha(2)beta(2) phenylalanine-tRNA synthetase (FARS). Collectively, the mutant alleles encompass a 5'-splice junction non-coding variant (SJV) and six missense variants, one of which is shared by unrelated individuals. The clinical condition is characterized by interstitial lung disease, cerebral aneurysms and brain calcifications, and cirrhosis. For the SJV, we confirmed exon skipping leading to a frameshift associated with noncatalytic activity. While the bi-allelic combination of the SJV with a p.Arg305Gln missense mutation in two individuals led to severe disease, cells from neither the asymptomatic heterozygous carriers nor the compound heterozygous affected individual had any defect in protein synthesis. These results support a disease mechanism independent of tRNA synthetase activities in protein translation and suggest that this FARS activity is essential for normal function in multiple organs.	[Xu, Zhiwen; Lo, Wing-Sze; Zhai, Liting; Lau, Ching-Fun; Yang, Xiang-Lei; Zhang, Mingjie; Schimmel, Paul] Hong Kong Univ Sci & Technol, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China; [Xu, Zhiwen; Lo, Wing-Sze; Lau, Ching-Fun] Pangu Biopharma, Edinburgh Tower,15 Queens Rd Cent, Hong Kong, Hong Kong, Peoples R China; [Xu, Zhiwen; Chong, Yeeting E.; Nangle, Leslie A.] ATyr Pharma, 3545 John Hopkins Court,Suite 250, San Diego, CA 92121 USA; [Beck, David B.; Chung, Wendy K.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Beck, David B.] NHGRI, NIH, Bethesda, MD 20892 USA; [Schuch, Luise A.; Seidl, Elias; Kappler, Matthias; Griese, Matthias] Univ Hosp Munich, Dr von Hauner Childrens Hosp, Div Pediat Pneumol, German Ctr Lung Res DZL, Lindwurmstr 4, D-80337 Munich, Germany; [Olahova, Monika; Alston, Charlotte L.; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Med Sch, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kopajtich, Robert; Wagner, Matias; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Kopajtich, Robert; Wagner, Matias; Prokisch, Holger] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Helmholtz Zentrum Munchen, Inst Human Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Timchak, Donna; LeDuc, Charles A.; Chung, Wendy K.] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Timchak, Donna] Atlantic Hlth Syst, Goryeb Childrens Hosp, Morristown, NJ 07960 USA; [Borczuk, Alain C.] Weill Cornell Med, Dept Pathol, New York, NY 10065 USA; [Teich, Andrew F.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Teich, Andrew F.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Juusola, Jane] GeneDx, Gaithersburg, MD 20877 USA; [Sofeso, Christina] Ctr Human Genet & Lab Diagnost AHC Dr Klein Dr Ro, Lochhamer Str 29, D-82152 Martinsried, Germany; [Mueller, Christoph] Univ Freiburg, Univ Med Ctr, Med Fac, Dept Pediat & Adolescent Med, D-79085 Freiburg, Germany; [Pierre, Germaine; Hilliard, Tom] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Hosp Children, Bristol BS2 8BJ, Avon, England; [Turnpenny, Peter D.] Royal Devon & Exeter NHS Fdn Trust, Exeter EX2 5DW, Devon, England; [Wagner, Matias] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Helmholtz Zentrum Munchen, Inst Neurogenom, D-85764 Neuherberg, Germany; [Brasch, Frank] Klinikum Bielefeld Mitte, Inst Pathol, Teutoburger Str 50, D-33604 Bielefeld, Germany; [Bouffard, John Paul] Morristown Mem Hosp, Dept Pathol, Morristown, NJ 07960 USA; [Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Scripps Labs tRNA Synthetase Res, 10650 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Yang, Xiang-Lei] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Schimmel, Paul] Scripps Florida, Scripps Labs tRNA Synthetase Res, 130 Scripps Way, Jupiter, FL 33458 USA	Hong Kong University of Science & Technology; Columbia University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Munich; Newcastle University - UK; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Columbia University; Atlantic Health System; Cornell University; Columbia University; Columbia University; University of Freiburg; Bristol Royal Hospital For Children; University of Bristol; University of Exeter; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Atlantic Health System; Scripps Research Institute; Scripps Research Institute; Hong Kong University of Science & Technology; State University System of Florida; University of Florida	Schimmel, P (corresponding author), Hong Kong Univ Sci & Technol, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China.; Chung, WK (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.; Chung, WK (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10032 USA.; Schimmel, P (corresponding author), Scripps Res Inst, Scripps Labs tRNA Synthetase Res, 10650 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Schimmel, P (corresponding author), Scripps Florida, Scripps Labs tRNA Synthetase Res, 130 Scripps Way, Jupiter, FL 33458 USA.	wkc15@cumc.columbia.edu; schimmel@scripps.edu	Lo, Cario Wing Sze/DGZ-8810-2022; BORCZUK, alain/AHA-5172-2022; Yang, Xiang-Lei/AAR-7107-2020; Alston, Charlotte/ABG-9602-2020; Borczuk, Alain/AFU-5278-2022; Wagner, Matias/L-4532-2019; Chong, Yeeting/AAE-3792-2020; Borczuk, Alain/AAI-8226-2021	Alston, Charlotte/0000-0003-2095-5464; Borczuk, Alain/0000-0001-6807-8064; Wagner, Matias/0000-0002-4454-8823; Borczuk, Alain/0000-0001-6807-8064; Prokisch, Holger/0000-0003-2379-6286; Teich, Andrew/0000-0002-1916-8490; Yang, Xiang-Lei/0000-0003-2554-084X; LeDuc, Charles/0000-0002-2073-5050	aTyr Pharma; National Foundation for Cancer Research; Research Grants Council of Hong Kong [16100015]; JPB Foundation; Simons Foundation; NIH [R01GM088278]; chILD-EU [305653]; Bundesministerium fur Bildung and Forschung (BMBF), Germany; e-rare projects HCQ4Surfdefect; European Union (chILD-EU) [305663, COST A16125]; GENOMIT [01GM1603, 01GM1207]; EU Horizon2020 Collaborative Research Project SOUND [633974]; Else Kroner-Fresenius-Stiftung; European Cooperation in Science and Technology COST [A16125]; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease; Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NHS Highly Specialized Service for Rare Mitochondrial Disorders of Adults and Children; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278] Funding Source: NIH RePORTER	aTyr Pharma; National Foundation for Cancer Research; Research Grants Council of Hong Kong(Hong Kong Research Grants Council); JPB Foundation; Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); chILD-EU; Bundesministerium fur Bildung and Forschung (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); e-rare projects HCQ4Surfdefect; European Union (chILD-EU); GENOMIT; EU Horizon2020 Collaborative Research Project SOUND; Else Kroner-Fresenius-Stiftung; European Cooperation in Science and Technology COST(European Cooperation in Science and Technology (COST)); Wellcome Centre for Mitochondrial Research; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mitochondrial Disease Patient Cohort (UK); Lily Foundation; UK NHS Highly Specialized Service for Rare Mitochondrial Disorders of Adults and Children; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by aTyr Pharma, by a grant from the National Foundation for Cancer Research (to P.S.), by a grant from the Research Grants Council of Hong Kong (16100015 to Z.X.), by funding from the JPB Foundation and the Simons Foundation (W.K.C.), by funding from the NIH (R01GM088278 to X.-L.Y.), by chILD-EU (FP7, No. 305653) (M.G.), the Bundesministerium fur Bildung and Forschung (BMBF), Germany, e-rare projects HCQ4Surfdefect (M.G.), European Union (chILD-EU FP7, 305663, COST A16125) (M.G.), GENOMIT (01GM1603 and 01GM1207) (H.P.), EU Horizon2020 Collaborative Research Project SOUND (633974) (H.P. and R.K.), Else Kroner-Fresenius-Stiftung (M.G.), European Cooperation in Science and Technology COST A16125, Wellcome Centre for Mitochondrial Research (203105/Z/16/Z) (R.W.T.), the Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease (R.W.T.), Mitochondrial Disease Patient Cohort (UK) (G0800674), the Lily Foundation, and the UK NHS Highly Specialized Service for Rare Mitochondrial Disorders of Adults and Children (R.W.T.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Antonellis A, 2018, HUM MUTAT, V39, P834, DOI 10.1002/humu.23424; Brasch F, 2006, AM J RESP CRIT CARE, V174, P571, DOI 10.1164/rccm.200509-1535OC; Cho JS, 2017, EPILEPSY RES, V129, P118, DOI 10.1016/j.eplepsyres.2016.11.022; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Dou XW, 2001, J MOL BIOL, V305, P451, DOI 10.1006/jmbi.2000.4312; Finarov I, 2010, STRUCTURE, V18, P343, DOI 10.1016/j.str.2010.01.002; Fu GS, 2012, J BIOL CHEM, V287, P9330, DOI 10.1074/jbc.C111.325902; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Griese M, 2018, THORAX, V73, P231, DOI 10.1136/thoraxjnl-2017-210519; Griese M, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0610; Guo M, 2014, TOP CURR CHEM, V344, P89, DOI 10.1007/128_2013_424; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/NCHEMBIO.1158, 10.1038/nchembio.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Hadchouel A, 2015, AM J HUM GENET, V96, P826, DOI 10.1016/j.ajhg.2015.03.010; He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kopajtich R, 2016, AM J HUM GENET, V99, P414, DOI 10.1016/j.ajhg.2016.05.027; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lechler A, 1998, J MOL BIOL, V278, P897, DOI 10.1006/jmbi.1998.1744; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; McMillan HJ, 2015, J CHILD NEUROL, V30, P1037, DOI 10.1177/0883073814553272; McMillan HJ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-36; Meyer-Schuman R, 2017, HUM MOL GENET, V26, pR114, DOI 10.1093/hmg/ddx231; Nafisinia M, 2017, EUR J HUM GENET, V25, P1134, DOI 10.1038/ejhg.2017.119; Oprescu SN, 2017, HUM MUTAT, V38, P1412, DOI 10.1002/humu.23287; Orenstein N, 2017, CLIN GENET, V91, P913, DOI 10.1111/cge.12930; Pang YLJ, 2014, WIRES RNA, V5, P461, DOI 10.1002/wrna.1224; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Rossor AM, 2016, CURR OPIN NEUROL, V29, P537, DOI 10.1097/WCO.0000000000000373; Sajish M, 2015, NATURE, V519, P370, DOI 10.1038/nature14028; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/nchembio.937, 10.1038/NCHEMBIO.937]; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Shi Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02349; Simons C., 2013, AM J HUM GENET, V96, P675; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Sleigh JN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10005-w; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Xu XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1686; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhang XC, 2014, AM J HUM GENET, V94, P547, DOI 10.1016/j.ajhg.2014.03.003	54	23	23	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 5	2018	103	1					100	114		10.1016/j.ajhg.2018.06.006	http://dx.doi.org/10.1016/j.ajhg.2018.06.006			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM5IG	29979980	hybrid, Green Published			2022-12-18	WOS:000438168800008
J	Lamers, IJC; Reijnders, MRF; Venselaar, H; Kraus, A; Jansen, S; de Vries, BBA; Houge, G; Gradek, GA; Seo, J; Choi, M; Chae, JH; van der Burgt, I; Pfundt, R; Letteboer, SJF; van Beersum, SEC; Dusseljee, S; Brunner, HG; Doherty, D; Kleefstra, T; Roepman, R				Lamers, Ideke J. C.; Reijnders, Margot R. F.; Venselaar, Hanka; Kraus, Alison; Jansen, Sandra; de Vries, Bert B. A.; Houge, Gunnar; Gradek, Gyri Aasland; Seo, Jieun; Choi, Murim; Chae, Jong-Hee; van der Burgt, Ineke; Pfundt, Rolph; Letteboer, Stef J. F.; van Beersum, Sylvia E. C.; Dusseljee, Simone; Brunner, Han G.; Doherty, Dan; Kleefstra, Tjitske; Roepman, Ronald		DDD Study	Recurrent De Novo Mutations Disturbing the GTP/GDP Binding Pocket of RAB11B Cause Intellectual Disability and a Distinctive Brain Phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							T-CELL LYMPHOMA; RECYCLING ENDOSOME; STRUCTURAL BASIS; IMAGE-ANALYSIS; PROTEIN; GTPASES; MEMBRANE; RHOA; CILIOGENESIS; SPECIFICITY	The Rab GTPase family comprises similar to 70 GTP-binding proteins, functioning in vesicle formation, transport and fusion. They are activated by a conformational change induced by GTP-binding, allowing interactions with downstream effectors. Here, we report five individuals with two recurrent de novo missense mutations in RAB11B; c. 64G>A; p.Val22Met in three individuals and c. 202G>A; p.Ala68Thr in two individuals. An overlapping neurodevelopmental phenotype, including severe intellectual disability with absent speech, epilepsy, and hypotonia was observed in all affected individuals. Additionally, visual problems, musculoskeletal abnormalities, and microcephaly were present in the majority of cases. Re-evaluation of brain MRI images of four individuals showed a shared distinct brain phenotype, consisting of abnormal white matter (severely decreased volume and abnormal signal), thin corpus callosum, cerebellar vermis hypoplasia, optic nerve hypoplasia and mild ventriculomegaly. To compare the effects of both variants with known inactive GDP- and active GTP-bound RAB11B mutants, we modeled the variants on the three-dimensional protein structure and performed subcellular localization studies. We predicted that both variants alter the GTP/GDP binding pocket and show that they both have localization patterns similar to inactive RAB11B. Evaluation of their influence on the affinity of RAB11B to a series of binary interactors, both effectors and guanine nucleotide exchange factors (GEFs), showed induction of RAB11B binding to the GEF SH3BP5, again similar to inactive RAB11B. In conclusion, we report two recurrent dominant mutations in RAB11B leading to a neurodevelopmental syndrome, likely caused by altered GDP/GTP binding that inactivate the protein and induce GEF binding and protein mislocalization.	[Lamers, Ideke J. C.; Letteboer, Stef J. F.; van Beersum, Sylvia E. C.; Dusseljee, Simone; Roepman, Ronald] Radboud Univ Nijmegen, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Lamers, Ideke J. C.; Letteboer, Stef J. F.; van Beersum, Sylvia E. C.; Dusseljee, Simone; Roepman, Ronald] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Reijnders, Margot R. F.; Jansen, Sandra; de Vries, Bert B. A.; Brunner, Han G.; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Reijnders, Margot R. F.; Jansen, Sandra; de Vries, Bert B. A.; Brunner, Han G.; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands; [Kraus, Alison] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds LS7 4SA, W Yorkshire, England; [DDD Study] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Houge, Gunnar; Gradek, Gyri Aasland] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Seo, Jieun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 03080, South Korea; [Choi, Murim; Chae, Jong-Hee] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul 03080, South Korea; [van der Burgt, Ineke; Pfundt, Rolph] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 ER Maastricht, Netherlands; [Brunner, Han G.] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol GROW, NL-6229 ER Maastricht, Netherlands; [Doherty, Dan] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Doherty, Dan] Seattle Childrens Res Inst, Seattle, WA 98195 USA	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Chapel Allerton Hospital; Wellcome Trust Sanger Institute; University of Bergen; Haukeland University Hospital; Seoul National University (SNU); Seoul National University (SNU); Radboud University Nijmegen; Maastricht University; Maastricht University; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Roepman, R (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.; Roepman, R (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands.; Reijnders, MRF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.; Reijnders, MRF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands.	margot.reijnders@radboudumc.nl; ronald.roepman@radboudumc.nl	Letteboer, Stef JF/P-8272-2015; , WaNgtJ/AAR-7045-2020; van Beersum, Sylvia E.C./P-8653-2015; Venselaar, Hanka/D-2009-2016; Pfundt, Rolph/L-4576-2015; Dusseljee, Simone/B-8275-2018; Roepman, Ronald/B-1339-2014; Choi, Murim/AAP-9120-2021; Kleefstra, Tjitske/G-2619-2012; Lamers, Ideke J.C./A-1731-2016	van Beersum, Sylvia E.C./0000-0002-4552-2908; Venselaar, Hanka/0000-0001-9824-6559; Roepman, Ronald/0000-0002-5178-8163; Lamers, Ideke J.C./0000-0003-3491-9667; Jansen, Sandra/0000-0001-9453-8124	Netherlands Organization for Scientific Research [NWO Vici-865.12.005]; Netherlands Organization for Health Research and Development, ZonMw [907-00-365]; TOP grant from the Netherlands Organization for Health Research and Development (ZonMw) [912-12-109]; Health Innovation Challenge Fund [HICF-1009-003]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development, ZonMw(Netherlands Organization for Health Research and Development); TOP grant from the Netherlands Organization for Health Research and Development (ZonMw); Health Innovation Challenge Fund	This work was supported by the Netherlands Organization for Scientific Research (NWO Vici-865.12.005) to R.R., Netherlands Organization for Health Research and Development, ZonMw (grant 907-00-365) to T.K., and by a TOP grant from the Netherlands Organization for Health Research and Development (ZonMw, grant no. 912-12-109) to B.B.A.d.V. and S.J. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003) see Nature 2015; 519:223-8 or http://www.ddduk.org/.	Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; D'Adamo P, 2014, NEUROSCI BIOBEHAV R, V46, P302, DOI 10.1016/j.neubiorev.2013.12.009; Damiano JA, 2017, EPILEPSIA, V58, pE40, DOI 10.1111/epi.13666; Dumas JJ, 1999, STRUCTURE, V7, P413, DOI 10.1016/S0969-2126(99)80054-9; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Feng SS, 2012, J BIOL CHEM, V287, P15602, DOI 10.1074/jbc.M111.333245; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; GOLDENRING JR, 1993, J BIOL CHEM, V268, P18419; Hehnly H, 2012, CURR BIOL, V22, P1944, DOI 10.1016/j.cub.2012.08.022; Houge G, 2011, MOL SYNDROMOL, V2, P60, DOI 10.1159/000335159; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; LAI F, 1994, GENOMICS, V22, P610, DOI 10.1006/geno.1994.1434; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Letteboer SJF, 2008, METHODS MOL BIOL, V484, P145, DOI 10.1007/978-1-59745-398-1_10; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Roosing S, 2014, AM J HUM GENET, V95, P131, DOI 10.1016/j.ajhg.2014.06.012; Sakaguchi A, 2015, DEV CELL, V35, P211, DOI 10.1016/j.devcel.2015.09.013; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Scapin SMN, 2006, J STRUCT BIOL, V154, P260, DOI 10.1016/j.jsb.2006.01.007; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thomas LL, 2016, J CELL BIOL, V215, P499, DOI 10.1083/jcb.201608123; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vaags AK, 2014, ANN NEUROL, V76, P758, DOI 10.1002/ana.24274; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Zhen Y, 2015, J CELL SCI, V128, P3171, DOI 10.1242/jcs.166074	47	23	24	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					824	832		10.1016/j.ajhg.2017.09.015	http://dx.doi.org/10.1016/j.ajhg.2017.09.015			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29106825	Green Published, Bronze			2022-12-18	WOS:000414251600013
J	Lee, JYW; Hsu, CK; Michael, M; Nanda, A; Liu, L; McMillan, JR; Pourreyron, C; Takeichi, T; Tolar, J; Reid, E; Hayday, T; Blumen, SC; Abu-Mouch, S; Straussberg, R; Basel-Vanagaite, L; Barhum, Y; Zouabi, Y; Al-Ajmi, H; Huang, HY; Lin, TC; Akiyama, M; Lee, JYY; McLean, WHI; Simpson, MA; Parsons, M; McGrath, JA				Lee, John Y. W.; Hsu, Chao-Kai; Michael, Magdalene; Nanda, Arti; Liu, Lu; McMillan, James R.; Pourreyron, Celine; Takeichi, Takuya; Tolar, Jakub; Reid, Evan; Hayday, Thomas; Blumen, Sergiu C.; Abu-Mouch, Saif; Straussberg, Rachel; Basel-Vanagaite, Lina; Barhum, Yael; Zouabi, Yasmin; Al-Ajmi, Hejab; Huang, Hsin-Yu; Lin, Ting-Chien; Akiyama, Masashi; Lee, Julia Y. Y.; McLean, W. H. Irwin; Simpson, Michael A.; Parsons, Maddy; McGrath, John A.			Large lntragenic Deletion in DSTYK Underlies Autosomal-Recessive Complicated Spastic Paraparesis, SPG23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-DEATH; VITILIGO; DATABASE; PIGMENTATION; REPLICATION; EXPRESSION; MUTATIONS; KINASES; DISEASE; DOMAIN	SPG23 is an autosomal-recessive neurodegenerative subtype of lower limb spastic paraparesis with additional diffuse skin and hair dyspigmentation at birth followed by further patchy pigment loss during childhood. Previously, genome-wide linkage in an Arab-Israeli pedigree mapped the gene to an approximately 25 cM locus on chromosome 1q24-q32. By using whole-exome sequencing in a further Palestinian-Jordanian SPG23 pedigree, we identified a complex homozygous 4-kb deletion/20-bp insertion in DSTYK (dual serine-threonine and tyrosine protein kinase) in all four affected family members. DSTYK is located within the established linkage region and we also found the same mutation in the previously reported pedigree and another Israeli pedigree (total of ten affected individuals from three different families). The mutation removes the last two exons and part of the 3' UTI2 of DSTYK. Skin biopsies revealed reduced DSTYK protein levels along with focal loss of melanocytes. Ultrastructurally, swollen mitochondria and cytoplasmic vacuoles were also noted in remaining melanocytes and some keratinocytes and fibroblasts. Cultured keratinocytes and fibroblasts from an affected individual, as well as knockdown of Dstyk in mouse melanocytes, keratinocytes, and fibroblasts, were associated with increased cell death after ultraviolet irradiation. Keratinocytes from an affected individual showed loss of kinase activity upon stimulation with fibroblast growth factor. Previously, dominant mutations in DSTYK were implicated in congenital urological developmental disorders, but our study identifies different phenotypic consequences for a recurrent autosomal-recessive deletion mutation in revealing the genetic basis of SPG23.	[Lee, John Y. W.; Takeichi, Takuya; McGrath, John A.] Kings Coll London, St Johns Inst Dermatol, Guys Campus, London SE1 9RT, England; [Hsu, Chao-Kai; Huang, Hsin-Yu; Lin, Ting-Chien; Lee, Julia Y. Y.] Natl Cheng Kung Univ, Dept Dermatol, Natl Cheng Kung Univ Hosp, Coll Med, Tainan 701, Taiwan; [Hsu, Chao-Kai] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 701, Taiwan; [Michael, Magdalene; Hayday, Thomas; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, Guys Campus, London SE1 9RT, England; [Nanda, Arti; Al-Ajmi, Hejab] Al Sabah Hosp, Asad Al Hamad Dermatol Ctr, Kuwait 13001, Kuwait; [Liu, Lu; McMillan, James R.] St Thomas Hosp, Natl Diagnost EB Lab, Viapath, London SE1 7EH, England; [Pourreyron, Celine] Univ Dundee, Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Dundee DD1 9SY, Scotland; [Takeichi, Takuya; Akiyama, Masashi] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4668560, Japan; [Tolar, Jakub] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Tolar, Jakub] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Reid, Evan] Univ Cambridge, CIMR, Cambridge CB2 0XY, England; [Reid, Evan] Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 0QQ, England; [Blumen, Sergiu C.] Hillel Yaffe Med Ctr, Dept Neurol, IL-38100 Hadera, Israel; [Blumen, Sergiu C.] Technion Israel Inst Technol, Rappaport Fac Med, IL-3525433 Haifa, Israel; [Abu-Mouch, Saif] Hillel Yaffe Med Ctr, Liver Unit, Dept Internal Med B, IL-38100 Hadera, Israel; [Straussberg, Rachel; Zouabi, Yasmin] Schneider Childrens Med Ctr, Neurogenet Serv, Neurol Inst, IL-49202 Petah Tiqwa, Israel; [Straussberg, Rachel; Basel-Vanagaite, Lina] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Basel-Vanagaite, Lina] Rabin Med Ctr, Raphael Recanati Genet Inst, Beilinson Campus, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Schneider Childrens Med Ctr, Pediat Genet Unit, IL-49202 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Rabin Med Ctr, Felsenstein Med Res Ctr, IL-4941492 Petah Tiqwa, Israel; [Barhum, Yael] Rabin Med Ctr, Lab Clin Neurosci, Felsenstein Med Res Ctr, IL-4941492 Petah Tiqwa, Israel; [Barhum, Yael] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, IL-69978 Tel Aviv, Israel; [McLean, W. H. Irwin; McGrath, John A.] Univ Dundee, Ctr Dermatol & Genet Med, Div Mol Med, Dundee DD1 5EH, Scotland; [Simpson, Michael A.] Kings Coll London, Dept Med & Mol Genet, Sch Med, Guys Hosp, London SE1 9RT, England	University of London; King's College London; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; University of London; King's College London; Al Sabah Hospital; Guy's & St Thomas' NHS Foundation Trust; University of Dundee; Nagoya University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; University of Dundee; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	McGrath, JA (corresponding author), Kings Coll London, St Johns Inst Dermatol, Guys Campus, London SE1 9RT, England.; McGrath, JA (corresponding author), Univ Dundee, Ctr Dermatol & Genet Med, Div Mol Med, Dundee DD1 5EH, Scotland.	john.mcgrath@kcl.ac.uk	Pourreyron, Celine/AAE-7362-2020; Nanda, Arti/H-8565-2019; Michael, Magdalene/AAR-8700-2020; Reid, Evan/F-3250-2010; McGrath, John/N-3529-2019; Akiyama, Masashi/I-1122-2012; Parsons, Maddy/B-2203-2013; McGrath, John/D-6824-2012; Simpson, Michael/F-4737-2011	Michael, Magdalene/0000-0003-2577-729X; Reid, Evan/0000-0003-1623-7304; Tolar, Jakub/0000-0002-0957-4380; Nanda, Arti/0000-0002-1223-3181; Hsu, Chao-Kai/0000-0003-4365-4533; Akiyama, Masashi/0000-0001-5863-9315; Parsons, Maddy/0000-0002-2021-8379; McGrath, John/0000-0002-3708-9964; Simpson, Michael/0000-0002-8539-8753	Wellcome Trust [098439/Z/12/Z]; MRC [MR/M018512/1]; UK National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre (BRC); King's College London; King's College Hospital NHS Foundation Trust; UK Medical Research Council Project [MR/M00046X/1]; Jean Shanks Foundation [SP3706]; British Association of Dermatologists; St. Thomas' NHS Foundation Trust; MRC [MR/M00046X/1, G0802780] Funding Source: UKRI; Medical Research Council [MR/M018512/1, G0802780, MR/M00046X/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre (BRC); King's College London; King's College Hospital NHS Foundation Trust; UK Medical Research Council Project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Jean Shanks Foundation; British Association of Dermatologists; St. Thomas' NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Centre for Dermatology and Genetic Medicine is supported by a Wellcome Trust Strategic Award (reference 098439/Z/12/Z). The work was supported by the MRC (MR/M018512/1) and the UK National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre (BRC) award to Guy's and St. Thomas' NHS Foundation Trust, in partnership with the King's College London and King's College Hospital NHS Foundation Trust. This study was also supported by UK Medical Research Council Project Grant (MR/M00046X/1) and Action Research grant SP3706 as well as medical student grants from the Jean Shanks Foundation and the British Association of Dermatologists. We thank Akemi Ishida-Yamamoto (Asahikawa, Japan) for help with transmission electron microscopy analysis.	ABDALLAT A, 1980, J NEUROL NEUROSUR PS, V43, P962, DOI 10.1136/jnnp.43.11.962; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Bamforth JS, 2003, CLIN DYSMORPHOL, V12, P137, DOI 10.1097/00019605-200304000-00013; Blumen SC, 2003, ANN NEUROL, V54, P796, DOI 10.1002/ana.10768; Chen JM, 2005, HUM MUTAT, V26, P362, DOI 10.1002/humu.20230; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Hensiek A, 2015, J NEUROL, V262, P1601, DOI 10.1007/s00415-014-7598-y; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Li K, 2014, INT J CLIN EXP PATHO, V7, P6486; LISON M, 1981, AM J MED GENET, V9, P351, DOI 10.1002/ajmg.1320090411; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Mandal S, 2009, J PEDIATR NEUROL, V7, P329, DOI 10.3233/JPN-2009-0306; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; MUKAMEL M, 1985, AM J DIS CHILD, V139, P1090, DOI 10.1001/archpedi.1985.02140130028023; Peng J, 2006, BBA-GENE STRUCT EXPR, V1759, P562, DOI 10.1016/j.bbaexp.2006.10.004; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Qiu FJ, 2012, HUM MUTAT, V33, pE2375, DOI 10.1002/humu.22163; Sanna-Cherchi S, 2013, NEW ENGL J MED, V369, P621, DOI 10.1056/NEJMoa1214479; Sheen CR, 2007, HUM MUTAT, V28, P1198, DOI 10.1002/humu.20591; Shen CB, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00003; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Spritz RA, 2013, J DERMATOL, V40, P310, DOI 10.1111/1346-8138.12147; Zha JK, 2004, BIOCHEM BIOPH RES CO, V319, P298, DOI 10.1016/j.bbrc.2004.04.194	24	23	24	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					364	370		10.1016/j.ajhg.2017.01.014	http://dx.doi.org/10.1016/j.ajhg.2017.01.014			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28157540	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000393352000016
J	Fish, AE; Capra, JA; Bush, WS				Fish, Alexandra E.; Capra, John A.; Bush, William S.			Are Interactions between cis-Regulatory Variants Evidence for Biological Epistasis or Statistical Artifacts?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUALITY-CONTROL; MISSING HERITABILITY; GENOME; LOCI; MAP	The importance of epistasis or statistical interactions between genetic variants to the development of complex disease in humans has been controversial. Genome-wide association studies of statistical interactions influencing human traits have recently become computationally feasible and have identified many putative interactions. However, statistical models used to detect interactions can be confounded, which makes it difficult to be certain that observed statistical interactions are evidence for true molecular epistasis. In this study, we investigate whether there is evidence for epistatic interactions between genetic variants within the cis-regulatory region that influence gene expression after accounting for technical, statistical, and biological confounding factors. We identified 1,119 (FDR = 5%) interactions that appear to regulate gene expression in human lymphoblastoid cell lines, a tightly controlled, largely genetically determined phenotype. Many of these interactions replicated in an independent dataset (90 of 803 tested, Bonferroni threshold). We then performed an exhaustive analysis of both known and novel confounders, including ceiling/floor effects, missing genotype combinations, haplotype effects, single variants tagged through linkage disequilibrium, and population stratification. Every interaction could be explained by at least one of these confounders, and replication in independent datasets did not protect against some confounders. Assuming that the confounding factors provide a more parsimonious explanation for each interaction, we find it unlikely that cis-regulatory interactions contribute strongly to human gene expression, which calls into question the relevance of cis-regulatory interactions for other human phenotypes. We additionally propose several best practices for epistasis testing to protect future studies from confounding.	[Fish, Alexandra E.; Capra, John A.] Vanderbilt Univ, Vanderbilt Genet Inst, 221 Kirkland Hall, Nashville, TN 37235 USA; [Capra, John A.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Capra, John A.] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Capra, John A.] Vanderbilt Univ, Dept Comp Sci, Nashville, TN 37235 USA; [Bush, William S.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Inst Computat Biol, Cleveland, OH 44106 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Case Western Reserve University	Bush, WS (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Inst Computat Biol, Cleveland, OH 44106 USA.	willbush@case.edu	Bush, William/N-1369-2019	Bush, William/0000-0002-9729-6519	NIH [T32GM080178]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Laura Wiley for normalizing gene expression values within the replication dataset. We also thank Jacob Hall, Corinne Simonti, and R. Michael Sivley for their help and advice on this project. This work was supported by a human genetics training grant, T32GM080178, from the NIH.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Becker J, 2012, EUR J HUM GENET, V20, P97, DOI 10.1038/ejhg.2011.156; Bloom JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9712; Brown AA, 2014, ELIFE, V3, DOI 10.7554/eLife.01381; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fiore C, 2016, GENOME RES, V26, P778, DOI 10.1101/gr.200733.115; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Herold C, 2009, BIOINFORMATICS, V25, P3275, DOI 10.1093/bioinformatics/btp596; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kooperberg C, 2008, GENET EPIDEMIOL, V32, P255, DOI 10.1002/gepi.20300; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lewis-Beck M., 2003, SAGE ENCY SOCIAL SCI; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Murk W, 2015, HUM GENET, V134, P837, DOI 10.1007/s00439-015-1564-3; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Pluzhnikov A, 2010, AM J HUM GENET, V87, P123, DOI 10.1016/j.ajhg.2010.06.005; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; Tyler AL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005805; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109; Zuvich RL, 2011, GENET EPIDEMIOL, V35, P887, DOI 10.1002/gepi.20639	43	23	23	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					817	830		10.1016/j.ajhg.2016.07.022	http://dx.doi.org/10.1016/j.ajhg.2016.07.022			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27640306	Green Published, Bronze			2022-12-18	WOS:000385333700003
J	Le Goff, C; Rogers, C; Le Goff, W; Pinto, G; Bonnet, D; Chrabieh, M; Alibeu, O; Nistchke, P; Munnich, A; Picard, C; Cormier-Daire, V				Le Goff, Carine; Rogers, Curtis; Le Goff, Wilfried; Pinto, Graziella; Bonnet, Damien; Chrabieh, Maya; Alibeu, Olivier; Nistchke, Patrick; Munnich, Arnold; Picard, Capucine; Cormier-Daire, Valerie			Heterozygous Mutations in MAP3K7, Encoding TGF-beta-Activated Kinase 1, Cause Cardiospondylocarpofacial Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIGNAL-TRANSDUCTION; CELL LYMPHOMA; TAK1; INFLAMMATION; EXPRESSION; PATHWAY; MAPKKK; TRAF6	Cardiospondylocarpofacial (CSCF) syndrome is characterized by growth retardation, dysmorphic facial features, brachydactyly with carpal-tarsal fusion and extensive posterior cervical vertebral synostosis, cardiac septal defects with valve dysplasia, and deafness with inner ear malformations. Whole-exome sequencing identified heterozygous MAP3K7 mutations in six distinct CSCF-affected individuals from four families and ranging in age from 5 to 37 years. MAP3K7 encodes transforming growth factor beta (TGF-beta)-activated kinase 1 (TAK1), which is involved in the mitogen-activated protein kinase ( MAPK)-p38 signaling pathway. MAPK-p38 signaling was markedly altered when expression of non-canonical TGF-b-driven target genes was impaired. These findings support the loss of transcriptional control of the TGF-beta-MAPK- p38 pathway in fibroblasts obtained from affected individuals. Surprisingly, although TAK1 is located at the crossroad of inflammation, immunity, and cancer, this study reports MAP3K7 mutations in a developmental disorder affecting mainly cartilage, bone, and heart.	[Le Goff, Carine; Munnich, Arnold; Cormier-Daire, Valerie] Paris Descartes Sorbonne Paris Cite Univ, Lab Mol & Physiopathol Bases Osteochondrodysplasi, Reference Ctr Skeletal Dysplasia, Dept Med Genet,INSERM,UMR 1163,AP HP,Inst Imagine, F-75015 Paris, France; [Le Goff, Carine; Munnich, Arnold; Cormier-Daire, Valerie] Hop Univ Necker Enfants Malad, F-75015 Paris, France; [Rogers, Curtis] Greenwood Genet Ctr, Greenville Off, 14 Edgewood Dr, Greenville, SC 29605 USA; [Le Goff, Wilfried] Univ Paris 06, Sorbonne Univ, Integrat Biol Atherosclerosis Team, Inst Cardiometab & Nutr,INSERM,ICAN,UMR S1166, 91 Blvd Hop, F-75013 Paris, France; [Pinto, Graziella] Hop Univ Necker Enfants Malad, Pediat Endocrinol Gynecol & Diabet, Ctr Malad Endocriniennes Rares Croissance, F-75015 Paris, France; [Bonnet, Damien] Univ Paris 05, Hop Univ Necker Enfants Malad, Ctr Reference Malformat Cardiaques Congenitales C, F-75015 Paris, France; [Chrabieh, Maya; Picard, Capucine] Univ Paris 05, Hop Necker Enfants Malad, Lab Human Genet Infect Dis, Necker Branch,UMR 1163,Sorbonne Paris Cite,Inst I, F-75015 Paris, France; [Alibeu, Olivier] Paris Descartes Sorbonne Paris Cite Univ, Inst Imagine, Genom Platform, INSERM,UMR 1163, F-75015 Paris, France; [Nistchke, Patrick] Paris Descartes Sorbonne Paris Cite Univ, Inst Imagine, Bioinformat Platform, INSERM,UMR 1163, F-75015 Paris, France; [Picard, Capucine] Hop Univ Necker Enfants Malad, Pediat Hematol Immunol Rheumatol Unit, AP HP, F-75015 Paris, France; [Picard, Capucine] Hop Univ Necker Enfants Malad, Study Ctr Immuno Deficiencies, AP HP, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Greenwood Genetic Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Cormier-Daire, V (corresponding author), Paris Descartes Sorbonne Paris Cite Univ, Lab Mol & Physiopathol Bases Osteochondrodysplasi, Reference Ctr Skeletal Dysplasia, Dept Med Genet,INSERM,UMR 1163,AP HP,Inst Imagine, F-75015 Paris, France.; Cormier-Daire, V (corresponding author), Hop Univ Necker Enfants Malad, F-75015 Paris, France.	valerie.cormier-daire@inserm.fr	chrabieh, maya/H-7370-2017; LE GOFF, Carine/AAG-2390-2020; Le Goff, Wilfried/N-6326-2017; Le Goff, Carine/N-9940-2017; Le Goff, Wilfried/N-7593-2019; cormier-daire, valerie/H-6520-2017	chrabieh, maya/0000-0003-0772-4805; LE GOFF, Carine/0000-0002-7788-708X; Le Goff, Wilfried/0000-0002-7611-9644; Le Goff, Wilfried/0000-0002-7611-9644; cormier-daire, valerie/0000-0002-2839-9856; Alibeu, Olivier/0000-0001-7984-8378	National Research Agency [ANR-10-IAHU-01]	National Research Agency(French National Research Agency (ANR))	We are grateful to the affected subjects and their families. We would like to thank J.L. Casanova for his comments. This research program has received a state subsidy managed by the National Research Agency under the Investments for the Future program bearing the reference ANR-10-IAHU-01.	Buglio D, 2012, BLOOD, V120, P347, DOI 10.1182/blood-2011-07-369397; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Gao L, 2013, J CELL SCI, V126, P5704, DOI 10.1242/jcs.135483; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Gu J, 2012, EXP CELL RES, V318, P2105, DOI 10.1016/j.yexcr.2012.06.015; Gunnell LM, 2010, J BONE MINER RES, V25, P1784, DOI 10.1002/jbmr.79; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Jung SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3562; Klein OD, 2007, CLIN GENET, V71, P260, DOI 10.1111/j.1399-0004.2007.00757.x; Liu W, 2007, CLIN CANCER RES, V13, P5028, DOI 10.1158/1078-0432.CCR-07-0300; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Sousa SB, 2010, AM J MED GENET A, V152A, P539, DOI 10.1002/ajmg.a.33277; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	17	23	25	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					407	413		10.1016/j.ajhg.2016.06.005	http://dx.doi.org/10.1016/j.ajhg.2016.06.005			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27426734	Green Published, Bronze			2022-12-18	WOS:000381617200011
J	Staples, J; Witherspoon, DJ; Jorde, LB; Nickerson, DA; Below, JE; Huff, CD				Staples, Jeffrey; Witherspoon, David J.; Jorde, Lynn B.; Nickerson, Deborah A.; Below, Jennifer E.; Huff, Chad D.		Univ Washington	PADRE: Pedigree-Aware Distant-Relationship Estimation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; DNA SAMPLES; RARE; INFERENCE; IDENTITY; DESCENT; LINKAGE; FAMILY; HEALTH; COMMON	Accurate estimation of shared ancestry is an important component of many genetic studies; current prediction tools accurately estimate pairwise genetic relationships up to the ninth degree. Pedigree-aware distant-relationship estimation (PADRE) combines relationship likelihoods generated by estimation of recent shared ancestry (ERSA) with likelihoods from family networks reconstructed by pedigree reconstruction and identification of a maximum unrelated set (PRIMUS), improving the power to detect distant relationships between pedigrees. Using PADRE, we estimated relationships from simulated pedigrees and three extended pedigrees, correctly predicting 20% more fourth-through ninth-degree simulated relationships than when using ERSA alone. By leveraging pedigree information, PADRE can even identify genealogical relationships between individuals who are genetically unrelated. For example, although 95% of 13th-degree relatives are genetically unrelated, in simulations, PADRE correctly predicted 50% of 13th-degree relationships to within one degree of relatedness. The improvement in prediction accuracy was consistent between simulated and actual pedigrees. We also applied PADRE to the HapMap3 CEU samples and report new cryptic relationships and validation of previously described relationships between families. PADRE greatly expands the range of relationships that can be estimated by using genetic data in pedigrees.	[Staples, Jeffrey; Nickerson, Deborah A.; Univ Washington] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Witherspoon, David J.; Jorde, Lynn B.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Below, Jennifer E.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Huff, Chad D.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Below, JE (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA.; Huff, CD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	jennifer.e.below@uth.tmc.edu; chad@hufflab.org	Below, Jennifer E/W-2179-2018	Below, Jennifer E/0000-0002-1346-1872; Blue, Elizabeth/0000-0002-0633-0305; Below, Jennifer/0000-0002-6372-6402	National Science Foundation [DGE-0718124]; University of Washington Center for Mendelian Genomics (UW-CMG) - National Human Genome Research Institute; National Heart, Lung and Blood Institute [U54HG006493];  [R01 GM104390]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104390] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); University of Washington Center for Mendelian Genomics (UW-CMG) - National Human Genome Research Institute; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lauren Petty for her helpful comments on the manuscript. J.S. was supported by the National Science Foundation Graduate Research Fellowship under grant DGE-0718124. D.A.N. was supported by the University of Washington Center for Mendelian Genomics (UW-CMG), funded by the National Human Genome Research Institute and the National Heart, Lung and Blood Institute, grant U54HG006493. C.D.H. was supported by R01 GM104390.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Alvarez-Cubero MJ, 2012, PATHOBIOLOGY, V79, P228, DOI 10.1159/000334982; Bellis MA, 2005, J EPIDEMIOL COMMUN H, V59, P749, DOI 10.1136/jech.2005.036517; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2012, ANNU REV GENET, V46, P617, DOI 10.1146/annurev-genet-110711-155534; Browning SR, 2012, GENETICS, V190, P1521, DOI 10.1534/genetics.111.136937; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hu H, 2014, NAT BIOTECHNOL, V32, P663, DOI 10.1038/nbt.2895; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Kerr SM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-38; Li H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004144; Lin TH, 2006, BIOINFORMATICS, V22, pE298, DOI 10.1093/bioinformatics/btl200; Morrison J, 2013, GENET EPIDEMIOL, V37, P635, DOI 10.1002/gepi.21737; Ng CT, 2014, BERNOULLI, V20, P1738, DOI 10.3150/13-BEJ539; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Palamara PF, 2015, AM J HUM GENET, V97, P775, DOI 10.1016/j.ajhg.2015.10.006; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Saad M, 2014, GENET EPIDEMIOL, V38, P579, DOI 10.1002/gepi.21844; Saad M, 2014, GENET EPIDEMIOL, V38, P1, DOI 10.1002/gepi.21776; Staples J, 2014, AM J HUM GENET, V95, P553, DOI 10.1016/j.ajhg.2014.10.005; Staples J, 2013, GENET EPIDEMIOL, V37, P136, DOI 10.1002/gepi.21684; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Wijsman EM, 2012, HUM GENET, V131, P1555, DOI 10.1007/s00439-012-1190-2; Wolf M, 2012, HUM NATURE-INT BIOS, V23, P208, DOI 10.1007/s12110-012-9143-y	28	23	24	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					154	162		10.1016/j.ajhg.2016.05.020	http://dx.doi.org/10.1016/j.ajhg.2016.05.020			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27374771	Green Published, Bronze			2022-12-18	WOS:000381616600012
J	Darnell, AJ; Austin, H; Bluemke, DA; Cannon, RO; Fischbeck, K; Gahl, W; Goldman, D; Grady, C; Greene, MH; Holland, SM; Hull, SC; Porter, FD; Resnik, D; Rubinstein, WS; Biesecker, LG				Darnell, Andrew J.; Austin, Howard; Bluemke, David A.; Cannon, Richard O., III; Fischbeck, Kenneth; Gahl, William; Goldman, David; Grady, Christine; Greene, Mark H.; Holland, Steven M.; Hull, Sara Chandros; Porter, Forbes D.; Resnik, David; Rubinstein, Wendy S.; Biesecker, Leslie G.			A Clinical Service to Support the Return of Secondary Genomic Findings in Human Research	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANAGING INCIDENTAL FINDINGS; GENETICS PROFESSIONALS; EXOME; PERSPECTIVES; PARTICIPANTS; DUTY	Human genome and exome sequencing are powerful research tools that can generate secondary findings beyond the scope of the research. Most secondary genomic findings are of low importance, but some (for a current estimate of 1%-3% of individuals) confer high risk of a serious disease that could be mitigated by timely medical intervention. The impact and scope of secondary findings in genome and exome sequencing will only increase in the future. There is considerable agreement that high-impact findings should be returned to participants, but many researchers performing genomic research studies do not have the background, skills, or resources to identify, verify, interpret, and return such variants. Here, we introduce a proposal for the formation of a secondary-genomic-findings service (SGFS) that would support researchers by enabling the return of clinically actionable sequencing results to research participants in a standardized manner. We describe a proposed structure for such a centralized service and evaluate the advantages and challenges of the approach. We suggest that such a service would be of greater benefit to all parties involved than present practice, which is highly variable. We encourage research centers to consider the adoption of a centralized SGFS.	[Darnell, Andrew J.] Duke Univ, Program Sci & Soc, Durham, NC 27710 USA; [Austin, Howard] NIDDK, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; [Bluemke, David A.] NIH Clin Ctr, Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Cannon, Richard O., III] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Fischbeck, Kenneth] NINCDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Gahl, William] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Goldman, David] NIAAA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Goldman, David] NIAAA, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Grady, Christine; Hull, Sara Chandros] NIH, Clin Res Ctr, Dept Bioeth, Bethesda, MD 20892 USA; [Greene, Mark H.] NCI, Clin Genet Branch, NIH, Bethesda, MD 20892 USA; [Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Hull, Sara Chandros] NHGRI, Bioeth Core, NIH, Bethesda, MD 20892 USA; [Porter, Forbes D.] NICHHD, Sect Mol Dysmorphol, NIH, Bethesda, MD 20892 USA; [Resnik, David] Natl Inst Environm Hlth Sci, Off Director, NIH, Bethesda, MD 20892 USA; [Rubinstein, Wendy S.] NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Informat Engn Branch, Bethesda, MD 20892 USA; [Biesecker, Leslie G.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Biesecker, LG (corresponding author), NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA.	leslieb@helix.nih.gov	Goldman, David/F-9772-2010; Majid, Salma/AAT-2616-2020	Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008824, ZIAHD000139] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200387, ZIAHG000215, ZIDHG200347, ZIDHG200352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bennette CS, 2015, GENET MED, V17, P587, DOI 10.1038/gim.2014.156; Berg JS, 2013, GENET MED, V15, P860, DOI 10.1038/gim.2013.133; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Bollinger JM, 2012, GENET MED, V14, P451, DOI 10.1038/gim.2011.66; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Daack-Hirsch S, 2013, CLIN GENET, V84, P11, DOI 10.1111/cge.12167; Fabsitz RR, 2010, CIRC-CARDIOVASC GENE, V3, P574, DOI 10.1161/CIRCGENETICS.110.958827; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Fernandez CV, 2013, GENET MED, V15, P558, DOI 10.1038/gim.2012.183; Fulda KG, 2006, J MED ETHICS, V32, P143, DOI 10.1136/jme.2004.010272; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Green RC, 2013, JAMA-J AM MED ASSOC, V310, P365, DOI 10.1001/jama.2013.41703; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Haga SB, 2012, GENET TEST MOL BIOMA, V16, P193, DOI 10.1089/gtmb.2011.0118; Hartz SM, 2015, GENET MED, V17, P374, DOI 10.1038/gim.2014.110; hhs, 1979, BELM REP ETH PRINC G; Issues USPCftSoB, 2013, ANT COMM ETH MAN INC; Jarvik GP, 2014, AM J HUM GENET, V94, P818, DOI 10.1016/j.ajhg.2014.04.009; Klitzman R, 2013, GENET MED, V15, P888, DOI 10.1038/gim.2013.87; Klitzman R, 2013, JAMA-J AM MED ASSOC, V310, P369, DOI 10.1001/jama.2013.41709; Knoppers BM, 2013, EUR J HUM GENET, V21, P245, DOI 10.1038/ejhg.2012.152; Lemke AA, 2013, CLIN GENET, V84, P230, DOI 10.1111/cge.12060; Meacham MC, 2010, J EMPIR RES HUM RES, V5, P31, DOI 10.1525/jer.2010.5.3.31; Olsen L., 2007, LEARNING HEALTHCARE, DOI DOI 10.17226/; Pyeritz RE, 2011, NEW ENGL J MED, V365, P1367, DOI 10.1056/NEJMp1107564; Ulrich M, 2013, AM J BIOETHICS, V13, P50, DOI 10.1080/15265161.2012.754067; Watson MS, 2015, GENET MED, V17, DOI [10.1038/gim.2015.94, 10.1038/gim.2014.151]; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23; Yu JH, 2014, AM J HUM GENET, V95, P77, DOI 10.1016/j.ajhg.2014.06.004	30	23	23	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					435	441		10.1016/j.ajhg.2016.01.010	http://dx.doi.org/10.1016/j.ajhg.2016.01.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26942283	Bronze, Green Published			2022-12-18	WOS:000372383100008
J	Symoens, S; Barnes, AM; Gistelinck, C; Malfait, F; Guillemyn, B; Steyaert, W; Syx, D; D'hondt, S; Biervliet, M; De Backer, J; Witten, EP; Leikin, S; Makareeva, E; Gillessen-Kaesbach, G; Huysseune, A; Vleminckx, K; Willaert, A; De Paepe, A; Marini, JC; Coucke, PJ				Symoens, Sofie; Barnes, Aileen M.; Gistelinck, Charlotte; Malfait, Fransiska; Guillemyn, Brecht; Steyaert, Wouter; Syx, Delfien; D'hondt, Sanne; Biervliet, Martine; De Backer, Julie; Witten, Eckhard P.; Leikin, Sergey; Makareeva, Elena; Gillessen-Kaesbach, Gabriele; Huysseune, Ann; Vleminckx, Kris; Willaert, Andy; De Paepe, Anne; Marini, Joan C.; Coucke, Paul J.			Genetic Defects in TAPT1 Disrupt Ciliogenesis and Cause a Complex Lethal Osteochondrodysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OSTEOGENESIS-IMPERFECTA; PRIMARY CILIA; I COLLAGEN; MUTATION CAUSES; IDENTIFICATION; HUMANS; WNT1; DIFFERENTIATION; SUBSTITUTION; CENTROSOME	The evolutionarily conserved transmembrane anterior posterior transformation 1 protein, encoded by TAPT1, is involved in murine axial skeletal patterning, but its cellular function remains unknown. Our study demonstrates that TAPT1 mutations underlie a complex congenital syndrome, showing clinical overlap between lethal skeletal dysplasias and ciliopathies. This syndrome is characterized by fetal lethality, severe hypomineralization of the entire skeleton and intra-uterine fractures, and multiple congenital developmental anomalies affecting the brain, lungs, and kidneys. We establish that wild-type TAPT1 localizes to the centrosome and/or ciliary basal body, whereas defective TAPT1 mislocalizes to the cytoplasm and disrupts Golgi morphology and trafficking and normal primary cilium formation. Knockdown of tapt1b in zebrafish induces severe craniofacial cartilage malformations and delayed ossification, which is shown to be associated with aberrant differentiation of cranial neural crest cells.	[Symoens, Sofie; Gistelinck, Charlotte; Malfait, Fransiska; Guillemyn, Brecht; Steyaert, Wouter; Syx, Delfien; D'hondt, Sanne; De Backer, Julie; Vleminckx, Kris; Willaert, Andy; De Paepe, Anne; Coucke, Paul J.] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Barnes, Aileen M.; Marini, Joan C.] NICHD, NIH, Bone & Extracellular Matrix Branch, Bethesda, MD 20892 USA; [Biervliet, Martine] Brussels Univ Hosp, Ctr Med Genet, B-1090 Brussels, Belgium; [Witten, Eckhard P.; Huysseune, Ann] Univ Ghent, Biol Dept, B-9000 Ghent, Belgium; [Leikin, Sergey; Makareeva, Elena] NICHD, NIH, Sect Phys Biochem, Bethesda, MD 20892 USA; [Gillessen-Kaesbach, Gabriele] Univ Lubeck, Inst Humangenet Lubeck, D-23538 Lubeck, Germany; [Vleminckx, Kris] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University Hospital Brussels; Ghent University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Lubeck; Ghent University	Coucke, PJ (corresponding author), Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium.	paul.coucke@ugent.be	Coucke, Paul J/AAO-2954-2020; De Backer, Julie/B-2897-2014; Makareeva, Elena/F-5183-2011; Vleminckx, Kris/AAZ-4170-2020; Leikin, Sergey/A-5518-2008; Witten, Paul Eckhard/AAY-3113-2020; Steyaert, Wouter/AAB-6700-2019; Willaert, Andy/AAZ-9111-2020	Coucke, Paul J/0000-0001-7119-586X; De Backer, Julie/0000-0001-8878-1507; Makareeva, Elena/0000-0002-5815-0760; Leikin, Sergey/0000-0001-7095-0739; Steyaert, Wouter/0000-0001-8393-0788; Malfait, Fransiska/0000-0002-5010-0304; Willaert, Andy/0000-0002-9543-1932; Witten, Paul Eckhard/0000-0002-2928-5762; Barnes, Aileen/0000-0001-8021-4997; Syx, Delfien/0000-0001-9421-4496	FWO [G.0171.05]; Methusalem grant [08/01M01108]; NICHD, NIH; Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) program [TAP P7/43-BeMGI]; Hercules Foundation, Flanders [AUGE/11/14]	FWO(FWO); Methusalem grant; NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) program; Hercules Foundation, Flanders	We wish to thank P. Tapaneeyaphan, J. Weytens, P. Vermassen, L. Demuynck, P. Simoens, H. De Saffel and M. Soenens for excellent technical assistance. We are grateful to E. Parthoens and Dr. C. Guerin for access to the BioImaging Core, Ghent Platform, VIB. A.M.B. and J.C.M. acknowledge the NICHD Microscopy and Imaging Core. F.M. is a senior clinical investigator at the Fund for Scientific Research-Flanders. Contract grants include FWO grant number G.0171.05 to A.D.P. and Methusalem grant number 08/01M01108 to A.D.P. and NICHD, NIH Intramural Funding went to J.C.M. This work was also supported by funding from the Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) program through the project TAP P7/43-BeMGI. The Leica TCS LSI Super Zoom confocal microscope is supported by the Hercules Foundation, Flanders (grant AUGE/11/14).	Al-Dosari MS, 2010, J MED GENET, V47, P411, DOI 10.1136/jmg.2009.076646; Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Arita M, 2015, AM J PATHOL, V185, P214, DOI 10.1016/j.ajpath.2014.09.003; Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2012, HUM MUTAT, V33, P1589, DOI 10.1002/humu.22139; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Cabral WA, 2005, J BIOL CHEM, V280, P19259, DOI 10.1074/jbc.M414698200; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Ching YH, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-106; Cho TJ, 2012, AM J HUM GENET, V91, P343, DOI 10.1016/j.ajhg.2012.06.005; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Czika W, 2002, AM J HUM GENET, V71, P1235, DOI 10.1086/344290; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Fahiminiya S, 2013, J MED GENET, V50, P345, DOI 10.1136/jmedgenet-2013-101567; Forlino A, 1997, BIOCHEM MOL MED, V62, P26, DOI 10.1006/bmme.1997.2620; Haycraft CJ, 2008, CURR TOP DEV BIOL, V85, P303, DOI 10.1016/S0070-2153(08)00811-9; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Howell GR, 2007, GENETICS, V175, P699, DOI 10.1534/genetics.106.065177; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Mahmood F, 2013, BRAIN, V136, P1488, DOI 10.1093/brain/awt043; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Marini JC, 2013, J CLIN ENDOCR METAB, V98, P3095, DOI 10.1210/jc.2013-1505; Martinez-Glez V, 2012, HUM MUTAT, V33, P343, DOI 10.1002/humu.21647; Mitchell RE, 2013, OSTEOARTHR CARTILAGE, V21, P269, DOI 10.1016/j.joca.2012.11.004; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; Pyott SM, 2013, AM J HUM GENET, V92, P590, DOI 10.1016/j.ajhg.2013.02.009; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Sarig O, 2012, AM J HUM GENET, V91, P337, DOI 10.1016/j.ajhg.2012.06.003; Schmidts M, 2014, J PEDIATR GENET, V3, P49, DOI 10.3233/PGE-14089; Schwend T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-59; Semler O, 2012, AM J HUM GENET, V91, P349, DOI 10.1016/j.ajhg.2012.06.011; Shaheen R, 2012, J MED GENET, V49, P630, DOI 10.1136/jmedgenet-2012-101142; Shaheen R, 2012, AM J HUM GENET, V91, P330, DOI 10.1016/j.ajhg.2012.05.025; SILLENCE DO, 1978, LANCET, V1, P1041; Smits P, 2010, NEW ENGL J MED, V362, P206, DOI 10.1056/NEJMoa0900158; Soltanoff CS, 2009, CRIT REV EUKAR GENE, V19, P1; Sperber SM, 2008, DEV BIOL, V321, P101, DOI 10.1016/j.ydbio.2008.06.004; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Symoens Sofie, 2013, Orphanet J Rare Dis, V8, P154, DOI 10.1186/1750-1172-8-154; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; van Dijk FS, 2013, NEW ENGL J MED, V369, P1529, DOI 10.1056/NEJMoa1308223; van Dijk FS, 2011, PEDIATR DEVEL PATHOL, V14, P228, DOI 10.2350/10-03-0806-CR.1; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Verstraeten Barbara, 2012, Methods Mol Biol, V887, P179, DOI 10.1007/978-1-61779-860-3_16; Vinogradova T, 2012, MOL BIOL CELL, V23, P820, DOI 10.1091/mbc.E11-06-0550; Volodarsky M, 2013, HUM MUTAT, V34, P582, DOI 10.1002/humu.22274; Wu KS, 2012, BIOL OPEN, V1, P559, DOI 10.1242/bio.20121388; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yuan X, 2015, ANN NY ACAD SCI, V1335, P78, DOI 10.1111/nyas.12463	66	23	25	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					521	534		10.1016/j.ajhg.2015.08.009	http://dx.doi.org/10.1016/j.ajhg.2015.08.009			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT2FL	26365339	Green Published, Bronze			2022-12-18	WOS:000362617300003
J	Darabi, H; Mccue, K; Beesley, J; Michailidou, K; Nord, S; Kar, S; Humphreys, K; Thompson, D; Ghoussaini, M; Bolla, MK; Dennis, J; Wang, Q; Canisius, S; Scott, CG; Apicella, C; Hopper, JL; Southey, MC; Stone, J; Broeks, A; Schmidt, MK; Scott, RJ; Lophatananon, A; Muir, K; Beckmann, MW; Ekici, AB; Fasching, PA; Heusinger, K; dos-Santos-Silva, I; Peto, J; Tomlinson, I; Sawyer, EJ; Burwinkel, B; Marme, F; Guenel, P; Truong, T; Bojesen, SE; Flyger, H; Benitez, J; Gonzalez-Neira, A; Anton-Culver, H; Neuhausen, SL; Arndt, V; Brenner, H; Engel, C; Meindl, A; Schmutzler, RK; Arnold, N; Brauch, H; Hamann, U; Chang-Claude, J; Khan, S; Nevanlinna, H; Ito, H; Matsuo, K; Bogdanova, NV; Dork, T; Lindblom, A; Margolin, S; Kosma, VM; Mannermaa, A; Tseng, CC; Wu, AH; Floris, G; Lambrechts, D; Rudolph, A; Peterlongo, P; Radice, P; Couch, FJ; Vachon, C; Giles, GG; McLean, C; Milne, RL; Dugue, PA; Haiman, CA; Maskarinec, G; Woolcott, C; Henderson, BE; Goldberg, MS; Simard, J; Teo, SH; Mariapun, S; Helland, A; Haakensen, V; Zheng, W; Beeghly-Fadiel, A; Tamimi, R; Jukkola-Vuorinen, A; Winqvist, R; Andrulis, IL; Knight, JA; Devilee, P; Tollenaar, RAEM; Figueroa, J; Garcia-Closas, M; Czene, K; Hooning, MJ; Tilanus-Linthorst, M; Li, JM; Gao, YT; Shu, XO; Cox, A; Cross, SS; Luben, R; Khaw, KT; Choi, JY; Kang, D; Hartman, M; Lim, WY; Kabisch, M; Torres, D; Jakubowska, A; Lubinski, J; McKay, J; Sangrajrang, S; Toland, AE; Yannoukakos, D; Shen, CY; Yu, JC; Ziogas, A; Schoemaker, MJ; Swerdlow, A; Borresen-Dale, AL; Kristensen, V; French, JD; Edwards, SL; Dunning, AM; Easton, DF; Hal, P; Chenevix-Trench, G				Darabi, Hatef; Mccue, Karen; Beesley, Jonathan; Michailidou, Kyriaki; Nord, Silje; Kar, Siddhartha; Humphreys, Keith; Thompson, Deborah; Ghoussaini, Maya; Bolla, Manjeet K.; Dennis, Joe; Wang, Qin; Canisius, Sander; Scott, Christopher G.; Apicella, Carmel; Hopper, John L.; Southey, Melissa C.; Stone, Jennifer; Broeks, Annegien; Schmidt, Marjanka K.; Scott, Rodney J.; Lophatananon, Artitaya; Muir, Kenneth; Beckmann, Matthias W.; Ekici, Arif B.; Fasching, Peter A.; Heusinger, Katharina; dos-Santos-Silva, Isabel; Peto, Julian; Tomlinson, Ian; Sawyer, Elinor J.; Burwinkel, Barbara; Marme, Frederik; Guenel, Pascal; Truong, Therese; Bojesen, Stig E.; Flyger, Henrik; Benitez, Javier; Gonzalez-Neira, Anna; Anton-Culver, Hoda; Neuhausen, Susan L.; Arndt, Volker; Brenner, Hermann; Engel, Christoph; Meindl, Alfons; Schmutzler, Rita K.; Arnold, Norbert; Brauch, Hiltrud; Hamann, Ute; Chang-Claude, Jenny; Khan, Sofia; Nevanlinna, Heli; Ito, Hidemi; Matsuo, Keitaro; Bogdanova, Natalia V.; Doerk, Thilo; Lindblom, Annika; Margolin, Sara; Kosma, Veli-Matti; Mannermaa, Arto; Tseng, Chiu-Chen; Wu, Anna H.; Floris, Giuseppe; Lambrechts, Diether; Rudolph, Anja; Peterlongo, Paolo; Radice, Paolo; Couch, Fergus J.; Vachon, Celine; Giles, Graham G.; McLean, Catriona; Milne, Roger L.; Dugue, Pierre-Antoine; Haiman, Christopher A.; Maskarinec, Gertraud; Woolcott, Christy; Henderson, Brian E.; Goldberg, Mark S.; Simard, Jacques; Teo, Soo H.; Mariapun, Shivaani; Helland, Aslaug; Haakensen, Vilde; Zheng, Wei; Beeghly-Fadiel, Alicia; Tamimi, Rulla; Jukkola-Vuorinen, Aria; Winqvist, Robert; Andrulis, Irene L.; Knight, Julia A.; Devilee, Peter; Tollenaar, Robert A. E. M.; Figueroa, Jonine; Garcia-Closas, Montserrat; Czene, Kamila; Hooning, Maartje J.; Tilanus-Linthorst, Madeleine; Li, Jingmei; Gao, Yu-Tang; Shu, Xiao-Ou; Cox, Angela; Cross, Simon S.; Luben, Robert; Khaw, Kay-Tee; Choi, Ji-Yeob; Kang, Daehee; Hartman, Mikael; Lim, Wei Yen; Kabisch, Maria; Torres, Diana; Jakubowska, Anna; Lubinski, Jan; McKay, James; Sangrajrang, Suleeporn; Toland, Amanda E.; Yannoukakos, Drakoulis; Shen, Chen-Yang; Yu, Jyh-Cherng; Ziogas, Argyrios; Schoemaker, Minouk J.; Swerdlow, Anthony; Borresen-Dale, Anne-Lise; Kristensen, Vessela; French, Juliet D.; Edwards, Stacey L.; Dunning, Alison M.; Easton, Douglas F.; Hal, Per; Chenevix-Trench, Georgia		German Consortium Hereditary Breas; kConFab-AOCS Investigators	Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BRCA2 MUTATION CARRIERS; MAMMOGRAPHIC DENSITY; COMMON VARIANTS; GENOTYPE IMPUTATION; ZNF365; TUMORS; ARCHITECTURE; STABILITY; AUTOPHAGY	Genome-wide association studies have identified SNPs near ZNF365 at 10q21.2 that are associated with both breast cancer risk and mammographic density. To identify the most likely causal SNPs, we fine mapped the association signal by genotyping 428 SNPs across the region in 89,050 European and 12,893 Asian case and control subjects from the Breast Cancer Association Consortium. We identified four independent sets of correlated, highly trait-associated variants (iCHAVs), three of which were located within ZNF365. The most strongly risk-associated SNP, rs10995201 in iCHAV1, showed clear evidence of association with both estrogen receptor (ER)-positive (OR = 0.85 10.82-0.881) and ER-negative (OR = 0.87 [0.82-0.911) disease, and was also the SNP most strongly associated with percent mammographic density. iCHAV2 (lead SNP, chr10: 64,258,684:0) and iCHAV3 (lead SNP, rs7922449) were also associated with ER-positive (OR = 0.93 10.91-0.951 and OR = 1.06 [1.03-1.091) and ER-negative (OR = 0.95 [0.91-0.98] and OR = 1.08 [1.04-1.131) disease. There was weaker evidence for iCHAV4, located 5' of ADO, associated only with ER-positive breast cancer (OR = 0.93 [0.90-0.961). We found 12, 17, 18, and 2 candidate causal SNPs for breast cancer in iCHAVs 1-4, respectively. Chromosome conformation capture analysis showed that iCHAV2 interacts with the ZNF365 and NRBF2 (more than 600 kb away) promoters in normal and cancerous breast epithelial cells. Luciferase assays did not identify SNPs that affect transactivation of ZNF365, but identified a protective haplotype in iCHAV2, associated with silencing of the NRBF2 promoter, implicating this gene in the etiology of breast cancer.	[Darabi, Hatef; Humphreys, Keith; Czene, Kamila; Hal, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Mccue, Karen; Beesley, Jonathan; French, Juliet D.; Edwards, Stacey L.; Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Genet, Brisbane, Qld 4006, Australia; [Michailidou, Kyriaki; Thompson, Deborah; Bolla, Manjeet K.; Dennis, Joe; Wang, Qin; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Nord, Silje; Borresen-Dale, Anne-Lise; Kristensen, Vessela] Radiumhosp, Oslo Univ Hosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Nord, Silje] Univ Oslo, Fac Med, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, N-0450 Oslo, Norway; [Kar, Siddhartha; Ghoussaini, Maya; Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Canisius, Sander; Broeks, Annegien; Schmidt, Marjanka K.] Anton van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Apicella, Carmel; Hopper, John L.; Giles, Graham G.; Milne, Roger L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic 3010, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Stone, Jennifer] Univ Western Australia, Ctr Genet Origins Hlth & Dis, Crawley, WA 6009, Australia; [Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci & Pharm, Discipline Med Genet, Fac Hlth, Newcastle, NSW 2308, Australia; [Scott, Rodney J.] John Hunter Hosp, Div Mol Med, Pathol North, Newcastle, NSW 2305, Australia; [Scott, Rodney J.] Hunter Med Res Inst, Newcastle, NSW 2305, Australia; [Lophatananon, Artitaya; Muir, Kenneth] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester M13 9PL, Lancs, England; [Beckmann, Matthias W.; Fasching, Peter A.; Heusinger, Katharina] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, Univ Breast Ctr Franconia,Ctr Erlangen EMN, D-91054 Erlangen, Germany; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Dept Med, Los Angeles, CA 90095 USA; [dos-Santos-Silva, Isabel; Peto, Julian] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemol, London WC1E 7HT, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford OX3 7BN, England; [Sawyer, Elinor J.] Guys Hosp, Div Canc Studies, Kings Coll London, Res Oncol, London SE1 9RT, England; [Burwinkel, Barbara; Marme, Frederik] Heidelberg Univ, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Burwinkel, Barbara] German Canc Res Ctr DZFK, Div Mol Gent Epidemiol, D-69047 Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Dept Obstet & Gynecol, D-69120 Heidelberg, Germany; [Guenel, Pascal; Truong, Therese] Univ Paris Sud, UMRS 1018, F-94807 Villejuif, France; [Guenel, Pascal; Truong, Therese] INSERM Natl Inst Hlth & Med Res, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Environm Epidemiol Canc, F-94807 Villejuif, France; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Bojesen, Stig E.] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, DK-2730 Herlev, Denmark; [Benitez, Javier; Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Gen CEGEN Unit, Madrid 28029, Spain; [Benitez, Javier] Spanish Natl Canc Ctr CNIO, Human Genet Grp, Madrid 28029, Spain; [Benitez, Javier] Biomed Network Rare Dis CIBERER, Madrid 28029, Spain; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92697 USA; [Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Arndt, Volker; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, D-69120 Heidelberg, Germany; [Brenner, Hermann; Brauch, Hiltrud] German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04107 Leipzig, Germany; [Meindl, Alfons] Tech Univ Munich, Div Gynaecol & Obstet, D-81675 Munich, Germany; [Schmutzler, Rita K.] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50932 Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Fac Med, Ctr Hereditary Breast & Ovarian Canc, D-50937 Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Fac Med, Ctr Integrated Oncol CIO, D-50937 Cologne, Germany; [Arnold, Norbert] Univ Kiel, Dept Obstet & Gynaecol, Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, D-72074 Tubingen, Germany; [Hamann, Ute; Kabisch, Maria; Torres, Diana] German Canc Res Ctr, Mol Genet Breast Canc, D-69120 Heidelberg, Germany; [Chang-Claude, Jenny; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Khan, Sofia; Nevanlinna, Heli] Univ Helsinki, Dept Obstet & Gynecol, Helsinki 00029, HUS, Finland; [Khan, Sofia; Nevanlinna, Heli] Helsinki Univ Hosp, Helsinki 00029, HUS, Finland; [Ito, Hidemi] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 4648681, Japan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 8128582, Japan; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; [Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, D-30625 Hannover, Germany; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden; [Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Sch Med, Kuopio 70211, Finland; [Kosma, Veli-Matti; Mannermaa, Arto] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, Kuopio 70211, Finland; [Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio 70211, Finland; [Tseng, Chiu-Chen; Wu, Anna H.; Haiman, Christopher A.; Henderson, Brian E.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Floris, Giuseppe] Univ Hosp Gashuisberg, B-3000 Leuven, Belgium; [Lambrechts, Diether] VIB, Vesalius Res Ctr VRC, B-3000 Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Leuven, Belgium; [Peterlongo, Paolo] IFOM, Inst Mol Oncol, I-20139 Milan, Italy; [Radice, Paolo] INT, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent & Predict Med, Fdn IRCCS Ist Ricovero & Cura Carattere Sci, I-20133 Milan, Italy; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Giles, Graham G.; Milne, Roger L.; Dugue, Pierre-Antoine] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic 3053, Australia; [McLean, Catriona] Alfred Hosp, Anat Pathol, Melbourne, Vic 3004, Australia; [Maskarinec, Gertraud] Univ Hawaii, Canc Epidemiol Program, Ctr Canc, Honolulu, HI 96813 USA; [Woolcott, Christy] Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS B3H 4R2, Canada; [Woolcott, Christy] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 4R2, Canada; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ H3A 1W7, Canada; [Simard, Jacques] McGill Univ, Royal Victoria Hosp, Div Clin Epidemiol, Ctr Hlth, Montreal, PQ H3H 2R9, Canada; [Simard, Jacques] Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Simard, Jacques] Univ Laval, Quebec City, PQ G1V 4G2, Canada; [Teo, Soo H.; Mariapun, Shivaani] Univ Malaya, Med Ctr UMMC, Breast Canc Res Unit, Canc Res Inst, Kuala Lumpur 50603, Malaysia; [Teo, Soo H.; Mariapun, Shivaani] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya 47500, Malaysia; [Helland, Aslaug] Radiumhosp, Oslo Univ Hosp, Dept Oncol, N-0310 Oslo, Norway; [Haakensen, Vilde] Radiumhosp, Oslo Univ Hosp, Dept Genet, N-0310 Oslo, Norway; [Zheng, Wei; Beeghly-Fadiel, Alicia; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37203 USA; [Tamimi, Rulla] Brigham & Womens Hosp, Dept Med, Charming Div Network Med, Boston, MA 02115 USA; [Tamimi, Rulla] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Tamimi, Rulla] Harvard Univ, Sch Med, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Tamimi, Rulla] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Jukkola-Vuorinen, Aria] Oulu Univ Hosp, Dept Oncol, Oulu 90014, Finland; [Jukkola-Vuorinen, Aria] Univ Oulu, Oulu 90014, Finland; [Winqvist, Robert] Univ Oulu, Lab Canc Genet & Tumor Biol, Dept Clin Chem, Oulu 90014, Finland; [Winqvist, Robert] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Winqvist, Robert] Northern Finland Lab Ctr NordLab, Lab Canc Genet & Tumor Biol, Oulu 90220, Finland; [Andrulis, Irene L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3G3, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Lab Med, Toronto, ON M5S 3G3, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Pathobiol, Toronto, ON M5S 3G3, Canada; [Knight, Julia A.] Mt Sinai Hosp, Prosserman Ctr Hlth Res, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON M5S 3G3, Canada; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Dept Pathol, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Tollenaar, Robert A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, NL-2333 ZC Leiden, Netherlands; [Figueroa, Jonine] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA; [Garcia-Closas, Montserrat; Schoemaker, Minouk J.; Swerdlow, Anthony] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Garcia-Closas, Montserrat] Breakthrough Breast Canc Res Ctr, Div Canc Studies, London SW3 6JB, England; [Hooning, Maartje J.] Erasmus MC Canc Inst, Dept Med Oncol, NL-3008 AE Rotterdam, Netherlands; [Tilanus-Linthorst, Madeleine] Erasmus Univ, Med Ctr, Dept Surg Oncol, NL-3075 EA Rotterdam, Netherlands; [Li, Jingmei] Genome Inst Singapore, Div Human Genet, Singapore 138672, Singapore; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai 200031, Peoples R China; [Cox, Angela] Univ Sheffield, Dept Oncol, Canc Res Ctr, Sheffield S10 2RX, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Sheffield S10 2HQ, S Yorkshire, England; [Luben, Robert] Univ Cambridge, Dept Publ Hlth & Primary Care, Clin Gerontol, Cambridge CB1 8RN, England; [Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; [Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul 110799, South Korea; [Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 110799, South Korea; [Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 110799, South Korea; [Hartman, Mikael; Lim, Wei Yen] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Hartman, Mikael; Lim, Wei Yen] Natl Univ Singapore, Dept Surg, Singapore 117597, Singapore; [Lim, Wei Yen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 119228, Singapore; [Lim, Wei Yen] Natl Univ Hlth Syst, Singapore 119228, Singapore; [Torres, Diana] Pontificia Univ Javeriana, Inst Human Genet, Bogota 12362, Colombia; [Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, PL-70115 Szczecin, Poland; [McKay, James] Int Agcy Res Canc, F-69372 Lyon 08, France; [Sangrajrang, Suleeporn] Natl Canc Inst, Bangkok 10400, Thailand; [Toland, Amanda E.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Yannoukakos, Drakoulis] Aghia Paraskevi Attikis, Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, IRRP, Athens 15310, Greece; [Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei 115, Taiwan; [Shen, Chen-Yang] China Med Univ, Sch Publ Hlth, Taichung 40402, Taiwan; [Yu, Jyh-Cherng] Triserv Gen Hosp, Dept Surg, Taipei 114, Taiwan; [Swerdlow, Anthony] Inst Canc Res, Div Breast Canc Res, Sutton SM2 5NG, Surrey, England; [Borresen-Dale, Anne-Lise; Kristensen, Vessela] Univ Oslo UiO, Inst Clin Med, N-0316 Oslo, Norway; [Kristensen, Vessela] Univ Oslo UiO, Dept Clin Mol Biol EpiGen, N-0316 Oslo, Norway	Karolinska Institutet; QIMR Berghofer Medical Research Institute; University of Cambridge; University of Oslo; University of Oslo; University of Cambridge; Netherlands Cancer Institute; University of Melbourne; University of Melbourne; University of Western Australia; University of Newcastle; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; University of Warwick; University of Manchester; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of California System; University of California Irvine; City of Hope; Beckman Research Institute of City of Hope; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Leipzig University; Technical University of Munich; University of Cologne; University of Cologne; University of Cologne; University of Kiel; Schleswig Holstein University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Hyvinkaan Sairaala; University of Helsinki; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; Aichi Cancer Center; Kyushu University; Hannover Medical School; Hannover Medical School; Karolinska Institutet; Karolinska Institutet; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Southern California; Flanders Institute for Biotechnology (VIB); KU Leuven; IFOM - FIRC Institute of Molecular Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Mayo Clinic; Cancer Council Victoria; Florey Institute of Neuroscience & Mental Health; Cancer Research Center of Hawaii; University of Hawaii System; Dalhousie University; Dalhousie University; McGill University; McGill University; Royal Victoria Hospital; Laval University; Laval University; Universiti Malaya; University of Oslo; University of Oslo; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Shanghai Jiao Tong University; University of Sheffield; University of Sheffield; University of Cambridge; University of Cambridge; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Pontificia Universidad Javeriana; Pomeranian Medical University; World Health Organization; International Agency for Research on Cancer (IARC); National Cancer Institute - Thailand; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Centre of Scientific Research "Demokritos"; Academia Sinica - Taiwan; China Medical University Taiwan; Tri-Service General Hospital; University of London; Institute of Cancer Research - UK; University of Oslo; University of Oslo	Chenevix-Trench, G (corresponding author), QIMR Berghofer Med Res Inst, Dept Genet, Brisbane, Qld 4006, Australia.	georgia.trench@qimr.edu.au	Teo, Soo-hwang/H-2353-2014; Jakubowska, Anna/O-8050-2014; Chenevix-Trench, Georgia/AAV-2014-2020; Arndt, Volker/B-4999-2014; Figueroa, Jonine/AAG-1065-2022; Figueroa, Jonine/AFK-2752-2022; Nord, Silje/R-5212-2016; Radice, Paolo/O-3119-2013; Khaw, Kay-Tee/AAZ-3209-2021; Stone, Jennifer/AAS-3805-2020; zhang, weihua/GXV-1334-2022; French, Juliet/AAV-4435-2020; Ekici, Arif B/C-3971-2013; Figueroa, Jonine/GWD-1322-2022; Schmidt, Marjanka K/G-9058-2011; Guenel, Pascal/AAS-7688-2021; Gonzalez-Neira, Anna/C-5791-2015; Margolin, Sara/AAX-9034-2020; Dörk, Thilo/J-8620-2012; Zheng, Wei/O-3351-2013; truong, therese/A-2837-2013; Edwards, Stacey/A-4980-2011; Garcia-Closas, Montserrat/AAZ-6930-2021; gao, yi/HCI-8298-2022; Fasching, Peter A/ABH-9912-2020; Guenel, Pascal/H-3728-2018; Lambrechts, Diether/AAJ-3167-2020; Bogdanova, Natalia V./Y-2205-2019; Andrulis, Irene L./E-7267-2013; Arndt, Volker/AAI-7282-2020; Li, Jingmei/I-2904-2012; DEVILEE, PETER/ABR-2140-2022; Arnold, Norbert/E-3012-2010; Brenner, Hermann/ABE-6383-2020; Matsuo, Keitaro/H-6758-2019; Devilee, Peter/GXV-8005-2022; Haviv, Izhak/E-3782-2015; Gao, Y./GWZ-3665-2022; Floris, Giuseppe/AFL-6620-2022; Flyger, Henrik/AAM-6494-2021; Helland, Åslaug/H-3910-2015; Brenner, Hermann/B-4627-2017; Gao, Yu/HGE-1937-2022; Peterlongo, Paolo/Q-4717-2018; Knight, Julia/R-5617-2019; Luben, Robert N/H-5519-2015; /AAM-5330-2020; Floris, Giuseppe/AAG-6754-2022; Michailidou, Kyriaki/ABD-5122-2020; Knight, Julia/A-6843-2012; benitez, javier/H-5232-2015; Scott, Rodney/B-2827-2013; Hartman, Mikael/B-4324-2011	Jakubowska, Anna/0000-0002-5650-0501; Chenevix-Trench, Georgia/0000-0002-1878-2587; Arndt, Volker/0000-0001-9320-8684; Figueroa, Jonine/0000-0002-5100-623X; Figueroa, Jonine/0000-0002-5100-623X; Nord, Silje/0000-0002-3271-5356; Radice, Paolo/0000-0001-6298-4111; French, Juliet/0000-0002-9770-0198; Ekici, Arif B/0000-0001-6099-7066; Figueroa, Jonine/0000-0002-5100-623X; Schmidt, Marjanka K/0000-0002-2228-429X; Guenel, Pascal/0000-0002-8359-518X; Gonzalez-Neira, Anna/0000-0002-5421-2020; Dörk, Thilo/0000-0002-9458-0282; Zheng, Wei/0000-0003-1226-070X; truong, therese/0000-0002-2943-6786; Garcia-Closas, Montserrat/0000-0003-1033-2650; Fasching, Peter A/0000-0003-4885-8471; Guenel, Pascal/0000-0002-8359-518X; Lambrechts, Diether/0000-0002-3429-302X; Arndt, Volker/0000-0001-9320-8684; Li, Jingmei/0000-0001-8587-7511; Arnold, Norbert/0000-0003-4523-8808; Brenner, Hermann/0000-0002-6129-1572; Matsuo, Keitaro/0000-0003-1761-6314; Haviv, Izhak/0000-0002-0837-5005; Floris, Giuseppe/0000-0003-2391-5425; Helland, Åslaug/0000-0002-5520-0275; Brenner, Hermann/0000-0002-6129-1572; Peterlongo, Paolo/0000-0001-6951-6855; Knight, Julia/0000-0002-7610-7635; Luben, Robert N/0000-0002-5088-6343; Floris, Giuseppe/0000-0003-2391-5425; Michailidou, Kyriaki/0000-0001-7065-1237; benitez, javier/0000-0002-0923-7202; Bojesen, Stig/0000-0002-4061-4133; Devilee, Peter/0000-0002-8023-2009; McLean, Catriona/0000-0002-0302-5727; Beesley, Jonathan/0000-0003-1942-325X; Scott, Rodney/0000-0001-7724-3404; DUGUE, PIERRE-ANTOINE/0000-0003-2736-3023; Dunning, Alison Margaret/0000-0001-6651-7166; Durocher, Francine/0000-0001-8012-4641; Hartman, Mikael/0000-0001-5726-9965; Lubinski, Jan/0000-0003-2931-3003; Yannoukakos, Drakoulis/0000-0001-7509-3510; Engel, Christoph/0000-0002-7247-282X; Cox, Angela/0000-0002-5138-1099; Kang, Daehee/0000-0003-4031-5878; Kar, Siddhartha P./0000-0002-2314-1426; Cross, Simon/0000-0003-2044-1754; Thorne, Heather/0000-0003-3610-2511; Margolin, Sara/0000-0002-5526-5570; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Giles, Graham/0000-0003-4946-9099; dos Santos Silva, Isabel/0000-0002-6596-8798; Winqvist, Robert/0000-0003-0932-9104; Stone, Jennifer/0000-0001-5077-0124; Brauch, Hiltrud/0000-0001-7531-2736; Simard, Jacques/0000-0001-6906-3390; Woolcott, Christy/0000-0002-4606-3125; Schoemaker, Minouk/0000-0001-8403-2234; Southey, Melissa/0000-0002-6313-9005; Khan, Sofia/0000-0003-4185-8882; Swerdlow, Anthony/0000-0001-5550-4159	NATIONAL CANCER INSTITUTE [R01CA176785, P01CA082267, R01CA128978, ZIACP010126, P50CA116201, U01CA116167] Funding Source: NIH RePORTER; Cancer Research UK [16563, 16565] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, 03/DHCS/03/G121/51] Funding Source: researchfish; Cancer Foundation Finland sr [130168] Funding Source: researchfish; National Breast Cancer Foundation [ECF-12-04, PF-11-20] Funding Source: researchfish; Cancer Research UK [14136] Funding Source: Medline; Medical Research Council [G0401527, G1000143] Funding Source: Medline; NCI NIH HHS [R01 CA176785, P01 CA082267, U01 CA116167, P50 CA116201, R01 CA128978] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Foundation Finland sr; National Breast Cancer Foundation; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antoniou AC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3121; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213; Couch FJ, 2012, CANCER EPIDEM BIOMAR, V21, P645, DOI 10.1158/1055-9965.EPI-11-0888; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Eriksson N, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-53; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Guo Q, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv081; Haakensen VD, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-77; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Larsson J, 2008, MOL CELL NEUROSCI, V39, P32, DOI 10.1016/j.mcn.2008.05.013; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Quigley DA, 2014, MOL ONCOL, V8, P273, DOI 10.1016/j.molonc.2013.11.008; Spencer AV, 2014, ANN HUM GENET, V78, P50, DOI 10.1111/ahg.12043; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Vachon CM, 2012, CANCER EPIDEM BIOMAR, V21, P1156, DOI 10.1158/1055-9965.EPI-12-0066; Varghese JS, 2012, CANCER RES, V72, P1478, DOI 10.1158/0008-5472.CAN-11-3295; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yasumo H, 2000, BBA-GENE STRUCT EXPR, V1490, P189, DOI 10.1016/S0167-4781(99)00244-4; Zhang YQ, 2013, CELL CYCLE, V12, P2817, DOI 10.4161/cc.25882; Zhang YQ, 2013, CANCER DISCOV, V3, P798, DOI 10.1158/2159-8290.CD-12-0536; Zheng W, 2013, HUM MOL GENET, V22, P2539, DOI 10.1093/hmg/ddt089; Zhong Y, 2014, J BIOL CHEM, V289, P26021, DOI 10.1074/jbc.M114.561134	38	23	25	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					22	34		10.1016/j.ajhg.2015.05.002	http://dx.doi.org/10.1016/j.ajhg.2015.05.002			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26073781	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000358189500003
J	Lim, ET; Liu, YFP; Chan, YL; Tiinamaija, T; Karajamaki, A; Madsen, E; Altshuler, DM; Raychaudhuri, S; Groop, L; Fannick, J; Hirschhorn, JN; Katsanis, N; Daly, MJ				Lim, Elaine T.; Liu, Yangfan P.; Chan, Yingleong; Tiinamaija, Tuomi; Karajamaki, AnnMari; Madsen, Erik; Altshuler, David M.; Raychaudhuri, Soumya; Groop, Leif; Fannick, Jason; Hirschhorn, Joel N.; Katsanis, Nicholas; Daly, Mark J.		Go-T2D Consortium	A Novel Test for Recessive Contributions to Complex Diseases Implicates Bardet-Biedl Syndrome Gene BBS10 in Idiopathic Type 2 Diabetes and Obesity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALZHEIMERS-DISEASE; VARIANTS; ASSOCIATION; DISRUPTION; CILIOPATHY; MUTATIONS; AUTISM; GWAS	Rare-variant association studies in common, complex diseases are customarily conducted under an additive risk model in both single-variant and burden testing. Here, we describe a method to improve detection of rare recessive variants in complex diseases termed RAFT (recessive-allele-frequency-based test). We found that RAFT outperforms existing approaches when the variant influences disease risk in a recessive manner on simulated data. We then applied our method to 1,791 Finnish individuals with type 2 diabetes (T2D) and 2,657 matched control subjects. In BBS10, we discovered a rare variant (c.1189A>G [p.Ile397Val]; rs202042386) that confers risk of T2D in a recessive state (p = 1.38 x 10(-6)) and would be missed by conventional methods. Testing of this variant in an established in vivo zebrafish model confirmed the variant to be pathogenic. Taken together, these data suggest that RAFT can effectively reveal rare recessive contributions to complex diseases overlooked by conventional association tests.	[Lim, Elaine T.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA; [Lim, Elaine T.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Lim, Elaine T.; Chan, Yingleong; Altshuler, David M.; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lim, Elaine T.; Chan, Yingleong; Altshuler, David M.; Raychaudhuri, Soumya; Fannick, Jason; Hirschhorn, Joel N.; Daly, Mark J.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Liu, Yangfan P.; Madsen, Erik; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Chan, Yingleong; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Chan, Yingleong; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Chan, Yingleong; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Tiinamaija, Tuomi] Univ Helsinki, Cent Hosp, Dept Internal Med Diabetol, Helsinki 00029, Finland; [Tiinamaija, Tuomi] Univ Helsinki, Folkhalsan Res Ctr, Inst Diabet Genet, FIN-00014 Helsinki, Finland; [Tiinamaija, Tuomi] Univ Helsinki, Res Program Diabet & Obes, FIN-00014 Helsinki, Finland; [Karajamaki, AnnMari] Vaasa Cent Hosp, Dept Primary Hlth Care, Vaasa 65130, Finland; [Karajamaki, AnnMari] Vaasa Hlth Care Ctr, Ctr Diabet, Vaasa 65100, Finland; [Altshuler, David M.; Fannick, Jason] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Raychaudhuri, Soumya] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Univ Manchester, Ctr Musculoskeletal Res, Inst Inflammat & Repair, Arthrit Res UK Epidemiol Unit, Manchester M13 9PT, Lancs, England; [Groop, Leif] Univ Helsinki, Inst Mol Med Finland, FIN-00014 Helsinki, Finland; [Groop, Leif] Lund Univ, Skane Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Ctr Diabet, S-20502 Malmo, Sweden; [Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Duke University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Helsinki; University of Helsinki; Vaasa Central Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Manchester; University of Helsinki; Lund University; Skane University Hospital; Harvard University; Massachusetts General Hospital	Lim, ET (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA.	tengting.lim@childrens.harvard.edu; mjdaly@atgu.mgh.harvard.edu	Daly, Mark J/B-2453-2017; Altshuler, David M/A-4476-2009; Lim, Elaine/H-9032-2016	Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; Karajamaki, Annemari/0000-0001-9115-5611; Raychaudhuri, Soumya/0000-0002-1901-8265; Lim, Teng Ting/0000-0003-3651-0654; Katsanis, Nicholas/0000-0002-2480-0171; Tuomi, Tiinamaija/0000-0002-8306-6202	NIH [R37GM04360, R01HD04260, R01DK072301, R01DK075972]; Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601, T32HD043029] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102923, RC2HL102925, UC2HL102925, RC2HL102926, UC2HL103010, RC2HL103010, RC2HL102923, UC2HL102926, RC2HL102924, UC2HL102924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972, R01DK072301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Botnia PPP and Direva studies are supported by grants from Academy of Finland and the Juselius and Folkhalsan Foundations. The in vivo functional study is supported by NIH grants R37GM04360, R01HD04260, R01DK072301, and R01DK075972 (N.K.). The authors would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010). Finally, the authors would also like to thank anonymous reviewers 1 and 2 for their words of encouragement and insightful, detailed feedback, which have helped improve this manuscript substantially.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Beales PL, 1999, J MED GENET, V36, P437; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Chan YL, 2014, AM J HUM GENET, V94, P437, DOI 10.1016/j.ajhg.2014.02.006; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cruchaga C, 2013, NEURON, V78, P256, DOI 10.1016/j.neuron.2013.02.026; Forsythe E, 2013, EUR J HUM GENET, V21, P8, DOI 10.1038/ejhg.2012.115; Gamsiz ED, 2013, AM J HUM GENET, V93, P103, DOI 10.1016/j.ajhg.2013.06.004; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harris JM, 2013, BLOOD, V121, P2483, DOI 10.1182/blood-2012-12-471201; Imhoff O, 2011, CLIN J AM SOC NEPHRO, V6, P22, DOI 10.2215/CJN.03320410; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kaneko M, 2010, NEUROPATHOLOGY; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Kenny EE, 2012, SCIENCE, V336, P554, DOI 10.1126/science.1217849; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu YP, 2014, J CLIN INVEST, V124, P2059, DOI 10.1172/JCI71898; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; McQuillan R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002655; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Numasawa Y, 2011, EUR J NEUROL, V18, P1179, DOI 10.1111/j.1468-1331.2010.03311.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Vukcevic D, 2011, GENET EPIDEMIOL; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041	39	23	23	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					509	520		10.1016/j.ajhg.2014.09.015	http://dx.doi.org/10.1016/j.ajhg.2014.09.015			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25439097	Green Published, Bronze			2022-12-18	WOS:000344845000003
J	Oustric, V; Manceau, H; Ducamp, S; Soaid, R; Karim, Z; Schmitt, C; Mirmiran, A; Peoc'h, K; Grandchamp, B; Beaumont, C; Lyoumi, S; Moreau-Gaudry, F; Guyonnet-Duperat, V; de Verneuil, H; Marie, J; Puy, H; Deybach, JC; Gouya, L				Oustric, Vincent; Manceau, Hana; Ducamp, Sarah; Soaid, Rima; Karim, Zoubida; Schmitt, Caroline; Mirmiran, Arienne; Peoc'h, Katell; Grandchamp, Bernard; Beaumont, Carole; Lyoumi, Said; Moreau-Gaudry, Francois; Guyonnet-Duperat, Veronique; de Verneuil, Hubert; Marie, Joelle; Puy, Herve; Deybach, Jean-Charles; Gouya, Laurent			Antisense Oligonucleotide-Based Therapy in Human Erythropoietic Protoporphyria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA; HUMAN TRANSFERRIN; LOW EXPRESSION; FERROCHELATASE; CELLS; MICE; RESTORATION; PHENOTYPE; FAMILIES; MUTATION	In 90% of people with erythropoietic protoporphyria (EPP), the disease results from the inheritance of a common hypomorphic FECH allele, encoding ferrochelatase, in trans to a private deleterious FECH mutation. The activity of the resulting FECH enzyme falls below the critical threshold of 35%, leading to the accumulation of free protoporphyrin IX (PPIX) in bone marrow erythroblasts and in red cells. The mechanism of low expression involves a biallelic polymorphism (c.315-48T>C) localized in intron 3. The 315-48C allele increases usage of the 30 cryptic splice site between exons 3 and 4, resulting in the transcription of an unstable mRNA with a premature stop codon, reducing the abundance of wild-type FECH mRNA, and finally reducing FECH activity. Through a candidate-sequence approach and an antisense-oligonucleotide-tiling method, we identified a sequence that, when targeted by an antisense oligonucleotide (ASO-V1), prevented usage of the cryptic splice site. In lymphoblastoid cell lines derived from symptomatic EPP subjects, transfection of ASO-V1 reduced the usage of the cryptic splice site and efficiently redirected the splicing of intron 3 toward the physiological acceptor site, thereby increasing the amount of functional FECH mRNA. Moreover, the administration of ASO-V1 into developing human erythroblasts from an overtly EPP subject markedly increased the production of WT FECH mRNA and reduced the accumulation of PPIX to a level similar to that measured in asymptomatic EPP subjects. Thus, EPP is a paradigmatic Mendelian disease in which the in vivo correction of a common single splicing defect would improve the condition of most affected individuals.	[Oustric, Vincent; Manceau, Hana; Ducamp, Sarah; Soaid, Rima; Karim, Zoubida; Schmitt, Caroline; Mirmiran, Arienne; Peoc'h, Katell; Grandchamp, Bernard; Beaumont, Carole; Lyoumi, Said; Puy, Herve; Deybach, Jean-Charles; Gouya, Laurent] Univ Paris 07, INSERM, U1149, Ctr Rech Inflammat, F-75018 Paris, France; [Karim, Zoubida; Schmitt, Caroline; Grandchamp, Bernard; Beaumont, Carole; Puy, Herve; Deybach, Jean-Charles] Univ Paris Diderot, F-75018 Paris, France; [Schmitt, Caroline; Puy, Herve; Deybach, Jean-Charles; Gouya, Laurent] Hop Louis Mourier, Assistance Publ Hop Paris, Ctr Francais Porphyries, F-92701 Colombes, France; [Grandchamp, Bernard; Puy, Herve; Deybach, Jean-Charles] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Lab Biochim Hormonale & Genet, F-75018 Paris, France; [Lyoumi, Said; Gouya, Laurent] Univ Versailles St Quentin Yvelines, F-78035 Versailles, France; [Moreau-Gaudry, Francois; Guyonnet-Duperat, Veronique; de Verneuil, Hubert] INSERM, Biotherapies Malad Genet & Canc U1035, Lab Excellence Globule Rouge, F-33000 Bordeaux, France; [Moreau-Gaudry, Francois; Guyonnet-Duperat, Veronique; de Verneuil, Hubert] Univ Bordeaux Segalen, F-33000 Bordeaux, France; [Marie, Joelle] CNRS, Ctr Genet Mol, UPR 3404, F-91198 Gif Sur Yvette, France; [Gouya, Laurent] Hop Ambroise Pare, Assistance Publ Hop Paris, Lab Biochimie Hormonale & Genet, F-92100 Boulogne Billancourt, France; [Gouya, Laurent] Lab Excellence GR Ex, F-75000 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Deybach, JC (corresponding author), Univ Paris 07, INSERM, U1149, Ctr Rech Inflammat, F-75018 Paris, France.	jc.deybach@wanadoo.fr	PUY, HERVE/O-1785-2017; Ducamp, Sarah/AAF-3899-2020; Manceau, Hana/P-2970-2017; Peoc'h, Katell/V-1604-2017; SCHMITT, Caroline/P-2859-2017	PUY, HERVE/0000-0003-3362-2634; Manceau, Hana/0000-0003-4158-0964; Peoc'h, Katell/0000-0002-8203-1243; SCHMITT, Caroline/0000-0001-5145-7260; Gouya, Laurent/0000-0002-1326-7025; KARIM, Zoubida/0000-0002-3724-5592; mirmiran, arienne/0000-0002-9513-7506	Association Francaise contre les Myopathies [16534]; Association Francaise contre les Myopathies; Societe Francaise d'Hematologie;  [ANR-11-LABX-0051]	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Societe Francaise d'Hematologie; 	We thank the anonymous family members for their cooperation and Vasco Pereira Da Silva, Sylvie Simonin, and Anne Marie Robreau-Fraolini for their expert laboratory assistance. This work was supported by the Association Francaise contre les Myopathies (L.G., grant reference No 16534) and by the ANR-11-LABX-0051 grant. V.O. was supported by grants from the Association Francaise contre les Myopathies and the Societe Francaise d'Hematologie. The authors declare competing financial interests. V.O., H.P., J.C.D., and L.G. have patents pending with the European Patent Office for the ASOs and the targeting approach.	Balwani Manisha, 2013, Mol Med, V19, P26, DOI 10.2119/molmed.2012.00340; Bloomer J, 1998, J CLIN INVEST, V102, P107, DOI 10.1172/JCI1347; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; Gouya L, 1996, AM J HUM GENET, V58, P292; Gouya L, 2002, NAT GENET, V30, P27, DOI 10.1038/ng809; Gouya L, 1999, BLOOD, V93, P2105, DOI 10.1182/blood.V93.6.2105.406k28_2105_2110; Gouya L, 2006, AM J HUM GENET, V78, P2, DOI 10.1086/498620; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Kole R, 2012, DISCOV MED, V14, P59; Kong XF, 2008, J HEPATOL, V48, P375, DOI 10.1016/j.jhep.2007.09.013; Kurreck J, 2002, J BIOL CHEM, V277, P7099, DOI 10.1074/jbc.M107206200; Lee JH, 2001, EUR J BIOCHEM, V268, P2004, DOI 10.1046/j.1432-1327.2001.02073.x; Lyoumi S, 2011, GASTROENTEROLOGY, V141, P1509, DOI 10.1053/j.gastro.2011.06.078; Meerman L, 2000, SCAND J GASTROENTERO, V35, P79; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Risheg H, 2003, MOL GENET METAB, V80, P196, DOI 10.1016/j.ymgme.2003.07.001; Roberts J, 2006, MOL THER, V14, P471, DOI 10.1016/j.ymthe.2006.05.017; Saruwatari H, 2006, J DERMATOL, V33, P603, DOI 10.1111/j.1346-8138.2006.00140.x; Sazani P, 2001, NUCLEIC ACIDS RES, V29, P3965, DOI 10.1093/nar/29.19.3965; Suwanmanee T, 2002, MOL PHARMACOL, V62, P545, DOI 10.1124/mol.62.3.545; Svasti S, 2009, P NATL ACAD SCI USA, V106, P1205, DOI 10.1073/pnas.0812436106; Tahara T, 2010, INT J HEMATOL, V92, P769, DOI 10.1007/s12185-010-0725-3; Whatley SD, 2010, BRIT J DERMATOL, V162, P642, DOI 10.1111/j.1365-2133.2010.09631.x; Wilner SE, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.14; Wilton SD, 1999, NEUROMUSCULAR DISORD, V9, P330, DOI 10.1016/S0960-8966(99)00010-3; Wiman A, 2003, J HUM GENET, V48, P70, DOI 10.1007/s100380300009; Xie SY, 2011, INT J HEMATOL, V93, P301, DOI 10.1007/s12185-010-0727-1	27	23	32	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					611	617		10.1016/j.ajhg.2014.02.010	http://dx.doi.org/10.1016/j.ajhg.2014.02.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24680888	Bronze, Green Published			2022-12-18	WOS:000333765300011
J	Parry, DA; Logan, CV; Stegmann, APA; Abdelhamed, ZA; Calder, A; Khan, S; Bonthron, DT; Clowes, V; Sheridan, E; Ghali, N; Chudley, AE; Dobbie, A; Stumpel, CTRM; Johnson, CA				Parry, David A.; Logan, Clare V.; Stegmann, Alexander P. A.; Abdelhamed, Zakia A.; Calder, Alistair; Khan, Shabana; Bonthron, David T.; Clowes, Virginia; Sheridan, Eamonn; Ghali, Neeti; Chudley, Albert E.; Dobbie, Angus; Stumpel, Constance T. R. M.; Johnson, Colin A.			SAMS, a Syndrome of Short Stature, Auditory-Canal Atresia, Mandibular Hypoplasia, and Skeletal Abnormalities Is a Unique Neurocristopathy Caused by Mutations in Goosecoid	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCING DATA; NEURAL CREST; MOUSE; GENE; MALFORMATION; EXPRESSION; FRAMEWORK; ORGANIZER; DEFECTS	Short stature, auditory canal atresia, mandibular hypoplasia, and skeletal abnormalities (SAMS) has been reported previously to be a rare, autosomal-recessive developmental disorder with other, unique rhizomelic skeletal anomalies. These include bilateral humeral hypoplasia, humeroscapular synostosis, pelvic abnormalities, and proximal defects of the femora. To identify the genetic basis of SAMS, we used molecular karyotyping and whole-exome sequencing (WES) to study small, unrelated families. Filtering of variants from the WES data included segregation analysis followed by comparison of in-house exomes. We identified a homozygous 306 kb microdeletion and homozygous predicted null mutations of GSC, encoding Goosecoid homeobox protein, a paired-like homeodomain transcription factor. This confirms that SAMS is a human malformation syndrome resulting from GSC mutations. Previously, Goosecoid has been shown to be a determinant at the Xenopus gastrula organizer region and a segment-polarity determinant in Drosophila. In the present report, we present data on Goosecoid protein localization in staged mouse embryos. These data and the SAMS clinical phenotype both suggest that Goosecoid is a downstream effector of the regulatory networks that define neural-crest cell-fate specification and subsequent mesoderm cell lineages in mammals, particularly during shoulder and hip formation. Our findings confirm that Goosecoid has an essential role in human craniofacial and joint development and suggest that Goosecoid is an essential regulator of mesodermal patterning in mammals and that it has specific functions in neural crest cell derivatives.	[Parry, David A.; Logan, Clare V.; Abdelhamed, Zakia A.; Khan, Shabana; Bonthron, David T.; Sheridan, Eamonn; Johnson, Colin A.] Univ Leeds, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Stegmann, Alexander P. A.; Stumpel, Constance T. R. M.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; [Stegmann, Alexander P. A.; Stumpel, Constance T. R. M.] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol GROW, NL-6202 AZ Maastricht, Netherlands; [Abdelhamed, Zakia A.] Al Azhar Univ Girls, Dept Anat & Embryol, Fac Med, Cairo 11754, Egypt; [Calder, Alistair] Great Ormond St Hosp Sick Children, Dept Radiol, London WC1N 3JH, England; [Bonthron, David T.; Sheridan, Eamonn; Dobbie, Angus] Chapel Allerton Hosp, Dept Clin Genet, Leeds LS7 4SA, W Yorkshire, England; [Clowes, Virginia; Ghali, Neeti] North Wick Pk Hosp, Dept Clin Genet, Harrow HA1 3UJ, Middx, England; [Chudley, Albert E.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3A 1R9, Canada; [Chudley, Albert E.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3A 1R9, Canada	University of Leeds; Maastricht University; Maastricht University; Egyptian Knowledge Bank (EKB); Al Azhar University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Chapel Allerton Hospital; University of Manitoba; University of Manitoba	Dobbie, A (corresponding author), Chapel Allerton Hosp, Dept Clin Genet, Leeds LS7 4SA, W Yorkshire, England.	angus.dobbie@leedsth.nhs.uk; c.johnson@leeds.ac.uk	Ghali, Neeti/L-5665-2019	Ghali, Neeti/0000-0003-2847-1376; Bonthron, David/0000-0001-8132-8179; Johnson, Colin/0000-0002-2979-8234; Parry, David/0000-0003-0376-7736; Logan, Clare/0000-0003-4323-1602; Stegmann, Alexander/0000-0002-9736-7137	Egyptian Government Scholarship; Sir Jules Thorn Award for Biomedical Research [JTA/09]; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	Egyptian Government Scholarship; Sir Jules Thorn Award for Biomedical Research; The Sir Jules Thorn Charitable Trust	The authors thank the individuals and families for participating in this study. We thank N. Lahiri, Great Ormond Street Hospital, for help with recruiting research participants. Z.A.A. received an Egyptian Government Scholarship. This work was supported by a Sir Jules Thorn Award for Biomedical Research (JTA/09 to C.A.J., E.S., and D.T.B.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamed ZA, 2013, HUM MOL GENET, V22, P1358, DOI 10.1093/hmg/dds546; Belo JA, 1998, MECH DEVELOP, V72, P15, DOI 10.1016/S0925-4773(97)00204-9; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; GARDNER E, 1953, AM J ANAT, V92, P219, DOI 10.1002/aja.1000920203; GAUNT SJ, 1993, DEVELOPMENT, V117, P769; Kalisz M, 2012, DEV BIOL, V362, P94, DOI 10.1016/j.ydbio.2011.11.017; Kelberman D, 2001, HUM GENET, V109, P638, DOI 10.1007/s00439-001-0626-x; Lemire EG, 1998, AM J MED GENET, V75, P256, DOI 10.1002/(SICI)1096-8628(19980123)75:3<256::AID-AJMG5>3.0.CO;2-O; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; McGonnell IM, 2002, CURR BIOL, V12, P767, DOI 10.1016/S0960-9822(02)00818-7; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Passos-Bueno MR, 2009, AM J MED GENET A, V149A, P1853, DOI 10.1002/ajmg.a.32950; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; RIVERAPEREZ JA, 1995, DEVELOPMENT, V121, P3005; Sadler TW, 2012, LANGMANS MED EMBRYOL, P151; Staack A, 2003, DIFFERENTIATION, V71, P402, DOI 10.1046/j.1432-0436.2003.7107004.x; Su PH, 2010, CLIN DYSMORPHOL, V19, P51, DOI 10.1097/MCD.0b013e328335c133; ter Heide H, 2002, AM J MED GENET, V110, P359, DOI 10.1002/ajmg.10441; YAMADA G, 1995, DEVELOPMENT, V121, P2917; Zhu CQC, 1998, DEV DYNAM, V211, P374, DOI 10.1002/(SICI)1097-0177(199804)211:4<374::AID-AJA8>3.0.CO;2-E	25	23	27	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1135	1142		10.1016/j.ajhg.2013.10.027	http://dx.doi.org/10.1016/j.ajhg.2013.10.027			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24290375	Green Published, Bronze			2022-12-18	WOS:000328521300013
J	Liu, DJ; Leal, SM				Liu, Dajiang J.; Leal, Suzanne M.			Estimating Genetic Effects and Quantifying Missing Heritability Explained by Identified Rare-Variant Associations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WINNERS CURSE; POPULATION; SUSCEPTIBILITY; COMMON; LOCI; GENOMEWIDE; STRATEGIES; PARAMETERS; DEEP	Next-generation sequencing has led to many complex-trait rare-variant (RV) association studies. Although single-variant association analysis can be performed, it is grossly underpowered. Therefore, researchers have developed many RV association tests that aggregate multiple variant sites across a genetic region (e.g., gene), and test for the association between the trait and the aggregated genotype. After these aggregate tests detect an association, it is only possible to estimate the average genetic effect for a group of RVs. As a result of the "winner's curse," such an estimate can be biased. Although for common variants one can obtain unbiased estimates of genetic parameters by analyzing a replication sample, for RVs it is desirable to obtain unbiased genetic estimates for the study where the association is identified. This is because there can be substantial heterogeneity of RV sites and frequencies even among closely related populations. In order to obtain an unbiased estimate for aggregated RV analysis, we developed bootstrap-sample-split algorithms to reduce the bias of the winner's curse. The unbiased estimates are greatly important for understanding the population-specific contribution of RVs to the heritability of complex traits. We also demonstrate both theoretically and via simulations that for aggregate RV analysis the genetic variance for a gene or region will always be underestimated, sometimes substantially, because of the presence of noncausal variants or because of the presence of causal variants with effects of different magnitudes or directions. Therefore, even if RVs play a major role in the complex-trait etiologies, a portion of the heritability will remain missing, and the contribution of RVs to the complex-trait etiologies will be underestimated.	[Liu, Dajiang J.; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Liu, Dajiang J.; Leal, Suzanne M.] Rice Univ, Dept Stat, Houston, TX 77005 USA	Baylor College of Medicine; Rice University	Leal, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	sleal@bcm.edu		Liu, Dajiang/0000-0001-6553-858X	National Institutes of Health [MD005964, HL102926, RL1HL092550, MH084676]; National Science Foundation [EIA-0216467]; Rice University; Sun Microsystems; Sigma Solutions, Inc.; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC4MD005964] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RL1HL092550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Rice University; Sun Microsystems; Sigma Solutions, Inc.; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research is supported by National Institutes of Health grants MD005964 and HL102926 (S.M.L.). We would like to thank Jonathan Cohen and Helen Hobbs for providing us with data on the ANGTPL family genes from the Dallas Heart Study, which was supported by National Institutes of Health grant RL1HL092550 (J.C.). We would also like to thank Shamil Sunyaev (S.S.) for sharing the simulated genetic datasets from his projects, which were supported by National Institutes of Health grant MH084676 (S.S). Computation for this research was supported in part by the Shared University Grid at Rice, which was funded by the National Science Foundation under grant EIA-0216467, and by a partnership among Rice University, Sun Microsystems, and Sigma Solutions, Inc.	Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Darvasi A, 2006, NAT GENET, V38, P861, DOI 10.1038/ng0806-861; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Joiner KA, 2005, AM J MED, V118, P1290, DOI 10.1016/j.amjmed.2005.08.018; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Liu DJJ, 2010, AM J HUM GENET, V87, P790, DOI 10.1016/j.ajhg.2010.10.025; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Middelberg RP, 2006, CLIN CHIM ACTA, V374, P87, DOI 10.1016/j.cca.2006.05.033; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Sun L, 2005, GENET EPIDEMIOL, V28, P352, DOI 10.1002/gepi.20068; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xiao R, 2011, GENET EPIDEMIOL, V35, P133, DOI 10.1002/gepi.20551; Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398; Xu LZ, 2011, ANN APPL STAT, V5, P201, DOI 10.1214/10-AOAS373; Zhang DW, 2001, BIOMETRICS, V57, P795, DOI 10.1111/j.0006-341X.2001.00795.x; Zhong H, 2010, GENET EPIDEMIOL, V34, P78, DOI 10.1002/gepi.20437; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	37	23	23	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					585	596		10.1016/j.ajhg.2012.08.008	http://dx.doi.org/10.1016/j.ajhg.2012.08.008			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23022102	Bronze, Green Published			2022-12-18	WOS:000309568500001
J	Lasky-Su, J; Won, S; Mick, E; Anney, RJL; Franke, B; Neale, B; Biederman, J; Smalley, SL; Loo, SK; Todorov, A; Faraone, SV; Weiss, ST; Lange, C				Lasky-Su, Jessica; Won, Sungho; Mick, Eric; Anney, Richard J. L.; Franke, Barbara; Neale, Benjamin; Biederman, Joseph; Smalley, Susan L.; Loo, Sandra K.; Todorov, Alexandre; Faraone, Stephen V.; Weiss, Scott T.; Lange, Christoph			On Genome-wide Association Studies for Family-Based Designs: An Integrative Analysis Approach Combining Ascertained Family Samples with Unselected Controls	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SCAN; GENE; REPLICATION; VARIANTS; TESTS; RISK; ADHD; SET	Large numbers of control individuals with genome-wide genotype data are now available through various databases. These controls are regularly used in case-control genome-wide association studies (GWAS) to increase the statistical power. Controls are often "unselected" for the disease of interest and are not matched to cases in terms of confounding factors, making the studies more vulnerable to confounding as a result of population stratification. In this communication, we demonstrate that family-based designs can integrate unselected controls from other studies into the analysis without compromising the robustness of family-based designs against genetic confounding. The result is a hybrid case-control family-based analysis that achieves higher power levels than population-based studies with the same number of cases and controls. This strategy is widely applicable and works ideally for all situations in which both family and case-control data are available. The approach consists of three steps. First, we perform a standard family-based association test that does not utilize the between-family component. Second, we use the between-family information in conjunction with the genotypes from unselected controls in a Cochran-Armitage trend test. The p values from this step are then calculated by rank ordering the individual Cochran-Armitage trend test statistics for the genotype markers. Third, we generate a combined p value with the association p values from the first two steps. Simulation studies are used to assess the achievable power levels of this method compared to standard analysis approaches. We illustrate the approach by an application to a GWAS of attention deficit hyperactivity disorder parent-offspring trios and publicly available controls.	[Lasky-Su, Jessica; Weiss, Scott T.; Lange, Christoph] Brigham & Womens Hosp, Channing Labs, Boston, MA 02115 USA; [Lasky-Su, Jessica; Weiss, Scott T.; Lange, Christoph] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lasky-Su, Jessica; Weiss, Scott T.; Lange, Christoph] Brigham & Womens Hosp, Ctr Genom Med, Boston, MA 02115 USA; [Won, Sungho] Chung Ang Univ, Dept Stat, Coll Nat Sci, Seoul 156756, South Korea; [Won, Sungho] Chung Ang Univ, Res Ctr Data Sci, Seoul 156756, South Korea; [Mick, Eric; Biederman, Joseph] Massachusetts Gen Hosp, Clin & Res Programs Pediat Psychiat & Adult ADHD, Dept Psychiat, Boston, MA 02114 USA; [Anney, Richard J. L.] Trinity Coll Dublin, Neuropsychiat Genet Res Grp, Dept Psychiat, Dublin 8, Ireland; [Franke, Barbara] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Franke, Barbara] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Neale, Benjamin] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Neale, Benjamin] Broad Inst, Cambridge, MA 02142 USA; [Smalley, Susan L.; Loo, Sandra K.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Todorov, Alexandre] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Faraone, Stephen V.; Weiss, Scott T.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Lange, Christoph] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Chung Ang University; Chung Ang University; Harvard University; Massachusetts General Hospital; Trinity College Dublin; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Lasky-Su, J (corresponding author), Brigham & Womens Hosp, Channing Labs, Boston, MA 02115 USA.	rejas@channing.harvard.edu	Faraone, Stephen V/O-7239-2018; Franke, Barbara/D-4836-2009; Faraone, Stephen/AAE-7334-2019	Faraone, Stephen V/0000-0002-9217-3982; Franke, Barbara/0000-0003-4375-6572; Faraone, Stephen/0000-0002-9217-3982; Mick, Eric/0000-0001-8505-8145; Anney, Richard/0000-0002-6083-407X	McNeil Pediatrics; Ortho-McNeil Janssen Scientific Affairs; Pfizer; Shire Pharmaceuticals; National Institute of Mental Health; Eli Lilly; National institutes of Health (NIH); McNeil; Janssen; Novartis; Alza; AstraZeneca; Bristol Myers Squibb; Merck; Organon; Otsuka; National Institute of Child Health and Human Development; Fundacion Areces; Medice Pharmaceuticals; Spanish Child Psychiatry Association; Abbott; Celltech; Cephalon; Esai; Forest; Glaxo; Gliatech; National Alliance for Research on Schizophrenia and Depression; National Institute on Drug Abuse; New River; Noven; Neurosearch; Pharmacia; Prechter Foundation; Stanley Foundation; UCB Pharma; Wyeth;  [KHL096840A];  [R01MH081862];  [1R01MH087590];  [P01 HL083069];  [mu 63706];  [NS54124];  [R01MH062873];  [U01MH085518];  [R01MH081803]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL096840, R00HL096840, P01HL083069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062873, R01MH081803, R01MH087590, R01MH083823, U01MH085518, R01MH081862, R01MH063706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054124] Funding Source: NIH RePORTER	McNeil Pediatrics; Ortho-McNeil Janssen Scientific Affairs(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Shire Pharmaceuticals; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eli Lilly(Eli Lilly); National institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McNeil; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Alza; AstraZeneca(AstraZeneca); Bristol Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); Organon; Otsuka(Otsuka Pharmaceutical); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fundacion Areces; Medice Pharmaceuticals; Spanish Child Psychiatry Association; Abbott(Abbott Laboratories); Celltech; Cephalon; Esai; Forest; Glaxo; Gliatech; National Alliance for Research on Schizophrenia and Depression(NARSAD); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); New River; Noven; Neurosearch; Pharmacia; Prechter Foundation; Stanley Foundation; UCB Pharma(UCB Pharma SA); Wyeth(Wyeth); ; ; ; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the following grants: KHL096840A awarded to J.L.-S., R01MH081862 and 1R01MH087590 awarded to CL., P01 HL083069 awarded to s.T.w., mu 63706 awarded to S.L.S., NS54124 awarded to S.K.L., and R01MH062873, U01MH085518, and R01MH081803 awarded to S.V.F. E.M. receives research support from McNeil Pediatrics, Ortho-McNeil Janssen Scientific Affairs, Pfizer, Shire Pharmaceuticals, and the National Institute of Mental Health and has had a consulting relationship with Shire Pharmaceuticals. In the past year, S.V.F. has received consulting fees and been on advisory boards for Eli Lilly, Ortho-McNeil, and Shire Development and has received research support from Eli Lilly, Pfizer, Shire, and the National institutes of Health (NIH). In previous years, he has received research support and/or consulting fees from Eli Lilly, McNeil, Janssen, Novartis, Shire, Pfizer, and NIH. J.B. is currently receiving research support from the following: Alza, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Janssen Pharmaceuticals, McNeil, Merck, Organon, Otsuka, Shire, the National Institute of Mental Health, and the National Institute of Child Health and Human Development. In 2009, J.B. received a speaker's fee from the following sources: Fundacion Areces, Medice Pharmaceuticals, and the Spanish Child Psychiatry Association. In previous years, J.B. received research support, consultation fees, or speaker's fees for and/or from the following additional sources: Abbott, AstraZeneca, Celltech, Cephalon, Eli Lilly, Esai, Forest, Glaxo, Gliatech, Janssen, McNeil, the National Alliance for Research on Schizophrenia and Depression, the National Institute on Drug Abuse, New River, Novartis, Noven, Neurosearch, Pfizer, Pharmacia, The Prechter Foundation, Shire, The Stanley Foundation, UCB Pharma, and Wyeth.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Comings DE, 2000, CLIN GENET, V58, P31, DOI 10.1034/j.1399-0004.2000.580106.x; DasBanerjee T, 2008, AM J MED GENET B, V147B, P1554, DOI 10.1002/ajmg.b.30877; Dorval KM, 2007, GENES BRAIN BEHAV, V6, P444, DOI 10.1111/j.1601-183X.2006.00273.x; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Ionita-Laza I, 2007, AM J HUM GENET, V81, P607, DOI 10.1086/519748; Lange C, 2002, GENET EPIDEMIOL, V23, P165, DOI 10.1002/gepi.209; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Laurin N, 2008, J PSYCHIATR RES, V42, P117, DOI 10.1016/j.jpsychires.2006.10.010; Li J, 2006, NEUROSCI LETT, V403, P172, DOI 10.1016/j.neulet.2006.04.036; LiptuYk T., 1958, MAGYAR TUD AKAD MAT, V3, P171; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Murphy A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000197; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Won S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000741	27	23	24	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					573	580		10.1016/j.ajhg.2010.02.019	http://dx.doi.org/10.1016/j.ajhg.2010.02.019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20346434	Bronze, Green Published			2022-12-18	WOS:000276716800007
J	Hellemans, J; Simon, M; Dheedene, A; Alanay, Y; Mihci, E; Rifai, L; Sefiani, A; van Bever, Y; Meradji, M; Superti-Furga, A; Mortier, G				Hellemans, Jan; Simon, Marleen; Dheedene, Annelies; Alanay, Yasemin; Mihci, Ercan; Rifai, Laila; Sefiani, Abdelaziz; van Bever, Yolande; Meradji, Morteza; Superti-Furga, Andrea; Mortier, Geert			Homozygous Inactivating Mutations in the NKX3-2 Gene Result in Spondylo-Megaepiphyseal-Metaphyseal Dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AXIAL SKELETON; BAPX1; BAGPIPE; ACTS; SHH	Spondylo-megaepiphyseal-metaphyseal dysplasia (SMMD) is a rare skeletal dysplasia with only a few cases reported in the literature. Affected individuals have a disproportionate short stature with a short and stiff neck and trunk. The limbs appear relatively long and may show flexion contractures of the distal joints. The most remarkable radiographic features are the delayed and impaired ossification of the vertebral bodies as well as the presence of large epiphyseal ossification centers and wide growth plates in the long tubular bones. Numerous pseudoepiphyses of the short tubular bones in hands and feet are another remarkable feature of the disorder. Genome wide homozygosity mapping followed by a candidate gene approach resulted in the elucidation of the genetic cause in three new consanguineous families with SMMD. Each proband was homozygous for a different inactivating mutation in NKX3-2, a homeobox-containing gene located on chromosome 4p15.33. Striking similarities were found when comparing the vertebral ossification defects in SMMD patients with those observed in the Nkx3-2 null mice. Distinguishing features were the asplenia found in the mutant mice and the radiographic abnormalities in the limbs only observed in SMMD patients. The absence of the latter anomalies in the murine model may be due to the perinatal death of the affected animals. This study illustrates that NKX3-2 plays an important role in endochondral ossification of both the axial and appendicular skeleton in humans. In addition, it defines SMMD as yet another skeletal dysplasia with autosomal-recessive inheritance and a distinct phenotype.	[Hellemans, Jan; Dheedene, Annelies; Mortier, Geert] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Simon, Marleen; van Bever, Yolande] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Meradji, Morteza] Erasmus MC, Dept Radiol, NL-3000 CA Rotterdam, Netherlands; [Alanay, Yasemin] Hacettepe Univ, Sch Med, Dept Pediat, Pediat Genet Unit, TR-06100 Ankara, Turkey; [Mihci, Ercan] Akdeniz Univ, Sch Med, Dept Pediat, Clin Genet Unit, TR-07059 Antalya, Turkey; [Rifai, Laila; Sefiani, Abdelaziz] Natl Inst Hlth, Dept Med Genet, Rabat 11400, Morocco; [Superti-Furga, Andrea] Univ Freiburg, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany	Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Hacettepe University; Akdeniz University; University of Freiburg	Mortier, G (corresponding author), Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium.	geert.mortier@ugent.be	Alanay, Yasemin/A-1516-2016; Mortier, Geert/D-2542-2012; superti-furga, andrea/E-9162-2015; Mihci, Ercan/C-9653-2016	Alanay, Yasemin/0000-0003-0683-9731; Mortier, Geert/0000-0001-9871-4578; superti-furga, andrea/0000-0002-3543-7531; 	Research Foundation-Flanders (FWO) [G.0279.07]; Ghent University	Research Foundation-Flanders (FWO)(FWO); Ghent University(Ghent University)	We are grateful to the patients for their collaboration. This work was supported by a grant (# G.0279.07) from the Research Foundation-Flanders (FWO). J.H. has a postdoctoral mandate at the FWO and G.M. is senior clinical investigator at the FWO. A.D. has a predoctoral grant (BOF) from the Ghent University.	Agarwal PP, 2003, PEDIATR RADIOL, V33, P893, DOI 10.1007/s00247-003-1033-3; Akazawa H, 2000, GENES CELLS, V5, P499, DOI 10.1046/j.1365-2443.2000.00339.x; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Breedveld GJ, 2002, HUM MOL GENET, V11, P971, DOI 10.1093/hmg/11.8.971; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Dentice M, 2006, J CLIN ENDOCR METAB, V91, P1428, DOI 10.1210/jc.2005-1350; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Heathcote K, 2005, HUM MOL GENET, V14, P585, DOI 10.1093/hmg/ddi055; Hirsinger E, 2000, INT REV CYTOL, V198, P1; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; MORTIER GR, 1995, HUM MOL GENET, V4, P285, DOI 10.1093/hmg/4.2.285; Murtaugh LC, 2001, DEV CELL, V1, P411, DOI 10.1016/S1534-5807(01)00039-9; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Provot S, 2006, DEVELOPMENT, V133, P651, DOI 10.1242/dev.02258; Rodrigo I, 2003, DEVELOPMENT, V130, P473, DOI 10.1242/dev.00240; Schorderet DF, 2008, AM J HUM GENET, V82, P1178, DOI 10.1016/j.ajhg.2008.03.007; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; SILVERMAN FN, 1985, RADIOLOGY, V156, P365, DOI 10.1148/radiology.156.2.3925497; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; TAM PPL, 1994, ANAT EMBRYOL, V189, P275; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tribioli C, 1997, GENE, V203, P225, DOI 10.1016/S0378-1119(97)00520-9; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yoshiura KI, 1997, GENOMICS, V45, P425, DOI 10.1006/geno.1997.4926; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002	30	23	25	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					916	922		10.1016/j.ajhg.2009.11.005	http://dx.doi.org/10.1016/j.ajhg.2009.11.005			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	20004766	Bronze, Green Published			2022-12-18	WOS:000272797100016
J	Martignoni, M; Riano, E; Rugarli, EI				Martignoni, Monica; Riano, Elena; Rugarli, Elena I.			The role of ZFYVE27/protrudin in hereditary spastic paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PROTEIN		[Martignoni, Monica] Ist Neurol C Besta, Div Biochem & Genet, I-20126 Milan, Italy; [Rugarli, Elena I.] Univ Milano Bicocca, Dept Neurosci & Med Biotechnol, I-20052 Milan, Italy	IRCCS Istituto Neurologico Besta; University of Milano-Bicocca	Rugarli, EI (corresponding author), Ist Neurol C Besta, Div Biochem & Genet, I-20126 Milan, Italy.	rugarli@istituto-besta.it		Rugarli, Elena/0000-0002-5782-1067	Telethon [GGP05057] Funding Source: Medline	Telethon(Fondazione Telethon)		Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027	4	23	24	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					127	128		10.1016/j.ajhg.2008.05.014	http://dx.doi.org/10.1016/j.ajhg.2008.05.014			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18606302	Green Published, Bronze			2022-12-18	WOS:000257784000016
J	Pociot, F; Karlsen, AE; Pedersen, CB; Aalund, M; Nerup, J				Pociot, F; Karlsen, AE; Pedersen, CB; Aalund, M; Nerup, J		European Consortium IDDM Genome St	Novel analytical methods applied to type 1 diabetes genome-scan data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; SUSCEPTIBILITY GENES; NEURAL-NETWORKS; COMPLEX TRAITS; HUMAN-DISEASES; MELLITUS; LOCI; IDENTIFICATION; ASSOCIATION; WORLDWIDE	Complex traits like type 1 diabetes mellitus (T1DM) are generally taken to be under the influence of multiple genes interacting with each other to confer disease susceptibility and/or protection. Although novel methods are being developed, analyses of whole-genome scans are most often performed with multipoint methods that work under the assumption that multiple trait loci are unrelated to each other; that is, most models specify the effect of only one locus at a time. We have applied a novel approach, which includes decision-tree construction and artificial neural networks, to the analysis of T1DM genome-scan data. We demonstrate that this approach ( 1) allows identification of all major susceptibility loci identified by nonparametric linkage analysis, ( 2) identifies a number of novel regions as well as combinations of markers with predictive value for T1DM, and ( 3) may be useful in characterizing markers in linkage disequilibrium with protective-gene variants. Furthermore, the approach outlined here permits combined analyses of genetic-marker data and information on environmental and clinical covariates.	Steno Diabet Ctr, DK-2820 Gentofte, Denmark; NeuroTech AS, Copenhagen, Denmark	Steno Diabetes Center	Pociot, F (corresponding author), Steno Diabet Ctr, Niels Steensensvej 2, DK-2820 Gentofte, Denmark.	fpoc@steno.dk	Kockum, Ingrid/O-8781-2018	Kockum, Ingrid/0000-0002-0867-4726; Pociot, Flemming/0000-0003-3274-5448				Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478; Bhat A, 1999, GENET EPIDEMIOL, V17, pS503; Bishop Christopher M., 1995, NEURAL NETWORKS PATT; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Bradley PS, 1999, INFORMS J COMPUT, V11, P217, DOI 10.1287/ijoc.11.3.217; Breiman L., 1984, CLASSIFICATION REGRE, DOI DOI 10.1201/9781315139470; Buhler J, 1997, HUM HERED, V47, P211, DOI 10.1159/000154415; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Cox NJ, 2001, AM J HUM GENET, V69, P820, DOI 10.1086/323501; Curtis D, 2001, ANN HUM GENET, V65, P95, DOI 10.1046/j.1469-1809.2001.6510095.x; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DUPUIS J, 1995, GENETICS, V140, P843; Farrall M, 1997, GENET EPIDEMIOL, V14, P103, DOI 10.1002/(SICI)1098-2272(1997)14:2<103::AID-GEPI1>3.0.CO;2-8; Flodman P, 2001, GENET EPIDEMIOL, V21, pS390, DOI 10.1002/gepi.2001.21.s1.s390; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Holm P, 2001, AM J HUM GENET, V69, P1301; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Lauer MS, 2002, CIRCULATION, V106, P685, DOI 10.1161/01.CIR.0000024410.15081.FD; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Lucek P, 1998, HUM HERED, V48, P275, DOI 10.1159/000022816; Lucek PR, 1997, GENET EPIDEMIOL, V14, P1101, DOI 10.1002/(SICI)1098-2272(1997)14:6<1101::AID-GEPI90>3.0.CO;2-K; Marinov M, 2001, HUM HERED, V51, P169, DOI 10.1159/000053338; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; POCIOT F, 1994, AUTOIMMUNITY, V19, P169, DOI 10.3109/08916939408995692; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Quinlan J.R., 1992, PROGRAMS MACHINE LEA; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-28; Shannon C, 1964, MATH THEORY COMMUNIC; Svensson J, 2002, DIABETES CARE, V25, P2197, DOI 10.2337/diacare.25.12.2197; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Toivonen HTT, 2000, AM J HUM GENET, V67, P133, DOI 10.1086/302954; Undlien DE, 2001, TRENDS GENET, V17, P93, DOI 10.1016/S0168-9525(00)02180-6; van Driel MA, 2003, EUR J HUM GENET, V11, P57, DOI 10.1038/sj.ejhg.5200918; Weir BS, 1999, AM J HUM GENET, V65, pA14; 1999, NAT GENET, V23, P375	42	23	25	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					647	660		10.1086/383095	http://dx.doi.org/10.1086/383095			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	15024687	Green Published, Bronze			2022-12-18	WOS:000220280800005
J	Spence, MA; Greenberg, DA; Hodge, SE; Vieland, VJ				Spence, MA; Greenberg, DA; Hodge, SE; Vieland, VJ			The emperor's new methods	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							LINKAGE ANALYSIS		Univ Calif Irvine, Dept Pediat, Irvine Med Ctr, Div Human Genet, Orange, CA 92868 USA; Columbia Univ, Div Stat Genet, Dept Biostat, Mailman Sch Publ Hlth, New York, NY 10027 USA; New York State Psychiat Inst & Hosp, Clin Genet Epidemiol Unit, New York, NY 10032 USA; Univ Iowa, Div Stat Genet, Dept Biostat, Coll Publ Hlth, Iowa City, IA USA; Univ Iowa, Dept Psychiat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of California System; University of California Irvine; Columbia University; New York State Psychiatry Institute; University of Iowa; University of Iowa	Spence, MA (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine Med Ctr, Div Human Genet, Bldg 2,101 City Dr, Orange, CA 92868 USA.							FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Greenberg DA, 1996, AM J HUM GENET, V58, P892; Hodge SE, 2001, AM J MED GENET, V105, P62, DOI 10.1002/1096-8628(20010108)105:1<62::AID-AJMG1063>3.0.CO;2-C; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; SPENCE MA, 1993, HUM HERED, V43, P166; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Terwilliger JD, 2000, HUM BIOL, V72, P63; WIJSMAN EM, 2001, GENET EPIDEMIOL S, V21	9	23	25	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1084	1087		10.1086/374826	http://dx.doi.org/10.1086/374826			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12704569	Bronze, Green Published			2022-12-18	WOS:000182474400002
J	Labuda, D; Krajinovic, M; Sabbagh, A; Infante-Rivard, C; Sinnett, D				Labuda, D; Krajinovic, M; Sabbagh, A; Infante-Rivard, C; Sinnett, D			Parental genotypes in the risk of a complex disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENETIC-ANALYSIS; CHILDHOOD LEUKEMIA; POLYMORPHISMS; SUSCEPTIBILITY; EXPOSURE; CANCER; PESTICIDES; MUTATION; CYP2E1	Our understanding of the genetic etiology of complex disorders is still elusive. According to the common-variant/ common-disease hypothesis, frequent functional polymorphisms are the best candidates for disease-susceptibility alleles. Implicitly, we also assume that disease-susceptibility alleles are preferentially transmitted from parents to the affected offspring and that this effect can be captured by the transmission/disequilibrium test (TDT). However, our study of genetic predisposition to childhood acute lymphoblastic leukemia suggests that a focus on the patient's genotype might, in certain instances, be misleading. Our results indicate that, at least at some loci, parental genetics might be of primary importance in predicting the risk of cancer in this pediatric model of a complex disease. Consequently, in addition to TDT, other complementary strategies will need to be simultaneously applied to dissect genetic predisposition to complex disorders.	Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; McGill Univ, Dept Epidemiol & Biostat & Occupat Hlth, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University	Labuda, D (corresponding author), Hop St Justine, Ctr Rech, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.		sinnett, daniel/S-4589-2017	sinnett, daniel/0000-0003-3625-6676; SABBAGH, Audrey/0000-0003-0283-8803				Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bell DA, 1997, SCIENCE, V275, P1327; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Courville Serge, 1996, ATLAS HIST QUEBEC PO; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Ferguson, 2000, Ann Epidemiol, V10, P471, DOI 10.1016/S1047-2797(00)00104-6; Godfrey K M, 2001, Public Health Nutr, V4, P611; HAINES JL, 1998, APPROACHES GENE MAPP; Hung HC, 1997, CANCER EPIDEM BIOMAR, V6, P901; Infante-Rivard C, 1999, LANCET, V354, P1819, DOI 10.1016/S0140-6736(05)70586-9; Infante-Rivard C, 2002, EPIDEMIOLOGY, V13, P277, DOI 10.1097/00001648-200205000-00007; Infante-Rivard C, 1999, EPIDEMIOLOGY, V10, P481, DOI 10.1097/00001648-199909000-00004; Krajinovic M, 2002, INT J CANCER, V97, P230, DOI 10.1002/ijc.1589; Krajinovic M, 2000, CANCER EPIDEM BIOMAR, V9, P557; Krajinovic M, 1999, BLOOD, V93, P1496, DOI 10.1182/blood.V93.5.1496.405a36_1496_1501; LACHIN JM, 2000, BIOSTATISTICAL METHO; Long AD, 1997, SCIENCE, V275, P1328; Miller MC, 2001, TOXICOL LETT, V120, P269, DOI 10.1016/S0378-4274(01)00279-X; Morley R, 2001, CLIN EXP PHARMACOL P, V28, P962, DOI 10.1046/j.1440-1681.2001.03557.x; MullerMyhsok B, 1997, SCIENCE, V275, P1328; Nyirenda MJ, 1998, INT J MOL MED, V2, P607; Perera FP, 1997, SCIENCE, V278, P1068, DOI 10.1126/science.278.5340.1068; Pericak-Vance Margaret A., 1998, P323; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Scott WK, 1997, SCIENCE, V275, P1327, DOI 10.1126/science.275.5304.1327; Shields PG, 1996, MOL CARCINOGEN, V17, P144, DOI 10.1002/(SICI)1098-2744(199611)17:3<144::AID-MC6>3.0.CO;2-F; Sinnett D, 2000, LEUKEMIA LYMPHOMA, V38, P447, DOI 10.3109/10428190009059264; Speer Marcy C., 1998, P161; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Terwilliger JD, 2000, HUM BIOL, V72, P63; WATANABE J, 1994, J BIOCHEM-TOKYO, V116, P321, DOI 10.1093/oxfordjournals.jbchem.a124526	38	23	25	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					193	197		10.1086/341345	http://dx.doi.org/10.1086/341345			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12058344	Green Published, Bronze			2022-12-18	WOS:000176307700022
J	van Geel, M; Eichler, EE; Beck, AF; Shan, ZH; Haaf, T; van der Maarel, SM; Frants, RR; de Jong, PJ				van Geel, M; Eichler, EE; Beck, AF; Shan, ZH; Haaf, T; van der Maarel, SM; Frants, RR; de Jong, PJ			A cascade of complex subtelomeric duplications during the evolution of the hominoid and old world monkey genomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RECEPTOR GENE FAMILY; GLOBIN GENE; REGION; IDENTIFICATION; CHROMOSOMES; PSEUDOGENES; MEMBERS; FISH; 4Q35	Subtelomeric duplications of an obscure tubulin "genic" segment located near the telomere of human chromosome 4q35 have occurred at different evolutionary time points within the last 25 million years of the catarrhine (i.e., hominoid and Old World monkey) evolution. The analyses of these segments reported here indicate an exceptional level of evolutionary instability. Substantial intra- and interspecific differences in copy number and distribution are observed among cercopithecoid (Old World monkey) and hominoid genomes. Characterization of the hominoid duplicated segments reveals a strong positional bias within pericentromeric and subtelomeric regions of the genome. On the basis of phylogenetic analysis from predicted proteins and comparisons of nucleotide-substitution rates, we present evidence of a conserved b-tubulin gene among the duplications. Remarkably, the evolutionary conservation has occurred in a nonorthologous fashion, such that the functional copy has shifted its positional context between hominoids and cercopithecoids. We propose that, in a chimpanzee-human common ancestor, one of the paralogous copies assumed the original function, whereas the ancestral copy acquired mutations and eventually became silenced. Our analysis emphasizes the dynamic nature of duplication-mediated genome evolution and the delicate balance between gene acquisition and silencing.	Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; NCI, Mol Cytogenet Sect, Expt Carcinogenesis Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; Max Planck Inst Mol Genet, Berlin, Germany; Leiden Univ, Med Ctr, Dept Human & Clin Genet, Leiden, Netherlands	Roswell Park Cancer Institute; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Jong, PJ (corresponding author), Childrens Hosp Oakland, 747 52nd St, Oakland, CA 94609 USA.		van der Maarel, Silvere/X-3631-2018	van der Maarel, Silvere/0000-0001-8103-711X				Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grewal PK, 1999, GENE, V227, P79, DOI 10.1016/S0378-1119(98)00587-3; KERMOUNI A, 1995, GENOMICS, V29, P371, DOI 10.1006/geno.1995.9992; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; LI WH, 1997, MOL EVOLUTION, P1; Meireles CM, 1999, MOL PHYLOGENET EVOL, V13, P434, DOI 10.1006/mpev.1999.0652; Ohno S, 1999, CELL MOL LIFE SCI, V55, P824, DOI 10.1007/s000180050336; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; Shan ZH, 2000, EUR J HUM GENET, V8, P167, DOI 10.1038/sj.ejhg.5200431; SHEN SH, 1981, CELL, V26, P191, DOI 10.1016/0092-8674(81)90302-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; van Geel M, 1999, GENOMICS, V61, P55, DOI 10.1006/geno.1999.5942; van Geel M, 2000, CYTOGENET CELL GENET, V88, P316, DOI 10.1159/000015518; Wirth J, 1999, J MED GENET, V36, P271; Yang ZH, 2000, GENETICS, V155, P431; Zerucha T, 2000, BIOCHEM CELL BIOL, V78, P593, DOI 10.1139/bcb-78-5-593	26	23	26	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					269	278		10.1086/338307	http://dx.doi.org/10.1086/338307			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11731935	Bronze, Green Published			2022-12-18	WOS:000172571900026
J	Stephens, M; Smith, NJ; Donnelly, P				Stephens, M; Smith, NJ; Donnelly, P			Comparisons of two methods for haplotype reconstruction and haplotype frequency estimation from population data - Reply	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Oxford, Dept Stat, Oxford OX1 3QU, England	University of Washington; University of Washington Seattle; University of Oxford; University of Oxford	Stephens, M (corresponding author), Univ Washington, Dept Stat, Box 354322, Seattle, WA 98195 USA.							Hull J, 2001, AM J HUM GENET, V69, P413, DOI 10.1086/321291; STEHENS M, 2001, AM J HUM GENET, V68, P978; Zhang SL, 2001, AM J HUM GENET, V69, P906, DOI 10.1086/323622	3	23	25	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					912	914		10.1086/323623	http://dx.doi.org/10.1086/323623			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP		Bronze			2022-12-18	WOS:000171008200028
J	Sengul, H; Weeks, DE; Feingold, E				Sengul, H; Weeks, DE; Feingold, E			A survey of affected-sibship statistics for nonparametric linkage analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALLELE-SHARING STATISTICS; PEDIGREE ANALYSIS; NUCLEAR FAMILIES; COMPLEX TRAITS; TESTS; STRATEGIES; DISEASE; SCORES	We have compared the power of a large number of allele-sharing statistics for "nonparametric" linkage analysis with affected sibships. Our rationale was that there is an extensive literature comparing statistics for sibling pairs but that there has not been much guidance on how to choose statistics for studies that include sibships of various sizes. We concentrated on statistics that can be described as assigning scores to each identity-by-descent-sharing configuration that a pedigree might take on (Whittemore and Halpern 1994). We considered sibships of sizes two through five, 27 different genetic models, and varying recombination fractions between the marker and the trait locus. We tried to identify statistics whose power was robust over a wide variety of models. We found that the statistic that is probably used most often in such studies-S-all-performs quite well, although it is not necessarily the best. We also found several other statistics (such as the R criterion, S-robdom, and the Sobel-and-Lange statistic C) that perform well in most situations, a few (such as S-#geno and the Feingold-and-Siegmund version of S-pairs) that have high power only in very special situations, and a few (such as S-#geno, the N criterion, and the Sobel-and-Lange statistic B) that seem to have low power for the majority of the trait models. For the most part, the same statistics performed well for all sibship sizes. We also used our results to give some suggestions regarding how to weight sibships of different sizes, in forming an overall statistic.	Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sengul, H (corresponding author), Univ Pittsburgh, Dept Human Genet, Crabtree Hall A300,130 DeSoto St, Pittsburgh, PA 15261 USA.		Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228; Feingold, Eleanor/0000-0003-2898-6484	NATIONAL INSTITUTE ON AGING [R01AG016989] Funding Source: NIH RePORTER; NIA NIH HHS [AG16989] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abel L, 1998, GENET EPIDEMIOL, V15, P371, DOI 10.1002/(SICI)1098-2272(1998)15:4<371::AID-GEPI4>3.0.CO;2-5; Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Davis S, 1997, AM J HUM GENET, V61, P1431, DOI 10.1086/301635; Davis S, 1997, GENETIC MAPPING OF DISEASE GENES, P189; Feingold E, 1997, AM J HUM GENET, V60, P965; Feingold E, 2000, GENET EPIDEMIOL, V19, pS92, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI14>3.0.CO;2-4; GREEN JR, 1977, TISSUE ANTIGENS, V9, P31; Greenwood CMT, 1999, AM J HUM GENET, V64, P1248, DOI 10.1086/302315; Holmans P, 2001, GENET EPIDEMIOL, V20, P44, DOI 10.1002/1098-2272(200101)20:1<44::AID-GEPI5>3.0.CO;2-E; KNAPP M, 1994, HUM HERED, V44, P37, DOI 10.1159/000154187; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; McPeek MS, 1999, GENET EPIDEMIOL, V16, P225, DOI 10.1002/(SICI)1098-2272(1999)16:3<225::AID-GEPI1>3.0.CO;2-#; Ott J, 1999, ANAL HUMAN GENETIC L; RISCH N, 1990, AM J HUM GENET, V46, P222; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Sham PC, 2000, AM J HUM GENET, V66, P1661, DOI 10.1086/302888; Sham PC, 1997, ANN HUM GENET, V61, P61; Sobel E, 1996, AM J HUM GENET, V58, P1323; SUAREZ BK, 1979, CLIN GENET, V15, P126; Teng J, 1997, AM J HUM GENET, V60, P979; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Whittemore AS, 1998, AM J HUM GENET, V62, P1228, DOI 10.1086/301820	24	23	23	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					179	190		10.1086/321264	http://dx.doi.org/10.1086/321264			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11404816	Green Published, Bronze			2022-12-18	WOS:000170108100017
J	Schaid, DJ; McDonnell, SK; Thibodeau, SN				Schaid, DJ; McDonnell, SK; Thibodeau, SN			Regression models for linkage heterogeneity applied to familial prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCUS	Linkage heterogeneity frequently occurs for complex genetic diseases, and statistical methods must account for it to avoid severe loss in power to discover susceptibility genes. A common method to allow for only a fraction of linked pedigrees is to fit a mixture likelihood and then to test for linkage homogeneity, given linkage (admixture test), or to test for linkage while allowing for heterogeneity, using the heterogeneity LOD (HLOD) score. Furthermore, features of the families, such as mean age at diagnosis, may help to discriminate families that demonstrate linkage from those that do not. Pedigree features are often used to create homogeneous subsets, and LOD or HLOD scores are then computed within the subsets. However, this practice introduces several problems, including reduced power (which results from multiple testing and small sample sizes within subsets) and difficulty in interpretation of results. To address some of these limitations, we present a regression-based extension of the mixture likelihood for which pedigree features are used as covariates that determine the probability that a family is the linked type. Some advantages of this approach are that multiple covariates can be used (including quantitative covariates), covariates can be adjusted for each other, and interactions among covariates can be assessed. This new regression method is applied to linkage data for familial prostate cancer and provides new insights into the understanding of prostate cancer linkage heterogeneity.	Mayo Clin & Mayo Fdn, Biostat Sect, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Expt Pathol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Schaid, DJ (corresponding author), Mayo Clin & Mayo Fdn, Biostat Sect, Dept Hlth Sci Res, Harwick 775, Rochester, MN 55905 USA.			McDonnell, Shannon/0000-0001-6201-369X	NCI NIH HHS [P30 CA015083, CA72818, N01 CA015083, R01 CA072818] Funding Source: Medline; NIDCR NIH HHS [DE13276] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072818, P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013276] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Bhat A, 1999, HUM HERED, V49, P229, DOI 10.1159/000022879; CHIANO MN, 1995, ANN HUM GENET, V59, P83, DOI 10.1111/j.1469-1809.1995.tb01607.x; Huang J., 2000, Genetic Epidemiology, V19, P253; Janssen B, 1997, HUM HERED, V47, P223, DOI 10.1159/000154416; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Leal SM, 2000, AM J HUM GENET, V66, P567, DOI 10.1086/302748; Logue Mark, 2000, Genetic Epidemiology, V19, P259; Ott J, 1999, ANAL HUMAN GENETIC L; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807	13	23	23	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1189	1196		10.1086/320102	http://dx.doi.org/10.1086/320102			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11309684	Bronze, Green Published			2022-12-18	WOS:000168171200012
J	Lichter-Konecki, U; Broman, KW; Blau, EB; Konecki, DS				Lichter-Konecki, U; Broman, KW; Blau, EB; Konecki, DS			Genetic and physical mapping of the locus for autosomal dominant renal Fanconi syndrome, on chromosome 15q15.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; FAMILY	Autosomal dominant renal Fanconi syndrome is a genetic model for the study of proximal renal tubular transport pathology. We were able to map the locus for this disease to human chromosome 15q15.3 by genotyping a central Wisconsin pedigree with 10 affected individuals. After a whole-genome scan with highly polymorphic simple sequence repeat markers, a maximum LOD score of 3.01 was calculated for marker D15SG53 on chromosome 15q15.3. Linkage and haplotype analysis for an additional 24 markers flanking D15SG53 narrowed the interval to similar to3 cM, with the two highest single-point LOD scores observed being 4.44 and 4.68 (for D15S182 and D15S537, respectively). Subsequently, a complete bacterial artificial chromosome contig was constructed, from the High Throughput Genomic Sequence Database, for the region bounded by D15S182 and D15S143. The identification of the gene and gene product altered in autosomal dominant renal Fanconi syndrome will allow the study of the physiology of proximal renaI tubular transport.	Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA; Marshfield Clin, Div Pediat Nephrol, Marshfield, WI USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA	Marshfield Clinic; Johns Hopkins University	Lichter-Konecki, U (corresponding author), NHGRI, Med Genet Branch, Bldg 10,Room 3D-55,10 Ctr Dr,MSC 1852, Bethesda, MD 20892 USA.			Broman, Karl/0000-0002-4914-6671				ALLAMAND V, 1995, AM J HUM GENET, V56, P1417; Allamand V, 1997, HUM HERED, V47, P237, DOI 10.1159/000154418; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Foreman JW, 1994, PEDIAT NEPHROLOGY, P537; FOUGEROUSSE F, 1994, HUM MOL GENET, V3, P285, DOI 10.1093/hmg/3.2.285; ILLIG R, 1961, HELV PAEDIATR ACTA, V16, P622; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; NIEMANN N, 1968, ARCH FR PEDIATR, V25, P43; TOLAYMAT A, 1992, J AM SOC NEPHROL, V2, P1310; WEN SF, 1989, AM J KIDNEY DIS, V13, P240, DOI 10.1016/S0272-6386(89)80059-9; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0; Yuan B, 1997, AM J HUM GENET, V60, P459	12	23	23	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					264	268		10.1086/316923	http://dx.doi.org/10.1086/316923			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11090339	Green Published, Bronze			2022-12-18	WOS:000166399900029
J	Salam, AA; Hafner, FM; Linder, TE; Spillmann, T; Schinzel, AA; Leal, SM				Salam, AA; Hafner, FM; Linder, TE; Spillmann, T; Schinzel, AA; Leal, SM			A novel locus (DFNA23) for prelingual autosomal dominant nonsyndromic heaving loss maps to 14q21-q22 in a Swiss German kindred	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN; CLONING; CELLS	DFNA23, a novel locus for autosomal dominant nonsyndromic hearing loss, was identified in a Swiss German kindred. DNA samples were obtained from 22 family members in three generations: 10 with hearing impairment caused by the DFNA23 locus, 8 unaffected offspring, and 4 spouses of hearing-impaired pedigree members. In this kindred, the hearing-impaired family members have prelingual bilateral symmetrical hearing loss. All audiograms from hearing-impaired individuals displayed sloping curves, with hearing ability ranging from normal hearing to mild hearing loss in low frequencies, normal hearing to profound hearing loss in mid frequencies, and moderate to profound hearing loss in high frequencies. A conductive component existed for 50% of the hearing-impaired family members. The majority of the hearing-impaired family members did not display progression of hearing loss. The DFNA23 locus maps to 14q21-q22. Linkage analysis was carried out under a fully penetrant autosomal dominant mode of inheritance with no phenocopies. A maximum multipoint LOD score of 5.1 occurred at Marker D14S290. The 3.0-LOD unit support interval is 9.4 cM and ranged from marker D14S380 to marker D14S104G.	Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, CH-8091 Zurich, Switzerland; Univ Zurich, Inst Med Genet, Zurich, Switzerland	Rockefeller University; University of Zurich; University Zurich Hospital; University of Zurich	Leal, SM (corresponding author), Rockefeller Univ, Lab Stat Genet, 1230 York Ave,Box 192, New York, NY 10021 USA.		Linder, Thomas/ABH-6961-2020		NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003594, R29DC003594] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00008] Funding Source: Medline; NIDCD NIH HHS [R01 DC003594, DC03594] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Heller S, 1998, NAT MED, V4, P560, DOI 10.1038/nm0598-560; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; PRINT CG, 1994, GENE, V144, P221, DOI 10.1016/0378-1119(94)90381-6; Quan TH, 1999, J BIOL CHEM, V274, P28566, DOI 10.1074/jbc.274.40.28566; Sobel E, 1996, AM J HUM GENET, V58, P1323; VanCamp G, 1997, AM J HUM GENET, V60, P758; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Yuan B, 1997, AM J HUM GENET, V60, P459; ZINE EA, 1993, NEUROREPORT, V4, P1350, DOI 10.1097/00001756-199309150-00016	12	23	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1984	1988		10.1086/302931	http://dx.doi.org/10.1086/302931			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10777717	Green Published, Bronze			2022-12-18	WOS:000088373800028
J	Sham, PC; Lin, MW; Zhao, JH; Curtis, D				Sham, PC; Lin, MW; Zhao, JH; Curtis, D			Power comparison of parametric and nonparametric linkage tests in small pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOD SCORE ANALYSIS; INFERRING MODE; INHERITANCE; SIMULATION; PENETRANCE; LOCI	When the mode of inheritance of a disease is unknown, the LOD-score method of linkage analysis must take into account uncertainties in model parameters. We have previously proposed a parametric linkage test called "MFLOD," which does not require specification of disease model parameters. In the present study, we introduce two new model-free parametric linkage tests, known as "MLOD" and "MALOD." These tests are defined, respectively, as the LOD score and the admixture LOD score, maximized (subject to the same constraints as MFLOD) over disease-model parameters. We compared the power of these three parametric linkage tests and that of two nonparametric linkage tests, NPLall, and NPLpairs, which are implemented in GENEHUNTER. With the use of small pedigrees and a fully informative marker, we found the powers of MLOD, NPLall, and NPLpairs, to be almost equivalent to each other and not far below that of a LOD-score analysis performed under the assumption the correct genetic parameters. Thus, linkage analysis is not much hindered by uncertain mode of inheritance. The results also suggest that both parametric and nonparametric methods are suitable for linkage analysis of complex disorders in small pedigrees. However, whether these results apply to large pedigrees remains to be answered.	Inst Psychiat, Dept Psychiat, London SE5 8AF, England; Inst Psychiat, Dept Biostat & Comp, London SE5 8AF, England; Royal London Hosp, Dept Adult Psychiat, London E1 1BB, England	University of London; King's College London; University of London; King's College London; Barts Health NHS Trust; Royal London Hospital	Sham, PC (corresponding author), Inst Psychiat, Dept Psychiat, De Crespigny Pk,Denmark Hill, London SE5 8AF, England.		Curtis, David/HGB-3921-2022	Curtis, David/0000-0002-4089-9183	NEI NIH HHS [EY12562] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; CURTIS D, 1995, AM J HUM GENET, V57, P703; Davis S, 1996, AM J HUM GENET, V58, P867; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 1997, AM J HUM GENET, V60, P217; Hodge SE, 1998, AM J MED GENET, V81, P66, DOI 10.1002/(SICI)1096-8628(19980207)81:1<66::AID-AJMG13>3.3.CO;2-V; HOLMANS P, 1993, AM J HUM GENET, V52, P362; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; MACLEAN CJ, 1993, AM J HUM GENET, V53, P353; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Rice JP, 1995, GENET EPIDEMIOL, V12, P659, DOI 10.1002/gepi.1370120623; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1984, AM J HUM GENET, V36, P363; SANDKUIJL LA, 1989, MULTIPOINT MAPPING L, V6; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; WEEKS DE, 1988, AM J HUM GENET, V42, P315	23	23	23	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1661	1668		10.1086/302888	http://dx.doi.org/10.1086/302888			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762550	Bronze, Green Published			2022-12-18	WOS:000088373700019
J	Graw, SL; Sample, T; Bleskan, J; Sujansky, E; Patterson, D				Graw, SL; Sample, T; Bleskan, J; Sujansky, E; Patterson, D			Cloning, sequencing, and analysis of Inv8 chromosome breakpoints associated with recombinant 8 syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INVERTED TANDEM DUPLICATION; GLOBIN GENE-CLUSTER; DISTAL 8P; MENTAL-RETARDATION; SHORT ARM; INVERSION DUPLICATION; INSITU HYBRIDIZATION; ALPHA THALASSEMIA; DELETION; TRANSLOCATION	Rec8 syndrome (also known as "recombinant 8 syndrome" and "San Luis Valley syndrome") is a chromosomal disorder found in individuals of Hispanic descent with ancestry from the San Luis Valley of southern Colorado and northern New Mexico. Affected individuals typically have mental retardation, congenital heart defects, seizures, a characteristic facial appearance, and other manifestations. The recombinant chromosome is rec(8)dup(8q) inv(8)(p23.1q22.1), and is derived from a parental pericentric inversion, inv(8)(p23.1q22.1). Here we report on the cloning, sequencing, and characterization of the 8p23.1 and 8q22 breakpoints from the inversion 8 chromosome associated with Rec8 syndrome. Analysis of the breakpoint regions indicates that they are highly repetitive. Of 6 kb surrounding the 8p23.1 breakpoint, 75% consists of repetitive gene family members-including Alu, LINE, and LTR elements -and the inversion took place in a small single-copy region Banked by repetitive elements. Analysis of 3.7 kb surrounding the 8q22 breakpoint region reveals that it is 99% repetitive and contains multiple LTR elements, and that the 8q inversion site is within one of the LTR elements.	Eleanor Roosevelt Inst Canc Res, Denver, CO 80206 USA; Childrens Hosp, Denver, CO 80218 USA	Children's Hospital Colorado	Graw, SL (corresponding author), Eleanor Roosevelt Inst Canc Res, 1899 Gaylord St, Denver, CO 80206 USA.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARBER JCK, 1994, AM J MED GENET, V50, P296, DOI 10.1002/ajmg.1320500315; Barber JCK, 1998, J MED GENET, V35, P491, DOI 10.1136/jmg.35.6.491; BARSH GS, 1983, NUCLEIC ACIDS RES, V11, P3939, DOI 10.1093/nar/11.12.3939; BLENNOW E, 1990, J MED GENET, V27, P327, DOI 10.1136/jmg.27.5.327; BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; CALABRETTA B, 1982, NATURE, V296, P219, DOI 10.1038/296219a0; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; DILL FJ, 1987, CLIN GENET, V32, P109; DRABKIN HA, 1985, P NATL ACAD SCI USA, V82, P464, DOI 10.1073/pnas.82.2.464; ENGELEN JJM, 1994, CLIN GENET, V45, P203; FAGAN K, 1988, HUM GENET, V79, P365; FELDMAN GL, 1993, AM J MED GENET, V47, P482, DOI 10.1002/ajmg.1320470410; Floridia G, 1996, AM J HUM GENET, V58, P785; FRYNS JP, 1989, ANN GENET-PARIS, V32, P171; FUJIMOTO A, 1975, HUMANGENETIK, V27, P67; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; GUO WJ, 1995, AM J MED GENET, V58, P230, DOI 10.1002/ajmg.1320580307; HENDERSON KG, 1992, AM J MED GENET, V44, P615, DOI 10.1002/ajmg.1320440517; HENTHORN PS, 1986, P NATL ACAD SCI USA, V83, P5194, DOI 10.1073/pnas.83.14.5194; HOBBS HH, 1986, J BIOL CHEM, V261, P3114; HUANG LS, 1989, J BIOL CHEM, V264, P11394; HUTCHINSON R, 1992, J MED GENET, V29, P407, DOI 10.1136/jmg.29.6.407; JONES C, 1981, SOMAT CELL GENET, V7, P399, DOI 10.1007/BF01542985; Kurahashi H, 1998, HUM GENET, V103, P189, DOI 10.1007/s004390050805; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MINELLI A, 1993, HUM GENET, V92, P391, DOI 10.1007/BF01247342; MITCHELL JJ, 1994, AM J MED GENET, V49, P384, DOI 10.1002/ajmg.1320490406; MOORE EE, 1977, AM J HUM GENET, V29, P389; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; NEVIN NC, 1990, J MED GENET, V27, P135, DOI 10.1136/jmg.27.2.135; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; OHASHI H, 1994, AM J HUM GENET, V55, P1202; OTTOLENGHI S, 1974, NATURE, V251, P389, DOI 10.1038/251389a0; PATTERSON D, 1993, GENOMICS, V15, P177, DOI 10.1006/geno.1993.1026; PECILE V, 1990, CLIN GENET, V37, P271; PETTENATI MJ, 1992, HUM GENET, V89, P602; PIERCE JC, 1992, METHOD ENZYMOL, V216, P549; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; SHECHTER I, 1994, GENOMICS, V20, P116, DOI 10.1006/geno.1994.1135; SMALL MF, 1985, AM J PRIMATOL, V9, P63, DOI 10.1002/ajp.1350090107; SMITH KA, 1987, IMMUNOL TODAY, V8, P8; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P103, DOI 10.1073/pnas.87.1.103; SUJANSKY E, 1993, AM J MED GENET, V47, P512, DOI 10.1002/ajmg.1320470415; TAYLOR JM, 1974, NATURE, V251, P392, DOI 10.1038/251392a0; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; WEINBERG J, 1992, CHROMOSOMA, V101, P265; Wu BL, 1996, AM J MED GENET, V62, P77, DOI 10.1002/(SICI)1096-8628(19960301)62:1<77::AID-AJMG16>3.0.CO;2-S	49	23	26	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1138	1144		10.1086/302821	http://dx.doi.org/10.1086/302821			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712224	Bronze, Green Published			2022-12-18	WOS:000088373200032
J	Collod-Beroud, G; Lackmy-Port-Lys, M; Jondeau, G; Mathieu, M; Maingourd, Y; Coulon, M; Guillotel, M; Junien, C; Boileau, C				Collod-Beroud, G; Lackmy-Port-Lys, M; Jondeau, G; Mathieu, M; Maingourd, Y; Coulon, M; Guillotel, M; Junien, C; Boileau, C			Demonstration of the recurrence of Marfan-like skeletal and cardiovascular manifestations due to germline mosaicism for an FBN1 mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							FIBRILLIN GENE; ECTOPIA LENTIS; DATABASE; SOFTWARE; ABNORMALITIES; EDITION; CALCIUM		Hop Necker Enfants Malad, INSERM U383, Clin Maurice Lamy, F-75743 Paris 15, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Boileau, C (corresponding author), Hop Necker Enfants Malad, INSERM U383, Clin Maurice Lamy, 149-161 Rue Svres, F-75743 Paris 15, France.		COLLOD-BEROUD, Gwenaëlle/A-8342-2008; boileau, catherine/M-4482-2017	COLLOD-BEROUD, Gwenaëlle/0000-0003-4098-6161; boileau, catherine/0000-0002-0371-7539				BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; Biery NJ, 1999, GENOMICS, V56, P70, DOI 10.1006/geno.1998.5697; Collod G, 1996, NUCLEIC ACIDS RES, V24, P137, DOI 10.1093/nar/24.1.137; COLLOD G, 1994, NAT GENET, V8, P264, DOI 10.1038/ng1194-264; Collod-Beroud G, 1998, NUCLEIC ACIDS RES, V26, P229, DOI 10.1093/nar/26.1.229; Collod-Beroud G, 1997, NUCLEIC ACIDS RES, V25, P147, DOI 10.1093/nar/25.1.147; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; GODFREY M, 1990, AM J HUM GENET, V46, P652; HAYWARD C, 1994, MOL CELL PROBE, V8, P325, DOI 10.1006/mcpr.1994.1045; HENRY I, 1984, AM J HUM GENET, V36, P760; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; LONNQVIST L, 1994, GENOMICS, V19, P573, DOI 10.1006/geno.1994.1110; MAGENIS RE, 1991, GENOMICS, V11, P346, DOI 10.1016/0888-7543(91)90142-2; MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589; Montgomery RA, 1998, AM J HUM GENET, V63, P1703, DOI 10.1086/302144; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; Rantamaki T, 1999, AM J HUM GENET, V64, P993, DOI 10.1086/302309; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sood S, 1996, NAT GENET, V12, P209, DOI 10.1038/ng0296-209; 1989, AM J MED GENET, V32, P239	26	23	24	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					917	921		10.1086/302545	http://dx.doi.org/10.1086/302545			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441597	Green Published, Bronze			2022-12-18	WOS:000082426400036
J	Dorum, A; Heimdal, K; Hovig, E; Inganas, M; Moller, P				Dorum, A; Heimdal, K; Hovig, E; Inganas, M; Moller, P			Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASHKENAZI JEWS; COMMON BRCA1; MUTATIONS; FAMILIES; RISK; FREQUENCY	For genetic counseling and predictive testing in families with inherited breast-ovarian cancer, penetrances and expressions of the underlying mutations should be known. We have previously reported two BRCA1 founder mutations in the Norwegian population. Index cases for the present study were found two different ways: through a series of consecutive ovarian cancers (n = 16) and through our family cancer clinic (n = 14). Altogether, 20 of the patients had BRCA1 1675delA, and 10 had 1135insA. Their relatives were described with respect to absence/presence of breast and/or ovarian cancer. Of 133 living female relatives, 83 (62%) were tested for the presence of a mutation. No difference, in penetrance and expression, between the two mutations were found, whereas differences according to method of ascertainment were seen. The overall findings were that disease started to occur at age 30 years and that by age 50 years 48% of the mutation-carrying women had experienced breast and/or ovarian cancer. More ovarian cancers than breast cancers were recorded. Both penetrance and expression (breast cancer vs. ovarian cancer) were different from those in reports of the Ashkenazi founder mutations. Whether the reported differences reflect true differences and/or methodological problems is discussed. An observed excess of mutation carriers could not be accounted for by methodological problems; possible explanations were a "true" low penetrance or preferential segregation.	Norwegian Radium Hosp, Unit Med Genet, N-0310 Oslo, Norway; Norwegian Radium Hosp, Dept Tumor Biol, N-0310 Oslo, Norway; Pharmacia Biotech, Uppsala, Sweden	University of Oslo; University of Oslo; Pfizer; Pharmacia Corporation	Moller, P (corresponding author), Norwegian Radium Hosp, Unit Med Genet, N-0310 Oslo, Norway.		Hovig, Eivind/H-2474-2011; Heimdal, Ketil Riddervold/H-3038-2019	Hovig, Eivind/0000-0002-9103-1077; Heimdal, Ketil Riddervold/0000-0002-8911-3508				Anderson TI, 1996, AM J HUM GENET, V59, P486; Collett D., 2014, MODELLING SURVIVAL D; Dorum A, 1997, EUR J CANCER, V33, P2390, DOI 10.1016/S0959-8049(97)00328-6; EASTON DF, 1995, AM J HUM GENET, V56, P265; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Katsouyanni K, 1997, EPIDEMIOLOGY, V8, P592, DOI 10.1097/00001648-199709000-00019; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Liede A, 1998, AM J MED GENET, V75, P55, DOI 10.1002/(SICI)1096-8628(19980106)75:1<55::AID-AJMG12>3.0.CO;2-R; Moller P, 1998, BREAST, V7, P55, DOI 10.1016/S0960-9776(98)90053-4; NAROD SA, 1995, AM J HUM GENET, V56, P254; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001	12	23	23	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					671	679		10.1086/302530	http://dx.doi.org/10.1086/302530			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441573	Green Published, Bronze			2022-12-18	WOS:000082426400011
J	Khaliq, S; Hameed, A; Ismail, M; Mehdi, SQ; Bessant, DAR; Payne, AM; Bhattacharya, SS				Khaliq, S; Hameed, A; Ismail, M; Mehdi, SQ; Bessant, DAR; Payne, AM; Bhattacharya, SS			Refinement of the locus for autosomal recessive retinitis pigmentosa (RP25) linked to chromosome 6q in a family of Pakistani origin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ALPHA-SUBUNIT; GENE; MUTATION; PHOSPHODIESTERASE; PROTEIN; TULP1; MAPS; RP12		UCL, Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England; Dr AQ Khan Res Labs, Biomed & Genet Engn Div, Islamabad, Pakistan	University of London; University College London	Bhattacharya, SS (corresponding author), UCL, Inst Ophthalmol, Dept Mol Genet, Bath St, London EC1V 9EL, England.	smbcssb@ucl.ac.uk	Payne, annette/F-8877-2013; Mehdi, Syed Qasim/L-2385-2015; Bhattacharya, Shom/N-2926-2016	Payne, annette/0000-0002-2009-0141; Bhattacharya, Shom/0000-0002-1601-6344				Banerjee P, 1998, NAT GENET, V18, P177, DOI 10.1038/ng0298-177; Bayes M, 1998, J MED GENET, V35, P141, DOI 10.1136/jmg.35.2.141; BIRD AC, 1995, AM J OPHTHALMOL, V119, P543, DOI 10.1016/S0002-9394(14)70212-0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; Finckh U, 1998, GENOMICS, V48, P341, DOI 10.1006/geno.1997.5194; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; JAY M, 1982, BRIT J OPHTHALMOL, V66, P405, DOI 10.1136/bjo.66.7.405; LEUTELT J, 1995, CLIN GENET, V47, P122; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Ruiz A, 1998, AM J HUM GENET, V62, P1452, DOI 10.1086/301866; VANSOEST S, 1994, GENOMICS, V22, P499, DOI 10.1006/geno.1994.1422; vanSoest S, 1996, CYTOGENET CELL GENET, V73, P81, DOI 10.1159/000134313	18	23	23	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					571	574		10.1086/302493	http://dx.doi.org/10.1086/302493			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417302	Green Published, Bronze			2022-12-18	WOS:000081836900035
J	Bergstrom, TF; Engkvist, H; Erlandsson, R; Josefsson, A; Mack, SJ; Erlich, HA; Gyllensten, U				Bergstrom, TF; Engkvist, H; Erlandsson, R; Josefsson, A; Mack, SJ; Erlich, HA; Gyllensten, U			Tracing the origin of HLA-DRB1 alleles by microsatellite polymorphism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II HAPLOTYPES; HLA SYSTEM; EVOLUTION; MHC; MUTATION; NOMENCLATURE; POPULATIONS; CHIMPANZEES; INSTABILITY	We analyzed the origin of allelic diversity at the class II HLA-DRB1 locus, using a complex microsatellite located in intron 2, close to the polymorphic second exon. A phylogenetic analysis of human, gorilla, and chimpanzee DRB1 sequences indicated that the structure of the microsatellite has evolved, primarily by point mutations, from a putative ancestral (GT)(x)(GA)(y)-complex-dinucleotide repeat. In all contemporary DRB1 allelic lineages, with the exception of the human *04 and the gorilla *08 lineages, the (GA)(y) repeat is interrupted, often by a G-->C substitution. In general, the length of the 3' (GA)(y) repeat correlates with the allelic lineage and thus evolves more slowly than a middle (GA)(z) repeat, whose length correlates with specific alleles within the lineage. Comparison of the microsatellite sequence from 30 human DRB1 alleles showed the longer 5' (GT)(x) to be more variable than the shorter middle (GA)(z) and 3' (GA)(y) repeats. Analysis of multiple samples with the same exon sequence, derived from different continents, showed that the 5' (GT)(x) repeat evolves more rapidly than the middle (GA)(z) and the 3' (GA)(y) repeats, which is consistent with findings of a higher mutation rate for longer tracts. The microsatellite-repeat-length variation was used to trace the origin of new DRB1 alleles, such as the new *08 alleles found in the Cayapa people of Ecuador and the Ticuna people of Brazil.	Univ Uppsala, Ctr Biomed, Dept Genet & Pathol, Unit Med Genet,Beijer Lab, S-75123 Uppsala, Sweden; Roche Mol Syst, Dept Human Genet, Alameda, CA USA; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Uppsala University; Roche Holding; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Gyllensten, U (corresponding author), Univ Uppsala, Ctr Biomed, Dept Genet & Pathol, Unit Med Genet,Beijer Lab, Box 589, S-75123 Uppsala, Sweden.		Bergström, Tomas/B-4681-2017	Bergström, Tomas/0000-0002-7480-2669; Mack, Steven/0000-0001-9820-9547				AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; Ayala FJ, 1996, MOL PHYLOGENET EVOL, V5, P188, DOI 10.1006/mpev.1996.0013; Bergstrom TF, 1998, NAT GENET, V18, P237, DOI 10.1038/ng0398-237; BLANQUERMAUMONT A, 1995, J MOL EVOL, V41, P492, DOI 10.1007/BF00160321; Bodmer JG, 1997, TISSUE ANTIGENS, V49, P297, DOI 10.1111/j.1399-0039.1997.tb02759.x; CrouauRoy B, 1996, HUM MOL GENET, V5, P1131, DOI 10.1093/hmg/5.8.1131; Epplen C, 1997, HUM GENET, V99, P399, DOI 10.1007/s004390050379; GARZA JC, 1995, MOL BIOL EVOL, V12, P594; GYLLENSTEN U, 1991, J IMMUNOL, V146, P4368; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jin L, 1996, P NATL ACAD SCI USA, V93, P15285, DOI 10.1073/pnas.93.26.15285; JUKES T H, 1969, P21; KAPPES D, 1988, ANNU REV BIOCHEM, V57, P991, DOI 10.1146/annurev.bi.57.070188.005015; KLEIN J, 1986, CRC CR REV IMMUNOL, V6, P295; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Macaubas C, 1997, GENOME RES, V7, P635, DOI 10.1101/gr.7.6.635; Mack SJ, 1998, TISSUE ANTIGENS, V51, P41, DOI 10.1111/j.1399-0039.1998.tb02945.x; Marsh SGE, 1997, TISSUE ANTIGENS, V50, P207, DOI 10.1111/j.1399-0039.1997.tb02862.x; MAYER WE, 1992, IMMUNOGENETICS, V37, P12; Petes TD, 1997, GENETICS, V146, P491; SLIERENDREGT BL, 1993, TISSUE ANTIGENS, V42, P55, DOI 10.1111/j.1399-0039.1993.tb02167.x; Smith AG, 1996, TISSUE ANTIGENS, V48, P118, DOI 10.1111/j.1399-0039.1996.tb02616.x; Sneath PHA., 1973, NUMERICAL TAXONOMY; TITUSTRACHTENBERG EA, 1994, AM J HUM GENET, V55, P160; TROWSDALE J, 1995, IMMUNOGENETICS, V41, P1, DOI 10.1007/BF00188427; Wierdl M, 1997, GENETICS, V146, P769; WILLIAMS TM, 1994, IMMUNOGENETICS, V40, P314; ZHANG L, 1994, NAT GENET, V7, P531, DOI 10.1038/ng0894-531	30	23	23	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1709	1718		10.1086/302401	http://dx.doi.org/10.1086/302401			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330359	Bronze, Green Published			2022-12-18	WOS:000080696200024
J	de Bernabe, DBV; Jimenez, FJ; Aquaron, R; de Cordoba, SR				de Bernabe, DBV; Jimenez, FJ; Aquaron, R; de Cordoba, SR			Analysis of alkaptonuria (AKU) mutations and polymorphisms reveals that the CCC sequence motif is a mutational hot spot in the homogentisate 1,2 dioxygenase gene (HGO)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								We recently showed that alkaptonuria (AKU) is caused by loss-of-function mutations in the homogentisate 1,2 dioxygenase gene (HGO). Herein we describe haplotype and mutational analyses of HGO in seven new AKU pedigrees. These analyses identified two novel single-nucleotide polymorphisms (INV4 + 31A --> G and INV11 + 18A-->G) and six novel AKU mutations (INV1-1G --> A, W60G, Y62C, A122D, P230T; and D291E), which further illustrates the remarkable allelic heterogeneity found in AKU. Reexamination of all 29 mutations and polymorphisms thus far described in HGO shows that these nucleotide changes are not randomly distributed; the CCC sequence motif and its inverted complement, GGG, are preferentially mutated. These analyses also demonstrated that the nucleotide substitutions in HGO do not involve CpG dinucleotides, which illustrates important differences between HGO and other genes for the occurrence of mutation at specific short-sequence motifs. Because the CCC sequence motifs comprise a significant proportion (34.5%) of all mutated bases that have been observed in HGO, we conclude that the CCC triplet is a mutational hot spot in HGO.	CSIC, Ctr Invest Biol, Dept Inmunol, E-28006 Madrid, Spain; Fdn Jimenez Diaz, Unidad Patol Mol, E-28040 Madrid, Spain; Fdn Jimenez Diaz, Unidad Invest, E-28040 Madrid, Spain; Ctr Hosp Reg & Univ Marseille, Hop Enfants La Timone, Biol Lab, Marseille, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	de Cordoba, SR (corresponding author), CSIC, Ctr Invest Biol, Dept Inmunol, Velazquez 144, E-28006 Madrid, Spain.		de Cordoba, Santiago Rodriguez/K-6727-2014	de Cordoba, Santiago Rodriguez/0000-0001-6401-1874				BURNS PA, 1988, CANCER RES, V48, P4455; COOPER DN, 1990, HUM GENET, V85, P55; Cooper DN, 1995, METABOLIC MOL BASES, P259; de Bernabe DBV, 1998, AM J HUM GENET, V62, P776, DOI 10.1086/301805; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Fleiss JL, 1981, STAT METHODS RATES P; Garrod AE, 1908, LANCET, V2, P73; Garrod AE, 1902, LANCET, V2, P1616; Gehrig A, 1997, CYTOGENET CELL GENET, V76, P14, DOI 10.1159/000134501; Granadino B, 1997, GENOMICS, V43, P115, DOI 10.1006/geno.1997.4805; Green NS, 1998, BIOESSAYS, V20, P227, DOI 10.1002/(SICI)1521-1878(199803)20:3<227::AID-BIES6>3.0.CO;2-O; Higashino K, 1998, CLIN GENET, V53, P228; KNOX WE, 1955, J BIOL CHEM, V216, P479; La Du BN, 1995, METABOLIC MOL BASES, P1371; LADU BN, 1958, J BIOL CHEM, V230, P251; REITSMA PH, 1993, THROMB HAEMOSTASIS, V69, P77; Smith DS, 1996, J IMMUNOL, V156, P2642	18	23	25	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1316	1322		10.1086/302376	http://dx.doi.org/10.1086/302376			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205262	Green Published, Bronze			2022-12-18	WOS:000080093000009
J	Selleck, SB				Selleck, SB			Overgrowth syndromes and the regulation of signaling complexes by proteoglycans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							HEPARAN-SULFATE; GROWTH-FACTOR; FIBROBLAST GROWTH; NERVOUS-SYSTEM; DROSOPHILA; GLYPICAN; PROTEIN; GENE; GLYCOSAMINOGLYCANS; DIFFERENTIATION		Univ Arizona, Dept Mol & Cellular Biol, Div Neurobiol, Tucson, AZ 85721 USA	University of Arizona	Selleck, SB (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Div Neurobiol, Tucson, AZ 85721 USA.	selleck@u.arizona.edu						Anderson KV, 1998, CELL, V95, P439, DOI 10.1016/S0092-8674(00)81610-4; AVIEZER D, 1994, P NATL ACAD SCI USA, V91, P12173, DOI 10.1073/pnas.91.25.12173; Binari RC, 1997, DEVELOPMENT, V124, P2623; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Duenas-Gonzalez A, 1998, J CELL BIOL, V141, P1407, DOI 10.1083/jcb.141.6.1407; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Lander AD, 1996, PERSPECT DEV NEUROBI, V3, P347; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; Moskaluk CA, 1996, BBA-REV CANCER, V1288, pM31, DOI 10.1016/S0304-419X(96)00033-9; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Nelson RM, 1995, ANNU REV CELL DEV BI, V11, P601, DOI 10.1146/annurev.cellbio.11.1.601; Neri G, 1998, AM J MED GENET, V79, P279, DOI 10.1002/(SICI)1096-8628(19981002)79:4<279::AID-AJMG9>3.0.CO;2-H; OLWIN BB, 1992, J CELL BIOL, V118, P631, DOI 10.1083/jcb.118.3.631; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; RAPRAEGER AC, 1995, CHEM BIOL, V2, P645, DOI 10.1016/1074-5521(95)90025-X; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Rosenberg RD, 1997, J CLIN INVEST, V100, pS67; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SANDERSON RD, 1994, J BIOL CHEM, V269, P13100; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Song HH, 1997, J BIOL CHEM, V272, P7574, DOI 10.1074/jbc.272.12.7574; ZIONCHECK TF, 1995, J BIOL CHEM, V270, P16871, DOI 10.1074/jbc.270.28.16871	30	23	25	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					372	377		10.1086/302266	http://dx.doi.org/10.1086/302266			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973275	Green Published, Bronze			2022-12-18	WOS:000078740600007
